<SEC-DOCUMENT>0001564590-22-011706.txt : 20220324
<SEC-HEADER>0001564590-22-011706.hdr.sgml : 20220324
<ACCEPTANCE-DATETIME>20220324172932
ACCESSION NUMBER:		0001564590-22-011706
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		72
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220324
DATE AS OF CHANGE:		20220324

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			89bio, Inc.
		CENTRAL INDEX KEY:			0001785173
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				831114349
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39122
		FILM NUMBER:		22767600

	BUSINESS ADDRESS:	
		STREET 1:		535 MISSION STREET
		STREET 2:		14TH FLOOR
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94105
		BUSINESS PHONE:		4155004614

	MAIL ADDRESS:	
		STREET 1:		535 MISSION STREET
		STREET 2:		14TH FLOOR
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94105
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>etnb-10k_20211231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml  version="1.0" encoding="utf-8"?>
<!-- DFIN ActiveDisclosure(SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-03-24T20:02:36.7902764+00:00 -->
<!-- Version            : 5.0.1.728 -->
<!-- Package ID         : 577eac3b881348d89343ad261f9a5e63 -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:etnb="http://www.89bio.com/20211231" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html" />
<title>
etnb-10k_20211231.htm
</title>
</head>
<!-- NG Converter v5.0.2.71 -->
<body><div style="display:none">
	<ix:header>
		<ix:hidden>
			<ix:nonNumeric id="F_000001" name="dei:AmendmentFlag" contextRef="C_0001785173_20210101_20211231">false</ix:nonNumeric>
			<ix:nonNumeric id="F_000004" name="dei:DocumentFiscalPeriodFocus" contextRef="C_0001785173_20210101_20211231">FY</ix:nonNumeric>
			<ix:nonNumeric id="F_000006" name="dei:EntityCentralIndexKey" contextRef="C_0001785173_20210101_20211231">0001785173</ix:nonNumeric>
			<ix:nonNumeric id="F_000010" name="dei:CurrentFiscalYearEndDate" contextRef="C_0001785173_20210101_20211231">--12-31</ix:nonNumeric>
			<ix:nonNumeric id="F_000317" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_0001785173_srtRangeAxis_srtMinimumMember_20210101_20211231">P3Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000299" name="dei:EntityIncorporationDateOfIncorporation" contextRef="C_0001785173_20210101_20211231">2019-06-30</ix:nonNumeric>
			<ix:nonNumeric id="F_000467" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231">P4Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000523" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="C_0001785173_srtTitleOfIndividualAxis_us-gaapShareBasedPaymentArrangementEmployeeMember_us-gaapAwardTypeAxis_etnbServiceBasedRSUsMember_20210201_20210228">P3Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000529" name="etnb:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary" contextRef="C_0001785173_srtTitleOfIndividualAxis_srtExecutiveOfficerMember_us-gaapAwardTypeAxis_etnbPerformanceRSUsMember_20210201_20210228">P1Y</ix:nonNumeric>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000066" name="us-gaap:CommitmentsAndContingencies" contextRef="C_0001785173_20211231" xsi:nil="true"></ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000067" name="us-gaap:CommitmentsAndContingencies" contextRef="C_0001785173_20201231" xsi:nil="true"></ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000068" name="us-gaap:PreferredStockValue" contextRef="C_0001785173_20211231" xsi:nil="true"></ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000069" name="us-gaap:PreferredStockValue" contextRef="C_0001785173_20201231" xsi:nil="true"></ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000151" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231" decimals="-3">0</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000152" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231" decimals="-3">0</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000153" name="etnb:IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231" decimals="-3">0</ix:nonFraction>
			<ix:nonNumeric id="F_000485" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001785173_srtRangeAxis_srtMinimumMember_20210101_20211231">P5Y6M</ix:nonNumeric>
			<ix:nonNumeric id="F_000486" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001785173_srtRangeAxis_srtMinimumMember_20200101_20201231">P4Y</ix:nonNumeric>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000489" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="C_0001785173_20210101_20211231" decimals="INF">0.869</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000490" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="C_0001785173_20200101_20201231" decimals="INF">0.864</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000493" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="C_0001785173_20210101_20211231" decimals="INF">0.007</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000494" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="C_0001785173_20200101_20201231" decimals="INF">0.002</ix:nonFraction>
			<ix:nonNumeric id="F_000487" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001785173_srtRangeAxis_srtMaximumMember_20210101_20211231">P6Y1M6D</ix:nonNumeric>
			<ix:nonNumeric id="F_000488" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001785173_srtRangeAxis_srtMaximumMember_20200101_20201231">P6Y1M6D</ix:nonNumeric>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000491" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="C_0001785173_20210101_20211231" decimals="INF">0.919</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000492" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="C_0001785173_20200101_20201231" decimals="INF">0.976</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000495" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="C_0001785173_20210101_20211231" decimals="INF">0.013</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000496" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="C_0001785173_20200101_20201231" decimals="INF">0.015</ix:nonFraction>
			<ix:nonNumeric id="F_000509" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20200101_20201231">P8Y7M6D</ix:nonNumeric>
			<ix:nonNumeric id="F_000510" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231">P8Y1M6D</ix:nonNumeric>
			<ix:nonNumeric id="F_000511" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231">P7Y3M18D</ix:nonNumeric>
		</ix:hidden>
		<ix:references>
			<link:schemaRef xlink:type="simple" xlink:href="etnb-20211231.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef>
		</ix:references>
		<ix:resources>
			<xbrli:context id="C_0001785173_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_iso4217USD">
				<xbrli:measure>iso4217:USD</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001785173_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_xbrlishares">
				<xbrli:measure>xbrli:shares</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001785173_20220301">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-03-01</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_iso4217USD_xbrlishares">
				<xbrli:divide>
					<xbrli:unitNumerator>
						<xbrli:measure>iso4217:USD</xbrli:measure>
					</xbrli:unitNumerator>
					<xbrli:unitDenominator>
						<xbrli:measure>xbrli:shares</xbrli:measure>
					</xbrli:unitDenominator>
				</xbrli:divide>
			</xbrli:unit>
			<xbrli:context id="C_0001785173_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementClassOfStockAxis_etnbConvertiblePreferredSharesMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">etnb:ConvertiblePreferredSharesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementClassOfStockAxis_etnbConvertiblePreferredSharesMember_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">etnb:ConvertiblePreferredSharesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200701_20200731">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">etnb:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-07-01</xbrli:startDate>
					<xbrli:endDate>2020-07-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200731">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">etnb:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-07-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200901_20200930">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">etnb:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-09-01</xbrli:startDate>
					<xbrli:endDate>2020-09-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200930">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">etnb:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-09-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210301_20210331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-03-01</xbrli:startDate>
					<xbrli:endDate>2021-03-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_xbrlipure">
				<xbrli:measure>xbrli:pure</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001785173_us-gaapTypeOfArrangementAxis_etnbSVBLeerinkLLCAndCantorFitzgeraldCoMember_20210331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:SVBLeerinkLLCAndCantorFitzgeraldCoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-03-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapTypeOfArrangementAxis_etnbSVBLeerinkLLCAndCantorFitzgeraldCoMember_20211001_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:SVBLeerinkLLCAndCantorFitzgeraldCoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-10-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_etnbSegment">
				<xbrli:measure>etnb:Segment</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001785173_srtRangeAxis_srtMinimumMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtRangeAxis_srtMaximumMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesShorttermDebtSecuritiesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMunicipalBondsMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtSecuritiesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCashEquivalentsMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesShorttermDebtSecuritiesMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMunicipalBondsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBillSecuritiesMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_etnbAgencyDiscountSecuritiesMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">etnb:AgencyDiscountSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCashEquivalentsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_20180501_20180531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-05-01</xbrli:startDate>
					<xbrli:endDate>2018-05-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_20180531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-05-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtStatementGeographicalAxis_etnbSanFranciscoOfficeMember_20191201_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">etnb:SanFranciscoOfficeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-12-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtStatementGeographicalAxis_etnbSanFranciscoOfficeMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">etnb:SanFranciscoOfficeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtStatementGeographicalAxis_etnbSanFranciscoOfficeMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">etnb:SanFranciscoOfficeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapBalanceSheetLocationAxis_etnbRestrictedCashAndOtherAssetsMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">etnb:RestrictedCashAndOtherAssetsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapBalanceSheetLocationAxis_etnbRestrictedCashAndOtherAssetsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">etnb:RestrictedCashAndOtherAssetsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20180401_20180430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TevaAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-04-01</xbrli:startDate>
					<xbrli:endDate>2018-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_etnbTevasGlycoPEGylatedFGF21ProgramMember_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20180401_20180430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TevaAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">etnb:TevasGlycoPEGylatedFGF21ProgramMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-04-01</xbrli:startDate>
					<xbrli:endDate>2018-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_etnbTevasDevelopmentProgramMember_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20180401_20180430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TevaAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">etnb:TevasDevelopmentProgramMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-04-01</xbrli:startDate>
					<xbrli:endDate>2018-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TevaAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TevaAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TevaAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermALoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20200430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TermALoanFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-04-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermBLoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20200430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TermBLoanFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-04-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20200401_20200430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-04-01</xbrli:startDate>
					<xbrli:endDate>2020-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20200430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-04-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapBalanceSheetLocationAxis_us-gaapOtherAssetsMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20200430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-04-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_20200401_20200430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-04-01</xbrli:startDate>
					<xbrli:endDate>2020-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermALoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TermALoanFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-05-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210501_20210531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-05-01</xbrli:startDate>
					<xbrli:endDate>2021-05-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-05-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermBLoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TermBLoanFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-05-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermALoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TermALoanFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermALoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TermALoanFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtRangeAxis_srtMinimumMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_us-gaapVariableRateAxis_us-gaapPrimeRateMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-05-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputRiskFreeInterestRateMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_us-gaapValuationTechniqueAxis_us-gaapValuationTechniqueOptionPricingModelMember_20210531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-05-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputExpectedDividendPaymentMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210501_20210531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendPaymentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-05-01</xbrli:startDate>
					<xbrli:endDate>2021-05-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_us-gaapValuationTechniqueAxis_us-gaapValuationTechniqueOptionPricingModelMember_20210531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-05-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputExpectedTermMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_us-gaapValuationTechniqueAxis_us-gaapValuationTechniqueOptionPricingModelMember_20210501_20210531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-05-01</xbrli:startDate>
					<xbrli:endDate>2021-05-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtRangeAxis_srtMaximumMember_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20191001_20191031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-10-01</xbrli:startDate>
					<xbrli:endDate>2019-10-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtRangeAxis_srtMaximumMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20191001_20191031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-10-01</xbrli:startDate>
					<xbrli:endDate>2019-10-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtRangeAxis_srtMinimumMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtRangeAxis_srtMaximumMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndTwentyEquityIncentivePlanMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndTwentyEquityIncentivePlanMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtTitleOfIndividualAxis_us-gaapShareBasedPaymentArrangementEmployeeMember_us-gaapAwardTypeAxis_etnbServiceBasedRSUsMember_20210201_20210228">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">etnb:ServiceBasedRSUsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-02-01</xbrli:startDate>
					<xbrli:endDate>2021-02-28</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtTitleOfIndividualAxis_us-gaapShareBasedPaymentArrangementEmployeeMember_us-gaapAwardTypeAxis_etnbServiceBasedRSUsMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">etnb:ServiceBasedRSUsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtTitleOfIndividualAxis_srtExecutiveOfficerMember_us-gaapAwardTypeAxis_etnbPerformanceRSUsMember_20210201_20210228">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">etnb:PerformanceRSUsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-02-01</xbrli:startDate>
					<xbrli:endDate>2021-02-28</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtTitleOfIndividualAxis_srtExecutiveOfficerMember_us-gaapAwardTypeAxis_etnbPerformanceRSUsMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">etnb:PerformanceRSUsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtConsolidatedEntitiesAxis_etnbEightyNineBioLtdMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">etnb:EightyNineBioLtdMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtConsolidatedEntitiesAxis_etnbEightyNineBioLtdMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">etnb:EightyNineBioLtdMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtConsolidatedEntitiesAxis_etnbEightyNineBioManagementIncorporationMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">etnb:EightyNineBioManagementIncorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtConsolidatedEntitiesAxis_etnbEightyNineBioManagementIncorporationMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">etnb:EightyNineBioManagementIncorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtConsolidatedEntitiesAxis_etnbUABEightyNineBioLithuaniaMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">etnb:UABEightyNineBioLithuaniaMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtConsolidatedEntitiesAxis_etnbUABEightyNineBioLithuaniaMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">etnb:UABEightyNineBioLithuaniaMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtStatementGeographicalAxis_countryUS_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtStatementGeographicalAxis_countryUS_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtStatementGeographicalAxis_countryIL_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtStatementGeographicalAxis_countryIL_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtStatementGeographicalAxis_countryIL_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtStatementGeographicalAxis_countryUS_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtStatementGeographicalAxis_countryUS_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtStatementGeographicalAxis_countryLT_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:LT</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtStatementGeographicalAxis_countryLT_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:LT</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_srtStatementGeographicalAxis_countryIL_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_etnbUnvestedRestrictedStockUnitsMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">etnb:UnvestedRestrictedStockUnitsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001785173_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
		</ix:resources>
	</ix:header>
</div>

<p style="border-top:Double 2.25pt;padding-top:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Washington, D.C. 20549</p>
<p style="text-align:center;border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:46.15%;margin-right:46.15%;text-indent:0%;font-size:3pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM <ix:nonNumeric id="F_000000" name="dei:DocumentType" contextRef="C_0001785173_20210101_20211231">10-K</ix:nonNumeric></p>
<p style="text-align:center;border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:46.15%;margin-right:46.15%;text-indent:0%;font-size:3pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Mark&#160;One) </p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Segoe UI Symbol;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000030" name="dei:DocumentAnnualReport" contextRef="C_0001785173_20210101_20211231" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p></td>
<td valign="top" style="width:96%;">
<p style="margin-top:2pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ANNUAL REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF&#160;1934 </p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the fiscal year ended <ix:nonNumeric id="F_000002" name="dei:DocumentPeriodEndDate" contextRef="C_0001785173_20210101_20211231" format="ixt:datemonthdayyearen">December 31, <ix:nonNumeric id="F_000003" name="dei:DocumentFiscalYearFocus" contextRef="C_0001785173_20210101_20211231">2021</ix:nonNumeric></ix:nonNumeric></p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">OR</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4%;">
<p style="margin-top:2pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Segoe UI Symbol;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000031" name="dei:DocumentTransitionReport" contextRef="C_0001785173_20210101_20211231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:96%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF&#160;1934 FOR THE TRANSITION PERIOD FROM&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; TO &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Commission File Number&#160;<ix:nonNumeric id="F_000020" name="dei:EntityFileNumber" contextRef="C_0001785173_20210101_20211231">001-39122</ix:nonNumeric> </p>
<p style="text-align:center;border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:46.15%;margin-right:46.15%;text-indent:0%;font-size:3pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000005" name="dei:EntityRegistrantName" contextRef="C_0001785173_20210101_20211231">89bio, Inc.</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of Registrant as specified in its Charter)</p>
<p style="text-align:center;border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:46.15%;margin-right:46.15%;text-indent:0%;font-size:3pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:49%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000021" name="dei:EntityIncorporationStateCountryCode" contextRef="C_0001785173_20210101_20211231" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td valign="top" style="width:2%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:49%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000022" name="dei:EntityTaxIdentificationNumber" contextRef="C_0001785173_20210101_20211231">36-4946844</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="bottom" style="width:49%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or other jurisdiction of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">incorporation or organization)</p></td>
<td valign="top" style="width:2%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:7pt;">&#160;</p></td>
<td valign="bottom" style="width:49%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(I.R.S. Employer</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Identification No.)</p></td>
</tr>
<tr>
<td valign="bottom" style="width:49%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000023" name="dei:EntityAddressAddressLine1" contextRef="C_0001785173_20210101_20211231">142 Sansome Street</ix:nonNumeric>, <ix:nonNumeric id="F_000024" name="dei:EntityAddressAddressLine2" contextRef="C_0001785173_20210101_20211231">Second Floor</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000025" name="dei:EntityAddressCityOrTown" contextRef="C_0001785173_20210101_20211231">San Francisco</ix:nonNumeric>, <ix:nonNumeric id="F_000026" name="dei:EntityAddressStateOrProvince" contextRef="C_0001785173_20210101_20211231" format="ixt-sec:stateprovnameen">California</ix:nonNumeric> <ix:nonNumeric id="F_000027" name="dei:EntityAddressPostalZipCode" contextRef="C_0001785173_20210101_20211231">94104</ix:nonNumeric></p></td>
<td valign="top" style="width:2%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:49%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">94104</p></td>
</tr>
<tr>
<td valign="bottom" style="width:49%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Address of principal executive offices)</p></td>
<td valign="top" style="width:2%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:7pt;">&#160;</p></td>
<td valign="bottom" style="width:49%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Zip Code)</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:3pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric id="F_000028" name="dei:CityAreaCode" contextRef="C_0001785173_20210101_20211231">415</ix:nonNumeric>)&#160;<ix:nonNumeric id="F_000029" name="dei:LocalPhoneNumber" contextRef="C_0001785173_20210101_20211231">432-9270</ix:nonNumeric> </p>
<p style="text-align:center;border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:46.15%;margin-right:46.15%;text-indent:0%;font-size:3pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section&#160;12(b) of the Act:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:39%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title of each class</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:20%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Trading<br />Symbol(s)</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:39%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name of each exchange on which registered</p></td>
</tr>
<tr>
<td valign="top" style="width:39%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000036" name="dei:Security12bTitle" contextRef="C_0001785173_20210101_20211231">Common stock, par value $0.001 per share</ix:nonNumeric></p></td>
<td valign="bottom" style="width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;">&#160;</p></td>
<td valign="bottom" style="width:20%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000037" name="dei:TradingSymbol" contextRef="C_0001785173_20210101_20211231">ETNB</ix:nonNumeric></p></td>
<td valign="bottom" style="width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;">&#160;</p></td>
<td valign="bottom" style="width:39%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000038" name="dei:SecurityExchangeName" contextRef="C_0001785173_20210101_20211231" format="ixt-sec:exchnameen">Nasdaq Global Market</ix:nonNumeric></p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section&#160;12(g) of the Act: <span style="font-weight:bold;">None</span></p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities Act.&#160;<span style="text-transform:uppercase;">Yes</span>&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span> <span style="text-transform:uppercase;"><ix:nonNumeric id="F_000012" name="dei:EntityWellKnownSeasonedIssuer" contextRef="C_0001785173_20210101_20211231">No</ix:nonNumeric></span>&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span></p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark if the Registrant is not required to file reports pursuant to Section&#160;13 or 15(d) of the Act. &#160;<span style="text-transform:uppercase;">Yes</span>&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span> <span style="text-transform:uppercase;"><ix:nonNumeric id="F_000008" name="dei:EntityVoluntaryFilers" contextRef="C_0001785173_20210101_20211231">No</ix:nonNumeric></span>&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span></p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the Registrant: (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the Registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days. &#160;<span style="text-transform:uppercase;"><ix:nonNumeric id="F_000007" name="dei:EntityCurrentReportingStatus" contextRef="C_0001785173_20210101_20211231">Yes</ix:nonNumeric></span>&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span> <span style="text-transform:uppercase;">No</span><span style="font-size:8.5pt;">&#160;</span><span style="font-size:8.5pt;font-family:Segoe UI Symbol;">&#9744;</span></p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the Registrant was required to submit such files). &#160;<span style="text-transform:uppercase;"><ix:nonNumeric id="F_000009" name="dei:EntityInteractiveDataCurrent" contextRef="C_0001785173_20210101_20211231">Yes</ix:nonNumeric></span>&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span> <span style="text-transform:uppercase;">No</span>&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span></p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act<span style="font-size:8.5pt;">.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Large&#160;accelerated&#160;filer</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="top" style="width:18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accelerated&#160;filer</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</p></td>
</tr>
<tr>
<td valign="top" style="width:18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td valign="top" style="width:48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td valign="top" style="width:18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td valign="top" style="width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
</tr>
<tr style="height:4.95pt;">
<td valign="top" style="width:18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000011" name="dei:EntityFilerCategory" contextRef="C_0001785173_20210101_20211231" format="ixt-sec:entityfilercategoryen">Non-accelerated filer</ix:nonNumeric></p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9746;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="top" style="width:18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Smaller&#160;reporting&#160;company</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000017" name="dei:EntitySmallBusiness" contextRef="C_0001785173_20210101_20211231" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="top" style="width:18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td valign="top" style="width:48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td valign="top" style="width:18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td valign="top" style="width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging growth company</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="top" style="width:48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000018" name="dei:EntityEmergingGrowthCompany" contextRef="C_0001785173_20210101_20211231" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;">&#160;</p></td>
<td valign="top" style="width:18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;">&#160;</p></td>
<td valign="top" style="width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:2pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an <span style="font-size:8pt;">emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#160;</span><span style="font-size:8pt;font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000019" name="dei:EntityExTransitionPeriod" contextRef="C_0001785173_20210101_20211231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.&#160;&#160;<span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000015" name="dei:IcfrAuditorAttestationFlag" contextRef="C_0001785173_20210101_20211231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the Registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act). &#160;<span style="text-transform:uppercase;">Yes</span>&#160;<span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000016" name="dei:EntityShellCompany" contextRef="C_0001785173_20210101_20211231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span> <span style="text-transform:uppercase;">No</span>&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span></p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The <span style="font-size:8pt;">aggregate market value of the voting and non-voting common equity held by non-affiliates of the Registrant, based on the closing price of the shares of common stock on The Nasdaq Global Market on June 30, 2021, the last business day of the Registrant&#8217;s most recently completed second fiscal quarter, was approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000013" name="dei:EntityPublicFloat" contextRef="C_0001785173_20210630" decimals="-5" scale="6">165.5</ix:nonFraction> million. Shares of common stock held by each officer and director and by each person who is known to own 10% or more of the outstanding common stock have been excluded in that such persons may be deemed to be affiliates of the Registrant. This determination of affiliate status is not necessarily a conclusive determination for other purposes. </span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The number of shares of Registrant&#8217;s common stock outstanding as of March 1, 2022 was <ix:nonFraction unitRef="U_xbrlishares" id="F_000014" name="dei:EntityCommonStockSharesOutstanding" contextRef="C_0001785173_20220301" decimals="INF" format="ixt:numdotdecimal">20,351,384</ix:nonFraction>. </p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DOCUMENTS INCORPORATED BY REFERENCE</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000032" name="dei:DocumentsIncorporatedByReferenceTextBlock" contextRef="C_0001785173_20210101_20211231">Portions of the registrant&#8217;s definitive proxy statement relating to its 2022 Annual Meeting of Stockholders, to be held on or about June 1, 2022, are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such proxy statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.</ix:nonNumeric></p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:97.18%;">
<tr>
<td valign="top" style="width:14.54%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Auditor Firm Id:</p></td>
<td valign="top" style="width:14.44%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000033" name="dei:AuditorFirmId" contextRef="C_0001785173_20210101_20211231">185</ix:nonNumeric></p></td>
<td valign="top" style="width:14.04%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Auditor Name: </p></td>
<td valign="top" style="width:15.2%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000034" name="dei:AuditorName" contextRef="C_0001785173_20210101_20211231">KPMG LLP</ix:nonNumeric></p></td>
<td valign="top" style="width:15.8%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Auditor Location:</p></td>
<td valign="top" style="width:25.96%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000035" name="dei:AuditorLocation" contextRef="C_0001785173_20210101_20211231">San Francisco, California, USA</ix:nonNumeric></p></td>
</tr>
</table></div>
<p style="border-bottom:Double 2.25pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:1pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Table of Contents</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:82.52%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Page</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">PART I</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%; border-top:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;1.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_1_BUSINESS"><span style="text-decoration:underline;">Business</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;1A.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_1A_RISK_FACTORS"><span style="text-decoration:underline;">Risk Factors</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;1B.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_1B_UNRESOLVED_STAFF_COMMENTS"><span style="text-decoration:underline;">Unresolved Staff Comments</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;2.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_2_PROPERTIES"><span style="text-decoration:underline;">Properties</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;3.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_3_LEGAL_PROCEEDINGS"><span style="text-decoration:underline;">Legal Proceedings</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;4.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_4_MINE_SAFETY_DISCLOSURES"><span style="text-decoration:underline;">Mine Safety Disclosures</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">PART&#160;II</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;5.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_5_MARKET_FOR_REGISTRANTS_COMMON_EQU"><span style="text-decoration:underline;">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;6.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_6_RESERVED"><span style="text-decoration:underline;">[Reserved]</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;7.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_7_MANAGEMENTS_DISCUSSION_ANALYSIS_F"><span style="text-decoration:underline;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;7A.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_7A_QUANTITATIVE_QUALITATIVE_DISCLOS"><span style="text-decoration:underline;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;8.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_8_FINANCIAL_STATEMENTS_SUPPLEMENTAR"><span style="text-decoration:underline;">Financial Statements and Supplementary Data</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_9_CHANGES_IN_DISAGREEMENTS_WITH_ACC"><span style="text-decoration:underline;">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9A.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_9A_CONTROLS_PROCEDURES"><span style="text-decoration:underline;">Controls and Procedures</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9B.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_9B_OR_INFORMATION"><span style="text-decoration:underline;">Other Information</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">87</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 9C.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_9C_DISCLOSURE_REGARDING"><span style="text-decoration:underline;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">87</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">PART&#160;III</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;10.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_10_DIRECTORS_EXECUTIVE_FICERS_CORPO"><span style="text-decoration:underline;">Directors, Executive Officers and Corporate Governance</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;11.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_11_EXECUTIVE_COMPENSATION"><span style="text-decoration:underline;">Executive Compensation</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;12.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_12_SECURITY_OWNERSHIP_CERTAIN_BENEF"><span style="text-decoration:underline;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;13.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_13_CERTAIN_RELATIONSHIPS_RELATED_TR"><span style="text-decoration:underline;">Certain Relationships and Related Transactions, and Director Independence</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;14.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_14_PRINCIPAL_ACCOUNTING_FEES_SERVIC"><span style="text-decoration:underline;">Principal Accounting Fees and Services</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">PART&#160;IV</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;15.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_15_EXHIBITS_FINANCIAL_STATEMENT_SCH"><span style="text-decoration:underline;">Exhibits, Financial Statement Schedules</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 16.</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_16_FORM_10K_SUMMARY"><span style="text-decoration:underline;">Form 10-K Summary</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">92</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td colspan="2" valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a href="#SIGNATURES"><span style="text-decoration:underline;">SIGNATURES</span></a></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.2%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">FORWARD-LOOKING STATEMENTS</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Annual Report on Form 10-K contains &#8220;forward-looking statements&#8221; within the meaning of the federal securities laws, which statements involve substantial risks and uncertainties. All statements, other than statements of historical facts included in this Annual Report on Form 10-K, including statements concerning our plans, objectives, goals, strategies, future events, future revenues or performance, financing needs, plans or intentions relating to acquisitions, business trends and other information referred to in &#8220;Business,&#8221; &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; are forward-looking statements. Forward-looking statements generally relate to future events or our future financial or operating performance. In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;objective,&#8221; &#8220;intend,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;can,&#8221; &#8220;would,&#8221; &#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;design,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;target,&#8221; &#8220;forecast,&#8221; or the negative of these terms, and similar expressions intended to identify forward-looking statements. Forward-looking statements are not historical facts and reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There are a number of risks, uncertainties and other important factors that could cause our actual results to differ materially from the forward-looking statements contained in this Annual Report on Form 10-K. Such risks, uncertainties and other important factors include, among others, the risks, uncertainties and factors set forth in &#8220;Risk Factors,&#8221; and the following risks, uncertainties and factors:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our plans to develop and commercialize pegozafermin (previously BIO89-100) or any future product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ongoing and planned clinical trials&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the timing of and our ability to obtain regulatory approvals for pegozafermin or any future product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the effect of the ongoing COVID-19 pandemic on our business&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our estimates regarding expenses, future revenue, capital requirements and needs for additional financing&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to identify additional products or product candidates with significant commercial potential that are consistent with our commercial objectives&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the rate and degree of market acceptance and clinical utility of pegozafermin or any future product candidates, if approved&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our commercialization, marketing and manufacturing capabilities and strategy&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">substantial competition in our industry and with respect to the product candidates that we are developing&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our intellectual property position&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">loss of key members of management&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">failure to successfully execute our growth strategy, including any delays in our planned future growth&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our failure to maintain effective internal controls.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There may be other factors that may cause our actual results to differ materially from the forward-looking statements, including factors disclosed in &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221; You should evaluate all forward-looking statements made in this Annual Report on Form 10-K in the context of these risks and uncertainties.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We caution you that the risks, uncertainties and other factors referred to above may not contain all of the risks, uncertainties and other factors that are important to you. In addition, we cannot assure you that we will realize the results, benefits or developments that we expect or anticipate or, even if substantially realized, that they will result in the consequences or affect us or our business in the way expected. All forward-looking statements in this Annual Report on Form 10-K apply only as of the date made and are expressly qualified in their entirety by the cautionary statements included in this Annual Report on Form 10-K. We undertake no obligation to publicly update or revise any forward-looking statements to reflect subsequent events or circumstances.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="PART_I">PART I</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">In this Annual Report on Form 10-K, unless context otherwise requires or where otherwise indicated, the terms &#8220;89bio&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;our company,&#8221; &#8220;the company,&#8221; and &#8220;our business&#8221; refer to 89bio, Inc. and its consolidated subsidiaries.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_1_BUSINESS">Item 1. Business. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Overview</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Our lead product candidate,&#160;pegozafermin (previously BIO89-100),&#160;a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (&#8220;FGF21&#8221;), is currently being developed for the treatment of nonalcoholic steatohepatitis (&#8220;NASH&#8221;) and for the treatment of severe hypertriglyceridemia (&#8220;SHTG&#8221;). NASH is a severe form of nonalcoholic fatty liver disease (&#8220;NAFLD&#8221;), characterized by inflammation and fibrosis in the liver that can progress to cirrhosis, liver failure, hepatocellular carcinoma (&#8220;HCC&#8221;) and death. There are currently no approved products for the treatment of NASH. In January 2022, we announced positive topline results from an expansion cohort (cohort 7) of the Phase 1b/2a trial of pegozafermin in NASH after announcing positive topline data from cohorts 1 through 6 in September 2020. We also initiated a Phase 2b trial (ENLIVEN) evaluating pegozafermin in fibrosis stage 2 or 3 NASH patients in June 2021. Patients will receive weekly doses or a every two-week dose of pegozafermin or placebo for 24 weeks followed by a blinded extension phase of an additional 24 weeks for a total treatment period of 48 weeks. We are making good progress in ENLIVEN and expect to report topline data from this trial in the first half of 2023. Based on learnings from our recent cohort, developments in the field, and feedback from our steering committee, we are working on steps to optimize the ENLIVEN trial<span style="color:#000000;">.</span> In 2021, we completed a pharmacokinetic study of pegozafermin in NASH patients with compensated cirrhosis (fibrosis stage F4) demonstrating that pegozafermin 30 mg has similar single-dose pharmacokinetics and pharmacodynamics in F4 as it does in non-cirrhotic NASH. We are currently evaluating the potential opportunity for pegozafermin in these fibrosis stage F4 patients. SHTG is a condition identified by severely elevated levels of triglycerides (&#8805;500 mg/dL), which is associated with an increased risk of NASH, cardiovascular events and acute pancreatitis. We initiated our Phase&#160;2 trial (ENTRIGUE) in SHTG patients in the third quarter of 2020 and expect to report topline data in the second quarter of 2022. We closed enrollment in this trial in February 2022 with 85 patients enrolled.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">FGF21 is a metabolic hormone that regulates energy expenditure and glucose and lipid metabolism. FGF21 analogs represent a promising class of drugs to treat NASH, because they not only address the liver manifestations, but also have an effect on the multiple co-morbidities that worsen NASH. <span style="Background-color:#FFFFFF;">FGF21 is a clinically validated mechanism that has been shown in humans to reduce steatosis, improve the histological features of NASH and address cardio-metabolic dysregulation.&#160;</span>It is thought to exert effects on liver fibrosis by improving metabolic regulation, which reduces ongoing liver injury thus giving the liver time to heal. FGF21 also generates an&#160;on-target&#160;effect to increase adiponectin, a hormone released from adipose tissue that, among other functions, can suppress development and progression of hepatic fibrosis. However, FGF21 in its native form suffers from a short half-life and a tendency to aggregate in solution, both of which impact its suitability as a viable drug. To address these challenges, we have specifically engineered&#160;pegozafermin&#160;to extend the half-life of the molecule while maintaining potency and thereby the clinical benefits of FGF21.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegozafermin may be a differentiated FGF21 therapy based on its robust and durable biological effects, a favorable tolerability profile and its potential for every two-week dosing. <span style="Background-color:#FFFFFF;">Given its ability to address the key liver pathologies in NASH, as well as the underlying metabolic dysregulation in NASH patients,&#160;</span>pegozafermin<span style="Background-color:#FFFFFF;"> has the potential to become a backbone of treatment in NASH. </span>Pegozafermin is the only FGF21 analog being developed for the treatment of SHTG and its broad metabolic effects could potentially differentiate it from competitors in this market. Pegozafermin has a long half-life which allows convenient weekly or every-two-week dosing and is currently the only FGF21 analog being tested for every-two-week dosing. The convenient dosing regimen may support adoption and compliance amongst patients living with these chronic and generally asymptomatic diseases. Pegozafermin is self-administered by patents subcutaneously in a liquid formulation.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In September 2020 and January 2022, we presented positive topline results from cohorts 1 through 6 and cohort 7 respectively in our Phase 1b/2a trial in NASH patients which has informed the advancement of our clinical </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">strategy in NASH. The 13-week multicenter, randomized, double-blind, placebo-controlled, multiple ascending dose-ranging</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> portion of the</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> trial enrolled a total of 81 patients in cohorts 1</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">through </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6 with biopsy-confirmed NASH and phenotypic NASH (&#8220;PNASH&#8221;). All dose groups demonstrated statistically significant reductions in liver fat at week 13, with relative reduction of up to 60% versus baseline, and up to 70% versus placebo, as measured by magnetic resonance imaging&#8212;proton density fat factor (&#8220;MRI-PDFF&#8221;). </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A majority of patients achieved a </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">greater than or equal to</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 30% (up to 88%) or a </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">greater than or equal to</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 50% (up to 71%) reduction in liver fat from baseline</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. ALT, a liver enzyme, was significantly reduced (up to 44%) in these patients and key lipid markers like triglycerides, LDL, and non-HDL were also significantly improved. Cohort 7 in the Phase 1b/2a trial was a single-arm cohort that enrolled 20 patients with biopsy-confirmed fibrosis stage F2 and F3 NASH who were treated once weekly for 20 weeks with 27 mg of pegozafermin. Cohort 7 data was consistent with previous findings and validate pegozafermin&#8217;s effect on histology. Meaningful changes were observed on key histology endpoints </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">with a greater than or equal to </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2-</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">point improvement in NAS and no worsening of fibrosis, NASH resolution without worsening of fibrosis, and improvement in at least one stage of fibrosis without worsening NAS. Clinically meaningful and significant changes were observed across key non-invasive tests (NITs) associated with fibrosis, risk of fibrosis, or NASH resolution suggesting pegozafermin is improving total liver health. In addition to significant improvement in liver health, </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">t</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">reatment with pegozafermin also had significant positive effects on glycemic control, lipids, </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">adiponectin, </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and body weight. In 83 patients treated with pegozafermin across the full Phase 1b/2a study in cohorts 1 </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">through</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 7, pegozafermin </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">was</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> generally well tolerated with a favorable safety profile. There </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">were</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> no drug-related serious adverse events and only one treatment-related discontinuation. Pooled pegozafermin treatment related adverse events in</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> greater than or equal to </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10% of patients were increased appetite (13% vs 0% placebo), diarrhea (13% vs 11% placebo), and nausea (12% vs 11% placebo). Most of the GI adverse events were mild and of short duration. A few mild injection site reactions were reported and there were no tremors and no hypersensitivity adverse events observed. </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">P</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">egozafermin had no adverse effects on blood pressure or heart rate</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Given the potential of FGF21 to meaningfully reduce triglycerides and provide other metabolic benefits, and the established regulatory path for approval, we are developing pegozafermin for the treatment of SHTG. We initiated our Phase 2 trial (ENTRIGUE) in SHTG patients in the third quarter of 2020 and <span style="color:#000000;">have closed enrollment with 85 patients either on stable background treatment with statins and/or prescription fish oil and/or fibrates or not on any background therapy. </span>In this randomized, double-blind, placebo-controlled study, patients receive pegozafermin administered weekly (9 mg, 18 mg or 27 mg) or every two weeks (36 mg) or placebo over an eight-week treatment period. The primary endpoint is the percentage change in fasting triglyceride levels from baseline. Key secondary endpoints include other lipid and metabolic markers and a sub-study evaluating change in liver fat measured by MRI-PDFF. <span style="color:#000000;">Screening in the fibrate cohort was stopped with the main study and will be analyzed as part of main ENTRIGUE trial. </span>Topline data from ENTRIGUE is expected in the second quarter of 2022.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Impact of&#160;COVID-19&#160;Pandemic</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The ongoing COVID-19 pandemic has disrupted and may continue to disrupt our business and delay our development timeline. The extent to which the COVID-19 pandemic may impact our future operating results and financial condition is uncertain.<span style="color:#000000;"> We initiated our Phase 2 trial (ENTRIGUE) in SHTG patients in the third quarter of 2020 and our Phase 2b trial in NASH patients in the middle of 2021. The COVID-19 pandemic has impacted execution and enrollment of these trials. We do not yet know the full extent of potential delays that may affect our clinical trials, which could prevent or delay us from obtaining approval for&#160;pegozafermin.&#160;Given the surges in cases of COVID-19 experienced previously and uncertainty regarding other variants, we cannot predict how our ongoing trials may be impacted. For more information regarding risks related to the ongoing&#160;COVID-19&#160;pandemic, please see the risk factor entitled &#8220;The ongoing COVID-19 pandemic has resulted and may in the future result in significant disruptions to our clinical trials or other business operations, which could have a material adverse effect on our business,&#8221; in Part I. Item 1A of this Annual Report on Form 10-K. To the extent the ongoing&#160;COVID-19&#160;pandemic adversely affects our business and financial results, it may also have the effect of heightening many of the other risks set forth under &#8220;Risk Factors&#8221; in this Annual Report on Form&#160;10-K.</span></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>

<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Strategy</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our goal is to become a leading biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The key components of our strategy are to:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;color:#000000;">Rapidly advance&#160;pegozafermin through clinical development for the treatment of NASH</span><span style="font-weight:bold;font-style:italic;color:#000000;">. </span><span style="color:#000000;">We believe&#160;pegozafermin may be a differentiated FGF21 therapy based on its robust and durable biological effects, a favorable tolerability profile and its potential for every two-week dosing. We reported positive topline results in September 2020 and January 2022 from our Phase 1b/2a trial&#160;in NASH patients and have initiated a Phase 2b trial (ENLIVEN) in NASH patients with F2 and F3 fibrosis that is expected to report topline data in the first half of 2023. We are also evaluating the potential opportunity for pegozafermin in NASH patients with compensated cirrhosis.</span><span style="font-weight:bold;font-style:italic;color:#000000;"> </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;color:#000000;">Pursue SHTG as a second indication with pegozafermin given its unique profile and its potential for a quicker path to market. </span><span style="color:#000000;">Pegozafermin&#8217;s mechanism of action supports its potential to become a differentiated treatment for SHTG patients with other metabolic co-morbidities. We expect to report topline data from the Phase 2 ENTRIGUE trial in the second quarter of 2022. We believe that a combination of smaller clinical trials and shorter development timelines could mean that SHTG potentially represents a quicker path to market for pegozafermin</span><span style="font-weight:bold;color:#000000;">.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;color:#000000;">Scale-up&#160;and optimize the manufacturing of&#160;pegozafermin. </span><span style="color:#000000;">We currently use an external contract manufacturing organization (&#8220;CMO&#8221;) to manufacture&#160;pegozafermin for our ongoing and planned clinical trials. While these trials are ongoing, we plan to work with our CMO to optimize and&#160;scale-up&#160;the manufacturing process for&#160;pegozafermin to support the increased production that will be needed for later-stage clinical trials and commercialization, if&#160;pegozafermin is approved.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;color:#000000;">Establish a commercial infrastructure in key geographies</span><span style="color:#000000;">. We have worldwide rights to&#160;pegozafermin&#160;and intend to develop the sales infrastructure required for commercialization in the United States. We also plan to evaluate options, including strategic collaborations, for commercializing&#160;pegozafermin,&#160;if approved, in other key markets, such as Europe and China.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;color:#000000;">Build a diversified multi-asset pipeline of novel therapies</span><span style="color:#000000;">. We intend to employ a value-driven strategy to identify, acquire, develop and commercialize product candidates for liver and cardio-metabolic diseases. We intend to focus on product candidates that we believe have attractive profiles and address a clear unmet medical need and can advance quickly and efficiently into late-stage development.</span></p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Our Focus on Liver and Cardio-Metabolic Disease</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are focused on developing and commercializing therapeutic interventions that have a clinically meaningful impact on patients with liver and cardio-metabolic diseases. These diseases, including NASH and SHTG, represent leading global causes of morbidity and mortality. Despite a wave of public health campaigns to promote better diet and exercise habits and a range of treatment options available for many of these diseases, there is a significant unmet medical need for more effective therapies to improve patient outcomes and reduce the burden on global healthcare systems.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are currently developing our lead product candidate, pegozafermin, a specifically engineered glycoPEGylated analog of FGF21, for the treatment of NASH and SHTG. We believe pegozafermin is an ideal candidate for the treatment of NASH based on its ability to address the key liver pathologies in NASH, its ability to address the underlying metabolic dysregulation in NASH patients, its favorable tolerability profile, and its potential for a longer dosing interval. Multiple epidemiological studies have linked NAFLD to increased cardiovascular disease, concluding that the majority of deaths among NAFLD patients are attributable to cardiovascular disease. As a result, we believe it is important that new therapeutics options for NASH address the underlying cardiovascular and metabolic dysregulations in these patients.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Given the potential of pegozafermin to meaningfully reduce triglycerides, we are also developing pegozafermin for the treatment of SHTG. Pegozafermin may have a competitive differentiation from approved therapies and other molecules in development based on its impact on improving liver fat and other metabolic </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">markers</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in addition to triglyceride reduction</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There is regulatory precedence for the approval of therap</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ies</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for the treatment of SHTG in the United States </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">based on </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">percent </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">reduction in triglycerides from baseline as the primary endpoint for full approval. Based </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">on </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the regulatory path followed by other companies that have successfully developed SHTG therapies, we believe that a combination of smaller clinical trials and shorter development timelines could mean that SHTG potentially represents a quicker path to market for </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">pegozafermin</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Disease Overview - NASH</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NASH, a severe form of NAFLD, is characterized histologically by the additional presence of inflammation and hepatocellular injury such as visible ballooning and has a significantly worse prognosis, with the potential to progress to liver fibrosis, cirrhosis or HCC. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NASH represents a large and rapidly growing problem in the United States and worldwide. Diagnoses have been on the rise and are expected to increase dramatically in the next decade. The prevalence of NAFLD, which affects approximately 25% of the global population, and NASH, which develops in approximately 20% to 25% of NAFLD patients, is driven primarily by the worldwide obesity epidemic. <span style="color:#000000;">As a result, the prevalence of NASH has increased significantly in recent decades, paralleling similar trends in the prevalence of obesity, insulin resistance and Type 2 diabetes. The prevalence of these conditions is expected to increase further in view of the unhealthy nutrition habits, such as consumption of a diet high in fructose, sucrose and saturated fats, and sedentary behavior that characterize modern lifestyle. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The critical pathophysiologic mechanisms underlying the development and progression of NASH include reduced ability to handle lipids, increased insulin resistance, injury to hepatocytes and liver fibrosis in response to hepatocyte injury. NASH patients have an excessive accumulation of fat in the liver resulting primarily from a caloric intake above and beyond energy needs. A healthy liver contains less than 5% fat, but a liver in someone with NASH can contain more than 20% fat. This abnormal liver fat contributes to the progression to NASH, a liver necro-inflammatory state, that can lead to scarring, also known as fibrosis, and, for some, can progress to cirrhosis and liver failure&#8212;cirrhosis develops in approximately 20% to 45% of patients. In some cases, cirrhosis progresses to decompensated cirrhosis, which results in permanent liver damage that can lead to liver failure. In addition, it is estimated that 8% of patients with advanced fibrosis will develop HCC. NASH is a complex, multifaceted disease that doesn&#8217;t just affect the liver. Patients with NASH frequently have other significant metabolic&#160;co-morbidities&#160;such as obesity, hyperglycemia, dyslipidemia and systemic hypertension (a constellation of which is commonly referred to as metabolic syndrome) and these further contribute to the risk of cardiovascular disease. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Disease Overview - SHTG</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are also developing pegozafermin for the treatment of SHTG. Hypertriglyceridemia (&#8220;HTG&#8221;) is characterized by elevated fasting plasma triglyceride levels &#62;200 mg/dL and SHTG is typically defined as triglyceride levels of &#8805;500 mg/dL. SHTG is associated with an increased risk of NAFLD, NASH and cardiovascular diseases, as well as acute pancreatitis, accounting for up to 10% of all acute pancreatitis episodes. A third-party study utilizing an omega-3 fatty acid (&#8220;omega-3 FA&#8221;) demonstrated the linkage between a reduction in triglycerides and favorable cardiovascular clinical outcomes. <span style="color:#000000;">Additionally, SHTG increases the risk of developing NAFLD, NASH and cardiovascular disease. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">It is estimated that there are 4 million patients in the United States with triglyceride levels of <span style="color:#000000;">&#8805;</span>500 mg/dL. Of these patients, it is estimated that up to 100% of patients have clinically meaningful hepatic fat (MRI-PDFF<span style="color:#000000;"> &#8805;5%&#59; baseline data from the sub-study in ENTRIGUE&#59; n&#61;14)</span>, up to 70% have Type 2 diabetes, and up to 65% have high LDL. This patient population is expected to increase due to the triple epidemic of obesity, metabolic syndrome and Type 2 diabetes. In addition, the addressable market has the potential to expand as a result of increasing awareness of the importance of treating elevated triglyceride levels, similar to the focus today of physicians on managing LDL levels, as well as due to third party commercial efforts expected to promote triglyceride reduction. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The treatment regimen for SHTG includes dietary restrictions and lipid-lowering drug treatment such as fibrates, omega-3 fish oils and niacin. Some statins are indicated in HTG but do not have an indication for use in SHTG.<span style="color:#000000;"> </span>Despite multiple agents approved for the treatment of SHTG, these agents have limitations that may not make them ideal for all patients. For example, fibrates have demonstrated reductions in triglycerides of up to </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">approximately 55% at 12 weeks of treatment. However, they have also shown increases in LDL-C (up to 45%), a detrimental effect in this patient population, risk of drug-drug interactions and increases in transaminases, as well as tolerability issues including myopathy. Omega 3 fish oils have shown more modest benefits in reduction of triglycerides from baseline of approximately 25% to 45%. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Some</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> fish oils have also showed major increases in LDL-C (up to 45%). Fish oils also have a significant pill burden given the high daily doses required. In addition, these agents fail to meaningfully address the related co-morbidities of SHTG, including</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> liver fat reduction and</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> glycemic control, which, when left untreated, may further exacerbate the condition. In third-party studies, up to 50% of treated SHTG patients were unable to reduce their triglyceride levels to &#60; 500 mg/dL despite using approved drugs and are considered refractory patients. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These refractory patients</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">have substantial unmet medical need and represent a significant market opportunity</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for pegozafermin as an add-on therapy along with the opportunity for pegozafermin to be used in patients not on any background therapy</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Given the continuing unmet need in SHTG and limitations of current treatments, there are several agents in development for the treatment of SHTG, including a fibrate, and novel drugs targeting </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">aspects of HTG and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SHTG, including ANGPTL3 and A</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PO</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">C</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> inhibitors. </span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Etiology of NASH</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Understanding of the pathophysiologic mechanisms that lead to NASH has evolved in recent years. Excessive caloric overload, metabolic dysregulation, cardio-metabolic co-morbidities and genetic risk factors increase the likelihood of developing NASH, with a multitude of potential mechanistic contributors to pathophysiology. In NASH, the liver&#8217;s capacity to handle the primary metabolic energy substrates, carbohydrates and fatty acids, is overwhelmed. This occurs when there is an excess of free fatty acids deposited in the liver or their disposal from the liver is impaired. The accumulation of surplus free fatty acids leads to the formation of toxic lipid species. These toxic lipids then induce endoplasmic reticulum stress, oxidative stress and an inflammatory response, which can result in hepatocellular injury and death. This may lead to fibrosis and genomic instability, which may worsen over time to cirrhosis and HCC, respectively.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The critical pathophysiologic mechanisms underlying development and progression of NASH include (1) reduced ability to handle lipids, (2) increased insulin resistance, (3) injury to hepatocytes and (4) development and progression of liver fibrosis in response to hepatocyte injury.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:normal;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Reduced Ability to Handle Lipids</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Excess consumption of calories, poor diet and a sedentary lifestyle, each often associated with obesity, can burden the body with a surplus of carbohydrates and lipids. This burden can be progressively more difficult for the liver to handle thereby resulting in steatosis in the liver. The problem is compounded further as insulin resistance develops.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Free fatty acids (&#8220;FFA&#8221;) accumulate in the liver primarily from three sources, namely, through (1) the transfer from peripheral adipose tissues where triglycerides are mobilized, (2) de-novo lipogenesis (&#8220;DNL&#8221;), and (3) direct dietary intake. The FFA that lead to NASH are believed to arise primarily from the peripheral tissue pool and secondarily through DNL. The increase in the influx of FFA to the liver from the peripheral tissues is driven by excessive caloric intake greater than the body&#8217;s demand and increased insulin resistance resulting in deposition of fat to the liver for processing. DNL is a distinct process in the liver by which hepatocytes convert excess carbohydrates, especially fructose, to fatty acids.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The three main fates of fatty acids in the liver are (1) mitochondrial beta-oxidation (to release ATP, or energy), (2) re-esterification to form triglyceride, which can then be exported into the blood as very low density lipoproteins, or (3) stored in lipid droplets, resulting in liver steatosis and ultimately NASH. Adiponectin, a hormone derived from adipose tissue, appears to have a pivotal role in improving fatty acid oxidation and decreasing fatty acid synthesis, components of lipid handling.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">An increase in cholesterol accumulation in the liver can also contribute to NASH, though its role is not as clearly defined as in the case of triglycerides. The dysregulation of the cholesterol pathway can result in an increase in the cholesterol levels in the liver. The increased cholesterol can accumulate in the liver cell membranes and </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">activate Kupffer cells (activated stellate macrophages), thereby triggering inflammatory pathways and resulting in the progression of NASH.</span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:normal;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Increased Insulin Resistance</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Insulin resistance, which typically develops in obese individuals, is considered to be a fundamental underlying mechanism in the majority of NASH patients. Fatty acids are primarily delivered to the liver from blood following lipolysis of triglycerides in adipose tissue, a process that is regulated by the actions of insulin on adipocytes. Insulin resistance in adipose tissue manifests as dysregulated lipolysis resulting in excessive delivery of FFA to the liver. The liver tries to cope with the large influx of FFA&#59; however, the build-up of metabolic intermediates interferes with signaling, resulting in hepatic insulin resistance and the inability of the liver to process this excess FFA influx. The state of hepatic insulin resistance further exacerbates the problem by triggering DNL and the build-up of excess fat in the liver.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:normal;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Injury to Hepatocytes</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">When the disposal of fatty acids through beta-oxidation or the formation of triglycerides is chronically overwhelmed, fatty acids can form lipotoxic species that lead to stress on the endoplasmic reticulum, oxidative stress and inflammation, all of which are pivotal processes in the development of NASH. Liver inflammation may be an important link between the initial metabolic stress and subsequent hepatocyte death and stimulation of fibrogenesis in NASH by promotion of the expression of pro-inflammatory cytokines and of apoptosis (cell death). These processes are core to the steatohepatitis that gives NASH its name. For example, hepatocyte apoptosis results in the ballooning of cells, a classic pathological feature of NASH. While hepatocytes are the primary and major target of toxic lipids, other cells such as Kupffer cells and hepatic stellate cells are also affected by lipotoxicity and contribute to the development of NASH pathology.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional factors, including dysregulation of cytokines and adipokines, energy depletion, anti-oxidant deficiencies, products of the gut microbiome and iron load may modulate hepatocyte vulnerability to the development of lipotoxic stress, injury and inflammation.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:normal;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Development and Progression of Liver Fibrosis in Response to Hepatocyte Injury</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Signaling from stressed or injured hepatocytes and Kupffer cells leads to activation of quiescent hepatic stellate cells. Upon activation, hepatic stellate cells release collagen and other factors. When the production of collagen and matrix proteins is faster than their degradation, accumulation of these proteins in the extracellular matrix can lead to progressive fibrosis. As the lipotoxicity and inflammation continue to damage the liver, the hepatic stellate cells continue to be activated resulting in greater collagen deposition that ultimately leads to fibrosis and cirrhosis.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Diagnosis</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Most people with NASH are asymptomatic and their disease is often discovered incidentally following a liver imaging procedure, such as an ultrasound, prescribed for other reasons or as part of an investigation for elevated liver enzymes. Once suspected clinically, a liver biopsy is required to definitively diagnose NASH, which necessitates the joint presence of steatosis, ballooning and lobular inflammation. Once pathologically confirmed, the severity of NAFLD and NASH is determined using the histologically validated NAS, which grades disease activity on a scale of 0 to 8. The NAS is the sum of the individual scores for steatosis (0 to 3), lobular inflammation (0 to 3), and hepatocellular ballooning (0 to 2) but does not include a score for fibrosis. Fibrosis staging (F0-F4) relies on the Kleiner classification (F0 &#61; no fibrosis&#59; F1 &#61; perisinusoidal or periportal fibrosis (not both)&#59; F2 &#61; both perisinusoidal and periportal fibrosis&#59; F3 &#61; bridging fibrosis&#59; F4 &#61; cirrhosis).</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Histological diagnosis remains the gold standard for assessment of NASH and fibrosis. However, given that liver biopsy is associated with risks of pain, bleeding and other morbidity, as well as significant cost, the procedure is not practical for general patient screening. Additionally, histology diagnosis is confounded by evaluation of a small sliver of a large heterogenous organ that may not represent the full organ, and significant variability in reading </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of slides including inter</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and intra</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">reader variability</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Several non-invasive tools such as clinical risk scores</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, serum markers</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and imaging techniques are increasingly used to assess NASH patients. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-invasive tests</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(&#8220;NITs&#8221;) </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">such as the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fibroscan-AST (</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">FAST</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> score, Fibrosis-4 index, the Enhanced Liver Fibrosis score and vibration-controlled transient elastography,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(&#8220;VCTE&#8221;), have been validated and are increasingly used. These </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NITs</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> have an excellent negative predictive value and an acceptable positive predictive value for detection of advanced (</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8805; </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">F3) fibrosis and are increasingly used in clinical settings. Additionally, evidence is emerging that shows a correlation between</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">reduction in steatosis as measured by MRI-PDFF </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and reduction in ALT </span><span style="color:#000000;"> &#8805;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17 U/L </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">histologic </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">improvement </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">on liver biopsy</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> In draft guidance, the FDA encouraged sponsors to identify biochemical or noninvasive imaging biomarkers that, once characterized and agreed by the FDA, could replace liver biopsies for patient selection and efficacy assessment in clinical trials.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect that the validation and subsequent adoption of these NITs will result in an increase in the diagnosis and treatment rates for NASH in the future.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">FGF21 Overview</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fibroblast growth factors (&#8220;FGFs&#8221;), including FGF21 and FGF19, are a large family of cell-signaling proteins involved in the regulation of many processes within the body. FGF21 is an endogenous metabolic hormone that regulates energy homeostasis, glucose-lipid-protein metabolism and insulin sensitivity, and modulates the pathways that mitigate against intracellular stress. FGF21 is secreted primarily by the liver but is also secreted by the white adipose tissue (&#8220;WAT&#8221;), skeletal muscle and the pancreas. FGF21 exerts its biological benefits through the activation of three fibroblast growth factor receptors (&#8220;FGFRs&#8221;), FGFR1c, FGFR2c and FGFR3c, and requires co-activation of the transmembrane protein cofactor beta Klotho (&#8220;&#223;-Klotho&#8221;). FGF21 is not believed to activate FGFR4, which has been associated with adverse effects. FGF21 can act directly or indirectly on target organs by mediating downstream regulators, such as adiponectin, and upstream regulators that induce FGF21, such as nutritional stress or transcription factors. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Biological Effects of FGF21: </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Reducing Liver Steatosis by Improving Lipid Handling and Insulin Sensitivity</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-weight:normal;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">FGF21 has been clinically shown to reduce liver steatosis. FGF21 reduces liver steatosis by (1) increasing fatty acid oxidation in the liver, (2) reducing the deposition of free fatty acids from peripheral tissue to the liver and (3) reducing DNL in the liver. FGF21 exerts its systemic effects by reducing the serum levels of lipids (e.g., triglycerides, LDL cholesterol) and increasing insulin sensitivity. Increasing insulin sensitivity reduces lipolysis and can also reduce serum levels of lipids. In particular, FGF21 has been demonstrated to reduce liver fat in patients with NASH in multiple clinical trials.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Improving Liver Inflammation and Fibrosis</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-weight:normal;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">FGF21 is also believed to reduce liver fibrosis, the pathological change mostly clearly linked to liver-related morbidity in NASH patients via two potential pathways. One pathway is through the metabolic benefits of FGF21 described above. Long-term improvements in metabolic regulation reduce the ongoing liver injury that drives fibrosis and thus allows the liver time to heal. The other pathway is a direct anti-fibrotic effect mediated via adiponectin, an adipokine that is upregulated by FGF21. Increased adiponectin downregulates the hepatic stellate cells that are activated upon hepatic injury and responsible for collagen deposition and subsequent fibrosis. FGF21 demonstrated an improvement in liver fibrosis in patients in NASH in a clinical trial.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">FGF21 Signaling</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As noted above, FGF21 exerts its biological benefits through the co-activation of FGFRs and &#223;-Klotho. FGFRs are expressed widely throughout the body whereas &#223;-Klotho is primarily expressed in metabolic tissues such as adipose tissue, liver, and pancreas, thereby providing organ specificity to FGF21. The binding of FGF21 is a two-step process. The C-terminus of FGF21 initially binds to &#223;-Klotho enabling the N-terminus to form an expanded complex with one of the FGFRs. Once the co-receptor complex has formed with &#223;<span style="font-style:italic;">-</span>Klotho and one of the FGFRs, a series of intracellular signaling cascades is initiated. These signaling cascades enable FGF21 to exert its biological functions.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">FGF21 activates three specific FGFRs (FGFR1c, FGFR2c and FGFR3c), which based on nonclinical studies and clinical trials, appear to be responsible for mediating the desired therapeutic actions of FGF21 in NASH. FGF21 is not believed to activate FGFR4. Activation of FGFR4 results in an increase in LDL cholesterol and has been implicated in the etiology or progression of HCC. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Pegozafermin</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Overview</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are developing <span style="color:#000000;">pegozafermin</span>, a specifically engineered glycoPEGylated analog of FGF21, for the treatment of NASH and SHTG. <span style="color:#000000;">Pegozafermin</span> has been specifically engineered to retain the activity of native FGF21 while extending its half-life. Specifically, it has been engineered to: (1) protect against proteolysis and reduce renal clearance, (2) have an extended half-life, (3) minimize susceptibility to aggregate in solution and (4) optimize its potency, enabling the potential use of lower dosage/doses. Additionally, we believe that <span style="color:#000000;">pegozafermin</span> may enhance binding affinity for &#223;-Klotho, by altering the conformation of the C-terminus which could have a positive impact on efficacy.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Primary Structure and Protein Engineering of Pegozafermin</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegozafermin<span style="color:#000000;"> has been optimally constructed with two mutations via substitutions with natural amino acids at site-specific positions (173 and 176) toward the C-terminus end of the hormone. The mutations were incorporated into the FGF21 sequence after existing proline to create a consensus sequence for glycosylation. Subsequently, the glycosyl linker and a single 20 kDa glycoPEG moiety were enzymatically introduced at the O-linked glycosylation consensus site (position 173) via the proprietary glycoPEGylation technology. Our glycoPEG moiety is an activated form of the PEG molecule with the use of Sialic Acid, CMP-SA-PEG. The proximity of the mutations ensures consistent and efficient attachment of the glycoPEG moiety.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegozafermin<span style="color:#000000;"> has two modified natural amino acid residues:</span></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#231F20;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">S173T: Serine modified to Threonine at position 173&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#231F20;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">R176A: Arginine modified to Alanine at position 176.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, a Methionine residue was introduced at the N-terminus which acts as the translation initiation signal. Figure 1 below shows the structure of <span style="color:#000000;">pegozafermin</span>.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"><span style="color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Figure </span><span style="color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">1</span><span style="color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">: Structure of </span><span style="color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">P</span><span style="color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">egozafermin</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gb2k1ptlkg5v000001.jpg" title="" alt="" style="width:553px;height:231px;" /></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The increase in the size of the molecule from 19.4 kDa to 40 kDa together with the site-specific mutations adjacent to the primary cleavage site of FGF21 (by the FAP enzyme between positions 171 and 172 on the native amino acid chain, which would be represented by positions 172 and 173 in our molecule starting with Methionine in position 1) are designed to prolong the half-life of the molecule. Additionally, we believe that the use of glycoPEGylation technology produces a comparatively stronger and more flexible structure, which aids in the development of a stable formulation. PEGylation technology has been used successfully in many pharmaceutical products including products that have been marketed for more than 10 years.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegozafermin<span style="color:#000000;"> uses a proprietary glycoPEGylation technology that has been previously validated by a third party, as this technology is incorporated in another pharmaceutical product (Lonquex&#174; by Teva) that has received regulatory approval and is currently commercialized in the European Union.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Figure 2: Summary of P<span style="color:#000000;">egozafermin</span> Attributes and Benefits</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#3297D3;width:20%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;margin-left:28.3pt;;text-indent:0pt;;font-weight:bold;color:#FFFFFF;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Features</p></td>
<td valign="top" style="background-color:#3297D3;width:50%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;margin-left:0.4pt;;text-indent:0pt;;font-weight:bold;color:#FFFFFF;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
<td valign="top" style="background-color:#3297D3;width:30%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;margin-left:34.25pt;;text-indent:0pt;;font-weight:bold;color:#FFFFFF;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Potential Benefit</p></td>
</tr>
<tr>
<td rowspan="3" valign="top" style="width:20%; border-top:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="margin-top:2pt;margin-bottom:0pt;margin-left:4.5pt;;margin-right:4.7%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Use of PEG (via glycoPEGylation)</p></td>
<td valign="top" style="width:50%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="margin-top:2pt;margin-bottom:0pt;margin-left:20pt;;margin-right:6.62%;text-indent:-15pt;;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9642;&#160;&#160;&#160;&#160;&#160;&#160;<span style="color:#000000;">Increases protein size and hydrodynamic volume that reduces renal filtration</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:20pt;;margin-right:6.62%;text-indent:-15pt;;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9642;&#160;&#160;&#160;&#160;&#160;&#160;<span style="color:#000000;">Prevents degradation by endocytosis and proteolytic enzymes</span></p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="margin-top:2pt;margin-bottom:0pt;margin-left:20pt;;text-indent:-15pt;;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9642;&#160;&#160;&#160;&#160;&#160;&#160;<span style="color:#000000;">Prolongs half-life</span></p></td>
</tr>
<tr>
<td valign="top" style="width:50%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:20pt;;margin-right:2.78%;text-indent:-15pt;;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9642;&#160;&#160;&#160;&#160;&#160;&#160;<span style="color:#000000;">Protects antigenic sites present on the protein surface (i.e. antigenic epitopes)</span></p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="margin-top:2pt;margin-bottom:0pt;margin-left:20pt;;text-indent:-15pt;;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9642;&#160;&#160;&#160;&#160;&#160;&#160;<span style="color:#000000;">Reduces immunogenicity</span></p></td>
</tr>
<tr>
<td valign="top" style="width:50%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="margin-top:2pt;margin-bottom:0pt;margin-left:20pt;;margin-right:1.71%;text-indent:-15pt;;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9642;&#160;&#160;&#160;&#160;&#160;&#160;<span style="color:#000000;">Steric repulsion between the PEGylated surfaces increases water solubility and reduces aggregates</span></p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="margin-top:2pt;margin-bottom:0pt;margin-left:20pt;;margin-right:6.41%;text-indent:-15pt;;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9642;&#160;&#160;&#160;&#160;&#160;&#160;<span style="color:#000000;">Results in more stable formulation</span></p></td>
</tr>
<tr>
<td valign="top" style="width:20%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="margin-top:2pt;margin-bottom:0pt;margin-left:4.5pt;;margin-right:8.97%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Site-Specific Mutations</p></td>
<td valign="top" style="width:50%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="margin-top:2pt;margin-bottom:0pt;margin-left:20pt;;margin-right:7.26%;text-indent:-15pt;;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9642;&#160;&#160;&#160;&#160;&#160;&#160;<span style="color:#000000;">Mutation at position 173 is immediately adjacent to the primary cleavage (FAP enzyme) site of FGF21</span></p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="margin-top:2pt;margin-bottom:0pt;margin-left:20pt;;text-indent:-15pt;;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9642;&#160;&#160;&#160;&#160;&#160;&#160;<span style="color:#000000;">Prolongs half-life</span></p></td>
</tr>
<tr>
<td rowspan="2" valign="top" style="width:20%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="margin-top:2pt;margin-bottom:0pt;margin-left:4.5pt;;margin-right:4.91%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GlycoPEGylation Technology</p></td>
<td valign="top" style="width:50%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="margin-top:2pt;margin-bottom:0pt;margin-left:20pt;;margin-right:1.5%;text-indent:-15pt;;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9642;&#160;&#160;&#160;&#160;&#160;&#160;<span style="color:#000000;">Allows site specific linkage (glycoPEG moiety to position 173)</span></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:20pt;;text-indent:-15pt;;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9642;&#160;&#160;&#160;&#160;&#160;&#160;<span style="color:#000000;">Proximity of the glycoPEG moiety to the</span></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:20pt;;margin-right:1.71%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">C-terminus induces conformational changes to the molecule</p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="margin-top:2pt;margin-bottom:0pt;margin-left:20pt;;margin-right:1.07%;text-indent:-15pt;;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9642;&#160;&#160;&#160;&#160;&#160;&#160;<span style="color:#000000;">Retains potency against receptor to improve efficacy</span></p></td>
</tr>
<tr>
<td valign="top" style="width:50%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="margin-top:2pt;margin-bottom:0pt;margin-left:20pt;;margin-right:2.14%;text-indent:-15pt;;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9642;&#160;&#160;&#160;&#160;&#160;&#160;<span style="color:#000000;">Provides a strong and flexible glycosyl bond that helps the glycoPEG moiety remain intact, further reducing degradation</span></p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="margin-top:2pt;margin-bottom:0pt;margin-left:20pt;;text-indent:-15pt;;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9642;&#160;&#160;&#160;&#160;&#160;&#160;<span style="color:#000000;">Further enhances half-life</span></p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Therapeutic Potential of Pegozafermin Supported by Preclinical Animal Models of NASH, Diabetes and Obesity</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegozafermin<span style="color:#000000;"> has been evaluated in three animal models of direct relevance to NASH. These included: (1) Stelic Animal Model, (&#8220;STAM&#8221;), (2) Diet-induced NASH (&#8220;DIN&#8221;) model and (3) spontaneous diabetic obese cynomolgus monkey model. Additional studies done in diabetes mouse model and diet induced obesity mouse model showed benefits in key markers of relevance in NASH.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A wide range of doses were tested in these studies as well as weekly and once every two-week dosing regimen was tested in a cynomolgus monkey study. The key outcomes of these studies are summarized in Figure 3 below.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Figure 3: Summary of NASH Pharmacology Studies</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100.46%;">
<tr style="height:37.75pt;">
<td valign="middle" style="background-color:#3297D3;width:31.02%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#FFFFFF;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Preclinical pharmacology study with</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#FFFFFF;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">pegozafermin</p></td>
<td valign="middle" style="background-color:#3297D3;width:11.5%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#FFFFFF;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Improved</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#FFFFFF;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Insulin</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#FFFFFF;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Sensitivity</p></td>
<td valign="middle" style="background-color:#3297D3;width:14.4%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#FFFFFF;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Improved Triglycerides and Cholesterol</p></td>
<td valign="middle" style="background-color:#3297D3;width:13.4%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#FFFFFF;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Reduced</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#FFFFFF;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Hepatocyte</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#FFFFFF;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Injury</p></td>
<td valign="middle" style="background-color:#3297D3;width:17.26%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#FFFFFF;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Reduced Liver Steatosis, Inflammation &#38; </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#FFFFFF;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fibrosis</p></td>
<td valign="middle" style="background-color:#3297D3;width:12.46%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#FFFFFF;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Body</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#FFFFFF;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weight</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#FFFFFF;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Reduction</p></td>
</tr>
<tr style="height:18.35pt;">
<td valign="middle" style="width:31.02%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DIN mouse model I (10 weeks)</p></td>
<td valign="middle" style="width:11.5%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#10003;</p></td>
<td valign="middle" style="width:14.4%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#10003;</p></td>
<td valign="middle" style="width:13.4%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#10003;</p></td>
<td valign="middle" style="width:17.26%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#10003;</p></td>
<td valign="middle" style="width:12.46%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#10003;</p></td>
</tr>
<tr style="height:18.35pt;">
<td valign="middle" style="width:31.02%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DIN mouse model II (19 weeks)</p></td>
<td valign="middle" style="width:11.5%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#10003;</p></td>
<td valign="middle" style="width:14.4%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#10003;</p></td>
<td valign="middle" style="width:13.4%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#10003;</p></td>
<td valign="middle" style="width:17.26%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#10003;</p></td>
<td valign="middle" style="width:12.46%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#10003;</p></td>
</tr>
<tr style="height:28.8pt;">
<td valign="middle" style="width:31.02%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Diabetic obese cynomolgus monkey study 1 (8 weeks&#59; weekly dosing)</p></td>
<td valign="middle" style="width:11.5%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#10003;</p></td>
<td valign="middle" style="width:14.4%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#10003;</p></td>
<td valign="middle" style="width:13.4%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#10003;</p></td>
<td valign="middle" style="width:17.26%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not evaluated</p></td>
<td valign="middle" style="width:12.46%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#10003;</p></td>
</tr>
<tr style="height:28.8pt;">
<td valign="middle" style="width:31.02%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Diabetic obese cynomolgus monkey study 2 (4 weeks&#59; QW or Q2W dosing)</p></td>
<td valign="middle" style="width:11.5%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#10003;</p></td>
<td valign="middle" style="width:14.4%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#10003;</p></td>
<td valign="middle" style="width:13.4%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#10003;</p></td>
<td valign="middle" style="width:17.26%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not evaluated</p></td>
<td valign="middle" style="width:12.46%; border-top:solid 0.75pt #231F20; border-bottom:solid 0.75pt #231F20; border-left:solid 0.75pt #231F20; border-right:solid 0.75pt #231F20;">
<p style="text-align:center;margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#10003;</p></td>
</tr>
</table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;font-size:10pt;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:'Times New Roman';"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#231F20;font-size:10pt;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:'Times New Roman';"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#10003;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Statistically significant benefit observed.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Pegozafermin Clinical Development in NASH</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Phase 1a Clinical Trial of Single-Dose of Pegozafermin in Healthy Volunteers</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:2pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:4pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We conducted a Phase 1a clinical trial to evaluate the safety, tolerability and PK of <span style="color:#000000;">pegozafermin</span> in 58 healthy volunteers. In this randomized, double-blind, placebo-controlled, Phase 1a, first-in-human, SAD clinical trial the PK profile of <span style="color:#000000;">pegozafermin</span> was generally dose-proportional or slightly more than dose-proportional with a half-life of approximately 55 to 100 hours. At single doses of 9.1 mg and higher, significant improvements were observed in key lipid parameters measured at Day 8 and Day 15 after dosing on Day 1. The mean changes versus baseline include significant reductions in triglycerides (up to 51%) and LDL-C (up to 37%) and increase in HDL-C (up to 36%) despite the baseline values being in the normal range. <span style="color:#000000;">Pegozafermin</span> demonstrated rapid (starting from Day 2), sustained and durable improvements on lipid parameters for two weeks or more after single-dose administration. P<span style="color:#000000;">egozafermin</span> was well tolerated across the dose range and there were no deaths, serious adverse events or discontinuations due to adverse events. The most commonly observed treatment-related adverse events, occurring in at least two subjects in the pooled <span style="color:#000000;">pegozafermin</span> group, were injection site reactions and headache, all of which were reported as mild. No clinically meaningful trends were observed in gastrointestinal events, laboratories or vital signs including blood pressure or heart rate changes. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Phase 1b/2a Proof of Concept Clinical Trial in NASH Patients</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In September 2020 and January 2022, we presented positive topline results from cohorts 1 to 6 and cohort 7 respectively in our Phase 1b/2a trial in NASH patients which has informed the advancement of our clinical strategy in <span style="color:#000000;">NASH</span>. <span style="Background-color:#FFFFFF;">The phase 1b/2a trial for cohorts 1 to 6 was multicenter, randomized, double-blind, placebo-controlled, multiple ascending dose-ranging and enrolled a total of 81 patients</span><span style="Background-color:#FFFFFF;">&#160;to receive weekly (3mg/9mg/18mg/27mg) or every two-week (18mg/36mg) </span><span style="Background-color:#FFFFFF;">dosing of pegozafermin or placebo for up to 12 weeks. Key endpoints assessed were safety, tolerability, and PK of pegozafermin </span><span style="Background-color:#FFFFFF;">as well as change in liver fat measured by MRI-PDFF and other metabolic markers. The trial design is shown in Figure 4 below. </span></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"><span style="color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Figure</span><span style="color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">4</span><span style="color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">: </span><span style="color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Phase 1b/2a Trial Design</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gb2k1ptlkg5v000002.jpg" title="" alt="" style="width:624px;height:141px;" /><span style="Background-color:#FFFFFF;"></span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">As shown in Figure 5 below, all dose groups in cohorts 1 to 6 demonstrated significant reductions in liver fat at week 13, with relative reductions up to 60% versus baseline and up to 70% versus placebo, as measured by MRI-PDFF. </span><span style="Background-color:#FFFFFF;">43% of the patients at the highest dose achieved normal liver fat content of &#60; 5%. </span><span style="Background-color:#FFFFFF;">A significant proportion of patients responded to therapy with up to 88% and 71% of patients achieving a&#160;&#8805;30% or a&#160;&#8805;50% reduction in liver fat versus baseline, respectively.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Figure 5: Relative Reduction in Liver Fat vs. Placebo at Week 13</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gb2k1ptlkg5v000003.jpg" title="" alt="" style="width:472px;height:308px;" /></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gb2k1ptlkg5v000004.jpg" title="" alt="" style="width:620px;height:24px;" /><span style="Background-color:#FFFFFF;"></span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">As shown in Figure 6 below for cohorts 1 to 6, treatment with </span>pegozafermin<span style="Background-color:#FFFFFF;"> also resulted in significant improvements in liver transaminases, with up to a 44% reduction in ALT and a 35 U/L decrease in ALT in patients with elevated baseline levels. Treatment with </span>pegozafermin<span style="Background-color:#FFFFFF;"> resulted in significant reductions in triglycerides (up to 28%&#59; p &#60;0.05), non-HDL (up to 16%&#59; p&#60;0.01) and LDL-C (up to 16%&#59; p&#60;0.05). Triglycerides were reduced to a greater extent in patients with elevated triglycerides at baseline (TG &#8805;200 mg/dL), and 53% of the </span>pegozafermin<span style="Background-color:#FFFFFF;"> patients in this group normalized triglyceride levels versus 0% in the placebo group. </span>Pegozafermin<span style="Background-color:#FFFFFF;"> also demonstrated significant increases in the insulin-sensitizing hormone adiponectin (up to 61%&#59; p&#60;0.001). Improvements were also noted across the spectrum of metabolic marker data vs. placebo for the 27mg QW dose group including HOMA-IR, glucose, HbA1c, and body weight (p&#60;0.05). </span></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"><span style="color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Figure </span><span style="color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">6</span><span style="color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">: </span><span style="color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Clinically Meaningful ALT Reduction&#59; Greater Reduction in Patients with High ALT</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gb2k1ptlkg5v000005.jpg" title="" alt="" style="width:624px;height:322px;" /><span style="Background-color:#FFFFFF;"></span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Additional analyses presented at the Endocrine Society&#8217;s annual meeting in March 2021 demonstrated that </span>pegozafermin<span style="Background-color:#FFFFFF;"> treatment resulted in significant reductions in liver volume of up to 15% and liver fat volume of up to 65% in treated patients at 13 weeks compared to baseline, as measured by MRI-PDFF. A post-hoc analysis presented at The Liver Meeting of AASLD in November 2021 assessed the effect of </span>pegozafermin<span style="Background-color:#FFFFFF;"> on spleen volume (SV) in NASH patients without advanced fibrosis. SV was evaluated by MRI in all eligible patients on </span>pegozafermin<span style="Background-color:#FFFFFF;"> 27mg every week dose (n&#61;8), </span>pegozafermin<span style="Background-color:#FFFFFF;"> 36mg every two-week dose (n&#61;8) and 16 patients on placebo. At baseline, it was observed that SV was correlated with liver volume, vibration-controlled transient elastography (VCTE) score and body mass index (BMI), and negatively correlated with platelet count. Findings at study Day 50 and Day 92 demonstrated that treatment with </span>pegozafermin<span style="Background-color:#FFFFFF;"> led to a progressive and significant decrease in SV compared to placebo (on Day 50, treated patients saw an average 7.4% decrease in SV and by Day 92 patients saw an average 11.8% decrease in SV).</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Paired-biopsy, Open-label Histology Cohort (Cohort 7)</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Cohort 7 in the Phase 1b/2a trial was a single-arm cohort that enrolled 20 patients with biopsy-confirmed fibrosis stage F2 and F3 NASH who were treated once weekly for 20 weeks with 27 mg of pegozafermin. 19 of 20 patents received an end of treatment biopsy and one patient withdrew consent. A greater than or equal to 2-point improvement in NAS (with 1-point from either ballooning or inflammation) and no worsening of fibrosis was the nominal primary endpoint. Key secondary endpoints included response rates on NASH resolution without worsening of fibrosis, improvement in at least one stage of fibrosis without worsening NAS and safety/tolerability. Patients had a mean BMI of 37 and type 2 diabetes was prevalent in most patients. 65% had fibrosis stage F3 NASH and 35% had fibrosis stage F2 NASH, a higher proportion of F3 patients than is typical for most proof-of-concept NASH studies. The baseline values for VCTE, ProC3, and transaminases were consistent with a more advanced population.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">74% of patients achieved a </span><span style="color:#000000;">greater than or equal to 2-point improvement in NAS with at least a 1-point improvement in ballooning or inflammation</span><span style="Background-color:#FFFFFF;">. Substantial reductions were observed across all 3 NAS components (&#8805;1 point change) &#8211; ballooning (79%), inflammation (47%), and steatosis (74%). All patients had improvement or no change in ballooning and inflammation. The histology results demonstrate proof-of-concept for the translation of pegozafermin&#8217;s effects on liver fat, ALT, and other relevant non-invasive measures into histological improvement.</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:12pt;font-family:Times New Roman;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Figure 7: Histology Results</span></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:99.95%;">
<tr>
<td style="width:73.99%;"></td>
<td style="width:25.96%;"></td>
</tr>
<tr>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">&#8805;2-point improvement in NAS without worsening of fibrosis<sup style="font-size:85%;line-height:120%;vertical-align:top">1</sup> (primary endpoint)</span></p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">63%</span></p></td>
</tr>
<tr>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">&#8805;2-point improvement in NAS<sup style="font-size:85%;line-height:120%;vertical-align:top">1</sup></span></p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">74%</span></p></td>
</tr>
<tr>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">NASH resolution without worsening of fibrosis</span></p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">32%&#59; 95% CI: 13%-57%</span></p></td>
</tr>
<tr>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">One-stage improvement of fibrosis without worsening of NASH</span></p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">26%&#59; 95% CI: 9%-51%</span></p></td>
</tr>
<tr>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">NASH resolution or fibrosis improvement</span></p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">47%</span></p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">NAS &#61; NAFLD Activity Score</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;"><sup style="font-size:85%;line-height:120%;vertical-align:top">1</sup>A 2-point improvement in NAS score required a 1-point improvement in either ballooning or inflammation</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Data from a new analysis of the same histology slides by a panel of an additional three expert liver pathologists resulted in a wide range of response rates, with rates of NASH resolution without worsening of fibrosis up to 47% and rates of &#8805; 1-stage improvement in fibrosis without worsening of NASH up to 42% as shown in Figure 8 below.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:12pt;font-family:Times New Roman;">&#160;</p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Figure 8: New Analysis of Cohort 7 Histology Slides By a Panel of Three Experts</span></p>
<p style="margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gb2k1ptlkg5v000006.jpg" title="" alt="" style="width:624px;height:264px;" /></p>
<p style="margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gb2k1ptlkg5v000007.jpg" title="" alt="" style="width:395px;height:21px;" /></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">To assess pegozafermin&#8217;s effect on the whole liver, a number of NITs including imaging, serum biomarkers, and risk stratification scores were built into the study. Clinically meaningful and significant changes were observed across these key NITs associated with fibrosis, risk of fibrosis, or NASH resolution. The consistency of data across all these endpoints and the magnitude of changes observed in these NITs suggest that pegozafermin is improving total liver health.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Figure 9: Non-Invasive Tests (NITs) [marker of]</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:99.95%;">
<tr>
<td style="width:44.18%;"></td>
<td style="width:25%;"></td>
<td style="width:30.77%;"></td>
</tr>
<tr>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&#160;</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Mean change from baseline at Week 20</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Responder rates by clinically relevant thresholds </p></td>
</tr>
<tr>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MRI-PDFF [liver fat content]<sup style="font-size:85%;line-height:120%;vertical-align:top">1</sup></p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-64%<sup style="font-size:85%;line-height:120%;vertical-align:top">***</sup></p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100%/78% [&#8805; 30%/&#8805; 50%]</p></td>
</tr>
<tr>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ALT (Alanine aminotransferase) [liver damage]<sup style="font-size:85%;line-height:120%;vertical-align:top">2</sup></p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-46%<sup style="font-size:85%;line-height:120%;vertical-align:top">***</sup></p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  71%<sup style="font-size:85%;line-height:120%;vertical-align:top">3</sup> [&#8805; 17 U/L]</p></td>
</tr>
<tr>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">FAST Score [risk for advanced fibrosis]<sup style="font-size:85%;line-height:120%;vertical-align:top">4</sup></p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-76%<sup style="font-size:85%;line-height:120%;vertical-align:top">***</sup></p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; 88% [&#8804; 0.35]</p></td>
</tr>
<tr>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">VCTE [liver stiffness]<sup style="font-size:85%;line-height:120%;vertical-align:top">5</sup></p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-31%<sup style="font-size:85%;line-height:120%;vertical-align:top">***</sup></p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160;72% [&#62; 20% decrease]</p></td>
</tr>
<tr>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pro-C3 [collagen deposition]<sup style="font-size:85%;line-height:120%;vertical-align:top">6</sup></p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-20%<sup style="font-size:85%;line-height:120%;vertical-align:top">***</sup></p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;  &#160;&#160;&#160;&#160;63% [&#62; 15% decrease]</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*** p&#60;0.001</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1 Changes from baseline &#8805; 30% and &#8805; 50% have been correlated with NASH improvement</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2 ALT changes &#8805; 17 U/L have been correlated with histological improvement</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 In patients with elevated ALT as defined by &#8805;30 U/L in women and &#8805;40 U/L in men (n&#61;14)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4 FAST score is a composite of imaging and blood markers and measured on 0-1 scale, a score &#8804; 0.35 predicts Fibrosis Stage F0/F1 and NAS &#60;4 </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5 VCTE is a Fibroscan assessment, &#62;20% reduction has been correlated with fibrosis improvement</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6 Pro-C3 is a blood-based measurement, &#62;15% reduction has been correlated with fibrosis improvement</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&#160;</p>
<p style="margin-top:1pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In addition to significant improvement in liver health, treatment with pegozafermin also had significant positive effects on glycemic control, lipids, adiponectin, and body weight. </span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Figure 10: Cardio-Metabolic Endpoints</span></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:88.41%;">
<tr>
<td style="width:44.18%;"></td>
<td style="width:44.23%;"></td>
</tr>
<tr>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Mean change from baseline at Week 20</span></p></td>
</tr>
<tr>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">HbA1c absolute change<sup style="font-size:85%;line-height:120%;vertical-align:top">1</sup> </span></p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; -0.9%**</span></p></td>
</tr>
<tr>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Triglycerides<sup style="font-size:85%;line-height:120%;vertical-align:top">2</sup></span></p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">-32%***</span></p></td>
</tr>
<tr>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">LDL-C</span></p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  &#160;&#160;-13%*</span></p></td>
</tr>
<tr>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">HDL-C</span></p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; +23%***</span></p></td>
</tr>
<tr>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Adiponectin</span></p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; +87%***</span></p></td>
</tr>
<tr>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Body Weight</span></p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-4%***</span></p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">*p&#60;0.05&#59; **p&#60;0.01&#59; ***p&#60;0.001</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;"><sup style="font-size:85%;line-height:120%;vertical-align:top">1</sup> In patients with HbA1c &#8805; 6.5% at baseline (n&#61;10)&#59; patients were all on concomitant diabetes medications</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;"><sup style="font-size:85%;line-height:120%;vertical-align:top">2</sup> In patients with elevated triglycerides at baseline (n&#61;11)&#59; reduction was -26% across total population</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In 83 patients treated with pegozafermin across the full Phase 1b/2a study in cohorts 1 to 7, pegozafermin continues to be generally well tolerated with a favorable safety profile. There have been no drug-related serious adverse events and only one treatment-related discontinuation. Pooled pegozafermin treatment related adverse events in </span><span style="color:#000000;">greater than or equal to</span><span style="Background-color:#FFFFFF;"> 10% of patients were increased appetite (13% vs 0% placebo), diarrhea (13% vs 11% placebo), and nausea (12% vs 11% placebo). Most of the GI adverse events were mild and of short duration. A few mild injection site reactions were reported and there were no tremors and no hypersensitivity adverse events observed. Pegozafermin had no adverse effects on blood pressure or heart rate. </span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:12pt;font-family:Times New Roman;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Phase 2b (ENLIVEN) Trial in Fibrosis Stage 2 or 3 NASH Patients </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The ENLIVEN trial </span>is planned to enroll NASH patients with fibrosis stage 2 or 3 and NAS &#8805;4. These patients will receive either 15 mg or 30 mg weekly doses or 44 mg every two-week dose of pegozafermin or placebo for 24 weeks followed by a blinded extension phase of an additional 24 weeks for a total treatment period of 48 weeks. We expect to report topline data in the first half of 2023<span style="color:#000000;">. Based on learnings from our recent cohort, developments in the field, and feedback from our steering committee, we are working on steps to optimize the ENLIVEN trial</span>.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Pegozafermin Clinical Development in SHTG</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegozafermin has demonstrated significant reduction in triglyceride levels across all our preclinical and clinical studies. In our Phase 1b/2a trial, treatment with pegozafermin in cohorts 1 to 6 (mean baseline TG&#61;174 mg/dL) and cohort 7 (mean baseline TG&#61;170 mg/dL) <span style="Background-color:#FFFFFF;color:#000000;">resulted in significant reductions in triglycerides (up to 28% and 26% respectively) Triglycerides were reduced to a greater extent in patients with elevated levels at baseline across cohorts 1 to 6 (TG &#8805; 200mg/mL) and cohort 7 (TG &#8805; 150mg/mL) of 37% </span>and 32%, respectively<span style="Background-color:#FFFFFF;color:#000000;">. </span>While </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">currently approved SHTG therapies decrease triglyceride levels, they generally do not have broader metabolic benefits</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> such as reduction in liver fat content, reduction in transaminases, and improvement in glycemic control</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> We presented data at the National Lipid Association meeting in 2021 that demonstrated a mean liver fat content of 20% at baseline in the first 14 patients in the MRI-PDFF sub</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">study of the ENTRIGUE trial. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We initiated the ENTRIGUE trial in SHTG patients in the third quarter of 2020 and have closed enrollment with 85 patients either on background lipid treatment with statins and/or prescription fish oil and/or fibrates or not on any background therapy. <span style="color:#000000;">In this randomized, double-blind, placebo-controlled study, patients receive pegozafermin administered weekly (9 mg, 18 mg or 27 mg) or every two weeks (36 mg) or placebo over an eight-week treatment period. The primary endpoint is the percentage change in fasting triglyceride levels from baseline. Key secondary endpoints include other lipids and metabolic markers and a sub-study evaluating change in liver fat measured by MRI-PDFF. </span>Screening in the fibrate cohort was stopped with the main study and will be analyzed as part of main ENTRIGUE trial.<span style="color:#000000;"> Topline data from ENTRIGUE is expected in the second quarter of 2022</span>.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There is regulatory precedence for the approval of therapies for the treatment of SHTG in the United States based on the reduction in triglycerides from baseline as the primary endpoint for full approval. The FDA surrogate endpoint table for drug approval lists a reduction in triglycerides from baseline as the endpoint for full approval of a therapy in SHTG. A clinical outcome study was not required for certain third-party approvals in SHTG or as a post-marketing commitment. The SHTG Phase 3 trial for some of these products consisted of a single study of 75 to 100 patients per treatment group with a 12-week duration. Based on the regulatory path followed by other companies that have successfully developed SHTG therapies, we believe that a combination of smaller clinical trials and shorter development timelines could mean that SHTG potentially represents a quicker path to market for pegozafermin. The Phase 3 trial could potentially evaluate pegozafermin as an add-on therapy in refractory patients or patients not on background therapy with a primary endpoint of percentage change in fasting triglyceride levels from baseline at 12-24 weeks. The key secondary endpoints could include an assessment of liver fat reduction, glycemic control, weight, and other lipids. The safety database could potentially include trials in other hypertriglyceridemia patient populations.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Figure 11: Pegozafermin Could Potentially Address Metabolic Conditions Associated With SHTG</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gb2k1ptlkg5v000008.jpg" title="" alt="" style="width:624px;height:304px;" /></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;font-style:italic;;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;font-style:italic;;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Agreements with Teva</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Agreements Relating to FGF21 Program</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2018, we entered into an Asset Transfer and License Agreement (the &#8220;FGF21 Agreement&#8221;) with Teva Pharmaceutical Industries Ltd (&#8220;Teva&#8221;), under which we acquired certain patents, intellectual property and other assets relating to Teva&#8217;s glycoPEGylated FGF21 program. Under this agreement, Teva also granted a perpetual, non-exclusive (but exclusive as to pegozafermin), non-transferable, worldwide license to patents and know-how related to glycoPEGylation technology for use in the research, development, manufacture and commercialization of the compound pegozafermin and products containing pegozafermin. In addition, we entered into a Sublicense Agreement with ratiopharm (the &#8220;ratiopharm Sublicense&#8221;), under which we were granted a perpetual, exclusive, worldwide sublicense to patents and know-how related to glycoPEGylation technology used in the development, manufacture and commercialization of pegozafermin and products containing pegozafermin.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the FGF21 Agreement, we are obligated to use commercially reasonable efforts to develop and commercialize pegozafermin in each of the United States and five major European countries. We have the right to sublicense all rights licensed to us by Teva under the FGF21 Agreement.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the FGF21 Agreement and the FASN Agreement (as defined and described below), we paid Teva a nonrefundable upfront payment of $6.0 million. In addition, under the FGF21 Agreement, we are required to make certain payments to Teva totaling $2.5 million for the achievement of certain clinical development milestones, and additional payments totaling up to $65.0 million upon achievement of certain commercial milestones. We are also obligated to pay Teva tiered royalties at percentages in the low-to-mid single-digits on worldwide net sales of products containing pegozafermin. Our royalty obligations will terminate, on a product-by-product and country-by-country basis, at the later of: (1) the date of expiration of the last to expire valid claim in the assigned patents that covers pegozafermin in such country, (2) the expiration of data or regulatory exclusivity for pegozafermin in such country and (3) 10 years from the first commercial sale of pegozafermin in such country. We are not required to make any payments to ratiopharm pursuant to the ratiopharm Sublicense.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The term of the FGF21 Agreement will continue, on a product-by-product and country-by-country basis, until the royalty term with respect to pegozafermin in such country expires. The ratiopharm Sublicense will continue until terminated in accordance with its terms. We may terminate the FGF21 Agreement and the ratiopharm Sublicense for any reason. Either party may terminate the FGF21 Agreement for cause for the other party&#8217;s uncured material breach. ratiopharm may terminate the ratiopharm Sublicense for certain material breaches by us. Either party may terminate the FGF21 Agreement or the ratiopharm Sublicense in the event of bankruptcy of the other party. Teva may terminate the FGF21 Agreement if we challenge the validity of any patent licensed to us under the FGF21 Agreement. Termination of the FGF21 Agreement or the ratiopharm Sublicense will impact our rights under the intellectual property licensed to us by Teva and ratiopharm, respectively, but will not affect our rights under the assets assigned to us.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2018, we also entered into a Reagent Supply and Technology Transfer Agreement, under which Teva will supply us with certain reagents required for the glycoPEGylation process that are necessary for our development and commercialization of pegozafermin, and transfer to us certain know-how required for the production of such reagents. The term of this agreement was extended by mutual agreement until December 31, 2022.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">FASN Agreements</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2018, we entered into an Asset Transfer and License Agreement with Teva under which we acquired from Teva patents, intellectual property and other assets relating to Teva&#8217;s development program of small molecule inhibitors of FASN (the &#8220;FASN Agreement&#8221;). Under the FASN Agreement we are obligated to use commercially reasonable efforts to develop and commercialize FASN in the United States and five major European countries. We have the right to sublicense all rights licensed to us by Teva under the FASN Agreement.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the FASN Agreement and the FGF21 Agreement (as described above), we paid Teva a nonrefundable upfront payment of $6.0 million. In addition, under the FASN Agreement, we are required to make certain payments to Teva totaling $2.5 million for the achievement of certain clinical development milestones, and </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">additional payments totaling up to $65.0 million upon achievement of certain commercial milestones. We are also obligated to pay Teva tiered royalties at percentages in the low-to-mid single-digits on worldwide net sales of products arising from the FASN program. Our royalty obligations will terminate, on a product-by-product and country-by-country basis, at the later of: (1) the date of expiration of the last to expire valid claim in the assigned patents that covers FASN in such country, (2) the expiration of data or regulatory exclusivity for such product arising from the FASN program in such country and (3) 10 years from the first commercial sale of a product arising from the FASN program in such country.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The term of the FASN Agreement will continue, on a product-by-product and country-by-country basis, until the royalty term with respect to the product arising from the FASN program in such country expires. We may terminate the FASN Agreement for any reason. Either party may terminate the agreement for cause for the other party&#8217;s uncured material breach, or in the event of bankruptcy of the other party.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Government Regulation and Product Approval</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FDA and other regulatory authorities at federal, state and local levels, as well as in foreign countries, extensively regulate, among other things, the research, development, testing, manufacture, quality control, import, export, safety, effectiveness, labeling, packaging, storage, distribution, record keeping, approval, advertising, promotion, marketing, post-approval monitoring and post-approval reporting of biologics, such as those we are developing. We, along with third-party contractors, will be required to navigate the various preclinical, clinical and commercial approval requirements of the governing regulatory agencies of the countries in which we wish to conduct studies or seek approval or licensure of our product candidates.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The process required by the FDA before biologic product candidates may be marketed in the United States is expensive and time-consuming. Generally, this process involves completing pre-clinical laboratory studies before the FDA will allow human clinical trials to commence. We are then required to complete human clinical trials to demonstrate that a product candidate is safe and effective. Following the completion of these clinical trials, we are required to prepare and submit a biologics license (&#8220;BLA&#8221;) application, which presents the FDA with detailed clinical and safety data, as well as manufacturing data. As part of the review of a BLA, the FDA may inspect manufacturing facilities to assure that the facilities, methods and controls are adequate to preserve the biological product&#8217;s continued safety, purity and potency, and may also inspect selected clinical investigation sites to assess compliance with current Good Clinical Practices (&#8220;cGCP&#8221;). This process takes many years from inception through filing of a BLA application and the likelihood of success is highly uncertain.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Preclinical and Clinical Development</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to beginning the first clinical trial with a product candidate, we must submit an investigational new drug (&#8220;IND&#8221;) application to the FDA. An IND is a request for authorization from the FDA to administer an investigational new drug product to humans. The central focus of an IND submission is the general investigational plan and the protocol(s) for clinical studies. Submission of an IND may or may not result in FDA authorization to begin a clinical trial.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clinical trials involve the administration of the investigational product to human subjects under the supervision of qualified investigators in accordance with cGCPs, which include the requirement that all research subjects provide their informed consent for their participation in any clinical study. Furthermore, an independent review board (&#8220;IRB&#8221;) for each site proposing to conduct the clinical trial must review and approve the plan for any clinical trial and its informed consent form before the clinical trial begins at that site, and must monitor the study until completed. Regulatory authorities, the IRB or the sponsor may suspend a clinical trial at any time on various grounds, including a finding that the subjects are being exposed to an unacceptable health risk or that the trial is unlikely to meet its stated objectives. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For purposes of BLA approval, human clinical trials are typically conducted in three sequential phases that may overlap.</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#231F20;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;font-style:italic;color:#000000;">Phase 1</span><span style="color:#000000;">&#8212;The investigational product is initially introduced into healthy human subjects or patients with the target disease or condition. These studies are designed to test the safety, dosage tolerance, </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap"></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="color:#000000;">absorption, metabolism and distribution of the investigational product in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#231F20;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;font-style:italic;color:#000000;">Phase 2</span><span style="color:#000000;">&#8212;The investigational product is administered to a limited patient population with a specified disease or condition to evaluate the preliminary efficacy, optimal dosages and dosing schedule and to identify possible adverse side effects and safety risks. Multiple Phase 2 clinical trials may be conducted to obtain information prior to beginning larger and more expensive Phase 3 clinical trials.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#231F20;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#231F20;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;font-style:italic;color:#000000;">Phase 3</span><span style="color:#000000;">&#8212;The investigational product is administered to an expanded patient population to further evaluate dosage, to provide statistically significant evidence of clinical efficacy and to further test for safety, generally at multiple geographically dispersed clinical trial sites. These clinical trials are intended to establish the overall risk/benefit ratio of the investigational product and to provide an adequate basis for product approval.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Concurrent with clinical trials, companies must finalize a process for manufacturing the product in commercial quantities in accordance with current<span style="letter-spacing:0.05pt;"> </span>good manufacturing<span style="letter-spacing:0.1pt;"> </span>practices<span style="letter-spacing:0.1pt;"> </span>(&#8220;cGMP&#8221;) requirements. The manufacturing process must be capable of consistently producing quality batches of the product candidate and, among other things, must develop methods for testing the identity, strength, quality and purity of the final product, or for biologics, the safety, purity and potency. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">BLA Submission and Review</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assuming successful completion of all required testing in accordance with all applicable regulatory requirements, the results of product development, nonclinical studies and clinical trials are submitted to the FDA as part of a BLA requesting approval to market the product for one or more indications. The submission of a BLA requires payment of a substantial application user fee to FDA, unless a waiver or exemption applies.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Once a BLA has been submitted, the FDA&#8217;s goal is to review standard applications within ten months after it accepts the application for filing, or, if the application qualifies for priority review, six months after the FDA accepts the application for filing. In both standard and priority reviews, the review process may be extended by FDA requests for additional information or clarification. The FDA reviews a BLA to determine, among other things, whether a product is safe, pure and potent and the facility in which it is manufactured, processed, packed, or held meets standards designed to assure the product&#8217;s continued safety, purity and potency. The FDA may convene an advisory committee to provide clinical insight on application review questions. Before approving a BLA, the FDA will typically inspect the facility or facilities where the product is manufactured. The FDA will not approve an application unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications. Additionally, before approving a BLA, the FDA will typically inspect one or more clinical sites to assure compliance with cGCP. If the FDA determines that the application, manufacturing process or manufacturing facilities are not acceptable, it will outline the deficiencies in the submission and often will request additional testing or information. Notwithstanding the submission of any requested additional information, the FDA ultimately may decide that the application does not satisfy the regulatory criteria for approval.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">After the FDA evaluates a BLA and conducts necessary inspections, the FDA may either issue an approval letter or a Complete Response letter. An approval letter authorizes commercial marketing of the product with specific prescribing information for specific indications. A Complete Response letter will describe deficiencies that the FDA has identified in the BLA. The FDA may delay or refuse approval of a BLA if applicable regulatory criteria are not satisfied, require additional testing or information and/or require post-marketing testing and surveillance to monitor safety or efficacy of a product.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If regulatory approval of a product is granted, such approval will be granted for particular indications and may entail limitations on the indicated uses for which such product may be marketed. For example, the FDA may approve the BLA with a Risk Evaluation and Mitigation Strategy (&#8220;REMS&#8221;) to ensure the benefits of the product outweigh its risks. A REMS is a safety strategy to manage a known or potential serious risk associated with a product and to enable patients to have continued access to such medicines by managing their safe use, and could include medication guides, physician communication plans, or elements to assure safe use, such as restricted </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">distribution methods, patient registries and other risk minimization tools. The FDA also may condition approval on, among other things, changes to proposed labeling or the development of adequate controls and specifications. Once approved, the FDA may withdraw the product approval if compliance with pre- and post-marketing requirements is not maintained or if problems occur after the product reaches the marketplace. The FDA may require</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or companies may voluntarily pursue,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> one or more Phase 4 post</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">market studies and surveillance to further assess and monitor the product&#8217;s safety and effectiveness after commercialization,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and may limit further marketing of the product based on the results of these post-marketing studies.</span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Expedited Programs for Serious Conditions</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FDA maintains several programs intended to facilitate and expedite development and review of new drugs and biologics to address unmet medical needs in the treatment of serious or life-threatening diseases or conditions. These programs include Fast Track designation, Breakthrough Therapy designation, Priority Review and Accelerated Approval. These programs can significantly reduce the time it takes for the FDA to review a BLA, but they do not guarantee that a product will receive FDA approval. Even if a product qualifies initially, the FDA may later decide that the product no longer meets the conditions for qualification or decide that the time period for FDA review will not be shortened.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Post-Approval Requirements</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any products manufactured or distributed pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including, among other things, requirements relating to record-keeping, reporting of adverse experiences, periodic reporting, product sampling and distribution, and advertising and promotion of the product. After approval, most changes to the approved product, such as adding new indications or other labeling claims, are subject to prior FDA review and approval. Biologic manufacturers and their subcontractors are required to register their establishments with the FDA and certain state agencies, and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with cGMP. Changes to the manufacturing process are strictly regulated, and, depending on the significance of the change, may require prior FDA approval before being implemented. FDA regulations also require investigation and correction of any deviations from cGMP and impose reporting requirements upon companies and third-party manufacturers. Accordingly, manufacturers must continue to expend time, money and effort in the area of production and quality control to maintain compliance with cGMP and other aspects of regulatory compliance.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FDA may withdraw approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information&#59; imposition of post-market studies or clinical studies to assess new safety risks&#59; or imposition of distribution restrictions or other restrictions under a REMS program, among other potential consequences. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FDA closely regulates the marketing, labeling, advertising and promotion of biologics. A company can make only those claims relating to safety and efficacy, purity and potency that are approved by the FDA and in accordance with the provisions of the approved label. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses. Failure to comply with these requirements can result in, among other things, adverse publicity, warning letters, corrective advertising and potential civil and criminal penalties. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>

<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Biosimilars and Reference Product Exclusivity</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Patient Protection and Affordable Care Act, as amended (collectively, the &#8220;Affordable Care Act&#8221;) includes a provision called the Biologics Price Competition and Innovation Act of 2009 (&#8220;BPCIA&#8221;), which created an abbreviated approval pathway for biological products that are biosimilar to or interchangeable with an FDA-approved reference biological product. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Biosimilarity, which requires that there be no clinically meaningful differences between the biological product and the reference product in terms of safety, purity and potency, can be shown through analytical studies, animal studies, and a clinical study or studies. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the BPCIA, an application for a biosimilar product may not be submitted to the FDA until four years following the date that the reference product was first licensed by the FDA. In addition, the approval of a biosimilar product may not be made effective by the FDA until 12 years from the date on which the reference product was first licensed. During this 12-year period of exclusivity, another company may still market a competing version of the reference product if the FDA approves a full BLA for the competing product containing that applicant&#8217;s own preclinical data and data from adequate and well-controlled clinical trials to demonstrate the safety, purity and potency of its product. At this juncture, it is unclear whether products deemed &#8220;interchangeable&#8221; by the FDA will, in fact, be readily substituted by pharmacies, which are governed by state pharmacy law.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The BPCIA is complex and continues to be interpreted and implemented by the FDA. In addition, recent government proposals have sought to reduce the 12-year reference product exclusivity period. Other aspects of the BPCIA, some of which may impact the BPCIA exclusivity provisions, have also been the subject of recent litigation. As a result, the ultimate impact, implementation, and impact of the BPCIA is subject to significant uncertainty.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Other U.S. Healthcare Laws and Compliance Requirements</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pharmaceutical companies are subject to additional healthcare regulation and enforcement by the federal government and by authorities in the states and foreign jurisdictions in which they conduct their business. Such laws include, without limitation: the federal Anti-Kickback Statute (&#8220;AKS&#8221;), the federal False Claims Act, HIPAA and similar foreign, federal and state fraud, abuse and transparency laws.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The federal AKS prohibits, among other things, any person or entity from knowingly and willfully offering, paying, soliciting or receiving any remuneration, to induce or in return for either the referral of an individual, or the purchase or recommendation of an item or service for which payment may be made under any federal healthcare program. The term remuneration has been interpreted broadly to include anything of value. The AKS has been interpreted to apply to arrangements between pharmaceutical manufacturers on one hand, and prescribers and purchasers on the other. Our practices may not in all cases meet all of the criteria for protection under a statutory exception or regulatory safe harbor. Failure to meet all of the requirements of a particular applicable statutory exception or regulatory safe harbor does not make the conduct per se illegal under the AKS. Instead, the legality of the arrangement will be evaluated on a case-by-case basis based on a cumulative review of all of its facts and circumstances. A person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The federal false claims laws, including the False Claims Act (&#8220;FCA&#8221;), which imposes significant penalties and can be enforced by private citizens through civil qui tam actions, and civil monetary penalty laws prohibit any person or entity from, among other things, knowingly presenting, or causing to be presented, a false or fraudulent claim for payment of federal government funds, including federal healthcare programs, such as Medicare and Medicaid. Pharmaceutical and other healthcare companies have been prosecuted under these laws for engaging in a variety of different types of conduct that caused the submission of false claims to federal healthcare programs. Under the AKS, for example, a claim resulting from a violation of the AKS is deemed to be a false or fraudulent claim for purposes of the FCA. The FCA imposes mandatory treble damages and per-violation civil penalties up to approximately $23,000.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>

<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HIPAA created additional federal criminal statutes that prohibit, among other things, executing a scheme to defraud any healthcare benefit program, including private third-party payors, and making false statements relating to healthcare matters. A person or entity does not need to have actual knowledge of the healthcare fraud statute implemented under HIPAA or specific intent to violate the statute in order to have committed a violation.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Also, many states have similar, and typically more prohibitive, fraud and abuse statutes or regulations that apply to items and services reimbursed under Medicaid and other state programs, or, in several states, apply regardless of the payor.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The U.S. federal Physician Payments Sunshine Act requires certain manufacturers of drugs and biologics covered by Medicare, Medicaid or the Children&#8217;s Health Insurance Program, with specific exceptions, to annually report to CMS information related to payments or other transfers of value made to physicians and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members. Beginning in 2022, such reporting obligations will be expanded to include payments and other transfers of value provided in 2021 to certain other healthcare professionals.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ensuring business arrangements with third parties comply with applicable healthcare laws and regulations is a difficult and costly endeavor. If our operations are found to be in violation of any of the federal and state healthcare laws described above or any other current or future governmental regulations that apply to us, we may be subject to significant penalties, including without limitation, civil, criminal and/or administrative penalties, damages, fines, disgorgement, imprisonment, exclusion from participation in government programs, such as Medicare and Medicaid, injunctions, private &#8220;qui tam&#8221; actions brought by individual whistleblowers in the name of the government, or refusal to allow us to enter into government contracts, contractual damages, reputational harm, administrative burdens, diminished profits and future earnings, additional reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with these laws, and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our results of operations.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Data Privacy and Security</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Numerous state, federal and foreign laws, govern the collection, dissemination, use, access to, confidentiality and security of personal information, including health-related information. In the United States, numerous federal and state laws and regulations, including state data breach notification laws, state health information privacy laws, and federal and state consumer protection laws and regulations, govern the collection, use, disclosure, and protection of health-related and other personal information could apply to our operations or the operations of our partners. Entities that are found to be in violation of HIPAA or other laws may be subject to significant civil, criminal and administrative fines and penalties and/or additional reporting and oversight obligations. Further, entities that knowingly obtain, use, or disclose certain individually identifiable health information in an improper fashion may be subject to criminal penalties.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Coverage, Pricing and Reimbursement</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Significant uncertainty exists as to the coverage and reimbursement status of any product candidates for which we may obtain regulatory approval. In the United States and in foreign markets, sales of any products for which we receive regulatory approval for commercial sale will depend, in part, on the extent to which third-party payors provide coverage and establish adequate reimbursement levels for such products. In the United States, third-party payors include federal and state healthcare programs, private managed care providers, private health insurers and other organizations. Adequate coverage and reimbursement from governmental healthcare programs, such as Medicare and Medicaid in the United States, and commercial payors are critical to new product acceptance.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>

<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decisions regarding whether to cover any of our product candidates, if approved, the extent of coverage and amount of reimbursement to be provided are made on a plan-by-plan basis. Further, no uniform policy for coverage and reimbursement exists in the United States, and coverage and reimbursement can differ significantly from payor to payor. Third-party payors often rely upon Medicare coverage policy and payment limitations in setting their own reimbursement rates, but also have their own methods and approval process apart from Medicare determinations. As a result, the coverage determination process is often a time-consuming and costly process that will require us to provide scientific and clinical support for the use of our product candidates to each payor separately, with no assurance that coverage and adequate reimbursement will be applied consistently or obtained in the first instance.</p>
<p style="margin-top:12pt;margin-bottom:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For products administered under the supervision of a physician, obtaining coverage and adequate reimbursement may be particularly difficult because of the higher prices often associated with such drugs. Additionally, separate reimbursement for the product itself or the treatment or procedure in which the product is used may not be available, which may impact physician utilization. In addition, companion diagnostic tests require coverage and reimbursement separate and apart from the coverage and reimbursement for their companion pharmaceutical or biological products. Similar challenges to obtaining coverage and reimbursement, applicable to pharmaceutical or biological products, will apply to companion diagnostics.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, the U.S. government, state legislatures and foreign governments have continued implementing cost-containment programs, including price controls, restrictions on coverage and reimbursement and requirements for substitution of generic products. Third-party payors are increasingly challenging the prices charged for medical products and services, examining the medical necessity and reviewing the cost effectiveness of pharmaceutical or biological products, medical devices and medical services, in addition to questioning safety and efficacy. Adoption of price controls and cost-containment measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit sales of any product that receives approval. Decreases in third-party reimbursement for any product or a decision by a third-party not to cover a product could reduce physician usage and patient demand for the product.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Healthcare Reform</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the United States and some foreign jurisdictions, there have been, and continue to be, several legislative and regulatory changes and proposed changes regarding the healthcare system that could prevent or delay marketing approval of product candidates, restrict or regulate post-approval activities, and affect the ability to profitably sell product candidates for which marketing approval is obtained. Among policy makers and payors in the United States and elsewhere, there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality and/or expanding access. In the United States, the pharmaceutical industry has been a particular focus of these efforts and has been significantly affected by major legislative initiatives.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For example, the Affordable Care Act has substantially changed healthcare financing and delivery by both governmental and private insurers. The Affordable Care Act and its implementing regulations, among other things, revised the methodology for calculating rebates for covered outpatient drugs and certain biologics owed by manufacturers to the state and federal government under the Medicaid Drug Rebate Program, increased the minimum Medicaid rebates owed by most manufacturers under the Medicaid Drug Rebate Program, extended the Medicaid Drug Rebate program to utilization of prescriptions of individuals enrolled in Medicaid managed care organizations, subjected manufacturers to new annual fees and taxes for certain branded prescription drugs, and expanded programs designed to test innovative payment models, service delivery models, or value-based arrangements, and fund comparative effectiveness research.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There remain legal and political challenges to certain aspects of the Affordable Care Act. In December 2018, a United States District Court judge in Texas ruled that the Affordable Care Act is unconstitutional in its entirety because the &#8220;individual mandate&#8221; was repealed by Congress in 2017. The decision was appealed to the United States Supreme Court, which overturned it on the basis that the plaintiffs lacked standing. The Supreme Court&#8217;s decision did not address the constitutionality of the Affordable Care Act, and left open the opportunity for additional challenges to the Affordable Care Act. It is unclear how such litigation and other efforts to repeal, replace or otherwise modify the Affordable Care Act will impact reimbursement of pharmaceutical and biological products.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>

<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We anticipate that the Affordable Care Act, if substantially maintained in its current form, will continue to result in additional downward pressure on coverage and the price that we receive for any approved product, and could seriously harm our business. Any reduction in reimbursement from Medicare and other government programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our products. Such reforms could have an adverse effect on anticipated revenue from product candidates that we may successfully develop and for which we may obtain regulatory approval and may affect our overall financial condition and ability to develop product candidates.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, further legislation or regulation could be passed that could harm our business, financial condition and results of operations. Other legislative changes have been proposed and adopted since the Affordable Care Act was enacted. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There has been increasing legislative and enforcement interest in the United States with respect to specialty drug pricing practices. Specifically, there have been several recent U.S. Congressional inquiries and proposed federal legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drugs. In October 2020, the FDA issued guidance describing procedures for manufacturers to facilitate the importation of FDA-approved biologics manufactured abroad and originally intended for sale in a foreign country into the United States. Previously, the Trump administration released a &#8220;Blueprint,&#8221; or plan, to lower drug prices and reduce out of pocket costs of drugs that contained proposals to increase drug manufacturer competition, increase the negotiating power of certain federal healthcare programs, incentivize manufacturers to lower the list price of their products, and reduce the out of pocket costs of drug products paid by consumers.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Although the Biden administration has stayed the effective dates of some last-minute drug price regulations issued by the Trump administration, Congress and the Biden administration have each indicated that it will continue to seek new legislative and/or administrative measures to control drug costs.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Additional Regulation</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to the foregoing, local, state and federal laws, including in the United States and Israel, regarding such matters as safe working conditions, manufacturing practices, environmental protection, fire hazard control and hazardous substances, including the Occupational Safety and Health Act, the Resource Conservancy and Recovery Act and the Toxic Substances Control Act, affect our business. These and other laws govern our use, handling and disposal of various biological, chemical and radioactive substances used in, and wastes generated by, our operations. If our operations result in contamination of the environment or expose individuals to hazardous or biohazardous substances, we could be liable for damages, environmental remediation, and/or governmental fines. We believe that we are in material compliance with applicable environmental laws and occupational health and safety laws that continued compliance therewith will not have a material adverse effect on our business. We cannot predict, however, how changes in these laws may affect our future operations. We may incur significant costs to comply with such laws and regulations now or in the future.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Competition</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The biopharmaceutical industry is intensely competitive and subject to rapid innovation and significant technological advancements. We believe the key competitive factors that will affect the development and commercial success of <span style="color:#000000;">pegozafermin</span> and any future product candidates are efficacy, safety and tolerability profile, reliability, convenience of dosing, price, the level of generic competition and reimbursement. Our competitors include multinational pharmaceutical companies, specialized biotechnology companies, universities and other research institutions. A number of biotechnology and pharmaceutical companies are pursuing the development or marketing of pharmaceuticals that target the same diseases that we are targeting. Smaller or earlier-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large, established companies. Given the high incidence of NASH, it is likely that the number of companies seeking to develop products and therapies for the treatment of liver and cardio-metabolic diseases, such as NASH, will increase.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>

<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If pegozafermin is approved for the treatment of NASH, future competition could also arise from select products currently in development, including: Firsocostat/GS-0976, an ACC inhibitor, and Cilofexor/GS-9674, an FXR agonist, from Gilead Sciences, Inc.&#59; Clesacostat/PF-05221304, an ACC inhibitor, and PF-06835919, a KHK inhibitor, from Pfizer Inc.&#59; Ocaliva, an FXR agonist from Intercept Pharmaceuticals, Inc.&#59; Resmetirom, a beta-thyroid hormone receptor agonist from Madrigal Pharmaceuticals, Inc.&#59; VK2809, a beta-thyroid hormone receptor agonist from Viking Therapeutics, Inc.&#59; Aldafermin, an FGF19 analog from NGM Biopharmaceuticals, Inc.&#59; MK-3655, an FGFR1c/KLB agonist antibody from Merck &#38; Co., Inc.&#59; Efruxifermin, a FGF21 fusion protein from Akero Therapeutics, Inc.&#59; Belapectin, a Galectin-3 inhibitor from Galectin Therapeutics Inc.&#59; Aramchol, a synthetic conjugate of cholic acid and arachidic acid from Galmed Pharmaceuticals Ltd.&#59; Semaglutide, a GLP-1 receptor agonist from Novo Nordisk A/S&#59; Pemvidutide/ALT-801, a dual GLP-1/glucagon agonist from Altimmune&#59; Tirzepatide, a dual GIP/GLP-1 receptor agonist from Eli Lilly and Company&#59; and Lanifibranor, a PPAR alpha/delta/gamma agonist from Inventiva&#59; NNC0194-0499, an FGF21 analog from Novo Nordisk&#59; BOS-580, an FGF21 analog from Boston Pharmaceuticals&#59; and BFKB8488A, an FGFR1/KLB agonist antibody from Genentech. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If pegozafermin is approved for the treatment of SHTG, we would face competition from currently approved and marketed products, including statins, fibrates, Vascepa (Pure EPA), and Lovaza (EPA and DHA), as well as generic products. Further competition could arise from products currently in development, including: Olezarsen/AKCEA-APOCIII-LRx, an APOC3 inhibitor from Ionis&#59; Evinacumab, an Anti-ANGPTL3 from Regeneron Pharmaceuticals, Inc.&#59; Pemafibrate, a PPAR alpha agonist from Kowa Research Institute, Inc.&#59; and ARO-APOC3, an ApoC-III inhibitor from Arrowhead Pharmaceuticals, Inc. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Many of our competitors have substantially greater financial, technical, human and other resources than we do and may be better equipped to develop, manufacture and market technologically superior products. In addition, many of these competitors have significantly longer operating histories and greater experience than we have in undertaking nonclinical studies and human clinical trials of new pharmaceutical products and in obtaining regulatory approvals of human therapeutic products. Many of our competitors have established distribution channels for the commercialization of their products, whereas we have no such channel or capabilities. In addition, many competitors have greater name recognition and more extensive collaborative relationships. As a result, our competitors may obtain regulatory approval of their products more rapidly than we do or may obtain patent protection or other intellectual property rights that limit our ability to develop or commercialize our product candidate or any future product candidates. Our competitors may also develop and succeed in obtaining approval for drugs that are more effective, more convenient, more widely used and less costly or have a better safety profile than our products and these competitors may also be more successful than we are in manufacturing and marketing their products. If we are unable to compete effectively against these companies, then we may not be able to commercialize our product candidate or any future product candidates or achieve a competitive position in the market. This would adversely affect our ability to generate revenue. Our competitors also compete with us in recruiting and retaining qualified scientific, management and commercial personnel, establishing clinical trial sites and enrolling patients for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Manufacturing and Supply</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We do not own or operate manufacturing facilities for the production of <span style="color:#000000;">pegozafermin</span>, nor do we have plans to develop our own manufacturing operations in the foreseeable future. We currently rely, and expect to continue to rely, on third parties for the manufacturing of our product candidates for preclinical and clinical testing, as well as for commercial manufacturing if <span style="color:#000000;">pegozafermin</span> or any future product candidate receives marketing approval.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegozafermin<span style="color:#000000;"> drug substance is manufactured by fermentation of a recombinant strain of the bacterium E. coli. Product accumulates as insoluble particles (inclusion bodies) within the cells and is recovered by cell disruption, followed by solubilization of the inclusion bodies, protein refolding and purification with two chromatographic separation columns. Purified material is glycoPEGylated in a 2-step enzymatic reaction where a 20kDa linear glycoPEG moiety is attached to the protein through GalNAc and Sialic Acid linkers.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GlycoPEGylated protein is purified with two chromatographic columns to yield product with target quality attributes. Purified glycoPEGylated protein is concentrated and then formulated to a target concentration with formulation buffer as drug product.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>

<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Northway Biotechpharma (&#8220;BTPH&#8221;) is our sole source supplier for <span style="color:#000000;">pegozafermin</span>. Any reduction or halt in supply of drug product from BTPH could limit our ability to develop <span style="color:#000000;">pegozafermin</span> until a replacement contract manufacturer is found and qualified. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are working with BTPH and a second vendor on process optimization to support large-scale production for future trials and commercialization. We have successfully developed a new refrigerated liquid formulation. This formulation is approved by the FDA and is currently in use in our trials. We are currently developing an additional liquid formulation at various concentrations. In parallel, we have entered into a contract with a vendor for Pre-Filled Syringe (&#8220;PFS&#8221;) development and commercial fill.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">BTPH Agreement</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May 2018, we entered into a master services agreement with BTPH, under which BTPH agreed to provide us certain services, including development, manufacturing, and storing of <span style="color:#000000;">pegozafermin</span>, under statements of work for such services to be agreed by the parties from time to time. The master services agreement will continue for the duration of time that BTPH is providing services to us, unless earlier terminated by either party upon its terms. We may terminate the agreement at any time after a specified notice period and subject to the payment of certain agreed upon fees where such termination results in cancellation of manufacturing scheduled within a certain period. In addition, either party may terminate the agreement for cause for the other party&#8217;s uncured material breach, in the event of bankruptcy of the other party, in the event of the commission of fraud by the other party or in the event of a force majeure.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Sales and Marketing</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We currently have no marketing, sales or distribution capabilities. In order to commercialize any products that are approved for commercial sale, we must either develop a sales and marketing infrastructure or collaborate with third parties that have sales and marketing experience.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may elect to establish our own sales force to market and sell a product for which we obtain regulatory approval if we expect that the geographic market for a product we develop on our own is limited or that the prescriptions for the product will be written principally by a relatively small number of physicians. If we decide to market and sell any products ourselves, we do not expect to establish direct sales capability until shortly before the products are approved for commercial sale.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We plan to seek third-party support from established pharmaceutical and biotechnology companies for those products that would benefit from the promotional support of a large sales and marketing force. In these cases, we might seek to promote our products in collaboration with marketing partners or rely on relationships with one or more companies with large established sales forces and distribution systems.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Intellectual Property</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our success depends in part upon our ability to protect our core technology and intellectual property. To protect our intellectual property rights, we rely on patents, trademarks, copyrights and trade secret laws, confidentiality procedures, and employee disclosure and invention assignment agreements. Our intellectual property is critical to our business and we strive to protect it through a variety of approaches, including by obtaining and maintaining patent protection in the United States and internationally for our product candidates, novel biological discoveries, new targets and applications, and other inventions that are important to our business. For our product candidates, we generally intend to pursue patent protection covering compositions of matter, methods of making and methods of use. As we continue the development of our product candidates, we plan to identify additional means of obtaining patent protection that would potentially enhance commercial success, including pursuit of claims directed to new therapeutic indications.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>

<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">FGF21 Patents</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our FGF21 patent portfolio includes four families:</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The first family is entitled &#8220;Remodeling and GlycoPEGylation of Fibroblast Growth Factor (FGF)&#8221;. This patent family provides granted patent protection in 39 countries around the globe, including the United States (U.S. Patent Number 9,200,049, expiry date: June 25, 2028&#59; and U.S. Patent No. 10,874,714, expiry date: October 10, 2028), Canada, Europe (broadly), and Japan (latter three expire October 31, 2025) for FGF21 conjugates comprising a variety of modifying groups that can be attached at several different amino acid positions. GlycoPEGylated FGF21 is specifically claimed. The granted claims broadly protect our lead drug candidate pegozafermin and pharmaceutical compositions thereof, as well as methods for making and using pegozafermin to treat FGF21 deficiency in a patient in need thereof. One U.S. application is pending in this family.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The second family is entitled &#8220;Mutant FGF-21 Peptide Conjugate and Uses Thereof&#8221; and is specifically directed to pegozafermin. The PCT Patent Application for this family was filed on September 4, 2018 (PCT/IB2018/00112). A U.S. Prioritized Examination Continuation Patent Application (Application Serial No. 16/225,640) was filed on December 19, 2018 as a continuation of PCT/IB2018/0112 and from which U.S. Patent Number 10,407,479 was issued on September 10, 2019. The term of the U.S. Patent Number 10,407,479 is September 4, 2038. The issued claims are directed to pegozafermin and a defined genus specifically encompassing pegozafermin and compositions thereof (including site-specific mutations at positions 173 and 176), as well as methods for making and using pegozafermin for a variety of therapeutic indications. Such indications include methods for treating NASH or metabolic syndrome. Subjects where there is a need to reduce blood glucose or to reduce HbA1C include those afflicted with diabetes Type 2, NASH and metabolic syndrome. The claims encompass different therapeutic regimens for administering pegozafermin (e.g., once a week or once every two weeks), which regimens are based on pegozafermin&#8217;s surprisingly long half-life in vivo. One U.S. application is pending in this family. National phase entry of this PCT Application has been initiated in Australia (granted), Korea (granted), Europe, China (allowed),&#160;Hong Kong, Japan (granted), Canada and Israel to pursue global protection of specific mutant FGF21 peptide conjugates, and particularly pegozafermin, in these jurisdictions. Australian patent No. 2018322943 was granted on September 17, 2020 (expiry date: September 4, 2038). Korean patent No. 10-2229037 was granted on March 11, 2021 (expiry date: September 4, 2038). Japan patent No. 6852939 was granted on March 15, 2021 (expiry date: September 4, 2038). </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The third family is entitled &#8220;Methods Of Treatment Using Mutant FGF-21 Peptide Conjugates&#8221;. A U.S. patent application was filed on May 28, 2020 (US Serial Number 16/885,353). This patent application is not published. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fourth family is entitled &#8220;Methods for promoting weight loss&#8221;. A PCT application was filed January 29, 2021 (PCT/IB2021/000044) with claims directed towards method to reduce total body weight, body fat content and/or BMI. National phase entry of this application is due by July 31, 2022. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We will continue to file patent applications to cover various formulations of FGF21. We have filed a provisional application on March 11, 2021 on stable liquid formulation of FGF21. A PCT patent application claiming the benefit and priority to the provisional application will be filed by the March 11, 2022 deadline.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">FASN Patents</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our FASN patent portfolio currently consists of three patent families, including patents and/or patent applications in the United States, the European Patent Convention, Canada, Mexico, Israel, China and Japan.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The first patent family, directed to TEV-48317, which we acquired from Teva under the FASN Agreement, and other 1,4-substituted piperidine-based FASN inhibitors, is currently protected by three granted U.S. patents that cover these compounds, pharmaceutical compositions comprising these compounds, and/or methods of treating FASN-mediated disorders using these compounds. The non-extended term for these patents would expire on June 17, 2036. A pending U.S. application has also been filed. The first patent family also includes twelve foreign patents and two foreign patent applications. The second patent family is directed to other 1,4-substituted piperidine-based FASN inhibitors, pharmaceutical compositions, and methods of treating FASN-mediated disorders. The second patent family includes one granted U.S. patent, one U.S. patent application, nine foreign patents, and two foreign patent applications. The third patent family is directed to spiropiperidine FASN inhibitors, pharmaceutical </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">compositions containing these compounds, and methods of treating FASN-mediated disorders using these compounds. The third patent family includes one granted U.S. patent, one U.S. patent application and five foreign patent applications</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Employees</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, we had 41 full-time employees, of which 28 employees are engaged in research and development activities. None of our employees are represented by labor unions or covered by collective bargaining agreements. We consider our relationship with our employees to be good.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Corporate Information</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We were incorporated in January 2018 in Israel under the name 89Bio Ltd. 89bio, Inc., the registrant whose name appears on the cover page of this Annual Report on Form 10-K, was incorporated in June 2019 for the purpose of an internal reorganization transaction. In September 2019, all of the equity holders of 89Bio Ltd. exchanged 100% of the equity of 89Bio Ltd. for 100% of the equity of 89bio, Inc. Following this exchange, 89Bio Ltd. became a wholly owned subsidiary of 89bio, Inc. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our principal executive offices are located at 142 Sansome Street, San Francisco, California 94104 and our telephone number is (415) 432-9270. Our website is <span style="font-style:italic;">www.89bio.com</span>. Information contained on or accessible through our website is not a part of this Annual Report on Form 10-K, and the inclusion of our website address in this Annual Report on Form 10-K is an inactive textual reference only.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We file electronically with the SEC our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). We make available on our website at <span style="font-style:italic;">www.89bio.com</span>, under &#8220;Investors,&#8221; free of charge, copies of these reports as soon as reasonably practicable after filing or furnishing these reports with the SEC.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Implications of Being an Emerging Growth Company and a Smaller Reporting Company</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are an &#8220;emerging growth company&#8221;, as defined in Section 2(a) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including relief from the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, as amended, less extensive disclosure obligations regarding executive compensation in our registration statements, periodic reports and proxy statements, exemptions from the requirements to hold a nonbinding advisory vote on executive compensation, and exemptions from stockholder approval of any golden parachute payments not previously approved. We may also elect to take advantage of other reduced reporting requirements in future filings. As a result, our stockholders may not have access to certain information that they may deem important and the information that we provide to our stockholders may be different than, and not comparable to, information presented by other public reporting companies. We could remain an emerging growth company until the earlier of (1) the last day of the year following the fifth anniversary of the completion of our initial public offering (&#8220;IPO&#8221;), (2) the last day of the year in which we have total annual gross revenue of at least $1.07 billion, (3) the last day of the year in which we are deemed to be a &#8220;large accelerated filer&#8221; as defined in Rule 12b-2 under the Exchange Act, which would occur if the market value of our common stock held by non-affiliates exceeded $700.0 million as of the last business day of the second fiscal quarter of such year or (4) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>

<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, the JOBS Act also provides that an emerging growth company may take advantage of the extended transition period provided in the Securities Act for complying with new or revised accounting standards. An emerging growth company may therefore delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to avail ourselves of this exemption and, as a result, will not be subject to the same implementation timing for new or revised accounting standards as are required of other public companies that are not emerging growth companies, which may make comparison of our consolidated financial information to those of other public companies more difficult.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are also a smaller reporting company, as defined in the Exchange Act. We may continue to be a smaller reporting company even after we are no longer an emerging growth company. We may take advantage of certain of the scaled disclosures available to smaller reporting companies and will be able to take advantage of these scaled disclosures for so long as (i) our voting and non-voting common stock held by non-affiliates is less than $250.0 million measured on the last business day of our second fiscal quarter or (ii) our annual revenue is less than $100.0 million during the most recently completed fiscal year and our voting and non-voting common stock held by non-affiliates is less than $700.0 million measured on the last business day of our second fiscal quarter.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_1A_RISK_FACTORS">Item 1A. Risk Factors.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">An<span style="letter-spacing:-0.05pt;">&#160;</span>investment<span style="letter-spacing:0.05pt;">&#160;</span>in our common<span style="letter-spacing:-0.05pt;">&#160;</span>stock<span style="letter-spacing:0.05pt;">&#160;</span>involves<span style="letter-spacing:0.05pt;">&#160;</span>a high degree of risk.<span style="letter-spacing:0.05pt;">&#160;</span>You<span style="letter-spacing:-0.05pt;">&#160;</span>should carefully<span style="letter-spacing:0.1pt;">&#160;</span>consider<span style="letter-spacing:0.05pt;">&#160;</span>the risks<span style="letter-spacing:0.05pt;">&#160;</span>and uncertainties<span style="letter-spacing:0.1pt;">&#160;</span>described<span style="letter-spacing:0.05pt;">&#160;</span>below before<span style="letter-spacing:0.05pt;">&#160;</span>deciding<span style="letter-spacing:0.05pt;">&#160;</span>whether to make an investment decision with respect to shares of our common<span style="letter-spacing:-0.05pt;">&#160;</span>stock.<span style="letter-spacing:0.05pt;">&#160;</span>You should also refer<span style="letter-spacing:0.05pt;">&#160;</span>to the other information<span style="letter-spacing:0.05pt;">&#160;</span>contained<span style="letter-spacing:0.05pt;">&#160;</span>in this<span style="letter-spacing:0.05pt;">&#160;</span>Annual Report on Form 10-K,<span style="letter-spacing:0.05pt;">&#160;</span>including<span style="letter-spacing:0.05pt;">&#160;</span>&#8220;Management&#8217;s<span style="letter-spacing:0.05pt;">&#160;</span>Discussion<span style="letter-spacing:0.05pt;">&#160;</span>and Analysis<span style="letter-spacing:0.05pt;">&#160;</span>of Financial<span style="letter-spacing:0.05pt;">&#160;</span>Condition and Results<span style="letter-spacing:0.05pt;">&#160;</span>of Operations&#8221; and our audited<span style="letter-spacing:0.05pt;">&#160;</span>consolidated financial<span style="letter-spacing:0.05pt;">&#160;</span>statements<span style="letter-spacing:0.05pt;">&#160;</span>and related<span style="letter-spacing:0.05pt;">&#160;</span>notes. Our<span style="letter-spacing:-0.05pt;">&#160;</span>business,<span style="letter-spacing:0.05pt;">&#160;</span>financial<span style="letter-spacing:0.05pt;">&#160;</span>condition,<span style="letter-spacing:0.05pt;">&#160;</span>results<span style="letter-spacing:0.05pt;">&#160;</span>of operations<span style="letter-spacing:0.05pt;">&#160;</span>and prospects<span style="letter-spacing:0.05pt;">&#160;</span>could be materially<span style="letter-spacing:0.05pt;">&#160;</span>and adversely<span style="letter-spacing:0.05pt;">&#160;</span>affected<span style="letter-spacing:0.05pt;">&#160;</span>by any of these<span style="letter-spacing:0.05pt;">&#160;</span>risks<span style="letter-spacing:0.05pt;">&#160;</span>or uncertainties.<span style="letter-spacing:0.1pt;">&#160;</span>In any such case, the trading<span style="letter-spacing:0.05pt;">&#160;</span>price<span style="letter-spacing:0.05pt;">&#160;</span>of our common<span style="letter-spacing:-0.05pt;">&#160;</span>stock<span style="letter-spacing:0.05pt;">&#160;</span>could decline,<span style="letter-spacing:0.05pt;">&#160;</span>and you could lose all or part of your investment. We caution you that the risks, uncertainties and other factors referred to below and elsewhere in this Annual Report on Form 10-K may not contain all of the risks, uncertainties and other factors that may affect our future results and operations. Moreover, new risks will emerge from time to time. It is not possible for our management to predict all risks.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Risk Factor Summary</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investing in our common stock involves significant risks. You should carefully consider the risks described below before making a decision to invest in our common stock. If we are unable to successfully address these risks and challenges, our business, financial condition, results of operations, or prospects could be materially adversely affected. In such case, the trading price of our common stock would likely decline, and you may lose all or part of your investment. Below is a summary of some of the risks we face.</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We are a clinical-stage biopharmaceutical company with a limited operating history and no products approved for commercial sale. We have incurred net losses since our inception, we expect to incur significant and increasing operating losses and we may never be profitable. Our stock is a highly speculative investment.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We will require substantial additional capital to finance our operations, which may not be available to us on acceptable terms, or at all. As a result, we may not complete the development and commercialization of pegozafermin or develop new product candidates.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">The ongoing COVID-19 pandemic has resulted and may in the future result in significant disruptions to our clinical trials or other business operations, which could have a material adverse effect on our business.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Our business depends on the success of pegozafermin, our only product candidate under clinical development, which has not completed a pivotal trial. If we are unable to obtain regulatory approval for and successfully commercialize pegozafermin or other future product candidates, or we experience significant delays in doing so, our business will be materially harmed.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Clinical drug development involves a lengthy and expensive process with uncertain timelines and uncertain outcomes, and the results of prior preclinical or clinical trials are not necessarily predictive of our future results.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">If we experience delays in clinical testing, our commercial prospects will be adversely affected, our costs may increase and our business may be harmed.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">If we encounter difficulties in enrolling patients in our clinical trials, our clinical development activities could be delayed or otherwise adversely affected.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We have relied on, and expect to continue to rely on, third-party manufacturers and vendors to produce and release pegozafermin or any future product candidates. Any failure by a third-party to produce and release acceptable product candidates for us pursuant to our specifications and regulatory standards may delay or impair our ability to initiate or complete our clinical trials, obtain and maintain regulatory approvals or commercialize approved products.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Pegozafermin and any future product candidates may cause undesirable side effects or have other properties that could delay or prevent their regulatory approval or limit the commercial profile of an approved label.</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="color:#000000;">We are developing </span><span style="color:#000000;">pegozafermin</span><span style="color:#000000;"> for the treatment of NASH, an indication for which there are no approved products. This makes it difficult to predict the timing and costs of the clinical development of </span><span style="color:#000000;">pegozafermin</span><span style="color:#000000;"> for the treatment of NASH.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Lack of efficacy, adverse events or undesirable side effects may emerge in clinical trials conducted by third parties developing FGF product candidates, which could adversely affect our stock price, our ability to attract additional capital and our development program.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Interim, topline and preliminary data from our clinical trials that we announce or publish from time to time may change as more patient data become available and are subject to audit and verification procedures that could result in material changes in the final data.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">The manufacture of biologic products is complex and we are subject to many manufacturing risks, any of which could substantially increase our costs and limit supply of our products.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We face substantial competition, which may result in others discovering, developing or commercializing competing products before or more successfully than us.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Unstable market and economic conditions may have serious adverse consequences on our business and financial condition.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Our Loan and Security Agreement with Silicon Valley Bank contains certain covenants that could adversely affect our operations and, if an event of default were to occur, we could be forced to repay any outstanding indebtedness sooner than planned and possibly at a time when we do not have sufficient capital to meet this obligation.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Pegozafermin has not received regulatory approval. If we are unable to obtain regulatory approvals to market pegozafermin or any future product candidates, our business will be adversely affected.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Our success depends upon our ability to obtain and maintain intellectual property protection for our products and technologies.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We rely on a license from Teva and a sublicense from ratiopharm to patents and know-how related to glycoPEGylation technology that are used in the development, manufacture and commercialization of pegozafermin. Any termination or loss of significant rights, including the right to glycoPEGylation technology, or breach, under these agreements or any future license agreement related to our product candidates, would materially and adversely affect our ability to continue the development and commercialization of the related product candidates.</span></p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Risks Related to Our Business and<span style="letter-spacing:-0.05pt;"> </span>Industry</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We are a clinical-stage biopharmaceutical<span style="letter-spacing:0.1pt;"> </span>company with a limited<span style="letter-spacing:0.1pt;"> </span>operating<span style="letter-spacing:0.05pt;"> </span>history<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>no<span style="letter-spacing:-0.05pt;"> </span>products approved<span style="letter-spacing:1.05pt;"> </span>for commercial<span style="letter-spacing:0.1pt;"> </span>sale. We have incurred net losses<span style="letter-spacing:0.05pt;"> </span>since our inception,<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>expect<span style="letter-spacing:0.05pt;"> </span>to incur significant<span style="letter-spacing:0.1pt;"> </span>and increasing<span style="letter-spacing:0.05pt;"> </span>operating<span style="letter-spacing:0.05pt;"> </span>losses<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>may never be profitable.<span style="letter-spacing:0.1pt;"> </span>Our<span style="letter-spacing:-0.05pt;"> </span>stock is a highly speculative<span style="letter-spacing:0.1pt;"> </span>investment.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are a clinical-stage<span style="letter-spacing:0.05pt;"> </span>biopharmaceutical<span style="letter-spacing:0.15pt;"> </span>company with a limited<span style="letter-spacing:0.1pt;"> </span>operating<span style="letter-spacing:0.05pt;"> </span>history<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>may make it<span style="letter-spacing:1.1pt;"> </span>difficult<span style="letter-spacing:0.1pt;"> </span>to evaluate<span style="letter-spacing:0.05pt;"> </span>the success<span style="letter-spacing:0.05pt;"> </span>of our business<span style="letter-spacing:0.05pt;"> </span>to date and to assess<span style="letter-spacing:0.05pt;"> </span>our future<span style="letter-spacing:0.05pt;"> </span>viability.<span style="letter-spacing:0.1pt;"> </span>We commenced operations<span style="letter-spacing:0.05pt;"> </span>in 2018, and to date, our operations<span style="letter-spacing:0.05pt;"> </span>have been focused on organizing<span style="letter-spacing:0.05pt;"> </span>and staffing<span style="letter-spacing:0.1pt;"> </span>our company, raising<span style="letter-spacing:0.05pt;"> </span>capital,<span style="letter-spacing:0.05pt;"> </span>acquiring<span style="letter-spacing:0.05pt;"> </span>our initial<span style="letter-spacing:0.1pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidate,<span style="letter-spacing:0.05pt;"> </span>pegozafermin and licensing<span style="letter-spacing:0.05pt;"> </span>certain related<span style="letter-spacing:0.05pt;"> </span>technology, conducting<span style="letter-spacing:0.05pt;"> </span>research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>activities,<span style="letter-spacing:0.1pt;"> </span>including<span style="letter-spacing:0.05pt;"> </span>preclinical<span style="letter-spacing:0.1pt;"> </span>studies<span style="letter-spacing:0.05pt;"> </span>and clinical<span style="letter-spacing:0.1pt;"> </span>trials,<span style="letter-spacing:0.1pt;"> </span>and providing<span style="letter-spacing:0.05pt;"> </span>general<span style="letter-spacing:0.05pt;"> </span>and administrative<span style="letter-spacing:0.15pt;"> </span>support<span style="letter-spacing:0.05pt;"> </span>for these<span style="letter-spacing:0.05pt;"> </span>operations.<span style="letter-spacing:0.05pt;"> </span>Investment<span style="letter-spacing:0.1pt;"> </span>in biopharmaceutical<span style="letter-spacing:0.15pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>development<span style="letter-spacing:0.05pt;"> </span>is highly speculative<span style="letter-spacing:0.1pt;"> </span>because<span style="letter-spacing:0.05pt;"> </span>it entails<span style="letter-spacing:0.05pt;"> </span>substantial<span style="letter-spacing:0.1pt;"> </span>upfront<span style="letter-spacing:0.05pt;"> </span>capital expenditures<span style="letter-spacing:0.1pt;"> </span>and significant<span style="letter-spacing:0.1pt;"> </span>risk<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>any potential<span style="letter-spacing:0.1pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidate<span style="letter-spacing:0.05pt;"> </span>will fail<span style="letter-spacing:0.05pt;"> </span>to demonstrate<span style="letter-spacing:0.1pt;"> </span>adequate<span style="letter-spacing:0.05pt;"> </span>effect<span style="letter-spacing:0.05pt;"> </span>and/or an acceptable<span style="letter-spacing:0.1pt;"> </span>safety<span style="letter-spacing:0.05pt;"> </span>profile,<span style="letter-spacing:0.05pt;"> </span>gain regulatory<span style="letter-spacing:0.1pt;"> </span>approval<span style="letter-spacing:0.05pt;"> </span>and become<span style="letter-spacing:0.05pt;"> </span>commercially<span style="letter-spacing:0.15pt;"> </span>viable.<span style="letter-spacing:0.05pt;"> </span>We have no products approved for commercial<span style="letter-spacing:0.1pt;"> </span>sale,<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>have not generated<span style="letter-spacing:0.05pt;"> </span>any revenue<span style="letter-spacing:0.05pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>sales<span style="letter-spacing:0.05pt;"> </span>to date and we<span style="letter-spacing:-0.05pt;"> </span>continue<span style="letter-spacing:0.05pt;"> </span>to incur<span style="letter-spacing:0.05pt;"> </span>significant<span style="letter-spacing:0.1pt;"> </span>research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>and other<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.05pt;"> </span>related<span style="letter-spacing:0.05pt;"> </span>to our ongoing operations.<span style="letter-spacing:0.05pt;"> </span>We have limited<span style="letter-spacing:0.1pt;"> </span>experience<span style="letter-spacing:0.05pt;"> </span>as a company conducting<span style="letter-spacing:0.05pt;"> </span>clinical<span style="letter-spacing:0.1pt;"> </span>trials<span style="letter-spacing:0.1pt;"> </span>and no experience<span style="letter-spacing:0.05pt;"> </span>as a company commercializing any products.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegozafermin is in development and, to date, we have not generated any revenue from the licensing or commercialization of pegozafermin. We will not be able to generate product revenue unless and until pegozafermin </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or any future product candidate, alone or with future partners, successfully completes clinical trials, receives regulatory approval and is successfully commercialized. As </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">pegozafermin</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> is in development, we do not expect to receive revenue from it for a number of years, if ever. Although we may seek to obtain revenue from collaboration or licensing agreements with third parties, we currently have no such agreements that could provide us with material, ongoing future revenue and we may never enter into any such agreements.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are not profitable and have incurred net losses since our inception. Consequently, predictions about our future success or viability may not be as accurate as they would be if we had a longer operating history or a history of successfully developing and commercializing pharmaceutical products. We have spent, and expect to continue to spend, significant resources to fund research and development of, and seek regulatory approvals for, pegozafermin and any future product candidates. We expect to incur substantial and increasing operating losses over the next several years as our research, development clinical trial and manufacturing activities increase. In addition, because of the numerous risks and uncertainties associated with pharmaceutical product development, including that our product candidates may not advance through development or achieve the endpoints of applicable clinical trials, we are unable to predict the timing or amount of increased expenses, or if or when we will achieve or maintain profitability. The size of our future net losses will depend, in part, on the rate of future growth of our expenses and our ability to generate revenue. The net losses we incur may fluctuate significantly from quarter-to-quarter such that a period-to-period<span style="letter-spacing:0.15pt;"> </span>comparison<span style="letter-spacing:0.05pt;"> </span>of our results<span style="letter-spacing:0.05pt;"> </span>of operations<span style="letter-spacing:0.05pt;"> </span>may not be a good indication<span style="letter-spacing:0.1pt;"> </span>of our future performance.<span style="letter-spacing:0.1pt;"> </span>Even if we<span style="letter-spacing:-0.05pt;"> </span>eventually<span style="letter-spacing:0.05pt;"> </span>generate<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>revenue,<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>may never be profitable<span style="letter-spacing:0.1pt;"> </span>and, if we<span style="letter-spacing:-0.05pt;"> </span>do achieve profitability,<span style="letter-spacing:0.15pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>may not be able to sustain<span style="letter-spacing:0.05pt;"> </span>or increase<span style="letter-spacing:0.05pt;"> </span>profitability<span style="letter-spacing:0.15pt;"> </span>on a quarterly<span style="letter-spacing:0.1pt;"> </span>or annual basis.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We<span style="letter-spacing:-0.05pt;"> </span>will require<span style="letter-spacing:0.05pt;"> </span>substantial<span style="letter-spacing:0.05pt;"> </span>additional<span style="letter-spacing:0.05pt;"> </span>capital<span style="letter-spacing:0.05pt;"> </span>to finance our operations, which<span style="letter-spacing:-0.05pt;"> </span>may not be available<span style="letter-spacing:0.05pt;"> </span>to us on<span style="letter-spacing:-0.05pt;"> </span>acceptable<span style="letter-spacing:0.05pt;"> </span>terms,<span style="letter-spacing:0.05pt;"> </span>or at all. As<span style="letter-spacing:-0.05pt;"> </span>a result,<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>may not complete<span style="letter-spacing:0.05pt;"> </span>the development<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>commercialization<span style="letter-spacing:0.15pt;"> </span>of pegozafermin<span style="letter-spacing:-0.05pt;"> </span>or develop<span style="letter-spacing:0.05pt;"> </span>new<span style="letter-spacing:-0.05pt;"> </span>product candidates.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a clinical-stage biopharmaceutical company, our operations have consumed significant amounts of cash since our inception. We expect our research and development expenses to increase in connection with our ongoing activities, particularly as we conduct clinical trials of and seek regulatory approvals for pegozafermin. We believe that our existing cash and cash equivalents and short-term available-for-sale securities, together with the proceeds available from our line of credit pursuant to our Loan and Security Agreement (as amended, the &#8220;2021 Loan Agreement&#8221;) with Silicon Valley Bank (&#8220;SVB&#8221;) will fund our projected operating requirements for a period of at least one year from the date of this Annual Report on Form 10-K is filed with the SEC. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We will require additional capital to discover, develop, obtain regulatory approval for and commercialize pegozafermin and any future product candidates. We do not have any committed external source of funds other than the unused portion of the line of credit available to us pursuant to the 2021 Loan Agreement and as a result of any sales that we may make pursuant to the sales agreement for our &#8220;at-the-market&#8221; offering facility. We expect to finance future cash needs through public or private equity or debt offerings or product collaborations. Additional capital may not be available in sufficient amounts or on reasonable terms, if at all. If we do not raise additional capital, we may not be able to expand our operations or otherwise capitalize on our business opportunities, our business and financial condition will be negatively impacted and we may need to: significantly delay, scale back or discontinue research and discovery efforts and the development or commercialization of any product candidates or cease operations altogether&#59; seek strategic alliances for research and development programs when we otherwise would not, or at an earlier stage than we would otherwise desire or on terms less favorable than might otherwise be available&#59; or relinquish, or license on unfavorable terms, our rights to technologies or any product candidates that we otherwise would seek to develop or commercialize ourselves. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-weight:normal;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">In addition, if pegozafermin receives approval and is commercialized, we will be required to make milestone and royalty payments to Teva, from whom we acquired certain patents and intellectual property relating to pegozafermin, and from whom we licensed patents and know-how related to glycoPEGylation technology that is used in the manufacture of pegozafermin. For additional information regarding this license agreement, please see Note 5 of our accompanying audited consolidated financial statements.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">T</span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">he ongoing</span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> COVID-19 pandemic</span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">has resulted and </span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">may </span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">in the future </span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">result in significant disruptions to our clinical trials or other business operations, which could have a material adverse effect on our business.</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our business and its operations, including but not limited to our research and development activities, could be adversely affected by health epidemics in regions where we have business operations, and such health epidemics could cause significant disruption in the operations of third parties upon whom we rely. In response to public health directives and orders related to COVID-19 and based on guidance from public health officials, we have implemented and may continue to implement work-from-home policies for our employees on an office-by-office basis. The effects of executive and similar government orders, shelter-in-place orders and our work-from-home policies may negatively impact our growth, including our ability to recruit and onboard new employees, and productivity, disrupt our business and delay our preclinical and clinical programs and timelines, the magnitude of which will depend, in part, on the length and severity of the restrictions and other limitations on our ability to conduct our business in the ordinary course. These and similar, and perhaps more severe, disruptions in our operations could negatively impact our business, operating results and financial condition. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our clinical trials have been and may continue to be affected by the COVID-19 pandemic. For example, while we initiated the Phase 2 trial (ENTRIGUE) of pegozafermin for the treatment of SHTG, our successful completion of these trials will depend on the external environment with respect to COVID-19 remaining conducive to executing the trial safely and effectively. The COVID-19 pandemic has impacted execution and enrollment of our trials. We expect to report topline data from this study in the second quarter of 2022. Given the surges in cases of COVID-19 experienced previously and uncertainty regarding other variants, we cannot predict how our ongoing trials may be impacted.&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, quarantines, shelter-in-place, executive and similar government orders, or the perception that such orders, shutdowns or other restrictions on the conduct of business operations could occur, related to COVID-19 or other infectious diseases, have impacted and may continue to impact personnel at third-party manufacturing facilities in the United States, Europe and other countries, or the availability or cost of materials we use or require to conduct our business, including product development, which would disrupt our supply chain. In particular, BTPH, our sole source supplier for pegozafermin, has missed certain project deadlines for our manufacturing scale-up due to quarantine orders and has forecasted other delays due to COVID-19-related impacts on their suppliers. Furthermore, we have experienced and may continue to experience delays due to widespread supply chain issues relating to the COVID-19 pandemic, as well as historically the designation of certain supplies for vaccine production, which may limit our ability to obtain sufficient materials for our drug products. However, we have not experienced and do not expect to experience any delays to the overall timeline for the delivery of clinical supplies.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If COVID-19 continues to spread in the United States and elsewhere, we may experience additional disruptions that could severely impact our business, preclinical studies and clinical trials, including: delays in receiving authorization from local regulatory authorities to initiate our planned clinical trials&#59; delays or difficulties in enrolling patients in our clinical trials&#59; delays or difficulties in clinical site initiation, including difficulties in recruiting clinical site investigators and clinical site staff&#59; delays in clinical sites receiving the supplies and materials needed to conduct our clinical trials&#59; changes in local regulations as part of a response to the COVID-19 pandemic which may require us to change the ways in which our clinical trials are conducted and result in unexpected costs, or discontinuing our clinical trials altogether&#59; a diversion of healthcare resources away from the conduct of clinical trials, including the diversion of hospitals serving as our clinical trial sites and hospital staff supporting the conduct of our clinical trials&#59; interruption of key clinical trial activities, such as clinical trial site monitoring and data entry and verification, due to limitations on travel imposed or recommended by federal or state governments, employers and others, or interruption of clinical trial subject visits and study procedures, the occurrence of which could affect the completeness and integrity of clinical trial data and, as a result, determine the outcomes of the trial&#59; the risk that participants enrolled in our clinical trials will acquire COVID-19 while the clinical trial is ongoing, which could impact the results of the clinical trial, including by increasing the number of observed adverse events&#59; the risk that participants enrolled in our clinical trials will not be able to travel to our clinical trial sites as a result of quarantines or other restrictions resulting from COVID-19 or comply with clinical trial protocols if quarantines impede patient movement or interrupt healthcare services&#59; interruptions or delays in preclinical studies due to restricted or limited operations at our research and development laboratory facilities&#59; limitations in employee resources that would otherwise be focused on the conduct of our clinical trials&#59; the refusal of the FDA to accept data from clinical trials in affected geographies&#59; and interruption or delays to our clinical activities.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The COVID-19 pandemic continues to evolve rapidly. The ultimate impact of the COVID-19 pandemic or a similar public health emergency is highly uncertain </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> subject to change. We do not yet know the full extent of potential delays or impacts on our business, our clinical trials, healthcare systems, or the global economy as a whole. However, any one or a combination of these events could have an adverse effect on the operation of and results from our clinical trials and on our other business operations, including preventing or delaying approval for </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">pegozafermin</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our<span style="letter-spacing:-0.05pt;"> </span>business depends on<span style="letter-spacing:-0.05pt;"> </span>the success<span style="letter-spacing:0.05pt;"> </span>of pegozafermin, our only product candidate<span style="letter-spacing:0.05pt;"> </span>under clinical<span style="letter-spacing:0.05pt;"> </span>development, which<span style="letter-spacing:-0.05pt;"> </span>has not completed<span style="letter-spacing:0.05pt;"> </span>a pivotal<span style="letter-spacing:0.05pt;"> </span>trial. If we are unable to obtain regulatory approval for and successfully commercialize pegozafermin or other future product candidates, or we<span style="letter-spacing:-0.05pt;"> </span>experience<span style="letter-spacing:0.05pt;"> </span>significant<span style="letter-spacing:0.1pt;"> </span>delays<span style="letter-spacing:0.05pt;"> </span>in doing so, our business will be materially<span style="letter-spacing:0.1pt;"> </span>harmed.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To date, the primary focus of our product development has been pegozafermin for the treatment of patients with NASH. Currently, pegozafermin is our only product candidate under clinical development. This may make an investment in our company riskier than similar companies that have multiple product candidates in active development and that therefore may be able to better sustain a failure of a lead candidate. Successful continued development and ultimate regulatory approval of pegozafermin for the treatment of NASH or other indications, including SHTG, is critical to the future success of our business. We have invested, and will continue to invest, a significant portion of our time and financial resources in the clinical development of pegozafermin. If we cannot successfully develop, obtain regulatory approval for and commercialize pegozafermin, we may not be able to continue our operations. The future regulatory and commercial success of pegozafermin is subject to a number of risks, including that if approved for NASH or SHTG, pegozafermin will likely compete with products that may reach approval for the treatment of NASH prior to pegozafermin, products that are currently approved for the treatment of SHTG and the off-label use of currently marketed products for NASH and SHTG. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Clinical<span style="letter-spacing:0.05pt;"> </span>drug development<span style="letter-spacing:0.05pt;"> </span>involves<span style="letter-spacing:0.05pt;"> </span>a lengthy and<span style="letter-spacing:-0.05pt;"> </span>expensive<span style="letter-spacing:0.05pt;"> </span>process<span style="letter-spacing:0.05pt;"> </span>with uncertain timelines<span style="letter-spacing:0.1pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>uncertain outcomes,<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>the results<span style="letter-spacing:0.05pt;"> </span>of prior preclinical<span style="letter-spacing:0.1pt;"> </span>or clinical<span style="letter-spacing:0.05pt;"> </span>trials<span style="letter-spacing:0.05pt;"> </span>are not necessarily<span style="letter-spacing:0.1pt;"> </span>predictive<span style="letter-spacing:0.1pt;"> </span>of our future results.<span style="letter-spacing:0.05pt;"> </span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pegozafermin and any future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>will be subject<span style="letter-spacing:0.05pt;"> </span>to rigorous<span style="letter-spacing:0.05pt;"> </span>and extensive<span style="letter-spacing:0.05pt;"> </span>clinical<span style="letter-spacing:0.1pt;"> </span>trials<span style="letter-spacing:0.1pt;"> </span>and extensive<span style="letter-spacing:0.05pt;"> </span>regulatory<span style="letter-spacing:0.1pt;"> </span>approval<span style="letter-spacing:0.05pt;"> </span>processes<span style="letter-spacing:0.05pt;"> </span>implemented<span style="letter-spacing:0.1pt;"> </span>by the FDA<span style="letter-spacing:-0.05pt;"> </span>and comparable<span style="letter-spacing:0.1pt;"> </span>foreign<span style="letter-spacing:0.05pt;"> </span>regulatory<span style="letter-spacing:0.1pt;"> </span>authorities before<span style="letter-spacing:0.05pt;"> </span>obtaining<span style="letter-spacing:0.05pt;"> </span>marketing<span style="letter-spacing:0.1pt;"> </span>approval<span style="letter-spacing:0.05pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>these<span style="letter-spacing:0.05pt;"> </span>regulatory<span style="letter-spacing:0.1pt;"> </span>authorities.<span style="letter-spacing:0.1pt;"> </span>The drug development<span style="letter-spacing:0.05pt;"> </span>and approval process<span style="letter-spacing:0.05pt;"> </span>is lengthy<span style="letter-spacing:0.05pt;"> </span>and expensive,<span style="letter-spacing:0.05pt;"> </span>and approval<span style="letter-spacing:0.05pt;"> </span>is never certain.<span style="letter-spacing:0.05pt;"> </span>Investigational<span style="letter-spacing:0.15pt;"> </span>new<span style="letter-spacing:-0.05pt;"> </span>drugs, such as pegozafermin, may not prove to be safe<span style="letter-spacing:0.05pt;"> </span>and effective<span style="letter-spacing:0.1pt;"> </span>in clinical<span style="letter-spacing:0.1pt;"> </span>trials.<span style="letter-spacing:0.1pt;"> </span>We have no direct<span style="letter-spacing:0.05pt;"> </span>experience<span style="letter-spacing:0.05pt;"> </span>as a company in conducting<span style="letter-spacing:0.05pt;"> </span>pivotal<span style="letter-spacing:0.05pt;"> </span>trials<span style="letter-spacing:0.1pt;"> </span>required<span style="letter-spacing:0.05pt;"> </span>to obtain<span style="letter-spacing:0.05pt;"> </span>regulatory<span style="letter-spacing:0.1pt;"> </span>approval.<span style="letter-spacing:0.05pt;"> </span>We may be unable to conduct clinical trials<span style="letter-spacing:0.1pt;"> </span>at preferred<span style="letter-spacing:0.1pt;"> </span>sites,<span style="letter-spacing:0.05pt;"> </span>enlist<span style="letter-spacing:0.05pt;"> </span>clinical<span style="letter-spacing:0.1pt;"> </span>investigators,<span style="letter-spacing:0.1pt;"> </span>enroll<span style="letter-spacing:0.05pt;"> </span>sufficient<span style="letter-spacing:0.1pt;"> </span>numbers<span style="letter-spacing:0.05pt;"> </span>of participants<span style="letter-spacing:0.1pt;"> </span>or begin or successfully<span style="letter-spacing:0.1pt;"> </span>complete<span style="letter-spacing:0.05pt;"> </span>clinical<span style="letter-spacing:0.1pt;"> </span>trials<span style="letter-spacing:0.1pt;"> </span>in a timely<span style="letter-spacing:0.05pt;"> </span>fashion,<span style="letter-spacing:0.05pt;"> </span>if at all.<span style="letter-spacing:0.05pt;"> </span>In addition,<span style="letter-spacing:0.05pt;"> </span>the design of a clinical<span style="letter-spacing:0.1pt;"> </span>trial<span style="letter-spacing:0.05pt;"> </span>can determine<span style="letter-spacing:0.1pt;"> </span>whether its<span style="letter-spacing:0.05pt;"> </span>results<span style="letter-spacing:0.05pt;"> </span>will support<span style="letter-spacing:0.05pt;"> </span>approval<span style="letter-spacing:0.05pt;"> </span>of a product,<span style="letter-spacing:0.05pt;"> </span>and flaws in the design of a clinical<span style="letter-spacing:0.1pt;"> </span>trial<span style="letter-spacing:0.05pt;"> </span>may not become<span style="letter-spacing:0.05pt;"> </span>apparent<span style="letter-spacing:0.05pt;"> </span>until<span style="letter-spacing:0.05pt;"> </span>the clinical<span style="letter-spacing:0.1pt;"> </span>trial<span style="letter-spacing:0.05pt;"> </span>is well advanced. We<span style="letter-spacing:-0.05pt;"> </span>may be unable to design and execute<span style="letter-spacing:0.05pt;"> </span>a clinical<span style="letter-spacing:0.1pt;"> </span>trial<span style="letter-spacing:0.05pt;"> </span>to support<span style="letter-spacing:0.05pt;"> </span>regulatory<span style="letter-spacing:0.1pt;"> </span>approval. Even if a current<span style="letter-spacing:0.05pt;"> </span>clinical<span style="letter-spacing:0.1pt;"> </span>trial<span style="letter-spacing:0.05pt;"> </span>is successful,<span style="letter-spacing:0.1pt;"> </span>it may be insufficient<span style="letter-spacing:0.15pt;"> </span>to demonstrate<span style="letter-spacing:0.1pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>pegozafermin is safe<span style="letter-spacing:0.05pt;"> </span>or effective<span style="letter-spacing:0.1pt;"> </span>for registration<span style="letter-spacing:0.15pt;"> </span>purposes.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There is a high failure<span style="letter-spacing:0.1pt;"> </span>rate<span style="letter-spacing:0.05pt;"> </span>for drugs and biologic<span style="letter-spacing:0.05pt;"> </span>products<span style="letter-spacing:0.05pt;"> </span>proceeding<span style="letter-spacing:0.05pt;"> </span>through clinical<span style="letter-spacing:0.1pt;"> </span>trials.<span style="letter-spacing:0.1pt;"> </span>Failure<span style="letter-spacing:0.05pt;"> </span>can occur at any time<span style="letter-spacing:0.05pt;"> </span>during the clinical<span style="letter-spacing:0.1pt;"> </span>trial<span style="letter-spacing:0.05pt;"> </span>process.<span style="letter-spacing:0.05pt;"> </span>The results<span style="letter-spacing:0.05pt;"> </span>of preclinical<span style="letter-spacing:0.1pt;"> </span>studies<span style="letter-spacing:0.05pt;"> </span>and early<span style="letter-spacing:0.05pt;"> </span>clinical<span style="letter-spacing:0.1pt;"> </span>trials<span style="letter-spacing:0.1pt;"> </span>of pegozafermin or any future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidate<span style="letter-spacing:0.05pt;"> </span>may not be predictive<span style="letter-spacing:0.1pt;"> </span>of the results<span style="letter-spacing:0.05pt;"> </span>of later-stage<span style="letter-spacing:0.15pt;"> </span>clinical<span style="letter-spacing:0.1pt;"> </span>studies<span style="letter-spacing:0.05pt;"> </span>or trials<span style="letter-spacing:0.1pt;"> </span>and the results<span style="letter-spacing:0.05pt;"> </span>of studies<span style="letter-spacing:0.05pt;"> </span>or trials<span style="letter-spacing:0.1pt;"> </span>in one set of patients<span style="letter-spacing:0.05pt;"> </span>or line<span style="letter-spacing:0.05pt;"> </span>of treatment<span style="letter-spacing:0.1pt;"> </span>may not be predictive<span style="letter-spacing:0.1pt;"> </span>of those obtained<span style="letter-spacing:0.05pt;"> </span>in another.<span style="letter-spacing:0.05pt;"> </span>In fact,<span style="letter-spacing:0.05pt;"> </span>many companies<span style="letter-spacing:0.05pt;"> </span>in the pharmaceutical<span style="letter-spacing:0.15pt;"> </span>and biotechnology<span style="letter-spacing:0.05pt;"> </span>industries<span style="letter-spacing:0.1pt;"> </span>have suffered significant<span style="letter-spacing:0.1pt;"> </span>setbacks<span style="letter-spacing:0.05pt;"> </span>in late<span style="letter-spacing:0.05pt;">-</span>stage<span style="letter-spacing:0.05pt;"> </span>clinical<span style="letter-spacing:0.1pt;"> </span>trials<span style="letter-spacing:0.1pt;"> </span>even after<span style="letter-spacing:0.05pt;"> </span>achieving<span style="letter-spacing:0.05pt;"> </span>promising<span style="letter-spacing:0.05pt;"> </span>results<span style="letter-spacing:0.05pt;"> </span>in preclinical<span style="letter-spacing:0.1pt;"> </span>studies<span style="letter-spacing:0.05pt;"> </span>and earlier<span style="letter-spacing:0.1pt;"> </span>stage<span style="letter-spacing:0.05pt;"> </span>clinical<span style="letter-spacing:0.1pt;"> </span>trials.<span style="letter-spacing:0.1pt;"> </span>In addition,<span style="letter-spacing:0.05pt;"> </span>data obtained<span style="letter-spacing:0.05pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>preclinical<span style="letter-spacing:0.1pt;"> </span>and clinical<span style="letter-spacing:0.1pt;"> </span>activities<span style="letter-spacing:0.1pt;"> </span>is subject<span style="letter-spacing:0.05pt;"> </span>to varying interpretations,<span style="letter-spacing:0.15pt;"> </span>which may delay, limit<span style="letter-spacing:0.1pt;"> </span>or prevent<span style="letter-spacing:0.05pt;"> </span>regulatory<span style="letter-spacing:0.1pt;"> </span>approval.<span style="letter-spacing:0.05pt;"> </span>It is impossible<span style="letter-spacing:0.1pt;"> </span>to predict<span style="letter-spacing:0.05pt;"> </span>when<span style="letter-spacing:-0.05pt;"> </span>or if pegozafermin or any future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidate<span style="letter-spacing:0.05pt;"> </span>will prove effective<span style="letter-spacing:0.1pt;"> </span>or safe<span style="letter-spacing:0.05pt;"> </span>in humans or will receive<span style="letter-spacing:0.05pt;"> </span>regulatory approval.<span style="letter-spacing:0.05pt;"> </span>Owing<span style="letter-spacing:-0.05pt;"> </span>in part<span style="letter-spacing:0.05pt;"> </span>to the complexity<span style="letter-spacing:0.1pt;"> </span>of biological<span style="letter-spacing:0.1pt;"> </span>pathways, pegozafermin or any future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidate may not demonstrate<span style="letter-spacing:0.1pt;"> </span>in patients<span style="letter-spacing:0.05pt;"> </span>the biochemical<span style="letter-spacing:0.1pt;"> </span>and pharmacological<span style="letter-spacing:0.15pt;"> </span>properties<span style="letter-spacing:0.1pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>anticipate<span style="letter-spacing:0.1pt;"> </span>based on laboratory<span style="letter-spacing:0.1pt;"> </span>studies<span style="letter-spacing:0.05pt;"> </span>or earlier<span style="letter-spacing:0.1pt;"> </span>stage<span style="letter-spacing:0.05pt;"> </span>clinical<span style="letter-spacing:0.1pt;"> </span>trials,<span style="letter-spacing:0.1pt;"> </span>and they may interact<span style="letter-spacing:0.1pt;"> </span>with human biological<span style="letter-spacing:0.1pt;"> </span>systems<span style="letter-spacing:0.05pt;"> </span>or other drugs in unforeseen,<span style="letter-spacing:0.05pt;"> </span>ineffective<span style="letter-spacing:0.1pt;"> </span>or harmful<span style="letter-spacing:0.05pt;"> </span>ways. The number<span style="letter-spacing:0.05pt;"> </span>of patients<span style="letter-spacing:0.05pt;"> </span>exposed to product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>and the average<span style="letter-spacing:0.05pt;"> </span>exposure<span style="letter-spacing:0.05pt;"> </span>time<span style="letter-spacing:0.05pt;"> </span>in the clinical<span style="letter-spacing:0.1pt;"> </span>development<span style="letter-spacing:0.05pt;"> </span>programs<span style="letter-spacing:0.05pt;"> </span>may be inadequate<span style="letter-spacing:0.05pt;"> </span>to detect<span style="letter-spacing:0.05pt;"> </span>rare<span style="letter-spacing:0.05pt;"> </span>adverse<span style="letter-spacing:0.05pt;"> </span>events<span style="letter-spacing:0.05pt;"> </span>or findings<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>may only be detected<span style="letter-spacing:0.05pt;"> </span>once a product<span style="letter-spacing:0.05pt;"> </span>candidate<span style="letter-spacing:0.05pt;"> </span>is administered<span style="letter-spacing:0.1pt;"> </span>to more<span style="letter-spacing:0.05pt;"> </span>patients<span style="letter-spacing:0.05pt;"> </span>and for greater periods<span style="letter-spacing:0.05pt;"> </span>of time.<span style="letter-spacing:0.05pt;"> </span>To<span style="letter-spacing:-0.05pt;"> </span>date, our Phase 1a and Phase 1b/2a clinical<span style="letter-spacing:0.1pt;"> </span>trials<span style="letter-spacing:0.05pt;"> </span>have involved<span style="letter-spacing:0.05pt;"> </span>small<span style="letter-spacing:0.05pt;"> </span>patient<span style="letter-spacing:0.05pt;"> </span>populations<span style="letter-spacing:0.05pt;"> </span>and, because<span style="letter-spacing:0.05pt;"> </span>of the small<span style="letter-spacing:0.05pt;"> </span></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">sample</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">size</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in such trial</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the results</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of th</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ese</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">clinical</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">trial</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">may be subject</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to substantial variability</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, including the inherent variability associated with biopsies in NASH patients,</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and may not be indicative</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of either</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">future</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">interim</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">results</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or final</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">results</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> future trials of</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> patients</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">with liver</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or cardio-metabolic</span><span style="letter-spacing:0.15pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">diseases.</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If we</span><span style="letter-spacing:-0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">are unable to successfully</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">demonstrate</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the safety</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and efficacy</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">pegozafermin</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or other</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">future</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">product</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">candidates</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and receive</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the necessary</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">regulatory</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">approvals,</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our business</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">will be materially harmed.</span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If we<span style="letter-spacing:-0.05pt;"> </span>experience<span style="letter-spacing:0.05pt;"> </span>delays<span style="letter-spacing:0.05pt;"> </span>in clinical<span style="letter-spacing:0.05pt;"> </span>testing,<span style="letter-spacing:0.05pt;"> </span>our commercial<span style="letter-spacing:0.1pt;"> </span>prospects<span style="letter-spacing:0.05pt;"> </span>will be adversely<span style="letter-spacing:0.05pt;"> </span>affected,<span style="letter-spacing:0.05pt;"> </span>our costs<span style="letter-spacing:0.05pt;"> </span>may increase<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>our business may be harmed.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We cannot guarantee<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>will be able to initiate<span style="letter-spacing:0.1pt;"> </span>and complete<span style="letter-spacing:0.05pt;"> </span>clinical<span style="letter-spacing:0.1pt;"> </span>trials and successfully<span style="letter-spacing:0.1pt;"> </span>accomplish<span style="letter-spacing:0.1pt;"> all </span>required<span style="letter-spacing:0.05pt;"> </span>regulatory<span style="letter-spacing:0.1pt;"> </span>activities<span style="letter-spacing:0.1pt;"> </span>or other<span style="letter-spacing:0.05pt;"> </span>activities<span style="letter-spacing:0.1pt;"> </span>necessary<span style="letter-spacing:0.05pt;"> </span>to gain approval and commercialize pegozafermin or any future product candidates.<span style="letter-spacing:0.1pt;"> </span>We currently<span style="letter-spacing:-0.05pt;"> </span>have two active<span style="letter-spacing:0.05pt;"> </span>investigational new drug (&#8220;IND&#8221;) applications<span style="letter-spacing:-0.05pt;"> </span>with the FDA<span style="letter-spacing:-0.05pt;"> </span>in the United States<span style="letter-spacing:0.05pt;"> </span>for pegozafermin. In the future,<span style="letter-spacing:-0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>may file<span style="letter-spacing:0.05pt;"> </span>an additional<span style="letter-spacing:0.1pt;"> </span>IND<span style="letter-spacing:-0.05pt;"> </span>with another<span style="letter-spacing:0.05pt;"> </span>division<span style="letter-spacing:0.05pt;"> </span>for any future<span style="letter-spacing:0.05pt;"> </span>indications or future product candidates.<span style="letter-spacing:-0.1pt;"> </span>If any such future<span style="letter-spacing:0.05pt;"> </span>IND<span style="letter-spacing:-0.05pt;"> </span>is not approved by the FDA,<span style="letter-spacing:-0.05pt;"> </span>our clinical<span style="letter-spacing:0.1pt;"> </span>development<span style="letter-spacing:0.05pt;"> </span>timeline<span style="letter-spacing:0.1pt;"> </span>may be negatively<span style="letter-spacing:0.05pt;"> </span>impacted<span style="letter-spacing:0.05pt;"> </span>and any future<span style="letter-spacing:0.05pt;"> </span>clinical programs<span style="letter-spacing:0.05pt;"> </span>may be delayed<span style="letter-spacing:0.05pt;"> </span>or terminated. As<span style="letter-spacing:-0.05pt;"> </span>a result,<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>may be unable to obtain<span style="letter-spacing:0.05pt;"> </span>regulatory<span style="letter-spacing:0.1pt;"> </span>approvals<span style="letter-spacing:0.05pt;"> </span>or successfully<span style="letter-spacing:0.1pt;"> </span>commercialize<span style="letter-spacing:0.15pt;"> </span>our products.<span style="letter-spacing:0.05pt;"> </span>We do not know<span style="letter-spacing:-0.05pt;"> </span>whether any other<span style="letter-spacing:0.05pt;"> </span>clinical<span style="letter-spacing:0.1pt;"> </span>trials<span style="letter-spacing:0.1pt;"> </span>will begin as planned, will need to be restructured<span style="letter-spacing:0.1pt;"> </span>or will be completed<span style="letter-spacing:0.05pt;"> </span>on schedule,<span style="letter-spacing:0.05pt;"> </span>or at all.<span style="letter-spacing:0.05pt;"> </span>Our product<span style="letter-spacing:0.05pt;"> </span>development<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>will increase<span style="letter-spacing:0.05pt;"> </span>if we<span style="letter-spacing:-0.05pt;"> </span>experience<span style="letter-spacing:0.05pt;"> </span>delays<span style="letter-spacing:0.05pt;"> </span>in clinical<span style="letter-spacing:0.1pt;"> </span>testing.<span style="letter-spacing:0.05pt;"> </span>Significant<span style="letter-spacing:0.1pt;"> </span>clinical<span style="letter-spacing:0.1pt;"> </span>trial<span style="letter-spacing:0.05pt;"> </span>delays<span style="letter-spacing:0.05pt;"> </span>also could shorten<span style="letter-spacing:0.05pt;"> </span>any periods during which we<span style="letter-spacing:-0.05pt;"> </span>may have the exclusive<span style="letter-spacing:0.05pt;"> </span>right<span style="letter-spacing:0.05pt;"> </span>to commercialize<span style="letter-spacing:0.15pt;"> </span>pegozafermin and any future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>or allow our competitors<span style="letter-spacing:0.1pt;"> </span>to bring products<span style="letter-spacing:0.05pt;"> </span>to market<span style="letter-spacing:0.05pt;"> </span>before<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>do, which would impair<span style="letter-spacing:0.05pt;"> </span>our ability<span style="letter-spacing:0.05pt;"> </span>to successfully commercialize<span style="letter-spacing:0.15pt;"> </span>pegozafermin or any future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>and may harm<span style="letter-spacing:0.05pt;"> </span>our business,<span style="letter-spacing:0.05pt;"> </span>results<span style="letter-spacing:0.05pt;"> </span>of operations<span style="letter-spacing:0.05pt;"> </span>and prospects.<span style="letter-spacing:0.05pt;"> </span>Our or our future<span style="letter-spacing:0.05pt;"> </span>collaborators&#8217;<span style="letter-spacing:0.15pt;"> </span>inability<span style="letter-spacing:0.1pt;"> </span>to timely<span style="letter-spacing:0.05pt;"> </span>complete<span style="letter-spacing:0.05pt;"> </span>clinical<span style="letter-spacing:0.1pt;"> </span>development<span style="letter-spacing:0.05pt;"> </span>could result<span style="letter-spacing:0.05pt;"> </span>in additional<span style="letter-spacing:0.1pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>to us as well as impair<span style="letter-spacing:0.05pt;"> </span>our ability<span style="letter-spacing:0.05pt;"> </span>to generate<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>revenue,<span style="letter-spacing:0.05pt;"> </span>continue<span style="letter-spacing:0.05pt;"> </span>development, commercialize<span style="letter-spacing:0.15pt;"> </span>pegozafermin and any future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidates,<span style="letter-spacing:0.05pt;"> </span>reach<span style="letter-spacing:0.05pt;"> </span>sales<span style="letter-spacing:0.05pt;"> </span>milestone<span style="letter-spacing:0.1pt;"> </span>payments<span style="letter-spacing:0.05pt;"> </span>and receive royalties<span style="letter-spacing:0.1pt;"> </span>on product<span style="letter-spacing:0.05pt;"> </span>sales.<span style="letter-spacing:0.05pt;"> </span>In addition,<span style="letter-spacing:0.05pt;"> </span>if we<span style="letter-spacing:-0.05pt;"> </span>make changes to a product<span style="letter-spacing:0.05pt;"> </span>candidate including, for example, a new formulation,<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>may need to conduct additional<span style="letter-spacing:0.1pt;"> </span>nonclinical<span style="letter-spacing:0.1pt;"> </span>studies<span style="letter-spacing:0.05pt;"> </span>or <span style="letter-spacing:0.05pt;">clinical</span><span style="letter-spacing:0.1pt;"> </span>trials<span style="letter-spacing:0.1pt;"> </span>to bridge<span style="letter-spacing:0.05pt;"> </span>or demonstrate<span style="letter-spacing:0.1pt;"> </span>the comparability<span style="letter-spacing:0.15pt;"> </span>of our modified<span style="letter-spacing:0.05pt;"> </span>product candidate<span style="letter-spacing:0.05pt;"> </span>to earlier<span style="letter-spacing:0.1pt;"> </span>versions,<span style="letter-spacing:0.05pt;"> </span>which could delay our clinical<span style="letter-spacing:0.1pt;"> </span>development<span style="letter-spacing:0.05pt;"> </span>plan or marketing<span style="letter-spacing:0.1pt;"> </span>approval<span style="letter-spacing:0.05pt;"> </span>for our current<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidate<span style="letter-spacing:0.05pt;"> </span>and any future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidates.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If we<span style="letter-spacing:-0.05pt;"> </span>encounter difficulties<span style="letter-spacing:0.15pt;"> </span>in enrolling<span style="letter-spacing:0.05pt;"> </span>patients<span style="letter-spacing:0.05pt;"> </span>in our clinical<span style="letter-spacing:0.05pt;"> </span>trials,<span style="letter-spacing:0.05pt;"> </span>our clinical<span style="letter-spacing:0.05pt;"> </span>development<span style="letter-spacing:0.05pt;"> </span>activities<span style="letter-spacing:0.1pt;"> </span>could be delayed<span style="letter-spacing:0.05pt;"> </span>or otherwise<span style="letter-spacing:0.05pt;"> </span>adversely<span style="letter-spacing:0.05pt;"> </span>affected.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The timely completion of clinical trials largely depends on patient enrollment. We may encounter delays in enrolling, or be unable to enroll, a sufficient number of patients to complete any of our future clinical trials, and even once enrolled, we may be unable to retain a sufficient number of patients to complete any of our trials. Furthermore, there are inherent difficulties in diagnosing NASH, which can currently only be definitively diagnosed through a liver biopsy, and identifying SHTG patients. Specifically, identifying patients most likely to meet NASH enrollment criteria on biopsy is an on-going challenge, with existing clinical indicators lacking both sensitivity and specificity. As a result, NASH trials often suffer from high levels of screen failure following central review of the baseline liver biopsy, which can lead to lower enrollment. As a result of such difficulties and the significant competition for recruiting NASH and SHTG patients in clinical trials, we or our future collaborators may be unable to enroll the patients we need to complete clinical trials on a timely basis, or at all. In addition, our competitors, some of whom have significantly greater resources than we do, are conducting clinical trials for the same indications and seek to enroll patients in their studies that may otherwise be eligible for our clinical studies or trials. Since the number of qualified clinical investigators is limited, we expect to conduct some of our clinical trials at the same clinical trial sites that some of our competitors use, which could further reduce the number of patients who are available for our clinical trials in these sites. Our inability to enroll a sufficient number of patients for our clinical trials would result in significant delays or may require us to abandon one or more clinical trials altogether. Even if we are able to enroll a sufficient number of patients in our clinical studies or trials, delays in patient enrollment may result in increased costs or may affect the timing or outcome of our clinical trials, which could prevent completion of these trials and adversely affect our ability to advance the development of pegozafermin and any future product candidates. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We have relied on, and expect to continue to rely on, third-party manufacturers and vendors to produce and release </span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">pegozafermin</span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> or any future product candidates. </span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Any failure by a third-party to produce and release acceptable product candidates for us pursuant to our specifications and regulatory standards may delay or impair our ability to initiate or complete our clinical trials, obtain and maintain regulatory approvals or commercialize approved products.</span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We do not own or operate manufacturing facilities for the production of clinical or commercial quantities of our product candidates, and we lack the resources and the capabilities to do so. As a result, we currently rely, and expect to rely for the foreseeable future, on third-party manufacturers to supply us with pegozafermin and any future product candidates. We currently have a sole source relationship with BTPH pursuant to which they supply us with pegozafermin. If there should be any disruption in our supply arrangement with BTPH, including any adverse events affecting BTPH, it could have a negative effect on the clinical development of pegozafermin and other operations while we work to identify and qualify an alternate supply source. In addition, we will require large quantities of pegozafermin for large clinical trials and to commercialize pegozafermin. Our current manufacturer may not be able to scale production to the larger quantities. We have identified a manufacturing partner for commercial-scale manufacturing, however, we cannot guarantee that such partner will be able to scale up and produce the quantities we would require to commercialize pegozafermin. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We do not have a long-term supply agreement with any third-party manufacturer. Reliance on third-party manufacturers entails risks to which we would not be subject if we manufacture product candidates or products ourselves. For example, if we do not maintain our key manufacturing relationships, we may fail to find replacement manufacturers or develop our own manufacturing capabilities in a timely manner or at all, which could delay or impair our ability to obtain regulatory approval for our products and substantially increase our costs or deplete profit margins, if any. If we do find replacement manufacturers, we may not be able to enter into agreements with them on terms and conditions favorable to us, and there could be a substantial delay before new facilities could be qualified and registered with the FDA and other comparable foreign regulatory authorities.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have begun producing certain of the reagents required for the glycoPEGylation at BTPH using the know-how transferred to us from Teva Pharmaceutical Industries Ltd (&#8220;Teva&#8221;) under our Reagent Supply and Technology Transfer Agreement. We have not completed the manufacturing process for all these reagents and cannot guarantee that we will be able to produce them successfully, or scale up our production for the quantities needed for commercialization.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Teva continues to supply us with certain reagents and will continue to do so until December 31, 2022. We expect the manufacturing of such reagents will be transferred to a new supplier prior to the end of 2022. Any complications arising under our agreement with Teva or any difficulties securing a new supplier could considerably delay the manufacture of pegozafermin. Any significant delay in the acquisition or decrease in the availability of these raw materials from Teva or any new supplier could considerably delay the manufacture of pegozafermin, which could adversely impact the timing of any planned trials or the regulatory approvals of pegozafermin. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We rely on third-party vendors for our assay development and testing. If such third-party vendors are unable to successfully produce or test such assays, it may substantially increase our cost or could adversely impact the timing of any planned trials or the regulatory approvals of pegozafermin.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FDA and other comparable foreign regulatory authorities require manufacturers to register manufacturing facilities. The FDA and other comparable foreign regulatory authorities also inspect these facilities to confirm compliance with cGMP. We have little to no control regarding the occurrence of third-party manufacturer incidents. Any failure to comply with cGMP requirements or other FDA or comparable foreign regulatory requirements could adversely affect our clinical research activities and our ability to develop pegozafermin or any future product candidates and market our products following approval. Our sole source supplier, BTPH, has not yet manufactured a commercial product, and as a result, has not been subject to inspection by the FDA and other comparable foreign regulatory authorities.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our current and anticipated future dependence upon others for the manufacture of our product candidates may adversely affect our future profit margins and our ability to develop our product candidates and commercialize any products that receive regulatory approval on a timely basis. If we are required to change manufacturers for any </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">reason, we will be required to verify that the new manufacturer maintains facilities and procedures that comply with quality standards and with all applicable regulations and guidelines. For example, in the event that we need to switch our third-party manufacturer of pegozafermin from BTPH, which is our sole manufacturing source for pegozafermin, we anticipate that the complexity of the glycoPEGylation manufacturing process may materially impact the amount of time it may take to secure a replacement manufacturer. The delays associated with the verification of a new manufacturer, if we are able to identify an alternative source, could negatively affect our ability to develop product candidates in a timely manner or within budget.</span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Pegozafermin and<span style="letter-spacing:-0.05pt;"> </span>any future product candidates<span style="letter-spacing:0.05pt;"> </span>may cause undesirable<span style="letter-spacing:0.05pt;"> </span>side effects<span style="letter-spacing:0.1pt;"> </span>or have other properties<span style="letter-spacing:0.05pt;"> </span>that could delay or prevent<span style="letter-spacing:0.05pt;"> </span>their<span style="letter-spacing:0.05pt;"> </span>regulatory<span style="letter-spacing:0.05pt;"> </span>approval or limit<span style="letter-spacing:0.1pt;"> </span>the commercial<span style="letter-spacing:0.1pt;"> </span>profile<span style="letter-spacing:0.05pt;"> </span>of an<span style="letter-spacing:-0.05pt;"> </span>approved label.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Undesirable<span style="letter-spacing:0.05pt;"> </span>side effects<span style="letter-spacing:0.1pt;"> </span>caused by pegozafermin or any future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>could cause us or regulatory<span style="letter-spacing:0.1pt;"> </span>authorities<span style="letter-spacing:0.1pt;"> </span>to interrupt,<span style="letter-spacing:0.1pt;"> </span>delay or halt<span style="letter-spacing:0.05pt;"> </span>clinical<span style="letter-spacing:0.1pt;"> </span>trials<span style="letter-spacing:0.1pt;"> </span>and could result<span style="letter-spacing:0.05pt;"> </span>in a more<span style="letter-spacing:0.05pt;"> </span>restrictive<span style="letter-spacing:0.15pt;"> </span>label<span style="letter-spacing:0.05pt;"> </span>or the delay or denial<span style="letter-spacing:0.05pt;"> </span>of regulatory<span style="letter-spacing:0.1pt;"> </span>approval<span style="letter-spacing:0.05pt;"> </span>by the FDA<span style="letter-spacing:-0.05pt;"> </span>or other<span style="letter-spacing:0.05pt;"> </span>comparable<span style="letter-spacing:0.1pt;"> </span>foreign<span style="letter-spacing:0.05pt;"> </span>regulatory<span style="letter-spacing:0.1pt;"> </span>authorities.<span style="letter-spacing:0.1pt;"> </span>Additional clinical<span style="letter-spacing:0.1pt;"> </span>studies<span style="letter-spacing:0.05pt;"> </span>may be required<span style="letter-spacing:0.05pt;"> </span>to evaluate<span style="letter-spacing:0.05pt;"> </span>the safety<span style="letter-spacing:0.05pt;"> </span>profile<span style="letter-spacing:0.05pt;"> </span>of pegozafermin or any future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidates. As with other drugs, we have seen evidence of adverse effects in animal and human studies and it is possible that other adverse effects will become apparent in ongoing or future animal or human safety studies. It may be difficult<span style="letter-spacing:0.1pt;"> </span>to discern<span style="letter-spacing:0.05pt;"> </span>whether certain<span style="letter-spacing:0.05pt;"> </span>events<span style="letter-spacing:0.05pt;"> </span>or symptoms<span style="letter-spacing:0.05pt;"> </span>observed<span style="letter-spacing:0.05pt;"> </span>during our clinical<span style="letter-spacing:0.1pt;"> </span>trials<span style="letter-spacing:0.1pt;"> </span>or by patients<span style="letter-spacing:0.05pt;"> </span>using our approved products<span style="letter-spacing:0.05pt;"> </span>are related<span style="letter-spacing:0.05pt;"> </span>to pegozafermin or any future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>or approved products<span style="letter-spacing:0.05pt;"> </span>or some other<span style="letter-spacing:0.05pt;"> </span>factor.<span style="letter-spacing:0.05pt;"> </span>As<span style="letter-spacing:-0.05pt;"> </span>a result,<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>and our development<span style="letter-spacing:0.05pt;"> </span>programs<span style="letter-spacing:0.05pt;"> </span>may be negatively<span style="letter-spacing:0.05pt;"> </span>affected<span style="letter-spacing:0.1pt;"> </span>even if such events<span style="letter-spacing:0.05pt;"> </span>or symptoms<span style="letter-spacing:0.05pt;"> </span>are ultimately<span style="letter-spacing:0.1pt;"> </span>determined<span style="letter-spacing:0.1pt;"> </span>to be unlikely<span style="letter-spacing:0.05pt;"> </span>related<span style="letter-spacing:0.05pt;"> </span>to pegozafermin or any future<span style="letter-spacing:0.05pt;"> </span>product candidates<span style="letter-spacing:0.05pt;"> </span>or approved products.<span style="letter-spacing:0.05pt;"> </span>Further,<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>expect<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>pegozafermin will require<span style="letter-spacing:0.05pt;"> </span>multiple<span style="letter-spacing:0.1pt;"> </span>administrations<span style="letter-spacing:0.15pt;"> </span>via subcutaneous injection<span style="letter-spacing:0.1pt;"> </span>in the course<span style="letter-spacing:0.05pt;"> </span>of a clinical<span style="letter-spacing:0.1pt;"> </span>trial. This<span style="letter-spacing:0.05pt;"> </span>chronic<span style="letter-spacing:0.05pt;"> </span>administration<span style="letter-spacing:0.15pt;"> </span>increases<span style="letter-spacing:0.1pt;"> </span>the risk<span style="letter-spacing:0.05pt;"> that </span>rare<span style="letter-spacing:0.05pt;"> </span>adverse<span style="letter-spacing:0.05pt;"> </span>events<span style="letter-spacing:0.05pt;"> </span>or chance findings<span style="letter-spacing:0.05pt;"> are discovered in the commercial setting, where </span>pegozafermin <span style="letter-spacing:0.05pt;">would be a</span>dministered<span style="letter-spacing:0.1pt;"> </span>to more patients<span style="letter-spacing:0.05pt;"> </span>or for greater<span style="letter-spacing:0.05pt;"> </span>periods<span style="letter-spacing:0.05pt;"> </span>of time, <span style="letter-spacing:0.05pt;">that were not uncovered by </span>our clinical<span style="letter-spacing:0.1pt;"> </span>drug development<span style="letter-spacing:0.05pt;"> </span>programs.<span style="letter-spacing:0.05pt;"> </span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We are developing pegozafermin for the treatment<span style="letter-spacing:0.1pt;"> </span>of NASH, an indication for which there are no approved products. This makes it difficult<span style="letter-spacing:0.1pt;"> </span>to predict<span style="letter-spacing:0.05pt;"> </span>the timing<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>of the clinical<span style="letter-spacing:0.05pt;"> </span>development<span style="letter-spacing:0.05pt;"> </span>of pegozafermin<span style="font-style:normal;"> </span>for the treatment<span style="letter-spacing:0.1pt;"> </span>of NASH.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;letter-spacing:0.05pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are developing pegozafermin for the treatment of NASH, an indication for which there are no approved products. Although there are guidelines issued by the FDA for the development of drugs for the treatment of NASH, the development of a novel product candidates such as pegozafermin may be more expensive and take longer than for other, better known or extensively studied product candidates. As other companies are in later stages of clinical trials for their potential NASH therapies, we expect that the path for regulatory approval for NASH therapies may continue to evolve in the near term as these other companies refine their regulatory approval strategies and interact with regulatory authorities. Such evolution may impact our future clinical trial designs, including trial size and endpoints, in ways that we cannot predict today. In particular, regulatory authority expectations about liver biopsy data may evolve especially as more information is published about the inherent variability in liver biopsy data. Certain of our competitors have experienced regulatory setbacks for NASH therapies following communications from the FDA. We currently do not know the impact, if any, that these setbacks could have on the path for regulatory approval for NASH therapies generally or for pegozafermin. Furthermore, the histology endpoints from our Phase 2b ENLIVEN trial may not be accepted as primary endpoints for a pivotal Phase 3 trial or for FDA approval.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;letter-spacing:0.05pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our anticipated development costs would likely increase if development of pegozafermin or any future product candidate is delayed because we are required by the FDA to perform studies or trials in addition to, or different from, those that we currently anticipate. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;letter-spacing:0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are also developing pegozafermin for the treatment of SHTG. Clinical trials for the treatment of SHTG may be relatively costly and time consuming. The requirements for approval by the FDA and comparable foreign regulatory authorities may change over time and this may require changes to ongoing or future clinical trial designs that could impact timelines and cost.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Lack of efficacy,</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">adverse</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">events</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">or undesirable</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">side effects</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">may emerge</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">in clinical</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">trials</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">conducted by third parties</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">developing</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">FGF</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">product candidates,</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">which</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">could adversely</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">affect</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">our stock price,</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">our ability</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">to attract additional</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">capital</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">and</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">our development</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">program.</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-weight:normal;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Lack of efficacy, adverse events or undesirable side effects may emerge in clinical trials conducted by third parties developing FGF product candidates like ours. For example, Novo Nordisk and Akero Therapeutics, Inc. are also developing FGF21 product candidates for the treatment of NASH. We have no control over their clinical trials or development program, and lack of efficacy, adverse events or undesirable side effects experienced by subjects in their clinical trials could adversely affect our stock price, our ability to attract additional capital and our clinical development plans for pegozafermin or even the viability or prospects of pegozafermin<span style="font-weight:bold;"> </span>as a product candidate, including by creating a negative perception of FGF therapeutics by healthcare providers or patients.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Interim, topline and preliminary data from our clinical trials that we announce or publish from time to time may change as more patient data become available and are subject to audit and verification procedures that could result in material changes in the final data.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-weight:normal;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">From time to time, we may publicly disclose preliminary or topline data from our clinical trials, which are based on a preliminary analysis of then-available data, and the results and related findings and conclusions are subject to change following a more comprehensive review of the data related to the particular study or trial. We also make assumptions, estimations, calculations and conclusions as part of our analyses of data, and we may not have received or had the opportunity to fully and carefully evaluate all data. As a result, the topline results that we report may differ from future results of the same studies, or different conclusions or considerations may qualify such results, once additional data have been received and fully evaluated. Topline data also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data we previously published. As a result, topline data should be viewed with caution until the final data are available. From time to time, we may also disclose interim data from our clinical trials. In addition, we may report interim analyses of only certain endpoints rather than all endpoints. Interim data from clinical trials that we may complete are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">The<span style="letter-spacing:-0.05pt;"> </span>manufacture<span style="letter-spacing:0.05pt;"> </span>of biologic<span style="letter-spacing:0.05pt;"> </span>products is complex<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>are subject<span style="letter-spacing:0.05pt;"> </span>to many manufacturing<span style="letter-spacing:0.05pt;"> </span>risks,<span style="letter-spacing:0.05pt;"> </span>any of which<span style="letter-spacing:-0.05pt;"> </span>could substantially<span style="letter-spacing:0.1pt;"> </span>increase<span style="letter-spacing:0.05pt;"> </span>our costs<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>limit<span style="letter-spacing:0.1pt;"> </span>supply of our products.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To<span style="letter-spacing:-0.05pt;"> </span>date, pegozafermin has been manufactured<span style="letter-spacing:0.1pt;"> </span>by a single<span style="letter-spacing:0.05pt;"> </span>third-party<span style="letter-spacing:0.1pt;"> </span>manufacturer,<span style="letter-spacing:0.1pt;"> </span>BTPH,<span style="letter-spacing:-0.1pt;"> </span>solely<span style="letter-spacing:0.05pt;"> </span>for preclinical<span style="letter-spacing:0.1pt;"> </span>studies<span style="letter-spacing:0.05pt;"> </span>and clinical<span style="letter-spacing:0.1pt;"> </span>trials.<span style="letter-spacing:0.1pt;"> </span>The process<span style="letter-spacing:0.05pt;"> </span>of manufacturing pegozafermin, and in particular,<span style="letter-spacing:0.1pt;"> </span>the glycoPEGylation<span style="letter-spacing:0.05pt;"> </span>process, is complex,<span style="letter-spacing:0.05pt;"> </span>highly regulated, subject<span style="letter-spacing:0.05pt;"> </span>to several<span style="letter-spacing:0.05pt;"> </span>risks and requires<span style="letter-spacing:0.05pt;"> </span>significant<span style="letter-spacing:0.1pt;"> </span>expertise<span style="letter-spacing:0.1pt;"> </span>and capital<span style="letter-spacing:0.05pt;"> </span>investment,<span style="letter-spacing:0.1pt;"> </span>including<span style="letter-spacing:0.05pt;"> </span>the development<span style="letter-spacing:0.05pt;"> </span>of advanced manufacturing techniques<span style="letter-spacing:0.05pt;"> </span>and process<span style="letter-spacing:0.05pt;"> </span>controls.<span style="letter-spacing:0.05pt;"> </span>Manufacturers<span style="letter-spacing:0.1pt;"> </span>of biologic<span style="letter-spacing:0.05pt;"> </span>products<span style="letter-spacing:0.05pt;"> </span>often<span style="letter-spacing:0.05pt;"> </span>encounter<span style="letter-spacing:0.05pt;"> </span>difficulties<span style="letter-spacing:0.15pt;"> </span>in production, including difficulties<span style="letter-spacing:0.15pt;"> </span>with production<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>and yields,<span style="letter-spacing:0.05pt;"> </span>quality<span style="letter-spacing:0.05pt;"> </span>control,<span style="letter-spacing:0.05pt;"> </span>including<span style="letter-spacing:0.05pt;"> </span>stability<span style="letter-spacing:0.1pt;"> </span>of the product, quality<span style="letter-spacing:0.05pt;"> </span>assurance<span style="letter-spacing:0.05pt;"> </span>testing,<span style="letter-spacing:0.05pt;"> </span>operator<span style="letter-spacing:0.05pt;"> </span>error<span style="letter-spacing:0.05pt;"> </span>and shortages<span style="letter-spacing:0.05pt;"> </span>of qualified<span style="letter-spacing:0.1pt;"> </span>personnel,<span style="letter-spacing:0.05pt;"> </span>as well as compliance<span style="letter-spacing:0.1pt;"> </span>with strictly enforced<span style="letter-spacing:0.05pt;"> </span>federal,<span style="letter-spacing:0.05pt;"> </span>state<span style="letter-spacing:0.05pt;"> </span>and foreign<span style="letter-spacing:0.05pt;"> </span>regulations.<span style="letter-spacing:0.1pt;"> </span>We cannot assure<span style="letter-spacing:0.05pt;"> </span>you that<span style="letter-spacing:0.05pt;"> </span>any stability<span style="letter-spacing:0.1pt;"> </span>or other<span style="letter-spacing:0.05pt;"> </span>issues<span style="letter-spacing:0.05pt;"> </span>relating<span style="letter-spacing:0.1pt;"> </span>to the manufacture<span style="letter-spacing:0.1pt;"> </span>of pegozafermin will not occur in the future. We have limited<span style="letter-spacing:0.1pt;"> </span>process<span style="letter-spacing:0.05pt;"> </span>development<span style="letter-spacing:0.05pt;"> </span>capabilities<span style="letter-spacing:0.15pt;"> </span>and have access<span style="letter-spacing:0.05pt;"> </span>only to external<span style="letter-spacing:0.05pt;"> </span>manufacturing capabilities.<span style="letter-spacing:0.15pt;"> </span>We do not have and we<span style="letter-spacing:-0.05pt;"> </span>do not currently<span style="letter-spacing:0.1pt;"> </span>plan to acquire<span style="letter-spacing:0.05pt;"> </span>or develop the facilities<span style="letter-spacing:0.15pt;"> </span>or capabilities<span style="letter-spacing:0.15pt;"> </span>to manufacture<span style="letter-spacing:0.1pt;"> </span>bulk drug substance<span style="letter-spacing:0.05pt;"> </span>or filled<span style="letter-spacing:0.05pt;"> </span>drug product<span style="letter-spacing:0.05pt;"> </span>for use in human clinical<span style="letter-spacing:0.1pt;"> </span>trials<span style="letter-spacing:0.1pt;"> </span>or commercialization.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We face substantial<span style="letter-spacing:0.05pt;"> </span>competition,<span style="letter-spacing:0.1pt;"> </span>which<span style="letter-spacing:-0.05pt;"> </span>may result<span style="letter-spacing:0.05pt;"> </span>in others discovering,<span style="letter-spacing:0.05pt;"> </span>developing<span style="letter-spacing:0.05pt;"> </span>or commercializing competing<span style="letter-spacing:0.05pt;"> </span>products before<span style="letter-spacing:0.05pt;"> </span>or more successfully<span style="letter-spacing:0.1pt;"> </span>than us.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The biopharmaceutical<span style="letter-spacing:0.15pt;"> </span>industry<span style="letter-spacing:0.05pt;"> </span>is intensely<span style="letter-spacing:0.05pt;"> </span>competitive<span style="letter-spacing:0.1pt;"> </span>and subject<span style="letter-spacing:0.05pt;"> </span>to rapid<span style="letter-spacing:0.05pt;"> </span>innovation<span style="letter-spacing:0.05pt;"> </span>and significant technological<span style="letter-spacing:0.1pt;"> </span>advancements.<span style="letter-spacing:0.1pt;"> </span>Our competitors include<span style="letter-spacing:0.05pt;"> </span>multinational<span style="letter-spacing:0.15pt;"> </span>pharmaceutical<span style="letter-spacing:0.15pt;"> </span>companies,<span style="letter-spacing:0.05pt;"> </span>specialized<span style="letter-spacing:0.1pt;"> </span>biotechnology<span style="letter-spacing:0.05pt;"> </span>companies,<span style="letter-spacing:0.05pt;"> </span>universities<span style="letter-spacing:0.1pt;"> </span>and other research<span style="letter-spacing:0.05pt;"> </span>institutions.<span style="letter-spacing:0.1pt;"> </span>A<span style="letter-spacing:-0.05pt;"> </span>number<span style="letter-spacing:0.05pt;"> </span>of biotechnology<span style="letter-spacing:0.05pt;"> </span>and pharmaceutical<span style="letter-spacing:0.15pt;"> </span>companies<span style="letter-spacing:0.05pt;"> </span>are pursuing<span style="letter-spacing:0.05pt;"> </span>the development<span style="letter-spacing:0.05pt;"> </span>or marketing<span style="letter-spacing:0.1pt;"> </span>of pharmaceuticals<span style="letter-spacing:0.15pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>target<span style="letter-spacing:0.05pt;"> </span>the same<span style="letter-spacing:0.05pt;"> </span>diseases<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>are targeting.<span style="letter-spacing:0.1pt;"> Certain of these companies have recently published positive data regarding their clinical trials, which may further increase the competition we face. </span>Smaller<span style="letter-spacing:0.05pt;"> </span>or earlier-stage companies<span style="letter-spacing:0.05pt;"> </span>may also prove to be significant<span style="letter-spacing:0.1pt;"> </span>competitors,<span style="letter-spacing:0.1pt;"> </span>particularly<span style="letter-spacing:0.15pt;"> </span>through collaborative<span style="letter-spacing:0.1pt;"> </span>arrangements<span style="letter-spacing:0.1pt;"> </span>with large,<span style="letter-spacing:0.05pt;"> </span>established<span style="letter-spacing:0.1pt;"> </span>companies.<span style="letter-spacing:0.05pt;"> </span>Given the high incidence<span style="letter-spacing:0.05pt;"> </span>of NASH<span style="letter-spacing:-0.1pt;"> </span>and <span style="letter-spacing:-0.05pt;">SHTG,</span> it is likely<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>the number<span style="letter-spacing:0.05pt;"> </span>of<span style="letter-spacing:1.15pt;"> </span>companies<span style="letter-spacing:0.05pt;"> </span>seeking<span style="letter-spacing:0.05pt;"> </span>to </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">develop products</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and therapies</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for the treatment</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of liver</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and cardio-metabolic</span><span style="letter-spacing:0.15pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">diseases, such as NASH</span><span style="letter-spacing:-0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and </span><span style="letter-spacing:-0.05pt;">SHTG,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> will increase.</span><span style="letter-spacing:0.05pt;"> </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There<span style="letter-spacing:0.05pt;"> </span>are numerous<span style="letter-spacing:1.05pt;"> </span>currently<span style="letter-spacing:0.1pt;"> </span>approved therapies<span style="letter-spacing:0.1pt;"> </span>for treating<span style="letter-spacing:0.1pt;"> </span>diseases<span style="letter-spacing:0.05pt;"> </span>other<span style="letter-spacing:0.05pt;"> </span>than NASH<span style="letter-spacing:-0.1pt;"> </span>and some of these<span style="letter-spacing:0.05pt;"> </span>currently<span style="letter-spacing:0.1pt;"> </span>approved therapies<span style="letter-spacing:0.1pt;"> </span>may exert<span style="letter-spacing:0.05pt;"> </span>effects<span style="letter-spacing:0.1pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>could be similar<span style="letter-spacing:0.1pt;"> </span>to pegozafermin in NASH. Many of these<span style="letter-spacing:0.05pt;"> </span>approved drugs are well-established<span style="letter-spacing:0.1pt;"> </span>therapies<span style="letter-spacing:0.1pt;"> </span>or products<span style="letter-spacing:0.05pt;"> </span>and are widely accepted<span style="letter-spacing:0.05pt;"> </span>by physicians,<span style="letter-spacing:0.05pt;"> </span>patients<span style="letter-spacing:0.05pt;"> </span>and third-party<span style="letter-spacing:0.1pt;"> </span>payors. Some of these<span style="letter-spacing:0.05pt;"> </span>drugs are branded and subject<span style="letter-spacing:0.05pt;"> </span>to patent<span style="letter-spacing:0.05pt;"> </span>protection,<span style="letter-spacing:0.1pt;"> </span>and others<span style="letter-spacing:0.05pt;"> </span>are available<span style="letter-spacing:0.1pt;"> </span>on a generic<span style="letter-spacing:0.05pt;"> </span>basis.<span style="letter-spacing:0.05pt;"> </span>This may make it difficult<span style="letter-spacing:0.1pt;"> </span>for us to differentiate<span style="letter-spacing:0.15pt;"> </span>our products<span style="letter-spacing:0.05pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>currently<span style="letter-spacing:0.1pt;"> </span>approved therapies,<span style="letter-spacing:0.1pt;"> </span>which may adversely<span style="letter-spacing:0.05pt;"> </span>impact<span style="letter-spacing:0.05pt;"> </span>our business<span style="letter-spacing:0.05pt;"> </span>strategy. We expect that<span style="letter-spacing:0.05pt;"> </span>if pegozafermin or any future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>are approved, they will be priced<span style="letter-spacing:0.05pt;"> </span>at a significant<span style="letter-spacing:0.1pt;"> </span>premium over competitive<span style="letter-spacing:0.1pt;"> </span>generic<span style="letter-spacing:0.05pt;"> </span>products,<span style="letter-spacing:0.05pt;"> </span>including<span style="letter-spacing:0.05pt;"> </span>branded generic<span style="letter-spacing:0.05pt;"> </span>products.<span style="letter-spacing:0.05pt;"> </span>Insurers<span style="letter-spacing:0.05pt;"> </span>and other<span style="letter-spacing:0.05pt;"> </span>third-party<span style="letter-spacing:0.1pt;"> </span>payors may also encourage<span style="letter-spacing:0.05pt;"> </span>the use of generic<span style="letter-spacing:0.05pt;"> </span>products<span style="letter-spacing:0.05pt;"> </span>or specific<span style="letter-spacing:0.1pt;"> </span>branded products prior to utilization of pegozafermin.<span style="letter-spacing:0.05pt;"> </span>In addition,<span style="letter-spacing:0.05pt;"> </span>many companies<span style="letter-spacing:0.05pt;"> </span>are developing<span style="letter-spacing:0.05pt;"> </span>new<span style="letter-spacing:-0.05pt;"> </span>therapeutics,<span style="letter-spacing:0.1pt;"> </span>and we<span style="letter-spacing:-0.05pt;"> </span>cannot predict<span style="letter-spacing:0.05pt;"> </span>what the standard<span style="letter-spacing:0.05pt;"> </span>of care will be as pegozafermin or any future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>progress<span style="letter-spacing:0.05pt;"> </span>through clinical<span style="letter-spacing:0.1pt;"> </span>development.<span style="letter-spacing:0.05pt;"> </span>In addition,<span style="letter-spacing:0.05pt;"> </span>to the extent<span style="letter-spacing:0.05pt;"> </span>pegozafermin or any future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>are approved for liver or cardio-metabolic<span style="letter-spacing:0.15pt;"> </span>indications,<span style="letter-spacing:0.1pt;"> </span>such as SHTG, the commercial<span style="letter-spacing:0.1pt;"> </span>success<span style="letter-spacing:0.05pt;"> </span>of our products<span style="letter-spacing:0.05pt;"> </span>will also depend on our ability<span style="letter-spacing:0.05pt;"> </span>to demonstrate<span style="letter-spacing:0.1pt;"> </span>benefits<span style="letter-spacing:0.05pt;"> </span>over the then-prevailing<span style="letter-spacing:0.1pt;"> </span>standard<span style="letter-spacing:0.05pt;"> </span>of care,<span style="letter-spacing:0.05pt;"> </span>including<span style="letter-spacing:0.05pt;"> </span>diet,<span style="letter-spacing:0.05pt;"> </span>exercise<span style="letter-spacing:0.05pt;"> </span>and lifestyle<span style="letter-spacing:0.1pt;"> </span>modifications.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Further,<span style="letter-spacing:0.05pt;"> </span>if pegozafermin or any future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>are approved for the treatment<span style="letter-spacing:0.1pt;"> </span>of SHTG,<span style="letter-spacing:-0.1pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>will compete<span style="letter-spacing:0.05pt;"> </span>with currently<span style="letter-spacing:0.1pt;"> </span>approved therapies<span style="letter-spacing:0.1pt;"> </span>and therapies<span style="letter-spacing:0.1pt;"> </span>further<span style="letter-spacing:0.05pt;"> </span>along in development.<span style="letter-spacing:0.05pt;"> </span>Our competitors<span style="letter-spacing:0.1pt;"> </span>both in the United States<span style="letter-spacing:0.05pt;"> </span>and abroad include<span style="letter-spacing:0.05pt;"> </span>large,<span style="letter-spacing:0.05pt;"> </span>well-established<span style="letter-spacing:0.15pt;"> </span>pharmaceutical<span style="letter-spacing:0.15pt;"> </span>and generic<span style="letter-spacing:0.05pt;"> </span>companies<span style="letter-spacing:0.05pt;"> </span>with significantly<span style="letter-spacing:0.15pt;"> </span>greater<span style="letter-spacing:0.05pt;"> </span>name recognition.<span style="letter-spacing:0.1pt;"> </span>Our competitors<span style="letter-spacing:0.1pt;"> </span>may be able to charge<span style="letter-spacing:0.05pt;"> </span>lower prices<span style="letter-spacing:0.05pt;"> </span>than we<span style="letter-spacing:-0.05pt;"> </span>can, which may adversely<span style="letter-spacing:0.05pt;"> </span>affect<span style="letter-spacing:0.05pt;"> </span>our market<span style="letter-spacing:0.05pt;"> </span>acceptance.<span style="letter-spacing:0.05pt;"> </span>Many of these<span style="letter-spacing:0.05pt;"> </span>competitors<span style="letter-spacing:0.1pt;"> </span>have greater<span style="letter-spacing:0.05pt;"> </span>resources<span style="letter-spacing:0.05pt;"> </span>than we<span style="letter-spacing:-0.05pt;"> </span>do, including<span style="letter-spacing:0.05pt;"> </span>financial,<span style="letter-spacing:0.1pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>development,<span style="letter-spacing:0.05pt;"> </span>marketing,<span style="letter-spacing:0.1pt;"> </span>personnel<span style="letter-spacing:0.05pt;"> </span>and other<span style="letter-spacing:0.05pt;"> </span>resources.<span style="letter-spacing:0.05pt;"> </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If our competitors<span style="letter-spacing:0.1pt;"> </span>market<span style="letter-spacing:0.05pt;"> </span>products<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>are more<span style="letter-spacing:0.05pt;"> </span>effective,<span style="letter-spacing:0.1pt;"> </span>safer<span style="letter-spacing:0.05pt;"> </span>or cheaper<span style="letter-spacing:0.05pt;"> </span>than our products<span style="letter-spacing:0.05pt;"> </span>or that reach<span style="letter-spacing:0.05pt;"> </span>the market<span style="letter-spacing:0.05pt;"> </span>sooner than our products,<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>may not achieve<span style="letter-spacing:0.05pt;"> </span>commercial<span style="letter-spacing:0.1pt;"> </span>success.<span style="letter-spacing:0.05pt;"> </span>Many of our competitors<span style="letter-spacing:0.1pt;"> </span>have substantially<span style="letter-spacing:0.1pt;"> </span>greater<span style="letter-spacing:0.05pt;"> </span>financial,<span style="letter-spacing:0.1pt;"> </span>technical,<span style="letter-spacing:0.1pt;"> </span>human and other<span style="letter-spacing:0.05pt;"> </span>resources<span style="letter-spacing:0.05pt;"> </span>than we<span style="letter-spacing:-0.05pt;"> </span>do and may be better<span style="letter-spacing:0.05pt;"> </span>equipped to develop, manufacture<span style="letter-spacing:0.1pt;"> </span>and market<span style="letter-spacing:0.05pt;"> </span>technologically<span style="letter-spacing:0.1pt;"> </span>superior<span style="letter-spacing:0.05pt;"> </span>products.<span style="letter-spacing:0.05pt;"> </span>As<span style="letter-spacing:-0.05pt;"> </span>a result,<span style="letter-spacing:0.05pt;"> </span>our competitors<span style="letter-spacing:0.1pt;"> </span>may obtain<span style="letter-spacing:0.05pt;"> </span>regulatory<span style="letter-spacing:0.1pt;"> </span>approval<span style="letter-spacing:0.05pt;"> </span>of their<span style="letter-spacing:0.05pt;"> </span>products<span style="letter-spacing:0.05pt;"> </span>more<span style="letter-spacing:0.05pt;"> </span>rapidly<span style="letter-spacing:0.05pt;"> </span>than we<span style="letter-spacing:-0.05pt;"> </span>do or may obtain<span style="letter-spacing:0.05pt;"> </span>patent<span style="letter-spacing:0.05pt;"> </span>protection<span style="letter-spacing:0.1pt;"> </span>or other<span style="letter-spacing:0.05pt;"> </span>intellectual<span style="letter-spacing:0.15pt;"> </span>property<span style="letter-spacing:0.05pt;"> </span>rights<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>limit<span style="letter-spacing:0.1pt;"> </span>our ability<span style="letter-spacing:0.05pt;"> </span>to develop or commercialize<span style="letter-spacing:0.15pt;"> </span>our product<span style="letter-spacing:0.05pt;"> </span>candidate<span style="letter-spacing:0.05pt;"> </span>or any future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidates.<span style="letter-spacing:0.05pt;"> </span>Our competitors<span style="letter-spacing:0.1pt;"> </span>may also develop and succeed<span style="letter-spacing:0.05pt;"> </span>in obtaining<span style="letter-spacing:0.05pt;"> </span>approval<span style="letter-spacing:0.05pt;"> </span>for drugs that<span style="letter-spacing:0.05pt;"> </span>are more<span style="letter-spacing:0.05pt;"> </span>effective,<span style="letter-spacing:0.1pt;"> </span>more<span style="letter-spacing:0.05pt;"> </span>convenient,<span style="letter-spacing:0.05pt;"> </span>more<span style="letter-spacing:0.05pt;"> </span>widely used and less costly<span style="letter-spacing:0.05pt;"> </span>or have a better<span style="letter-spacing:0.05pt;"> </span>safety<span style="letter-spacing:0.05pt;"> </span>profile<span style="letter-spacing:0.05pt;"> </span>than our products<span style="letter-spacing:0.05pt;"> </span>and these<span style="letter-spacing:0.05pt;"> </span>competitors<span style="letter-spacing:0.1pt;"> </span>may also be more<span style="letter-spacing:0.05pt;"> </span>successful<span style="letter-spacing:0.1pt;"> </span>than we<span style="letter-spacing:-0.05pt;"> </span>are in manufacturing<span style="letter-spacing:0.1pt;"> </span>and marketing<span style="letter-spacing:0.1pt;"> </span>their<span style="letter-spacing:0.05pt;"> </span>products.<span style="letter-spacing:0.05pt;"> </span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Unstable market<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>economic<span style="letter-spacing:0.05pt;"> </span>conditions<span style="letter-spacing:0.05pt;"> </span>may have serious<span style="letter-spacing:0.05pt;"> </span>adverse<span style="letter-spacing:0.05pt;"> </span>consequences on<span style="letter-spacing:-0.05pt;"> </span>our business and financial<span style="letter-spacing:0.05pt;"> </span>condition.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Global credit<span style="letter-spacing:0.05pt;"> </span>and financial<span style="letter-spacing:0.1pt;"> </span>markets<span style="letter-spacing:0.05pt;"> </span>have experienced<span style="letter-spacing:0.05pt;"> </span>extreme<span style="letter-spacing:0.05pt;"> </span>disruptions<span style="letter-spacing:0.1pt;"> </span>at various<span style="letter-spacing:0.05pt;"> </span>points<span style="letter-spacing:0.05pt;"> </span>over the last few decades.<span style="letter-spacing:0.1pt;"> </span>If another<span style="letter-spacing:0.05pt;"> </span>such disruption<span style="letter-spacing:0.05pt;"> </span>in credit<span style="letter-spacing:0.05pt;"> </span>and financial<span style="letter-spacing:0.1pt;"> </span>markets<span style="letter-spacing:0.05pt;"> </span>and deterioration<span style="letter-spacing:0.15pt;"> </span>of confidence<span style="letter-spacing:0.05pt;"> </span>in economic<span style="letter-spacing:0.05pt;"> </span>conditions occurs,<span style="letter-spacing:0.05pt;"> </span>it may make any necessary<span style="letter-spacing:0.05pt;"> </span>debt or equity<span style="letter-spacing:0.05pt;"> </span>financing<span style="letter-spacing:0.05pt;"> </span>more<span style="letter-spacing:0.05pt;"> </span>difficult<span style="letter-spacing:0.1pt;"> </span>to complete,<span style="letter-spacing:0.05pt;"> </span>more<span style="letter-spacing:0.05pt;"> </span>costly,<span style="letter-spacing:0.05pt;"> </span>and more<span style="letter-spacing:0.05pt;"> </span>dilutive.<span style="letter-spacing:0.05pt;"> </span>Failure<span style="letter-spacing:0.05pt;"> </span>to secure<span style="letter-spacing:0.05pt;"> </span>any necessary<span style="letter-spacing:0.05pt;"> </span>financing<span style="letter-spacing:0.05pt;"> </span>in a timely<span style="letter-spacing:0.05pt;"> </span>manner<span style="letter-spacing:0.05pt;"> </span>and on favorable<span style="letter-spacing:0.05pt;"> </span>terms<span style="letter-spacing:0.05pt;"> </span>could have a material<span style="letter-spacing:0.1pt;"> </span>adverse<span style="letter-spacing:0.05pt;"> </span>effect<span style="letter-spacing:0.05pt;"> </span>on our growth strategy,<span style="letter-spacing:0.05pt;"> </span>financial<span style="letter-spacing:0.1pt;"> </span>performance<span style="letter-spacing:0.1pt;"> </span>and share<span style="letter-spacing:0.05pt;"> </span>price<span style="letter-spacing:0.05pt;"> </span>and could require<span style="letter-spacing:0.05pt;"> </span>us to delay or abandon development<span style="letter-spacing:0.05pt;"> </span>or commercialization<span style="letter-spacing:0.2pt;"> </span>plans. In addition,<span style="letter-spacing:0.05pt;"> </span>there<span style="letter-spacing:0.05pt;"> </span>is a risk<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>one or more<span style="letter-spacing:0.05pt;"> </span>of our service<span style="letter-spacing:0.05pt;"> </span>providers,<span style="letter-spacing:0.05pt;"> </span>manufacturers<span style="letter-spacing:0.15pt;"> </span>or other<span style="letter-spacing:0.05pt;"> </span>partners<span style="letter-spacing:0.05pt;"> </span>would not survive<span style="letter-spacing:0.05pt;"> </span>or be able to meet<span style="letter-spacing:0.05pt;"> </span>their<span style="letter-spacing:0.05pt;"> </span>commitments<span style="letter-spacing:0.15pt;"> </span>to us under such circumstances,<span style="letter-spacing:0.15pt;"> </span>which could directly<span style="letter-spacing:0.1pt;"> </span>affect<span style="letter-spacing:0.05pt;"> </span>our ability<span style="letter-spacing:0.05pt;"> </span>to attain<span style="letter-spacing:0.05pt;"> </span>our operating<span style="letter-spacing:0.05pt;"> </span>goals on schedule<span style="letter-spacing:0.05pt;"> </span>and on budget.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">The 2021 Loan Agreement contains certain covenants that could adversely affect our operations and, if an event of default were to occur, we could be forced to repay any outstanding indebtedness sooner than planned and possibly at a time when we do not have sufficient capital to meet this obligation.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the 2021 Loan Agreement, we have pledged substantially all of our assets, other than our intellectual property rights, and have agreed that we may not sell or assign rights to our patents and other intellectual property without the prior consent of SVB. Additionally, the 2021 Loan Agreement contains certain affirmative and negative covenants that could prevent us from taking certain actions without the consent of our lenders. These covenants may limit our flexibility in operating our business and our ability to take actions that might be </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">advantageous to us and our stockholders. The 2021 Loan Agreement also includes customary events of default, including, among other things, a change of control. Upon the occurrence and continuation of an event of default, all amounts due under the 2021 Loan Agreement become (in the case of a bankruptcy event) or may become (in the case of all other events of default and at the option of SVB), immediately due and payable. If an event of default under the 2021 Loan Agreement should occur, we could be required to immediately repay any outstanding indebtedness. If we are unable to repay such debt, the lenders would be able to foreclose on the secured collateral, including our cash accounts, and take other remedies permitted under the 2021 Loan Agreement. Even if we are able to repay any indebtedness on an event of default, the repayment of these sums may significantly reduce our working capital and impair our ability to operate as planned.</span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We may encounter difficulties<span style="letter-spacing:0.15pt;"> </span>in managing our growth, which<span style="letter-spacing:-0.05pt;"> </span>could adversely<span style="letter-spacing:0.05pt;"> </span>affect<span style="letter-spacing:0.05pt;"> </span>our operations.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are in the early<span style="letter-spacing:0.05pt;"> </span>stages<span style="letter-spacing:0.05pt;"> </span>of building<span style="letter-spacing:0.05pt;"> </span>the full<span style="letter-spacing:0.05pt;"> </span>team<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>anticipate we<span style="letter-spacing:-0.05pt;"> </span>will need to complete<span style="letter-spacing:0.05pt;"> </span>the development<span style="letter-spacing:0.05pt;"> </span>pegozafermin and other<span style="letter-spacing:0.05pt;"> </span>future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidates.<span style="letter-spacing:0.05pt;"> </span>As we<span style="letter-spacing:-0.05pt;"> </span>advance our preclinical<span style="letter-spacing:0.1pt;"> </span>and clinical<span style="letter-spacing:0.1pt;"> </span>development<span style="letter-spacing:0.05pt;"> </span>programs<span style="letter-spacing:0.05pt;"> </span>for product<span style="letter-spacing:0.05pt;"> </span>candidates,<span style="letter-spacing:0.05pt;"> </span>seek regulatory<span style="letter-spacing:0.1pt;"> </span>approval in the United States<span style="letter-spacing:0.05pt;"> </span>and elsewhere<span style="letter-spacing:0.05pt;"> </span>and increase<span style="letter-spacing:0.05pt;"> </span>the number<span style="letter-spacing:0.05pt;"> </span>of ongoing product<span style="letter-spacing:0.05pt;"> </span>development<span style="letter-spacing:0.05pt;"> </span>programs,<span style="letter-spacing:0.05pt;"> </span>we anticipate<span style="letter-spacing:0.1pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>will need to increase<span style="letter-spacing:0.05pt;"> </span>our product<span style="letter-spacing:0.05pt;"> </span>development,<span style="letter-spacing:0.05pt;"> </span>scientific<span style="letter-spacing:0.1pt;"> </span>and administrative<span style="letter-spacing:0.15pt;"> </span>headcount.<span style="letter-spacing:0.05pt;"> </span>We will also need to establish<span style="letter-spacing:0.1pt;"> </span>commercial<span style="letter-spacing:0.1pt;"> </span>capabilities<span style="letter-spacing:0.15pt;"> </span>in order<span style="letter-spacing:0.05pt;"> </span>to commercialize<span style="letter-spacing:0.15pt;"> </span>any product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>may be approved. Such an evolution<span style="letter-spacing:0.05pt;"> </span>may impact<span style="letter-spacing:0.05pt;"> </span>our strategic<span style="letter-spacing:0.1pt;"> </span>focus and our deployment<span style="letter-spacing:0.05pt;"> </span>and allocation<span style="letter-spacing:0.1pt;"> </span>of resources.<span style="letter-spacing:0.05pt;"> </span>Our ability to manage our operations and growth effectively depends upon the continual improvement of our procedures, reporting systems and operational, financial and management controls. We may not be able to implement administrative and operational improvements in an efficient or timely manner and may discover deficiencies in existing systems and controls. In addition, in order to continue to meet our obligations as a public company and to support our anticipated long-term growth, we will need to increase our general and administrative capabilities. Our management,<span style="letter-spacing:0.1pt;"> </span>personnel<span style="letter-spacing:0.05pt;"> </span>and systems<span style="letter-spacing:0.05pt;"> </span>may experience<span style="letter-spacing:0.05pt;"> </span>difficulty<span style="letter-spacing:0.1pt;"> </span>in adjusting<span style="letter-spacing:0.05pt;"> </span>to our growth and strategic<span style="letter-spacing:0.1pt;"> </span>focus.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We must attract<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>retain<span style="letter-spacing:0.05pt;"> </span>highly skilled<span style="letter-spacing:0.05pt;"> </span>employees<span style="letter-spacing:0.05pt;"> </span>in order to succeed. If we<span style="letter-spacing:-0.05pt;"> </span>are not able to retain<span style="letter-spacing:0.05pt;"> </span>our current senior management<span style="letter-spacing:0.05pt;"> </span>team<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>our scientific<span style="letter-spacing:0.1pt;"> </span>advisors<span style="letter-spacing:0.05pt;"> </span>or continue to attract<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>retain<span style="letter-spacing:0.05pt;"> </span>qualified scientific,<span style="letter-spacing:0.1pt;"> </span>technical<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>business personnel, our business will suffer.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may not be able to attract<span style="letter-spacing:0.1pt;"> </span>or retain<span style="letter-spacing:0.05pt;"> </span>qualified<span style="letter-spacing:0.1pt;"> </span>personnel<span style="letter-spacing:0.05pt;"> </span>and consultants<span style="letter-spacing:0.1pt;"> </span>due to the intense competition<span style="letter-spacing:0.1pt;"> </span>for such individuals in the biotechnology<span style="letter-spacing:0.05pt;"> </span>and pharmaceutical<span style="letter-spacing:0.15pt;"> </span>industries.<span style="letter-spacing:0.1pt;"> </span>If we<span style="letter-spacing:-0.05pt;"> </span>are not able to attract<span style="letter-spacing:0.1pt;"> </span>and retain<span style="letter-spacing:0.05pt;"> </span>necessary<span style="letter-spacing:0.05pt;"> </span>personnel<span style="letter-spacing:0.05pt;"> </span>and consultants<span style="letter-spacing:0.1pt;"> </span>to accomplish<span style="letter-spacing:0.1pt;"> </span>our business<span style="letter-spacing:0.05pt;"> </span>objectives,<span style="letter-spacing:0.1pt;"> </span>it may significantly<span style="letter-spacing:0.15pt;"> </span>impede<span style="letter-spacing:0.05pt;"> </span>the achievement<span style="letter-spacing:0.1pt;"> </span>of our development<span style="letter-spacing:0.05pt;"> </span>and commercial<span style="letter-spacing:0.1pt;"> </span>objectives<span style="letter-spacing:0.1pt;"> </span>and our ability<span style="letter-spacing:0.05pt;"> </span>to implement<span style="letter-spacing:0.1pt;"> </span>our business<span style="letter-spacing:0.05pt;"> </span>strategy. In addition, we are highly dependent<span style="letter-spacing:0.05pt;"> </span>on the development,<span style="letter-spacing:0.05pt;"> </span>regulatory,<span style="letter-spacing:0.1pt;"> manufacturing, </span>commercialization<span style="letter-spacing:0.2pt;"> </span>and financial<span style="letter-spacing:0.05pt;"> </span>expertise<span style="letter-spacing:0.1pt;"> </span>of the members<span style="letter-spacing:0.05pt;"> </span>of our executive<span style="letter-spacing:0.05pt;"> </span>team,<span style="letter-spacing:0.05pt;"> </span>as well as other<span style="letter-spacing:0.05pt;"> </span>key employees<span style="letter-spacing:0.05pt;"> </span>and consultants.<span style="letter-spacing:0.1pt;"> </span>If we<span style="letter-spacing:-0.05pt;"> </span>lose one or more<span style="letter-spacing:0.05pt;"> </span>of our executive<span style="letter-spacing:0.05pt;"> </span>officers<span style="letter-spacing:0.1pt;"> </span>or other<span style="letter-spacing:0.05pt;"> </span>key employees<span style="letter-spacing:0.05pt;"> </span>or consultants,<span style="letter-spacing:0.1pt;"> </span>our ability<span style="letter-spacing:0.05pt;"> </span>to implement<span style="letter-spacing:0.1pt;"> </span>our business<span style="letter-spacing:0.05pt;"> </span>strategy successfully<span style="letter-spacing:0.1pt;"> </span>could be seriously<span style="letter-spacing:0.05pt;"> </span>harmed.<span style="letter-spacing:0.05pt;"> </span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We are developing<span style="letter-spacing:0.05pt;"> </span>a new<span style="letter-spacing:-0.05pt;"> </span>drug product formulation<span style="letter-spacing:0.05pt;"> </span>for pegozafermin and<span style="letter-spacing:-0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>may be unsuccessful.<span style="letter-spacing:0.05pt;"> </span>Any<span style="letter-spacing:-0.05pt;"> </span>changes in methods<span style="letter-spacing:0.05pt;"> </span>of product candidate<span style="letter-spacing:0.05pt;"> </span>manufacturing<span style="letter-spacing:0.05pt;"> </span>or formulation<span style="letter-spacing:0.05pt;"> </span>may result<span style="letter-spacing:0.05pt;"> </span>in the need to perform<span style="letter-spacing:0.05pt;"> </span>new<span style="letter-spacing:-0.05pt;"> </span>clinical trials or obtain new drug product,<span style="letter-spacing:0.05pt;"> </span>which<span style="letter-spacing:-0.05pt;"> </span>would<span style="letter-spacing:-0.05pt;"> </span>require<span style="letter-spacing:0.05pt;"> </span>additional<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>cause delay.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our current drug product comes in two formulations, frozen and liquid, with the latter being used in all new studies, beginning with our ENLIVEN study. We are developing a new drug product formulation of pegozafermin for late-stage clinical trials and commercialization. We have commenced development of a pre-filled syringe for the new drug product formulation and we also plan to begin development of a pen-type autoinjector. There is no assurance that we will be successful in developing a new drug product formulation, a pre-filled syringe or an autoinjector on a timely basis or at all, any of which could impede our development and commercialization strategy for pegozafermin. The FDA or other comparable foreign regulatory authorities could require nonclinical studies or clinical trials to support introduction of any new formulation, pre-filled syringe and autoinjector, which could delay completion of clinical trials, require the conduct of bridging clinical trials or the repetition of one or more clinical </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">trials, increase our clinical trial costs, delay approval of </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">pegozafermin</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and jeopardize our ability to commence product sales and generate revenue from </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">pegozafermin</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, if approved.</span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We rely on third parties for certain aspects of our product candidate development process and we may not be able to obtain and maintain the third-party relationships that are necessary to develop, commercialize and manufacture some or all of our product candidates. </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect to depend on collaborators, partners, licensees, clinical investigators, contract research organizations, manufacturers and other third parties to support our discovery efforts, to formulate product candidates, to conduct clinical trials for some or all of our product candidates, to manufacture clinical and commercial scale quantities of our drug substance and drug product and to market, sell and distribute any products we successfully develop. Any<span style="letter-spacing:-0.05pt;"> </span>of these<span style="letter-spacing:0.05pt;"> </span>third<span style="letter-spacing:0.05pt;"> </span>parties<span style="letter-spacing:0.05pt;"> </span>may terminate<span style="letter-spacing:0.1pt;"> </span>their engagements<span style="letter-spacing:0.05pt;"> </span>with us at any time.<span style="letter-spacing:0.05pt;"> </span>If we<span style="letter-spacing:-0.05pt;"> </span>need to enter<span style="letter-spacing:0.05pt;"> </span>into alternative<span style="letter-spacing:0.1pt;"> </span>arrangements,<span style="letter-spacing:0.1pt;"> </span>it would delay our product development<span style="letter-spacing:0.05pt;"> </span>activities<span style="letter-spacing:0.1pt;"> </span>and such alternative<span style="letter-spacing:0.1pt;"> </span>arrangements<span style="letter-spacing:0.1pt;"> </span>may not be available<span style="letter-spacing:0.1pt;"> </span>on terms<span style="letter-spacing:0.05pt;"> </span>acceptable<span style="letter-spacing:0.1pt;"> </span>to us. We also expect<span style="letter-spacing:0.05pt;"> </span>to rely<span style="letter-spacing:0.05pt;"> </span>on other<span style="letter-spacing:0.05pt;"> </span>third<span style="letter-spacing:0.05pt;"> </span>parties<span style="letter-spacing:0.05pt;"> </span>to store<span style="letter-spacing:0.05pt;"> </span>and distribute<span style="letter-spacing:0.1pt;"> </span>drug supplies<span style="letter-spacing:0.05pt;"> </span>for our clinical<span style="letter-spacing:0.1pt;"> </span>trials. Any<span style="letter-spacing:-0.05pt;"> </span>performance<span style="letter-spacing:0.1pt;"> </span>failure<span style="letter-spacing:0.1pt;"> </span>on the part<span style="letter-spacing:0.05pt;"> </span>of our distributors<span style="letter-spacing:0.1pt;"> </span>could delay clinical<span style="letter-spacing:0.1pt;"> </span>development,<span style="letter-spacing:0.05pt;"> </span>marketing<span style="letter-spacing:0.1pt;"> </span>approval and/or<span style="letter-spacing:0.05pt;"> </span>commercialization<span style="letter-spacing:0.2pt;"> </span>of pegozafermin or any future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidates,<span style="letter-spacing:0.05pt;"> </span>producing<span style="letter-spacing:0.05pt;"> </span>additional<span style="letter-spacing:0.1pt;"> </span>losses<span style="letter-spacing:0.05pt;"> </span>and depriving<span style="letter-spacing:0.05pt;"> </span>us of potential<span style="letter-spacing:0.1pt;"> </span>revenue.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Business disruptions could seriously harm our future revenue and financial condition and increase our costs and expenses.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our operations, and those of our contract research organizations, CMO, suppliers, and other contractors and consultants, could be subject to earthquakes, power shortages, telecommunications failures, water shortages, floods, hurricanes, typhoons, fires, extreme weather conditions, acts of war, medical pandemics or epidemics, such as the novel coronavirus, and other natural or man-made disasters or business interruptions. The occurrence of any of these business disruptions could seriously harm our operations and financial condition and increase our costs and expenses.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If we fail to develop and commercialize additional product candidates, we may be unable to grow our business.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;letter-spacing:-0.05pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Although the development<span style="letter-spacing:0.05pt;"> </span>and commercialization<span style="letter-spacing:0.2pt;"> </span>of pegozafermin is currently<span style="letter-spacing:0.1pt;"> </span>our primary<span style="letter-spacing:0.05pt;"> </span>focus, as part of our longer-term<span style="letter-spacing:0.1pt;"> </span>growth strategy,<span style="letter-spacing:0.05pt;"> </span>we plan to evaluate<span style="letter-spacing:0.05pt;"> </span>the development<span style="letter-spacing:0.05pt;"> </span>and commercialization<span style="letter-spacing:0.2pt;"> </span>of other therapies<span style="letter-spacing:0.1pt;"> </span>related<span style="letter-spacing:0.05pt;"> </span>to NASH<span style="letter-spacing:-0.1pt;"> </span>and other<span style="letter-spacing:0.05pt;"> </span>liver<span style="letter-spacing:0.05pt;"> </span>and cardio-metabolic<span style="letter-spacing:0.15pt;"> </span>diseases.<span style="letter-spacing:0.05pt;"> </span>The success<span style="letter-spacing:0.05pt;"> </span>of this<span style="letter-spacing:0.05pt;"> </span>strategy<span style="letter-spacing:0.05pt;"> </span>depends primarily<span style="letter-spacing:0.1pt;"> </span>upon our ability<span style="letter-spacing:0.05pt;"> </span>to identify<span style="letter-spacing:0.05pt;"> </span>and validate<span style="letter-spacing:0.05pt;"> </span>new therapeutic<span style="letter-spacing:0.1pt;"> </span>candidates,<span style="letter-spacing:0.05pt;"> </span>and to identify,<span style="letter-spacing:0.05pt;"> </span>develop and commercialize<span style="letter-spacing:0.15pt;"> </span>new drugs and biologics.<span style="letter-spacing:0.05pt;"> </span>Our research<span style="letter-spacing:0.05pt;"> </span>efforts<span style="letter-spacing:0.1pt;"> </span>may initially<span style="letter-spacing:0.1pt;"> </span>show promise<span style="letter-spacing:0.05pt;"> </span>in discovering<span style="letter-spacing:0.05pt;"> </span>potential new drugs and biologics<span style="letter-spacing:0.05pt;"> </span>yet fail<span style="letter-spacing:0.05pt;"> </span>to yield<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>for clinical<span style="letter-spacing:0.1pt;"> </span>development<span style="letter-spacing:0.05pt;"> </span>for a number<span style="letter-spacing:0.05pt;"> </span>of reasons.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We may use our limited<span style="letter-spacing:0.1pt;"> </span>financial<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>human<span style="letter-spacing:-0.05pt;"> </span>resources<span style="letter-spacing:0.05pt;"> </span>to pursue a particular<span style="letter-spacing:0.05pt;"> </span>research<span style="letter-spacing:0.05pt;"> </span>program or product candidate<span style="letter-spacing:0.05pt;"> </span>that is ultimately<span style="letter-spacing:0.1pt;"> </span>unsuccessful<span style="letter-spacing:0.05pt;"> </span>or less<span style="letter-spacing:0.05pt;"> </span>successful<span style="letter-spacing:0.05pt;"> </span>than other programs<span style="letter-spacing:0.05pt;"> </span>or product candidates<span style="letter-spacing:0.05pt;"> </span>that we may have forgone or delayed.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;letter-spacing:-0.05pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because we have limited<span style="letter-spacing:0.1pt;"> </span>personnel<span style="letter-spacing:0.05pt;"> </span>and financial<span style="letter-spacing:0.1pt;"> </span>resources,<span style="letter-spacing:0.05pt;"> </span>we may forego<span style="letter-spacing:0.05pt;"> </span>or delay the development<span style="letter-spacing:0.05pt;"> </span>of certain<span style="letter-spacing:0.05pt;"> </span>programs<span style="letter-spacing:0.05pt;"> </span>or product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>later<span style="letter-spacing:0.05pt;"> </span>prove to have greater<span style="letter-spacing:0.05pt;"> </span>commercial<span style="letter-spacing:0.1pt;"> </span>potential<span style="letter-spacing:0.1pt;"> </span>than the programs<span style="letter-spacing:0.05pt;"> </span>or product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>we do pursue. Our resource<span style="letter-spacing:0.05pt;"> </span>allocation<span style="letter-spacing:0.1pt;"> </span>decisions<span style="letter-spacing:0.05pt;"> </span>may cause us to fail<span style="letter-spacing:0.05pt;"> </span>to capitalize<span style="letter-spacing:0.1pt;"> </span>on viable<span style="letter-spacing:0.05pt;"> </span>commercial<span style="letter-spacing:0.1pt;"> </span>products<span style="letter-spacing:0.05pt;"> </span>or profitable<span style="letter-spacing:0.1pt;"> </span>market<span style="letter-spacing:0.05pt;"> </span>opportunities.<span style="letter-spacing:0.1pt;"> </span>Our spending on current<span style="letter-spacing:0.05pt;"> </span>and future<span style="letter-spacing:0.05pt;"> </span>research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>programs<span style="letter-spacing:0.05pt;"> </span>for product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>may not yield<span style="letter-spacing:0.05pt;"> </span>any commercially<span style="letter-spacing:0.15pt;"> </span>viable<span style="letter-spacing:0.05pt;"> </span>products.<span style="letter-spacing:0.05pt;"> </span>Similarly,<span style="letter-spacing:0.1pt;"> </span>our decisions<span style="letter-spacing:0.05pt;"> </span>to delay or terminate<span style="letter-spacing:0.1pt;"> </span>drug development<span style="letter-spacing:0.05pt;"> </span>programs<span style="letter-spacing:0.05pt;"> </span>may also be incorrect<span style="letter-spacing:0.1pt;"> </span>and could cause us to miss valuable<span style="letter-spacing:0.05pt;"> </span>opportunities.<span style="letter-spacing:0.1pt;"> </span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We may seek to establish commercial collaborations for our product candidates, and, if we are not able to establish them on commercially reasonable terms, we may have to alter our development and commercialization plans.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our drug development programs and the potential commercialization of our product candidates will require substantial additional cash to fund expenses. We may decide to collaborate with other pharmaceutical and </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">biotechnology companies for the development and potential commercialization of our product candidates. Collaborations are complex and time-consuming to negotiate and document. We may not be able to negotiate collaborations on a timely basis, on acceptable terms, or at all. If we are unable to do so, we may have to curtail the development of the product candidate for which we are seeking to collaborate, reduce or delay its development program or one or more of our other development programs, delay its potential commercialization or reduce the scope of any sales or marketing activities or increase our expenditures and undertake development or commercialization activities at our own expense.</span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We may not be successful in our efforts to identify, in-license or acquire, discover, develop or commercialize additional product candidates.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may seek to identify, in-license or acquire, discover, develop and commercialize additional product candidates. We cannot assure you that our effort to in-license or acquire additional product candidates will be successful. Even if we are successful in in-licensing or acquiring additional product candidates, their requisite development activities may require substantial resources, and we cannot assure you that these development activities will result in regulatory approvals.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our<span style="letter-spacing:-0.05pt;"> </span>international<span style="letter-spacing:0.05pt;"> </span>operations<span style="letter-spacing:0.05pt;"> </span>may expose us to business, regulatory,<span style="letter-spacing:0.05pt;"> </span>political,<span style="letter-spacing:0.1pt;"> </span>operational,<span style="letter-spacing:0.05pt;"> </span>financial,<span style="letter-spacing:0.05pt;"> </span>pricing and<span style="letter-spacing:-0.05pt;"> </span>reimbursement<span style="letter-spacing:0.1pt;"> </span>risks<span style="letter-spacing:0.05pt;"> </span>associated<span style="letter-spacing:0.05pt;"> </span>with doing business outside<span style="letter-spacing:0.05pt;"> </span>of the United States.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our use of our international<span style="letter-spacing:0.15pt;"> </span>facilities<span style="letter-spacing:0.15pt;"> </span>subjects<span style="letter-spacing:0.05pt;"> </span>us to U.S.<span style="letter-spacing:-0.05pt;"> </span>and foreign<span style="letter-spacing:0.05pt;"> </span>governmental<span style="letter-spacing:0.1pt;"> </span>trade,<span style="letter-spacing:0.05pt;"> </span>import<span style="letter-spacing:0.05pt;"> </span>and export,<span style="letter-spacing:0.05pt;"> </span>and customs<span style="letter-spacing:0.05pt;"> </span>regulations<span style="letter-spacing:0.1pt;"> </span>and laws. Compliance<span style="letter-spacing:0.05pt;"> </span>with these<span style="letter-spacing:0.05pt;"> </span>regulations<span style="letter-spacing:0.1pt;"> </span>and laws is costly<span style="letter-spacing:0.05pt;"> </span>and exposes us to penalties<span style="letter-spacing:0.1pt;"> </span>for non-compliance.<span style="letter-spacing:0.1pt;"> </span>Doing business<span style="letter-spacing:0.05pt;"> </span>internationally<span style="letter-spacing:0.15pt;"> </span>potentially<span style="letter-spacing:0.1pt;"> </span>involves<span style="letter-spacing:0.05pt;"> </span>a number<span style="letter-spacing:0.05pt;"> </span>of risks,<span style="letter-spacing:0.05pt;"> any of which could </span>harm<span style="letter-spacing:0.05pt;"> </span>our ongoing international<span style="letter-spacing:0.15pt;"> </span>clinical<span style="letter-spacing:0.1pt;"> </span>operations<span style="letter-spacing:0.05pt;"> </span>and supply chain, as well as any future<span style="letter-spacing:0.05pt;"> </span>international<span style="letter-spacing:0.15pt;"> </span>expansion<span style="letter-spacing:0.05pt;"> </span>and operations<span style="letter-spacing:0.05pt;"> </span>and, consequently,<span style="letter-spacing:0.05pt;"> </span>our business,<span style="letter-spacing:0.05pt;"> </span>financial<span style="letter-spacing:0.1pt;"> </span>condition, prospects<span style="letter-spacing:0.05pt;"> </span>and results<span style="letter-spacing:0.05pt;"> </span>of operations.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Product liability lawsuits against us could cause us to incur substantial liabilities and to limit commercialization of any products that we may develop.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We face<span style="letter-spacing:0.05pt;"> </span>an inherent<span style="letter-spacing:0.05pt;"> </span>risk<span style="letter-spacing:0.05pt;"> </span>of product<span style="letter-spacing:0.05pt;"> </span>liability<span style="letter-spacing:0.1pt;"> </span>exposure<span style="letter-spacing:0.05pt;"> </span>related<span style="letter-spacing:0.05pt;"> </span>to the testing<span style="letter-spacing:0.05pt;"> </span>of our product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>in human clinical<span style="letter-spacing:0.1pt;"> </span>trials<span style="letter-spacing:0.1pt;"> </span>and will face<span style="letter-spacing:0.05pt;"> </span>an even greater<span style="letter-spacing:0.05pt;"> </span>risk<span style="letter-spacing:0.05pt;"> </span>if we<span style="letter-spacing:-0.05pt;"> </span>commercialize<span style="letter-spacing:0.15pt;"> </span>any resulting<span style="letter-spacing:0.1pt;"> </span>products.<span style="letter-spacing:0.05pt;"> </span>Product liability<span style="letter-spacing:0.1pt;"> </span>claims<span style="letter-spacing:0.05pt;"> </span>may be brought against<span style="letter-spacing:0.05pt;"> </span>us by subjects<span style="letter-spacing:0.05pt;"> </span>enrolled<span style="letter-spacing:0.05pt;"> </span>in our clinical<span style="letter-spacing:0.1pt;"> </span>trials,<span style="letter-spacing:0.1pt;"> </span>patients,<span style="letter-spacing:0.05pt;"> </span>or others<span style="letter-spacing:0.05pt;"> </span>using our products.<span style="letter-spacing:0.05pt;"> </span>Our clinical<span style="letter-spacing:0.1pt;"> </span>trial<span style="letter-spacing:0.05pt;"> </span>liability<span style="letter-spacing:0.1pt;"> </span>insurance<span style="letter-spacing:0.05pt;"> </span>coverage<span style="letter-spacing:0.05pt;"> </span>may not adequately<span style="letter-spacing:0.05pt;"> </span>cover all<span style="letter-spacing:0.05pt;"> </span>liabilities<span style="letter-spacing:0.15pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>may incur. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our<span style="letter-spacing:-0.05pt;"> </span>employees,<span style="letter-spacing:0.05pt;"> </span>contractors,<span style="letter-spacing:0.05pt;"> </span>vendors, principal<span style="letter-spacing:0.05pt;"> </span>investigators,<span style="letter-spacing:0.1pt;"> </span>consultants<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>future partners<span style="letter-spacing:0.05pt;"> </span>may engage in misconduct<span style="letter-spacing:0.05pt;"> </span>or other improper<span style="letter-spacing:0.05pt;"> </span>activities,<span style="letter-spacing:0.1pt;"> </span>including noncompliance<span style="letter-spacing:0.05pt;"> </span>with regulatory<span style="letter-spacing:0.05pt;"> </span>standards and<span style="letter-spacing:-0.05pt;"> </span>requirements and<span style="letter-spacing:-0.05pt;"> </span>insider<span style="letter-spacing:0.05pt;"> </span>trading.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are exposed to the risk<span style="letter-spacing:0.05pt;"> </span>of fraud<span style="letter-spacing:0.05pt;"> </span>or other<span style="letter-spacing:0.05pt;"> </span>misconduct<span style="letter-spacing:0.05pt;"> </span>by our employees,<span style="letter-spacing:0.05pt;"> </span>contractors,<span style="letter-spacing:0.1pt;"> </span>vendors, principal<span style="letter-spacing:0.1pt;"> </span>investigators,<span style="letter-spacing:0.1pt;"> </span>consultants<span style="letter-spacing:0.1pt;"> </span>or future<span style="letter-spacing:0.05pt;"> </span>partners.<span style="letter-spacing:0.05pt;"> </span>Misconduct<span style="letter-spacing:0.05pt;"> </span>by these<span style="letter-spacing:0.05pt;"> </span>parties<span style="letter-spacing:0.05pt;"> </span>could include<span style="letter-spacing:0.05pt;"> </span>failures<span style="letter-spacing:0.1pt;"> </span>to comply<span style="letter-spacing:0.05pt;"> </span>with FDA<span style="letter-spacing:-0.05pt;"> </span>regulations,<span style="letter-spacing:0.1pt;"> </span>to provide<span style="letter-spacing:0.05pt;"> </span>accurate<span style="letter-spacing:0.05pt;"> </span>information<span style="letter-spacing:0.1pt;"> </span>to the FDA,<span style="letter-spacing:-0.05pt;"> </span>to comply<span style="letter-spacing:0.05pt;"> </span>with federal<span style="letter-spacing:0.05pt;"> </span>and state healthcare<span style="letter-spacing:0.1pt;"> </span>fraud<span style="letter-spacing:0.05pt;"> </span>and abuse laws and regulations,<span style="letter-spacing:0.1pt;"> </span>to report<span style="letter-spacing:0.05pt;"> </span>financial<span style="letter-spacing:0.1pt;"> </span>information<span style="letter-spacing:0.1pt;"> </span>or data timely,<span style="letter-spacing:0.05pt;"> </span>completely<span style="letter-spacing:0.1pt;"> </span>or accurately,<span style="letter-spacing:0.1pt;"> </span>or to disclose<span style="letter-spacing:0.05pt;"> </span>unauthorized<span style="letter-spacing:0.05pt;"> </span>activities<span style="letter-spacing:0.1pt;"> </span>to us. Most states<span style="letter-spacing:0.05pt;"> </span>also have statutes<span style="letter-spacing:0.1pt;"> </span>or regulations<span style="letter-spacing:0.1pt;"> </span>similar<span style="letter-spacing:0.1pt;"> </span>to these<span style="letter-spacing:0.05pt;"> </span>federal<span style="letter-spacing:0.05pt;"> </span>laws, which may apply to items such as pharmaceutical<span style="letter-spacing:0.15pt;"> </span>products<span style="letter-spacing:0.05pt;"> </span>and services<span style="letter-spacing:0.05pt;"> </span>reimbursed<span style="letter-spacing:0.1pt;"> </span>by private<span style="letter-spacing:0.05pt;"> </span>insurers.<span style="letter-spacing:0.05pt;"> </span>We and/or<span style="letter-spacing:0.05pt;"> </span>our future<span style="letter-spacing:0.05pt;"> </span>partners<span style="letter-spacing:0.05pt;"> </span>may be subject<span style="letter-spacing:0.05pt;"> </span>to administrative,<span style="letter-spacing:0.15pt;"> </span>civil<span style="letter-spacing:0.05pt;"> </span>and criminal<span style="letter-spacing:0.1pt;"> </span>sanctions<span style="letter-spacing:0.05pt;"> </span>for violations<span style="letter-spacing:0.1pt;"> </span>of any of these<span style="letter-spacing:0.05pt;"> </span>laws.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We depend on<span style="letter-spacing:-0.05pt;"> </span>our information<span style="letter-spacing:0.05pt;"> </span>technology<span style="letter-spacing:0.05pt;"> </span>systems<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>those of our third-party<span style="letter-spacing:0.1pt;"> </span>collaborators,<span style="letter-spacing:0.1pt;"> </span>service providers,<span style="letter-spacing:0.05pt;"> </span>contractors<span style="letter-spacing:0.05pt;"> </span>or consultants.<span style="letter-spacing:0.05pt;"> </span>Our<span style="letter-spacing:-0.05pt;"> </span>internal<span style="letter-spacing:0.05pt;"> </span>computer<span style="letter-spacing:0.05pt;"> </span>systems,<span style="letter-spacing:0.05pt;"> </span>or those of our third-party<span style="letter-spacing:0.1pt;"> </span>collaborators, service<span style="letter-spacing:0.05pt;"> </span>providers,<span style="letter-spacing:0.05pt;"> </span>contractors<span style="letter-spacing:0.05pt;"> </span>or consultants,<span style="letter-spacing:0.05pt;"> </span>may fail<span style="letter-spacing:0.05pt;"> </span>or suffer<span style="letter-spacing:0.05pt;"> </span>security<span style="letter-spacing:0.05pt;"> </span>breaches, disruptions,<span style="letter-spacing:0.05pt;"> </span>or incidents, which<span style="letter-spacing:-0.05pt;"> </span>could result<span style="letter-spacing:0.05pt;"> </span>in a material<span style="letter-spacing:0.1pt;"> </span>disruption<span style="letter-spacing:0.05pt;"> </span>of our development<span style="letter-spacing:0.05pt;"> </span>programs<span style="letter-spacing:0.05pt;"> </span>or loss of data or compromise<span style="letter-spacing:0.1pt;"> </span>the privacy,<span style="letter-spacing:0.05pt;"> </span>security,<span style="letter-spacing:0.05pt;"> </span>integrity<span style="letter-spacing:0.1pt;"> </span>or confidentiality<span style="letter-spacing:0.15pt;"> </span>of sensitive<span style="letter-spacing:0.1pt;"> </span>information<span style="letter-spacing:0.05pt;"> </span>related<span style="letter-spacing:0.05pt;"> </span>to our business and<span style="letter-spacing:-0.05pt;"> </span>have a material<span style="letter-spacing:0.1pt;"> </span>adverse<span style="letter-spacing:0.05pt;"> </span>effect<span style="letter-spacing:0.05pt;"> </span>on<span style="letter-spacing:-0.05pt;"> </span>our reputation,<span style="letter-spacing:0.05pt;"> </span>business, financial<span style="letter-spacing:0.05pt;"> </span>condition<span style="letter-spacing:0.05pt;"> </span>or results<span style="letter-spacing:0.05pt;"> </span>of operations.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the ordinary course of our business, we collect, store and transmit large amounts of confidential information, including intellectual property, proprietary business information and personal information. Our internal </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">technology</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">systems</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and infrastructure,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and those of our current</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or future</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">third-party</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">collaborators, service</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">providers,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">contractors</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and consultants</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">are vulnerable</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to damage</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">from</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">computer</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">viruses,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">unauthorized access</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or use resulting</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">from</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">malware,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">natural</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">disasters,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">terrorism,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">war and telecommunication</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and electrical failures,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">denial-of-service</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">attacks,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">cyber-attacks</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or cyber-intrusions</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">over the Internet,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">hacking, phishing</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and other social</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">engineering</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">attacks,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">persons</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">inside</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our organizations</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(including</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">employees</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or contractors),</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">loss or theft,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or persons</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">with access</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to systems</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">inside</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our organization</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> From time to time, we are subject to periodic phishing attempts. In the third quarter of 2021, we discovered a business email compromise caused by phishing. The phishing attack did not result in the misappropriation of any funds. Even though we are implementing remedial measures promptly following this incident and do not believe that it had a material adverse effect on our business, we cannot guarantee that our implemented remedial measures will prevent additional related, as well as unrelated, incidents.</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">I</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">f </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a material</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> system</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">failure,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">accident</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or security</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">breach were to occur and cause interruptions</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in our operations</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or the operations</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of third-party</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">collaborators,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">service</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">providers, contractors</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and consultants,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">it could result</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in a material</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">disruption</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of our development</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">programs</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and significant reputational,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">financial,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">legal,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">regulatory,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">business</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or operational</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">harm.</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the extent that any real or perceived security breach affects our systems (or those of our third-party collaborators, service providers, contractors or consultants), or results in the loss of or accidental, unlawful or unauthorized access to, use of, release of, or other processing of personally identifiable information or damage to our data or applications or other data or applications relating to our technology or product candidates, or inappropriate disclosure of confidential or proprietary information, we could incur liabilities and the further development of our product candidates could be delayed. Any failure or perceived failure by us or any third-party collaborators, service providers, contractors or consultants to comply with our privacy, confidentiality, data security or similar obligations, or any data security incidents or other security breaches that result in the accidental, unlawful or unauthorized access to, use of, release of, processing of, or transfer of sensitive information, including personally identifiable information, may result in negative publicity, harm to our reputation, governmental investigations, enforcement actions, regulatory fines, litigation or public statements against us, could cause third parties to lose trust in us or could result in claims by third parties, including those that assert that we have breached our privacy, confidentiality, data security or similar obligations, any of which could have a material adverse effect on our reputation, business, financial condition or results of operations. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Risks Related to Regulatory Approvals</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Pegozafermin has not received regulatory approval. If we are unable to obtain regulatory approvals to market pegozafermin<span style="letter-spacing:-0.05pt;"> </span>or any future product candidates,<span style="letter-spacing:0.05pt;"> </span>our business will be adversely<span style="letter-spacing:0.05pt;"> </span>affected.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We do not expect pegozafermin or any future product candidate to be commercially available for several years, if at all. Pegozafermin is and any future product candidate will be subject to strict regulation by regulatory authorities in the United States and in other countries. We cannot market any product candidate until we have completed all necessary preclinical studies and clinical trials and have obtained the necessary regulatory approvals. We do not know whether regulatory agencies will grant approval for pegozafermin or any future product candidate. Even if we complete preclinical studies and clinical trials successfully, we may not be able to obtain regulatory approvals or we may not receive approvals to make claims about our products that we believe to be necessary to effectively market our products. Data obtained from preclinical studies and clinical trials is subject to varying interpretations that could delay, limit or prevent regulatory approval, and failure to comply with regulatory requirements or inadequate manufacturing processes are examples of other problems that could prevent approval. The regulatory authorities in the United States and the EU have not approved any products for the treatment of NASH, and while there are guidelines issued by the FDA for the development of drugs for the treatment of NASH and an FDA surrogate endpoint table for drug approval that includes SHTG, it is unclear whether the requirements for approval will change in the future. Any such changes may require us to conduct new trials that could delay our timeframe and increase the costs of our programs related to pegozafermin or any future product candidate for the treatment of NASH or SHTG. While the FDA has approved reduction in triglycerides levels as a surrogate endpoint for the full approval of drugs for the treatment of SHTG, it is unclear whether this endpoint will apply to any product candidates that we develop. If such endpoint is not deemed to apply to our product candidates, it would delay our development timeline and increase the costs of our programs for the treatment of SHTG. We have not had any discussions with the FDA regarding a surrogate endpoint or accelerated approval regulations. However, we currently expect that our SHTG program would be subject to smaller clinical trials and that we may expect a relatively quicker overall development timeline for this indication. These expectations are based on a published </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">FDA</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">surrogate</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">endpoint</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">table</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for drug approval</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">that</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">includes </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SHTG,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> as well as the development</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">path followed</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">by other</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">companies</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">that</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">developed</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">an SHTG</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">therapy.</span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Even<span style="letter-spacing:-0.05pt;"> </span>if we<span style="letter-spacing:-0.05pt;"> </span>are able to obtain regulatory<span style="letter-spacing:0.05pt;"> </span>approvals<span style="letter-spacing:0.05pt;"> </span>for pegozafermin or any future product candidate,<span style="letter-spacing:0.05pt;"> </span>if they exhibit<span style="letter-spacing:0.05pt;"> </span>harmful<span style="letter-spacing:0.05pt;"> </span>side effects<span style="letter-spacing:0.1pt;"> </span>after<span style="letter-spacing:0.05pt;"> </span>approval, our regulatory<span style="letter-spacing:0.05pt;"> </span>approvals<span style="letter-spacing:0.05pt;"> </span>could be revoked or otherwise<span style="letter-spacing:0.05pt;"> </span>negatively impacted,<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>could be subject<span style="letter-spacing:0.05pt;"> </span>to costly<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>damaging product liability<span style="letter-spacing:0.1pt;"> </span>claims.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Even if we receive regulatory approval for pegozafermin or any future product candidates, we will have tested them in only a small number of patients during our clinical trials. If our applications for marketing are approved and more patients begin to use our product, new risks and side effects associated with our products may be discovered. As a result, regulatory authorities may revoke their approvals. We have not had any discussions with the FDA regarding a surrogate endpoint or accelerated approval regulations. However, based on recent guidelines issued by the FDA for the development of drugs for the treatment of NASH, if pegozafermin is approved by the FDA based on a surrogate endpoint pursuant to section 506(c) of the Federal Food, Drug, and Cosmetic Act and the accelerated approval regulations (21 C.F.R. part 314, subpart H&#59; 21 C.F.R. part 601, subpart E), consistent with FDA guidance, we will be required to conduct additional clinical trials establishing clinical benefit on the ultimate outcome of NASH. If pegozafermin is approved by the FDA for the treatment of SHTG based on an endpoint of the reduction of triglycerides, the FDA may still require a cardiovascular outcomes study as part of a post-marketing authorization commitment. Such a study would be time consuming and costly and we cannot guarantee that we will see positive results, which could result in the revocation of the approval. Additionally, we may be required to conduct additional clinical trials, make changes in labeling of our product, reformulate our product or make changes and obtain new approvals for our and our suppliers&#8217; manufacturing facilities for pegozafermin and any future product candidates. We might have to withdraw or recall our products from the marketplace. We may also experience a significant drop in the potential sales of our product if and when regulatory approvals for such product are revoked. As a result, we may experience harm to our reputation in the marketplace or become subject to lawsuits, including class actions. Any of these results could decrease or prevent any sales of our approved product or substantially increase the costs and expenses of commercializing and marketing our product<span style="letter-spacing:-0.1pt;">.</span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">The<span style="letter-spacing:-0.05pt;"> </span>regulatory<span style="letter-spacing:0.05pt;"> </span>approval processes<span style="letter-spacing:0.05pt;"> </span>of the FDA<span style="letter-spacing:-0.1pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>comparable<span style="letter-spacing:0.05pt;"> </span>foreign<span style="letter-spacing:0.05pt;"> </span>regulatory<span style="letter-spacing:0.05pt;"> </span>authorities<span style="letter-spacing:0.05pt;"> </span>are lengthy, time-consuming<span style="letter-spacing:0.1pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>inherently<span style="letter-spacing:0.05pt;"> </span>unpredictable.<span style="letter-spacing:0.05pt;"> </span>Our<span style="letter-spacing:-0.05pt;"> </span>inability<span style="letter-spacing:0.1pt;"> </span>to obtain regulatory<span style="letter-spacing:0.05pt;"> </span>approval for pegozafermin<span style="font-style:normal;"> </span>or any future product candidates<span style="letter-spacing:0.05pt;"> </span>would<span style="letter-spacing:-0.05pt;"> </span>substantially<span style="letter-spacing:0.1pt;"> </span>harm our business.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Currently,<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>do not have any product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>have received<span style="letter-spacing:0.05pt;"> </span>regulatory<span style="letter-spacing:0.1pt;"> </span>approval.<span style="letter-spacing:0.05pt;"> </span>The time required<span style="letter-spacing:0.05pt;"> </span>to obtain<span style="letter-spacing:0.05pt;"> </span>approval<span style="letter-spacing:0.05pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>the FDA<span style="letter-spacing:-0.05pt;"> </span>and comparable<span style="letter-spacing:0.1pt;"> </span>foreign<span style="letter-spacing:0.05pt;"> </span>regulatory<span style="letter-spacing:0.1pt;"> </span>authorities<span style="letter-spacing:0.1pt;"> </span>is unpredictable<span style="letter-spacing:0.1pt;"> </span>but typically<span style="letter-spacing:0.1pt;"> </span>takes<span style="letter-spacing:0.05pt;"> </span>many years<span style="letter-spacing:0.05pt;"> </span>following<span style="letter-spacing:0.05pt;"> </span>the commencement<span style="letter-spacing:0.1pt;"> </span>of preclinical<span style="letter-spacing:0.1pt;"> </span>studies<span style="letter-spacing:0.05pt;"> </span>and clinical<span style="letter-spacing:0.1pt;"> </span>trials<span style="letter-spacing:0.1pt;"> </span>and depends upon numerous<span style="letter-spacing:0.05pt;"> </span>factors,<span style="letter-spacing:0.05pt;"> </span>including<span style="letter-spacing:0.05pt;"> </span>the substantial<span style="letter-spacing:0.1pt;"> </span>discretion<span style="letter-spacing:0.1pt;"> </span>of the regulatory<span style="letter-spacing:0.1pt;"> </span>authorities.<span style="letter-spacing:0.1pt;"> </span>In addition,<span style="letter-spacing:0.05pt;"> </span>approval policies,<span style="letter-spacing:0.05pt;"> </span>regulations<span style="letter-spacing:0.1pt;"> </span>or the type and amount<span style="letter-spacing:0.05pt;"> </span>of clinical<span style="letter-spacing:0.1pt;"> </span>data necessary<span style="letter-spacing:0.05pt;"> </span>to gain approval<span style="letter-spacing:0.05pt;"> </span>may change during the course<span style="letter-spacing:0.05pt;"> </span>of a product<span style="letter-spacing:0.05pt;"> </span>candidate&#8217;s<span style="letter-spacing:0.1pt;"> </span>development<span style="letter-spacing:0.05pt;"> </span>and may vary among jurisdictions.<span style="letter-spacing:0.15pt;"> </span>It is possible<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>none of pegozafermin or any future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>will ever obtain<span style="letter-spacing:0.05pt;"> </span>regulatory<span style="letter-spacing:0.1pt;"> </span>approval. Pegozafermin or any future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidate<span style="letter-spacing:0.05pt;"> </span>could fail<span style="letter-spacing:0.05pt;"> </span>to receive<span style="letter-spacing:0.05pt;"> </span>regulatory<span style="letter-spacing:0.1pt;"> </span>approval<span style="letter-spacing:0.05pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>the FDA<span style="letter-spacing:-0.05pt;"> </span>or comparable<span style="letter-spacing:0.1pt;"> </span>foreign<span style="letter-spacing:0.05pt;"> </span>regulatory<span style="letter-spacing:0.1pt;"> </span>authorities<span style="letter-spacing:0.1pt;"> </span>for many reasons<span style="letter-spacing:0.05pt;">, including those referenced in Part I, Item 1. &#8220;Business&#8212;</span>Government Regulation and Product Approval<span style="letter-spacing:0.05pt;">&#8221; in this Annual Report on Form 10-K</span>. If we<span style="letter-spacing:-0.05pt;"> </span>were to obtain<span style="letter-spacing:0.05pt;"> </span>approval,<span style="letter-spacing:0.05pt;"> </span>regulatory<span style="letter-spacing:0.1pt;"> </span>authorities<span style="letter-spacing:0.1pt;"> </span>may approve any of our product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>for fewer or more<span style="letter-spacing:0.05pt;"> </span>limited indications<span style="letter-spacing:0.1pt;"> </span>than we<span style="letter-spacing:-0.05pt;"> </span>request,<span style="letter-spacing:0.05pt;"> </span>may grant<span style="letter-spacing:0.05pt;"> </span>approval<span style="letter-spacing:0.05pt;"> </span>contingent<span style="letter-spacing:0.05pt;"> </span>on the performance<span style="letter-spacing:0.1pt;"> </span>of costly<span style="letter-spacing:0.05pt;"> </span>post-marketing<span style="letter-spacing:0.15pt;"> </span>clinical trials<span style="letter-spacing:0.1pt;"> </span>or may approve a product<span style="letter-spacing:0.05pt;"> </span>candidate<span style="letter-spacing:0.05pt;"> </span>with a label<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>does not include<span style="letter-spacing:0.05pt;"> </span>the labeling<span style="letter-spacing:0.05pt;"> </span>claims<span style="letter-spacing:0.05pt;"> </span>necessary<span style="letter-spacing:0.05pt;"> </span>or desirable<span style="letter-spacing:0.1pt;"> </span>for the successful<span style="letter-spacing:0.1pt;"> </span>commercialization<span style="letter-spacing:0.2pt;"> </span>of the<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidate.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Even<span style="letter-spacing:-0.05pt;"> </span>if pegozafermin or any future product candidate<span style="letter-spacing:0.05pt;"> </span>receives<span style="letter-spacing:0.05pt;"> </span>regulatory<span style="letter-spacing:0.05pt;"> </span>approval, it may still<span style="letter-spacing:0.05pt;"> </span>face future development<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>regulatory<span style="letter-spacing:0.05pt;"> </span>difficulties.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Even if we<span style="letter-spacing:-0.05pt;"> </span>obtained<span style="letter-spacing:0.05pt;"> </span>regulatory<span style="letter-spacing:0.1pt;"> </span>approval<span style="letter-spacing:0.05pt;"> </span>for a product<span style="letter-spacing:0.05pt;"> </span>candidate,<span style="letter-spacing:0.05pt;"> </span>it would be subject<span style="letter-spacing:0.05pt;"> </span>to ongoing requirements<span style="letter-spacing:0.1pt;"> </span>by the FDA<span style="letter-spacing:-0.05pt;"> </span>and comparable<span style="letter-spacing:0.1pt;"> </span>foreign<span style="letter-spacing:0.05pt;"> </span>regulatory<span style="letter-spacing:0.1pt;"> </span>authorities<span style="letter-spacing:0.1pt;"> </span>governing<span style="letter-spacing:0.05pt;"> </span>the manufacture,<span style="letter-spacing:0.1pt;"> </span>quality control,<span style="letter-spacing:0.05pt;"> </span>further<span style="letter-spacing:0.05pt;"> </span>development,<span style="letter-spacing:0.05pt;"> </span>labeling,<span style="letter-spacing:0.05pt;"> </span>packaging,<span style="letter-spacing:0.05pt;"> </span>storage,<span style="letter-spacing:0.05pt;"> </span>distribution,<span style="letter-spacing:0.1pt;"> </span>safety<span style="letter-spacing:0.05pt;"> </span>surveillance,<span style="letter-spacing:0.1pt;"> </span>import,<span style="letter-spacing:0.05pt;"> </span>export, advertising,<span style="letter-spacing:0.1pt;"> </span>promotion,<span style="letter-spacing:0.05pt;"> </span>recordkeeping<span style="letter-spacing:0.1pt;"> </span>and reporting<span style="letter-spacing:0.05pt;"> </span>of safety<span style="letter-spacing:0.05pt;"> </span>and other<span style="letter-spacing:0.05pt;"> </span>post-market<span style="letter-spacing:0.1pt;"> </span>information.<span style="letter-spacing:0.1pt;"> </span>In addition,<span style="letter-spacing:0.05pt;"> </span>manufacturers<span style="letter-spacing:0.15pt;"> </span>of drug products<span style="letter-spacing:0.05pt;"> </span>and their<span style="letter-spacing:0.05pt;"> </span>facilities<span style="letter-spacing:0.15pt;"> </span>are subject<span style="letter-spacing:0.05pt;"> </span>to continual<span style="letter-spacing:0.05pt;"> </span>review and periodic<span style="letter-spacing:0.05pt;"> </span>inspections<span style="letter-spacing:0.1pt;"> </span>by the FDA<span style="letter-spacing:-0.05pt;"> </span>and other<span style="letter-spacing:0.05pt;"> </span>regulatory<span style="letter-spacing:0.1pt;"> </span>authorities<span style="letter-spacing:0.1pt;"> </span>for compliance<span style="letter-spacing:0.1pt;"> </span>with cGMP,<span style="letter-spacing:-0.05pt;"> </span>regulations<span style="letter-spacing:0.1pt;"> </span>and standards.<span style="letter-spacing:0.05pt;"> </span>If we<span style="letter-spacing:-0.05pt;"> </span>or a regulatory<span style="letter-spacing:0.1pt;"> </span>agency discover<span style="letter-spacing:0.05pt;"> </span>previously<span style="letter-spacing:0.05pt;"> </span>unknown<span style="letter-spacing:-0.05pt;"> </span>problems<span style="letter-spacing:0.05pt;"> </span>with a product,<span style="letter-spacing:0.05pt;"> </span>such as adverse events<span style="letter-spacing:0.05pt;"> </span>of unanticipated<span style="letter-spacing:0.1pt;"> </span>severity<span style="letter-spacing:0.05pt;"> </span>or frequency,<span style="letter-spacing:0.05pt;"> </span>or problems<span style="letter-spacing:0.05pt;"> </span>with </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the facility</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">where the product</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">is manufactured,</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a regulatory</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">agency may impose</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">restrictions</span><span style="letter-spacing:0.15pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">on that</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">product,</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the manufacturing</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">facility</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or us, including</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">requiring recall</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or withdrawal</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of the product</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">from</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the market</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or suspension</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of manufacturing.</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If we,</span><span style="letter-spacing:-0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our product candidates</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or the manufacturing</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">facilities</span><span style="letter-spacing:0.15pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for our product</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">candidates</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">fail</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to comply</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">with applicable</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">regulatory requirements,</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or undesirable</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">side effects</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">caused by such products</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">are identified,</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a regulatory</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">agency may:</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">issue</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">safety</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">alerts,</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dear Healthcare</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provider</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">letters,</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">press</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">releases</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or other</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">communications containing</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">warnings about such product&#59;</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">mandate</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">modifications</span><span style="letter-spacing:0.15pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to promotional</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">materials</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or require</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">us to provide</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">corrective</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">information</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to healthcare</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">practitioners&#59;</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">require</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">that</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we</span><span style="letter-spacing:-0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">conduct post-marketing</span><span style="letter-spacing:0.15pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">studies&#59;</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">require</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">us to enter</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">into a consent</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">decree,</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">which can include</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">imposition</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of various</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">fines, reimbursements</span><span style="letter-spacing:0.15pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for inspection</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">costs,</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">required</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">due dates</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for specific</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">actions</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and penalties</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for noncompliance&#59;</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">seek an injunction</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or impose</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">civil</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or criminal</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">penalties</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or monetary</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">fines&#59;</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">suspend marketing</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of, withdraw regulatory</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">approval</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of or recall</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">such product&#59;</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">suspend any ongoing clinical</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">studies&#59;</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">refuse</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to approve pending applications</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or supplements</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to applications</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">filed</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">by us&#59;</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">suspend or impose</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">restrictions</span><span style="letter-spacing:0.15pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">on operations,</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">including</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">costly</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">new</span><span style="letter-spacing:-0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">manufacturing</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">requirements&#59;</span><span style="letter-spacing:0.15pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">seize</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or detain</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">products,</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">refuse</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to permit</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the import</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or export</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of products</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or require</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">us to initiate</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a product</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">recall.</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The occurrence</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of any event or penalty</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">described</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">above may inhibit</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our ability</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to commercialize</span><span style="letter-spacing:0.15pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our products</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and generate</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">product</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">revenue.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#auto;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Risks Relating to Intellectual<span style="letter-spacing:0.1pt;"> </span>Property</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our<span style="letter-spacing:-0.05pt;"> </span>success<span style="letter-spacing:0.05pt;"> </span>depends upon<span style="letter-spacing:-0.05pt;"> </span>our ability<span style="letter-spacing:0.05pt;"> </span>to obtain and<span style="letter-spacing:-0.05pt;"> </span>maintain<span style="letter-spacing:0.05pt;"> </span>intellectual<span style="letter-spacing:0.1pt;"> </span>property<span style="letter-spacing:0.05pt;"> </span>protection<span style="letter-spacing:0.05pt;"> </span>for our products and<span style="letter-spacing:-0.05pt;"> </span>technologies.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our success<span style="letter-spacing:0.05pt;"> </span>will depend in significant<span style="letter-spacing:0.1pt;"> </span>part<span style="letter-spacing:0.05pt;"> </span>on our current<span style="letter-spacing:0.05pt;"> </span>or future<span style="letter-spacing:0.05pt;"> </span>licensors&#8217;,<span style="letter-spacing:0.1pt;"> </span>licensees&#8217;<span style="letter-spacing:0.1pt;"> </span>or collaborators&#8217;<span style="letter-spacing:0.15pt;"> </span>ability<span style="letter-spacing:0.05pt;"> </span>to establish<span style="letter-spacing:0.1pt;"> </span>and maintain<span style="letter-spacing:0.1pt;"> </span>adequate<span style="letter-spacing:0.05pt;"> </span>protection<span style="letter-spacing:0.1pt;"> </span>of our owned<span style="letter-spacing:-0.05pt;"> </span>and licensed<span style="letter-spacing:0.05pt;"> </span>intellectual property<span style="letter-spacing:0.05pt;"> </span>covering<span style="letter-spacing:0.05pt;"> </span>the product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>plan to develop, and the ability<span style="letter-spacing:0.05pt;"> </span>to develop these<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidates and commercialize<span style="letter-spacing:0.15pt;"> </span>the products<span style="letter-spacing:0.05pt;"> </span>resulting<span style="letter-spacing:0.1pt;"> </span>therefrom,<span style="letter-spacing:0.1pt;"> </span>without infringing<span style="letter-spacing:0.1pt;"> </span>the intellectual<span style="letter-spacing:0.15pt;"> </span>property<span style="letter-spacing:0.05pt;"> </span>rights<span style="letter-spacing:0.05pt;"> </span>of others. In addition<span style="letter-spacing:0.05pt;"> </span>to taking<span style="letter-spacing:0.05pt;"> </span>other<span style="letter-spacing:0.05pt;"> </span>steps<span style="letter-spacing:0.05pt;"> </span>to protect<span style="letter-spacing:0.05pt;"> </span>our intellectual<span style="letter-spacing:0.15pt;"> </span>property,<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>hold issued<span style="letter-spacing:0.05pt;"> </span>patents,<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>have applied<span style="letter-spacing:0.05pt;"> </span>for patents,<span style="letter-spacing:0.05pt;"> </span>and we<span style="letter-spacing:-0.05pt;"> </span>intend<span style="letter-spacing:0.05pt;"> </span>to continue<span style="letter-spacing:0.05pt;"> </span>to apply for, patents<span style="letter-spacing:0.05pt;"> </span>with claims<span style="letter-spacing:0.05pt;"> </span>covering<span style="letter-spacing:0.05pt;"> </span>our technologies,<span style="letter-spacing:0.1pt;"> </span>processes<span style="letter-spacing:0.05pt;"> </span>and product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>when<span style="letter-spacing:-0.05pt;"> </span>and where we<span style="letter-spacing:-0.05pt;"> </span>deem it appropriate<span style="letter-spacing:0.1pt;"> </span>to do so. We have filed<span style="letter-spacing:0.05pt;"> </span>numerous<span style="letter-spacing:0.05pt;"> </span>patent<span style="letter-spacing:0.05pt;"> </span>applications both in the United States<span style="letter-spacing:0.05pt;"> </span>and in certain<span style="letter-spacing:0.05pt;"> </span>foreign<span style="letter-spacing:0.05pt;"> </span>jurisdictions<span style="letter-spacing:0.15pt;"> </span>to obtain<span style="letter-spacing:0.05pt;"> </span>patent<span style="letter-spacing:0.05pt;"> </span>rights<span style="letter-spacing:0.05pt;"> </span>to inventions<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>have discovered,<span style="letter-spacing:0.05pt;"> </span>with claims<span style="letter-spacing:0.05pt;"> </span>directed<span style="letter-spacing:0.05pt;"> </span>to compositions<span style="letter-spacing:0.1pt;"> </span>of matter,<span style="letter-spacing:0.1pt;"> </span>methods<span style="letter-spacing:0.05pt;"> </span>of use and other<span style="letter-spacing:0.05pt;"> </span>technologies<span style="letter-spacing:0.1pt;"> </span>relating<span style="letter-spacing:0.1pt;"> </span>to our programs.<span style="letter-spacing:0.05pt;"> </span>There can be no assurance<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>any of these<span style="letter-spacing:0.05pt;"> </span>patent<span style="letter-spacing:0.05pt;"> </span>applications<span style="letter-spacing:0.1pt;"> </span>will issue<span style="letter-spacing:0.05pt;"> </span>as patents<span style="letter-spacing:0.05pt;"> </span>or, for those applications<span style="letter-spacing:0.1pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>do mature<span style="letter-spacing:0.05pt;"> </span>into patents,<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>the claims<span style="letter-spacing:0.05pt;"> </span>of the patents<span style="letter-spacing:0.05pt;"> </span>will exclude<span style="letter-spacing:0.05pt;"> </span>others<span style="letter-spacing:0.05pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>making,<span style="letter-spacing:0.05pt;"> </span>using or selling<span style="letter-spacing:0.05pt;"> </span>our product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>or products<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>compete<span style="letter-spacing:0.05pt;"> </span>with or are similar<span style="letter-spacing:0.1pt;"> </span>to our product<span style="letter-spacing:0.05pt;"> </span>candidates.<span style="letter-spacing:0.05pt;"> </span>In countries where we<span style="letter-spacing:-0.05pt;"> </span>have not sought and do not seek patent<span style="letter-spacing:0.05pt;"> </span>protection,<span style="letter-spacing:0.1pt;"> </span>third<span style="letter-spacing:0.05pt;"> </span>parties<span style="letter-spacing:0.05pt;"> </span>may be able to manufacture<span style="letter-spacing:0.1pt;"> </span>and sell<span style="letter-spacing:0.05pt;"> </span>our product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>without our permission,<span style="letter-spacing:0.1pt;"> </span>and we<span style="letter-spacing:-0.05pt;"> </span>may not be able to stop them<span style="letter-spacing:0.05pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>doing so.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">With<span style="letter-spacing:0.05pt;"> </span>respect<span style="letter-spacing:0.05pt;"> </span>to patent<span style="letter-spacing:0.05pt;"> </span>rights,<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>do not know<span style="letter-spacing:-0.05pt;"> </span>whether any of the pending patent<span style="letter-spacing:0.05pt;"> </span>applications<span style="letter-spacing:0.1pt;"> </span>for any of our product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>will result<span style="letter-spacing:0.05pt;"> </span>in the issuance<span style="letter-spacing:0.05pt;"> </span>of patents<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>effectively<span style="letter-spacing:0.1pt;"> </span>protect<span style="letter-spacing:0.05pt;"> </span>our technologies,<span style="letter-spacing:0.1pt;"> </span>processes and product<span style="letter-spacing:0.05pt;"> </span>candidates,<span style="letter-spacing:0.05pt;"> </span>or if any of our issued<span style="letter-spacing:0.05pt;"> </span>patents<span style="letter-spacing:0.05pt;"> </span>or our current<span style="letter-spacing:0.05pt;"> </span>or future<span style="letter-spacing:0.05pt;"> </span>licensors&#8217;,<span style="letter-spacing:0.1pt;"> </span>licensees&#8217;<span style="letter-spacing:0.1pt;"> </span>or collaborators&#8217;<span style="letter-spacing:0.15pt;"> </span>issued<span style="letter-spacing:0.05pt;"> </span>patents<span style="letter-spacing:0.05pt;"> </span>will effectively<span style="letter-spacing:0.1pt;"> </span>prevent<span style="letter-spacing:0.05pt;"> </span>others<span style="letter-spacing:0.05pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>commercializing<span style="letter-spacing:0.15pt;"> </span>competitive<span style="letter-spacing:0.1pt;"> </span>technologies, processes<span style="letter-spacing:0.05pt;"> </span>and products.<span style="letter-spacing:0.05pt;"> </span>We cannot be certain that we or our current or future licensors, licensees or collaborators were the first to make the inventions claimed in our owned or licensed patents or pending patent applications, or that we or our current or future licensors, licensees or collaborators were the first to file for patent protection of such inventions. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any changes we make to our pegozafermin or any future product candidates to cause them to have what we view as more advantageous properties<span style="letter-spacing:0.1pt;"> </span>may not be covered<span style="letter-spacing:0.05pt;"> </span>by our existing<span style="letter-spacing:0.05pt;"> </span>patents<span style="letter-spacing:0.05pt;"> </span>and patent<span style="letter-spacing:0.05pt;"> </span>applications, and we<span style="letter-spacing:-0.05pt;"> </span>may be required<span style="letter-spacing:0.05pt;"> </span>to file<span style="letter-spacing:0.05pt;"> </span>new<span style="letter-spacing:-0.05pt;"> </span>applications<span style="letter-spacing:0.1pt;"> </span>and/or<span style="letter-spacing:0.05pt;"> </span>seek other<span style="letter-spacing:0.05pt;"> </span>forms<span style="letter-spacing:0.05pt;"> </span>of protection<span style="letter-spacing:0.1pt;"> </span>for any such altered product<span style="letter-spacing:0.05pt;"> </span>candidates.<span style="letter-spacing:0.05pt;"> </span>The patent<span style="letter-spacing:0.05pt;"> </span>landscape<span style="letter-spacing:0.05pt;"> </span>surrounding<span style="letter-spacing:0.05pt;"> </span>the technology<span style="letter-spacing:0.05pt;"> </span>underlying<span style="letter-spacing:0.05pt;"> </span>our product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>is crowded, and there<span style="letter-spacing:0.05pt;"> </span>can be no assurance<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>would be able to secure<span style="letter-spacing:0.05pt;"> </span>patent<span style="letter-spacing:0.05pt;"> </span>protection<span style="letter-spacing:0.1pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>would adequately cover an alternative<span style="letter-spacing:0.1pt;"> </span>to pegozafermin or any future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidates.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We<span style="letter-spacing:-0.05pt;"> </span>and our current<span style="letter-spacing:0.05pt;"> </span>or future licensors,<span style="letter-spacing:0.1pt;"> </span>licensees<span style="letter-spacing:0.1pt;"> </span>or collaborators<span style="letter-spacing:0.1pt;"> </span>may not be able to prepare,<span style="letter-spacing:0.05pt;"> </span>file<span style="letter-spacing:0.05pt;"> </span>and prosecute<span style="letter-spacing:0.05pt;"> </span>all<span style="letter-spacing:0.05pt;"> </span>necessary<span style="letter-spacing:0.05pt;"> </span>or desirable patent<span style="letter-spacing:0.05pt;"> </span>applications<span style="letter-spacing:0.1pt;"> </span>at a reasonable<span style="letter-spacing:0.05pt;"> </span>cost or in a timely<span style="letter-spacing:0.05pt;"> </span>manner.<span style="letter-spacing:0.05pt;"> </span>It is also possible<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>or our current<span style="letter-spacing:0.05pt;"> </span>or future licensors,<span style="letter-spacing:0.1pt;"> </span>licensees<span style="letter-spacing:0.1pt;"> </span>or collaborators<span style="letter-spacing:0.1pt;"> </span>will fail<span style="letter-spacing:0.05pt;"> </span>to identify<span style="letter-spacing:0.05pt;"> </span>patentable<span style="letter-spacing:0.1pt;"> </span>aspects<span style="letter-spacing:0.05pt;"> </span>of inventions<span style="letter-spacing:0.05pt;"> </span>made in the course<span style="letter-spacing:0.05pt;"> </span>of development<span style="letter-spacing:0.05pt;"> </span>and commercialization<span style="letter-spacing:0.2pt;"> </span>activities<span style="letter-spacing:0.1pt;"> </span>before<span style="letter-spacing:0.05pt;"> </span>it is too late<span style="letter-spacing:0.05pt;"> </span>to obtain<span style="letter-spacing:0.05pt;"> </span>patent<span style="letter-spacing:0.05pt;"> </span>protection<span style="letter-spacing:0.1pt;"> </span>for them.<span style="letter-spacing:0.05pt;"> </span>Moreover, in some circumstances,<span style="letter-spacing:0.15pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>may not have the right<span style="letter-spacing:0.05pt;"> </span>to control<span style="letter-spacing:0.05pt;"> </span>the preparation,<span style="letter-spacing:0.1pt;"> </span>filing<span style="letter-spacing:0.05pt;"> </span></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and prosecution</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of patent applications,</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or to maintain</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or enforce</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the patents,</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">covering</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">technology</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">that</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we</span><span style="letter-spacing:-0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">license</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">from</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or license</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to third parties</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and may be reliant</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">on our current</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or future</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">licensors,</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">licensees</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or collaborators</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to perform</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">these</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">activities, which means</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">that</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">these</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">patent</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">applications</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">may not be prosecuted,</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and these</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">patents</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">enforced,</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in a manner consistent</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">with the best interests</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of our business.</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If our current</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or future</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">licensors,</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">licensees</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or collaborators</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">fail to establish,</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">maintain,</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">protect</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or enforce</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">such patents</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and other</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">intellectual</span><span style="letter-spacing:0.15pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">property</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">rights,</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">such rights</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">may be reduced</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or eliminated.</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If our current</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or future</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">licensors,</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">licensees</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or collaborators</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">are not fully</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">cooperative</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or disagree</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">with us as to the prosecution,</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">maintenance</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or enforcement</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of any patent</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">rights,</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">such patent</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">rights</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">could be compromised.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Similar to the patent rights of other biotechnology companies, the scope, validity and enforceability of our owned and licensed patent rights generally are highly uncertain and involve complex legal and factual questions. The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and our patents may be challenged in the courts or patent offices in the United States and abroad. In recent years, these areas have been the subject of much litigation in the industry. As a result, the issuance, scope, validity, enforceability and commercial value of our and our current or future licensors&#8217;, licensees&#8217; or collaborators&#8217; patent rights are highly uncertain. Our and our current or future licensors&#8217;, licensees&#8217; or collaborators&#8217; pending and future patent applications may not result in patents being issued that protect our technology or product candidates, or products resulting therefrom, in whole or in part, or that effectively prevent others from commercializing competitive technologies and products. The patent examination process may require us or our current or future licensors, licensees or collaborators to narrow the scope of the claims of pending and future patent applications, which would limit the scope of patent protection that is obtained, if any. Our and our current or future licensors&#8217;, licensees&#8217; or collaborators&#8217; patent applications cannot be enforced against third parties practicing the technology that is currently claimed in such applications unless and until a patent issues from such applications, and then only to the extent the claims that issue are broad enough to cover the technology being practiced by those third parties.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;letter-spacing:-0.05pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furthermore,<span style="letter-spacing:0.1pt;"> </span>given the amount<span style="letter-spacing:0.05pt;"> </span>of time<span style="letter-spacing:0.05pt;"> </span>required<span style="letter-spacing:0.05pt;"> </span>for the development,<span style="letter-spacing:0.05pt;"> </span>testing<span style="letter-spacing:0.05pt;"> </span>and regulatory<span style="letter-spacing:0.1pt;"> </span>review of new product<span style="letter-spacing:0.05pt;"> </span>candidates,<span style="letter-spacing:0.05pt;"> </span>patents<span style="letter-spacing:0.05pt;"> </span>protecting<span style="letter-spacing:0.1pt;"> </span>such candidates<span style="letter-spacing:0.05pt;"> </span>might<span style="letter-spacing:0.05pt;"> </span>expire<span style="letter-spacing:0.05pt;"> </span>before<span style="letter-spacing:0.05pt;"> </span>or shortly<span style="letter-spacing:0.05pt;"> </span>after<span style="letter-spacing:0.05pt;"> </span>the resulting products<span style="letter-spacing:0.05pt;"> </span>are commercialized.<span style="letter-spacing:0.15pt;"> </span>As a result,<span style="letter-spacing:0.05pt;"> </span>our owned and in-licensed<span style="letter-spacing:0.1pt;"> </span>patents<span style="letter-spacing:0.05pt;"> </span>may not provide<span style="letter-spacing:0.05pt;"> </span>us with sufficient rights<span style="letter-spacing:0.05pt;"> </span>to exclude<span style="letter-spacing:0.05pt;"> </span>others<span style="letter-spacing:0.05pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>commercializing<span style="letter-spacing:0.15pt;"> </span>products<span style="letter-spacing:0.05pt;"> </span>similar<span style="letter-spacing:0.1pt;"> </span>or identical<span style="letter-spacing:0.1pt;"> </span>to ours. We expect<span style="letter-spacing:0.05pt;"> </span>to seek extensions of patent<span style="letter-spacing:0.05pt;"> </span>terms<span style="letter-spacing:0.05pt;"> </span>for our issued<span style="letter-spacing:0.05pt;"> </span>patents,<span style="letter-spacing:0.05pt;"> </span>where available.<span style="letter-spacing:0.1pt;"> </span>The applicable<span style="letter-spacing:0.1pt;"> </span>authorities,<span style="letter-spacing:0.1pt;"> </span>including<span style="letter-spacing:0.05pt;"> </span>the FDA in the United States,<span style="letter-spacing:0.05pt;"> </span>and any comparable<span style="letter-spacing:0.1pt;"> </span>foreign<span style="letter-spacing:0.05pt;"> </span>regulatory authorities,<span style="letter-spacing:0.1pt;"> </span>may not agree<span style="letter-spacing:0.05pt;"> </span>with our assessment<span style="letter-spacing:0.1pt;"> </span>of whether such extensions<span style="letter-spacing:0.05pt;"> </span>are available,<span style="letter-spacing:0.1pt;"> </span>and may refuse<span style="letter-spacing:0.05pt;"> </span>to grant extensions<span style="letter-spacing:0.05pt;"> </span>to our patents,<span style="letter-spacing:0.05pt;"> </span>or may grant<span style="letter-spacing:0.05pt;"> </span>more<span style="letter-spacing:0.05pt;"> </span>limited<span style="letter-spacing:0.1pt;"> </span>extensions<span style="letter-spacing:0.05pt;"> </span>than we request.<span style="letter-spacing:0.05pt;"> </span>In addition,<span style="letter-spacing:0.05pt;"> </span>we may not be granted<span style="letter-spacing:0.05pt;"> </span>an extension<span style="letter-spacing:0.05pt;"> </span>because<span style="letter-spacing:0.05pt;"> </span>of, for example,<span style="letter-spacing:0.05pt;"> </span>failing<span style="letter-spacing:0.05pt;"> </span>to apply within applicable<span style="letter-spacing:0.1pt;"> </span>deadlines,<span style="letter-spacing:0.05pt;"> </span>failing<span style="letter-spacing:0.05pt;"> </span>to apply prior to the expiration<span style="letter-spacing:0.1pt;"> </span>of relevant<span style="letter-spacing:0.05pt;"> </span>patents<span style="letter-spacing:0.05pt;"> </span>or otherwise<span style="letter-spacing:0.05pt;"> </span>failing<span style="letter-spacing:0.05pt;"> </span>to satisfy<span style="letter-spacing:0.05pt;"> </span>applicable<span style="letter-spacing:0.1pt;"> </span>requirements.<span style="letter-spacing:0.1pt;"> </span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We may not be able to protect<span style="letter-spacing:0.05pt;"> </span>our intellectual<span style="letter-spacing:0.1pt;"> </span>property<span style="letter-spacing:0.05pt;"> </span>rights<span style="letter-spacing:0.05pt;"> </span>throughout the world.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;letter-spacing:-0.05pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The legal<span style="letter-spacing:0.05pt;"> </span>protection<span style="letter-spacing:0.1pt;"> </span>afforded<span style="letter-spacing:0.05pt;"> </span>to inventors<span style="letter-spacing:0.05pt;"> </span>and owners of intellectual<span style="letter-spacing:0.15pt;"> </span>property<span style="letter-spacing:0.05pt;"> </span>in countries<span style="letter-spacing:0.05pt;"> </span>outside<span style="letter-spacing:0.05pt;"> </span>of the United States<span style="letter-spacing:0.05pt;"> </span>may not be as protective or effective as that in the United States and we may, therefore, be unable to acquire and enforce intellectual property rights outside the United States to the same extent as in the United States. Whether filed in the United States or abroad, our patent applications may be challenged or may fail to result in issued patents. Filing, prosecuting, enforcing and defending patents on product candidates in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the United States are less extensive than those in the United States. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and certain state laws in the United States.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;letter-spacing:-0.05pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, or from selling or importing products made using our inventions in and into the United States or other jurisdictions. Competitors may use technologies in jurisdictions where we have not obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories where we have patent protection, but enforcement is not as strong as that in the United States. These products may compete with pegozafermin or any future product candidates and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We rely</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">on</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">a license</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">from</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Teva and</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">a sublicense</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">from</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">ratiopharm</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">to patents</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">and</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">know-how</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">related</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">to glycoPEGylation</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">technology</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">that are used in the development,</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">manufacture</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">and</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">commercialization</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">of </span><span style="font-style:normal;">pegozafermin</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">.</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Any</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">termination</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">or loss of significant</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">rights,</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">including the right to glycoPEGylation</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">technology, or breach, under these agreements</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">or any future license</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">agreement</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">related</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">to our product candidates,</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">would materially</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">and</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">adversely</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">affect</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">our ability</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">to continue the development</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">and</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">commercialization</span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </span><span style="font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">of the related product candidates.</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In <span style="letter-spacing:-0.05pt;">April</span> 2018, we<span style="letter-spacing:-0.05pt;"> </span>entered<span style="letter-spacing:0.05pt;"> </span>into an Asset Transfer<span style="letter-spacing:0.05pt;"> </span>and License<span style="letter-spacing:0.05pt;"> </span>Agreement<span style="letter-spacing:0.05pt;"> </span>(the<span style="letter-spacing:0.05pt;"> </span>&#8220;FGF21<span style="letter-spacing:-0.05pt;"> </span>Agreement&#8221;) with Teva under which we<span style="letter-spacing:-0.05pt;"> </span>acquired<span style="letter-spacing:0.05pt;"> </span>certain<span style="letter-spacing:0.05pt;"> </span>patents,<span style="letter-spacing:0.05pt;"> </span>intellectual<span style="letter-spacing:0.15pt;"> </span>property<span style="letter-spacing:0.05pt;"> </span>and other<span style="letter-spacing:0.05pt;"> </span>assets<span style="letter-spacing:0.05pt;"> </span>relating<span style="letter-spacing:0.1pt;"> </span>to Teva&#8217;s glycoPEGylated<span style="letter-spacing:0.05pt;"> </span>FGF21<span style="letter-spacing:-0.05pt;"> </span>program,<span style="letter-spacing:0.05pt;"> </span>including<span style="letter-spacing:0.05pt;"> </span>pegozafermin. Under this<span style="letter-spacing:0.05pt;"> </span>agreement, we<span style="letter-spacing:-0.05pt;"> </span>were granted<span style="letter-spacing:0.05pt;"> </span>a perpetual,<span style="letter-spacing:1.1pt;"> </span>non-exclusive<span style="letter-spacing:0.1pt;"> </span>(but exclusive<span style="letter-spacing:0.05pt;"> </span>as to pegozafermin), non-transferable,<span style="letter-spacing:0.15pt;"> </span>worldwide license<span style="letter-spacing:0.05pt;"> </span>to patents<span style="letter-spacing:0.05pt;"> </span>and know-how related<span style="letter-spacing:0.05pt;"> </span>to glycoPEGylation<span style="letter-spacing:0.05pt;"> </span>technology<span style="letter-spacing:0.05pt;"> </span>used in the development,<span style="letter-spacing:0.05pt;"> </span>manufacture<span style="letter-spacing:0.1pt;"> </span>and commercialization<span style="letter-spacing:0.2pt;"> </span>of pegozafermin and products<span style="letter-spacing:0.05pt;"> </span>containing<span style="letter-spacing:0.05pt;"> </span>pegozafermin. The FGF21<span style="letter-spacing:-0.05pt;"> </span>Agreement<span style="letter-spacing:0.05pt;"> </span>also contains<span style="letter-spacing:0.05pt;"> </span>numerous<span style="letter-spacing:0.05pt;"> </span>covenants<span style="letter-spacing:0.05pt;"> </span>with which we<span style="letter-spacing:-0.05pt;"> </span>must<span style="letter-spacing:0.05pt;"> </span>comply,<span style="letter-spacing:0.05pt;"> </span>including<span style="letter-spacing:0.05pt;"> </span>the utilization<span style="letter-spacing:0.1pt;"> </span>of commercially<span style="letter-spacing:0.15pt;"> </span>reasonable<span style="letter-spacing:0.05pt;"> </span>efforts<span style="letter-spacing:0.1pt;"> </span>to develop and ultimately commercialize<span style="letter-spacing:0.15pt;"> </span>pegozafermin, as well as certain<span style="letter-spacing:0.05pt;"> </span>reporting<span style="letter-spacing:0.05pt;"> </span>covenants<span style="letter-spacing:0.05pt;"> </span>and the obligation<span style="letter-spacing:0.05pt;"> </span>to make royalty<span style="letter-spacing:0.05pt;"> </span>payments,<span style="letter-spacing:0.05pt;"> </span>if and when<span style="letter-spacing:-0.05pt;"> </span>pegozafermin is approved for commercialization.<span style="letter-spacing:0.2pt;"> </span>Our failure<span style="letter-spacing:0.1pt;"> </span>to satisfy<span style="letter-spacing:0.05pt;"> </span>any of these<span style="letter-spacing:0.05pt;"> </span>covenants<span style="letter-spacing:0.05pt;"> </span>could result<span style="letter-spacing:0.05pt;"> </span>in the termination<span style="letter-spacing:0.1pt;"> </span>of the FGF21<span style="letter-spacing:-0.05pt;"> </span>Agreement.<span style="letter-spacing:0.05pt;"> </span>In addition,<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>entered<span style="letter-spacing:0.05pt;"> </span>into a Sublicense<span style="letter-spacing:0.05pt;"> </span>Agreement<span style="letter-spacing:0.05pt;"> </span>with ratiopharm<span style="letter-spacing:0.1pt;"> </span>(the<span style="letter-spacing:0.05pt;"> </span>&#8220;ratiopharm<span style="letter-spacing:0.1pt;"> </span>Sublicense&#8221;),<span style="letter-spacing:0.1pt;"> </span>under which we<span style="letter-spacing:-0.05pt;"> </span>were granted<span style="letter-spacing:0.05pt;"> </span>a perpetual,<span style="letter-spacing:0.05pt;"> </span>exclusive,<span style="letter-spacing:0.05pt;"> </span>worldwide sublicense<span style="letter-spacing:0.05pt;"> </span>to patents<span style="letter-spacing:0.05pt;"> </span>and know-how<span style="letter-spacing:-0.05pt;"> </span>related<span style="letter-spacing:0.05pt;"> </span>to glycoPEGylation<span style="letter-spacing:0.05pt;"> </span>technology<span style="letter-spacing:0.05pt;"> </span>used in the development, manufacture<span style="letter-spacing:0.1pt;"> </span>and commercialization<span style="letter-spacing:0.2pt;"> </span>of pegozafermin and products<span style="letter-spacing:0.05pt;"> </span>containing<span style="letter-spacing:0.05pt;"> </span>pegozafermin. Termination<span style="letter-spacing:0.1pt;"> </span>of the FGF21<span style="letter-spacing:-0.05pt;"> </span>Agreement<span style="letter-spacing:0.05pt;"> </span>or the ratiopharm<span style="letter-spacing:0.1pt;"> </span>Sublicense<span style="letter-spacing:0.05pt;"> </span>will impact<span style="letter-spacing:0.05pt;"> </span>our rights<span style="letter-spacing:0.05pt;"> </span>under the intellectual<span style="letter-spacing:0.15pt;"> </span>property<span style="letter-spacing:0.05pt;"> </span>licensed<span style="letter-spacing:0.05pt;"> </span>to us by Teva and ratiopharm,<span style="letter-spacing:0.1pt;"> </span>respectively, including<span style="letter-spacing:0.05pt;"> </span>our license<span style="letter-spacing:0.05pt;"> </span>to glycoPEGylation<span style="letter-spacing:0.05pt;"> </span>technology,<span style="letter-spacing:0.05pt;"> </span>but will not affect<span style="letter-spacing:1.1pt;"> </span>our rights<span style="letter-spacing:0.05pt;"> </span>under the assets<span style="letter-spacing:0.05pt;"> </span>assigned<span style="letter-spacing:0.05pt;"> </span>to us.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;letter-spacing:-0.05pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beyond this<span style="letter-spacing:0.05pt;"> </span>agreement,<span style="letter-spacing:0.1pt;"> </span>our commercial<span style="letter-spacing:0.1pt;"> </span>success<span style="letter-spacing:0.05pt;"> </span>will also depend upon our ability,<span style="letter-spacing:0.05pt;"> </span>and the ability<span style="letter-spacing:0.05pt;"> </span>of our licensors,<span style="letter-spacing:0.1pt;"> </span>to develop, manufacture,<span style="letter-spacing:0.1pt;"> </span>market<span style="letter-spacing:0.05pt;"> </span>and sell<span style="letter-spacing:0.05pt;"> </span>our product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>and use our proprietary<span style="letter-spacing:0.1pt;"> </span>technologies without infringing<span style="letter-spacing:0.1pt;"> </span>the proprietary<span style="letter-spacing:0.1pt;"> </span>rights<span style="letter-spacing:0.05pt;"> </span>of third<span style="letter-spacing:0.05pt;"> </span>parties.<span style="letter-spacing:0.05pt;"> </span>A third<span style="letter-spacing:0.05pt;"> </span>party<span style="letter-spacing:0.05pt;"> </span>may hold intellectual<span style="letter-spacing:0.15pt;"> </span>property<span style="letter-spacing:0.05pt;"> </span>rights, including<span style="letter-spacing:0.05pt;"> </span>patent<span style="letter-spacing:0.05pt;"> </span>rights,<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>are important<span style="letter-spacing:0.1pt;"> </span>or necessary<span style="letter-spacing:0.05pt;"> </span>to the development<span style="letter-spacing:0.05pt;"> </span>of our product<span style="letter-spacing:0.05pt;"> </span>candidates.<span style="letter-spacing:0.05pt;"> </span>As a result, we may enter<span style="letter-spacing:0.05pt;"> </span>into additional<span style="letter-spacing:0.1pt;"> </span>license<span style="letter-spacing:0.05pt;"> </span>agreements<span style="letter-spacing:0.1pt;"> </span>in the future.<span style="letter-spacing:0.05pt;"> </span>If we fail<span style="letter-spacing:0.05pt;"> </span>to comply<span style="letter-spacing:0.05pt;"> </span>with the obligations<span style="letter-spacing:0.1pt;"> </span>under these<span style="letter-spacing:0.05pt;"> </span>agreements,<span style="letter-spacing:0.1pt;"> </span>including<span style="letter-spacing:0.05pt;"> </span>payment<span style="letter-spacing:0.05pt;"> </span>and diligence<span style="letter-spacing:0.05pt;"> </span>obligations,<span style="letter-spacing:0.1pt;"> </span>our licensors<span style="letter-spacing:0.1pt;"> </span>may have the right<span style="letter-spacing:0.05pt;"> </span>to terminate these<span style="letter-spacing:0.05pt;"> </span>agreements,<span style="letter-spacing:0.1pt;"> </span>in which event we may not be able to develop, manufacture,<span style="letter-spacing:0.1pt;"> </span>market<span style="letter-spacing:0.05pt;"> </span>or sell<span style="letter-spacing:0.05pt;"> </span>any product<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>is covered<span style="letter-spacing:0.05pt;"> </span>by these<span style="letter-spacing:0.05pt;"> </span>agreements<span style="letter-spacing:0.1pt;"> </span>or to engage in any other<span style="letter-spacing:0.05pt;"> </span>activities<span style="letter-spacing:0.1pt;"> </span>necessary<span style="letter-spacing:0.05pt;"> </span>to our business<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>require<span style="letter-spacing:0.05pt;"> </span>the freedom<span style="letter-spacing:0.05pt;"> </span>to operate<span style="letter-spacing:0.05pt;"> </span>afforded<span style="letter-spacing:0.05pt;"> </span>by the agreements,<span style="letter-spacing:0.1pt;"> </span>or we may face<span style="letter-spacing:0.05pt;"> </span>other<span style="letter-spacing:0.05pt;"> </span>penalties<span style="letter-spacing:0.1pt;"> </span>under the agreements.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We may be unable to obtain intellectual<span style="letter-spacing:0.1pt;"> </span>property<span style="letter-spacing:0.05pt;"> </span>rights<span style="letter-spacing:0.05pt;"> </span>or technology<span style="letter-spacing:0.05pt;"> </span>necessary<span style="letter-spacing:0.05pt;"> </span>to develop<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>commercialize pegozafermin and<span style="letter-spacing:-0.05pt;"> </span>any future product candidates.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The patent<span style="letter-spacing:0.05pt;"> </span>landscape<span style="letter-spacing:0.05pt;"> </span>around our programs<span style="letter-spacing:0.05pt;"> </span>is complex,<span style="letter-spacing:0.05pt;"> </span>and we<span style="letter-spacing:-0.05pt;"> </span>are aware of several<span style="letter-spacing:0.05pt;"> </span>third-party<span style="letter-spacing:0.1pt;"> </span>patents and patent<span style="letter-spacing:0.05pt;"> </span>applications<span style="letter-spacing:0.1pt;"> </span>containing<span style="letter-spacing:0.05pt;"> </span>subject<span style="letter-spacing:0.05pt;"> </span>matter<span style="letter-spacing:0.1pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>might<span style="letter-spacing:0.05pt;"> </span>be relevant<span style="letter-spacing:0.05pt;"> </span>to pegozafermin. Depending on what claims<span style="letter-spacing:0.05pt;"> </span>ultimately<span style="letter-spacing:0.1pt;"> </span>issue<span style="letter-spacing:0.05pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>these<span style="letter-spacing:0.05pt;"> </span>patent<span style="letter-spacing:0.05pt;"> </span>applications,<span style="letter-spacing:0.1pt;"> </span>and how<span style="letter-spacing:-0.05pt;"> </span>courts<span style="letter-spacing:0.05pt;"> </span>construe<span style="letter-spacing:0.05pt;"> </span>the issued<span style="letter-spacing:0.05pt;"> </span>patent<span style="letter-spacing:0.05pt;"> </span>claims,<span style="letter-spacing:0.05pt;"> </span>as well as depending on the ultimate<span style="letter-spacing:0.1pt;"> </span>formulation<span style="letter-spacing:0.1pt;"> </span>and method<span style="letter-spacing:0.05pt;"> </span>of use of pegozafermin or any future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidates,<span style="letter-spacing:0.05pt;"> </span>we may need to obtain<span style="letter-spacing:0.05pt;"> </span>a license<span style="letter-spacing:0.05pt;"> </span>to practice<span style="letter-spacing:0.1pt;"> </span>the technology<span style="letter-spacing:0.05pt;"> </span>claimed<span style="letter-spacing:0.05pt;"> </span>in such patents.<span style="letter-spacing:0.05pt;"> </span>There can be no assurance<span style="letter-spacing:0.05pt;"> </span>that such licenses<span style="letter-spacing:0.05pt;"> </span>will be available<span style="letter-spacing:0.1pt;"> </span>on commercially<span style="letter-spacing:0.15pt;"> </span>reasonable<span style="letter-spacing:0.05pt;"> </span>terms,<span style="letter-spacing:0.05pt;"> </span>or at all.<span style="letter-spacing:0.05pt;"> </span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We may become<span style="letter-spacing:0.05pt;"> </span>involved<span style="letter-spacing:0.05pt;"> </span>in lawsuits<span style="letter-spacing:0.05pt;"> </span>or other proceedings<span style="letter-spacing:0.05pt;"> </span>to protect<span style="letter-spacing:0.05pt;"> </span>or enforce<span style="letter-spacing:0.05pt;"> </span>our intellectual<span style="letter-spacing:0.1pt;"> </span>property, which<span style="letter-spacing:-0.05pt;"> </span>could be expensive,<span style="letter-spacing:0.05pt;"> </span>time-consuming<span style="letter-spacing:0.1pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>unsuccessful<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>have a material<span style="letter-spacing:0.1pt;"> </span>adverse<span style="letter-spacing:0.05pt;"> </span>effect<span style="letter-spacing:0.05pt;"> </span>on<span style="letter-spacing:-0.05pt;"> </span>the success of our business.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Third parties<span style="letter-spacing:0.05pt;"> </span>may infringe<span style="letter-spacing:0.05pt;"> </span>our patents<span style="letter-spacing:0.05pt;"> </span>or misappropriate<span style="letter-spacing:0.15pt;"> </span>or otherwise<span style="letter-spacing:0.05pt;"> </span>violate<span style="letter-spacing:0.05pt;"> </span>our intellectual<span style="letter-spacing:0.15pt;"> </span>property rights.<span style="letter-spacing:0.05pt;"> </span>In the future,<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>may initiate<span style="letter-spacing:0.1pt;"> </span>legal<span style="letter-spacing:0.05pt;"> </span>proceedings<span style="letter-spacing:0.05pt;"> </span>to enforce<span style="letter-spacing:0.05pt;"> </span>or defend our intellectual<span style="letter-spacing:0.15pt;"> </span>property<span style="letter-spacing:0.05pt;"> </span>rights,<span style="letter-spacing:0.05pt;"> </span>to protect<span style="letter-spacing:0.05pt;"> </span>our trade<span style="letter-spacing:0.05pt;"> </span>secrets<span style="letter-spacing:0.05pt;"> </span>or to determine<span style="letter-spacing:0.1pt;"> </span>the validity<span style="letter-spacing:0.05pt;"> </span>or scope of intellectual<span style="letter-spacing:0.15pt;"> </span>property<span style="letter-spacing:0.05pt;"> </span>rights<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>own<span style="letter-spacing:-0.05pt;"> </span>or control. Also, third<span style="letter-spacing:0.05pt;"> </span>parties<span style="letter-spacing:0.05pt;"> </span>may initiate<span style="letter-spacing:0.1pt;"> </span>legal<span style="letter-spacing:0.05pt;"> </span>proceedings<span style="letter-spacing:0.05pt;"> </span>against<span style="letter-spacing:0.05pt;"> </span>us to challenge<span style="letter-spacing:0.05pt;"> </span>the validity<span style="letter-spacing:0.05pt;"> </span>or scope of intellectual property<span style="letter-spacing:0.05pt;"> </span>rights<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>own,<span style="letter-spacing:-0.05pt;"> </span>control<span style="letter-spacing:0.05pt;"> </span>or to which we<span style="letter-spacing:-0.05pt;"> </span>have rights.<span style="letter-spacing:0.05pt;"> </span>An<span style="letter-spacing:-0.05pt;"> </span>adverse<span style="letter-spacing:0.05pt;"> </span>result<span style="letter-spacing:0.05pt;"> </span>in any litigation<span style="letter-spacing:0.1pt;"> </span>proceeding<span style="letter-spacing:0.05pt;"> </span>could put one or more<span style="letter-spacing:0.05pt;"> </span>of our patents<span style="letter-spacing:0.05pt;"> </span>at risk<span style="letter-spacing:0.05pt;"> </span>of being invalidated,<span style="letter-spacing:0.1pt;"> </span>narrowed, held unenforceable<span style="letter-spacing:0.1pt;"> </span>or interpreted<span style="letter-spacing:0.1pt;"> </span>in such a manner<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>would not preclude<span style="letter-spacing:0.05pt;"> </span>third<span style="letter-spacing:0.05pt;"> </span>parties<span style="letter-spacing:0.05pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>entering<span style="letter-spacing:0.05pt;"> </span>the market<span style="letter-spacing:0.05pt;"> </span>with competing<span style="letter-spacing:0.05pt;"> </span>products.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Third-party</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">pre-issuance</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">submission</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of prior</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">art</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to the USPTO,</span><span style="letter-spacing:-0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or opposition,</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">derivation,</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">revocation, reexamination,</span><span style="letter-spacing:0.1pt;"> </span><span style="font-style:italic;">inter</span><span style="font-style:italic;letter-spacing:0.05pt;"> </span><span style="font-style:italic;">partes</span><span style="font-style:italic;letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">review or interference</span><span style="letter-spacing:0.15pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">proceedings,</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or other</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">pre-issuance</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or post-grant</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">proceedings</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or other</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">patent</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">office</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">proceedings</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or litigation</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in the United States</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or other</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">jurisdictions</span><span style="letter-spacing:0.15pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">provoked by third</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">parties</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or brought by us, may be necessary</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to determine</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the inventorship,</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">priority,</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">patentability</span><span style="letter-spacing:0.15pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or validity</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of inventions with respect</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to our patents</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or patent</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">applications.</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">An</span><span style="letter-spacing:-0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">unfavorable</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">outcome</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">could leave</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our technology</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or product candidates</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">without patent</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">protection,</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">allow third</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">parties</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to commercialize</span><span style="letter-spacing:0.15pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our technology</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or product</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">candidates and compete</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">directly</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">with us, without payment</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to us, or could require</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">us to obtain</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">license</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">rights</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">from</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the prevailing</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">party</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in order</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to be able to manufacture</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or commercialize</span><span style="letter-spacing:0.15pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our product</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">candidates</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">without infringing third-party</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">patent</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">rights.</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our business</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">could be harmed</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">if the prevailing</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">party</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in such a case does not offer</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">us a license</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">on commercially</span><span style="letter-spacing:0.15pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">reasonable</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">terms,</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or at all.</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Even if we</span><span style="letter-spacing:-0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">obtain</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a license,</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">it may be non-exclusive,</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">thereby giving our competitors</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">access</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to the same</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">technologies</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">licensed</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to us. In addition,</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">if the breadth</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or strength</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of protection</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">provided</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">by our patents</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and patent</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">applications</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">is threatened,</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">it could dissuade</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">companies</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">from collaborating</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">with us to license,</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">develop or commercialize</span><span style="letter-spacing:0.15pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">current</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or future</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">product</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">candidates.</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Even if we successfully</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">defend such litigation</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or proceeding,</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we</span><span style="letter-spacing:-0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">may incur</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">substantial</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">costs</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and our defense</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">may distract our management</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and other</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">employees.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furthermore,<span style="letter-spacing:0.1pt;"> </span>because<span style="letter-spacing:0.05pt;"> </span>of the substantial<span style="letter-spacing:0.1pt;"> </span>amount<span style="letter-spacing:0.05pt;"> </span>of discovery<span style="letter-spacing:0.05pt;"> </span>required<span style="letter-spacing:0.05pt;"> </span>in connection<span style="letter-spacing:0.05pt;"> </span>with intellectual property<span style="letter-spacing:0.05pt;"> </span>litigation,<span style="letter-spacing:0.1pt;"> </span>there<span style="letter-spacing:0.05pt;"> </span>is a risk<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>some of our confidential<span style="letter-spacing:0.1pt;"> </span>information<span style="letter-spacing:0.1pt;"> </span>could be compromised<span style="letter-spacing:0.1pt;"> </span>by disclosure during this<span style="letter-spacing:0.05pt;"> </span>type of litigation.<span style="letter-spacing:0.1pt;"> </span>In addition,<span style="letter-spacing:0.05pt;"> </span>many foreign<span style="letter-spacing:0.05pt;"> </span>jurisdictions<span style="letter-spacing:0.15pt;"> </span>have rules<span style="letter-spacing:0.05pt;"> </span>of discovery<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>are different than those in the United States<span style="letter-spacing:0.05pt;"> </span>and that<span style="letter-spacing:0.05pt;"> </span>may make defending<span style="letter-spacing:0.05pt;"> </span>or enforcing<span style="letter-spacing:0.05pt;"> </span>our patents<span style="letter-spacing:0.05pt;"> </span>extremely<span style="letter-spacing:0.1pt;"> </span>difficult.<span style="letter-spacing:0.1pt;"> </span>There could also be public<span style="letter-spacing:0.05pt;"> </span>announcements<span style="letter-spacing:0.05pt;"> </span>of the results<span style="letter-spacing:0.05pt;"> </span>of hearings,<span style="letter-spacing:0.05pt;"> </span>motions<span style="letter-spacing:0.05pt;"> </span>or other<span style="letter-spacing:0.05pt;"> </span>interim<span style="letter-spacing:0.1pt;"> </span>proceedings<span style="letter-spacing:0.05pt;"> </span>or developments.<span style="letter-spacing:0.1pt;"> </span>If securities<span style="letter-spacing:0.1pt;"> </span>analysts<span style="letter-spacing:0.05pt;"> </span>or investors<span style="letter-spacing:0.05pt;"> </span>perceive<span style="letter-spacing:0.05pt;"> </span>these<span style="letter-spacing:0.05pt;"> </span>results<span style="letter-spacing:0.05pt;"> </span>to be negative,<span style="letter-spacing:0.05pt;"> </span>it could have a material adverse<span style="letter-spacing:0.05pt;"> </span>effect<span style="letter-spacing:0.05pt;"> </span>on the price<span style="letter-spacing:0.05pt;"> </span>of shares<span style="letter-spacing:0.05pt;"> </span>of our common<span style="letter-spacing:0.05pt;"> </span>stock.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Third parties<span style="letter-spacing:0.05pt;"> </span>may initiate<span style="letter-spacing:0.1pt;"> </span>legal<span style="letter-spacing:0.05pt;"> </span>proceedings<span style="letter-spacing:0.05pt;"> </span>against us alleging<span style="letter-spacing:0.05pt;"> </span>that we<span style="letter-spacing:-0.05pt;"> </span>infringe<span style="letter-spacing:0.05pt;"> </span>their<span style="letter-spacing:0.05pt;"> </span>intellectual<span style="letter-spacing:0.1pt;"> </span>property rights<span style="letter-spacing:0.05pt;"> </span>or we<span style="letter-spacing:-0.05pt;"> </span>may initiate<span style="letter-spacing:0.1pt;"> </span>legal<span style="letter-spacing:0.05pt;"> </span>proceedings<span style="letter-spacing:0.05pt;"> </span>against third parties<span style="letter-spacing:0.05pt;"> </span>to challenge<span style="letter-spacing:0.05pt;"> </span>the validity<span style="letter-spacing:0.1pt;"> </span>or scope of intellectual<span style="letter-spacing:0.1pt;"> </span>property<span style="letter-spacing:0.05pt;"> </span>rights<span style="letter-spacing:0.05pt;"> </span>controlled<span style="letter-spacing:0.05pt;"> </span>by third parties.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Third parties<span style="letter-spacing:0.05pt;"> </span>may initiate<span style="letter-spacing:0.1pt;"> </span>legal<span style="letter-spacing:0.05pt;"> </span>proceedings<span style="letter-spacing:0.05pt;"> </span>against<span style="letter-spacing:0.05pt;"> </span>us alleging<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>infringe<span style="letter-spacing:0.05pt;"> </span>their intellectual<span style="letter-spacing:0.15pt;"> </span>property<span style="letter-spacing:0.05pt;"> </span>rights<span style="letter-spacing:0.05pt;"> </span>or we<span style="letter-spacing:-0.05pt;"> </span>may initiate<span style="letter-spacing:0.1pt;"> </span>legal<span style="letter-spacing:0.05pt;"> </span>proceedings<span style="letter-spacing:0.05pt;"> </span>against<span style="letter-spacing:0.05pt;"> </span>third<span style="letter-spacing:0.05pt;"> </span>parties<span style="letter-spacing:0.05pt;"> </span>to challenge<span style="letter-spacing:0.05pt;"> </span>the validity<span style="letter-spacing:0.05pt;"> </span>or scope of intellectual<span style="letter-spacing:0.15pt;"> </span>property<span style="letter-spacing:0.05pt;"> </span>rights<span style="letter-spacing:0.05pt;"> </span>controlled<span style="letter-spacing:0.1pt;"> </span>by third<span style="letter-spacing:0.05pt;"> </span>parties,<span style="letter-spacing:0.05pt;"> </span>including<span style="letter-spacing:0.05pt;"> </span>in oppositions,<span style="letter-spacing:0.05pt;"> </span>interferences, revocations,<span style="letter-spacing:0.1pt;"> </span>reexaminations,<span style="letter-spacing:0.1pt;"> </span><span style="font-style:italic;">inter</span><span style="font-style:italic;letter-spacing:0.05pt;"> </span><span style="font-style:italic;">partes</span><span style="font-style:italic;letter-spacing:0.05pt;"> </span>review or derivation<span style="letter-spacing:0.1pt;"> </span>proceedings<span style="letter-spacing:0.05pt;"> </span>before<span style="letter-spacing:0.05pt;"> </span>the USPTO<span style="letter-spacing:-0.1pt;"> </span>or its<span style="letter-spacing:0.05pt;"> </span>counterparts in other<span style="letter-spacing:0.05pt;"> </span>jurisdictions.<span style="letter-spacing:0.15pt;"> </span>These proceedings<span style="letter-spacing:0.05pt;"> </span>can be expensive<span style="letter-spacing:0.05pt;"> </span>and time-consuming<span style="letter-spacing:0.15pt;"> </span>and many of our adversaries<span style="letter-spacing:0.1pt;"> </span>in these<span style="letter-spacing:0.05pt;"> </span>proceedings<span style="letter-spacing:0.05pt;"> </span>may have the ability<span style="letter-spacing:0.05pt;"> </span>to dedicate<span style="letter-spacing:0.05pt;"> </span>substantially<span style="letter-spacing:0.1pt;"> </span>greater<span style="letter-spacing:0.05pt;"> </span>resources<span style="letter-spacing:0.05pt;"> </span>to prosecuting<span style="letter-spacing:0.05pt;"> </span>these<span style="letter-spacing:0.05pt;"> </span>legal actions<span style="letter-spacing:0.05pt;"> </span>than we<span style="letter-spacing:-0.05pt;"> </span>can. We could be found liable<span style="letter-spacing:0.05pt;"> </span>for monetary<span style="letter-spacing:0.05pt;"> </span>damages,<span style="letter-spacing:0.05pt;"> </span>including<span style="letter-spacing:0.05pt;"> </span>treble<span style="letter-spacing:0.05pt;"> </span>damages<span style="letter-spacing:0.05pt;"> </span>and attorneys&#8217;<span style="letter-spacing:0.1pt;"> </span>fees,<span style="letter-spacing:0.05pt;"> </span>if we<span style="letter-spacing:-0.05pt;"> </span>are found to have willfully<span style="letter-spacing:0.1pt;"> </span>infringed<span style="letter-spacing:0.05pt;"> </span>a patent<span style="letter-spacing:0.05pt;"> </span>of a third<span style="letter-spacing:0.05pt;"> </span>party.<span style="letter-spacing:0.05pt;"> </span>A<span style="letter-spacing:-0.05pt;"> </span>finding<span style="letter-spacing:0.05pt;"> </span>of infringement<span style="letter-spacing:0.1pt;"> </span>could prevent<span style="letter-spacing:0.05pt;"> </span>us from commercializing<span style="letter-spacing:0.15pt;"> </span>our pegozafermin or any future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>or force<span style="letter-spacing:0.05pt;"> </span>us to cease<span style="letter-spacing:0.05pt;"> </span>some of our business operations,<span style="letter-spacing:0.05pt;"> </span>which could materially<span style="letter-spacing:0.15pt;"> </span>harm<span style="letter-spacing:0.05pt;"> </span>our business.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Although we<span style="letter-spacing:-0.05pt;"> </span>have reviewed<span style="letter-spacing:0.05pt;"> </span>certain<span style="letter-spacing:0.05pt;"> </span>third-party<span style="letter-spacing:0.1pt;"> </span>patents<span style="letter-spacing:0.05pt;"> </span>and patent<span style="letter-spacing:0.05pt;"> </span>filings<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>believe<span style="letter-spacing:0.05pt;"> </span>may be relevant<span style="letter-spacing:0.05pt;"> </span>to our therapeutic<span style="letter-spacing:0.1pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>or products,<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>have not conducted<span style="letter-spacing:0.05pt;"> </span>a freedom-to-operate<span style="letter-spacing:0.2pt;"> </span>search<span style="letter-spacing:0.05pt;"> </span>or analysis for any of our therapeutic<span style="letter-spacing:0.1pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>or products,<span style="letter-spacing:0.05pt;"> </span>and we<span style="letter-spacing:-0.05pt;"> </span>may not be aware of patents<span style="letter-spacing:0.05pt;"> </span>or pending or future<span style="letter-spacing:0.05pt;"> </span>patent applications<span style="letter-spacing:0.1pt;"> </span>that,<span style="letter-spacing:0.05pt;"> </span>if issued,<span style="letter-spacing:0.05pt;"> </span>would block us from<span style="letter-spacing:0.05pt;"> </span>commercializing<span style="letter-spacing:0.15pt;"> </span>our product<span style="letter-spacing:0.1pt;"> </span>candidates.<span style="letter-spacing:0.05pt;"> </span>Thus, we<span style="letter-spacing:-0.05pt;"> </span>cannot guarantee<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>our product candidates,<span style="letter-spacing:0.05pt;"> </span>or our commercialization<span style="letter-spacing:0.2pt;"> </span>thereof,<span style="letter-spacing:0.05pt;"> </span>do not and will not infringe<span style="letter-spacing:0.05pt;"> </span>any third<span style="letter-spacing:0.05pt;"> </span>party&#8217;s<span style="letter-spacing:0.05pt;"> </span>intellectual<span style="letter-spacing:0.15pt;"> </span>property.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Risks Related to Ownership of Our Common Stock</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">The<span style="letter-spacing:-0.05pt;"> </span>price<span style="letter-spacing:0.05pt;"> </span>of our common stock may be volatile,<span style="letter-spacing:0.1pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>you may lose all or part of your investment.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The market<span style="letter-spacing:0.05pt;"> </span>price<span style="letter-spacing:0.05pt;"> </span>of our common<span style="letter-spacing:0.05pt;"> </span>stock could fluctuate<span style="letter-spacing:0.1pt;"> </span>significantly,<span style="letter-spacing:0.15pt;"> </span>and you may not be able to resell your shares<span style="letter-spacing:0.05pt;"> </span>at or above the price you paid for your shares.<span style="letter-spacing:0.05pt;"> </span>Those fluctuations<span style="letter-spacing:0.1pt;"> </span>could be based on various<span style="letter-spacing:0.05pt;"> </span>factors<span style="letter-spacing:0.05pt;"> </span>in addition<span style="letter-spacing:0.05pt;"> </span>to those otherwise<span style="letter-spacing:0.05pt;"> </span>described<span style="letter-spacing:0.05pt;"> </span>in this<span style="letter-spacing:0.05pt;"> </span>prospectus,<span style="letter-spacing:0.05pt;"> </span>including<span style="letter-spacing:0.05pt;"> </span>those described<span style="letter-spacing:0.05pt;"> </span>in these<span style="letter-spacing:0.05pt;"> </span>&#8220;Risk Factors.&#8221;<span style="letter-spacing:0.05pt;"> </span>Any<span style="letter-spacing:-0.05pt;"> </span>of these factors<span style="letter-spacing:0.05pt;"> </span>may result<span style="letter-spacing:0.05pt;"> </span>in large<span style="letter-spacing:0.05pt;"> </span>and sudden changes in the volume<span style="letter-spacing:0.05pt;"> </span>and trading<span style="letter-spacing:0.05pt;"> </span>price<span style="letter-spacing:0.05pt;"> </span>of our common<span style="letter-spacing:0.05pt;"> </span>stock. In the past, following<span style="letter-spacing:0.05pt;"> </span>periods<span style="letter-spacing:0.05pt;"> </span>of volatility<span style="letter-spacing:0.1pt;"> </span>in the market<span style="letter-spacing:0.05pt;"> </span>price<span style="letter-spacing:0.05pt;"> </span>of a company&#8217;s<span style="letter-spacing:0.05pt;"> </span>securities,<span style="letter-spacing:0.1pt;"> </span>stockholders<span style="letter-spacing:0.1pt;"> </span>have often<span style="letter-spacing:0.05pt;"> </span>instituted securities<span style="letter-spacing:0.1pt;"> </span>class<span style="letter-spacing:0.05pt;"> </span>action<span style="letter-spacing:0.05pt;"> </span>litigation<span style="letter-spacing:0.1pt;"> </span>against<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>company.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Sales of our common stock, or the perception that such sales may occur, could depress the price of our common stock. </span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales of a substantial number of shares of our common stock in the public market, or the perception that such sales may occur, could depress the market price of our common stock. Certain holders of shares of our common stock have rights, subject to certain conditions, to require us to file registration statements covering their shares or to include their shares in registration statements that we may file for ourselves or other stockholders. In addition, we have filed a registration statement registering under the Securities Act the shares of our common stock reserved for issuance under our 2019 Equity Incentive Plan, including shares issuable upon exercise of outstanding options. These shares can be freely sold in the public market upon issuance, subject to volume limitations applicable to affiliates. Further, as opportunities present themselves, we may enter into financing or similar arrangements in the future, including the issuance of debt or equity securities. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Raising additional<span style="letter-spacing:0.05pt;"> </span>capital<span style="letter-spacing:0.05pt;"> </span>may cause dilution<span style="letter-spacing:0.05pt;"> </span>to existing stockholders,<span style="letter-spacing:0.05pt;"> </span>restrict<span style="letter-spacing:0.1pt;"> </span>our operations<span style="letter-spacing:0.05pt;"> </span>or require<span style="letter-spacing:0.05pt;"> </span>us to relinquish<span style="letter-spacing:0.05pt;"> </span>rights<span style="letter-spacing:0.05pt;"> </span>to our technologies.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Existing stockholders<span style="letter-spacing:0.05pt;"> </span>could suffer<span style="letter-spacing:0.05pt;"> </span>dilution<span style="letter-spacing:0.05pt;"> </span>or be negatively<span style="letter-spacing:0.05pt;"> </span>affected<span style="letter-spacing:0.1pt;"> </span>by fixed payment<span style="letter-spacing:0.05pt;"> </span>obligations<span style="letter-spacing:0.1pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>may incur<span style="letter-spacing:0.05pt;"> </span>if we<span style="letter-spacing:-0.05pt;"> </span>raise<span style="letter-spacing:0.05pt;"> </span>additional<span style="letter-spacing:0.1pt;"> </span>funds through the issuance<span style="letter-spacing:0.05pt;"> </span>of additional<span style="letter-spacing:0.1pt;"> </span>equity securities, including under the ATM Facility,<span style="letter-spacing:0.1pt;"> </span>or debt or pursuant to the 2021 Loan Agreement. Furthermore,<span style="letter-spacing:1.05pt;"> </span>these<span style="letter-spacing:0.05pt;"> </span>securities<span style="letter-spacing:0.1pt;"> </span>may have rights<span style="letter-spacing:0.05pt;"> </span>senior<span style="letter-spacing:0.05pt;"> </span>to those of our common<span style="letter-spacing:0.05pt;"> </span>stock and could contain<span style="letter-spacing:0.05pt;"> </span>covenants<span style="letter-spacing:0.05pt;"> </span>or protective rights<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>would restrict<span style="letter-spacing:0.1pt;"> </span>our operations<span style="letter-spacing:0.05pt;"> </span>and potentially<span style="letter-spacing:0.1pt;"> </span>impair<span style="letter-spacing:0.05pt;"> </span>our competitiveness,<span style="letter-spacing:0.15pt;"> </span>such as limitations<span style="letter-spacing:0.15pt;"> </span>on our ability<span style="letter-spacing:0.05pt;"> </span>to incur<span style="letter-spacing:0.05pt;"> </span>additional<span style="letter-spacing:0.1pt;"> </span>debt, limitations<span style="letter-spacing:0.15pt;"> </span>on our ability<span style="letter-spacing:0.05pt;"> </span>to acquire,<span style="letter-spacing:0.05pt;"> </span>sell<span style="letter-spacing:0.05pt;"> </span>or license<span style="letter-spacing:0.05pt;"> </span>intellectual<span style="letter-spacing:0.15pt;"> </span>property<span style="letter-spacing:0.05pt;"> </span>rights<span style="letter-spacing:0.05pt;"> </span>and other<span style="letter-spacing:0.05pt;"> </span>operating<span style="letter-spacing:0.05pt;"> </span>restrictions<span style="letter-spacing:0.15pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>could adversely<span style="letter-spacing:0.05pt;"> </span>impact<span style="letter-spacing:0.05pt;"> </span>our ability<span style="letter-spacing:0.05pt;"> </span>to conduct our business.<span style="letter-spacing:0.05pt;"> </span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">General Risk Factors</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our<span style="letter-spacing:-0.05pt;"> </span>directors,<span style="letter-spacing:0.05pt;"> </span>executive<span style="letter-spacing:0.05pt;"> </span>officers<span style="letter-spacing:0.1pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>current holders of 5% or more of our capital<span style="letter-spacing:0.05pt;"> </span>stock have substantial<span style="letter-spacing:0.05pt;"> </span>control<span style="letter-spacing:0.05pt;"> </span>over our company,<span style="letter-spacing:0.05pt;"> </span>which<span style="letter-spacing:-0.05pt;"> </span>could limit<span style="letter-spacing:0.1pt;"> </span>your ability<span style="letter-spacing:0.05pt;"> </span>to influence<span style="letter-spacing:0.05pt;"> </span>the outcome<span style="letter-spacing:0.05pt;"> </span>of matters<span style="letter-spacing:0.05pt;"> </span>subject<span style="letter-spacing:0.05pt;"> </span>to stockholder<span style="letter-spacing:0.05pt;"> </span>approval, including a change of control.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;letter-spacing:0.05pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, our executive officers, directors and other holders of 5% or more of our common stock beneficially owned a majority of our outstanding common stock. As<span style="letter-spacing:-0.05pt;"> </span>a result, our executive officers,<span style="letter-spacing:0.1pt;"> </span>directors<span style="letter-spacing:0.1pt;"> </span>and other holders of 5% or more of our common stock, if they act, will be able to influence or control matters<span style="letter-spacing:0.1pt;"> </span>requiring approval by our stockholders,<span style="letter-spacing:0.1pt;"> </span>including the election of directors<span style="letter-spacing:0.1pt;"> </span>and the approval of mergers, acquisitions<span style="letter-spacing:0.1pt;"> </span>or other extraordinary<span style="letter-spacing:0.1pt;"> </span>transactions.<span style="letter-spacing:0.1pt;"> </span>In addition, our current directors,<span style="letter-spacing:0.1pt;"> </span>executive officers<span style="letter-spacing:0.1pt;"> </span>and other holders of 5% or more of our common stock, acting together, would have the ability to control the management<span style="letter-spacing:0.1pt;"> </span>and affairs<span style="letter-spacing:0.1pt;"> </span>of our company. They may also have interests<span style="letter-spacing:0.1pt;"> </span>that differ from yours and may vote in a way<span style="letter-spacing:-0.05pt;"> </span>with which you disagree and that may be adverse to your interests.<span style="letter-spacing:0.1pt;"> </span>This concentration<span style="letter-spacing:0.1pt;"> </span>of ownership may have the effect of delaying, preventing or deterring<span style="letter-spacing:0.1pt;"> </span>a change of control of our company, could deprive our stockholders<span style="letter-spacing:0.1pt;"> </span>of an opportunity to receive a premium for their shares of our common stock as part of a sale of our company.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We previously identified<span style="letter-spacing:0.1pt;"> </span>material<span style="letter-spacing:0.1pt;"> </span>weaknesses in our internal<span style="letter-spacing:0.05pt;"> </span>control<span style="letter-spacing:0.05pt;"> </span>over financial<span style="letter-spacing:0.05pt;"> </span>reporting, which have been remediated. If we identify additional material weaknesses in the future or otherwise fail to maintain<span style="letter-spacing:0.05pt;"> </span>an<span style="letter-spacing:-0.05pt;"> </span>effective<span style="letter-spacing:0.1pt;"> </span>system<span style="letter-spacing:0.05pt;"> </span>of internal<span style="letter-spacing:0.05pt;"> </span>controls, we<span style="letter-spacing:-0.05pt;"> </span>may not be <span style="letter-spacing:-0.1pt;">able</span> to produce timely and accurate financial<span style="letter-spacing:0.05pt;"> </span>statements, and we or our independent registered public accounting firm may conclude that our internal control over financial reporting is not effective,<span style="letter-spacing:0.05pt;"> </span>which<span style="letter-spacing:-0.05pt;"> </span>could adversely<span style="letter-spacing:0.05pt;"> </span>affect<span style="letter-spacing:0.05pt;"> our </span>investors&#8217;<span style="letter-spacing:0.05pt;"> </span>confidence and our stock price.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As an emerging growth company under the JOBS Act, our management is required to report upon the effectiveness of our internal control over financial reporting under Section<span style="letter-spacing:0.05pt;"> </span>404 of the Sarbanes-Oxley<span style="letter-spacing:0.05pt;"> </span>Act. Our independent registered public accounting firm is not required to formally attest to the effectiveness of our internal control over financial reporting until the date we are no longer an emerging growth company and reach accelerated filer status. Any failure<span style="letter-spacing:0.1pt;"> </span>to implement<span style="letter-spacing:0.1pt;"> </span>required<span style="letter-spacing:0.05pt;"> </span>new<span style="letter-spacing:-0.05pt;"> </span>or improved<span style="letter-spacing:0.05pt;"> </span>controls,<span style="letter-spacing:0.05pt;"> </span>or difficulties<span style="letter-spacing:0.15pt;"> </span>encountered<span style="letter-spacing:0.05pt;"> </span>in their<span style="letter-spacing:0.05pt;"> </span>implementation, could cause us to fail<span style="letter-spacing:0.05pt;"> </span>to meet<span style="letter-spacing:0.05pt;"> </span>our reporting<span style="letter-spacing:0.05pt;"> </span>obligations.<span style="letter-spacing:0.1pt;"> </span>In addition,<span style="letter-spacing:0.05pt;"> </span>any testing<span style="letter-spacing:0.05pt;"> </span>by us conducted<span style="letter-spacing:0.05pt;"> </span>in connection with Section<span style="letter-spacing:0.05pt;"> </span>404, or any subsequent<span style="letter-spacing:0.05pt;"> </span>testing<span style="letter-spacing:0.05pt;"> </span>by our independent<span style="letter-spacing:0.05pt;"> </span>registered<span style="letter-spacing:0.1pt;"> </span>public<span style="letter-spacing:0.05pt;"> </span>accounting<span style="letter-spacing:0.05pt;"> </span>firm,<span style="letter-spacing:0.05pt;"> </span>may reveal<span style="letter-spacing:0.05pt;"> </span>deficiencies<span style="letter-spacing:0.1pt;"> </span>in our internal<span style="letter-spacing:0.1pt;"> </span>controls<span style="letter-spacing:0.05pt;"> </span>over financial<span style="letter-spacing:0.1pt;"> </span>reporting<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>are deemed<span style="letter-spacing:0.05pt;"> </span>to be material<span style="letter-spacing:0.1pt;"> </span>weaknesses<span style="letter-spacing:0.05pt;"> </span>or that<span style="letter-spacing:0.05pt;"> </span>may require prospective<span style="letter-spacing:0.1pt;"> </span>or retroactive<span style="letter-spacing:0.1pt;"> </span>changes to our consolidated<span style="letter-spacing:0.1pt;"> </span>financial<span style="letter-spacing:0.1pt;"> </span>statements<span style="letter-spacing:0.1pt;"> </span>or identify<span style="letter-spacing:0.05pt;"> </span>other<span style="letter-spacing:0.05pt;"> </span>areas<span style="letter-spacing:0.05pt;"> </span>for further attention<span style="letter-spacing:0.1pt;"> </span>or improvement.<span style="letter-spacing:0.1pt;"> As previously disclosed, </span>in connection<span style="letter-spacing:0.05pt;"> </span>with our financial<span style="letter-spacing:0.1pt;"> </span>statement<span style="letter-spacing:0.1pt;"> </span>close<span style="letter-spacing:0.05pt;"> </span>process<span style="letter-spacing:0.05pt;"> </span></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for 2018, we</span><span style="letter-spacing:-0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">identified</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">material</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">weaknesses in the design and operating</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">effectiveness</span><span style="letter-spacing:0.15pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of our internal</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">control</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">over financial</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">rep</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">orting</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> While w</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">e</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> have </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">remediated such material weaknesses, w</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">e</span><span style="letter-spacing:-0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">cannot assure</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">you that we have identified</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">all</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">material</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">weaknesses</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or that</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">there</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">will not be additional</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">material</span><span style="letter-spacing:0.1pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">weaknesses</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or deficiencies that</span><span style="letter-spacing:0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we</span><span style="letter-spacing:-0.05pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">will identify</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in the future</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our amended and restated certificate of incorporation, amended and restated bylaws and Delaware law could prevent a third party from acquiring us (even if an acquisition would benefit our stockholders), may limit the ability of our stockholders to replace our management and limit the price that investors might be willing to pay for shares of our common stock.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our amended and restated certificate of incorporation<span style="letter-spacing:0.1pt;"> </span>and our amended and restated bylaws could have the effect<span style="letter-spacing:0.05pt;"> </span>of making<span style="letter-spacing:0.05pt;"> </span>it more<span style="letter-spacing:0.05pt;"> </span>difficult<span style="letter-spacing:0.1pt;"> </span>for a third<span style="letter-spacing:0.05pt;"> </span>party<span style="letter-spacing:0.05pt;"> </span>to acquire,<span style="letter-spacing:0.05pt;"> </span>or of discouraging<span style="letter-spacing:0.05pt;"> </span>a third<span style="letter-spacing:0.05pt;"> </span>party<span style="letter-spacing:0.05pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>attempting<span style="letter-spacing:0.1pt;"> </span>to acquire,<span style="letter-spacing:0.05pt;"> </span>control<span style="letter-spacing:0.05pt;"> </span>of us. These provisions<span style="letter-spacing:0.05pt;"> </span>could delay or prevent<span style="letter-spacing:0.05pt;"> </span>a change in control<span style="letter-spacing:0.05pt;"> </span>of the company and could limit<span style="letter-spacing:0.1pt;"> </span>the price<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>investors might<span style="letter-spacing:0.05pt;"> </span>be willing<span style="letter-spacing:0.05pt;"> </span>to pay in the future<span style="letter-spacing:0.05pt;"> </span>for shares<span style="letter-spacing:0.05pt;"> </span>of our common<span style="letter-spacing:0.05pt;"> </span>stock. In addition, as<span style="letter-spacing:-0.05pt;"> </span>a Delaware corporation,<span style="letter-spacing:0.1pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>are subject<span style="letter-spacing:0.05pt;"> </span>to the anti-takeover<span style="letter-spacing:0.1pt;"> </span>provisions<span style="letter-spacing:0.05pt;"> </span>of Section<span style="letter-spacing:0.05pt;"> </span>203 of the Delaware General<span style="letter-spacing:0.05pt;"> </span>Corporation<span style="letter-spacing:0.05pt;"> </span>Law,<span style="letter-spacing:-0.05pt;"> </span>which prohibits<span style="letter-spacing:0.05pt;"> </span>a Delaware corporation<span style="letter-spacing:0.1pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>engaging in a business combination<span style="letter-spacing:0.1pt;"> </span>specified<span style="letter-spacing:0.1pt;"> </span>in the statute<span style="letter-spacing:0.05pt;"> </span>with an interested<span style="letter-spacing:0.1pt;"> </span>stockholder<span style="letter-spacing:0.05pt;"> </span>(as defined<span style="letter-spacing:0.05pt;"> </span>in the statute)<span style="letter-spacing:0.1pt;"> </span>for a period<span style="letter-spacing:0.05pt;"> </span>of three years<span style="letter-spacing:0.05pt;"> </span>after<span style="letter-spacing:0.05pt;"> </span>the date of the transaction<span style="letter-spacing:0.1pt;"> </span>in which the person first<span style="letter-spacing:0.05pt;"> </span>becomes<span style="letter-spacing:0.05pt;"> </span>an interested<span style="letter-spacing:0.1pt;"> </span>stockholder,<span style="letter-spacing:0.05pt;"> </span>unless<span style="letter-spacing:0.05pt;"> </span>the business<span style="letter-spacing:0.05pt;"> </span>combination<span style="letter-spacing:0.1pt;"> </span>is approved in advance by a majority<span style="letter-spacing:0.1pt;"> </span>of the independent<span style="letter-spacing:0.05pt;"> </span>directors<span style="letter-spacing:0.1pt;"> </span>or by the holders<span style="letter-spacing:0.05pt;"> </span>of at least<span style="letter-spacing:0.05pt;"> </span>two-thirds<span style="letter-spacing:0.05pt;"> </span>of the outstanding<span style="letter-spacing:0.05pt;"> </span>disinterested<span style="letter-spacing:0.15pt;"> </span>shares.<span style="letter-spacing:0.05pt;"> </span>The application<span style="letter-spacing:0.1pt;"> </span>of Section<span style="letter-spacing:0.05pt;"> </span>203 of the Delaware General Corporation<span style="letter-spacing:0.05pt;"> </span>Law<span style="letter-spacing:-0.05pt;"> </span>could also have the effect<span style="letter-spacing:0.05pt;"> </span>of delaying<span style="letter-spacing:0.05pt;"> </span>or preventing<span style="letter-spacing:0.05pt;"> </span>a change of control<span style="letter-spacing:0.05pt;"> </span>of us.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our<span style="letter-spacing:-0.05pt;"> </span>amended and restated certificate of incorporation provides<span style="letter-spacing:0.05pt;"> </span>that the Court of Chancery of the State of Delaware and<span style="letter-spacing:-0.05pt;"> </span>the federal<span style="letter-spacing:0.05pt;"> </span>district<span style="letter-spacing:0.1pt;"> </span>courts of the United States<span style="letter-spacing:0.05pt;"> </span>will be the exclusive<span style="letter-spacing:0.05pt;"> </span>forum for substantially<span style="letter-spacing:0.1pt;"> </span>all disputes<span style="letter-spacing:0.05pt;"> </span>between us and<span style="letter-spacing:-0.05pt;"> </span>our stockholders,<span style="letter-spacing:0.05pt;"> </span>which<span style="letter-spacing:-0.05pt;"> </span>could limit<span style="letter-spacing:0.1pt;"> </span>our stockholders&#8217;<span style="letter-spacing:0.1pt;"> </span>ability<span style="letter-spacing:0.05pt;"> </span>to obtain a favorable<span style="letter-spacing:0.05pt;"> </span>judicial<span style="letter-spacing:0.05pt;"> </span>forum for disputes<span style="letter-spacing:0.05pt;"> </span>with us or our directors,<span style="letter-spacing:0.05pt;"> </span>officers<span style="letter-spacing:0.1pt;"> </span>or employees.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our amended and restated certificate of incorporation<span style="letter-spacing:0.1pt;"> </span>provides<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>the Court of Chancery of the State<span style="letter-spacing:0.05pt;"> </span>of Delaware is the exclusive<span style="letter-spacing:0.05pt;"> </span>forum<span style="letter-spacing:0.05pt;"> </span>for certain actions<span style="letter-spacing:0.05pt;"> </span>or proceedings<span style="letter-spacing:0.05pt;"> </span>under Delaware statutory<span style="letter-spacing:0.1pt;"> </span>or common<span style="letter-spacing:0.05pt;"> </span>law.<span style="letter-spacing:0.05pt;"> </span>Our amended and restated certificate of incorporation<span style="letter-spacing:0.1pt;"> </span>provides further<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>the federal<span style="letter-spacing:0.05pt;"> </span>district<span style="letter-spacing:0.1pt;"> </span>courts<span style="letter-spacing:0.05pt;"> </span>of the United States<span style="letter-spacing:0.05pt;"> </span>will be the exclusive<span style="letter-spacing:0.05pt;"> </span>forum<span style="letter-spacing:0.05pt;"> </span>for resolving<span style="letter-spacing:0.05pt;"> </span>any complaint<span style="letter-spacing:0.1pt;"> </span>asserting<span style="letter-spacing:0.1pt;"> </span>a cause of action<span style="letter-spacing:0.05pt;"> </span>arising<span style="letter-spacing:0.05pt;"> </span>under the Securities<span style="letter-spacing:0.1pt;"> </span>Act.<span style="letter-spacing:0.05pt;"> </span>These choice<span style="letter-spacing:0.05pt;"> </span>of forum<span style="letter-spacing:0.05pt;"> </span>provisions<span style="letter-spacing:0.05pt;"> </span>may limit<span style="letter-spacing:0.1pt;"> </span>a stockholder&#8217;s ability<span style="letter-spacing:0.05pt;"> </span>to bring a claim<span style="letter-spacing:0.05pt;"> </span>in a judicial<span style="letter-spacing:0.1pt;"> </span>forum<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>it finds<span style="letter-spacing:0.05pt;"> </span>favorable<span style="letter-spacing:0.05pt;"> </span>for disputes<span style="letter-spacing:0.05pt;"> </span>with us or our directors,<span style="letter-spacing:0.1pt;"> </span>officers<span style="letter-spacing:0.1pt;"> </span>or other<span style="letter-spacing:0.05pt;"> </span>employees.<span style="letter-spacing:0.05pt;"> </span>If a court<span style="letter-spacing:0.05pt;"> </span>were to find the choice<span style="letter-spacing:0.05pt;"> </span>of forum<span style="letter-spacing:0.05pt;"> </span>provision<span style="letter-spacing:0.05pt;"> </span>contained<span style="letter-spacing:0.05pt;"> </span>in our amended and restated certificate of incorporation<span style="letter-spacing:0.1pt;"> </span>to be inapplicable<span style="letter-spacing:0.1pt;"> </span>or unenforceable,<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>may incur<span style="letter-spacing:0.05pt;"> </span>additional<span style="letter-spacing:0.1pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>associated<span style="letter-spacing:0.1pt;"> </span>with resolving<span style="letter-spacing:0.05pt;"> </span>such action<span style="letter-spacing:0.05pt;"> </span>in other<span style="letter-spacing:0.05pt;"> </span>jurisdictions.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_1B_UNRESOLVED_STAFF_COMMENTS">Item 1B. Unresolved Staff Comments. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">None.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_2_PROPERTIES">Item 2. Properties. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We lease<span style="letter-spacing:0.05pt;"> </span>office<span style="letter-spacing:0.05pt;"> </span>space, which consists<span style="letter-spacing:0.05pt;"> </span>of approximately<span style="letter-spacing:0.1pt;"> </span>1,600 square<span style="letter-spacing:0.05pt;"> </span>feet<span style="letter-spacing:0.05pt;"> </span>located<span style="letter-spacing:0.05pt;"> </span>at 6 Hamada Street, Herzliya,<span style="letter-spacing:0.05pt;"> </span>4673340, Israel.<span style="letter-spacing:0.05pt;"> </span>This lease<span style="letter-spacing:0.05pt;"> </span>expires<span style="letter-spacing:0.05pt;"> </span>on April 30, 2022. We also lease<span style="letter-spacing:0.05pt;"> </span>office<span style="letter-spacing:0.05pt;"> </span>space at 142 Sansome<span style="letter-spacing:0.05pt;"> </span>Street,<span style="letter-spacing:0.05pt;"> </span>San Francisco,<span style="letter-spacing:0.05pt;"> </span>California<span style="letter-spacing:0.1pt;"> </span>94104, which consists of approximately 3,600 square feet.<span style="letter-spacing:0.05pt;"> </span>This lease<span style="letter-spacing:0.05pt;"> </span>expires<span style="letter-spacing:0.05pt;"> </span>on January 14, 2023. We believe<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>our current<span style="letter-spacing:0.05pt;"> </span>spaces are adequate<span style="letter-spacing:0.05pt;"> </span>for our needs. We also believe<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>will be able to obtain<span style="letter-spacing:0.05pt;"> </span>additional<span style="letter-spacing:0.1pt;"> </span>space, as needed, on commercially<span style="letter-spacing:0.15pt;"> </span>reasonable<span style="letter-spacing:0.05pt;"> </span>terms<span style="color:#000000;">. </span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_3_LEGAL_PROCEEDINGS">Item 3. Legal Proceedings. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are currently not a party to any material legal proceedings. From time to time, we may become involved in legal proceedings arising in the ordinary course of our business. Regardless of outcome, litigation can have an adverse impact on us due to defense and settlement costs, diversion of management resources, negative publicity, reputational harm and other factors, and there can be no assurances that favorable outcomes will be obtained.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_4_MINE_SAFETY_DISCLOSURES">Item 4. Mine Safety Disclosures.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not applicable.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="PART_II">PART II</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_5_MARKET_FOR_REGISTRANTS_COMMON_EQU">Item 5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Market Information</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our common stock is traded on The Nasdaq Global Market under the symbol &#8220;ETNB.&#8221; </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of March 1, 2022, there were approximately 7 stockholders of record of our common stock.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Dividend Policy</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have never declared or paid cash dividends on our capital stock and have no present intention to pay cash dividends on our common stock for the foreseeable future. Any determination to pay dividends to holders of our common stock will be at the discretion of our board of directors and will depend on many factors, including our financial condition, results of operations, liquidity, earnings, projected capital and other cash requirements, legal requirements, restrictions in the agreements governing any indebtedness we may enter into, business prospects and other factors that our board of directors deems relevant.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_6_RESERVED">Item 6. [Reserved]. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_7_MANAGEMENTS_DISCUSSION_ANALYSIS_F">Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">You<span style="letter-spacing:-0.05pt;"> </span>should read the following<span style="letter-spacing:0.05pt;"> </span>discussion<span style="letter-spacing:0.05pt;"> </span>and analysis<span style="letter-spacing:0.05pt;"> </span>of our financial<span style="letter-spacing:0.05pt;"> </span>condition<span style="letter-spacing:0.05pt;"> </span>and results<span style="letter-spacing:0.05pt;"> </span>of operations<span style="letter-spacing:0.05pt;"> </span>together<span style="letter-spacing:0.05pt;"> </span>with our consolidated<span style="letter-spacing:0.05pt;"> </span>financial<span style="letter-spacing:0.05pt;"> </span>statements<span style="letter-spacing:0.05pt;"> </span>and related<span style="letter-spacing:0.05pt;"> </span>notes and other financial<span style="letter-spacing:0.05pt;"> </span>information included<span style="letter-spacing:0.05pt;"> </span>elsewhere<span style="letter-spacing:0.05pt;"> </span>in this<span style="letter-spacing:0.05pt;"> Annual Report on Form 10-K. </span><span style="Background-color:#FFFFFF;color:#000000;">Some of the information contained in this discussion and analysis includes forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those described in or implied by these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those identified below and those discussed in the section titled &#8220;Risk Factors&#8221; included elsewhere in this </span><span style="letter-spacing:0.05pt;">Annual Report on Form 10-K</span><span style="Background-color:#FFFFFF;color:#000000;">.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;color:#auto;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;">Overview</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Our lead product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (&#8220;FGF21&#8221;), is currently being developed for the treatment of nonalcoholic steatohepatitis (&#8220;NASH&#8221;) and for the treatment of severe hypertriglyceridemia (&#8220;SHTG&#8221;). NASH is a severe form of nonalcoholic fatty liver disease (&#8220;NAFLD&#8221;), characterized by inflammation and fibrosis in the liver that can progress to cirrhosis, liver failure, hepatocellular carcinoma (&#8220;HCC&#8221;) and death. There are currently no approved products for the treatment of NASH. In January 2022, we announced positive topline results from an expansion cohort (cohort 7) of the Phase 1b/2a trial of pegozafermin in NASH after announcing positive topline data from cohorts 1 through 6 in September 2020. We also initiated a Phase 2b trial (ENLIVEN) evaluating pegozafermin in fibrosis stage 2 or 3 NASH patients in June 2021. Patients will receive weekly doses or a every two-week dose of pegozafermin or placebo for 24 weeks followed by a blinded extension phase of an additional 24 weeks for a total treatment period of 48 weeks. <span style="color:#000000;">We are making good progress in ENLIVEN and expect to report t</span>opline data from this trial in the first half of 2023. <span style="color:#000000;">Based on learnings from our recent cohort, developments in the field, and feedback from our steering committee, we are working on steps to optimize the ENLIVEN trial.</span> In 2021, we completed a pharmacokinetic study of pegozafermin in NASH patients with compensated cirrhosis (fibrosis stage F4) demonstrating that pegozafermin 30 mg has similar single-dose pharmacokinetics and pharmacodynamics in F4 as it does in non-cirrhotic NASH. We are currently evaluating the potential opportunity for pegozafermin in these fibrosis stage F4 patients. SHTG is a condition identified by severely elevated levels of triglycerides (&#8805;500 mg/dL), which is associated with an increased risk of NASH, cardiovascular events and acute pancreatitis. We initiated our Phase 2 trial (ENTRIGUE) in SHTG patients in the third quarter of 2020 and expect to report topline data in the second quarter of 2022. We closed enrollment in this trial in February 2022 with 85 patients enrolled.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We commenced operations in 2018 and have devoted substantially all of our resources to raising capital, acquiring our initial product candidate, identifying and developing pegozafermin, licensing certain related technology, conducting research and development activities (including preclinical studies and clinical trials) and providing general and administrative support for these operations.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As<span style="letter-spacing:-0.05pt;"> </span>of December 31, 2021, our cash and cash equivalents and short-term available-for-sale securities<span style="letter-spacing:0.1pt;"> </span>totaled<span style="letter-spacing:0.05pt;"> </span>$150.7 million.<span style="letter-spacing:0.1pt;"> </span>Based on our current<span style="letter-spacing:0.05pt;"> </span>operating<span style="letter-spacing:0.05pt;"> </span>plan, we<span style="letter-spacing:-0.05pt;"> </span>believe<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>our cash and cash equivalents and short-term available-for-sale securities together with the proceeds available under our term loan facility will be sufficient<span style="letter-spacing:0.1pt;"> </span>to meet<span style="letter-spacing:0.05pt;"> </span>our anticipated cash requirements<span style="letter-spacing:0.1pt;"> for a period of at least one year from the date this Annual Report on Form 10-K is filed with the Securities and Exchange Commission (&#8220;SEC&#8221;).</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have incurred<span style="letter-spacing:0.05pt;"> </span>net losses<span style="letter-spacing:0.05pt;"> </span>since<span style="letter-spacing:0.05pt;"> </span>our inception.<span style="letter-spacing:0.05pt;"> </span>Our net losses for the years ended December 31, 2021 and 2020 were $90.1 million and $49.5 million, respectively. As<span style="letter-spacing:-0.05pt;"> </span>of December 31, 2021, we<span style="letter-spacing:-0.05pt;"> </span>had an accumulated<span style="letter-spacing:0.1pt;"> </span>deficit<span style="letter-spacing:0.1pt;"> </span>of<span style="color:#000000;"> </span>$213.2 million.<span style="letter-spacing:0.1pt;"> </span>We expect<span style="letter-spacing:0.05pt;"> </span>to continue<span style="letter-spacing:0.05pt;"> </span>to incur<span style="letter-spacing:0.05pt;"> </span>significant<span style="letter-spacing:0.1pt;"> </span>expenses<span style="letter-spacing:0.05pt;"> </span>and increasing<span style="letter-spacing:0.1pt;"> </span>operating<span style="letter-spacing:0.05pt;"> </span>losses<span style="letter-spacing:0.05pt;"> </span>as we<span style="letter-spacing:-0.05pt;"> </span>advance pegozafermin and any future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidates<span style="letter-spacing:0.05pt;"> </span>through clinical<span style="letter-spacing:0.1pt;"> </span>trials,<span style="letter-spacing:0.1pt;"> </span>seek regulatory<span style="letter-spacing:0.1pt;"> </span>approval<span style="letter-spacing:0.05pt;"> </span>for pegozafermin and any future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidates,<span style="letter-spacing:0.05pt;"> </span>expand our clinical,<span style="letter-spacing:0.1pt;"> </span>regulatory,<span style="letter-spacing:0.1pt;"> </span>quality,<span style="letter-spacing:0.05pt;"> </span>manufacturing<span style="letter-spacing:0.1pt;"> </span>and commercialization capabilities,<span style="letter-spacing:0.15pt;"> </span>protect<span style="letter-spacing:0.05pt;"> </span>our intellectual<span style="letter-spacing:0.15pt;"> </span>property,<span style="letter-spacing:0.05pt;"> </span>prepare<span style="letter-spacing:0.05pt;"> </span>for and, if approved, proceed<span style="letter-spacing:0.05pt;"> </span>to commercialization<span style="letter-spacing:0.2pt;"> </span>of pegozafermin and any future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidates,<span style="letter-spacing:0.05pt;"> </span>expand our general<span style="letter-spacing:0.05pt;"> </span>and administrative<span style="letter-spacing:0.15pt;"> </span>support<span style="letter-spacing:0.05pt;"> </span>functions, including<span style="letter-spacing:0.05pt;"> </span>hiring<span style="letter-spacing:0.05pt;"> </span>additional<span style="letter-spacing:0.1pt;"> </span>personnel,<span style="letter-spacing:0.05pt;"> </span>and incur<span style="letter-spacing:0.05pt;"> </span>additional<span style="letter-spacing:0.1pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>associated<span style="letter-spacing:0.1pt;"> </span>with operating<span style="letter-spacing:0.05pt;"> </span>as a public<span style="letter-spacing:0.05pt;"> </span>company. Our net losses<span style="letter-spacing:0.05pt;"> </span>may fluctuate<span style="letter-spacing:0.1pt;"> </span>significantly<span style="letter-spacing:0.15pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>quarter-to-quarter<span style="letter-spacing:0.2pt;"> </span>and year-to-year,<span style="letter-spacing:0.1pt;"> </span>depending on the timing<span style="letter-spacing:0.05pt;"> </span>of our clinical<span style="letter-spacing:0.1pt;"> </span>trials<span style="letter-spacing:0.1pt;"> </span>and our expenditures<span style="letter-spacing:0.1pt;"> </span>on other<span style="letter-spacing:0.05pt;"> </span>research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>activities.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Impact of COVID-19 Pandemic</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The ongoing COVID-19 pandemic has disrupted and may continue to disrupt our business and delay our development timeline. The extent to which the COVID-19 pandemic may impact our future operating results and financial condition is uncertain. We initiated our Phase 2 trial (ENTRIGUE) in SHTG patients in the third quarter of 2020 and our Phase 2b trial in NASH patients in the middle of the 2021. The COVID-19 pandemic has impacted execution and enrollment of our trials. We do not yet know the full extent of potential delays that may affect our clinical trials, which could prevent or delay us from obtaining approval for pegozafermin. Given the surges in cases of COVID-19 experienced previously and uncertainty regarding other variants, we cannot predict how our ongoing trials may be impacted. For more information regarding risks related to the ongoing COVID-19 pandemic, please see the risk factor entitled &#8220;The ongoing COVID-19 pandemic has resulted and may in the future result in significant disruptions to our clinical trials or other business operations, which could have a material adverse effect on our business,&#8221; in Part I. Item 1A of this Annual Report on Form 10-K. To the extent the ongoing COVID-19 pandemic adversely affects our business and financial results, it may also have the effect of heightening many of the other risks set forth under &#8220;Risk Factors&#8221; in this Annual Report on Form 10-K.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;color:#auto;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;">Components of Results of Operations</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Research and<span style="letter-spacing:-0.05pt;"> </span>Development Expenses</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.05pt;"> </span>consist<span style="letter-spacing:0.05pt;"> </span>primarily<span style="letter-spacing:0.1pt;"> </span>of costs<span style="letter-spacing:0.05pt;"> </span>incurred<span style="letter-spacing:0.05pt;"> </span>for the development<span style="letter-spacing:0.05pt;"> </span>of our lead product<span style="letter-spacing:0.05pt;"> </span>candidate,<span style="letter-spacing:0.05pt;"> </span>pegozafermin. Our research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.05pt;"> </span>consist<span style="letter-spacing:0.05pt;"> </span>primarily<span style="letter-spacing:0.1pt;"> </span>of external<span style="letter-spacing:0.05pt;"> </span>costs related<span style="letter-spacing:0.05pt;"> </span>to preclinical<span style="letter-spacing:0.1pt;"> </span>and clinical<span style="letter-spacing:0.1pt;"> </span>development,<span style="letter-spacing:0.05pt;"> </span>including<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>related<span style="letter-spacing:0.05pt;"> </span>to acquiring<span style="letter-spacing:0.05pt;"> </span>patents<span style="letter-spacing:0.05pt;"> </span>and intellectual property,<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.05pt;"> </span>incurred<span style="letter-spacing:0.05pt;"> </span>under license<span style="letter-spacing:0.05pt;"> </span>agreements<span style="letter-spacing:0.1pt;"> </span>and agreements<span style="letter-spacing:0.1pt;"> </span>with contract<span style="letter-spacing:0.05pt;"> </span>research<span style="letter-spacing:0.05pt;"> </span>organizations<span style="letter-spacing:0.1pt;"> </span>and consultants,<span style="letter-spacing:0.1pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>related<span style="letter-spacing:0.05pt;"> </span>to acquiring<span style="letter-spacing:0.05pt;"> </span>and manufacturing<span style="letter-spacing:0.1pt;"> </span>clinical<span style="letter-spacing:0.1pt;"> </span>trial<span style="letter-spacing:0.05pt;"> </span>materials,<span style="letter-spacing:0.1pt;"> </span>including<span style="letter-spacing:0.05pt;"> </span>under agreements<span style="letter-spacing:0.1pt;"> </span>with contract<span style="letter-spacing:0.05pt;"> </span>manufacturing<span style="letter-spacing:0.1pt;"> </span>organizations<span style="letter-spacing:0.1pt;"> </span>and other<span style="letter-spacing:0.05pt;"> </span>vendors, costs<span style="letter-spacing:0.05pt;"> </span>related<span style="letter-spacing:0.05pt;"> </span>to the preparation<span style="letter-spacing:0.1pt;"> </span>of regulatory submissions<span style="letter-spacing:0.1pt;"> </span>and expenses<span style="letter-spacing:0.05pt;"> </span>related<span style="letter-spacing:0.05pt;"> </span>to laboratory<span style="letter-spacing:0.1pt;"> </span>supplies<span style="letter-spacing:0.05pt;"> </span>and services,<span style="letter-spacing:0.05pt;"> </span>as well as personnel<span style="letter-spacing:0.05pt;"> </span>costs.<span style="letter-spacing:0.05pt;"> </span>Personnel<span style="letter-spacing:0.05pt;"> </span>costs consist<span style="letter-spacing:0.05pt;"> </span>of salaries,<span style="letter-spacing:0.1pt;"> </span>employee<span style="letter-spacing:0.05pt;"> </span>benefits<span style="letter-spacing:0.05pt;"> </span>and stock-based<span style="letter-spacing:0.1pt;"> </span>compensation<span style="letter-spacing:0.1pt;"> </span>for individuals<span style="letter-spacing:0.1pt;"> </span>involved<span style="letter-spacing:0.05pt;"> </span>in research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>efforts.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expense all<span style="letter-spacing:0.05pt;"> </span>research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.05pt;"> </span>in the periods<span style="letter-spacing:0.05pt;"> </span>in which they are incurred.<span style="letter-spacing:0.05pt;"> </span>We accrue for costs<span style="letter-spacing:0.05pt;"> </span>incurred<span style="letter-spacing:0.05pt;"> </span>as the services<span style="letter-spacing:0.05pt;"> </span>are being provided<span style="letter-spacing:0.05pt;"> </span>by monitoring<span style="letter-spacing:0.1pt;"> </span>the status<span style="letter-spacing:0.05pt;"> </span>of specific<span style="letter-spacing:0.1pt;"> </span>activities<span style="letter-spacing:0.1pt;"> </span>and the invoices<span style="letter-spacing:0.05pt;"> </span>received<span style="letter-spacing:0.05pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>our external<span style="letter-spacing:0.05pt;"> </span>service<span style="letter-spacing:0.05pt;"> </span>providers.<span style="letter-spacing:0.05pt;"> </span>We adjust<span style="letter-spacing:0.05pt;"> </span>our accrued expenses<span style="letter-spacing:0.05pt;"> </span>as actual<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>become<span style="letter-spacing:0.05pt;"> </span>known.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payments<span style="letter-spacing:0.05pt;"> </span>associated<span style="letter-spacing:0.1pt;"> </span>with licensing<span style="letter-spacing:0.05pt;"> </span>agreements<span style="letter-spacing:0.1pt;"> </span>to acquire<span style="letter-spacing:0.05pt;"> </span>licenses<span style="letter-spacing:0.05pt;"> </span>to develop, use, manufacture<span style="letter-spacing:0.1pt;"> </span>and commercialize<span style="letter-spacing:0.15pt;"> </span>products<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>have not reached<span style="letter-spacing:0.05pt;"> </span>technological<span style="letter-spacing:0.1pt;"> </span>feasibility<span style="letter-spacing:0.15pt;"> </span>and do not have alternate<span style="letter-spacing:0.1pt;"> </span>commercial<span style="letter-spacing:0.1pt;"> </span>use are expensed as incurred.<span style="letter-spacing:0.05pt;"> </span>Where<span style="letter-spacing:0.05pt;"> </span>contingent<span style="letter-spacing:0.05pt;"> </span>milestone<span style="letter-spacing:0.1pt;"> </span>payments<span style="letter-spacing:0.05pt;"> </span>are due to third<span style="letter-spacing:0.05pt;"> </span>parties<span style="letter-spacing:0.05pt;"> </span>under research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>arrangements<span style="letter-spacing:0.1pt;"> </span>or license<span style="letter-spacing:0.05pt;"> </span>agreements,<span style="letter-spacing:0.1pt;"> </span>the milestone<span style="letter-spacing:0.1pt;"> </span>payment<span style="letter-spacing:0.05pt;"> </span>obligations<span style="letter-spacing:0.1pt;"> </span>are expensed when<span style="letter-spacing:-0.05pt;"> </span>the milestone<span style="letter-spacing:0.1pt;"> </span>results<span style="letter-spacing:0.05pt;"> </span>are probable<span style="letter-spacing:0.05pt;"> </span>and estimable,<span style="letter-spacing:0.1pt;"> </span>which is generally<span style="letter-spacing:0.05pt;"> </span>upon achievement<span style="letter-spacing:0.1pt;"> </span>of milestones.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect our research and development expenses to increase for the foreseeable future as we continue the development of pegozafermin and continue to invest in research and development activities. The process of conducting the necessary clinical research to obtain regulatory approval is costly and time consuming, and the successful development of pegozafermin and any future product candidates is highly uncertain. To the extent that pegozafermin continues to advance into larger and later stage clinical trials, our expenses will increase substantially and may become more variable. The actual probability of success for pegozafermin or any future product candidate may be affected by a variety of factors, including the safety and efficacy of our product candidates, investment in our clinical programs, manufacturing capability and competition with other products. As a result, we are unable to determine the timing of initiation, duration and completion costs of our research and development efforts or when and to what extent we will generate revenue from the commercialization and sale of pegozafermin or any future product candidate.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">General and<span style="letter-spacing:-0.05pt;"> </span>Administrative Expenses </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General<span style="letter-spacing:0.05pt;"> </span>and administrative<span style="letter-spacing:0.15pt;"> </span>expenses<span style="letter-spacing:0.05pt;"> </span>consist<span style="letter-spacing:0.05pt;"> </span>primarily<span style="letter-spacing:0.1pt;"> </span>of personnel<span style="letter-spacing:0.05pt;"> </span>costs,<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.05pt;"> </span>for outside professional<span style="letter-spacing:0.1pt;"> </span>services,<span style="letter-spacing:0.05pt;"> </span>including<span style="letter-spacing:0.05pt;"> </span>legal,<span style="letter-spacing:0.05pt;"> </span>human resource,<span style="letter-spacing:0.05pt;"> </span>audit<span style="letter-spacing:0.05pt;"> </span>and accounting<span style="letter-spacing:0.05pt;"> </span>services,<span style="letter-spacing:0.05pt;"> </span>consulting<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>and allocated<span style="letter-spacing:0.1pt;"> </span>facilities<span style="letter-spacing:0.15pt;"> </span>costs.<span style="letter-spacing:0.05pt;"> </span>Personnel<span style="letter-spacing:0.05pt;"> </span>and related<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>consist<span style="letter-spacing:0.05pt;"> </span>of salaries,<span style="letter-spacing:0.1pt;"> </span>benefits<span style="letter-spacing:0.05pt;"> </span>and stock-based<span style="letter-spacing:0.1pt;"> </span>compensation for personnel<span style="letter-spacing:0.05pt;"> </span>in executive,<span style="letter-spacing:0.05pt;"> </span>finance<span style="letter-spacing:0.05pt;"> </span>and other<span style="letter-spacing:0.05pt;"> </span>administrative<span style="letter-spacing:0.15pt;"> </span>functions.<span style="letter-spacing:0.05pt;"> </span>Facilities<span style="letter-spacing:0.1pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>consist<span style="letter-spacing:0.05pt;"> </span>of rent<span style="letter-spacing:0.05pt;"> </span>and maintenance<span style="letter-spacing:0.1pt;"> </span>of facilities.<span style="letter-spacing:0.15pt;"> </span></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our general</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and administrative</span><span style="letter-spacing:0.15pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">expenses</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to increase</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for the foreseeable future</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">as we</span><span style="letter-spacing:-0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">increase</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the size</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of our administrative</span><span style="letter-spacing:0.15pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">function</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to support</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the growth of our business</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and support our continued</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">research</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and development</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">activities.</span><span style="letter-spacing:0.1pt;"> </span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Other Expenses, Net</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other expenses<span style="letter-spacing:-0.2pt;">,</span><span style="letter-spacing:-0.4pt;"> </span><span style="letter-spacing:-0.15pt;">net</span><span style="letter-spacing:-0.4pt;"> primarily </span><span style="letter-spacing:-0.2pt;">consists</span><span style="letter-spacing:-0.4pt;"> </span><span style="letter-spacing:-0.1pt;">of</span><span style="letter-spacing:-0.4pt;"> amortization of deferred debt issuance costs and amortization of premium on available-for-sale securities offset by </span><span style="letter-spacing:-0.2pt;">interest income on available-for-sale securities.</span><span style="letter-spacing:-0.4pt;"> </span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;">Results of Operations</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Years Ended<span style="letter-spacing:-0.05pt;"> </span>December 31, 2021<span style="font-weight:normal;color:#000000;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>2020</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following<span style="letter-spacing:0.05pt;"> </span>table<span style="letter-spacing:0.05pt;"> </span>summarizes<span style="letter-spacing:0.1pt;"> </span>our results<span style="letter-spacing:0.05pt;"> </span>of operations<span style="letter-spacing:0.05pt;"> </span>for the periods<span style="letter-spacing:0.05pt;"> </span>presented<span style="letter-spacing:0.05pt;"> </span>(in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.94%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Change</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70,330</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,199</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,131</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,413</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,156</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,257</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating expenses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89,743</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49,355</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,388</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss from operations</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(89,743</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(49,355</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(40,388</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other expenses, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(526</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(203</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(323</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax benefit</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(90,122</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(49,499</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(40,623</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Research and<span style="letter-spacing:-0.05pt;"> </span>Development<span style="letter-spacing:0.05pt;"> </span>Expenses</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following<span style="letter-spacing:0.05pt;"> </span>table<span style="letter-spacing:0.05pt;"> </span>summarizes<span style="letter-spacing:0.1pt;"> </span>the period-over-period<span style="letter-spacing:0.15pt;"> </span>changes in research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>expenses for the periods<span style="letter-spacing:0.05pt;"> </span>presented (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.94%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Change</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clinical development</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,500</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,613</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,887</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contract manufacturing</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,584</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,995</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,589</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Personnel-related expenses</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,725</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,841</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,884</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preclinical costs</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,684</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,618</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other expenses</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,455</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,066</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">389</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total research and development expenses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70,330</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,199</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,131</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.05pt;"> </span>increased<span style="letter-spacing:0.05pt;"> </span>by $34.1 million,<span style="letter-spacing:0.1pt;"> </span>or 94%, to $70.3 million in 2021 compared to $36.2 million in 2020. The change<span style="letter-spacing:0.05pt;"> </span>was primarily<span style="letter-spacing:0.1pt;"> </span>due to an increase of $15.9 million in clinical development costs related to our ongoing clinical trials and an increase of $14.6 million in contract manufacturing costs, mainly as a result of the manufacture of supplies and the scaling up of manufacturing for our ongoing clinical trials. The increase of $4.9 million in personnel-related costs, including stock-based compensation, was due to higher headcount and the increase of $0.4 million in other expenses was primarily due to higher allocated facilities and overhead costs. The increases were partially offset by a decrease of $1.6 million in preclinical costs&#59; the timing of such costs is dependent upon the status and stage of our clinical trials.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">General<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>Administrative<span style="letter-spacing:0.1pt;"> </span>Expenses</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General<span style="letter-spacing:0.05pt;"> </span>and administrative<span style="letter-spacing:0.15pt;"> </span>expenses<span style="letter-spacing:0.05pt;"> </span>increased<span style="letter-spacing:0.05pt;"> </span>by $6.3 million,<span style="letter-spacing:0.1pt;"> </span>or 48%, to $19.4 million in 2021 compared to $13.2 million in 2020. The change<span style="letter-spacing:0.05pt;"> </span>was due to an increase of $4.1 million<span style="letter-spacing:0.1pt;"> </span>in personnel-related<span style="letter-spacing:0.15pt;"> </span>costs,<span style="letter-spacing:0.05pt;"> </span>including<span style="letter-spacing:0.05pt;"> </span>stock-based compensation,<span style="letter-spacing:0.1pt;"> </span>driven<span style="letter-spacing:0.05pt;"> </span>by higher headcount, an increase of $1.1 million in professional<span style="letter-spacing:0.1pt;"> </span>services primarily due </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">legal and consulting service</span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">an increase of $</span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.7</span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million in insurance related costs and </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">an </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">increase of $0.4 million</span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in other costs primarily </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">due to higher allocated facilities and overhead costs.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Other<span style="letter-spacing:0.05pt;"> </span>Expenses, Net</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other expenses,<span style="letter-spacing:0.05pt;"> </span>net increased<span style="letter-spacing:0.05pt;"> </span>by $0.3 million<span style="letter-spacing:0.1pt;"> to $0.5</span> million <span style="letter-spacing:0.1pt;">in</span> 2021<span style="letter-spacing:0.1pt;"> </span>compared to $0.2 million<span style="letter-spacing:0.1pt;"> in 2020, primarily due to higher amortization of debt issuance costs in 2021.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;">Liquidity and<span style="letter-spacing:-0.05pt;"> </span>Capital Resources</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To date, we have incurred significant net losses and negative cash flows from operations. <span style="color:#231F20;">As</span><span style="color:#231F20;letter-spacing:-0.05pt;"> </span><span style="color:#231F20;">of December 31, 2021, we</span><span style="color:#231F20;letter-spacing:-0.05pt;"> </span><span style="color:#231F20;">had available</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">cash and cash equivalents and short-term available-for-sale securities</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">of $150.7 million</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">and an accumulated</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">deficit</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">of $213.2 million. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;letter-spacing:0.1pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In July 2020, we completed an underwritten public offering of 3,047,040 shares of our common stock, at a public offering price of $27.50 per share. Upon completion of the offering, we received proceeds of $78.2 million, net of underwriting discounts and commissions and offering expenses.<span style="Background-color:#FFFFFF;color:#000000;"> In September 2020, we completed an underwritten public offering of 3,025,000 shares of our common stock, at a public offering price of $28.00 per share. Upon completion of the offering, we received proceeds of $79.5 million, net of underwriting discounts and commissions and offering expenses</span>.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;letter-spacing:0.1pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2021, we entered into a sales agreement (the &#8220;Sales Agreement&#8221;) with SVB Leerink LLC and Cantor Fitzgerald &#38; Co. (the &#8220;Sales Agents&#8221;) pursuant to which we may offer and sell up to $75.0 million of shares of our common stock, from time to time, in &#8220;at-the-market&#8221; offerings (the &#8220;ATM Facility&#8221;). The Sales Agents are entitled to compensation at a commission equal to 3.0% of the aggregate gross sales price per share sold under the Sales Agreement. During the fourth quarter of 2021, we received proceeds of $3.3 million, net of commissions and offering expenses from sales of 186,546 shares of our common stock at a weighted-average price of $17.97 per share pursuant to the ATM Facility.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;letter-spacing:0.1pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May 2021, we amended our secured term loan facility (&#8220;2021 Loan Agreement&#8221;) to increase the aggregate committed principal amount up to $25.0 million. As of December 31, 2021, we had drawn $20.0 million under our term loan facility and <span style="color:#000000;">$5.0 million remains available to be drawn on the achievement of certain milestones and is available to be drawn on or before September 30, 2022.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our primary<span style="letter-spacing:0.05pt;"> </span>use of cash is to fund operating<span style="letter-spacing:0.05pt;"> </span>expenses,<span style="letter-spacing:0.05pt;"> </span>which consist<span style="letter-spacing:0.05pt;"> </span>primarily<span style="letter-spacing:0.1pt;"> </span>of research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>expenditures<span style="letter-spacing:0.1pt;"> </span>related<span style="letter-spacing:0.05pt;"> </span>to our lead product<span style="letter-spacing:0.05pt;"> </span>candidate,<span style="letter-spacing:0.05pt;"> </span>pegozafermin. We plan to increase<span style="letter-spacing:0.05pt;"> </span>our research and development<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.1pt;"> </span>for the foreseeable<span style="letter-spacing:0.1pt;"> </span>future<span style="letter-spacing:0.05pt;"> </span>as we<span style="letter-spacing:-0.05pt;"> </span>continue<span style="letter-spacing:0.05pt;"> </span>the clinical<span style="letter-spacing:0.1pt;"> </span>development<span style="letter-spacing:0.05pt;"> </span>of our current<span style="letter-spacing:0.05pt;"> </span>and future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidates.<span style="letter-spacing:0.05pt;"> </span>At this<span style="letter-spacing:0.05pt;"> </span>time,<span style="letter-spacing:0.05pt;"> </span>due to the inherently<span style="letter-spacing:0.1pt;"> </span>unpredictable<span style="letter-spacing:0.1pt;"> </span>nature<span style="letter-spacing:0.05pt;"> </span>of clinical development,<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>cannot reasonably<span style="letter-spacing:0.05pt;"> </span>estimate<span style="letter-spacing:0.1pt;"> </span>the costs<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>will incur<span style="letter-spacing:0.05pt;"> </span>and the timelines<span style="letter-spacing:0.1pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>will be required<span style="letter-spacing:0.05pt;"> </span>to complete<span style="letter-spacing:0.05pt;"> </span>development,<span style="letter-spacing:0.05pt;"> </span>obtain<span style="letter-spacing:0.05pt;"> </span>marketing<span style="letter-spacing:0.1pt;"> </span>approval,<span style="letter-spacing:0.05pt;"> </span>and commercialize<span style="letter-spacing:0.15pt;"> </span>our current<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidate<span style="letter-spacing:0.05pt;"> </span>or any future<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>candidates.<span style="letter-spacing:0.05pt;"> </span>For the same<span style="letter-spacing:0.05pt;"> </span>reasons,<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>are also unable to predict<span style="letter-spacing:0.05pt;"> </span>when,<span style="letter-spacing:-0.05pt;"> </span>if ever, we<span style="letter-spacing:-0.05pt;"> </span>will generate revenue<span style="letter-spacing:0.05pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>product<span style="letter-spacing:0.05pt;"> </span>sales<span style="letter-spacing:0.05pt;"> </span>or our current<span style="letter-spacing:0.05pt;"> </span>or any future<span style="letter-spacing:0.05pt;"> </span>license<span style="letter-spacing:0.05pt;"> </span>agreements<span style="letter-spacing:0.1pt;"> </span>which we<span style="letter-spacing:-0.05pt;"> </span>may enter<span style="letter-spacing:0.05pt;"> </span>into or whether, or when,<span style="letter-spacing:-0.05pt;"> </span>if ever, we<span style="letter-spacing:-0.05pt;"> </span>may achieve<span style="letter-spacing:0.05pt;"> </span>profitability.<span style="letter-spacing:0.15pt;"> </span>Clinical<span style="letter-spacing:0.05pt;"> </span>and preclinical<span style="letter-spacing:0.1pt;"> </span>development<span style="letter-spacing:0.05pt;"> </span>timelines,<span style="letter-spacing:0.1pt;"> </span>the probability<span style="letter-spacing:0.1pt;"> </span>of success,<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>can differ<span style="letter-spacing:0.05pt;"> </span>materially<span style="letter-spacing:0.15pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>expectations.<span style="letter-spacing:0.1pt;"> </span>In addition,<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>cannot forecast<span style="letter-spacing:0.1pt;"> </span>the timing<span style="letter-spacing:0.05pt;"> </span>and amounts<span style="letter-spacing:0.05pt;"> </span>of milestone,<span style="letter-spacing:0.1pt;"> </span>royalty<span style="letter-spacing:0.05pt;"> </span>and other<span style="letter-spacing:0.05pt;"> </span>revenue<span style="letter-spacing:0.05pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>licensing<span style="letter-spacing:0.05pt;"> </span>activities,<span style="letter-spacing:0.1pt;"> </span>which future<span style="letter-spacing:0.05pt;"> </span>product candidates<span style="letter-spacing:0.05pt;"> </span>may be subject<span style="letter-spacing:0.05pt;"> </span>to future<span style="letter-spacing:0.05pt;"> </span>collaborations,<span style="letter-spacing:0.1pt;"> </span>when<span style="letter-spacing:-0.05pt;"> </span>such arrangements<span style="letter-spacing:0.1pt;"> </span>will be secured,<span style="letter-spacing:0.05pt;"> </span>if at all,<span style="letter-spacing:0.05pt;"> </span>and to what degree<span style="letter-spacing:0.05pt;"> </span>such arrangements<span style="letter-spacing:0.1pt;"> </span>would affect<span style="letter-spacing:0.05pt;"> </span>our development<span style="letter-spacing:0.05pt;"> </span>plans and capital<span style="letter-spacing:0.05pt;"> </span>requirements.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Based on our research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>plans, we<span style="letter-spacing:-0.05pt;"> </span>expect<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>our existing<span style="letter-spacing:0.05pt;"> </span>cash and cash equivalents and short-term <span style="letter-spacing:0.1pt;">available-for-sale securities as of December 31, 2021,</span> together with the proceeds available from our term loan facility and our ATM Facility,<span style="letter-spacing:0.1pt;"> </span>will be sufficient<span style="letter-spacing:0.1pt;"> </span>to fund our operations<span style="letter-spacing:0.05pt;"> for a period of at least one year from the date this Annual Report on Form 10-K is filed with the SEC</span>.<span style="letter-spacing:0.05pt;"> </span>However, our operating<span style="letter-spacing:0.05pt;"> </span>plans and other<span style="letter-spacing:0.05pt;"> </span>demands<span style="letter-spacing:0.05pt;"> </span>on our cash resources<span style="letter-spacing:0.05pt;"> </span>may change as a result<span style="letter-spacing:0.05pt;"> </span>of many factors,<span style="letter-spacing:0.05pt;"> </span>and we<span style="letter-spacing:-0.05pt;"> </span>may seek additional<span style="letter-spacing:0.1pt;"> </span>funds sooner than planned. There can be no assurance<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>will be successful<span style="letter-spacing:0.1pt;"> </span>in acquiring<span style="letter-spacing:0.05pt;"> </span>additional<span style="letter-spacing:0.1pt;"> </span>funding at levels<span style="letter-spacing:0.05pt;"> </span>sufficient<span style="letter-spacing:0.1pt;"> </span>to fund our operations<span style="letter-spacing:0.05pt;"> </span>or on terms<span style="letter-spacing:0.05pt;"> </span>favorable<span style="letter-spacing:0.05pt;"> </span>to us.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our future</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">funding requirements</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">will depend on many factors,</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">including</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the following:</span></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="color:#231F20;">the progress,</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">timing,</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">scope, results</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">and costs</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">of our clinical</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">trials</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">of pegozafermin and preclinical studies</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">or clinical</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">trials</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">of other</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">potential</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">product</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">candidates</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">we</span><span style="color:#231F20;letter-spacing:-0.05pt;"> </span><span style="color:#231F20;">may choose to pursue in the future, including</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">the ability</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">to enroll</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">patients</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">in a timely</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">manner</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">for our clinical</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">trials&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="color:#231F20;">the costs</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">and timing</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">of obtaining</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">clinical</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">and commercial</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">supplies</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">and validating</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">the commercial manufacturing</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">process</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">for pegozafermin and any other</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">product</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">candidates</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">we</span><span style="color:#231F20;letter-spacing:-0.05pt;"> </span><span style="color:#231F20;">may identify</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">and develop&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="color:#231F20;">the cost, timing</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">and outcomes</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">of regulatory</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">approvals&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="color:#231F20;">the timing</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">and amount</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">of any milestone,</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">royalty</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">or other</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">payments</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">we</span><span style="color:#231F20;letter-spacing:-0.05pt;"> </span><span style="color:#231F20;">are required</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">to make pursuant</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">to current</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">or any future</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">collaboration</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">or license</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">agreements&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="color:#231F20;">costs</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">of acquiring</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">or in-licensing</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">other</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">product</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">candidates</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">and technologies&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="color:#231F20;">the terms</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">and timing</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">of establishing</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">and maintaining</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">collaborations,</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">licenses</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">and other</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">similar arrangements&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="color:#231F20;">the costs</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">associated</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">with attracting,</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">hiring</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">and retaining</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">additional</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">qualified</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">personnel</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">as our business</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">grows&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="color:#231F20;">our efforts</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">to enhance operational</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">systems</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">and hire</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">additional</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">personnel</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">to satisfy</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">our obligations</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">as a public</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">company, including</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">enhanced internal</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">controls</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">over financial</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">reporting&#59;</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="color:#231F20;">the cost of preparing,</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">filing,</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">prosecuting,</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">defending</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">and enforcing</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">any patent</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">claims</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">and other intellectual</span><span style="color:#231F20;letter-spacing:0.15pt;"> </span><span style="color:#231F20;">property</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">rights.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect to continue to generate substantial operating losses for the foreseeable future as we expand our research and development activities. We will continue to fund our operations primarily through utilization of our current financial resources and through additional raises of capital to advance our current product candidate through clinical development, to develop, acquire or in-license other potential product candidates and to fund operations for the foreseeable future. However, there is no assurance that such funding will be available to us or that it will be obtained on terms favorable to us or will provide us with sufficient funds to meet our objectives. Any failure to raise capital as and when needed could have a negative impact on our financial condition and on our ability to pursue our business plans and strategies. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the extent that we raise additional capital through partnerships or licensing arrangements with third parties, we may have to relinquish valuable rights to our product candidates, future revenue streams or research programs or to grant licenses on terms that may not be favorable to us. If we raise additional capital through public or private equity offerings, the ownership interest of our then-existing stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect our stockholders&#8217; rights. If we raise additional capital through debt financing, we may be subject to covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we are unable to obtain adequate financing when needed, we may have to delay, reduce the scope of or suspend one or more of our clinical trials or preclinical studies, research and development programs or commercialization efforts or grant rights to develop and market our product candidates even if we would otherwise prefer to develop and market such product candidates ourselves.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Cash</span><span style="letter-spacing:-0.05pt;"> </span><span style="font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Flows</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following<span style="letter-spacing:0.05pt;"> </span>table<span style="letter-spacing:0.05pt;"> </span>summarizes<span style="letter-spacing:0.1pt;"> </span>our cash flows for the periods presented<span style="letter-spacing:0.05pt;"> </span>(in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.4%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Net cash used in (provided by)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating activities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(76,781</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(46,244</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investing activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,159</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(106,832</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing activities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,871</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">157,924</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net change in cash and cash equivalents, and</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; restricted cash</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(45,751</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,848</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Operating Activities</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2021, net cash used in operating<span style="letter-spacing:0.05pt;"> </span>activities<span style="letter-spacing:0.1pt;"> </span>was $76.8 million, which consisted<span style="letter-spacing:0.05pt;"> </span>of a net loss of $90.1 million, partially offset by non-cash charges of<span style="letter-spacing:0.1pt;"> $10.1 million </span>and a net change of $3.3 million<span style="letter-spacing:0.1pt;"> </span>in our net operating<span style="letter-spacing:0.05pt;"> </span>assets<span style="letter-spacing:0.05pt;"> </span>and liabilities.<span style="letter-spacing:0.1pt;"> </span>The non-cash<span style="letter-spacing:0.05pt;"> </span>charges<span style="letter-spacing:0.05pt;"> </span>were primarily<span style="letter-spacing:0.1pt;"> </span>comprised of $8.7 million<span style="letter-spacing:0.1pt;"> </span>in stock-based compensation, $0.9 million in amortization of premium on available-for-sale securities and $0.6 million in amortization of debt issuance costs.<span style="letter-spacing:0.1pt;"> </span>The change in our operating<span style="letter-spacing:0.05pt;"> </span>assets<span style="letter-spacing:0.05pt;"> </span>and liabilities<span style="letter-spacing:0.15pt;"> </span>was due to a $8.9 million<span style="letter-spacing:0.1pt;"> </span>increase<span style="letter-spacing:0.05pt;"> </span>in accounts payable and accrued<span style="letter-spacing:0.05pt;"> </span>expenses due to the timing of our accounts payable as well as continued expansion of our operations, offset in part by a $5.7 million increase in prepaid and other current assets due to timing of payments.<span style="letter-spacing:0.1pt;"> </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2020, net cash used in operating<span style="letter-spacing:0.05pt;"> </span>activities<span style="letter-spacing:0.1pt;"> </span>was $46.2 million, which consisted<span style="letter-spacing:0.05pt;"> </span>of a net loss of $49.5 million and a net change of $1.0 million in our net operating assets and liabilities,<span style="letter-spacing:0.1pt;"> </span>partially<span style="letter-spacing:0.1pt;"> </span>offset<span style="letter-spacing:0.05pt;"> </span>by non-cash<span style="letter-spacing:0.05pt;"> </span>charges<span style="letter-spacing:0.05pt;"> </span>of $4.3 million. The change in our operating<span style="letter-spacing:0.05pt;"> </span>assets<span style="letter-spacing:0.05pt;"> </span>and liabilities<span style="letter-spacing:0.15pt;"> </span>was primarily<span style="letter-spacing:0.1pt;"> </span>due to a $3.6 million<span style="letter-spacing:0.1pt;"> </span>increase<span style="letter-spacing:0.05pt;"> </span>in prepaid and other current assets<span style="letter-spacing:0.05pt;"> </span>due to the timing<span style="letter-spacing:0.05pt;"> </span>of payments as well as increased scale of operations and the initiation of clinical trials in the second half of 2020, offset in part by a $2.6 million increase in accounts payable and accrued expenses as we grew our operations.<span style="letter-spacing:0.15pt;"> </span>The non-cash<span style="letter-spacing:0.05pt;"> </span>charges<span style="letter-spacing:0.05pt;"> </span>were primarily<span style="letter-spacing:0.1pt;"> </span>comprised of $3.8 million<span style="letter-spacing:0.1pt;"> </span>in stock-based compensation, $0.3 million in amortization of premium on available-for-sale securities and $0.2 million in amortization of debt issuance costs.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Investing<span style="letter-spacing:0.05pt;"> </span>Activities</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2021, net cash provided by investing activities was $7.2 million, which consisted primarily of $148.4 million in proceeds from sales and maturities of available-for-sale securities, offset in part by $141.2 million in purchases of available-for-sale securities.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2020, net cash used in investing activities<span style="letter-spacing:0.1pt;"> was $106.8 million, which </span>consisted<span style="letter-spacing:0.05pt;"> </span>of $118.9 million in purchases<span style="letter-spacing:0.05pt;"> </span>of available-for-sale securities and $0.1 million in purchases of property and equipment, offset in part by $12.2 million in proceeds from maturities of available-for-sale securities.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Financing Activities</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2021, net cash provided by financing<span style="letter-spacing:0.05pt;"> </span>activities was $23.9 million, which consisted of $20.0 million in proceeds from our term loan facility, $3.3 million in net proceeds from the sale and issuance of common stock pursuant to our ATM Facility and $0.6 million in proceeds from the issuance of common stock upon exercise of stock options and employee stock purchase plan (&#8220;ESPP&#8221;) purchases.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2020, net cash provided by financing<span style="letter-spacing:0.05pt;"> </span>activities was $157.9 million, which<span style="letter-spacing:0.1pt;"> </span>consisted of $157.7 million in net proceeds from the sale and issuance of common stock from our public offerings and $0.4 million in proceeds from the issuance of common stock upon exercise of stock options and ESPP purchases, offset in part by a $0.2 million payment of debt issuance costs.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-weight:bold;font-style:italic;font-size:10pt;text-transform:none;font-variant: normal;">Debt Obligations</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our 2021 Loan Agreement provides for a total term loan facility of $25.0 million. As of December 31, 2021, we had drawn $20.0 million under the term loan facility and<span style="color:#231F20;letter-spacing:0.1pt;"> are required to make interest-only payments until October 1, 2022 followed by consecutive monthly payments of principal and interest starting on October 1, 2022 and continuing through September 1, 2024, the maturity date of the term loan</span>. The interest-only period may be extended to April 1, 2023, if on or before September 20, 2022, we receive net cash proceeds of at least $75.0 million from the sale of our equity securities. Our term loan bears interest at the greater of (i) 4.25% and (ii) the sum of (a) the Prime Rate as reported in The Wall Street Journal plus (b) 1.00% (or 4.25% initially and as of December 31, 2021). In addition, a final payment fee of 5% of the principal amount of the loan is due when the term loan becomes due or upon prepayment of the term loan. If we elect to prepay the loan, there is also a prepayment fee of between 1% and 3% of the principal amount of the term loan depending on the timing of prepayment. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;">Other Contractual Obligations<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:0.05pt;"> </span>Commitments</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our cash requirements greater than twelve months related to other contractual obligations and commitments include:</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2018, we entered into two agreements with Teva Pharmaceutical Industries Ltd (the &#8220;Teva Agreements&#8221;) under which we acquired certain patents and intellectual property relating to two programs. Pursuant to the Teva Agreements, we could be obligated to pay Teva up to $67.5 million under each program, for a total of $135.0 million, upon the achievement of certain clinical development and commercial milestones. In addition, we are obligated to pay Teva tiered royalties at percentages in the low-to-mid single-digits on worldwide net sales on all products containing the Teva compounds. As of December 31, 2021, the timing and likelihood of achieving the milestones and generating product sales are uncertain.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We lease office space for our corporate headquarters in San Francisco under a lease that expires in January 2023. We also lease office space in Israel under a lease that expires in April 2022. As of December 31, 2021, undiscounted future minimum lease payments of $0.2 million remain on both leases.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, we enter into agreements in the normal course of business with <span style="color:#231F20;">contract</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">research organizations,</span> <span style="color:#231F20;">contract</span><span style="color:#231F20;letter-spacing:0.05pt;"> </span><span style="color:#231F20;">manufacturing</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">organizations</span> and other vendors for research and development services. Such agreements generally provide for termination upon written notice but obligate us to reimburse vendors for any time or costs incurred through the date of termination.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;">Critical<span style="letter-spacing:0.05pt;"> </span>Accounting<span style="letter-spacing:-0.05pt;"> </span>Estimates</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our management&#8217;s<span style="letter-spacing:0.1pt;"> </span>discussion<span style="letter-spacing:0.05pt;"> </span>and analysis<span style="letter-spacing:0.05pt;"> </span>of our financial<span style="letter-spacing:0.1pt;"> </span>condition<span style="letter-spacing:0.05pt;"> </span>and results<span style="letter-spacing:0.05pt;"> </span>of operations<span style="letter-spacing:0.05pt;"> </span>is based on our consolidated<span style="letter-spacing:0.1pt;"> </span>financial<span style="letter-spacing:0.1pt;"> </span>statements,<span style="letter-spacing:0.1pt;"> </span>which have been prepared<span style="letter-spacing:0.05pt;"> </span>in accordance<span style="letter-spacing:0.05pt;"> </span>with United States<span style="letter-spacing:0.05pt;"> </span>generally accepted<span style="letter-spacing:0.05pt;"> </span>accounting<span style="letter-spacing:0.05pt;"> </span>principles (&#8220;U.S. GAAP&#8221;). The preparation<span style="letter-spacing:0.1pt;"> </span>of these<span style="letter-spacing:0.05pt;"> </span>consolidated<span style="letter-spacing:0.1pt;"> </span>financial<span style="letter-spacing:0.1pt;"> </span>statements<span style="letter-spacing:0.1pt;"> </span>requires<span style="letter-spacing:0.05pt;"> </span>us to make<span style="letter-spacing:1.1pt;"> </span>estimates<span style="letter-spacing:0.1pt;"> </span>and assumptions<span style="letter-spacing:0.1pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>affect<span style="letter-spacing:0.05pt;"> </span>the reported<span style="letter-spacing:0.05pt;"> </span>amounts<span style="letter-spacing:0.05pt;"> </span>of assets<span style="letter-spacing:0.05pt;"> </span>and liabilities<span style="letter-spacing:0.15pt;"> </span>and the disclosure<span style="letter-spacing:0.1pt;"> </span>of contingent<span style="letter-spacing:0.05pt;"> </span>assets<span style="letter-spacing:0.05pt;"> </span>and liabilities<span style="letter-spacing:0.15pt;"> </span>as of the date of the consolidated<span style="letter-spacing:0.1pt;"> </span>financial<span style="letter-spacing:0.1pt;"> </span>statements,<span style="letter-spacing:0.1pt;"> </span>as well as the reported expenses<span style="letter-spacing:0.05pt;"> </span>incurred<span style="letter-spacing:0.05pt;"> </span>during the reporting<span style="letter-spacing:0.05pt;"> </span>periods.<span style="letter-spacing:0.05pt;"> </span>Our estimates<span style="letter-spacing:0.1pt;"> </span>are based on our historical<span style="letter-spacing:0.1pt;"> </span>experience<span style="letter-spacing:0.05pt;"> </span>and on various<span style="letter-spacing:0.05pt;"> </span>other<span style="letter-spacing:0.05pt;"> </span>factors<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>believe<span style="letter-spacing:0.05pt;"> </span>are reasonable<span style="letter-spacing:0.05pt;"> </span>under the circumstances,<span style="letter-spacing:0.15pt;"> </span>the results<span style="letter-spacing:0.05pt;"> </span>of which form<span style="letter-spacing:0.05pt;"> </span>the basis for making<span style="letter-spacing:0.05pt;"> </span>judgments<span style="letter-spacing:0.05pt;"> </span>about the carrying<span style="letter-spacing:0.05pt;"> </span>value of assets<span style="letter-spacing:0.05pt;"> </span>and liabilities<span style="letter-spacing:0.15pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>are not readily<span style="letter-spacing:0.05pt;"> </span>apparent<span style="letter-spacing:0.05pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>other sources.<span style="letter-spacing:0.05pt;"> </span>Actual results<span style="letter-spacing:0.05pt;"> </span>may differ<span style="letter-spacing:0.05pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>these<span style="letter-spacing:0.05pt;"> </span>estimates<span style="letter-spacing:0.1pt;"> </span>under different<span style="letter-spacing:0.1pt;"> </span>assumptions<span style="letter-spacing:0.1pt;"> </span>or conditions.<span style="letter-spacing:0.05pt;"> </span>We believe that<span style="letter-spacing:0.05pt;"> </span>the accounting<span style="letter-spacing:0.05pt;"> </span>policies<span style="letter-spacing:0.05pt;"> </span>discussed<span style="letter-spacing:0.05pt;"> </span>below are critical<span style="letter-spacing:0.1pt;"> </span>to understanding<span style="letter-spacing:0.05pt;"> </span>our historical<span style="letter-spacing:0.1pt;"> </span>and future<span style="letter-spacing:0.05pt;"> </span>performance, as these<span style="letter-spacing:0.05pt;"> </span>policies<span style="letter-spacing:0.05pt;"> </span>relate<span style="letter-spacing:0.05pt;"> </span>to the more<span style="letter-spacing:0.05pt;"> </span>significant<span style="letter-spacing:0.1pt;"> </span>areas<span style="letter-spacing:0.05pt;"> </span>involving<span style="letter-spacing:0.05pt;"> </span>management&#8217;s<span style="letter-spacing:0.1pt;"> </span>judgments<span style="letter-spacing:0.05pt;"> </span>and estimate<span style="color:#000000;">s.</span></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">While our significant accounting policies are described in the notes to our </span><span style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">consolidated </span><span style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">financial statements included elsewhere in this Annual Report on Form 10-K, we believe that the following critical accounting policies are most important to understanding and evaluating our reported financial results.</span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Accrued Research and Development Expenses</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We record accrued expenses for estimated preclinical and clinical trial and research expenses related to the services performed but not yet invoiced pursuant to contracts with research institutions, contract research organizations and clinical manufacturing organizations that conduct and manage preclinical studies, and clinical trials, and research services on our behalf. Payments for these services are based on the terms of individual agreements and payment timing may differ significantly from the period in which the services were performed. Our estimates are based on factors such as the work completed, including the level of patient enrollment. We monitor patient enrollment levels and related activity to the extent reasonably possible and make judgments and estimates in determining the accrued balance in each reporting period. Our estimates of accrued expenses are based on the facts and circumstances known at the time. If we underestimate or overestimate the level of services performed or the costs of these services, our actual expenses could differ from our estimates. As actual costs become known, we adjust our accrued expenses. To date, we have not experienced significant changes in our estimates of preclinical studies and clinical trial accruals.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Stock-Based Compensation</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We measure compensation related to all equity awards granted to employees, directors, and non-employee service providers, including stock options and restricted stock units based on the estimated fair value. We recognize forfeitures as they occur.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We estimate the fair value of stock option awards on the date of grant, and the resulting stock-based compensation, using the Black-Scholes option-pricing model. The grant date fair value of stock option awards, which have graded vesting, is recognized as an expense using the straight-line method over the requisite service period of each award, which is generally the vesting period of the respective awards.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We use the Black-Scholes option-pricing model to estimate the fair value of stock option awards that requires the use of subjective assumptions to determine the fair value of equity awards. These assumptions include:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Expected volatility&#8212; Since we have limited trading history for our common stock, expected volatility is estimated based on weighting our volatility and the volatility of comparable publicly traded biotechnology companies during the equivalent period of the calculated expected term of the options granted. We chose comparable companies based on their similar size, stage in the life cycle or area of specialty. There is a degree of uncertainty in determining a comparable peer group as each of the peers are engaged in varied research and development activities, the timing and progress of which differ within the peer group.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Expected term&#8212;The expected term of options granted to employees and directors is determined using the &#8220;simplified&#8221; method. Under this approach, the expected term is presumed to be the midpoint between the weighted-average vesting term and the contractual term of the option. The simplified method makes the assumption that the employee will exercise share options evenly over the period when the share options are vested and ending on the date when the share options would expire. The expected option term for options granted to non-employees is estimated on a grant-by-grant basis.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Risk-free interest rate&#8212;The risk-free interest rate is based on the U.S. Treasury zero coupon bonds in effect on the grant date for periods with an equivalent expected term as the option.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Expected dividend&#8212;We have never paid dividends and have no foreseeable plans to pay dividends on our shares of common stock. Therefore, we use an expected dividend of zero.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We will continue to use judgment in evaluating the expected volatility and expected term utilized for our stock-based compensation calculations on a prospective basis. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of </span><span style="color:#000000;">restricted stock units is based on the fair value of our common stock on the date of grant</span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. The grant date fair value of restricted stock units with service vesting conditions is recognized over the requisite service period on a straight-line basis. For restricted stock units with performance vesting conditions, we evaluate the probability of achieving the performance condition at each reporting date and recognize expense for such performance awards over the requisite service period using the accelerated attribution method. </span><span style="color:#000000;">We recognize forfeitures as they occur</span><span style="color:#000000;">.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Note 2 to our consolidated<span style="letter-spacing:0.1pt;"> </span>financial<span style="letter-spacing:0.1pt;"> </span>statements<span style="letter-spacing:0.1pt;"> </span>appearing under Part II, Item 8<span style="letter-spacing:0.05pt;"> </span>for more information<span style="letter-spacing:0.1pt;"> </span>about recent<span style="letter-spacing:0.05pt;"> </span>accounting<span style="letter-spacing:0.05pt;"> </span>pronouncements,<span style="letter-spacing:0.1pt;"> </span>the timing<span style="letter-spacing:0.05pt;"> </span>of their<span style="letter-spacing:0.05pt;"> </span>adoption,<span style="letter-spacing:0.05pt;"> </span>and our assessment,<span style="letter-spacing:0.1pt;"> </span>to the extent<span style="letter-spacing:0.05pt;"> </span>we<span style="letter-spacing:-0.05pt;"> </span>have made one yet, of their<span style="letter-spacing:0.05pt;"> </span>potential<span style="letter-spacing:0.1pt;"> </span>impact<span style="letter-spacing:0.05pt;"> </span>on our financial<span style="letter-spacing:0.1pt;"> </span>condition<span style="letter-spacing:0.05pt;"> </span>of results<span style="letter-spacing:0.05pt;"> </span>of operations.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;">JOBS<span style="letter-spacing:-0.05pt;"> </span>Act Accounting Election</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are an emerging<span style="letter-spacing:0.05pt;"> </span>growth company,<span style="letter-spacing:0.05pt;"> </span>as defined<span style="letter-spacing:0.05pt;"> </span>in the JOBS<span style="letter-spacing:-0.05pt;"> </span>Act. Under the JOBS<span style="letter-spacing:-0.05pt;"> </span>Act, emerging growth companies<span style="letter-spacing:0.05pt;"> </span>can delay adopting<span style="letter-spacing:0.05pt;"> </span>new<span style="letter-spacing:-0.05pt;"> </span>or revised<span style="letter-spacing:0.05pt;"> </span>accounting<span style="letter-spacing:0.05pt;"> </span>standards<span style="letter-spacing:0.05pt;"> </span>issued<span style="letter-spacing:0.05pt;"> </span>subsequent<span style="letter-spacing:0.05pt;"> </span>to the enactment<span style="letter-spacing:0.1pt;"> </span>of the JOBS<span style="letter-spacing:-0.05pt;"> </span>Act until<span style="letter-spacing:0.05pt;"> </span>such time<span style="letter-spacing:0.05pt;"> </span>as those standards<span style="letter-spacing:0.05pt;"> </span>apply to private<span style="letter-spacing:0.05pt;"> </span>companies.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;;font-weight:normal;font-style:normal;color:#231F20;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We have elected<span style="letter-spacing:0.05pt;"> </span>to use this<span style="letter-spacing:0.05pt;"> </span>extended<span style="letter-spacing:0.05pt;"> </span>transition<span style="letter-spacing:0.1pt;"> </span>period<span style="letter-spacing:0.05pt;"> </span>to enable<span style="letter-spacing:0.05pt;"> </span>us to comply<span style="letter-spacing:0.05pt;"> </span>with new<span style="letter-spacing:-0.05pt;"> </span>or revised accounting<span style="letter-spacing:0.05pt;"> </span>standards<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>have different<span style="letter-spacing:0.1pt;"> </span>effective<span style="letter-spacing:0.1pt;"> </span>dates<span style="letter-spacing:0.05pt;"> </span>for public<span style="letter-spacing:0.05pt;"> </span>and private<span style="letter-spacing:0.05pt;"> </span>companies<span style="letter-spacing:0.05pt;"> </span>until<span style="letter-spacing:0.05pt;"> </span>the earlier<span style="letter-spacing:0.1pt;"> </span>of the date we<span style="letter-spacing:-0.05pt;"> </span>(i)<span style="letter-spacing:0.05pt;"> </span>are no longer<span style="letter-spacing:0.05pt;"> </span>an emerging<span style="letter-spacing:0.05pt;"> </span>growth company or (ii)<span style="letter-spacing:0.05pt;"> </span>affirmatively<span style="letter-spacing:0.15pt;"> </span>and irrevocably<span style="letter-spacing:0.1pt;"> </span>opt out of the extended<span style="letter-spacing:0.05pt;"> </span>transition<span style="letter-spacing:0.1pt;"> </span>period<span style="letter-spacing:0.05pt;"> </span>provided<span style="letter-spacing:0.05pt;"> </span>in the JOBS<span style="letter-spacing:-0.05pt;"> </span>Act. As<span style="letter-spacing:-0.05pt;"> </span>a result,<span style="letter-spacing:0.05pt;"> </span>our consolidated<span style="letter-spacing:0.1pt;"> </span>financial<span style="letter-spacing:0.1pt;"> </span>statements<span style="letter-spacing:0.1pt;"> </span>and our interim<span style="letter-spacing:0.1pt;"> </span>consolidated financial<span style="letter-spacing:0.1pt;"> </span>statements<span style="letter-spacing:0.1pt;"> </span>may not be comparable<span style="letter-spacing:0.1pt;"> </span>to companies<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>comply<span style="letter-spacing:0.05pt;"> </span>with new or revised<span style="letter-spacing:0.05pt;"> </span>accounting<span style="letter-spacing:0.05pt;"> </span>pronouncements.<span style="letter-spacing:0.1pt;"> </span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;" id="ITEM_7A_QUANTITATIVE_QUALITATIVE_DISCLOS">Item 7A. Quantitative and Qualitative Disclosures About Market Risk.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are a smaller reporting company, as defined by Rule 12b-2 under the Securities and Exchange Act of 1934 and in Item 10(f)(1) of Regulation S-K, and are not required to provide the information under this item.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_8_FINANCIAL_STATEMENTS_SUPPLEMENTAR">Item 8. Financial Statements and Supplementary Data.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">89BIO, INC.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:90.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:4.86%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.86%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Page</p></td>
</tr>
<tr style="height:9.1pt;">
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:90.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:3pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:4.86%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:3pt;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.86%; border-top:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:3pt;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:90.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#REPORT_INDEPENDENT_REGISTERED_PUBLIC_ACC"><span style="text-decoration:underline;">Report of Independent Registered Public Accounting Firm</span></a><span style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span></p></td>
<td valign="top" style="background-color:#FFFFFF;width:4.86%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.86%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:90.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial Statements:</p></td>
<td valign="top" style="background-color:#FFFFFF;width:4.86%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.86%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:90.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:36pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#CONSOLIDATED_BALANCE_SHEETS"><span style="text-decoration:underline;">Consolidated Balance Sheets</span></a></p></td>
<td valign="top" style="background-color:#FFFFFF;width:4.86%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.86%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:90.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:36pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#CONSOLIDATED_STATEMENTS_OPERATIONS_COMPR"><span style="text-decoration:underline;">Consolidated Statements of Operations and Comprehensive Loss</span></a></p></td>
<td valign="top" style="background-color:#FFFFFF;width:4.86%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.86%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:90.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:36.5pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#CONSOLIDATED_STATEMENTS_STOCKHOLDERS_EQU"><span style="text-decoration:underline;">Consolidated Statements of Stockholders&#8217; Equity</span></a></p></td>
<td valign="top" style="background-color:#FFFFFF;width:4.86%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.86%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:90.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:36pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#CONSOLIDATED_STATEMENTS_CASH_FLOWS"><span style="text-decoration:underline;">Consolidated Statements of Cash Flows</span></a></p></td>
<td valign="top" style="background-color:#FFFFFF;width:4.86%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.86%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:90.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:36pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#NOTES_TO_CONSOLIDATED_FINANCIAL_STATEMEN"><span style="text-decoration:underline;">Notes to Consolidated Financial Statements</span></a></p></td>
<td valign="top" style="background-color:#FFFFFF;width:4.86%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.86%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;color:#231F20;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;" id="REPORT_INDEPENDENT_REGISTERED_PUBLIC_ACC">Report of Independent Registered<span style="letter-spacing:0.05pt;"> </span>Public Accounting Firm</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the Stockholders and Board of Directors<br />89bio, Inc.:</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Opinion on the Consolidated Financial Statements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have audited the accompanying consolidated balance sheets of 89bio, Inc. and subsidiaries (the Company) as of December&#160;31, 2021 and 2020, the related consolidated statements of operations and comprehensive loss, stockholders&#8217; equity, and cash flows for each of the years in the two&#8209;year period ended December&#160;31, 2021, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December&#160;31, 2021 and 2020, and the results of its operations and its cash flows for each of the years in the two&#8209;year period ended December&#160;31, 2021, in conformity with U.S. generally accepted accounting principles.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Basis for Opinion</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;/s/ KPMG LLP</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have served as the Company&#8217;s auditor since 2020.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">San Francisco, California</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 24, 2022<br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="CONSOLIDATED_BALANCE_SHEETS">Consolidated Balance Sheets</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">(in thousands, except share and per share amounts)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.4%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current assets:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000039" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">52,432</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000040" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">98,183</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000041" name="us-gaap:RestrictedCashCurrent" contextRef="C_0001785173_20211231" decimals="-3" scale="3">25</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000042" name="us-gaap:RestrictedCashCurrent" contextRef="C_0001785173_20201231" decimals="-3" scale="3">25</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term available-for-sale securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000043" name="etnb:ShortTermAvailableForSaleSecuritiesCurrent" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">98,288</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000044" name="etnb:ShortTermAvailableForSaleSecuritiesCurrent" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">106,446</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid and other current assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000045" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,237</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000046" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,548</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000047" name="us-gaap:AssetsCurrent" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">161,982</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000048" name="us-gaap:AssetsCurrent" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">210,202</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000049" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_0001785173_20211231" decimals="-3" scale="3">150</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000050" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_0001785173_20201231" decimals="-3" scale="3">166</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000051" name="us-gaap:OtherAssetsNoncurrent" contextRef="C_0001785173_20211231" decimals="-3" scale="3">290</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000052" name="us-gaap:OtherAssetsNoncurrent" contextRef="C_0001785173_20201231" decimals="-3" scale="3">706</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000053" name="us-gaap:Assets" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">162,422</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000054" name="us-gaap:Assets" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">211,074</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Liabilities and stockholders&#8217; equity</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current liabilities:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000055" name="us-gaap:AccountsPayableCurrent" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,843</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000056" name="us-gaap:AccountsPayableCurrent" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,065</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000057" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,194</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000058" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,048</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term loan, current</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000059" name="etnb:TermLoanCurrent" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,500</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000060" name="us-gaap:LiabilitiesCurrent" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,537</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000061" name="us-gaap:LiabilitiesCurrent" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,113</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term loan, non-current, net</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000062" name="us-gaap:LongTermDebtNoncurrent" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">16,898</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other non-current liability</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000063" name="etnb:OtherNonCurrentLiability" contextRef="C_0001785173_20211231" decimals="-3" scale="3">30</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000064" name="us-gaap:Liabilities" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">36,465</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000065" name="us-gaap:Liabilities" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,113</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commitments and contingencies (Note 5)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000066">&#160;</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000067">&#160;</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stockholders&#8217; equity:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preferred stock, $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000082" name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="C_0001785173_20211231" decimals="INF"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000083" name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="C_0001785173_20201231" decimals="INF">0.001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="U_xbrlishares" id="F_000084" name="us-gaap:PreferredStockSharesAuthorized" contextRef="C_0001785173_20211231" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_000085" name="us-gaap:PreferredStockSharesAuthorized" contextRef="C_0001785173_20201231" decimals="INF" format="ixt:numdotdecimal">10,000,000</ix:nonFraction></ix:nonFraction> shares authorized</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; as of December 31, 2021 and 2020, respectively, <ix:nonFraction unitRef="U_xbrlishares" id="F_000086" name="us-gaap:PreferredStockSharesIssued" contextRef="C_0001785173_20211231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_xbrlishares" id="F_000087" name="us-gaap:PreferredStockSharesIssued" contextRef="C_0001785173_20201231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_xbrlishares" id="F_000088" name="us-gaap:PreferredStockSharesOutstanding" contextRef="C_0001785173_20211231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_xbrlishares" id="F_000089" name="us-gaap:PreferredStockSharesOutstanding" contextRef="C_0001785173_20201231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; issued and outstanding as of December 31, 2021 and 2020, respectively</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000068">&#8212;</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000069">&#8212;</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock, $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000090" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_0001785173_20211231" decimals="INF"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000091" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_0001785173_20201231" decimals="INF">0.001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="U_xbrlishares" id="F_000092" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_0001785173_20211231" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_000093" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_0001785173_20201231" decimals="INF" format="ixt:numdotdecimal">100,000,000</ix:nonFraction></ix:nonFraction> shares authorized</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; as of December 31, 2021 and 2020, respectively&#59; <ix:nonFraction unitRef="U_xbrlishares" id="F_000094" name="us-gaap:CommonStockSharesIssued" contextRef="C_0001785173_20211231" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_000096" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_0001785173_20211231" decimals="INF" format="ixt:numdotdecimal">20,317,204</ix:nonFraction></ix:nonFraction> and</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; <ix:nonFraction unitRef="U_xbrlishares" id="F_000095" name="us-gaap:CommonStockSharesIssued" contextRef="C_0001785173_20201231" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_000097" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_0001785173_20201231" decimals="INF" format="ixt:numdotdecimal">19,931,660</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of December 31, 2021</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; and 2020, respectively</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000070" name="us-gaap:CommonStockValue" contextRef="C_0001785173_20211231" decimals="-3" scale="3">20</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000071" name="us-gaap:CommonStockValue" contextRef="C_0001785173_20201231" decimals="-3" scale="3">20</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional paid-in capital</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000072" name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">339,218</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000073" name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">326,046</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated other comprehensive loss</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000074" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="C_0001785173_20211231" decimals="-3" sign="-" scale="3">64</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000075" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="C_0001785173_20201231" decimals="-3" sign="-" scale="3">10</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated deficit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000076" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_0001785173_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">213,217</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000077" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_0001785173_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">123,095</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stockholders&#8217; equity</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000078" name="us-gaap:StockholdersEquity" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">125,957</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000079" name="us-gaap:StockholdersEquity" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">202,961</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities and stockholders&#8217; equity</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000080" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">162,422</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000081" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">211,074</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">The accompanying notes are an integral part of these consolidated financial statements.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="CONSOLIDATED_STATEMENTS_OPERATIONS_COMPR">Consolidated Statements of Operations and Comprehensive Loss</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">(In thousands, except share and per share amounts)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000098" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001785173_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">70,330</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000099" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001785173_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">36,199</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000100" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_0001785173_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,413</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000101" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_0001785173_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,156</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating expenses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000102" name="us-gaap:OperatingExpenses" contextRef="C_0001785173_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">89,743</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000103" name="us-gaap:OperatingExpenses" contextRef="C_0001785173_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">49,355</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss from operations</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000104" name="us-gaap:OperatingIncomeLoss" contextRef="C_0001785173_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">89,743</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000105" name="us-gaap:OperatingIncomeLoss" contextRef="C_0001785173_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">49,355</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other expenses, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000106" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="C_0001785173_20210101_20211231" decimals="-3" sign="-" scale="3">526</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000107" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="C_0001785173_20200101_20201231" decimals="-3" sign="-" scale="3">203</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss before income tax</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000108" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0001785173_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">90,269</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000109" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0001785173_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">49,558</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax benefit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000110" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0001785173_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">147</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000111" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0001785173_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">59</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000112" name="us-gaap:NetIncomeLoss" contextRef="C_0001785173_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">90,122</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000113" name="us-gaap:NetIncomeLoss" contextRef="C_0001785173_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">49,499</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other comprehensive (loss) income:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrealized (loss) gain on available-for-sale securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000114" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" contextRef="C_0001785173_20210101_20211231" decimals="-3" sign="-" scale="3">71</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000115" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" contextRef="C_0001785173_20200101_20201231" decimals="-3" scale="3">8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign currency translation adjustments</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000116" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="C_0001785173_20210101_20211231" decimals="-3" scale="3">17</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000117" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="C_0001785173_20200101_20201231" decimals="-3" sign="-" scale="3">18</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total other comprehensive loss</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000118" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_0001785173_20210101_20211231" decimals="-3" sign="-" scale="3">54</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000119" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_0001785173_20200101_20201231" decimals="-3" sign="-" scale="3">10</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Comprehensive loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000120" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="C_0001785173_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">90,176</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000121" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="C_0001785173_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">49,509</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share, basic and diluted</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000122" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001785173_20210101_20211231" decimals="2" sign="-">4.48</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000123" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001785173_20200101_20201231" decimals="2" sign="-">3.08</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average shares used to compute net loss per share,</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; basic and diluted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000124" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001785173_20210101_20211231" decimals="0" format="ixt:numdotdecimal">20,098,340</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000125" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001785173_20200101_20201231" decimals="0" format="ixt:numdotdecimal">16,087,785</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The accompanying notes are an integral part of these consolidated financial statements.</span></p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="CONSOLIDATED_STATEMENTS_STOCKHOLDERS_EQU">Consolidated Statements of Stockholders&#8217; Equity</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">(In thousands, except share amounts)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.24%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.9%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.24%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Additional</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.24%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.24%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:36.9%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.76%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Common Stock</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.24%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Paid-in</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.24%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Comprehensive</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.24%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.24%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stockholders&#8217;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:36.9%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amounts</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.24%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Capital</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.24%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.24%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Deficit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.24%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Equity</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2019</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000126" name="us-gaap:SharesOutstanding" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231" decimals="INF" format="ixt:numdotdecimal">13,788,982</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000127" name="us-gaap:StockholdersEquity" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231" decimals="-3" scale="3">14</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000128" name="us-gaap:StockholdersEquity" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">163,526</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000129" name="us-gaap:StockholdersEquity" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20191231" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000130" name="us-gaap:StockholdersEquity" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">73,596</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000131" name="us-gaap:StockholdersEquity" contextRef="C_0001785173_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">89,944</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon public offerings,</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; net of issuance costs of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000194" name="etnb:TemporaryEquityIssuanceCosts" contextRef="C_0001785173_us-gaapStatementClassOfStockAxis_etnbConvertiblePreferredSharesMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,208</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000132" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">6,072,040</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000133" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200101_20201231" decimals="-3" scale="3">6</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000134" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">157,674</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000135" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000136" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">157,680</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon exercise of stock options</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000137" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">63,366</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000138" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" scale="3">271</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000139" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000140" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001785173_20200101_20201231" decimals="-3" scale="3">271</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon ESPP purchase</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000141" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">7,272</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000142" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" scale="3">134</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000143" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000144" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="C_0001785173_20200101_20201231" decimals="-3" scale="3">134</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock warrant in connection with term loan facility</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000145" name="etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" scale="3">634</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000146" name="etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000147" name="etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" contextRef="C_0001785173_20200101_20201231" decimals="-3" scale="3">634</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000148" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,807</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000149" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000150" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001785173_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,807</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000154" name="us-gaap:NetIncomeLoss" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000155" name="us-gaap:NetIncomeLoss" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">49,499</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000156" name="us-gaap:NetIncomeLoss" contextRef="C_0001785173_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">49,499</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:36.9%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other comprehensive loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000157" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231" decimals="-3" sign="-" scale="3">10</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000158" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_0001785173_20200101_20201231" decimals="-3" sign="-" scale="3">10</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2020</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000159" name="us-gaap:SharesOutstanding" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231" decimals="INF" format="ixt:numdotdecimal">19,931,660</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000160" name="us-gaap:StockholdersEquity" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231" decimals="-3" scale="3">20</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000161" name="us-gaap:StockholdersEquity" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">326,046</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000162" name="us-gaap:StockholdersEquity" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20201231" decimals="-3" sign="-" scale="3">10</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000163" name="us-gaap:StockholdersEquity" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">123,095</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000164" name="us-gaap:StockholdersEquity" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">202,961</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon at-the-market public</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; offerings, net of issuance costs of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000195" name="etnb:TemporaryEquityIssuanceCosts" contextRef="C_0001785173_us-gaapStatementClassOfStockAxis_etnbConvertiblePreferredSharesMember_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210101_20211231" decimals="-3" scale="3">165</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000165" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">186,546</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000166" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,289</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000167" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210101_20211231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000168" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,289</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon exercise of stock options</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000169" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">188,286</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000170" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231" decimals="-3" scale="3">487</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000171" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20210101_20211231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000172" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001785173_20210101_20211231" decimals="-3" scale="3">487</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon ESPP purchase</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000173" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">10,712</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000174" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231" decimals="-3" scale="3">144</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000175" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20210101_20211231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000176" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="C_0001785173_20210101_20211231" decimals="-3" scale="3">144</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock warrant in connection with term loan facility</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000177" name="etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231" decimals="-3" scale="3">574</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000178" name="etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20210101_20211231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000179" name="etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" contextRef="C_0001785173_20210101_20211231" decimals="-3" scale="3">574</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000180" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,678</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000181" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20210101_20211231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000182" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001785173_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,678</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000183" name="us-gaap:NetIncomeLoss" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20210101_20211231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000184" name="us-gaap:NetIncomeLoss" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">90,122</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000185" name="us-gaap:NetIncomeLoss" contextRef="C_0001785173_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">90,122</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:36.9%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other comprehensive loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000186" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20210101_20211231" decimals="-3" sign="-" scale="3">54</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000187" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_0001785173_20210101_20211231" decimals="-3" sign="-" scale="3">54</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:36.9%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2021</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000188" name="us-gaap:SharesOutstanding" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20211231" decimals="INF" format="ixt:numdotdecimal">20,317,204</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000189" name="us-gaap:StockholdersEquity" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20211231" decimals="-3" scale="3">20</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000190" name="us-gaap:StockholdersEquity" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">339,218</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000191" name="us-gaap:StockholdersEquity" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20211231" decimals="-3" sign="-" scale="3">64</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000192" name="us-gaap:StockholdersEquity" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">213,217</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000193" name="us-gaap:StockholdersEquity" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">125,957</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The accompanying notes are an integral part of these consolidated financial statements.</span></p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">89bio, Inc.</span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="CONSOLIDATED_STATEMENTS_CASH_FLOWS"><span style="Background-color:#FFFFFF;">Consolidated Statements of Cash Flows</span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">(In thousands)</span></p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.52%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.9%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.52%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Cash flows from operating activities:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000196" name="us-gaap:ProfitLoss" contextRef="C_0001785173_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">90,122</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000197" name="us-gaap:ProfitLoss" contextRef="C_0001785173_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">49,499</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjustments to reconcile net loss to net cash used in operating activities:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000198" name="us-gaap:ShareBasedCompensation" contextRef="C_0001785173_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,678</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000199" name="us-gaap:ShareBasedCompensation" contextRef="C_0001785173_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,807</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of premium on available-for-sale securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000200" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" contextRef="C_0001785173_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">865</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000201" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" contextRef="C_0001785173_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">268</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of debt issuance costs and accretion of final payment fee</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000202" name="etnb:AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" contextRef="C_0001785173_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">617</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000203" name="etnb:AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" contextRef="C_0001785173_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">230</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000204" name="us-gaap:Depreciation" contextRef="C_0001785173_20210101_20211231" decimals="-3" scale="3">79</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000205" name="us-gaap:Depreciation" contextRef="C_0001785173_20200101_20201231" decimals="-3" scale="3">60</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000206" name="etnb:DeferredTaxAssets" contextRef="C_0001785173_20210101_20211231" decimals="-3" scale="3">150</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000207" name="etnb:DeferredTaxAssets" contextRef="C_0001785173_20200101_20201231" decimals="-3" scale="3">69</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in operating assets and liabilities:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid and other current assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000208" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_0001785173_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,672</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000209" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_0001785173_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,600</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000210" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="C_0001785173_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,778</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000211" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="C_0001785173_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,131</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.52%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000212" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="C_0001785173_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,146</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000213" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="C_0001785173_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,428</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.52%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash used in operating activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000214" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_0001785173_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">76,781</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000215" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_0001785173_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">46,244</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Cash flows from investing activities:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from sales and maturities of available-for-sale securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000216" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" contextRef="C_0001785173_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">148,422</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000217" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" contextRef="C_0001785173_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">12,189</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchases of available-for-sale securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000218" name="etnb:PaymentForPurchaseOfAvailableForSaleSecurities" contextRef="C_0001785173_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">141,200</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000219" name="etnb:PaymentForPurchaseOfAvailableForSaleSecurities" contextRef="C_0001785173_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">118,895</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.52%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchases of property and equipment</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000220" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_0001785173_20210101_20211231" decimals="-3" scale="3">63</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000221" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_0001785173_20200101_20201231" decimals="-3" scale="3">126</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.52%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash provided by (used in) investing activities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000222" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_0001785173_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,159</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000223" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_0001785173_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">106,832</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Cash flows from financing activities:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from term loan facility, net of issuance costs</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000224" name="us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt" contextRef="C_0001785173_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,951</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from issuance of common stock upon public offerings,</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; net of issuance costs</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000225" name="etnb:ProceedsFromIssuancePublicOffering" contextRef="C_0001785173_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,289</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000226" name="etnb:ProceedsFromIssuancePublicOffering" contextRef="C_0001785173_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">157,680</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from issuance of common stock upon stock option exercises</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000227" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" contextRef="C_0001785173_20210101_20211231" decimals="-3" scale="3">487</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000228" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" contextRef="C_0001785173_20200101_20201231" decimals="-3" scale="3">271</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from issuance of common stock upon ESPP purchases</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000229" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20210101_20211231" decimals="-3" scale="3">144</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000230" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20200101_20201231" decimals="-3" scale="3">134</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.52%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payment of debt issuance costs</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000231" name="us-gaap:PaymentsOfDebtIssuanceCosts" contextRef="C_0001785173_20200101_20201231" decimals="-3" scale="3">161</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.52%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash provided by financing activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000232" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_0001785173_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">23,871</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000233" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_0001785173_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">157,924</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net change in cash and cash equivalents, and restricted cash</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000234" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_0001785173_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">45,751</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000235" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_0001785173_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,848</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.52%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents, and restricted cash at beginning of period</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000236" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">98,208</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000237" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_0001785173_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">93,360</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.52%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents, and restricted cash at end of period</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000238" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">52,457</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000239" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">98,208</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Components of cash and cash equivalents, and restricted cash:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000240" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">52,432</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000241" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">98,183</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.52%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000242" name="us-gaap:RestrictedCashCurrent" contextRef="C_0001785173_20211231" decimals="-3" scale="3">25</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000243" name="us-gaap:RestrictedCashCurrent" contextRef="C_0001785173_20201231" decimals="-3" scale="3">25</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.52%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash and cash equivalents, and restricted cash</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000244" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">52,457</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000245" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">98,208</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Supplemental disclosures of cash information:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.52%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid for interest</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000246" name="us-gaap:InterestPaidNet" contextRef="C_0001785173_20210101_20211231" decimals="-3" scale="3">16</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.52%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid for income taxes</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000247" name="us-gaap:IncomeTaxesPaidNet" contextRef="C_0001785173_20200101_20201231" decimals="-3" scale="3">142</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Supplemental disclosures of noncash information:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.52%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock warrant in connection with term loan facility</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.88%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000248" name="etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" contextRef="C_0001785173_20210101_20211231" decimals="-3" scale="3">574</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000249" name="etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" contextRef="C_0001785173_20200101_20201231" decimals="-3" scale="3">634</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The accompanying notes are an integral part of these consolidated financial statements.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="NOTES_TO_CONSOLIDATED_FINANCIAL_STATEMEN">Notes to Consolidated Financial Statements</p><ix:nonNumeric id="F_000250" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1. Organization and Basis of Presentation </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Description of Business</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc. (&#8220;89bio&#8221; or the &#8220;Company&#8221;) is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The Company&#8217;s lead product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21, is currently being developed for the treatment of nonalcoholic steatohepatitis and for the treatment of severe hypertriglyceridemia. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc. was formed as a Delaware corporation in <span style="-sec-ix-hidden:F_000299">June 2019</span> to carry on the business of 89Bio Ltd., which was incorporated in Israel in January 2018. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Public Offerings</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In July 2020, the Company completed an underwritten public offering of <ix:nonFraction unitRef="U_xbrlishares" id="F_000300" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200701_20200731" decimals="INF" format="ixt:numdotdecimal">3,047,040</ix:nonFraction> shares of its common stock at the public offering price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000302" name="us-gaap:SharesIssuedPricePerShare" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200731" decimals="2">27.50</ix:nonFraction> per share. The Company raised a total of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000301" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200701_20200731" decimals="-5" scale="6">78.2</ix:nonFraction> million in net proceeds after deducting underwriting discounts and commissions of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000303" name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200701_20200731" decimals="-5" scale="6">5.0</ix:nonFraction> million and offering costs of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000304" name="etnb:PaymentsOfStockIssuanceCostsOther" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200701_20200731" decimals="-5" scale="6">0.6</ix:nonFraction> million. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In September 2020, the Company completed an underwritten public offering of <ix:nonFraction unitRef="U_xbrlishares" id="F_000305" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200901_20200930" decimals="INF" format="ixt:numdotdecimal">3,025,000</ix:nonFraction> shares of its common stock, at a public offering price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000306" name="us-gaap:SharesIssuedPricePerShare" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200930" decimals="2">28.00</ix:nonFraction> per share. The Company raised a total of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000307" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200901_20200930" decimals="-5" scale="6">79.5</ix:nonFraction> million in net proceeds after deducting underwriting discounts and commissions of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000308" name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200901_20200930" decimals="-5" scale="6">4.6</ix:nonFraction> million and offering costs of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000309" name="etnb:PaymentsOfStockIssuanceCostsOther" contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200901_20200930" decimals="-5" scale="6">0.6</ix:nonFraction> million.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2021, the Company entered into a sales agreement (the &#8220;Sales Agreement&#8221;) with SVB Leerink LLC and Cantor Fitzgerald &#38; Co. (the &#8220;Sales Agents&#8221;) pursuant to which it may offer and sell up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000310" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001785173_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210301_20210331" decimals="-5" scale="6">75.0</ix:nonFraction> million of shares of the Company&#8217;s common stock, from time to time, in &#8220;at-the-market&#8221; offerings (the &#8220;ATM Facility&#8221;). The Sales Agents are entitled to compensation at a commission equal to <ix:nonFraction unitRef="U_xbrlipure" id="F_000311" name="etnb:SellingCommissionPerSharesSoldPercentage" contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbSVBLeerinkLLCAndCantorFitzgeraldCoMember_20210331" decimals="3" scale="-2">3.0</ix:nonFraction>% of the aggregate gross sales price per share sold under the Sales Agreement. <span style="color:#231F20;letter-spacing:0.1pt;">During the fourth quarter of 2021, the Company received proceeds of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000312" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbSVBLeerinkLLCAndCantorFitzgeraldCoMember_20211001_20211231" decimals="-5" scale="6">3.3</ix:nonFraction> million, net of commissions and offering expenses from sales of <ix:nonFraction unitRef="U_xbrlishares" id="F_000313" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbSVBLeerinkLLCAndCantorFitzgeraldCoMember_20211001_20211231" decimals="INF" format="ixt:numdotdecimal">186,546</ix:nonFraction> shares of its common stock at a weighted-average price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000314" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbSVBLeerinkLLCAndCantorFitzgeraldCoMember_20211001_20211231" decimals="2">17.97</ix:nonFraction> per share pursuant to the ATM Facility.</span> </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Liquidity </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. To date, the Company has not generated revenues from its activities and has incurred substantial operating losses. Management expects the Company to continue to generate substantial operating losses for the foreseeable future until it completes development of its products and seeks regulatory approvals to market such products. The Company had cash and cash equivalents and short-term available-for-sale securities of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000315" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" contextRef="C_0001785173_20211231" decimals="-5" scale="6">150.7</ix:nonFraction> million as of December 31, 2021. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company expects that its cash and cash equivalents and short-term available-for-sale securities as of December 31, 2021, together with proceeds available from the Company&#8217;s term loan (see Note 6) and its ATM Facility, will be sufficient to fund operating expenses and capital expenditure requirements for a period of at least one year from the date these audited consolidated financial statements are filed with the Securities and Exchange Commission (&#8220;SEC&#8221;).</p></ix:nonNumeric><ix:nonNumeric id="F_000251" name="us-gaap:SignificantAccountingPoliciesTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true" continuedAt="F_000251_dcnt_0a89522b-9d5b-42a6-bfd3-cdba9ca33c38">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2. Summary of Significant Accounting Policies</p><ix:nonNumeric id="F_000260" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Basis of Presentation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;).</p></ix:nonNumeric></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p><ix:continuation id="F_000251_dcnt_0a89522b-9d5b-42a6-bfd3-cdba9ca33c38" continuedAt="F_000251_dcnt_77d7646c-4aca-4ecd-bcde-2f6a791de5f1"><ix:nonNumeric id="F_000261" name="us-gaap:ConsolidationPolicyTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Principles of Consolidation</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.</p></ix:nonNumeric><ix:nonNumeric id="F_000262" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Foreign Currencies</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain transactions during the years ended December 31, 2021 and 2020 were denominated in currencies other than the U.S. dollar. Gains and losses from foreign currency transactions were not material for all periods presented and are reflected in the consolidated statements of operations and comprehensive loss as a component of other expenses, net. The Company&#8217;s subsidiary in Lithuania uses the Euro as its functional currency for financial reporting. The re-measurement from Euros to U.S. dollars results in translation gain and loss adjustments, which are reflected as a component of comprehensive loss as foreign currency translation adjustments.</p></ix:nonNumeric><ix:nonNumeric id="F_000263" name="us-gaap:UseOfEstimates" contextRef="C_0001785173_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions made in the accompanying consolidated financial statements include but are not limited to accrued research and development expenses and the fair value of stock options. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.</p></ix:nonNumeric><ix:nonNumeric id="F_000264" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Fair Value Measurements </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial assets and liabilities are recorded at fair value on a recurring basis in the consolidated balance sheets. The carrying values of Company&#8217;s financial assets and liabilities, including cash and cash equivalents, restricted cash, prepaid and other current assets, accounts payable, and accrued expenses approximate to their fair value due to the short-term nature of these instruments. The fair value of the Company&#8217;s term loan approximates its carrying value, or amortized cost, due to the prevailing market rates of interest rates it bears. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. Assets and liabilities recorded at fair value are categorized based upon the level of judgment associated with the inputs used to measure their fair value. Hierarchical levels are directly related to the amount of subjectivity with the inputs to the valuation of these assets or liabilities as follows: </p>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1<span style="font-weight:normal;">&#8212;Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date&#59; </span></p>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2<span style="font-weight:normal;">&#8212;Inputs (other than quoted prices included in Level&#160;1) are either directly or indirectly observable inputs for similar assets or liabilities. These include quoted prices for identical or similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active&#59; and </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Level 3<span style="font-weight:normal;">&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></p></ix:nonNumeric><ix:nonNumeric id="F_000265" name="us-gaap:ConcentrationRiskCreditRisk" contextRef="C_0001785173_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentrations of Credit Risk</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial<span style="letter-spacing:0.05pt;"> </span>instruments<span style="letter-spacing:0.1pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>potentially<span style="letter-spacing:0.1pt;"> </span>subject<span style="letter-spacing:0.05pt;"> </span>the Company to a concentration<span style="letter-spacing:0.1pt;"> </span>of credit<span style="letter-spacing:0.05pt;"> </span>risk<span style="letter-spacing:0.05pt;"> </span>consist primarily<span style="letter-spacing:0.1pt;"> </span>of cash and cash equivalents and short-term available-for-sale securities.<span style="letter-spacing:0.1pt;"> </span>Bank<span style="letter-spacing:-0.05pt;"> </span>deposits<span style="letter-spacing:0.05pt;"> </span>are held by accredited<span style="letter-spacing:0.1pt;"> </span>financial<span style="letter-spacing:0.1pt;"> </span>institutions<span style="letter-spacing:0.1pt;"> </span>and these deposits<span style="letter-spacing:0.05pt;"> </span>may at times<span style="letter-spacing:0.05pt;"> </span>be in excess<span style="letter-spacing:0.05pt;"> </span>of insured<span style="letter-spacing:0.05pt;"> </span>limits. The Company limits<span style="letter-spacing:0.1pt;"> </span>its<span style="letter-spacing:0.05pt;"> </span>credit<span style="letter-spacing:0.05pt;"> </span>risk<span style="letter-spacing:0.05pt;"> </span>associated<span style="letter-spacing:0.1pt;"> </span>with cash and cash equivalents<span style="letter-spacing:0.1pt;"> </span>by placing<span style="letter-spacing:0.05pt;"> </span>them<span style="letter-spacing:0.05pt;"> </span>with financial<span style="letter-spacing:0.1pt;"> </span>institutions<span style="letter-spacing:0.1pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>it believes<span style="letter-spacing:0.05pt;"> </span>are of high quality.<span style="letter-spacing:0.05pt;"> </span>The Company has not experienced<span style="letter-spacing:0.05pt;"> </span>any losses<span style="letter-spacing:0.05pt;"> </span>on its<span style="letter-spacing:0.05pt;"> </span>deposits<span style="letter-spacing:0.05pt;"> </span>of cash or cash equivalents. The Company <span style="color:#000000;">limits amounts invested in available-for-sale securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. The Company is not exposed to any significant concentrations of credit risk from these financial instruments.</span></p></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p><ix:continuation id="F_000251_dcnt_77d7646c-4aca-4ecd-bcde-2f6a791de5f1" continuedAt="F_000251_dcnt_79e08489-b1a4-46dc-9126-659aee1b488c"><ix:nonNumeric id="F_000266" name="etnb:OtherRisksAndUncertaintiesPolicyTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Other<span style="font-weight:normal;font-style:normal;"> </span>Risks and Uncertainties </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s future results of operations involve a number of other risks and uncertainties. Factors that could affect the Company&#8217;s future operating results and cause actual results to vary materially from expectations include, but are not limited to, the Company&#8217;s early stages of clinical drug development&#59; the Company&#8217;s ability to advance product candidates into, and successfully complete, clinical trials on the timelines it projects&#59; the Company&#8217;s ability to adequately demonstrate sufficient safety and efficacy of its product candidates&#59; the Company&#8217;s ability to enroll patients in its ongoing and future clinical trials&#59; the Company&#8217;s ability to successfully manufacture and supply its product candidates for clinical trials&#59; the Company&#8217;s ability to obtain additional capital to finance its operations&#59; uncertainties related to the projections of the size of patient populations suffering from the diseases the Company is targeting&#59; the Company&#8217;s ability to obtain, maintain, and protect its intellectual property rights&#59; developments relating to the Company&#8217;s competitors and its industry, including competing product candidates and therapies&#59; general economic and market conditions&#59; and other risks and uncertainties.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s product candidates will require approvals from the U.S. Food and Drug Administration and comparable foreign regulatory agencies prior to commercial sales in their respective jurisdictions. There can be no assurance that any product candidates will receive the necessary approvals. If the Company was denied approval, approval was delayed or the Company was unable to maintain approval for any product candidate, it could have a materially adverse impact on the Company.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The ongoing COVID-19 pandemic has disrupted and may continue to disrupt the Company&#8217;s business and delay its preclinical and clinical programs and timelines. <span style="color:#000000;">The Company does not yet know the full extent of potential delays to clinical trials, which could prevent or delay the Company from obtaining approval for&#160;pegozafermin.&#160;</span>The extent to which the COVID-19 pandemic may impact the Company&#8217;s future operating results and financial condition is uncertain.</p></ix:nonNumeric><ix:nonNumeric id="F_000267" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Segment Reporting</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has <ix:nonFraction unitRef="U_etnbSegment" id="F_000316" name="us-gaap:NumberOfOperatingSegments" contextRef="C_0001785173_20210101_20211231" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction> operating<span style="letter-spacing:0.05pt;"> </span>segment.<span style="letter-spacing:0.05pt;"> </span>The Company&#8217;s chief<span style="letter-spacing:0.05pt;"> </span>operating<span style="letter-spacing:0.05pt;"> </span>decision<span style="letter-spacing:0.05pt;"> </span>maker,<span style="letter-spacing:0.05pt;"> </span>its<span style="letter-spacing:0.05pt;"> </span>Chief Executive<span style="letter-spacing:0.05pt;"> </span>Officer,<span style="letter-spacing:0.05pt;"> </span>manages<span style="letter-spacing:0.05pt;"> </span>the Company&#8217;s operations<span style="letter-spacing:0.05pt;"> </span>on a consolidated<span style="letter-spacing:0.1pt;"> </span>basis<span style="letter-spacing:0.05pt;"> </span>for the purposes<span style="letter-spacing:0.05pt;"> </span>of allocating resources<span style="letter-spacing:0.05pt;"> </span>and evaluating<span style="letter-spacing:0.05pt;"> </span>financial<span style="letter-spacing:0.1pt;"> </span>performance.</p></ix:nonNumeric><ix:nonNumeric id="F_000268" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" contextRef="C_0001785173_20210101_20211231" escape="true" continuedAt="F_000268_cnt_1">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Cash and Cash Equivalents</p></ix:nonNumeric><ix:continuation id="F_000268_cnt_1" continuedAt="F_000268_cnt_2">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be cash equivalents. Cash equivalents consist primarily of amounts invested in money market funds and commercial paper that are stated at fair value.</p></ix:continuation><ix:continuation id="F_000268_cnt_2" continuedAt="F_000268_cnt_3">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Restricted Cash</p></ix:continuation><ix:continuation id="F_000268_cnt_3">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash consists of a money market account that serves as collateral for the Company&#8217;s operating lease agreement for its facility in Israel.</p></ix:continuation><ix:nonNumeric id="F_000272" name="us-gaap:InvestmentPolicyTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true" continuedAt="F_000272_dcnt_5acfca79-84cb-4237-83fb-4696d32d82b9">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Investments </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investments have been classified as available-for-sale and are carried at estimated fair value as determined based upon quoted market prices or pricing models for similar securities. Management determines the appropriate classification of its available-for-sale investments in debt securities at the time of purchase. Generally, investments with original maturities beyond three months at the date of purchase are classified as short-term because it is management&#8217;s intent to use the investments to fund current operations or to make them available for current operations. </p></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p><ix:continuation id="F_000251_dcnt_79e08489-b1a4-46dc-9126-659aee1b488c" continuedAt="F_000251_dcnt_3f5f1d65-4c7b-415a-9749-e8728009e80a"><ix:continuation id="F_000272_dcnt_5acfca79-84cb-4237-83fb-4696d32d82b9">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrealized gains and losses are excluded from earnings and are reported as a component of comprehensive loss.&#160;The Company periodically evaluates whether declines in fair values of its available-for-sale securities below their book value are other-than-temporary. This evaluation consists of several qualitative and quantitative factors regarding the severity and duration of the unrealized loss as well as the Company&#8217;s ability and intent to hold the available-for-sale security until a forecasted recovery occurs. Additionally, the Company assesses whether it has plans to sell the security or it is more likely than not it will be required to sell any available-for-sale securities before recovery of its amortized cost basis. Realized gains and losses and declines in fair value judged to be other than temporary, if any, on available-for-sale securities are included in other expenses, net. The cost of investments sold is based on the specific-identification method.</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> The Company has not experienced material realized gains or </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">losses</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or other-than-temporary losses in the periods presented.</span><span style="font-size:12pt;color:#000000;">&#160;</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest on available-for-sale securities is included in other expenses, net and is not material for all periods presented.</span></p></ix:continuation><ix:nonNumeric id="F_000273" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Property<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>Equipment, Net</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property<span style="letter-spacing:0.05pt;"> </span>and equipment<span style="letter-spacing:0.05pt;"> </span>are stated<span style="letter-spacing:0.05pt;"> </span>at cost, less<span style="letter-spacing:0.05pt;"> </span>accumulated<span style="letter-spacing:0.1pt;"> </span>depreciation.<span style="letter-spacing:0.1pt;"> </span>Depreciation<span style="letter-spacing:0.1pt;"> </span>is calculated<span style="letter-spacing:0.1pt;"> </span>on a straight-line<span style="letter-spacing:0.15pt;"> </span>basis<span style="letter-spacing:0.05pt;"> </span>over the estimated<span style="letter-spacing:0.1pt;"> </span>useful<span style="letter-spacing:0.05pt;"> </span>lives<span style="letter-spacing:0.05pt;"> </span>of the related<span style="letter-spacing:0.05pt;"> </span>assets,<span style="letter-spacing:0.05pt;"> </span>generally<span style="letter-spacing:0.05pt;"> </span>ranging<span style="letter-spacing:0.05pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>three<span style="letter-spacing:0.05pt;"> </span>to <ix:nonNumeric id="F_000318" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_0001785173_srtRangeAxis_srtMaximumMember_20210101_20211231" format="ixt-sec:durwordsen">seven years</ix:nonNumeric>.<span style="letter-spacing:0.05pt;"> </span><ix:nonNumeric id="F_000319" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" contextRef="C_0001785173_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20210101_20211231">Leasehold<span style="letter-spacing:0.05pt;"> </span>improvements<span style="letter-spacing:0.1pt;"> </span>are amortized<span style="letter-spacing:0.1pt;"> </span>on a straight-line<span style="letter-spacing:0.15pt;"> </span>basis<span style="letter-spacing:0.05pt;"> </span>over the shorter<span style="letter-spacing:0.05pt;"> </span>of the assets&#8217;<span style="letter-spacing:0.05pt;"> </span>estimated useful<span style="letter-spacing:0.05pt;"> </span>life<span style="letter-spacing:0.05pt;"> </span>or the remaining<span style="letter-spacing:0.1pt;"> </span>term<span style="letter-spacing:0.05pt;"> </span>of the lease.</ix:nonNumeric><span style="letter-spacing:0.05pt;"> </span><span style="color:#000000;">Upon retirement or sale of the assets, the cost and related accumulated depreciation and amortization are removed from the consolidated balance sheets and the resulting gains or losses are recorded in the consolidated statements of operations and comprehensive loss. </span>Maintenance<span style="letter-spacing:0.1pt;"> </span>and repair<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>are expensed as incurred.</p></ix:nonNumeric><ix:nonNumeric id="F_000274" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Impairment<span style="letter-spacing:0.1pt;"> </span>of Long-Lived Assets</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company periodically<span style="letter-spacing:0.1pt;"> </span>evaluates<span style="letter-spacing:0.05pt;"> </span>its<span style="letter-spacing:0.05pt;"> </span>long-lived<span style="letter-spacing:0.05pt;"> </span>assets,<span style="letter-spacing:0.05pt;"> </span>including<span style="letter-spacing:0.05pt;"> </span>property<span style="letter-spacing:0.05pt;"> </span>and equipment,<span style="letter-spacing:0.05pt;"> </span>for impairment<span style="letter-spacing:0.1pt;"> </span>whenever events<span style="letter-spacing:0.05pt;"> </span>or changes in business<span style="letter-spacing:0.05pt;"> </span>circumstances<span style="letter-spacing:0.15pt;"> </span>indicate<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>the carrying<span style="letter-spacing:0.05pt;"> </span>amount<span style="letter-spacing:0.05pt;"> </span>of the assets or group of assets<span style="letter-spacing:0.05pt;"> </span>may not be fully<span style="letter-spacing:0.05pt;"> </span>recoverable.<span style="letter-spacing:0.1pt;"> </span>If indicators<span style="letter-spacing:0.1pt;"> </span>of impairment<span style="letter-spacing:0.1pt;"> </span>exist<span style="letter-spacing:0.05pt;"> </span>and the undiscounted<span style="letter-spacing:0.05pt;"> </span>future cash flows that<span style="letter-spacing:0.05pt;"> </span>the assets<span style="letter-spacing:0.05pt;"> </span>are expected<span style="letter-spacing:0.05pt;"> </span>to generate<span style="letter-spacing:0.05pt;"> </span>are less<span style="letter-spacing:0.05pt;"> </span>than the carrying<span style="letter-spacing:0.05pt;"> </span>value of the assets,<span style="letter-spacing:0.05pt;"> </span>the Company reduces<span style="letter-spacing:0.05pt;"> </span>the carrying<span style="letter-spacing:0.05pt;"> </span>amount<span style="letter-spacing:0.05pt;"> </span>of the assets<span style="letter-spacing:0.05pt;"> </span>through an impairment<span style="letter-spacing:0.1pt;"> </span>charge,<span style="letter-spacing:0.05pt;"> </span>to their<span style="letter-spacing:0.05pt;"> </span>estimated<span style="letter-spacing:0.1pt;"> </span>fair<span style="letter-spacing:0.05pt;"> </span>values<span style="letter-spacing:0.05pt;"> </span>based on a discounted<span style="letter-spacing:0.05pt;"> </span>cash flow approach<span style="letter-spacing:0.05pt;"> </span>or, when<span style="letter-spacing:-0.05pt;"> </span>available<span style="letter-spacing:0.1pt;"> </span>and appropriate,<span style="letter-spacing:0.1pt;"> </span>to comparable<span style="letter-spacing:0.1pt;"> </span>market<span style="letter-spacing:0.05pt;"> </span>values.<span style="letter-spacing:0.05pt;"> </span>There were no such indicators<span style="letter-spacing:0.1pt;"> </span>for the periods<span style="letter-spacing:0.05pt;"> </span>presented.</p></ix:nonNumeric><ix:nonNumeric id="F_000275" name="etnb:AccruedResearchAndDevelopmentExpensesPolicyTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;color:#231F20;letter-spacing:0.05pt;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Accrued Research and Development Expenses</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company estimates preclinical<span style="letter-spacing:0.1pt;"> </span>and clinical<span style="letter-spacing:0.1pt;"> </span>study and research<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.05pt;"> </span>based on the services<span style="letter-spacing:0.05pt;"> </span>performed,<span style="letter-spacing:0.1pt;"> </span>pursuant<span style="letter-spacing:0.05pt;"> </span>to contracts<span style="letter-spacing:0.1pt;"> </span>with research<span style="letter-spacing:0.05pt;"> </span>institutions<span style="letter-spacing:0.1pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>conduct and manage<span style="letter-spacing:0.05pt;"> </span>preclinical<span style="letter-spacing:0.1pt;"> </span>and clinical<span style="letter-spacing:0.1pt;"> </span>studies<span style="letter-spacing:0.05pt;"> </span>and research<span style="letter-spacing:0.05pt;"> </span>services<span style="letter-spacing:0.05pt;"> </span>on its<span style="letter-spacing:0.05pt;"> </span>behalf. The Company records<span style="letter-spacing:0.05pt;"> </span>the costs<span style="letter-spacing:0.05pt;"> </span>of research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>activities<span style="letter-spacing:0.1pt;"> </span>based upon the estimated<span style="letter-spacing:0.1pt;"> </span>services<span style="letter-spacing:0.05pt;"> </span>provided<span style="letter-spacing:0.05pt;"> </span>but not yet invoiced<span style="letter-spacing:0.05pt;"> </span>and includes<span style="letter-spacing:0.05pt;"> </span>these<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>in accrued<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.15pt;"> </span>in the consolidated<span style="letter-spacing:0.1pt;"> </span>balance sheets.<span style="letter-spacing:0.05pt;"> </span>These costs<span style="letter-spacing:0.05pt;"> </span>are a component<span style="letter-spacing:0.05pt;"> </span>of the Company&#8217;s research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>expenses.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accrues for these costs based on factors such as estimates of the work completed in accordance with agreements established with its third-party service providers. The Company makes judgments and estimates in determining the accrued expenses balance. As actual costs become known, the Company adjusts its accrued expenses. The Company has not experienced any material differences between accrued costs and actual costs incurred. However, the status<span style="letter-spacing:0.05pt;"> </span>and timing<span style="letter-spacing:0.05pt;"> </span>of actual<span style="letter-spacing:0.05pt;"> </span>services<span style="letter-spacing:0.05pt;"> </span>performed<span style="letter-spacing:0.1pt;"> </span>may vary from<span style="letter-spacing:0.05pt;"> </span>the Company&#8217;s estimates,<span style="letter-spacing:0.1pt;"> </span>resulting<span style="letter-spacing:0.1pt;"> </span>in adjustments<span style="letter-spacing:0.1pt;"> </span>to expense in future<span style="letter-spacing:0.05pt;"> </span>periods.<span style="letter-spacing:0.05pt;"> </span>Changes in these<span style="letter-spacing:0.05pt;"> </span>estimates that<span style="letter-spacing:0.05pt;"> </span>result<span style="letter-spacing:0.05pt;"> </span>in material<span style="letter-spacing:0.1pt;"> </span>changes to the Company&#8217;s accrued expenses<span style="letter-spacing:0.05pt;"> </span>could materially<span style="letter-spacing:0.15pt;"> </span>affect<span style="letter-spacing:0.05pt;"> </span>the Company&#8217;s results<span style="letter-spacing:0.05pt;"> </span>of operations.<span style="letter-spacing:0.05pt;"> </span>Contingent<span style="letter-spacing:0.05pt;"> </span>milestone<span style="letter-spacing:0.1pt;"> </span>payments,<span style="letter-spacing:0.05pt;"> </span>if any, are expensed when<span style="letter-spacing:-0.05pt;"> </span>the milestone<span style="letter-spacing:0.1pt;"> </span>results<span style="letter-spacing:0.05pt;"> </span>are probable and estimable, which is generally<span style="letter-spacing:0.05pt;"> </span>upon achievement<span style="letter-spacing:0.1pt;"> </span>of the milestone.</p></ix:nonNumeric><ix:nonNumeric id="F_000276" name="us-gaap:LesseeLeasesPolicyTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true" continuedAt="F_000276_cnt_1">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Leases</p></ix:nonNumeric><ix:continuation id="F_000276_cnt_1">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company leases<span style="letter-spacing:0.05pt;"> </span>its<span style="letter-spacing:0.05pt;"> </span>office<span style="letter-spacing:0.05pt;"> </span>facilities<span style="letter-spacing:0.1pt;"> </span>under non-cancelable<span style="letter-spacing:0.1pt;"> </span>operating<span style="letter-spacing:0.05pt;"> </span>lease<span style="letter-spacing:0.05pt;"> </span>agreements<span style="letter-spacing:0.1pt;"> </span>and recognizes related<span style="letter-spacing:0.05pt;"> </span>rent<span style="letter-spacing:0.05pt;"> </span>expense on a straight-line<span style="letter-spacing:0.15pt;"> </span>basis<span style="letter-spacing:0.05pt;"> </span>over the term<span style="letter-spacing:0.05pt;"> </span>of the lease.</p></ix:continuation></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p><ix:continuation id="F_000251_dcnt_3f5f1d65-4c7b-415a-9749-e8728009e80a" continuedAt="F_000251_dcnt_2329d9ac-122e-43b6-aa43-0214434cdc8e"><ix:nonNumeric id="F_000278" name="us-gaap:ResearchAndDevelopmentExpensePolicy" contextRef="C_0001785173_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Research and<span style="letter-spacing:-0.05pt;"> </span>Development<span style="letter-spacing:0.05pt;"> </span>Expenses<span style="font-weight:normal;"> </span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.05pt;"> </span>consist<span style="letter-spacing:0.05pt;"> </span>primarily<span style="letter-spacing:0.1pt;"> </span>of costs<span style="letter-spacing:0.05pt;"> </span>incurred<span style="letter-spacing:0.05pt;"> </span>for the development<span style="letter-spacing:0.05pt;"> </span>of the Company&#8217;s lead product<span style="letter-spacing:0.05pt;"> </span>candidate,<span style="letter-spacing:0.05pt;"> </span>pegozafermin. Research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.05pt;"> </span>consist<span style="letter-spacing:0.05pt;"> </span>primarily<span style="letter-spacing:0.1pt;"> </span>of external<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>related<span style="letter-spacing:0.05pt;"> </span>to<span style="letter-spacing:0.1pt;"> </span>preclinical<span style="letter-spacing:0.1pt;"> </span>and clinical development<span style="letter-spacing:0.05pt;"> </span>and related<span style="letter-spacing:0.05pt;"> </span>supplies, and personnel<span style="letter-spacing:0.05pt;"> </span>costs.<span style="letter-spacing:0.05pt;"> </span>Personnel<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>consist<span style="letter-spacing:0.05pt;"> </span>of salaries,<span style="letter-spacing:0.1pt;"> </span>employee<span style="letter-spacing:0.05pt;"> </span>benefits<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:1.05pt;"> </span>stock-based<span style="letter-spacing:0.1pt;"> </span>compensation<span style="letter-spacing:0.1pt;"> </span>for individuals<span style="letter-spacing:0.1pt;"> </span>involved<span style="letter-spacing:0.05pt;"> </span>in research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>efforts. Payments<span style="letter-spacing:0.05pt;"> </span>associated<span style="letter-spacing:0.1pt;"> </span>with agreements<span style="letter-spacing:0.1pt;"> </span>to acquire<span style="letter-spacing:0.05pt;"> </span>licenses<span style="letter-spacing:0.05pt;"> </span>to develop, use, manufacture<span style="letter-spacing:0.1pt;"> </span>and commercialize<span style="letter-spacing:0.15pt;"> </span>products and purchases of pegozafermin from contract manufacturing organizations<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>have not reached<span style="letter-spacing:0.05pt;"> </span>technological<span style="letter-spacing:0.1pt;"> </span>feasibility<span style="letter-spacing:0.15pt;"> </span>and do not have alternate<span style="letter-spacing:0.1pt;"> future </span>commercial<span style="letter-spacing:0.1pt;"> </span>use are expensed as incurred.</p></ix:nonNumeric><ix:nonNumeric id="F_000279" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" contextRef="C_0001785173_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Stock-Based Compensation</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company provides equity awards in the form of stock options and restricted stock units. The Company measures<span style="letter-spacing:0.05pt;"> </span>its<span style="letter-spacing:0.05pt;"> </span>equity<span style="letter-spacing:0.05pt;"> </span>awards made to employees,<span style="letter-spacing:0.05pt;"> </span>directors,<span style="letter-spacing:0.1pt;"> </span>and<span style="color:#000000;"> </span>non-employee<span style="letter-spacing:0.05pt;"> </span>service<span style="letter-spacing:0.05pt;"> </span>providers<span style="letter-spacing:0.05pt;"> </span>based on estimated fair values and recognizes stock-based compensation over the requisite service period. The Company accounts<span style="letter-spacing:0.05pt;"> </span>for forfeitures<span style="letter-spacing:0.15pt;"> </span>as they occur.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company estimates<span style="letter-spacing:0.1pt;"> </span>the fair<span style="letter-spacing:0.05pt;"> </span>value of stock option<span style="letter-spacing:0.05pt;"> </span>awards on the date of grant<span style="letter-spacing:0.05pt;"> </span>using a<span style="color:#000000;"> </span>Black-Scholes<span style="letter-spacing:0.05pt;"> </span>option pricing<span style="letter-spacing:0.05pt;"> </span>model.<span style="letter-spacing:0.05pt;"> </span>The Company recognizes<span style="letter-spacing:0.05pt;"> </span>compensation<span style="letter-spacing:0.1pt;"> </span>for the value of stock options<span style="letter-spacing:0.05pt;"> </span>awards, which have graded vesting,<span style="letter-spacing:0.05pt;"> </span>using the straight-line<span style="letter-spacing:0.15pt;"> </span>method<span style="letter-spacing:0.05pt;"> </span>over the requisite<span style="letter-spacing:0.1pt;"> </span>service<span style="letter-spacing:0.05pt;"> </span>period<span style="letter-spacing:0.05pt;"> </span>of each award. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Black-Scholes option pricing model requires a number of assumptions, of which the most significant are expected volatility, expected option term (the time from the grant date until the options are exercised or expire), risk-free rate, and expected divided rate. These assumptions include:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Expected volatility&#8212;Since the Company has limited trading history for its common stock, expected volatility is estimated based on weighting the Company&#8217;s volatility and the volatility of comparable publicly traded biotechnology companies during the equivalent period of the calculated expected term of the options granted. The comparable companies were chosen based on their similar size, stage in the life cycle or area of specialty. There is a degree of uncertainty in determining a comparable peer group as each of the peers are engaged in varied research and development activities, the timing and progress of which differ within the peer group. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Expected term&#8212;The expected term of options granted to employees and directors is determined using the &#8220;simplified&#8221; method. Under this approach, the expected term is presumed to be the midpoint between the weighted-average vesting term and the contractual term of the option. The simplified method makes the assumption that the employee will exercise share options evenly over the period when the share options are vested and ending on the date when the share options would expire. The expected option term for options granted to non-employees is estimated on a grant-by-grant basis.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Risk-free interest rate&#8212;The risk-free interest rate is based on the U.S. Treasury zero coupon bonds in effect on the grant date for periods with an equivalent expected term as the option.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Expected dividend&#8212;The Company has never paid dividends and has no foreseeable plans to pay dividends on its shares of common stock. Therefore, an expected dividend of zero is used.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of restricted stock units is based on the fair value of the Company&#8217;s common stock on the date of grant. The grant date fair value of restricted stock units with service vesting conditions is recognized over the requisite service period on a straight-line basis. For restricted stock units with performance vesting conditions, the Company evaluates the probability of achieving the performance condition at each reporting date and recognizes expense for such performance awards over the requisite service period using the accelerated attribution method.</p></ix:nonNumeric><ix:nonNumeric id="F_000280" name="us-gaap:IncomeTaxPolicyTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true" continuedAt="F_000280_dcnt_77f348a4-87b3-428a-827d-b2ffe04d38bb">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Income Taxes</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income<span style="letter-spacing:0.05pt;"> </span>taxes<span style="letter-spacing:0.05pt;"> </span>are accounted<span style="letter-spacing:0.05pt;"> </span>for under the asset<span style="letter-spacing:0.05pt;"> </span>and liability<span style="letter-spacing:0.1pt;"> </span>method.<span style="letter-spacing:0.05pt;"> </span>Under this<span style="letter-spacing:0.05pt;"> </span>method,<span style="letter-spacing:0.05pt;"> </span>deferred<span style="letter-spacing:0.05pt;"> </span>tax assets<span style="letter-spacing:0.05pt;"> </span>and liabilities<span style="letter-spacing:0.15pt;"> </span>are recognized<span style="letter-spacing:0.05pt;"> </span>for the future<span style="letter-spacing:0.05pt;"> </span>tax consequences<span style="letter-spacing:0.05pt;"> </span>attributable<span style="letter-spacing:0.15pt;"> </span>to differences<span style="letter-spacing:0.1pt;"> </span>between the consolidated<span style="letter-spacing:0.1pt;"> </span>financial<span style="letter-spacing:0.1pt;"> </span>statements<span style="letter-spacing:0.1pt;"> </span>carrying<span style="letter-spacing:0.05pt;"> </span>amounts<span style="letter-spacing:0.05pt;"> </span>of existing<span style="letter-spacing:0.05pt;"> </span>assets<span style="letter-spacing:0.05pt;"> </span>and liabilities<span style="letter-spacing:0.15pt;"> </span>and their<span style="letter-spacing:0.05pt;"> </span>respective<span style="letter-spacing:0.1pt;"> </span>tax bases and operating<span style="letter-spacing:0.05pt;"> </span>loss and tax credit<span style="letter-spacing:0.05pt;"> </span>carryforwards.<span style="letter-spacing:0.1pt;"> </span>Deferred<span style="letter-spacing:0.05pt;"> </span>tax assets<span style="letter-spacing:0.05pt;"> </span>and liabilities<span style="letter-spacing:0.15pt;"> </span>are measured<span style="letter-spacing:0.05pt;"> </span>using enacted<span style="letter-spacing:0.05pt;"> </span>tax rates<span style="letter-spacing:0.05pt;"> </span>applied<span style="letter-spacing:0.05pt;"> </span>to </p></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p><ix:continuation id="F_000251_dcnt_2329d9ac-122e-43b6-aa43-0214434cdc8e" continuedAt="F_000251_dcnt_8b7ffe62-84e5-4761-80ca-cb335d6760d6"><ix:continuation id="F_000280_dcnt_77f348a4-87b3-428a-827d-b2ffe04d38bb">
<p style="margin-bottom:0pt;margin-top:6pt;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">taxable</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">income</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in the years</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in which those temporary</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">differences</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">are expected</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to be realized.</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The effect</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">on deferred</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tax assets</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and liabilities</span><span style="letter-spacing:0.15pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of a change in tax rates</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">is recognized</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">as income</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or loss in the period that</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">includes</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the enactment</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">date. A</span><span style="letter-spacing:-0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">valuation</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">allowance</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">is established</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">when</span><span style="letter-spacing:-0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">necessary</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to reduce</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">deferred</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tax assets</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to the amount</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">expected</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to be realized.</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and penalties</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">related</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to unrecognized</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tax benefits</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">are included</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">within the provision</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of income</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tax. </span></p></ix:continuation><ix:nonNumeric id="F_000281" name="us-gaap:EarningsPerSharePolicyTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Basic and<span style="letter-spacing:-0.05pt;"> </span>Diluted Net Loss per Share</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic loss per share<span style="letter-spacing:0.05pt;"> </span>is computed<span style="letter-spacing:0.05pt;"> </span>by dividing<span style="letter-spacing:0.05pt;"> </span>the net loss by the weighted-average<span style="letter-spacing:0.05pt;"> </span>number<span style="letter-spacing:0.05pt;"> </span>of common stock<span style="letter-spacing:0.05pt;"> </span>outstanding<span style="letter-spacing:0.05pt;"> </span>during the period.<span style="letter-spacing:0.05pt;"> </span>Diluted<span style="letter-spacing:0.05pt;"> </span>loss per share<span style="letter-spacing:0.05pt;"> </span>is computed<span style="letter-spacing:0.05pt;"> </span>by dividing<span style="letter-spacing:0.05pt;"> </span>the net loss by the weighted-average<span style="letter-spacing:0.05pt;"> </span>number<span style="letter-spacing:0.05pt;"> </span>of common stock<span style="letter-spacing:0.05pt;"> </span>outstanding<span style="letter-spacing:0.05pt;"> </span>together<span style="letter-spacing:0.05pt;"> </span>with the number<span style="letter-spacing:0.05pt;"> </span>of additional<span style="letter-spacing:0.1pt;"> shares of </span>common stock<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>would have been outstanding<span style="letter-spacing:0.05pt;"> </span>if all<span style="letter-spacing:0.05pt;"> </span>potentially<span style="letter-spacing:0.1pt;"> </span>dilutive<span style="letter-spacing:0.05pt;"> </span>common stock<span style="letter-spacing:0.05pt;"> </span>had been issued.<span style="letter-spacing:0.05pt;"> </span>Since the Company is in a loss position<span style="letter-spacing:0.05pt;"> </span>for the periods<span style="letter-spacing:0.05pt;"> </span>presented,<span style="letter-spacing:0.05pt;"> </span>basic<span style="letter-spacing:0.05pt;"> </span>net loss per share<span style="letter-spacing:0.05pt;"> </span>is the same<span style="letter-spacing:0.05pt;"> </span>as diluted<span style="letter-spacing:0.05pt;"> </span>net loss per share<span style="letter-spacing:0.05pt;"> </span>since<span style="letter-spacing:0.05pt;"> </span>the effects of potentially<span style="letter-spacing:0.1pt;"> </span>dilutive<span style="letter-spacing:0.05pt;"> </span>securities<span style="letter-spacing:0.1pt;"> </span>are antidilutive.</p></ix:nonNumeric><ix:nonNumeric id="F_000282" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Comprehensive<span style="letter-spacing:0.05pt;"> </span>Loss</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s comprehensive loss is comprised of net loss and changes in unrealized gains or losses on available-for-sale securities and foreign currency translation adjustments.</p></ix:nonNumeric><ix:nonNumeric id="F_000283" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true" continuedAt="F_000283_dcnt_377e6df5-58bf-4908-8ad3-fa249aa2042f">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2016, the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-02&#8212;<span style="font-style:italic;">Leases </span>(&#8220;ASU 2016-02&#8221;), requiring the recognition of lease assets and liabilities on the balance sheet. The standard: (a) clarifies the definition of a lease&#59; (b) requires a dual approach to lease classification similar to current lease classifications&#59; and (c) causes lessees to recognize leases on the balance sheet as a lease liability with a corresponding right-of-use asset for leases with a lease-term of more than twelve months. As an emerging growth company, ASU 2016-02 is effective for the Company for the year ending December 31, 2022 and interim periods within the year ending December 31, 2023. The Company expects to adopt ASC 842 using the modified retrospective method with a cumulative effect adjustment, if any, to equity at the beginning of the period of adoption. The Company anticipates electing several practical expedients that permit the Company not to reassess (i) whether a contract is or contains a lease, (ii) the classification of existing leases, and (iii) whether previously capitalized initial direct costs would qualify for capitalization. The Company also anticipates electing not to separate non-lease components from the associated lease components and to not to recognize lease assets and liabilities for leases with a term of 12 months or less. Based on its existing facility leases as of December 31, 2021, the Company does not expect the adoption of this new standard to have a material impact on the Company&#8217;s consolidated financial statements.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In June 2016, the FASB issued ASU 2016-13,&#160;</span><span style="font-style:italic;Background-color:#FFFFFF;">Financial Instruments&#8212;Credit Losses (Topic 326)</span><span style="Background-color:#FFFFFF;">: </span><span style="font-style:italic;Background-color:#FFFFFF;">Measurement of Credit Losses on Financial Instruments </span><span style="color:#000000;">(&#8220;ASU 2016-13&#8221;)</span><span style="Background-color:#FFFFFF;">, which replaces the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measured at amortized cost to be presented at the net amount expected to be collected. As an emerging growth company, ASU 2016-13 is effective for the Company </span><span style="color:#000000;">for the year ending December 31, 2023 and interim periods within that fiscal year</span><span style="Background-color:#FFFFFF;"> and must be adopted using a modified retrospective approach, with certain exceptions. The Company is evaluating the impact of this standard on its consolidated financial statements and related disclosures.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;">&#160;</p></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p><ix:continuation id="F_000251_dcnt_8b7ffe62-84e5-4761-80ca-cb335d6760d6"><ix:continuation id="F_000283_dcnt_377e6df5-58bf-4908-8ad3-fa249aa2042f">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:continuation></ix:continuation><ix:nonNumeric id="F_000252" name="us-gaap:FairValueDisclosuresTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true" continuedAt="F_000252_dcnt_de59bf31-f334-4438-a5a3-e5dee9b91fc7">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">3. Fair Value Measurements </p><ix:nonNumeric id="F_000284" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true" continuedAt="F_000284_cnt_1">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents the Company&#8217;s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of December 31, 2021 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Valuation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Hierarchy</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000320" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">21,477</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000338" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">21,477</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000321" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">59,647</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000331" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20211231" decimals="-3" scale="3">10</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000339" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">59,637</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government bonds</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000322" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesShorttermDebtSecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">21,662</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000332" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesShorttermDebtSecuritiesMember_20211231" decimals="-3" scale="3">42</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000340" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesShorttermDebtSecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">21,620</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000323" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,776</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000328" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20211231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000333" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20211231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000341" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,776</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency bonds</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000324" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,747</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000329" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20211231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000334" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20211231" decimals="-3" scale="3">7</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000342" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,741</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Municipal bonds</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000325" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMunicipalBondsMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,251</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000335" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMunicipalBondsMember_20211231" decimals="-3" scale="3">4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000343" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMunicipalBondsMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,247</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-U.S. debt securities</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000326" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtSecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,506</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000336" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtSecuritiesMember_20211231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000344" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtSecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,505</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000327" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">126,066</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000330" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231" decimals="-3" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000337" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231" decimals="-3" scale="3">65</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000345" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">126,003</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Classified as:</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000346" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCashEquivalentsMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">27,715</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term available-for-sale securities</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000347" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">98,288</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000348" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">126,003</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p><ix:nonNumeric id="F_000285" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true" continuedAt="F_000285_cnt_1">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the Company&#8217;s cash equivalents and available-for-sale securities by contractual maturity as of December 31, 2021 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.14%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Within one year</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000349" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">120,726</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">After one year through two years</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000350" name="etnb:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,277</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000351" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">126,003</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&#160;</p><ix:continuation id="F_000284_cnt_1">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents the Company&#8217;s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of December 31, 2020 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Valuation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Hierarchy</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000352" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">46,134</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000368" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">46,134</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000353" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">76,605</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000364" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231" decimals="-3" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000369" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">76,603</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency bonds</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000354" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">29,654</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000361" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20201231" decimals="-3" scale="3">15</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000370" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">29,669</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000355" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,890</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000365" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20201231" decimals="-3" scale="3">6</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000371" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,884</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government bonds</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000356" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesShorttermDebtSecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,093</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000372" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesShorttermDebtSecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,093</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Municipal bonds</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000357" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMunicipalBondsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,592</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000362" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMunicipalBondsMember_20201231" decimals="-3" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000366" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMunicipalBondsMember_20201231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000373" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMunicipalBondsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,593</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. treasury bills</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000358" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBillSecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,680</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000374" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBillSecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,680</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency discount securities</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000359" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_etnbAgencyDiscountSecuritiesMember_20201231" decimals="-3" scale="3">200</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000375" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_etnbAgencyDiscountSecuritiesMember_20201231" decimals="-3" scale="3">200</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000360" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">181,848</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000363" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" scale="3">17</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000367" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" scale="3">9</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000376" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">181,856</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Classified as:</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000377" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCashEquivalentsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">75,410</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term available-for-sale securities</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000378" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">106,446</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000379" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">181,856</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&#160;</p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p><ix:continuation id="F_000252_dcnt_de59bf31-f334-4438-a5a3-e5dee9b91fc7">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000285_cnt_1">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the Company&#8217;s cash equivalents and available-for-sale securities by contractual maturity as of December 31, 2020 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.14%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Within one year</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000380" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">160,304</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">After one year through two years</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000381" name="etnb:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">21,552</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000382" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">181,856</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:continuation></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;">&#160;</p><ix:nonNumeric id="F_000253" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">4. Consolidated Balance Sheet Components </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Prepaid and Other Current Assets</p><ix:nonNumeric id="F_000286" name="etnb:ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid and other current assets consist of the following as of the periods presented (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.4%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid research and development</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000383" name="etnb:PrepaidResearchAndDevelopmentCurrent" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,895</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000384" name="etnb:PrepaidResearchAndDevelopmentCurrent" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,534</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid taxes</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000385" name="us-gaap:PrepaidTaxes" contextRef="C_0001785173_20211231" decimals="-3" scale="3">836</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000386" name="us-gaap:PrepaidTaxes" contextRef="C_0001785173_20201231" decimals="-3" scale="3">481</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid other</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000387" name="us-gaap:OtherPrepaidExpenseCurrent" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,506</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000388" name="us-gaap:OtherPrepaidExpenseCurrent" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,533</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total prepaid and other current assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000389" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,237</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000390" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,548</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&#160;</p><ix:nonNumeric id="F_000287" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Accrued Expenses </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses consist of the following as of the periods presented (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.4%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued research and development expenses</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000391" name="etnb:AccruedResearchAndDevelopmentExpenseCurrent" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,195</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000392" name="etnb:AccruedResearchAndDevelopmentExpenseCurrent" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,884</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued employee and related expenses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000393" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,168</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000394" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,552</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued professional and legal fees</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000395" name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="C_0001785173_20211231" decimals="-3" scale="3">495</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000396" name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="C_0001785173_20201231" decimals="-3" scale="3">453</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued other</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000397" name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="C_0001785173_20211231" decimals="-3" scale="3">336</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000398" name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="C_0001785173_20201231" decimals="-3" scale="3">159</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accrued expenses</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000399" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,194</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000400" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,048</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:5pt;">&#160;</p><ix:nonNumeric id="F_000254" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true" continuedAt="F_000254_dcnt_f1ce26d5-065b-4f50-82de-319ab8c9f4c3">
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">5. Commitments and Contingencies </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Leases</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May 2018, the Company entered<span style="letter-spacing:0.05pt;"> </span>into an operating<span style="letter-spacing:0.05pt;"> </span>lease<span style="letter-spacing:0.05pt;"> </span>agreement<span style="letter-spacing:0.1pt;"> </span>for its<span style="letter-spacing:0.05pt;"> </span>facility<span style="letter-spacing:0.1pt;"> </span>in Israel.<span style="letter-spacing:0.05pt;"> </span><ix:nonNumeric id="F_000401" name="us-gaap:DescriptionOfLesseeLeasingArrangementsOperatingLeases" contextRef="C_0001785173_20180501_20180531">The Company amended the lease term to expire in April 2022, with an option to renew for an additional <ix:nonNumeric id="F_000403" name="us-gaap:LesseeOperatingLeaseTermOfContract" contextRef="C_0001785173_20180531" format="ixt-sec:durmonth">12</ix:nonNumeric> months.</ix:nonNumeric> Under the lease agreement,<span style="letter-spacing:0.1pt;"> </span>monthly<span style="letter-spacing:0.05pt;"> </span>lease<span style="letter-spacing:0.05pt;"> </span>payments<span style="letter-spacing:0.05pt;"> </span>are approximately<span style="letter-spacing:0.1pt;"> </span>$<ix:nonFraction unitRef="U_iso4217USD" id="F_000402" name="etnb:OperatingLeaseMonthlyRentalPayments" contextRef="C_0001785173_20180501_20180531" decimals="0" format="ixt:numdotdecimal">4,200</ix:nonFraction>. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2019, the Company entered into an operating lease for its headquarters in San Francisco, <ix:nonNumeric id="F_000404" name="us-gaap:DescriptionOfLesseeLeasingArrangementsOperatingLeases" contextRef="C_0001785173_srtStatementGeographicalAxis_etnbSanFranciscoOfficeMember_20191201_20191231">with a lease term that was due to expire in January 2022. In July 2021, the Company amended the lease agreement to extend the term of the lease to January 2023, with an option to renew the term for <ix:nonNumeric id="F_000406" name="us-gaap:LesseeOperatingLeaseRenewalTerm" contextRef="C_0001785173_srtStatementGeographicalAxis_etnbSanFranciscoOfficeMember_20211231" format="ixt-sec:durwordsen">one year</ix:nonNumeric>.</ix:nonNumeric>&#160;Under the lease agreement, monthly lease payments are approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000405" name="etnb:OperatingLeaseMonthlyRentalPayments" contextRef="C_0001785173_srtStatementGeographicalAxis_etnbSanFranciscoOfficeMember_20200101_20201231" decimals="0" format="ixt:numdotdecimal">18,000</ix:nonFraction>. </p><ix:nonNumeric id="F_000288" name="us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Future minimum<span style="letter-spacing:0.1pt;"> </span>lease<span style="letter-spacing:0.05pt;"> </span>payments<span style="letter-spacing:0.05pt;"> </span>under the Company&#8217;s non-cancellable<span style="letter-spacing:0.1pt;"> </span>operating<span style="letter-spacing:0.05pt;"> </span>lease<span style="letter-spacing:0.05pt;"> </span>obligations<span style="letter-spacing:0.1pt;"> </span>as of December<span style="letter-spacing:0.05pt;"> </span>31, 2021, are as follows<span style="letter-spacing:0.05pt;"> </span>(in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:77.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000407" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="C_0001785173_20211231" decimals="-3" scale="3">212</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:77.1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000408" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="C_0001785173_20211231" decimals="-3" scale="3">7</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:77.1%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total future minimum annual payments</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000409" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDue" contextRef="C_0001785173_20211231" decimals="-3" scale="3">219</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p><ix:continuation id="F_000254_dcnt_f1ce26d5-065b-4f50-82de-319ab8c9f4c3">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Rent expense was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000410" name="us-gaap:LeaseAndRentalExpense" contextRef="C_0001785173_20210101_20211231" decimals="0" format="ixt:numdotdecimal">290,000</ix:nonFraction> and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000411" name="us-gaap:LeaseAndRentalExpense" contextRef="C_0001785173_20200101_20201231" decimals="0" format="ixt:numdotdecimal">273,000</ix:nonFraction> for the years ended December 31, 2021 and 2020, respectively. The Company has security deposit balances of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000413" name="us-gaap:SecurityDeposit" contextRef="C_0001785173_us-gaapBalanceSheetLocationAxis_etnbRestrictedCashAndOtherAssetsMember_20201231" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_iso4217USD" id="F_000412" name="us-gaap:SecurityDeposit" contextRef="C_0001785173_us-gaapBalanceSheetLocationAxis_etnbRestrictedCashAndOtherAssetsMember_20211231" decimals="0" format="ixt:numdotdecimal">95,000</ix:nonFraction></ix:nonFraction>, a portion of which is included in restricted cash and a portion in other assets in the consolidated balance sheets as of December 31, 2021 and 2020.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Asset Transfer and License Agreement with Teva Pharmaceutical Industries Ltd </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2018, the Company concurrently entered into two Asset Transfer and License Agreements (the &#8220;Teva Agreements&#8221;) with Teva Pharmaceutical Industries Ltd (&#8220;Teva&#8221;) under which it acquired certain patents and intellectual property relating to two programs: (1)&#160;Teva&#8217;s glycoPEGylated FGF21 program, including the compound TEV-47948 (pegozafermin), a glycoPEGylated long-acting FGF21 and (2)&#160;Teva&#8217;s development program of small molecule inhibitors of fatty acid synthase. Pursuant to the Teva Agreements, the Company paid Teva an initial nonrefundable upfront payment of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000414" name="etnb:AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment" contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20180401_20180430" decimals="-5" scale="6">6.0</ix:nonFraction>&#160;million and the Company could be obligated to pay Teva up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000415" name="etnb:ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones" contextRef="C_0001785173_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_etnbTevasGlycoPEGylatedFGF21ProgramMember_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20180401_20180430" decimals="INF" scale="6"><ix:nonFraction unitRef="U_iso4217USD" id="F_000416" name="etnb:ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones" contextRef="C_0001785173_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_etnbTevasDevelopmentProgramMember_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20180401_20180430" decimals="INF" scale="6">67.5</ix:nonFraction></ix:nonFraction>&#160;million under each program, for a total of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000417" name="etnb:ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones" contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20180401_20180430" decimals="INF" scale="6">135.0</ix:nonFraction>&#160;million, upon the achievement of certain clinical development and commercial milestones. In addition, the Company is obligated to pay Teva tiered royalties at percentages in the low-to-mid single-digits on worldwide net sales on all products containing the Teva compounds. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Teva Agreements can be terminated (i)&#160;by the Company without cause upon <ix:nonNumeric id="F_000418" name="etnb:AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice" contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20210101_20211231" format="ixt-sec:durday">120</ix:nonNumeric> days&#8217; written notice to Teva, (ii)&#160;by either party, if the other party materially breaches any of its obligations under the Teva Agreements and fails to cure such breach within <ix:nonNumeric id="F_000419" name="etnb:AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure" contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20210101_20211231" format="ixt-sec:durday">60</ix:nonNumeric> days after receiving notice thereof, or (iii)&#160;by either party, if a bankruptcy petition is filed against the other party and is not dismissed within <ix:nonNumeric id="F_000420" name="etnb:AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled" contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20210101_20211231" format="ixt-sec:durday">60</ix:nonNumeric> days. In addition, Teva can also terminate the agreement related to the Company&#8217;s glycoPEGylated FGF21 program in the event the Company, or any of its affiliates or sublicensees, challenges any of the Teva patents licensed to the Company, and the challenge is not withdrawn within 30 days of written notice from Teva. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the years ended December 31, 2021 and 2020, none of the development and commercial milestones were met and accordingly, there were <ix:nonFraction unitRef="U_iso4217USD" id="F_000422" name="etnb:MilestonePayment" contextRef="C_0001785173_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20200101_20201231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_iso4217USD" id="F_000421" name="etnb:MilestonePayment" contextRef="C_0001785173_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20210101_20211231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> milestone payments related to the Teva Agreements. </p></ix:continuation><ix:nonNumeric id="F_000255" name="us-gaap:LongTermDebtTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true" continuedAt="F_000255_dcnt_17b54c41-e76e-4ac6-a180-e20f3125b8e9">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">6. Term Loan</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Loan and Security Agreement</p><ix:nonNumeric id="F_000425" name="us-gaap:LineOfCreditFacilityDescription" contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20200401_20200430"><p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2020, the Company entered into a Loan and Security Agreement, (the &#8220;Loan Agreement&#8221;) with the lenders referred to therein (the &#8220;Lenders&#8221;), and Silicon Valley Bank (&#8220;SVB&#8221;), as collateral agent. The Loan Agreement provided for (i) a secured term A loan facility (the &#8220;Term A Loan Facility&#8221;) of up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000423" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermALoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20200430" decimals="-5" scale="6">10.0</ix:nonFraction> million and (ii) a secured term B loan facility (the &#8220;Term B Loan Facility&#8221;) of up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000424" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermBLoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20200430" decimals="-5" scale="6">5.0</ix:nonFraction> million that became available upon the satisfaction of certain milestones, each of which was available to be drawn through May 31, 2021 pursuant to an amendment executed in April 2021. The term loan is secured by certain assets of the Borrowers (as defined in the Loan Agreement), including substantially all of the assets of the Company, excluding the Company&#8217;s intellectual property. The term loan contains customary representations, warranties, affirmative covenants and also certain restrictive covenants.</p></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2020, in connection with the execution of the Loan Agreement, the Company issued SVB a warrant to purchase <ix:nonFraction unitRef="U_xbrlishares" id="F_000426" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermALoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20200430" decimals="INF" format="ixt:numdotdecimal">25,000</ix:nonFraction> shares of the Company&#8217;s common stock with a warrant exercise price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000427" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermALoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20200430" decimals="2">22.06</ix:nonFraction> per share that is immediately exercisable and expires on<span style="font-size:12pt;">&#160;</span><ix:nonNumeric id="F_000428" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20200430" format="ixt:datemonthdayyearen">June 30, 2025</ix:nonNumeric>, as amended. The fair value of the warrant at issuance date was determined by using the Black-Scholes option-pricing model with the following assumptions: risk-free interest rate of <ix:nonFraction unitRef="U_xbrlipure" id="F_000431" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="C_0001785173_20200401_20200430" decimals="4" scale="-2">0.75</ix:nonFraction>%, no dividends, expected volatility of <ix:nonFraction unitRef="U_xbrlipure" id="F_000432" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="C_0001785173_20200401_20200430" decimals="3" scale="-2">92.3</ix:nonFraction>% and expected term of <ix:nonNumeric id="F_000433" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001785173_20200401_20200430" format="ixt-sec:duryear">10.0</ix:nonNumeric> years. Upon issuance, the fair value allocated to the warrant of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000429" name="us-gaap:DeferredFinanceCostsGross" contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20200430" decimals="-5" scale="6">0.6</ix:nonFraction> million met the requirements for equity classification within additional paid-in capital in the consolidated balance sheets. Additionally, the Company incurred $<ix:nonFraction unitRef="U_iso4217USD" id="F_000430" name="us-gaap:DeferredFinanceCostsGross" contextRef="C_0001785173_us-gaapBalanceSheetLocationAxis_us-gaapOtherAssetsMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20200430" decimals="-5" scale="6">0.2</ix:nonFraction> million in closing costs, which together with the value of the warrants, were recorded as debt issuance costs classified within other assets in the consolidated balance sheets.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000438" name="us-gaap:LineOfCreditFacilityDescription" contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210501_20210531">In May 2021, the parties further amended the Loan Agreement (as amended, the &#8220;2021 Loan Agreement&#8221;). The 2021 Loan Agreement increased the Term A Loan Facility to up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000434" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermALoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210531" decimals="-5" scale="6">20.0</ix:nonFraction> million thereby increasing the total term loan facility from $<ix:nonFraction unitRef="U_iso4217USD" id="F_000435" name="etnb:LineOfCreditFacilityIncreaseInBorrowingCapacity" contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210501_20210531" decimals="-5" scale="6">15.0</ix:nonFraction> million to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000436" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="C_0001785173_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210531" decimals="-5" scale="6">25.0</ix:nonFraction> million. The Term B Loan Facility of up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000437" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermBLoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210531" decimals="-5" scale="6">5.0</ix:nonFraction> million remains available to be drawn upon the achievement of certain additional milestones, and each loan facility is available to be drawn upon on or before September 30, 2022.</ix:nonNumeric> </p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p><ix:continuation id="F_000255_dcnt_17b54c41-e76e-4ac6-a180-e20f3125b8e9" continuedAt="F_000255_dcnt_74483396-4a09-4043-b6e5-eb1b9292cf61">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Concurrent with the closing and as a condition of the 2021 Loan Agreement, the Company drew $</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000439" name="us-gaap:LineOfCredit" contextRef="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermALoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20211231" decimals="-5" scale="6">1.5</ix:nonFraction></span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and in </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December 2021, drew the remaining $18.5 million </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">under</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the Term Loan A Facility. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 2021 Loan Agreement provides for interest</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">only payments </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">until</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> October 1, 2022, followed by consecutive monthly payments of principal and interest starting on October 1, 2022 and continuing through</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000440" name="us-gaap:LineOfCreditFacilityExpirationDate1" contextRef="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermALoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210101_20211231" format="ixt:datemonthdayyearen">September 1, 2024</ix:nonNumeric></span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the maturity date of the term loan. The interest only period may be extended to April 1, 2023, if on or before September 20, 2022, the Company receives net cash proceeds of at least $</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000441" name="etnb:NetCashProceedsFromSaleOfEquitySecurities" contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210101_20211231" decimals="-5" scale="6">75.0</ix:nonFraction></span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million from the sale of its equity securities. The term loan bears interest at the greater of (i) </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000442" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="C_0001785173_srtRangeAxis_srtMinimumMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210101_20211231" decimals="4" scale="-2">4.25</ix:nonFraction></span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">% and (ii) the sum of (a) the Prime Rate as reported in The Wall Street Journal plus (b) </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000443" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_us-gaapVariableRateAxis_us-gaapPrimeRateMember_20210101_20211231" decimals="4" scale="-2">1.00</ix:nonFraction></span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">% (or </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for both amounts drawn </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.25% initially and as of </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 3</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, 2021). In addition, a final payment fee of </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000444" name="etnb:PercentageOfFeeOnLoan" contextRef="C_0001785173_20210101_20211231" decimals="2" scale="-2">5</ix:nonFraction>%</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the principal amount of the loan is due when the term loan becomes due or upon prepayment of the term loan. If the Company elects to prepay the loan, there is also a prepayment fee of between 1% and 3% of the principal amount of the term loan depending on the timing of prepayment.</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May 2021, in connection with the execution of the 2021 Loan Agreement, the Company issued SVB a warrant to purchase <ix:nonFraction unitRef="U_xbrlishares" id="F_000445" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210531" decimals="INF" format="ixt:numdotdecimal">33,923</ix:nonFraction> shares of the Company&#8217;s common stock with a warrant exercise price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000446" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210531" decimals="2">19.12</ix:nonFraction> per share that is immediately exercisable and expires on <ix:nonNumeric id="F_000447" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210531" format="ixt:datemonthdayyearen">May 28, 2031</ix:nonNumeric>. The Company determined the fair value of the warrant at the issuance date by using the Black-Scholes option-pricing model with the following assumptions: risk-free interest rate of <ix:nonFraction unitRef="U_xbrlipure" id="F_000448" name="us-gaap:DebtInstrumentMeasurementInput" contextRef="C_0001785173_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputRiskFreeInterestRateMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_us-gaapValuationTechniqueAxis_us-gaapValuationTechniqueOptionPricingModelMember_20210531" decimals="3" scale="-2">1.6</ix:nonFraction>%, <ix:nonFraction unitRef="U_iso4217USD" id="F_000449" name="etnb:FairValueOfWarrantsAssumptionsDividends" contextRef="C_0001785173_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputExpectedDividendPaymentMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210501_20210531" decimals="-3" format="ixt-sec:numwordsen" scale="3">no</ix:nonFraction> dividends, expected volatility of <ix:nonFraction unitRef="U_xbrlipure" id="F_000450" name="us-gaap:DebtInstrumentMeasurementInput" contextRef="C_0001785173_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_us-gaapValuationTechniqueAxis_us-gaapValuationTechniqueOptionPricingModelMember_20210531" decimals="3" scale="-2">98.6</ix:nonFraction>% and expected term of <ix:nonNumeric id="F_000451" name="us-gaap:DebtInstrumentTerm" contextRef="C_0001785173_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputExpectedTermMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_us-gaapValuationTechniqueAxis_us-gaapValuationTechniqueOptionPricingModelMember_20210501_20210531" format="ixt-sec:duryear">10.0</ix:nonNumeric> years. Upon issuance, the fair value of the warrant of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000452" name="us-gaap:DeferredFinanceCostsGross" contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210531" decimals="-5" scale="6">0.6</ix:nonFraction> million was recorded as a debt issuance cost and met the requirements for equity classification within additional paid-in capital in the consolidated balance sheets. In addition, closing costs incurred were not material. In connection with Term Loan B Facility, if funded, the Company will issue additional warrant to purchase <ix:nonFraction unitRef="U_xbrlishares" id="F_000453" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermBLoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210531" decimals="INF" format="ixt:numdotdecimal">11,305</ix:nonFraction> shares of the Company&#8217;s common stock with the exercise price at the Company&#8217;s stock price at the time of issuance.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 2021 Loan Agreement was accounted for as a modification to a credit facility. The related debt issuance costs incurred in May 2021, including the fair value of the warrant, together with the remaining unamortized debt issuance costs related to the Loan Agreement of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000454" name="us-gaap:DeferredTaxAssetsGross" contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210531" decimals="-5" scale="6">0.4</ix:nonFraction> million were recorded as deferred assets and recognized on a straight-line basis as interest expense over the availability of the draw period. As of December 31, 2021, all amounts were drawn under the Term Loan A Facility such that all debt issuance costs were recorded as a debt discount. The carrying value of the debt discount, together with the final payment fee, are recognized using the effective interest method. Interest expense is recorded within other expenses, net in the consolidated statements of operations and comprehensive loss. </p><ix:nonNumeric id="F_000289" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true" continuedAt="F_000289_cnt_1">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;<span style="font-size:10pt;">The expected repayments of principal amount due on the term loan, excluding the final payment fee, as of December 31, 2021 are as follows (in thousands):</span></p></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;">&#160;</p><ix:continuation id="F_000289_cnt_1">
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000455" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,500</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000456" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000457" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,500</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total principal repayments</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000458" name="us-gaap:DebtInstrumentCarryingAmount" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">20,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: unamortized debt discount</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000459" name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="C_0001785173_20211231" decimals="-3" scale="3">602</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total term loan, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000460" name="us-gaap:LongTermDebt" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,398</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: term loan, current</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000461" name="us-gaap:LongTermDebtCurrent" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,500</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term loan, non-current, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000462" name="us-gaap:LongTermDebtNoncurrent" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">16,898</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:12pt;">&#160;</p></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p><ix:continuation id="F_000255_dcnt_74483396-4a09-4043-b6e5-eb1b9292cf61">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:continuation><ix:nonNumeric id="F_000256" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true" continuedAt="F_000256_dcnt_32af596b-de16-4c85-bb2f-62901bd56d92">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">7. Stock-Based Compensation </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Equity Incentive Plans</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s board of directors approved the 2019 Equity Incentive Plan (the &#8220;2019 Plan&#8221;), which became effective in September 2019. The Company initially reserved <ix:nonFraction unitRef="U_xbrlishares" id="F_000463" name="etnb:NumberOfSharesIssuableUnderShareBasedPaymentArrangement" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">2,844,193</ix:nonFraction> shares of common stock for issuance under the 2019 Plan. In addition, the number of shares of common stock reserved for issuance under the 2019 Plan will automatically increase on the first day of January for a period of up to <ix:nonNumeric id="F_000464" name="etnb:PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance" contextRef="C_0001785173_srtRangeAxis_srtMaximumMember_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231" format="ixt-sec:durwordsen">ten years</ix:nonNumeric>, commencing on January 1, 2020, in an amount equal to <ix:nonFraction unitRef="U_xbrlipure" id="F_000465" name="etnb:PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231" decimals="2" scale="-2">4</ix:nonFraction>% of the total number of shares of the Company&#8217;s capital stock outstanding on the immediately preceding December 31, or a lesser number of shares determined by the Company&#8217;s board of directors. As of December 31, 2021, there were <ix:nonFraction unitRef="U_xbrlishares" id="F_000466" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20211231" decimals="INF" format="ixt:numdotdecimal">1,428,304</ix:nonFraction> shares of common stock available for issuance as future option grants under the 2019 Plan. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000469" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231">The board of directors determines the period over which options become exercisable and options generally vest over a <span style="-sec-ix-hidden:F_000467">four-year</span> period, with <ix:nonFraction unitRef="U_xbrlipure" id="F_000468" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231" decimals="2" scale="-2">25</ix:nonFraction>% of options vesting on the first anniversary of employment, and thereafter, the remaining options vesting quarterly, over the following <ix:nonNumeric id="F_000470" name="etnb:ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231" format="ixt-sec:durmonth">36</ix:nonNumeric>-month period. The options will expire within <ix:nonNumeric id="F_000471" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231" format="ixt-sec:durwordsen">ten years</ix:nonNumeric> from the date of grant.</ix:nonNumeric> The exercise price of awards granted will not be less than the estimated fair value of the shares on the date of grant.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Employee Stock Purchase Plan</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In October 2019, the Company adopted the 2019 Employee Stock Purchase Plan (&#8220;ESPP&#8221;), which became effective in November 2019. The Company initially reserved <ix:nonFraction unitRef="U_xbrlishares" id="F_000472" name="etnb:NumberOfSharesIssuableUnderShareBasedPaymentArrangement" contextRef="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20191001_20191031" decimals="INF" format="ixt:numdotdecimal">225,188</ix:nonFraction> shares of common stock for purchase under the ESPP. The number of shares of common stock reserved for issuance under the ESPP will automatically increase on the first day of January for a period of up to <ix:nonNumeric id="F_000473" name="etnb:PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance" contextRef="C_0001785173_srtRangeAxis_srtMaximumMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20191001_20191031" format="ixt-sec:durwordsen">ten years</ix:nonNumeric>, in an amount equal to <ix:nonFraction unitRef="U_xbrlipure" id="F_000474" name="etnb:PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding" contextRef="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20191001_20191031" decimals="2" scale="-2">1</ix:nonFraction>% <span style="color:#000000;">of the total number of shares of the Company&#8217;s common stock outstanding on the immediately preceding December 31, or a lesser number of shares determined by the Company&#8217;s board of directors. Purchases will be accomplished through the participation of discrete offering periods and each offering is expected to be 6 months long. For each offering period, ESPP participants will purchase shares of common stock at a price per share equal to</span> <ix:nonFraction unitRef="U_xbrlipure" id="F_000475" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" contextRef="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20191001_20191031" decimals="2" scale="-2">85</ix:nonFraction>% <span style="color:#000000;">of the lesser of the fair market value of the Company&#8217;s common stock on (1) the first trading day of the applicable offering period or (2) the last trading day of the applicable offering period</span>. The first <ix:nonNumeric id="F_000476" name="etnb:ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriod" contextRef="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20191001_20191031" format="ixt-sec:durwordsen">six month</ix:nonNumeric> offering period under the ESPP commenced on <ix:nonNumeric id="F_000477" name="etnb:ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate" contextRef="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20191001_20191031" format="ixt:datemonthdayyearen">January 1, 2020</ix:nonNumeric>.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, there were <ix:nonFraction unitRef="U_xbrlishares" id="F_000478" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20211231" decimals="INF" format="ixt:numdotdecimal">544,410</ix:nonFraction> shares of common stock available for issuance under the ESPP.</p><ix:nonNumeric id="F_000290" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true" continuedAt="F_000290_cnt_1">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recorded stock-based compensation for the periods presented as follows (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p></ix:nonNumeric><ix:continuation id="F_000290_cnt_1">
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.54%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000479" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001785173_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,966</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000480" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001785173_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,250</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000481" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001785173_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,712</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000482" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001785173_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,557</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stock-based compensation</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000483" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001785173_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,678</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000484" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001785173_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,807</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p></ix:continuation><ix:nonNumeric id="F_000291" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true" continuedAt="F_000291_cnt_1">
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of stock options granted for the periods presented was estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions: </p></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p><ix:continuation id="F_000291_cnt_1" continuedAt="F_000291_dcnt_a639fd0c-1666-4b73-9a13-870621b9991e">
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.54%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (years)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000485">5.5-6.1</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000486">4.0-6.1</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000489">86.9-91.9%</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000490">86.4-97.6%</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000493">0.7-1.3%</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000494">0.2-1.5%</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p></ix:continuation></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p><ix:continuation id="F_000256_dcnt_32af596b-de16-4c85-bb2f-62901bd56d92"><ix:continuation id="F_000291_dcnt_a639fd0c-1666-4b73-9a13-870621b9991e">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:continuation><ix:nonNumeric id="F_000292" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true" continuedAt="F_000292_cnt_1">
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes stock option activity for the year ended December 31, 2021: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;">&#160;</p></ix:nonNumeric><ix:continuation id="F_000292_cnt_1">
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Term</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In years)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In&#160;thousands)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance outstanding as of December 31, 2020</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000497" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20201231" decimals="INF" format="ixt:numdotdecimal">1,898,395</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000503" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20201231" decimals="2">12.79</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000509">8.6</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000512" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">25,918</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000498" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">830,013</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000504" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231" decimals="2">22.22</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000499" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">188,286</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000505" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231" decimals="2">2.59</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cancelled and forfeited</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000500" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">133,454</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000506" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231" decimals="2">19.55</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance outstanding as of December 31, 2021</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000501" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20211231" decimals="INF" format="ixt:numdotdecimal">2,406,668</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000507" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20211231" decimals="2">16.46</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000510">8.1</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000513" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,970</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercisable as of December 31, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000502" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20211231" decimals="INF" format="ixt:numdotdecimal">922,104</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000508" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20211231" decimals="2">10.76</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000511">7.3</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000514" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,800</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-right:1.92%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:continuation>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The estimated grant date fair value of stock options that vested during the year ended December 31, 2021, was $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000515" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndTwentyEquityIncentivePlanMember_20210101_20211231" decimals="-5" scale="6">7.0</ix:nonFraction> million. The weighted-average<span style="letter-spacing:0.1pt;"> </span>grant<span style="letter-spacing:0.05pt;"> </span>date fair<span style="letter-spacing:0.05pt;"> </span>value of stock options<span style="letter-spacing:0.05pt;"> that were </span>granted<span style="letter-spacing:0.05pt;"> </span>during the years ended December 31, 2021 and 2020 was $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000516" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndTwentyEquityIncentivePlanMember_20210101_20211231" decimals="2">16.18</ix:nonFraction> and $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000517" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndTwentyEquityIncentivePlanMember_20200101_20201231" decimals="2">21.88</ix:nonFraction> per share, respectively.<span style="letter-spacing:0.05pt;"> </span>As<span style="letter-spacing:-0.05pt;"> </span>of December<span style="letter-spacing:0.05pt;"> </span>31, 2021, there<span style="letter-spacing:0.05pt;"> </span>was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000518" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20211231" decimals="-5" scale="6">17.9</ix:nonFraction> million of unrecognized<span style="letter-spacing:0.05pt;"> </span>stock-based compensation<span style="letter-spacing:0.1pt;"> </span>cost related<span style="letter-spacing:0.05pt;"> </span>to stock options<span style="letter-spacing:0.05pt;"> </span>granted<span style="letter-spacing:0.05pt;"> </span>under the 2019 Plan, which is expected<span style="letter-spacing:0.05pt;"> </span>to be recognized<span style="letter-spacing:0.05pt;"> </span>over a weighted-average<span style="letter-spacing:0.1pt;"> </span>period<span style="letter-spacing:0.05pt;"> </span>of <span><span style="color:#000000;"><ix:nonNumeric id="F_000519" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231" format="ixt-sec:duryear">2.3</ix:nonNumeric></span> years</span>. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Restricted Stock Units (&#8220;RSUs&#8221;) </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2021, the Company granted <ix:nonFraction unitRef="U_xbrlishares" id="F_000520" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_0001785173_srtTitleOfIndividualAxis_us-gaapShareBasedPaymentArrangementEmployeeMember_us-gaapAwardTypeAxis_etnbServiceBasedRSUsMember_20210201_20210228" decimals="INF" format="ixt:numdotdecimal">56,545</ix:nonFraction> service-based RSUs to its employees with a total grant date fair value of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000521" name="etnb:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue" contextRef="C_0001785173_srtTitleOfIndividualAxis_us-gaapShareBasedPaymentArrangementEmployeeMember_us-gaapAwardTypeAxis_etnbServiceBasedRSUsMember_20210201_20210228" decimals="-5" scale="6">1.3</ix:nonFraction> million. The RSUs vest annually over a <span style="-sec-ix-hidden:F_000523">three-year</span> period. During the year ended December 31, 2021, the Company recognized $<ix:nonFraction unitRef="U_iso4217USD" id="F_000522" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001785173_srtTitleOfIndividualAxis_us-gaapShareBasedPaymentArrangementEmployeeMember_us-gaapAwardTypeAxis_etnbServiceBasedRSUsMember_20210101_20211231" decimals="INF" scale="6">0.3</ix:nonFraction> million in expense related to the service-based RSUs. As of December 31, 2021, <ix:nonFraction unitRef="U_xbrlishares" id="F_000524" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="C_0001785173_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">11,651</ix:nonFraction> RSUs were cancelled and <ix:nonFraction unitRef="U_xbrlishares" id="F_000525" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_0001785173_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20211231" decimals="INF" format="ixt:numdotdecimal">44,894</ix:nonFraction> remain outstanding.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2021, the Company granted <ix:nonFraction unitRef="U_xbrlishares" id="F_000526" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_0001785173_srtTitleOfIndividualAxis_srtExecutiveOfficerMember_us-gaapAwardTypeAxis_etnbPerformanceRSUsMember_20210201_20210228" decimals="INF" format="ixt:numdotdecimal">61,500</ix:nonFraction> performance-based RSUs to certain executives, one-third of which vest on each <span style="-sec-ix-hidden:F_000529">one-year</span> anniversary of the grant date subject to achievement of a development milestone and continued service to the Company. The performance-based RSUs have a total grant date fair value of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000527" name="etnb:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue" contextRef="C_0001785173_srtTitleOfIndividualAxis_srtExecutiveOfficerMember_us-gaapAwardTypeAxis_etnbPerformanceRSUsMember_20210201_20210228" decimals="-5" scale="6">1.4</ix:nonFraction> million. During the year ended December 31, 2021, the Company recognized $<ix:nonFraction unitRef="U_iso4217USD" id="F_000528" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001785173_srtTitleOfIndividualAxis_srtExecutiveOfficerMember_us-gaapAwardTypeAxis_etnbPerformanceRSUsMember_20210101_20211231" decimals="INF" scale="6">0.8</ix:nonFraction> million in expense, using the accelerated attribution method, related to the performance-based RSUs. As of December 31, 2021, all of the performance-based RSUs remain outstanding. Subsequently, one-third of the performance-based RSUs vested in February 2022, upon achievement of the development milestone and satisfaction of the continued service condition.</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:continuation><ix:nonNumeric id="F_000257" name="us-gaap:IncomeTaxDisclosureTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true" continuedAt="F_000257_dcnt_dc275849-15bb-47f6-b922-73f640a7f951">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;color:#auto;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;">8. Income Taxes</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Tax Rates Applicable to the Income of the Company and its Subsidiaries</p><ix:nonNumeric id="F_000293" name="etnb:ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is taxed according to U.S. federal and state tax laws and Israeli tax laws. The statutory tax rates applicable to the income of the Company and its subsidiaries for the periods presented are as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.52%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc.</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000530" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="C_0001785173_20210101_20211231" decimals="2" scale="-2">21</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000531" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="C_0001785173_20200101_20201231" decimals="2" scale="-2">21</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89Bio Ltd.</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000532" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="C_0001785173_srtConsolidatedEntitiesAxis_etnbEightyNineBioLtdMember_20210101_20211231" decimals="2" scale="-2">23</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000533" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="C_0001785173_srtConsolidatedEntitiesAxis_etnbEightyNineBioLtdMember_20200101_20201231" decimals="2" scale="-2">23</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89bio Management, Inc.</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000534" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="C_0001785173_srtConsolidatedEntitiesAxis_etnbEightyNineBioManagementIncorporationMember_20210101_20211231" decimals="2" scale="-2">21</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000535" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="C_0001785173_srtConsolidatedEntitiesAxis_etnbEightyNineBioManagementIncorporationMember_20200101_20201231" decimals="2" scale="-2">21</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UAB 89bio Lithuania</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000536" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="C_0001785173_srtConsolidatedEntitiesAxis_etnbUABEightyNineBioLithuaniaMember_20210101_20211231" decimals="2" scale="-2">15</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000537" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="C_0001785173_srtConsolidatedEntitiesAxis_etnbUABEightyNineBioLithuaniaMember_20200101_20201231" decimals="2" scale="-2">15</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">82</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p><ix:continuation id="F_000257_dcnt_dc275849-15bb-47f6-b922-73f640a7f951" continuedAt="F_000257_dcnt_05e4ffd7-1d1f-4983-910c-87fc29774149">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:nonNumeric id="F_000294" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The income<span style="letter-spacing:0.05pt;"> </span>tax benefit<span style="letter-spacing:0.05pt;"> </span>is comprised<span style="letter-spacing:0.05pt;"> </span>of (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000538" name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="C_0001785173_20200101_20201231" decimals="-3" sign="-" scale="3">11</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000539" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="C_0001785173_20210101_20211231" decimals="-3" sign="-" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000540" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="C_0001785173_20200101_20201231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000541" name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="C_0001785173_20210101_20211231" decimals="-3" sign="-" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000542" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="C_0001785173_20210101_20211231" decimals="-3" sign="-" scale="3">3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000543" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="C_0001785173_20200101_20201231" decimals="-3" sign="-" scale="3">10</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000544" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="C_0001785173_20210101_20211231" decimals="-3" scale="3">150</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000545" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="C_0001785173_20200101_20201231" decimals="-3" scale="3">69</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000546" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="C_0001785173_20210101_20211231" decimals="-3" scale="3">150</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000547" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="C_0001785173_20200101_20201231" decimals="-3" scale="3">69</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax benefit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000548" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0001785173_20210101_20211231" decimals="-3" sign="-" scale="3">147</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000549" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0001785173_20200101_20201231" decimals="-3" sign="-" scale="3">59</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Deferred<span style="letter-spacing:0.05pt;"> </span>Income Taxes</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred<span style="letter-spacing:0.05pt;"> </span>income<span style="letter-spacing:0.05pt;"> </span>taxes<span style="letter-spacing:0.05pt;"> </span>reflect<span style="letter-spacing:0.1pt;"> </span>the net tax effects<span style="letter-spacing:0.1pt;"> </span>of temporary<span style="letter-spacing:0.1pt;"> </span>differences<span style="letter-spacing:0.1pt;"> </span>between the carrying<span style="letter-spacing:0.05pt;"> </span>amounts of assets<span style="letter-spacing:0.05pt;"> </span>and liabilities<span style="letter-spacing:0.15pt;"> </span>for financial<span style="letter-spacing:0.1pt;"> </span>reporting<span style="letter-spacing:0.05pt;"> </span>purposes<span style="letter-spacing:0.05pt;"> </span>and the amounts<span style="letter-spacing:0.05pt;"> </span>used for income<span style="letter-spacing:0.05pt;"> </span>tax purposes. <ix:nonNumeric id="F_000295" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true" continuedAt="F_000295_cnt_1">Significant<span style="letter-spacing:0.1pt;"> </span>components<span style="letter-spacing:0.05pt;"> </span>of the Company&#8217;s deferred<span style="letter-spacing:0.05pt;"> </span>tax assets<span style="letter-spacing:0.05pt;"> for the periods presented </span>are as follows<span style="letter-spacing:0.05pt;"> </span>(in thousands):</ix:nonNumeric></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000295_cnt_1">
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. net operating loss carryforwards</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000550" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="C_0001785173_srtStatementGeographicalAxis_countryUS_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">29,094</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000551" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="C_0001785173_srtStatementGeographicalAxis_countryUS_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,342</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expenses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000552" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,529</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000553" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,392</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Israel net operating loss carryforwards</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000554" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="C_0001785173_srtStatementGeographicalAxis_countryIL_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,262</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000555" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="C_0001785173_srtStatementGeographicalAxis_countryIL_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,978</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000556" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,969</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000557" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="C_0001785173_20201231" decimals="-3" scale="3">610</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000558" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" contextRef="C_0001785173_20211231" decimals="-3" scale="3">220</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000559" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" contextRef="C_0001785173_20201231" decimals="-3" scale="3">635</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000560" name="us-gaap:DeferredTaxAssetsOther" contextRef="C_0001785173_20211231" decimals="-3" scale="3">191</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000561" name="us-gaap:DeferredTaxAssetsOther" contextRef="C_0001785173_20201231" decimals="-3" scale="3">48</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000562" name="us-gaap:DeferredTaxAssetsGross" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">42,265</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000563" name="us-gaap:DeferredTaxAssetsGross" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">22,005</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: valuation allowance</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000564" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_0001785173_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">42,046</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000565" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_0001785173_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">21,936</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000566" name="us-gaap:DeferredTaxAssetsNet" contextRef="C_0001785173_20211231" decimals="-3" scale="3">219</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000567" name="us-gaap:DeferredTaxAssetsNet" contextRef="C_0001785173_20201231" decimals="-3" scale="3">69</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As<span style="letter-spacing:-0.05pt;"> </span>of December<span style="letter-spacing:0.05pt;"> </span>31, 2021 and 2020, the Company recorded<span style="letter-spacing:0.05pt;"> </span>a valuation<span style="letter-spacing:0.05pt;"> </span>allowance<span style="letter-spacing:0.05pt;"> </span>of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000568" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_0001785173_20211231" decimals="-5" scale="6">42.0</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000569" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_0001785173_20201231" decimals="-5" scale="6">21.9</ix:nonFraction> million, respectively,<span style="letter-spacing:0.1pt;"> </span>in respect<span style="letter-spacing:0.05pt;"> </span>of deferred<span style="letter-spacing:0.05pt;"> </span>tax assets<span style="letter-spacing:0.05pt;"> </span>resulting<span style="letter-spacing:0.1pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>tax loss carryforwards<span style="letter-spacing:0.1pt;"> </span>and other<span style="letter-spacing:0.05pt;"> </span>temporary<span style="letter-spacing:0.1pt;"> </span>differences.<span style="letter-spacing:0.1pt;"> </span>Realization of deferred tax assets is dependent upon future earnings, if any, the time and amount of which are uncertain. The Company regularly assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes based upon the weight of available evidence that it is more likely than not that all or a portion of deferred tax assets will not be realized, a valuation allowance is established through an adjustment to income tax expense. The valuation allowance increased by $<ix:nonFraction unitRef="U_iso4217USD" id="F_000570" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="C_0001785173_20210101_20211231" decimals="-5" scale="6">20.1</ix:nonFraction> million in 2021, which primarily relates to significant taxable losses. The Company continues to record a partial valuation allowance against the deferred tax assets in Israel due to achievement of recent profitability and the expectation of future profitability in the jurisdiction. The valuation allowance increased by $<ix:nonFraction unitRef="U_iso4217USD" id="F_000571" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="C_0001785173_20200101_20201231" decimals="-5" scale="6">11.9</ix:nonFraction> million in 2020, which primarily relates to significant taxable losses. The change in valuation allowance during 2020 also includes a partial release of the valuation allowance against deferred tax assets in Israel due to achievement of recent profitability and the expectation of future profitability in the jurisdiction, which decreased the valuation allowance by $<ix:nonFraction unitRef="U_iso4217USD" id="F_000572" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="C_0001785173_srtStatementGeographicalAxis_countryIL_20200101_20201231" decimals="0" sign="-" format="ixt:numdotdecimal">69,000</ix:nonFraction> in 2020. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Available<span style="letter-spacing:0.05pt;"> </span>Carryforward<span style="letter-spacing:0.05pt;"> </span>Tax <span style="letter-spacing:-0.05pt;">Losses and Credits</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, the Company had an accumulated tax loss carryforward of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000573" name="etnb:AccumulatedTaxLossCarryForward" contextRef="C_0001785173_srtStatementGeographicalAxis_countryUS_20211231" decimals="-5" scale="6">138.5</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000575" name="etnb:AccumulatedTaxLossCarryForward" contextRef="C_0001785173_srtStatementGeographicalAxis_countryIL_20211231" decimals="-5" scale="6">18.5</ix:nonFraction> million for U.S. and Israeli tax purposes, respectively. As of December 31, 2020, the Company had an accumulated<span style="letter-spacing:0.1pt;"> </span>tax loss carryforward<span style="letter-spacing:0.1pt;"> </span>of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000574" name="etnb:AccumulatedTaxLossCarryForward" contextRef="C_0001785173_srtStatementGeographicalAxis_countryUS_20201231" decimals="-5" scale="6">54.1</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000576" name="etnb:AccumulatedTaxLossCarryForward" contextRef="C_0001785173_srtStatementGeographicalAxis_countryIL_20201231" decimals="-5" scale="6">17.3</ix:nonFraction> million for U.S. and Israeli tax purposes, respectively. <ix:nonNumeric id="F_000577" name="us-gaap:OperatingLossCarryforwardsLimitationsOnUse" contextRef="C_0001785173_20200101_20201231">Federal net operating losses generated after 2017 can be carried forward indefinitely but utilization will be limited to <ix:nonFraction unitRef="U_xbrlipure" id="F_000578" name="etnb:TaxableIncomeUtilizationPercentage" contextRef="C_0001785173_20201231" decimals="2" scale="-2">80</ix:nonFraction>% of taxable income in the period that net operating losses are being utilized.</ix:nonNumeric> Carryforward tax losses in Israel have no expiration date.<span style="letter-spacing:0.1pt;"> </span></p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p><ix:continuation id="F_000257_dcnt_05e4ffd7-1d1f-4983-910c-87fc29774149">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;letter-spacing:0.1pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021 and 2020, the Company had federal research and development credit carryforwards of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000579" name="etnb:DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal" contextRef="C_0001785173_20211231" decimals="-5" scale="6">2.1</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000580" name="etnb:DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal" contextRef="C_0001785173_20201231" decimals="-5" scale="6">0.6</ix:nonFraction> million, respectively, which expire beginning in 2040. As of December 31, 2021 and December 31, 2020, the Company has state research and development credit carryforwards of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000581" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" contextRef="C_0001785173_20211231" decimals="-5" scale="6">1.1</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000582" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" contextRef="C_0001785173_20201231" decimals="-5" scale="6">0.7</ix:nonFraction> million, respectively, which will carry forward indefinitely. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Loss from Operations, Before Income Tax</p><ix:nonNumeric id="F_000296" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-weight:normal;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">The Company recorded a loss from operations, before income tax for the periods presented as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.77%;font-family:Times New Roman;font-size:10pt;font-weight:bold;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000583" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0001785173_srtStatementGeographicalAxis_countryUS_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">91,141</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000584" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0001785173_srtStatementGeographicalAxis_countryUS_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">58,760</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lithuania</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000585" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0001785173_srtStatementGeographicalAxis_countryLT_20210101_20211231" decimals="-3" scale="3">10</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000586" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0001785173_srtStatementGeographicalAxis_countryLT_20200101_20201231" decimals="-3" sign="-" scale="3">73</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Israel</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000587" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0001785173_srtStatementGeographicalAxis_countryIL_20210101_20211231" decimals="-3" scale="3">862</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000588" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0001785173_srtStatementGeographicalAxis_countryIL_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,275</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss before income tax</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000589" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0001785173_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">90,269</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000590" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0001785173_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">49,558</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Reconciliation of Income Tax Benefit</p><ix:nonNumeric id="F_000297" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The reconciliation<span style="letter-spacing:0.15pt;"> </span>of income tax benefit based on the statutory<span style="letter-spacing:0.1pt;"> </span>tax rate<span style="letter-spacing:0.05pt;"> </span>to the effective<span style="letter-spacing:0.1pt;"> </span>tax rate<span style="letter-spacing:0.05pt;"> for the periods presented </span>is as follows<span style="letter-spacing:0.05pt;"> </span>(in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax benefit computed at statutory rates</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000591" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="C_0001785173_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">18,757</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000592" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="C_0001785173_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,285</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in valuation allowance</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000593" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="C_0001785173_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">20,111</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000594" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="C_0001785173_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">11,914</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign rate differential</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000595" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="C_0001785173_20210101_20211231" decimals="-3" sign="-" scale="3">19</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000596" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="C_0001785173_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,671</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in Israel effective tax rate due to the 2019</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; reorganization</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000597" name="etnb:IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization" contextRef="C_0001785173_20210101_20211231" decimals="-3" sign="-" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000598" name="etnb:IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization" contextRef="C_0001785173_20200101_20201231" decimals="-3" scale="3">647</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development credits, net of</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; uncertain tax position</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000599" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" contextRef="C_0001785173_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,331</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000600" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" contextRef="C_0001785173_20200101_20201231" decimals="-3" scale="3">815</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000601" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="C_0001785173_20210101_20211231" decimals="-3" scale="3">191</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000602" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="C_0001785173_20200101_20201231" decimals="-3" scale="3">555</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax benefit</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000603" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0001785173_20210101_20211231" decimals="-3" sign="-" scale="3">147</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000604" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0001785173_20200101_20201231" decimals="-3" sign="-" scale="3">59</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Utilization of U.S. federal and state net operating losses and credit carryforwards may be subject to an annual limitation provided for in Section 382 of the Internal Revenue Code and similar state codes. Any annual limitation could result in a deferral of the utilization of the net operating loss and credit carryforwards.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Unrecognized Tax Benefits </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the years ended December 31, 2021 and 2020, the amount of gross unrecognized tax benefits increased by $<ix:nonFraction unitRef="U_iso4217USD" id="F_000605" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" contextRef="C_0001785173_20210101_20211231" decimals="-5" scale="6">0.5</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000606" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" contextRef="C_0001785173_20200101_20201231" decimals="-5" scale="6">0.3</ix:nonFraction> million, respectively. If the total amount of unrecognized tax benefits was recognized, it would <ix:nonFraction unitRef="U_iso4217USD" id="F_000607" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_0001785173_20211231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction>t have an impact to the effective tax rate as it would be offset by the reversal of related deferred tax assets which are subject to a full valuation allowance.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes interest and penalties related to uncertain tax positions as part of the income tax provision. As of December 31, 2021 and 2020, such interest and penalties were not material.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is subject to taxation in the United States, California, and several foreign jurisdictions. To date, the Company has not been subject to any federal or state income tax audits. The Company is currently under examination by the Israeli taxing authorities for 2018 and 2019. As of December 31, 2021 all tax years remain open to examination. </p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:nonNumeric id="F_000258" name="us-gaap:EarningsPerShareTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">9. Net Loss Per Share </p><ix:nonNumeric id="F_000298" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following outstanding potentially dilutive shares, including all outstanding stock options, have been excluded from the calculation of diluted net loss per share for the periods presented due to their anti-dilutive effect: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.52%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options to purchase common stock</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000608" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001785173_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">2,406,668</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000609" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001785173_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">1,898,395</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested restricted stock units</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000610" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001785173_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_etnbUnvestedRestrictedStockUnitsMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">106,394</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants to purchase common stock</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000611" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001785173_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">58,923</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000612" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001785173_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">2,571,985</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000613" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001785173_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">1,898,395</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000259" name="us-gaap:SubsequentEventsTextBlock" contextRef="C_0001785173_20210101_20211231" escape="true">&#160;</ix:nonNumeric></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">85</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_9_CHANGES_IN_DISAGREEMENTS_WITH_ACC">Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">None. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_9A_CONTROLS_PROCEDURES">Item 9A. Controls and Procedures.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Evaluation of Disclosure Controls and Procedures </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, our management, with the participation and supervision of our principal executive officer and our principal financial officer, evaluated our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company&#8217;s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost benefit relationship of possible controls and procedures. Based on this evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were effective as of December 31, 2021 to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and our principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Changes in Internal Control over Financial Reporting </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">There were no changes in our internal control over financial reporting (as defined in Rules&#160;13a-15(f)&#160;and&#160;15d-15(f)&#160;under the Exchange Act) occurred during the quarter ended December&#160;31, 2021 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Management&#8217;s Annual Report on Internal Control Over Financial Reporting</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) under the Exchange Act). Internal control over financial reporting is a process designed under the supervision and with the participation of our management, including our principal executive officer and our principal financial officer, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">As of December 31, 2021, our management assessed the effectiveness of our internal control over financial reporting using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework. Based on this assessment, our management concluded that our internal control over financial reporting was effective as of December 31, 2021. </span></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Attestation Report of Registered Public Accounting Firm </span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">As an emerging growth company, we are not required to provide and this Annual Report on Form 10-K does not include an attestation report on our internal control over financial reporting issued by the Company&#8217;s independent registered public accounting firm. Our auditors will not be required to formally opine on the effectiveness of our internal control over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act of 2002 until we are no longer an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012, and are no longer a non-accelerated filer.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_9B_OR_INFORMATION">Item 9B. Other Information. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">None. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_9C_DISCLOSURE_REGARDING">Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not applicable. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">87</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="PART_III">PART III </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_10_DIRECTORS_EXECUTIVE_FICERS_CORPO">Item 10. Directors, Executive Officers and Corporate Governance. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The information required by this Item 10 is incorporated herein by reference to information in our proxy statement for our 2022 Annual Meeting of Stockholders (the &#8220;2022 Proxy Statement&#8221;), which we expect to be filed with the SEC within 120 days of the end of our fiscal year ended December 31, 2021, including under the heading &#8220;Directors, Executive Officers and Corporate Governance.&#8221;</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">We have adopted a written code of business conduct and ethics that applies to our directors, officers and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A copy of the code is available on our website located at </span><span style="Background-color:#FFFFFF;">www</span><span style="Background-color:#FFFFFF;">.89bio.com</span><span style="Background-color:#FFFFFF;">, under &#8220;Corporate Governance</span><span style="Background-color:#FFFFFF;">.</span><span style="Background-color:#FFFFFF;">&#8221;</span><span style="Background-color:#FFFFFF;"> We intend to disclose on our website any amendments to, or waivers from, the code of business conduct and ethics that are required to be disclosed pursuant to the disclosure requirements of Item 5.05 of Form 8-K within four business days following the date of the amendment or waiver.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_11_EXECUTIVE_COMPENSATION">Item 11. Executive Compensation. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information required by this Item 11 is incorporated herein by reference to information in our 2022 Proxy Statement, including under headings &#8220;Executive Compensation&#8221; and &#8220;Directors, Executive Officers and Corporate Governance.&#8221;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_12_SECURITY_OWNERSHIP_CERTAIN_BENEF">Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information required by this Item 12 is incorporated herein by reference to information in our 2022 Proxy Statement, including under headings &#8220;Security Ownership of Certain Beneficial Owners and Management&#8221; and &#8220;Executive Compensation-Securities Authorized for Issuance Under Equity Compensation Plans.&#8221;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_13_CERTAIN_RELATIONSHIPS_RELATED_TR">Item 13. Certain Relationships and Related Transactions, and Director Independence. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information required by this Item 13 is incorporated herein by reference to information in our 2022 Proxy Statement, including under headings &#8220;Directors, Executive Officers and Corporate Governance&#8221; and &#8220;Certain Relationships and Related Party Transactions.&#8221;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_14_PRINCIPAL_ACCOUNTING_FEES_SERVIC">Item 14. Principal Accountant Fees and Services. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information required by this Item 14 is incorporated herein by reference to information in our 2022 Proxy Statement, including under the heading &#8220;Ratification of Selection of Independent Registered Public Accounting Firm.&#8221;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="PART_IV">PART IV </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_15_EXHIBITS_FINANCIAL_STATEMENT_SCH">Item 15. Exhibits, Financial Statement Schedules. </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The following documents are filed as a part of this report: </p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.47%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Financial Statements</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:15.38%;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Index to Consolidated Financial Statements at Part II Item 8 &#8220;Financial Statements and Supplementary Data.&#8221;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.47%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2)</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Financial Statement Schedules </p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:15.38%;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The financial statement schedules are omitted as they are either not applicable or the information required is presented in the financial statements and notes thereto under Part II Item 8 &#8220;Financial Statements and Supplementary Data.&#8221;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.47%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3)</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Exhibits:</p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit Index</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-Right:0pt;padding-Top:0pt;width:8.04%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0pt;padding-Top:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0pt;padding-Top:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">&#160;&#160;&#160;&#160;1.1</span></p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1785173/000119312521093314/d150630dex12.htm"><span style="text-decoration:underline;">Sales Agreement, by and among the Company, SVB Leerink LLC and Cantor Fitzgerald &#38; Co, dated March 25, 2021 (filed with the SEC as Exhibit 1.2 to the Company&#8217;s Form S-3 filed on March 25, 2021) </span></a></p></td>
</tr>
<tr style="height:8.25pt;">
<td valign="top" style="padding-Right:0.75pt;padding-Top:0.75pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:8.25pt;">
<td valign="top" style="padding-Right:0.75pt;padding-Top:0.75pt;width:8.04%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">&#160;&#160;&#160;&#160;2.1</span></p></td>
<td valign="top" style="width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001785173/000119312519266760/d743471dex21.htm"><span style="text-decoration:underline;">Contribution and Exchange Agreement, dated as of September 17, 2019, by and among 89Bio Ltd., the Company and its shareholders (filed with the SEC as Exhibit 2.1 to the Company&#8217;s Form S-1 filed on October 11, 2019)</span></a></p></td>
</tr>
<tr style="height:8.25pt;">
<td valign="top" style="padding-Right:0.75pt;padding-Top:0.75pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-Right:0pt;padding-Top:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">&#160;&#160;&#160;&#160;3.1</span></p></td>
<td valign="top" style="width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001785173/000119312519292680/d829788dex31.htm"><span style="text-decoration:underline;">Second Amended and Restated Certificate of Incorporation of the Company (filed with the SEC as Exhibit 3.1 to the Company&#8217;s Form 8-K filed on November 15, 2019)</span></a></p></td>
</tr>
<tr style="height:8.25pt;">
<td valign="top" style="padding-Right:0.75pt;padding-Top:0.75pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-Right:0pt;padding-Top:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;3.2 </p></td>
<td valign="top" style="width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001785173/000119312519292680/d829788dex32.htm"><span style="text-decoration:underline;">Second Amended and Restated Bylaws of the Company (filed with the SEC as Exhibit 3.2 to the Company&#8217;s Form 8-K filed on November 15, 2019)</span></a></p></td>
</tr>
<tr>
<td valign="top" style="padding-Right:0.75pt;padding-Top:0.75pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-Right:0pt;padding-Top:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;4.1</p></td>
<td valign="top" style="width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001785173/000119312519275407/d743471dex41.htm"><span style="text-decoration:underline;">Specimen common stock certificate of the Company (filed with the SEC as Exhibit 4.1 to the Company&#8217;s Form S-1/A filed on October 28, 2019)</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0.75pt;padding-Top:0.75pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0pt;padding-Top:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;4.2</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001785173/000119312519266760/d743471dex42.htm"><span style="text-decoration:underline;">Investors&#8217; Rights Agreement, dated as of September 17, 2019, by and among the Company and certain of its shareholders (filed with the SEC as Exhibit 4.2 to the Company&#8217;s Form S-1 filed on October 11, 2019)</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0.75pt;padding-Top:0.75pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0pt;padding-Top:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;4.3<span style="Background-color:#FFFFFF;">*</span></p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="etnb-ex43_8.htm"><span style="text-decoration:underline;">Description of Securities </span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0.75pt;padding-Top:0.75pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">&#160;</span></p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0pt;padding-Top:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;4.4</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1785173/000119312520104858/d912211dex41.htm"><span style="text-decoration:underline;">Form of Warrant to Purchase Common Stock for Silicon Valley Bank (filed with SEC as Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on April 13, 2020)</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0.75pt;padding-Top:0.75pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0.75pt;padding-Top:0.75pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;4.5</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001785173/000119312521182891/d127486dex41.htm"><span style="text-decoration:underline;">Form of Warrant to Purchase Common Stock for Silicon Valley Bank (filed with the SEC as Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on June 4, 2021)</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0.75pt;padding-Top:0.75pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0pt;padding-Top:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.1+</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1785173/000119312519266760/d743471dex101.htm"><span style="text-decoration:underline;">Form of Indemnification Agreement for directors and executive officers (filed with the SEC as Exhibit 10.1 to the Company&#8217;s Form S-1 filed on October 11, 2019)</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0.75pt;padding-Top:0.75pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0pt;padding-Top:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.2+</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001785173/000119312519275407/d743471dex102.htm"><span style="text-decoration:underline;">Amended and Restated 2019 Equity Incentive Plan and form of agreements thereunder (filed with the SEC as Exhibit 10.2 to the Company&#8217;s Form S-1/A filed on October 28, 2019)</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0.75pt;padding-Top:0.75pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0pt;padding-Top:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.3+</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1785173/000119312519275407/d743471dex103.htm"><span style="text-decoration:underline;">2019 Employee Stock Purchase Plan (filed with the SEC as Exhibit 10.3 to the Company&#8217;s Form S-1/A filed on October 28, 2019)</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0.75pt;padding-Top:0.75pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0pt;padding-Top:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.4+</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1785173/000119312520132419/d898684dex101.htm"><span style="text-decoration:underline;">Executive Employment Offer Letter, dated April 15, 2020, by and between the Company and Rohan Palekar (filed with the SEC as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on May 4, 2020)</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0.75pt;padding-Top:0.75pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0pt;padding-Top:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.5+</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1785173/000119312520245305/d23969dex105.htm"><span style="Background-color:#FFFFFF;text-decoration:underline;">Amended and Restated Executive Employment Agreement, dated July&#160;28, 2020, by and between 89Bio Ltd. and Ram Waisbourd</span><span style="text-decoration:underline;"> (filed with the SEC as Exhibit 10.5 to the Company&#8217;s S-1 filed on September 14, 2020)</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0.75pt;padding-Top:0.75pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0pt;padding-Top:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;<span style="color:#000000;">&#160;</span>10.6+</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1785173/000119312520132419/d898684dex103.htm"><span style="text-decoration:underline;">Executive Employment Offer Letter, dated April 15, 2020, by and between the Company and Hank Mansbach (filed with the SEC as Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed on May 4, 2020)</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0.75pt;padding-Top:0.75pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0pt;padding-Top:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.7+</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1785173/000119312520132419/d898684dex104.htm"><span style="text-decoration:underline;">Executive Employment Offer Letter, dated April 15, 2020, by and between the Company and Quoc Le-Nguyen (filed with the SEC as Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K filed on May 4, 2020)</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0.75pt;padding-Top:0.75pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0pt;padding-Top:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.8+</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1785173/000119312520132419/d898684dex102.htm"><span style="text-decoration:underline;">Executive Employment Offer Letter, dated April 15, 2020, by and between the Company and Ryan Martins (filed with the SEC as Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on May 4, 2020)</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0.75pt;padding-Top:0.75pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-Right:0pt;padding-Top:0pt;width:8.04%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0pt;padding-Top:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.9+</span></p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1785173/000119312519266760/d743471dex109.htm"><span style="text-decoration:underline;">Director Offer Letter, dated July 1, 2018, by and between 89Bio Ltd. and Michael Hayden (filed with the SEC as Exhibit 10.9 to the Company&#8217;s Form S-1 filed on October 11, 2019)</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0.75pt;padding-Top:0.75pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0pt;padding-Top:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.10+</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1785173/000156459020053677/etnb-ex101_102.htm"><span style="text-decoration:underline;">Non-Employee Director Compensation Policy (filed with the SEC as Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q filed on November 13, 2020)</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0.75pt;padding-Top:0.75pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0pt;padding-Top:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.11<span style="color:#000000;">&#8224;</span></p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1785173/000119312519266760/d743471dex1011.htm"><span style="text-decoration:underline;">Asset Transfer and License Agreement&#8212;FGF21 by and among 89Bio Ltd., ratiopharm GmbH, Teva Branded Pharmaceutical Products R&#38;D, Inc. and Teva Pharmaceutical Industries Ltd, dated as of April 16, 2018 (filed with the SEC as Exhibit 10.11 to the Company&#8217;s Form S-1 filed on October 11, 2019)</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0.75pt;padding-Top:0.75pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0pt;padding-Top:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.12+</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1785173/000119312519266760/d743471dex1012.htm"><span style="text-decoration:underline;">Reagent Supply and Technology Transfer Agreement by and between 89Bio Ltd. and Teva Biotech GmbH, dated as of April 16, 2018, as amended (filed with the SEC as Exhibit 10.12 to the Company&#8217;s Form S-1 filed on October 11, 2019)</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-Right:0pt;padding-Top:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.13+</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1785173/000119312519266760/d743471dex1013.htm"><span style="text-decoration:underline;">Sublicense Agreement by and between 89Bio Ltd. and ratiopharm GmbH, dated as of April 16, 2018 (filed with the SEC as Exhibit 10.13 to the Company&#8217;s Form S-1 filed on October 11, 2019)</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;<span style="color:#000000;">10.14+</span></p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1785173/000119312519266760/d743471dex1014.htm"><span style="text-decoration:underline;">Master Services Agreement by and between 89Bio Ltd. and Biotechpharma UAB, dated as of May 7, 2018, as amended (filed with the SEC as Exhibit 10.14 to the Company&#8217;s Form S-1 filed on October 11, 2019)</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;<span style="color:#000000;">10.15</span></p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1785173/000156459020011636/etnb-ex1015_527.htm"><span style="text-decoration:underline;">Office Lease by and between 89bio, Inc. and King Family Irrevocable Trust, dated as of December 5, 2019 (filed with the SEC as Exhibit 10.15 to the Company&#8217;s Annual Report on Form 10-K filed on March 18, 2020)</span></a><span style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;<span style="color:#000000;">10.16</span></p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1785173/000119312520104858/d912211dex101.htm"><span style="text-decoration:underline;">Loan and Security Agreement, dated as of April 7, 2020, among Silicon Valley Bank, the Lenders party thereto, 89bio, Inc., 89bio Management, Inc. and 89Bio Ltd. (filed with the SEC as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on April 13, 2020)</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.17</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001785173/000156459021027662/etnb-ex101_9.htm"><span style="text-decoration:underline;">First Amendment to Loan and Security Agreement, dated as of March 31, 2021, among Silicon Valley Bank, the Lenders party thereto, 89bio Management, Inc. and 89Bio Ltd. (filed with the SEC as Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q filed on May 15, 2021)</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.18</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001785173/000156459021027662/etnb-ex102_86.htm"><span style="text-decoration:underline;">S</span><span style="text-decoration:underline;">econd Amendment to Loan and Security Agreement, dated as of April 30, 2021, among Silicon Valley Bank, the Lenders party thereto, 89bio Management, Inc. and 89Bio Ltd. (filed with the SEC as Exhibit 10.2 to the Company&#8217;s Quarterly Report on Form 10-Q filed on May 15, 2021)</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.19</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001785173/000119312521182891/d127486dex101.htm"><span style="text-decoration:underline;">Third Amendment to Loan and Security Agreement, dated as of May 28, 2021, among Silicon Valley Bank, the Lenders party thereto, 89bio, Inc., 89bio Management, Inc. and 89Bio Ltd. (filed with the SEC as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on June 4, 2021)</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;<span style="color:#000000;">10.20</span></p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001785173/000156459021056616/etnb-ex101_191.htm"><span style="text-decoration:underline;">First Amendment to Office Lease, dated as of July 27, 2021, by and between King Family Irrevocable Trust and the Company </span><span style="text-decoration:underline;">(filed with the SEC as Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q filed on November 12, 2021)</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;<span style="color:#000000;">16.1</span></p></td>
<td valign="top" style="width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1785173/000119312520117165/d919569dex161.htm"><span style="text-decoration:underline;">Letter from Deloitte &#38; Touche LLP, dated April 21, 2020 (filed with the SEC as Exhibit 16.1 to the Company&#8217;s Current Report on Form 8-K filed on April 23, 2020)</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;21.1+</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1785173/000119312519266760/d743471dex211.htm"><span style="text-decoration:underline;">List of subsidiaries (filed with the SEC as Exhibit 21.1 to the Company&#8217;s Form S-1 filed on October 11, 2019)</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">&#160;&#160;23.1*</span></p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="etnb-ex231_7.htm"><span style="text-decoration:underline;">Consent of Independent Registered Public Accounting Firm</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">&#160;&#160;31.1*</span></p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="etnb-ex311_9.htm"><span style="text-decoration:underline;">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">&#160;&#160;31.2*</span></p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="etnb-ex312_6.htm"><span style="text-decoration:underline;">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-Right:0pt;padding-Top:0pt;width:8.04%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
</tr>
<tr style="height:16.35pt;">
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">&#160;</span><span style="Background-color:#FFFFFF;">&#160;</span><span style="Background-color:#FFFFFF;">32.1#</span></p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="etnb-ex321_10.htm"><span style="text-decoration:underline;">Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350</span></a></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">101.INS</span></p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Instance Document</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">101.SCH</span></p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Schema Document</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">101.CAL</span></p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Calculation Linkbase Document</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">101.DEF</span></p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Definition Linkbase Document</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">101.LAB</span></p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Label Linkbase Document</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">101.PRE</span></p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Presentation Linkbase Document</p></td>
</tr>
<tr style="height:4.65pt;">
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">104&#8239; </span></p></td>
<td valign="top" style="background-color:#FFFFFF;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:91.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Cover Page Interactive Data File</span></p></td>
</tr>
</table></div>
<p style="border-bottom:Solid 0.75pt;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;margin-right:84.62%;text-indent:0%;font-size:6pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:2pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</span></p></td>
<td valign="top">
<p style="margin-top:2pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Filed herewith.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Indicates management contract or compensatory plan.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8224;</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Portions of the exhibit have been omitted for confidentiality purposes.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">#</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Furnished herewith and not deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Exchange Act, and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act.</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.24%;text-indent:-5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_16_FORM_10K_SUMMARY">Item&#160;16. Form 10-K Summary. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">None.</span></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">92</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="SIGNATURES"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">SIGNAT</span><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">URES</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized<span style="font-weight:bold;">.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc.</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: March 24, 2022 </p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Rohan Palekar</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Rohan Palekar</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer and Director</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">(principal executive officer)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: March 24, 2022 </p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Ryan Martins</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Ryan Martins</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer<span style="font-style:italic;font-weight:normal;"> </span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">(principal financial and accounting officer)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p>
<p style="text-align:center;margin-top:4pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">POWER OF ATTORNEY</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Rohan Palekar, Ram Waisbourd and Ryan Martins, and each of them, the true and lawful attorneys-in-fact and agents of the undersigned, with full power of substitution and resubstitution, for and in the name, place and stead of the undersigned, to sign in any and all capacities (including, without limitation, the capacities listed below), this Annual Report on Form 10-K, any and all amendments thereto, and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the Securities and Exchange Commission, and hereby grants to such attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and anything necessary to be done to enable the registrant to comply with the provisions of the Securities Exchange Act and all the requirements of the Securities and Exchange Commission, as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his or her substitute, or substitutes, may lawfully do or cause to be done by virtue hereof.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.02%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.98%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:4pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:4pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.02%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:4pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:4pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:4pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Rohan Palekar</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.02%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer and Director</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 24, 2022</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.98%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Rohan Palekar</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">principal executive officer</span>)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:4pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Ryan Martins</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.02%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 24, 2022</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.98%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ryan Martins</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">principal financial and accounting officer</span>)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:4pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Steven Altschuler</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.02%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 24, 2022</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.98%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Steven Altschuler, M.D.</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:4pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Derek DiRocco</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.02%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 24, 2022</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.98%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Derek DiRocco, Ph.D.</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:4pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Gregory Grunberg</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.02%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 24, 2022</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.98%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gregory Grunberg, M.D.</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:4pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Michael Hayden</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.02%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 24, 2022</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.98%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Michael Hayden, M.B., Ch.B., Ph.D.</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:4pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Kathy LaPorte</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.02%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 24, 2022</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.98%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Kathy LaPorte</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:4pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Lota Zoth</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.02%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 24, 2022</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.98%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Lota Zoth, C.P.A.</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:31.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Edward Morrow Atkinson III</p></td>
<td valign="top" style="width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:35.02%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="top" style="width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:30%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 24, 2022</p></td>
</tr>
<tr>
<td valign="top" style="width:31.98%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Edward Morrow Atkinson III</p></td>
<td valign="top" style="width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:35.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:30%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">94</p></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>2
<FILENAME>etnb-ex43_8.htm
<DESCRIPTION>EX-4.3
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
etnb-ex43_8.htm
</title>
</head>
<!-- NG Converter v5.0.2.71 -->
<body>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:right;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 4.3</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">DESCRIPTION OF REGISTRANT&#8217;S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:10.46%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following description of our capital stock is intended as a summary only and therefore is not a complete description of our capital stock. This description is based upon, and is qualified by reference to, our second amended and restated certificate of incorporation (the &#8220;Amended Certificate&#8221;), our&#160;second amended and restated bylaws (the &#8220;Amended Bylaws&#8221;) and applicable provisions of Delaware corporate law. You should read our Amended Certificate and&#160;Amended Bylaws,&#160;which are filed as exhibits to our Annual Report on Form 10-K, to which this exhibit is also appended.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:10.46%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our authorized capital stock consists of 100,000,000 shares of common stock and 10,000,000 shares of preferred stock. </p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Common Stock</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:10.46%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our Amended Certificate authorizes the issuance of up to&#160;100,000,000&#160;shares of our common stock. All outstanding shares of our common stock are validly issued, fully paid and nonassessable.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:10.46%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The holders of our common stock are entitled to one vote per share on all matters submitted to a vote of stockholders. A majority vote of the shares present in person or represented by proxy and entitled to vote on the subject matter is required for the holders of our common stock to take action on all matters (except for election of directors (as discussed below)), except as otherwise required by law, our Amended Certificate or our Amended Bylaws. Our Amended Certificate does not provide for cumulative voting in the election of directors. The holders of our common stock will receive ratably any dividends declared by our board of directors out of funds legally available therefor. In the event of our liquidation, dissolution or&#160;winding-up,&#160;the holders of our common stock will be entitled to share ratably in all assets remaining after payment of or provision for any liabilities.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Preferred Stock</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:10.46%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the terms of our Amended Certificate, our board of directors has the authority, without further action by our stockholders, to issue up to&#160;10,000,000&#160;shares of preferred stock in one or more series, to establish from time to time the number of shares to be included in each such series, to fix the dividend, voting and other rights, preferences and privileges of the shares of each wholly unissued series and any qualifications, limitations or restrictions thereon, and to increase or decrease the number of shares of any such series, but not below the number of shares of such series then outstanding.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:10.46%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of our common stock. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in our control and may adversely affect the market price of our common stock and the voting and other rights of the holders of our common stock. </p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Registration Rights</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:10.46%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain holders of shares of our common stock are entitled to rights with respect to the registration of these securities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). These rights are provided under the terms of our investors&#8217; rights agreement, effective as of September 17, 2019 (the &#8220;IRA&#8221;). The IRA includes demand registration rights, short-form registration rights and piggyback registration rights. All fees, costs and expenses of underwritten registrations under this agreement will be borne by us and all selling expenses, including underwriting discounts and selling commissions, will be borne by the holders of the shares being registered.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Demand Registration Rights</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:10.46%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain holders of</font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shares of our common stock</font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> are entitled to demand registration rights. Under the terms of the IRA, we will be required, upon the written request of at least 50% of the holders of the registrable securities, including either </font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">OrbiMed</font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Israel Partners II, L.P. or </font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">OrbiMed</font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Private Investments VI, LP, provided that the anticipated aggregate offering price is at least $10&#160;million, to file a registration statement on Form&#160;S-1&#160;and use commercially reasonable efforts to effect the registration of these shares for public resale. The right to have such shares registered on Form&#160;S-1&#160;is further subject to other specified conditions and limitations.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Piggyback Registration Rights</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:10.46%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the IRA, if we register any of our common stock either for our own account or for the account of other security holders, the holders of registrable shares party to the IRA are entitled to include their shares in the registration, subject to certain marketing and other limitations. We may terminate or withdraw any registration initiated before the effective date of such registration in our sole discretion.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Form&#160;S-3&#160;Registration Rights</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:10.46%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the IRA, if we are eligible to file a registration statement on Form&#160;S-3,&#160;upon the written request of at least 10% of the holders of registrable securities to sell registrable securities at an aggregate price of at least $5&#160;million, we will be required to use commercially reasonable efforts to effect a registration of such shares. The right to have such shares registered on Form&#160;S-3&#160;is further subject to other specified conditions and limitations.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Anti-Takeover Effects of Our Amended Certificate, Amended Bylaws and Delaware Law</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:10.46%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our Amended Certificate and our Amended Bylaws include a number of provisions that may have the effect of delaying, deferring or preventing another party from acquiring control of us and encouraging persons considering unsolicited tender offers or other unilateral takeover proposals to negotiate with our board of directors rather than pursue&#160;non-negotiated&#160;takeover attempts.</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;;font-weight:bold;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;;font-weight:bold;font-style:italic;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:bold;font-style:italic;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;;font-weight:bold;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Issuance of undesignated preferred stock:&#160;</font><font style="font-weight:normal;font-style:normal;color:#000000;">Under our Amended Certificate, our board of directors has the authority, without further action by the stockholders, to issue up to&#160;10,000,000&#160;shares of undesignated preferred stock with rights and preferences, including voting rights, designated from time to time by our board of directors. The existence of authorized but unissued shares of preferred stock enables our board of directors to make it more difficult to attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;;font-weight:bold;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;;font-weight:bold;font-style:italic;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:bold;font-style:italic;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;;font-weight:bold;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Classified board:&#160;</font><font style="font-weight:normal;font-style:normal;color:#000000;">Our Amended Certificate establishes a classified board of directors consisting of three classes of directors, with staggered three-year terms. Only one class of directors will be elected at each annual meeting of our stockholders, with the other classes continuing for the remainder of their respective three-year terms. This provision may have the effect of delaying a change in control of our board of directors.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;;font-weight:bold;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;;font-weight:bold;font-style:italic;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:bold;font-style:italic;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;;font-weight:bold;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Election and removal of directors and board vacancies:&#160;</font><font style="font-weight:normal;font-style:normal;color:#000000;">Our Amended Bylaws provide that directors will be elected by a plurality vote. Our Amended Certificate and Amended Bylaws also provide that our board of directors has the right to increase or decrease the size of the board and to fill vacancies on the board. Directors may be removed only for cause by the affirmative vote of the holders of at least 66<sup style="font-size:85%;line-height:120%;vertical-align:top">2</sup>&#8260;<sub style="font-size:85%; vertical-align:bottom">3</sub>% of the votes that all our stockholders would be entitled to cast in an annual election of directors. Only our board of directors is authorized to fill vacant directorships. In addition the number of directors constituting our board of directors may be set only by resolution adopted by a majority vote of the directors then in office. These provisions prevent stockholders from increasing the size of our board of directors and gaining control of our board of directors by filling the resulting vacancies with its own nominees.</font></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;;font-weight:bold;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;;font-weight:bold;font-style:italic;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:bold;font-style:italic;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;;font-weight:bold;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></font><font style="color:#000000;"></font><font style="color:#000000;">Requirements for advance notification of stockholder nominations and proposals:&#160;</font><font style="font-weight:normal;font-style:normal;color:#000000;">Our Amended Bylaws establish advance notice procedures with respect to stockholder proposals and the nomination of candidates for election as directors that specify certain requirements as to the timing, form and content of a stockholder&#8217;s notice. Business that may be conducted at an annual meeting of stockholders will be limited to those matters properly brought before the meeting. These provisions may make it more difficult for our stockholders to bring matters before our annual meeting of stockholders or to nominate directors at annual meetings of stockholders.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;;font-weight:bold;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;;font-weight:bold;font-style:italic;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:bold;font-style:italic;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;;font-weight:bold;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">No written consent of stockholders:&#160;</font><font style="font-weight:normal;font-style:normal;color:#000000;">Our Amended Certificate provides that all stockholder actions be taken by a vote of the stockholders at an annual or special meeting, and that stockholders may not take any action by written consent in lieu of a meeting. This limit may lengthen the amount of time required to take stockholder actions and would prevent the amendment of our Amended Bylaws or removal of directors by our stockholders without holding a meeting of stockholders</font><font style="color:#000000;">.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;;font-weight:bold;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;;font-weight:bold;font-style:italic;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:bold;font-style:italic;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;;font-weight:bold;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">No stockholder ability to call special meetings:&#160;</font><font style="font-weight:normal;font-style:normal;color:#000000;">Our Amended Certificate and Amended Bylaws provide that only a majority of the members of our board of directors then in office may be able to call special meetings of stockholders and only those matters set forth in the notice of the special meeting may be considered or acted upon at a special meeting of stockholders.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;;font-weight:bold;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;;font-weight:bold;font-style:italic;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:bold;font-style:italic;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;;font-weight:bold;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Amendments to certificate of incorporation and bylaws:&#160;</font><font style="font-weight:normal;font-style:normal;color:#000000;">Any amendment to our Amended Certificate will be required to be approved by a majority of our board of directors as well as, if required by law or the Amended Certificate, a majority of the outstanding shares entitled to vote on the amendment and a majority of the outstanding shares of each class entitled to vote thereon as a class, except that the amendment of provisions to board classification, stockholder action, certificate amendments, and liability of directors must be approved by not less than 66<sup style="font-size:85%;line-height:120%;vertical-align:top">2</sup>&#8260;<sub style="font-size:85%; vertical-align:bottom">3</sub>% of the outstanding shares entitled to vote on the amendment, voting together as a single class. Any amendment to our Amended Bylaws must be approved by either a majority of our board of directors or not less than 66<sup style="font-size:85%;line-height:120%;vertical-align:top">2</sup>&#8260;<sub style="font-size:85%; vertical-align:bottom">3</sub>% of the outstanding shares entitled to vote on the amendment, voting together as a single class.</font></p></td></tr></table></div>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:10.46%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These provisions are designed to enhance the likelihood of continued stability in the composition of our board of directors and its policies, to discourage certain types of transactions that may involve an actual or threatened acquisition of us and to reduce our vulnerability to an unsolicited acquisition proposal. We also designed these provisions to discourage certain tactics that may be used in proxy fights. However, these provisions could have the effect of discouraging others from making tender offers for our shares and, as a consequence, they may also reduce fluctuations in the market price of our shares that could result from actual or rumored takeover attempts.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Section&#160;203 of the Delaware General Corporation Law</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:10.46%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are subject to the provisions of Section&#160;203 of the Delaware General Corporation Law. In general, Section&#160;203 prohibits a publicly held Delaware corporation from engaging in a &#8220;business combination&#8221; with an &#8220;interested stockholder&#8221; for a three-year period following the time that this stockholder becomes an interested stockholder, unless the business combination is approved in a prescribed manner.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Choice of Forum</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:10.46%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our Amended Certificate requires that the Court of Chancery of the State of Delaware be the exclusive forum for the following types of actions or proceedings under Delaware statutory or common law: (1)&#160;any derivative action or proceeding brought on our behalf; (2)&#160;any action asserting a breach of fiduciary duty owed by any director, officer or other employee to us or our stockholders; (3)&#160;any action asserting a claim against us or any director or officer or other employee arising pursuant to the Delaware General Corporation Law, our Amended Certificate or Amended Bylaws; or (4)&#160;any action asserting a claim against us or any director or officer or other employee that is governed by the internal affairs doctrine. This provision would not apply to claims brought to enforce a duty or liability created by the Securities Exchange Act of 1934, as amended, or any other claim for which the federal courts have exclusive jurisdiction. Our Amended Certificate provides further that the federal district courts of the United States will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act, subject to and contingent upon a final adjudication in the State of Delaware of the enforceability of such exclusive forum provision. Although we believe these provisions benefit us by providing increased consistency in the application of Delaware law for the specified types of actions and proceedings, the provisions may have the effect of discouraging lawsuits against us or our directors or officers.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Transfer Agent and Registrar</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:10.46%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">American Stock Transfer and Trust Company, LLC serves as the transfer agent and registrar for our common stock.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Listing</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:10.46%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our common stock is listed on The Nasdaq Global Market under the symbol &#8220;ETNB.&#8221;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</a></p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>etnb-ex231_7.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
etnb-ex231_7.htm
</title>
</head>
<!-- NG Converter v5.0.2.71 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 23.1</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="text-align:center;margin-bottom:20pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Consent of Independent Registered Public Accounting Firm</p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We consent to the incorporation by reference in the registration statements (No. 333-254684) on Form S-3 and (No. 333-254683) on Form S-8 of our report dated March 24, 2022, with respect to the consolidated financial statements of 89bio, Inc.</p>
<p style="text-align:center;margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ KPMG LLP</p>
<p style="margin-top:10pt;margin-bottom:10pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk66889358"></a>San Francisco, California<br />March 24, 2022</p>
<p style="text-align:left;margin-top:63pt;margin-bottom:6pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>etnb-ex311_9.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
etnb-ex311_9.htm
</title>
</head>
<!-- NG Converter v5.0.2.71 -->
<body>

<p style="text-align:right;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 31.1</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CERTIFICATION PURSUANT TO</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">I, Rohan Palekar, certify that:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">1.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">I have reviewed this Annual Report on Form 10-K of 89bio, Inc.;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">2.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">3.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">4.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">c</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">d</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">5.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.43%;text-indent:-5.43%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: March 24, 2022</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:5.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;<font style="color:#000000;">Rohan Palekar</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Rohan Palekar</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">(principal executive officer)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>etnb-ex312_6.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
etnb-ex312_6.htm
</title>
</head>
<!-- NG Converter v5.0.2.71 -->
<body>

<p style="text-align:right;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 31.2</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CERTIFICATION PURSUANT TO</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">I, Ryan Martins, certify that:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">1.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">I have reviewed this Annual Report on Form 10-K of 89bio, Inc.;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">2.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">3.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">4.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><a name="_Hlk67433007"></a><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))<a name="_Hlk67433007"></a> and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">b</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">c</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">d</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">5.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.43%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.43%;text-indent:-5.43%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: March 24, 2022</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:5.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;<font style="color:#000000;">Ryan Martins</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Ryan Martins</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">(principal financial and accounting officer)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>etnb-ex321_10.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
etnb-ex321_10.htm
</title>
</head>
<!-- NG Converter v5.0.2.71 -->
<body>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:right;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 32.1</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CERTIFICATION PURSUANT TO</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the Annual Report of 89bio, Inc. (the &#8220;Company&#8221;) on Form 10-K for the year ending December 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), each of the undersigned officers of the Company hereby certifies, pursuant to 18 U.S.C. &#167;&#160;1350, as adopted pursuant to &#167;&#160;906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2)</font></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.24%;text-indent:-5.24%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: March 24, 2022</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Rohan Palekar</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Rohan Palekar</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">(principal executive officer)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk26284955"></a>Date: March 24, 2022</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Ryan Martins</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Ryan Martins</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">(principal financial and accounting officer)</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. &#167;&#160;1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Note: A signed original of this written statement required by &#167;&#160;906 has been provided to 89bio, Inc. and will be retained by 89bio, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>gb2k1ptlkg5v000007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gb2k1ptlkg5v000007.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !#!-,# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M\Y\:_&'X2?#76_!'AGXC?%+X<^ /$GQ,UE/#OPW\/^-?&_AGPKK?Q \02:CH
MNCQZ%X(TK7=3L+_Q7K,FK^)/#NEIIF@V]_>MJ.O:+8K ;G5+&*?T:O\ .N^*
M%[^W?\6/C9X7\'?#Z?\ ;E^*=AX:\1_M)^*/V-[S]K?P9=/^T+8W7@GPEH\7
MQVT?0?%'B>?X@?:?CM\#+[X01:-"OP:\<7OC3P/\7O!>E_$SX3>"O@Y^T%XO
ML_#]A_6_^R;^V-\'/A!_P27\!_M=^+OB9^T-\9/AKX+\(^+KO6_B#\7(-/\
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MR15E4::4C]H**_'']HK_ (+B_L<_L\?'3Q9^SX- ^-?QN\;^ ])\27WC6^^
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M!GQ \>6&K:YX0T^Q36->\/:E<Z/KLV@W%SK_ (>T_7=&\->-;[PQ_*1^U/\
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MW_X9S\<Z+J^N^)[VVTGX??#^[\#_ +._AQ?!PMH/%?ACQ+<_#'XC_%CX\_\
M"'^._ASX U6TF\5VGQB\;RZI9)H_B#QIK,..!R]X_$5L/"JJ3ITYU(.K&W,U
M4A2ITY6E:$ISJ1BW>2B^YIBL6L+1IU9P=13G"$E3=[)QE.4XW5Y*,8MI63DN
MQ_==17XA?\%3?C!\._VG/^"*?Q6^-/@.2#6? /Q4\)_ #Q5IEGJ$N@:I>:6]
MU^T#\)6U+PMXGBT+5?$6@VOC#P7KMO?>%_&.C6>L:FOA[Q?H>KZ-+=R76FRL
M/8]#_:LUSX _\$8?A1^U?XM\4_V_\1]%_8)^!/BS3/$WQ(M_&7CY/&OQV\=_
M"#P/HWP\_P"%@R:)>?\ "8Z]#X\^,7BCPUI_B[7)=:TV<1:WJ.NZ[XHT*RAU
M'Q!8Y?4ZOL:517]I5QE7!*CROG52E'#OYN4JZAR\MTX];V5_68>TG#[$,-3Q
M/M+^ZZ<Y55^"I<U[V:?2VOZM45_$Q_P2*\2_%7]CG_@H;\&+']H#Q#:1Q?\
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M1117,;A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQYJE]XDU345U'X/>(]9\.KXZM]?O]4\1>"_$NN1WVNZCI_B'5)+W])_V#_\
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MTTOR_P#X=A? 3_AOW_AXW_PF'Q@_X7=_;/\ ;G_"*_V]X*_X55]J_P"&>_\
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M\6:'X*^(#^$Y-9U3P-?:/IOBFV/@[QMX;\>:8-,O=?T'Q-I,(GUCPOI]M?\
MVK1+TRZ;->0VYM;J2&\M_0?A!\,]"^"OPE^%WP;\+7>KZAX8^$OP[\$_#/PY
M?^()[.ZUZ]T'P'X:TSPMI%WK=UIMAI6G7.KW.GZ5;S:E/8:7IME->/-):V%G
M R6\?#B<PJ8O TJ6(K5*V(IXNK4O.[M1E1I1BE+_ !QF[=+WZG51P<,/BYU*
M-.%.C+#PA:&EZBJ3;;7^#E5ST2BBBO+.\**** "BBB@ HHHH **** "BBB@
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; HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>gb2k1ptlkg5v000006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gb2k1ptlkg5v000006.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" ,Z!YX# 2(  A$! Q$!_\0
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M3_PY'Q$_^:FC_A M#_Y_O&G_ (<CXB?_ #4UVE%'-+^:7WO^NB^X.2/\L?\
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M_P"$"T/_ )_O&G_AR/B)_P#-37:44<TOYI?>_P"NB^X.2/\ +'_P%?Y'%_\
M"!:'_P _WC3_ ,.1\1/_ )J:/^$"T/\ Y_O&G_AR/B)_\U-=I11S2_FE][_K
MHON#DC_+'_P%?Y'%_P#"!:'_ ,_WC3_PY'Q$_P#FIH_X0+0_^?[QI_X<CXB?
M_-37:44<TOYI?>_ZZ+[@Y(_RQ_\  5_D<7_P@6A_\_WC3_PY'Q$_^:FC_A M
M#_Y_O&G_ (<CXB?_ #4UVE%'-+^:7WO^NB^X.2/\L?\ P%?Y'%_\(%H?_/\
M>-/_  Y'Q$_^:FC_ (0+0_\ G^\:?^'(^(G_ ,U-=I11S2_FE][_ *Z+[@Y(
M_P L?_ 5_D<7_P (%H?_ #_>-/\ PY'Q$_\ FIH_X0+0_P#G^\:?^'(^(G_S
M4UVE%'-+^:7WO^NB^X.2/\L?_ 5_D<7_ ,(%H?\ S_>-/_#D?$3_ .:FC_A
MM#_Y_O&G_AR/B)_\U-=I11S2_FE][_KHON#DC_+'_P !7^1Q?_"!:'_S_>-/
M_#D?$3_YJ:/^$"T/_G^\:?\ AR/B)_\ -37:44<TOYI?>_ZZ+[@Y(_RQ_P#
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MYI?>_P"NB^X.2/\ +'_P%?Y'%_\ "!:'_P _WC3_ ,.1\1/_ )J:/^$"T/\
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MON#DC_+'_P !7^1Q?_"!:'_S_>-/_#D?$3_YJ:/^$"T/_G^\:?\ AR/B)_\
M-37:44<TOYI?>_ZZ+[@Y(_RQ_P# 5_D<7_P@6A_\_P!XT_\ #D?$3_YJ:/\
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M_P .1\1/_FIH_P"$"T/_ )_O&G_AR/B)_P#-37:44<TOYI?>_P"NB^X.2/\
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M#):QZOK>L:[+;M=Z=))<"*ZUN^U"[2.610YB6<1!AE4!)SWM<7H?_(X>./\
MN6?_ $URUVE$M_\ MV'_ *2@AM_V])?=)A1114E!1110!DZ_-+!H6M3PR/%-
M#I.HRQ2H2KQRQV<SQR(PY5T8!E8<@@$5QVB>"M)O-&TB[N-1\:27%UIEA<3R
M?\+&^(2;YI[2*65]B>)U1=SLS;4557.%4  5UOB3_D7=?_[ NJ?^D,]'AO\
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M.:7\TOO?]=%]P<D?Y8_^ K_(XO\ X0+0_P#G^\:?^'(^(G_S4T?\(%H?_/\
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M<D?Y8_\ @*_R.+_X0+0_^?[QI_X<CXB?_-31_P (%H?_ #_>-/\ PY'Q$_\
MFIKM**.:7\TOO?\ 71?<')'^6/\ X"O\CB_^$"T/_G^\:?\ AR/B)_\ -31_
MP@6A_P#/]XT_\.1\1/\ YJ:[2BCFE_-+[W_71?<')'^6/_@*_P CB_\ A M#
M_P"?[QI_X<CXB?\ S4T?\(%H?_/]XT_\.1\1/_FIKM**.:7\TOO?]=%]P<D?
MY8_^ K_(XO\ X0+0_P#G^\:?^'(^(G_S4T?\(%H?_/\ >-/_  Y'Q$_^:FNT
MHHYI?S2^]_UT7W!R1_EC_P" K_(XO_A M#_Y_O&G_AR/B)_\U-'_  @6A_\
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M0+0_^?[QI_X<CXB?_-31_P (%H?_ #_>-/\ PY'Q$_\ FIKM**.:7\TOO?\
M71?<')'^6/\ X"O\CB_^$"T/_G^\:?\ AR/B)_\ -31_P@6A_P#/]XT_\.1\
M1/\ YJ:[2BCFE_-+[W_71?<')'^6/_@*_P CB_\ A M#_P"?[QI_X<CXB?\
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M4T?\(%H?_/\ >-/_  Y'Q$_^:FNTHHYI?S2^]_UT7W!R1_EC_P" K_(XO_A
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MH?\ S_>-/_#D?$3_ .:FNTHHYI?S2^]_UT7W!R1_EC_X"O\ (XO_ (0+0_\
MG^\:?^'(^(G_ ,U-'_"!:'_S_>-/_#D?$3_YJ:[2BCFE_-+[W_71?<')'^6/
M_@*_R.+_ .$"T/\ Y_O&G_AR/B)_\U-'_"!:'_S_ 'C3_P .1\1/_FIKM**.
M:7\TOO?]=%]P<D?Y8_\ @*_R.+_X0+0_^?[QI_X<CXB?_-31_P (%H?_ #_>
M-/\ PY'Q$_\ FIKM**.:7\TOO?\ 71?<')'^6/\ X"O\CB_^$"T/_G^\:?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-WB:#X82>%M+_:'?7/'NM>'?&>EZ+H.L>./"'PL\-_&/1GTC6-"A\::]\/\
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M8=8>K*%2$IO$*+]E3:YK0D[6N^7^9.\H:.^G[UT445Q'2%%%?/W[6?Q6\1?
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MPSXB^%1\8>(-)\0:1XP.C:?X3_X2V>*ZU+41J=A?PZC>?6/_  <KPPS?L3?
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MD%%%%(H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _G8_X.7/^3+OV?O\
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M\_$_6/'>L> XX_#7B7Q(/B-<_!#3?&OB[6=:TSP)XEAE^)WACX2>)-9TG7/
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M#HOB"#2OAQ\1_">MZ?X>\8Z+#K%W9Z18:'JF@>.+?3=(\0:Q<1>*-,T7M_\
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M]8\-?M!>-]?N]7UOP7J>H?![P9\4/AIX6^*G@SPU>^$/#.LWVJ:UXZ\&^/\
M4?"\OAG5YM!\+>)O#^HZ]H/B;7+32]0FM[OZ]_;4_:E_:D_X*S_MIWW[''P0
M\4>'A\&;WXC>,/A7\*O 7A7XH _!;XI>&/A]XDN/%-Q^T#\4_%.G8T?XFZ=>
M:9\-[;XQ^&H;71/%-MX"\+Z-I>C_  A\/>+?'T^L^)_B=^WO_!%O_@F[\+_V
M8O!][^T['\9/AM^T-\6/BEH?BKP#I/Q&^ _C^7QO\!-"^&5IXXM!J_AOP-K]
MBFFV/CS7M9\5^ -'O/'/BG6M)BG\+ZSX=C^'_A73](32/&?B'XB_QQ_"_P"
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M?VI= \&Z3_;6K:9H7P^\?WUH;_2]-%OX1^%/Q@^'OQ1\?ZRUSK%]I]FZ^'?
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MT?QW\./&'@[Q_P"#=*M/$]II7BG1=9\,^)/AOXDL+_Q1[-_P10_Y2B_L6?\
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MZR_#V]M/A7X-\+VVB:C=:=HAT?P_X-M+"YL-#%GU/[7G_!./]LO]AS1/A?\
MM5?&_5/#L/B7XF?$BT\0R^-_"'Q-O_$/Q;^'WQ]U"TG^*=G-X[\336NF:G=?
M%6ZU/2_%NO\ _"?_  \\3?$+2T\4>#M=U:Z\>0W>H>%-0\36_P#G-A_WF _]
M_MK^AK_@Y2_Y,G^"'_9X'@S_ -43^T57ORQ;PV,R3"TJ.'4<9A</#$3E2BZD
MZ?+RQI\VEHP;E-+5.4M=+I^/'#JOALRQ%2K6<L/B*SHQ51J$9W3<[:WE)*,?
M)+36S7TE_P $./VI/B5^U'^P_;WGQ;U77?%GCCX)_%#Q/\#+WXB^*-?B\0^)
MOB/I.B>&O!7C[POXA\0W*Z)I-T-9T7PS\1](^'M_?ZU?^+/%'B^;P2WQ!\6^
M+=7\4>+]7%M]=_\ !1S_ )1Y_MX_]F9?M0_^J0\<U^67_!M;_P F3_&__L\#
MQG_ZHG]G6OU-_P""CG_*//\ ;Q_[,R_:A_\ 5(>.:^/S"G"CF^)ITXJ$(8UJ
M,5M%>T3LET2OHMDM%H?28.<JF H3FW*4L/%RD]6WR;M]6^KZO4_BE_X),_MN
M?"S]@K]HSQI\8/B[X;^(GBCPWXD^"GB/X;66G_#/2_#&KZ]#KFL>.OAQXHMK
MR[MO%GB_P5IR:1'8>#M2@GGAU6XO5O+BPCCT^6"2YN;7^I?]EG_@MY^RQ^UQ
M\?/A]^SK\.?AK^T7H/C3XD2>*8]%U?QSX6^%VG>%+(^$O _B?Q]J+:O>>'_C
M!XGUF%;C2?"E_9V/V'0=1:35+BQBN%M;.2YOK7^:7_@BI^RA\ _VP_VIO'WP
MS_:*\#S^/_!.A_ #Q3XZTO1K?QCX[\$/;>*=,^(OPJ\/V6IG5?A[XG\*:U<+
M#I/B?6[4Z?=:C-I<IO5N9K*2[M+*>V_K6^!G_!)[]@7]FSXK>$OC;\%_@;?^
M$/B=X&?7'\+^(YOC'\>/%,6FMXD\,:UX.UDOH'C'XG>(/#6H_;/#GB+6-/4:
MIH]ZMJUVM]9BWU&UL[NW^AXDGE:Q5>->EBY8YX:/LZE.5-4%)PE[+FBY*5E*
MW/:.JV/&R:./>'I.E4PZPJK/GA.,G5:YH^TY6E:[5^771[^7\?\ _P %P/%G
MBJU_X*G?M$^*+;Q-X@M_$WPA_P"%(?\ "IO$4.M:E%KOPO\ [(^!'PL^(>D_
M\*ZU9+E;_P $_P!E^/\ Q!KWCG3AX9N-,^Q>,=;UCQ/;>5K>IWM]/^_7_!RE
M_P F3_!#_L\#P9_ZHG]HJOYY?^"X_P#RDQ_;,_[I#_ZRO\%J_H:_X.4O^3)_
M@A_V>!X,_P#5$_M%5<HQC5X1:BDY4X.322;?)AM6UN]7OW%S-T^($VVE4=KM
MNVM5:=ME]R/YVOV*_P!AK]M#_@H1\-O$OP>^$6I:-H_[._PQ^(^I?%C4+_XJ
M:EJ_AGX//\>/$OA+P=X*EMK"\\-^#_%FM^,/B?;_  XT739K:W_LC6-/^&?A
M.\U.6YU+P3<?%ZQMOB+TG[#W[4WQQ_X)6?M?Z1X+^.%U\2OA+\*O#?CS4]"_
M:B^!.LZGJ7_"(Z;IGB[2]&T?7OBK<>#O#^C?$#2O$?B#P;IFF>#OB7X:\;?"
M_2+_ ,2_%+P=X/TGPEX*\>7?P]\?SS:K^X7_  ;5_%/X>']GWX\? W_A+M(3
MXMVOQVUOXPOX#FDFM]=N/AIKGPU^#7@6T\7Z;%<0Q6^LZ5:^+/"FIZ+KK:/<
M7\_ABZN_#?\ PDL.DQ^,/";ZU_/_ /\ !2+QG9_MK?\ !1WX]7?[.]I)XUD^
M+OQ/\'?!CX40_P!N>#8-/^(7BSP_X5\%? 30]0\,^*X/%%[X*F\'?$;QAX:7
M6/ ?BJ]\26.G7WA'Q!H.MZW_ &!)/?V6G]T:\\9F&;Y;B</1A@:="K4YO9<D
MHS;CRUI5'O.JI3JJ>C3@G%KE;?*Z4</A,NQM"O4EBJE6G"WM+J44G>DH+:--
MQC3<=GS-26J2^Z?^#EF>Z\1_MK?"?P=KMU<:QX5T/]E/PGKN@^&]5FDU'0-"
MU_Q?\6?C7I?BK7='T:\:;3M-UCQ)IW@[PA8:_J5E;07NLV7A3PW:ZC/<P:'I
M<=KRG[(/_!/_ /X*(?M%_M)?L[_\%#/B=\--;\=Z5XI_:B_9P^,_BOXD?$#Q
M3\.-!\=>-/!&G^/$UG5OBOI7A#5M:T&_L/ 7P^\-?#_1+;PWX?L-$\/-/X,\
M2?#&W_9_\$>)_AW:RR>%>G_X./O^3^_AU_V9_P###_U='[1U?U:?\$]?^3!/
MV'?^S/\ ]FC_ -4OX*KRZV-E@,BRN5&C0=3$T\11G4J4^:4:3D^>,;.+O-\M
MVV](K2]FNVGAHXO-<=&I4JJ%&5&I&$)<J<U&/*Y73NHV=E;J]>_\>W_!1#]L
M_P#:A_X*7_M4^)OV8O@HVI^-O@Y#\0O$7PE^#7P0^"?C >)? GQWL?"GC>._
MTKXR>.M;M;S2?!?Q M?$ESX*T3XJ:%XB\631_"WX&^"M,L=8TO5K :5\0/BS
MXVX;]HO_ ()3_MO?\$U_!6C?M37WC;P%I4GAWQA:>"]/\;?LM^-_C(WC[X<Q
M^-/#OB32&\4:OXI3X4_#23X?^%=5A,OP]O-;B\3PI>ZUXW\/^$4%U+XHCMWX
M#_@F/K^@?L<?\%+/@<?VFM;T;X/VOP8\;_%7X6_%/4_$.IV-YH'@7QK+\,OB
M5\'9;'7O$OAZ?6?#MIHVF_$#5[/2=:\9#5'\$Z%IRW?BC6/$5EX4T^^UNW_J
M9_X+W_%CX;^#O^">OQ'^%_B?QGI.B_$+XUZY\-]-^%O@^626?Q!XRF^'_P 8
M/AI\0/&MQI^G6EO=SP:'X:\,:/++KOB34$LO#VFZAJOAKP_=:M!XB\7^%--U
M?MK8BIEV-RG+,'0HO!XBEA_:OV*F\1[:HX5IN=G>U-*I)INW->;<+)<U*E'&
M87,,=B:M18FC4K>S_>.*H^SIQE3BHJUKR;IKO:T5S7/C[X3?\%G?B3\0/^"4
MW[5OQBU-=(7]KG]F;3?AU\.-3US0X(=)MKU_C]XGT3X4_!_]HV33-;^'^M?#
M:'Q%IWB74O%VMZS\*]/MM?\ #_B'Q!\*KDW>F_#OPA\3/#>B:#^&W[ 7["GB
M?_@JO\<?C##\1?VDK3P[XQ\+^ O"_BKQ'XW^*,^L?&WXY?%&0W%AX&TA[73?
M%/BW1?$/B_PMX'\/Z#IVB^-?&^L^.9YO!,NJ_"/PK;Z)JUKXOCN_#7Z;_P#!
M _P=X!T_]G7_ (*+>._VE;_PEX,_95^*EA\'O@#XL\=>./B1H?P\\+7UT=(^
M*NC_ ! \':EXD7Q5H&O^#;F;1OCU\-=.T[79;OP\VI:EX[TRR\&ZW=^(+&_A
MTSQ?]MW_ ((47GPQ^#_B#]IG]D7XRZ!^T)^SGI/PWE^*VHZ3XQU;PT_C>7X9
M6/AGPKK<WC3P9XY\+65K\+/C+H>HZ+-XT^)-S<6EC\,'L_!>F:+HO@G3?BIX
MEU2U%YG1G@<#C<SP5"K'+Z]7$TXX3&NA&O2A>%*<\,N=.$$IRFK2<8I25W>$
M4[J1Q6)PV!Q-2$L72IT)/$89594IRM*<8UFXVE*\8Q=U=MQ;2:E)G]$W_!)_
M]G']IS]E+]GGQE\$OVHO$_\ PE^O>$OBS]E^%^LZ=\1-;^(G@I/@W;_!WX.Z
M=X8T'X;3>)8M+\0^$O _A+7]/\6>$[/P9JGA/P0FF:QHFMZAHGAV7PUJ^B^(
M_$'\E'_!#[Q9XJN/^"IO[.WB>X\3>(+CQ+\7O^%W_P#"V?$4^M:E-KOQ0_M?
MX$?%+XAZM_PL75Y+EM0\;?VIX_\ #^@^.=1/B:XU/[=XQT32/$]SYNMZ;9WT
M/[W?\&^'[6O[0'[0OP^_:&^''QO^(.L?%&P^"^K_  WU7P-XO\;ZAK'B7XEB
M'XK7/Q0OO$F@>)?'&LZI?:CXIT'2M0\'VE[X0_MI+G7?#\6L:QH"Z[=>$+'P
M9X<\)?SX_P#!#C_E)C^QG_W5[_UE?XTUA0H5:7^M$,4J,J\,)"4I4H)4[SH5
MJD905ER<T7"322M+T1I5JPG_ &%*@ZD:4J\HJ,Y-RM&M1@XR=_>LU))]5ZF_
M_P %0OVE/BW^V;^W?\5?A!XI^(4/A/X3^"?VE&^ ?PX\!_$OXE2:=^SS\,-2
M^%_C/7O@=/\ &GQA-9^'+30_#_V_5=2\>?$3QS\2-5\)^*/'?@3P/XMU?P&G
MB7Q1X1\%Z!8U^Y_[%G_!'_\ :6_X)]_MJ?"#Q_\ #GXZ1?$[]F?Q&^NV?Q[T
M_P .7.L?![5;S5(/A+\<;/P3J'C_ .%!\4Z[X5^)'@CPGXJU3PG:^&-47Q;X
MC\7:1XT\=F_L_AUI'A_0=;\<0]3^W7_P2Q_9B_X*-?%?XW?%?]F?]I[P7I_[
M67A+^Q?#WQD\%V'COP_\3_ ,'B[P?X<\6^ _#.@?$_PWX<U'4O'GP*\6:UJ7
M@C1/!>KZ[;_VKH^CZ5\,_$LMK\%?$'CR;Q/K%Q^*/[%7C+]L'_@FU_P4D\!?
MLCWOB[^Q+/6_VB_A_P#"OXP?"R/Q%?>+?@OXUT;XUZS\.-&?XG:+H-IJ.FV$
M'C'5_ ,_@GQ;X#\?-8>'_B)HEM9:%X4\=Z;!HQ\<_#&_TA56.RQ8;+:U'#SH
M8"2QF75\-"];]W%3KPK./-S7?-3FGK.4)5.1LF4'A<;[?&TJE:-;%Q^KXVE7
ME:G[]XTI4D^7ELK3BU\,91AS=/[RZ***^'/J HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ KF?"7_(*NO^QF\:_P#J9:]735S/A+_D%77_
M &,WC7_U,M>I]'ZK\F2_CC_AE^<"#P5_R![S_L;?'W_J=^(ZZVN2\%?\@>\_
M[&WQ]_ZG?B.NMH>[]7^80^"/^&/Y(****104444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX^/&N6\*>./BCXR;Q$=?_P"%I^#!$-0'Q)731H_]B2&T.BF].JW7]IBTT_\
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MG!6A",815V[1BE&*NVV[))7;;?5A1114%!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!Q>A_\CAXX_P"Y9_\ 37+7:5Q>A_\ (X>./^Y9_P#37+7:
M54MU_AA_Z1$F.S_Q3_\ 2Y!1114E!1110!B^)/\ D7=?_P"P+JG_ *0ST>&_
M^1=T#_L"Z7_Z0P4>)/\ D7=?_P"P+JG_ *0ST>&_^1=T#_L"Z7_Z0P57V/\
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M/B#4K3XH?&[]F[X6^%VT*[N-/\1_"O3?'_Q?\07/BG^T--6TTO4O!OB'PG\
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M:7_9>VU-[_:5I]A_\%.O^"8O_#QS_A2/_%[O^%-_\*;_ .%E?\TU_P"%A_\
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M5D^9W;E[[]_WC\1/^"C_ /P1N/\ P4$^/WAWXY?\-&CX2#0/@]X7^% \+?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!Q>A_\ (X>./^Y9_P#37+7:5Q>A_P#(X>./^Y9_]-<M
M=I52W7^&'_I$28[/_%/_ -+D%%%%24%%%% &+XD_Y%W7_P#L"ZI_Z0ST>&_^
M1=T#_L"Z7_Z0P4>)/^1=U_\ [ NJ?^D,]'AO_D7= _[ NE_^D,%5]C_M[]"?
MM_\ ;OZFU1114E!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7,^$O^05=?]C-XU_]3+7JZ:N9\)?\@JZ_[&;QK_ZF
M6O4^C]5^3)?QQ_PR_.!!X*_Y ]Y_V-OC[_U._$==;7)>"O\ D#WG_8V^/O\
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M[H'_ &!=+_\ 2&"J^Q_V]^A/V_\ MW]3:HHHJ2@HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF?"7_(*NO^QF\:_^
MIEKU=-7,^$O^05=?]C-XU_\ 4RUZGT?JOR9+^./^&7YP(/!7_('O/^QM\??^
MIWXCKK:Y+P5_R![S_L;?'W_J=^(ZZVA[OU?YA#X(_P"&/Y(****104444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Q>A
M_P#(X>./^Y9_]-<M=I7%Z'_R.'CC_N6?_37+7:54MU_AA_Z1$F.S_P 4_P#T
MN04445)04444 8OB3_D7=?\ ^P+JG_I#/1X;_P"1=T#_ + NE_\ I#!1XD_Y
M%W7_ /L"ZI_Z0ST>&_\ D7= _P"P+I?_ *0P57V/^WOT)^W_ -N_J;5%%%24
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %<SX2_Y!5U_V,WC7_P!3+7JZ:N9\)?\ (*NO^QF\:_\ J9:]3Z/U7Y,E
M_''_  R_.!!X*_Y ]Y_V-OC[_P!3OQ'76UR7@K_D#WG_ &-OC[_U._$==;0]
MWZO\PA\$?\,?R04444B@HHKP;]J?XF^)?@I^S#^T=\9?!EGHNH>,/A)\!OB_
M\3?"EAXDM;Z^\.WWB7P%\/O$/BK0K37[+2]3T74[S1;G5-*M8=4M=.UC2;ZX
ML7GBM-3L+AX[J*HQ<Y1A'>4E%>LG9?BQ-J*<GLDV_1*[/GW]H3_@J'^PG^RQ
M\2[WX/?''X\VGA3XD:9HFDZ_J_AG2/A_\5OB#-H=EKL4]UI-MKVH?#?P+XNT
MC0M>O=.BAUF/POJ^H67B5?#^J>'_ !#)I*:)XE\/ZAJ?MJ?M=_LV2?LU']L&
M/XO>%I/V;U\(R>-#\3XVU&33QI4-XVD2Z7_8B6!\5?\ "<1>)4?P3)\-?["_
MX6*GQ#1OATWA8>.5/AX?R[?\$P/VM?V8_@]^RS\8?''Q3_8L_;$_:G^(?C+6
M?CFG[6_[2-I^SK\./COX(N?#'BBST/6O'/PU\4_&G6_$FGZ\_P .=6^'VC^#
M?B9\6O!_QBU&YBN_&GBGQ5XNUM[CP]J^BR0=A_P4%\3?LV?M.:'_ ,$//#OP
M%\(W'@C]C#]H?]H[Q'X?UOX >&]'O_@AX8B;Q/\ M"? 7X:_$?3-6\$?#N^T
M'1M%\>>&-7\:_&?PTGCGP5>W+V^I^+O''B3X<^.]0TGQBWB;7/=GE$(8B&'<
M,5",)UHUL4W2E2J+#X>KB*JHTHQ4J4YQHS]BJM6?-&TFE9H\J&82G2=52H2E
M.-)TZ"4U.#K5:=*FZE1R:J1BZD?:.G"*B]$W=,_H#_9U_P""E'[#O[5OBN7P
M)\#/V@_#'B;QP#;KI_@[Q#HOC/X9>*?$KSZ3X@UZ:/P3X?\ BGX:\%ZMX\FT
MC0_"VNZSXEA\%VFO2^%=+LDU#Q*FDVE[82W6A\;_ /@HM^Q)^SC\2/#WPA^,
MW[1?@+P?\1O$&N67AV3PPC:SXDN?!NHZE!X5OM.D^+-YX2TG7M+^"ND7^D^-
M?#GB"R\0_%^^\#^'[KPQ=W?BF#4Y/#NC:WJ>G?B3_P %J?V=?V?/V(M-_8K_
M &W/@?\  ?X,?#W3_P!GG]J'0=9\5_"'X3_"[P/\(4^,FI6$FC?&KPK=Z]XX
M\'Z'&-+E\*2_ #5_#^E/J'@[Q:T#?$>\UFT-D=$GTOQ%\1?M+Z3XL^!O[1?_
M  56^!GQ_P#V6_C=^U5\<_V^_%;P?L6^+_"&@^.]52X\!>#O&E]^T3-:^"OB
M->6%E\4_&&A?L^^#-8_9ROO%WPB^#/AGX@?#VZ\4?L\Z-\&_'ESHGPXT'2/$
M\$T<MPN(]C5ISKJA6I3<:4IT?;JI3Q-&A5_>.$:<H4Z=58F3Y(^Y&4&U:52-
M5,9B*7M*<XTG4ISBG4C&I[)QG1G5A[BE*<93G!T%[[7,U*SNJ<O[(OBU\6OA
MO\"?AQXN^+GQ=\7Z1X#^'/@72FUCQ/XHUJ25;2PMC/!96=M;VUK%<ZCJ^LZQ
MJ=U9:)X=\.Z-9ZAK_B;Q!J.F>'O#^F:GK>IV%A<Z_P /_'?A3XI> _!/Q-\!
MZLNO^!_B+X1\-^._!FNI9ZAIZ:UX4\7:-9>(/#NK+8:M:6&J62ZCI&H6=XMI
MJ5C9ZA;"80WEI;W"20I_'QJ_QV_9R_:I\"_L?? #]J?XL:?\-/\ @G=^P[^S
MU\$H/BMJGAZTTO6-8_:._;,^&G@?P3\)/&?PC^!GC7X<^)O%GQ(^*?PZ^'WA
MCXI0V/BSXB?LO^$]9TS0_".M^*_&%_XRMO!GQ6_9H^-^E?UW?"'XN_#;X]?#
M3P;\8?A!XNTSQU\-_'^CQ:YX5\3Z4+J*"^LWEEMKFVO+#4+>RU?0]<T?4;:\
MT7Q)X9U[3],\1^%O$.G:IX=\1Z5I>NZ7J&GVW#BL&\+2IN2J2G.<N:?(U0A&
MR=*GS..M></WTXJ?[NG*G%KGY^7IP^)5><TG!1C&-H\R=5R_Y>2LGI2C)^SC
M+E]^<9M/EY7+T>BBODW]IO\ ;D_9:_8XG\&6W[2'Q0_X5S-\08M?G\()_P (
M3\1/%_\ :\7AA]'CUQMW@3PEXH2P^POK^DC;J;637/VO-F+@07)AY*5*K6FJ
M=&G4JU)7Y:=*$JDY63D[1BG)VBFW9:)-O1'3.I"G%SJ3C3A&UYSDHQ5VDKRD
MTE=M)7>K:6Y]945\@?LT?M[_ +(_[8&K>*- _9V^,>F^/]=\'6.G:IK^BS>&
M?''@O5H-,U2:[MK?4=/TWQ_X8\*WFNV,%Q9M!JEWH,.I6^BS76EQ:S)8/K.D
M+??7]%6E5H3=.M2J4:BLW3JPE3FKJZO&:4E=--76J=UH*%2%6*G3G"I!WM.$
ME.+L[.THMIV>CUT84445F6%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Q>A_P#(X>./
M^Y9_]-<M=I7%Z'_R.'CC_N6?_37+7:54MU_AA_Z1$F.S_P 4_P#TN04445)0
M4444 8OB3_D7=?\ ^P+JG_I#/1X;_P"1=T#_ + NE_\ I#!1XD_Y%W7_ /L"
MZI_Z0ST>&_\ D7= _P"P+I?_ *0P57V/^WOT)^W_ -N_J;5%%%24%%%% 'YU
M_MW?\%#/#7['47A'P#X'^&?B?]IO]J;XE#^T?AO^S!\,Y-7G\<ZWX0TQ[^\\
M5>/-=_X1CPE\0/$'A_POI6B:!XH?0Y+3P5X@U7QCK^AZAINC:6- \._$+Q=X
M$@_9/_;+_:0^,WQS^)/P'_:+_8$^+G[*FJ^"?!=AXQT3XCS>)I/B[\$?%CM/
MX;35O"=M\8=)\!^#O 4_C!+7QEH&HZ!H_@S6_'PU*WTCXD6?B&Y\':WX N-)
MU;\5/'E_^USXB_X.#OVA;;]F'0?@G\2_B/X$^$OAFU\-WO[5+>*]=^&W[/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4;)I_4Z-Z37.O9*"LI:3Y*BK0=32\Y*JO:-W3E-MRO<****X#J/QZ_X*E_\
M)8?^"67_ &D#^%7_ *.BK]A:_'K_ (*E_P#)8?\ @EE_VD#^%7_HZ*OV%KOQ
M/^Y9=_@Q7_J3(Y*'^\XW_'0_],0"BBBN ZPHHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^Q_V]^A/V_\ MW]3:HHHJ2@HHHH **** "BBB@ HHHH **** /QZ_P""I?\
MR6'_ ()9?]I _A5_Z.BK]A:_'K_@J7_R6'_@EE_VD#^%7_HZ*OV%KOQ/^Y9=
M_@Q7_J3(Y*'^\XW_ !T/_3$ HHHK@.L**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF
M?"7_ ""KK_L9O&O_ *F6O5TU<SX2_P"05=?]C-XU_P#4RUZGT?JOR9+^./\
MAE^<"#P5_P @>\_[&WQ]_P"IWXCKK:Y+P5_R![S_ +&WQ]_ZG?B.NMH>[]7^
M80^"/^&/Y(****104444 %%%% !1110 4444 %%%% 'X]_\ .=O_ +QG_P#O
MPE?L)7X]_P#.=O\ [QG_ /OPE?L)7?C]\'_V 8;\I')A-\5_V%U?R@%%%%<!
MUA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 <7H?_(X>./\ N6?_ $URUVE<7H?_ ".'
MCC_N6?\ TURUVE5+=?X8?^D1)CL_\4__ $N04445)04444 8OB3_ )%W7_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MFN>(/$&N:I/:Z9HVB:-IEK=:CJNJZC=6UAIUA;3W=W/#;PR2+_!7H>J>./\
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MOCQJOA[]M[]J(WFK>/OAWXH\#>*OB_\ &KX*>%(M0A\;Z7IGQ07X7>&_BO\
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M_P"D,%'B3_D7=?\ ^P+JG_I#/1X;_P"1=T#_ + NE_\ I#!5?8_[>_0G[?\
MV[^IM4445)04444 %%%% !1110 4444 %%%% 'X]?\%2_P#DL/\ P2R_[2!_
M"K_T=%7["U^/7_!4O_DL/_!++_M('\*O_1T5?L+7?B?]RR[_  8K_P!29')0
M_P!YQO\ CH?^F(!1117 =84444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO]8_#[P)X5^%G@+P1\,? FEMHG@CX<^$/#7@/P;HSZAJFKOI'A7PAHUEX?\
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M@ZX\6^)O%/BKQ5X^?Q;XDU8:K;?J/\)_A/\ #GX&?#GPC\)/A)X1TKP+\.O
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M"UWXG_<LN_P8K_U)D<E#_><;_CH?^F(!1117 =84444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MNKZ[\7_!W[3OBG7Y(]0^+MQX^T#Q;;V-EKVM0WUMX6T?K?V$OVM/@_\ L?\
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MGPAKEUXJU'2]&^#6M^'-&^&7[-^C>*?&^I7GP\A\$ZE?VOA&Q?P;\%_'4?\
M4A7CYA0P^%G3PU&3JUZ,6L954DZ<J[:;ITDK^[0_ARE>\YJ6B21Z.$JUJ\95
MZD5"E4E?#TW%J:I+13J/^:K\:BE:,>75ML****\\ZPHHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\3^.O$Z>()->F^'_ ,.9+1KF3QN^GOI"Z%=BW32EO1JD[7YL['^^SQ[^QO\
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M(\,?%W3IM.L-'\'Z+=^%]53_ (5O:IXA^(TEGX%NO$^J:7\0+/\ 0+_@M?\
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MX_\ )]Y_]D=P[_Z<S$****_7#^, HHHH **** "BBB@ HHHH **** /[//\
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MZ$_;_P"W?U-JBBBI*"BBB@ HHHH **** "BBB@ HHHH _'K_ (*E_P#)8?\
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MX>^*.A#P^/'G_"TM0R?"Y^)"W9U8^#,:V-%:W_LS2#J8GT_[*CG^755CIXC
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ KF?"7_ ""KK_L9O&O_ *F6O5TU<SX2_P"0
M5=?]C-XU_P#4RUZGT?JOR9+^./\ AE^<"#P5_P @>\_[&WQ]_P"IWXCKK:Y+
MP5_R![S_ +&WQ]_ZG?B.NMH>[]7^80^"/^&/Y(****104444 %%%% !1110
M4444 %%%% 'X]_\ .=O_ +QG_P#OPE?L)7X]_P#.=O\ [QG_ /OPE?L)7?C]
M\'_V 8;\I')A-\5_V%U?R@%%%%<!UA1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^O/!3_DBE_V-L?\ ^DX<_P 5OIX_\GWG_P!D=P[_ .G,Q"BBBOUP_C ****
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M;_T7_P"-G_AU?'7_ ,OJ^E_X@)F/_118+_P@K_\ R\_+?^*BW#/_ $;+/O\
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M "^H_P"("9C_ -%%@O\ P@K_ /R\/^*BW#/_ $;+/O\ Q(,O_P#G?Z_T]/\
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MU<)3S+"4L5'#U*T(PA5G2510E.,(QDU=12=@HHHKS#ZL**** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@#^SS_@CE_R81\+_P#L9/B;_P"I_K]?J)7Y=_\
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M444 %%%% !1110!^#/\ P7Q_Y(3\#O\ LK6H_P#J':K7\LM?U-?\%\?^2$_
M[_LK6H_^H=JM?RRU_8_@[_R0F7_]A>9?^IE4_P /?IN_\I"\3?\ 8GX6_P#5
M%@PHHHK]1/Y)"BBB@ HHHH **** "BBB@ HHHH _LJ_X(R?\F)>"/^QV^)'_
M *E%U7ZK5^5/_!&3_DQ+P1_V.WQ(_P#4HNJ_5:OX1XY_Y++B?_L>9E_ZE5#_
M *&O #_DR'A-_P!F_P"%O_51A0HHHKY4_7@HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8VG1IU%4C"+>M-IJW-&_NV5M-2BBBO%/2"BBB@ HHHH **** "BBB@ HHHH
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MOR[_ .".7_)A'PO_ .QD^)O_ *G^OU^HE?P?QM_R6'%'_8^S7_U,K'_0_P"
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M?^I,CDH?[SC?\=#_ -,0"BBBN ZPHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH _!G_@OC_P D)^!W_96M1_\
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M  8K_P!29')0_P!YQO\ CH?^F(!1117 =84444 %%%% !1110 4444 %%%%
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MK_,(?!'_  Q_)!1112*"BBB@ HHHH **** "BBB@ HHHH _'O_G.W_WC/_\
M?A*_-[_@E[\0_$WB/X,_\%?O^"MD-MH&I_'#7;[XU2?#SPC\3+34?B/?_"8?
M#7X6W/[0MA\.Y_BP^J>%_&'B7X5ZA;^/O@[\.[GP1H-E\.;*U\+_  #\&?V?
M+:0Q>&M,\#_0W[:_P\\7?%W_ (*(?M;?"?P!HP\1>//B?_P0T^/7P\\$^'VO
MM+TM==\7>-?&'BOPWX;T8ZGKE[INB:<-3UG4[*R-]K&HV&EV@G^T:A>VMI'-
M/'[!_P $6Y_A'^T5_P $G=#^!NJN_B[0-*D^/WP ^.GAI/\ A*?#9@D^(?B;
MQ/XWU3PK%K]F-"OI?[6^%'Q@\):FOB+P5K,BZ<WB V5KK=CXFT;4[32_HZKC
M3P"K-<W/2RC#U(KXEAY+$XBHO)5)X:G'IK'?H>/3YIXN5-/EY:F858-[>V2P
MU*#_ .W(UIOKH]C\P_ GP_\ ^"A_QS_X)_\ B/\ X*K6'_!2_P".-O\ %+PY
M:>(OC'!\(Y;K6/ ?P=C\(?LH^*_B9X+^)^DZAX(\"ZR_PIU[6O&6C?"[0O&O
MAW1H?@IH'P\U_6=/\2>"/BAX:\40?%._^)/@C[Y_:$_;1^+/[0G_  0?\2?M
M>Z5=:S\!OBWXEL_!]K<ZE\'?'/BOPU?:-K/A#]KKPY\)?$&K^$/%&E7FE>+/
M#ND^.+3P[J6HMX=.LZC=Z-H/B:Y\%:GXD\6PVMWKFL?#'[:'_!-#Q_\ L+?L
M<?'&-/\ @K/\3?!'[.>H7FOV7PT_9P\1^#/&3V7Q&UC6;#XHR>$/V>;:3PG\
M==+L=0?XGVOCGQ6GQF7P?\,-%^&_C(1:K\:?BK\+G\._#6UF\'_I!^P1\(?@
MIJ7_  1Z_93^ '[:Y\&^'O W[0=\+?PUX4\6?%>S\$+\3M1^*_QZ\8?'?]G_
M $#PCXF\)^,]"U74O%WCS0G\)>,- \$^'==7Q==Q_:?#^KZ(MW9Z]HL.M>IA
M>2AC;T<12I9O1=&%'"^QE'!1C*K5PKA*E1A5=.,:2:O4A&4M:G[UMYTH8CFJ
M8;]Y1J3RZHJDJM?VJ>*;A3IUU*-2I*FIN52SM"4E'2"<$<W\)?\ @DA^VI\/
M/BQ\+/B#XH_X+$_M-?$CPSX!^)?@#QQXD^'.MP_')=$^(7A_PAXMT?Q%K7@/
M6FU7]KWQ'I8T?QEIFFW7AO5/[3\.^(--^P:G<?;]"UBT\[3KG\^OCM^TU^UQ
M^TY\3O\ @J)\9_!?[8/BK]EKP;_P3!^(FBZ%\$OA7;?$#3O!'PX\8>+-'^-<
MWPPUT?$#Q-HOAG28/BY-\1/^&;_&EU\-_@-\6_"OQ#T[7OC!\=/"7PHM_&6F
M^ X/$VG?$+=_X*R_L0_ /_@G]HO[+/QK_P""?&E^,?@M^V!<_'H^%OA?X?\
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M:<L3S\[DZCY:\U#D=[6BKJ5T[+E2L>=_M]7'_!0?6?#_ ,.?AI_P3\TGX?\
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M*&LI\;OV?]#\/?%&30Y];UKXO^(=7LO&^G:;=VWG:1\05\ Z=X8\%^!_S?\
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M1K5\).,Y*4VE1G.;E-2:G[]"G-RN[]D[H_HKHHHKPSU HHHH **** "BBB@
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M+_\ L9/B;_ZG^OU^HE?P?QM_R6'%'_8^S7_U,K'_ $/^ W_)DO"7_LW7!_\
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MWXG_ '++O\&*_P#4F1R4/]YQO^.A_P"F(!1117 =84444 %%%% !117\M_\
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MDEK<?]HT_8RJ>SJ*I&N\-]7:BZLL0K?NX\LG%Z-2YE+E4;M[6/Z>**Y'X?\
MA+_A / 7@CP'_P )-XN\:_\ "$^$?#?A'_A,OB!K1\2>/?%O_"-Z-9:-_P )
M-XW\1&VLSK_B[7OL7]J^)-:-I:_VIK-W>WWV:#S_ "EZZO)=DVD[I-V=K771
MVZ7['H*]E=6?5;V\KA1112 **** "BBB@ HHHH **** "BBB@#\&?^"^/_)"
M?@=_V5K4?_4.U6OY9:_J:_X+X_\ )"?@=_V5K4?_ %#M5K^66O['\'?^2$R_
M_L+S+_U,JG^'OTW?^4A>)O\ L3\+?^J+!A1117ZB?R2%%%% !1110 4444 %
M%%% !1110!_95_P1D_Y,2\$?]CM\2/\ U*+JOU6K\J?^",G_ "8EX(_[';XD
M?^I1=5^JU?PCQS_R67$__8\S+_U*J'_0UX ?\F0\)O\ LW_"W_JHPH4445\J
M?KP4444 %%%% !1110 4444 %%%% 'P3_P %#/V%=(_X*!_"CX;_  @\0_$7
M4/AKX>\'_'+P=\5_$.I:/X9M/$>NZ_X?T'PYXT\*Z[X2\/W&H:MI^G^$]>UK
M2?&MX=(\9ZAIOC"PT"]M89KWP3XEM99K$_RS_P#!7C_@GY^Q+^P3X&^"_A?X
M/?%;XG^(/VC/$=[OUGP+X[\3^&/$=WK/PB2^^)FHZC\7O%5CX6^'/ANS\+ZU
M_P )1?>"?A7X/$-_X2\.^+?#7@S5KC0O!GB;QAX6^*WC<?UU?MJ?LNZ)^V?^
MS#\5OV:]?\4ZGX(M/B/IV@/8>+M)T^SUB?P]XF\%^+_#WQ \':I=Z+?26L6N
MZ);>+O"FB-XCT&'4]"U#7/#W]IZ5I7B;POJEY9^(=,_CF_X*#?\ !$+XM_L1
M_!2'XXZ/\9/#_P"T!\.M)U.'2/BU<V?@F3X,>(OAW:^(=1TC0?!GB'3='O?B
M7X__ .$TT+6/$NIIX8UW^Q]<TSQ/X9U35/"U]9^'/$?AN_\ %VO^ OJ>'L3&
M-7#TJF9U<.EB&J6!C2E[+$2J12C[2M%N*YZCY>6I"3T7+)-JWA9Q0;IUJD,%
M3JN5).IBG./M*,:;N^2G+5V@KWA*.[YDTG?]L/\ @E9\-?BK\9/^"'OC;X/6
MDGPG@7XK^"_VQ?AO^S_+:WGB?3K&+2_'>I_$7PS>2_&J_P#[)U\V.O)\?-5^
M*+ZE>>"="UJSMOAL/"$_]DZCXN37K.;XQ_:1_P""!W[/?[-'[&7Q>^,_BS]J
MGQW/\6OA9X%\2>*[?Q-K.F?#_P $_!;Q5K=GKDMQX.\"P?#_ %+^T_%^G>(O
M'EG-HGPI\/2Q_&W59]0^)6O:;XATOP[J<5Y9_#2?[X_X(,_MS>,OVI_@=\2/
M@U\3(-)E\;_LOWG@+3M$U7PE\//!/PU\&-\%OB#I_B6S^%GA:Q\-^ 9-'\+V
M.L> KWX:^.?"RZ?X8^'?@/POIGPZLOAA:6T?B+Q./&&M2?F+_P %;/V[?$O_
M  4&^,OP^_8/_8:O/&?Q,\'1>++W2O%$?@+4=*_X1/\ :/\ B3;S:?J&B0Z9
M<"VMI-1^%/P:30M=\22>.-:\6Z?\*=;U"74?BAJ>FGPG\*OA]\5;O3#?VI'.
M,9AZ=18.E'&RQF.E!Q]C3I*3J7E4E%.4)4W:$'RJ;ES3BDI.$5_J+R[#59P^
ML5'AHX?"QE?VLYM*%HP4FE)32<Y+F<;6C)MQ4OSC_8"\1?M':1\%/^"GVB?!
M3P=!XO\  GBO]A76X?C)9Z[X=L)/!4>EVWQ*\%^%=6U76/&EU<Z!-H_B[PE^
MS3\1/VM_&'PY\(Q^+;>/QEJ6BZS=GP5\1+KPI9Z%%\YQ^$?V?#^P=/\ $#^U
M/#)_:Z3]NE? 7]@GXFZF/&:?LHG]F:+Q,-:7X+CQ7_8K>%#\;BVG?\+3/@8:
MG_;)?P@/%WV5/[%K^X;_ ()Q_P#!-;P/^Q5^S'XJ^#OQ 7P=\7_&OQP^UW_[
M0^H7WA+0K_P=XDL]5\.+X:/P?L(M6T&#6?%WP>\,:/<:W96%C\0!?GQ#K7B_
MXB>*AH'@_3?'<G@+P_\ C/\ \%'OV"/^"='_  32A\+?M-^'O"/Q!^('C7Q%
MXPM-#^"?['GC?XF^%?$?[.]WKVA>"Y/MWC?XFZ-XLT:[_:)\??"+P1JUGI?C
M/QOX>MOBMKUMXN^(GB;P7\+_ !/<^&_A=X_NTT3MI9SA\1F6(IT(8CFK8W#U
M:$L-&-\7]7H^R=.MSSI\E*I;VG-)-1A=S2:.>IEU:E@J4JLZ-J>%K4ZJK2E:
MA[:HJBG2Y8SYIP7N<JMS2LHMW/._VI/VT?'/Q,_9&_89_P""5'[%NB_$S7OC
M)XN_9D_9-TKXPQ>!H+?P]9Z[X0\2?LR^$O$FD? C3M0UG3[.2\\.>(?">O>'
MOB+\7?'>F^(_"'P[\*?#S2?^$0\9>*]?\*:Y\:?#W@K^E#]A']BGX=_L%_ +
M3?@CX U?6O%-W>ZY=^.?B+XWUV6>&Z\<?$?6-)T/1M;\167A_P"W7^F>#=#7
M2_#FA:'X>\)Z--+#IFAZ-82ZWJGBGQA=^)?&7B/^1#6/ _QA_P""8O[.GPZ_
M:L\<W'_"'?\ !2S]JSXN^*=9^&6K_%K1KOXM_$SX8?LXZ5X<LM6^,7Q%DL_'
MWAO6/!G@K]ICXH>.?''A;PQ\2M5^*%Y\0OB'%\&OB;JOA[1=.\"?$;6_C0GA
MSL/V0OVH/^"CO[*_[67[#7@7XA?M.:]\6_!'[<>D_L@?&"X\'_$KXG_$C]HC
M3W^ W[1_BWQ#X(\.VM[J7Q@LM/\ %?PJ^*6AV%_XD\0WUE\*/$8\,W7BO1/
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M6G^@:I\2OASH?_"4_P!M>/\ P5H__"#?V)_PFW]J>*M"T_\ X0__ (2;R_\
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MA^UM4^)7PYT/_A*?[:\?^"M'_P"$&_L3_A-O[4\5:%I__"'_ /"3>7_PC?\
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M_"4_VUX_\%:/_P (-_8G_";?VIXJT+3_ /A#_P#A)O+_ .$;_P"$I^UW\/\
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M^+O$'P.T.[OO"R^*M)BO4ATY?%'@#QGK^AVGBN_\!:I#<^%=8U;0/LK]M_\
M9>\5_P#!;S]D7]F?]MG]F;P5X1\$_$2S\%?&?PWXT^%?C]]'TSQU\0])T'7]
M;\/#P-X9^,.GQ_V7J\7A?XG^ _&EA\(M,^($7@CPGK6D_&'5?'/B/7/@WJ4?
MB#PUK'YB?\%'_P#@K5XC_P""D?PY^!'P'\)_L_2?#^XC^(=GXMUG0+'Q'JGQ
M5\8^*/C%=WWC3X:_#'P)\+GT7PYX4N=?T_5?"/C"&[N[.?P5+XL\4_$3Q;:>
M#/#>DZ?8> X?$7Q6_HS^#GB33/\ @D)_P28^'#_M!ZQHS^/_ (=^ _%FJ6'@
M#6=3L?#5[XM^.WQ4UWQU\8-%_9ST;4_"EQ\4[?4]9TC7_$5YX"U+QUX6M_%>
MBKX>\)^(_C%>:7IG@G2]8CT?S<7[7"4LMQ$,%A<'G,L55IQPV&I04:N'E&=/
M]Y1C*:ESN48)RDVU)N,DV[=F']GB*F-HRQ-?$Y:J$)RK5ZDFX5HRA-<E248N
M/*E)M)))I73Z_P PW[0%I^V#^R7X^\:?M=?MI>/X?!W[>?Q4TSQ%X/\ !G@^
MT\<?#32?BAIWP[\3_ ?7_@7XF_:O\0WW[+LDW@;P'H_@OP8D7PS^!>GZ/XG^
M&_C?Q%\8=-U'XLRSWV@_ CQ3X6^+_P!*_ C]J3X0?\$*=-\7_#_QU\!M'^,_
M[>^L2^#)OC)?S>*8?A5X _9_^$GCCP?I'C#PU^SUIGQGO]+^):>-/&^FR1^!
M?B!\0W^&'PTTOX5^(]2^(&D^$Y/BOX[U/X#:%)/]C?\ !(#]G+QK^W1^T?\
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M** "BBB@ HHHH **** "BBB@#^RK_@C)_P F)>"/^QV^)'_J475?JM7Y4_\
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M\<OM'_&-?[-?_$Q_X5G_ &AI/_$IM/LGRG_(K?\ 5+/^%6?\7L_XO9_Q6_\
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M;_\ #*O_  G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\
M$IM/LGRG_(K?]4L_X59_Q>S_ (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0
M?'+[1_QC7^S7_P 3'_A6?]H:3_Q*;3[)\I\7]_G_ .XG/[3_ ,*_:^U^M_\
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M\?\ "\O^"D'QR^T?\8U_LU_\3'_A6?\ :&D_\2FT^R?*?%_?Y_\ N)S^T_\
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M]C_W+>P^K?\ AF^J?5/[&_ZD/]G_ -@_\TE_JE_QS^?\BM_U2S_A5G_%[/\
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M%1>*Y?\ A(_VA=)_X6#%XGU?_A<_[7/C[,OV_P#:0_:%^R?\)=XE^'7VEO\
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MHHHK]</XP"BBB@ HHHH **** "BBB@ HHHH _L\_X(Y?\F$?"_\ [&3XF_\
MJ?Z_7ZB5^7?_  1R_P"3"/A?_P!C)\3?_4_U^OU$K^#^-O\ DL.*/^Q]FO\
MZF5C_H?\!O\ DR7A+_V;K@__ -4.!"BBBOES]9"BBB@ HHHH **** "BBB@#
MB]#_ .1P\<?]RS_Z:Y:[2N+T/_D</''_ '+/_IKEKM*J6Z_PP_\ 2(DQV?\
MBG_Z7(****DH**** ,7Q)_R+NO\ _8%U3_TAGH\-_P#(NZ!_V!=+_P#2&"CQ
M)_R+NO\ _8%U3_TAGH\-_P#(NZ!_V!=+_P#2&"J^Q_V]^A/V_P#MW]3:HHHJ
M2@HHHH **** "BBB@ HHHH **** /QZ_X*E_\EA_X)9?]I _A5_Z.BK]A:_'
MK_@J7_R6'_@EE_VD#^%7_HZ*OV%KOQ/^Y9=_@Q7_ *DR.2A_O.-_QT/_ $Q
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M^Q_!W_DA,O\ ^PO,O_4RJ?X>_3=_Y2%XF_[$_"W_ *HL&%%%%?J)_)(4444
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M^QVO/_47U^O[EJ_AI_X)F_\ )]O[-W_8[7G_ *B^OU_<M7\K^.__ "4N4?\
M8CA_ZGXX_P!?/V>7_)J^,O\ LX&(_P#6<X?"BBBOP\_OP**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[#ZM_P"&;ZI]4_L;_J0_V?\ V#_S27^J7_'/Y_R*W_5+/^%6?\7L_P"+V?\
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M "*W_5+/^%6?\7L_XO9_Q6__  RK_P )Q_S>[^V[_P ?'_"\O^"D'QR^T?\
M&-?[-?\ Q,?^%9_VAI/_ !*;3[)\I_R*W_5+/^%6?\7L_P"+V?\ %;_\,J_\
M)Q_S>[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_:&D_\2FT^R?*?\BM_
MU2S_ (59_P 7L_XO9_Q6_P#PRK_PG'_-[O[;O_'Q_P +R_X*0?'+[1_QC7^S
M7_Q,?^%9_P!H:3_Q*;3[)\I_R*W_ %2S_A5G_%[/^+V?\5O_ ,,J_P#"<?\
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MN\2_#K[2W_"IO!&D?#[0/LME]O\ *;\U?^16_P"J6?\ "K/^+V?\7L_XK?\
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M]&^ VG^(9OA);BVTGPWX*U_Q5X=\;_%#PKH41^)FJZUKWT]^WCIG[.7[2?\
MP1J\1_%W_@GEIFD?![X2^$OBEX-^-OQC^"_P.^%ND>";K7[W1M,L? OQ"\ _
M'OP+\++O2](T/4/A7IOB+P3\9O&7B37+/QKX7M_#'P3\&^-],O;_ ,!KX.^)
M.E>)Z!!_P2-U_P#X(LZ[XMD\$?L]>'OCIX=^!,W@S4+S6H_"FI?M3Z?^UOJK
M^.T\ 3WNM>%-;\4?&O2],^*WQ=^'OB;Q_P##[0M3UBQ\-7?[/6G:FNO^&/#G
MP3\->,/#/ASJ/^#8SP_J]O'^VUXKF\/ZS;Z!K,G[.'AW3?%4^D7T/A[6=9\,
M)\=]3USP]IFO26ZZ;J6M>&;'Q?X=U/7M'M+N>_T2P\7>&[W4;:UM_$.ERWG+
MB(4(1Q6;4H8NGB<OS.C[6.*J*4,9.-:-UI%<DH\UTHIJG3MR[IQWHRK2E0R^
MI/#SHXO U.26'@XRP\94VT[W?,G:VOQRUEM:7X,>,?BI;_M _LR?L%?LI?#W
MPKXNG^(_[- _;5N_&VI>(9_!6@?#O6M+^.'Q;L?C;I?B+2?%U_XR,.@>$?AQ
M\/\ PQKNJ?%GQG\3K3X>^$? &D:?JWB74M9D\&:/JWB.P_6?Q/\ $+4/^"V7
M_!0*[O?'&J^!O /[ 7[$-OXW^(&K^,-=T[Q?HGAJ3]GC3_%^@2>*]8\:_$R\
MT_X>ZQX&\;_M/:+X#L=9ATSQ;XC^&UG\(?ACX-\4:UH5AXH\6_"#QMJ?Q&]1
M_P""G'Q4^%GQ(_:KTS]AG_@FYX$^"OA7]H+]H#QKXN^%7[9OQN^$GP6T+1O&
MWBO5/'/BG0]6\6?"GQ?\<?AQH&I>/-4\%:1JFE>)_B-^VHVG^']?6SA\*V>D
M^+_%,G_")_''P#7P[_P68^"\W[#OPL_9&_8I\':/XPU?P#\,?AO\2_V@O$'Q
MKO[,^&?"/[1'[0OQ$U_4=!\27.J>#M#T:U\,WGC/X&^%O">E:!X/U/5O%?C_
M .(7@CX,_&#POX U'719F3Q)X^[:52-?ZG&%-X/%8A8ZK@_:3]O5PM'$N5?%
MXUIQI^_/D=+!02B^5SJRFXOW>:=.5'ZRY3^LT*+PM/$<D?90KU*"A1P^%OS3
M]V'-[3%3;>O+!136O]KOP'^)7[/?Q*^'U@W[,?C_ .#7C[X5^!6M/ASIC? ?
MQ5X(\5?#[P<_AK0]':Q\"6!^'U_?^'/#S>'_  WJ'A]K3PQ;_9#I6AWNCF&Q
M@L+FRW^RU_%Q^QM^S_HG[&/_  <#:'^S5\+_ !Q\3=4\$>"8_$_A=M:\8Z_H
M\?BGQ[X9\8_L6I\:M0\/>.G\!^'O GA?Q+X>L/B!?:9K.F:)+X5@TV#4O W@
MW7+FTN_$GARSUT?VCU\AF&$CA*E#V=65:EB<-2Q=*<X>SGR5G)*-2'--*:<'
M>TI)IIWU/H<)B)8B%3FIJG.A7GAZD8RYX<U-1=X2Y8MQ:DK7BFM@HHHK@.L*
M*** "BBB@ HHHH **** "BBB@#^2_P#X+Q?\G>?#G_LV_P (?^K.^,%?B?7[
M8?\ !>+_ ).\^'/_ &;?X0_]6=\8*_$^O[D\.O\ DB.&_P#L6T__ $NH?\_W
MTG?^3^^*7_93U_\ U%PH4445]H?A 4444 %%%% !1110 4444 %%%% '^D!1
M117^<Y_T\!1110 4444 %%%% !1110!^.G_!<7_DR_3/^RU^!O\ TP^-*_D*
MK^O7_@N+_P F7Z9_V6OP-_Z8?&E?R%5_7G@I_P D4O\ L;8__P!)PY_BM]/'
M_D^\_P#LCN'?_3F8A1117ZX?Q@%%%% !1110 4444 %%%% !1110!_9Y_P $
M<O\ DPCX7_\ 8R?$W_U/]?K]1*_+O_@CE_R81\+_ /L9/B;_ .I_K]?J)7\'
M\;?\EAQ1_P!C[-?_ %,K'_0_X#?\F2\)?^S=<'_^J' A1117RY^LA1110 44
M44 %%%% !1110!Q>A_\ (X>./^Y9_P#37+7:5Q>A_P#(X>./^Y9_]-<M=I52
MW7^&'_I$28[/_%/_ -+D%%%%24%%%% &+XD_Y%W7_P#L"ZI_Z0ST>&_^1=T#
M_L"Z7_Z0P4>)/^1=U_\ [ NJ?^D,]'AO_D7= _[ NE_^D,%5]C_M[]"?M_\
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M:\-> KO58?%6NZ3;VGA+Q7=3ZCI>DW5G%;>&?$,\DRQ:+J36WIE?SN?M*?\
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M6_\ 5%@PHHHK]1/Y)"BBB@ HHHH **** "BBB@ HHHH _LJ_X(R?\F)>"/\
ML=OB1_ZE%U7ZK5^5/_!&3_DQ+P1_V.WQ(_\ 4HNJ_5:OX1XY_P"2RXG_ .QY
MF7_J54/^AKP _P"3(>$W_9O^%O\ U484****^5/UX**** "BBB@ HHHH *_S
MI/&?_(X>+/\ L9==_P#3I=5_HMU_G2>,_P#D</%G_8RZ[_Z=+JOZ(\ ?XO%/
M_7O)O_2LT/\ ,S]HY_N?A%_V$\<_^FN$SFJ***_I _RZ"BBB@ HHHH ****
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M_P"&5?\ A./^;W?VW?\ CX_X7E_P4@^.7VC_ (QK_9K_ .)C_P *S_M#2?\
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MG]I_X5^U]K];_P"HWV_UW_F:?VI_QG!_"_Z<^Q_[EO8?5O\ PS?5/JG]C?\
M4A_L_P#L'_FDO]4O^.?S_D5O^J6?\*L_XO9_Q>S_ (K?_AE7_A./^;W?VW?^
M/C_A>7_!2#XY?:/^,:_V:_\ B8_\*S_M#2?^)3:?9/E/^16_ZI9_PJS_ (O9
M_P 7L_XK?_AE7_A./^;W?VW?^/C_ (7E_P %(/CE]H_XQK_9K_XF/_"L_P"T
M-)_XE-I]D^4_Y%;_ *I9_P *L_XO9_Q>S_BM_P#AE7_A./\ F]W]MW_CX_X7
ME_P4@^.7VC_C&O\ 9K_XF/\ PK/^T-)_XE-I]D^4_P"16_ZI9_PJS_B]G_%[
M/^*W_P"&5?\ A./^;W?VW?\ CX_X7E_P4@^.7VC_ (QK_9K_ .)C_P *S_M#
M2?\ B4VGV3Y3XO[_ #_]Q.?VG_A7[7VOUO\ ZC?;_7?^9I_:G_&<'\+_ *<^
MQ_[EO8?5O_#-]4^J?V-_U(?[/_L'_FDO]4O^.?S_ )%;_JEG_"K/^+V?\7L_
MXK?_ (95_P"$X_YO=_;=_P"/C_A>7_!2#XY?:/\ C&O]FO\ XF/_  K/^T-)
M_P")3:?9/E/^16_ZI9_PJS_B]G_%[/\ BM_^&5?^$X_YO=_;=_X^/^%Y?\%(
M/CE]H_XQK_9K_P")C_PK/^T-)_XE-I]D^4_Y%;_JEG_"K/\ B]G_ !>S_BM_
M^&5?^$X_YO=_;=_X^/\ A>7_  4@^.7VC_C&O]FO_B8_\*S_ +0TG_B4VGV3
MY3_D5O\ JEG_  JS_B]G_%[/^*W_ .&5?^$X_P";W?VW?^/C_A>7_!2#XY?:
M/^,:_P!FO_B8_P#"L_[0TG_B4VGV3Y3XO[_/_P!Q.?VG_A7[7VOUO_J-]O\
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M_%[/^+V?\5O_ ,,J_P#"<?\ -[O[;O\ Q\?\+R_X*0?'+[1_QC7^S7_Q,?\
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M .DX<_Q6^GC_ ,GWG_V1W#O_ *<S$****_7#^, HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?\WN_MN_\?'_  O+_@I!\<OM'_&-?[-?_$Q_X5G_ &AI/_$IM/LGRG_(K?\
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M/^%6?\7L_P"+V?\ %;_\,J_\)Q_S>[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\
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M_%[/^+V?\5O_ ,,J_P#"<?\ -[O[;O\ Q\?\+R_X*0?'+[1_QC7^S7_Q,?\
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M'QR^T?\ &-?[-?\ Q,?^%9_VAI/_ !*;3[)\I_R*W_5+/^%6?\7L_P"+V?\
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MC_PK/^T-)_XE-I]D^7]*O^"?J?V-9_%3PEY'_"%_9+KP;XR_X5%XKE_X2/\
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M@G_X0VO_ /S;4?\ #\;]M#_H%_!/_P (;7__ )MJ_'.BC_B'_!7_ $3.4_\
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M*_Z)G*?_  EC_F'_ !,AX[_]'5XR_P##K4_R_KYL_8S_ (?C?MH?] OX)_\
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MJG]@8K_B GV-K?[<?QHMO^$W^WVO@GX2_P!FZ;X:\9Z]_P +1T/4-2_X9&^
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M1O[2T_\ X3#5M2\N??\ '/\ R*W_ %2S_A5G_%[/^+V?\5O_ ,,J_P#"<?\
M-[O[;O\ Q\?\+R_X*0?'+[1_QC7^S7_Q,?\ A6?]H:3_ ,2FT^R?*?\ (K?]
M4L_X59_Q>S_B]G_%;_\ #*O_  G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU
M_P#$Q_X5G_:&D_\ $IM/LGRD>'\E]WERS"/X.6U)3O\ [O[/EM];Y[_[+R6^
MN^U]I0M_:?UZG_KL5/$CCS]Y[7BK.8_QO:^TQ4J/+_R,OK'M.99-[#DMF_MN
M;^POJGU;,N?_ %4_L#$_\0$^QM;_ &X_C1;?\)O]OM?!/PE_LW3?#7C/7O\
MA:.AZAJ7_#(WP$O/*_LOQ]^U-_PCFMV7_"2_M1?'S<G_  I#]D+X;_V)X@T;
M^TM/_P"$PU;4O+GWFM_MQ_&BV_X3?[?:^"?A+_9NF^&O&>O?\+1T/4-2_P"&
M1O@)>>5_9?C[]J;_ (1S6[+_ (27]J+X^;D_X4A^R%\-_P"Q/$&C?VEI_P#P
MF&K:EY<^_P".?^16_P"J6?\ "K/^+V?\7L_XK?\ X95_X3C_ )O=_;=_X^/^
M%Y?\%(/CE]H_XQK_ &:_^)C_ ,*S_M#2?^)3:?9/E/\ D5O^J6?\*L_XO9_Q
M>S_BM_\ AE7_ (3C_F]W]MW_ (^/^%Y?\%(/CE]H_P",:_V:_P#B8_\ "L_[
M0TG_ (E-I]D^4CP_DON\N681_!RVI*=_]W]GRV^M\]_]EY+?7?:^TH6_M/Z]
M3_UV*GB1QY^\]KQ5G,?XWM?:8J5'E_Y&7UCVG,LF]AR6S?VW-_87U3ZMF7/_
M *J?V!B?^("?8VM_MQ_&BV_X3?[?:^"?A+_9NF^&O&>O?\+1T/4-2_X9&^ E
MYY7]E^/OVIO^$<UNR_X27]J+X^;D_P"%(?LA?#?^Q/$&C?VEI_\ PF&K:EY<
M^\UO]N/XT6W_  F_V^U\$_"7^S=-\->,]>_X6CH>H:E_PR-\!+SRO[+\??M3
M?\(YK=E_PDO[47Q\W)_PI#]D+X;_ -B>(-&_M+3_ /A,-6U+RY]_QS_R*W_5
M+/\ A5G_ !>S_B]G_%;_ /#*O_"<?\WN_MN_\?'_  O+_@I!\<OM'_&-?[-?
M_$Q_X5G_ &AI/_$IM/LGRG_(K?\ 5+/^%6?\7L_XO9_Q6_\ PRK_ ,)Q_P W
MN_MN_P#'Q_PO+_@I!\<OM'_&-?[-?_$Q_P"%9_VAI/\ Q*;3[)\I'A_)?=Y<
MLPC^#EM24[_[O[/EM];Y[_[+R6^N^U]I0M_:?UZG_KL5/$CCS]Y[7BK.8_QO
M:^TQ4J/+_P C+ZQ[3F63>PY+9O[;F_L+ZI]6S+G_ -5/[ Q/_$!/L;6_VX_C
M1;?\)O\ ;[7P3\)?[-TWPUXSU[_A:.AZAJ7_  R-\!+SRO[+\??M3?\ ".:W
M9?\ "2_M1?'S<G_"D/V0OAO_ &)X@T;^TM/_ .$PU;4O+GW^G_#']K3XS>-_
MBQ;^";_P1I>@RZQJG@G5M3\%^)A#I.N_LW_!37)8K?PSXA_:<\40WTFC1_M-
M_M&ZA+9VWPB_9H\%6%AJ7@72]6CUGQS?:Q%IURDGYU?\BM_U2S_A5G_%[/\
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M#ZOF,99?D+R'$X;P(_=RBBBOQ4_NT**** "BBB@ HHHH **** /P9_X+X_\
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M;_\ #*O_  G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\
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M?\WN_MN_\?'_  O+_@I!\<OM'_&-?[-?_$Q_X5G_ &AI/_$IM/LGRG_(K?\
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M9+PE_P"S=<'_ /JAP(4445\N?K(4444 %%%% !1110 4444 <7H?_(X>./\
MN6?_ $URUVE<7H?_ ".'CC_N6?\ TURUVE5+=?X8?^D1)CL_\4__ $N04445
M)04444 8OB3_ )%W7_\ L"ZI_P"D,]'AO_D7= _[ NE_^D,%'B3_ )%W7_\
ML"ZI_P"D,]'AO_D7= _[ NE_^D,%5]C_ +>_0G[?_;OZFU1114E!1110 444
M4 %%%% !1110 4444 ?CU_P5+_Y+#_P2R_[2!_"K_P!'15^PM?CU_P %2_\
MDL/_  2R_P"T@?PJ_P#1T5?L+7?B?]RR[_!BO_4F1R4/]YQO^.A_Z8@%%%%<
M!UA1110!_/'XR_XI;Q?XJ_Y%OX6?\*L\2:Y\;/\ BNO^*W\(?LJ_\)QJ=U_Q
MF[^UG_Q\?\+R_;\^.7VC_C$_]FO_ (F/_"L],U#0/^)3:?9/EYO_ )%;_JEG
M_"K/^+V?\7L_XK?_ (95_P"$X_YO=_;=_P"/C_A>7_!2#XY?:/\ C&O]FO\
MXF/_  K/^T-)_P")3:?9/EZ3QE_Q2WB_Q5_R+?PL_P"%6>)-<^-G_%=?\5OX
M0_95_P"$XU.Z_P",W?VL_P#CX_X7E^WY\<OM'_&)_P"S7_Q,?^%9Z9J&@?\
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M^G/L?^Y;V'U;_P ,WU3ZI_8W_4A_L_\ L'_FDO\ 5+_CG\_Y%;_JEG_"K/\
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M&O\ 9K_XF/\ PK/^T-)_XE-I]D^4_P"16_ZI9_PJS_B]G_%[/^*W_P"&5?\
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M/^T-)_XE-I]D^4_Y%;_JEG_"K/\ B]G_ !>S_BM_^&5?^$X_YO=_;=_X^/\
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M* "O\Z3QG_R.'BS_ +&77?\ TZ75?Z+=?YTGC/\ Y'#Q9_V,NN_^G2ZK^B/
M'^+Q3_U[R;_TK-#_ #,_:.?[GX1?]A/'/_IKA,YJBBBOZ0/\N@HHHH ****
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M/^%6?\7L_P"+V?\ %;_\,J_\)Q_S>[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\
M$Q_X5G_:&D_\2FT^R?*?\BM_U2S_ (59_P 7L_XO9_Q6_P#PRK_PG'_-[O[;
MO_'Q_P +R_X*0?'+[1_QC7^S7_Q,?^%9_P!H:3_Q*;3[)\I_R*W_ %2S_A5G
M_%[/^+V?\5O_ ,,J_P#"<?\ -[O[;O\ Q\?\+R_X*0?'+[1_QC7^S7_Q,?\
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M@_\ -)?ZI?\ '/Y_R*W_ %2S_A5G_%[/^+V?\5O_ ,,J_P#"<?\ -[O[;O\
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M_P 2FT^R?*?\BM_U2S_A5G_%[/\ B]G_ !6__#*O_"<?\WN_MN_\?'_"\O\
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M?\WN_MN_\?'_  O+_@I!\<OM'_&-?[-?_$Q_X5G_ &AI/_$IM/LGRG_(K?\
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M;_\ #*O_  G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\
M$IM/LGR])XR_XI;Q?XJ_Y%OX6?\ "K/$FN?&S_BNO^*W\(?LJ_\ "<:G=?\
M&;O[6?\ Q\?\+R_;\^.7VC_C$_\ 9K_XF/\ PK/3-0T#_B4VGV3Y>;_Y%;_J
MEG_"K/\ B]G_ !>S_BM_^&5?^$X_YO=_;=_X^/\ A>7_  4@^.7VC_C&O]FO
M_B8_\*S_ +0TG_B4VGV3Y?Z(H^]1I?;YZ=/_ *><_M(KSQGM?:_6^^.]O]=_
MYFG]J?\ &<?YFXW]UC,7_P N?8XJO_U#>P^K59_]B7ZI]4_L;MD']G_V#_S2
M7^J7_'/Y_P BM_U2S_A5G_%[/^+V?\5O_P ,J_\ "<?\WN_MN_\ 'Q_PO+_@
MI!\<OM'_ !C7^S7_ ,3'_A6?]H:3_P 2FT^R?*?\BM_U2S_A5G_%[/\ B]G_
M !6__#*O_"<?\WN_MN_\?'_"\O\ @I!\<OM'_&-?[-?_ !,?^%9_VAI/_$IM
M/LGRG_(K?]4L_P"%6?\ %[/^+V?\5O\ \,J_\)Q_S>[^V[_Q\?\ "\O^"D'Q
MR^T?\8U_LU_\3'_A6?\ :&D_\2FT^R?*?\BM_P!4L_X59_Q>S_B]G_%;_P##
M*O\ PG'_ #>[^V[_ ,?'_"\O^"D'QR^T?\8U_LU_\3'_ (5G_:&D_P#$IM/L
MGRZ?%_?Y_P#N)S^T_P#"OVOM?K?_ %&^W^N_\S3^U/\ C..7^%_TY]C_ -RW
ML/JW_AF^J?5/[&_ZD/\ 9_\ 8/\ S27^J7_'/Y_R*W_5+/\ A5G_ !>S_B]G
M_%;_ /#*O_"<?\WN_MN_\?'_  O+_@I!\<OM'_&-?[-?_$Q_X5G_ &AI/_$I
MM/LGRG_(K?\ 5+/^%6?\7L_XO9_Q6_\ PRK_ ,)Q_P WN_MN_P#'Q_PO+_@I
M!\<OM'_&-?[-?_$Q_P"%9_VAI/\ Q*;3[)\I_P BM_U2S_A5G_%[/^+V?\5O
M_P ,J_\ "<?\WN_MN_\ 'Q_PO+_@I!\<OM'_ !C7^S7_ ,3'_A6?]H:3_P 2
MFT^R?*?\BM_U2S_A5G_%[/\ B]G_ !6__#*O_"<?\WN_MN_\?'_"\O\ @I!\
M<OM'_&-?[-?_ !,?^%9_VAI/_$IM/LGRGQ?W^?\ [B<_M/\ PK]K[7ZW_P!1
MOM_KO_,T_M3_ (S@_A?].?8_]RWL/JW_ (9OJGU3^QO^I#_9_P#8/_-)?ZI?
M\<_G_(K?]4L_X59_Q>S_ (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[
M1_QC7^S7_P 3'_A6?]H:3_Q*;3[)\I_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*
MO_"<?\WN_MN_\?'_  O+_@I!\<OM'_&-?[-?_$Q_X5G_ &AI/_$IM/LGRG_(
MK?\ 5+/^%6?\7L_XO9_Q6_\ PRK_ ,)Q_P WN_MN_P#'Q_PO+_@I!\<OM'_&
M-?[-?_$Q_P"%9_VAI/\ Q*;3[)\I_P BM_U2S_A5G_%[/^+V?\5O_P ,J_\
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MY?9/V>]$V?&WX9>'/^$(UR'_ (0SQ;IOQ1_X5O\ $SQ+YE_\%O\ A9KM8?\
M#4W[<OC#S3_PL;_@H+^T[_:']@_!'X(>?=?\*6\-^(/[4_L^P_LK>G)F$O\
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M/^3$O!'_ &.WQ(_]2BZK]5J_*G_@C)_R8EX(_P"QV^)'_J475?JM7\(\<_\
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M^'NG_L\_M0Z#K/BOX0_"?X7>!_A"GQDU*PDT;XU>%;O7O''@_0XQI<OA27X
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M-?[-?_$Q_P"%9_VAI/\ Q*;3[)\I_P BM_U2S_A5G_%[/^+V?\5O_P ,J_\
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M\8U_LU_\3'_A6?\ :&D_\2FT^R?*?\BM_P!4L_X59_Q>S_B]G_%;_P##*O\
MPG'_ #>[^V[_ ,?'_"\O^"D'QR^T?\8U_LU_\3'_ (5G_:&D_P#$IM/LGRG_
M "*W_5+/^%6?\7L_XO9_Q6__  RK_P )Q_S>[^V[_P ?'_"\O^"D'QR^T?\
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MJW_AF^J?5/[&_P"I#_9_]@_\TE_JE_QS^?\ (K?]4L_X59_Q>S_B]G_%;_\
M#*O_  G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ $IM/
MLGR_I5_P3]3^QK/XJ>$O(_X0O[)=>#?&7_"HO%<O_"1_M"Z3_P +!B\3ZO\
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M_P"D,%'B3_D7=?\ ^P+JG_I#/1X;_P"1=T#_ + NE_\ I#!5?8_[>_0G[?\
MV[^IM4445)04444 ?F;\;/\ @DI^QY^TS\<OB/\ 'O\ :0TSXJ_&GQ)X\L?
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M:^'O[W57^(T?AS^P-1N-0\#^%/!_@?P1X8^''A+P1I5AK$&N_DW)KOB#X?\
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MO_B+)XO_ &S_ !GX6\<>%?'GC7PQ\4-4EUC2(OA_XPU>":Z^*9TSP[X@\/\
MC^6RO/C+='Q=XH^)6H_&/QP=+\)7/BG5?!'AC\/_ (M_L\_'_P#:7_9M_;/_
M ."FUU\+;7X3^'/!WP"TSX/_ /!//X66.D?#[X56_@;_ ()X:9K?B;P_\;M9
M\8_"V9=1\-'17_8Z\=?%2Q\%_;_'NOG5;[QK\5O%7P9\#Z=I-M^R?KFF1_\
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MU_QF[^UG_P ?'_"\OV_/CE]H_P",3_V:_P#B8_\ "L],U#0/^)3:?9/EYO\
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MW_U&^W^N_P#,T_M3_C.#^%_TY]C_ -RWL/JW_AF^J?5/[&_ZD/\ 9_\ 8/\
MS27^J7_'/Y_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"<?\WN_MN_\?'_  O+
M_@I!\<OM'_&-?[-?_$Q_X5G_ &AI/_$IM/LGRG_(K?\ 5+/^%6?\7L_XO9_Q
M6_\ PRK_ ,)Q_P WN_MN_P#'Q_PO+_@I!\<OM'_&-?[-?_$Q_P"%9_VAI/\
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M_,T_M3_C.#^%_P!.?8_]RWL/JW_AF^J?5/[&_P"I#_9_]@_\TE_JE_QS^?\
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MOPR\.?\ "$:Y#_PAGBW3?BC_ ,*W^)GB7S+_ ."W_"S7:P_X:F_;E\8>:?\
MA8W_  4%_:=_M#^P?@C\$//NO^%+>&_$']J?V?8?V5O3QO\ Y%;_ *I9_P *
ML_XO9_Q>S_BM_P#AE7_A./\ F]W]MW_CX_X7E_P4@^.7VC_C&O\ 9K_XF/\
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M%%?*GZ\%%%% !1110 4444 %?YTGC/\ Y'#Q9_V,NN_^G2ZK_1;K_.D\9_\
M(X>+/^QEUW_TZ75?T1X _P 7BG_KWDW_ *5FA_F9^T<_W/PB_P"PGCG_ --<
M)G-4445_2!_ET%%%% !1110 4444 %%%% !1110!]U?\$S?^3[?V;O\ L=KS
M_P!1?7Z_N6K^&G_@F;_R?;^S=_V.UY_ZB^OU_<M7\K^._P#R4N4?]B.'_J?C
MC_7S]GE_R:OC+_LX&(_]9SA\****_#S^_ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MYGPE_P @JZ_[&;QK_P"IEKU=-7,^$O\ D%77_8S>-?\ U,M>I]'ZK\F2_CC_
M (9?G @\%?\ ('O/^QM\??\ J=^(ZZVN2\%?\@>\_P"QM\??^IWXCKK:'N_5
M_F$/@C_AC^2"BBBD4%%%% !1110 4444 %%%% !1110!^/?_ #G;_P"\9_\
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M;_\ #*O_  G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\
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M'QR^T?\ &-?[-?\ Q,?^%9_VAI/_ !*;3[)\I_R*W_5+/^%6?\7L_P"+V?\
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M17RY^LA1110 4444 %%%% !1110!Q>A_\CAXX_[EG_TURUVE<7H?_(X>./\
MN6?_ $URUVE5+=?X8?\ I$28[/\ Q3_]+D%%%%24%%%% &+XD_Y%W7_^P+JG
M_I#/1X;_ .1=T#_L"Z7_ .D,%'B3_D7=?_[ NJ?^D,]'AO\ Y%W0/^P+I?\
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MOGIT_P#IYS^TBO/&>U]K];[X[V_UW_F:?VI_QG'^9N-_=8S%_P#+GV.*K_\
M4-[#ZM5G_P!B7ZI]4_L;MD']G_V#_P TE_JE_P <_G_(K?\ 5+/^%6?\7L_X
MO9_Q6_\ PRK_ ,)Q_P WN_MN_P#'Q_PO+_@I!\<OM'_&-?[-?_$Q_P"%9_VA
MI/\ Q*;3[)\I_P BM_U2S_A5G_%[/^+V?\5O_P ,J_\ "<?\WN_MN_\ 'Q_P
MO+_@I!\<OM'_ !C7^S7_ ,3'_A6?]H:3_P 2FT^R?*?\BM_U2S_A5G_%[/\
MB]G_ !6__#*O_"<?\WN_MN_\?'_"\O\ @I!\<OM'_&-?[-?_ !,?^%9_VAI/
M_$IM/LGRG_(K?]4L_P"%6?\ %[/^+V?\5O\ \,J_\)Q_S>[^V[_Q\?\ "\O^
M"D'QR^T?\8U_LU_\3'_A6?\ :&D_\2FT^R?+I\7]_G_[B<_M/_"OVOM?K?\
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M\?\ "\O^"D'QR^T?\8U_LU_\3'_A6?\ :&D_\2FT^R?*?%_?Y_\ N)S^T_\
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M]C_W+>P^K?\ AF^J?5/[&_ZD/]G_ -@_\TE_JE_QS^?\BM_U2S_A5G_%[/\
MB]G_ !6__#*O_"<?\WN_MN_\?'_"\O\ @I!\<OM'_&-?[-?_ !,?^%9_VAI/
M_$IM/LGR^R?L]Z)L^-OPR\.?\(1KD/\ PAGBW3?BC_PK?XF>)?,O_@M_PLUV
ML/\ AJ;]N7QAYI_X6-_P4%_:=_M#^P?@C\$//NO^%+>&_$']J?V?8?V5O3QO
M_D5O^J6?\*L_XO9_Q>S_ (K?_AE7_A./^;W?VW?^/C_A>7_!2#XY?:/^,:_V
M:_\ B8_\*S_M#2?^)3:?9/E]D_9[T39\;?AEX<_X0C7(?^$,\6Z;\4?^%;_$
MSQ+YE_\ !;_A9KM8?\-3?MR^,/-/_"QO^"@O[3O]H?V#\$?@AY]U_P *6\-^
M(/[4_L^P_LK>G)F$O]@QTN;?"8F7-S[\]&;YO:?6->?ZW?G^M5/:_7;_ %C'
M?VG[3C;W.&8?\9)P_2]G\.>933]E['X?8X_#Q]G]7_LU<GL/['Y?8_V1AOJG
M]A<G]FY!_JI]5\!/W<HHHK^?C_2 **** "BBB@ HHHH **** /P9_P""^/\
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M-?[-?_$Q_P"%9_VAI/\ Q*;3[)\I_P BM_U2S_A5G_%[/^+V?\5O_P ,J_\
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M7_Q,?^%9_P!H:3_Q*;3[)\I_R*W_ %2S_A5G_%[/^+V?\5O_ ,,J_P#"<?\
M-[O[;O\ Q\?\+R_X*0?'+[1_QC7^S7_Q,?\ A6?]H:3_ ,2FT^R?*?\ (K?]
M4L_X59_Q>S_B]G_%;_\ #*O_  G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU
M_P#$Q_X5G_:&D_\ $IM/LGRGQ?W^?_N)S^T_\*_:^U^M_P#4;[?Z[_S-/[4_
MXS@_A?\ 3GV/_<M[#ZM_X9OJGU3^QO\ J0_V?_8/_-)?ZI?\<_G_ "*W_5+/
M^%6?\7L_XO9_Q6__  RK_P )Q_S>[^V[_P ?'_"\O^"D'QR^T?\ &-?[-?\
MQ,?^%9_VAI/_ !*;3[)\I_R*W_5+/^%6?\7L_P"+V?\ %;_\,J_\)Q_S>[^V
M[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_:&D_\2FT^R?*?\BM_U2S_ (59
M_P 7L_XO9_Q6_P#PRK_PG'_-[O[;O_'Q_P +R_X*0?'+[1_QC7^S7_Q,?^%9
M_P!H:3_Q*;3[)\I_R*W_ %2S_A5G_%[/^+V?\5O_ ,,J_P#"<?\ -[O[;O\
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M\2FT^R?*?%_?Y_\ N)S^T_\ "OVOM?K?_4;[?Z[_ ,S3^U/^,X/X7_3GV/\
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M_P#D]GA+_P!G&X-_]7^ /[.Z***_@X_Z( HHHH **** "BBB@ HHHH _DO\
M^"\7_)WGPY_[-O\ "'_JSOC!7XGU^V'_  7B_P"3O/AS_P!FW^$/_5G?&"OQ
M/K^Y/#K_ )(CAO\ [%M/_P!+J'_/]])W_D_OBE_V4]?_ -1<*%%%%?:'X0%%
M%% !1110 4444 %%%% !1110!_I 4445_G.?]/ 4444 %%%% !1110 4444
M?CI_P7%_Y,OTS_LM?@;_ -,/C2OY"J_KU_X+B_\ )E^F?]EK\#?^F'QI7\A5
M?UYX*?\ )%+_ +&V/_\ 2<.?XK?3Q_Y/O/\ [([AW_TYF(4445^N'\8!1110
M 4444 %%%% !1110 4444 ?V>?\ !'+_ ),(^%__ &,GQ-_]3_7Z_42OR[_X
M(Y?\F$?"_P#[&3XF_P#J?Z_7ZB5_!_&W_)8<4?\ 8^S7_P!3*Q_T/^ W_)DO
M"7_LW7!__JAP(4445\N?K(4444 %%%% !1110 4444 <7H?_ ".'CC_N6?\
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M?C+_ (I;Q?XJ_P"1;^%G_"K/$FN?&S_BNO\ BM_"'[*O_"<:G=?\9N_M9_\
M'Q_PO+]OSXY?:/\ C$_]FO\ XF/_  K/3-0T#_B4VGV3Y>;_ .16_P"J6?\
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MV?\ %[/^*W_X95_X3C_F]W]MW_CX_P"%Y?\ !2#XY?:/^,:_V:_^)C_PK/\
MM#2?^)3:?9/ET^+^_P __<3G]I_X5^U]K];_ .HWV_UW_F:?VI_QG'+_  O^
MG/L?^Y;V'U;_ ,,WU3ZI_8W_ %(?[/\ [!_YI+_5+_CG\_Y%;_JEG_"K/^+V
M?\7L_P"*W_X95_X3C_F]W]MW_CX_X7E_P4@^.7VC_C&O]FO_ (F/_"L_[0TG
M_B4VGV3Y3_D5O^J6?\*L_P"+V?\ %[/^*W_X95_X3C_F]W]MW_CX_P"%Y?\
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MC-X+\/S_ !H\)_!M(_$5K>:#->>)QX9\(OJLUOXHGT/6?G;PEX>\"_$'X_\
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M$WQ7_875_* 4445P'6%>2_'G6_\ A&O@O\4/$?\ PF^F_#+_ (1_P3X@UO\
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M^%6?\7L_XO9_Q6__  RK_P )Q_S>[^V[_P ?'_"\O^"D'QR^T?\ &-?[-?\
MQ,?^%9_VAI/_ !*;3[)\I_R*W_5+/^%6?\7L_P"+V?\ %;_\,J_\)Q_S>[^V
M[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_:&D_\2FT^R?+_ $#\7]_G_P"X
MG/[3_P *_:^U^M_]1OM_KO\ S-/[4_XSC_-O^%_TY]C_ -RWL/JW_AF^J?5/
M[&_ZD/\ 9_\ 8/\ S27^J7_'/Y_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"<
M?\WN_MN_\?'_  O+_@I!\<OM'_&-?[-?_$Q_X5G_ &AI/_$IM/LGRG_(K?\
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M9_VAI/\ Q*;3[)\I_P BM_U2S_A5G_%[/^+V?\5O_P ,J_\ "<?\WN_MN_\
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M6_\ PRK_ ,)Q_P WN_MN_P#'Q_PO+_@I!\<OM'_&-?[-?_$Q_P"%9_VAI/\
MQ*;3[)\I\7]_G_[B<_M/_"OVOM?K?_4;[?Z[_P S3^U/^,X/X7_3GV/_ '+>
MP^K?^&;ZI]4_L;_J0_V?_8/_ #27^J7_ !S^?\BM_P!4L_X59_Q>S_B]G_%;
M_P##*O\ PG'_ #>[^V[_ ,?'_"\O^"D'QR^T?\8U_LU_\3'_ (5G_:&D_P#$
MIM/LGRG_ "*W_5+/^%6?\7L_XO9_Q6__  RK_P )Q_S>[^V[_P ?'_"\O^"D
M'QR^T?\ &-?[-?\ Q,?^%9_VAI/_ !*;3[)\I_R*W_5+/^%6?\7L_P"+V?\
M%;_\,J_\)Q_S>[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_:&D_\2FT^
MR?*?\BM_U2S_ (59_P 7L_XO9_Q6_P#PRK_PG'_-[O[;O_'Q_P +R_X*0?'+
M[1_QC7^S7_Q,?^%9_P!H:3_Q*;3[)\I\7]_G_P"XG/[3_P *_:^U^M_]1OM_
MKO\ S-/[4_XS@_A?].?8_P#<M[#ZM_X9OJGU3^QO^I#_ &?_ &#_ ,TE_JE_
MQS^?\BM_U2S_ (59_P 7L_XO9_Q6_P#PRK_PG'_-[O[;O_'Q_P +R_X*0?'+
M[1_QC7^S7_Q,?^%9_P!H:3_Q*;3[)\I_R*W_ %2S_A5G_%[/^+V?\5O_ ,,J
M_P#"<?\ -[O[;O\ Q\?\+R_X*0?'+[1_QC7^S7_Q,?\ A6?]H:3_ ,2FT^R?
M*?\ (K?]4L_X59_Q>S_B]G_%;_\ #*O_  G'_-[O[;O_ !\?\+R_X*0?'+[1
M_P 8U_LU_P#$Q_X5G_:&D_\ $IM/LGRG_(K?]4L_X59_Q>S_ (O9_P 5O_PR
MK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H:3_Q*;3[)\I\7
M]_G_ .XG/[3_ ,*_:^U^M_\ 4;[?Z[_S-/[4_P",X/X7_3GV/_<M[#ZM_P"&
M;ZI]4_L;_J0_V?\ V#_S27^J7_'/Y_R*W_5+/^%6?\7L_P"+V?\ %;_\,J_\
M)Q_S>[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_:&D_\2FT^R?+^E7_!
M/U/[&L_BIX2\C_A"_LEUX-\9?\*B\5R_\)'^T+I/_"P8O$^K_P#"Y_VN?'V9
M?M_[2'[0OV3_ (2[Q+\.OM+?\*F\$:1\/M ^RV7V_P IOS5_Y%;_ *I9_P *
ML_XO9_Q>S_BM_P#AE7_A./\ F]W]MW_CX_X7E_P4@^.7VC_C&O\ 9K_XF/\
MPK/^T-)_XE-I]D^7]*O^"?J?V-9_%3PEY'_"%_9+KP;XR_X5%XKE_P"$C_:%
MTG_A8,7B?5_^%S_M<^/LR_;_ -I#]H7[)_PEWB7X=?:6_P"%3>"-(^'V@?9;
M+[?Y3?-\7>]P_CG\5WA9W^.]\9AY\_-?$WO]9]I[7VL[_6_:_7I_VA]?XO\
MU'P8_=^)'#T;>RM'-Z');V'+;(\RH?5_9\N5\MO[*^K_ %/ZE0Y?[&^I_P"K
MM'_5G_5SP4_1:BBBOQ<_NL**** "BBB@ HHHH **** /\^O]I;_DXWX__P#9
M;/BK_P"IUKU>)U[9^TM_R<;\?_\ LMGQ5_\ 4ZUZO$Z_T+RW_D78#_L"PO\
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M_P!C[-?_ %,K'_0_X#?\F2\)?^S=<'_^J' A1117RY^LA1110 4444 %%%%
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M(/CE]H_XQK_9K_XF/_"L_P"T-)_XE-I]D^73XO[_ #_]Q.?VG_A7[7VOUO\
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M&O\ 9K_XF/\ PK/^T-)_XE-I]D^4_P"16_ZI9_PJS_B]G_%[/^*W_P"&5?\
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M/^T-)_XE-I]D^4_Y%;_JEG_"K/\ B]G_ !>S_BM_^&5?^$X_YO=_;=_X^/\
MA>7_  4@^.7VC_C&O]FO_B8_\*S_ +0TG_B4VGV3Y3XO[_/_ -Q.?VG_ (5^
MU]K];_ZC?;_7?^9I_:G_ !G!_"_Z<^Q_[EO8?5O_  S?5/JG]C?]2'^S_P"P
M?^:2_P!4O^.?S_D5O^J6?\*L_P"+V?\ %[/^*W_X95_X3C_F]W]MW_CX_P"%
MY?\ !2#XY?:/^,:_V:_^)C_PK/\ M#2?^)3:?9/E/^16_P"J6?\ "K/^+V?\
M7L_XK?\ X95_X3C_ )O=_;=_X^/^%Y?\%(/CE]H_XQK_ &:_^)C_ ,*S_M#2
M?^)3:?9/E/\ D5O^J6?\*L_XO9_Q>S_BM_\ AE7_ (3C_F]W]MW_ (^/^%Y?
M\%(/CE]H_P",:_V:_P#B8_\ "L_[0TG_ (E-I]D^4_Y%;_JEG_"K/^+V?\7L
M_P"*W_X95_X3C_F]W]MW_CX_X7E_P4@^.7VC_C&O]FO_ (F/_"L_[0TG_B4V
MGV3Y3XO[_/\ ]Q.?VG_A7[7VOUO_ *C?;_7?^9I_:G_&<'\+_IS['_N6]A]6
M_P##-]4^J?V-_P!2'^S_ .P?^:2_U2_XY_/^16_ZI9_PJS_B]G_%[/\ BM_^
M&5?^$X_YO=_;=_X^/^%Y?\%(/CE]H_XQK_9K_P")C_PK/^T-)_XE-I]D^7V3
M]GO1-GQM^&7AS_A"-<A_X0SQ;IOQ1_X5O\3/$OF7_P %O^%FNUA_PU-^W+XP
M\T_\+&_X*"_M._VA_8/P1^"'GW7_  I;PWX@_M3^S[#^RMZ>-_\ (K?]4L_X
M59_Q>S_B]G_%;_\ #*O_  G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$
MQ_X5G_:&D_\ $IM/LGR^R?L]Z)L^-OPR\.?\(1KD/_"&>+=-^*/_  K?XF>)
M?,O_ (+?\+-=K#_AJ;]N7QAYI_X6-_P4%_:=_M#^P?@C\$//NO\ A2WAOQ!_
M:G]GV']E;TY,PE_L&.ES;X3$RYN??GHS?-[3ZQKS_6[\_P!:J>U^NW^L8[^T
M_:<;>YPS#_C).'Z7L_ASS*:?LO8_#[''X>/L_J_]FKD]A_8_+['^R,-]4_L+
MD_LW(/\ 53ZKX"?NY1117\_'^D 4444 %%%% !1110 4444 ?@S_ ,%\?^2$
M_ [_ +*UJ/\ ZAVJU_++7]37_!?'_DA/P._[*UJ/_J':K7\LM?V/X._\D)E_
M_87F7_J95/\ #WZ;O_*0O$W_ &)^%O\ U18,****_43^20HHHH **** "BBB
M@ HHHH **** /[*O^",G_)B7@C_L=OB1_P"I1=5^JU?E3_P1D_Y,2\$?]CM\
M2/\ U*+JOU6K^$>.?^2RXG_['F9?^I50_P"AKP _Y,AX3?\ 9O\ A;_U484*
M***^5/UX**** "BBB@ HHHH *_SI/&?_ ".'BS_L9==_].EU7^BW7^=)XS_Y
M'#Q9_P!C+KO_ *=+JOZ(\ ?XO%/_ %[R;_TK-#_,S]HY_N?A%_V$\<_^FN$S
MFJ***_I _P N@HHHH **** "BBB@ HHHH **** /NK_@F;_R?;^S=_V.UY_Z
MB^OU_<M7\-/_  3-_P"3[?V;O^QVO/\ U%]?K^Y:OY7\=_\ DI<H_P"Q'#_U
M/QQ_KY^SR_Y-7QE_V<#$?^LYP^%%%%?AY_?@4444 %%%% !1110 4444 %%%
M% !7\1G_  <F_P#)\7P\_P"S0/ ?_JWOV@J_K/\ VT_A_P#M#?%7]F+XJ?#K
M]E7XBZ1\)OCGXPL?#NB^%/B%K>KZMX>M/#NCW/C+P[_PL*2U\0Z!X8\7^(/#
MVN:A\-E\7Z1X:U_P]HH\0:)XCU#2M4T/6O"^JVEIXGT?^7CXA?\ ! G_ (*7
M_%[68?$GQ<_:@^#/Q9\1VVD0>'[7Q%\4?CK^T5\1-?M= M;K4+^VT.TUOQC\
M)-:U.UT:VO\ 5M5OK?2[>ZCL8+W4]1NXH%N+ZZDE^CX=EAL/B?KF)QE"@H1J
MTE2J<ZJ2YX*TU:+CRW=M[W3TVOX^<*O6H_5Z.&JU7)PG[2'+R1Y9W<7>2?-9
M7VMJM=[?V5U_+-_P7 _X*1Q^+U;_ ()\_LI>(O&/B/X@>(/&=EX0^/>K?"Z1
M=0776OOMWAL?LKZ)#I.DZKXE\6^)_%/B?4])@^).F>";_29+:?28/@GJTGC"
M;Q=\4_ GAOZW_9._82_X*?\ P@^$'[:7@GXS?MG:=\2?$_QM^ /B'P/\"-8U
M#XW?M+?$'Q%\,_C%<>&/'&D^%/'FC_%#QI_9>I_!_1='U#Q):W7B$^!O 7C'
MQ9XDOK?PSXAT_6O"]Q\-[?1O'7Y2>"O^#>__ (**?#7Q+H_C3X;_ +0G[/OP
M[\9>'3>'P_XN\!_%SX\>#?%&AG4-+O=#U#^R/$'AOX,Z9J^FB^T74M1TB\6S
MO(1=:9?WEA.)+6YFB=Y7ALMP^+K5,5C\+5^J^SEA5[ZH5JTH<ZG-N',X496B
MXJ.L];VCRRG'5L;6P]*%#"UZ?M^98AKE=:E3C+E<8I2Y>:K&[4F](Z6N[Q_9
M3_@CI_P3$U+]A7P'XD^)OQAFTG4?VC_C)HN@V6O:-96?AW4[/X*^#-/FN=53
MX;Z)XRM+6ZU36-?\0:G<V&J_%V^T;7V\ :MK7A;P1HGAO3]8M_A];_$7QUP/
M_!2G_@E+_P $[-;\-_&#]LOXI7/Q7^ <_A?2_&_Q2^+%Y^SWXN^&GAB?XP>*
M-0L](%G9Q>&?C7X<\5_#>U^)?C'Q)8+IGABV\*'X<O\ $OXI_$/4;_QUJ'B?
MQ7XFAU>V\+_9Z_X)R?\ !:'X3_'CX-?$;Q?^W[IGC3P)X2^)W@C5/B3X/\1?
MM*?M(?$G3_%7PN'B+3[?XH>'(?!GQ&^&>H^#M6UK6_A_/XDTWPU-JJ6$NC^(
M[G2M<TC7_#.MZ;IWB/2MG_@JI^Q]_P %"?\ @HI^U%\,O@=X7^'.E_"C]C;X
M7ZM'<Z?\?]6^)GAGQ!H'B#7?%G@[1-1\8?%+Q+\%--^(>E^+M7USX>QC7?A/
M\)/"C>!K/57UV_\ &E]??%3PS\._BUJ6J^"%*<WFOMY9S22K0=7$XK#5)T>6
ME!V>'A&7*YS<80C1IQYV_=E9N+8XQBL![)9;-NG)4Z.'KPA4YJDDK5IR5U&/
M-*3J3?+LU=<R1^0WPF^#FD?%+P9^T%_P4U^.?P$\%_"_]C/]GGX2W/A;]D3X
M&>*[WXC^/O@UXI^,^EZOI'P__9^^$^I^$FAN/&/Q;^!\OQ=U^YU?]I7Q5_;G
MPQ\*?%O]H7QYXL\1^*9+_3?$G[16B^&?&U_;#_X*E-X!?_@HE_PVGX_71$_:
M&'[*@T<^/M2^P/\ %4_L[)XY_ME?V5/^$"_X9-/@T?#EC<?VM_PCW]I?\+-5
MO%/_  A/_"0#_A-:_MC^('[%OP9U_P#8P\;?L1_#[PAX+^''PLUKX4^)/AWX
M(L)_"$'C?0_ >OZC!>ZEX:^)4V@:UJ=K>>+_ !GX7^(DUE\5I/$.K>([?QAK
M_P 0[$^,;_Q?%XONY?$B_P H?AS_ ((P_P#!4^?5=&_8M\5)X1T3]DB^^..E
M?'/Q1\6O#WB;X1>*OA9HOQ&D^$MMX-UKXE:%INI'P;^U3XCUK3_!2S_"W3/!
M-_X7\+>"]9\80P7UU%H/ANZF^*EIZ&$S+ XMUIXGZK25.O2C"EC(JJEED8R]
MI3I<\:KEB:D_?K2B_:59OFN^5'+7P>*P\:<:"KU'.E4E.>&DZ=\:Y1Y)SY7!
M*C"-XTXM<D(JUDV[_P!@G[+WQ(\3?&3]FC]G?XO>-+;0[/QC\5?@7\)/B1XL
MM/#%I?V'AJU\3>./ 'A_Q/KUMX>L=4U37-3LM#@U35+J+2;34=:UB_MK!;>&
M\U34+A)+N;W2O._A#\--$^"_PF^%_P '?#-]K.J>&_A-\._!/PT\/ZEXCGL;
MOQ#J.B>!/#6F>%M)OM=NM,T[2--N=9N[#2K>XU2XT_2=,L9KV2>2TTZR@:.V
MB]$KX^HXNI-TTU!SDX)[J%WRI^:5CZ&',H14]9\L>9K^:RYOQN%%%%04%%%%
M !1110 4444 %%%% !1110 5S/A+_D%77_8S>-?_ %,M>KIJYGPE_P @JZ_[
M&;QK_P"IEKU/H_5?DR7\<?\ #+\X$'@K_D#WG_8V^/O_ %._$==;7)>"O^0/
M>?\ 8V^/O_4[\1UUM#W?J_S"'P1_PQ_)!1112*"BBB@ HHHH **** "BBB@
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M^J6?\*L_XO9_Q>S_ (K?_AE7_A./^;W?VW?^/C_A>7_!2#XY?:/^,:_V:_\
MB8_\*S_M#2?^)3:?9/E/^16_ZI9_PJS_ (O9_P 7L_XK?_AE7_A./^;W?VW?
M^/C_ (7E_P %(/CE]H_XQK_9K_XF/_"L_P"T-)_XE-I]D^4_Y%;_ *I9_P *
ML_XO9_Q>S_BM_P#AE7_A./\ F]W]MW_CX_X7E_P4@^.7VC_C&O\ 9K_XF/\
MPK/^T-)_XE-I]D^4_P"16_ZI9_PJS_B]G_%[/^*W_P"&5?\ A./^;W?VW?\
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M/^T-)_XE-I]D^4_Y%;_JEG_"K/\ B]G_ !>S_BM_^&5?^$X_YO=_;=_X^/\
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MEKM*XO0_^1P\<?\ <L_^FN6NTJI;K_##_P!(B3'9_P"*?_I<@HHHJ2@HHHH
MQ?$G_(NZ_P#]@75/_2&>CPW_ ,B[H'_8%TO_ -(8*/$G_(NZ_P#]@75/_2&>
MCPW_ ,B[H'_8%TO_ -(8*K['_;WZ$_;_ .W?U-JBBBI*"BBB@ HHHH ****
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MU_QF[^UG_P ?'_"\OV_/CE]H_P",3_V:_P#B8_\ "L],U#0/^)3:?9/EYO\
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MW_U&^W^N_P#,T_M3_C.#^%_TY]C_ -RWL/JW_AF^J?5/[&_ZD/\ 9_\ 8/\
MS27^J7_'/Y_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"<?\WN_MN_\?'_  O+
M_@I!\<OM'_&-?[-?_$Q_X5G_ &AI/_$IM/LGRG_(K?\ 5+/^%6?\7L_XO9_Q
M6_\ PRK_ ,)Q_P WN_MN_P#'Q_PO+_@I!\<OM'_&-?[-?_$Q_P"%9_VAI/\
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M_,T_M3_C.#^%_P!.?8_]RWL/JW_AF^J?5/[&_P"I#_9_]@_\TE_JE_QS^?\
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MOPR\.?\ "$:Y#_PAGBW3?BC_ ,*W^)GB7S+_ ."W_"S7:P_X:F_;E\8>:?\
MA8W_  4%_:=_M#^P?@C\$//NO^%+>&_$']J?V?8?V5O3QO\ Y%;_ *I9_P *
ML_XO9_Q>S_BM_P#AE7_A./\ F]W]MW_CX_X7E_P4@^.7VC_C&O\ 9K_XF/\
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M%%?*GZ\%%%% !1110 4444 %?YTGC/\ Y'#Q9_V,NN_^G2ZK_1;K_.D\9_\
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MO9_Q>S_BM_\ AE7_ (3C_F]W]MW_ (^/^%Y?\%(/CE]H_P",:_V:_P#B8_\
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M_P"&5?\ A./^;W?VW?\ CX_X7E_P4@^.7VC_ (QK_9K_ .)C_P *S_M#2?\
MB4VGV3Y3_D5O^J6?\*L_XO9_Q>S_ (K?_AE7_A./^;W?VW?^/C_A>7_!2#XY
M?:/^,:_V:_\ B8_\*S_M#2?^)3:?9/E/^16_ZI9_PJS_ (O9_P 7L_XK?_AE
M7_A./^;W?VW?^/C_ (7E_P %(/CE]H_XQK_9K_XF/_"L_P"T-)_XE-I]D^4^
M+^_S_P#<3G]I_P"%?M?:_6_^HWV_UW_F:?VI_P 9P?PO^G/L?^Y;V'U;_P ,
MWU3ZI_8W_4A_L_\ L'_FDO\ 5+_CG\_Y%;_JEG_"K/\ B]G_ !>S_BM_^&5?
M^$X_YO=_;=_X^/\ A>7_  4@^.7VC_C&O]FO_B8_\*S_ +0TG_B4VGV3Y3_D
M5O\ JEG_  JS_B]G_%[/^*W_ .&5?^$X_P";W?VW?^/C_A>7_!2#XY?:/^,:
M_P!FO_B8_P#"L_[0TG_B4VGV3Y3_ )%;_JEG_"K/^+V?\7L_XK?_ (95_P"$
MX_YO=_;=_P"/C_A>7_!2#XY?:/\ C&O]FO\ XF/_  K/^T-)_P")3:?9/E/^
M16_ZI9_PJS_B]G_%[/\ BM_^&5?^$X_YO=_;=_X^/^%Y?\%(/CE]H_XQK_9K
M_P")C_PK/^T-)_XE-I]D^4^+^_S_ /<3G]I_X5^U]K];_P"HWV_UW_F:?VI_
MQG!_"_Z<^Q_[EO8?5O\ PS?5/JG]C?\ 4A_L_P#L'_FDO]4O^.?S_D5O^J6?
M\*L_XO9_Q>S_ (K?_AE7_A./^;W?VW?^/C_A>7_!2#XY?:/^,:_V:_\ B8_\
M*S_M#2?^)3:?9/E_2K_@GZG]C6?Q4\)>1_PA?V2Z\&^,O^%1>*Y?^$C_ &A=
M)_X6#%XGU?\ X7/^USX^S+]O_:0_:%^R?\)=XE^'7VEO^%3>"-(^'V@?9;+[
M?Y3?FK_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"<?\WN_MN_\?'_  O+_@I!
M\<OM'_&-?[-?_$Q_X5G_ &AI/_$IM/LGR_I5_P $_4_L:S^*GA+R/^$+^R77
M@WQE_P *B\5R_P#"1_M"Z3_PL&+Q/J__  N?]KGQ]F7[?^TA^T+]D_X2[Q+\
M.OM+?\*F\$:1\/M ^RV7V_RF^;XN][A_'/XKO"SO\=[XS#SY^:^)O?ZS[3VO
MM9W^M^U^O3_M#Z_Q?^H^#'[OQ(X>C;V5HYO0Y+>PY;9'F5#ZO[/EROEM_97U
M?ZG]2H<O]C?4_P#5VC_JS_JYX*?HM1117XN?W6%%%% !1110 4444 %%%% '
M^?7^TM_R<;\?_P#LMGQ5_P#4ZUZO$Z]L_:6_Y.-^/_\ V6SXJ_\ J=:]7B=?
MZ%Y;_P B[ ?]@6%_],4S_FDXH_Y*;B+_ +'N;_\ JPQ 4445VGA!1110 444
M4 %%%% !1110 5^HO_!''_D_;X8_]BU\3/\ U =>K\NJ_47_ ((X_P#)^WPQ
M_P"Q:^)G_J Z]7S'&O\ R1_%'_8@S;_U!KGZQX#_ /)[/"7_ +.-P;_ZO\ ?
MV=T445_!Q_T0!1110 4444 %%%% !1110!_)?_P7B_Y.\^'/_9M_A#_U9WQ@
MK\3Z_;#_ (+Q?\G>?#G_ +-O\(?^K.^,%?B?7]R>'7_)$<-_]BVG_P"EU#_G
M^^D[_P G]\4O^RGK_P#J+A0HHHK[0_" HHHH **** "BBB@ HHHH **** /]
M("BBBO\ .<_Z> HHHH **** "BBB@ HHHH _'3_@N+_R9?IG_9:_ W_IA\:5
M_(57]>O_  7%_P"3+],_[+7X&_\ 3#XTK^0JOZ\\%/\ DBE_V-L?_P"DX<_Q
M6^GC_P GWG_V1W#O_IS,0HHHK]</XP"BBB@ HHHH **** "BBB@ HHHH _L\
M_P"".7_)A'PO_P"QD^)O_J?Z_7ZB5^7?_!'+_DPCX7_]C)\3?_4_U^OU$K^#
M^-O^2PXH_P"Q]FO_ *F5C_H?\!O^3)>$O_9NN#__ %0X$****^7/UD**** "
MBBB@ HHHH **** .+T/_ )'#QQ_W+/\ Z:Y:[2N+T/\ Y'#QQ_W+/_IKEKM*
MJ6Z_PP_](B3'9_XI_P#I<@HHHJ2@HHHH Q?$G_(NZ_\ ]@75/_2&>CPW_P B
M[H'_ &!=+_\ 2&"CQ)_R+NO_ /8%U3_TAGH\-_\ (NZ!_P!@72__ $A@JOL?
M]O?H3]O_ +=_4VJ***DH**** "BBB@ HHHH **** "BBB@#\>O\ @J7_ ,EA
M_P""67_:0/X5?^CHJ_86OQZ_X*E_\EA_X)9?]I _A5_Z.BK]A:[\3_N67?X,
M5_ZDR.2A_O.-_P =#_TQ ****X#K"BBB@#^>/QE_Q2WB_P 5?\BW\+/^%6>)
M-<^-G_%=?\5OX0_95_X3C4[K_C-W]K/_ (^/^%Y?M^?'+[1_QB?^S7_Q,?\
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M\<OM'_&-?[-?_$Q_X5G_ &AI/_$IM/LGRG_(K?\ 5+/^%6?\7L_XO9_Q6_\
MPRK_ ,)Q_P WN_MN_P#'Q_PO+_@I!\<OM'_&-?[-?_$Q_P"%9_VAI/\ Q*;3
M[)\I\7]_G_[B<_M/_"OVOM?K?_4;[?Z[_P S3^U/^,X/X7_3GV/_ '+>P^K?
M^&;ZI]4_L;_J0_V?_8/_ #27^J7_ !S^?\BM_P!4L_X59_Q>S_B]G_%;_P##
M*O\ PG'_ #>[^V[_ ,?'_"\O^"D'QR^T?\8U_LU_\3'_ (5G_:&D_P#$IM/L
MGRG_ "*W_5+/^%6?\7L_XO9_Q6__  RK_P )Q_S>[^V[_P ?'_"\O^"D'QR^
MT?\ &-?[-?\ Q,?^%9_VAI/_ !*;3[)\I_R*W_5+/^%6?\7L_P"+V?\ %;_\
M,J_\)Q_S>[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_:&D_\2FT^R?*?
M\BM_U2S_ (59_P 7L_XO9_Q6_P#PRK_PG'_-[O[;O_'Q_P +R_X*0?'+[1_Q
MC7^S7_Q,?^%9_P!H:3_Q*;3[)\I\7]_G_P"XG/[3_P *_:^U^M_]1OM_KO\
MS-/[4_XS@_A?].?8_P#<M[#ZM_X9OJGU3^QO^I#_ &?_ &#_ ,TE_JE_QS^?
M\BM_U2S_ (59_P 7L_XO9_Q6_P#PRK_PG'_-[O[;O_'Q_P +R_X*0?'+[1_Q
MC7^S7_Q,?^%9_P!H:3_Q*;3[)\I_R*W_ %2S_A5G_%[/^+V?\5O_ ,,J_P#"
M<?\ -[O[;O\ Q\?\+R_X*0?'+[1_QC7^S7_Q,?\ A6?]H:3_ ,2FT^R?*?\
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M?!?XH>(_^$WTWX9?\(_X)\0:W_PLC5?#7_"9VOP^_LJPFO\ _A-XO!_E3_\
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M2?\ B4VGV3Y?Z!^+^_S_ /<3G]I_X5^U]K];_P"HWV_UW_F:?VI_QG'^;?\
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M#XY?:/\ C&O]FO\ XF/_  K/^T-)_P")3:?9/E/^16_ZI9_PJS_B]G_%[/\
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M )%;_JEG_"K/^+V?\7L_XK?_ (95_P"$X_YO=_;=_P"/C_A>7_!2#XY?:/\
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MA]6_\,WU3ZI_8W_4A_L_^P?^:2_U2_XY_/\ D5O^J6?\*L_XO9_Q>S_BM_\
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M_P#[+9\5?_4ZUZO$Z]L_:6_Y.-^/_P#V6SXJ_P#J=:]7B=?Z%Y;_ ,B[ ?\
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M8_\ "L],U#0/^)3:?9/EYO\ Y%;_ *I9_P *L_XO9_Q>S_BM_P#AE7_A./\
MF]W]MW_CX_X7E_P4@^.7VC_C&O\ 9K_XF/\ PK/^T-)_XE-I]D^7^B*/O4:7
MV^>G3_Z><_M(KSQGM?:_6^^.]O\ 7?\ F:?VI_QG'^9N-_=8S%_\N?8XJO\
M]0WL/JU6?_8E^J?5/[&[9!_9_P#8/_-)?ZI?\<_G_(K?]4L_X59_Q>S_ (O9
M_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H:3_Q*
M;3[)\I_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"<?\WN_MN_\?'_  O+_@I!
M\<OM'_&-?[-?_$Q_X5G_ &AI/_$IM/LGRG_(K?\ 5+/^%6?\7L_XO9_Q6_\
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M;_\ #*O_  G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\
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M?\WN_MN_\?'_  O+_@I!\<OM'_&-?[-?_$Q_X5G_ &AI/_$IM/LGRG_(K?\
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M\E^/.M_\(U\%_BAXC_X3?3?AE_PC_@GQ!K?_  LC5?#7_"9VOP^_LJPFO_\
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MS?5/JG]C?]2'^S_[!_YI+_5+_CG\_P"16_ZI9_PJS_B]G_%[/^*W_P"&5?\
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M/EROEM_97U?ZG]2H<O\ 8WU/_5VC_JS_ *N>"GZ+4445^+G]UA1110 4444
M%%%% !1110!_GU_M+?\ )QOQ_P#^RV?%7_U.M>KQ.O;/VEO^3C?C_P#]EL^*
MO_J=:]7B=?Z%Y;_R+L!_V!87_P!,4S_FDXH_Y*;B+_L>YO\ ^K#$!1117:>$
M%%%% !1110 4444 %%%% !7ZB_\ !''_ )/V^&/_ &+7Q,_]0'7J_+JOU%_X
M(X_\G[?#'_L6OB9_Z@.O5\QQK_R1_%'_ &(,V_\ 4&N?K'@/_P GL\)?^SC<
M&_\ J_P!_9W1117\''_1 %%%% !1110 4444 %%%% '\E_\ P7B_Y.\^'/\
MV;?X0_\ 5G?&"OQ/K]L/^"\7_)WGPY_[-O\ "'_JSOC!7XGU_<GAU_R1'#?_
M &+:?_I=0_Y_OI._\G]\4O\ LIZ__J+A0HHHK[0_" HHHH **** "BBB@ HH
MHH **** /]("BBBO\YS_ *> HHHH **** "BBB@ HHHH _'3_@N+_P F7Z9_
MV6OP-_Z8?&E?R%5_7K_P7%_Y,OTS_LM?@;_TP^-*_D*K^O/!3_DBE_V-L?\
M^DX<_P 5OIX_\GWG_P!D=P[_ .G,Q"BBBOUP_C **** "BBB@ HHHH ****
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M&;ZI]4_L;_J0_P!G_P!@_P#-)?ZI?\<_G_(K?]4L_P"%6?\ %[/^+V?\5O\
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MW_U&^W^N_P#,T_M3_C.#^%_TY]C_ -RWL/JW_AF^J?5/[&_ZD/\ 9_\ 8/\
MS27^J7_'/Y_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"<?\WN_MN_\?'_  O+
M_@I!\<OM'_&-?[-?_$Q_X5G_ &AI/_$IM/LGR^R?L]Z)L^-OPR\.?\(1KD/_
M  AGBW3?BC_PK?XF>)?,O_@M_P +-=K#_AJ;]N7QAYI_X6-_P4%_:=_M#^P?
M@C\$//NO^%+>&_$']J?V?8?V5O3QO_D5O^J6?\*L_P"+V?\ %[/^*W_X95_X
M3C_F]W]MW_CX_P"%Y?\ !2#XY?:/^,:_V:_^)C_PK/\ M#2?^)3:?9/E]D_9
M[T39\;?AEX<_X0C7(?\ A#/%NF_%'_A6_P 3/$OF7_P6_P"%FNUA_P -3?MR
M^,/-/_"QO^"@O[3O]H?V#\$?@AY]U_PI;PWX@_M3^S[#^RMZ<F82_P!@QTN;
M?"8F7-S[\]&;YO:?6->?ZW?G^M5/:_7;_6,=_:?M.-O<X9A_QDG#]+V?PYYE
M-/V7L?A]CC\/'V?U?^S5R>P_L?E]C_9&&^J?V%R?V;D'^JGU7P$_=RBBBOY^
M/]( HHHH **** "BBB@ HHHH _!G_@OC_P D)^!W_96M1_\ 4.U6OY9:_J:_
MX+X_\D)^!W_96M1_]0[5:_EEK^Q_!W_DA,O_ .PO,O\ U,JG^'OTW?\ E(7B
M;_L3\+?^J+!A1117ZB?R2%%%% !1110 4444 %%%% !1110!_95_P1D_Y,2\
M$?\ 8[?$C_U*+JOU6K\J?^",G_)B7@C_ +';XD?^I1=5^JU?PCQS_P EEQ/_
M -CS,O\ U*J'_0UX ?\ )D/";_LW_"W_ *J,*%%%%?*GZ\%%%% !1110 444
M4 %?YTGC/_D</%G_ &,NN_\ ITNJ_P!%NO\ .D\9_P#(X>+/^QEUW_TZ75?T
M1X _Q>*?^O>3?^E9H?YF?M'/]S\(O^PGCG_TUPF<U1117]('^704444 %%%%
M !1110 4444 %%%% 'W5_P $S?\ D^W]F[_L=KS_ -1?7Z_N6K^&G_@F;_R?
M;^S=_P!CM>?^HOK]?W+5_*_CO_R4N4?]B.'_ *GXX_U\_9Y?\FKXR_[.!B/_
M %G.'PHHHK\//[\"BBB@ HHHH **** "OYK?^#@7_D,?LK?]@WXR_P#I5\,*
M_I2K^:W_ (.!?^0Q^RM_V#?C+_Z5?#"OTCPD_P"3@9%_AS3_ -4^//Y<^F=_
MRCAX@?\ 7WA'_P!;;AT_G1HHHK^T#_"H**** "BBB@ HHHH **** "BBB@ K
M^V#_ ()'?\H]?V??^ZK_ /J[OB37\3]?VP?\$CO^4>O[/O\ W5?_ -7=\2:_
M%O'7_DD<N_[*/"?^JS-S^[?V>W_)Y^)O^S89U_ZU?!1^D%%%%?R@?[%A1110
M 4444 %%%% !1110 5S/A+_D%77_ &,WC7_U,M>KIJYGPE_R"KK_ +&;QK_Z
MF6O4^C]5^3)?QQ_PR_.!!X*_Y ]Y_P!C;X^_]3OQ'76UR7@K_D#WG_8V^/O_
M %._$==;0]WZO\PA\$?\,?R04444B@HHHH **** "BBB@ HHHH **** /Q[_
M .<[?_>,_P#]^$K]A*_'O_G.W_WC/_\ ?A*_82N_'[X/_L PWY2.3";XK_L+
MJ_E ****X#K"O)?CSK?_  C7P7^*'B/_ (3?3?AE_P (_P""?$&M_P#"R-5\
M-?\ "9VOP^_LJPFO_P#A-XO!_E3_ /"5ZEX4\C^WM&\->1-_;NL6%CI?E2?:
MMA]:KR7X\ZW_ ,(U\%_BAXC_ .$WTWX9?\(_X)\0:W_PLC5?#7_"9VOP^_LJ
MPFO_ /A-XO!_E3_\)7J7A3R/[>T;PUY$W]NZQ86.E^5)]JV'KP"YL=@H\O/S
M8O#1Y>3VG->M!<OL_J^+Y^;;D^J8KFOR_5ZU_9R\?B*I[+A_/:OM/8^SR?,Z
MGM?;?5O9<F"KR]I]8_M+)O8<EN;VW]KY5[*W/_:6!Y?K5+\&?^16_P"J6?\
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MO9_Q>S_BM_\ AE7_ (3C_F]W]MW_ (^/^%Y?\%(/CE]H_P",:_V:_P#B8_\
M"L_[0TG_ (E-I]D^4_Y%;_JEG_"K/^+V?\7L_P"*W_X95_X3C_F]W]MW_CX_
MX7E_P4@^.7VC_C&O]FO_ (F/_"L_[0TG_B4VGV3Y3_D5O^J6?\*L_P"+V?\
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M_P"&5?\ A./^;W?VW?\ CX_X7E_P4@^.7VC_ (QK_9K_ .)C_P *S_M#2?\
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MHWV_UW_F:?VI_P 9P?PO^G/L?^Y;V'U;_P ,WU3ZI_8W_4A_L_\ L'_FDO\
M5+_CG\_Y%;_JEG_"K/\ B]G_ !>S_BM_^&5?^$X_YO=_;=_X^/\ A>7_  4@
M^.7VC_C&O]FO_B8_\*S_ +0TG_B4VGV3Y?TJ_P""?J?V-9_%3PEY'_"%_9+K
MP;XR_P"%1>*Y?^$C_:%TG_A8,7B?5_\ A<_[7/C[,OV_]I#]H7[)_P )=XE^
M'7VEO^%3>"-(^'V@?9;+[?Y3?FK_ ,BM_P!4L_X59_Q>S_B]G_%;_P##*O\
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MN(O^Q[F__JPQ 4445VGA!1110 4444 %%%% !1110 5^HO\ P1Q_Y/V^&/\
MV+7Q,_\ 4!UZORZK]1?^"./_ "?M\,?^Q:^)G_J Z]7S'&O_ "1_%'_8@S;_
M -0:Y^L> _\ R>SPE_[.-P;_ .K_  !_9W1117\''_1 %%%% !1110 4444
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M%U3_ -(9Z/#?_(NZ!_V!=+_](8*K['_;WZ$_;_[=_4VJ***DH**** "BBB@
MHHHH **** "BBB@#\>O^"I?_ "6'_@EE_P!I _A5_P"CHJ_86OQZ_P""I?\
MR6'_ ()9?]I _A5_Z.BK]A:[\3_N67?X,5_ZDR.2A_O.-_QT/_3$ HHHK@.L
M**** /YX_&7_ !2WB_Q5_P BW\+/^%6>)-<^-G_%=?\ %;^$/V5?^$XU.Z_X
MS=_:S_X^/^%Y?M^?'+[1_P 8G_LU_P#$Q_X5GIFH:!_Q*;3[)\O-_P#(K?\
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M'QR^T?\ &-?[-?\ Q,?^%9_VAI/_ !*;3[)\I_R*W_5+/^%6?\7L_P"+V?\
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M3_DQ+P1_V.WQ(_\ 4HNJ_5:ORI_X(R?\F)>"/^QV^)'_ *E%U7ZK5_"/'/\
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M4 %%%% '^?7^TM_R<;\?_P#LMGQ5_P#4ZUZO$Z]L_:6_Y.-^/_\ V6SXJ_\
MJ=:]7B=?Z%Y;_P B[ ?]@6%_],4S_FDXH_Y*;B+_ +'N;_\ JPQ 4445VGA!
M1110 4444 %%%% !1110 5^HO_!''_D_;X8_]BU\3/\ U =>K\NJ_47_ ((X
M_P#)^WPQ_P"Q:^)G_J Z]7S'&O\ R1_%'_8@S;_U!KGZQX#_ /)[/"7_ +.-
MP;_ZO\ ?V=T445_!Q_T0!1110 4444 %%%% !1110!_)?_P7B_Y.\^'/_9M_
MA#_U9WQ@K\3Z_;#_ (+Q?\G>?#G_ +-O\(?^K.^,%?B?7]R>'7_)$<-_]BVG
M_P"EU#_G^^D[_P G]\4O^RGK_P#J+A0HHHK[0_" HHHH **** "BBB@ HHHH
M **** /]("BBBO\ .<_Z> HHHH **** "BBB@ HHHH _'3_@N+_R9?IG_9:_
M W_IA\:5_(57]>O_  7%_P"3+],_[+7X&_\ 3#XTK^0JOZ\\%/\ DBE_V-L?
M_P"DX<_Q6^GC_P GWG_V1W#O_IS,0HHHK]</XP"BBB@ HHHH **** "BBB@
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M $A@JOL?]O?H3]O_ +=_4VJ***DH**** "BBB@ HHHH **** "BBB@#\>O\
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M<?\ -[O[;O\ Q\?\+R_X*0?'+[1_QC7^S7_Q,?\ A6?]H:3_ ,2FT^R?*?\
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M!A1117ZB?R2%%%% !1110 4444 %%%% !1110!_95_P1D_Y,2\$?]CM\2/\
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M5Y+\>=;_ .$:^"_Q0\1_\)OIOPR_X1_P3X@UO_A9&J^&O^$SM?A]_95A-?\
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MW_U&^W^N_P#,T_M3_C.#^%_TY]C_ -RWL/JW_AF^J?5/[&_ZD/\ 9_\ 8/\
MS27^J7_'/Y_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"<?\WN_MN_\?'_  O+
M_@I!\<OM'_&-?[-?_$Q_X5G_ &AI/_$IM/LGRG_(K?\ 5+/^%6?\7L_XO9_Q
M6_\ PRK_ ,)Q_P WN_MN_P#'Q_PO+_@I!\<OM'_&-?[-?_$Q_P"%9_VAI/\
MQ*;3[)\I_P BM_U2S_A5G_%[/^+V?\5O_P ,J_\ "<?\WN_MN_\ 'Q_PO+_@
MI!\<OM'_ !C7^S7_ ,3'_A6?]H:3_P 2FT^R?*?\BM_U2S_A5G_%[/\ B]G_
M !6__#*O_"<?\WN_MN_\?'_"\O\ @I!\<OM'_&-?[-?_ !,?^%9_VAI/_$IM
M/LGRGQ?W^?\ [B<_M/\ PK]K[7ZW_P!1OM_KO_,T_M3_ (S@_A?].?8_]RWL
M/JW_ (9OJGU3^QO^I#_9_P#8/_-)?ZI?\<_G_(K?]4L_X59_Q>S_ (O9_P 5
MO_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H:3_Q*;3[)
M\I_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"<?\WN_MN_\?'_  O+_@I!\<OM
M'_&-?[-?_$Q_X5G_ &AI/_$IM/LGRG_(K?\ 5+/^%6?\7L_XO9_Q6_\ PRK_
M ,)Q_P WN_MN_P#'Q_PO+_@I!\<OM'_&-?[-?_$Q_P"%9_VAI/\ Q*;3[)\I
M_P BM_U2S_A5G_%[/^+V?\5O_P ,J_\ "<?\WN_MN_\ 'Q_PO+_@I!\<OM'_
M !C7^S7_ ,3'_A6?]H:3_P 2FT^R?*?%_?Y_^XG/[3_PK]K[7ZW_ -1OM_KO
M_,T_M3_C.#^%_P!.?8_]RWL/JW_AF^J?5/[&_P"I#_9_]@_\TE_JE_QS^?\
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MBB@ HHHH **** /\^O\ :6_Y.-^/_P#V6SXJ_P#J=:]7B=>V?M+?\G&_'_\
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M[&V/_P#2<.?XK?3Q_P"3[S_[([AW_P!.9B%%%%?KA_& 4444 %%%% !1110
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M^%_TY]C_ -RWL/JW_AF^J?5/[&_ZD/\ 9_\ 8/\ S27^J7_'/Y_R*W_5+/\
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M?'_"\O\ @I!\<OM'_&-?[-?_ !,?^%9_VAI/_$IM/LGRGQ?W^?\ [B<_M/\
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M;_\ #*O_  G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\
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M?^%C?\%!?VG?[0_L'X(_!#S[K_A2WAOQ!_:G]GV']E;T\;_Y%;_JEG_"K/\
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M -3*I_A[]-W_ )2%XF_[$_"W_JBP84445^HG\DA1110 4444 %%%% !1110
M4444 ?V5?\$9/^3$O!'_ &.WQ(_]2BZK]5J_*G_@C)_R8EX(_P"QV^)'_J47
M5?JM7\(\<_\ )9<3_P#8\S+_ -2JA_T-> '_ "9#PF_[-_PM_P"JC"A1117R
MI^O!1110 4444 %%%% !7^=)XS_Y'#Q9_P!C+KO_ *=+JO\ 1;K_ #I/&?\
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M?X<T_P#5/CS^7/IG?\HX>('_ %]X1_\ 6VX=/YT:***_M _PJ"BBB@ HHHH
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M/_!/C_H"?%[_ ,.MJW_R'7[545I_;><+;,\;I_U$5?+^]Y?U=G,\CR9N[RK
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M-'_#CO\ 8G_Z"'[07_A\O%7_ ,37[#45G_:N9?\ 0=B?_!LO+S\D='U#!_\
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MQ_T!/B]_X=;5O_D.OVJHH_MS./\ H9X[_P *:O\ \E_7S8?V%DW_ $*LO_\
M"2AY?W/)'XJ_\."?^"?'_0$^+W_AUM6_^0Z/^'!/_!/C_H"?%[_PZVK?_(=?
MM511_;F<?]#/'?\ A35_^2_KYL/["R;_ *%67_\ A)0\O[GDC\>?^''?[$__
M $$/V@O_  ^7BK_XFC_AQW^Q/_T$/V@O_#Y>*O\ XFOV&HK+^U<R_P"@[$_^
M#9>7GY(ZOJ&#_P"@:C_X O+_ "1^//\ PX[_ &)_^@A^T%_X?+Q5_P#$T?\
M#CO]B?\ Z"'[07_A\O%7_P 37[#44?VKF7_0=B?_  ;+R\_)!]0P?_0-1_\
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M *:Y:[2JENO\,/\ TB),=G_BG_Z7(****DH**** ,7Q)_P B[K__ &!=4_\
M2&>CPW_R+N@?]@72_P#TA@H\2?\ (NZ__P!@75/_ $AGH\-_\B[H'_8%TO\
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M(M]D_P""GVM3?\(?\2-;^,FD_P!J?LI^$]<^U_%[Q!YGV_XJ^*?[:^+NH?\
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M+"\U"_L]"LOV2_ U[;P7FJ7+7=_.L^K?%34+UFN;AVE97N612<1JBX6O2O\
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M]#_7[C+_ **+,_\ P<O_ )'R7W'SG_$$?!W_ *-?P'_XBN3?_,?DON/Y?O\
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M?_(^2^X^,_X@CX._]&OX#_\ $5R;_P"8_)?<?R_?\0YWC+_H_B?_ ,1DLO\
MY^='_$.=XR_Z/XG_ /$9++_Y^=?U T4?Z_<9?]%%F?\ X.7_ ,CY+[@_X@CX
M._\ 1K^ _P#Q%<F_^8_)?<?R_?\ $.=XR_Z/XG_\1DLO_GYT?\0YWC+_ */X
MG_\ $9++_P"?G7]0-%'^OW&7_119G_X.7_R/DON#_B"/@[_T:_@/_P 17)O_
M )C\E]Q_+]_Q#G>,O^C^)_\ Q&2R_P#GYT?\0YWC+_H_B?\ \1DLO_GYU_4#
M11_K]QE_T469_P#@Y?\ R/DON#_B"/@[_P!&OX#_ /$5R;_YC\E]Q_+]_P 0
MYWC+_H_B?_Q&2R_^?G1_Q#G>,O\ H_B?_P 1DLO_ )^=?U T4?Z_<9?]%%F?
M_@Y?_(^2^X/^((^#O_1K^ __ !%<F_\ F/R7W'\OW_$.=XR_Z/XG_P#$9++_
M .?G1_Q#G>,O^C^)_P#Q&2R_^?G7]0-%'^OW&7_119G_ .#E_P#(^2^X/^((
M^#O_ $:_@/\ \17)O_F/R7W'\OW_ !#G>,O^C^)__$9++_Y^=?7GPO\ ^"87
M[=7P7\"Z'\-/AA_P5A\1^$O WAK^T_[#\/V?[)7@2[MM/_MC6-0U_4O+N-4^
M*5]?2?:M8U74+U_/NI=DERR1;(5CC3]Q:*X\;Q=Q'F5*-#,<UKX^A"HJL*.-
MA0Q5*-6,90C4C3KTJD(U%"<X*:2DHSE%.TFG[61>&OA_POBZF8<,\&\.\.X^
MMAIX.KC<BRK"91BZN$J5:-:IA:F)R^GAZT\-.MA\/5G0E-TI5:%&I*+E2@X_
MCS_PPI_P4H_Z3">+/_$0?AI_\\>C_AA3_@I1_P!)A/%G_B(/PT_^>/7[#45Y
MG]IXKM@__#;EW_S(?5_4J'\V)_\ "W&__-!^//\ PPI_P4H_Z3">+/\ Q$'X
M:?\ SQZ/^&%/^"E'_283Q9_XB#\-/_GCU^PU%']IXKM@_P#PVY=_\R!]2H?S
M8G_PMQO_ ,T'PQ^RQ^SG^UA\&O&'B'7?C]^W-K7[4WAO5/#9TG1O!^I_ [PE
M\+HO#VN'5+"\'B2/6/#_ (JUZYU"1;"VO-+_ +-FMH8"NH-=&?S+=(W^YZ**
MY*U:=>;J5.3F:2_=TJ5&&BLK4Z,*=-/NU%-[N[.BG3C2CR0YVKM^_4J59:_W
MZDIS?DG*RZ!1116184444 %<SX2_Y!5U_P!C-XU_]3+7JZ:N9\)?\@JZ_P"Q
MF\:_^IEKU/H_5?DR7\<?\,OS@0>"O^0/>?\ 8V^/O_4[\1UUM<EX*_Y ]Y_V
M-OC[_P!3OQ'76T/=^K_,(?!'_#'\D%%%%(H**** "BBB@ HHHH **** "BBB
M@ HHHH **^=/VJ?VI_@]^QQ\&/$WQR^-FN3:9X8T("QT?0]*2SO/&/Q \77=
MM=W&A?#_ , :+>WVF0:YXP\0_8;MK.WNM1TS1M(TRRU;Q5XMUOPYX+\/^(_$
MFD?D7X!_X.2?^">GC3Q7I_AS6-'_ &A/AUIL\6IS:QXR\5^!/ _B+0?"T>G:
M7?7\7]M:+\(_BA\3OB)=/JMY:0:%IT7AGP-XBE&KZG8MJ*:?I*ZAJMAU4<%C
M,1!U:&&K5:<6TY0@Y)R2NXQM\4DFFXQN]5IJC"IB</1FH5:U.G-I-1E))V;L
MF[[)O1-V39^_]%8OAOQ+X=\9^'= \8>#]?T7Q7X2\5Z+I7B3POXH\-ZI8Z[X
M=\2>'==L8-4T37] UO2Y[K3-8T76-,NK;4=*U73KFYL=0L;F"[M)YK>:.1OE
MW]M?]LOP)^PK\'K/XX?$SX??%_Q[X'?QKHO@S7)?A!X8T'Q)=>"QK^G:W<Z;
MXL\;2^)?%G@S1O#O@N;6-)T_P:NN76L%I?&OB_P9X>M[2>YUZ)XL(4YU*D:4
M(N52<E",$O>E)NRBEW;T-93C",IR:C"*<I2>RBE=M^26I]>45Q?PV\9GXC_#
MKP#\0SX3\:^ CX\\%^%O&9\"_$G0QX8^(O@L^*-#L=</A/Q]X:6[U!?#WC7P
MY]N_L?Q3H:W]ZNDZY9WU@+NY%OYS]I4.ZT?30H**^#_V(_V_O O[=7_"W/\
MA!?@E^TG\(O^%*Z_H?@[QE_PT!\/- \#8\>ZA_PD'_"1_#JQ_L'QOXSV^/\
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MY^1W7O<C2EHG=6;MJE?I<E3C*4X)WE#EYU9Z<RO'6UG==F[=0HHHJ"@HHHH
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M3[_%#>&/^$/C^*__  D6[QRN/#GB+_A(7\/_ -@#;X7/]A#5OM9SXCTS[/\
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M&491<91DM&I1=FFGHTU=&D9*45*+4HR2<91:<9)ZIIK1IK5-:,**\@UGX_\
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M)-1;5W=I7U:5KM+=VNKVVNK[GK]%><?%WXN_#7X#?#;Q=\7OC!XQT?P#\-_
MNF?VMXG\4ZY+*MG8P27-O86-I;6UK%<ZCK&MZWJUY8:%X:\-Z+9ZCXA\4>(M
M2TKPYX=TS5-<U33]/N?Q=^#W_!Q=^P)\6OB+X2^'MYI'QO\ A*GB?54T>_\
M'?Q6TCX0Z=\/_ =U<V\YTZY^(.L^#?C3XWU'PWHU[J<=OHLWB)M&N_#_ (?G
MO4UKQ;J?A[PC8:WXDTK>CA,5B(SG0H5:L*?QRA!R2TO;3=VU<5=VUM8RJ8BA
M1E&-6K"G*?PJ4DF[OE3UV3;LF[*^FY^]-%%%<YL%%%% !1110 4444 %%%%
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M2Y7:5O1Z,E2BY2BFG*-N9=8\RNK^JU045\D?M,_MW_LC_L>'2;?]HKXW>&?
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MPKXG\3SZ7ID=U?0^'O#FO:U) NFZ/J%S;XFAM45\]_M!?M)^"/V;_P#A2/\
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MKLUK!;:GXFT+7]0^ 'PC@UOP5XFO]6\$:MI_A:31]0\.W.E>)_%MEKOZF?\
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M?[!GCS]LSX-^!?&7P#U1] _:C_9K\2:IX^^#6IVGBC7/!VM:S9:C;:=<^*?
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MK?47[7-:7MDX8.I2^JRA!2E&,%*A"$H656K!*:ES<TXU'4OHZ#J0C*'UI*&
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M_@?_ ()8?M2^/M!_X+8_#KQEI6B_!RW_ &ROVA-"^)?[._C;Q)KGA?Q?X?\
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MX$TF+PW_ ,+ O?!JZ%'?Z/JVN6^KWLOBO[5/PB_;)_8C_P""C?Q/_P""FWP
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M2O#_ /PDUUI">(/$'AO16O\ Q!IO\NGQ>_8D_;?_ &GOV;/A3\!/A+_P2)\
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M'QB_9^^-?Q9_8%U3QYIOQ+\%_'_P;'HNN:5\/O#&MP:UX%\+>(?$?BZ3X?\
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M:<''#IU(IQ<9.$[P6]DN5IH^0]%_;%_X*P?L>?M.?LD^$/VXM4^ /Q.\+?\
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M\O?B/\=?B!X$\!3W_CF]^'OA2/QI>^%?B#XY;QMX:O\ QII7C+PMJWPVDN]
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MB+7_ !9?7GQ6^)UOI2>&M>^*MA/<Z;XCT'Q3_@C-\=?@?\%_CCX\_9T^(OP
M_;._9Y_:\_;"\2ZY\4(=0_:SUGQ%X_U?XL:)X'T#Q/XML3/K^I?!S]G[6='U
MO4=1'[1'C67Q#XB^#=S9^*=0TGQ/%X@^._B;Q)=^!OA[H?U_\!W\<?L\? #_
M (*<>*O'W[*GQ5^-.C^-/^"F7Q[U)?@;:?#/7-9\3?&;X$_&+QQ\'_ 'B3Q7
MX)\#ZIX9U.#XH>$SX&UOQ9XGM+3[%_PA7C?3O#>IZ-JGBKP[H4VJ^)M&PK4Z
M,:]:+PU/E_X3.2G'V=&.)3J15>=)TYRIQIUZGM$I1J24(M7<>7ECK2G4=*FU
M7DW_ +;S3:G5=&T6Z49J4(RE*E%PO%Q3E*^CO=\/^PUXV_X++_&CP?)^TE?_
M !O_ &"OBM\&/V@? /BKX@?"WP=JP\9_;?@OXKOO ?Q#N?A_\,87^%OPM\(W
M%E8>#OC5?^"_A_\ 'O2/'WQ#^-7CCPYX<\ ^*]$T'Q2WQ!M=1U+7?AC_ ()'
M-^V__P -V_\ !1;_ (02+]E3S3^U?X5_X;8_X2V?XN^6B_\ "^_VD_\ A+O^
M&6?[&M]TC"?_ (6N?#G_  MKR@8?^%>+J>'_ .$D:N<_X)IZ3^S]\8/^"DOP
M$^.__!,S]F+]I;X._LJ> OAK\6O G[1'Q$\=>/\ 4->\"^)-;N?!FNW-AX,U
M#5;KQY\3X]7O(/$7B7X)>(KKP9>?&CQAJGB*_C\(^.[3X,>!K7X5:M\2O%ON
M?[%WQ.\2?L'_ /!4']M;X2_';X _M Q^(/\ @H=^UQ=/^S=K'A'P1HNO>#O$
M7A32/BE\;OB'K?Q!D\1S>+=,AUCP;X6^'WQV\&>-O']WX%M_&>J?#'0[7Q+%
M\1])\*ZUX?O](CWG%4XYC2I4\.YUL%1K1H2HTJ-6G&.,2E3J4X59P]K3I1]L
MW&5Y0]G6E%2<D90DYO!SG.LHT\34IRJJI4J0FY8=.,H3E3C+DJ3?L[.-E+GI
MJ3T/ZB*_C^_;G_8.^"'[$W[:'_!(BX^&.H?$WQCX]^,'[;/A_7?C'\6_B]\0
M=8\<_$'XJ:YIW[5_[-'B32=<\5X&D^#(-=L+CXB^)+.ZUOPQX-\.ZMXI@DM=
M0\;WOBCQ# ^MS?V U_)]_P %!OCC\7_VN/VA?^"=GQA^'7_!/;_@H[H'AS]D
MCX[Z=\5?B/IOCK]E;7=,\0ZYX?@^*_[/?CR2P\$VF@Z[XFTZ_P!<72/A1XBM
MOLWB'5?#%C_:5YHL']H_9KB^N].\W)W6]O4C"3C1E0Q,:RYU",G+"8F-",[M
M<UZLERK5<_*VKI-=F8^R]G3<TG4C6H2IOE<I1C'$X>55QLG:T(WD]^6ZV;1_
M6#17DGP*^+)^.7PL\,?%$_#+XM_!P^)GUY#\.?CKX.3P!\4_#W]@^)=9\-[O
M$_A*/5-932DUG^Q_[?T%AJ5S_:'AK5=&U0^2;TV\7K=>3*+A*49*THMQDNS3
MLUIIHUT/0C)22E'522:?=-73^X****0PHHHH *_)S_@N-_RBZ_:9_P"OGX%?
M^M(?""OUCK\R/^"QO@+QU\3_ /@G'^T-X'^&O@OQ9\0_&NMW'P9;1O!_@;PY
MK'BWQ3JXTOX_?"S6=3.F>'] L]0U:_&G:/IVH:K?FUM)1::;8WE]<>7:VTTJ
M=F7-+,,"VTDL9A6V]$DJ\&VV]$DMV<^,3>$Q22;;P]=))7;;I2LDNY_,[^V;
MK'_!/S6O^"=G["OP.^ ?PY^%WBS]NGQ9X(_90U?QO;_L]_#SPZOQ'U/5_$'P
M=\2>$/&.@?%;Q?X.^$OBB;XH>./$/Q*>+P[K?[/W_"P/"OQFN/B1X@\#?$+6
M+74-*T=O#GC7]S?BGX>_X+Q?$*P\._"3X2>,/V:O@/+\)_AW^S];>-?VHO$N
MJ^&?$NL?M2_%RX^$[2?'?6? OAE?@Q\3-#^'WPTT_P")FH7.F_\ ".>*?@%\
M-?%=Q?>&=$\4>#?%#^$/%.L^!/#GU=^P#^QW\!/AK^SE^QW\0M0_98^$/P__
M &D/#7[./P>D\3^.+WX'^#?"GQOT#XA:Q\&]&T'XCOKWB6?PQ8>/-)\9ZI-J
MGB31O&[:C>V^N7LNHZYIVO>8]W?PR?AW_P %"_#VA^&O^"I?CKQ1_P %!OV>
M/VL_VDOV,/B'X?\  O@/]D'PG\--=\<:OX?M_C[\1O"/P/T&+0/A,^C?&/X;
MZ+X5\3>+=6^$GQ?M/$/PDT37;'QUXUUS^P_&TWP\US3-2T/Q9)[$*U/%U?J]
M./-'"_6\0I8J,,75JU*M2A%T\/1E4H4FE&"E"G.HX\OM:CO)1/-E3GAZ?MYN
MTJ_U:CRT'/#PA"G"HU.M4C&K--N34IQA>ZIP5HMGZ)?L0_MI_MO_ +1WPM_;
M)_9_MY?V>/$'[>'[%_Q9\(?":3QYXW\/^-O#O[.OQ!T:U\5WGP^\3^)_%,W@
M?44\9:CX\U?4/@_\=M=DN/"7PY^%O@F.[UKX7QZ5X,TK36\2Z;I7Q)_P;?M^
MU+_PI[6!X$C^ /\ PR&?V@O&O_"U'\6S?$7_ (:0'CC_ (9Z^%ATD?#Z/1X/
M^%8MX4\[_A6(U$^(Y%U?RSX\:V&X>'U/JO\ P;]?!SXI?#/Q[^WSXD\<?LT?
M%W]F'P;\1=<^">J?"WP'\5/#'Q-TT:+X;M/%'[2M]'X&T#QA\4O#7AGQ#\15
M^'.C^(/#6@7_ (JO+&/5M6@ETC7M9M;.?7H(WXW_ ((2_$[Q)^R5JVO_ /!,
M_P".WP!_:!\%?M(^-?B3\0_CS+->>"-%?X=>%?AEX>^&W@3X:S^+]>\4IXM^
MWWW@W5?'_P )=9\&^&?B1X1T#Q1\+_%'B37O"&F>'_&VHOKL3Q57C3ITLYP^
M&IT)13P-;EM3;C%X><L1.G:I)6HSE>*A.:I2FTG),5)SG/+:U:=5-QQ-.]YI
M.2K05*,[PB[U8QM+GC%U%%-I-'%_!B^_X*??$SXO_M]? 3]@"^\'? 7PSX:_
MX*+?M4_%_P")7[47Q+L-*O\ P[XBUCQ%XFTKP5H?P"\)VWBCX2?%W29M;L-/
M\/:A\1_%DNA^#=;U*UM'\&0Z_P"+/A;9ZCH.E?&GV+PI_P %VOB%_P .P?$O
M[8OC/X,^#+KXQR?M&ZQ^S!X MO"5SK5O\(K_ ,2ZA\*K;XT^'/B;XVT76-?N
M?&7A[PAX;\'7>H:/K'A'0_%OB?6O'/BOPUID=EXE^'>C?$*YU'X8_I7_ ,$U
MO ?CGP)_PWY_PF_@SQ7X-_X3+_@I?^U1X\\(?\)5X=UCP]_PE7@;Q#_P@G]@
M>,_#?]KV=G_;GA37/L=W_8_B+3/M6D:G]EN/L5Y/Y$NW^:;X9_\ !/?]K_XA
M?\$._%OPLB^ WQ'\,?$SX??MLR?';6/A-X^\&>,? OQ2\6_#'3/V3/#7PYUF
MZ^&G@SQ!X>L]3\8>(+;6?$,US8Z# MI=>([;PMXKT3PD^O\ CVVT3P9KUWP6
M*Q-2&)IX:%.EB<O2JJ7).I"I"2K*K5YKRA)J";T5)? X*[<_[30HPE1G6E*I
M0QDG!I2C"4)Q=-PARV4DG+E6KJ?:YM#]&?B9\;_^"ZO[$'A#5/VT_P!H_P 1
M_LW?&#X'3:KX4N/'G[+UE)X8T;4_@OHOQ(\9:!*FBZ5XJ\*_#7PMK-OK/A.^
MN[/X)Z+XA3XO_M/V.EWWBZ#Q9K7AKXNZ;I-WXTT_[C_X*'_$#PE\6/A]_P $
MI?BGX U5M=\"?$O_ (*4?L,>/_!6N-IVJZ0VL^$O&6B>-O$7AO56TG7+'3-;
MTMM1T?4;.[.G:QINGZI9&;[-J%C:7<4T$?YM?M9_\%"?BC_P56_9U\9?L3?L
MB?L=?'E_C^?&7@/2?VI?"_C70/"-OX-^$<_@/_A(OB'K7@)?BM>_$KPG9?#_
M ,:?\+>^$UCX4\/:C\=_!GP]B\7:)H7C;P]%X5T'X@7VCZ?I/Z0?M0?LU^//
M '[/W_!(_P"!G@S3?%/Q?D_9F_;,_8)T/QGXK\)>!M8*Q^"O@SX*\0>#_$7Q
M4\1:#I-QXG/@CPDK65KJ6KW>J:U?:1X:&IVUE?>(+G]W=W&2C&G5P4Z]+#X7
M%NMBXSIT>2$7AOJ\/8SJ0C*48MU'5C3FVI58ZOGLI/1RE.&)C2J5J^']GAW&
M=3FD_;NJ_:0A*45)KD5.4HZJ$GIR\S1\O_$3]L7_ (*3_MW_ +3?[2?[-7_!
M.#4/AC^S3X,_9$\9_P#")?$7XR_%^+PWJ7C+Q7XTT'Q3\0/A[J&B16&J>"_C
MGHFF>"_'FM^&_$NL^![+2?A1J&NIHWPIB\3>+OBGX(O?'MM\(5^JO^"=7[:W
M[0OC?XZ?'S]@S]MVR^'MO^U1^SAH'A7Q!IWB[X<1:D=,^,OPZ72?"NG:W\0-
M8@T[36\%Z-K=S=>*_AWXZ:6RF^'<NOZ=\9+'1--^!OP\N?AMXMM*_,_0/CUX
MA_X(L_MM_P#!0'XF_M:_ GXFZ[\"_P!LOXL6WC[X9?&[X1+H^M^#WO+WXC_'
M7X@>!/ 4]_XYO?A[X4C\:7OA7X@^.6\;>&K_ ,::5XR\+:M\-I+O0/"/CKX>
M>+-%^(D7U#^P+\-?CIJ_[=?[;O\ P56_:F\%:A^RS\(O%_PR\2^%/ .E?%_0
M]%^&6H/\)="\3>'+!?&OQ.TWQ#\2]8\1?"'5_A7\,?V9O!=[\1KCQGH]EX.\
M<ZA\1=1\>^ ==TWP-HL%E<SB*%".&KVHX>.&6#PTL%B8.+KUL9+ZM[6',IN=
M23YL2JM*4>6BHIJ,+)R=*K5=:E^\K.N\17CB:,D_94\.O;*$K.*C!+EHNG.,
MKU')W<N9V^6] _;B_P""K_[8/A'X[?M[_LN?&/X"_"C]CS]F+Q?\3GOO@7XU
M\#V=GXV^(/@+X.Z+:?'>U@\:V=S\.?C7JU_XQ\:?"/QCX7\#>-;GX>_M#?"S
M0WUK2KY_!-OX(O&;Q=?^^R_M9?M!?M'_ +*W_!-?]H/XHW'[,MU=?&+_ (*Q
M_LY^'_#*?";X6W?BO1-,^'%@_C+P?XGT#6;#]J#P7XLUGP%\;O"WQ6\+_$?P
MU>_$;X076GWNCZ?I.E7_ ,*_B?-I^KWVM:O_ #V?"?3OC5\2/V?9]"LOV.?^
M"H'Q)^'?QDU_5/'?BVP_9B\<ZK\,OV2O%WC*/Q9&R7_A[X*_#[_@GQ\7O@QH
M\_@S5?"/A[1'L[;7/$.E>&O$7@2TBT&P\):9H>C>&?#_ /1OJ7Q@^$O[;7[,
M7_!-K5OV'_AO\7;KX6_LU_\ !3;]D[X=>)/ NJ^$?$NN>+/@OX)^"?A;4T6^
M\;ZI9:KX^MKKPEH_P\\2?#WQ#<_$23QOXFTJ'3?%&EV_B_Q)9>-8?$>B:5VX
MG#4*%6G35"AR1Q,X.I3C2_<PCAYJ%*M4C4E4=6I4C*2=6-.3Y6FKODAS4*]6
MK"<G5J\[HQDH3=3]Y-U:?-4I0E3C!0A"48M4Y3C>2=_M2Q?VN?VU/V__ (T_
M\%"O'_\ P3A_8@^)7[/G[,OB+X8^'_"WC&T^)?Q3O+*_\4_%O4#\-O"GQ!\3
M^"= _P"$G^%OQ@\-V]RWASXJV.O67@+2/A7J/BXZ/\&?&'C^3XIZ=X;N]3\&
M67RG_P %ZS^W2/V./@*/VJ5_9-;P3_PM6R/BQOV?G^,*>*1\=/[!_:J_L!/#
MJ?$:-])/PG'[/W_".#6)-2D'C _&/^VVLHE\%?8%KVK_ (*]?&?]B;7?C/K?
MP:_:L_8&_:2^(7[0C:-K'PA_8P^*WPQNKSP1I?QTO?&?P\^&_B32-(\->,+C
M5=%3QGJG@;XR_$K_ (0Z'PW#\)/VJ-&^'&MWESK.F^%-7USXF^+/AA=>+?M3
M?LA_M?>-/^"#?[%GPB'P9^+GBKXM_#'XN67BKQ3\.!9WWBOXG>"OA)JFG_M&
M^$OAG;?\(1%?:CXQ6R\*>&?B/\)_#L'PVT;2[CQ'\*O"KPZ1K_A/PAH7@'Q/
M!X6QP:I4I937]G0PZ]MAZ<HU84N:K*I2FYXFGB%5<ITW)1]I"I""P]2<(1;O
M)+3$.I-8^DYU:K]G5G%TY5.6G&%2FE1E2Y%&,TF^64)2]M",Y-;']*_[-)_:
MP/@;6/\ AL1/V>$^)?\ PEU]_8 _9ID^),O@8^ _[%T#^S3K#?%&*+7QXN_X
M2+_A*1?+9*=&_L4: ;=OMQU$#G/BA^P]^R/\;_B\OQT^-/P ^'7Q?^(Z?#+3
M_@_'>_%'2&^('AB'P#I7BK6/&NFZ=!\./%L^K_#>#6;+Q%X@URYMO&47A)/&
MD5EJVH:(OB$:'=2Z:V?^Q/\ MF?#W]N_X*_\+Z^%7@OXI^#O 5SXOU_PCH4_
MQ4\/Z!H=UXM/AJ/3H]4\3>$9_"_BOQGH7B#PE#K5WJ/A0ZS8ZVYA\6^%_%F@
M7=K;7VAW*'\PO^"W_P 1_P!IOQ?X4\'_ +'GP ^"G[6NK^#/B?\ V!XE_:/^
M,WP%^#^M_$G0KCX,:IJ7BCPKK?P3TV#1X+$^)/$6LM8-XO\ 'O@^7XA?"F#5
M_"6F^%?A[K_B'6O ?QC\:VNC^+1H5ZV.]@G'"U92E&HXR]G"E&S]KI&6J4;_
M +N+;F_<2;=CTJE6C3PJJ24J]-*+A=<\JDKKD>JM?FL^=I*/Q-I*YXE_P31T
M3X/^+O\ @LM^WC\4?V2=%^&C_LI^"O@5X4^&V@ZO\']-\*>%/AMH7B'Q*GP+
MM8M,\'>&-&AT5-4\/^,?%WP0^->N6'C/P?HFH>"/$!\/3^(;?Q#=V?BKPQJ&
MO_TR5^-7_!.KXP_![X3V'PT_9 ^"/_!/C_@H;\!?"NIS:]?ZQ\7?C]^SCIW@
M_P ,:QXNL/"%]K>M>/\ XT_$BS\87;3^+/&:>%K'PSIMY'H4>EP7\W@WP#X7
MTCPSX,TSP[HNA_LK59I.<\2E*$XQIT*-&E[1QE4G2HP5*-2HXN2YZC@YR2=H
MWY5=)-K QC&@[2C*4ZM2I4Y$U"%2K+VDH0347RPYE%-J\K<SLVTBBBBO..P*
M*** "BBB@#^3SQGJG[(7A_\ X+N?M]>)_P!MO3O@KJGP8\+_ ++VB^(;>S^.
M?A/PUXZT*;QEH_PN_8YU"QA\&>#?$.D>(+OQ5\3)O"EMXRB\+^&_!>AZQX^U
MZS;7-*\,Z5J,MU<V<W _\$W=?_:%TWXT?\%5OVC/^":WP4TKXA? S4]2O_"_
MP;^#?BF\T#P%X=^(/Q0U[XV1W_PC\1^%_$FO?#KX*:!X?^'7P-^#GBCXM?$W
M6/V>G\7?#GQAX4\"?$;X2_";7-1\1^*]4T/XKZ?]O^$_V1&^*/\ P78_;&\;
M?'K]F!OB+^SOKG[._AYO!GB_XN_!0^+O@MK'CW3?!_['VBP-X8\0>,O#.H>!
MM0\86%IIWC[283I5W+K5M;6'C"QCV16NM11_>7_!03X.>._ O_!.+XS?#']@
MKP1K/PL\8^%[7PEXD^&W@O\ 9;B3X1Z]I%EIGQL\)_$?XGI\/-,^',_A2Y34
M]=\.Q>.]2U?PSX25O$'Q$N-5UGP]I^D>)M?\5+H^K?2UL52MA\)%\T\7@LIP
M]25:K_L=&$5AJCE*G"TN=2@E.7/%P@Y\MF[KQ:="=ZV(?NQP^*S"M"-*#^LU
M)/VL$HS>G*U*\8\K4Y*%[I'Y<_'G]I?_ (*^?\$UO$'AK]IG]M#XW?LW_&7]
MFKXA?&_2/AUK7P6^%/@\:OJW@GP[XFO=;^)NOO\ "LS_  M^ /B8:[X7^&7P
M\\8^#OAY>_%'XW^/].%]JVE3>/-/\8:AN\3Z=PW_  6C/[57_#PC_@G'Y,?[
M/IT ?M"Z1_PQ>99?B,-7;QI_PG/[(7_"3C]J )"UE'X7'Q>_X1[^P3\*6DU4
M_#<:S_:"CQ.;''XZ?%WX+_#CXP_LR_"KP#^QA_P3<_;$_P"&D_A=<#X;?MD_
M&6S\)?&WQAX3'QJ^'?POM=&^)WPMT;X=Z#XH^*?A?PQJ6N?$+7Y/&6LVWB31
M?A#XQ\ P:#X5\/6G@JYM_'>IVOAG^B?_ (+@>$/B+HOQ?_X)N_M7Z1\+OB#\
M0?@U^R%\8_%OQ5^/&L?#G1;7Q+JG@KPGX:\:?L^_%F;4=2TAM3L)]/TBZ\)?
M!GQ_-+XQUB32_ 'AV]TNQL_&7BWPW-K_ (>75>F,*6'Q>!E&%!5JL,RHS3HT
M:"ERT+8=NE3KUH1=24G",Y3C*K">L=4WBYU*V'Q2E*K[.%3!5(VJ5:K2=5.M
M:I.E3E)04>=QC%QISC=/1HV/^"H7C?\ :1^&O[*'[!?Q'^./@;X??$K]I#X?
M_P#!17X)^-M4^&O[- ^(=SX.^(&L^%%^-^N^!/!'PY7Q-H/B#XB3:WXL\/V'
MAC0KF/\ X1K7=1;QEJ&HIH.BZM:_V;9W'C>B_MB_\%8/V//VG/V2?"'[<6J?
M 'XG>%O^"@7Q?T;PYH?P@\,1V6D>*OV:-,U+Q7X(\,^(?#FA^*_!G@O2-'EF
M\ :O\>?!:7MEXG\5_M+KXPTSX:S>'='^*VD7NOW7Q/U;Z\_:1^(.K_MO? G_
M ()>?M _!GX/_&N+PGX@_P""BO[+WQ@N-!\2^ 9_^$Q\+?"7P_JOQ+L)?BCX
MNT[PE?>+M*T;X<ZEIHTOQ;H_CC^W+GPO?>#O$OACQ!_:L5MK5LM><?\ !63X
M/?%SXC?MS?\ !'3Q=\/?A;\1O'GA3X8_M!^(-:^)7B?P9X(\3>*/#WP]T>;X
MU_L=ZK#JWCC6M$TR^TWPGIDNE^&/$NI17^O7.GVLEAX>UR\64V^DW\EOQTIT
MG##8;$4,-[_]IJMS)*5"454E"-)J5J/+42:Y=9I*+<H:/HJ1FI5J]*K6]UX'
MV=G[M6,G",Y3]V]2].7O7=E=R24M1?VN?VV/VWOC)^VKXT_X)L_\$[].\"_"
MWXB_#CP#8^-_BW^T3\71H=TGAVWN-*^&/C^QOOA[I-_IOQ!T=?"ZZ;XZ\)?#
M/7[_ %OX4?$SQ3KWBGXD7\>D>#?AWH'P]?XLZQM_L:_MA_MG_"?]L;2?^"<_
M_!1W5?A3XV^)7C/X47?Q(^!OQV^&UM<QWGQ4O;>[\7>*-5T+7],\*^#/"WA2
MVL[?PKX>\?:3H^LZK\.O@0VAR? R_P!/OM/^)FI_$SPIXLN_EW]ICQ5\0?\
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M7C;_ (++_&CP?)^TE?\ QO\ V"OBM\&/V@? /BKX@?"WP=JP\9_;?@OXKOO
M?Q#N?A_\,87^%OPM\(W%E8>#OC5?^"_A_P#'O2/'WQ#^-7CCPYX<\ ^*]$T'
MQ2WQ!M=1U+7>X^ [^./V>/@!_P %./%7C[]E3XJ_&G1_&G_!3+X]ZDOP-M/A
MGKFL^)OC-\"?C%XX^#_@#Q)XK\$^!]4\,ZG!\4/"9\#:WXL\3VEI]B_X0KQO
MIWAO4]&U3Q5X=T*;5?$VC?E[_P $T])_9^^,'_!27X"?'?\ X)F?LQ?M+?!W
M]E3P%\-?BUX$_:(^(GCKQ_J&O>!?$FMW/@S7;FP\&:AJMUX\^)\>KWD'B+Q+
M\$O$5UX,O/C1XPU3Q%?Q^$?'=I\&/ UK\*M6^)7BW*5*C*GCW"E2C[-RJ+$S
MA3JTG&&$IS6'3E5C.A4E4_@U*<9^VJ5/927+%VT52K&>$YJE1J=HNC!SIS3G
MB)1]M[L'&K!0M[2$I0]G"+J)WEKT?_!(YOVW_P#ANW_@HM_P@D7[*GFG]J_P
MK_PVQ_PEL_Q=\M%_X7W^TG_PEW_#+/\ 8UOND83_ /"USX<_X6UY0,/_  KQ
M=3P__"2-7]4GQ)^'G@_XN_#KQ]\)_B'I!U_P!\3_  7XI^'GCG05U'5=';6_
M!_C70[[PWXFT@:MH5]IFN:6=2T74[VS&HZ-J6G:K9&;[3IU]:7<4-Q'_ #5_
ML7?$[Q)^P?\ \%0?VUOA+\=O@#^T#'X@_P""AW[7%T_[-VL>$?!&BZ]X.\1>
M%-(^*7QN^(>M_$&3Q'-XMTR'6/!OA;X??';P9XV\?W?@6W\9ZI\,=#M?$L7Q
M'TGPKK7A^_TB/^C[XS>.-=^&/P>^*_Q*\+>!=:^*/B;X>_#7QUXX\._#/PVF
MI2>(OB)KOA/POJFO:1X%T&/1M$\3:P^M>+M0T^WT#2TTKPWX@U)K[4(!8Z)J
MUT8K"XX\V<JF+I3C"E&-2AA71G3Y8J?^ST8MN2E;W*BE33DUR<O*_A9TY>E#
M#SBY5'*%6NJD)\S</WM1I*+5_>C:>E^;FNMT?Q@?\%+?VKO^"8WACX6_&W]C
M3]F/]@S2O 7Q[^$WQ$M/@GJOQTO?A=\%+7Q1H^B? ;X@QV7BS7O"WQ+\/>(?
MB3\>/B5KOC2;X>P>#;J7QZ?"7B/Q+X<\:Z]XK\9^)9=?L+KPIXE_K[_8Z\*+
MX"_9%_98\#+XE\&>,U\&?LX_ _PFOC#X<:V/$WP\\5KX=^&7AC1QXE\!^)!:
M:>/$'@S719_VIX7UP6%D-6T.ZL;\6EM]H\E/PD_::_X*X>%OVJ/@/^T!^Q;I
M7_!/S]KWQ'^UEX@^!4/_  FGP$UKX1:9XI'PEUSQ+I?A*Z@^(&H:-9/KWQ=.
MG_"_5O%OA;X@?#3Q1J_P%\*7OB77X/AS=I%\/KKQ-I^LZ)^LW_!+/]G?XD_L
MI_L&_ 7X&_%_3=$T7XC^&(/B-K_BC0] U>WUZST&Z^)7Q<\??%&TT&\U>RAC
MTN^\0Z)IOC.RTKQ9+H=QJ_AT>*;36(_#OB/Q1H::?XCU3;,+K+\/"I&=&K'%
MU)NE6Q$<54K^THPY\3&:LX4TX1@HJ+C-SYE.33MEA+/&59P<:D)8>$5.G1=&
M%+DJ2Y:+B[\TVI.7,VI14>5QBFC] Z***\$]4**** "BBB@ HHHH *YGPE_R
M"KK_ +&;QK_ZF6O5TU<SX2_Y!5U_V,WC7_U,M>I]'ZK\F2_CC_AE^<"#P5_R
M![S_ +&WQ]_ZG?B.NMKDO!7_ "![S_L;?'W_ *G?B.NMH>[]7^80^"/^&/Y(
M****104444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'YG_ +3G_!*S
M]GS]I7X]>&/VG[7QO\<_V<?C[X?TV\TS4_BE^R_XU\._#+Q=XW630XO"FF:E
MXNU?4O!/BV[D\1:#X,.I>!K+Q1X>D\.^(]5\":K_ ,(7XLU3Q'X8\.^"=+\+
M['[&O_!+[]F_]B?Q[X]^+_@/5OB[\2OC7\2I?&:>+_C!\9_B WB;QCJ^E?$#
M7?"?B[Q7I.HV/AC2?!7@C6)]7\;>$;7QE>>,M>\(:M\2;O7=6U];SQM<Z1J(
MTJ#]&**Z?KF*='V'MZOL>7DY.9VY.;F5/NX*6J@WRIZI&/U>@JGM?90]I?FY
MN77F:LY=E)K1RMS6TN%%?@S\8O\ @X;_ &-O@E\5_B=\'O%?PE_:BOO%'PJ^
M(WCOX8ZU=Z'X:^!SZ-J^N_#_ ,5:KX0U:]\.S:U\?]$U&ZT>^U+2+B?29]2T
MO2;^6RFMGOM.T^Z:6TA_77]GK]I/X'?M6?#J+XK?L_?$+2OB/X%?6M6\-W&J
M:?::QI%_I7B'0Y8UU'0_$/AOQ)IVB^*/#6K);7.GZO:Z?X@T;3+K4?#NL:#X
MGTV*[\.Z_HNIW[K8+%X>G&K6P]:G2G;EJ2A)0?,N:*YK63E'6*;3:NU=)BIX
MG#U9RITJU.<XWYHQDG)6=GINTGHVM$]&>XT445RFX4444 %%?G1_P3&_;YN/
M^"B_P!\3?'"X^$</P9?P[\4]3^&H\+0_$%_B2EX-.\!_#SQJ=;.NOX&^'YMC
M,_CQM+_LS^Q9Q&NDK?\ ]H.=0-E8_HO6E:E4H59T:L>2I3ERSC=.S[7BW%_)
MM$4ZD*L(U*;YH35XRLU==[-)_>@HHHK,L**** "BBB@ HHHH **** "BBB@
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M271!3I0HQY:<;*[D[N4I2D]Y2E)N4I/K*3;?<****R- HHHH **** "BBB@
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M5>,%&+LM-%8HHHKE-PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7PZHPG.=.$I<JE)<W+%U(Q=W*,IW_2^BBBO!/5"BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 <7H?_ ".'CC_N6?\ TURU
MVE<7H?\ R.'CC_N6?_37+7:54MU_AA_Z1$F.S_Q3_P#2Y!1114E!1110!B^)
M/^1=U_\ [ NJ?^D,]'AO_D7= _[ NE_^D,%'B3_D7=?_ .P+JG_I#/1X;_Y%
MW0/^P+I?_I#!5?8_[>_0G[?_ &[^IM4445)04444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *YGPE_R"KK_L9O&O_J9:]735S/A+_D%77_8S>-?_ %,M>I]'ZK\F2_CC
M_AE^<"#P5_R![S_L;?'W_J=^(ZZVN2\%?\@>\_[&WQ]_ZG?B.NMH>[]7^80^
M"/\ AC^2"BBBD4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 <7H?\ R.'CC_N6?_37+7:5Q>A_\CAXX_[EG_TURUVE
M5+=?X8?^D1)CL_\ %/\ ]+D%%%%24%%%% &+XD_Y%W7_ /L"ZI_Z0ST>&_\
MD7= _P"P+I?_ *0P4>)/^1=U_P#[ NJ?^D,]'AO_ )%W0/\ L"Z7_P"D,%5]
MC_M[]"?M_P#;OZFU1114E!1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH XO0_P#D</''_<L_
M^FN6NTKB]#_Y'#QQ_P!RS_Z:Y:[2JENO\,/_ $B),=G_ (I_^ER"BBBI*"BB
MB@#%\2?\B[K_ /V!=4_](9Z/#?\ R+N@?]@72_\ TA@H\2?\B[K_ /V!=4_]
M(9Z/#?\ R+N@?]@72_\ TA@JOL?]O?H3]O\ [=_4VJ***DH**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M .$IUS_HF_C3_P #OAW_ /-[1_PE.N?]$W\:?^!WP[_^;VNTHHNOY5_Y-_\
M)?U?TL<K_GE]T?\ Y$XO_A*=<_Z)OXT_\#OAW_\ -[1_PE.N?]$W\:?^!WP[
M_P#F]KM**+K^5?\ DW_R7]7]+'*_YY?='_Y$XO\ X2G7/^B;^-/_  .^'?\
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MOAW_ /-[1_PE.N?]$W\:?^!WP[_^;VNTHHNOY5_Y-_\ )?U?TL<K_GE]T?\
MY$XO_A*=<_Z)OXT_\#OAW_\ -[1_PE.N?]$W\:?^!WP[_P#F]KM**+K^5?\
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MOAW_ /-[1_PE.N?]$W\:?^!WP[_^;VNTHHNOY5_Y-_\ )?U?TL<K_GE]T?\
MY$XO_A*=<_Z)OXT_\#OAW_\ -[1_PE.N?]$W\:?^!WP[_P#F]KM**+K^5?\
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M7]+'*_YY?='_ .1.+_X2G7/^B;^-/_ [X=__ #>T?\)3KG_1-_&G_@=\._\
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MI_X'?#O_ .;VNTHHNOY5_P"3?_)?U?TL<K_GE]T?_D3B_P#A*=<_Z)OXT_\
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MP[_^;VNTHHNOY5_Y-_\ )?U?TL<K_GE]T?\ Y$XO_A*=<_Z)OXT_\#OAW_\
M-[1_PE.N?]$W\:?^!WP[_P#F]KM**+K^5?\ DW_R7]7]+'*_YY?='_Y$XO\
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#?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>gb2k1ptlkg5v000008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gb2k1ptlkg5v000008.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" .Y!YX# 2(  A$! Q$!_\0
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MM%+(C?RC?\-:?M5?]',_M!?^'F^(W_S25_4U_P %.O\ DQ?X\_\ 8/\  _\
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M@O\ P\WQ&_\ FDKY]HH_U:X=_P"A!DO_ (:L#_\ */)?<'^M7%'_ $4F?_\
MAXS#_P":/)?<?07_  UI^U5_T<S^T%_X>;XC?_-)1_PUI^U5_P!',_M!?^'F
M^(W_ ,TE?/M%'^K7#O\ T(,E_P##5@?_ )1Y+[@_UJXH_P"BDS__ ,/&8?\
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M^U5_T<S^T%_X>;XC?_-)1_PUI^U5_P!',_M!?^'F^(W_ ,TE?/M%'^K7#O\
MT(,E_P##5@?_ )1Y+[@_UJXH_P"BDS__ ,/&8?\ S1Y+[CZ"_P"&M/VJO^CF
M?V@O_#S?$;_YI*/^&M/VJO\ HYG]H+_P\WQ&_P#FDKY]HH_U:X=_Z$&2_P#A
MJP/_ ,H\E]P?ZU<4?]%)G_\ X>,P_P#FCR7W'T%_PUI^U5_T<S^T%_X>;XC?
M_-)1_P -:?M5?]',_M!?^'F^(W_S25\^T4?ZM<._]"#)?_#5@?\ Y1Y+[@_U
MJXH_Z*3/_P#P\9A_\T>2^X^@O^&M/VJO^CF?V@O_  \WQ&_^:2C_ (:T_:J_
MZ.9_:"_\/-\1O_FDKY]HH_U:X=_Z$&2_^&K _P#RCR7W!_K5Q1_T4F?_ /AX
MS#_YH\E]Q]!?\-:?M5?]',_M!?\ AYOB-_\ -)1_PUI^U5_T<S^T%_X>;XC?
M_-)7S[11_JUP[_T(,E_\-6!_^4>2^X/]:N*/^BDS_P#\/&8?_-'DON/H+_AK
M3]JK_HYG]H+_ ,/-\1O_ )I*/^&M/VJO^CF?V@O_  \WQ&_^:2OGVBC_ %:X
M=_Z$&2_^&K __*/)?<'^M7%'_129_P#^'C,/_FCR7W'T%_PUI^U5_P!',_M!
M?^'F^(W_ ,TE?7/A7]I#]HBX_8C^+_BRX^/7QHG\4Z9^T#\)-&TWQ+-\4?'$
MNOZ?H^I>#_B#=:CI-CK+ZZVHVFFW]S96=Q>V,%S':W4]I;2SQ2201,GYB5]I
M^$/^3!/C9_V<G\%__4(^)=?+<6</9!3P>4NGD>3TW+BCA>G)PRS!1<J=3/,#
M"<&XT%>$X-QG%^[*+Y6FM#Z[@SB;B2KC<Y53B#.ZBAPAQ=5@IYKCYJ-2GP_C
MITZD5*N^6=.<8RA-6E"45*+329Y=_P -:?M5?]',_M!?^'F^(W_S24?\-:?M
M5?\ 1S/[07_AYOB-_P#-)7S[17U/^K7#O_0@R7_PU8'_ .4>2^X^1_UJXH_Z
M*3/_ /P\9A_\T>2^X^@O^&M/VJO^CF?V@O\ P\WQ&_\ FDH_X:T_:J_Z.9_:
M"_\ #S?$;_YI*^?:*/\ 5KAW_H09+_X:L#_\H\E]P?ZU<4?]%)G_ /X>,P_^
M:/)?<?07_#6G[57_ $<S^T%_X>;XC?\ S24?\-:?M5?]',_M!?\ AYOB-_\
M-)7S[11_JUP[_P!"#)?_  U8'_Y1Y+[@_P!:N*/^BDS_ /\ #QF'_P T>2^X
M^@O^&M/VJO\ HYG]H+_P\WQ&_P#FDH_X:T_:J_Z.9_:"_P##S?$;_P":2OGV
MBC_5KAW_ *$&2_\ AJP/_P H\E]P?ZU<4?\ 129__P"'C,/_ )H\E]Q]!?\
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MJK_HYG]H+_P\WQ&_^:2OGVBC_5KAW_H09+_X:L#_ /*/)?<'^M7%'_129_\
M^'C,/_FCR7W'T%_PUI^U5_T<S^T%_P"'F^(W_P TE'_#6G[57_1S/[07_AYO
MB-_\TE?/M%'^K7#O_0@R7_PU8'_Y1Y+[@_UJXH_Z*3/_ /P\9A_\T>2^X^@O
M^&M/VJO^CF?V@O\ P\WQ&_\ FDH_X:T_:J_Z.9_:"_\ #S?$;_YI*^?:*/\
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M_P!',_M!?^'F^(W_ ,TE'_#6G[57_1S/[07_ (>;XC?_ #25\^T4?ZM<._\
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M'_#6G[57_1S/[07_ (>;XC?_ #25\^T4?ZM<._\ 0@R7_P -6!_^4>2^X/\
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M4>2^X/\ 6KBC_HI,_P#_  \9A_\ -'DON/H+_AK3]JK_ *.9_:"_\/-\1O\
MYI*/^&M/VJO^CF?V@O\ P\WQ&_\ FDKY]HH_U:X=_P"A!DO_ (:L#_\ */)?
M<'^M7%'_ $4F?_\ AXS#_P":/)?<?07_  UI^U5_T<S^T%_X>;XC?_-)1_PU
MI^U5_P!',_M!?^'F^(W_ ,TE?/M%'^K7#O\ T(,E_P##5@?_ )1Y+[@_UJXH
M_P"BDS__ ,/&8?\ S1Y+[CZ"_P"&M/VJO^CF?V@O_#S?$;_YI*/^&M/VJO\
MHYG]H+_P\WQ&_P#FDKY]HH_U:X=_Z$&2_P#AJP/_ ,H\E]P?ZU<4?]%)G_\
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M  \9A_\ -'DON/H+_AK3]JK_ *.9_:"_\/-\1O\ YI*/^&M/VJO^CF?V@O\
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M/-\1O_FDH_X:T_:J_P"CF?V@O_#S?$;_ .:2OGVBC_5KAW_H09+_ .&K _\
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M!?\ AYOB-_\ -)7S[11_JUP[_P!"#)?_  U8'_Y1Y+[@_P!:N*/^BDS_ /\
M#QF'_P T>2^X^@O^&M/VJO\ HYG]H+_P\WQ&_P#FDH_X:T_:J_Z.9_:"_P##
MS?$;_P":2OGVBC_5KAW_ *$&2_\ AJP/_P H\E]P?ZU<4?\ 129__P"'C,/_
M )H\E]Q]!?\ #6G[57_1S/[07_AYOB-_\TE'_#6G[57_ $<S^T%_X>;XC?\
MS25\^T4?ZM<._P#0@R7_ ,-6!_\ E'DON#_6KBC_ **3/_\ P\9A_P#-'DON
M/JWP)^U9^U%>>./!MI=_M)?'RZM;KQ7X=M[FVN/C#\0Y[>XMY]7LXIH)X9?$
M31S0S1LT<L4BLDB,R.I4D5_;'7\$'P[_ .2@>!?^QQ\,_P#I[L:_O?K^+OI8
MY=E^7XS@=9?@,%@55PV?NJL'A:&&51PJY0H.HJ-."FX*4E'FORJ3M:[/[O\
MH9YIF>9X#Q >99CCLP='%\-JB\=B\1BW24Z.=<ZINO4J."GRQYE&W-RQO>R"
MBBBOY"/[:"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#X+_X*=?\ )B_QY_[!_@?_
M -6?X)K^..O['/\ @IU_R8O\>?\ L'^!_P#U9_@FOXXZ_P!!OHF_\F^SS_LL
ML=_ZI,@/\TOIF_\ )RN'O^R&P'_J_P"(PHHHK^HC^1 HHHH **** "BBB@ H
MHHH **^ZO^"?W[)WAG]KWXO^(_ ?B_Q/KOA;0?#?@#4O&,USX;BT]]7OKJ#7
M?#VAVEA%+JEM>6=I;YUN2\N)WM+J1A:):Q1(;EKJV_3C4_\ @D?^R+/XCG^'
MNA_M4:U8_$J)_+;PEJ?B+X9:SXC@DDLA=Q1S^#K.#1-?WF*>TOMI>)I+)@5"
MK<17,?X[Q9XZ>'_!F?8SAS.L7F4<TR^.&>+IX7+*]>E2>+PM#&T(JM>$)R>&
MQ-&I+V?-&//R.7M(SC']QX-^CSXD\=\.X#BG(<'E4LHS*6+C@ZF+S:AAJU58
M+&5\!B)NA:<Z<8XK#8BG%5.2<E3<U'V<Z<I_SNT5]S_MF?L&?$S]CB_T6^UK
M6M.\>_#OQ-='3?#_ (_TC3;G15;68;/[7<:)XA\/W%YJA\/:M-'#>WFEV\.M
M:W9ZEIEI-<V^I-=6NIV&G_#%?HG#7$V2<7Y/A<]X>QT,PRS%^TC3K1A4I3A4
MI3=.M0KT*T*=:A7I334Z=6G&5G&I'FI3ISE^8<5<*9_P3GF+X=XER^IEN:X+
MV<JM"<Z5:$Z5:"JT*^'Q%"=2AB*%:G)2A5HU)QNI4Y\M6G4IP****]X^="BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OM/PA_R8)\;/\
MLY/X+_\ J$?$NOBROM/PA_R8)\;/^SD_@O\ ^H1\2Z^4XO\ ]SRC_LJ^%/\
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M3D/B?_V1'4__ %// E?4'[7G_!5SXK? +XX_$OX->#/AE\/=1'@K4-)LM/\
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M,)FKSBEEV*QN%IX6$57J_O\ '2PDXUYXR?UB.$KKV>-I<]3@HX_*/$.MX\\
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MVC6E5C1P^+^MK XG NC3IXB>(_D8HHHK_1,_S""BBB@ HHHH **** "BBB@
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M9')@HHHKZL^."BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K[3_:I_P"24_L2?]FV3?\
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M@ HHHH **** .Q^'?_)0/ O_ &./AG_T]V-?WOU_!!\._P#DH'@7_L<?#/\
MZ>[&O[WZ_B'Z7O\ OO ?_8+Q#_Z=R<_T ^A+_P B_P 1/^PSAG_TSG84445_
M&I_= 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 ?!?_!3K_DQ?X\_]@_P/_ZL_P $
MU_''7]CG_!3K_DQ?X\_]@_P/_P"K/\$U_''7^@WT3?\ DWV>?]EECO\ U29
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MY9A*-.M%5Z>6U<%5JRBE0SY1C/$1J4*C_-VBBBOZ[/XG"BBB@ HHHH ****
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M2WU2'1K1[R6RBU!O%5^MK//'&R0.UI,IF*(RJK%U;_P1&_Y.0^)__9$=3_\
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M+/[0A@O[4E3IXVE0RF%.K*51Y3FF I>SPZ^KRE_+E1117]UG^>!_1?\  /\
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MI["CS5S^?7XW?##4_@M\7OB/\*=6::6[\!^+];\.QW<T0A?4]-LKR0:-K2Q
MGRX=<T=K'5[=3@BWO8MRJV5'EM?M)_P6H^##>%OC9X&^-6F67EZ3\5O"QT+Q
M!/;V5VRCQKX!^S62WFJ:EE[&&;5_!^H^&]/T>P86]Q/#X0U>YB^U)#<FT_%N
MOW'PPXLCQKP)PYQ ZD9XO$8"&'S-)KFAFN ;P>8\T.><J<:V)HSQ-"%23J/"
MUZ%1MJ:D_P"??%O@V? 7B)Q1PTJ<J>"PN8U,5E+:?+/)LQ2QV6<L^2G"K*AA
M:]/"8B=**IK%X?$4HI.G*,2BBBOO3\X"BBB@ HHHH ^T_P!O;_DNND?]D._9
MZ_\ 5,^#*^+*^T_V]O\ DNND?]D._9Z_]4SX,KXLKY3@7_DB^%?^Q!E7_J'2
M/LO$3_DN^+_^RBS;_P!3*H4445]6?&A1110 4444 %%%% !1110!T7A#PMJ_
MCGQ=X5\$>'HHKCQ!XS\2Z#X1T"WFF6WBN=<\2ZM::)I%L\[_ "1"YU&^MH-[
M9"F0'!Z'^I;4_P#@D/\ LB2^!]2\+Z-I/B"'Q_'X1-E8^-;SQIXAFO8/$,VG
M7%GIOBS4O#T.H#1#%<:O:RWL^GPZ5%ILPAN[.TAB2+$7Y/?\$@O@L_Q(_:DC
M^(%_;32>'?@EX=OO%4DGEVDUC<>+=?AN?#7A/3+U)U>='6&[\0>*-.N+-8WA
MU'PE;&2X2-O(N?T%^#G[8I\3_P#!5GXN^!9-4,G@7Q3X>E^"7A>(E1;IXB^#
M7]J:W!=&Y+>7-:W>O3?%9-*>(!+L^)M.2%I2RR7'\=^./$O&F9\69MDW!.<Y
MWE%#PYX1?$N?2RC&8[!+%U\9B\NJU:&+E@L1"G7IX3)ZV'S##1Q5.;C".:)4
ME0E5K+^X?H^<*\!Y3P9DV>\?Y%D.=XCQ0XUCPIPY'.L#E^8/!X? X/-*-'$8
M*./PU2KAZF-SRCB<MQ4\)4@I3EE#=5UXTJ#_ )M-8TC4O#^KZIH.LV<VG:QH
MFHWVD:MI]P MQ8ZEIMS+9WUG.%+*)K:ZAE@E 9@'1@"1S7[A?\$U/V&OV</V
M@?V?_%GQ1^,_A_6?$&L6'Q&U[P];O;^*-?T&PTO0=!\->&-4REMH-Y927-S-
M<ZQ?375Q<O<9ABM(;:& Q3O=?)W_  55^##?"7]KKQAK%A9?9O#7Q?L;'XHZ
M.T%E=Q6::KJ[3Z=XUM7U"8O:WVKS^,-+U?Q+?P6KH]C9>)](6>VC2XMI[K]9
M?^"/D$UU^Q9X_MK>-I9[GXK_ !"@@B7[TDTW@;P-''&N<#<[LJC)')KT_&7Q
M"S3,/!;@WC#AG-\?DN)S[/,IABZ^38[$8"M"7]D9\\RR]8C"8A5E2H9I@G2J
M4_;MN>%C&K>49(\KP+\,LIRSQYXZX'XLR3+L_P +P[P]G-3!X?/<OPV8T*D/
M[:X<65YF\+C<,Z#K8C*,PC6IU?J\4H8N4J5HRBSR?P;^QI_P2I_:=O;WPG\"
M?B9XDT[Q;;6@O$L?#?B_7K3798+1FFN+JUT3XK^'M1DUBR"R1QZLVE6LGV6V
M5"ESIL[FZ;\@/VG?V1?B!^S9\=;3X'W$O_"<ZAXF31;SX=:KHFGRV\WC;3O$
M>IW&BZ,L&B_:;Z;3]:EUJTNM'N=&-Y>-%?P VMW>V5S9WES]]?\ !.W]A7]J
M'P/^U-\//BAX_P#AQJ?P\\%^ /\ A)=2UG5?$=_I]G>7\FI^$==\/V&CZ'IE
MG=7FH:C=7M[K,#7CRPV>E6VCP:I)<:E]O&G:5JGWK\3M6\'?%G_@J]^S[X.M
M9;#6)?@3\,/%_B7Q,HG6>*U\5:AIVLW6BZ0\4<;>5JF@&\\-^)LM.H1[FV1@
MDUK)#-\?A./<V\.^.,QP62^(68^*W#-'@K-<\S&OF&92SK#8#-,+@\PJ8"A'
M,*6*QJI0EF%#*,-B*N%KPI1IYS*E6HRQ.'A)?;XSPYR7Q.\/\KS#/O#3+/!S
MBS$<>Y-P]EF'RS*HY#BLRRG&8[+*698B66U<)@)5:D<NQ&=8O"T<9AZE653(
MXU:%>.%Q$XR\"\"?\$R/V4_V</AG9_$W]N'XA0WU_<+!%J&C'Q+J'A7P1INI
MW=HMZGAG1!X<DM_''CCQ+;I9:F_F:-J%O_:%E%=R6GAD1Z<^I2=5X _9=_X)
M'?M5'5_!?P&U2]TWQ?96LER6T'Q7\7-#\61VZ)#))?Z3H?QG6^LM=L[,21B]
MN-/T+4K:T,IBNY8)2FSY/_X+9>-M8U/]H3X<^ GNY_\ A'/"7PJL]=L]/8X@
M7Q!XL\2^(8=8U! '*L;C2_#OAVU!=%=#92@$I("?S*_9R\5:QX(^/WP7\5:#
M=3V>IZ-\3_!%S$]O<3VQG@?Q#I]O?Z=<26[I(]AJNGS76F:E;%C%>:=>75I.
MDD$\D;?09%P?XA\7>'^*\1,=XK\89?G^98/'Y_EN5Y=FF*P?#V'P^$IXN6'P
M=? X2M"E".,EAZ,W/"4J5'!T:DZ<\%CJO-)_.<0\;^&7!?B5@_##+_!O@C,N
M&\KQN6\.9IF^:91@\=Q-B<3C:F"CB<=A\PQE"=6I+!0Q->FH8VM6KXZO3IU:
M>/R^BHP/1/VP?V4O%_[(OQ7E^'OB"];Q%H.J:;%K_@KQK#ID^FV'B;1)II;:
M96A::\M[+7-(O()+36M'CU"\FLA)I]^6.GZQID]S]^?L-?\ !+O1_BUX!L?C
MS^T=KNK^%/AUJ-I)KGA?PEIUU:Z#>ZYX;L\7+^+/%/B"_CF.A>%+ZV@N7LK>
MTAM-1U'2FCU^+6]+T]K*34?LG_@LSX"L?&/@;]G*1?*M]>N_C0O@+3=2E0LM
MG8^.M'=K_P S8#(T7VWP]H]PZ)R1;' +$5W_ /P5O\47_P *_P!BW2_!_@=8
M] T/Q;X\\$_"N[M-.,MH+/P79>'/$WB)-'L&A=&AM)6\%:7I-S!N,5SH\U[8
M3K)!<R(WA/Q9XYXSX3\,>$\JS2>5<3\99IC\ISWB3"PCA\53P.78^C@Z6,PK
MIU*/L:U;"UIXS,)X.KA<3*O@)T\%[&&-5*/OKP9\/N!.,_%GC/.,HIYQPCP-
ME.79QP]PMC)RQ.$JYAFF75L=5P.,52E6]O0H8NC3P66PQM'&82.'S*%3,/;S
MP$JTO 6^!?\ P1?^(FHW/PN\)>-]'\+^,KUCI=CXGT7XF?$JUE&H%TLXFT/Q
M#\0[K7/A?JU_<W,\1L8%M=5M]0FPME:W$(DCK\[?!_[%OPQE_;3^*G[.OQ)^
M,?\ PB/PN^%-AXC\1ZQ\03=>'=%U&[T#2[?1+JUL#JNNFY\.:)K5O!XAMQJM
M_=Z?J=I!<:3J,:Z1B15MOS@KL_AGX%OOB5\0_A_\,]&N;'3-1\?^,_"G@72K
MR^$RZ;I][XJURPT"QN;P6L4TZV-K/?Q2W MH)9A!&XAB=]J']LR_PWXIX9PO
M$=2?B]Q;C<!C^',9A9U\Z5?-\7DN+IUL/7CG.65*V-JU*56CE\,QP[I894:L
MJF(H8E5*E;"8=4_P3,O%/A'BW&<+4:?@GP9@,RR[BC 8NGA\A>'R7!9]@ZM#
M$8>>19M3H8"C2K4<1F4\KQ,:V+E7I0I8;$85TZ='&8J57^A#X3? [_@C5\7/
M%MK\'?A[*?&'Q$N+?6+>RDO/$W[0&AWFLSZ$C_VE<:5J^I3^'O NL7JQ13ZC
M9P:.D\&J:?;W.IZ79WFEVT\\?YD?\%$OV+]/_8_^)'AF+PAK.HZU\-?B3IVK
M:EX2_MQH9-=T74/#\^GP>(O#U_=VT-O;:I;V0UC1[[3=46VLYY+35!I]Y;2W
M.FR:IJGZK_LD_P#!)2_^ _QJ\+?%_P ?_%;2_%8\#37.I^'O#?AG0K_38[S7
M)K*YLK2]U?5+^],J66F"Y>[CT^TM"U_>);?:;R*RAN;._P#SY_X*X_''Q7\3
M_CQX>\#ZMX"\6?#_ ,,?"O0=2@\,6WC;2/[*UCQ3=^)=21=>\:::8+^^L+KP
MGJR^'-'T_P /R6LCS[M&U&74I8+^>;1=%_'_  VXEQ-?QDR7)>$O$?BWCSA&
MMP_B\3GM7BC'9@_9XRC@<>IK!X3.%A:SC#,%E=6D\-A98B%+%5:52IB*&%KX
MH_;O%3A3"X?P,S_/N,_"[@SPZXUH<28+"\/4>$<ORU.K@:^8Y<X/&XW(WC**
ME4RV6;T:RQ>+AAJE;!T:U.GAL1B\/@S\HJ***_M(_@T**** "BBB@ HHHH *
M*** .Q^'?_)0/ O_ &./AG_T]V-?WOU_!!\._P#DH'@7_L<?#/\ Z>[&O[WZ
M_B'Z7O\ OO ?_8+Q#_Z=R<_T ^A+_P B_P 1/^PSAG_TSG84445_&I_= 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 ?!?_!3K_DQ?X\_]@_P/_ZL_P $U_''7]CG
M_!3K_DQ?X\_]@_P/_P"K/\$U_''7^@WT3?\ DWV>?]EECO\ U29 ?YI?3-_Y
M.5P]_P!D-@/_ %?\1A1117]1'\B!1110 4444 %%%?T)_LC?L*_L;^)/V,/"
M?[0_QYT76KJYGT3QOXM\:>)#XJ\8:?8Z3HOASQ3XCTP"UT;PK=1.UM8Z1HL,
MLBQ6E]J-W=O<R(S++;VD'Y[XA^)61>&N"RW&YYA,WQJS7&RP.$P^38;#8G$N
MK"DZLI3CB\;@::A;E@E&K.K*I4@HTI1YY0_3/#+PJXA\5<?FN7\/XW),!+)\
M!',<9B<]Q>+PF%5"=:-&,83P> S"JZEW*HW.C"C&G3FYU8RY(S_GLHK^C'P[
M_P $_P#_ ()P_M5Z/K__  S)\6_$>C^(=%@DD9-#U^]UD:5-/;-9V%YXA\$_
M$/2X/%5_X>^W 7#/I^J: ;ZZ5[.WU^WC/DI^%7QW^#/BS]GSXL^,_A!XU^RR
M:_X.U&*UDO=/=Y-/U73[^RM=5T;6;!I%606NK:1?65_'#,J7-J9VM+N.*[MY
MXD\[@7Q>X6X^S+'9+E^'SO)\ZP%!8JIE'$. IX#&U<)^YYL31C0Q6-HRA!XB
MAS4ZE:GB.6K&K&C*A>JO3\0_!+C#PXRK+L^S+$Y!G>0YEB'@Z6=<,YC5S+ 4
ML9^_<<+7EB,'@*T:E18;$.%6E0JX;FI3HSKQKVI/R.BBBOU,_( HK](OV,/^
M"=>M_MB^ /%GCO3/BEI7@2/PQXLD\)C3+_PK=Z\]_<1Z+IFL?:S=V^MZ8MK"
M5U2*WV"WN7S'))TVH?S=KY[*>*LASS-<_P DRO'_ %K,^&*^%P^>8;ZKC:/U
M&MC8XB6&A[;$8>CA\3[586N^;!U<1&'L_P!Y*#E#F^FSG@[B/A_)^',_S?+O
MJF4\6X?%XKA[%_6\#B/[0H8"6&CBY^PPN*K8G">R>,PRY<=1PTY^T_=QFH5.
M4HHHKZ$^9"BBB@ HHK](OVN?^"=>M_LG_![P=\7-0^*6E>-;;Q9XLT'PF=#L
M_"MWHD^GW&N^%_$7B:.[%]/K>I1W<-O'X=GLW3[+:N[W$4R[0KQU\]FW%>09
M'FN09)FF/^JYGQ/7Q6&R/#?5<;7^O5L$L/+$P]MA\/6P^&]FL50?-C*N'A/V
MG[N4W&?+]-DW!W$?$&3\1Y_E&7?6\IX2H8/%<0XOZW@</_9]#'RQ,<)/V&*Q
M5'$XOVLL'B%RX*CB9T_9WJ1@IT^;\W:*_1[_ ()V^,?V*_!OB#XHWO[8.EZ)
M?"?0_#Z?#VX\3^#_ !'XXT&W$%QK-QXOMSH>@:3KX&M7B)X<?2KRZTEY5@M-
M3L+"\@GU![34/D']H#5?ACK?QL^*.K?!C37TGX67WC36Y_ ]B;.?3HDT(W;K
M!/8Z==2276G:7>R++>Z1IUVEK=V&EW%I:76G:9/#)IUKYN!XNKXSC;.^#I\-
MYYA:649;A<RI\25L+-9%F,<5#!-8?"XIPC%XE5<3B*,(1E452>5YDDXRPLXK
MU<QX*H8'@#(..8<4\/XRMG>:XS*JO"M#%PEQ#E<\)/')XK%X-3E)89TL)AJ]
M2<H4G2IYOE+:G'&4YGC]%%%?9GP@45_1?XO^'O@"T_X(S67B*U\#>#[;Q!_P
MKGP3J_\ ;MOX9T6'6/[6O_BKH0OM3_M..R6]_M&]%W="[O?/^TW(N;CSI7\Z
M3=^;_P"R5^SK^S)^T7\-_$W@GQ%\;G^&O[5&K^*T7X8:;X@M;JW\&7FBZ=96
M*V^F27#6JZ;J]WXMU+5;VSDM[?7;;Q5IMQHVFWVCZ%J.GVVJV?B+\(R7QURW
M'9)Q/GN:</9IE^$X9XE_U?Q,LN^L9]"--PK3CF^/EALOP]3+<OINA-8NI*CB
M(T'*A3I3Q.(Q%*@_Z)SWZ/&:Y?GW"7#^4<391F6,XLX5_P!9<+#-/JW#E256
M-3#PEDF70Q>98JEFF9U5BJ<L'2AB,-+$*&)J5887#8:KB%^>;H\9"R(Z,51P
MKJRDI*BRQ. P!*R1NDB-T=&5U)5@2ROZE_VYOV>_@MXX^(_A;XU?MB_%S3_A
MO\)_#/PBM?!&A>&/#]]>-XI\1_$V]OO%.K>(]2TZ.'2=2O;G3= L[W0Y]*TW
M1='U>_UK4+;S-973M(L18Z__ "\ZO;Z?::MJEII&HMK&E6NHWMOIFKO92::^
MJ:?#<RQV6HOITTL\M@U];+'<M92S326IE,#RR-&7/T?A;XI8/Q+RQXFEE./R
MW&87#TJF8)T,57R>&(JXK&4?J6#SBKA,)3Q>,HX?#X;&8R@J,(T(9A0I4*V-
M=#%5:/R_B]X0X[PHS982MG.79K@<7BJU++6L1@\/GD\+2PF!K_7\=D='&8VK
M@\%7Q.)Q>!P6)=><L1/+,16Q%#+UB,'2K9U%%%?JA^/!1110 4444 %?:?A#
M_DP3XV?]G)_!?_U"/B77Q97VGX0_Y,$^-G_9R?P7_P#4(^)=?*<7_P"YY1_V
M5?"G_J^P)]EP3_OV=_\ 9&\8_P#K.Y@?%E%%%?5GQH4444 %%%% !1110 44
M44 %?U!_\%(_&?C#P-^P3\%=8\$^*_$G@_5YO$GPBL)=4\+:YJGA_49;";X;
M>)YYK*2^TFZM+E[26:VMII;9I3#)+;P2,A>*,K_+Y7TE\4OVN_VB?C3\//#G
MPJ^)GQ&F\3> O"=WHU]H6A'PUX-T@VMUX?T>\T'2)I]5T'P[I>M:D;32]0N[
M?;JFHWJ7$DHO+I9KV*&XC_&O$WPXS3CCBCPRS?"5\JAEO!V>5\RSK#9C+$.K
MC<)4QV08KZO@Z%/!XFAB)5:>58BE5ABZV&IKVM/6I%S4?W3PG\4\I\/N$?%C
M)<9A\YJ9KQQP_A\JR'%97'#*C@,;2R_B/!_6L=B*N.PN)PT:57.,-6HSP=#%
M57[&KI2E&FY^4>*_BE\3?'EI;6'CGXB^._&=C97!O+.R\5^+O$'B*TM+LQ/"
M;JVMM7U"\A@N#"[Q&>)$E,3O'NVL0?Z%?^"R?_)JOP'_ .RD:!_ZKGQ-7\U]
M?2'QD_:Y_:'_ &@/"_AWP9\7?B))XN\,^%+Z+4M!TL^&/!F@I97T&GRZ5#<R
M7/AGP[HU[?21Z?/-;I_:%S=JHFED \V1I#U<6^'F+S?B_P ,L\R2.39=E7!>
M99UC<SPC57"5:\<RAE4:7]GX?"8*KAZE5/ U76^L5<*O>I\LZC<N3DX,\3<'
MDO!/BSP_G\L]S/-^/,JR# 93C4Z6-HX>64U,WE5698G&X^EBJ5%QQ]%8?ZM1
MQC]VJI0II1Y_Z&?$?P8\:_'[_@E!\-/AK\.X+&\\9:A\'/@_K&BZ7J%['IT>
MLR^&3H'B"XT>VO9\6D&I:C9Z=<6^EM?2VNGO?M;QW]]I]F\U];^;?\$E_P!F
M'XL_L^6WQL^(OQL\/77PXM=>L_#^B:/I7B&\M[.Z:P\-2ZYJ7B+Q#JUL+AK;
M3]+MC<V,.EW]Y(&N(EUBY06^GK!<ZA^(L7[:_P"U%;^%?A=X*LOBUJNF^'?@
MOJFCZQ\-+72=$\)Z3>>&[[0=#U;PSIV=:TW0+76]9L_^$>UW6-%O],\0:CJN
MF:QIFI7=GJ]I?0RE*[7XK_\ !1+]KGXS>"KGX>^,_BDZ>%=4TT:7XCL?#?AW
MPWX6N/%%NQD%RNN:EH>E66HO;:A#*UIJ>D:?=:?H&HVF;:\TF:)Y%?\ &JW@
MYXL0R3/N \/C^"O]4N,^)Z_$&;9CSYK6S;*N7'8#%0C2C.AA*5?VU++,"X4(
M4*O-B85J-3%X/#S6*E^Z4/'+P:GGW#?B)B<NX]?&G G".&X:R;+.3)Z&39S?
M+LQP4YUI4\1C:V']C5S;,.?$5,12Y,+.C7IX+&XF'U./ZQ?\$HO&6G?$7]I'
M]N_X@Z1O_LGQUXUL_&6E^9')%)_9WB?QY\3-;LM\4JK+$_V:^BW1RJLB'*NH
M8$5^$_[1G_)PGQW_ .RR_$__ -3?7*U?@7^TY\<?V:[OQ'??!3QN?!=SXMM]
M-M?$,G_"-^$?$0U"#2)+R;3D,7BS0==BM3;2:A>,)+)+>203%9GD54"^-Z_K
MNK>*-=UKQ+KUX^HZYXBU;4==UG4)$BCDOM6U>\FU#4;R2.WCA@C>ZO+B:=D@
MBBA1G*QQH@51^Q\)>'F8\-^(W%_%,L5@JN1YUDG#>49515:O4S6G_8>4Y9EU
M2>84W@J&$A[26!G*$L/B*O.I1E*E1;<(?AO&?B9E?%/A?P1PA'"8^CG^09]Q
M5G.;UI8?#T\GJ?ZP9SFN:4J>6U5C\1C9^RCCZ<)PQ6&H\DHSC&K6454G_43\
M0M/U7]A;]E+X4:G^QE\!-)^)OB_Q&WAFQ\0>.;7P1K'C76KFWU;PQ>ZS>>./
M$8\*,GB.]76[S=:Z7/<:I!X6\/\ ]HV>B6T4=M<:+I$_4_%3Q;\:O'?_  2_
M^*7B_P#:"\*VW@KXG^(/AOXAU'5O#%OI5WH,FEZ9/XA!\.)?Z'?WVHZCHNJ3
MZ"-/NM1TG4IX]4TZZGDM-3LM.OX;FPMOP3^$?_!1/]K?X*>#;/P!X,^)WG^$
MM(L'T[P_I?B;P[X=\3OX<MS@6\>CZEJ^FW&K1VM@BK#IFDW=]>:'I]NJV]II
M<4"B,<GXA_;E_:L\6^#_ (@^ O$_QAUC7_"GQ1O[G4?&VF:MHGA*^?4IKNTT
MFQEM[#49_#[ZKX;TI;30]-BMM$\,7VC:-9B&9[2P@DO;Y[G\'H?1]X\GBZ=+
M%_ZF5ZV7\6T.(:O&>)QF=OB'B'"^TI26!E25'%T,%2I4U6K8FA.BE+'+"4\-
MB*E&GB<9B?Z+K_26\.J>#J5\'_KWAZ&8\&8CAFEP)A,#D$>&N&L7[*K%YA"L
MZ^"Q./K5JKH4,)B(5Y2A@'C:N*PM*O5PN!PW[2_\$BK.;Q!^Q#\>_#&E&&YU
MS4OB;\1[.UT_[1#%*9M;^$?P^T_2S*TTB);PWEY#/#%<3M'#N@G)D AD*_%/
M_!/#P=\0/V5/VV_AWX?^.W@O5/AS=?%SP;XR\(>&7\3BSM([B^GGCGT\P3"]
M:/S=4UOPS'X>TZ)#+<7UYK.EK:P26^IVMTWY\? K]IKXX?LUZIK6J_!?QW=^
M#IO$EO8VOB&U_LS0]<TK68=-EN)=/-]I'B+3-6TY[FQ:\O5LK^.VBU"SBOKZ
M&UNX8KVY25OQN_:6^-?[1/BG0_&7Q:\:W'B'7_#-A'IOAVYL],T;PY%HMK'>
M/J -A:^&]/TFWCNWOG-U)J#QR:@[I ANO(M+2*#[W&^%7&^)XL\3<-3Q/#U+
M@SQ,POM,?F4YXVKG>7XC X#'PRBAA,)%4L/SQS;%TZN91K>VH8G*:<XX;&X/
M'RC!?G.!\8_#_"\&>$V*JX7B:KQWX48OV67973A@*.09EAL?F.63SNOC<;)U
ML3[.IDV"JT<KE0]AB,+G-2$L7@<;ET74E_0U^V%^T7_P46^#GQGU70?@O\$+
M3XE?"C4['3=3\&:_X>^$_CKX@WT,2Z9IT6NZ;XGNO">KM!I6J6OB%M1%C;WM
MI9&_T<V=W:?:"EZ+;\MOVS_B9^WG\;](^!G@G]H;X7Z?X&M/'?BJ_G^%?A>Q
MT.Q\):OXL\6(-&\/A-6L_$/B74-:T&YT_P#X2VQL;6'7V\,61.O3SWBW/V03
MZ=Y_X0_X*C_MK^#]!B\/1?%E/$5M::>-.T^_\7^%?#'B+7K-455CNY=?O-+_
M +7UO4(]I)O/$UWK<L[2,;LW!";/G'XO_M/?'KX\^)/#GBWXJ?$O7?$NO>#V
M:3PE=P1:9X<A\,W$ES:7DE[H.G^%K#1-.TK4I;FPT^:;4[*TAU&=].T\S74G
MV&U\G@X \)^+>'LTR=9CPAX8X7^P\/BH/BS!5,ZQ.=XW%PRZK1RG'8.A.='#
MQQ,,?[&IFL\;A:,,5AI5WAZ-"NHJIZ/B1XS<%\391GDLLXU\6L9_K!BL'-<&
M8^ED.$R# X*IFE"OG67XW$4Z=;$RPM3+O;TLGA@,97J83%PPZQ5;$8>4W3_<
M?]DG]H?_ (*'^"OB=X)_9Q_: _9^\:^._"1U"T\(ZI\0-:\+:O%JGAW1?)L;
M=O$-]\4+1KSX>^.?#GA[3C)-J=Y-+J&M:_<&2R_X2J]UW9I]U^?W_!6KX5_#
M/X5?M1V=M\--(TKPY#XO^'.A^,O%/AW1(8;72M/\3WNO^*-*GNK33[4)9Z3_
M &MINCZ;?W&FV\,*F[EN-69/^)L&/)V7_!5;]N"RT,Z,/BS8W4H6..'7;WP#
MX"N=<@BCCECV"=_#GV*Y9Q(C27-_87EX\EO$YN,M<>?\)>,O&?BSXA^*-9\:
M^.?$.K>*O%?B&[^VZSK^MWDM]J5_<"..",S3S,2L-M;0P6=E:Q".UL;&WMK*
MSA@M+>&&/U?#WPOXKR?Q#K\9YI@>%^$L*LNQF!S#*N#<5F57+N)L;B*L^7&3
MP.8.I3RO+X)T<51PV'>'JK%X2A.6'BJ^)/&\3/%W@W._#.AP+E&8<7<:XN69
MX#'Y;G''6#RJCFG"> PM&GS8&&898J=7-\SJ-8C!U\7B8XBC+!XW$0CB9_5\
M(<S1117])'\KA1110 4444 %%%% !1110!]I_$+_ ),1_9N_[+C^T#_Z9_AC
M7Q97VG\0O^3$?V;O^RX_M _^F?X8U\65\IP?_P B_-/^RKXP_P#6FS0^QXW_
M .1GE7_9'<#_ /K(Y,%%%%?5GQP4444 %%%% !1110!_0Y_P0M_Y O[2W_84
M^%'_ *2?$*OE']H'_@J'^V'I'Q,^*G@#PQXZT#PKH_A?XB>.O"^F7>C^"/#,
M^K_V/HWB/4](LH9;W7+#65%PMG:QAKVV@MKL3;IXYHY-A3Y:_90_;A^+/['D
M'CJV^&>@_#[78?B!-X<GUA?'>D>(M3-I)X937([)M+;P_P"*_##0_:5UZY%Z
M+PWP?[/:&V%J5N/M/RSXP\4:EXW\6^*?&FLK;+K'B_Q'K?BC55LHG@LUU+7]
M3NM6OEM(9)9Y(;875W*((GFF>.+8C2R$%S_.63>#4,7XG\<\4\99%DV;Y'FN
M(H8K((8N5/&N->%6E*<Z^"E'D490@XSIUXU:=2-X3A*,FG_46>^.E3!^$GA[
MPCP-Q#GN2<09-A:^#XDG@H5, IX>=&I&G##8^$O:.4*E3FA5P\J-:E+WX3C*
M*:]-^&?Q U35/VBOAC\2/B/XIU/6K]?BW\/O$7BOQ9XHU:XU'4)K?3/%.BSW
MFH:IJVIW$DTB6EA:8,MS<".WM;=(PT<,2A?WI_X+/?!;XI?$WP[\ O$WP[\#
M^)O'%EX-U;XB:/XBM?"6BZEXBU;3IO&5OX(GT2[FTK2+6\OETR5O">IVEQJ1
M@%G:WTVFV<TJ7&I6<<O\TU?K'\+?^"PW[3'PZ^'UEX(U;0_ 'Q(O]"T:/2?#
MWC+QE;>(V\1-]F#QV,WBZ72?$&G1>*S9VPMK1KA!HNM:BEN;K6-;U'5+FYU&
M7J\3^#N-J?%7 '&OASE66YC7X0P^-RV60U*V"RRE' 8FE]55/#/%5\)A(X>>
M KXO"<E.I1J8'EP]7#4Z]W&AR>$G'/ -7@[Q(X!\4<XS7*\/QMBL#FL.(Z5#
M'YK6EF.%K?6W5Q2PF'QN-EBJ>8X;!8WGJ4J]+,%/$TL54P_*IXC]6/V$O@A\
M1?@1^P7\0M ^)^AR>&/$GBR#XH>/(O#EXP&L:-H^L>!].TO3+;7K9=PT[5[B
M+0WU&?2I'-[IL%[;6>JQ6.KPW^G6?P;_ ,$.?^2I?'3_ +$#PW_ZD4U?+NE_
M\%5_VJ[2#XJP:Y=>!_&B?%87EO=+XIT776@\%:3<Z=?Z5#H7@&PT'Q1H.F:-
MI=C9W[>2-2LM:OKV[A34M;OM5U*XU"[O? OV5?VOOB7^R#XA\5>)/AKHO@?6
M[WQAHUGHFIP>.-,UW4K.&UL;TW\$UBF@^)?#5Q%<^:61VGN;F%HF($ <+(/S
MW#>#WB/B>%O&;#YMALCAGWB+F7"^;X.C@,P?]GQQ6&XDQF>YO2YZZG4PU+#Q
MQCIX>-6I7E-PY(UJUE5G^F8OQO\ "["\7^!6)R;%<05.'/##*N+LDQU;,<MC
M_:4L)B^%<#P]DE?DP[ITL55Q,L$JF)E1IX=4U+G>'HW]C#+_ &S/^3M?VD_^
MRW?$K_U+-4K^D/\ 9/\ B#XXD_X)G^"?%/P%TS1/%7Q-\%?#S6K#1/"^OV=]
MJMGJ/B/P9XBU*#5/#]UIFBZQHVIR:AJ^G6=PV@6T6J6<TT^I:-<NLMO/Y$W\
MK?Q)\>ZU\4OB%XW^)7B.+3X-?\>^*M>\7ZQ;Z3!/;:7;ZCXAU.YU2[M]-M[F
MYO;F&P@FNGAM([F\O+E;=(Q<75S-OF?WS]F/]M3X[?LEW.LCX6ZQI%YX?\02
M+=ZOX(\9Z?>:YX.O-6BM_LUOK0L;'5-%U33M42 107-WHFLZ5+JEM;65MJK7
ML.G:<EI]MQ[X39YQ-X7<!9)@U@I\2\$Y=D'-EF+JIY9FE7 Y/AL!F673Q,72
M<.>I14L/B/:TZ-2$*E&HZ2Q$<5AO@/#CQFX?X3\7O$7B#'?7Z?"O'V9\2<N:
MX.BUFV44<PSO%9EE>9PPLE64_9TJSCB<,J56M2G4IUZ2K/#3PF+_ $.TS_@K
M+^WIK6OOX4T;]GWX;:MXHCFEMY/#>F?"CXRW^OI/ XCGA?1[7XCRZBLT,A$<
ML;6X>-R$=0QQ7Y:?M+_$[XC?&+XY_$+X@?%OP[8^$OB/JNIV.E^+/#.G:1JN
M@VVA:EX2T32_!XTS^R-<O]4U:PN;2UT&WBO8+^_N+C[:MPS% PB3]*]=_P""
MV_[0MYIMK;^'_A?\(=$U+[.T>HZE?6_B_6XI9VBC47&EV"^)M*73]DPFE2&_
MN-;38\43F3RGDG_(CQOXQU_XA^,O%7CWQ7=K?^)O&GB+6?%/B"]C@AM8[K6-
M>U"XU/49H;2V2.VM87NKF4PVMO'';VT6R&&-(D51Z/A-PKGF49UC<RS3POX4
MX I2RO$X&.(RK-5F6;8RI4Q66UX46L-C,;@Z>72C0K3K.I56)>)H8;DA&ESR
MJ>9XS<8</9UD. RK*/%WC+Q)K1S?"YA+#9QD[RO)L#3I8+-,-4KIXO X#'5<
MSC/$4(4%3I2PJPN)Q;G4E6Y(P]N_8S_Y.U_9L_[+=\-?_4LTNOVE_P""QOPO
M^-'Q$\0? 67X4?#OXH>.K?2M'^(4>M2?#SPEXK\3PZ;->7OA%K%-4?PWI]\E
MG+=);7+6BW9C:=()S"&$4FW^?CX<>/-;^%WQ \$_$GPVEC+K_@+Q5H/B_1H=
M4@ENM,GU+P]J=MJEI;ZC;P3VD\UC/-:K#=QV]W:7#6[R"WNK:;9,GZI?\/L_
MVJO^A _9]_\ "5^(W_SUZX/$?@'C/,O%+AKC[AS)\@S[!Y-P[+*JV69YC8X>
MC6Q4ZG$$).M2G0J1E2ITLXHUZ$XN3^L8=J4(<L)3]'PM\2.!,K\(>*O#CBG.
M^).',=GO%$,XH9MP_@)8FO0PE.GPU."H5H8BE*%:I6R.OA\1"48Q^K8A.$ZC
ME.$/S/\ B!\'?CC\/=/L]?\ BI\*_BMX'TJ^OXM$T_6OB!X'\7^&M/O-3DMK
MW48=(L]2\1Z796UQ?O9V.HWT5A!,]PUM9WMRL1BMYW3^EW]ESQWK_P ,/^"3
M6D?$7PK):Q>)/!/PF^+OB70Y+ZV6\LTU32/&?CR\LVN;1F1;B$31(9(691(N
M5)&:_$/]J'_@HK\</VLOA]IGPU^(?ASX8:#H&E^+M.\8I<>!]#\4:?JEUJ&F
M:3KND6]E=7'B'QGXGMO[-,>O7%U*EK9VMZUW:66V^2U%W:W=/P[_ ,%"/C9X
M8_9AN/V3]/\ #_PTD^'MSX7\4^$)-=N]#\2R>-QI/B[5M7U;4]NH1>+X?#XN
MHGUJ[L[.8^&2(K-(/.CN+Q'NY/-XYX!\0/$+(N$L)F?#G#>45<CXKG7Q65Y=
MF:GE\N'GA<"G.$G3@O;U*SQU*>%IQBE3ITY)WJ'J^'GB/X:^&7$7&6-RGBCB
MK.Z&?\&T\/A,WS3*90S*/$RQ>.?LZD8U:C^KTJ$<!6ABZDIMU:E6#35)7M?$
MW_@IA^V3\4M'O?#NI_%63POH6I0"WO['P%H>C>$KJYCZ.G_"0Z?:?\)5;QSK
MNCNK>TUVWM;J&1X+B"6%C'7[(?\ !-?P]X._95_8;\0_M#_$<'1HO'-QJ'Q$
M\2ZD++?JR>#=$N)/#?@G28HE*/?B\D&H:WH%LK[[B;QGY47SW 4?R]5]V?%O
M_@H5\;?C!\ =%_9NU70/AGX6^'.BZ?X+TA1X+T+Q'IVL:AHW@*VM(M TB_GU
M;Q=K>F"P2YT[2M2GCT_2+"1K[2[+[/+;68GM)_9\1_"".;9+P_P?P-DF3</Y
M!C.(\'C^,,;@H8?!XYY?@Y2ITFG-.IFE6E',,;B:-/$RJ.G/"8>C3J4J4O9R
M\/PM\;99-GW$G&_B%G^>\2\1X'A?&Y=P3@,?/%8W+_[2QT:=2LGR25+*:5:6
M68#"XBKAH4U5IXS$UZM.M7@JD?U#T+]J_P#X)&>&?%>F>.= ^&5[I?B_1M;M
M_$>F>(;7X>>(%U.TURVNQ?PZDEPVK,6N1=KYSF0.LQ++,LB.ZMZ+_P %;OAW
MHGQN_91^'_[1/@B>#6[7P#=:+XKTS6;269X-3^%_Q7M='M9KVSAB#)="XU-O
M VJQ33+BSTN/4YTDB22<2_S%U^@&A?\ !2'X\Z/^S;/^R]>:%\,O$W@.;P'X
M@^'*:[XDT+Q+=>-+;PUK<.HVEG';7]AXQTW05N_"MC?P6/A>XD\.2BS@TC26
MOX]2N8)[BZ^6S+P#S/A;B7@OBG@#-\[SK%Y)FE*>:T.*,VP%:;RFC.E_LN75
MX8' JE"KAYYAA:N'GSQE'%1G1J865.3J_7Y3](_*>+^%>.^$/$G)<@R'!9_E
M%6&48GA')<QHP6=5X55]<S/#SS#,)5JE#$T\MQE'$P=.47@ITJU+&1JPC1_/
M^BBBOZO/XU"BBB@ HHHH **** "OM/\ :I_Y)3^Q)_V;9-_ZMGXC5\65]I_M
M4_\ )*?V)/\ LVR;_P!6S\1J^4SW_D?\$_\ 8WS7_P!9G.3['A[_ ))SCW_L
M291_ZUF1'Q91117U9\<%%%% !1110 5_4Q\ -(U_7_\ @CVVB>%M,U?6O$>J
M_!3XT6&B:1H%E>ZCK>I:E=>+?'T-I9:58:=%-?WE]<2LL5O;6D4EQ-(RI$C,
M0*_EGK]*/@/_ ,%3/VA?V>OA3X4^#_@_PI\']9\->#DU:+2;_P 5^'?&-WKK
MPZOKFIZ_/%>7.B>/M T^98+O5;B&V:/2X)!:I"D[W$RO/)^%^./ 7$G'&#X4
M?#=#+L7B,BS[^TL3A<QQ7U6E7H^RCRQYI4YPG3<Z2IUH.2GRU$X1FN?D_H7Z
M/OB-PMX?YAQ@N*L1F>"PW$/#O]E87&99A'BZM"NZ[YI<L:L*D*D:=5U:,U&4
M.:E)2E"3IJ?S/<?LP_M>3PO%=?L\_M(36[ &2.X^$OQ.DA(0AP7230"A",H<
M%A\I4-P0#7Z$?\$1'5_VC?B:Z,KH_P #]19'4AE96\=^!"K*PR&5@0002"#D
M<5F_\/L_VJO^A _9]_\ "5^(W_SUZ^%/V7_VK_B5^R=X]\0?$7X?:;X0\0Z[
MXF\+WGA35(?'.F:K?Z:]I?:SH^N37T-OX<USPM<0ZD+S1H$1ENS8K;W-VAL&
M<VTEMXO$G#7B5Q?P!Q=PEBN$.$>'*F8PR:ME<,ES2/L<3C,-GN58O&?6DJ%.
ME1Y<#@I.%5J4JDH4Z.W*U[_"O%?A3P3XD\%<9X/C;C7BBEEE3/,/G$\^RB7M
M\)@<7PYF^!P7U-_6*M6O?,<?%3HJ484H3J54F[\WZ=?MQ?\ !1_]JCX0?M&_
M%KX1?#GQ5X<\-^&O"FJ:)::)>#P9H&KZW;0WOA30M7N ]SKUKJMC<,UYJ-PR
MM/ILFV/RXUP%.?AS]EO0O'?[:_[9WPTA^+OB#6_B,UQKB^*?'6H>)IY-6@;P
M9X-^T>)+O0);>3_1=-\.ZM<Q1>&;;2]/@M=-LGU](K2UMTDX^8?C9\7O%'QZ
M^*?C#XN^,[71;+Q-XUOK6_U2T\.VMY9:+;/9Z98Z1;0Z?:W^H:K>Q01V>GVZ
M_P"E:C=S/('D>9BW'I?[+'[6'C_]D7Q?XB\;_#CPYX!U[7?$GAL^%;J7QUI.
MN:G'9:2^IV&KW$>FG0?$GAJY@>[O-,L&NA-<W$$JVD&8!)$DB^U@_#&/#7AI
M6P7"W#>0X7Q"QO!V$R3&YFE1A7EF6,R_"X'.:ZS6:=6,(U7B,=&-.4</7Q%"
MC.5"H[1?@X[Q:GQ5XK8?'\7\5<18OPSP''6,X@P.5-UZF'AE6!S+%X_(\.\F
M@U2E4E16&R^<JD)8G#8;$5X0KP]Z1_1U^V=^TE^P?H?C;3?A/^U'X>F\;^(?
M"=C#XAL=,'A?4?$-CH7_  DT$9&^6QO;:.#4;NQLK2X>"9&ECLIK65"L=U\_
M9_L5?M$?L9_$%O$OP?\ V6].;PLFDVEUX]U/P=<>'[[08;RUNY])T#5M:L+;
M4+J[^TQ03OH5EJ@A*10R7^GL\9>[9F_E ^,OQ:\7?';XG^,?BUXZDL7\4^-M
M4&IZE'I<$]KI=DD%I;:=IVEZ7;W-U?74.FZ3I=E9:7IZ7=[>W8L[2'[5>75Q
MYD\G3_LZ?M#?$+]F#XGZ;\5OALVD3:W9:;J^C7FD>(K2\OO#NO:1K-HT$^FZ
MU:Z;J.D:E+;6]ZEAK5I]AU:PECU;2=.EEEFM$N;.Y_+,7]%Z+X"I4,+GN?5.
M+X8+"8W^R<1F6!?"M/.Y^R>.HT\,L#&K&$*4\5A:.-6-YW/EQ,HSIREA9?K^
M"^EU+_B(U7$8OAWAVEP1/'XW ?VSA\JS#_7">00]K' 5ZF+>82HRJ3K4\'C,
M1@'E_LU!2PD)0JQAC8Z_[6GP9;]G_P#:+^*_PJB@:#2/#WBFYN?"P,EQ<;O!
MNO1Q>(/"(-U<YDNKB#P_J>GVE_,7EQJ-O>1-+(\3M4/[)=GX/U']IWX!V'CV
M.";PG>?%CP/;:M!>103:?<^=K]E'8VNJQW0-LVC76I-9V^LBY'V<:7+=F;]V
M&J?]I[]IOQQ^U?\ $.P^)?Q!T#P3X?\ $%AX5T[PD8? NF:SI>FWMCI>I:QJ
M5M?7\6N>(/$EY/JN=9ELWN5OHH386>GP);(T#R2_.=?T?E63YWF/AYA^'>)*
M]3 9[BN%ZN0YICL%6IU:U'%SP%3+)YGAJU)QINO/3'TW'V:A5FH\M-Q<8_RW
MG&>9!E?B=B.)^%L-3S+A[!\74>(\HR_'T*M"C6P=/,:6;4\IQ="LIU%0IOFR
MZKS>T<Z5-R4JJDIR_J)_X*TZC^U+H>F_ GQ)\ Q\0H_"_AOQ-X@UKQ=??#BU
MO[^[T[Q78)H5QX'N_%-CI<=S>R^'Q;Q^)H[9KNSG\+/?O)8>)#]MU#PS;7?K
M'P3U_3/^"C/[-VJ>"/VGO@9XN\):OI4FFPZGJFI^&]6\,Z1J7B*".^@L_'?P
MG\0:C;)<6&L6#0W,>KZ?&+B/3%U&;0-1.N>']7O;2Z_&WX-_\%=_VHOA;X>T
MCPIXA@\&_%G2-'M[6RMM2\<6>LKXR_L^T58H;:;Q-H^L6*ZC,+=1&^IZ[I6L
MZM<2*D]Y?7,OG&:?XM_\%@/VJ/B-HVH^'O"T7@OX2:?J,=Q;2:KX)T_5)_&*
M6=RK120P>(]=U;4H=.N!"VV'5-#TC1]6M9BUU8WUK.L#0?R+5\$_%%Y7E'"%
M'A3A?#8CA_-\1C,I\2<#G-++L8J%?&/$\N,CAZKS;%>SK.-?#5ZF62Q6"I4<
M/1PJA.G4]O\ VM1\?/"*.;YUQM7XQXNQ6&XER3#8'.O"O,,CK9G@98C#X&.%
M4L!+%4HY+@_:4%/#XNA3S6.#S"M7Q-?&.<*M-X?[V_X+-Z7X]D^#WP@\$^"_
MAMKNH_"[PIKEUXN\2>*](TY]3TGPG<>&O#EYX:\,:=>&T:ZOM)M(M$USQ%+=
MZKJD-IIGEBQMX;^YN6NHK?\ FSK]%[/_ (*A?M.GX$^*_@-XIN?"7Q#TGQ5X
M+UWP!/XV\<6&OZG\0+?PUXCT.X\.:@DNNV'B72XM<U>#3+J=]/U[Q'8ZMJSZ
MF_V_7KG7UW6S?G17]%>!_"?$W W#..X6XCRS+<(\OS;$5L#F>68QXNEGU/&)
M5:N.J1G-5Z$J%J6!IPKX/+YRH8>DY89SYZU7^8/I \9\)^(7%>7<7\+YOFN-
M_M+)L-0S#*,UP'U*KPY4P+]C1R^G*G3>'Q$<1>MCZL\/C<RIQQ&)K1CBU3=.
MA1_J%_X(_P 4L_[%/Q!@@CDFFF^*OQ$BAAB1I)999/ O@=(XXXT!=Y'<A410
M69B%4$D"OPI\#_L,_M<^/?$FG>&=-_9\^*NAW&H2A6U;QQX*\0^!?#=A"&'G
M7>H^(/%>G:5ID$5O&6E,$<\VH7*H8K"RO+IH[=_2/V7_ /@HK\</V3?A_J7P
MV^'GASX8:[H&I^*K_P 7O-XWT/Q1J&IVVI:EIFCZ7<V]M<>'_&?AF#["8=$M
M9DCN;2YN$N);@_:C"T4,/O.M?\%HOVMM4L9;2Q\/?!/PW<2 A-4T7P?XJGOH
M"01F*/Q#X]U[3"0?F'G:=,,@9!&0?S[*N#O&/@GBCQ-S;A3*.%,PI<;\0ULS
MPF+S7-*R6#PT<SSC&8:3P=)X6<ZTJ&;SA5A.JH4J]*,D\123C5_2LXXY\#>/
MN$?"?)N,L[XRRVMP!PS0RC&X/)\HH-XW%2RG(\#BDL=56,A##PQ&2PJ4ITZ#
MJ5L-5G%K#5G&5/\ 2W]JC4?"/["7_!-^#X#VFIZ?J'BGQ1X'O?@_X?M4BEM/
M^$FUWQQ]LN_BSXI@LX8[J>PTVWM-=\6^(%GNPUK'JM_H&A7NHI?:U9S3?/W_
M  0M_P"0+^TM_P!A3X4?^DGQ"K\+_BQ\9?BA\<_%DWCCXL^--8\;^)IK>*S2
M_P!5>"."QL8"S1:?H^E6$%GH^AZ:LLDUS_9VCV%C9->7-U>M ;N[N9I??/V4
M/VX/BU^QY#XYM_AGH7P^UV'Q_+X=FUB/QWI'B'4_LLOAI-:2R?2V\/\ BKPP
M\/GIKMTMXMVU\K^3:FW6V*S&?DQW@1Q-A?"O.N&\-C\!G/%W$?$V"XAS6M&I
M]2RRG*B[5*&%J5:5)U(P;JUO;2PN%=659TXX:E"E#F[\O^D5PIB_&#(N*<5E
MV8Y%P5POPGC^&<GH2I+'YM4C7Y73Q&,I4:U94I34:5'V,<7C%2AAU4EBJU2M
M/E\O_:*UK6$_:"^.J)JVIJB_&3XG*JK?72JJKXVUL*JJ)0       !P*_H7_
M &;9Y[G_ ((U>)IKB:6XF?\ 9]_:SWRS2/+*^W6_C*B[I'+,VU555R3A0%'
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M?P0?#O\ Y*!X%_[''PS_ .GNQK^]^OXA^E[_ +[P'_V"\0_^G<G/] /H2_\
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M_P#K,YR?8\/?\DYQ[_V),H_]:S(CXLHHHKZL^."BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *^T_VJ?^24_L2?\ 9MDW_JV?B-7Q97VG^U3_ ,DI_8D_
M[-LF_P#5L_$:OE,]_P"1_P $_P#8WS7_ -9G.3['A[_DG./?^Q)E'_K69$?%
ME%%%?5GQP4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% 'VG^WM_R772/^R'?L]?\
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MHY)=OR_S#F7?^OZ_K<ZZBN1_X3"R_P"?6Z_\A?\ QRC_ (3"R_Y];K_R%_\
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MPLO^?6Z_\A?_ !RCDEV_+_,.9=_Z_K^MSKJ*Y'_A,++_ )];K_R%_P#'*/\
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M _XE3\8_^A3E'_A^R_\ ^6?U\F?SAT5_1Y_PYS_9R_Z*?\;/^_O@7_YF:/\
MASG^SE_T4_XV?]_? O\ \S-'_$ROA5_T,\T_\,N._P#D _XE3\8_^A3E'_A^
MR_\ ^6?U\F?SAT5_1Y_PYS_9R_Z*?\;/^_O@7_YF:/\ ASG^SE_T4_XV?]_?
M O\ \S-'_$ROA5_T,\T_\,N._P#D _XE3\8_^A3E'_A^R_\ ^6?U\F?SAT5_
M1Y_PYS_9R_Z*?\;/^_O@7_YF:/\ ASG^SE_T4_XV?]_? O\ \S-'_$ROA5_T
M,\T_\,N._P#D _XE3\8_^A3E'_A^R_\ ^6?U\F?SAT5_1Y_PYS_9R_Z*?\;/
M^_O@7_YF:/\ ASG^SE_T4_XV?]_? O\ \S-'_$ROA5_T,\T_\,N._P#D _XE
M3\8_^A3E'_A^R_\ ^6?U\F?SAT5_1Y_PYS_9R_Z*?\;/^_O@7_YF:/\ ASG^
MSE_T4_XV?]_? O\ \S-'_$ROA5_T,\T_\,N._P#D _XE3\8_^A3E'_A^R_\
M^6?U\F?SAT5_1Y_PYS_9R_Z*?\;/^_O@7_YF:/\ ASG^SE_T4_XV?]_? O\
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M9<=_\@?.?\2I^,?_ $*<H_\ #]E__P L_KY,_G#HK^CS_ASG^SE_T4_XV?\
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M@'_$J?C'_P!"G*/_  _9?_\ +/Z^3/YPZ*_H\_X<Y_LY?]%/^-G_ ']\"_\
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M_AEQW_R ?\2I^,?_ $*<H_\ #]E__P L_KY,_G#HK^CS_ASG^SE_T4_XV?\
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M@'_$J?C'_P!"G*/_  _9?_\ +/Z^3/YPZ*_H\_X<Y_LY?]%/^-G_ ']\"_\
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M\.<_V<O^BG_&S_O[X%_^9FC_ (F5\*O^AGFG_AEQW_R ?\2I^,?_ $*<H_\
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M_P#,S1_PYS_9R_Z*?\;/^_O@7_YF:/\ B97PJ_Z&>:?^&7'?_(!_Q*GXQ_\
M0IRC_P /V7__ "S^ODS^<.BOZ//^'.?[.7_13_C9_P!_? O_ ,S-'_#G/]G+
M_HI_QL_[^^!?_F9H_P")E?"K_H9YI_X9<=_\@'_$J?C'_P!"G*/_  _9?_\
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M\.<_V<O^BG_&S_O[X%_^9FC_ (F5\*O^AGFG_AEQW_R ?\2I^,?_ $*<H_\
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M_P#,S1_PYS_9R_Z*?\;/^_O@7_YF:/\ B97PJ_Z&>:?^&7'?_(!_Q*GXQ_\
M0IRC_P /V7__ "S^ODS^<.BOZ//^'.?[.7_13_C9_P!_? O_ ,S-'_#G/]G+
M_HI_QL_[^^!?_F9H_P")E?"K_H9YI_X9<=_\@'_$J?C'_P!"G*/_  _9?_\
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M*/\ P_9?_P#+/Z^3/YPZ*_H\_P"'.?[.7_13_C9_W]\"_P#S,T?\.<_V<O\
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M7_13_C9_W]\"_P#S,T?\.<_V<O\ HI_QL_[^^!?_ )F:/^)E?"K_ *&>:?\
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M<O\ HI_QL_[^^!?_ )F:/^)E?"K_ *&>:?\ AEQW_P @'_$J?C'_ -"G*/\
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M*/\ P_9?_P#+/Z^3/YPZ*_H\_P"'.?[.7_13_C9_W]\"_P#S,T?\.<_V<O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ->?_D"V'_7[>_\
MH%O616O/_P @6P_Z_;W_ - MZR*!O?Y+\D%%%% @HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(I8V:.2-E=&*D$SU]%<_HU24DI1:E&23C).Z::NFFM&FM4UHT%%%% PHHHH
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M'YF39_@<[IU'AG*G5I2:J8>KRJJJ?,U"JE%M2A-6NXM\DWR2^RY?EO@MX_\
M WCA@<SK<,U<1@,URC$UH8[A_-?8T\UIX#V\J>!S:%.C4J4Z^"QE-TO:3H3J
M?4L7.6#Q#3^KUL3U5%%%>V?N(4444 %%%% !1110 4444 :\_P#R!;#_ *_;
MW_T"WK(K7G_Y MA_U^WO_H%O610-[_)?D@HHHH$%%%% !1110 4444 %%%%
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M7+:7.X^T7P1T4E'3;5WQ="E*M'$.%ZT(.G&?-+2#O=<M^5_$]7%O7?8_&?\
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MM?RWN/\ @ANT_P"V$O[6 _:A"%?VNK;]J@^ O^%)ELK;_'B+XV?\('_PE/\
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M?L^_M!:Z%U]1;Z3\.?B-JUP%77%4+#9>%?%5[,P U@ )!HNM3OC5!Y=A?O\
MVCY$]]\7E?&N$Q^8U<)6I_5:-2:C@:\Y?Q'I'DQ%WRTYU9>]3M[JNJ4FY)2G
M_%/A=]-OA#CSQ&S/A#.<N7"V2YCC:>%X$SS'5^5X^:4:*PG$"E)T,NQF9UKU
M\NE2G]6I>TAEN(J3Q,:>*Q7[P5^5_P#P4(_X*(:-^S3I=[\,/AA<V.N_';6-
M/_>2X@O=+^&-E>Q*T&LZY PD@O/$EQ;R"YT#P[.K1HK0:UKL3:8UCIVO1?\
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MWE]6P.'NE*<Y6].>=N>M/EC&/P0C_E)F69^+'TQO%:AAL/1?*G46 P$9UO\
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MDDFOVH_X)P?\$X)OB?-HWQX^/&C2V_PWMY8M0\$>!]1B>*;Q[-$X>#6=9MY
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M#*=<U_RY4O8_#6C\7>M3:=%<7<=LN6%G:?:M4L/XP_BI\8?B%\9OB%K'Q/\
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M_/,?"#7/.SF\-@,,YU(9=E\)RI86E.<I2K8NOBL57****]@_9 HHHH ****
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MC@,!&K]2]JH4:,$_:XRK=*-2I!:VYM:5)_#\<_?LH?YW_2)^D3Q+]('B7"\
M< 87,_\ 4O\ M.CA,GR?"4:W]J\9YI[94\+C\?A::]K]7]K:>595-6PZY<;C
M8_7.2&!/@'\ _B/^TA\1](^&?PTT@W^KZ@?M.I:E<^;%HGAC1(I8X[[Q%XBO
MDCE%CI5B)4!(26ZO;J6VTW3;:\U.\M+2?^P7]E7]E;X=?LG?#>#P/X(@^WZS
MJ/V6^\<>-KRWCBUKQGKL$3H+N["-+]BTFP\^Y@T#0H9I;72+2:8F6\U.]U75
M-13]E7]E7X<?LG?#BW\$^";<:AK6H"VO/&_C>]MHXM;\9:W%$R_:KK:TIL=(
ML3+/#H.@PSRVNDVLLK-+>:G>:IJFH?3E?=<,\,T\GIK$XE1JYE5C[TM)0PL)
M+6C1>SFUI5JKXM80?L[NI_=OT8/HPY;X-9;2XFXFIX7,_$K,\+RXC$1Y*^%X
M7PF(A^\RC**FL9XN<).GFN:T_P"/[V#P<E@55JXXHHK\H_\ @J1^UQ\3_P!G
M?P%HO@[X9>']<TC4OB3:WMK<_%Y8@NE^&;5&D@NM#\.W44CRV_C:[@!N!?W4
M=M_8VERQW>BM=ZO.+WP]]!F&/H9;@ZV-Q'/[*C%-J$7*4I2:C"*2T3E)J/-)
MJ,;WE)*[/Z(\1./<C\,N#L[XVXB6+EE628>-:K2P.&J8K%8BM6JPP^$PM&$%
MR0GBL55HX>-?$3HX6@ZBJXFO1HQE-?HCX5^,?PN\<>,_&WP\\)>.-!U_QK\.
M9[>V\:>'M/NC+?:'-<*IV2918;L6LKK9:F^G2W::1JF=)U5K/4U:T'I=?PB_
M"OXP_$+X,_$+1_B?X \17NC^+M'O3=K?"1I4U".5C]ML-6@D+1:EI^I1-)!?
MVETLD5S%(ZR*<YK^N3]D/]MOX:_M2?#2[\3F_P!+\'>,_!VEF\^)GA74M0AM
M8/#T-K"7N_$UG=WLJ"7P?*$DG_M*>3_B3G-GJTJLMO>7WSW#_%=#.)5,/B(0
MPF,4ISI4^=NG6HIMKDG*UZM./\2.G,DZL$H\T:?\[?1X^EGP_P",N)S#A[/\
M+@^$N,*-;&XO+,M^MRJ8#.,EA.I6I?4L7B>24\URW!I+-,-)4_K$*53-,%2A
MAGB<+EWV7?ZA8Z587NJ:I>VFFZ9IMI<W^HZC?W,-G86%A9PO<7=[>W=P\=O:
MVEK;QR3W-S/)'#!#&\LKJBLP_E]_X*+?\%%K_P"/%_J7P;^#>I7>F_!C3;OR
M=<UR'SK._P#B=?V<P99IE81W%KX/M;B-9M*TJ98YM3FCBUC6(EG73M.T<_X*
M+?\ !1:_^/%_J7P;^#>I7>F_!C3;OR=<UR'SK._^)U_9S!EFF5A'<6O@^UN(
MUFTK2IECFU.:.+6-8B6==.T[1_R2TS3-2UO4;#1]'L+O5-5U2[M[#3=-L+>6
M[OK^^NY5@MK2TMH%>:XN+B9TBAAB1GD=E55)(%?+\5<5/%N>6974?U>[IXG$
MTWKB7LZ-%K7V%])S7\;X8_NKNK_*_P!*[Z5]7BZKCO"[PNQU1\..I+ <2<28
M"<O:\35>;V=3)\FJTGS_ -A\]Z6*Q5+WL[E>A0?]E<TLS-,TS4M;U&PT?1["
M[U35=4N[>PTW3;"WEN[Z_OKN58+:TM+:!7FN+BXF=(H88D9Y'95522!7]2'_
M  3K_P""=]A^SUI^G_%_XM6-MJ/QLU2R+Z5I<GEW-G\--/OK=HY;2W8%XKCQ
M7=VTKP:KJ,9:/3X9)=+T]V5KRZNV_P#!.W_@G;IW[/NG:?\ %WXNZ?::I\:]
M4M!-I.DS"*[L?AG8W<7S6ULWSPW'BRXA<QZGJ<99--1GTW37.;N[NOULKUN%
M.%5A%3S+,J=\4[3PV&FKK#)V<:M1=<1_+!_P=W^]_A_K?T3OHG0X1AEWB9XF
M9?&?%4XT\9PSPUBZ:E#AJ,DIT<TS.C--2X@DFIX7"S362JU6HO[5Y5EI117B
M'[1WQ:U7X&_!?QW\4M%\$ZS\0-1\):/)J$'AW18_,D/S+&^J:GL;[3%H&CJY
MU+7;FSAN+FUTNWN;@1)#%-<P?>5JL*%*I6J-JG1ISJU&HRDU"$7*348IRE9)
MNT4V^B/[ZS?-<%D659EG69U)T<NRC 8O,L?6IT*^)G2P>!H3Q.)J0P^&IU<1
M6E"C3G)4J-*I5G;EA"4FD=%XR^,WPL^'OBKP-X(\:^.=!\-^*_B3J,NE>"=$
MU*Z:*[UR^BBDD\J,K&\-DD[Q_8K*YU*6SM=0U66VT>QFN-5N[6SF]-K^$OXP
M_&?XA?'3XA:S\3/B+KUSK'B;5[D2K(&>*TTFTB<FQTK1;56V:=ING)B.SMH,
M! #*[/.\DK_O?_P3<_X*1IX[30_V?OV@=<5/'"+;Z5\._B)JMP%3QHBA8;/P
MOXHO)F 7Q>H"0:1J\[@>*0$LKU_^$E\F;Q%\;E/&F%S#,*N$KTUA*=2HHX"K
M.7\3:*IXB[Y85JDKRI\ON:JDVYJ,JO\ %WA+]-GA3Q"\0<TX/SS+H<*9;F6/
MCA^ <WQE>W]HQM"C#+\_<IRP^!S7,:ZEB,N="?U-^VAE,ZD\92H8G,OW%K\D
M_P#@HE_P42T[]GW3M0^$7PBU"TU3XUZI:&'5M6A,5W8_#.QNXOEN;E?GAN/%
MEQ"XDTS3) R::C)J6I(<VEI='_!1+_@HEIW[/NG:A\(OA%J%IJGQKU2T,.K:
MM"8KNQ^&=C=Q?+<W*_/#<>++B%Q)IFF2!DTU&34M20YM+2Z_EQU/5-2UK4;_
M %C6+Z[U35=4N[B_U+4K^XEN[Z_OKN5I[F[N[J=GFN+BXF=Y9II79Y'9F9B2
M37+Q5Q6L(JF6Y;4OBG>&)Q,'=89/>G2DG_O&ZG+_ )<[+][_  _E?I8_2QAP
ME#,/#/PSS",^*IQJ83B;B;"5%*'#4))PK97E=:#<99_*+<,5BH-K)4W3IO\
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M37M=O(-.T31- T_3?%=S=ZQJ^L:A<VUCI6FZ=#<7FH7EQ!;6D,TTL:-\<_\
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M.4I,HHHK0](**** "BBB@ HHHH **** "M>'_D"7O_7_ &?_ **N*R*UX?\
MD"7O_7_9_P#HJXI/;YK\T-;/T_5&11113$%%%% !1110 4444 %%%% %2_L+
M'5;"]TO5+*TU+3-2M+FPU'3K^VAO+"_L+R%[>[LKVTN$DM[JTNK>22"YMIXY
M(9X9'BE1D9E/\OO_  46_P""=-_\![_4OC)\&]-N]2^#&I7?G:YH</G7E_\
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M)X9%5XY8W5T=0RD$55=WD=I)&9W=F=W<EG=V)9F9B269B268DDDDDYK]>?\
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M !ZZ/_UX-_Z53UD5KZE_QZZ/_P!>#?\ I5/0-;/T_5&11110(**** "BBB@
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M.I5:<WA\#AW*<,ORZ%25'"4I2;E6Q5;%8K$%%%%>N?L(4444 %%%% !1110
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M1P>#];CUK7?'OPN^&_B3XG>*_&-SKUI)=:/X@^(MI?>&XO#OPX\/^![30)/
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M:W80?@?_ ,%!OCYX-_:D_:C_ &@OVA?A_I?BO0O"?Q2@\%:EI>A>.++1-/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO_\ ",ZM_P \8O\ P(A_^+H_X1G5O^>,7_@1#_\ %T^9=U]X6?9_<8%%;_\
MPC.K?\\8O_ B'_XNC_A&=6_YXQ?^!$/_ ,71S+NOO"S[/[C HK?_ .$9U;_G
MC%_X$0__ !='_",ZM_SQB_\  B'_ .+HYEW7WA9]G]Q@45O_ /",ZM_SQB_\
M"(?_ (NC_A&=6_YXQ?\ @1#_ /%T<R[K[PL^S^XP**W_ /A&=6_YXQ?^!$/_
M ,71_P (SJW_ #QB_P# B'_XNCF7=?>%GV?W&!16_P#\(SJW_/&+_P "(?\
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M"BM__A&=6_YXQ?\ @1#_ /%T?\(SJW_/&+_P(A_^+HYEW7WA9]G]Q@45O_\
M",ZM_P \8O\ P(A_^+H_X1G5O^>,7_@1#_\ %T<R[K[PL^S^XP**W_\ A&=6
M_P">,7_@1#_\71_PC.K?\\8O_ B'_P"+HYEW7WA9]G]Q@45O_P#",ZM_SQB_
M\"(?_BZ/^$9U;_GC%_X$0_\ Q=',NZ^\+/L_N,"BM_\ X1G5O^>,7_@1#_\
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M(?\ XNC_ (1G5O\ GC%_X$0__%T<R[K[PL^S^XP**W_^$9U;_GC%_P"!$/\
M\71_PC.K?\\8O_ B'_XNCF7=?>%GV?W&!16__P (SJW_ #QB_P# B'_XNC_A
M&=6_YXQ?^!$/_P 71S+NOO"S[/[C K7A_P"0)>_]?]G_ .BKBK'_  C.K?\
M/&+_ ,"(?_BZT8]!U)=,N;8Q1^;)=VTJ#SHL%(XYE8[MV 06'!.3VZ&DVNZW
M7YH:3UT>W;S1Q]%;_P#PC.K?\\8O_ B'_P"+H_X1G5O^>,7_ ($0_P#Q=/F7
M=?>*S[/[C HK?_X1G5O^>,7_ ($0_P#Q='_",ZM_SQB_\"(?_BZ.9=U]X6?9
M_<8%%;__  C.K?\ /&+_ ,"(?_BZ/^$9U;_GC%_X$0__ !=',NZ^\+/L_N,"
MBM__ (1G5O\ GC%_X$0__%T?\(SJW_/&+_P(A_\ BZ.9=U]X6?9_<8%%;_\
MPC.K?\\8O_ B'_XNC_A&=6_YXQ?^!$/_ ,71S+NOO"S[/[C HK?_ .$9U;_G
MC%_X$0__ !='_",ZM_SQB_\  B'_ .+HYEW7WA9]G]Q@45O_ /",ZM_SQB_\
M"(?_ (NC_A&=6_YXQ?\ @1#_ /%T<R[K[PL^S^XP**W_ /A&=6_YXQ?^!$/_
M ,71_P (SJW_ #QB_P# B'_XNCF7=?>%GV?W&!16_P#\(SJW_/&+_P "(?\
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M_P#X1G5O^>,7_@1#_P#%T?\ ",ZM_P \8O\ P(A_^+HYEW7WA9]G]Q@45O\
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MM_\ X1G5O^>,7_@1#_\ %T?\(SJW_/&+_P "(?\ XNCF7=?>%GV?W&!16_\
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MA_\ BZ/^$9U;_GC%_P"!$/\ \71S+NOO"S[/[C HK?\ ^$9U;_GC%_X$0_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ J4?ZE_\ ?3^35%4H_P!2_P#OI_)J (J*** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH E/^I3_ 'W_ )+452G_ %*?[[_R6HJ "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *ED^[%_N'_P!"-15+)]V+_</_ *$: (J*** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH EF^\/]Q/\ T$5%4LWWA_N)_P"@BHJ
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M:CJ1/N2_[J_^AK4= !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %2C_ %+_ .^G
M\FJ*I1_J7_WT_DU $5%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 2G_ %*?
M[[_R6HJE/^I3_??^2U%0 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4LGW8O\
M</\ Z$:BJ63[L7^X?_0C0!%1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $L
MWWA_N)_Z"*BJ6;[P_P!Q/_0145 !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 *.
MH^H_G6O60.H^H_G6O0!E2?ZR3_?;_P!"-,I\G^LD_P!]O_0C3* "BBB@#_/:
MT3_E---_VE]\0?\ K=VI5_H2U_GM:)_RFFF_[2^^(/\ UN[4J_T):^EXA_AY
M/_V+*/\ Z3$\3)M\P_[#:GYL_P ]W_@M([1_\%0_VS9$.'CUKX*NIQG#+^RA
M\!&4X/!P0.#Q7[P^,/\ @VI_9JG\+ZI;?#;]I/\ :-T'QM,^FG1M=^)4/PD^
M(GA'3XHM5L9=874O!O@WX=?!O6]6DOM#CU+3],DMO'^C)I.KW=AK-U#K5EIU
MQH&J?@W_ ,%I_P#E*!^VA_V%_@O_ .LG? 6O]"6NO,L=B\%EV02PM>I0<L))
MR4'[LW"&&Y>>+O&:7,]))JS:M9LQP>%P^)QN;*O2A5Y:\5'F6L>9U>;E:LU>
MRU33T1_!-_P2X_:@_: _8H_;D\&? /5-/UF^T/QS\<(_V8_C#\#-5^(FJ+X0
M\&_$'QI\3_!'PN\6?$32;'PKK.O?#C4?B?\ #77?"&FV+^*H]+\30>*/!>C>
M(O NB^(M(LO%-AXQT/S/_@M/_P I0/VT/^PO\%__ %D[X"U/^U3')^T%_P %
M;_B;X1^&H3]E;7/''[;5I\$/#OC#P 6EU'P1\0;'XJZ7\&I/C_I(\-_\*YO&
M\:>+_'6FW'QVOXK'5=&UW_A,?$MY%-XVU#6A-XROH/\ @M/_ ,I0/VT/^PO\
M%_\ UD[X"U[E",99M@\5R1IU\7DTJN(A%6]_FH.[U:O[SA?=J"NWN>74E)9?
MBJ',YTL/F4:=&3=_<_>*R\O=4K=Y,_T):**_CO\ VDO^#@K]L/X/_M&_M"?"
M'PQX8_9'N?#?PG^.WQA^&'AZX\0^"?BA=^(9M#^'WQ%\2>$-)EU^[T_]H#1[
M"YUQ[#1K=M8GLM(TFTEU$W,EMIFGPLEI#\!@LOQ.83G3PT8.5.*G+GJ1IJS=
MM')J[OT1]9B<71PD8RK.24Y<J<82GKOKRIV/Z&/^"FW[4U]^Q_\ L7_%_P"+
M7AC6-&TGXFWFG6/P_P#A!_:6N>'-)U&3XC^/+R/0M.UOPOIOBC1?$FE^--?^
M&^AS>(/B^W@67P]JT'B70OAWKEIJB:?H*ZMK6F?R(?\ !+?_ ()[I_P4M^,/
MQAU3XK_%OQ3HG@WX;V^E^*_BSK.E:I_;/QL\?>,_C#<^.Y?#=_8^)?&FC^*]
M&2?4/$'A/Q5XJ\>^-O%MMXHUK4[NS@T>#0;^^\87_C+P;]+?M?\ [8?QQ_X*
M*?\ !)/3?C?\1_"'@B;5/A1_P4@TKPAK5S\$O"7C"V\(^%? MC^R]KTNG>)/
M&9UWQC\0[C19+OQM\7+#PJ==O-:TK1KB_P#$7@WP_!91ZOJD#ZM^A7_!MC\4
M=#U;X _M&_!6WT[7(O$OP_\ C#H'Q1U;5KBVL%\-7NA_%_P7:>$_#VG:3=QZ
ME+JD^N:7?_ _Q/<^(;:\T>QL+6PU?PQ+INI:K<7FJVNC?28>%;*<CS"M3M#'
M?7%AJM:#C)T8)TE:,E=?;=FK>]44EK&)XM:5/,,TP=.=Y87ZLZ].G).*J2:F
M[M:/:*NGT@ULW?E?C+_P;4?"&Z\%6UC^S_\ M#_%FP\:W/BSPU!K=[\>CX"\
M9>%?^%>7U^FF^.3I6F?#3X;?#+5$\7:/HMY-XH\+0W^I76C>)M3T)? >KW'A
M.S\6GXB^"?Z<:**^9Q..Q>,C2CB:TZ_L>?V;J6<U[3DYDYVYI)\D;<S=M;6N
MSVZ.%P^&<W0I1I>TY>=0NHODYN7W;\J?O.]DK];A1117(= 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% $B?<E_W5_\ 0UJ.I$^Y+_NK_P"A
MK4= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17"?$SX
MF>!_@]X'\0_$?XC^(;'POX.\+V+W^KZO?N0D: A(+6UA0-<7VHWUPT=GINFV
M<<U[J%[-#:6D,L\J(?RV_9+_ ."N7PV_:'^,_B7X4^,=!A^&$&NZ_P#9_@?K
M&I7H*>)K'RH+:#P[XNF>9[+2_&NJW<<^H:.EG(-(O5O8O"\4DFM6%E>^*.'$
MYG@<)B,/A<1B:=*OBG:C3D]7T3D]H*<O<@YN*G/W87::7Y_Q/XI\ <&\2<,\
M)<2\39=E7$'%U>=#(\OQ-1J=9I3C3J8FHDZ6 H8K$1^HX&MC9T*>.Q\EA,*Z
MU:-2,/V$HHHKN/T **** "BBB@ HHHH **** "BBB@ HHHH *E'^I?\ WT_D
MU15*/]2_^^G\FH BHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HK^:GX+_ /!8N'QY_P %<_&/PBN/$L<G[+_CJ.R_9[^%\QN5.CQ_$?P?
MJ>I/H7Q!MY-S1/'\3/%FI>(O"=K<6T<<FIZ1JGP[?4'$?A\%?Z5J^;X:XKR?
MBNCF-?**_MJ>69KC,JQ#]W6KA9I1KTK-\^&Q-*4*V'JZ*<6U\4))?MGC=X >
M(WT?LSX-RKQ%RIY;BN.. N'./\G257]W@,_PSG6RK&^TIP6'SO(L;3KY;G.
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MM:K< 1Q_&O5M7O\ 5?!GBRX+$1Q2Z_KFLZKX0O%A2*)Y/%6G7=TZVVBPB/\
M.N*/$7*^&.*.%N&L5R.IGU::Q==SM_9M"KS8;+JU1:+EQF8VI.<VHTJ%'$59
M;1/[,\"/H:<=^.G@1X\>-F1+$T\)X39?AI\.Y73P_M)<:9M@'0SKC'+\+-*=
M1U>'N#G+'T\/0IRKYAFN8Y3@:#?-B(K^Y>BBBOT4_C,**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@"6;[P_W$_\ 01452S?>'^XG_H(J*@ HHHH
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MC'QC_JEP?BEAJOL\VSOGRO+>5VJ4E5A_MN,C;WE]5PTFH5%_#Q5;"MZ,_P!
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M_7+A# XNO5Y\URZV69NF[SGBL-"/L\7+9OZ[AW2Q$I)*'MY5Z4+^R9_RJ?M
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MHQA9H)E >*>"5"]O>V%[;O%>:=J-G+/8ZC8SV][97$]M/%*WT3^S1^W'\?\
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MQ\3?TM_9+_X*W_M3_ WX%?M>>.?^"C/A3XC>)==^%'CKX,^ ?@KI7B#X+/\
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M+/%_A^\UCQGK'A#QCH_@71(OAA=6$OPWEU.\\+^)=+T/X66>@Z=\+AH^N?\
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M#_@+Q;X/\4_&VY^'>A:;-'JFD^+O%&C^)?.^&MK!\2=<\6:SX4:Y\9W/AO\
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MI./P\\J<4U+[+DY12V+'[//_  7A_;;^#'Q-\2:5^U5=K\;/#.F2>+=#\4^
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MQ#^%NH_\%._^"J7_  4$^,7C30_^";G@6Y\!_#CX;+?ZM'9VWAOX-7WB>_\
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MO^QAX#\0/^U#JGQ]T[X#_'G3?@G\&?&/QMU#X5W?ASPAXG\?:]XJ\%^%]?\
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M]7U4OI$UE<RB&\EGT^V_4S_@KI^PY\6OV^?V?_A?\*?@[X@^'?AOQ#X*^/\
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MBB@ HHHH D3[DO\ NK_Z&M1U(GW)?]U?_0UJ.@ HHHH **** "BBB@ HHHH
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MHH **** "BBB@ HHHH **** "BBB@ J63[L7^X?_ $(U%4LGW8O]P_\ H1H
MBHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@"6;[P_W$_P#01452S?>'^XG_
M *"*BH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@!1U'U'\ZUZR!U'U'\ZUZ ,J
M3_62?[[?^A&F4^3_ %DG^^W_ *$:90 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M2)]R7_=7_P!#6HZD3[DO^ZO_ *&M1T %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5*/]2_^^G\FJ*I1_J7_P!]/Y-0!%1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% $I_U*?[[_R6HJE/^I3_ 'W_ )+45 !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %2R?=B_W#_Z$:BJ63[L7^X?_0C0!%1110 4444 %%%% !1110 4444
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M#6G_ ,8H_P"$CUG_ )^Q_P" UI_\8K$HHLNR^X.9]W]YM_\ "1ZS_P _8_\
M :T_^,4?\)'K/_/V/_ :T_\ C%8E%%EV7W!S/N_O-O\ X2/6?^?L?^ UI_\
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MYM_\)'K/_/V/_ :T_P#C%'_"1ZS_ ,_8_P# :T_^,5B44679?<',^[^\V_\
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M?L?^ UI_\8K$HHLNR^X.9]W]YM_\)'K/_/V/_ :T_P#C%'_"1ZS_ ,_8_P#
M:T_^,5B44679?<',^[^\V_\ A(]9_P"?L?\ @-:?_&*/^$CUG_G['_@-:?\
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M>L_\_8_\!K3_ .,5B44679?<',^[^\V_^$CUG_G['_@-:?\ QBC_ (2/6?\
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M_C%'_"1ZS_S]C_P&M/\ XQ6)119=E]P<S[O[S;_X2/6?^?L?^ UI_P#&*/\
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M ,!K3_XQ1_PD>L_\_8_\!K3_ .,5B44679?<',^[^\V_^$CUG_G['_@-:?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH U];_ ./R/_KRL?\ TEBK(K7UO_C\
MC_Z\K'_TEBK(I+9>B_(;W?J_S"BBBF(**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** )8/]
M?#_UUC_]#%>UUXI!_KX?^NL?_H8KVNLZG3Y_H:PV^?Z(\=U/_D):A_U_7?\
MZ4251J]J?_(2U#_K^N__ $HDJC5K9>B_(R"BBBF 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)P^)G4Q.+PU514J$HRIN*:YJ,TG%RO*7OQ3CS-63;TBK,^@J***\L[0HHHH
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M8O,\FI5&ZU&%1R56E3J.*H8G%8*U-YCA</4JU\![>BL5"E*4HP]PHHK^>O\
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M?L(_] ?X^?\ AOO#?_S?5\E_Q%'P]_Z*_)/_  LC_EY_U9G]"_\ $BOTP?\
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MW_\ )M'_  \5_81_Z.W^ ?\ X<GPW_\ )M'^LW#?_109)_X=<!_\T>:^\/\
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M.?#^&>9_#/A^&#6O$WPXU3QUH7A;5]:^'/P6\-VF@3Z7)HF@WVC:G9^&]/\
M"OAR[L+#]*/B!_P;J?$+PUX#\;>(_ W[4=A\2_&N@>$?$FM>#_AQ#\!;3P=-
M\0/%.E:->WWA_P $Q>+M>_:)FT/PK)XJU:"TT)/$FLPRZ3H;7XU/48WL[693
M]YSX'+?[*P]?&RPU;!0]M5HQHRJ*I4Q,;5%4G%-1WJQ751FI/3E/EN7$XWZ_
M6I895J>)E[.%252,'"-%IPY(RLY7M!RZ-Q<=[W_1G_@A1^T!_P +9_8M@^&6
MM:R-0\9?LZ^,];\ S0ZMX^;Q?XOO?A[XBF?QO\-]?OM$OH8M8\%>#=.@UOQ#
M\'OAWHTDVJ:$-%^#5S;>&]3M[33KCPQX8_G T3_E,3-_VEG\0?\ K<6I5]1?
M\$#_ (\7/P__ &QKOX2M=ZQ<>%?VD?A[K&D1:=I&D^'KO3I/'GPSTW5/B3X/
M\4>(]:OWMO$&E:+HW@>S^+6@V<'AVXO(-4U_QOHPUK0KN"UM-<\-_!OQ5^(L
M_P 'O^"CWQJ^+MMH<7B>?X4?\%$/C/\ $V'PU/JSZ##XBD\ ?M8>+/%J:%)K
MD>EZX^C)JYT@:>VK+HNKMIPN/M@TR_,/V658;!O#YQF]*G'W<1@*E:BEU5>4
M=%TLJO/%:VLD%;$*KE^7SD]:.*ITZC?1THO5^;ARR?J?Z&=?QM_\'"7_ ">Y
M\.?^S5_ /_JV_CM7U7X/_P"#CZ'4/%WA6P^(?[)NA?#OX?WWB70;/QU\08_V
MBO$7C"7P)X,NM5M(/%/C.+PCI'[,UMJOBN7PMH4E_KD7AK3+FUO]>DL%TJSN
M;>XNXYD^5/\ @X2_Y/<^'/\ V:OX!_\ 5M_':O.R/!8K!9M1CBJ,J+J4*[AS
M.+YE&*O9QE):75UOJ=F9XFAB<OJ.A4511JTE*RDK-NZ^)+='],O_  3V_P"3
M!?V'O^S0/V:?_5,>"J^OZ^0/^">W_)@O[#W_ &:!^S3_ .J8\%5]?U\Q4_B5
M/\<O_2F>W#X(_P"&/Y(_C$_X.#/^3^O!?_9H'PF_]7/^TM7B7Q+_ ."G'[;V
MF_LS?#K]D#7O#WA#X/\ P]O?@!X,\,:3=P_"[6--\=?%S]F_5/AWK/PLTB[O
M;SXG:MXLT?4_!?Q"T:WN;M/'_P .O#/A:YU#7= >3PGXETW3XM6TJY]M_P"#
M@S_D_KP7_P!F@?";_P!7/^TM7[ ?&C]FBT_:?_X(G_!'PY;Z=KFI>./AE^R+
M\!OC?\*[3PUHOB/Q5X@U#QY\./@1IEVOAC0_!WAK5]+N?%>M?$/PC?\ BSX9
M:-IMU;^((M/U7QI9^)=.\,ZUXBT'1+6OLJ.)PV'RW(GBL/3KTYU:L>>I_P N
M/WS_ 'J6L9<MTY*2V6FI\Y4HUZV-S14*LZ4XTX/EA_R]]R/[MO1J^J375ZZ'
MQ7_P2&^$OA;]F7]E7]J?_@I(GB7X=_&[Q;X=^!_CV/PU\/\ P1XD\7Z+J_@'
M3/AKX.3XM_$?X4_%+4M:TFVL?#?Q!\:^)=$\#65Q!_PKKQ98^&/#'A?PW\1?
MA]XX\>>"_BRL!_)S]E'QU^SG\;_VM?%?Q1_X*?\ Q%\7^)/"/B#P?XK\5ZWX
MDN&\;-)XY^*37GA3P[X8\-:Y!\(M"G\6:)X:T_PMJ'B'5_#FE^"1X,\.>&3X
M%\+>%[2YL/"4%OX-UCZ0_P""/WC[5?'6M?M-?L#ZM\0T\(^!_P!M3]G/XM>$
M/!\]YHOB[QDOAWXSIX%U72X?$7AKP_IVO:;X0TR*]^%.H^.]=\>SZT-"NO')
M^&'PR\,P>-](N-,TG2]8^:_V6?%W@3]A+]K3Q9IO[<O[+EU\3--\/>$/%GPT
M\;_"7Q)X9\ >,-9\%^)M2O/"GBOP_P"./#WACQW,? /B^]DC\.VND:'KEIXM
MT32K_P !?$'4_&?A/Q=KFDRV6C^*^R%*I'%9XIRKU<7.G0G1EAY0I8J6#::2
MP\G%PBXN/)-QCK.*VG*#.>52$J&6."I0H1G4C556,IT%B%9MUDFG+F3<XJ3T
MC)_93,[]LS6/V4_AM^U%X-^('_!.+Q9JJ>!?#&D_#?XE>'=1U;3/%>JVGP\^
M.'@SQ5J=Y:Q>'].^-OAO_A(]8L=)D\*^!_'A7QBGC'2[GQ%K^JV4&H2:)!#X
M7T+ZH_X+R_M$^(/B!^V1KOPGU6R33?!?[*WA32M%\/Q"?3+Z35M9^)W@;P/\
M6?&_C!;A- TW6-).J:=J/@GP=+X:O-;\1Z7"/AQ;>)=-FTR[\4:OIT/U;XA_
MX*L?\$@+#0;S5-,_X)EQ33Z?=Z1-J%EXF_9M_9(T2U/AD:Q8#QCJ-G>Z%XS\
M9O<ZUHWA)M;U?PYH-W86&G^*/$-AIGAK5/$G@_3-7NO%NB_'?_!=[X*ZCX&_
M;J\7>,M1EU;4?#O[2/P[\&>.-+O)_"U]I&@V%YX3\*Z5\%_$_@C2?$LUU>Z9
MXPUG0[3P+X;\9^(S9#3KWPY8_%#PIIVJZ+%!<Z1K?B&<-5]IC\OA7PN)HU:.
M$Q<,/5Q\H3KUY_N>6\HQBW*G#VVKBFU-M:ME5J?)A,7*G6HU*=2OAI5:>$4E
M2I1]_FLFY)*4O9Z)NSBKV5DOH_\ ;\_X(T_![]CW]C/Q)^T#X7^,GQ5\8_$+
MX>:A\(K3Q=8^*-/\$KX$\52>-O&WA3X8:TWA+0-&T/2_$G@2,>)_&-AXNTH:
M]XX^)<NFZ)H]UX4N9-7O]3A\7:7ZQ_P;<_\ (9_;9_[!G[,/_I5^T;7B7_!0
MS_@M!\,/VLOV3-2_9_\ "WP4\;>%-2^(]EX!U3XD^)O&'BSPY9:+\/\ Q-X#
M^(OPR^)&GZ3X'CTBUUN\^*&B:QJ_AG6_#T^M^(8?A%J-E:)HNJV_AO4;G6+W
M1M"]M_X-N?\ D,_ML_\ 8,_9A_\ 2K]HVN/$?VBN'\<LR<_;?6:3@JC@YJFZ
MU'7W+VBYJ?)?HGR^YRG31^I_VKAOJ:C[/V-3G<%+EY^2?\WVE'EYK=U?WKGS
M5_P;O?\ )XGQ#_[-7\6_^K1^"=9'_!P9_P G]>"_^S0/A-_ZN?\ :6KXE_8E
M_:0\>_\ !.G]KG3_ !1XN\/WY'@;6?%_P0_:1^&NB:AX-U+6+S1K'4YO#GCO
MPQI7B'9XAT&;7OA]\0_#FD>+]._X1WQ#I%EXPUCP%;^#I?'FB>$_%.L:VD__
M  4<_;1\/?MT_M+Q?%W0/ ]]\/+'P_\ #32_A;HFB:QXELM?US6_"?A3XB?$
M[Q-X=\9ZU:6&E6%KX7U?7+'X@)#J_A:SU#Q7IVB:C83VFG^,/$=NHOW])82O
M+/Z..C#FPCPBM64H\K<J4J<8K6[E)RBTDG>+YMKVX57I1RFKA92M76(_AV?-
M:,X2;VLDDFKNVJMO8_4'_@I%\>?$7@W_ ()3?\$ROV=-)T^(:#^T'^SC\&?%
M'C?6)9=,N5ET+X#_  R^!.O:/X0_LC4/#^H3K_:WCKQCX0\:1^)='U[0-4T:
MY^&]OHK0ZQI/BS58K.#_ ()U_P#!&KX"?M=?LJ^ OVBOBA\8/CAI&L^//$7Q
M$BLO#7PRN/AQX<T#1M&\"^/O$'PV&FZI+XQ^'_Q%U;7M6N]9\&:UKLFMZ??^
M%[./3=;T[04\/FZT*Y\0Z_:_X*0? 7Q%XT_X)3?\$R_VB=(OHVT3]GW]G'X,
M^&/&NCR1:9;K%H/QW^&/P*T+2?%QU;4/$&GW#?V3XY\'>$/!D?AO1M!\0:KK
M-S\1K?66ET?2?"NJS7>1^P7_ ,%EO@]^R!^QCX?^ /B/X+_$_P 5?$;X<S_%
M>[\&S>&]2\(1> O&5UXS\7>*/B;HO_"7>)-6U6Q\2> (I_%7B^_\,:P^A^!?
MB9)I6B:;;>++*'6[[4I?"&F>726+>3Q_LKG^L?VC6^M>P:56W-4Y>9NSY>7V
M-[/:U_=YCNFZ"S%_7N7V/U.G[#VJ;I[0YK+:_-[2WG?K8L_MK_\ !&WX<_LH
M?L3>-?COJ_[0WQQ^+7Q8^$^G^ ?#VAV.HS>%?#_P7L=#\6?'72])GT7PM\.;
MW1?&'C#P?HT47Q+\1^)+C2M/^+5U97_Q#U/6_&+Q0)K^HZ*WGG_!,7_@E!\
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MGPQ/X5\.?%OXYZCI&OQ^*=7\2?$?6]3\67'A3X,V^L>#_-\+:+XM\%:=XC\
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MK5L/^/+6/^O2#_TMMZRJ2W?K^B&]EZ?JPHHHIB"BBB@ HHHH **** "BBB@
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MA6C4=.7]>E%%%?UX?\[@4444 %%%% !1110 4444 %%%% !1110!+!_KX?\
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MP0W-M-'-&CKTWQ#_ &<_V>_BYK=OXF^*_P "/@U\3O$EGI5OH-IX@^(?PO\
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M6/\ Z2Q5D4ELO1?D-[OU?YA1113$%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $L'^OA_
MZZQ_^ABO:Z\4@_U\/_76/_T,5[76=3I\_P!#6&WS_1'CNI_\A+4/^OZ[_P#2
MB2J-7M3_ .0EJ'_7]=_^E$E4:M;+T7Y&04444P"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* -6P_X\M8_Z](/_ $MMZRJU;#_CRUC_ *](/_2VWK*I+=^OZ(;V7I^K"BBB
MF(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "M>'_ ) E[_U_V?\ Z*N*R*UX?^0)>_\
M7_9_^BKBD]OFOS0UL_3]49%%%%,04444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &O
M/_R!;#_K]O?_ $"WK(K7G_Y MA_U^WO_ *!;UD4#>_R7Y(****!!1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 5KZE_QZZ/\ ]>#?^E4]9%:^I?\ 'KH__7@W_I5/0-;/
MT_5&11110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#7UO_C\C_P"O*Q_])8JR
M*U];_P"/R/\ Z\K'_P!)8JR*2V7HOR&]WZO\PHHHIB"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@"6#_7P_\ 76/_ -#%>UUXI!_KX?\ KK'_ .ABO:ZSJ=/G^AK#;Y_H
MCQW4_P#D):A_U_7?_I1)5&KVI_\ (2U#_K^N_P#THDJC5K9>B_(R"BBBF 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*.:7=_U_7]:ARKM_7]+^KLP_^$:TK_GKJ'_?VV_^1J/^$:TK_GKJ'_?VV_\
MD:MRBCFEW?\ 7]?UJ'*NW]?TOZNS#_X1K2O^>NH?]_;;_P"1J/\ A&M*_P">
MNH?]_;;_ .1JW**.:7=_U_7]:ARKM_7]+^KLP_\ A&M*_P">NH?]_;;_ .1J
M/^$:TK_GKJ'_ ']MO_D:MRBCFEW?]?U_6H<J[?U_2_J[,/\ X1K2O^>NH?\
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M]_;;_P"1J/\ A&M*_P">NH?]_;;_ .1JW**.:7=_U_7]:ARKM_7]+^KLP_\
MA&M*_P">NH?]_;;_ .1J/^$:TK_GKJ'_ ']MO_D:MRBCFEW?]?U_6H<J[?U_
M2_J[,/\ X1K2O^>NH?\ ?VV_^1J/^$:TK_GKJ'_?VV_^1JW**.:7=_U_7]:A
MRKM_7]+^KLP_^$:TK_GKJ'_?VV_^1J/^$:TK_GKJ'_?VV_\ D:MRBCFEW?\
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M*_YZZA_W]MO_ )&K<HHYI=W_ %_7]:ARKM_7]+^KLP_^$:TK_GKJ'_?VV_\
MD:C_ (1K2O\ GKJ'_?VV_P#D:MRBCFEW?]?U_6H<J[?U_2_J[,/_ (1K2O\
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M_P C5N44<TN[_K^OZU#E7;^OZ7]79A_\(UI7_/74/^_MM_\ (U'_  C6E?\
M/74/^_MM_P#(U;E%'-+N_P"OZ_K4.5=OZ_I?U=F'_P (UI7_ #UU#_O[;?\
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MK^E_5V8?_"-:5_SUU#_O[;?_ "-1_P (UI7_ #UU#_O[;?\ R-6Y11S2[O\
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M]_;;_P"1J/\ A&M*_P">NH?]_;;_ .1JW**.:7=_U_7]:ARKM_7]+^KLP_\
MA&M*_P">NH?]_;;_ .1J/^$:TK_GKJ'_ ']MO_D:MRBCFEW?]?U_6H<J[?U_
M2_J[,/\ X1K2O^>NH?\ ?VV_^1J/^$:TK_GKJ'_?VV_^1JW**.:7=_U_7]:A
MRKM_7]+^KLP_^$:TK_GKJ'_?VV_^1J/^$:TK_GKJ'_?VV_\ D:MRBCFEW?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH D3[DO\ NK_Z&M1U(GW)?]U?
M_0UJ.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>RY>1SUER<U[)JW)OUMJ)9GAWA)8VU7V,9\C7*N>_,H:1YK6NU]I:?<?>O\
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M *W=J5?K5_P<V_\ (9_88_[!G[4__I5^S571:=_P1#_:PM/^"@\G[6,GC_\
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M98R0 ZYN?M/_ /!"K]M+X/?'&]\2_L<^$-,^)/PO'Q$U;QI\%9_A_P#%/1_
M/Q$^!VD^']5T+Q/\/-)\17WQG\?^&]8'BCP9J5X="\#^//!_Q"\?:]KC?#U?
MB%XHN?A_K^NZ=X?AMV?_  ;U_M]^/=(T_P"(_C+XI? C2OB-X_U'7?%WQ \*
M^/\ QOX_UWQ=I6K>)[7PUXGDU/QC\0_#W@OQMI7BWXDZGXMUSX@V'Q&M]*N=
M;T"TU+0M+\3Z'\4/B4OCB^3PEZ"Q.5RS3#YN\RHQC+#*E]7:;JQJ.$HOVEOX
M<8Q>KDM9JT6U)')[#'QP-;+E@ZDG&MS^V37)*"G&2Y+_ !R;6R>D7=I.+/HG
M_@J%_P H-/\ @EI_W9Q_ZQ)\4ZI?\$L_^4'?_!5W_K]_;#_]83^#E?HU^V3_
M ,$T_CM^T/\ \$X/V+_V/_!?BOX2Z7\2_P!G3_A0?_";ZYXHU[QC9>!=3_X5
M9^SKXT^$?B'_ (174])\!:WK]_\ ;/$OB.QO=&_M?PQH7VC0XKNZOO[.OXX=
M,GK?L7_\$S?CS^SI_P $Y/VW/V0O&_BOX1:I\2OVDKGX]2^!-;\*Z_XROO V
MEI\4OV:_ /P<\/\ _"6ZGJ_@#0]?T]K/Q/X6U&^UD:/X9U\6^@S65U9-J.H2
MSZ5;>(\9AO[(5#VT/;?VQ[?V>O-[&[?M+6^&QZ<</768.JZ<O9_V<J7/;3VE
MH^YZZ,_%?_@W/_Y2$>.O^S-?B[_ZNW]F&OD3_@B0[K_P4Q_8F5695DN_C D@
M5B!(@_9,^.D@1P#AE$D:.%;(WHC8W*"/Z!?^"4/_  2._:1_84_:F\2?&[XM
M^-?@AXB\):Q\ /'?PKMK#X<^)?'FK^(H_$7B?XB_!SQ=I]Y/9^)OAIX0TU=%
MBTWX>ZU#>7,>L27T=]<Z7%!IMQ;SW=U8^$?\$[O^"'_[6/[)'[8'[.G[0'Q'
M^('[/&M^#?A'<>/)?$VF>"/%OQ)U+Q/>+XH^!GQ+^&>GC0K+7OA)X;TJ[:'7
M_&6EW5X-0UK2Q'H\%_<0&XO8K?3[KT<5F."G5X@E#$TVL5@\-3P[3?[V<*%2
M,XQTW3:3O;<XJ&"Q4890I49IT,56G56G[N,JM-QE+79J+?R/BW_@XQ)_X>#^
M!5R<#]C;X1D#)P"?C;^TX"0.@)"J">^!GH*_J\_8$18_V$OV*HT&U$_9*_9Q
M15&>%7X.^#54<\\  <U^1?\ P5>_X)'?M)?MU_M3^'/C=\)/&GP/\.^$='_9
M_P# GPKN+#XC>)O'ND>(Y/$?ACXB_&3Q=J-W#9>&?AGXNTPZ)+IGQ"T.&RNG
MUF.^EOK;58I],MK>WM+J_P#VX_9B^&NO_!C]FO\ 9Z^#WBNZT>^\4?"?X'?"
M;X:>)+WP]<WMYH%YK_@3P%H'A?6+K0[O4M.TC4;K1[C4=*N9=,N;_2=+O9[)
MX);K3K*=I+:+Q\?B</4R;*</3JQE7H.O[6FK\U-2DVN;32]UU/2PM"K#,\?6
ME3E&E5C2Y)OX9M1C>WHTSW&BBBO /6"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@"1/N2_P"ZO_H:U'4B?<E_W5_]#6HZ "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HKRSXO_&SX6? 3PFOC?XN^,M+\$^&9-5TW1(-0U+[
M3,]WJFJW"P6MG8Z?807>I:A.%\V\N4L;2X:STVUO=2NA%8V5S/%Z/IVHZ?J^
MGV.K:3?6>J:7JEG;:CINI:=<PWNGZCI]["ES9WUC>6SRVUW9W=O+'<6US;R2
M03PR)+$[QNK&%4IN<J2G!U(1C*=-2BYPC/F4)2@GS1C)QDHMI*7+*U[,X:>9
MY;6S#%931S#!5<TP.'PV+QN6T\50GC\)A<;*O#!XG$X.-1XBA0Q<\-B8X:M5
MIQIUY8>LJ4I.E/EN445^>W[?'[?'@G]C;P3]CLOL'BGXU^*;"9O W@9IBT-C
M"QDMQXO\7BWD2XLO#5E<(ZVULKP7WB2^@DTW39(((-5U72,L7B\/@</4Q6*J
M1I4:2O*<ON48K>4Y.T8Q5Y2DTDCQ^,.,>'. N',SXKXKS.AE.1Y30=?%XNNV
MW)OW:.&PU&-ZN*QF*JN-#"82A&=?$5YPITH2E(F_;R_;W\!_L:^"FMH#8>*O
MC5XFT^5_ G@ S.8[>-S+;KXM\8&V=)]/\+6-Q&XBMUE@U'Q+>POI>DO!#%JV
MLZ+_ #^?LC_\%3OC1\'/C1X@\5?&3Q'K_P 4?A[\4O$ U3XCZ1>7"S7VCW\Z
MPVD?B?P+;2/!I^C76CV,-M8KX;LQ8:#J>A6-IHC1V#6&B:GHWYN?$?XC^-OB
MWXV\0_$7XB^(;_Q3XQ\4W\FHZSK.HR!IIYF 2*"") EO96%E;I%9Z=IUG%!8
MZ=8P6]E96\%M!%$OVE^P/^P/XV_;)\;?;;W[?X6^"GA:_A7QSXY6$+-?3*([
M@^$/"!N(WM[WQ+>V[HUS<LD]CX;L9X]2U*.>>?2M*U;\HQ'$&<9SF^&>6>TI
M>RJ_[%AH/2STG4Q6O)+FA=57)^SITVXK[4Y_X_<1?2+\:O''QHX8GX6+-,I>
M59K-<#\,8*HG2]DU*GB\TXK]YX'%_6L"ZJS:6,<LKRS+)5\+1ER/%8O&?V5>
M _'G@_XG>#_#_C[P#X@T_P 4^#_%.GQ:IH6NZ7*9;2]M)2R,"KJD]M=VTZ2V
MFH:?=Q07^FW\%S87]M;7MM/!'UM<1\./AQX)^$G@GP]\.OAUX>L/"W@[PM81
MZ=HVC:=&5A@A4EY9YY7+W%[?WMP\MYJ.HWDL]]J-]/<7M[<3W,\LK=O7ZY3]
MI[.G[7D]KR1]K[/F]G[3E7/R<WO<G-?EYM>6U]3_ &9RMYF\LRYYTL%'./J.
M$_M598Z\LN69>PI_75@)8E+$O!+$^U^JO$)5W0Y/:KGY@HHHJSN"BBB@ HHH
MH **** "BBB@ HHHH *E'^I?_?3^35%4H_U+_P"^G\FH BHHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@"4_ZE/]]_Y+452G_4I_OO\ R6HJ "BBB@ HHHH
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M)U?]';_"?_P8:I_\JJ_SAZ*_#/\ B9/BK_H0\/\ W9C_ /-I_JI_Q1-\ O\
MHZ_C!_X,X+_^A;U_I:_Z/'_#UO\ X)U?]';_  G_ /!AJG_RJH_X>M_\$ZO^
MCM_A/_X,-4_^55?YP]%'_$R?%7_0AX?^[,?_ )M#_BB;X!?]'7\8/_!G!?\
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M]#)\6/\ PUVJ?_)U9?\ $2. ?^BPX?\ _#GA?_EG]?)G?_Q)3]+?_I'+Q?\
M_$(SO_YE/VXHK\1_^(@C_@G5_P!#)\6/_#7:I_\ )U?H+^R'^VG\#OVWO!/B
M;X@? B_\2:AX=\)^*6\':Q)XF\/7'AR[36ETG3=:*6]K<33-/;_8=5M&^T*P
M7S#)'C*$GORSC/A3.L7# 93Q#E&8XV<)U(87!XVA7KRA3CSU)1IPFY-0C[TG
M;1)M[,^0XY^C3]('PSX>Q'%GB#X.>(?!O#.%KX7"XG/>(N&,SRO*Z&(QM94,
M)1JXO%4*=&%3$UI1I48.5YS:C&[9]9T445],?AX4444 %%%% !1110 4444
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M<(WFI\W*E=Z)-6=U9K7=!1117F':%%%% !1110 4444 %%%% !1110 4444
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M^$"\#?\ 0E^$_P#PG-'_ /D.NLHH]A0_Y\4O_!</_D?)?<']K9K_ -#/,/\
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MOK."?!7*^"<_H9_A<[Q^.K4*&)H+#XC#X>G3DL32=*4G*F^9.*;:2W=D_/\
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M?[A_]"-15+)]V+_</_H1H BHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"6
M;[P_W$_]!%15+-]X?[B?^@BHJ "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 4=1
M]1_.M>L@=1]1_.M>@#(EDMQ)(&NK52'<%6N(U93N.592V0P/!!Y!X-,\RV_Y
M_+/_ ,"8O_BJ\WU/_D):A_U_7?\ Z4251K10ND[O6WZ?\'^EKG[1]OZ_J_\
M6_JWF6W_ #^6?_@3%_\ %4>9;?\ /Y9_^!,7_P 57E-%/D\W_7]/^EJ<[[?U
M_5_Z6OJWF6W_ #^6?_@3%_\ %4>9;?\ /Y9_^!,7_P 57E-%')YO^OZ?]+4Y
MWV_K^K_TM?5O,MO^?RS_ / F+_XJCS+;_G\L_P#P)B_^*KRFBCD\W_7]/^EJ
M<[[?U_5_Z6OJWF6W_/Y9_P#@3%_\51YEM_S^6?\ X$Q?_%5Y311R>;_K^G_2
MU.=]OZ_J_P#2U]6\RV_Y_+/_ ,"8O_BJ/,MO^?RS_P# F+_XJO*:*.3S?]?T
M_P"EJ<[[?U_5_P"EKZMYEM_S^6?_ ($Q?_%4>9;?\_EG_P"!,7_Q5>4T4<GF
M_P"OZ?\ 2U.=]OZ_J_\ 2U]6\RV_Y_+/_P "8O\ XJCS+;_G\L__  )B_P#B
MJ\IHHY/-_P!?T_Z6ISOM_7]7_I:^K>9;?\_EG_X$Q?\ Q5'F6W_/Y9_^!,7_
M ,57E-%')YO^OZ?]+4YWV_K^K_TM?5O,MO\ G\L__ F+_P"*H\RV_P"?RS_\
M"8O_ (JO*:*.3S?]?T_Z6ISOM_7]7_I:^K>9;?\ /Y9_^!,7_P 51YEM_P _
MEG_X$Q?_ !5>4T4<GF_Z_I_TM3G?;^OZO_2U]6\RV_Y_+/\ \"8O_BJ/,MO^
M?RS_ / F+_XJO*:*.3S?]?T_Z6ISOM_7]7_I:^K>9;?\_EG_ .!,7_Q5'F6W
M_/Y9_P#@3%_\57E-%')YO^OZ?]+4YWV_K^K_ -+7U;S+;_G\L_\ P)B_^*H\
MRV_Y_+/_ ,"8O_BJ\IHHY/-_U_3_ *6ISOM_7]7_ *6OJWF6W_/Y9_\ @3%_
M\51YEM_S^6?_ ($Q?_%5Y311R>;_ *_I_P!+4YWV_K^K_P!+7U;S+;_G\L__
M  )B_P#BJ/,MO^?RS_\  F+_ .*KRFBCD\W_ %_3_I:G.^W]?U?^EKZMYEM_
MS^6?_@3%_P#%4>9;?\_EG_X$Q?\ Q5>4T4<GF_Z_I_TM3G?;^OZO_2U]6\RV
M_P"?RS_\"8O_ (JCS+;_ )_+/_P)B_\ BJ\IHHY/-_U_3_I:G.^W]?U?^EKZ
MMYEM_P _EG_X$Q?_ !5'F6W_ #^6?_@3%_\ %5Y311R>;_K^G_2U.=]OZ_J_
M]+7U;S+;_G\L_P#P)B_^*H\RV_Y_+/\ \"8O_BJ\IHHY/-_U_3_I:G.^W]?U
M?^EKZMYEM_S^6?\ X$Q?_%4>9;?\_EG_ .!,7_Q5>4T4<GF_Z_I_TM3G?;^O
MZO\ TM?5O,MO^?RS_P# F+_XJCS+;_G\L_\ P)B_^*KRFBCD\W_7]/\ I:G.
M^W]?U?\ I:^K>9;?\_EG_P"!,7_Q5'F6W_/Y9_\ @3%_\57E-%')YO\ K^G_
M $M3G?;^OZO_ $M?5O,MO^?RS_\  F+_ .*H\RV_Y_+/_P "8O\ XJO*:*.3
MS?\ 7]/^EJ<[[?U_5_Z6OJWF6W_/Y9_^!,7_ ,51YEM_S^6?_@3%_P#%5Y31
M1R>;_K^G_2U.=]OZ_J_]+7U;S+;_ )_+/_P)B_\ BJ/,MO\ G\L__ F+_P"*
MKRFBCD\W_7]/^EJ<[[?U_5_Z6OJWF6W_ #^6?_@3%_\ %4>9;?\ /Y9_^!,7
M_P 57E-%')YO^OZ?]+4YWV_K^K_TM?5O,MO^?RS_ / F+_XJCS+;_G\L_P#P
M)B_^*KRFBCD\W_7]/^EJ<[[?U_5_Z6OJWF6W_/Y9_P#@3%_\51YEM_S^6?\
MX$Q?_%5Y311R>;_K^G_2U.=]OZ_J_P#2U]:22 I+BZM2 JEB+B,A!YB\N0WR
M@G !/!8@=2*C\RV_Y_+/_P "8O\ XJO/K#_CRUC_ *](/_2VWK*I<F^KT?Z)
M_P"?];G.]--U^MOT_KKZMYEM_P _EG_X$Q?_ !5'F6W_ #^6?_@3%_\ %5Y3
M13Y/-_U_3_I:G.^W]?U?^EKZMYEM_P _EG_X$Q?_ !5'F6W_ #^6?_@3%_\
M%5Y311R>;_K^G_2U.=]OZ_J_]+7U;S+;_G\L_P#P)B_^*H\RV_Y_+/\ \"8O
M_BJ\IHHY/-_U_3_I:G.^W]?U?^EKZMYEM_S^6?\ X$Q?_%4>9;?\_EG_ .!,
M7_Q5>4T4<GF_Z_I_TM3G?;^OZO\ TM?5O,MO^?RS_P# F+_XJCS+;_G\L_\
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MMO\ G\L__ F+_P"*KRFBCD\W_7]/^EJ<[[?U_5_Z6OJWF6W_ #^6?_@3%_\
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MO,MO^?RS_P# F+_XJCS+;_G\L_\ P)B_^*KRFBCD\W_7]/\ I:G.^W]?U?\
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M)B_^*H\RV_Y_+/\ \"8O_BJ\IHHY/-_U_3_I:G.^W]?U?^EKZMYEM_S^6?\
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M4/\ K^N__2B2J-:K9>B_(Q"BBBF 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!JV'_ !Y:
MQ_UZ0?\ I;;UE5JV'_'EK'_7I!_Z6V]95);OU_1#>R]/U84444Q!1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 5KP_P#($O?^O^S_ /15Q616O#_R!+W_ *_[/_T5<4GM
M\U^:&MGZ?JC(HHHIB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH UY_^0+8?]?M[
M_P"@6]9%:\__ "!;#_K]O?\ T"WK(H&]_DOR04444""BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ K7U+_CUT?_KP;_TJGK(K7U+_ (]='_Z\&_\ 2J>@:V?I^J,BBBB@
M04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% &OK?_ !^1_P#7E8_^DL59%:^M_P#'
MY'_UY6/_ *2Q5D4ELO1?D-[OU?YA1113$%%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9F7LH-TUB*%:EC,GS)4OW,<WRO,(4?W,:;91117V1_-H4444 %%%% !1110
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MOX0>+;;6]1,TS^+?%FI7GAWQ%)]@FT?PW\=_\%MF _X*#?MH$D +9?#/<20
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M** "BBB@ HHHH **** "BBB@ HHHH **** -6P_X\M8_Z](/_2VWK*K5L/\
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MA,)AJ$)UL1B<16G"C0H483JUJLX4Z<)3DD^NHKX'_P"'HW_!/O\ Z.K^%O\
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M'_TEBK(K7UO_ (_(_P#KRL?_ $EBK(I+9>B_(;W?J_S"BBBF(**** "BBB@
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M?\BU_P 2+_D%_P"BUZ_10FU>S:NK.VET]T_+R':^ZO9W6G7OZA1112 ****
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M.I74,.IWH3R[*TL_T0_X)X?\%#]+_:,TNQ^%'Q7OK+2/CEI%ELLKU_)LM/\
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MM(\,V\VL7J7FLZ[-:>)/ASXMU"77-52UTJPO+E=3CM/L&BZ9%!8P2I=3W?\
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M,^I_7/J?U?ZU]4Q7U?VGMOJU?D]E+_+7HK_4HHK^7_\ B6#_ *KC_P UG_\
M& _W/_XKH?\ 6+G_ )VW_P#)&?Y:]%?ZE%%'_$L'_5<?^:S_ /C '_%=#_K%
MS_SMO_Y(S_+7K_3_ / W_(D^#_\ L5O#_P#Z:;2NIHK]5\,/"W_B&]3.JG]N
M_P!L_P!KPP$+?V7_ &=]7^HRQCO?^T,=[7VOUNUK4N3V>\^;W?X'^G-]._\
MXG0POAIAO^(5_P#$-O\ B'>(XMK\_P#KQ_KC_;'^M-/ARGR<O^I_"W]G_4?]
M7[\W-COK7UNUL/["]8HHHK];/\]PHHHH **** "BBB@ HHHH **** "BBB@
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M_P#H8KVNLZG3Y_H:PV^?Z(\=U/\ Y"6H?]?UW_Z4251J]J?_ "$M0_Z_KO\
M]*)*HU:V7HOR,@HHHI@%%?S(?$#_ (+V?$?X1_M;_'_X;>,/@5X.\1?!'X9^
M-/C'\*O"FG^%=4UC3/BG)XT^&6I:KX5T#Q+XF\::SJMWX2O?"7C'Q?X5OH]9
MT;2/AUIVM>"/#WC*RU"PU+Q[J/@"XTGXC>P?\$R/^"P7Q2_:M^+_ ,4/AO\
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M-"T#4= U?Q(9='^'>H>'+#3+3Q3X9%EJ7B"S\1W&H:C:Z#/X:U[YG_X*<?\
M!7F[_8T\=Q? ?X+>!?"'Q ^+Q\*:/XI\3>*?&&OC4/!'PUGUC6K.?2?">N>"
M/"6K:?XMUSQ9K7@VTU;7+O3=4\2_#A?#&E>)OAIXML)?'NF^(-0T;3OYW_VQ
M/^"J'QR_;R^%7ASX5_%7PA\&++3?!_QC\,_$_1/$'PKM?%V@W.G3:#\._B[X
M'US0==TWQ)XR^(,.OMK4OQ%T._TZ\LM0\*2>&5\.:I;WEEXH/B2UF\,=.6Y+
MB\1/"8FI04L).K3<E*I&,IT>>*E)0YE/DLV[JS<=4FFF\,;F5"E&O1A5:Q$:
M<U%J,FHU.5\L7*SCS7]4GHVGH?U?_P#!+/\ ;4\=_MT?LY^(/B=\3/"GA+PM
MXV\%_%KQ-\+]:/@4:S:^%?$ T[PUX+\;Z9KFEZ'K^I:_JWATQZ/X]T_P_?:;
M=^*/$OVS4M!O/$-O?Z?:ZY#X<T/]):_FB_X(Y_$7Q#\'_P#@E7^W1\6O",&C
M77BOX7?$7]H3XB^&+;Q'9WVH>'KCQ#X)_95^#OB718->L-,U31-2OM&EU+3+
M:/5+/3]:TB^N;%IX;35+"=X[N+[!_P""1?\ P4&^/7[=Q_:"_P"%W:'\(=%7
MX5I\)!X9'PK\*>,_#)N9/&X^)?\ ;S:Z?%OQ(^((O40^$-(.D1Z>NDM9"34A
M>2:I]IM38X8_+YPK9E6P].,<)@\0J<O?^#VDXQA&,9-SDKR7>R?9&V%Q<73P
M5.K-NOB*/.O=?O<L>:3;2Y4[)OI>W??]G**_FK_;Z_X+7?'K]E+]LSXB? [P
M'\*?A%KOPP^"TWPVA\8KXN3QG=>/?'__  D/@/P?\5O$C>&O%.C>)]%\/?#W
M[1X<\;6?@[0UU3P+\1_[(UO1KGQE?MK]AJ\7@K2/UO\ V\?V\OAG^P7\-=!\
M:>-M#U?QQXH\<ZOK/ASX??#[PWK'AC3-8UG5M+\,:MKKZWK3:[JUKJFF?#G2
M]4MO#WAKQCXQ\->'_&VH^%=2\<>$BWA35#JL$+<LLNQ<?JG[KF>.CS8:,91E
M*:]UZI/W;*46^:UDVW:SMLL7AW]8_>66&?+6<E)*#UZM:ZIKW;W>BW5_N6O/
M_B/\6?A7\'-$L_$OQ=^)?P_^%?AS4=6AT#3]?^(_C+PYX'T2^UVYLK_4K?1;
M/5?$^I:787.K7&G:5JE_#IT,[WDMEIM_=1PM!9W$D?\ (OH/_!Q3^UW9>(?#
M]GXM\ ?LIZQ:PZII5SXE\/Z#X9^)WA7Q#K>@1W<,NLZ?X?U#4_C5XOC\.:IJ
M6GK<VVE:[?\ AWQ99:/=RPW]UX?UZ"VDTZZ\3_X*2_\ !6&\_;RL?"OPA\'^
M&O GAWX2^"[GX:_$35%@N?%.N_$$?&Z+X8:G:?$'PZ/$.KP>"M._X0KP'K/Q
M*\1?#A8U^&KW/BG6/ J?$+1_%R>&O%-CX<L/2I</8YXFC2KPC3IU&^>I"K2G
MR*/+SJW-K-*2:CU5VKV=N.IF^&5&K4I2<IP2Y82A4CS<U^5WY?A=GKTZVNK_
M -M/@CQWX'^)GAC3/&WPX\9>%/B!X,UHWHT?Q=X(\0Z1XK\,:L=,U&[TC4AI
MFOZ#>7^E7YT_5M/O]+O?LMW+]DU&RN[*?R[FVFB3\3OVN?\ @MOI_P"R)^U3
MX_\ V>_%/[-E[XL\)?#C4_ /]N?$;P_\6;>V\1W?AOQ5X$\&^.]<U/2/AUJ/
MPZCTR?6]"M?$]_I^E:#??$C3K'Q%<Z3:2WGB/PU#JTITK\F?^":O_!6CXW?!
MOQ?^RM^Q?)X6^">O?!;6/B[X>^%0\S3_ !=HWQ?@?X[?%&XACUH>+CX]U/PI
M,_AOQ?\ $-=<BTG_ (5=$=>\-Z6GA4:CI&IZB/&=EWG_  5=_;#^'/PS_P""
MA7BF'6_V'_V4OB[9_L_0^%I?&^I?$[PYXNO_ !;\;D\;?!_P5KOBV'Q;+H7B
MK0OAMKJVWPVUC0/A[\-?^%T_"CX\I\+-:\-GQ[X<BE_M&W\*:1I1RAT,PKX7
M$89XN'U?$5:"AB(4I.$*BA3K2:J+E=E9TF[ISOROE:(GC_;82E6I5UAY>VHP
MJN5&4US3AS3I13B[J[NIK2T=)*Z9_8-17YP_\% _^"E'PF_8+\/Z)9:EID?Q
M.^-'BT66H>%O@WI?B.'P]J'_  B3:G)8ZIXY\7Z__9'B-O!_A>,6.K:=X:N)
M]!U._P#&OBJPGT30M/DTS1?&_B3P9_/K-_P<#_MXKHEAJR_#K]E.*UU;5O$/
MAS2M<F^&'QD;1-2\2>%+#P[JGBC1+!A^T'#'>ZMX9T[QCX0U+Q#I%MJ3W^D6
M'BCP[=:@EK!KNF2W'GX7)\?C*2K4:453DW&G*I4A3]K);JFIM.5K-7MRW32;
M::777S#"X>;IU)MSBDYJ$)3Y$[6<W%-1NFG;>S3MJK_V445\!_\ !//]O?PI
M^WW\)_$?CG3_  @GPR\;^!O%]WX5\;_#2;QKHWC6[TNUN8AJ?@_Q;IVHV=EH
M&M7/A7Q=H[S6MEJ7B#P;X4<^,O#/C_PUI4&NZ;X4B\4:U^'7PV_X.-OB2MY\
M0M4^*7[-_@S7= U6VL]6^#&A?#_Q1K'A'4/#B2>)X#=>&_BOXR\2R^,X/$[+
MX$U*6ZM/&?@[P#X76;Q=X273KGP)::+\0#J_PUFEE6/KU,11IX=NKAG"-:FY
M0C*+J-J-N:24D[.7,FXJ*YF[6953'X6E"E4G62A74G3FHR:DHI.6T6TU=*S2
M?-I:^A_6#17\COP>_P"#BGXYVWBNQN_CG\&/A%XU^'$T=O::G'\$[?Q7X+\:
MZ;(^LZ3_ &CX@TB?QM\0/B!X<\32:9X?CU];'P/>GP>FOZ]<:/'=?$7PMI]K
M?2W?]97A[Q#H'B[0-#\5^%-<T?Q/X6\3Z/IGB'PUXE\/:G9:UH'B'0-:LH-2
MT;7-#UG39[G3M6T?5M.N;:_TS4["YN+*_LKB"ZM9Y8)8Y&C&Y=B\OE36)IJ*
MJING*,HSA+EMS).+>L>973MNFKIICPV,H8M2=&3ER-*<91<91O>UT^CL[-7V
M9L4445PG4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% &K8?\ 'EK'_7I!_P"EMO656K8?
M\>6L?]>D'_I;;UE4EN_7]$-[+T_5A1113$%%%% !1110 4444 %%%% !1110
M 4444 4M2TW3M9TZ_P!'UBPL]5TG5;.YT[4],U&UAO=/U'3[V%[:\L;ZSN4D
MM[JTNK>22"YMIXY(9X9'CD1D8@_RY?\ !1/_ ()V:C^S]J.H?%[X0Z?>:K\$
MM5O/,U72H_.O=0^&&H7LP6.RO9&,EQ=^$KNXD6#1=:G:2:RFDBT36Y6O&TW4
MM=_J:JEJ6FZ=K.G7^CZQ86>JZ3JMG<Z=J>F:C:PWNGZCI]["]M>6-]9W*26]
MU:75O))!<VT\<D,\,CQR(R,0?&SO),+G>%=&LN2M"[PV)C%.=&;Z?WJ<[)5*
M;=I*S3C.,9+\5\</ _A;QOX6GDN=0C@<ZP,:U;AOB6C1C/'9+C9Q5TU>#Q66
M8MPIPS'+IU(PQ%.,*M*=#&4,-B:/\*WP;^#?C_X\>/\ 1/AM\-]$GUOQ'K<X
M4!0R6.F6*%?MFKZO>;3%8:781$S75U,0JJ!'&))I(XW_ *]_V/?V//A_^R1X
M!CT/0H[?6_'>M6\$OCKQY-;*E_K5ZH5SI^GEP9=/\.6,HQ8:>K S,HO;WS+I
MQY7:? +]E7X*?LT1^*Q\)_"_]D7'C'6;O5=5U&^N3J>IQVDUR]Q9>'++4)XQ
M<P>'-%#^3IEA))-.559]2O-1OMUVWT77D\-<+4\G3Q6*]G7S"7,HRC>5+#0=
MURT7))NI-?'4<4TG[."4>=U/R7Z,_P!%;+/!JE+B?BJ6 SWQ#Q*K4:6+PRG7
MRSAS S<J;H9/+$4J-2ICL91UQV93HTJL:51X#"PIT/K57'E%%%?7G]B!1110
M 4444 %%%% !1110 4444 %%%% !1110 5KP_P#($O?^O^S_ /15Q616O#_R
M!+W_ *_[/_T5<4GM\U^:&MGZ?JC(HHHIB"BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% &K8?\>6L?\ 7I!_Z6V]95:MA_QY:Q_UZ0?^EMO6
M526[]?T0WLO3]6%%%%,04444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %:\/_($O?\ K_L_
M_15Q616O#_R!+W_K_L__ $5<4GM\U^:&MGZ?JC(HHHIB"BBB@ HHHH ****
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MQ!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\H_^^%_PH\J+_GE'_P!\+_A1S^3_ *_I_P!/0]GY_A_P3Q.BO;/*B_YY1_\
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M\H_^^%_PH\J+_GE'_P!\+_A1S^3_ *_I_P!/0]GY_A_P3Q.BO;/*B_YY1_\
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M #RC_P"^%_PHY_)_U_3_ *>A[/S_  _X)XG17MGE1?\ /*/_ +X7_"CRHO\
MGE'_ -\+_A1S^3_K^G_3T/9^?X?\$\3HKVSRHO\ GE'_ -\+_A1Y47_/*/\
M[X7_  HY_)_U_3_IZ'L_/\/^">)T5[9Y47_/*/\ [X7_  H\J+_GE'_WPO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV_Q%G/QF/CMOCH/#C>*?^$!_: ^!NP_#X^"]>.B?VL?%.[_A.=7^PG1<7O\
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M?P"J'_@UQ_Y04?L,_P#=S/\ ZV'^T%0/HO5_@D?@A_P5:_X*U?\ !1G_ (*
M_P#!5:X_X(Q_\$G_ (N?\*)T+1/'>K?!3QC\4_"?B/4_A?XZ\<?$[X;16OC_
M ..7B;7OBUJGAO1?B3\)/ 7[/%W\/?&GA:?1O@>\WB/XHZ5X2^(%U8:Q\9M
M^)O@7X=Z1Y!\?_\ @VT_;V_X(X_!OX@_\%"_^">__!2KQ3XO^+'[._A^?XA?
M$CPKH?PZD_9YO=:^ W@.:#XD?$66>]U#XU_$[P5\7-"\-W'@GP]XQ\4_ ;XD
MZ!_PAOQ)\,>'-7M_+\4>*--\,_#[QG^7O@K]G#]M']JS_@X(_P""H'P7_8/_
M &QM!_8O_:#UW]IG]O75-.\9:O\ 'CXH?L_ZA\3/".@?M1ZEJ_B/X2^%=?\
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M(X?B[KO[,OC_ .!5]X<T[1?%'AL:A;^%/$W[=/QBNO@'KNO:XEXFAW'A6_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M35?B%X(LO#?ANR\$S:?JFGS>*M3U/Q5H%QH&DZ3XJ /W7HKR/]G_ .,_A?\
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MP'\??V>?VG?BK_P3U_X)P_\ !/[XP_MA?MF?"'P]X8\7?$?69_ GC#Q_\,/
MGA7Q+H7P7\>:3XCTGX:_ ^[U;XH_$O0[_P ,?%%_!_B/5M=UWX&Z?\/O']WX
M4GMKGXCZ?J3:3-^$'[%GB/\ ;%_X-MO^"U?PM_X)93_$!OVC_P!D/]MGQS^S
MI:V%KXDL[#P!I6NG]H'7=(^$5A^TC\/?"6D^,?BI>?"CQ[\.?B9I'BSX=>+M
M"U?4MOQN\#?#6"/Q'I.FQS_!KQ]\/?WZ_P""J'_!?;XH?L[_ +9'AS_@EO\
M\$V_V66_:\_X*#>*%\)6VJVGC%M?TKX6_##7_%UCX5^(>A^'M0T*RN/".H_$
M4W7P6O\ 6/'?COQBOQ+^%WPO^"?AW4O#?C+Q/X]\3P:%\3?"?@P#S_KI?O\
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M$$>@>)/%'BCQ1XD\-:/H_AL^'SXR\9>"/P*^ /\ P=%_M;?L:_&;X=_L;?\
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MN_M#?\6K_8JUN[\/GQ%^T$?^*'&F_P#"]/VB/!_P\_:<S\6/&_\ :GPILO\
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M_%OPI/BV%UTCQ\?!?_"=^'X;;0?$>FV\7\U?AKPGX6\&?\'RUUI/@_PUX?\
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M  ZXC895[S]LU&'(RK?\,G*1D<C@]:^^_P#B"O\ ^"5O_1<?V]__  ZO[/\
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MQ>? 7PTN_!/Q%\-:0#7^6_35:_\  [>A]._\$@O^#AKX@?M>_M/O_P $Y_\
M@H7^RCXA_8X_;P7P_JFM^&M)@\*_$CPQX5^(=]IV@^(/BK?^%M6^%7Q&TZ]^
M(OP(U_3O@<F@>-O#=QXQ\6>-?"WQ,T[3?%6N6WB7P-?:G\/? WBS^4G_ (*S
M?M[?M=_%7_@N1^PO^T)\9O\ @F?\7?V=_C_^R[XD_9U\->"/V1=2\<ZQX_\
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M/B9X ^/G@3XY^%[GXGP^(HO OB>3P]X3^(?P[U?PQKOB#PIIGB/7_":CP_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6]U]LO8KB_NO[M**!W_K[O\ (_C,_P""77_!%3]NOXU_\%/?B+_P60_X+/\
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MM=>/K[4O$=WHMY>_#K]H3QA_;W@_Q'X(E^&?@S]GCXI:SXAUWQQ\,=2T;5_
M(CURPTOXD_T9T4!?T^[T_P OS/\ .U^(_P"RY_P7/_X..?C-^Q:W[??[#/A[
M]C3]EO\ 9Y^,/CG0?B)\0['0?%?[-/Q#M/ 7CN#X4>)OBW-I'PX_:%\??%7X
MI>)]>U#PQX!T7PS\&O%?AOX.ZC\-O^%D:Y=6'C+69=%T3Q9>^#_V6_X.$O\
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MWX&\:^.O#_@O3]"M_$UO\-=/^*?Q!_HXHH'_ %^7]?TS^<']FG]@K]K'X?\
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M/C+_ ,$U?A_^S1\,/A]\??A9\4-:^*'C7X;?%S]E8^']5OM ^)7P\L=:N?\
MAHWXO:]K_P 1? GAS0?&'BOQ!X[TWX+?#7Q_XWT;^S_#NVQ%YK>A:%XI_P!&
MJB@+_P!?UK^)Y%^S]\%_"W[-_P !?@E^SOX&O]?U3P5\!?A%\-O@OX/U/Q7=
M:??>*-1\+?"WP;HO@?P_?^)+W2-+T/2KS7[S2="M+C6+K3-$T?3[C49+B:RT
MO3[9XK2'UVBB@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
40 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>gb2k1ptlkg5v000005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gb2k1ptlkg5v000005.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" /N!YX# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OXGO!W
M_!RA^W'\5KCPS=_#W]GW]G6+_A9^JZ2/AU\/O^$5^+WCSQHO_"=:G!%X$\!_
MVGHGQ0\-_P#">>,R-6T?PR=1T+P9X;_X3'Q$?M6C^#]!_M2UT"S_ +8:_P M
M[_@FE_R7C_@F_P#]G'_L/_\ JZ?A37TN24,*\NSW&8C"TL3/ 8:G7HQJ\W+>
M-#'591]UJRFZ--2>Z2TMK?QLSJ5UB<LP]&M.A'%8AT:DH6O:53#P3U3UBIR:
MZ7>I_1'J7_!?W]OOX'?$W0_#/[47[(OPU\+0MHW_  D^K?#34O!/QH^!'Q-U
MGPQJ\7B71?#>O:'JOQ#\5>-TTC1IO%VB7:_VS<_#OQ%I^MQ>&O$OARPDL-3$
MNKZ-_03_ ,$^O^"@_P '/^"@_P (#XZ\!/!X4^)?@^/1=-^.'P0O]:M]7\4_
M"7Q3K%M>26&;U++29/%7PZ\6G2M8O/AC\3+;1=(T_P ::;I6KZ?J.C^$_B#X
M4^(/P^\%?DG_ ,'-R>"V_9X_90=U\%_\+5C_ &E]2_L)KW^PQ\1A\(&^"OQ,
M7XI#PSYY'B<^ V^(/_"@C\0%TG/A\^)5^%;>)!_:2>$R/@[_ ((1_M,_"?\
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M4W_$ZV?\(3_PH/RO^%M_\5KY>S=_Q._^$VK7_P""4/\ P]P_X5WXY_X=G_\
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MK$&@:Q\(_%NA^.?"7C;X;_!S2-5\=O/\);OQ_KWA;PYX/U37QXUT*>^U;1-
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M')2LI22<8MK[0^!?_!PS^PK\=OB'\&/ASIWA;]HKP%>_';QAX&\ >"]?\?>
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MTLUTWOK?0_T2**_.WXV?\%7OV _V=/BAXZ^#'QD^/+^#OB5\-9M%M_&GAO\
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MFIKJ/@[QCX-\7:?J7A7Q)XBTK^R_$]EINH7NG^*M.\1^'=$^PZ_C<_X()?\
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M]Z^B<G]DY'F&8K&0P/U7#^WJ4I5HKVLN7DC&M)MRM9.U"IIY+N?WR_##X^?
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M/B/PYKVDW%WI6MZ#K>E7=IJ>D:OIEW=:?J6GW5O>V5Q-;31R-_%1_P $=_\
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M=/ ^IVVK>'KNWDLO&7@!?'.C:0/&6@-H,NH>)O"[>,M%TCP@;ZTT'1O[Q_\
M@F;\??BI^T]^PC^S=\;_ (V>$O$'A#XH>,?!%W:^*D\36,.F:GXUF\'^)]?\
M#:9\9H=,LO"7@?2M,T/X^:)X:TWXW^%].T#PY;>&+#PS\0=(M/"]_KWAV'3-
M?U/ISC*UELL'.E7^L8;'X?ZQAYN#IS4%##S_ 'D6]54AB*=2F[1DDYTZE.$J
M:E5QR['2QBQ$:E+V-;"U52JQ4E.+DY58^ZUUC*E.,E>2TC*,Y*34/NNBBBO'
M/1"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *_RE_V./#GB_P 9:A^R3X,^'NN_\(K\1/&GBG]GGP;\
M.O%G]J:GH?\ PB?Q#\6>)O!OA[P+XJ_MW0X+K7-"_P"$:\6:EH^N?VYH5K=:
MYHWV#^T]'M;G4K6U@D_U:*_@C_8=_P""+O\ P4Q^#_Q8_8F\4?$7]F=_#NB?
M"/XW?LK>+/B'=_\ "X_V?M7;P]X=^''Q2^'VO^--3^S:%\5]3N=671=%T35-
M0-IH<.IZCJ*6OV;2;._OI[:TF^HR/&4\'EG$$G5H1KO#4YX:E6E3;KU:>'S!
MQA"C-WKWG*G&5.*ES<\8M>^D_$S3#SQ&+RJ*A5E2^L-5ITU+]U3G5PR<Y5(K
M]U:*DU-M6Y7*_NL^U]<_X("_\%"?CE\2O#WB']I;]KKX7>*;?^R9_#&L_$_7
M/'7QN^/'Q*\-^&-+L/%.M>%]*\/>'_'WA+P.GB328_'&KA)_#MU\3O!FGZ/8
M>)_%/BC3KF^U>'^P?$!_P62_8<^!W[ O_!-?]G+X,_!^\\;Z[I?B'_@I-;?%
M#7_%'Q-\16WB/Q;XF\=>(?V5/VF-&CO;C^R-(\-^%-&M]"\%>%O"_@W1=*\)
M>%/#>FG1_"]IK&L6VK^-M5\5>*_$/]@M?)G[<_[*>F?MN?LJ?%O]F/5/'.M_
M#0?$BQ\,W&D^.]!TVQUNY\->*_ 7C?PS\2?!>H:CX?U&2UA\2>&/^$O\'Z)!
MXS\,0:KX<U/Q+X0FUS0M&\7>#]7U"Q\4:1S8;.Z]3,LOQ&/J7PV&K1M3ITXP
MIT(3BZ,ZM.E3C[U2E"4JD;WFVG3A*$9:;5<KHQP>+HX6/+6Q%&<74G.4I5)7
MYXPJ3DVU3G)1C4C&R<=6G)7/XBO^"7W[,'[:O[3OB']H.R_8N^/\O[.^H^ =
M'^#%U\4]6/Q6^*WPEA\>67C"\^,$7@"PCO/A1H/B"Z\32>#9_"7CJXEMO$D5
MC!H"^+XI-">[DUW6UM/N7QI_P;T_\%#_ (B>*_$GQ \>_'K]G'QU\0/%TEA<
M^*?&WC/XJ?'#Q)XM\47>CZ'IOAK1Y_$?B?6?@GJ&M:Q+I?AW1=&\/Z?/J-U=
MR6&AZ3INEVNRQL+6WBP=%_X)&_\ !6?]B']H\?$3]C]-'\::KHN@^)=)\,_&
MKP!XW^%/AVRUGP3XLUG5=,N?!'CWX<_&W7M'%QJ5[IOAOPAXZ\2^#+W1?B#\
M.="\32>"-4\,>./%'C#P-;:UX=];^(/[-W_!R7^TIJGASPEXP^)_CGX-*^E>
M.])T[XE:!\?OA#\$/!?A&YU?PU)J5OJ?C^W_ &3-='Q \4I=ZQX:T7P]X7O;
M3P!\0=6\*:QKSW%C!X;\.ZOXSUR+W<7C:]-XS$8;-,D>'E"O.G&"IO'5(33G
M"BZ2C>4Y3Y82E*?3VLXIIP7DX?"T:D</1KX'-/:ITXU')R6%@T^6515'*RBH
M7G:,=VZ<&U:3]-_X++?!_P 3?L]?\$<_^":7P"\:7>@7_C'X'>/_ -E_X/\
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MTU9N4-;M7]6E3JO/,=B)TY\E3"KEJN#4)5'+"\RA.W+S64[J+O92TLF?(/\
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MK_@Z'_M'_A9G_!._R/,_LS_A#?VUO[0^_P"3]H_M?]CO^S]V/E\__C\\K?\
M\LOM.WFOFB\_X(>_\%1OV6/BK\.?B;\ ;_P)\5O&OP_\<>(?$7P^^*?P>^(&
MB?#SQ!X;C\-7:Z3X=U[QCX4^,=]X-LM&N/BKX0UK5+#Q9\+_  [XC^,O@MM
MN?'GPQ\<^)/%G@[5H9_&V_K_ /P2._X*W_MN?M'/\0?VN(M(\&ZOKVA>&]-\
M2_&WXC>//A7XDTG0/!GA36="T:#P3X"^&GP2\1:R]MJEGH_B+Q?X_P##'@;2
M]!^'/PS\1^*;7QSJ7BSX@>#_ !IX_N?$'B/MI_4,-G5;/99K@ZF%E"M5ITJ=
M24\;.57"2PCIRP_*JD5%.4H7C[1PC3HNE&_M5S2^M5<LI92L!B(XB,E3E4G!
M1PJC'%/%>T5;F<'+7ET?)S+GC4D_</+/@7+:2?\ !NW_ ,%(%M@!+#_P4)^
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M?\EV_P"%@^,_^%T_\@+_ (IG_DIG_"3_ /(H_P#%'?\ 0J?\2#^SZ_K_ /\
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M+EC*LI3E;V<;.2@HKW&Z<&TE?X2_X.-?^4E_A3_LQ?X$?^K^_:]K])OV0/\
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MJ^'OPG\7^.=?UOXH_!/P_I.B_%[PQX?N_@UK/@SPIH'BOQ7X,\4V>@6OPO\
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M#+7?&GBCX;_#[Q-\1_ 8^%GQ#\1>"/"FN^/?ABOBG2_'"_#GQGJ^@V&H>*/
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M ((^?M<?LR_&OXY?\* \8? K]O[6/"-OI_AKP;X%M=5L(/$?QHU74++QU?\
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MFC^$[^\3PGJ/AGQ3XC\?ZWHFD^+K3Q)\*/&WAY?#O^"-7_*5O]A7_L</CO\
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MOC6?BC\;_"GB;QE<>+_VC]5\)7>CVOQ-^(;V7A746T?1]"CGN_"^@:+X;O\
MQ5IO@SPA>^'?#NI^![/P5\'(]2\._"NX\(7&@>#;?3OZPOV,?VCOV1?VM/\
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MAZEI6OV>GZM9_P!2/_!KS_R9W^UI_P!G^>-O_66OV1J_DI_X)B_\EQ_X)O\
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MC;D<;*WIRIPQ&8Y+&O%58RRNA4DIZJ<J>$G5BYIZ3O.*<U*ZGJIJ2E)/L/\
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MOKMO\-_VGK"V_9NU:WL]=\4)X8LOB)X[\3>';GX$^,=8\%>'=#\0V_C/7?\
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MY<ZJ/&C?#H?LI>'8/ 1U,:^?AW%XU;XO?%F3XMCP4;M?^$63QI/H2_!3_A:
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M1?P+XKF_::_X*&^!=3T'5_#/B?7/VHOVP;C3]*\4:7?:!>RZ=X^^,OQ#\7^
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M?\,>;_\ AF7[?X'_ .%3;O\ AC''V/\ X55X"_X3/9_PL_\ XN#M_P"%F_\
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MJTZ<Z=ZJER\UW-0:ORV/X^M!72_AO\7_ !#-^U?\%?C-X]UFSN9O%OC[X/\
MC;Q_XQ_9P^+GB?XD>,-2\,_$\W?QN\8^._AC\0_BQI5M\2O#^N:QJ'CZ9_"^
M@?%[Q%_PL/3OB'HWQ$T+6+9;CQ!_HX?L<?&GX)?M!_LQ?!GXJ_LXZ _A#X*:
MUX1BT+P'X'?P?:^ #\/=/\ 7]]\/-0^&Z^#],0:!HD7PZUOPKJG@B"W\(W&I
M^!9H=!CN_ >N>(/!UQH>MZA_"7_P5G_;%\#_ +;O[:'B3XR_#?2M5TCX8^!O
MAGX5^!/@O6=>NA%=_$'1/A[XR^)WB^Z^*LF@2Z?9W/@G3?%&K_$O5;+P[X<U
M6]U'7&\&^'O#GB?Q3%X2\4>(]:^'7@K^K/\ X(5_LD?$G]DK]BG4H/BWIFL>
M%?'G[0'QE\4?M ZG\.O$6@P:%XB^&^F:KX*^'7PK\*>'M?2+7-7GN-8UWPC\
M)="^(U_::Q8>$_$OA";QR?AWXK\)Z7XE\&ZM->>KQ334HY9BZG/2QE>ARUL)
M*K*I&G%4X3E*"E=4N2K+V<HP4>?G7,G*DV<&12<9X[#PY:F'ISYZ>)4%&56;
MJ64)R23FY0E.HIS;Y'"2C[M6)^S%%%%?(GT 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+I_LD?'K]L?]F?X&_#[]GCX9-\4O&/@[]JGPU\2-8TL>*? /A(:#X5L/@?\
M'[P==>)FO_B%XJ\)Z9=+;:YXV\/Z1]@TJ[U#76;6EO(-+DT^SU.]L/./^"%G
M[$G[77[&V@_M,Q?M+Z1_P@GASXBZ]\+)OAS\,_\ A8VC^,_L.O>%-+\:Q_$+
MXB?V/X,UCQ)X$T'_ (3;3?$/PY\+?VI;:W_PFGB'_A6/V/Q1H^GZ!X:\"7^L
MY3PE&.7T<8L92G7J8B5&6"7+[:G!1J-5I6J.?*W"*]ZE&%IQM4<O<=QQ%1XR
MIAGAJD:4**J+%._LYS;BO9KW>6Z3>U1SO%WIJ/OG[YT445PG4%%%% !1110
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M6^IZ7X9U/Q-!I%GXLO\ P[XMM?#$NK3>#_%*:1]HU_G4_P#!6WXY^*/VE_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN[^+6US[ )ZQCA<2XIZI2E1Q7,UV<N2GS6WY8WV5OL7_ (.A?^2E_P#!//\
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MD^%W@_QO\68?BS\6-=L_'<'BOP=XTTWQ9X[^)^J?$_P'HW@;^9/]OC_DO_\
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M%*S\>>"_B[\1;2[\*ZI^S#\5M%\>7_C*#X?^!_#^L_!'6?V==?\ %=W%\3_
M6D_#KPE =)\3_"33/ >E>(O#&J?!VSADM-5\.^$K7P;J.DZE<A++5KC^Q/\
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M^@O_ (((_P#**C]F_P#[&O\ :D_]:]^/5>CGO_(MX<_[ JO_ *;P)QY7_O\
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MKFE2O"LI4\+BL#@(^RDZ<%4I5*>(KRG\,959)14[N/L7>:4J<)'W!_P;#?\
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M%JOAC_A<_B:R\8_,G_!M/_PN#_AK7]H[_A'=G_"@O^&=-!_X7#C_ (0[S/\
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M_*U9]U&5.I%J[4\--+E:;/C'_@Z%_P"2E_\ !//_ +$K]M;_ -/7['%?9/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^2_^$D/+_J:>?Y=S]CZ*_'#^ROC!_P! WXD_^ ?B?_XW1_97Q@_Z!OQ)_P#
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M+^'/F^%=.UE=6.L1^+]$&I^ 5N_%<5?_ (*A-_P[L_X+;?L]_M^:EMLOA/\
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MQ!_\/=?_ .@T/^)?Z/\ T7^2_P#A)#R_ZFGG^7<_8^BOQP_LKXP?] WXD_\
M@'XG_P#C=']E?&#_ *!OQ)_\ _$__P ;H_XJ>9C_ -(P^(/_ (>Z_P#]!H?\
M2_T?^B_R7_PDAY?]33S_ "[G['T5^.']E?&#_H&_$G_P#\3_ /QNOK3]E"T\
M:VVL^,#XJM?%%O"^F:6+0^((-6BB:475SYHMCJ*JAD"%=_E98*5W<8K]/\&/
MIZ8WQ<\3>%?#JKX"\9<(T^)L1CZ$N(LSS6KB,#EGU+*,PS15,11EPQ@%.-9X
M%86">+HVJ5X2O*W)+Y_BGP<I<-9!F.>1XQRO,W@*=&:P.'PT85L1[7$T,/RP
MFL?6:Y/;>T?[N5XPM97NOMNBBBO]$#\1"BBB@ HKY0_:NMO%5SX?\)KX5M_$
M%Q<+K-\;M?#\6HRS+";)0AN!IRLXCW\*9/EW=.:^'_[*^,'_ $#?B3_X!^)_
M_C=?P'X\_3CQG@EXEYQX=T? [B_C:GE.$RC%+B+*<TJX; XO^U<LPN8NE3HQ
MX;S%1EA7B7AJC^MU.:=.4K0OR+]FX.\(Z7%F0X7.Y<79;E+Q-7$TW@<3AXU*
MM/ZOB)T.9R>.H-JIR<\?W<;*25WN?L?17XX?V5\8/^@;\2?_  #\3_\ QNC^
MROC!_P! WXD_^ ?B?_XW7XY_Q4\S'_I&'Q!_\/=?_P"@T^H_XE_H_P#1?Y+_
M .$D/+_J:>?Y=S]CZ*_'#^ROC!_T#?B3_P" ?B?_ .-T?V5\8/\ H&_$G_P#
M\3__ !NC_BIYF/\ TC#X@_\ A[K_ /T&A_Q+_1_Z+_)?_"2'E_U-//\ +N?L
M?17XX?V5\8/^@;\2?_ /Q/\ _&Z/[*^,'_0-^)/_ (!^)_\ XW1_Q4\S'_I&
M'Q!_\/=?_P"@T/\ B7^C_P!%_DO_ (20\O\ J:>?Y=S]<?%/BKPQX&\,>(_&
MWC;Q'H/@[P9X.T'5_%/B[Q=XIU?3_#WACPMX8\/:?<:MK_B/Q'K^K7%II6AZ
M#H>E6EWJ>KZOJ=W:Z?INGVMQ>WMQ#;0R2+_-!^SK^W+_ ,%-O^"L'[0'B.?]
ME+5+;]B/]C?X=7/B:/4/BOXA^$O@;XG^)[L:MHWAZ7P'X)\7P>.9/$6@^-_C
MI/<V$GC'6/!/PCU+P5X*^"_@'Q[J5G\2?'WQ%UN#X(ZK\6?T^_:P-_8?\$A?
MVU'\5QZE#=6O[$G[94VK)JZW46HI;)\+_BM+FX%X8[I<V/EM"9"G[@Q,C"/8
M:_.W_@V/\0:#-^RO^U'X3B\1:)=>*K+]KBZ\<7OA:#6+&X\1Z5X+\8?L]_ 3
MPYX2\4:CH27#:GIWAWQ3XA^'7Q!TCPYK%S:Q:9KFJ>"_%MEIES=7?A[6(K/_
M %'\/.*/];O#/@WQ _L:>4XKC/).&<Z>49E&&,KY!#/N':6?5,MQ"KX:E2K8
MS#U,1' U:]7!T6I86M*%*C.?+'^=<]R]Y?Q)F60O%NO0RJMF='ZUAI2H0S">
M!S*G@(5:<J=3VD*3CS8CDIUIJ2JTU.4H1]_S;]I/_@H?_P %#O\ @DC^U!X+
M\*_M=^-_#'[:7[-'Q>T@>*?"/BC1/A[\-?A7\4]2\*?#>TM]/^-6G?#GPMX-
MO?#-IX;^*?@WQ!\1_ NM7F@_$^Y\=?#KXE^$X/ &C^"OB/\ #+Q'XI^*]]\,
M/U1_:@TS_@I/\?O%OP=UW_@G]^TG^R5\,_V3/%'A_P"%'CG4OC&;2Y^)OQ=\
M8V/B34?&G_"8:EX*BO\ P#\3_@AXY^$5[\+?$/PW^(/PSBT74/ OBGQEX]T"
M73;OXL>&/AYK4UQ?_F__ ,'//Q&\%Z1^S9^R]\,]3UYK#QKKG[1.N?&'2]%;
M2]:EM[_X=?"7X)_$KP7\0=<N-<M["3P]IR^'O$?QS^%]N-,U75+35]7_ +>:
M[T+3M3M-#\076D?I#X+^.7@;_@E[_P $LOV4]6_:\:X\"^(/@O\ LM_LY?!K
M5OAGH=UX<\4>//%WQO\ "_P7\/:%/\%_AI9Z3KS^&O&GC6ZU?PQK\45WIOB5
M/ VD^']"\0_$3Q1XP\/?"[POXH\;Z+]C54G+*L1AL-1EBL=AZT9T(X>G5I3K
M4L54PU.O#"SC.E&6(7N\D8>P53#U)4Z<+N*\NDTUF%"M6FJ&%JX=QJRK3IU(
MTJE#VU6G+$*4*G+2<$Y5'/VJAB+3J64&?F5XO_;[_P""@'[!?_!27X*_L8_'
MWXN?#7]LCP!^T#XH_9?M;/Q-?_#31?@KXQ\*^"?C[\3/%OP*BUW0H_AWI5OH
MFA>*="^)EIJ/B#7?#GB5?BWI/C#P+X#\.Z;H/B'X6:_X^U[4/"O6_MR?M_\
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M**_2CP0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@#RCX\_![PW^T-\#?C/\ /&6I>(=&\(?'+X4?$7X/>*M7\)
M7=AI_BK2O#?Q,\(:QX+US4O#-_JNEZWI=CXAL=,UNZNM%O-2T75["VU**VFO
M-+O[=)+27_.U_84^)%[^QG_P4&_9F\=_'/P]H/AS7/@1^T-J?PD^-MCXH^(O
MA;PWX9^$NJ^+[#QM^RI\:?%/B;XC6O\ PDO@MM$^!/\ PL#QAXTUW4+74_\
MA&-?LO UW:0^+]&TC4AXGLO]*&OYT/VT/^#>;X<?M3?M!?%[XV^"OCVGP1T7
MXX31>(?'/PQM_@?X>\4Z!'\0-2TI=(\>^*O#]YX?\:_#);2#XD36MOXW\7VN
MN:7XC\2:Q\4]=^(?CC4_&6HIXQM=#\-^YEN-P\,OS?+L74]G#%T(U<--QJ34
M<;0;]E%QIQDXQJ2E"=23M%K#P@_B37F8[#UI8K+\90A[26%K2C5IJ48.>&K*
M/MK2G**;48<BC=.U64HM-6E[I_P6-_X)??%G_@HA=_LU>*?@[\0OAWX3\1_
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MY-O6. P<<-+!JA'V$[.<;RO.2Y6IRG?GYE*"E%J24)?PU!61_')X5_X("?\
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MOCAXK:/XOW/@GQ!IWA73? /C'XQ^*X_$]]=:J/$/BK5?]$_X%_"/P_\ L_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M= 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#/QYJ.C7=S\=;7QYX.@^%?Q+?0/C%\/&-S?Z=X(^''BR7-_X-K]''@?X@?\
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M+)\'/".E1?$#Q%I>E?$GQW\%]*\9Z'XC\+>'8O&^@^ /"/B'PC\2)/$">%/
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M:/0--U;Q#H&EW^LO:#3K/4=<T>RN+F.YU.RBG_C$_P""KO[*'P(^&'_!9?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?\+=_M__ (2SX3_M-_"__A</_" _V7]@_P"&C->^*NN?VY_PK[_A-=1^U?\
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MYITU34'I)<ME2AI&R?+JG=W_ !K_ &D/^"2/_#07_!/S]BG]A3_AH'_A$?\
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M#4E*$:M6G&<9)QE&:ISA[2+3:<9\T?(_++]G/]@'X[?#;P'>?L]?M!?MG/\
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MUTN#XA7T^E^&? WPC^)=SH/@GQ;XFU+3/B'\%O\ 0$KB_B%\-_AW\7/"6I>
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M;](;7]0\.76F_!KX]ZC\7?&6N;]5^"_BOX7>,-$M_BQ\3/A;_6K^R1KGQ/\
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M3\1W'A$6D7@#P[KVG6'Q#\4^$H_@KX=:X\4^)-<^"'ACP/X8\+?$+Q_XDO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO1C\56DK[7J17YOS/I2BOFG_ (;0_8[_ .CL/V:?_#[?"[_YJ:/^&T/V._\
MH[#]FG_P^WPN_P#FII_5,7_T"XC_ ,$U/_D1?6</_P _Z/\ X-A_\EYK[SZ6
MHKYI_P"&T/V._P#H[#]FG_P^WPN_^:FC_AM#]CO_ *.P_9I_\/M\+O\ YJ:/
MJF+_ .@7$?\ @FI_\B'UG#_\_P"C_P"#8?\ R7FOO/I:BOFG_AM#]CO_ *.P
M_9I_\/M\+O\ YJ:/^&T/V._^CL/V:?\ P^WPN_\ FIH^J8O_ *!<1_X)J?\
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MBSZ.HKYI_P"&T/V._P#H[#]FG_P^WPN_^:FC_AM#]CO_ *.P_9I_\/M\+O\
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M&M/V5?\ HYG]GW_P\WPY_P#FDI>PK_\ /BM_X+G_ /(^:^\OVM/_ )^0_P#
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M_HZS]FW_ ,/G\,/_ )J*/J>+_P"@7$_^"*O_ ,CYK[P^MX7_ *":'_@ZG_\
M)>:^\^DJ*^;?^&R_V0/^CK/V;?\ P^?PP_\ FHH_X;+_ &0/^CK/V;?_  ^?
MPP_^:BCZGB_^@7$_^"*O_P CYK[P^MX7_H)H?^#J?_R7FOO/I*BOFW_ALO\
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M<\9NW]H-%?C-_P %NOV[/'G[$_[,7A"/X'^,=(\)?M!?&CXH:)X7\#:@NI>
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>UMK^TV-OJ6#O;ZIAK6O;ZO2M>ZU^#?^NI^8G_#D3_@E_P#]&Q_^9H_:$_\
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M9AW.$(.$W1Q'M*;G!MN,G&\;Z-'XSX\UZV3^'V)QN45:N5XR.:993CB\NG/
MXF-.I5FJD%7PSI55":24XJ?+):-,_ 3^P-)_Y]/_ "/<_P#QZC^P-)_Y]/\
MR/<__'JV**_L7_5KAS_HG\D_\-6 _P#E!_#G^N?&/_15\2_^'W-/_FHQ_P"P
M-)_Y]/\ R/<__'J/[ TG_GT_\CW/_P >K8HH_P!6N'/^B?R3_P -6 _^4!_K
MGQC_ -%7Q+_X?<T_^:C'_L#2?^?3_P CW/\ \>H_L#2?^?3_ ,CW/_QZMBBC
M_5KAS_HG\D_\-6 _^4!_KGQC_P!%7Q+_ .'W-/\ YJ,?^P-)_P"?3_R/<_\
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M5JBOY9_M3,O^AACO_"O$?_+#^O\ ZC@O^@/"_P#A/2_^0/RE_P"'(G_!+_\
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M-,%/+\TG/"9CF6,QN%G.GA)2ISEA\36JTI2A+WH2<&XRUBTSZR_X<B?\$O\
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M_P#QZC^P-)_Y]/\ R/<__'JV**/]6N'/^B?R3_PU8#_Y0'^N?&/_ $5?$O\
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MG[0G_!'K1/CW^T;_ ,%%=$\4)\<M;O[+0OV.O&?P._9T^'?Q)^+8_9]_;/\
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MCC(RDZN(C"<E_M,91BE&*:E:,6W*?Y*?L!?&C_@G%8?\$;?@9:?&=_A)X?\
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MK_0^_P""=_\ R8M^R;_V0?X<_P#J.V=?SK](W_DG>'_^QU4_]0:Y_3WT7?\
MDI^)/^Q#2_\ 5AAS[*HHHK^03^V@KP;]JC_DV']H[_L@WQ?_ /5?>(:]YKP;
M]JC_ )-A_:._[(-\7_\ U7WB&O0RG_D:Y9_V,,%_ZDTSSLX_Y%.:?]B[&_\
MJ-5/\W"BBBO].#_)@**** "BBB@ HHHH *_K\_X-V?\ DV+XW_\ 9>)/_5?>
M#:_D#K^OS_@W9_Y-B^-__9>)/_5?>#:_'O'7_DW>8?\ 8?E7_J9 _</H\?\
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MXI\(>*/B#X@U2[UKQ=X7T75OA_!>^!AXAMIM=\-)K/B#PQ::[-X#TOP%X/\
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MWQ!?:I\??C5\$/A?X3N]'M-/N-,T37/"?C.']HO4-3\737NJZ=<:?X?F\&_
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MJ^(O_5OC#_;;PZ_Y-]P)_P!D;PQ_ZI,"%%%%?*'V1S_BS_D5?$W_ &+^L_\
MINN:_@/K^_#Q9_R*OB;_ +%_6?\ TW7-?P'U_;?T0?\ =N/O^O\ PU_Z;ST_
M@3Z;?^\^&_\ UXXL_P#3G#H4445_9I_"04444 %%%% !1110!_13_P $,?\
MD5/VC/\ L8?AO_Z;?&%?O/7X,?\ !#'_ )%3]HS_ +&'X;_^FWQA7[SU_EW]
M('_D[_&/_7[)_P#UGLI/]=OHV?\ )D^!O^P?.O\ UI,Y"BBBOQL_<@HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;^(O_H_PW7Q/B1_R07%O_8CQW_IIGWWA9_R<;@S_ +*#+_\ T\C^V*BBBO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP?\ #J^^.UA\+_@+\0?"GBK]E/Q;\,6\7?%6YMOB5J6I?"?X/^-/#VA6%O\
M%GQ/\/M.^)VCZC?-J4^OZ)KVG>,8C87OB[6H[GHC&AEV)IU)1Q5*-3#9C24Y
M0PN(J4ZM;!5</0K4J2JPA)T*U>%62J5(7Y4X/F1C)U<90G",J$Y0KX.IRJ5>
MC"=.GB85JM.<W3E./M:=*5-.$)+WFI*S-'PM_P $QO\ A%_&'@?Q?_P\*_X*
M@>(O^$(\>>!_'?\ PB_BG]K'^U_!_B__ (0CQ7H_BO\ X0WQQHG_  @-O_;_
M (#\7_V1_P (WXX\/?:;3^W_  IJFL:/]LM/MOVB+]/Z_A,_X*W_  J\(_\
M!'3]KOX6_'+]AKXIW?@G6=6^&=_\5]3^ K>./%#/X"TCX1^-/AIK-AX4\?Z]
MH/Q$T7XJ^,?V8/VK/$_@J7_A(/AKX[U-K;Q+XA^$WQ9L=,\?:OH(T+P?\(_[
MLZY,PIRA5H576>(CB\+#$TJDJ2H3]G[:OA^2I13DH3A4P]1>[*<)PY)PJ24M
M.G"2C[.K25/V4J&(E3JTU-U8>TE1P]53A4DHRE&=*I2^*$'&2DN7[4BBBBN
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MOAG_ ()Q_L;Z/^PK^R/\,?@3'#H-QX_6TN/'/QR\4Z"+&[MO&GQP\:^3JOQ
MU:#Q%!X.\":OXL\->'KK[)\.?A=K'C#P]!XRLO@UX'^''ACQ!<7-SX>62ON:
MN+%5_K6*Q&*]FJ7UBM*K&E%)*E3TC1I:>ZW2HQITY327M)0=1I.3.FA2^KT*
M-#F]HZ--0E/?GGK*K-.[=IU93E%-OEBXP3Y8I(HHHK U"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /P-\&_\
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MO_)N\P_[#\J_]3('[A]'C_DYN7?]BW-__4.9_091117\,'^A 4444 ?YZO\
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MJ^(O_5OC#_;;PZ_Y-]P)_P!D;PQ_ZI,"%%%%?*'V1S_BS_D5?$W_ &+^L_\
MINN:_@/K^_#Q9_R*OB;_ +%_6?\ TW7-?P'U_;?T0?\ =N/O^O\ PU_Z;ST_
M@3Z;?^\^&_\ UXXL_P#3G#H4445_9I_"04444 %%%% !1110!_13_P $,?\
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M,8I=VVDO,4I**<I-1C%.4I2=E%)7;;>B26K;T2/4**_F*_8N^/\ _P %3O\
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MQI\6M?CU*_\ #GAWPGH\UO9^(_'6K66CK:Z#9R6^B6^G6U[+J%_#<ZE=YO\
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M>NLI6O*3O*3U;9]6T5\I?\-X?L._]'E_LI?^)$?"'_YL*/\ AO#]AW_H\O\
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M"CZKB?\ H'K_ /@FI_\ (A[>C_S^I?\ @R'^9]6T5\I?\-X?L._]'E_LI?\
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MPMJ_TO\ \-X?L._]'E_LI?\ B1'PA_\ FPH_X;P_8=_Z/+_92_\ $B/A#_\
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M7,:S6]U:W$+/#/;W$+I+#-$[QRQNKHS*P)L5@:A1110 4444 %%%% !1110
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MX\ U*.*<6FGC<2TT[IIR5FFM&@HHHKRCO"BBB@ HHHH \=\(_L\? #P!X_\
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M_P!D;^(O_H_PW7XLU^TW_!!3_D_.'_LC?Q%_]'^&Z^)\2/\ D@N+?^Q'CO\
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MR?C 4444 %%%% !1110!_9[_ ,$Z_P#DRG]GS_L3KK_U(]<K[3KXL_X)U_\
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ML#ZC@O\ H#PO_A/2_P#D#XE_X=T?L;?]$=_\R%\4_P#YMZ/^'='[&W_1'?\
MS(7Q3_\ FWK[:HH_M3,O^AACO_"O$?\ RP/J."_Z \+_ .$]+_Y ^)?^'='[
M&W_1'?\ S(7Q3_\ FWH_X=T?L;?]$=_\R%\4_P#YMZ^VJ*/[4S+_ *&&._\
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MOK?_  M?XWZM_9FKV4*-:W?]FZY\2M3TB]\IB3]GU"PN[5^DD+BOZ *^(?\
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M#2?^?3_R/<__ !ZOT0_X)9?LV?!7]H[]L_X>?"?XS^"_^$R^'^NZ#\0+W5=
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M*_@C^U,R_P"AACO_  KQ'_RP_P!&_J."_P"@/"_^$]+_ .0/RE_X<B?\$O\
M_HV/_P S1^T)_P#/8H_X<B?\$O\ _HV/_P S1^T)_P#/8K]6J*/[4S+_ *&&
M._\ "O$?_+ ^HX+_ * \+_X3TO\ Y S](TJPT+2M,T32H/LNEZ-I]EI6FVOF
MS3_9K#3[:.TLX/.N9)KB;R;>&./S9Y99I-N^61W+,="BBN&YU!1110 4444
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MOBE^R9XP^'WQ0N?&7]L'BGX$^(_@I^QWXD_9^_X)^Z!\-_@QXOT+X>:SX+^
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MHHHKR3O"BBB@ HHHH **** "BBB@ HHHH S]6!.EZD%5F)T^\ 5($NG8FWD
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M4D&GZG8PQ=?52W^4?/[*_KRV%';YRZ?WG_7GN?S3?\%P?^2U?!G_ +)=?_\
MJ6:G7XD5^V__  7!_P"2U?!G_LEU_P#^I9J=?B17^IO@7_R:;@O_ +%V(_\
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M^D#_ ,G?XQ_Z_9/_ .L]E)_KM]&S_DR? W_8/G7_ *TF<A1117XV?N04444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '\^
M_P#P5$_Y29_\$AO^RK:G_P"I[\,:_H(K^??_ (*B?\I,_P#@D-_V5;4__4]^
M&-?T$5ZV/_W')O\ L%Q'_J97.'"_[SF/_812_P#46@%%%%>2=P5^0_[57_)<
MO%__ %[^&_\ U&-(K]>*_(?]JK_DN7B__KW\-_\ J,:10!\[T444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% 'H'PF_Y*I\-/\ LH'@W_U(]-K]P*_#
M_P"$W_)5/AI_V4#P;_ZD>FU^X% !1110 4444 %%%% !7Q#_ ,%)_P#DPS]J
MS_LC?BK_ -$1U]O5\0_\%)_^3#/VK/\ LC?BK_T1'7N<,?\ )2\/?]CS*?\
MU/PY\_Q9_P DKQ-_V3^<_P#JNQ)_GJT445_I8?Y3A1110 4444 %%%% !111
M0 4444 %%%% !1110 5^M7_!$/\ Y2*?";_L5_BM_P"JX\1U^2M?K5_P1#_Y
M2*?";_L5_BM_ZKCQ'7R/'_\ R0_%_P#V3><_^J^N?:^&_P#R<'@G_LJ<B_\
M5EAS^YZBBBO\Y3_4,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M /)^?[5G_99/%7_H^.OB&O\ 2OA?_DF>'?\ L191_P"J_#G^4_%G_)5<3?\
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MG+?Y1Z?W5_7GN*.WSE_Z4_Z\MC^:;_@N#_R6KX,_]DNO_P#U+-3K\2*_;?\
MX+@_\EJ^#/\ V2Z__P#4LU.OQ(K_ %.\"_\ DTW!?_8NQ'_JRQQ_C_\ 2&_Y
M/-QY_P!C/"_^JG+PHHHK]9/Q@**** "BBB@ HHHH _L]_P""=?\ R93^SY_V
M)UU_ZD>N5]IU\6?\$Z_^3*?V?/\ L3KK_P!2/7*^TZ_R"X\_Y+CC/_LJ^(O_
M %;XP_VV\.O^3?<"?]D;PQ_ZI,"%%%%?*'V1S_BS_D5?$W_8OZS_ .FZYK^
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X&^#?^
M5A;XL_\ 9GNF_P#I)\-*_?*OP-\&_P#*PM\6?^S/=-_])/AI7[Y5ZF:;Y?\
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M "*OB;_L7]9_]-US7\!]?WX>+/\ D5?$W_8OZS_Z;KFOX#Z_MOZ(/^[<??\
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MX8U_017K8_\ W')O^P7$?^IE<X<+_O.8_P#812_]1: 4445Y)W!7Y#_M5?\
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M .GD?VQ4445_G:?Z='%>%O)_MWXD^5]C\S_A-;#[3]E_M#S_ #_^%=> =O\
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M +SF/_812_\ 46@%%%%>2=P5^0_[57_)<O%__7OX;_\ 48TBOUXK\A_VJO\
MDN7B_P#Z]_#?_J,:10!\[T444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% 'H'PF_P"2J?#3_LH'@W_U(]-K]P*_#_X3?\E4^&G_ &4#P;_ZD>FU^X%
M!1110 4444 %%%% !7Q#_P %)_\ DPS]JS_LC?BK_P!$1U]O5\0_\%)_^3#/
MVK/^R-^*O_1$=>YPQ_R4O#W_ &/,I_\ 4_#GS_%G_)*\3?\ 9/YS_P"J[$G^
M>K1117^EA_E.%%%% !1110 4444 %%%% !1110 4444 %%%% !7ZU?\ !$/_
M )2*?";_ +%?XK?^JX\1U^2M?K5_P1#_ .4BGPF_[%?XK?\ JN/$=?(\?_\
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MO_)N\P_[#\J_]3('[A]'C_DYN7?]BW-__4.9_091117\,'^A 4444 ?YZO\
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M5?$W_8OZS_Z;KFOX#Z_OP\6?\BKXF_[%_6?_ $W7-?P'U_;?T0?]VX^_Z_\
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M@5^'_P )O^2J?#3_ +*!X-_]2/3:_<"@ HHHH **** "BBB@ KXA_P""D_\
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M "BBB@ HHHH **** "BBB@#/U8$Z7J0568G3[P!4@2Z=B;>0 +;2$1W#$\+
MY"3'$;$*QJAX45D\+>&T=)(W70-'5TFL8M,E1ETZV#)+IT!:#3Y%((>RA9HK
M1@8(R4C!J[K.W^R-5W^7L_LV^W^=YWD[?LLN[S?L_P"_\O&=_D?OMN?+^?;6
M=X.\O_A$?"WD_9_)_P"$<T3ROLGVO[+Y?]F6NS[-]N_T[[/MQY/VS_2O+V_:
M/WV^J^Q_V]^A/VE_A?7S73]3HZ***DH**** "BBB@ HHHH **** "BBB@ HH
MHH *_C:_X.&_^3TOAC_V:]X+_P#5K_&NO[):_C:_X.&_^3TOAC_V:]X+_P#5
MK_&NOV?P%_Y.!A_^Q5F?_INF?A7TB_\ DVN*_P"QOE/_ *>F?@Y1117]PG^?
M@4444 %%%% !1110 5_H??\ !.__ ),6_9-_[(/\.?\ U';.O\\&O]#[_@G?
M_P F+?LF_P#9!_AS_P"H[9U_.OTC?^2=X?\ ^QU4_P#4&N?T]]%W_DI^)/\
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M9_R2O$W_ &3^<_\ JNQ)_GJT445_I8?Y3A1110 4444 %%%% !1110 4444
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MM:TEAI_QK\,6\NJ>#="\9^'M:^+6N>+-<73OB9\4;Z]\,6C:G\.8=%\7:?\
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MNUR:WMHY-6\3^*]=UKQ+K]^UQJNNZMJ.J7=U>3;E<!U!1110 5_&U_P<-_\
M)Z7PQ_[->\%_^K7^-=?V2U_&U_P<-_\ )Z7PQ_[->\%_^K7^-=?L_@+_ ,G
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M'_\ EW7]==%'_$UGB3_T+N$?_#9FG_S\_J_I8_XDX\*_^AGQM_X=LH_^A_\
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M4 %%%% ']%/_  0Q_P"14_:,_P"QA^&__IM\85^\]?@Q_P $,?\ D5/VC/\
ML8?AO_Z;?&%?O/7^7?T@?^3O\8_]?LG_ /6>RD_UV^C9_P F3X&_[!\Z_P#6
MDSD****_&S]R"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=U\+/'UYJ'[15C\:O%-G>0:./AQX'%_X]^(O@&SU#6[O4-$U!_@MXM\0P^)
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MN74_A[7-)UR&VFL+!(KB72;^WOXX)70[UCF>W$;LGS*K$KR!7V)110 4444
M%%%% !1110 5\0_\%)_^3#/VK/\ LC?BK_T1'7V]7Q#_ ,%)_P#DPS]JS_LC
M?BK_ -$1U[G#'_)2\/?]CS*?_4_#GS_%G_)*\3?]D_G/_JNQ)_GJT445_I8?
MY3A1110 4444 %%%% !1110 4444 %%%% !1110 5^M7_!$/_E(I\)O^Q7^*
MW_JN/$=?DK7ZU?\ !$/_ )2*?";_ +%?XK?^JX\1U\CQ_P#\D/Q?_P!DWG/_
M *KZY]KX;_\ )P>"?^RIR+_U98<_N>HHHK_.4_U#"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\#?!O_ "L+?%G_ +,]TW_T
MD^&E?OE7X&^#?^5A;XL_]F>Z;_Z2?#2OWRKU,TWR_P#[%>"_](D<.!VQ?_8=
MB?\ TM!1117EG<%%%% !1110 4444 %%%% !1110!FZSM_LC5=_E[/[-OM_G
M>=Y.W[++N\W[/^_\O&=_D?OMN?+^?;6=X.\O_A$?"WD_9_)_X1S1/*^R?:_L
MOE_V9:[/LWV[_3OL^W'D_;/]*\O;]H_?;ZT]6)&EZD5+*1I]X0R3I:NI%O(0
M5N9 8[=@>5G<%(3B1@54U0\*,S^%O#;.\DCMH&CL\DU[%J<KL=.MBSRZE %@
MU"1B27O856*[8F>,!) *K['_ &]^A/VE_A?3S77]#?KY,_:>_;E_9:_8TN/
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MXRA.+M*$XN,HNU[.+2:=FGJMF*,HSBI1:E%ZJ46G%ZVT:NGJFM.H45\B1?\
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MNFFK]&F5&2DE*+4HO9Q::=G9V:T>J:]58****D84444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOA31?"OB/Q+X&73/@_+XS\6:-JOC;1-7UV^^)7BS4O$/B?\ M^+P._P]\#>
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M'_=N/O\ K_PU_P"F\]/X$^FW_O/AO_UXXL_].<.A1117]FG\)!1110 4444
M%%%% ']%/_!#'_D5/VC/^QA^&_\ Z;?&%?O/7X,?\$,?^14_:,_[&'X;_P#I
MM\85^\]?Y=_2!_Y._P 8_P#7[)__ %GLI/\ 7;Z-G_)D^!O^P?.O_6DSD***
M*_&S]R"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6G+?Y1Z?W5_7GN*.WSE_Z4_Z\M@HHHI#/C[]J3XS_M9_"C6/AM9?LS_L6_\
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MF<A1117XV?N04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?#?_ ).#P3_V5.1?^K+#G]SU%%%?YRG^H84444 %%%% !1110 4444 %%%%
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MG14445)04444 %%%% !1110 4444 %%%% !1110 5_&U_P '#?\ R>E\,?\
MLU[P7_ZM?XUU_9+7\;7_  <-_P#)Z7PQ_P"S7O!?_JU_C77[/X"_\G P_P#V
M*LS_ /3=,_"OI%_\FUQ7_8WRG_T],_!RBBBO[A/\_ HHHH **** "BBB@ K_
M $/O^"=__)BW[)O_ &0?X<_^H[9U_G@U_H??\$[_ /DQ;]DW_L@_PY_]1VSK
M^=?I&_\ ).\/_P#8ZJ?^H-<_I[Z+O_)3\2?]B&E_ZL,.?95%%%?R"?VT%>#?
MM4?\FP_M'?\ 9!OB_P#^J^\0U[S7@W[5'_)L/[1W_9!OB_\ ^J^\0UZ&4_\
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M&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;3_Z-"_:A_\ # ?%?_YDJ/[=R3_H<97_ .'#"?\ R[S7WA_J_G__ $(\X_\
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M$-?Z5\+_ /),\._]B+*/_5?AS_*?BS_DJN)O^R@SG_U8XD****]T^?"BBB@
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M_OP\6?\ (J^)O^Q?UG_TW7-?P'U_;?T0?]VX^_Z_\-?^F\]/X$^FW_O/AO\
M]>.+/_3G#H4445_9I_"04444 %%%% !1110!_13_ ,$,?^14_:,_[&'X;_\
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MSU%%%?YRG^H84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P#[)O.?_5?7/M?#?_DX/!/_ &5.1?\ JRPY_<]1117^<I_J&%%%% !1110
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M5K+%0C1@L3A*M*G4IRK2]B_;P56G.-947)J5)3=O8)J<>25E+F7ZF45_-/\
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M?C)_P4<_:<T.QO\ XB_M+^$;.#X5_$JYN;CP]XI\>Z/\4O&^J_&#]HOXG/\
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M=P4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MA1HO@GPIJUAX?\*>,?%$FN:]\-?A987/PY^!GA+PK_PL;Q3J<MC\*_W>\?\
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MI7B/1?&&H?"NQN/V7=,\16\5C/X'^$_PZ^!OC6V^%_C^?X>Z%;Q^-=G]H?\
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M\6M6\?Z%\8_ 7PI^)GP;^/5OX1L=1AUNUA_9=TWXGV'[-W@7P'X>\)?$R_\
M!7PO\9>(?&.F^(/AQ\,-$\8:/IW7?M4?M;_';]E__@J7\6_^"E>F?"+]HKX'
M^'O'5@R?#+X<_M*>#KWX-Z9\0HD_9'\%_ S5M(^+'A6X^)7ACQ#XX^"/PO\
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M_P (Z1X&O/#/@3]GCX;Z5X!^-_\ 9E^SE_P4G_8K_:U^)5W\(/V?/C/_ ,+
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MJ,*DZU.<J]+E4I1YJ/)2J-)N5-8F-.J^>)]04445YIVA1110!_GJ_P#!2?\
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M82P\9V(D$4]Q,ZO_ ,*]\!D"XCF CM9O+,;+!:9MVMV@N6/VJXN0.SJI;_\
M;L?_ $E"CM_V]+_TIA1114C"BBB@ HHHH **** "BBB@ HHHH **** .?\6?
M\BKXF_[%_6?_ $W7-?P'U_?AXL_Y%7Q-_P!B_K/_ *;KFOX#Z_MOZ(/^[<??
M]?\ AK_TWGI_ GTV_P#>?#?_ *\<6?\ ISAT****_LT_A(**** "BBB@ HHH
MH _HI_X(8_\ (J?M&?\ 8P_#?_TV^,*_>>OP8_X(8_\ (J?M&?\ 8P_#?_TV
M^,*_>>O\N_I _P#)W^,?^OV3_P#K/92?Z[?1L_Y,GP-_V#YU_P"M)G(4445^
M-G[D%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!_/O\ \%1/^4F?_!(;_LJVI_\ J>_#&OZ"*_GW_P""HG_*3/\ X)#?
M]E6U/_U/?AC7]!%>MC_]QR;_ +!<1_ZF5SAPO^\YC_V$4O\ U%H!1117DG<%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !7Q#_P %)_\ DPS]JS_LC?BK_P!$1U]O5\0_\%)_^3#/VK/^R-^*
MO_1$=>YPQ_R4O#W_ &/,I_\ 4_#GS_%G_)*\3?\ 9/YS_P"J[$G^>K1117^E
MA_E.%%%% !1110 4444 %%%% !1110 4444 %%%% !7ZU?\ !$/_ )2*?";_
M +%?XK?^JX\1U^2M?K5_P1#_ .4BGPF_[%?XK?\ JN/$=?(\?_\ )#\7_P#9
M-YS_ .J^N?:^&_\ R<'@G_LJ<B_]66'/[GJ***_SE/\ 4,**** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** .,^('PY^'OQ9\)ZEX"^*G@/P9\2_ NLSZ
M3<ZOX+^('A?1/&7A/5;G0-9T_P 1Z%<:EX<\1V.I:/?3Z+XATC2M>TF6ZLY9
M--UG3-/U2S:&^LK:>)/A]\./AY\)/"6F^ ?A5X"\%_#+P)HUQK%WI'@KX?>%
MM#\&>$M*NO$.MZCXEU^YTWPYX<L=-T>QN-<\1ZQJWB#6)K6SBDU/6]4U'5;U
MI[^^N9Y>THI\SLHW?*FVHW=DY**DTMDY*,4VMU&-]D*RNW97:2;MJTKV3?5+
MFE;M=VW84444AA1110!^!O@W_E86^+/_ &9[IO\ Z2?#2OWRK\#?!O\ RL+?
M%G_LSW3?_23X:5^^5>IFF^7_ /8KP7_I$CAP.V+_ .P[$_\ I:"BBBO+.X**
M** "BBB@ HHHH **** "BBB@#-UG;_9&J[_+V?V;?;_.\[R=OV67=YOV?]_Y
M>,[_ "/WVW/E_/MK.\'>7_PB/A;R?L_D_P#".:)Y7V3[7]E\O^S+79]F^W?Z
M=]GVX\G[9_I7E[?M'[[?6GJQ(TO4BI92-/O"&2=+5U(MY""MS(#';L#RL[@I
M"<2,"JFJ'A1F?PMX;9WDD=M T=GDFO8M3E=CIUL6>74H L&H2,22]["JQ7;$
MSQ@)(!5?8_[>_0G[2_POIYKK^AOT445)04444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% 'COC']GCX ?$3QWX<^*/Q ^!GP=\=?$WP>_AF3PE\1?&/PR\%>)_'?A9_
M!7B*Y\7^#7\.>+M;T2^\0:(_A+Q9>WGBCPRVF:A:G0?$5W<ZWI1M-2GEN7]B
MHHIN4I6<FY-145=MVC'X8J^T5=V6ROH))*Z223DY.RM>3LG)VWD[*[W=EV"B
MBBD,**** "BBB@#_ #U?^"D__)^?[5G_ &63Q5_Z/CKXAK[>_P""D_\ R?G^
MU9_V63Q5_P"CXZ^(:_TKX7_Y)GAW_L191_ZK\.?Y3\6?\E5Q-_V4&<_^K'$A
M1117NGSX4444 %%%% !7[3?\$%/^3\X?^R-_$7_T?X;K\6:_:;_@@I_R?G#_
M -D;^(O_ */\-U\3XD?\D%Q;_P!B/'?^FF??>%G_ "<;@S_LH,O_ /3R/[8J
M***_SM/].CD/#1<ZS\0=YF*CQ?9"(2S6\J*G_"!>""1;I"/,MH?,,C-#=YN&
MN&GN%/V6>V Z^N.\,KMUKXB'9MW^,;)L_8?LGF8^'_@9-_GY/]IXV[/MN%\O
M9_9V/^)?N;L:J6__ &['I_=7]>>XEM\Y?^E,****D84444 %%%% !1110 44
M44 %%%% !1110!S_ (L_Y%7Q-_V+^L_^FZYK^ ^O[\/%G_(J^)O^Q?UG_P!-
MUS7\!]?VW]$'_=N/O^O_  U_Z;ST_@3Z;?\ O/AO_P!>.+/_ $YPZ%%%%?V:
M?PD%%%% !1110 4444 ?T4_\$,?^14_:,_[&'X;_ /IM\85^\]?@Q_P0Q_Y%
M3]HS_L8?AO\ ^FWQA7[SU_EW]('_ )._QC_U^R?_ -9[*3_7;Z-G_)D^!O\
ML'SK_P!:3.0HHHK\;/W(**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@#^??\ X*B?\I,_^"0W_95M3_\ 4]^&-?T$5_/O
M_P %1/\ E)G_ ,$AO^RK:G_ZGOPQK^@BO6Q_^XY-_P!@N(_]3*YPX7_><Q_[
M"*7_ *BT HHHKR3N"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ KXA_X*3_\ )AG[5G_9&_%7_HB.OMZOB'_@
MI/\ \F&?M6?]D;\5?^B(Z]SAC_DI>'O^QYE/_J?ASY_BS_DE>)O^R?SG_P!5
MV)/\]6BBBO\ 2P_RG"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K]:O^
M"(?_ "D4^$W_ &*_Q6_]5QXCK\E:_6K_ ((A_P#*13X3?]BO\5O_ %7'B.OD
M>/\ _DA^+_\ LF\Y_P#5?7/M?#?_ ).#P3_V5.1?^K+#G]SU%%%?YRG^H844
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?@;X-
M_P"5A;XL_P#9GNF_^DGPTK]\J_ WP;_RL+?%G_LSW3?_ $D^&E?OE7J9IOE_
M_8KP7_I$CAP.V+_[#L3_ .EH****\L[@HHHH **** "BBB@ HHHH **** ,_
M5QNTK4UP6W:?>C:J)(S9MI1A8Y/W;D] DGR,>'^4FL[PDI3PIX90HZ%/#VBJ
M4DAAMW3;IML-KP6_^CP.N,-#!^YC(*1?(JUH:Q@Z3J@8*1_9U[D.CNA'V:7.
MY(_G=<?>5/G89"\D5G>$-H\)^%P@C"#P[H@00QRPQ!?[-MMHBBGS/%&!C9',
M?-1<+)\X-5]C_M[]"?M?]N_J=%1114E!1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% '^>K_ ,%)_P#D_/\ :L_[+)XJ_P#1\=?$-?;W
M_!2?_D_/]JS_ ++)XJ_]'QU\0U_I7PO_ ,DSP[_V(LH_]5^'/\I^+/\ DJN)
MO^R@SG_U8XD****]T^?"BBB@ HHHH *_:;_@@I_R?G#_ -D;^(O_ */\-U^+
M-?M-_P $%/\ D_.'_LC?Q%_]'^&Z^)\2/^2"XM_[$>._]-,^^\+/^3C<&?\
M909?_P"GD?VQ4445_G:?Z='&>%WC;6_B,J-:LT?C.Q246[:B94D/P]\!R!;X
M7I^S+=&)XG1='QIWV)[-I1_:S:H3V=<AX:=VUGX@J\DSK'XOLDB675+?4$A0
M^ O!$ACM[2%5DT.$R/)*VE79>XFN)9];5A:ZQ;(O7TY;_*/_ *2OZ\MA1V^<
MNG]Y_P!>>X4444AA1110 4444 %%%% !1110 4444 %%%% '/^+/^15\3?\
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MOT445)04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_
MGJ_\%)_^3\_VK/\ LLGBK_T?'7Q#7V]_P4G_ .3\_P!JS_LLGBK_ -'QU\0U
M_I7PO_R3/#O_ &(LH_\ 5?AS_*?BS_DJN)O^R@SG_P!6.)"BBBO=/GPHHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^K+#G]SU%%%?YRG^H84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM_ZKCQ'7Y*U^M7_!$/\ Y2*?";_L5_BM_P"JX\1U\CQ__P D/Q?_ -DWG/\
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M JOL?]O?H3]I?X7T\UU_0WZ***DH**** "BBB@ HHHH **** "BBB@ HHHH
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MGJT445_I8?Y3A1110 4444 %%%% !1110 4444 %%%% !1110 5^M7_!$/\
MY2*?";_L5_BM_P"JX\1U^2M?K5_P1#_Y2*?";_L5_BM_ZKCQ'7R/'_\ R0_%
M_P#V3><_^J^N?:^&_P#R<'@G_LJ<B_\ 5EAS^YZBBBO\Y3_4,**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /P-\&_\K"WQ9_[
M,]TW_P!)/AI7[Y5^!O@W_E86^+/_ &9[IO\ Z2?#2OWRKU,TWR__ +%>"_\
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MY-_V"XC_ -3*YPX7_><Q_P"PBE_ZBT HHHKR3N"BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!^!O@W_E86^+/_9GNF_\ I)\-*_?*OP-\&_\ *PM\6?\
MLSW3?_23X:5^^5>IFF^7_P#8KP7_ *1(X<#MB_\ L.Q/_I:"BBBO+.X****
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M_P ,>6?_ #+Y+[CX-_X=@?L _P#1K'PO_P# '4__ )9T?\.P/V ?^C6/A?\
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M"?X#^!O WC?28-0M=-\2:':WT6HV=OJME/INHQ0O-?3QA;NQN9[:7,9)CE8
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M+_9MMM$44^9XHP,;(YCYJ+A9/G!JOL?]O?H3]K_MW]5T_K\#HJ***DH****
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MCX26]U\---@7P]X5\.^(/'GAKQ#X[U;QOK?B3\4(_P#@AY_P5#\*?LS?&_\
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MUHJ6K$'@M;*MN3S"HCV@5]C_ +>_0G[7_;O;S77^OQ-^BBBI*"BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7&2GAG#ZOA\7%86A2O7YU*HG.K-SC3A[?$24W&G3C,_I+_X+X_\ !-'XW_\
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M^*B_X5=_PK?R/^*6_P"$:K\C_P#@AOG_ (>__MR?\*$W_P##'_\ PA?[5_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5@^*?"WACQSX
M8\1^"?&WAS0?&/@SQCH.K^%O%WA'Q3H^G^(?#'BGPQXAT^XTG7_#GB/0-6M[
MO2M<T'7-*N[O3-7TC4[2ZT_4M/NKBRO;>:VFDC;>HIIM---IIW36C36S3Z-
M?FU^U+_P34_9J^*'[,7[1GPQ^"7[,G[*/PY^,OQ$^ _Q=\"?"+X@#X,> ?"
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M=YN-*FG)I:E%%%<9TA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#<7BOQCHUUXP\0Q66MZCX>\)6^MZUI'ACQ7JMA9>&]5^#O\ @W\_Y11_L_\
M_93/VS?_ %N+]I"OSS_X.//CGIFJ:S^S-^RK92>']0NO#T^L_M1^.+*]\/\
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M6_!WC'Q]KOB>;Q+K6GR^(/B_\.=9^$FE7&@ZW/X?T\_$OP_=^,-*\&Z)\*?
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M8^UY*7M?9>UY/:>RI\_+S<D+\J****Y#U0HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** /C?]N7]ACX)?\%!?@O9_!#XYR>,-/T'1_'&@_$3P
MUXB\!ZOIFD^*/#?BC1;#6_#UQ<V2>(M#\5^$=5L_$/@GQ7XS\"ZYIGBOPGXB
ML/[!\6ZGJ.CV^C^,-/\ #/BC0/C'Q)_P1"_9L^*'BSP7XE_:*^/G[;7[4UAX
M%M_%MEHGA'X_?M$W'B?18;'QKI5OI^O6=AKGAWPIX2^(OA6*[OM+\+^(KE_
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M/VB_#/P[^)_PGU2SL]?_ +.U/PWX+^%GP[^"7COPW>ZKJ>@Z7H-YXW\(^,O
MQUOQ1X?\,:MXH'ASP1\2_A%K&OWFEWGCFRT>V_3O]C;_ (+1?LY_L_?\$W/A
M?\.O$/A/Q0W[0'[+WP=\"_L_>#/@K#<7]Q9?&A/A5X0\)^ / GQ"TWXJV_AB
M;PQX*\'>*=)@L->^(-OXHL%\;?#R^T?X@:)X1\'?&&'1OA_K7Q5\//8<;1X#
M\(5X6K.%@)Y9">:/AKVJ3XAE3P/UEYS+#^[]4_M)YJJWUY_V:JRQ"S#6.'M]
M/E,^")>*_BZ_%K^P_K4*N#CP\N*UAOJJR&,<5;^RX8_]T\4\%_9,L.L(GC9*
M5:6$3E+$M_S^?\$V?CCXN\!_MC?L/_&GX5SQ66I>/_B[\&?A5KNGZA>Z]%I6
MO_"']IWQGX+^&WQ"\+^([7P[KOAP^((=)TWQ1I_Q"\+Z3KDVH^&M/^+OPZ^&
M_C+5/#FMS>$K+3W\0_;[_P"2L?\ !1W_ +.:_P""@?\ ZT%\;*^N?^"3_P"Q
M_P"/_CA^U1^S!X-^'EMKMIX$_9M^(7P2^,'Q0^)%MH-MJFA^#?"GP,\2Z7\0
M/"VC^(?M>O\ AR"/5OC5XH^'5G\+] LM,U'5O$]JFO\ B7XB6/A+Q3X6^&7C
ME+'Y&_;[_P"2L?\ !1W_ +.:_P""@?\ ZT%\;*^_S*> EQ[XF_4_J_UJ'A/"
M&=_5[<KSA?VA*?M+>][19;++(^^^;V<:::4E)R_+*,,7'PJX6;^M?V+/QOA+
MAJ.+]IS+)_J-9<U'GVH2QJQ=U'3ZXL9)KFE)O^D3_@Y0_P"1J_89_P"Q?_:O
M_P#3C^R_7KW_  ;'_P#)J'[8O_:03QK_ .LI_L@UY_\ \')OA/Q3-'^Q5\1(
M=*1O .B:C^T'\.-:\1/J6CP_8_'_ ,0-.^$/C#P+X:BTF?4XM?U"?Q!X5^$'
MQ5UH7NEZ/?Z1I=OX-N(M<U+2;S4_#]KK7Q[_ ,$D_P#@HS\&/^"?W[*7[8_A
M;QKH_BCQ9\6_$GQ\F^//PA\"V-N--T'XGR^-/@[\'?A/!X1;QW!!KD/@AO!W
MB/X1WOB3XBZWXE\/)%8> ?$NAWWPWT[XK^-+?6? >G_D6,R+..*/ OPWP7#V
M78K.,5A>(LXH8JA@*3KU,++$YIGTJ4\4H76&PZC6HRJXK$.GAJ$:U*=>K3C4
M@W^X4\]R;A3Z1?&^8<29E@\DP..X&P'U/%YC6AA:&)E2AP^Y4Z%2HU&K6E]0
MQD:5&'-4K5,/4I4HSJI0?XG_ /!.O_DI'_!-G_LY;]@+_P!:$^#%?N?_ ,%[
M/V9_@E^SS\7/V?/%7P?\%MX1U[]HW4/VO/B?\9K]O$WB_P 1'QCXXC\:_ OQ
M(FM?9O%6OZY:>'536?BEXZNUTOPI;Z'HRKK@M!IPLM*T6WT[\7?V*/#]EX2_
M:!_8+\)Z??G5+3PM^U_^Q#X;COV\K?<MH/[3/PCTJ9YD@9XHIQ/:2)<6ZLQM
MYED@<EXVK^BK_@Y2T;7)/$?[#/B6+0M;F\+Z?I7[5'AO4O%,6DW\GAC2_$WB
M*Y_9LUCPUX9U/7T@.EV'B/Q-HW@[QIK'AS0[JZBU/7-)\%^,-2TRVN;/PSK4
MUE^E9IB\7@/I#<"8*.-K8?#XO@'"87'T*.)J4\+C?8QXYGAZ6(A"<:6*A#%P
MI5,/&K&:5=4ZE-*HHL_,,FP^ SKP*\7LP^I4,;*CQSF.:996Q&#A4Q&#=5\/
MN6+PWMJ;K8.M]2JUH5:E/V=6-"=:G-J#G%^7?\$)/V'_ -E7]L/X"_M#?$']
MIGX.:%\8/$?PS_;3UCX>>$X_%&J>)QX87P+X<^!?[-/Q&T[PEXD\"Z7KNG>!
M_'7A^;Q;XU\4WFM:7XY\.^([3Q+INLW7AKQ''JOAE8-'B_-G_@J5^U%\7OVF
MOVN_VBGUN[N+71?@A\4OB]\!_@A\.M:\0_VGX.\&V'PE\4WWPRU?6X)-(\.Z
M$\-S\8/&O@.Y^)OBV]N-+UGQ9IMEKFA?#RY\4^*?#WPT\%O9_I=_P0M_;:_9
M/_8V^ OQ^^'_ .TG\;O#OPI\1_%+]LK5?B3X8;Q)H_C!/#5MX+\2? W]FSX;
MV7B+Q7XZL_#EYX$\$:+:^+? _BBWUG6/&'B71-,\.Z/I<GB;Q%=:3X>8:B/R
M5_X*?_ W6_A-^VW^VC\)+_7_ !+!?>-OB1X\^,_AKQD_AC5/ ES=>&/VHK_6
M_B[I6M^"?-U*\;7M$^'_ (G\7^+/A##X_P!$U4Z?XA\<?"/QBR0^'=;T[6/"
M_A_PO#R&<Q\4^-GQ33SRMGM'),_?"=/.*N)ABY99_;%6G;A_$9IS4H4JD92I
M8*MA7+#*A4QLJ7-A_K3/6X^GDK\">#?]4)Y'2R^>.X.CQW/(J6%DHXS^PDZL
MN)*.6<E:>(CF,</+%PQO+C*F*6%3?M)09[C^U+XX_P""6VO?LZ6'A;]D;X.?
MM->"_P!HSPSJGPY?3OB1\5=7T&;P_P#$/2--U/3=$^)4?Q1M+#XF^-M'L;S7
MO!E[XD\8:/\ \*N^'G@B./XK:1X.LXIM!^&\WB;PWJ'V)_P;L_%_QSX>_;#^
M,W[/%C=P2_"OXI_L[^(_CSKFDW=WX@E?1OBC\&OB'\'/AKI>O^%],36X_"6E
MW/C?P7\99]'^)>KR>&KKQ1XIM/AA\'-..OV>C^!H=-N_O#X-_MU?\$0_'/PO
M\%^*OBM^SY^S;\#OB3J^C1R>./A1J'[*$'Q!/@SQ+;3366JZ?IGCKP5\#+K0
M/%WARXN;9]2\*>(DM]!U?5_#%[I%[XF\'^!_$TVK^#M#^LO^":_[1O\ P3\_
M:E^(?Q>U[]DO]DC2_@+\1?@]X$^'VG>+_&6H? OX%_#7Q)?^#OCAK?C&]M?!
MVC>)?A7XB\3ZQ?:7_;OP+&J>+M%OKG3]#FO]/\&ZA:-K=S9F31_FO$+B'&5O
M#_,<DQG!GB!@Z?\ ;.7XC#YYQQBL3CW@\9[2TJ6$Q>84XXBM"OA,/BZ$88>I
M.C1^L3J-Q5:,:OTOAWPS@*7B-P[GN X\\,\56I99F>&JY#P'@L-EU7,\#/ U
MG_M^#RZLZ4:N'Q%;#8J=3&TH8B;PL8OGGAXJE])_\%+_ -HOQG^RE^P]\>OC
M?\.[5IO'FA:1X2\(^#M06XTR%_"GB3XN?$3PA\']'^(4=OK?AGQ?HFM2_#6^
M\>0_$&+PMK6@7.C>+Y/#2^%M5NM(L-8N-8L/XR?^"5?[)/PX_:Y_;*\"_LZ^
M+M5N_"WPU\!_"7Q7\>O$OA?PQ810W/CCP9\*/&GPE\#6WPHM-8CO;5_ NC^)
MM9^*F@R^(O$FF6.I:\?!6@>)O#'A*3PCXL\1Z)\2O W]@/\ P5R^$'Q&^.?_
M  3M_:3\ _"C2CK_ (Y@T?P'\1-.\-V^G^(M8UGQ5IGP8^+'@/XQ^*O"7A#0
MO">@>)_$/B+X@>*_"?@/7/#OPZ\-Z;HTS^(_'>I^'=$GN])M;^?5['^0+_@E
MK^U?\/\ ]CK]M'P3^T%XUT2_\4?#SQM\*O%?[/\ XK\1^&-0MIKKP)X.^*WC
M?X2^-X/BS::0MK<GQYHGA;6?A7H*^(O#ND:CI^O-X&U[Q-XI\&1>,O%GAW0O
MAKX[Y_#>.:KP=X]GP8L5_KC+/<#"N\H53^V_[%C'+'1^I.A_M/.N?.G3]A^_
M4/K;PK^L^SMZWB[+*_\ B+OA=3XU^KK@1X3-9369N*R5YSR8J,7F'M_]E]C&
ML\D]N\5^X5"<OK%L,ZU_Z@OAA_P1H^%7P(_;J^&?[6_P.^(=YX$^&_P[M-7G
MB_9YU#PUJ_C(OXC\0_"KXD_"O7;[1?BUKOQ";7=,T&^M_&6@^*(]"U[PSXPU
M*R\0:1XIA@\3CP_XJ\/Z+\/OXU/VZO%4/@;]H']O?QE/8MJ<?A;]J_\ ;2U\
MZ>LBPM>/I/[1'Q5O8K<3NDJP&66%%^T>5*8,^:L4C($;^N^S_P""Z/PK\:_M
ME?"K]FGX(? KXC_'+X:_$[Q;X!^']M\;/!<VJVOB2V\3^,QJ+Z[XBL?@AKG@
MJPUVZ^$7PJM&T;7/BE\0/$/BWPCJWASPCHWQ;\8V_@;4_#?P]\/:C\2?XW?^
M"E__ "47_@I-_P!G'?MS_P#J_?BU7N>'6+XWR_%^(&8<53Q]'B+!^&D<9@:N
M:1I2S&GAL+2QE3+:F,A.,JLL1"=)RJ1S*+QLY*^+4G+7YKQ7POA_C^'.$L#P
M5'*ZF08OQ:PF$S6&1RJ0RN>88G+:=/'PP,Z+CA8TI8.IA4I93)8*,F_8M5U6
MM^V?_!5W_@G!\&_^"?W[)?['GB7PEKOBGQI\8O$/QV7X&_%[XA7LJZ/H'Q.N
M/&/P@^,?Q=NO%47P^DGUV#P-#X.U_P"$MIX6^&F@^'?$;/IOP^\1:K9?$W6O
MB]XYMM-^(-M]9_\ !M;XL\6/<_MP?#B75HF^'FC7G[./Q.T3PW'I6CP/9?$7
MXAZ?\9_!/C_Q//K,&G1:]J,OB+PC\%_A'H@T_4]6O=)TF+P7%/HFG:7>:OK]
MSJ_J_P#P<R?\FH_LA?\ 9_/A+_UD_P#:_K\\?^"0<?CN7]FO_@M)%\+7\=Q_
M$V3]CKX?Q_#F3X7-XC3XFIX[?P%^VROA!_AT_@[/BY/':^(#I[>$6\+ ^(U\
M0#3SH?\ Q,Q:UXU3&9EQ=X$TZN>9G6S#'T_$6A@<-F6:XBIB*F&IUJ.%@I5<
M36E.I[*C_:6*UE)^SH2]G'EI4X1C]#4RG)^#_I$</87AW*L-E& Q?AYC:^-P
M&486GAZ>+E1EG;O]7HJ$)UZG]F8)R=E*M6H0J5)2JRE.7H'@G]@C_@C_ /L?
MZEX/\/?M8_M[I\>?$W@[Q'XX\*:EX ^$.CWNF> "?A[H-G\-_$/@'XP>&/@K
M'\;OB;\/_%7@KXAW6IZU:VP^+WPLU.[UWP]#X0GT/6]-\#_$2SU[\6?VH-#^
M",7[1G[1'AW]GO4]1\8_LNW?C"TE^"^K^(X=02^U#P1XN^'OA#Q!XJ\,7-GX
M@T7P]XE_L7P+\1=<\>_#?PO+XOT9/%.H>"_"WA^\\1:SXSU:XO/'7B?U7]A$
M?L>VW[0W@^W_ &TK7Q$/V<AX1\60 >#O[:BT2S\81:1;GP3_ ,)M#X%,?Q _
MX5W_ &?'KUO:K\, _B2+XAO\-!J<!^&A\?S6_G?[3=U\&-0_:;^/.H?LT:=?
MZ'^S3/XST6S^!NA:JVMRZE9^%M!^'O@KP[XFU::X\4:EK/BJ2P\:_$[2?'GC
MSPW%XIU6?Q#9^$_$^@V>KZ=X5OX;CP7X;_?^&LHQN!XNS/+\XS;Q(XCQ#RB<
M<RQV=8;!8;PZQ;Q;PLW2RG 4H1IT<=3IR5"='"JI3II8VG5G:3B?SCQ7G>79
MSP8\QRC(O"WAG"2SU/ Y=@<3C\9XHTG1JU&Z^-QU24IUL!4<Y3G5Q7L83Y:;
MHTE.%)GZ8?\ !5#6O$?B3]D;_@ACXB\8>)?$'C3Q;K_["OBS6O%/C'Q9K&H^
M(?%/BSQ'JOPR_87OM;\2^)=?UBZO=6USQ!KNISW6J:SK&J7MWJ.IZC=7-[>W
M5Q<SRROT_P#P1@_X)Q? []NKX9_M3_%#XTZKXM32_!OQ!\1_LP> _"_@Z>W\
M,WG@_P 9-\,?A?\ %36OC[%XA8ZK;>(?%FG+\5-%T3X?^#]?\.7/@#1KC0_%
MVM_$/P_\5AXQ\.:5\-N)_P""G?\ R9E_P0?_ .S!O$'_ *JK]A.OTW_X-C_^
M34/VQ?\ M()XU_\ 64_V0:_GS&\19YP]X!>'<\CS3&Y56Q>=9Q2Q&)P->>'Q
M52C0S?.\1&C]9IM5X4YUJ=.5:,*D57C#V5;GHRJ4Y_T-EG#^2<4_2#XFI\1Y
M9@\ZHX7@3)LPI8;,:%/%83Z[/"</87ZQ5PM6,L/6G&CC,3&G[:G.-.53VL(Q
MJPISA_,__P $Z?BEXQ@_:=_X)^?%GP??6WA;Q=X@_:&_9EL)[M=+TK6([3PY
M\;O&OA?X3_%K0;*#7['5[:!?%'PK^)/C[P3%JT<":WI%KK[:MH>HZ1X@M-/U
M:Q]C_:PGU#Q7_P %(_VE;O\ :?U'QAX.T_7/VWO$OAGXI^*H?!4'A_Q[X=_9
MM\-_%&P^''@3Q?X>\,:=X%OI==N] _9!\/> M<^&&KMX&\87WQ(T*R\(^+)+
M7X@S>*?MOB#Y9_X)L_\ )4/^";O_ &</^PO_ .KQ^$E?3/[:6HZEXB_X*.?M
M1:I\:[GQC;,W[;%[I?Q:FM_"FA^%_B6WP!\%_$#PYX5\-6?A70M0TC0]#_MV
MZ_8_\/>![;X+>*?$.FOIWCC1+GP!\2M=U?Q+:>*KOQ9K/[;B*#K>)6=8FFJE
M+%8_P9PLJV)RMTX\01Q6(S?,:*Q63T914:F*A3PU%)\\%"M0R^"YE+EE^)RG
M#"^&F.RR+2R_ >.WL\/AL=&M4R&.%I9=RO#9W6A+VM'+7:$YJ/M:DW&K*%-U
M)3JP^F?^"L7PN_80^%?Q6^#NF_L*^+/#NO:9K/P^\4WWQ=T+P-\2-2^+'@/P
MY?V7B/2X/AOJVE^--0O_ !7GQ=XOM[CXA6?C+PO#X_U;^P-&\%?#[5I/!_@[
M_A+$UKQ]^AG[)TU_^P#_ ,$-/B;^VYX \ >(/#W[5?QLTC_A%-0\<>)+W4M'
MO[O2?$G[8'Q)^"_[*_Q=L/!GC/0?$WP[GT3X;?#?XXZ+\5_!]OI?P\L]$^.O
MABUT$>(M:U6P\367BZV_.[3]1_X(DZ+J5IK>L^#?^"G'Q)T;3+?76U/X;:CK
M/[/7AO3/'$.H>&M:T>WTF[\1> _&OPR\>:'<6%_J5IXBT+4O"7Q+\"7T'B71
M-%_M37)?#3:YHVJ_T0_M7M\"?V]?^"2'Q_\ #'[#_B+3M<\ _#OPGI(\#>!_
M@]\*-;N=8L=8_9#\6^"/C#HW[.OAKX%P6/@WQ9X5UOQOHOPW\/>!OAUX?@\-
M6MQ;^%_'O@?QWX+\+>,/"NI^%;+Q)^5>(.88G#S\,^%L\I<95>&L#Q!AI9_Q
M!Q?&I1IY]3Q.9T*\Z&)<:]:CB99?@?KD(?79?6:6&@O9QG3]IB*OZYX6Y;@,
M?F_'_%^35> <-Q%B.':U#AWA?@YT:\LFKT< \.\QP\*F&H3POUS$*A3JO+X>
MPK3Q-2.)<)SA3E_)?^R_XR_9UM?V@I?'7[<?A_XN?&/X5W?A_P =:]KVE^"_
M$4M[X^\>?&#Q!JNC?V3JGCWQ!KGB[PEXAU;0+BUU;Q[XO\3:YI_C_2_&>I_$
M*Q\%S:A<ZYX?U#QC87V!^U[??LN>-OC5X@OOV3/ GCWP;^SKXE\!^&(I_A[\
M8)]/U76=$\>AO$&B>.M(T58O$'CB>^^&NM>';/P9K]F?%OC7Q+XF;QKKWQ&L
MRVG>"X?!NAZ7Z!_P3K^-O[/7P?\ VI/ GQ+_ &B?AKX7^-W[/_C7P%K_ ,-?
M$-MK^D:)X[\-^!8/'VO> /$OAWX]:=X&UK0?$.F>.+KP<_@S^PKN#2FTOQ39
M?#KX@>.]=\&W7B;7+"S^&WC[^B;XC_MX?\$)O ^CV&I^&?V>?@_\8KV\UB+3
M+CP[\./V,O!^EZQI5E)I^I7K^(;^?XN^#?A9X?DT>"YL;72)8-+UW4M?.H:S
MILD&AS:5%K&IZ5^K<09]F>2\:8V-#@GQ%XAP]7"4L-3A@<95Q7!6*PE? TH2
MC3RYTIY9A:E.4)TZWMW2Q+KQJ2DY8?$P]M^,\,\/99G_  .X9AQQX:<.8Q8[
M%8C&RSS 4J/'>&QE#'2J\ZS2I5AFN)A6A&$HT\+&I1]G4E1=/ZS"K)=Q^S#X
M(^)__!5+_@AY\+_AE\2OBK'X.^('C&Y7X>ZK\7;_ $+Q-\5-6UC2?V0/VQ;S
MPOHOB;QA:^+/B)8^(_&'Q$^)W@WX":8WQ"\6ZCXY@-U\0/%>O^-;;3OL2V_A
M4^H?\$\?^"/>@_L(?';Q3\?KSX\:M\6O$^J?"76/@_X=TBV^'=A\/="T;0?%
MWC'P9XT\9ZEK0E\6^/-4\0ZM=ZA\-/ =KX9-AJ/A>PT"SB\6C5[+Q9<>(-$G
M\'^M^-OVM_A%^RG_ ,$PO!_[97[-?[.6A:;\'=7\%? ;XK?#_P#9_P!+C\*?
M 2STW0/VK_B5\/[J_EU"W\!>'?'?A+PSXHL9_C+JGCOQ7::#I6OV?B7QA#J]
ML==>77)?%">2_P#!/'_@L%H?[=_QT\4_ 2\^ NL?"7Q)I/PFU?XO>'M:MOB%
M8_$+0-8T/PEXP\&^#/&.EZT\OA+P'J7A[6+:_P#B3X%N_"ZV&G>)['Q!92>+
MSJU[X3N/#VBP>,/Y!PT^-ZOAYGM7+8U(>&T\_H5,TC%Y9*C#-IU,I>#C*=3_
M (5I)2EDT>:A_LDJGU?VGOMG]H8B' -'CC@NEGV(HXKQ*IY#4I9#BI?VNJF)
MP<,+C8XZNO8MY3^_2S.I36/;Q'O5?J[<K'[-T445^?'ZD%%%% !7RU#^W+^Q
M1<113P?MA?LM3P3QI-#-#^T#\)I(IHI%#QRQ2)XM9)(Y$8.CH2K*0RD@@U]2
MU^"=G_P;M_L5V5I:V:?%+]J65+2V@MDDF\:_"7S9%@B6)7E\KX(11^8X0,_E
MQ1IN)V(BX4?7\*X/@O%K'_ZWYUG&4.F\)_9RRK+J>/6(4_K7UQXASG'V+HN&
M$]BDG[3VM6[7LU?XWB_&\<8.. ?!>1Y-G,JDL3_:*S?,ZF7+#QBJ'U5X?V<)
M^V=5RQ'M;M>S]G3M?G=OVL^'/Q9^%GQAT>_\1?"/XE_#_P"*?A_2M8F\/:GK
MOPY\9>'/&^CZ=K]OI^FZM/H=_J?AG4M3LK/6(-+UG2-2FTRXGCO8]/U73;QX
M%M[ZUDE_G'_:N_X*7_\ !5_X9:S^U)I6A?LLQ^!_@]\-O$WQ]T?P[^T/-^S9
M\;/*\*?"KP/KWC#3?#_QLE\7^+O$>K?"2YCT;P7I-EX]?Q;X@\,ZA\,KY;<Z
M]?>'[GPC.^F-]X^%_@)^QY_P0Y^ O[0?[36C:9\<O'MAXOUWX">'_B;K%QJW
MA7Q;\0]1TF;XCV?PI^%7AS0=#:7X4?#VT\/>#O&'QP\4^*M4OC!:^+;VS\4>
M(_MVL^*(-%\$>%])]P^!W_!6']@CX[Z9/<Z1^T!X4^'.M:7X>\&Z[XD\*_'&
M4_!W4] N?&=IJ<\7AJ#7?&YTSP#X[\1>&[G1M2TWQE'\*/&7Q TCPW=KIEQ>
MZO\ V3XF\*:EKOT'#JHY-B\VS; <#SX^X:EF-3+<MQV:9?C/9T9X64,3#VT,
M$JU*AB\3A*]"<Z&(O&<.;DA)0JQC\UQ%4Q6<9=D>4YOQS1\..*IX99GCL'E&
M98&4\12<:F&JTL/4S'V4\1A:-9<WM:*YJ=2*YG9QD_X@?@"O[,NN?%"UU7]M
MKQ/\==6^%&H^,?#>J>/&^'.G7GQ$\<?%&R\7ZSX@F^*>N?%'XC:I\1=!^*6@
MV,%_>Z'XR\>>,/AYI?QC^._Q0T'4?B59^";7PW\66\'^)]6_8;_@X-^,47Q,
M^-?[(^D>&/"ZZW\)++]G3Q#\8?A?^T9H&L?\)!\-OC!%\>/%FAVNL>%_ FMZ
M=I;>%M97P)X9^$/PU\=:AK&@>+_$7]J:#\;O!5W/I>@:<^B:IXN_*+]N'XN?
M"OXX?M@?M+_&WX,Z5)X;^#WQ"^(:>(_!UOJ'A6S\!S7L-AX*\*:#XU\?7GAN
M&42Z7_PM?XB:'XT^,#3^(K;1O&VH0^.UU;XD>'_#?Q!O?%.A:=]E?MX?!+]H
MSX,?\$\O^"1"?'.VU:=-)L/VK/"^NZCXJU[61XF^'NJ_'CQ;X8^.O[,/P%UO
MPO\ $.#0OB'HVO>!_P!G7P-XN\$ZMX3M?#LGA3X1WWP=N/AM;:C%I-OX'?6O
MZ=Q]&A1\5/"'B;,,1B\!B,_R?.L(N',RG0C_ &!5GP[6>&P>%HT:&%4)QQF:
MK+*ZKT76J8A4=54@J=/^4\HJ8F7AWXZ\'9;3P>=4\FQ.!S*KQAERQ$ZV?QPN
M?498S$8ZO6Q>-C7A4P.7XK'8=X>K[&$'CZBJ8B-:-9_J_P#\&R<CR_LH_MB,
MYW$?\% ?&,8. ,)%^R?^Q_%&O  ^5$5<]3C+$DDG^6[]J$)=_M&?M]6]VR_9
MC^V[^WW;2;A&%6VD_:E^,_F!BRE"H$DA)D##!^;*C%?OC_P0B_;9_9B_98^$
M?[6?PH^.7CN;X9:U??$_Q)^UMI^N^(=*N)O"GBSP5%\&_@K\+?$/A/P/=:$F
MJ:SXB^+>A:I\+5U9/A5!H8\:^/M,\8://\)-/^(U[H?Q'T_P%^$GB_PCXL_:
M[_:)^*7ACX"^'M:M/&O[9W[4'QMUWX7:'XNT^YGU3PC<?M+_ !E\;^/;#4OB
M7#\,[7XBOIFB?";P]XQN?%/Q?U[PFGC;2?!O@WP9XO\ %$6HZWH&@RZK-\)P
M%EF9<-\4^-&<YW@L7@\LPF5<2TYXG%T*M'#8JI7S.>,P\L/5JJ-/$_6,+0G.
M@Z3G*<,32M_'BI?9>(>;97Q+X3>"_#F1YAA,;G6.S+@S#4,!A*]&MBZ%; 9%
MB,HQ:J4*4I5*+PN88BEAJG/&/+4=NCM_HB_LK>//BA\4_P!F#]G#XG?&[P9_
MPKGXT?$;X#?"#QY\7?A[_P ([XA\(?\ ""?$_P 7_#WP[X@\?>#?^$3\77FH
M>*_"_P#PB_BO4-6T3_A'?$]_?>(=$^P_V;K5Y<ZE;7,S_P ,_P#P5B_Y2I?M
M\_\ 92_@3_ZQ%^RK7^@C7\+G_!<'X*:G\)/^"CGQ.\=7=WK6I:/^U/X-^&OQ
MKT"_NO!^H:'X=TW4O W@#PE^SGXN^'VA>*YK^_TKQWK7A:V^$7@GX@>+7T]-
M(U#PI8_&GP5I6L:%%;WFA^(/$WQ?T<,11H>(=2G5J0ISQ?#V98?#1D[.M7CB
M,!BI4J:?Q36'PV(K-+7DI3ELF?J?TEL/7K^%F/G1I3JQPN;91B,0X1<O94%B
M)475G;:"JUJ4')Z)S5]#^MC_ ()R_P#*/;]A#_LS3]F#_P!4CX'K^7?_ (.#
MO^4AWA7_ +,P^"O_ *O#]JNOUG_X)!_\%)_@+KO['/P[^#/QW^*/PO\ @I\5
M/V9O#N@?!J>T\<Z]HWPQ\+>-_AKX6M[K0?@QXS\!ZKXR\:ZG%XKO9OAMH6AZ
M'\5(4U'2];T?XK:)XKU-O WACX=>*OA;J/BC^=?_ (*J?MJ?#7]L+]J3Q3\?
MO!NC:OX/^%?P_P#ACH7P?\.^)_&4W]FW_CKPA\.?%7Q(\8M\4[WPU<VEK>^
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MX#>$M4\1:YX5^"7_  3/^-?PB\,ZUXON]/U#Q9K'A_X;?LM>)?!NC:IXHO\
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M3-%M?B(L6BZ9KUD?ZQ?C]_P5 _9G^$GP%7XP?#[Q7H?QX\4^)+'1$^&WP?\
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M2M8-7T/4]-UG3)I[:.._TG4+'4;1I;.[@FD_6#P+\2_AS\4=,O\ 6OAGX_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!\5OCE;7M[I,'BSQKXUMEUF[M_B;'<Z_?V>M_$#Q)!9:SKDNH:S9>&O^$?\
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M8R4.://*-*G[*A!RA">)JT8U*E*FYU(?%>(?&F&X X1S7B?$86IF%3!1P]#
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M_!0[X4?L8V^F^&+O2;[XG_&[Q5X<UOQ!X1^$WA[5],TG^S]/M](\2#PQXO\
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M<,5A\;PC3XCGBJSGS0K0KSSS*OJT84_W;I*G5YG>?M%I%?CS_P /L_V5?^A
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MOQ!X:@\;P1_%S_A%;G3/%T/A?5?!?P[^(W@3X6:/XF/B;QMX8/A2TE\0>/\
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M9;G.:8?*IUG:G'-\=E678W Y5)_%*.8XG#.G!2J5%&$927[I45\8Z?\ MW_
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M[^S_ .T/!/CSQC_;/]H?\(SXI^U^5_PA']G?V=]AMO,_M/[7]N3[%]EN_FN
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M]?)L%C:F(K4:#PN+S"C6IUJU*E5A"=2$9?N11117PI^A!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %?PF?\%I_A;X_\/\ [5G_  4TDU#15T^7XY>
M?!GQ*^%,MOJVFWU]XG\&/^Q[\.?@A#KGV+2=1OK_ $0'XI_!CXE^%[33]:LM
M)UJYE\-3ZK;V%QH>I:'J>H?W9U^.'_!6?]AWQY^T=HWPS^+?P ^'^F>-/C7X
M)UBT\!>,=#CUWP/X*UCQK\%/$UY/*95UWQ5ING6_B?6/A#XRN8?%7A?PWXC^
M(_@_P[H_@3QC\?+[P]:>*/B+KWA?PMKOZOX.9WE64<68O!YWC:65Y9Q3PYGO
M">(S:O94,KGG.%4<-C*\I.,:=&.+HT*-:M4G"E0I5IUZTX4:<Y+\A\<.'LYX
MBX!Q4>'\)+,<XR3-<DXEP.60^/,Y9'F-'&5L%32NYU:N%C7="E&,JE>O"G1I
MQE4J11^Q]%?S)?L4?\%/]9_9.\#^'_V4OVD/A-XJ_P"$>^!7A6P\$^$+C0]!
MM?!?Q;^''A33O#'PZO/@W\'?'GP<\4V?@ZVV:%\.M9O;C3_'=_KOA'Q2O@:U
M^%=AKO@+QQXAUGQ5\6M4Z_5OV[/^"BO[>/BK6? ?["?AE?@'X%M/&]AX)U+X
MWZ3X*\%?&/7_ (96I\90Z/KOC_Q_J_QAN_#'P2N=6T/X/?%CX2?''4/V5]"L
M)OBXESX8UZV\%?$OXJ>$-;66'#,_!_CC)*.98W.\'@,IRG+:&(Q']N8W-L!'
M*,RC3HRK82GD^(IUJE7,\1FJ5.&6X;#4)8BI4K4X8FEA7"O[%97XY< 9U_9V
M%RG%YIF&?YAB,+A?]5,+DN8SXCR_$5Z]/#XE9K@IT*=++,/E<ISJ9EF&,Q-+
M+J-&E*I2Q==5<*L1\6?\''?B;7?!OQ2\=^*_#.H2Z3XA\/?L,:!J^BZI!'#)
M-I^I67CS]HJ>TNX4N8IH#+!,BR1^;$ZAU!VD@5_4GXL_9H^$VN?LY?$S]EKP
MAX>LO@G\*?B;\/OBO\/+K3_@=HOA;X>3>$;7XS6?BB/QMXF\#6%EX>NO"NB>
M,+S6?&&O^,%U:Z\-:G;7?C&_N->UK3]7N+N^2Z_E/_X.8O\ D<?BK_V8/I?_
M *F_[1E?V75['BAC<70RSP>5'%8BDL)X;Y-C,+&%6I&.&Q<LTS+FQ5"*ERTL
M1+ZMAU*M!*<E0HJ4FJ4.7RO"W"86IQEXXUIX;#SJU^.J&$K594:<JE;"QX>R
MV4<-5J.+G4P\95JTHT9-TU*K4:C><F_Y*O\ @A9\8_$NG?MK^,?@S%IOAV3P
M]\9OV,KSXQ>+=:FL;S_A*8/$OP!^+/PT\*^"]-TB_AU*'3H/#M[8_M1?$2[U
M^QO](U*\GU&Q\,3:/J6B06NN6WB#[8L/^"A'[*OP,^,)^%O_  3U_8?\ ?$#
M_A);7_A"-<\6_ 71/!?PHM?B78_"S0%UWX<Z?\)-+^%?PS\::O\ &7X>^%=+
MU_XQ?8]7U2+P?H_A2ST'4_$GPTT_QS\/_'3>,K;\=O\ @EM\/O$_Q;_;!\?_
M  I\$_$C7?@WXS^)O_!(']L+X>^$?B]X734'\3?"KQ/XT^*'['OAS0/B1X=3
M2=>\+:J^N^!M5U*T\3Z0NF>)_#FH-J&EVXLM>TBY,>H6_J_[#GQR\:_\$[_V
ME9KS]H3]G>;PU-XH^%C^!_B+X7\0^%[33OCW\)+'2O$'B<66M?!/Q!=7R>%/
M&?PI\>_$?P1/X/\ &EKHNLP?#KXNVG@?P)\6?A[\6-5LO@]IWA7XG?KO$O".
M59WXD>->(CDE;B[-\IS[)I95P+A\XJ9)0S&EC*56..SC$/#5:&-QJRE6Y*.
MK0G3EC*CQ#A3Q$)K\5X6XOS;AGPE\$Z%'.<-P?D>;U.,\+GG'V(R.&>3X=A@
MLYS&659=AJ6(I5L#A*F>5.?"0Q..HU</26#B_9U%!TY'_!4;Q_KOQ^\9>'OB
MG\1OV5/B%^S/X[U7X-^*_A9JEYX\UCQO=K\4/ _A/5;KQ%X9L]'T/Q5X0\%>
M']//PTUCXE>.I=4U30M#O=4UD?$_3;/Q3J+V6A^%+.+[U_;X^,OBC]HS_@D_
M_P $YOVA/&]AH.E^-/CO<?LS?&7Q=IGA6UU"Q\+Z=XH^*'[(/Q/\;Z_8>&[+
M5]4US5;/0;/5=<N[?1[74]:UC4+?3X[>*]U34+E);N;\Y?\ @HK^V9XX_:S\
M4>']=\4^!D\!?"BQTC]H"]_9ANV\)>+[*\\7?#S3+SX9>#_B=?\ BSXBW]_J
M'P\\9>+=!\;>&M$NM9T7P)#H<?PT/BX> M6;QQ=:#_PL#7?MW]J3PKXH\"_\
M$4/^"3W@CQOX;U[P=XT\'>"OV-O"OB[PCXJT?4/#WBCPKXH\/?L0>/M(U_PW
MXDT#5[>SU70]>T/5;.[TS6-'U.TM=0TS4+6XLKVW@N8)8E]>AA88+C?Z.N%6
M58+(ZN'PW%E"MD^ S:KGF'RR4,SS6:P:S6OB\=7Q-2E[23Q%.IBZWU'%3KY=
M3<*6$ITH>51QL\QX6^E)C_[>Q_%%'%Y)P=6P_$.8Y)1X?K9O3628[#_7*>6X
M; Y=AXX:V'C0PN)HX2G#&X:A1Q?-5=9U9_;'_!!K0/#=[_P3Z\ _%^3PKX3@
M^*OQ&\>_M)^&?B%\1M-\*^'M(\:^.O#_ ,(OVQOVE_"'PNT?QCXDTK3;/5O$
MVG_#[PQ+<Z)X/MM:NKV/0+"]U"'31;_VA>FX_'WXQZA>?L=?\%@O#%Y\/YV\
M9W6I?\%&?@WIZW'Q/"ZY-IEG_P %!=<\*:'\7(-+D\.KX3>W7P3H_P"U9\0]
M-^$9D:=] L=&\&6OBQO'$&GZY'XB_9;_ (('?\HM/@=_V5G]M?\ ];I_:4K\
M7/\ @HQ_REZ\"_\ :2;_ ()7?^IC^QU7X?X<XC$8NAXV_6J];$O$>&6?8^NZ
M]2=:5?&T>*>&?98NM*HY.IB:?UG$<M:;=1>WJ^][\K_MGB'A<-A<F\ 887#T
M,-##>*GAOAL-"A1IT88?#ULNS&G5H48TXQC2HU(*,9TX*,)*,4U[JM]"_P#!
M9^\M-(_;S^%VKZOX'\(_$?1-.^ 7P/\ $VI?#WQ-KWA:;0?B?HO@/]H#XOZ]
MXH^%?Q'T46/C?7?"?@7XAZ1=1^#G\0>-/AUJ/A;QEI.O>.;7P3IWQ!O/AW\2
M] \/^C_\%-?^"A'[.G[3?[,'PY^'WPZ\)7^O>,/%'B3P5\5-8U_Q]HVE^'M6
M_91E\$_V5KVN0O?7=IXBT[5_BIXMT75_$WP.U"3X5>)+[P5%\//$GQEU&]^+
MDFE)X8\(?%WXJ_X++^'=&TG]MOXG>(];^,O@'XIZ:DWP,^,VK>!/B187_C'X
M9_LZ6OP5TKX5^(-*_9]^.'AC7?%-CX9UCX0_%F[\'ZI\:_%7P]\,>*/!E]JG
M@WXO?$.X\;Z!\.E\;^ OBG\9/T=U3]M'3_V?H(?C!J'_  1YTWX+'PA>6D&G
M?$W5/#D'PR@\-:OXPE7P#I=M#XZG_9ITO^P;SQ7=^*H_!-H(+Z*ZUF7Q(OAZ
MWBO9=76PN?V/+<C<\!X1\3T.%\QXESSA[A')*^0SP_&'#W"N QN-I9EC\9@L
MOQV1YVZ>=8C^S,54IQI8[*9.AGTJCBXUL-[*F_R//N(I8/B;QJX>?%>5\+93
MQ/G]? 9_1Q? _$_&N.P>75.&LKP&*SC+<VX;53*L-5S'#U,9[3*,^BY95]7I
M37L_K%5P\AD^'OQV_8[_ ."''[4Y^)\E[=ZM^TG\3],T.R^#OQDT_6Q9_ _X
M&_M;?$[X(_LG>*/ NDZ1;>.[BXT?5O%7@_Q!XY_:)TG1)8/!;^$OB]\9;[1_
MB)\-9?$FC^-;3Q'XY_P3;^*FN_ .7XG_ !2^'/[#7C/]IKXE:UJY^'4_QJ\&
M'QA-=_#[P%;Z'X)\3S_!"T_LCX>?$+2O#[ZCXB>T^)GC"32I_#>L>-[;5OAI
M%XSL=:T[X<_#B]T_]5_"'QK^#/\ P67_ &6/VA?V;]4\,^)OA)\2-%\)_":_
M\9Z3KUOJWBGPSX ^)FJ>1\2?@Q\5_A[XN\*ZUX#3XO>!/ 'Q[^%NK/8:%X@N
M?A9XO\82_"2[B^)GPN\'> O'_AA_%?Y=_L<_M#?M(?\ !,/XBW7@#]J'X-^*
MO!?PA^,5G/XT\5_#.XTKPGJGC+PY\6M,\%>"8+[QQ\)OBAX?U^3X??%G3H=#
MN/A]\-OBYX5L_&.N>'-%NH?"/B+PSXK\$>)_#OCCP3\7_E>$(U<WX0XWX7QO
M!^%XEXWCXA?ZPYSP;C,US#AO&U\#++\11JU\#2P&/R_%9A_9&9?6'5R]5:U#
M#T<93Q=2FZJP4G])QI'#9+GOA)Q-E'&^,R#P_P NX#Q7#&4\>X#*,MXHPF7X
MKERVCA?[1>/R_,<+E_\ ;F PL,)/,7AJ=6.)PM7"UJE"F\4E@?\ !0SPW\>/
MVXO$]C\0)OV OVA_ASK<?PCU[X2^.P_A?XS?$>#QUX.BU'4]<\%:?;^'AX \
M-:-H$WA.\\7?$\W4^A:%-X@\;+XWLK+6]4FM?!OA>SMOZ;_V6/\ A=__  S%
M^SC_ ,--<_M(_P#"A_A!_P -!G_BD>?C?_PK[P]_PM<_\6__ .*#_P"1\_M_
M_D2?^*1_Z%O_ (DWV*OR3^*G_!<WPUI_]F:9^SG^RG\6?C[XWU;0?B!=Z+\-
M+K6[3PG\1/&OBGPAX4N?&VD^#OAEX1\ >'?CCKGCW4M6\,^'_'.LZXMA8V6J
M>&=,\,IJ5IHGB:PN=7N/#G[R5^;^*V*SF/\ JID>;\'8;@N&191BZ.699#-*
M^;8WZAC,QK8A1QM;&X['9C1C2Q/UAX'#8ZI"=/"UHO#P6!EA;?I_@[A<BK8S
MC;B7*./<7X@8KB+&Y(LXS6IDN&R? PQ>4Y?6PM'ZE'+\OR_+,55J8.K0I8ZK
M@X57&>$HPQ,HXGVO/^+G_!<K_DV7X+_]G/\ AW_U2?QYK\]OV??^5;2/_LNW
MQA_]>Y^.Z_0G_@N5_P FR_!?_LY_P[_ZI/X\U\)?![PQXE\)?\&X5AIGBOP]
MKGAC4K_XK>-O%MCI_B'2;_1;Z]\*^//^"I7B/QQX&\36EIJ5O;3W'A_QGX*\
M1>'_ !AX3UF&-].\1>%M=T?Q!H]S>:3J=E=S_H'"+_X3_HPKK_Q%?'NWIQ?P
MO?[KK[T?%\7?\EA](;_LQ^$_]5?%)[?_ ,&^N@>&_$OP\_:W^)NN>%?">I?$
MOP/^UWXW^"OA+XC3^%?#P\?:#\(M0_9V_8^^(>H?#33_ !G'IJ>)(_!.H>.K
MA_%U]X<;4WTN\\0QVNJW-M+>65G+!^?_ /P6WU"\_9$_; ^)7[3G@&=O%WC7
M3O /P*_;/TOPU\20NM^!-+^)WP3OI/"WA3P[8:7H*^%]<A^'M\O[-7@G7M<T
MH^(W\12^)-=\9ZCI/BK1H=2T>TT#]%/^#=G_ )(+^W#_ -I"?%?_ *R)^QO7
MYO?\',7_ "./Q5_[,'TO_P!3?]HRO(X/Q.(Q''_C,\17K5WC."O%2CBI5JDZ
MDL327/)4ZTIRE*I!2HTFHS;2=.%OA5IXLPN&P_@9X/+#X:A06'S/P;Q=!4:-
M.DJ.*Q%7*IU\324(Q4*]>>)Q,ZU6*4ZL\16E.4I59N7]EU?F3_P5[^*]G\./
MV%?BMX38Z!<:S^T4+3]FK2-%\3Z!XEUS2/$.B?%6VU&V^,6FB3PY-9Q:%K=I
M^SUI?Q@\0>$==\2ZE9>%[?QCHF@66H6_B.YO['P?XC_3:OY+O^"SWQ/OOC/^
MVKX2^$7PXTO0?'?B_P#9X\$:3\'O!?ANWM+SPGXLO?VE?VM-7^'WB2Y^&&H>
M+_'FJZ#\/K[1_%7A?3OV3)/!NO:=/IGAWP_K/C7QG8^+_&US<6U[I/@?X3PD
MR/!YSQOEU?-6HY#PU1Q7%W$-6<>:E3R?ANE_:-:->+7O4,37IX;!5DG%^SQ4
MG&<':2_6O%_B7%<+\ 9YBLL4IY[FD*'#G#M&F[5JV>\05X97@/8:Q7M<//$2
MQJO)+EPLMW:+]*_X)*_&K]EW]E'1_CM\1/C5\;9O#?Q#^-6L^!/#&F?#NR\-
M_$/Q+H7A3X6_!FU\6_\ "(ZG>Q^'OA5+8:;X\\6^,/B5\3=2UE=+\;>,=$G^
M'EO\)HS#X5\76GC/0X_SCA^('PS_ &6_VZ= _:"^&.L^ ;[X!_L__M4ZG\1_
M!GBJ+X1>*_"?@OP=^RO\6M'U?P_\7-$\%?![P9<GQIIT_P"SW\!/C-\4/A?\
M.=-TO0[<>(_%7PE\,^*-,^&EQX7UK3O!-U_6A\#OV$?V?_A?\%?@_P##3QU\
M*_@E\7_&_P ._A=\/_ WC'XM:[\#O =AK?Q1\5>$O">DZ!XA^(NL6-_;^)KZ
MRU7QMJ^GWGB74+2\\2>(+JVN]3FAN-<U:9'O[C\;/^"T7[(?AKX<W?P/^.WP
M=^$GACPO\-M3@\5_!/X[V'@/1?$6GZ197^L_9?%'P3\8:SX(\.:0WPK\+>&4
MNK/XK?#SQA\2=2_X1CQ/XF\8_$3X%?#R]N?&=N/"=EX/_8.$>)> .,N)^*\B
MHTN,L)F7BYALUR[%5^(,SR3&9-ALZQ=2KFN38BEA<ORG"8N-?"9K3I8/*DJ^
M(A36)5&=*JIJ=/\ !.+>"?$_@S@+AC'_ %C@/&8#P=KY7Q)E]'(LJX@PF>8K
M"Y/'V6<0K8[&YOBL%.ECLOK8W%YPOJ%&.)=.4Z<:+Y8+](?^"S7_ "CL^,?_
M &4']E?_ -:X^!5?+W_!O_\ \D%_; _[/BU;_P!9&_8_KYE\3?M&ZM^T#_P0
M6\8Q^._%Q\6_%;X$?&C]GK]G/XIZS>CQY<:Q>:KX _:^_9ZNOAAK'BWQ5\1+
M_6=5\?\ Q"\=_ 'Q1\&?B)\1?&^G^(M=TKQ!\0_&OB0)+H^K0:IX4\/\3_P2
M_P#VZ/A+^Q3\,_CQX,^*GAWXBZ_JGQ0_:-OOB_H$_P /](\-:K86?AJY^!?P
M'^&,=CK$OB/Q=X4N+?7!KWPOU^[>VLK74+ :1>:/<#4VO;B]L-/^9RW@SBGB
M'P5EDN2Y)C<RS7*O&;,Y9C@L-&#KX2.%X-PN!Q#K1E.*BJ6+J0H3U;5225M[
M?5YQQ[PCDGC9P[Q5G.>83*\ASOP4E++,QQCE"CB7F7%6"S#!PBX1J?O*V#IU
M*R6JY82?-HK_ -6U?QT?\'!?_)S?Q-_[1X>!/_5@?MC5_0K^S!_P4@^!_P"U
ME\4[SX1_#KPK\5M%\26/@#Q#\1Y;WQKH?A#3M#;0_#7B+P5X9OK6.YT+QSXC
MOSJLM_X[TB:T@;34M)+2VU*2:^@FAM;>\_GH_P"#@Z1(OVF?B?)(ZQQI_P $
M[_ K.[L$1%'Q _;&)9F8A5 '))( K@\+<ES7AWC;BK)\[P-;+<SP?A]Q>\3@
M\2HQK45B,@6*H\ZC*45[3#UJ56.OP3BW;8[_ !HXBR3BOPDAG/#N8X?-\KQ'
M%O"5*AC<(Y2HU:E#BK+Z-:$7*,9.5.K&4)+E^)-']C-%%%?A)_1I_&+X+TK1
MOVT/^"MWB[1?B[H6AV>D?$?]OOX_>!_'FD^%-(L#I'C;PA^PW:?$SP)X!\-^
M,M)\<P>.]-\1:)\3_ G[(_@/P;\;]*N[5+#Q7X?\4^/[#PS;^"DU;2/[!_L?
M\2^&O#GC/PYK_@_QAH&B>*_"7BO1-5\->*?"WB72K'7?#GB7PYKMC/I>MZ!K
M^B:I!=:9K.B:SIEU=:=JNE:C:W-CJ%C<SVEW!-;S21M_,;_P45_9!^.7[,W[
M2_B+]MSX!6&F:?X"O?B5IO[0=EJ/PV\'^(O#^G?!7QYX*\,:9XF^*\GQVTGX
M>^(O#FH:]\)?C1?^%?'_ (Y^-/Q$@\1^"-(^(.D?$[XI_#/XI7OAW4M=T?Q;
M\5?HCXO_ /!=SP?X>^$-OKWP_P#A(^D?$?\ L:6;QG?_ !?\5Z7I'PA^%KGP
M7KEW=^*;?7-$G_M[XIZ-X7\=0^'[*7P_JMM\"SXJ\%W&N:[+XT\"ZQI]EH.H
M_P!'\8\'<2^(/^HV?\$T(9MD-#@;A?)U4PV88.C1X5Q^3818;-,NS5U\11J9
M:\'BXU<7+&XF%*EBZ55XVG5J_O)1_F'A#C;A;PSS;Q.R;CW%3R'.\T\0^)>)
M<#4QF7XVM+B7(,U>'JY+/**^'PU?^U)8?#K^SUEV&E5JX:O%4(T55K3@OSK_
M ."?VHS?LV_\%9/A9\'O";Q^+-/UKXF_MF?L1ZCXS^(\:ZO\0[WX7_##PU\5
MOBA:>(X]7\,V_A70XOB'XF\6?LA?#*Z\6:@WA^/PI>:=?^+X--\*:;J%WX>O
M?#^7^PK_ ,I@K;_M)+_P53_]/W[>U?=?_!(7]A#XR:+\99?VM_V@?#FLZ5IO
M@OPO\1O 'POTCX_^%-=U;]HKQ7\6O$OB#2M(^(7[26K:Q\0T@\9^!;[^Q-&\
M>?#W3?%^L6DWCSX\Z=\6_B?XNDN-)^%][X2\2?&WX4_85_Y3!6W_ &DE_P""
MJ?\ Z?OV]J^BSK-\NSO._I 8W+,91S.A#@3(\!6S7#OFP^:8[+*W#V7YACJ%
M1:5J-3&8:M"EB(WIXF%..(HRJ4:M.I/Y#+LHS#)^"_ VEC\OQ.3QQWC[3SC+
M<FQ=/V&)RG)\V_UQQV6X*MAO^82HL-6AB)87XJ#KN%2,*JG"/]EM>9?%KXS?
M"SX$^$+KQW\7O'7A_P !>&+?[=%!>ZY>".[UK4;#0]8\2R^'_"NBVZW&N>,?
M%ESH?A_6M0TKP?X4TW6?%.MQZ9>1Z-I%_/$T5>FU_//_ ,%%=2_X)\:5^WO;
M7_[3WA;]I[QE\3K/]E;X/?VGX9^&U_\ #_2_A'K_ ,+K_P"(W[5^F>"+;4=1
MC\4>#OC%8^,]+\977Q!UW4;G0/$_A_2!#8> 5T^]O5/C32;S^?\ @3ANEQ7Q
M#0RFM1SO$TGA\5BIX7A["8;&9MBEA:3J?5\-'&8C#86@ZFT\77G4IX>-YNA6
M=J;_ *;X_P"):O"/"N8Y]0JY)AZN%G@*,,1Q'C<3E^2X:6/S#"X!8C'8C!X7
M&8N5*@\3[18?#4'6Q4XQP\*E'VGMJ=7]I'_@JCXD_:/UCQ#^R;^QW\$)?B1<
M?$W0=?\ !>LZEXT\!P?$_5_$?@7Q5J^N?!?Q)XJL?@@UAKOA30/A+9ZQXZ^$
M'B.\^,'[0)U3X7Z'H7BG5/#'Q]^$7A329Y-4'3_L%?\ !*OXK^!/CC\,/VN_
MVB_$6@^!O%?@?6O'_P 1O"WP'\$VVBZQ>Z;XK^,'PJN?"U[%\0_%6D!/A]X.
MC\!I\5_C;X.NO@W\$M.\5> +:]TCX9>(?A[\;H? >EZE\--4]0\(?\%@/V)/
MA[X>LO"7@'X*?%WP/X4TV749].\,^$/AO\)/#7A[3YM7U.\UK5IK+1=%^)EE
MIMK+J>LZCJ&K:C)!;1O>ZG?7E_<F6ZNIY7]E^#G_  5L_9Q^-_QM^$OP&\*>
M"OC7I_B_XR>(/$_ASPQJ/B+P_P" ++PY8WWA/X8>/OBQJ,NN75A\2]4U:&VF
M\._#K6[*S.E:+J]P^LW6F0W-O:Z;+?:I8?JW%F6^(&0<*9QE>3^'&*X'X)JQ
MH3SW%8APS3.,TITL11^KSSG.<1*\:?UGV$X87*\'E^'A-NG*-6GS7_$.%,X\
M-N)^+<@S;B?Q4R_C[C?#XJ7^K.5X)5<FX<R7'8B#361Y'04JF*Q?LW.E]>SW
M,,SK5(QA5I4L)6IPY/U&K^-'_@AY_P I-/"W_:-GX^?^M ?L2U^VFL?\%IOV
M6]$\6?$7P;=^ OCY)J?PS^*WQ9^#^O3VOAKX;3Z?=^)?@Y\2?%/PN\37VDS?
M\+76:;1+[7_".I7>B37UMI^J2Z3-9R:KI.D:DUUIEI_/M_P3E^+_ (:_9"_;
M!T;]H'XE6.N:WX-T[]D?XG? 2?3/ ]M8:EXG?QAXT^*'[._C72]2BLM?U/PS
MI3>&K?2OA)XDM]0O'UI-4BU"]T2*WT:ZMKF_N]-]#A3PUX[_ .(4>(V!_P!6
M,S^M\0YAX<8[)</[.G[3,<'@:W$5?%XC#KVEG3H4<;A*E1R<6HUX63=TN;CS
MQ0\/Z7C%X5XBIQ5E4:/"5?Q,P'$E1U*G+D^,Q.287+L/A\6_9>[.KCL/6PT.
M3G3J4Y*]E<_N#KXF_P""A_[1/_#,_P"R3\6?&NB^,O\ A"?BIXH\/:G\,/@)
MJ=G#X'U3Q!'\</'>D:GIG@76_#_A/X@WUKH'C<?#B1+_ .,'C+PU]B\179^&
M7PZ\=:XGA3Q+:Z)=Z/=^O?LQ_M%>"OVK?@OX:^.GP\TOQ1HWA+Q3K7Q!T+3]
M.\96NBV7B*&[^&WQ'\6_##7)+VU\/Z]XETJ*"ZU_P;JEWIGDZQ/</I,]C)J-
MOINI-=Z99_S8_P#!;K]H'Q#XP_:;T[X2^&+G7/&7A;]G/P)HMI;?"?P9H7Q%
MG\4>,?VI/C4+/4['PXOAI))] ^*'BO\ X5KJ7P9\._ R[\#^$]4U_1]9^-WQ
M=\#6WB35M4\5ZQX3\/?F'AEPI0XBXTP^#SM?5\BR"GC.(.+:E6+Y,+D7#Z^L
MYE#$<JE*$<1.-++I349.G/%QGRM19^O>)?',>%_#_&\19+*..S/-J&#R[A"G
M12J/,L[X@Y,/DCP].27MU&5=8^5)\KJX;#58IQ;1TW_!!?\ 9R\(:_\ %?XG
M?&8>$87\&?LHZ!X:^ 'P2OC<>!=6\.:1\5_&/A2+6_BS)9Z'=:?J/CWPO\1/
MAI\%]0^$_ASP]XWTR_\ #.D:EX'_ &C/BQX-=O%L]WKUOX5_JCKYU_9+_9WT
M/]E#]G3X5? '0M4?Q"/ .@7 \1>*GBUFT'C3X@^*-8U/QG\3_'<.CZ[XE\87
MGABU\=?$?Q%XJ\76?@RV\2:GH?@FTUJ'PCX9>W\-Z+I5G;_15?.\9<3XKC+B
MC.^)L7&4*F;8^K7HT)6;PF"C:CE^"O%R@_J6!IX?"\T'RR]CS123L>QX><(T
MN!N#,AX9A/VU?+\&I9EB[RG+'9OBYSQF;8V=2?[RI]9S"OB*E-U7*<:+ITW)
MJ"/CS_@H=_R8!^W+_P!F>?M,_P#JE?&U?B[_ ,$#$<?'?]O&0HXC?X4_L3*C
ME2$=D\6?MK%U5L;69 Z%@"2N]<XW#/\ 1;\3?AQX-^,?PV^(7PB^(VD/X@^'
MOQ4\#^+/AQX\T&/5-8T1];\&>.-!O_#'BC2$UKP]J&DZ_I#ZEHFJ7UDNJ:'J
MFFZQ8&87>F:A9WL4%Q'_ ";>'K;]IG_@CM^TW?>*?$WAIOB7H6O^#[GX3QZK
M<:KXX^&7P)_::BUC3?$WCGX:7NBZW81^,/"W@SXY>$]4^'/BO5[GPKX@\.?%
MGQU\)_A_??'+2?#VB:WX'^)'AOXQZS^B\#X*?%GASQ=P/E-7#RXI?$&1<2Y7
ME.(Q%#"UL\PF&P^+R_'8;+*F(J4J-;'8-8BGBI8252%;$47_ +)"O.%2-/\
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MP5\!WO@K]G[4]<\4O!X@O=*^$VBV\^C>%+&RL/"&@?SP>-73_@K-_P %(?\
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M??$_POX0\;/X4F\1Z7I'BU= /AGQ!++H.JZE;3?SYPKC<#EO$_#F8YG%RRW
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M@/PE_P $K?V?O@=\5? MQX4UZSA_8_\ B=\(/@]!XP\<^/?'&@7^KRZK\/\
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M-&OF4\!C\EQ^,I82G*4(5<7[!5*\<+1O5FHU'3@XTYN/Y_DN(CDW@S]'C/\
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M?PY>>%/$5]^T/^T'-JM]8W\_BC2?'?P1T7X5?";PE'H5\FJPZ59Z/?\ A?\
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MP#<ZU!J/B'2OA7X$\!^%M6UW7)O#RZG<_C%_P7A^!/P\LOC)X!\90:>8[O\
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M;G4/B)X6;PO^VGJW@#6_AOJ?A_\ M;_A)?#7P:\222_$G4O"6I6Q^('ZZ_\
M!1C]F3PYX[_8 \?_  W^%_P_T32;KX >#= ^)/P%\%?#_P"#EEXTU3PX_P
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M;XDVNJ^%_'&I?MX7WPY\<>(;+7[W4O$'@#2O@Y^W1XP^ O[+VA:3X3@M-,\
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MB_Y/A[C*?%7 '%>4/A[!\=<78OCJEQ5F>08K.\?D6,S;+L1EM>%7,\&\NS#
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MK_BIJ'Q!U/Q!8ZUXAUO7Y/#=_#K>G[=;CUS[$_X+W?\ (Z?L>_\ 8D_M5_\
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MSG&\/Y[DF;95P4^",ERG'Y=F>349TI97CUE'#V%QV683#X?ZUEF/E7KT\O\
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MU>QNM$L= ^%/V/\ _E,OX2_[21?\%//_ $U?\% *^F_^#??_ ).?_P""CO\
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MFG^,X]-3Q)'X)U#QU</XNOO#C:F^EWGB&.UU6YMI;RRLY8/$/@]X8\2^$O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME**4I1L[I-M6=]BX5J-24H4ZM.I."3G&$XRE!.UG*,6W%.ZM=*]UW/=:*_D
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M=:UXR\*^&?'%CJO@JQ\37_U5^VU_P6(^+&L^"/\ @G1\'/V0[CPI\(?VG/\
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M?'_ACQ7IEB)_$_@+PIJ1U/3;*SUF,:6;*'48["^U&UN^2_X(+_\ !2SXI?\
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MO?XM^%O'_P 49OB+\ _A;^VG^U5X2U+X26WPE^#TFKZI^SY\&_VCO%_P^O\
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MM3E4C+%5%3HM<E6=.<92YKN%232A)-<W+&7]JM%?G_\ LB_MS^&_C;_P3O\
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M7IWYZ49Q=1)?:<+\ZCLTW%*S3ZGUS17Y2ZE_P6\_X)=Z9=:]:O\ M26>H_\
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MP\VKVE[?1ZO\3?!OQ3^#GA/2[33]%O=?NY_%'C;XM>!/!/@_P:B:?I]PD?\
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MAYX0^$7_  7!_P""8'PH^'VE2:'X"^&/P[_X)"_#SP1HDVJ:QKDNC^$/!?\
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MQ;XIUO63<^&-:\0Z[\8[C]H31[:P\,S:=<Z'X0\(^$T\2^&+"[U"S\0>+/\
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M2:>:<M?&8B@IQK5L[PV:X=U.5QBJ$LQFHUI<Z]_FQ=*Z7NR4:EYQM'F(8/\
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MY02JJK%V7\H7_!-#5/VN?VUO^"F>K?&3XL_'#X5_LL_MD_&+X.ZQ\?\ PO\
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MLJ5>=1QCRJKC:E*?UG$5&EB\15K>S^K3M0H\D:SIN=-OG]G&?(IU)2C^,?\
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MT73;NQ\__A*M-GL_&T4/B2/#/_!(7_@G<?@Q+^SV?V>O^+03?'(_M)2>$?\
MA;/QQ^;XTGX4K\$#XS_M_P#X67_PDX_XM>J^&/\ A'5UH>%./[:_L+_A(2=6
MIK-J,9T)QC7C*E]5?,E!24J&1T,L;BU4NG]8I.I!W3]ERR=IWIIU,%4G"M"]
M/]YALQH)-RMS8O-,+C:?-[C]U4:$XU-&U4<8Q4HMS7\>/_!8*RL=+_X)J_\
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MQ?J&@6>O_#G1?CAXGT#P[;^-/##:UX<USPUJ=M\4-!U+4_A67\:+_3/\>?\
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MO_#/W_"'Q?VY_P -@?\ "._\*Z_X:BV?$C_AH[^SO^&G?]"_MK_A:7_#0O\
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MO^"MG_!,;]J']LG_ (*??LR_%GP;\&;SQ[^RWIWA?]BSX?\ QV\2V/Q6\$^
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M ,&V<7P!3]@+]KN#X@I\%?\ A&5^)=U%\3X_%P\$-IY_99'[-GPT70E^*O\
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M>*O$*:YXBUNUM/B7!^WSK_C?P+\*K5M.\'^(Y/$?@WX:77A7PU<ZY=Z%XO\
M%G[7_#/_ ()#_P#!.KX0?$;P/\5_ 7[-VFZ?XZ^''B"W\5>#=3UGXB?%_P 9
M:=I'B6QMKF#2M<?POXT^(/B'PKJFJ:#<7*ZWX:O-8T34)O#/BK3]$\8: VF^
M*O#VA:SIWT+^TW^QE^S+^V/I/A'1OVD?A3I?Q(MO 6KZAK7@^\?6?%7A37M
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M4(1<ZD9U9VITJ;E6FG.53FFH1@H4H_Q[6'_*VMKW_9:=-_\ 7,(K4^+=G<_
M?_@Z1\"?$?XLPOX3\&_%7XJ_##Q+\.]5LQ_PDUQXHT3XP?L$ZI^Q+\/]1N]%
M\'GQ#KVBVNL_M-:#K?PX>7Q/I>AIHL6DOXVUQM.^'T:>*W_<_P#X<B?\$O\
M_HV/_P S1^T)_P#/8KZ$^*__  3K_8R^.'PI^"'P4^*/P1TWQ1\._P!F_1=)
M\-?!33CXL^(.C:]X%\-:+X1LO ]KX;M/'?A_Q;I/CW5O#UWX=TG0H]=T/Q#X
MFU?2O$VK^&?"?B;Q'::KXF\)^'-8TO6IC,%*K649XIT,7EN'P-:;P]&%6C+!
M0R[ZO5I4UBIPKQK5< G6A*KAW2IS<83J2]Y1&ABE"#<:"J4<74Q-.*K5)0J1
MKO$JM3G/ZO&5)QIXEJG-4ZRE-*4H12Y7_'K_ ,'$_P 3O >J?\%.Y;2Q\0E[
MWP3^SC^S[\!/%%I=Z?K&E1:=\4;SQ9\<OC3:>'[*YUC3M/L-?-Q\-_C)\/M=
M.K^&;S6M(6;5YM FO8_$>A:]I.F_HG^UE\8OAIK7_!L7^ROX9T_Q-J$FJ>,_
MA[^P;^SKX867PQXSMI=3^,/[,7Q&^&NH_&?PM=37'AR-=*M?#-M^S%\:C%XN
MUL:9X)\5CPK;#PGXCUI?%_@QO$'[P_ K_@F9^PK^S=>_$G4/A+^SMX4TRX^+
MW@.7X7?$1?%^L>,_BM:^(?AM>O=R:YX#-A\6/$OC>PTKPCXP:YB_X3[P_HEM
MINE_$)='\+IXXMO$">$/"RZ/XAI/_!$'_@EWH]QX?N(?V7+741X;U30M6L[/
MQ+\7OCYXNTG4IO#U]::A9V7BS1/%7Q3UG1_'6@WTUE%;^)?#'C6Q\0>'/&.E
MRWVB^+M*UO1]2U&QNNC^U<&ZN6UG#$\V2RA]4@HTN7&0IQPE2/UF7M;X67UO
M#U9VI+$WH5U2YN>DJL\?J6)4<=%2H6S2,?K,FYMX>45B*,70CR)5TL-6A%J;
MH7JTN?2-1PC^+7B[P-XL^'__  :DZ%IGC'2(=%O_ !/XH^%?Q9T.W@U+1]5A
MO_A[\<O^"I?A+XT?"KQ(EWH6HZI8H/%WPQ\?>$?%1L);J/5M).LG2M?L-)UZ
MRU+2K/\ /?XT0VUE_P &[/\ P3BURQLK#3]8\?\ _!3OXYW?CO4M.T^RT^]\
M:7FD2_\ !1CP)I5[XKGLX()/$-[IO@KP+X)\)6-YJQN[FU\.>#_"^C0RII^@
MZ7;VO]T?[0'[/OPB_:E^$_B3X'?'?PC_ ,)U\+?%U[X2U'Q#X7_M[Q/X8_M"
M\\#>,_#WQ!\+3?VWX.UKP]XBM/[+\7^%=!U?R['5[:*]^P?8-12[TRZO;*X^
M8]<_X);?L)>)/V</A9^R1K7P+^V_L]_!7XF^(?C'\,OA_P#\+-^,5O\ \(U\
M1_%5Y\4;_7_$?_"5VGQ"@\;ZS]ON_C/\2I?[(\0>)-5T*U_X23R[+2[>+1]
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M]K>A:7\0[J?P)I&I^,_%%YJD-OIFNZ^]S_4Q\4_AGX(^-7PQ^(WP;^)NB?\
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MK24I./\ &_\ \$H/V0H/VG/V#_VQ=+M_VQ/@I^S1\"[C5M(LOVB?!OC7X!?
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MN:46FUF53&P@J]?#J5.KE=' 2C*M07M*<U556O:*G":M&=_:U%'^$;_@I_\
ML#VG[(AT[7O@!^V%\,OVD/!U_P#$/XO>"/C?\/O@POPS^&WACX&_M5:=I?Q#
MNO@AX5\3? KX??%SQ?9^'=;ATNR_;#\,_#W1+#P%X2\.? [3O!?Q%^'.B0>&
MK/Q''X9D^^/^#GIO@B__  P\_P  6^$3:"W[''[1;.WPC/@AK!O@(UM\%#^R
MNT+>#\QGX0E#\:S\!#;G_A##%_PM ^ /W?\ PE=?U2> /^"9_P"PQ\,?A!\8
M_@/X-_9Y\,6?PP^/[6+?%O1-6USQMXJU;Q9_8UI!;>&5'C7Q9XGUOQSH">";
MN!O$GP]C\,>)-%C^'GCF]U;X@^!UT#QSK>K^(;[PW4/^"('_  2WU7PUKGA'
M4?V5M.O-%\176FW>I>?\5OCJVKAM+TCQ9H<5MIGB7_A9X\2:%IE]IWC76UU[
M1]#U;3M*\37<'AK4_$=EJNI^"O!EYH%SS.A4;K59XJ5>.%S7!QBJ5&-*O''P
MQ'L\35Y*L51J<^(M7HTZ-2#C1H2C5<J;C*(X.K#EIPC05)UL%7;<ZDJE)X>I
M3G4HP<H2=6/N-TJLZD)<U2HG3C&:Y?MW]JJT^#FL?LX?&KPC^T%\2]%^#WP;
M^)/P\\1_"'QY\1]>\8>%/ %IX:TGXQV+_"R"6R\7>.4G\)Z1XBU'4O%]CH_A
M-M;M-0M+WQ3J.CZ<-+U6:[BTZZ_DUU7XMZI_P1;\+?LJ:1^UQ\+_ -D#_@H7
M^RP-=_:"^.?[&/Q=^'F@Z;XF^-_P@^&UO\5?@1\5?$WQ2^%GCWQMX)F\%:3=
M>+(/&&F?&WPC\,]+\::_>:_\3=0TK0M*_:HTKX;?#/P->P_U[_&OX*?"O]HS
MX5^-?@E\;?!6D_$+X7_$+2?[&\5>%=9^UPPW<,-W;:EIFHZ=J>FW-CK?ASQ-
MX<UNQTWQ)X0\7^&]2TCQ7X,\5Z1HOBSPGK6C>)-&TO5+3XJ^&O\ P2#_ ."<
M_P (_B+X$^*_@7]FW3;'QS\-?$5MXN\%ZEK7Q%^,/C/3-(\3Z?;W4.CZ]+X6
M\:?$+Q#X3U?5/#UU<IKWA>\UO0]1E\+^+M.T'QIX>;3/%WAS0-:TWAH8C#QP
M5>A6]K4G*.*]E15*"IQJUL/&E2K1Q2K1KT>6:OB:"HUZ.,I0ITJL4E==-6C5
MEB*-6GR1494?:S<Y<TJ5.LJDZ3HNG*G4YXW5.KSTJN&G*4Z4WS2B_P"<#X,_
M#/\ :4^*'_!?#]L#1?$WQZ\%_LS_ +3&G^+_ -HK7OA9\4?$WPL^ _QGU>Y\
M#V\GPWTG]GKP5\/_  +JEY8>%X/B%KW[!NK>&-8D\9Z+.?C1HOPL\*?$;0/'
M*&3Q9\6B/A3_ (*4?\$[/AW^R-X8T+XF?!O_ (*!_#7X^V]E^U=>?"OXW?LU
M_!?PCX+\!^$_AY\4-1^&W[5NO^&];\7^ OAQ\8_%OA/X>:G\*]5\"?&GX:?#
M_P"&\WPX\-67@*Q\4?$+PCX)7PGH^B:WX7O/[A/VF/\ @GO^QW^V%XJ\*^./
MVB?@MIWC[Q?X,T#4/"NA>([;Q7X_\#ZO_P (WJ.HPZL=$UF\^'GBOPG+XHTW
M2]3CN[_PU:^)VUB+PE=:[XKF\++H[^,?%9UGQ:3_ ((X?\$VI/AM>_"5_P!F
M;3/^$'U+XH:+\8]0M%^)/QE37K[Q[X:\!^+/AIX<O+OQLGQ%7QO<>'_#WA#Q
M]XZM-"\"2^(F\!Z1JWC/Q7XJT_PU;^*_$.KZW>>G_;--5*5:$JM-^SPT:E"E
M@\'25.>%RYX*G.GC*<HXJNE42J4HUN1X>G4E2C.:I0YN*675)0KTVH2<GC'2
MJSQ.)FFL7B:E:4)862="BE"K*G*=/FYW3C-P4ZDI1_D _P""P5E8Z7_P35_X
M(.:?I6GZ=I6G>*?^"9OQV\;>)-.TK3[+3=.USQEXR^#W[#?CCQ=XKU2PL8(+
M2]\1^*/&?B;Q)XL\0ZU/"^HZSXC\0:YK6HW-QJ.K7]Q<?TG_ +<G[+_B#X\_
M\%"_@1^T3^PU^U=^SCH_[=G[*6C:7X>^)?[/OQ6^(&DWR:7\&X=-\6:T^LZS
MX$\%^'/&_P 1](F\3:'^T:_@?Q?IWB/P_I-MK'@#XP^#O''P_P#B#\*/'7A;
MPMJGC[[;^,G_  2I_8(_: ^&_P"S_P#"/XN? ?\ X2WX>_LM_"G5/@A\"/#_
M /PM#XS:#_P@OPOUKP[\/_">I^&/[6\,_$31M;\3_:?#_P +? EA_;7C'4O$
M/B&'^POM5OJT5[J>L7.H6_CO_P $M?V"_P!I;XJZW\;OC-^SYI/B;XH^)M(\
M/Z-XG\5:3XU^)W@27Q-!X6M9=-T'4?$FE_#[QMX5T/7_ !-8Z*UGX;_X3#5]
M,O/%EUX4T'PEX3O-:N/#?@WPII>C<-#&4(QPD*DJL(4,NE@ZB6&HXFG4;S+$
MXSD=&I7HJ5'V=>+C-5*56EB8QJTU[BE+LK4)REB)TXP<JF,6)I7JSH2@EAJ-
M!2]I3IU.6I%TY>XX5*=2F_9S]V<DOX._"7[1?PW_ &G?^"F_[!/Q ^&/[+?P
M5_9.TK2_B5_P2=\(:]X*^ WAK2/!'@;QKXMT[]LMM:UCXF1^ ]*\*>&I/ D^
ML1>(;'PUI_A#6-1\>:WH/ACPEX>L+[Q_KXBBBL/VS_X-.O"?BKP-%^VGX/\
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MV)]C_LCP[_9&A7%UID_EWA7_ ()E?L,_LW?$(_M0_ S]E*Y@^-'PT'Q%\<^
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MEG\<_B/\8_\ @GY\#/VXO^"3WQ1E7Q?X?N?VA_@]XS\2>(=1\)>$(-&C\&_
MJQF^*4OQEMM5\*^/=6UWPK\1OVE="\'_ +"'BGP_\//$FJ?$_P /^"_A[IOQ
M-\,:I;>#?B5]IU'5?[V1_P $]?V/Q^UH?VY_^%1?\93'7QXG/Q1_X3[XH?\
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M*S?OW<N517-_GB_MG?L@R_LR_L(?L,^/M?TC0K/Q;^T]\&?V_/BQHTUOX?\
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M5%AL;1Y:5+ZS3<*-"G4G4H8=^QJ4Y<LY4Z;4:LIP<H0HPITU23A!RJ5&_P"
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M'^%M/T?PGH6A1V_AC1-%T_PW:VVE0^Q>(O\ @F%^PUXK_9R^&W[)6O\ P/\
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ME%3FHMJZ4Y):2=^BRYN:RYN64.:WO<DI0G*%]^64J=.4H[.5.#:O&+7\;?\
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M?'6M:=XO^'WP,\;?$'7/AWXQTKP]_H'5\<?%'_@GM^Q%\8_#7C_PKXY_9?\
M@ZUC\4_&^A_$OXB:KX0\(V/PS\:>+_B'X=\0>)O$^F>-];^(?PT'A'Q]=>*O
M[6\<^/\ ^T==/B5=2UO3/B+\1]!UJXU#0?B%XSTW7(69TJTJDL53J1E7PE?
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MU9_ 'BF6&^TB2ZATB32%;5;G3GO=,-Y^MGP _P""7O["/[+WQ)TGXO\ P2^
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M^I:C8W7U-^T_^PO^RO\ MF7?@&^_:3^%O_"R+KX86_B^T\#2_P#";?$;P?\
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MN>!CAI15'E<*:]LIU%^^G:G*,/B@Y3_!#XX?#VR_9.UK]MW_ (*)?LV_$O\
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M_P %''\(&W'A$0'X!OXP_9D;]ELP#P0!HPA/[,Y^$AC%X!XM";?^$_ \>?\
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M'<=V/B%#J\?QZC^,\'P9_P""A<?P/72ELT7PBGAV/P*WQ[7XIC4P/$(\2/\
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M445YYUA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
,% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>gb2k1ptlkg5v000004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gb2k1ptlkg5v000004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  G!"4# 2(  A$! Q$!_\0
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M+E HSG)!Z,1_=')I6 T:*K+J-B]\UBEY;M>(,M )5,@'J5SGN*HWNKW*:O\
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M 8X 8$9]NE+IWB"YN)M.2]L(K=-1B,EN\-P9>0H;# HN#@]L]*+,+HWZ*P]
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M\-I9AX[A0%)=Y-AY!!& P.%& <\Z=YI,]_=>(8_+=&DCMWMI&! \Q 2I!]F
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M!V]>E:_A>TFLM$6.:)H-TTLD<#8S$C.2J\<# (X[=*V:*3=P2"BBBD,****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
7"BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>gb2k1ptlkg5v000002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gb2k1ptlkg5v000002.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" &\!YX# 2(  A$! Q$!_\0
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M]X!_Z\/&?_I-HM %W_A"K#_H,>,/_"R\2_\ RRH_X0JP_P"@QXP_\++Q+_\
M+*NPHH X_P#X0JP_Z#'C#_PLO$O_ ,LJ/^$*L/\ H,>,/_"R\2__ "RKL**
M./\ ^$*L/^@QXP_\++Q+_P#+*C_A"K#_ *#'C#_PLO$O_P LJ["B@#C_ /A"
MK#_H,>,/_"R\2_\ RRH_X0JP_P"@QXP_\++Q+_\ +*NPHH X_P#X0JP_Z#'C
M#_PLO$O_ ,LJ/^$*L/\ H,>,/_"R\2__ "RKL** ./\ ^$*L/^@QXP_\++Q+
M_P#+*C_A"K#_ *#'C#_PLO$O_P LJ["B@#C_ /A"K#_H,>,/_"R\2_\ RRH_
MX0JP_P"@QXP_\++Q+_\ +*NPHH X_P#X0JP_Z#'C#_PLO$O_ ,LJ/^$*L/\
MH,>,/_"R\2__ "RKL** ./\ ^$*L/^@QXP_\++Q+_P#+*C_A"K#_ *#'C#_P
MLO$O_P LJ["B@#C_ /A"K#_H,>,/_"R\2_\ RRH_X0JP_P"@QXP_\++Q+_\
M+*NPHH X_P#X0JP_Z#'C#_PLO$O_ ,LJ/^$*L/\ H,>,/_"R\2__ "RKL**
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MHH X_P#X0JP_Z#'C#_PLO$O_ ,LJ/^$*L/\ H,>,/_"R\2__ "RKL** ./\
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MHH X_P#X0JP_Z#'C#_PLO$O_ ,LJ/^$*L/\ H,>,/_"R\2__ "RKL** ./\
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MKL** ./_ .$*L/\ H,>,/_"R\2__ "RH_P"$*L/^@QXP_P#"R\2__+*NPHH
MX_\ X0JP_P"@QXP_\++Q+_\ +*C_ (0JP_Z#'C#_ ,++Q+_\LJ["B@#C_P#A
M"K#_ *#'C#_PLO$O_P LJ/\ A"K#_H,>,/\ PLO$O_RRKL** ./_ .$*L/\
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M<?\ #G_D1?"W_8(MOY&@"7_A"K#_ *#'C#_PLO$O_P LJ/\ A"K#_H,>,/\
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M\2__ "RH_P"$*L/^@QXP_P#"R\2__+*NPHH X_\ X0JP_P"@QXP_\++Q+_\
M+*C_ (0JP_Z#'C#_ ,++Q+_\LJ["B@#C_P#A"K#_ *#'C#_PLO$O_P LJ/\
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MF-)KZ>>4*9KB5R W);GH,=]7"^$_^0YX_P#^QFM__3!I%=U0!Q7@?_CSU_\
M['7QC_Z?KRNUKBO _P#QYZ__ -CKXQ_]/UY7:T %%%% !1110 4444 %<%KO
M_(_> ?\ KP\9_P#I-HM=[7!:[_R/W@'_ *\/&?\ Z3:+0!WM%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %<.__ "4FW_[$>\_]/UC7<5P[_P#)2;?_ +$>\_\ 3]8T =Q1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M86MA:]6A"%2*K4ZLFZ_LY49*=*I4O%/^F.BOXE/!G_!3_P#X+)>"=.T+X_\
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MM2L8?%'AOX3:Y%INJZ+)X1\"6;WB>'M?^+W@KQ!)!J_BC4/$]IXH^'W@+6-
M/P]\3^$/&WBB\\:Z)\-OS9\2_MH_\%YO!_@BY\=^+)OVF?"_A#3SXS76O%&N
M?L7_  YTJ#PQ8?#[1-#\0^*O$_B]=0_9UB7P=X.L]'U^UO++QQXILM)\%:\=
M.\4VWA[6=4NO!7C"#0N?*/"GB/-,NP.9XC&Y!D.'S3WLKI\09I_9^)S*#LXU
M,)AXT*]2<9J494^=4Y5*<X581E2J4YRZ<Z\8N%\HS3,,IPV XDXBQ.4:9O4X
M:RC^T\)E<T[2IXW$RQ.'IPE3:E&HZ;JPIU(5*-24:U.I3C_:917X,?\ !+3_
M (*^>*_VQOBGXI^ W[0?A3X<>"OB->Z7J/C'X1>(?A]/=>&O#'B_2-#MM-'B
M/X;W?ACQQXW\3>)]0^)6E6IU/Q[I%_X3OM7T[Q#X$T[QI-JWA[P/_P *V&L?
M$'X(_P""HO\ P5D_;:_9H_;@^,?@'X._$/PYX;^&GP&MOAK-8?#NZ^'?@O7]
M#^(+7/PN\%_%W6Q\0=;UW1]1\>A?$5]XPN_"&I#X?^,? )M/!^F:3_8!T7Q<
M-3\6ZGQX7PSXIQ'$>/X6J4,+@\UR_+JN:U5B\0XX:K@J3HQ57#5Z%.O&M[65
M>"IV27,IQJ2ISISC'NQ7BMPAAN%\NXOI8C%X[)\RS2AD]%X/#*6*HX^LJS='
M%8?$5</*@Z*H3E5O)RY7"=&-6%2G*7];U%%?S$_\$8/V]_VQOVHOVJ_&/PZ_
M:"^.NI_$WP5HW[._C'QC8:%>?#WX,^$T3Q7I?Q'^#^A:?KSZE\//AKX.UF2X
MMM)\1:_9BP;4CHLHU6:>XTN:ZM-,GL?"RCA?,LZRCB'.\)/"QPG#-'!U\PC7
MJU(5YPQTZ].BL+"-&I"I)/#5'452I148\O*Y-V7T.=<797D.=\,Y#C88R6-X
MKKX[#Y9*A1IU,/"IE]/#5*[Q<YUJ<Z49+%4E3=.G6<I<W,H)7?\ 3M17XL_\
M%._^"M_AO]C.=?@[\$8?!OQ)_:;:;0[_ ,3:/XB74=7\"_!_PU>K8:U&/B':
M^'-<\/:O>>./&7AVYAE\(>!;'7]'U'2M"UBP^)?BNYM- G\$>'OB?^+/AK]L
M[_@O3XE\#VGCGPW-^TYXM\)WS^#8M(\3Z/\ L6_#?5U\3V?C[1-<\0^%_$WA
M:#1?V<C_ ,)9X0N](T"ZN[_QOX7T_4O!>@2:AX7M/$.LZ5=^-/"%MKOT>1^&
M/$&=950SJKC,BR#+<94]G@,1Q%F7]F_V@^;EYL)!4*\YQ<M(2G&G[725'VD&
MI/Y?B#Q:X;R'.,1D-' \0\1YI@J?M,RPW#&5/-'EJ<5.V-FZ^'IPDH.\XTY5
M71UC6]G-.*_M,HK^9C_@FC_P6R^)OQL^-W@#]GG]J33_ (<7%A\1-#T/PE\.
M?C5X72S\#W]U\3--TB[DA'Q3L]7\5#P=KEQ\:KF&STCPF_PMT7P@VG?%"]T'
MPCH?PZUW1OB#!>_#>3_@M!_P41_:[_9A_:9^'?P=_9[^*%I\+/"K? K0_B7K
M5UIW@+X>^+-=\3>(/&7C_P"(GA=K?6+SXD^%_&UC:Z3X=T[X;V,GA^V\-Z9X
M?NFO/$7B:7Q%?>(86\.6_AN(>&'%3XKH\'UJ.#PV9XC"U,;AZ]?$MY?7P=.G
M4J/$4L31I5I3A)TITTE1]I&K%PJ0A9M:3\6N#UP=7XXH5\;B\HPV+I8#$T,/
MA4LRP^-JU*5-86MA:]6A"%2*K4ZLFZ_LY49*=*I4O%/^F.BOXE/!G_!3_P#X
M+)>"=.T+X_\ BY_C#XU^!\&AZ=X@&I?%K]CO2_"'P!\7:%XXLH]*\&:_<_$S
MP?\ !GX5:C=:3J>H>)- U;P?J'A3XIZ39>(-3;P_")=:T?4KC2]5^_/'G_!5
MC]I_]J;]B7PMXJ_8ST'XH>&?VP/AO\:_AKX7_:/\'_!;X%R_&RQ;P/XQ^&OQ
MNN]/\:>%M+U_P!\68-.^&_C+Q=X#M9ECO /&GP_\1Z/%X,US7]4T36/#OBGX
MD]F-\)N),&L)7^N\/8O+L3CZ66U<XP6;PQ&69?BJSY81S&O[*-3#0YG"$JGL
M9QC4J4J<FJE6G&7#@/&7A;'/&8?ZAQ-@LTPN75<UI9)C\DJ8;-LRP=&/-.66
M8?VTZ6+J<JG.-)5X3G3I5JL4Z5&I./\ 3?17\*/CC_@J5_P5Y^%^OIX3^*/Q
MK^+'PO\ %4NCV7B&'PS\3/V7O@G\/O$-QX?U*]U73=/UVVT3QC^SYHNIW.C7
MVHZ%K6GVFJ06LEC/?:1J=I%.UQ8W,<7UA^RA^V5_P6@^)OQN_9IG\7WG[3OB
M#X#?$#XK_!B;Q3XH_P"&+_"&G_#_ %[X1>*O&'AJ37-<;XB:-^SAIUC8>"]6
M\&7]U?/XUTCQ)IUO::%<-KVG:_91QPZE%WXSP9X@P. _M*OGW!RPDJ5>M0JK
M.ZO+BUAXN52&$G/ 0IUZBY7!1A-^_P"ZVCSL#XZ\-9AF*RK#\.<</&QK8>AB
M*4LAH\V">*G"-*IC80S&=3#4GS<[G4IKW$Y14E:_]?U%%?@K_P %7OV\?VR_
M@Y\7/#_[+?[%WP]UO6O&VL_!"P^.'B;QE\//A=KGQV^+FBZ#-\3[GPG$_A/X
M;V'AGQ;H6EZ%8S>%9]"\5^(O$_@SQY;ZK'\1=-L=%A\#:_HFGZWK?YWD&0XW
MB/,89;@JF#H5'3JUZN)S#%4\%@L+AZ,>:K7Q&(JZ0IP35U",ZC;2C"6MOTWB
M/B+ \+Y74S7'TL=B*<:M'#T<+EN#JX['XO$XB7+1P^&PU)7G5J-.SG*G323<
MJD=+_O517\5?Q)_X*<?\%@?V0_C2O@7]H'QM8'QEX;TB'7KGX8?$_P"$GP<N
M_ ?BW1O%>A:E:>'M=/B+X-Z)X*UGQ-X=L=3-S<6NI_#GXIZ=9Q^,_">J>$M>
MU&>?0?%OA8?V*_"CXC:-\8/A;\-?BWX<LM7TWP]\4O '@[XBZ#IVOP65MKMA
MHWC?P[IWB;2[+6K?3;_5=.M]7M;'4X(-2@L-4U*RBO$FCM;^\@6.XD]OBO@3
M..$</EF.QF)RK,LMS>-26 S/)<:\=@:SIJ,I05:5&@VW":G"482I5(J7LZDG
M":CX/!WB)DG&F*S7+\%A,YRO-,EE268Y5GV 679A0C5<HPG*C&OB(I*<'"<)
M5(UJ<G#VE.,:E-R[^BBBOBC[P**** "N&\.?\C;\1/\ L)^'O_48TVNYKAO#
MG_(V_$3_ +"?A[_U&--H [FBBB@ HHHH ***\4_:+^/OP^_9=^"WCWX\_%*7
M64\$_#[3;.]U.#PYI$^N:_JE]K&L:;X;\.:#HVG1/! VI^(O$VLZ/H-E=ZK?
M:3X>TRXU&/4_$VNZ#X>L]3UJPVP]"OBZ]#"X:E4KXG$UJ>'P]"E%SJUJ]:<:
M=*E3A&\IU*E2480BDW*326K,<3B:&#P]?%XJM3P^%PM&KB<3B*TE3I4*%"$J
MM:M5G)J,*=*G&4YSDTHQBVW9'M=%?Q/>)?\ @L5_P5 _:+^*^JP_LY?V[X:C
MM]"U;5]-^!G[/7P%T?X[ZWI_@S3O%<L47B_Q/+K_ ,-OB=X_US5M*@\6^$?!
MOBOQCI%IX*^']]?V_A^\L/ /@_4M?N+34/OC_@G'_P %)?V]M6_:V^&G[(O[
M:'@_6;VY^--CX[\4:'J_Q8^$MQ\ OC'X2L-(\ ^(_%6@7UAX9L?"'@;1/$GP
MZN+GX3^-=!@M=0\ VGB6Y\1^(=4U4_$BXTWP2O@J[_2\S\).)\IR[%XW%XSA
M[ZS@,#4S'&Y+2S>G4SK#82C2=>O5GA?9*C-4J*=27L<35YHK]WSMI/\ *<I\
M:.$\YS/!X#!X+B7ZIF.84LKP&?5<DJT\BQ6-KUEAZ%&GC/:NM!UJ\HTH^VPM
M+ED_WOLXIM?TTT5_.S_P5!_X+0M\#/$.N?L^_LA:MX1U_P")_A^3Q+X?^+WQ
M>U*QA\4>&_A-KD6FZKHLGA'P)9O>)X>U_P"+W@KQ!)!J_BC4/$]IXH^'W@+6
M- /P]\3^$/&WBB\\:Z)\-OS9\2_MH_\ !>;P?X(N?'?BR;]IGPOX0T\^,UUK
MQ1KG[%_PYTJ#PQ8?#[1-#\0^*O$_B]=0_9UB7P=X.L]'U^UO++QQXILM)\%:
M\=.\4VWA[6=4NO!7C"#0LLH\*>(\TR[ YGB,;D&0X?-/>RNGQ!FG]GXG,H.S
MC4PF'C0KU)QFI1E3YU3E4ISA5A&5*I3G+7.O&+A?*,TS#*<-@.).(L3E&F;U
M.&LH_M/"97-.TJ>-Q,L3AZ<)4VI1J.FZL*=2%2C4E&M3J4X_VF45^#'_  2T
M_P""OGBO]L;XI^*?@-^T'X4^''@KXC7NEZCXQ^$7B'X?3W7AKPQXOTC0[;31
MXC^&]WX8\<>-_$WB?4/B5I5J=3\>Z1?^$[[5].\0^!-.\:3:MX>\#_\ "MAK
M'Q!^"/\ @J+_ ,%9/VVOV:/VX/C'X!^#OQ#\.>&_AI\!K;X:S6'P[NOAWX+U
M_0_B"US\+O!?Q=UL?$'6]=T?4?'H7Q%?>,+OPAJ0^'_C'P";3P?IFD_V =%\
M7#4_%NI\>%\,^*<1Q'C^%JE#"X/-<ORZKFM58O$..&JX*DZ,55PU>A3KQK>U
ME7@J=DES*<:DJ<Z<XQ[L5XK<(8;A?+N+Z6(Q>.R?,LTH9/1>#PREBJ./K*LW
M1Q6'Q%7#RH.BJ$Y5;R<N5PG1C5A4IRE_6]117\Q/_!&#]O?]L;]J+]JOQC\.
MOV@OCKJ?Q-\%:-^SOXQ\8V&A7GP]^#/A-$\5Z7\1_@_H6GZ\^I?#SX:^#M9D
MN+;2?$6OV8L&U(Z+*-5FGN-+FNK33)['PLHX7S+.LHXASO"3PL<)PS1P=?,(
MUZM2%><,=.O3HK"PC1J0J23PU1U%4J45&/+RN3=E]#G7%V5Y#G?#.0XV&,EC
M>*Z^.P^62H4:=3#PJ9?3PU2N\7.=:G.E&2Q5)4W3IUG*7-S*"5W_ $[45_.S
M_P %0?\ @M"WP,\0ZY^S[^R%JWA'7_B?X?D\2^'_ (O?%[4K&'Q1X;^$VN1:
M;JNBR>$? EF]XGA[7_B]X*\020:OXHU#Q/:>*/A]X"UC0#\/?$_A#QMXHO/&
MNB?#;\V?$O[:/_!>;P?X(N?'?BR;]IGPOX0T\^,UUKQ1KG[%_P .=*@\,6'P
M^T30_$/BKQ/XO74/V=8E\'>#K/1]?M;RR\<>*;+2?!6O'3O%-MX>UG5+KP5X
MP@T+ZG*/"GB/-,NP.9XC&Y!D.'S3WLKI\09I_9^)S*#LXU,)AXT*]2<9J494
M^=4Y5*<X581E2J4YR^0SKQBX7RC-,PRG#8#B3B+$Y1IF]3AK*/[3PF5S3M*G
MC<3+$X>G"5-J4:CINK"G4A4HU)1K4ZE./]IE%?@Q_P $M/\ @KYXK_;&^*?B
MGX#?M!^%/AQX*^(U[I>H^,?A%XA^'T]UX:\,>+](T.VTT>(_AO=^&/''C?Q-
MXGU#XE:5:G4_'ND7_A.^U?3O$/@33O&DVK>'O __  K8:Q\0? _^"T'_  41
M_:[_ &8?VF?AW\'?V>_BA:?"SPJWP*T/XEZU=:=X"^'OBS7?$WB#QEX_^(GA
M=K?6+SXD^%_&UC:Z3X=T[X;V,GA^V\-Z9X?NFO/$7B:7Q%?>(86\.6_AOS\-
MX<<3U^+/]3*M##8+.71J8A/%UVL'+#TZ,JZKPQ&'IXCVE*I"+4'3IS?M+TYJ
M$H5%#TL5XI<)8?@Q\=TL1BL?D:K4L-)8/#7QL,55KPP[PU3#8BIAO95:4YJ5
M2-6I!>SM4IRJ0G3<_P"F.BOXE/!G_!3_ /X+)>"=.T+X_P#BY_C#XU^!\&AZ
M=X@&I?%K]CO2_"'P!\7:%XXLH]*\&:_<_$SP?\&?A5J-UI.IZAXDT#5O!^H>
M%/BGI-EX@U-O#\(EUK1]2N-+U7[\\>?\%6/VG_VIOV)?"WBK]C/0?BAX9_;
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M*U+AG&YCB<1'"X7#TL?[>6(IRQ&)G&C#ZQ@J').7[_V,5*2_H$HK^=[]L?\
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M(Q%::IX?!X/#TTZF(Q6(J-0ITX+EC'GK5ITL/2K5J?[#T5_,+<_$[_@N)/\
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M32Q5-/#353]Y"2YH.,9QYW#KJ***^'/T **** (I_P#43?\ 7*3_ - -<?\
M#G_D1?"W_8(MOY&NPG_U$W_7*3_T UQ_PY_Y$7PM_P!@BV_D: .UHHHH ***
M* "BBO'_ (^_''P+^S;\(/&_QL^),FL+X.\":?9W>HP>'])GUK7-2O=6U;3_
M  ]X?T32=/B:&%M0U[Q'J^DZ+:7>J7FEZ!ILU^FI>)-;T/0+34M8L=:%&MB:
MU'#8>E.M7Q%6G0H4:<7.I5K59JG3ITXJ[E.<Y1C&*5Y2:2U9R8_'X/*\#C<S
MS'%4,#E^783$8['XW%5(T<-@\%A*,\1BL5B*TVH4J&'H4YU:M2;484X2E)I)
ML]@HK^/'Q'_P5C_X*/?'CXGZE'\!9M<\/+#H>K:MIOP1^ ?P.TKXVZS8^#]-
M\4R1Q^+?$!UGX=?$KX@Z[JFE0>+/"7@_Q7XOTFW\'^ ;V^A\/WECX#\'ZEX@
MGM+_ .X/^"?_ /P4)_;<U3]J3X=?LL_M<^%]7O9OC%9^-?$NCZG\4_A;/\"_
MBYX4L--\#>(?$^@7EAX:L_"?@C2=?\ 3W'PM\9:)#9ZEX%M?$ESX@U[5-4/Q
M$FT[P6/!MW]_F'AEQ#EF!Q.+Q.*R/ZQ@L)/'8O*:>:4YYMA\+2INM6JSPWLU
M2DJ5).I+V5>HY17[OG;2?\X\-?2N\->*\_RK)LJRGC[^S<]SJAP_DW&6*X1Q
M5#@[,<VQ>*C@L'A*.:/$2Q5*>*Q<X8>F\7E^'5.I)?6?814I+^BZBOYL/VW/
M^"Q7CSQ!X]A^"G[ 6L:5J=G<WVF^&O\ A=V@>%[#XC>(?'?CF]\3:"NDZ1\
M='U.#Q!X/UWPW?FWO/!I\2ZOX-\<?\+.D\4RW7PNMM$L=(\)_$#QK\KZ_P#M
MT_\ !8WX1V'ACXC_ !0_X7/HG@* Z'XKU*X^(_[*?A3PKX'NM*'Q NO!$'A/
MXBZ]#\'/#&H>!)_&'B32FT&+P]>>(_ WQ"U+1=?\.^(O"<MGI_B_P9XCU*L#
MX8<0XO"X+$XC%Y'E-3,HQGE^ S?,EA,QQD9I.DZ&%5&J^:K=<E.<H55]N$#+
MB#Z67AKDN;YYEF79/Q_QGA>&*U2AQ)Q%P7PM+.N&LCK4)..*CC\VGCL'!0PK
M4G6Q.'IU\*U&7L:]6UC^O>BOR@_X)B?\%&M2_;6TGQUX*^*F@>#_  ?\</AX
M8M?D@\'7HT_PO\0OA]K6J7MO9>(?"7A#Q!XH\0^.M+OO =Q_97A;XDQ7-UK_
M (<@O=<\"^)=/\46UQ\0G\ ^!_S"OO\ @J%^V/;?\%(T^%\?C_03\'6_;@T_
M]FP_"=_ /@X^&_\ A!+OXZVW[/TFICQ&-'7XH?\ "5+I4S>/TO\ _A8']E#X
M@A=VB-X!!\!'RL/P+Q!6Q^>Y9.C0PF,X>P%;,<?2Q-9Q4L/1C&HOJTZ4*T*T
MJU.<:E%WC2G!INI$^QS'Z07AQ@>'O#SBG#XW,,XR3Q,XBP/#'#F+RG!1JNGF
M6-K5,-+^U*.+Q&"JX&G@<32J8?'PY*V+HUH2C#"U;-K^IRBO#?VGO%/B7P-^
MS5^T-XV\&:S-X<\8>#_@;\6O%/A3Q#;66DZC<:%XE\/^ ?$&K:%K,&GZ]IVK
MZ%?S:7JEI:WL5EK6DZGI-T\"P:CIU[9O-;2_E7_P1J_:P_:0_:?OOVE1\?\
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M0J8=5Z6(H3J?U045_'_I'_!27_@K3\"I;WQY\9-*^).I>%=4A/A#1]._:?\
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MK)L=6?XWZCI7B_PIX'\;>,H(O%?@3X>?$)+R^\8VWAK7M&U;T3_@X5_Y/O\
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MCA_-*5"E1YO;5I2PE3FH4E%.4JE>GST806M24U#[1\%_\&Z'P8\"1_"_X_\
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MK'+]6Q6)^L?6_;4+\_)[+ZLN7F]K+E^//C&7_:%_X*V^,O#'QID;QQHOC_\
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MT":G+\)=/:95#M"M[^R]\&+9I50E0[1B4N%+ ,1@D9S7MW_!+/X6>)/VV?\
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MO[$/_)EW[(?_ &:_\ ?_ %5'A.O'\1?^3&>"_P#U\XB_]2YGM^&7_*0WCO\
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M444 %<#\-/\ D5(O^PQXD_\ 4AU.N^K@?AI_R*D7_88\2?\ J0ZG0!WU%%%
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MGIVK6#R+=Z=?6EY%#<1_Q^?LF?&SQ7_P3Y_:BO\ Q!\8_A?XFL=3T/PEXO\
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M%CBVLQC@<QG]:HJE.CAH^TE1I5)K'1=65:C+!57U>$7%7$E;Q.XWX)K<<?\
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M /!UYXPCNQXMOM>^(NA>*]7_ .$MCU=?%/BSP[J>J>#-/\'^!-)\3_=NK?\
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M,OX$>TE^XO\ @WR_X_?VO_\ KU_9Y_\ 1OQVK]NOVR/^30_VJ?\ LV_XX_\
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M-IQFI3^L?6L)4=&=:\I.IRR=:\KI1Q,9IMSE;^8\SP.-E]'#.L^P-.>7\/\
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M/_L,^%/A=8_#;]H;X#_#?PQX&^'%M9GX6?%7P5\.?!ND>%_"OAS49]2U/7_
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MD%O0!N4444 %%%% !1110 4444 <+X3_ .0YX_\ ^QFM_P#TP:17=5POA/\
MY#GC_P#[&:W_ /3!I%=U0!Q7@?\ X\]?_P"QU\8_^GZ\KM:XKP/_ ,>>O_\
M8Z^,?_3]>5VM !1110 4444 %%%% !7!:[_R/W@'_KP\9_\ I-HM=[7!:[_R
M/W@'_KP\9_\ I-HM '>T444 %%%% !1110!^4G[3?_!&7]B?]IOQ+XG\>WNA
M>/?@Y\2O''C2/QQXV\??!;Q=!I-[XGU)M(NM-U6UNO!OC[1?B+\*M(@\37TU
MOXK\5ZIX7^'V@>*?$?C*TE\3:KXAN-2\0>+Y/$6K^RG_ ,$?OV,/V4=73Q9I
MGACQ#\;OB#8:[#KOAKQ_^T%<>%?&NL>"Y["_\)ZWH/\ PA_A[P[X/\%_#K0]
M7\+^)O"%IXF\+^/(?!#_ !/T+5-3UFWL?'$>B75OI%I^HU%?1/B[BF67?V3+
MB+.I99[-4?J+S+%O#^P2Y50]FZMO8*/NJA_"MIR6/F8\%\(QS/\ MJ/#&11S
M;VKK_P!H+*L$L5]8<N9XCVJH\WUGF][ZQ_&O=\]VSQ/]H#]G+X*_M2_#R?X5
M_'KP'8?$#P/+K.D>(H=-N=0UO0]0TS7M"N&FT[6= \3>%]3T/Q3X<U-89;W2
MKN]T#6M-N-3\.ZMKOAC4Y+SP[K^M:7?_ ),C_@WQ_8C'CL^+O^$V_:0/A\^-
M/^$I'PM/CGX??\((NA_VT-4_X5L-0'PH'Q-_X0O["#X;^W-\1F^(G]BL9_\
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MAL3F=/!X>&8XC#P]GR8>OC8TUB:M&'LJ7+2J594X^RIVBN2-BOE/]I7]B/\
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M>$]0\#W^M'Q[\3O%+3^%M5U?0->U#2_L'C3QIXCTN(7&K>%]"NS>064>H(;
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MD:7X,\;^'=&8VFL^-/$MX=0?3FU2X_M(6]U?3VMEIT%I]1?#GX?^$?A-\/?
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MXLXAQF4\D:<LOQ.;XZMAJE*&L*-6G4K25:C#3DHU>>E#E@HP7LX<OQN"\.^
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M1"]TZ]LK==7O/AI\*_AYXPMO[)N+N#5].;P[XJT&1]1TVRCU-]2TM]1TV_\
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M?#T^!)/'R>'8_%I_X2WQSXH&JIX3;7F\/@+XR\3>(DL#8'Q/KA+:8MDUW]M
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MH **** "BBB@ HHHH *X=_\ DI-O_P!B/>?^GZQKN*X=_P#DI-O_ -B/>?\
MI^L: .XHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P"1%\+?]@BV_D: .UHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#GO%W_(J>)_^Q>UK_TVW-2^
M&/\ D6O#W_8#TG_T@MZB\7?\BIXG_P"Q>UK_ --MS4OAC_D6O#W_ & ])_\
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M%?,'N'"^$_\ D.>/_P#L9K?_ -,&D5W5<+X3_P"0YX__ .QFM_\ TP:17=4
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M ( Z+_\ *RC_ (:5^.7_ $4+4_\ P!T7_P"5E']G5_YJ7_@4_P#Y /[4P_\
M)6_\!A_\L/Z/:*_G"_X:5^.7_10M3_\  '1?_E91_P -*_'+_HH6I_\ @#HO
M_P K*/[.K_S4O_ I_P#R ?VIA_Y*W_@,/_EA_1[17\W[_M+_ !R&,?$+4^__
M "XZ)[?]0NHV_:9^.@!(^(>I_P#@!HGK_P!@NJ668AJ_/1_\"G_\K#^U,/\
MR5O_  &'_P L/Z1**_FND_:>^/"GCXBZF.3_ ,P_0NW_ '"JH2?M2?'Q>GQ'
MU,<#_F': >_OI-/^R\1_/1_\"G_\K)_M;#[\E?\ \!I^7_3SS1_3!17\Q\O[
M5?[0*YV_$G4Q][_F&>'CTZ=='JC)^UC^T,O3XEZF.!_S"O#GK[Z-1_9>(_GH
M_P#@4_\ Y6+^U\-_)7_\!I__ "T_I^HK^723]K?]HI<X^)NIC&/^83X;]O\
MJ"U3D_:\_:-7./B?J8QC_F$>&?;UT2C^R\1_/1_\"G_\K#^U\-_)7_\  :?_
M ,M/ZEZ*_E9E_;"_:27.WXHZF/O?\P?POVZ==#JC)^V1^TLO3XIZF.!_S!?"
MOK[Z%5+*,2U?GH?^!5/_ )4']KX;^2O_ . T_P#Y:?U:45_)])^V=^TTN<?%
M74QC'_,$\*>W_4!JG)^VG^T\N<?%?4QC'_,#\)>WKX?I_P!D8G^>A_X%4_\
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M:E_X%/\ ^0#^U,/_ "5O_ 8?_+#^CVBOYPO^&E?CE_T4+4__  !T7_Y64?\
M#2OQR_Z*%J?_ ( Z+_\ *RC^SJ_\U+_P*?\ \@']J8?^2M_X##_Y8?T>T5_.
M%_PTK\<O^BA:G_X Z+_\K*/^&E?CE_T4+4__  !T7_Y64?V=7_FI?^!3_P#D
M _M3#_R5O_ 8?_+#^CVBOYPO^&E?CE_T4+4__ '1?_E91_PTK\<O^BA:G_X
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M_P"H+5*3]KS]HY>GQ/U,<C_F$>&?3WT2C^R\1_/1_P# I_\ RL/[7PW\E?\
M\!I__+3^IBBOY6)/VP_VDE''Q2U,<'_F#^%^WUT.J,G[9/[2ZYQ\5-3&,?\
M,%\*^WKH57_9&)?VZ'7[53II_P ^@_MC#+[%?I]FGUT_Y^G]6M%?R?2?MG?M
M-+G'Q5U,8Q_S!/"GM_U :I2?MI_M/+T^*^ICD?\ ,#\)>GOX?H_LC$_ST/\
MP*I_\J)>=85?\N\1_P" 4^R?_/WS/ZSJ*_DBD_;:_:C4<?%G4QP?^8#X0_KX
M>JA)^W!^U.O3XN:F.1_S /!Q[>_AVJ638I[5*'7[53I;_IUYB_MO"_\ /O$?
M^ 4__EI_7917\@DG[<_[5BYQ\7M3'&?^1>\&>_\ U+E4)/V[?VL5Z?&#4QR/
M^9=\%>GOX:I/)\4O^7E#_P "J=D_^?7F2\]PB_Y=XG_P"EV3_P"?WF?V%45_
M'-)^WI^UJN<?&/4^F?\ D6_!'O\ ]2S5"3]OK]KI>GQEU,<C_F6? _I_V+%-
M9+BG_P O,/\ ^!5/)_\ /KS%_;V#_P"?>)_\ I?_ "X_LHKA=*_Y*!XO_P"P
M'X4_]&:Y7\@LG[?_ .U\N<?&?4Q\V/\ D6/ OO\ ]2O7VK\+_P!I[X[>(/@O
MX7\9ZO\ $+4+KQ-JWB_QII&HZJ-+\/VTEUIVB0^'7TNV>WM-(@LU6T;4KXI)
M';I*_P!H;SI) L82*F4XFDHN4Z#YI<JM*H]>64M;TUI:+^=C6EG.%JN2C3Q"
MY8\[YHTUIS1CI:J];R7RN?TOT5_.%_PTK\<O^BA:G_X Z+_\K*/^&E?CE_T4
M+4__  !T7_Y65E_9U?\ FI?^!3_^0-/[4P_\E;_P&'_RP_H]HK^<+_AI7XY?
M]%"U/_P!T7_Y64?\-*_'+_HH6I_^ .B__*RC^SJ_\U+_ ,"G_P#(!_:F'_DK
M?^ P_P#EA_1[17\X7_#2OQR_Z*%J?_@#HO\ \K*/^&E?CE_T4+4__ '1?_E9
M1_9U?^:E_P"!3_\ D _M3#_R5O\ P&'_ ,L/Z/:*_G"_X:5^.7_10M3_ / '
M1?\ Y64?\-*_'+_HH6I_^ .B_P#RLH_LZO\ S4O_  *?_P @']J8?^2M_P"
MP_\ EA_1[17\X7_#2OQR_P"BA:G_ . .B_\ RLH_X:5^.7_10M3_ / '1?\
MY64?V=7_ )J7_@4__D _M3#_ ,E;_P !A_\ +#^CVBOYPO\ AI7XY?\ 10M3
M_P# '1?_ )64?\-*_'+_ **%J?\ X Z+_P#*RC^SJ_\ -2_\"G_\@']J8?\
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M*?77_GZ?UGT5_)#)^VU^U&O3XM:F.!_S ?"'K[^'JH2?MP_M4*>/BYJ8Y/\
MS+_@[M]?#M4LFQ35_:4-[?%4\O\ IUYA_;>%_P"?>(Z?8I]=/^?I_7;17\@<
MG[<_[5B]/B]J8X'_ #+W@P]_?PY5"3]NW]K%3Q\8=3')_P"9<\%?U\-5/]CX
ME?;H=/M5.NO_ #Z(_M["?\^\3T^Q2ZZ_\_C^PNBOXY9/V]/VMEZ?&/4QP/\
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MM_X##_Y8?T>T5_.%_P -*_'+_HH6I_\ @#HO_P K*/\ AI7XY?\ 10M3_P#
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MRL_[.K_S4O\ P*?_ ,@:?VIA_P"2M_X##_Y8?T>T5_.%_P -*_'+_HH6I_\
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MO3XPZF.!_P RYX*]??PU2_L;%:?O*&O]ZIY/_GUYDO/<(O\ EWB?_ *79/\
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MYQ\1M3'WO^8=H/;IUTFJ$G[4_P ?ESCXD:F,8_YAOA_V_P"H11_9>(_GH_\
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M,3C.>M#,,YRNE&A[+"U(\T*U2I[1P7LN5RE'^R^BOX9O^'E7[;O_ $7;4_\
MPCOAQ_\ ,=1_P\J_;=_Z+MJ?_A'?#C_YCJ^Q_P"(%<7?]#'AS_PKS/\ ^=!^
M _\ %0CP8_Z)GQ/_ /#+PI_]&I_<S17\,W_#RK]MW_HNVI_^$=\./_F.H_X>
M5?MN_P#1=M3_ /".^''_ ,QU'_$"N+O^ACPY_P"%>9__ #H#_BH1X,?]$SXG
M_P#AEX4_^C4_N9HK^&;_ (>5?MN_]%VU/_PCOAQ_\QU'_#RK]MW_ *+MJ?\
MX1WPX_\ F.H_X@5Q=_T,>'/_  KS/_YT!_Q4(\&/^B9\3_\ PR\*?_1J?W,T
M5_#-_P /*OVW?^B[:G_X1WPX_P#F.H_X>5?MN_\ 1=M3_P#".^''_P QU'_$
M"N+O^ACPY_X5YG_\Z _XJ$>#'_1,^)__ (9>%/\ Z-3^YFBOX9O^'E7[;O\
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M.V_X*>_MU $CX^:G_P"$5\,_7_L2ZK-_P5!_;M!('Q^U/_PB?AEZ?]B51_Q
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M ,(3X5>G_8BU6D_X*M_\% %Z?M#ZF.1_S(?PJ]/^Q$J/^()\5?\ 0PX?Z?\
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M+:Y<9\-'_K]_[AK'=@=\1_V#_P#NQAR[1117&=04444 %%%% !1110 4444
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ME3=?Q'\JU9N__ JRINOXC^5:K;YQ_*)+V^:_-&9-W_X%65-U_$?RK5F[_P#
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MD*N/]T_A_,53?[Q_#^0K(]2ET_Q?Y%-_NG\/YBJ;_>/X?R%7'^Z?P_F*IO\
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M,,5RF(YI]*U&V74(+6XO[;3]4&H:5'J5\;*2XD^8?VN0%_:/^*P4 #^WK4X
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M\+:OJ_@[P!$FIZ+HNCV4_A^XOTM_M=Q)IVMZ]KVM2_$7QK_:O\4?M)^!=$\
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MU=-:;QDK7>U[M-')C,*L,J4H3]I2KT^>G-QY7;]WO%Z[2B[M+>UDTS+F[_\
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M[&G[3_A[Q9:_!_3_ (@?"CQW8KI6JWXU35O$6J:GH\4^HZ@^GD:-XC\3>-?
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MOU?'_(@_!/\ [(MX#_\ 26ZKEQF]+UG^2.[![5_\,/\ TLS****Y#J"BBB@
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M_A&?$/\ PCGV<7?]O_V+J7]B?9,[/M7]J_9OL/V??\GG>?Y>[Y=V>*Y6;I^
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MUN+*\M99(+FTNX);:YMYHSMDAG@F5)8948%7CD174@A@#7[W_'K5?C_\#O\
MA ?A9^R'\'[>U^'NC>&I]2U74M'\(2>(!)JU]J]RD6EQS27*6L-\?LFHZ]XM
MU/4[;6-?\4ZGXDL-4EU73[JUU23Q!Y1^V1X+NOB=^R)X5^/?Q.\(/\//C7X&
M_P"$8@\26MMI,5I=:G%K'BI/ 5YX?O+=YM<U"V\*W^L:]:^._#EG=:I/JOAV
M,0V]SJD45]XFAU+.&8.4Z?-"FH59<BY:L93A=I*4X[I:]5'37M?2IEBC"IR5
M*DJE*'/+FHRC3G9-N-.75Z:6<M;+2[:F^#"*?^"8OC[*K\WA?XL.?E'+KJVI
M[6/'++L3:QY&U<'Y1C\5KCPGXJ7P_P#\)8WAGQ OA;>D/_"2MHVHCP_YSW0L
MTB_MDVW]G>8UXRVJI]IW-<L( #*0M?O-^R3J_A'0/V!K[6_'NAP^)_!FDV/Q
M-U'Q+X<N+"TU2#7])M-9U6>ZT:;3K\C3[Z/4D3[&]KJ!%A,)BEZ1;&4CFOV4
M_P!O36OCQ\7+SX3>.O!G@_0-&\3Z9K;^ X=#34I)XETFSN=2G\->(/[2O+NQ
MUPR^&K74)VU&PT_P_;A]+EB.C-%J"BPQIUZU">,G3HJI".(G*<G-1M:<M$MW
MZI/T-ZE"C7IX&%2LZ<Y8>G&G%0<N9N$-6]EVLVO4_ N7O_O?XUJZ!X&\;>,8
M[N;PAX.\4^*H;"46M]+X;\/ZMKD=G<M#'<+;W;Z9:72V\[03PSB&8I(89HI
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MEY2=ET5E=V"OSU_X*)_\DPT'_L)7'_I;H%?H57YZ_P#!1/\ Y)AH/_82N/\
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MJIR?UN-1PY73A6<*%[6OH[[].6S3;:N?KC_P3*.GCX%_%\ZO>1:=I(\97O\
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M7PG_ ,ASQ_\ ]C-;_P#I@TBNZKA?"?\ R'/'_P#V,UO_ .F#2*[J@#BO _\
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MTW7YR_\ #,'_  ;:?]%5_8R_\6$ZK_\ 1(T?\,P?\&VG_15?V,O_ !83JO\
M]$C70?\ $-Y^P[_T53]JW_PN/A#_ /.,H_XAO/V'?^BJ?M6_^%Q\(?\ YQE>
M]];P_P#T46<_^ 5__FKU_I:^5]7K?]";+O\ P*E_\H]?Z6OWG^P+\,/^";'P
MW/Q8'_!/7Q7\&/$YUD> S\7A\(OVA;OX\?81I_\ PF?_  K\^(1=?$GXA?\
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MEQGPT?\ K]_[AK'=@=\1_P!@_P#[L8<NT445QG4%%%% !1110 4444 %%%%
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MNR;5M=5X]_P4LGFNOCC\.[FXD:6>X_9Z\ 3SRM]Z2:;Q?\2I))&Q@;G=F8X
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M_P"-:+9>B_(DSY>_^[_C7[#_ !!_Y#>F_P#8F> /_4*T&OQXE[_[O^-?L/\
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MI[CQUYFG:;IVJYET?P9=W%OXAM4BM]2LC:^*+OQ'_8FG+!'IMG<S^*HTB@N
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MX2?\C_,/^Q/5_P#4W G\/?3O_P"3;\(?]EO#_P!4.;GS=1117]"'^6 4444
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M8,C^)GQ:_9K\5_%#XP?%#QAHUUH^C^#]6T;QA97&D:5>ZA;:O%X.TOQ!XI\
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M9= K\]?^"B?_ "3#0?\ L)7'_I;H%?H57YZ_\%$_^28:#_V$KC_TMT"HP_\
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MRF^9179S5XW]%Y/OO"/Q%\(Z7^R3\5OA??ZF]OXX\2?&O3O%6B:,;#4)5O\
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MI3P;^U__ ,%IOVN_VC?A]X>\9^%?!WQ(_99MWT70OB#:>';#Q?8KX1E_9/\
M .H'5[3PGXG\8Z!#]IU;PKJ%W8"Q\1ZB9-+GLI;K[)>27%C;=]/ Y@J&.GCJ
M>-A2I8.I4INK*M&#K*I144[NTO<E-\KT=KV]TY9XK!NKA8X6>&E.>)A":IJG
M*7LW"HY-65X^]RZK7IW/ZEZ***\ ]8X7PG_R'/'_ /V,UO\ ^F#2*[JN%\)_
M\ASQ_P#]C-;_ /I@TBNZH XKP/\ \>>O_P#8Z^,?_3]>5VM<5X'_ .//7_\
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M#R__ ,.=#_+^K>@?\1V\._\ H.S/_P -.(\O[WK]WF?I?17YH?\ #SWXJ_\
M1$?V;/\ PD_B1_\ /7H_X>>_%7_HB/[-G_A)_$C_ .>O1_Q!?CO_ * \O_\
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MK_T1']FS_P )/XD?_/7H_P"(+\=_] >7_P#ASH?Y?U;T#_B.WAW_ -!V9_\
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M_LM_L>'IU\"_%ST_[+?2_P!0N)X[X3#>7^VT>T5^A:\1.$GHL;BO_#?7\O\
M-_=YGU?+W_WO\:_2'X+?\FX>!O\ LH/Q)_\ 2;P?7X22?\%4?'@_YM8_8Y/S
M=_ OQ=]_3XX"OT-\,?\ !0GQ[9?LC?!?XC:?\$OV=M/O?&'Q3^-V@7OAVT\+
M?$)/"^GP^$+3X;26E_I-F_Q0DU.'4M3.OSKK$UWJ][;SI9Z>+2UL3%.;G"7
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MXY\'_$OIS_U5P53;_@J'\3OF_P"+ _LO'&>O@[XF_P#SWJS?A)QLE=X/ _\
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MHL^Y:*_-#_AY[\5?^B(_LV?^$G\2/_GKT?\ #SWXJ_\ 1$?V;/\ PD_B1_\
M/7KU_P#B"_'?_0'E_P#X<Z'^7]6]#P_^([>'?_0=F?\ X:<1Y?WO7[O,_2^B
MOS0_X>>_%7_HB/[-G_A)_$C_ .>O1_P\]^*O_1$?V;/_  D_B1_\]>C_ (@O
MQW_T!Y?_ .'.A_E_5O0/^([>'?\ T'9G_P"&G$>7][U^[S/TOHK\T/\ AY[\
M5?\ HB/[-G_A)_$C_P">O1_P\]^*O_1$?V;/_"3^)'_SUZ/^(+\=_P#0'E__
M (<Z'^7]6] _XCMX=_\ 0=F?_AIQ'E_>]?N\S]+Z*_-#_AY[\5?^B(_LV?\
MA)_$C_YZ]'_#SWXJ_P#1$?V;/_"3^)'_ ,]>C_B"_'?_ $!Y?_X<Z'^7]6]
M_P"([>'?_0=F?_AIQ'E_>]?N\S]+Z*_-#_AY[\5?^B(_LV?^$G\2/_GKT?\
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MW^-P<#X._ /I_P!"UX[_ /GD57;]O3QR 3_PISX!?^$UX\_^>34?\2^^)/\
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M9X?_ "&O&SP]=O\ A0S'I_S*<3Y>?K]WF;DO?_=_QK]A_B#_ ,AO3?\ L3/
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MF!OVW?& !/\ PI_X$_\ A.>./_GB5'_PV_XQ_P"B/_ C_P )SQS_ //%J?\
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M*OG0_M^^,3U^!'[.!_[E3XA__/1JH_[?WB_C/P%_9M.?7PI\1.W_ '5.E_Q
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M/]F _7PC\2OI_P!%9JO^(.\=I6^HX#[+_P"1GA^B7EY%?\1Q\/):+'YET?\
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M4T7AK4#X?UC7K&_T[7K33-)\R_TJZC\.Z;#IDMA8:$UI%?6=UJ >:/\ 3O\
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MQJ4<EJ1RO+L/+)LXGB:.(R_'U,136'G1QU&<%0QG\QOC_P  ^-OA;XNU_P
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M]ER^$O\ ZGWA^O\ 2L\,?\BUX>_[ >D_^D%O7^:G^S'_ ,G)_L]?]ER^$O\
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M2?#'A[Q1I,UAXC\/6UEXO\"^)+?3M8\.>+_#4FB^*=#TSQ+X=N+*Q\W^)/\
MP2M_X)U?%30M.\.^(OV/O@GH&G:7KMMXBMIOA/X67X$ZW-J%K8:EIT=OJ?B;
MX(W'P^\2:SH3V^K74MSX7UC5;[PS>ZA%IFK7FD3ZIHNCWEA^'?\ P3DU.?\
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MK;XA_P"3,OV"/^Q#^/\ _P"M,?$NOR2EZ_BW\Z_6WQ#_ ,F9?L$?]B'\?_\
MUICXEU.5_P#)0\.?]C'&_P#K/YV7FO\ R2_%/_8IR_\ ]:;AX\%HHHK]?/Q$
M**** "BBB@ HHHH **** "BBB@ J*7I^#?RJ6HI>GX-_*L'N_5_F5#XE\_R9
MF2_Q?A_2J<G;\?Z5<E_B_#^E4Y.WX_TK"KU_P_YG;1W^;_(SY.WX_P!*HO\
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MS+\R_,,CYEYY%?R2/]T_A_,53?[Q_#^0KSL!X>?4J7!5/^V/:_ZGXG-L1?\
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M!\9]9T32;OPY>>/-,\8?#?0_'7C75=>URT\/:7XR\>7'Q$\-^&YX-?\ &_\
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M5BIT*V)GAE0I35:E3PSE4]I-)J$IU96BXQNY)05F[7>FG7T445X9ZAPOA/\
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M*1(M:\1VWQ*FL+6*[O MW:>&LVD*+I]_*WTE_P %Y/$FD?LS_P#!.O\ 9?\
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M#>:OX=T.2P\-RHLBND5UHOB36])\26<Y :&ZT6%XV64(P^I/^#B?XT>--?\
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M --_P8K\J)>_^]_C7ZKZ#_R8'^S5_P!EQ_::_P#3?\&*Y\!_R4/#'_8VQ/\
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M\;?VJ_B9<? /P/K6CCQ)I_@FPTZR_P"$_C\-21?:;?6_%^K^)'B\/^ ([BP
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M5[W3-=TF.W@E;1]3M]2TO1W73&U;YK_92\&_%O\ :*_:_P#A!8>'M6\5:_\
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M:^&MYKK3/L&MW(MM5#6DMQ9>5/FW>2/RS^Q__!!SXH^+-!_:@\7?"J#5+Q_
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M[7(<-1S;'PQLG1Q#A+&/%+*JDIUW]9G15",L-/\ VFI\*?\ !4'_ ()R:/\
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MK2C"EA\)A,-"I7Q%>K-J-.C1ISJ3DU&,6W8\\?[I_#^8JF_WC^'\A7Z^3?\
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MO'\/Y"JDW7\1_*L'O\E^2/1I=/\ %_D49NGX#^=5'^Z?P_F*MS=/P'\ZJ/\
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M+RQGN?Z%?V8?^"EO[%G[9/C_ %?X8?LY?%S5?'WC?0O!^H>/=4T>]^$/QN\
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MST_[/P>-ITYQEC92@^7$Y93=2I"$9-XJM&%3VBI^T7]J5M\.=-_X*0_LK_\
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M6CZN9Y[;X)\!?&G0_CY_P< Z'X^\*ZC'JOA.#X@>)O!7AK4+=X9K*^T[X>_
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M$+P]XMU?5;'69M$TO09/[-G\/>.O"MHEH;/1[&007UC?D7*.XD\N1H:_;O\
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MT^?Z';#?Y?JBG+W_ -[_ !K]5]!_Y,#_ &:O^RX_M-?^F_X,5^5$O?\ WO\
M&OU7T'_DP/\ 9J_[+C^TU_Z;_@Q7/@/^2AX8_P"QMB?_ %09V;8__DF.+?\
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MS[&X/-L?CJ>1)3PN,I/)*M:AAJ;K2A.A[;*(QA*I*4^2K)MR<8M_8W_!O/\
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M:8^)=?DE+U_%OYU^MOB'_DS+]@C_ +$/X_\ _K3'Q+J<K_Y*'AS_ +&.-_\
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M/B;QGH/AW3O&%^OVK5?&7@OX>->^)8;Z6]NH]7^V/]I\2_X(/6/A[XU?&?\
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MGO;>X^T:9<>+'N;348(D@O[C^RHXQ+:RB3;_ !1_MQ?MX?&O]OOXC>&?B/\
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MHZ;J>FWT1M=5T36--O(Y+>]TO5;-Y+:X4"&\M':+4=)O=-UFRT_4K3]3XO\
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M_P $O])U#P1_P3@^)OBSQ=X5\0?'KP/XV\5>-K^U^!W@_0K;Q/XDO?#>W3/
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M%EJ\_B/Q[XL@N=)@.K37XLH;2V9M2M=/NWF8V<25'&7A5GN<^(M#/,NEA_\
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M^+29UMKI/BEI-S+(Q<!M,LK2]O-:MP4BF.Z[T>"_M4!0(SS*LDL$9:>/IO\
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MA_,4CV*73_%_D>U?LQ_\G)_L]?\ 9<OA+_ZGWA^O]*SPQ_R+7A[_ + >D_\
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M^S1X4/B?XI_$_P"%WBRZTK34TSP7H O/&WC35OB-\+?$M_%\/?'9L?AM\*/
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MJ&-P&*Q.!QF'J*IA\7@Z]7#8FA4VYZ->C*%6E.S:YH3C*S:OJ?9OC7_@I/\
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M?\+?\)K\19-%GTPW7AWPPJWCMJG]F7=_;:GJZK'IU](UKH5GJ=\L=M)(UL$
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M )%";K^(_E523M^/]*MS=?Q'\JJ2=OQ_I7+/XG\OR1W4MU_7V$9LO?\ W?\
M&J3]/Q_H:NR]_P#=_P :I/T_'^AKCG\+^7YH[J73_%_D4)>_^]_C5(]3]3_.
MKLO?_>_QJD>I^I_G7)/?YO\ *)VPW^7ZHIR]?Q;^=?K;XA_Y,R_8(_[$/X__
M /K3'Q+K\DI>OXM_.OUM\0_\F9?L$?\ 8A_'_P#]:8^)=3E?_)0\.?\ 8QQO
M_K/YV7FO_)+\4_\ 8IR__P!:;AX\%HHHK]?/Q$**** "BBB@ HHHH **** "
MBBO7=7^ WQ=T#X-^%?V@M9\#ZGIWP<\<>)K[P=X1\<W,^FII^O\ B+3/[86_
ML-.LOMQUB5+63P_K=O+?G3ETT76F7=H+PW,1BKGKXO"X5X>.)Q.'P\L7B(X3
M"QKUJ=%XG%3A4JPPV'52476Q$Z=*K4C1I\U24*52:BXPDUTX?!XS%QQ,L)A,
M3BHX/#3QF,EAZ%6M'"8.G4I4IXK$NG&2H8:%6M1ISKU>6E&I5I0<E*I%/R*H
MI>GX-_*I:BEZ?@W\J;W?J_S,(?$OG^3.I^'OQ2^)/P>\46_C7X4^//%WPY\6
MVD1MX?$7@OQ!JGAS5C9R36\\^GSWFE7-K+=:9=R6UN;W3+HS6%\L21W=M-&-
MM?5VN?\ !43_ (*!Z[I-UHM]^U7\4X;*^MWMIY-(U'3O#^J")EVDVVN:#INF
MZW8S8/%S9:A;W(/S"4-S7PK+_%^']*IR=OQ_I7@YGP_D.9UX8K,LDRC,,33@
ME3Q&.RW!XNO346W%0K8BC4J047K%1DDGJM3ZC*>)>(\IP\\'E6?YWEF$JSG*
MKA<OS7'8/#U)2CRRE4H8:O3ISE*.DG*+;6CT&:MJ6HZSJ-]K&L7][JNK:K>W
M>I:IJFI74]]J.I:C?3O=7M_?WMU)+<WE[>7,LMQ=75Q+)/<3R2332/([,<1_
MNG\/YBKTG;\?Z51?[I_#^8KJ:48<L4HQBE&,8JRBE9))+1)+1):)'+3E*<G*
M3<I2E*4I2;E*4FKN4F[MMMW;>K>K*;_>/X?R%49.WX_TJ\_WC^'\A7KFI?LZ
M_&O3?@;H7[2EW\/M77X'>(O%-YX*TKXAPS:9=Z3)XGLGO(Y]+O+6TOY]7TIC
M+I]Y#;W6JZ=96-Y/ 8+2YGE9$;S<7B\+A98=8K$X?#/%5Z>$PRQ%:G1>(Q55
M3E3PU#VDH^VQ%2-.<H4:?-4FH3<8M1=O5P>#QF,6)>$PF)Q2PF&GC,6\-0JU
MUA<'2E&-7%XATH2]CAJ4JE.-2O4Y:4)5(*4TY1OX+)V_'^E47^Z?P_F*O2=O
MQ_I5%_NG\/YBLWL_1_D$-ODOSD4W^\?P_D*HR=OQ_I5Y_O'\/Y"J,G;\?Z5Q
MSW^7ZL[:6[_[>_\ 2BA+U_%OYU5EZ?@W\JM2]?Q;^=59>GX-_*N2>S_PK_TE
M'?3W7K+\V9DO\7X?TJG)V_'^E7)?XOP_I5.3M^/]*Y9_"_E^:.ZCO\W^1GR=
MOQ_I50]3]3_.K<G;\?Z54/4_4_SKCJ]?\/\ F=M/K\OU*+]?P_J:_HJU_P#Y
M))^R+_V:)\%O_2+5Z_G5?K^']37]%6O_ /))/V1?^S1/@M_Z1:O7T7A]_P E
MUD__ &+\[_\ 3&'/E_$S_DWN=_\ 8RR'_P!2,2< _P!T_A_,5#4S_=/X?S%0
MU_3A_)85"_WC^'\A4U0O]X_A_(4GL_1_D7#?Y?JAAZ'Z'^505.>A^A_E4%8&
MRW7JOS(#U/U/\ZKGJ?J?YU8/4_4_SJN>I^I_G2>S]'^14-_E^J&GH?H?Y54D
M[?C_ $JV>A^A_E523M^/]*RG\3^7Y(Z8_#_V\OS16?K^']35)_NG\/YBO6/B
MO\'?B9\$O$&G>%OBMX/U/P3XBU3P]IOBFST;5VM/M[:'JTMW#87D\%K<W+63
MS2V-W$]E>_9[^VD@=+JUA; /D[_=/X?S%>7A,;@\QPE+'9?B\-C\%B:?M,/C
M,'7I8K"XBF[I5*.(H3G2JP;32E3G*-TU?0]/%X#'97B\3E^9X+%Y=C\+4]EB
ML%CL-6PF+PU5*[IXC#8B%.M1J)--PJ0C))IVU*1ZGZG^=>P?"O\ :*^.OP*D
MNV^$'Q8\=?#Z"_E-UJ&F^'=?OK31-2NO*6!;O4M :231-0O(X(TBAN[VPGN(
M8U"12HHQ7CYZGZG^=02]_P#=_P :Y,PR[+\UPE7!9I@<'F6#JI>UPF/PM'&8
M6IRZQ]IA\1"I2GRO5<T'9ZH[<IS/,LGQ=+'Y3F&.RO'49/V6-R[%XC!8NES)
M*7L\3AJE*M#F6CY9JZT9](_$K]M7]K#XL^'KGPK\0/C[\2M?\,W\$]MJ>@?\
M)!/I6D:O:SILEL]:T_1%TVUUJS=>MIJL=Y;9PPB# &OE2K<O3\&_E52O/R_)
MLHR3#RPV395EN48:=3VD\/EF!PN H2J--.I*EA*5*G*;6CDXN7F>IF>>YWG^
M)CB\]SC-<ZQ4*?LH8G-LPQ>8XB%---4XUL96K5(P3U4%)178IR=OQ_I6?)V_
M'^E:$G;\?Z5GR=OQ_I734Z?/]#FZOT7YLJ'J?J?YU4E[_P"]_C5L]3]3_.JD
MO?\ WO\ &N2IN_6/YHZ8?9_[=_0J/U_#^IJD_P!T_A_,5[-H/P+^+7BSX6>-
M?C;X;\$:KK/PM^'.IZ;HWC?Q;8R6$MKX<O\ 5VMEL$O['[8-7^SRM>VBR7\&
MGS6%LUQ$+JZ@+BO&7^Z?P_F*\RCCL%BY8JGA,7A<54P57ZKC*>'Q%*M/"8E4
MH5'A\5"G.4J%=4YPFZ550J*$XRY;23?KUL!C\%3PM7&8+%X2EC\/'%X&IB<-
M6H4\;A7.=-8G"3JPA'$X=U*=2FJU%SIN<)PYN:+2IO\ >/X?R%1/T_'^AJ5_
MO'\/Y"HGZ?C_ $-4*ET_Q?Y%5^OX?U-1GH?H?Y5(_7\/ZFHST/T/\JP>_P E
M^2.R'Q+Y_DRI)V_'^E1U))V_'^E1U$_A?R_-$D!ZGZG^=)2GJ?J?YTE9R^S_
M (4;K9>B_(*_7[]J#_DJD?\ V3?X-_\ JIO!E?D#7Z_?M0?\E4C_ .R;_!O_
M -5-X,HR+_DNLH_[)?BG_P!6?"!/$7_)O<Z_[*WA#_U5<:GSL_3\?Z&HJE?I
M^/\ 0U%7Z\?B05"_WC^'\A4U0O\ >/X?R%)[/T?Y%PW^7ZHC?[I_#^8J&IG^
MZ?P_F*AK WA\2^?Y,KU7JQ5>D]OFOS15/K\OU&O]T_A_,54?K^']35M_NG\/
MYBJC]?P_J:PG]K_M[]3IAM\_T15DZM]/Z53?I^/]#5R3JWT_I7H'COX-_$[X
M:^&?AYXO\=^#]3\,^'?BOHDWB7X>ZCJ36:CQ/H,"6$C:M9VL5S+>P64L.JZ=
M<6LM_;6@O;6]M[JS\^WD$M>9B,;@\/6PN%Q&+PU#%8^=6G@,-6KTJ5?&U*%&
M>)KT\)1G.-3$SHX>G4Q%6-&,Y4Z-.=6:4(RDO3PN QV)PN-QF&P6+Q&$RV%&
MKF.*H8:M5P^ I8BO3PF'J8VO3A*EA:=?%5:6&HSKRIQJXBI3HP<JDXQ?DU>O
M_"O]HKXZ_ F2\;X0?%CQU\/H+^;[3J&F^'=?OK31-2NO)CMQ=ZEH#22:)J%Y
M'!&D,-W>V$]Q#&H2*5%&*\@JO+_%^']*Y,QR_+\UPE7!9G@<'F.#J\OM<)C\
M+1QF&J<K37M*&(A4I3L]5S0=GJCLRG,\RR?%TL?E.88[*\=1D_98W+L7B,%B
MZ7,DI>SQ.&J4JT.9:/EFKK1GTC\2_P!M7]K#XL>'[KPI\0/C]\2M?\,W\$MM
MJ>@?\)!/I6D:O:W V36>M:?HBZ;;:U9R+P;/58[RVS\PB##-?*IZ'Z'^56IN
MGX#^=53T/T/\JX,OR;*,DH2PV395EN48:<G4GA\LP.%P%"51N*=25+"4J5.4
MVM')Q<O,]7,<]SO/\5#%Y[G&:YUBH05*&)S;,,7F.(A34DU3C6QE:M4C!/50
M4E%=BE+W_P!W_&J#]?P_J:OR]_\ =_QJ@_7\/ZFNB>_S?Y1.8J53D[?C_2KE
M>F:A\#?BSI_P?T;X^W7@G54^#^O>)KOP;IGCJ.2QN-*E\2V:W+3Z5<0V]W+J
M.GRG['=+!-J%E:VMV\$L=K/-(I6O+QN.P6"EAUC,7A<(\9BZ.!P:Q->E0>+Q
MM92G2PF&56</;XJK"E4E3P]+FJSC3G*,&H2:]3!Y?C\?]9>!P.+QJP.%J9AC
MGA,-6Q*P> H3IPK8W%.C"?U?"49U:4:N)K<E&G*I3C.:<XI^.2=6^G]*IOT_
M'^AJY)U;Z?TJF_3\?Z&BIL_2/Y(<-OG^B*9ZGZG^=12=OQ_I4IZGZG^=12=O
MQ_I7.]GZ/\CII=/\7^15?[Q_#^0J-_NG\/YBI'^\?P_D*C?[I_#^8K%[_)?D
MCMAO\OU14?K^']33*>_7\/ZFF5$_A?R_-$%>BBBLY_$_E^2.@OZ5_P A33?^
MO^S_ /2B.OT*_;!_Y.@^.7_90]=_]'"OSUTK_D*:;_U_V?\ Z41U^A7[8/\
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M %(_#5?1>'W_ "7/"/\ V464?^IM$^1\3/\ DWO&O_9,YQ_Z@UC^+*BBBO\
M1@_R_"BBB@ HHHH **** "BBB@ K]Y?^"F5B_P"RU^Q#^PE^Q%I7D:;JFI>&
M[[X[?&BTM;F87-YXTOX8Q;I=MOCFO],_X2?Q/X[MK8:A;+&J>%= %I'#_9BP
MVOXS?!;1-.\3?&/X3>&]8@6ZTGQ!\3/ >B:I;.D<B7&G:KXITJPO8'2:.6%U
MFMIY8V26*2-@Q#QNI*G];_\ @OWJ\VI?MT:39R*P30/@/\/](MR9-X:&;Q%X
M\UYF5?+3RE\_6YU\LM+EE:7S )1%'^8\3268^(7 .356_JF!IYWQ-5HOF=/$
M8S!X:.#RN5HU(<E3!5<17Q,9RC43NJ7+RSJ,_6N$X/+/#+Q(SZBE]<Q]3(>%
M*-:/*JN&P.-Q?U[-H^]3GST\?1P^&PLH1E3<>5U>;FITT?DOI?P/^,6N?#Z+
MXKZ+\,/'.K_#>?Q;:^ X?&FE^&M5U#P_-XQOFM8[+PY%?VEM+')JEY/?65G:
MVZ9-Q?WEKI\)>^N(K=_6O'7["W[8GPV^'_\ PM#QU^S?\6O#7@5+,:C?Z[J'
MA+4,:#I_D/<OJ'BK38$FU?PC80Q1G[3>^)[#2;:UE:*WN98KB>&*3]Q/V*OC
MWKG[,?\ P18^)_QN\*>'O#WB#QGX,^.^M1^##XFM$OM-T#Q)XGO_ (?>#[+Q
M4EH\4@N;[P]%K]SJ%E;[X%N)XUMYYUMI9T?SS_@CU^W)^TW\8OVP[[X2?&OX
MK>*OB_X$^+G@WX@7FL^'?'E_%K>E:3K6EZ3'K<.H>'[&[M)8M#TV2QTW4="G
M\*:)_97A2>TUNYN9](ENK2S>+Y;%>(/&OL>,LWPF4<./(^#>(<VRK$SQ6(S"
M&.S*CEV(ITO8X2G1]K3P^*IT*E.M6Q>(OAZDJ].E0PW[NM./U>$\-. 5B>!<
MEQV=<4KB'COAK)<XPE/!X7+)Y=E5?,\+5J^WQM6NJ57$X2KB*53#T,'A;8FE
M'#U:V(Q=JM"$_P";Z7K^+?SJ@_W3^'\Q7WIH/C*#]DS]NCXD7O@CX/\ @OXR
M6/PS^*GQN\#^&?AI\0/#]]XNT&]TBRU3Q7X5LI)-*ADDNKJ]T72HQ>V]Q*+L
MQ-;//(-X^T1??A_X*J?$@#/_  [!_9:/M_PHC7O_ )#KZ//N-<^P%; K*^$\
M)FN$QN683,(XG%<89)D=6,L4I-T/J>/BZTE248KZQ']U4E*48:TY'S7#G 7#
MN94<>\WXRQN3XW 9MC,MEA<)P1G_ !!1G'!RA&.)^O9=-4(.M*<O]FE^]I1C
M"<]*L#\ 9?XOP_I7[C^'_P#@KU\*OV9?#_A#P-^Q)^Q5\'?#&E:3HOAVU\;^
M/_C5H\OB'XC_ !#U.WTX#Q#=7]UX5UW3M0LY9M5FNGTJ\U;QAXJM+>TD9;70
M-)M98M*LOE?]M_\ ;,\0_M)>$/!GA3Q%^R#\$/V=I="\1W?B&P\3_#WX:WW@
MWQ-KL:Z8^G7FA/J=]' T^@[KZSU#4K"%)%EU"ST6XE:,VL0D^./@%\ _B?\
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MXC^5?J!\"_\ E'KXR_[/-\+?^J/\35^7\W7\1_*OU ^!?_*/7QE_V>;X6_\
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MORHE[_[W^-?JOH/_ "8'^S5_V7']IK_TW_!BN? ?\E#PQ_V-L3_ZH,[-L?\
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M1\3:C ;BS$UAH-G<S:K>1?:[7S+>UD3[1!GS5_<MO^"J'Q'7I_P3$_99;Z?
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MXJ?&NS-W-;Z?;V\,MR;2SM+4SNC2FWM;:#?Y4$2K^,/PN_Y*C\-_^Q\\'_\
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MP5-<\84J4L52IXURY9MU5.*4?:.2_!1^OX?U-4I>_P#O?XU=?K^']35*7O\
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MK7B35;31M+AE>..5TCDOKV!'=(I756)6-R I_9?_ (+8^(=)\!>/?V=/V,_
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M5TZPN9=8OHEL;Z5+2SCDN+BWLKRZMHYK>TN)8^P^,O[&/[5?P"\-VGC#XP?
M;XC^!O"=WY:?\)-JF@S3Z!8SW,EO#:6FM:OIC7UAH%_>S7,4-CI^N7&G7M],
M)8K2":2WN%B_?[Q)^U1X^_9*_P"",?['WCCX466B6OQ)\9SZS\-- \=ZE86F
MHZI\/;#7-4^(^N:YK/AJWO;6YMCK%];>&H-+B>Z#6ENMQ]LEMKN2V@C')_\
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M+JFBZY>ZG'KU[H&EMXBN?!WA;PUX3LO#,%NGYB?\$AX[*7_@H_\ LM)J#*D
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M2-8[1='_ -'D2Q#S_H?^U#\ /V,/VX_BIK'[47PT_;\^#/PH3XB:=H-UXR\
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M --_P8K\J)>_^]_C7ZKZ#_R8'^S5_P!EQ_::_P#3?\&*Y\!_R4/#'_8VQ/\
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MCGPAJ_P^\;>,/ 7B"-8M>\$>*?$'A#6XDW;8M7\-:M=Z-J4:[@&VI>64RC<
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MY8><G5I\W[Y4VX4H4G^\?P_D*B?I^/\ 0U*_WC^'\A43]/Q_H:_13\PI=/\
M%_D57Z_A_4U&>A^A_E4C]?P_J:C/0_0_RK![_)?DCLA\2^?Y,J2=OQ_I4=22
M=OQ_I4=1/X7\OS1) >I^I_G24IZGZG^=)6<OL_X4;K9>B_(*_7[]J#_DJD?_
M &3?X-_^JF\&5^0-?K]^U!_R52/_ +)O\&__ %4W@RC(O^2ZRC_LE^*?_5GP
M@3Q%_P F]SK_ +*WA#_U5<:GSL_3\?Z&HJE?I^/]#45?KQ^)!4+_ 'C^'\A4
MU0O]X_A_(4GL_1_D7#?Y?JB-_NG\/YBH:F?[I_#^8J&L#>'Q+Y_DRO5>K%5Z
M3V^:_-%4^OR_4:_W3^'\Q51^OX?U-6W^Z?P_F*J/U_#^IK"?VO\ M[]3IAM\
M_P!$?H7_ ,$JO',/@?\ ;G^#QO;R*RTWQ=_PE7@:]DF$ $TWB+PGJZ:!9QO/
MC9+>>*[;0+:/R72>1I/(C\WS3!+\]?MK>"]0^'_[6G[1GA?4;?[,\'QA\<ZM
M81;@Q.@^*-<O/%'AF=BD-N@DNO#NLZ7<R)'$D<;S,D>Z-58^&>&_$NM^#/$W
MA_QAX:OI-+\1^%-<TGQ+H&IPA&FT[6M"OK?5-*OHED5XVDM+ZU@N$#JR%HP&
M4KD'[I_X*/?%KX*_M#?$3X;?M ?"GQ!9R>)_B3\,/#J?&;P)'H^OVFH^"/B'
MX:L[;39$O]9U72]-T[78;G29;'P[I]QH[WJ^3X,DU"6<6>K:6M?CV,P&+R?Q
M@R[.J6&Q-3*N+^$\3D&,JT*$JM#"YYD>(EF^#Q&.Q#<_JL,5E,,5A,-2C[&E
M5K4')JK5=X?MF!S'!YWX'YKD5;%82EG'!/&>$XCP-'$8B-'$XOA[B##PR7'8
M; 85*'UNIA,YG@\9BJTW7K4:&(C%.C12C4^A_P#@JW)')\%/^";[1NDBM^SB
MDBLC*P:.3PG\)#'(I4D%' )1A\K ':3BF?\ !/&2,?L'_P#!3Y"Z!U^%E@64
MLNY1+X(^)B1$KG($CHZ1DC#LK*N2I _%RJ\O\7X?TKS:/A/]7\.LAX"_M_G_
M +#SBCFW]K?V5R_6O99[B\Y^K_4?[1E[#F^M?5O:_7*UO9^V]F^;V4?6J^,W
MUGQ/XD\1_P#5OD_UAR6MDW]C?VQS?4_;</8'(OK/]H_V7'ZQR_4_K7L?J-"_
MM/8>U7)[:7TS^SI^V?\ M!?LFV_BZU^"'BK3/#4'CB;1+CQ&M_X4\->(FO)?
M#ZZI%I9CEUS3+Z:V6!-9OP8X)$C<R[F3<,GZ3/\ P60_;Y )_P"%I>'.G_1,
M?A]_\SU?F)-T_ ?SJJ>A^A_E7T&;>&O ><X_$YIF?"V58O'XR2JXK%5*,E4K
MU(QIT_:5/9SA%S<8KGERWF[SFY3E*3^=R7Q5\1<CP&$RC*N+LXP66X*#I83"
M4ZT)4\/3E4E4]G3=2G.<::E.7)#FY81:A!1A&,5]"_%'XQ?&#]M'XV>%-8^+
M'C'P_>>-_%4_A+X;:=XCU73](\(>&-#TZYUAK+3)=8/AW28HK32-/O=:N]1U
M75'L;^^BMI+AP)XK>VM8_M./_@B5^W%+XB.DS:9\+;30ED(;QY/\1K%O"GV1
M8O..HB""QF\7?8RI(&[PJEQE2S6ZQ8E/Y-2]_P#=_P :D?6]9_L[^QO[7U/^
MR,?\@K[?=_V;_P ?!NO^/'S?LO\ Q]?Z3_JO]?\ OO\ 6?-7%F_#O$>%PN5Y
M=P+G>5<+Y7@H?5*F"Q&1_P!IJE0D^;ZQ@ZD\932J4$[4\)5I^RK2;E/$TTN6
M7?D_$_"V*Q>;YIXAY!G/%V;8ZK]<I8[#<0O*76Q$80C]6QU.G@:K=+$./[S&
MT:OMJ$4HT\+5<N>'ZW?\%!_B_P#"#X8? 'X*?\$[OV?_ !C;_$30_@WJDGC#
MXS_$C1G']@^*?B?<0ZN]QI>E75O?WT%];V^K>)O$>KZMIT-YJVEZ!*WA;P]#
MJ]]K/AK5H[#;_P""%'AUI/VK/B!\1=1)LO"OPS^!/BW4M;UN5UCL-/NM8UWP
MQ:6D-XQRZK-I%MXDU%65=BQZ/.SNI$:2_BQ7ZB_!#]HOX0?LX_\ !.W]H/PK
MX2\6Q:O^T_\ M4^(8_AWKOAJWTCQ !X(^$.FV%]IEW>:K?W]E;>'97U+1];\
M:6]G+H>IW5^]YXUT(S6LP\-:L-/^%XNX7JY'X>5^$<HEB<USCB_.L-@,7FF*
MI5*D\9F^>XV.+SG.\>L/>&$HK#X?%58WE&CAU##TI3Q%33$?H'!?%E+B'Q/P
M_&F=+"Y/D?!.18G,<%E.#JTJ<,%DW#V >"R/(<N>)_>8RM+%8G!TI)1E7Q+J
M8FK"&&I:X;\V/B;XQG^(?Q%^('C^YA:"X\<^-/%7C"X@8JS0S>)M;OM:EB9D
M"HS1R7K(2BA21E0!@5Y\_3\?Z&KDG5OI_2J;]/Q_H:_6J.'IX3"T,)135'"X
M>AAZ2D^:2IT:<*<%*7VGRQ5WU>I^,8C%5<;B<5C*[3KXO$U\36<5RQ=6O4E5
MJ.,=>5.<W9=%H4SU/U/\ZBD[?C_2I3U/U/\ .HI.WX_TI/9^C_(=+I_B_P B
MJ_WC^'\A4;_=/X?S%2/]X_A_(5&_W3^'\Q6+W^2_)';#?Y?JBH_7\/ZFF4]^
MOX?U-,J)_"_E^:(*]%%%9S^)_+\D=!?TK_D*:;_U_P!G_P"E$=?H5^V#_P G
M0?'+_LH>N_\ HX5^>NE?\A33?^O^S_\ 2B.OT*_;!_Y.@^.7_90]=_\ 1PKX
MO//^2BR;_L2Y_P#^IW#A^<>,W_)M5_V7/#W_ *H.,#YNHHHJC^1@HHHH ***
M* "BBB@ HHHH **** "J\O\ %^']*L57E_B_#^E:SV^?Z,:W7JOS*\O\7X?T
MJJ_W3^'\Q5J7^+\/Z55?[I_#^8K(]&ET_P /^17?[I_#^8JF_P!X_A_(5<?[
MI_#^8JF_WC^'\A6#W^2_)'J4NG^+_(IO]T_A_,53?[Q_#^0JX_W3^'\Q5-_O
M'\/Y"D>Q2Z?XO\BK+_%^']*JO]T_A_,5:E_B_#^E57^Z?P_F*A;?./Y1/4I=
M/\/^17?[I_#^8JF_WC^'\A5Q_NG\/YBJ;_>/X?R%9'J4NG^+_(IO]T_A_,53
M?[Q_#^0JX_W3^'\Q5-_O'\/Y"@]>&WS_ $17?[Q_#^0JI-U_$?RJV_WC^'\A
M52;K^(_E6#W^2_)'HTNG^+_(HS=/P'\ZJ/\ =/X?S%6YNGX#^=5'^Z?P_F*1
M[%+I_B_R/:OV8_\ DY/]GK_LN7PE_P#4^\/U_I6>&/\ D6O#W_8#TG_T@MZ_
MS4_V8_\ DY/]GK_LN7PE_P#4^\/U_I6>&/\ D6O#W_8#TG_T@MZ_F_QN_P"1
MED/_ & XK_T]2/\ 0KZ'7_).\9?]CC+/_4&J;E%%%?AY_9!_/+_P<IG_ (PG
M^"'O^V!X, ]_^+$?M%'C\ 3^%?G[9?\ !;3]FV'_ ()?VG[$4GP;_:8'Q2B_
M8*@_96?Q,/#_ ,%S\.AX_C_9[3X2-KHU0?'3_A*3X*_X2('4/M__  AW]OG0
MO](_X1K^T?\ B5U_0[_P4B^.7[(/[/7P"T?XB_MF?"32OCAX$A^)GAW1_ 7P
MZOOA9X,^+&J:M\4=3T+Q4+.[\+Z/\1)+#P5H6MZ3X"@^(.IW'B77_$/AB.+P
MW;>(-"TW5+W6]>TSPYKV_P##C]E'_@G=\6_AYX#^*WP]_9+_ &4O$'@'XF^#
M/"_Q"\#Z]_PS1\-=*_MOPAXTT.Q\2>&M7_LO6_ 6FZUIO]I:+J5E>?8-7TZP
MU2S\[[/?V5K=QRP1^[A\3A88##0QN$Q<XTL57J4*U&I"G3G-J@YP?/"7,X<L
M+I=);WV\JM0KRQ=>>&Q&'C*I0I0JTZD93G&*=3EDE&2LI7=FUT^_^>C_ ()Z
M?\%Q?V8_V/?V/_A#^SG\0_@]^TUXI\8?#O\ X3_^U]>^'OAOX,W_ (0OO^$M
M^*'C7QUI_P#9%WXK^.?@[7Y?LNE^)[*SO_M_AS3O+U2WO8K7[79);7]UZS_P
M2\_:1\'_ +7G_!:K]L7]H_X?^'?&?A7P;\3?V8+6?0M"^(-IX<L?&%E'X0C_
M &1_A[J)UBS\)^)_&.@0&YUGPCJ5WIXL?$>HF32Y[&:Z^R7DL]C;?K3^S1\/
M?^"4'[87@35OB7^SI^SA^RI\0_!.A^++OP/JFM-^R;X7\(?9?%%CH7A[Q+=:
M9_9OCOX6>&-7G\K1?%6@WAO;:PFTYS?&UCNVO+2^M[;['^&_[,_[.'P;U^Y\
M5?"']G[X(_"KQ1>Z1<^'[SQ)\-_A1X$\#:_=Z!>WNG:E>:)<ZQX8T'2]1GTB
M[U'2-)O[G39;A[*>]TO3KJ6%Y[*V>+7%8[ 1GF,H8/'4<9C(UH557J0Y*<J]
M6-:=Z7LXSC:4=$W=)V=R*&%Q<HX-2Q.&J8?#RI2@Z4)<TXTJ;IQ]_GE%W3U:
M6K^X]NHHHKYT]@X7PG_R'/'_ /V,UO\ ^F#2*[JN%\)_\ASQ_P#]C-;_ /I@
MTBNZH XKP/\ \>>O_P#8Z^,?_3]>5VM<5X'_ .//7_\ L=?&/_I^O*[6@ HH
MHH **** "BBB@ K\1/\ @O1_R9I_W-NA?^I'X:K]NZ^,_P!LG]E_P#^V!X:\
M,?!#XEZOXPT/PIK5QJNLW6H>!K_1=,\0QW7AV?0=3LH[>[U_P_XFTU()9XE2
MZ63299'A)6*6!\2#Z'A+,L-D_%'#^:XUSCA,NS? 8W$RIP=2:H8?$TZM1P@M
M9R4(NT5N]#YGC3*L7GG"/$F38",)8W-,ES' X6-6:ITW7Q.&J4J2G4::A'GD
MN:33LM;'^>'17]DO_$/)^Q;_ -%._:A_\+3X4?\ SE*/^(>3]BW_ **=^U#_
M .%I\*/_ )RE?V#_ ,1Y\/O^@C-?_#95_P#D_P"K>E_XC_XET\2O^@7*/_#M
M2_\ E?\ 5O0_C:HK^R7_ (AY/V+?^BG?M0_^%I\*/_G*4?\ $/)^Q;_T4[]J
M'_PM/A1_\Y2C_B//A]_T$9K_ .&RK_\ )_U;TN?\2Z>)7_0+E'_AVI?_ "O^
MK>A_&U17]DO_ !#R?L6_]%._:A_\+3X4?_.4H_XAY/V+?^BG?M0_^%I\*/\
MYRE'_$>?#[_H(S7_ ,-E7_Y/^K>ES_B73Q*_Z!<H_P##M2_^5_U;T/XVJ*_L
ME_XAY/V+?^BG?M0_^%I\*/\ YRE'_$/)^Q;_ -%._:A_\+3X4?\ SE*/^(\^
M'W_01FO_ (;*O_R?]6]+G_$NGB5_T"Y1_P"':E_\K_JWH?QM45_9+_Q#R?L6
M_P#13OVH?_"T^%'_ ,Y2C_B'D_8M_P"BG?M0_P#A:?"C_P"<I1_Q'GP^_P"@
MC-?_  V5?_D_ZMZ7/^)=/$K_ *!<H_\ #M2_^5_U;T/XVJ*_LE_XAY/V+?\
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M_P#$2+UPV4[K_F:4NC_P'\4LG;\?Z53E_B_#^E?VPG_@W$_8@;K\4_VJ^/\
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M $-?W*-_P;0_L)MG/Q8_:UY]/'?P=_\ G#5&?^#9S]A$\'XL_M;?^%W\'/\
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M4?\ AVI?_*_ZMZ'\;5%?V2_\0\G[%O\ T4[]J'_PM/A1_P#.4H_XAY/V+?\
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MI7]RK?\ !M#^PFW7XL?M:_AX[^#OT_Z(,:C/_!LY^PBW7XL_M;\?]3W\'/\
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MOD^,J5L?[#!8S$5J[6"FY*%7*<RP<7&/->3]MBJ2:6T7*7V2L=X.\:5\CSS
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MZ>-?A-_\Y*HS_P &ZO[$[=?BC^U-Q_U.WPE_^<C64_'3@&6V(S3:W_(MJ?\
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M  M/A1_\Y2C_ (AY/V+?^BG?M0_^%I\*/_G*5#\>O#YV_P!IS71)?\BRK_\
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M)'[2O_A8?"__ .<Y6$OI$^&S_P"8G-]_^A35[)?\_/(Z/^)8O%3_ *!,E_\
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M2'_A7_#'_P"<_1_PX=_9#_Z*-^TA_P"%?\,?_G/T?\1HX(_Y_P"9?^&^I_\
M)_U]P?\ $BOC[_T+^&/_ !)<-_\ *?ZMZ7_DOHK^M#_AP[^R'_T4;]I#_P *
M_P"&/_SGZ/\ AP[^R'_T4;]I#_PK_AC_ /.?H_XC1P1_S_S+_P -]3_Y/^ON
M#_B17Q]_Z%_#'_B2X;_Y3_5O2_\ )?17]:'_  X=_9#_ .BC?M(?^%?\,?\
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MPM>6(I>UE"G!-^[[.LJ\7&R=^91A9IMQ<6KIH****XCI"BBB@ HHHH ****
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M+W+'W/1117RA[YPOA/\ Y#GC_P#[&:W_ /3!I%=U7"^$_P#D.>/_ /L9K?\
M],&D5W5 '%>!_P#CSU__ +'7QC_Z?KRNUKBO _\ QYZ__P!CKXQ_]/UY7:T
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M]NC>Q:O#9HXO?A/X4G""!["X93&&VD^:=V,@#I7J7_#:6F?]"!?_ /A06_\
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M^";?[:GBS_@C9^Q9^REX>^"QU'X^?"?]JGQ_\1_B#X#'Q%^$UH/#O@O6K_\
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M ,.62_\ SR/MVBOB+_AM+3/^A O_ /PH+?\ ^5-'_#:6F?\ 0@7_ /X4%O\
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M?$O_ *)BK_X<LE_^>1]NT5\1?\-I:9_T(%__ .%!;_\ RIH_X;2TS_H0+_\
M\*"W_P#E31_Q/W]$;_H\."_\1+C_ /\ H4#_ (@SXE_]$Q5_\.62_P#SR/MV
MBOB+_AM+3/\ H0+_ /\ "@M__E31_P -I:9_T(%__P"%!;__ "IH_P")^_HC
M?]'AP7_B)<?_ /T*!_Q!GQ+_ .B8J_\ ARR7_P">1]NT5\1?\-I:9_T(%_\
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M^A O_P#PH+?_ .5-'_#:6F?]"!?_ /A06_\ \J:/^)^_HC?]'AP7_B)<?_\
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M8J_^'+)?_GD?;M%?$7_#:6F?]"!?_P#A06__ ,J:/^&TM,_Z$"__ /"@M_\
MY4T?\3]_1&_Z/#@O_$2X_P#_ *% _P"(,^)?_1,5?_#EDO\ \\C[=HKXB_X;
M2TS_ *$"_P#_  H+?_Y4T?\ #:6F?]"!?_\ A06__P J:/\ B?OZ(W_1X<%_
MXB7'_P#]"@?\09\2_P#HF*O_ (<LE_\ GD?;M%?$7_#:6F?]"!?_ /A06_\
M\J:/^&TM,_Z$"_\ _"@M_P#Y4T?\3]_1&_Z/#@O_ !$N/_\ Z% _X@SXE_\
M1,5?_#EDO_SR/MVBOB+_ (;2TS_H0+__ ,*"W_\ E31_PVEIG_0@7_\ X4%O
M_P#*FC_B?OZ(W_1X<%_XB7'_ /\ 0H'_ !!GQ+_Z)BK_ .'+)?\ YY'V[17Q
M%_PVEIG_ $(%_P#^%!;_ /RIH_X;2TS_ *$"_P#_  H+?_Y4T?\ $_?T1O\
MH\."_P#$2X__ /H4#_B#/B7_ -$Q5_\ #EDO_P \C[=HKXB_X;2TS_H0+_\
M\*"W_P#E31_PVEIG_0@7_P#X4%O_ /*FC_B?OZ(W_1X<%_XB7'__ -"@?\09
M\2_^B8J_^'+)?_GD?;M%?$7_  VEIG_0@7__ (4%O_\ *FC_ (;2TS_H0+__
M ,*"W_\ E31_Q/W]$;_H\."_\1+C_P#^A0/^(,^)?_1,5?\ PY9+_P#/(^W:
M*^(O^&TM,_Z$"_\ _"@M_P#Y4T?\-I:9_P!"!?\ _A06_P#\J:/^)^_HC?\
M1X<%_P"(EQ__ /0H'_$&?$O_ *)BK_X<LE_^>1]NT5\1?\-I:9_T(%__ .%!
M;_\ RIH_X;2TS_H0+_\ \*"W_P#E31_Q/W]$;_H\."_\1+C_ /\ H4#_ (@S
MXE_]$Q5_\.62_P#SR/MVBOB+_AM+3/\ H0+_ /\ "@M__E31_P -I:9_T(%_
M_P"%!;__ "IH_P")^_HC?]'AP7_B)<?_ /T*!_Q!GQ+_ .B8J_\ ARR7_P">
M1]NT5\1?\-I:9_T(%_\ ^%!;_P#RIH_X;2TS_H0+_P#\*"W_ /E31_Q/W]$;
M_H\."_\ $2X__P#H4#_B#/B7_P!$Q5_\.62__/(^W:_G _X)W>'K#]O_ /X*
M4_M/?\%0KF?7-1^#/PCUR7X%_LGQ:IXG\2ZE92:C;> ;+PAJGBSP_I6I:KX/
M\1> -$F^%^L:C\0+_P"$GC+X7/X9'BW]JS7-6L[^X^(OP_UK7KS]8O\ AM+3
M/^A O_\ PH+?_P"5-'_#:6F?]"!?_P#A06__ ,J:Z:'[03Z(U"GB8Q\7L$ZF
M(I*@JO\ JKQ^O9TG-2K)1_U3=Y55&-/FYERP=16?/>.-7P3\2ZLZ,I<-5>2C
M-U'#^T<E]^:BU3;E_:>BIMN?+9\TN1W7+9_;M?Q+?\%NOAKXX^%'[=WQ\OM*
M\!>,/BW_ ,/ _P!GSX.>%/AVFA^$]=M)/#GBWP)\7OV<-3N?A]X'_L^Q\4GX
MT>.KC7OV3/ =S=>%M!7PMK>EK\?/"7FZ?<R:3HS>._ZC/^&TM,_Z$"__ /"@
MM_\ Y4T?\-I:9_T(%_\ ^%!;_P#RIK7+_P!H3]$? 8CVW_$7<#6BX.$J;X5X
M_@I6G"K3;E_JE+X*U.G4:M[RCRZ7NL\7X(>)>*I>S_U;K4Y*2E&:S')9.-XR
MA-)/,UK*G.<+W]WFOK:S_"K_ (+"_#7QG_P3Q_X=V?M+_LK:>3XL_9Y^#7BO
M]BO3OC?\1]0TGQ7JFEVEC\'K_P $_ ^?5?!#7NB>&M:\>:?X/\3?M&>/+#Q#
MI/P[/@Z?Q=IUG;?$;2-4\-#PKX(OOK[]E3X.)\%O^#?SQU;W6G^!;76_B;^Q
M7^TM\=M;UKP/:"&'Q1I_QA^&_CSQM\.=6\4ZA+HNAWNL>,M(^#6I?#;P7K]W
M?0WZ:6WA.W\,:-K6L>&= T._F_1?_AM+3/\ H0+_ /\ "@M__E31_P -I:9_
MT(%__P"%!;__ "IK5_M#OHD/#X6A+Q=P3EAZ\:LZO^JW'_-7C3J5JM*G)?ZI
M>ZJ<L17M*\E::]U<NN:\#/$E5J]5<-U4JU*5.-/^T,EY:3G"E"I-?\*>O.J-
M*ZM&W*]7S'\]'_!+G]JG_@CO\#/V3_@8/VF]$^".F_M8^ O%WQ,\5:UXUUW]
MDSQ7\0/B7HNJP_'KX@^+?A=KUM\5_#_P8\4W$^JZ)X,G\%7?AK4-+\5W-]X8
MM[/2M,@DTR\T865E](_\%_=3\ :+\?O^"4.M?%FVTJ^^%&A_'[Q'K_Q6L=<T
M&3Q7HEW\+-#^*_[*6J?$B#6_"D.GZO/XIT23P9:ZU'J_AN'2-7EU[3WN-)CT
MO49+Q+*?]AO^&TM,_P"A O\ _P *"W_^5-'_  VEIG_0@7__ (4%O_\ *FK_
M .*AGT0(XU8R/BU2N_K:J4ZG#W'D],52J4K49K@J'L?9^UE)<T:M[16EFW/_
M ! WQ/>&^KRX=6GU;DG'%9/'_=YPG^]B\YE[3G]FD[2IVN]]$O'?V%/VF/\
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M_H\."_\ $2X__P#H4#_B#/B7_P!$Q5_\.62__/(^W:*^(O\ AM+3/^A O_\
MPH+?_P"5-'_#:6F?]"!?_P#A06__ ,J:/^)^_HC?]'AP7_B)<?\ _P!"@?\
M$&?$O_HF*O\ X<LE_P#GD?;M%?$7_#:6F?\ 0@7_ /X4%O\ _*FC_AM+3/\
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M O\ _P *"W_^5-'_  VEIG_0@7__ (4%O_\ *FC_ (G[^B-_T>'!?^(EQ_\
M_0H'_$&?$O\ Z)BK_P"'+)?_ )Y'V[17Q%_PVEIG_0@7_P#X4%O_ /*FC_AM
M+3/^A O_ /PH+?\ ^5-'_$_?T1O^CPX+_P 1+C__ .A0/^(,^)?_ $3%7_PY
M9+_\\C[=HKXB_P"&TM,_Z$"__P#"@M__ )4T?\-I:9_T(%__ .%!;_\ RIH_
MXG[^B-_T>'!?^(EQ_P#_ $*!_P 09\2_^B8J_P#ARR7_ .>1]NT5\1?\-I:9
M_P!"!?\ _A06_P#\J:/^&TM,_P"A O\ _P *"W_^5-'_ !/W]$;_ */#@O\
MQ$N/_P#Z% _X@SXE_P#1,5?_  Y9+_\ /(^W:*^(O^&TM,_Z$"__ /"@M_\
MY4T?\-I:9_T(%_\ ^%!;_P#RIH_XG[^B-_T>'!?^(EQ__P#0H'_$&?$O_HF*
MO_ARR7_YY'V[17Q%_P -I:9_T(%__P"%!;__ "IH_P"&TM,_Z$"__P#"@M__
M )4T?\3]_1&_Z/#@O_$2X_\ _H4#_B#/B7_T3%7_ ,.62_\ SR/MVBOB+_AM
M+3/^A O_ /PH+?\ ^5-'_#:6F?\ 0@7_ /X4%O\ _*FC_B?OZ(W_ $>'!?\
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M !$N/_\ Z% _X@SXE_\ 1,5?_#EDO_SR/MVBOB+_ (;2TS_H0+__ ,*"W_\
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M?_1,5?\ PY9+_P#/(^W:*^(O^&TM,_Z$"_\ _"@M_P#Y4T?\-I:9_P!"!?\
M_A06_P#\J:/^)^_HC?\ 1X<%_P"(EQ__ /0H'_$&?$O_ *)BK_X<LE_^>1]N
MT5\1?\-I:9_T(%__ .%!;_\ RIH_X;2TS_H0+_\ \*"W_P#E31_Q/W]$;_H\
M."_\1+C_ /\ H4#_ (@SXE_]$Q5_\.62_P#SR/MVBOB+_AM+3/\ H0+_ /\
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M /X4%O\ _*FC_AM+3/\ H0+_ /\ "@M__E31_P 3]_1&_P"CPX+_ ,1+C_\
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MH4^L>#];TS0]!_KD_P"&TM,_Z$"__P#"@M__ )4T?\-I:9_T(%__ .%!;_\
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M=4\(:S-HEW90:#>'P[#?WETNH:5I,4W[9?\ #:6F?]"!?_\ A06__P J:/\
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MT]M:ZW^Q]\4=-N)[;R_M$,5W\2?@O"\D/FI)'YBJQ*[T9<XRI'%?MW_P</\
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MV!11_P 21?14_P"C+\,?^%&>_P#SV#_B+/B+_P!%5F'_ (+P?_S-_7S9\?\
M_#&O@;_H:?%GYZ/_ /*RC_AC7P-_T-/BS\]'_P#E97V!11_Q)%]%3_HR_#'_
M (49[_\ /8/^(L^(O_159A_X+P?_ ,S?U\V?'_\ PQKX&_Z&GQ9^>C__ "LH
M_P"&-? W_0T^+/ST?_Y65]@44?\ $D7T5/\ HR_#'_A1GO\ \]@_XBSXB_\
M159A_P""\'_\S?U\V?'_ /PQKX&_Z&GQ9^>C_P#RLH_X8U\#?]#3XL_/1_\
MY65]@44?\21?14_Z,OPQ_P"%&>__ #V#_B+/B+_T568?^"\'_P#,W]?-GQ__
M ,,:^!O^AI\6?GH__P K*/\ AC7P-_T-/BS\]'_^5E?8%%'_ !)%]%3_ *,O
MPQ_X49[_ //8/^(L^(O_ $568?\ @O!__,W]?-GQ_P#\,:^!O^AI\6?GH_\
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MGQ9^>C__ "LH_P"&-? W_0T^+/ST?_Y65]@44?\ $D7T5/\ HR_#'_A1GO\
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M,:^!O^AI\6?GH_\ \K*/^&-? W_0T^+/ST?_ .5E?8%%'_$D7T5/^C+\,?\
MA1GO_P ]@_XBSXB_]%5F'_@O!_\ S-_7S9\?_P##&O@;_H:?%GYZ/_\ *RC_
M (8U\#?]#3XL_/1__E97V!11_P 21?14_P"C+\,?^%&>_P#SV#_B+/B+_P!%
M5F'_ (+P?_S-_7S9\?\ _#&O@;_H:?%GYZ/_ /*RK^E?LB^"M)U33=5A\2^*
M9)M,O[/4(HY3I/E22V=Q'<QI)LTY6V,T85]K*VTG# X-?6-%;X;Z%?T6\'B<
M/B\-X-\-4<3A:]+$X>K'$9YS4J]"I&K2J1OFS7-"I&,E=-76J:(J>*WB'5IS
MI5.*<?*G4A*G.+AA+2A-<LHNV&3U3:=G?5]S_)__ &]./VY?VSQZ?M8?M%?^
MK?\ &%?W)?\ !MO_ ,HQO"O_ &6+XN?^GBQKXO\ V_O^#;[Q1^TG^U)\0/C_
M / ?XZ^"O F@?&/Q5>>./'GA#X@Z'K]S=^'_ !=K]P][XNU;PQJ/A^*[BUNT
MU[5Y;K7DTG58=#?3[V_N[1=5N+06[0_T$?L-_LB>#/V&/V9/AO\ LV>"-7O?
M$MCX(M=3N=9\6ZE:16&H>+O%?B+5KS7O$GB&XT^&>ZCTV&\U._FBTK2EO+XZ
M1HMMINER:AJ,MF]_<_8\!\&Y]DO&><9CF&$5# *EF%*AB?:T9QQ3Q6,HU:+H
MPA.53E=*$IS<X0]F[4YI3?*O]$/I:?25\)/$WZ,GAMP5P?Q#/-.+'C^#\?FV
M2++\QP];(*>1<-YA@LRI9EB,5A:&$=:GF&*HX2A'"5\3'%KVF*P\YX6"JR^M
MJ***_<3_ "M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\>?V^+#_@K
M]XO_ &D/A3X)_8*UKP/\+/@"WPXN+[QW\7_%<?P>OM+C^)E[J7C*XN]&\;:?
MXWTCXE?$DZ)I.@^%O!%CX-E^%GPID63Q)\2-7?QCJVJ:+9+>?#_]AJ_#7_@L
M;_P5;N/V&O#UC\#_ (,VC7'[3GQ+\&'Q99>*]8T;[3X/^"WPXU#4M<\/0?$1
MX]6LYM$\<>/M4U?P[XATWP!X,\O4_#^BWFB:CXS^*,$FA:?X6^'_ ,7.[+H5
MZF+I4\/0HXBK/FC&%>FJE&-T[U)QE[MJ:O*\U**M=QD[(YL9*G##SE6JU*-.
M-G*=*3A4=FK0C)>]>;M&T;2=[)K<^5/^"3__  44_;-\=?M5_M/_  5_;R^*
MOA-/"OP,^"_Q(\:?$&X\;:#\'_!!^"OB[X&?$?POX.\=M=>/_AE;^&_ C>$+
M*Q\2^*)?'^L:]>^+M$B;P?X=UKPCXHT#0X?$DGBOY@\#?M\?\%B_VQO!W[8/
M[67P2^*GP^_9X_9[_9X\/ZM\0M3\#:]X!\+ZUI&E>&_#W@?Q+XMU'P!\+OB#
MX@_9]\<R_%3XC^&O#/@^VUCXBOXH\4>$+9/$'CSPSK%CHO@CP;XNT#PSX=[S
M_@G3^PG^RYX=_9?_ &@_AOX;_:\_95\=?\% /VQOV1OCE^SIX&^&?@S]I3X?
M^*_#'PF\-^/_ (;ZE?#P%'HGPU\1>*[WQUK=E=^'-#\6_%KQOH?A[Q?:>%=)
M\'7&B_"^VNO#NC^*?&7Q3^>/^"=/[5WP&\/_ /!)K_@IE^S!XS^(WA#P!\4_
M%'PU^/\ XG^'5AX\\9>"/"</Q:F^,?[,^H> _#OA/X566L^)[7Q)XX\9:3KO
MPTF7Q+HND^'W2R@\9^ 5L+S5+W7KBSTSZ2<,(ZN88C"8/#U9T:F6X>,)86+P
M]JLG#$5J.'G%Q4:LX<D)\NBO*+]Z[\6$L1R8*CB,36IQJ0QE64E7:J^Y&,J-
M.I6BU)RA&;E*+>KLFO=LOZ"O^"/'[:/Q1_;@_9)N/'WQETS2$^(OPT^)>K_!
MC7_%VB^196_Q/?PYX*\ >+;7XAWWAJRTZPTOPAK^JVGCJ'2?$FAZ$9?#EWK^
MAZEXF\.6/A30O$.G^!/"GQI_P2F_;D_:I^)'[</[7W[%W[2?Q7;]HB/X,P?$
M>W\,?%EO!/PU^%*Z?J7P ^-%O\&_%*)X$^'?@RP6?_A:,_B^P\0.NK^,=6'@
M8^!ET;3DUC_A(K_5+/J?^#<C1M<TS]A3Q]?:MH6LZ3I_B/\ :=\>ZSX8U#5-
M+OK"Q\4:'!\-_@_X>N-=\.7=W;PV^N:-;^)M!\1>&9]4TN2[L8?$/AW7M%DN
M%U/1]1M+;\EO^"N7C7QA^Q!_P5^U/]I7X>:PGB3XE>-?@/:?$GX?PFQTO2&^
M$7B#XB? GXG_ +%V@^(1+KECXZT;QL_@74O!^H?&9-/U;POI^E^*?,/PYO[*
MTM5G\677)'!T*N8YUEU&E3O.G6>#]U-TZ^'J1JJG3DTY4U*/M*<N625DHR4E
M9+>6(K4\'EF,J3G:,Z2Q.K2G2K0<'4FKI2:?)-73U;::9Z[^R_\ \%C/C[\2
M?^"HGA#P/XH_:@N->_8K^)'[2GQ1\&?#[0C\%O!&FG7_  3\1Y_B%X5_98\/
MO=:9\(M/^,&CK=>-->^$-FVJ:_?:9JU@(7N_B5J5KI$?BNX'Z(?\-L_M>^(?
M^"Z__#&VCZK(/V6_ VB[_%7A/PI\.=&U1'T.Z_98'Q0@^(7Q,\=7VB:]XJ\.
MX^,?C/PSX*L=2T;Q%X*\'S$?#WPG+I-UXCU[5;KQ;_,/XA_9Q\7?L^_L6_L3
M_P#!0GX17P@\;?$'X]_&NZD^)JPZ1(GPK\;?!WQ;X=T;]F_P*G@KQ3XB\2:#
MXRGL_%/P3_: ^*X\3VWP\M=*F754\#_$."_M-$\&-K?[L?\ ! _P'J'QR_:5
M_;D_X*+ZMX3USP%8?$KQCXX\)>#_  W;>,/#?B+PS;:Y\<?B/%^T'\9/"FK*
MNCZ=XNU37OAK]D^#EKX>\72:;X0\.:UIWC/Q+Y6CZQJ:30^#NW'X3 TJ.)QM
M&C2]C2P=;+E'DI_[]3Q2PWM[)+]\Z;E54[<UDIW32YN;"8C%5*E##5*E3VL\
M32QCESR_W65#V_LMV_9\]J;AMJXM:Z?,7_!/;]I[_@N'_P %$_#_ (UO?@]^
MVG\+=!NOA?H_PVNO%\OQ3^&?P=\._P!HS_$6R\3S:9)H2>#OV6O&\=QY4G@[
M5VU-;Q-(2V^T:>+);Q9;@6?T-_P4T_;!_P""F_[!7PB_8)\(^(/VE?#!^/'C
M[1_VM;KX\^-/ ?P^^%'B3POXYG\'_$'X17'PIDTV'QG\$M#ATC_A%O OCY]%
MO$T#P;X434=0EO)=777YK2QUA_QH_P""57[*O[ G[37A7XA?\-Q_M(:9^S[_
M ,(3X?\ A!_PJ_\ M'XP?!?X4?\ "7?\))IWC+_A-?)_X6]X=U_^W_[ _L#P
MEYG_  CWV3^R_P"VD_M;S_[1TSR?L7_@M'X"^$/PN^!'_!+/X>_ /XV:O^T/
M\'/"/A#]MO1OA[\5M:^(_A;XL7.K>'K;XB?L\^1X:L?''@FRTWPK?^'?AM,T
M_P ,_">D:)8VUGX0\+^$-'\'>7YN@R,=:E#"_P!KX+"JAAG2=6DYT5EU.FO>
MP,IVEB;-5U*4G-TW%<LK;NG<RA5Q']G8C$.M7]IR34:CQDYO_>H0TH?\NG&*
MY>=2=TWTJ6/WI_93^"W_  6F\)?'SP%XA_:T_:X_9]^)_P"S[IY\4_\ "P/
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M7>.?@[P%Q%@N$^-/$O@SAGB3,%1EA\FSC/L#@L;&GB6EAJN+IU:J67T<3?\
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MR[KF2=MFTK[%2IPG*$Y14I4VY0;5^633BVO.S:OYZ!111699POA/_D.>/_\
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MWCO4?C_X9O\ XK?\+#N_'/@3]HWXI^++B*_^,/Q UKP>)O&MCX \7Q>+(X?
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOZG/SL**** "BBB@#A?"?_(<\?\ _8S6_P#Z8-(KNJX7PG_R'/'_ /V,UO\
M^F#2*[J@#BO _P#QYZ__ -CKXQ_]/UY7:UQ7@?\ X\]?_P"QU\8_^GZ\KM:
M"BBB@ HHHH **** /X7O^#J;Q=XANOVLOV=/ <^IW3^%-"_9W/B_3-&,TOV*
MV\1>+/B3XWT77M42W\SR!=WVF>"O#=I).(A,T.G0QM(R(BIZ%_P03U_5]1_8
MO_:/\-7M]<7.B^%OVDOAYJV@6$LCO#I=]XM^''B>V\0R6:,Q6!=4C\,:(US'
M&%226QCE<&3YJ\9_X.GO^3XO@7_V:EX<_P#5O?&&O3O^" W_ ":9^U=_V7_X
M-?\ J ?$:O\ .+Z6C=3@CQZC4_>1?!N?IJ?O)^PR^A4HZ2NOW-2E2G2_Y]SI
MPE&TH1:_W-RS#8>E^S^\*W3H4H.G7X*Q--QIQBX8C%^(48XJO!I>[6Q$<5B8
MUJBM.I'$5E-M5)I_T=ZO\(?A_+KND_#+1M:\;:1\0?$_A)-4T;Q9J>EZ7XE\
M Z+JS^%-4\2O=^)]&T]_#>KP^'X4TN2$'_A)+!KB\N;+2AJ<%Q=P7+]=^ROX
MQDT'X1?$SQQ%I5UYEE:Z+KJ:+JJMIU]&7TNXN!I^HHHN#97D/F>3=1@3&"='
MCR^W)ZO7_&=K)>:=?ZM\3?A[=_!?_A M+T_QOX&U$V?C>Y\0:/-HS6OB;PXW
MP^TZPU76=7O-4MI)+*6R%I-(8Y7MY;*_59='NHOV8="\.>+_  A\6] M[+6-
M)\*Z[J=G:6>G7M^MUKVFZ)<V]\;*QOM3>YU=;K5+2T\FWO+UKW4A<7,<LWVR
M[W^?)^?X;P_\..'?'3P^?@3E?"G"O&?]J?2,X=R.OEJR3!RS&A_Q""CCN#\Y
MPN&P/$?%E+..&LJSC&5<&N(<WP>58JMF"Q>'K9#3PSA/%_Y@3SK/<;PAG?\
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M&1?A5_S\>+/_  ;V?_RIIRX)_:Q3C2A+QHX3E"@XRHQ=;@IJE*'P2@O^(?\
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M^.WQ/^&/BKPSXRT%],A\=V_PQ\>:3X4TGXZZ/HMQHW]D:+\7FNOA_K6O7?\
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M_P 0]_:K?]'>X+_\T;_Z7H?VW]'7_HF<U_\ ,O\ _/KR_J[/)O\ AM+5/^A
ML/\ PH+C_P"5-'_#:6J?]"!8?^%!<?\ RIKUG_AD7X5?\_'BS_P;V?\ \J:/
M^&1?A5_S\>+/_!O9_P#RIH_XA[^U6_Z.]P7_ .:-_P#2]#^V_HZ_]$SFO_F7
M_P#GUY?U=GDW_#:6J?\ 0@6'_A07'_RIH_X;2U3_ *$"P_\ "@N/_E37K/\
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M  ;V?_RIH_XA[^U6_P"CO<%_^:-_]+T/[;^CK_T3.:_^9?\ ^?7E_5V>3?\
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MPJ_Y^/%G_@WL_P#Y4T?\0]_:K?\ 1WN"_P#S1O\ Z7H?VW]'7_HF<U_\R_\
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M;2U3_H0+#_PH+C_Y4UZS_P ,B_"K_GX\6?\ @WL__E31_P ,B_"K_GX\6?\
M@WL__E31_P 0]_:K?]'>X+_\T;_Z7H?VW]'7_HF<U_\ ,O\ _/KR_J[/)O\
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M:I_T(%A_X4%Q_P#*FC_AM+5/^A L/_"@N/\ Y4UZS_PR+\*O^?CQ9_X-[/\
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M $(%A_X4%Q_\J:]9_P"&1?A5_P _'BS_ ,&]G_\ *FC_ (9%^%7_ #\>+/\
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MP_\ "@N/_E37K/\ PR+\*O\ GX\6?^#>S_\ E31_PR+\*O\ GX\6?^#>S_\
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M1U_Z)G-?_,O_ //KR_J[/)O^&TM4_P"A L/_  H+C_Y4T?\ #:6J?]"!8?\
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M -+T/[;^CK_T3.:_^9?_ .?7E_5V>3?\-I:I_P!"!8?^%!<?_*FC_AM+5/\
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M%A_X4%Q_\J:/^&TM4_Z$"P_\*"X_^5->L_\ #(OPJ_Y^/%G_ (-[/_Y4T?\
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M_P ,B_"K_GX\6?\ @WL__E31_P 0]_:K?]'>X+_\T;_Z7H?VW]'7_HF<U_\
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MR;_AM+5/^A L/_"@N/\ Y4T?\-I:I_T(%A_X4%Q_\J:]9_X9%^%7_/QXL_\
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MK_T3.:_^9?\ ^?7E_5V>3?\ #:6J?]"!8?\ A07'_P J:/\ AM+5/^A L/\
MPH+C_P"5->L_\,B_"K_GX\6?^#>S_P#E31_PR+\*O^?CQ9_X-[/_ .5-'_$/
M?VJW_1WN"_\ S1O_ *7H?VW]'7_HF<U_\R__ ,^O+^KL\F_X;2U3_H0+#_PH
M+C_Y4T?\-I:I_P!"!8?^%!<?_*FO6?\ AD7X5?\ /QXL_P#!O9__ "IH_P"&
M1?A5_P _'BS_ ,&]G_\ *FC_ (A[^U6_Z.]P7_YHW_TO0_MOZ.O_ $3.:_\
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M $(%A_X4%Q_\J:]9_P"&1?A5_P _'BS_ ,&]G_\ *FC_ (9%^%7_ #\>+/\
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MP_\ "@N/_E37K/\ PR+\*O\ GX\6?^#>S_\ E31_PR+\*O\ GX\6?^#>S_\
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MAS3?"MUX+2+09_%FC_$:WOE'B:RUV./Z:KYI_9N\7P^)M*U_3M$T^73?!7A
M:)X>\+)JU[)JWBO45$>I:GJ>L>(-1"P65H+F>_@L=-\-:;;W-EHL&ERW=OJT
MUOK,.A^'?I:O]E/"W/N%N)^ >'>(."I9/+AK-L/BL9E\>'XQ62T:E7,<9_:.
M%RZ<,)@(5\/A,S6-PJQ<,%AH8V5&6+A1A&LD?YF<0X/,<OSG'8+-5BEC\-.G
M2K/&MO%2C&A2]A4KIU:SA.IAW2J.FZM1TE)4W)N%PHHHK[\\4**** "BBB@#
MA?"?_(<\?_\ 8S6__I@TBNZKA?"?_(<\?_\ 8S6__I@TBNZH XKP/_QYZ_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MF_$O_GP\#?\ @VU__P"4M'F_$O\ Y\/ W_@VU_\ ^4M=S10!PWF_$O\ Y\/
MW_@VU_\ ^4M'F_$O_GP\#?\ @VU__P"4M=S10!PWF_$O_GP\#?\ @VU__P"4
MM'F_$O\ Y\/ W_@VU_\ ^4M=S10!QOA/2-<TZ?Q%>Z[_ &4MSK>JQ:@D6DW%
?W<01+'I]K9%&>\M+23<?LJN,(P^8_,, 5V5%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>gb2k1ptlkg5v000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gb2k1ptlkg5v000001.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" +3!L,# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF]\-V_@\:[I<F@2:XFM3VEA<?(?_  _A_P""5W_1R?B#_P 1K_:N_P#G'5^
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=IQBOZR+G_@V'U9H76S_ &Z=/@N"#LEN?V6+F[A4X."\$7[2=D[@-@D"XCR
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MNO\ ^@E_P31_;U\,?M\_L\Z5X\GN/!NB?&SPD5T'XZ_##PMJ>IW)\%^('O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7=YXOO[?3;K_ $QZ*];_ %H5)3>$RK!X:I45IU(V?-IHY*G2HN5GK[TV>?\
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M,6<1E1Q&!QZ3<:-2-.K;7W>?FCIYIU(W[N/5G]97_!??P!\;_BC^QGX!\#_
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MC=)M-I-;83*L/A*CK<U2O7=[5*K3<;Z-Q5M)-:<S<I6NDTFT?B%_P<%_$U_
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC)+MJHOS3VYD?.8ZG+#XN59I^RK-.,NBE:/-%OI*\>9+JGI\+M^F^H:SH+:
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M'45U.Z%[N+_.6-RLGWOF/.[FOT/^&'AO3[Q($D$8RJY+8QR!_7G/I[<5Y_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG'3-=]\,_P!J#]FGXTZ_=>%/@Y^T/\#/BSXIL='N?$-[X:^&?Q:\ ^/-?L]
ML[W3M-O-<NM&\+>(-5U&WT>UU'5])L+G4Y;9+*"]U33K66=9[VVCETE0KP3<
MZ-6*6[E3G%+U;2L0JM*32C4IR;V2G%M^B3/<Z***R- HKXJ^+'_!1S]A'X)Z
M9XVU#X@?M7_!*"\^'.NS>%_&OA#PEXVTSXE_$S0/$MGXDB\(ZKX>N/A-\-)/
M%WQ.GUS0/$$KV7B?2K+PE<W_ (7BLM6U#Q#!IFFZ-JUY9>P_#?\ :A_9G^,G
MB:Y\%?"']HGX%_%7QE9:'=^)[SPE\-_BWX \<^)K3PU87VEZ7?>(;G0?#'B#
M5-5@T.SU/7-%TZ[U:6T2PM[[5]+M)KA+C4+2.;5T:R@JKHU53>U1TYJ#VVFU
MR]5UZKNB%5IN7(JD'/\ E4HN7_@-[]'TZ'NE%%>#^$?VI_V8OB!X>\?>+O ?
M[1OP'\;>%/A3H0\4?%'Q/X1^+WP^\2>'OAMX9-CK>ICQ%X^UK1O$-[IO@[0C
MIOAKQ'J U?Q%<Z=IYL= UN[^T>1I5])!"C)IM1DU&RDTFTN9VC=K:[T5]WL4
MY)-)M)N]DVDW;5V6[MUMMU/>**^,4_X*,?L#-K.K:&W[9O[,D$^B:#H/B2^U
M.\^-7P_LO"KZ9XCO?$=AIZZ;XUO->@\'ZUJUM-X6U.77O#^C:[?Z_P"%;"Z\
M-ZIXGTS1],\8^$+O7/LZG.E5IV]I3G3YE=<\)0NM-5S)76JV[H49PG=PG&:6
MCY9*5O6S845C^(O$7A_PAX?UWQ9XLUW1_"_A7POH^I^(O$OB7Q%J=EHGA_P[
MX?T2RGU+6==UW6=2GMM.TC1](TZVN=0U/4]0N;>RL+*WGNKJ>*"*21?D?P/_
M ,%%?V&/B1\2M=^$7@O]JCX,:SX\T+6? OAV+3?^$QL-.TGQCX@^)-NDW@_0
M_A5XNU9K'P=\9M7OIIH-)U'3OA+K_C6[\-^([JT\+^)H='\1W=MI<KA2JU%)
MPIU)J"O-PA*2BN\FDU%>;L*52$&E*<(N6D5*23EZ)M-_(^'_ (H_\%D=-^$G
M_!22R_8$\2_L^7UYH6H?$WX-?"JU^,^A?$ZWNM6&O_''P=X!U7PI?3_"S4/
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M>J:37W"C*,US0E&47UBU)?>KH*_/?_@I-^W9-_P3W^!OA/XSP_"F/XP'Q/\
M%G0_A@WAJ3QXWP\%@FM>#O'?BO\ MU=97P5XZ^UM;-X*73_[*.DVHF75&O/[
M2B-B+2]_0BOY^/\ @Y#_ .3'?A7_ -G6^!__ %4/QSKNRNA2Q.882A6CSTJM
M51G&\HWC9NW-%J2VW33.;'U:E'!XBK3?+.%-RC*R=G==))I_-'[7? 3XGO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOBO0_P"8_P#X)8_\$M]:_P""B5QXD_:Y_;,^(WQ=\1_#JV\5Z-X;T"#7M?\
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MOPK_ .SK? __ *J'XYU_0/7\_'_!R'_R8[\*_P#LZWP/_P"JA^.=<.1_\C;
M?]?U_P"DR.K-/^1?BO\ KT_S1^K7[!__ "8[^QI_V:E^SO\ ^JA\'U_/Q_P2
ML_Y3B?\ !2#_ +O _P#6N_AW7] _[!__ "8[^QI_V:E^SO\ ^JA\'U_/Q_P2
ML_Y3B?\ !2#_ +O _P#6N_AW7=A/X?$?_7B?_J2SEQ'QY-_U]C_Z8/JW_@Y#
M_P"3'?A7_P!G6^!__50_'.OS?_8%_P""1GQ9_P""@O@O0_C]^W-\0_B]X$^%
M.F?"?X??"3]F30_#\WAG0_B5K/PT^'6EV&B^#M>L;'Q5X-\3>&_ WP5T_0+6
MZ@\&6'_"(_\ "3?&/7/$/B'XR3W>F:/J.E^,_C9^D'_!R'_R8[\*_P#LZWP/
M_P"JA^.=?JU^P?\ \F._L:?]FI?L[_\ JH?!]:0QM?!9!A)8=JG5J8S$P]LH
MIU:<+1E)4Y/X'.T5)K6RLK$2PU+$YM759.<(8>A+V;;4)2NTG.*^+EULGI=Z
MIG\9'_!1']CKQ[_P2-_:I^$7C?\ 9O\ B;\1[#PUK>@_\)S\#OBWKMWX'?QU
MH'CKPIL\/?$[P3K$.AQ6FG>++2PL]<\.ZOJTNN?#3PSX#\8>"?BL/AAJ&A^-
M+?0/'-WJG]P'[.GQ9D^/?[/GP)^.DWAU?!\WQH^#?PP^+,OA)=8_X2%?"\GQ
M&\$Z'XP?PZNO_P!EZ'_;BZ(VL'3!K']BZ1_:8MOMO]EZ?Y_V2'^:;_@YV_X_
M/V'/^O;]I[_T;^SM7[^_\$]?^3!/V'?^S/\ ]FC_ -4OX*J,UJ3Q649/C*[Y
M\3-XJC.LU:<X4JKC!3:^)I1O=]7)[R=ZP$(T,QS'#4ERT8K#U(T]>6,ITXRD
MXKI?FMZ**VBC^7W_ ((;_M6?!C]C3X-_M]_&_P".7B-M%\,:5-^S/I.AZ+IL
M=O?>,?B#XRO[;]HFYT+X?_#_ $*XN[$:_P"+]=CT^^N(+>6\L-(T71=-UOQA
MXNUGPWX(\->)O$VC8'PR^&O[5O\ P7Z_:HO/BK\6;W4OA5^RI\*]4GT.5O#\
M[WWAOX7^'KUM/U>7X0?"&?6-.BL/&WQU\9:<FB:I\2/B5JVA_9-)M&T3Q;XK
MT#3O#%G\$?@?JOYU?LM?L(^)OVM?V>OVNOBO\+]/\7^*_C+^S%'\%]8\*?#3
MPGI&D:W=?$;P9\0M1^(,/Q.TNPLKF?3]>D\5>'M)\%:5XT\-67AJ\UC5/$\?
MAS6? FD>!/%OB_Q=X1N- _H>_P"" O\ P4)T;X@^ (OV(_B/)\-/"/B_X9Z4
MMY^S]+H-G9^$-1^+W@^ZE\2>)/'&CW/A_2=#T_PGJOQ!\!RI_P )1JWB/3]5
M7QE\4O#WB'5_&'B#PSJ>O^ OB;\3/%?NYHEA:N:YC@DJV/C/#T:TFO>R^A+"
M45[:E3:?.ZBM>MM!.22Y85;^7@6Z\,!@\2W2PDHUJE-)^[BZL<1-^SJ2NN50
M>U.UY-)WO.G;]GOB+K?P=_X)X?L9>./$/@'P;X,\'?"_]G#X4>(]6\#_  \G
M\3VW@70_$&O65M>77A?P0_C+6H-;N/\ A,/BW\0M0L- _P"$DU6V\4>+/%WQ
M \8C4KVW\5^+-<DBU/\ DD_8@_8W^,'_  6B_:&^,7QZ_:;^*'Q&\/?"3POJ
M&J_V[K^AW/BK5M5DU[X@:SXT\9>&_@9^SMX@^*MK\1O!O@SX??"C4-=O?$VM
M>&+R^\73?#WPMKG@7PKIW@MU^*<7CWPC_11_P72DBB_X):_M+-.0$.I_L^1J
M2P3]]-^T]\&(;<9/4F=XP%ZN2$'+"OP#_P""1?[&/QL_:L^"WQ.U#X+_ /!2
M3XH_LIW'@SXJO:>*/@G\+K[Q7=SS0ZWX/\,3:!\5_$.B^$_CE\.)--3QK)IF
MN^#='U/4O#4PU@_"W5+:RUZ__L2[T[1O)RGEI97C\<\4L+B:F)CAWC)TZM:=
M*#4*DG'V<:DU.M*;BYVW2;E=(]#'WGCL)A50=>C"C*M]6A.%*,Y)RA&_/*$7
M&FHW4+VLVK-7/KG_ (*8_P#!"GX#_#7X"?&S]H[]E>;XC:+K?@#3=,\<ZG\#
M]9\2^'?$_P ,;?X8^%]*MK/XH-X;U7QK_9OC_3=1TO0X-4^+>H7GBCXC_$6?
M5&T/Q!X'\(^$1-XE\+6GAS[J_P""$O[;GCO]K#]G+QWX"^-'C\>/_C)^SSXK
MT'09M6OM(UY/%VI?!KQ?X>5_A9XB^(/BZ]$NA^-_&5YXD\*?%;PO<ZW874?B
MB\T/P5H.L?$2SOO%6N7'C?QQY/X@_P""+G[8GBS0=;\+>*?^"QO[2WB7PQXE
MTC4O#_B/PYX@T+XHZSH.OZ#K-G-IVKZ)K>D:C^U-<Z?JND:KI]S<6.I:;?6\
M]G?6<\UK=0RP2NC?:'_!,C_@F#H'_!.'3_C+-;_%_5_C!XJ^,]]X$CUC59O!
MMCX"T'2/#OPWM_%C>&=.T[P_'K_C#4Y=9EU/Q]XNNM<UJ[\526%]8OX=L-.\
M.Z-<:1JNI^),<9B\+5RN>'K9DLQQ=.O"IA:CH8J-2$'RQJPE5KTXWCRIRUDY
M.5KWLK:8;#UZ>/C6IX)X/#SI2A7@JM!PE)7=.4:=*;M*]HZ122OM=W_F%_X*
MP+\0[[_@L+\=O"GPH$<_Q!^*;_"[X$>'=)F_X198O%#?M#_LM?#[X$:IX)DG
M\:[/#-@/'.B?$;4_!ZZKJ=UIBZ1)K::I:ZSHU[9V^JV?ZI>$/^#9[X*ZE\&?
M"VD?%?X^_%*V^-.H6F@CXF7_ ,.F\(2_"F"UN?$5I=^-O#/@+1O$G@>'Q>UP
MO@=]3\%>%?'WB#7Q /%(L/B?JWPQ.DBX^$1X'_G9_P#\_P#2/:OZM*VS3,L5
MA,/E-##5/8*64X*K4J02]I4O3E3C3G)IMTX*,FH?"Y5)-IZ&6!P6'Q%;,*U>
M/M'',<5"$9-\D+2C)SBDU:<KQ3EO:$4%%%%?*'OA1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %-=TC1Y)&"1QJSN['"JB@LS,3T"@$D]@*=
M6;K&G_VMI&JZ496@&IZ;?:>9TR'A^V6LMMYJ$<AH_,WJ1SD"@#^1?XK_ !#U
MS]I7XX^-_BIKMQ-<V^M:S<6OA:SD+^3HO@S3IY+;PQI%K"P58%@TQ8I[WRXX
MOMFK7.H:E,@NKV=F]=\)?"Y;FWB(M\Y4=%_PY[_3N..1XA\/]'NO#VLWOA_6
M;9K/5M#U2]T?5+23'F6NH:9=2V5];28_C@NX)8F[94U^D?PN_LK9;_:O+V;5
MSG&,8&.O?&?TSWKZNK+V48Q@DHQ48Q2V44DDE;K9??;4^/H4_;3E.HVY2E>5
M]W*6K;\[MZ=#Y;\3?"M8+9V-OC )^X?0],_Y '?&!Z+^QW^TKK/[,OQ.L?"O
MB'4II/@YXYUBVT[Q)I]U.39>%-4OY8K2T\;6 D)6S%HWE)XB2$HE_HJO/-%<
M7NFZ8(O?/B5_8WD2_9-FW8?[O]./R[]><5^:7Q:^SYNMNWH_I[Y]_NXS^&.*
MSBEB(.G45XS6O5IZ6:OLU?1]_5HTJ7PM2-6E*THOFT>C2WB^ZEM)=4V?U\@Y
M (Y!Y!'((/0@T5X+^RWXIOO&O[./P0\3ZG*\^IZI\,?![ZC<R9,EUJ%MHUK9
M7MVY+,2]W<VTMRQSRTI.!T'O5?-3BX2E![QDXOUBVOT/JH24X1FMIQC)>DDF
MOS"BBBI*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH _.K_@J3\,_P!KKXJ_LEZYX?\
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MBTE9+FON^6>7S5:K6PN+J85UWS5H*$*L)2ZRC&?PS>K<E=W;:ML?QW?L>?\
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M_P#V3XT^#?PWU7^V]#U/2?[,^(GP^_X7'_PGW@'4/M]K;_8O&O@?_A)/#O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 5@>*]*GUWPMXDT.VE\BXUG0-8TJ"?C]S-J.G7-I%+\RLO[MYE?YE9>.5(
MXK?HIIM--='?[A-733V:M]Y_';\+]/?3[TZ=J%N]I?6%S+97MK.FR:VNK:0P
M7,$J'E)(98WCD4Y*NK=<9K]+/A?;:2\< NM@4JA.0.#@9P.!G'..@]^:Y/\
M;\_9RU;X+_%?4?C1X5TN23X9?$K56U+5Y+&WD^S^$/&]ZR-JMKJ/E@I;V'B>
M]:76-*NG*0MJ%SJ.EE(?LUC]L\%\(_%!+:WCQ<A2%_O8[=.OUSCUSWY^EE)8
MFG"K3>DTMG?EEUB[=8OW?3R:;^5I1^J594*FDH2T;^U&ZY9)]4U;TNUNFCZ[
M^)MIHT<,OV385VD \ X' )';CKZ<X]OS/^+:P1M.T;!64ED9#@JRMD%2,%2I
M&01R"..F*^@O%'Q22YMGW7(/RG^,'VP#GD^Y_4=/D[48?$?Q4\9^'_A]X+LI
M-8\4^,M:LM T/3XBW[V^U"=8$>>0!A;6=JK/=:A>R@6]C903WEPZ002NNF'@
MX).3T2NV[))))N[LM--]O,SQ=2-1)05W*R45JVVU9*V[>EEW?<_K/_9[\97O
MQ#^!/P=\<:G(TNJ^*?AIX*UK5Y6!!EU>]\/V$NJRC.25DU$W+H3RR%6/6O8:
MXCX9^"K3X:_#CP#\/+"4W%GX%\&>&?"%M<D$-<Q>'-%LM(2Y<,2V^Y%IY[[B
M6+R,6)))KMZ^7FTYR<?A<I./HV[?@?64U)4X*>LU"*D^\E%<WXW"BBBI+"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME;]@V+2]-^-'B;7=8^(WB'1$\3>&/@[\.-$3Q-\1M=\-CQ'I_ANXU^2._O\
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ML?##XC:GI\G@SQ+JOA&]\3^%?'_@+4="B\6ZQJWBWX&:GI6E>,_'FM^)M?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-OX2?2/%0\2^/?'4'@[Q3IVI:AKVO_"70_%7AE[%OA]K$DT__!M+\4?#VJ_
M']I/X*6MAKD?BKP%\9/#WQ7UO4[BVLU\-WFA?&'P/8^#O#5CI-XFHRZC/K>G
M7WP'\4S^(+6YTFRL;2QU/PS-8:AJEQ?:G;:0W_@Y3^,M_P"&_@?^SI\"+7P_
MI5S:_%KXA^,/B%J?BJ_L_#NJ7VBVWP7T?0-+@T'0K76_"VK:EH.I>);_ .+M
MI?7/C?P?XE\)>([#1/"^K>!KI]=\(?$?Q7IE?0\LWQ;9P]I+Z[S6D[6A&ESJ
M5WUITUSQ75Q21X_-%</WYG!?5K72O>3J<O+I_/-\C?12;?4^Y/\ @E9^R?\
MLB:5^PG\!?%OA/X;_!WXD^(/B_\ L[W7A[XP?$W4_!GPL\7>+_&UM\4;Z3Q%
M\:O@=XZ\::-X8M[KQ/X(\(>/6U/X87_PY\43ZI_8VG^ -(\(>,H]4U_PQ=W;
M_P UGQ:T']GOX6_\%TM.\ ?"[X7_  (\:? >\_:X^"7P@NOAAKFC:?\ $KX-
MV]]\:K#X??##XTZ+'X3.J7&@Z?KOP_\ B/\ $/XAP^'/"+?\4]\)_B3X7TK1
M4\)6FF^#$\)6_P!+?!'_ (([_P#!0VS\#VFN_L:?\%%OA(GP;\73V_B<ZY^S
MW^UM^T1X,^'OBOXDVVBZ+X2^)MQY7P:\+:AX-\4S^%O&?A/4OAI!XON;^ZU[
M7M!\#Z/+XAT/P;J27/@3PW^H'_!-S_@C+K7[,/QH7]K?]J/XOQ_&+]I&-O&6
MHZ)8>$]3\7W?A+PQXQ\=3^,M"\:?$'Q%X_\ $TFC>+?C/XJ\9>"?$/E_\53X
M2\+:/X8UKQ-XWN=0TSX@^(8O!/CKPNXU\+@99IBGF:Q<L90Q%&EAX*M&JZE:
M2<9UU.*5)T;-7YN9*_([M0:=*OBHX"@L$\.L-5HU*E:;I."A3C:4:7*WSJH[
M.UK.R;36J]]_X+,^'?#_ (/_ ."3_P ?_"7A+0M&\+^%?"^C? 3P[X9\,^'=
M+LM$\/\ AWP_HGQW^$&F:-H6A:-ID%MIND:-I&FVUMI^F:9I]M;V5A96\%I:
M01011QJ?\$9O#GA[QA_P2?\ @#X1\7:#HWBGPIXIT;X^>'/$_ACQ'I=EK?A[
MQ'X>UOX[_%_3-:T'7M%U."ZTW5]&U?3;JYT_5-+U"VN+'4+&XGM+N"6"62-M
MG_@MW_RB_P#VG/\ NB__ *T)\)Z/^"(G_*+_ /9C_P"ZT?\ K0GQ8KS[O_5N
M^M_[=O?K?ZAO?N=G_,ZM;3^R[6_[FS^:S]@:^\8_\$N_^"O=G\!/B'IH\8W&
MO^,A^Q_XDU^PT72GU[6?"7QN\1^ ]4^#WQ1T#2-/^(UUHW@Z#Q9KMM\%_B%X
MLTC5_$?C'5_!WPRUCQ?X??0]3^(-C96]M_1=_P %S/C]?_ O_@GK\1],T.YU
MO3O$GQ^\0>'OV>])U32M&\.:U86>E>-;?6/$'Q*L?$\7B1Y([#0?%?P=\&_$
M7P,FKZ-IVJ>(],U_Q1H5UHR:-<I_PE/A_P#&_P#X.1OV3KG1?B?\-?VMM'TK
M0D\#?%CPW:? _P")T>G:%X<T6\;XH^&+7Q'K7A+Q'XFU6/6D\0^/M9^(/PP%
M_P"$[:Y?PO+#X+\-? ;2=+U3Q//;:_X4T33/DO\ X*%_M@R_\%3?BG_P3W^%
MWP^U_P"&-QXQN/AS\.? 'BK4D\+?%+P%X>\'?M>_M)^*O"'A/XL^!KZ]\66V
MM:E>_"[PQKOA;X:'PYJ_A/2?&+16M]XADB\5^/;@V=MIGM+#QS3$9/FLK.G[
M*7]HRM>,:F 7.W-=JS7+;^2SU3/+=9X"EF. C?G]HOJ:OK*&*M'EAW=-.]_Y
MK['[5?\ !NC^S<?AS^RSX[_:4O=>;4+_ /:A\60Z?H^BV.IBZT;1/ _P"\0^
M/O >GS7VG3^&],O-+\<:G\0M6^*2ZZ(/$7B;0KWP?IWPZGL1HNM+XFLYOP^_
M8V^'$W_!9+_@IUXO^('QSM1I'@SQE_PD7[0GQ<\%V'B<:+XB7X6>#X/"O@+X
M=?!_0?%OA+P+H;:]+X?35/A'\,_$7BG^S_A]XMU_X;:+XK\5V/BK0_B7)IE]
M/_<C\&OA?HGP0^$'PI^"_AG4M<UCPW\(?AMX&^%_A_5_$]QI]WXEU71/ 'AC
M2_"FE:EXANM(TS1-*N=<OK#2;>ZU:XTS1M(T^:_EN)++3+"V:.UB_B@_X(?^
M.-._9,_X*57OPE^/=N?!'C?QAX1^)'[)UQ!<:YX-ET+PI\;;+QSX/UA?#/B'
MQ*?%$>C7?]L^)?A3J7PP\*GP?=^++OQ5\2?$_@O0=!L[ZTUQM5M.7!8J>)_U
MBS"FW'%.@I4&G^]IT)2FI<C3NO9TJ=)<RU3C%WOOT8JA&C_8V#E9T%6M53TA
M.K%0<>9/1\\Y5'RO?F:/ZO?&_P#P3#_X)X^/_#FL>%]8_8P_9TT:RUZ33I-1
MU7X=_"_PS\)?&>[2]5L=8MOL'Q"^%=CX-\>Z0DMWIUO!J4>D>)+&/6=)>]T'
M6%OM#U/4M.N_F/Q_\+_A/_P1H_X)D?M*W7[/5]\2H=0L++7?$FF^/]9E\*^/
M/'MW\>OB^_A#X)_#CXA:UI6MZ?X?^&_]E>#-7N/AE%JVCZ7X1LM"/@_P;<ZA
M/X0\6^*+S5T\3_L/7X\?\%1?&?@G]K+_ ()7_M::A^R_\0?AG\?-,\-6O@C6
M?$.M?"WXE^ ?%WA[1M.^%?Q&^%?QE^(PU#Q%I?B.;0K?5?"WPHL+GQS-X??4
M?^$@U'29=+CT;2]2O]<T2RU'PL)5JUJV'P]:K5EA)XS#.M"<Y.DKU.1RDFW%
M/D<U?2Z6M^56]6O"%.G6JTJ<(XB.'K*G*,4IZ1YK*UFUS*.G1]KZ_C3_ ,$'
M_P!B?P/^U9XR^/W[57[4G@%_C9I'AKQ%:>%?!=[\4M5T/Q]X0\>_%GQGI^O^
M(OC5K?Q%\'^(9-8U[QKXN\.:#X@\ :GINM>/(;CPK?ZC\3-8U^VM_$?CWPY9
M:UX%_=/]I[_@C[^P]^T#\&_$?PW\%? OX0?LV>-+F>'7/!GQ=^!?PA\!>!/$
MWACQ;IT%W%IL^OV?A/2_#,?Q!\$WJ7ESI_BWP!X@OX['6M,NFOM$U/PGXZTG
MPAXZ\+?F]_P;6?&WP%<?!SX^_LW&_:S^*&B?%)_CK'IE_=Z';KXB\!^,/"'@
M3X>SWOA6P_ME_$NKGP3X@\ 6T/CZ\_X1^VT/P[_PL'X;0?VQ>7_B?[%9?T>?
M$'QYX5^%G@+QO\3O'>IOHG@?X<^$/$OCSQEK*:=JFKOI'A3PAHU[X@\0ZFFD
MZ'9:EK>J/8:1IUY=+IVCZ=J&J7IB%MI]E=7<L,$GH9UB<9#.:_)4JTY4:E.&
M&A3<HJ$(QA[)4X+2TKJ5DK2<GIK8Y,MH8:66TN:%.<:L)2K2DDW*3;]HYR>M
MU:UV[Q459Z'\B/\ P;2_&GQPOQU^-OP+M=06[^%'C+X,M\;9-,O;O6[AM%\=
M^#O%W@'P98:IX9L!K2>&M)/BWPQ\0;FU\>7P\/7.N^(QX)^&UN=:L].\*)8W
MWEG_  <DHTO[<WPYB7&Z3]D/P#&N>!N?XO\ [0*C)YP,GG@URW_!N3\&]+\4
M_ML2>+M>\&ZWKMM\ /@%XH\0>%?&EO'XCA\.^"/B7XENO#/PMTJ+6-3TF2U\
M/S:UXM^&7BGXPV7A[PWXH:ZAU:RT[Q/XAT;2)M2\&KJVA=/_ ,')A*_MQ_#M
ME)!'[(/@(@@D$$?%[]H(@@CD$'D$=*^@BHKBMM)*4L%S5DK:5705]NKBHMNR
MO>]NK\AN3R!)MM+$\M-O7W%6TZ;*5UIII\E^F7C[_@Y6_9CL/">J7?PL_9Z_
M: \7>.X6TW^Q/#OQ$E^&OPT\'ZA'+JUA#K#:KXU\,>-/B]K>CO8Z%)J>HZ8E
MG\/==75M6M+'1;N71;/4;C7]+_';]C?]DWX]?\%F_P!K[QW^T7\>(M!N/A+-
M\1_#VK_M->,K+1-5\)^#O$5GHNF>'+&S_9M^&5IX7US1_$*:[<_##2?#?@=M
M8@\93^+/AE\/Y=(^(_CWQEXD^(.K^$K7XG?V'R_\$_?V#)XVBF_8D_9%FB<8
M>.7]FWX-21L/1D?P858>Q!KZZKYV.:X/!TZRRS!5*.(KTY4I8FO7]K.G3E:\
M:48QC%-VOS734E%M2227KO XG$3I/&XF%2E2FJBHTJ7)&<XK1SDVVTG?W;6:
M;UB?DY_P7&_Y1=?M,_\ 7S\"O_6D/A!7\S7_  3AM?\ @LE-\%/&#_\ !.S4
M;VU^"_\ PMG6AXMB@C_9+9/^%JCP7X!_MEL_'JPN?%^X^#CX$!_LR3_A&N!]
MC4:K_;)/],O_  7&_P"477[3/_7S\"O_ %I#X05\I?\ !MK_ ,F1?&'_ +.V
M\;?^J6^ -=> Q'U;AW$U?88?$_\ "FH^SQ5-U:6M"C[W*I0?,NCOIJ88JC[?
M.*,/:UJ/^Q.7/0GR3TJU-.9QEH^JMJ>+?!"S_P"#D*/XW?!1_C-JNI3_  :7
MXQ_"L_&*)H_^"?H1_A+_ ,)]X>_X6:KGPGIL/BT)_P (/_;V_P#X1.1/%.S/
M_".'^VOL->P?\'*,,,O[$_P2DEV[[;]K_P &3V^[&?.;X%?M$6S;,\[OL]Q/
MG;SLW?PYK^AFOS!_X+!_LO:A^U5^PE\4_#/A7PP?%GQ.^&,^E_&[X5:9#)XR
MFU.7Q-X!6]3Q/8>'/#_@FTU34?&?C+Q1\)M9^)/@GP-X0OM$U?3-9\9>*-!5
MHM*U&#3O$>B<&&Q].IFF7XBIAL)A*=*O24UA:3HT[.IK4J)SG=QO=NZ]V.SL
M==;"3A@<71A6Q&(G4IS<77J>TG=1TA%J,;*5K6MK)[ZGF/\ P0<^'_A'P;_P
M3:^%/B/PWI)T[6?BSXR^+7Q \?WAU#5+T:]XNTWXAZ[\*[+5EMM0O;NTT@0^
M _AIX)T/^S]#@TS2Y6T8ZK-92:UJ>L:EJ''?\%(_VUO^"DW[.?Q\\->!/V/O
MV3H?CK\+M2^$'AKQ;K/B^3]GSX^?%0Z?X^U+QG\1-&U?PV/$_P ,/&?A[PW;
M"R\/>'O">J?V#<V$FN61UDZA>7<MAJ^E0V_Y8_\ !O3^W1\-OA)K'CG]CKXH
M:OHOA"/XV?$72OB!\$O$]S8S6UEXC^*VM>'=&\#>)?A]XF\5SZ\^FV.I^*M%
M\'?#J/X/Z<?#>G6VM^([3Q?X9NO%=]XL\4_#/PCJG]A=:9E%X#.<7/%8:.)A
M4JUJU.%5S5.I3KR<Z<HRB[OV=^31V4H..EK*,$UB\MP\*%>5"4*=.G.5-1<X
M3I)1DFFK+GMS:K6,KZW/XS_B=_P7I_X*C?!W6H_"7Q5_9K^ ?PG\87NB0>(=
M.\._$[X#_M#^#-:N-$OKS4M-T_7H]"\1_'/1=4N]$NM3T?5K"#4($6TN;S2M
M2M(+HW%C<I%_1G_P4]_95U+]L7]BKXP_"'PII>BZC\3K:QTSX@?"%M4T+P]J
M]^OQ$\ :E;^(;'0?#.H^)=;\-:;X+U[XF:%;>(?@\WCN7Q!ID'A?0_B+K=]J
MHU70?[6T+5?YB/\ @X^_Y/[^'7_9G_PP_P#5T?M'5_;I6V9>PH8?)<PP>&IX
M2M6>(K25-R<>>A4H>S^)MM)W?2_,TS+!*K4JYG@\36GB*=-4::<U%/EJPJ<^
MRT;5N^JOO<_DV_X-JOVE5CU+X\?L?W6A[[?5+6?]J/PGXGTW3E,7VFT'P[^$
MGQ&TKQ7K,_B3+/=V<OPBN_A[I^C^$67R[#XE77B+Q(O_ !2VF/E?\'+_ .T+
M=?\ "3_L\_LQ6MYK5AH7AWPUK?[1GCRVNM&\.-X8UO4-:O-;^''PNU'3/$#/
M<^+H-=\%Z=X=^-<&OZ1#'HWARYTWQ[X?O+A_$NIVMLOA/XL^+'A/_AU%_P %
MH/"WCG5;7P3X>^$5E\9F^,O@^^A\$BU\)^$OV7_V@[OQCX(\<1>%/AI\,->U
M;7-'?X+>#O%'Q7^&/@;3[:RL[S6-9^&6E^*K+X=2^%==TOPG?>C_ ++>EV/_
M  4X_P""XOBSXVZ?XFT:P\!>"/B;+^TUIFK^%;?Q!X,U7QG\+/V9];^'GP_^
M ESIVA^-?#WB;4AK/BV?3O@=+\5M(\16W@ZXG\.:C\1)-!F\$>(!X<T6S]9T
M*4<R>?*-\'_9_P#:*WY?K3A['V-_^?G._:>4]+*QYZJU'@EE3E_M/UOZF^C5
M!24_:V_DY/=7>'5G] :_LSS?L>?\$8OBY^SK?:V_B'7? /[%?[2USXOU5=2&
ML:;-X^\;^!?B5\0OB#;>&=1/AOPC=7/@C3?&_BS7]-\!?VKX>L-=B\%V>@P>
M(#>:Y'J%_=?+_P#P;>?\F._%3_LZWQQ_ZJ'X&5^K7[>'_)CO[9?_ &:E^T1_
MZJ'QA7Y2_P#!MY_R8[\5/^SK?''_ *J'X&5XE.I*KD>95)OFG4S'#SG+O*:E
M*3^;;9ZDHQIYI@H15HPP=:$5VC'E27R2/O/XJ_\ !.S]@K5?CQ\2OVX?CY\/
M/"?B#Q%-X2TO6/'VJ?&/Q(;WX(^'=.^'?@+6_">M?$'Q)X/\4WR?#_RC\-5T
M2P\27'C>#5?!GAVV^''A?QKX>T;PIXRA\4^+?$7QW\<?A)_P0G^+_P &?B9\
M.O!OCC_@EE\'?%?CCPAJ^E>$_BW\.=5_9?\ #7BOP!XO:$W7A3QII^H^ ?%7
M@/Q'JD/AWQ+;Z;J^J^%XO%VD:5XVTFUO_!WB6:X\-Z[J]G<_B!^UQXJ_:)_X
M*G?\%4?%7['-G\4+_P"'O@#3/CYXU^$O@+P7XJ\0ZMXE^%?P^T_]F_3?B'I7
MC7XKVG@CPWI_AFQ\3?$;Q+HGAWXI>,=#364M_%$U[XUTSX-:I\6M(\ Z3IWB
M+0OU=\3?\&XW[!WA;1=>\7>*/VE_VLO"7A7PWI.I^(O$6O:W\0_V<-'\.>&]
M T:RFU'6-:UG6=8_9Q2TTK1M)T^VN;_4M3U*]CM+&S@GNKJXB@B=UVEAX8..
M">/S/&QQ$J%&MAZ&&A*K]7HNWL8\U2K"*:<6N2G'E3B_B33><:TL3+$K"8+#
M2HQJU*5:K7DH>VJ*SJ/EA3E)JSOS3=VFMFN4^??^#8JU@2[_ &X[Y8E%U<6_
M[,5K-,%&]X+.3]HB:VC9L;BL4E]=,BDD*9G*@%FSY-_P<D?"3X5?#?XA_LB>
M(_AW\,OA]X"\0_%&']K3Q)\3->\%^"_#GA;6OB)XB@US]G&_AU_QUJFAZ;8W
MWB[6H;[Q-XDO8M5\03ZA?1W?B#6[E)Q-JM^\_L/_  ;&?\WN?]VV?^]]K3_X
M.;OA]XPU+1_V,?BK9:.9_ /@S4_C[\/O$NO_ &_2XQIGC#XFVOP<\1^!]'_L
MN:^CUN\.N:+\)?B%>C4-/TV[TO3?^$>-OK%]I]WJVAP:GZ%23AQA9-QC*I14
MDG92O@(.S6B=Y.^N[\SCBN;AR[7,XQFTVKM6Q<KM=K173H?JG^QC^Q!^Q9XP
M_8X_91\3>+?V0?V7O%'B/Q1^S/\  O7?$WB#Q%\ /A1K>M^(M;UOX6^%M0UG
M6-=U74_"5S?ZOJNKW]S<WNIZAJ%Q<7=_=W$]S=S2S2R.U/\ X+=_\HO_ -IS
M_NB__K0GPGKWG_@FE\0_"'Q._8!_9"\2>!]6;6M%TWX#?#_X>WMXVFZMI1A\
M7_"/18/A1\0M)^S:S8Z=>2KH'C[P7XET)=2AMY-*UA=.&KZ#?:IH=]IVIW?@
MW_!;O_E%_P#M.?\ =%__ %H3X3UX5"=26>895)3ER9K224W)\O\ MD4TDWIM
MJM-CU:L81RNNXQBN; 3;<4ES?[/*S;6YYO\ \$J/BCH/P0_X(P_#GXT^*K'6
MM3\,?"'X;_M0_%#Q'IOANWL;OQ%J&@^ /B[\;/%>L6.@VNJ:CH^FW.M7>GZ3
M<6^EV^HZMI=C-?201W>HV5NTES%^"O\ P2%_9\U/_@H_^W'\2OCI^UY;Z[\>
MM ^'7A^S^)OQ%\0^)]8\-QZ+XM^,^N:[I.D_"?PCXZ\&JEO=:Q\/KKPWX>^(
M.K:7X'\):-IGPWT6Q^&/ASX?Z];6GP\O;+X>^*?VE_8(\#^+OB;_ ,$![KX;
M?#_1CXC\>?$+]G+]M?P/X)\/"_TO2CKOB[Q9XX^/^@^&]&&J:Y?:7HNFG5-9
MO[*R%_K&I:=I=F9_M&H7UI:1S7$?YF?\&V'QO\ >$/C;^T'\#]?U'^S_ !G\
M=/!OP_\ %'PYENKS0K/1]?D^#$WC^X\3^%-.>]UFVUG5_&=[H/Q(/C#1=#T#
M1=7$O@[P)\0_$&IW>E6GAU/M_LIRI4N*\10;6*CC)4^>.E2G0GC*BJ.+5I14
MH\SDT_\ EVG]D\UJ-2>0TJNM!X93Y7\$ZL</#D4D[J5GRI)K[;7VC^A+XL?\
M$J_^"??Q7^'7C7X>']E'X%_#&7QGI#Z<OQ$^"OPD^&GPN^*GA/4(IX+[2_$?
MA'QOX;\(P7]AJVD:G:6E\MEJ46K^&/$$$,_AWQGX=\3^$-6USP[JG\R'_!'O
M6O'G[+?_  5S\4_LJ^&_%\?BSP;K?C']HW]G;XG7EU:ZYH6E>*U^ %K\2]<\
M._$'3?!MCXMN]&TOQA;>*?AF]EHL_B";QJWA;P?X[^(?AW2KC[7XCGUV+^W>
MOX-_V$?"W@#]J/\ X+<GQ=H^@:]\3_A#K7[6G[3'[4FC:YINE>-]&MM&T;2?
M%GQ-^-7P5^)'BA;:VT+7?"6B6?Q,D^%2QV?C.'1]/O?$FL>'O ?BK3KR;Q$_
MAS4^/)ZM2K@LZI5YSGAE@*E5J;<XPQ"NZ,HJ3LIN4;Q7,N9P79-=.8PA3Q66
M5*48QK/%PIWBE&4J+LJB=E=QBG:]GRJ3[G[@_P#!R'_R8[\*_P#LZWP/_P"J
MA^.=<E_P2)_X(^_ ;PE\!_#7[0W[2OA#X;?M#>._V@O 'A;Q?X4\&>,?".E^
M-/A7\*?ACXML=+\8>&K#3_#/C'1YM/U[XI:_93Z3JGC?QKJ.D*/"S*GP\^'B
MV^DVGC/QO\6NM_X.0_\ DQWX5_\ 9UO@?_U4/QSK]6OV#_\ DQW]C3_LU+]G
M?_U4/@^HGB*U'AW"0I5)4U6QN(C4Y'RN48I24>9:J-]6DU>RO=%1HTZF<8B5
M2$9NGAJ+AS*ZBVVG))Z7ML[770_DU_X. /V,/@W^S=\9_@S\0?@UX3\'?#GP
M;\?? WBW1=<^$W@CPE%X9\):1XJ^$$WA33]3\7:796&J_P#"-Z7:^-O"_P 0
MO"6C7?A+POX0\+:38ZKX'U7QA?3^(/$?Q!UV[M?ZX_V,O'?C#XI?L??LH_$W
MXA:TWB7Q]\1?V:_@7X[\<>(VT[2M(;7_ !?XN^%_A;Q!XEUMM)T&QTO0],;5
M=:U"]OCIVC:;IVDV1G^S:=8VEG%#;Q_SK?\ !SM_Q^?L.?\ 7M^T]_Z-_9VK
M]_?^">O_ "8)^P[_ -F?_LT?^J7\%49A.57(LEJ5).=13QE/GEK+DC5<8QYG
MK91A%)=HKL+!I4\US.$$HPY<-+EBK1YG3C)NRZMRDWYMGU3X@\/Z#XLT'6_"
MOBK1-(\3>&/$VD:EX?\ $?ASQ!IMGK.@^(-!UFSFT[6-$UO1]1AN=/U72-5T
M^YN+#4M-O[>>SOK.>:UNH98)71OX5/VFOA+\*O#O_!>H?!GP_P##+X?:%\'W
M_:S_ &)_#;_"G1_!GAS3/ALWAWQ;\./V9[WQ5H+>!;+38/"[:+XFO->UR[\0
M:6=+-CK-SK.K3ZE!<RZC>/-_>%7\/O\ P4B/_#.'_!=2S^/7QG5O!WPGO/C-
M^Q[^T):^*E4^)6G^$'PY\*?!OP=XR\7)H'A'^W_$X.C^)?A!\1=,'AY]%7Q5
MJ3>'?M>D:'?V&KZ#=:H<-RDL7BH*4O>R_%.,4W[TTH6M%;R2O:RO:]BLYBGA
MZ,G%76+H)R:6D7)W5^B>E^FQ_7QX&_8__9*^&'BO2/'GPU_9<_9U^'GCCP^U
M\^@^,_ WP2^&GA+Q7HCZII=]H>IMI'B+0/#.GZOIK:CHNIZEH]\UE>0F[TO4
M+[3[@R6EW<0R?R=_\%W?CSXP_: _;N\+_L:Z%\1V\#?#WX6)\*/">I:?\4M5
MTWP9\$-)^.'Q5LH?$TGQE\3^)-#76]7D\&Z#\-?B;X"T+5_%'BS39;KX>6VB
M_$J7PEX;M=/\0:]JOC3^TZOX1/\ @L'X?TOX:?\ !7[QCXY^/_@77-=^"7C+
M7OV;/BI?^&_#&I:3/XG^)OP)\/\ @/X=> ?B#9^'H]-\5Z%?:+K6N:S\,?B?
MX&TBWUW7O!.L?VCI<>K6VH:9HM[HOB*X?#C]KF4IU93J5*6#KSHMVJ3]HN5+
MD4W9R4)5'%72OU2NR<Y7L\%&%.,80J8BC&HDN2'([M\[BM(N48)NST[Z(_HT
M^!WAO_@BM\!?@5-^SUX=^*O[!OC'P-KVD>%=.^)UY\4OBG^SAX_\2_''4/!N
MNWOBS0/$7QHU+6+\VGCS5='\7ZGJ?B;PQ8WVFP>%_A_>WBZ9\-?#O@SPUINB
MZ%IG\R_[=_B#X"?L1_\ !2KPE^T;^Q3XT\!_$/X9>']5^'G[2^G>"/V>?B+:
M:/X6\.ZA8ZYJNG_%#X 6OQ!\%Z_X\L]'T?XEVOA7Q(^N:'8Z-8>'?#OPY^,B
M_#JV^&]SX$T^SL=<_I[\-_\ !&C_ ().^,_#N@>,/!_P"T7Q7X2\5Z+I7B3P
MOXH\-_'WX[:[X=\2>'==L8-4T37] UO2_B_=:9K&BZQIEU;:CI6JZ=<W-CJ%
MC<P7=I/-;S1R-UFC?\$6/^"8^AZQI.MVO[+6CWMUHVIZ?JUM9^(?B3\:/%GA
M^[N--NX;V"UUWPKXH^(^L>&/$^BW$L"PZKX=\2:1JN@:W8/<:9K.F7^FW5S:
M2WA<QRS"5,14=7-L1]9I5:5:E7I8;DJNHDN:;^LR?,FE:5G)*ZV;3FO@\=B(
M48>SP%'V%2G4I3I3K<U-0>T%[!*S7V;I-V?1,_%#_@Y4_:'\47GQ.^!7[*"V
M"6/@'POX'L_VEM7U)Y=+O?\ A)O&OBC6/B3\*_"T:VLWAP:UX>E^'/ASPOX\
MV7>F>+)=.\6Q?%BYM]9\.V]SX-T/4KO]F_V0O^"1/['_ ,"?V?OA]X"^+O[.
MOP'^./Q<33;'Q'\5?B!\3_ /A#XR3WWQ-U72M.7Q7:>!M>\?^![._P!%^&NB
M7UJ=&\!:%I_A_P ,!= L;?7?$>F7OC[7O&/B/7?P4_X.4_ OBRU_:T^"WQ"O
M=*%MX&\9_LV67@7PUKYO]+E.I^+/A]\2OB-K?CC2AI,5^^MVH\/Z/\4OA[>M
M?W^G6FEZC_PD:6VDW]_=Z9K4&F_US?L^_'/P%^TO\%/AE\>OAE>M>>"OBEX2
MTOQ5I,-Q>:#>ZMH5Q=QF+6_!_BC_ (1G6O$6AV'C;P/KT&J>#?'6A6.N:H/#
MGC'0M<T"XNY+K39R)QTZE'(\FCAY2A1K/%5*[IR:YZ\9Q4>>2=VX_O$HO;E_
MN*U86,*F:9C*JE*I35"%)32?+2<&WR)WLF^5MKK*_P!K7XW^%O\ P27_ &*?
M@I^U5I/[7/PJ\ ZYX)\=>'[/Q?)X>\$Z-XLU2/X3^'?%OCM/%6F^)_'>@^$)
MC-=Z/J=SX1\:>(/ FE^"M/UR#X.^%O"UQ:+X3^&6AZYI>F:Y:?@'_P %\/AO
MXA^,O_!3#]F3X0>$IM$MO%?Q5^!WP8^&WAFY\2W=]8>'+?Q#XY^/WQC\,:+/
MK]]IFEZYJ5EHD6I:I;2:K=Z?HNKWUO8K/-::7J$Z1VDO];6J?&CX.Z'\3?#G
MP4UKXL?#31_C+XPTJ37?"7PDU3QWX6T_XF^*=#BMO$E[+K/ASP%=ZK#XJUO2
MH[/P;XONY-1TS2KJS2V\*^))VF$6AZF]K_,M_P %4_\ E.)_P3?_ .[/_P#U
MKOXB49%B,1/,76JU*E2I3P&(]G.JW-J-.FW!)RO>,6G;=;H,THT8X/V=.$(0
MGBZ//&"44Y3FE)M1M:35K[/9GZX?LL_\$AOV*?V=O@UX8^''C#X)_"/]H[QS
M9R2ZUXU^,/QJ^$7@7QCXF\4^+M1AM%U2YT"R\4Z=XG'P^\$V?V*UL?"/@#0M
M3N;/0]*M(;O7-6\7>.=3\6^.O%/\L_\ PJRX_80_X+B_#GX3_!KQ*+#2?"?[
M9GP/\.>$[LZ,-0DT/X2?M+W_ ((BU?X:D^-]4\>:AJD^C_!GXTZS\'[OQYJ.
MJS>*]:-O<^/K&?PSXEOK1='_ +W*_B"_;;_Y6'/"_P#V>3_P3R_],O[+U7DF
M)Q&(K9I&O6J5HU<LQ=2I&I)RC*:<$I.+TNE.25DK)M+0G,Z-*C3P#I4X4W3Q
MV&A!PBHN,7S75UJ[\L6[WNU?<_HC_P""W?\ RB__ &G/^Z+_ /K0GPGK\D/^
M"(?_  2>^$OQ%^'FD?MK?M'Z9X.^+NB>-4\8Z+\'/@GK>B0>(? >EV>D:[KO
M@#Q9X\^+&B^(--;2?&7BV[U;1==TGP1X1FM-4\'>$M%5?'=_<>)?'VM>%XO@
MY^M__!;O_E%_^TY_W1?_ -:$^$]'_!$3_E%_^S'_ -UH_P#6A/BQ65'$5L/P
MW4]C4E3=7-W1G*+M)TW@X3<5+=*4J<;V:;2<7HVG=2E3JYU#VD(S5/+E4@I*
MZ4UB914K/1M*3M>]G9K5)GX^?\' G["OP!^"GPV^!7[1/P*^'?PY^"CGQY<?
M [QGX%^&/@#3O!GA_P 9Q^)/#OBCXA>$/%<MAX:O]'\):-JW@M_!'C/2-0NK
M3P3<>(O'%KXZT>/7/%,.F_#GPYI,W[,?\$6_&OBKQ[_P3'_97UCQCJXUK4](
MT+XA?#[3+E=-TG25L_!?PI^,/Q#^%_PYT&.TT6QTZR>/PO\ #[P?X8\-1W\M
MO)JNK1Z2NJZ[?:GKE[J.I7?QI_P<E?\ )D7P>_[.V\$_^J6^/U?4?_!"W_E%
MK^S3_P!A/]H+_P!:=^,]&)G.KPY@IU).I.&8U:<)3?-*--TJDN12>O+>SM?H
MELDDJ$8T\ZQ,814(RP<)RC%63DITTI66E[-_>WNS^:W]GW2]2_X+(?\ !5Z;
M7?BI)\3?B!\!]4UOXC?$35-*UGQ#X8\#>)OAQ^RUX/N-<N_A!\.I;'1-4DM]
M'T9?$_B7X9?#?QKI?PJN[_QA>7WCKQAX_@\3+XFOO$_Q4MOZY_$7_!-G_@GS
MXGTG7](U']B;]EJS3Q)HVJZ%J.K^&O@;\.O!GBVWLM9LI["\N-!\<>$/#^A^
M,O"VM1P7,DNF>)/#&O:/XBT2^6#5-%U33]2M;:[B_DP_X(>>-]._9/\ ^"E%
M]\)OCU ?!'CCQ?X/^)'[*$]O<:WX.FT/PI\;;#QSX.U<^%_$'B5?$ZZ)=MJW
MB3X4ZI\,O"[>$+WQ7<^*?B/XD\&Z!H-K?VNN'5+7^Z>KXBJU:.+PU"C.=/#4
M<'A_JJIR<(.+3O4CRM)R;5G):VC'M<G)H0JX>M5JQC.O4Q-55W-*4KZ>X^97
MLD[\NVK/X0_A1X-\1?\ !-;_ (+9>"/@/\'?B!JWC/2=%^/7P@^"NJZIXMCN
M](G\5_";]I32?AS?:CX>\=Z9X-UG0-)\3ZYX/\-_$S2=6TZ^DMK'PAJ7Q5\!
M^%/B1_PK[3+:QL?!^G_MK_P<A_\ )COPK_[.M\#_ /JH?CG7X??M@>%O '[6
M7_!=;QIX#T_0->^+7PZ^)G[5GP(^$?Q)\-:%I7C?3M1O?#WP\\(?"/X-_M$6
M$G]D6VC>+]+T/P9;?#_XCS>(O&NC365CIGACP_JOCW2?$D7AFWMO$:_N#_P<
MA_\ )COPK_[.M\#_ /JH?CG7I5&YYGPU5J7>*JX2A+$-I*<GRMQG/KS2;G>\
M5:UKO9<<$HX'.J=/^!3Q%54DM8QU7-&/3E2Y;6;WOUN_T2_9T^*.@_!#_@E]
M\"?C3XJL=:U/PQ\(?V"OAA\4/$>F^&[>QN_$6H:#X _9ZT/Q7K%CH-KJFHZ/
MIMSK5WI^DW%OI=OJ.K:78S7TD$=WJ-E;M)<Q?RT?\$A?V?-3_P""C_[<?Q*^
M.G[7EOKOQZT#X=>'[/XF_$7Q#XGUCPW'HOBWXSZYKNDZ3\)_"/CKP:J6]UK'
MP^NO#?A[X@ZMI?@?PEHVF?#?1;'X8^'/A_KUM:?#R]LOA[XI_I2\)^!_%WQ-
M_P"",GAKX;?#_1CXC\>?$+_@F+HW@?P3X>%_I>E'7?%WBS]E6VT'PWHPU37+
M[2]%TTZIK-_960O]8U+3M+LS/]HU"^M+2.:XC_!__@VP^-_@#PA\;?V@_@?K
M^H_V?XS^.G@WX?\ BCX<RW5YH5GH^OR?!B;Q_<>)_"FG/>ZS;:SJ_C.]T'XD
M'QAHNAZ!HNKB7P=X$^(?B#4[O2K3PZGV_BPCE2P/$6(H-K%1JTZ?/'2I3H3Q
M$E4<6K2BI1YG)I_\NT_LG3B%&IBLFI5=:#ISGROX)U8TH\BDG=2L^5)-?;:^
MT?T)?%C_ ()5_P#!/OXK_#KQK\/#^RC\"_AC+XSTA].7XB?!7X2?#3X7?%3P
MGJ$4\%]I?B/PCXW\-^$8+^PU;2-3M+2^6RU*+5_#'B""&?P[XS\.^)_"&K:Y
MX=U3^9#_ ((]ZUX\_9;_ ."N?BG]E7PWXOC\6>#=;\8_M&_L[?$Z\NK77-"T
MKQ6OP M?B7KGAWX@Z;X-L?%MWHVE^,+;Q3\,WLM%G\03>-6\+>#_ !W\0_#N
ME7'VOQ'/KL7]N]?P;_L(^%O '[4?_!;D^+M'T#7OB?\ "'6OVM/VF/VI-&US
M3=*\;Z-;:-HVD^+/B;\:O@K\2/%"VUMH6N^$M$L_B9)\*ECL_&<.CZ?>^)-8
M\/> _%6G7DWB)_#FIY9/5J5<%G5*O.<\,L!4JM3;G&&(5W1E%2=E-RC>*YES
M."[)K3,80IXK+*E*,8UGBX4[Q2C*5%V51.RNXQ3M>SY5)]SUW_@LAXG\2_&?
M_@K+X/\ @7^T;KFL?"?]FKPGK_[/_P /?"?C"74+WP/H6F_!CXI0^!=;^,WQ
MUTO6_B'-K7PWAUC3/$WB'QYX5UOXFZ?H,'A*&S^#7A[PYXPL-4OOASJ[R_U5
M^/\ ]D+]A72_@1X\^'_CK]GS]FWP-^SU;S>*?BMXZT__ (0/P#\,O GA;6H_
M U[X:\4?&:;6M&L?#=MX#\::)\/TO+"7XP:=J6A>+O"_A^T\VT\4Z9;V$4L'
M\M__  5_U+3?VL/^"LNC?LW^-/'WP>_9L\ _"/PAX&^'>N_'+XKZGX0T/PW8
M:%J_@G_AH'Q?XU\3>,KK0O#&M.UOHOC-?!/PY^%WBWQ]>^#'\<:2EWH?B#X>
MW7Q@\;W]OZA;_P#!%?\ X+$6/@)/AM9?MQ>%(_AZG@Q?AW'\*?\ AKW]KQ?A
M3!X!30E\,Q^ [;P,?A9+X1M_!D7AY$\/Q>&X?"\>BQ:(#IL>GK9?Z,W5B*-.
MI@<EC4Q]/+I4L)&K[.7MK2C4J7CB*4J47%UI\O/*-U*+<;M7N\*-64,5F3AA
M)XR-3$.GSQ]GI*$$I4:D:C35.+=E*SC))V3MI\^_\&[5GX#\:_M>^// 'Q$^
M$'P>\=W4?P0MOCOX4\3^// .E>+O'WPS^('P6^*/PWTGPYJ/PP\1:U]JB\%J
M]Q\7+W5-?O-+TY->O==\,> -0L-:TL>')(=0E_X+-?!GQ9^Q7_P4C\&?M:^
MM!\$-X>^*/C'P3^TE\,-,G\-:9HW@^V^-/P5U?P3>_$/P[XFT#POXLL_$WB:
M35O'&F^%?B_XY\:&T\#3>+-1^,NI:98:AJ/B;0?$?B:X_I6_X)L_\$V/A_\
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MVOQ%O_&@T?Q)J7AAM!2VBKAY9-EV91E=5\9BG@:$FK-X6B^>I57]VM&7(_\
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M>)],^*FE-X]\:SF\TW6=5USX^Q_&A=<UWP[IE_K-K?#4?%<'B3R&Q_X)>?\
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MM>;DN9_:M=MVO:V.'P-'#S=12K5:CA[-5*]6562AHW&-[)+1=.B/Y ?VK/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M37O$EEINEMH/A_4=/US6%NCI^DWMK?W%O/'^)/\ P2._X*K?M7_M_?M!>//
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6/>$HR2]>5NS\GJ3T445B:!1110 4444 %%%% !1110 4444 %%%% !1110
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M-M^K=V?6QBH1C%;1BHJ_9*R_!!1112*"BBB@ HHHH _B,_X-LO\ D^+XA_\
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M7P%XUMO!/A#3? 8T+61-J'B0Z]\-?B4?%NERPZ3I:^"[J%];N/V$_P"">O\
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M-\0_ GQG-Y\,O!@\,ZG_ ,+$\$O_ ,(G_P *XO/&A\8^&C8?$C3_ (@^'_[
MN1X"%SXC_.C_ ()R_P#!9'_AWE\$?%/P6_X9XM/BW_PD_P 5-;^*'_"1W'QG
M_P"%=/9?VUX1\#^%/[$&B?\ "J_''VI;;_A"OMXU7^UK?SSJ1M/[.B^P_:;O
M^DG_ (+P_P#**[]I/_L8/V:__6KO@=7SE_P;>?\ )COQ4_[.M\<?^JA^!E>E
MA,1@H\/5I5,![6$,92A6I_6JT/;UN2#]OSQC>EI9>RC>.E[ZG%B*.*EF])0Q
MGLY3H5)4Y?5Z<O94U)WI6;M.[N^>5I*^B/U/_84_:F_X;4_98^&/[2__  A$
M/PX_X6/-X^A_X0RW\6?\)Q%H_P#P@_Q,\9?#K*^*/^$<\)?VDVI?\(E_:TB?
M\(_8?V?)?OIFZ]^Q?;[KY8_X)@_\%.Y_^"CO_"\/.^!L7P8'P;'PTV^5\4'^
M)'_"2'XA_P#"P-P8-\.? ']C#1O^$&7:0=6.I?VJV1I_V ?;?U?K^4O_ (-C
M/^;W/^[;/_>^UY-"AAJ^ SK%^QY)8>>"EA8^TJ2]A#$8J<)0O=*K:FE#FJ1;
MTYE9MGH5:M>EB\LP_M.:-:.)5=\D%[65&A&49VLW#W[RY8-+6SNDC^B_]J+]
MJ+X/?L??!SQ'\;OC9X@;1O"NA[;'2]*T]+:\\6>.O%=Y;W4^B>!/ FBW-W8I
MKGBW7OL5TUI:RWECI>EZ;9ZKXF\3ZMH'A#0?$'B#2OYA/&?_  <_>.C%X-7P
MY^RO\,_ -]%XRT&^\<6OC/XW:QX_B\1_#Z'[4/$OA7P;/8> ?A--X5\9:NS6
M:Z#X^U>S\;Z)X?\ LUU]O^&WB<WD0L/ _P#@MGXF^(7[57_!4KP]^ROX6D30
M+_P7'\$?V=?AK%XO\::]=?#B[\??'.+PQXW/Q%O=$T_0;T^ TU.^^*W@_P %
M^.;K0-(\5:[K.@?"S0-7GGU,VNB^&-#_ +./A+\)?AQ\"?AQX1^$7PB\(:3X
M$^'/@324T;POX7T9)OLMA:^=-=W5S<W5W-=:EJ^LZOJ5U>ZUXB\1:U>ZAK_B
M;7]0U/Q!X@U/4];U._O[CI]A@,MP>#K8O"O'8K'0=>--UZE"E0H:<CO3UG.H
MI7UT6JM%Q7/C[7%XW$XBGAZZPM#"R]DYJE"K4JU?M:3TA&%K::O1Z\S4/QS_
M &%_^"[/P%_:W^(^C_!KXB^ -3_9T^)?C/6+O3/AP^J^,]+\<_#;QE<M#H4?
MAWPP/';:-X'U+1/B/XNU*^URR\.>&-0\&'PYJTFC:9I.E^.[_P ;^+_#W@NY
M_7CX]?$]O@E\#/C/\9UT(>*&^$7PG^(OQ/7PTVJ'0U\1-X!\'ZQXK&A-K0TW
M6#HXU8Z3]@.J#2-5.GBX^UC3;[R?LTO\@W_!Q+^RU\$/@I\;_@[\6OAMX9/A
M;Q/^U3;?&K7?BYH6G201>"]:\4_#V\^%JW?CNP\/K: :/XL\<M\3KF;XAS6-
MW'H_BK6--M_%]QHL/C?7O'?B;Q=_0'JOQ8O/CG_P1>\9_%C5_&^C?$;Q3XT_
MX)R?$'4?'WC'0I?#SV6J_$^W_9YU[3?BE%<6WA."T\/:1K>D_$2R\3Z+XD\.
M:98Z;#X7\1:=JGAV32M*GTN73K:<7@<&X99CL)"=/#8ZM[&KAJDY3=&I"HH3
MC&K\4H32G9R?-9*5_>Y8&'Q6(4L;A<1*,Z^%I^TA7C!152$H<T7*"]U2BW&Z
M2Y=6K>[>7P/;_P#!QC\+$_9EU/XNZI\#+6W^.,_Q@OOAUX._9QTOXSIJ]QJ/
M@S1/#O@#Q)KOQ=\;?$ _"S3W^'_A8)XNUCP[X8L'\">(]0\9^+_#W]FZ&TFC
MV_CWQ#\-_G[P;_P<Z/=^)+L^+OV2]/NO!-[XTT,6]SX(^-(N_%/@WX>OI?AF
MS\2I/9:OX @T7XE>.+76(?&/B;0%_M7X1Z#J6FZGX8\#ZD^D7&BZK\1=?Y;_
M (-^/V!/A!\5TUO]MOXH%_&GB'X1_%6[\!?"+X=ZCIT(\)>$O&WAWPSX.\8R
M?%_5R]S<'Q9XKTU/&6FV7PXTZ\LK+1OA[K.EZEX[6#Q%XW?X?ZW\,/TP_P"#
M@'X)>!?B'^P)XC^+.NV;Q>.?V>/&G@'Q1X!URPM-"&HM!\0_'?A7X3>+O"&J
M:KJ&BZCK<?@K7--\867BG5-#\/:GX??5?&G@#X=ZKJMY>V/ALZ5>]U2CD=#,
M_P"S/J-6M[3$1H2Q#Q-6'L)U91C"%*FF^>%-RCS3J2<I/FM>*2ERPJ9I5P/U
MWZW3I\E)U8TE0IR]K&FFY2J3:]R4TI6C"*BER[2NU^O7PC^+GPU^//PW\(_%
M[X0>,-(\>_#CQUI8U?PQXIT225K2^MTN)[&]M+FVNHK;4='UO1=5L[_0_$GA
MS6K/3_$'ACQ%INJ>'?$6F:9KFEZAI]MZ-7\_'_!MWKFNZK^PY\4]/U?7=;U?
M3O"_[5OCK0_"NG:KJU_J.G^%="NOA)\#O$]UH/ABRNYYK;0-$NO%/B/Q+XIN
M=)TJ.UL)_$WB7Q%KTL#:KK>I75S_ $#U\YC</]4Q>)PRDYJA6G34GNXQ;Y6]
ME>UKVTO>Q[6&K.OAZ-9KE=6G";2V3DDVEY7O;K;<^!?^"CO[%/B']OCX!:5\
M"=%^.6I_ JQB^)/A[QQXHU2R\*7WC;3O&^B^&]$\46]CX(\1^&;3QW\/X=1T
M>/Q=JWA?QY;G4=4U"TM/$/@70KV'2O[4M].U;2?Y[O\ @KK_ ,$T_P!E?]@S
M]A[X:ZE\%O#.OZM\1/$O[3O@SPWXH^+WQ&UT>)_B'KGAM?AU^T?XEM/#\365
MCH?@[PGI$$]WIEAJ-GX \'^$4\7VWA#P3?>/?^$K\0^%]+UR+^PNOY[_ /@Y
M*_Y,B^#W_9VW@G_U2WQ^KTLDQ>)6-P&$56<<,\6JDJ4;1C.;2NZG*E*I;EC9
M3<E%J\4F<.:8>C]5Q6(=.+K>PY%4=VXQ3VC=M0W=W%)N^K9]6_\ !#G_ )1=
M?LS?]?/QU_\ 6D/B_7UU^W5H.L>*OV(_VQO"_A[P]K?B[Q!XD_96_:%T'0_"
MGAK1[_Q%XC\3ZQK'PD\7Z?IGA[0/#^E6]WJFN:WK5[<0:;I6CZ;:W-_J=]<P
M65G;S7$\<;?(O_!#G_E%U^S-_P!?/QU_]:0^+]?J3XD\2^'?!GAW7_&'C#7]
M%\*>$O"FBZKXD\4>*/$FJ6.A>'?#?AW0K&?5-;U_7];U2>UTS1]%T?3+6YU'
M5=5U&YMK'3[&VGN[N>&WADD7CQ\G#-,9-*[CF&(DEW<<1-I?.QTX-<V PL6[
M*6#H)M=+T8J_R/XS?^#=+XW_  (^&?Q_^-WA#XFZEX.\+^/_ (N^"?AIH_P8
M\>>+;SP-H4%S<6OCJ?1/$/P>\,^)_$.M:?XDO/&/Q@\1>./A=J7AOX?^$;#5
M8_&S_#2ZO-2$.I>&/#%OJ'["?\'!?C+X/:7_ ,$__$/@3QSJW@Z+XL>-_'OP
MUU+X :'K6FV^L>+9_$7@GXB^#]2^)'B/P7$+&_OO#?\ 9/PAU'QIX8\1^.$;
M2-,L]-\=P^!+[7$OOB-HVA>(/YW?^"B'B+]E/]NG]M"PT;_@G=\(/B#XS^)?
MQSU+PK%J&OZ1.?!O@+XO^/-6TKQ3KGCW5M)^!7C+X=Z%XO\ "FL)I\^@ZU\3
M_BQXJ\<>!O",3>#_ (D>+_%WPQMHY=>^-OBGY>^/_P #?V@_V:/VAO GB_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO3O!_P 2(=.L@J2H,QX)W <8Q@'/3_\ 7]/-/B3XVM[V*=S(A+*Y)!'<<_\
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M_B-\)=%^#/BWP3;>-YK;PCX-U.\@?4_'#>']4\/Z-::?XLUN/P_I6JU^S?\
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MW34X5*3M-O52I3^)K73?JQ<JKDZ<LN6,H.*Y6ITKJ>S4H5%>-MU..WKMQO\
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M (6)_P *6_X9_P#^$5^Q_9?^$:_X0O\ X1O_ (N#_P )]_PDO]N?VY_Q0/\
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M? =YH?B_2]-U7XPZ]X]^&'Q)TG1?'4'BSP;XB^'NK/\ #CX:_$?0_%>C:O\
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M)H=Y%H9U6#3-9T;\/(/^#7O3[5_-M?VS;.VDVE?,@_9B@A?:<$KOC^/*MM)
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MZ?2])U/7]+\':)/J>C>#-)\*^"[?48[J[T/PMH_VVYCD_#SX\_\ !NNOQO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<-3PE)4J=VDW*4I?%.3M>3MIT226R270****P.@**** "BBB@ HHHH ****
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MGQ%H6J0-:ZGHNNZ=9ZOI.HVSXWV]]INH0W%G=P-@;HKB&2-L#*G%?EW\>?\
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M[,*?LF?L7_"'X:WVG#3_ !MK>DCXD?$U7MUMKUO'OCBWM=2U"QU.-))4:_\
M"^DIHG@J66.1TEC\,PR*S!MQ]RA_L63XC$[5\SF\'0?586DU+%37]VI*U&6^
MJ6AY=7_:<QHT=Z6"C]8J]O;STH1?]Z,;U%Y-^1]_4445X9Z@4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *S]6TC2M>TV]T;7=+T_6M(U&![74-*U:RMM1TV_MI/OV][8W
MD4UK=0/@;X9XGC;'*FM"BA-K5:-:IKH!^6OQY_X(U?\ !/WX]+>7=U\&+?X4
M>(KN)81XF^"%ZOP\N+1%);-MX6@M-1^''G,YW/<W/@FYN9"-KS&-G1_R-^*G
M_!OY^T1\.EGO?V3/VJH-<TA+^YU6+P'\2%UKP3<1%+98K>WM]6T"7Q/X;\1:
MG.L:V\EQJFA>$K-XO(6:5?LB._\ 5Y17J8?.<QPR48XB56GM[+$)8BG965DJ
MJE**T6D)1."MEF"KW<J$82?VZ7[J5^_N63?^),_@F^)O@C_@HU^RI%,_[0G[
M.OB^Y\+Z9$9=1\<Z-H\6N^&X8BY6$W/CKP%+KG@>R>1/WBVMX;>^,?F-+'&\
M%PD7U!^QU\:_^":GQ!U_2Y/VG/C5\4?!^KQ7-B/^$)\6> 7\*> -1U&24[M.
MOO'7@W7_ (@:G=Z,ORBZOM4@^&*Q2!TDN3;['N?[.:^)/CO_ ,$X_P!B?]I#
M[9=?%']GKP%=:_?3/=W'C#PMI\G@+QC/?M&8UOM0\2>"YM"U+6YH@04B\02Z
MM9OM59[6:,;#Z*SK"XB'L\5A*F&E+>OETXP?3:C74XJVKO&HG9V5GJ><\FG2
MDIT*M.NHNZI8R,G'YSI.-]%:SIM=T]C^>5!X2\$_$;Q1X<\&^-?"_P 0/"&F
MZU=?\(IXQ\(>(-+\3Z%XA\,W$\DVAZC;:OHUW>V$T[V1C@U2WBN9'T[6+?4=
M,N=MU93HGVAX#^(D5A;Q,DP!"CH1Z9R>?R/?J/0>8?&3_@W+T;3[FY\2_LE_
MM*^+O FM6T,LFD^'/BA VH6YOI'\P(OQ#\#0Z)J^BV*86*(#P3X@O5C6&26Y
MN)X7DN/S3^)GPC_X*K?L6WES:_$?X6:I\4O!6GLT5OXT\/:5+\0/"]S96[,9
M+]/$OA*.V\0Z7]HB1YH_^$WL;*_BA!GGTQ$AECC[HTL%CDEA<?1J5+*]+$1>
M&JMJRT4[PG)[OE;7I8X7'%X&4G5PLU3N[3I-58)/75QU22T3DHMVU1^O?CSX
MB17]O*SS DJ<\CTR2.3Z]3]3W!_/CXG>(H7O8[J/+S6UQOBV9,C;_E>-0/F8
MR< +C)95[J*^-M*_X*$>'];4V/C'P[KO@^_W-%*\;#6M.C,9*NT[QPV.IPON
M'$":7<E"'1I20ID_87_@F3\#?AI^TG\0=$^,'B;XI_#+Q!I'@ZZA\2>&_A#I
M'C3PYK7CW6M3T^7SM/UGQKX/M[V;6/#?AC3+J-+R&PU>QM[_ %B\MDCN[:VT
MJ)_[2FKAJN7TY5<13G"$5I9<RD[:)2C>-WIUM;5Z7:R526/JPHT;.4FM6[<L
M=+R=VG:.]MV](ZGC<.J^*OACX@U#P=XWT;4_"WB?0YUMM4T76()+2]M9"JR1
MN4D 66WN8GCGM+F$R6UW;2Q7-K-+#*CMVUU\7 UJ4^U?P]V(' QU+8_/H>*_
M67_@K7IWPFT#]BGXX_%_QUX3M-2\7^"/ \VE?#KQ+923Z;XIT'Q?XSU.P\(>
M%[G3M5T^>TOKBRTSQ!K]EKE[I%Q+<:9-;V%Q<7-HPB:5/YEO^";7BWX5_M0^
M,=+^ GQV^->M_"CXCZM/;6'P[\0W&BZ=JOA_XC7#,$7PG>:K=ZKI0T'QQ.H6
M+0'O8[^T\73N;!98/$@T^Q\2YX6$L7@JN.5*484)\E513F[J,)RE!13E*,5)
M.6EXIW=TG);8FE/"XF&%C5C-U8\U.\E3T<K1C-RM!3;BTO>M*VB3<8GNWCWQ
MZVH,T$+///,XBAAB#232RR,$CBBC0,\DLCD*B*"SL0J@YK]A/ G_  3XUR__
M &$1X8U/3(M.^/6M^(7^->FVNH*+2\TK6)=-M]-T_P"'^H7$HCEMFO?"%O\
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MN#,\Q%)/W98?#*M4LVDKT:52=6_?EA**NW>R=OT[^(WC^.ZCFS,#PW\6>H/
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M/X9)24K::,_I HK\\/V"?^"E_P "?^"B7_"UO^%*>$_BWX7_ .%/_P#""_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;_@Z%_8"'3X2?M?MS_#X ^#7Y_-\?E_Q]J;_ ,10W[ ?_1(?VP?_  @/@O\
M_1 5_!Z$/?C]?ZTOE^_Z?_7K3_B%/"/_ #YQ_P#X6S_^1/IXYYF,59U83?\
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MOZ!_;V8?S4O_  4O\S^\'_B*&_8#_P"B0_M@_P#A ?!?_P"B H_XBAOV _\
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M *)#^V#_ .$!\%__ *("OX/O+]_T_P#KT>7[_I_]>C_B%/"/_/G'_P#A;/\
M^1_J_H']O9A_-2_\%+_,_O!_XBAOV _^B0_M@_\ A ?!?_Z("C_B*&_8#_Z)
M#^V#_P"$!\%__H@*_@^\OW_3_P"O1Y?O^G_UZ/\ B%/"/_/G'_\ A;/_ .1_
MJ_H']O9A_-2_\%+_ #/[P?\ B*&_8#_Z)#^V#_X0'P7_ /H@*/\ B*&_8#_Z
M)#^V#_X0'P7_ /H@*_@^\OW_ $_^O1Y?O^G_ ->C_B%/"/\ SYQ__A;/_P"1
M_J_H']O9A_-2_P#!2_S/[P?^(H;]@/\ Z)#^V#_X0'P7_P#H@*/^(H;]@/\
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M^B0_M@_^$!\%_P#Z("OX/O+]_P!/_KT>7[_I_P#7H_XA3PC_ ,^<?_X6S_\
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M_HD/[8/_ (0'P7_^B K^#[R_?]/_ *]'E^_Z?_7H_P"(4\(_\^<?_P"%L_\
MY'^K^@?V]F'\U+_P4O\ ,_O!_P"(H;]@/_HD/[8/_A ?!?\ ^B H_P"(H;]@
M/_HD/[8/_A ?!?\ ^B K^#[R_?\ 3_Z]'E^_Z?\ UZ/^(4\(_P#/G'_^%L__
M )'^K^@?V]F'\U+_ ,%+_,_O!_XBAOV _P#HD/[8/_A ?!?_ .B H_XBAOV
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M&_8#_P"B0_M@_P#A ?!?_P"B K^#[R_?]/\ Z]'E^_Z?_7H_XA3PC_SYQ_\
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M_8#_ .B0_M@_^$!\%_\ Z("OX/O+]_T_^O1Y?O\ I_\ 7H_XA3PC_P ^<?\
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M*&_8#_Z)#^V#_P"$!\%__H@*_@^\OW_3_P"O1Y?O^G_UZ/\ B%/"/_/G'_\
MA;/_ .1_J_H']O9A_-2_\%+_ #/[P?\ B*&_8#_Z)#^V#_X0'P7_ /H@*/\
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M8/\ XA-\%_\ Z8'7PEY?O^G_ ->CR_?]/_KU]G[3,_\ H=8__P )\G_^=?\
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MAOV _P#HD/[8/_A ?!?_ .B K^#S8WI_+_&C:P['^?\ *O._XA3PC_SYQ_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%%1A2ITU&$(125HQBDET/$!H#D9VD?A_]:I!X>8]N?\ =;_ZU?0T/A%B%_=
M=?4\_D1[=JO)X.Z_N@>G^>3Q^M9O"I:67K\TN_G_ ,-TZUQC-V_>/HU;_MW_
M "_3LSYL_P"$=?L&'_ 2/YU,/#K@#Y7/_ <YS[@U]*CP:W7RN#ZX_KG_ #ZU
M*O@XC'R#G&>!QZXXJ'A8^7]<OW;??\T-<83T_>/IUM_+UMZ??VL?,X\..?X"
M/JI'_LU._P"$:?T'^?\ @5?3@\&'O&I_X#C^M.'@T?\ /(?Y_"I^JQ_X;_MW
MS]?N7S%Q?+3]Z^G6_P#+Z>7WGS#_ ,(T_H/\_P# J/\ A&G]!_G_ (%7U!_P
MA@_YYI^?_P!:C_A#!_SS3\__ *U'U:&GR_\ ;?/^K+RN_P#6^6G[Z73K_A\_
M3[SY?_X1I_0?Y_X%1_PC3^@_S_P*OJ#_ (0P?\\T_/\ ^M1_PA@_YYI^?_UJ
M/JT-/E_[;Y_U9>5S_6^6G[Z73K_A\_3[SY?_ .$:?T'^?^!4?\(T_H/\_P#
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M5S_6^6G[Z73K_A\_3[SY?_X1I_0?Y_X%1_PC3^@_S_P*OJ#_ (0P?\\T_/\
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M_P"V^?\ 5EY7/];Y:?OI=.O^'S]/O/E__A&G]!_G_@5'_"-/Z#_/_ J^H/\
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MSMZZ&?\ KO;_ )?=MFW_ "?U_P .>4_V3[?I_P#7H_LGV_3_ .O7JO\ 8_\
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MTX553JT_3RKQ+K97B85H5/:T6XJOAIR?)6A[B:O9\E1*_LZB3<7NI0E*$O\
M5ZHK\5/^"-'_  4@D_;,^$<WPK^*VJ";]I'X.Z+9CQ'?7#*LWQ-\$1S0:9IO
MQ$B4!2=:M;F:ST;QU$BF(:Q<Z;KD3Q1>)4T[3?VKK^,<\R7'\/9IB\HS*E[+
M%X.IR2M=TZL))2I5Z,FEST:]-QJ4Y63Y9)249J45_2639O@<]RW"YIEU55L+
MBH<T7ISTYI\M2C5BF^6K2FI0J1NU=7BY1<9,HHHKR3TPHHHH **** "BBB@
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MZ)?>(O$FK?V9HMEJ.LZC_9NC:=>WGV#2=/O]3O/)^SV%E=74D4#_ !Q^P_\
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M'06)Q%..89E@\KI58T74INI"E7QM*I64).HJ$:DJ5.K44*4_VNHK\@?V/O\
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M]XNGVE_<\_3[_(\"_P"$77_GB?R6C_A%U_YXG\EKWW^P%_YY-^9_QH_L!?\
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M_GDWYG_&CZC+^5].G^'^OD^RL+.ZFG[Q=/M+^YY^GW^1X%_PBZ_\\3^2T?\
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MW4T_>+I]I?W//T^_R/ O^$77_GB?R6C_ (1=?^>)_):]]_L!?^>3?F?\:/[
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M6(P>88',*<JN QN$QU*,N253!XFCB:<9K>,IT9SBI+^5N_D%%>3^+?CW\#/
M/C?PW\,_'7QH^$_@OXD>,FT1/"'P^\6_$7P?X<\;^*G\3:U/X:\-KX;\*:QK
M%GKVN-X@\1VMSH&B+IEA='5M:MY]*L!<7T,D"^3_ !0_;J_9 ^"WQ4\/?!3X
MI_M"?#;P3\2O$1UD?V#K&M;+3PI_8GAC3_&4O_"T/$MO#/X5^#XUCPWJNFZA
MX./Q6UOP8/'K7D%CX(/B#47^R5='+LQQ,H0P^ QM>=2C/$4X4<+7JRGAZ?\
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M%X>>+A;GOSX:-1UHV]G._-!6Y)_RNWK%%%%<9W!1110 4444 %%%% !1110
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MTZ-?@C]3\%LTKYCXE<-T:JO3I5,?BVF_M83*\97HM><:\*4EVY4_3Y>BT#)
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MPLF'_G@/S3_XBCV.<?\ 0/#\/+_)_<@^L9)_T$5?O?EY^;^]'C?_  J#4_\
MGD/^^6H_X5!J?_/(?]\M7LG_  LF'_G@/S3_ .(H_P"%DP_\\!^:?_$4>QSC
M_H'A^'E_D_N0?6,D_P"@BK][\O/S?WH\;_X5!J?_ #R'_?+4?\*@U/\ YY#_
M +Y:O9/^%DP_\\!^:?\ Q%'_  LF'_G@/S3_ .(H]CG'_0/#\/+_ "?W(/K&
M2?\ 015^]^7GYO[T>-_\*@U/_GD/^^6H_P"%0:G_ ,\A_P!\M7LG_"R8?^>
M_-/_ (BC_A9,/_/ ?FG_ ,11['./^@>'X>7^3^Y!]8R3_H(J_>_+S\W]Z/&_
M^%0:G_SR'_?+4?\ "H-3_P">0_[Y:O9/^%DP_P#/ ?FG_P 11_PLF'_G@/S3
M_P"(H]CG'_0/#\/+_)_<@^L9)_T$5?O?EY^;^]'C?_"H-3_YY#_OEJ/^%0:G
M_P \A_WRU>R?\+)A_P"> _-/_B*/^%DP_P#/ ?FG_P 11['./^@>'X>7^3^Y
M!]8R3_H(J_>_+S\W]Z/&_P#A4&I_\\A_WRU'_"H-3_YY#_OEJ]D_X63#_P \
M!^:?_$4?\+)A_P"> _-/_B*/8YQ_T#P_#R_R?W(/K&2?]!%7[WY>?F_O1XW_
M ,*@U/\ YY#_ +Y:C_A4&I_\\A_WRU>R?\+)A_YX#\T_^(H_X63#_P \!^:?
M_$4>QSC_ *!X?AY?Y/[D'UC)/^@BK][\O/S?WH\;_P"%0:G_ ,\A_P!\M1_P
MJ#4_^>0_[Y:O9/\ A9,/_/ ?FG_Q%'_"R8?^> _-/_B*/8YQ_P! \/P\O\G]
MR#ZQDG_015^]^7GYO[T>-_\ "H-3_P">0_[Y:C_A4&I_\\A_WRU>R?\ "R8?
M^> _-/\ XBC_ (63#_SP'YI_\11['./^@>'X>7^3^Y!]8R3_ *"*OWOR\_-_
M>CQO_A4&I_\ /(?]\M1_PJ#4_P#GD/\ OEJ]D_X63#_SP'YI_P#$4?\ "R8?
M^> _-/\ XBCV.<?] \/P\O\ )_<@^L9)_P!!%7[WY>?F_O1XW_PJ#4_^>0_[
MY:C_ (5!J?\ SR'_ 'RU>R?\+)A_YX#\T_\ B*/^%DP_\\!^:?\ Q%'L<X_Z
M!X?AY?Y/[D'UC)/^@BK][\O/S?WH\;_X5!J?_/(?]\M1_P *@U/_ )Y#_OEJ
M]D_X63#_ ,\!^:?_ !%'_"R8?^> _-/_ (BCV.<?] \/P\O\G]R#ZQDG_015
M^]^7GYO[T>-_\*@U/_GD/^^6H_X5!J?_ #R'_?+5[)_PLF'_ )X#\T_^(H_X
M63#_ ,\!^:?_ !%'L<X_Z!X?AY?Y/[D'UC)/^@BK][\O/S?WH\;_ .%0:G_S
MR'_?+4?\*@U/_GD/^^6KV3_A9,/_ #P'YI_\11_PLF'_ )X#\T_^(H]CG'_0
M/#\/+_)_<@^L9)_T$5?O?EY^;^]'C?\ PJ#4_P#GD/\ OEJ/^%0:G_SR'_?+
M5[)_PLF'_G@/S3_XBC_A9,/_ #P'YI_\11['./\ H'A^'E_D_N0?6,D_Z"*O
MWOR\_-_>C]C_ -FC_@G9^RGK_P "/ACXA\=_#63Q;XO\0^&;77=>US4/%OC7
M3II[[5I)KYK6.Q\/^(M'TJVL]+CFCTNQ6"PCF>TLX9K^:\U"2ZO+CW3_ (=K
M_L3_ /1$+7_PNOB?_P#-K7MG[+ER+W]G;X,W@&!=_#_P]<@>@GLDE XQTW>E
M?SF_'OQ#HT?QY^.D6JZ/I^IWL/QI^+$+WE]:6EW<O##\0/$45G$T]S!+*8K6
MS2"TMHRY6"V@B@B"11HB_P 6Y%D_%7'G%^>Y3@^(,=A\3AO[2Q\ZF(QN.J1]
MEA\RH8-TER5KWB\534/LJ$.565K?WAQ#GG!_AWP3PYG6-X:R_%87%K*<MITL
M-@,OI357%97B,:JLG.AROF6#J<_VI3J<S;U/UO\ CO\ \$\OV1O#/P1^,/B7
MPI\'XM+\4^'?AAX\U[PSJ,/C#XC7\MGXAT?POJFHZ+<)87GB^XM;XQZE;6Q^
MQ7$$T-X,VTD;K*0?Y[_^%0:G_P \A_WRU>D?\)%X4W1/_P (OH6^"XMKN!O[
M*TW=#=6<\=U:7,3?9,QW%K=0PW-M,A$D$\4<T3+(BL/T-_X)^>!H?C5\87\2
MZG#,/#'PDALO$U[;(+*2UU?Q+J7VZR\(Z3J:S0-=+907%OJ7BJ.33Y;:1]2\
M*Z=8WLD^DWVH6%[^Y9+E'$/A/PUQ)G'$&9U<[PM-83$TJ$JU9PHUE/ZI"%*>
M*G-TZF.Q&(PM&I.*:4:-&7).4>1_S[GN=\,^,O%7"N1\-Y12R#%U'C,+6Q$:
M-",ZU!QCC9U*L,'&FJM/+\+A<97I0DTW.O5CSTXS<UG_ +-'_!)>Y\9Z=H7C
MOX]:]K7A'0M0M[;5+/X;:+8+IOC.\MI)K*]L?^$JU768;C_A$X;NTCN;75O"
M\>@R^*$MM119=9\':[ITUK7ZB:!^PM^QIX!TI[:'X(^ 6LFF+R7WC1[[Q;=&
M::::8@:MXUU/6;N%7DFD$5K!<PVT40BMK>"*VMK>&+2_;"_:6M/V:?AG#KEK
M;Q:CXR\5:B_A_P ':?,T)MX;I+62[U'7]1ADGBFFTO1+=8EDCM4N))M5U'1K
M.>.&SN[F]M?YZ/%'QT\0>-=9N_$/B[5]5\1ZS>RSRS:AK&H37TR+/=7%Y]DM
M//WQV&F6\UU,-/TFQ2VTS2[=EL].M+6TBB@3\WR')/$?Q<GB<_Q.?8C*<GAB
M:F'H1PL\5#"QKTZ<92IY=E=/$T*<J5&-2%.MC*^)]M.3Y'5Q56E65+]2XCX@
M\+?!6&$X;PO#F&SK.YX6EBL1+%0P=3&2P]6HX*KFF;UL+B*L:U>5.=6A@</A
M?80BN=4<'1K8=UOW_P!>_83_ &,O']AL;X+>!HX$9DCOO!5Q?^%I8IT2103=
M>#]3TM;B2+[1YA@O/M,#L(#<02K%$J_CA^VQ_P $]M _9_N_#7B/X:ZYK6K^
M#/%=WJ&GR:5XC^RW.J^'=5M(8;R&%-6L;>QBU+3K^WDNA:+-I\%[8KIY2ZO-
M3>X^T1_/.G_%>[T?4(]8T2\U30=;@M+VQM->\/ZK>Z%K]C:Z@(1>Q:=KFD2V
M6K:=]H-O;/(]C>6\GFVUM*'$MO"Z>K^/_P!L'XD_%+PKX8\*>/\ 6AXDA\*Z
MCK.H6>K7%G86>L:@=5>-;.WUB33+:QTZ]3P]8H=,T>\&FPZM/:S7$_B#4M=U
M2>346^\X<\//$OA//L!5PO$-7.,AG7?]I87%UZ\+TYT5&=18'$U<71C54U#D
MK8?$JNU2I\_[N]-?G7%'B=X4\9<.9A1QG#%/).(Z="/]E8O!4,-4<:D*ZE"E
M_:.%I8*O*DX2FYT,3A7ATZTW#]YRU"+]AW]E'P3\6/CO8^'OBOI5SK/A"P\,
M^(==GT."_O\ 2H=8OK6.VL;&UO[[2Y[/58K.WDU)M4"Z;?V,TUWI]I#<32Z?
M)>V=U^T__#M?]B?_ *(A:_\ A=?$_P#^;6OSV_X)O>+8]>_:)ELTB"&/X?\
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M(?\ ?+4?\*@U/_GD/^^6KV3_ (63#_SP'YI_\11_PLF'_G@/S3_XBCV.<?\
M0/#\/+_)_<@^L9)_T$5?O?EY^;^]'C?_  J#4_\ GD/^^6H_X5!J?_/(?]\M
M7LG_  LF'_G@/S3_ .(H_P"%DP_\\!^:?_$4>QSC_H'A^'E_D_N0?6,D_P"@
MBK][\O/S?WH\;_X5!J?_ #R'_?+4?\*@U/\ YY#_ +Y:O9/^%DP_\\!^:?\
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M@C=O!/B_4SI?A]3OFM4NO!.M^)/%'B(C-K\+?"VAV0>1PW][?0]\'_$/PT\
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MMJFH7LSW-W>ZAJ%[+/=W=W<W$LD\]Q/+)+++(\CLS,2?M[]CG4U^#WCCX/\
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MXA_]'TXO_P#$>X2\O^I;Y?CZW_FV_P"'KW_!4C_I%1\4_P#PT_[1'_S&T?\
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MXA\03W_Q!N]3\/6WPVTR.\\?W'BOPE#X;?Q-I7]#?_!&+_E&M^S=_P!UA_\
M5]_%*OR]_P"=E/\ S_T8367#&+^H>(GC/CO88?%/!9%XB8Q8;%TU6PN(>%SW
M#UU1Q-)V56A5=-0K4VTITY2CU-N+,&LQ\,? G+WB,3A%C^(O#'!2Q6#JNAB\
M-'%\/8G#RKX6LDW2Q%)5'4HU4FX5(QE9V.X\"?\ !N;\*#\'=%M_B-\>OB9I
MOQ_E\&WB:Q??#]?!E[\#-!\=7EM>R:5%IGA/Q#X"L/B%XL\'^$[BXTW3KYY?
M'O@/5O']MH]UJ]K;_#%]?BT+P[\+_P#!%3XX?&[]G?\ ;K'[&_B^QUFR\/\
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M%J_A_P 4Z1JLO@G6?'-EXOA\.ZMHESI?BB71$\.:A/IUGJLVIV?P+_P<E?\
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M9F>!5"CBOKF78;#SKXS"_5L3*&&Q#Q&&A5I>PKSA0K<_LZLHTY2:YS_ATO\
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M2/"&@O<--;Z9:S/%;-J6HNOEOK?B":TM+C6[Y//6RTS3HM-T;3/!_P"WXO\
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M=MJ&I36UI/K^OZ)HT4S:CJMA;7'ZF_L=Z)K7AG]D;]EGPWXDT?5?#WB+P_\
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M?C_QX?X4?6H_TO\ @^:^\/[/J?\ /J?3[+_N_P!?+RU^O?\ A-O^FQ_[[/\
MC1_PFW_38_\ ?9_QKY"_X3)O^?C_ ,>'^%'_  F3?\_'_CP_PH^M1_I?\'S7
MWA_9]3_GU/I]E_W?Z^7EK]>_\)M_TV/_ 'V?\:/^$V_Z;'_OL_XU\A?\)DW_
M #\?^/#_  H_X3)O^?C_ ,>'^%'UJ/\ 2_X/FOO#^SZG_/J?3[+_ +O]?+RU
M^O?^$V_Z;'_OL_XT?\)M_P!-C_WV?\:^0O\ A,F_Y^/_ !X?X4?\)DW_ #\?
M^/#_  H^M1_I?\'S7WA_9]3_ )]3Z?9?]W^OEY:_7O\ PFW_ $V/_?9_QH_X
M3;_IL?\ OL_XU\A?\)DW_/Q_X\/\*/\ A,F_Y^/_ !X?X4?6H_TO^#YK[P_L
M^I_SZGT^R_[O]?+RU^O?^$V_Z;'_ +[/^-'_  FW_38_]]G_ !KY"_X3)O\
MGX_\>'^%'_"9-_S\?^/#_"CZU'^E_P 'S7WA_9]3_GU/I]E_W?Z^7EK]>_\
M";?]-C_WV?\ &C_A-O\ IL?^^S_C7R%_PF3?\_'_ (\/\*/^$R;_ )^/_'A_
MA1]:C_2_X/FOO#^SZG_/J?3[+_N_U\O+7Z]_X3;_ *;'_OL_XT?\)M_TV/\
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M%_PF3?\ /Q_X\/\ "C_A,F_Y^/\ QX?X4?6H_P!+_@^:^\/[/J?\^I]/LO\
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M  E.IV7CN=1*$5D^U^.-/\179B14400M.8K4;OLR1;WW?S77\%^)\AS*KC.
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M?N^(?!4><$G_ )Z?K7Z;_P#!:6^_L[]DGPY>9V^3\;O!_.<8\SPGX_BZ_P#
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MAAU25'#O#XB@Z56C0=.G[)3I)+V49*,915O[#_\ ATM^R#_T"_B'_P"%Y?\
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MU[_PFW_38_\ ?9_QH_X3;_IL?^^S_C7R%_PF3?\ /Q_X\/\ "C_A,F_Y^/\
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M?\)DW_/Q_P"/#_"CZU'^E_P?-?>']GU/^?4^GV7_ '?Z^7EK]>_\)M_TV/\
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MG5?W?Z?H_-GY:^'JDMZ,NGV?\/\ 7RUZV]T_X2$?\]#^='_"0C_GH?SKPO\
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MRPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:)^8_P#BJ\3_ +</]\?]]_\ UZ/[</\ ?'_??_UZ7]I_WET[_P!W_+\_(/\
MB'W_ $Y73I_A\OZOZW]L_P"$A_Z:)^8_^*H_X2'_ *:)^8_^*KQ/^W#_ 'Q_
MWW_]>C^W#_?'_??_ ->C^T_[RZ=_[O\ E^?D'_$/O^G*Z=/\/E_5_6_MG_"0
M_P#31/S'_P 51_PD/_31/S'_ ,57B?\ ;A_OC_OO_P"O1_;A_OC_ +[_ /KT
M?VG_ 'ET[_W?\OS\@_XA]_TY73I_A\OZOZW]L_X2'_IHGYC_ .*H_P"$A_Z:
M)^8_^*KQ/^W#_?'_ 'W_ /7H_MP_WQ_WW_\ 7H_M/^\NG?\ N_Y?GY!_Q#[_
M *<KIT_P^7]7];^V?\)#_P!-$_,?_%4?\)#_ --$_,?_ !5>)_VX?[X_[[_^
MO1_;A_OC_OO_ .O1_:?]Y=._]W_+\_(/^(??].5TZ?X?+^K^M_;/^$A_Z:)^
M8_\ BJ/^$A_Z:)^8_P#BJ\3_ +</]\?]]_\ UZ/[</\ ?'_??_UZ/[3_ +RZ
M=_[O^7Y^0?\ $/O^G*Z=/\/E_5_6_MG_  D/_31/S'_Q5'_"0_\ 31/S'_Q5
M>)_VX?[X_P"^_P#Z]']N'^^/^^__ *]']I_WET[_ -W_ "_/R#_B'W_3E=.G
M^'R_J_K?VS_A(?\ IHGYC_XJC_A(?^FB?F/_ (JO$_[</]\?]]__ %Z/[</]
M\?\ ??\ ]>C^T_[RZ=_[O^7Y^0?\0^_Z<KIT_P /E_5_6_MG_"0_]-$_,?\
MQ5'_  D/_31/S'_Q5>)_VX?[X_[[_P#KT?VX?[X_[[_^O1_:?]Y=._\ =_R_
M/R#_ (A]_P!.5TZ?X?+^K^M_;/\ A(?^FB?F/_BJ/^$A_P"FB?F/_BJ\3_MP
M_P!\?]]__7H_MP_WQ_WW_P#7H_M/^\NG?^[_ )?GY!_Q#[_IRNG3_#Y?U?UO
M[9_PD/\ TT3\Q_\ %4?\)#_TT3\Q_P#%5XG_ &X?[X_[[_\ KT?VX?[X_P"^
M_P#Z]']I_P!Y=._]W_+\_(/^(??].5TZ?X?+^K^M_;/^$A_Z:)^8_P#BJ/\
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M^/\ OO\ ^O1_:?\ >73O_=_R_/R#_B'W_3E=.G^'R_J_K?VS_A(?^FB?F/\
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M+^K^M_;/^$A_Z:)^8_\ BJ/^$A_Z:)^8_P#BJ\3_ +</]\?]]_\ UZ/[</\
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MKQ/^W#_?'_??_P!>C^W#_?'_ 'W_ /7H_M/^\NG?^[_E^?D'_$/O^G*Z=/\
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M'_??_P!>C^W#_?'_ 'W_ /7H_M3^_P!NK_N^7D_O?S/^(>K_ )\KIT_P_P#
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MFO\ S,__ (*#_5O_ *C?_+;_ .[G^/QN/J?SHW'U/YU_L#T4?\1I_P"J:_\
M,S_^"@_U;_ZC?_+;_P"[G^/QN/J?SHW'U/YU_L#T4?\ $:?^J:_\S/\ ^"@_
MU;_ZC?\ RV_^[G^/QN/J?SHW'U/YU_L#T4?\1I_ZIK_S,_\ X*#_ %;_ .HW
M_P MO_NY_C\;CZG\Z-Q]3^=?[ ]%'_$:?^J:_P#,S_\ @H/]6_\ J-_\MO\
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M*#_5O_J-_P#+;_[N?X_&X^I_.C<?4_G7^P/11_Q&G_JFO_,S_P#@H/\ 5O\
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MT4?\1I_ZIK_S,_\ X*#_ %;_ .HW_P MO_NY_C\;CZG\Z-Q]3^=?[ Q(& 2
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MHU4 5JT45\"VVVVVVVVV[MMO5MM[MO=GK!1112 **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M>#?M)^+_ !)X0^$WB&3P=I&N:OXJUY1X:T5-!TV_U&YL)M4BG%WJLIT^-YK-
M;#38;V6TNSM5=3^P1@YD%?B!:_#/Q99WUA<^-/#/B_PQX6_M+3XM?\17WAO5
MXK?2--NKV"VN;^62:RV$PK-N1#EII=D2*SNJG^CBOFW]KW_DW/XF?]>.A?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJR\'?^31>%G_ &;C@?\ ]9G*RN/?^2YXT_[*SB/_ -7&,"BBBOT<^3/Y&?\
M@K;_ ,I[?^"6W_=I_P#ZUK\0J_KFK^1G_@K;_P I[?\ @EM_W:?_ .M:_$*O
MZYJ^WXJ_Y$O!/_8BJ_\ J=6/-P/^\9E_V%1_],P"BBBOB#T@HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MULW>R;M9,RG7I4I0A4J0A.I)1IQE)*4Y-V2C%N[U:6BW:74_6VBBOPQ^._\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/XE:[\.V^+/B/PA8V6K^ ]$\)?$WQO\ #[Q3H/PS^(U[XWBQ=3:)K LKO7?
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M/Z/\2]-UKP7K_@75=5\-:KH&BV?C"PU_P]I7B;P'<?VI#H&IM_//_P $4/\
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M<]+&9AB8RQ.&HX=X52DJ=.I*I'$5HP=FXR7[N#;345)63NG>RD?D-_P;:?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO_Q5G@NV_P"$T\._V%\2?#?]J?#KQI]LNO\ A"O%7B'^Q]:_L_ZH_P""R?\
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M$,>-O"UG<:FL_P 2X]>@\4WGA2;X?^%-/D^(<.O67AF/PCH'CX>+=63P//\
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M>!_ZUW\.Z_JTK^</_@G)^S!^T)\,_P#@L)_P41^+'C_X1>-?"/PQUG_A=?\
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M%WP\O++1M-\!?"[0M2TM]2O_  S;>']7\.^%OA!X3L/"7Q4^\/\ @KI\'/\
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M  1V_P""8EW^PQX UOXG_&!-)O?VEOC#H.C67B+3+:T\-ZK%\%O!EO/)J_\
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M[:GIVB>)=3\%^,=.\/ZK=VL-AK-_X3\2VFG3W-QH6J1VOZZ_MX?\F._ME_\
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M'M<L8-3T77M!UK3)[K3=8T76--NK;4-+U33[FXL=0L;B"[M)YK>:.1OXG_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%8F49P]^#C2:E#WE=:GM5%?*L_[;7[,=M<:9;3_$J2,ZKJFGZ1!<-X(^(O\
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M=O'K&EZ5?I=V5K\'_#_P7\4_VT/CCJEQK?BC3(Y[&V\.ZQ\7?%\<EG%<>"/
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M632SPW-K[3\,O$&J>+/AO\/O%6N"P&M>)O!'A/Q!K TJUN++2QJFLZ#8:CJ
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MN/C5H8/B6O4P%&A6Q].E4K*7]E1I5)4<%45.2I*K>NER4Z[IMSQ,?V@K\F_
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"P2PU!8-?1D^JK"*C36&6&7B9[)8=4.7V2H*E^Z]CR>S]G[G+RZ'YK[:M_Q
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M0>.?B@LUM\$[&TU[3?!GA>V\2:I_PD'CK5=4UG6M0UW4O[4TC5X]0^'WP_\
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M'P[#X:>&XTF^@\075QXAO/$":E%+<MKM]XIU+5+WQ+K'B:[O+_4O%&LZM?\
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M72OM:NZB:7NQ?NQ2BD@HHHK]4/B@HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=(E\/W.F:UXYT3XM>)])T:/P-\-=?\(Z;:V.D^&]"&OW/@SQ%IUMIWAOX/\
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M%33?$_B;XHZ]XGT'P-KVAW<FMZ)9>)-%\,:]X3\.Z#J_CCQ7=^-]?F\/>&/
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MQ-2=>4'5]Q*A2P]",%&BF_E_]LW_ )-K^)'_ ')__J>^%J_(FQ^'O[3?P_\
M!OA;XY?!V]^)Y\->([/5+ZYUKX(V$OB3Q+X5UG2]?U?X76.@^-_@R\'C/_A<
MEA=KXGU+Q/X3U2+X:>/M \'._B'7O$_AOP'/X$T'X@>)_P!B?VM-$UKQ'^S[
MX_T;P]H^JZ]K%Z?"@L])T33KS5=3N_(\;^&[J?[-86$-Q=3B"VAFN9S%$PAM
MH9IY2L44CJ?LEZ)K7AS]GWP!HWB'1]5T'6+(^*Q>:3K>G7FE:G:>?XW\274'
MVFPOX;>Z@$]M-#<P&6)1-;30SQ%HI8W;^<?$#PUI^(7TG,-#&8GB;(J66>!%
M#'9'Q;PUBL3E>-R7B7#>(.,HT9X/,X4YX66*>6YAC:5? 5U55; XJLW3@_9U
MZ?ZQPOQ=/A;P>K2P]')\RGC/$JIALQR/-Z-+&8?,,HK<+8>I4C7PDIQK*DL7
MA</.EB:;A[/$T8+GDN:G/\G;OP-^US^U=XLO+S7?"'BB_P!?\'2^-)_!^K_&
MWX=2_ GPA\/=*^)9.O#P3H7B23X6Z5XS\1>#I[_X>^&?#US/HVB_%[QCH9LO
M"E_X[NYFOUUN\_;+X8?#?PW\(_ N@_#WPD-2.A>'TOS!-K&HSZKJ=Y>ZOJE]
MKNLZE>W<Y""?4]:U/4-1>SL(+'1M-^U#3M"TO2=%M+#3;3O:*_9?#?P;R3P\
MS3/.)JN=<0\9<:<24Z&&SCB[BS&4L=FU3 X;V?L,LP;I4*,,%ET/8X9RP\/:
M.I+#8:,JCHX7"4</\#Q;Q_F/%6"R[)X9?E60</Y3.I5P&19)AYX; PQ-52]K
MC*ZG4J2Q&*E[2K:K+E456K-1]I7KU*OY#_M1?L-^*Y/%Y\6_ [0_$/BS3O'_
M (YU/Q5XHT2V\<6NA>)_AOXZU/6-0\?3?$?POXP\3>+?#NK6>AOXQC_M32K?
MPYKS>,_AGXTN]#F^'UG_ ,(8+2V^%OGEE^TA^W-KVA>!O"6G^'/CW8Z[/XTM
MPWCF]_96\2Z'KOB6/6]2U>TL/#7CF;Q/\(+7X=>$?!>GR:SIT=QXGC\-^!+K
M2=-\-:1J?B/QM':-XHU'7/V[HKY3-/HZ95_;^>Y]P7Q]XA>&JXJQ4\;Q+E/!
MV<8?"93F&-JM2KYAA<-B,'7GEF8UYNK.>+P]67LY57'#4L/2YJ<_;P7BOC?[
M,RW+>(>&.%N+O[$HQP^48[/\!5KXW"X>"<:>%K5:5>G'&82G%0C&A5@N=03K
M3JSY9Q_-?]D3]E'Q;H7B2'XX_'2RUW0_B'INM>*9?"7@V\\56>M:E976I1:Y
MX;U?Q[X^USPOK^N:1XHUKQ9I>JZO<Z%H3Z]KNFZ9I6MQ^)O%7VGXB75CIGPT
ME_;,\,_M20?$3PY\2O@C?_$^#PKX3^'.MWM\_P -O%4>I?V3K^C1>*1JLNL_
M _69K[1?BCJ6N>&_$L$?@C2]/^'WQ3U:\\0Z"SC0=%\1Z)\/[S5/TCHKZ?#^
M"'">5^'M/P[X;S'B?A7!4\QI9TN(>'\ZG@N*ZV>0K0KU,XQ>;NC46*QF+E3A
M3Q2JX=T)8:-/#4:-"C1P\*/C5?$7.\9Q3+BK-L)DV=8B>%GE_P#96:9?'$9)
M#+90E3A@*& 52'L*%!2E.CR554564ZU2I5J5*KJ?AUX_^,O[:GQ[NM%\!6_P
MV^,WA33M>M/$=O<^%?"?P,^('PN\/>-((;2Q\1Q6/CSXG_%;2X;'PDME;^';
MW3M,LW^)'PS\/^-?^$BU3P5XHLO&(UG2M#B_2[]F/]G?3?@!X2U"*ZETS6/'
M_B^73K[QMXDLM-L(25TRUDBT;P?I>K+IMCKVI^$/"LU]K=YHB^()IYFUSQ-X
MMUZSLO#\'B1] T[Z7HK+@KP7P'#'%,^.,^XMXL\0.+XY;/)LNSCBO&86I3R7
M*JLN>OALHR_ X7"87"SQ<K_6L1*-6K43FJ?L?;XKZQ?$/B#B<XR:/#F69'DG
M"^12Q<<?B\!DF'K0EF&-@N6G6QV*Q-:O6K1H*WL:2<(1:BY^T]E1]E^<O[.?
M@KQKH_[8?[2&K:SX.\5Z-H=M_P )/Y/B/5O#^JZ;X9UO_A/O&>E^+?#/_")^
M);RUAT+QIYFA6%U/KG_"(ZAK?_"'7R1Z%XR_L#7[BVTR;ZO_ &B?AKX@^+_P
M<\8_#[PMK6F:!K^M#0+K3=0UJSNKS2I9?#WBC1/$TFD7_P!BE2[L;?Q#;Z/+
MH#ZW;P:G-X>_M/\ MU-"\0MIPT+4?:Z*]SACPIX;X9X,XAX$A4S'-,BXGQ?%
M6(S:&8UZ2Q%6CQ=4Q/\ :6#IUL#0P?LZ,</B98>E.,?;K6I[7F:4?.SCC;-\
MXX@RKB64,+@LRR:ADM+!2PE.I[*%3(HTOJF(E#$5:_-4=6C&K.+?LWI#DLFY
M?@+X*/[87P2UWQ!\-/ /A3XW>"+SQCKOAQM6L]%^"6G>-/"-OXZ\1K\.UM_%
MO_"U'^'GC;P"TZ^$O#6D_#_Q+J\OC_4/AOX3T&^\22ZQ#H7C+1K?Q1X;_3+X
MS:/\3?$?[%-S9>)M"U[6_BLGPQ^'FM>.-"TW3]+UGQ-=>)_#\GA7Q#X\M['1
MO JWNF:[KD4^F:V]OH?@.#4EUN_B32_!ECJ<MWI=G<_9%%?(<*> F X7X4XJ
MX)GQ[Q_GW#7$?#&8\'X/+,ZS7!8C#\-9)F.&QN%J?V-0IY=2PT,PITL=.,,7
M5H3I*G2H45A(T:?LW[N=^)N)SG.\DXACPSPQEN;Y3G.%S[$8S+\%B*57-\PP
MM7#UH?VA4EBIUI864\-%RH0JQGS3J3==U)<Z^<OV2-%UKP_^SK\,=/\ $&C:
MKX?U272]5U=]&UW3[O1];L;/Q%XDUKQ!I<6L:+J$5OJFAZHVE:G92W^A:S:6
M&N:+=22Z7K>G:=JUI>6-O\*?M1?L-^*Y/%Y\6_ [0_$/BS3O'_CG4_%7BC1+
M;QQ:Z%XG^&_CK4]8U#Q]-\1_"_C#Q-XM\.ZM9Z&_C&/^U-*M_#FO-XS^&?C2
M[T.;X?6?_"&"TMOA;^O%%>]Q!X*<&\4>'?#7AQG#S2IEW"& R'!\/9YA<73P
M?$F58GAW 4<MP&;8/,*6&]A2S&6&HVKOZG+"5)5)2^JQ<*/LO,ROQ#S_ ";B
MO-^+< L%#%9[BLSQ&:9=6H3KY3C:.:XJIB\3@:^&J5?:SPJJS_=_[0J\%!+V
M[YJG/^(EE^TA^W-KVA>!O"6G^'/CW8Z[/XTMPWCF]_96\2Z'KOB6/6]2U>TL
M/#7CF;Q/\(+7X=>$?!>GR:SIT=QXGC\-^!+K2=-\-:1J?B/QM':-XHU'7/I/
M]D3]E'Q;H7B2'XX_'2RUW0_B'INM>*9?"7@V\\56>M:E976I1:YX;U?Q[X^U
MSPOK^N:1XHUKQ9I>JZO<Z%H3Z]KNFZ9I6MQ^)O%7VGXB75CIGPT_2BBOG>'?
M #+<#Q'DG%/&''/'7B7F?"\_;<,4>,<UHXK*LDQ:C3C',\/EV&PM"%?-X>RI
MR688FI5FZM.CB)0>*P^'KTO5S7Q/Q>)RG,<ER'ASAOA#!YS'V><5,@P52CC<
MQH-RD\'5Q56M4E3P,N>2>%HPA%0G4I*2HU:M*?Q#^W]H?B+6/@79W?AWPQXJ
M\6OX>\>^']9U32?!7AC7O&OB4:9-INO>'Q=:=X2\*Z?K'BC71#J>NZ:MY#H6
MCZE<V%A)=:S?0V^BZ9JFH67U#\*]&U/PY\,/AQX>UJU-CK.A> O!^C:M9&:W
MN39ZGI?A[3K&_M3<6<UQ:3FWNH)8C-:W$]M+LWP32Q,KMWM%?HV X!RK+O$'
MB#Q&HXK,)YOQ%D.4</XO!U)X=Y=1PV45JU6E6P\(X:.)5>M[2$:GM,34IKDD
MXP7.E#Y3%<3XW%<+Y7PI.AA8X'*LSQV:4,1"-98NI6QU.G"=.K)UG1=.'))Q
MY*,)/F2<O=;E^=?[>OPJ^(OQ$O/A!J7@?PAJOBBRT%O%FB:S)I M;FXT[4/'
M?B+X6Z)X:\_3OM*ZHVG374%[=:QKL%E+H/A+1=-U+Q%XOU/0=!L;C4D^M_V?
MO#&N^"?@+\$?!GBBP.E>)O"/PB^&WACQ%I9N;*].FZ[H/@W1=*U>P-YIMS>:
M==FSU"TN+<W5A>75E/Y?FVMS/ \<K>NT5SY+X;Y)D?B%QGXD83%YI4SKCC!9
M%@<UPF(K86668:GD&"I8#"SP%*G@Z6*ISK4*%%XCZQC,3%U54E35.,XTX:9A
MQ;F&8\+</\)UZ&#AE_#F(S+$X*O2A66,JRS3$2Q-:.*G.O.C.-.I4FJ7LJ%%
MJ#BI\\HN4BOD']J=OVKKJZ^'VB_LU1RZ9IMS!XPU7Q]XLL!\,I-6T^]TM_"M
MGX-\-PP?$Z>_TYM-\10:SXOU34)=+\*ZA?17?A/2DD\1>'K:9],\5?7U%?1\
M3Y%+B;(<QR*.=Y]PX\PITZ?]M<,8ZGEN?8'V>(I5W/+L=5PV,IX:I55)T*DW
MAZC>'JU81Y)RC./E9/F2RC,L+F3R[+,V6%G.?]GYQAIXO+<3S4ITU'%8:%:A
M*K"#G[6$55@E5A"3YHIQ?XI^-_@!^W+\4+C1[KXGP:OX\E\/0ZI!H)U/4_@/
MH:Z5'K;Z9)JXA7P5%X6^U&_;1=*WG4_MWV<62BR^S>?=_:.HTCPG_P %,?A]
MX>TRQ\&7>J:KIO@C1K*T\*?#_5&_9KDT'4K'PU8Q0Z%X.U'4A::/XHDTB\M[
M*UT6\OAXTTK7WLY)+@>*+'43_:T7["45_/V ^BWDV6Y]CN)\'XN>.='/\T6"
MAFV;1XTRE8[-J.70I4\'A\SQ2X75?&X>A2HTJ-.CB*DX1HPC3BE%)'ZAB?&;
M'XO+</D^(X%\-ZF68-XB6"P+X>QSPV"J8J4YXBK@Z+SET\/5JSG*I.I2C&4J
MDG-MMMA7X5VO[-/Q8^/G[1/Q%A^)/P^^(GAWP[XR^)MMXC^+>N^*] TCPPUK
M\-O$&C3WOA?P+9^+?AWXL\,^'?%^NZ=\*?"OA;X W_C7X%^.O'_B#X=:_P#V
M)XH\5ZKJFLZ?J&H:C^ZE%?JOB/X79%XH1X6PW$F,S6.5\,<283B:63X*MA:>
M7YYB<#3J1PV$SFG7PF(JUL'%U)QG3P]7#3G0KXFGSJ=2E6P_Q?"?&>9<&O.J
MV4X?!/&YQE-?*%C\13K2Q66T<1*$JM?+Y4Z]*%/$/DBU*K"K%5*=&?*XPG3J
ME>%_M+?"_P 3_&?X(^.?AKX/\36_A37O$L&AB"_OAJ TK5+#2?$VBZ[KG@S7
M7TN:.\@\.?$/0M+U+P#XDNDMM9AM-!\2ZC<W?AGQ79Q3^&M5]THK[S-,NPN<
M99F.48Z-2>"S3 XO+L9&E5J4*LL+CL/4PV(C3KT90K4:CI59J%6E.%2G)J<)
M1DDU\S@L76P&,PF.PSC'$8+$T,70<Z<*L%6PU6%:DYTJBE3J14X1<H3C*$U>
M,DXMH_$R'6/VZ?V;O%-G]N@^.7CO1=9\6>-M2?0)-%\0?M)^%/%<FG:79>&Q
MJ=UX@T*P\>?$+X8^$;F$Z-XH\$>%$\5?">WO]3M[V\F\(OJ,_C[2KK/N/!_[
M:/[5G[[Q!H_B\:'IWC+QE+HEG\6= 7X(>$O!>JW.C-K%A;?\(]=>#]'^(7B'
MPS9VEY:>"/"?CN/P7\4=8L!J6K6,_B*[ED\>7U?N'17\WXKZ,>#S'"RR'-O%
MOQ@S;@B52$Y\(8_BJC6PF(HTY4IQRW&9A_9ZQV)RF,J4?9X)S@Z24)TZ\<3#
MZQ+]:H^,.(PE99G@>!^ \%Q$H2C'/<-DU2%>E4DIQ>+H87ZU]7HXV49OGQ"3
M4VY1E3=*7LEX1^SQ\ _#G[/'@2Y\(Z)JFJ^(-4U_7I_&/C7Q)JD]T/[?\7WN
MD:+H5U>:5HDE[>:?X3T&TT;P]HFC:+X<TES%;:?I<%_K=_XB\7ZCXD\6:_\
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M[M&C!::::'Y7F&-KYEC\;F.)?-B,?B\3C<1+7WJV*K3KU7KWJ5),****](Y
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
9BB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>gb2k1ptlkg5v000003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gb2k1ptlkg5v000003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (Z VH# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD_Z=/_(G_P!:C^WLO_Y^?A+_ "#ZG7_E_(W:*PO^$D_Z=/\ R)_]:C_A)/\
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MJE;^7\C<HK#_ .$C3_GV;_OO_P"M1_PD:?\ /LW_ 'W_ /6H_MS ?\_/P?\
MD'U2M_+^1N45A_\ "1I_S[-_WW_]:G?\)%%_S[O^8IK.\ _^7GX/_(/JE;^4
MVJ*Q?^$BB_YX/^8H_P"$BB_YX/\ F*?]M8#_ )^+[G_D+ZI6_E-JBBBO4.<*
M*YK2[C4/$D$FHQZC-8632LEK';QQEG121O<NK<D@X Q@>M3:/J.H7J:GIMQ+
M"NHV$@B^T+'E7#+E'V9X)'49ZBG85S?HKFC<:AI?BC3-/?49;^"^CEWK/'&'
MB*#.X%%7@YQR#3]+UB>)M?BU.7>VFSM(&V@?N"N].@&<#(_"BP7.BHKD?"OB
M&]FT+4)M;<?:K+][)\H7$;()%Z#T)'X=ZVO#DE]/X>LI]2D+W<L8DD.T+C=R
M!@ #@$#\*&K G<U***RY==MHII(GCEW(Q4X QQ^-<V(Q5'#I.M*US2%.4_A5
MS4HK)_X2&T_YYS_]\C_&C_A(;3_GG/\ ]\C_ !KF_M? _P#/Q&GU:M_*:U%9
M/_"0VG_/.?\ [Y'^-'_"0VG_ #SG_P"^1_C1_:^!_P"?B#ZM6_E-:BLG_A(;
M3_GG/_WR/\:4>(+,]5F'U4?XT?VM@?\ GZ@^K5?Y35HK+_M^S])?^^?_ *]'
M]OV?I+_WS_\ 7I_VK@O^?J^\7U:K_*S4HJI9ZA#?%Q$'^3&=PQUJW792JPK0
M4Z;NF9RBXNT@HHHK0D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M!" >H!^M)L3^XOY4ZBE9,+C=B?W%_*C8G]Q?RIU%'*NP[L;L3^XOY4;$_N+^
M5.HHY5V"[&[$_N+^5&Q/[B_E3J*.5=@NQNQ/[B_E1L3^XOY4ZBCE78+L;L3^
MXOY4;$_N+^5.HHY5V"[&[$_N+^5'EH1@HOY4ZBERQ[!=D?D0_P#/)/\ OD4>
M1#_SR3_OD5)12]G#L@YF1^1#_P \D_[Y%'D0_P#/)/\ OD5)11[.'9!S,C\B
M'_GDG_?(H\B'_GDG_?(J2BCV<.R#F9'Y$/\ SR3_ +Y%'D0_\\D_[Y%244>S
MAV0<S(_(A_YY)_WR*/(A_P">2?\ ?(J2BCV<.R#F9'Y$/_/)/^^12K%&IRL:
M@CN%I]%"A!= NPHHHJQ'+Z>9/#FIZI#=6MU):7ETUW!/;V[S#+ ;D8("5(/0
MD8/X8JMIFI6USX]NYKK?9SO:I!9P74;1O,@)8N,\<D_=^]P<@5V-1R6\,SQO
M+#'(T3;XV902C8QD>AP357%8XK2],O8_&+6,EI,--LKB>^@G9#L9I N%!Z94
MM)1H^EWB>+38S6LZ:;IL\]U;S,I\N1I<;0#T)7=)TKN:*.8+!1114C&/%'+C
MS(U?'3<,XIOV6W_YX1?]\"I:*ATX2=VD-2:V9%]EM_\ GA%_WP*/LMO_ ,\(
MO^^!4M%+V-/^5?</FEW(OLMO_P \(O\ O@4?9;?_ )X1?]\"I:*/8T_Y5]P<
MTNY ;.U/6VA/U04?8;3_ )]8/^_8J>BE]7I?RK[D'/+N0?8;3_GU@_[]BC[#
M:?\ /K!_W[%3T4OJ]'^1?<@YY=R#[#:?\^L'_?L4?8;3_GU@_P"_8J>BCZO1
M_D7W(.>7<@^PVG_/K!_W[%'V&T_Y]8/^_8J>BCZO1_D7W(.>7<@^PVG_ #ZP
M?]^Q1]AM/^?6#_OV*GHH^KT?Y%]R#GEW(/L-I_SZP?\ ?L4?8;3_ )]8/^_8
MJ>BCZO1_D7W(.>7<@^PVG_/K!_W[%(;&T(Q]EA_[X%6**/J]'^1?<@YY=RM_
M9]G_ ,^T7_?-']GV?_/M%_WS5FBE]5H?R+[D/VD^[*W]GV?_ #[1?]\T?V?9
M_P#/M%_WS5FBCZK0_D7W(/:3[LK?V?9_\^T7_?-']GV?_/M%_P!\U9HH^JT/
MY%]R#VD^[&10QP)MB147.<*,4^BBMHQ45:*LB6V]6(0""#T-5_[/L_\ GVB_
M[YJS143I4ZGQQ3]4-2DMF5O[/L_^?:+_ +YH_L^S_P"?:+_OFK-%1]5H?R+[
MD/VD^[*W]GV?_/M%_P!\T?V?9_\ /M%_WS5FBCZK0_D7W(/:3[LK?V?9_P#/
MM%_WS3?[,LO^?9/RJW12>$P[W@ON0>TGW94_LRR_Y]DH_LRR_P"?9*MT4OJ>
M&_Y]Q^Y#]K/^9A111729G*:#,_AK3VTB_M+T_9Y',$UO:R3)+&S$@Y0':1G!
M#8_'-5=#UB"+4/$5Y/%,NI22"3^S?+/VCRT7:F%_B)Z_+D#(YKM:C:WA:X2X
M:&,S(I5)"HW*#U /4 X'Y55Q6.6\.3B:_;4=3BO?[6NQL"FPG6.VCZB,,R >
MY.>3^%5?%NG7SZVBV5K/-!JT"V5T\:DK$!(#O;T&QG%=O11S:W"VAPWB?2[P
MZXMO8VL[VFKP1VMU)$I*PJCC))Z %&85W"JJ*%4 *HP .PI:*3=PL%4I-*LI
M9&D>#+,<D[B,G\ZNT5C5H4JRM4BI>JN7&<H_"[%#^QM/_P"??_Q]O\:/[&T_
M_GW_ /'V_P :OT5A_9^$_P"?4?\ P%?Y%^VJ_P S^\H?V-I__/O_ ./M_C1_
M8VG_ //O_P"/M_C5^BC^S\)_SZC_ . K_(/;5?YG]Y0_L;3_ /GW_P#'V_QI
M#HM@>D)'T<_XUH44?V?@_P#GU'_P%?Y![>K_ #/[S._L2Q_YY-_WV:/[$L?^
M>3?]]FM&BE_9N#_Y]1^Y![>K_,RM:V,%F6,*E=V,Y)-6:**ZJ=*%*/)35EV1
MG*3D[L****L04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?7UC%9LTY-_++&LN0%W?,1N(W?*?3.*[6DU8$[A1112&%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 50O-.DN;A9X=3O;-@
MFPB!D*L,YY5U8 ^X /Z5?HH Q_\ A&[+^R;^P:2=S?AOM-PS RR$C&<XP..@
M P/2K%QI%O<OIS.\H-A()(MI')"E?FX]#VQ6A13NPL<KXKT(SVU]J%K%//<S
MQ10R1(W(C23<60<'>.2.>PXIMH)#K]@=(&KBU ?[:;]KC9MQ\H GYW;O[O;.
M:ZRBGS:"L%%%%2,**** "BBB@ HHHH **** (YXWF@>-)Y(&88$D84LOTW C
M\P:H6VBI%?)>W5Y=7US$I6)[@H!$#UVJBJN3ZD9[9K3HHN!0MM)@M9]0F1Y"
MU_())0Q& =H7Y>/0=\U5?PU9OX>MM$,L_P!FMS'L8,-YV,&&3C'4>E;-%.["
MQP*6Q@BU9;FVUN+4Y;F9X4L6N1$=WW&4H?+YX)W=\YP.*[/3!>#2K0:@5-[Y
M2^>5QC?CGIQU]*MT4-W$E8****0PHHHH **** "BBB@ HHHH P?^$9?^UEU,
MZYJ1NEB,(8K!C83NVX\K'4=>M6;C0D?4I+^TO;JQN)E"S-;[")<?=+!U89'3
M(Q6K13NQ6,6+PQ80_9&5YS);W1NS(S@M-*5*EGX[@]L=L<5=CTR&/69]4#2>
M?-"D+*2-H522,<9S\Q[U=HHNQV./UG0EL+&SBMHKR>T_M,W=T\+,9H]V22FS
M#8R<'&3@GZU9T<7'_"0NUB-2&D_9L2_V@TV3-NXV";Y^F<_P].]=/13YM!6"
MBBBI&%%%% !1110 4444 %9>N:'#KUO#!/<W$,<4@EVQ;"'(Z;@RL& ZX(Q6
MI10!3LK*>U=C-J=W=@C 6=8@%]QL1?UIFFZ3!IDEY+')+++>3F:624@DG& !
M@#@ 8 J_11<"A;:3!:SZA,CR%K^022AB, [0OR\>@[YJJ_AJS?P];:(99_LU
MN8]C!AO.Q@PR<8ZCTK9HIW86.,EMXX?$>KSZG;:L@F,9MVT\W.R10N,GR3]_
M(Q\V. ,>M;WAM=130;==5W_:AN_UC OMR=NXC@MMQFM6BANXK!1112&%%%%
M!1110 4444 %9.N:$-=MI+6?4+R&UD4+)# (\-@YSED+9Z=#VK6HHO8#*N-"
MCO=-6TO+RZN&202Q7#;%DB<?=*[5 R/<'KSFFIX?C-XEW>7MW?3Q(R0M/Y8$
M6X88J$51DCC)!K7HIW8K&/\ \(Y9G0+71O,G^SVQC*-N&\[&##)QCJ.>*L7>
ME1SZI;ZH&?[5:Q21Q)D!#OQG/&>P[UH4478['G5K:W%MX<BMK.WUR#7T.%C#
M7 MT??D\L?),>/KD>]>B+NV+NQNQSCIFEHH;N)*P4444AA1110 4444 %%%%
M !6)+X;%Q UK<ZMJ4]DQ^:VDD3#+G.TOL\PCZMDCJ36W11<#-O\ 1+>]DM9D
MDEM+BTR()K?:&12,%<,"I!P."#TJJWA:RDM9HI9KF6:>>.XFN69?,D9&!4'"
MX & , #CWYK<HIW8K%*73(9M7MM39I!-;Q/$B@C:0Q&<\9S\H[UA>(M",>DZ
MO+8Q3W$U_-%+/&&^950KDQXP=P"Y R>?RKJJ*$V@L<G:"0Z_8'2!JXM0'^VF
M_:XV;<?* )^=V[^[VSFNLHHH;N""BBBD,**** "BBB@ HHHH **** "BBB@
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MW3T]0HHHJ1A1110 4444 %%%% !1110 4444 %%%% !7*>./^9;_ .P[:_\
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M.VO_ +-51W$]CJZ***D9XU\6O^1JM?\ KR3_ -#>N#KO/BU_R-5K_P!>2?\
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M78_#?_D8KC_KT;_T-*YL9_ EZ'5@O]XAZGJ-%%%?,GU@4444 9^O?\B[J?\
MUZ2_^@&O#:]RU[_D7=3_ .O27_T UX;7MY5\$O4\'./CCZ!1117J'CA1110
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MF>7T445[9\^%%%% !1110 4444 %:GAK_D:M'_Z_8?\ T,5EUJ>&O^1JT?\
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M****V.<**** "BBB@ HHHH ZCX=?\CWIO_;7_P!%/7O->#?#K_D>]-_[:_\
MHIZ]YKR<?_%7I_F>UEW\)^O^04445PGH!1110!\O4445](?*A1110 4444 %
M%%% !1110!ZA\'O^8U_VP_\ :E>HUY=\'O\ F-?]L/\ VI7J->)C/XTOZZ'T
M&"_@1^?YA1117,=05R_Q%_Y$34O^V7_HU*ZBN7^(O_(B:E_VR_\ 1J5K1_BQ
M]495_P"%+T9X-1117OGS04444 %%%% !1110 4444 >\_#K_ )$33?\ MK_Z
M->NHKE_AU_R(FF_]M?\ T:]=17@5OXLO5GTM#^%'T04445D:A7EWQA_Y@O\
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M0C-]W_51].O5^OM_]>K% !7ANO?\C%J?_7W+_P"AFO<J\-U[_D8M3_Z^Y?\
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M *Y3QQ_S+?\ V';7_P!FKJZY3QQ_S+?_ &';7_V:JCN)['5T445(SQKXM?\
M(U6O_7DG_H;UP==Y\6O^1JM?^O)/_0WK@Z][#?PHGSN*_C2"BBBMCG"BBB@
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M.<?''T"BBBO4/'"BBB@ HHHH **** "O4?AO_P B[<?]?;?^@)7EU>H_#?\
MY%VX_P"OMO\ T!*X,Q_@?,]'*_\ >/DSL:***^?/I0HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *Y3QQ_P RW_V';7_V:NKKE/''_,M_]AVU_P#9JJ.X
MGL=71114C/&OBU_R-5K_ ->2?^AO7!UWGQ:_Y&JU_P"O)/\ T-ZX.O>PW\*)
M\[BOXT@HHHK8YPHHHH **** "BBB@#J/AU_R/>F_]M?_ $4]>\UX-\.O^1[T
MW_MK_P"BGKWFO)Q_\5>G^9[67?PGZ_Y!1117">@%%%% 'R]1117TA\J%%%%
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M73^-'T;1117SI].5T_Y",WW?]5'TZ]7Z^W_UZL573_D(S?=_U4?3KU?K[?\
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M^C4KJ*Y?XB_\B)J7_;+_ -&I6M'^+'U1E7_A2]&>#4445[Y\T%%%% !1110
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ML8+% S&<7C%@H[E3& /?YN/>N>\1P/9'3M6.H2ZELNT^SV<^S8Y<@9C$87+
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M](?*A1110 4444 %%%% !1110!ZA\'O^8U_VP_\ :E>HUY=\'O\ F-?]L/\
MVI7J->)C/XTOZZ'T&"_@1^?YA1117,=05R_Q%_Y$34O^V7_HU*ZBN7^(O_(B
M:E_VR_\ 1J5K1_BQ]495_P"%+T9X-1117OGS04444 %%%% !1110 4444 >\
M_#K_ )$33?\ MK_Z->NHKE_AU_R(FF_]M?\ T:]=17@5OXLO5GTM#^%'T044
M45D:A7EWQA_Y@O\ VW_]IUZC7EWQA_Y@O_;?_P!IUTX/^-'^NARXW^!+Y?F>
M7T445[9\^%%%% !1110 4444 %:GAK_D:M'_ .OV'_T,5EUJ>&O^1JT?_K]A
M_P#0Q4S^%ET_C1]&T445\Z?3E=/^0C-]W_51].O5^OM_]>K%5T_Y",WW?]5'
MTZ]7Z^W_ ->K% !7ANO?\C%J?_7W+_Z&:]RKPW7O^1BU/_K[E_\ 0S7JY5\<
MO0\?./@CZF?1117M'@A1110 4444 %%%% !78_#?_D8KC_KT;_T-*XZNQ^&_
M_(Q7'_7HW_H:5S8S^!+T.K!?[Q#U/4:***^9/K HHHH S]>_Y%W4_P#KTE_]
M ->&U[EKW_(NZG_UZ2_^@&O#:]O*O@EZG@YQ\<?0****]0\<**** "BBB@ H
MHHH *]1^&_\ R+MQ_P!?;?\ H"5Y=7J/PW_Y%VX_Z^V_] 2N#,?X'S/1RO\
MWCY,[&BBBOGSZ4**** "BBB@ HHHH **** "BBB@ HHHH **** "N4\<?\RW
M_P!AVU_]FKJZY3QQ_P RW_V';7_V:JCN)['5T445(SQKXM?\C5:_]>2?^AO7
M!UWGQ:_Y&JU_Z\D_]#>N#KWL-_"B?.XK^-(****V.<**** "BBB@ HHHH ZC
MX=?\CWIO_;7_ -%/7O->#?#K_D>]-_[:_P#HIZ]YKR<?_%7I_F>UEW\)^O\
MD%%%%<)Z 4444 ?+U%%%?2'RH4444 %%%% !1110 4444 >H?![_ )C7_;#_
M -J5ZC7EWP>_YC7_ &P_]J5ZC7B8S^-+^NA]!@OX$?G^84445S'4%<O\1?\
MD1-2_P"V7_HU*ZBN7^(O_(B:E_VR_P#1J5K1_BQ]495_X4O1G@U%%%>^?-!1
M110 4444 %%%% !1110![S\.O^1$TW_MK_Z->NHKE_AU_P B)IO_ &U_]&O7
M45X%;^++U9]+0_A1]$%%%%9&H5Y=\8?^8+_VW_\ :=>HUY=\8?\ F"_]M_\
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M $4]>\UX-\.O^1[TW_MK_P"BGKWFO)Q_\5>G^9[67?PGZ_Y!1117">@%%%%
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M .O27_T UX;7N6O?\B[J?_7I+_Z :\-KV\J^"7J>#G'QQ] HHHKU#QPHHHH
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M?PGZ_P"04445PGH!1110!\O4445](?*A1110 4444 %%%% !1110!ZA\'O\
MF-?]L/\ VI7J->7?![_F-?\ ;#_VI7J->)C/XTOZZ'T&"_@1^?YA1117,=05
MR_Q%_P"1$U+_ +9?^C4KJ*P?&>G7>K>$KZQL8O-N9?+V)N"YQ(I/)('0&M*+
M2J1;[HRK)NE)+LSY\HKJ/^%=>*O^@5_Y,1?_ !5'_"NO%7_0*_\ )B+_ .*K
MW/;4_P"9?>?/^PJ_RO[CEZ*ZC_A77BK_ *!7_DQ%_P#%4?\ "NO%7_0*_P#)
MB+_XJCVU/^9?>'L*O\K^XY>BNH_X5UXJ_P"@5_Y,1?\ Q5'_  KKQ5_T"O\
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M#RC:B]D24X206$X0^^XIC'OG%%@-:BJ%[K-C87"6\TDC7#KO$,$+S/MZ;BJ
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M\2?:C917*"V90QF0+N##(*\G@CGG'455?Q>Z.R_\(SXA.TXR+1<'_P ?K/\
M"=[I_P#PE?B.&VNK8K)-"($CD7YE6/'R@=0,=O2M+QKJ4MGH7V2T/^GZBXM+
M<9YRW!/'H,\_2JLKV%?0?:>+["\T&+5HX+M8YIO(AA:,>;*^< * <>O?L<UH
MZ9JT&J+.$BF@FMW\N:"=0'C.,C."000<Y!(K+O/#)30]*L]->-)=+FCFA\W.
MV0KG(8CD9R><&L"_,\5YJ\%W<1PM=!;C59;8EEMK=5VK&K$ EWP>PX)XZ463
MV"[1VFEZK!J\$EQ:I)Y"RM&DK !9<<%EYY7.1GCI4UY?6MA"9;J98U )YY)
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M'X;_ /(NW'_7VW_H"5P9C_ ^9Z.5_P"\?)G8T445\^?2A1110 4444 %%%%
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MBB@#U#X/?\QK_MA_[4KU&O+O@]_S&O\ MA_[4KU&O$QG\:7]=#Z#!?P(_/\
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M &?KW_(NZG_UZ2_^@&O#:]VU:"2ZT:^MX5W2RV\B(N<9)4@#FO*O^$(\1?\
M0._\CQ__ !5>OEM6$(2YFD>)FM*I.<7"+>G1'/45T/\ PA'B+_H'?^1X_P#X
MJC_A"/$7_0._\CQ__%5Z7UBC_.OO1Y?U:O\ R/[F<]170_\ "$>(O^@=_P"1
MX_\ XJC_ (0CQ%_T#O\ R/'_ /%4?6*/\Z^]!]6K_P C^YG/45T/_"$>(O\
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MF.]<#H<C!^II=+O+_P (/J&F3:'J5[$]R\]I-9P[U97.=K'/RD'U_P#UP_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:0EI+/Y\G#-(>6)V@$%OXL8P#@84 =JV**+L+(****0PHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
(* "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>15
<FILENAME>etnb-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-03-24T17:57:06.7575097+00:00 -->
<!-- Version            : 5.0.1.728 -->
<!-- Package ID         : 577eac3b881348d89343ad261f9a5e63 -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:etnb="http://www.89bio.com/20211231" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.89bio.com/20211231" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" namespace="http://xbrl.sec.gov/country/2021" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" namespace="http://xbrl.sec.gov/currency/2021" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" namespace="http://xbrl.sec.gov/dei/2021q4" />
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd" namespace="http://xbrl.sec.gov/exch/2021" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" namespace="http://xbrl.sec.gov/naics/2021" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd" namespace="http://xbrl.sec.gov/sic/2021" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" namespace="http://fasb.org/srt/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd" namespace="http://fasb.org/srt-roles/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" namespace="http://fasb.org/srt-types/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" namespace="http://xbrl.sec.gov/stpr/2021" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" namespace="http://fasb.org/us-gaap/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd" namespace="http://fasb.org/us-roles/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" namespace="http://fasb.org/us-types/2021-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType id="TemplateLink" roleURI="http://www.89bio.com/20211231/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="etnb-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation Links, all" xlink:type="simple" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="etnb-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="etnb-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="etnb-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" id="Role_StatementConsolidatedBalanceSheets">
        <link:definition>100010 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" id="Role_StatementConsolidatedBalanceSheetsParenthetical">
        <link:definition>100020 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" id="Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss">
        <link:definition>100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" id="Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit">
        <link:definition>100040 - Statement - Consolidated Statements of Stockholders&apos; Equity (Deficit)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" id="Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical">
        <link:definition>100050 - Statement - Consolidated Statements of Stockholders&apos; Equity (Parenthetical)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" id="Role_StatementConsolidatedStatementsOfCashFlows">
        <link:definition>100060 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentation" id="Role_DisclosureOrganizationAndBasisOfPresentation">
        <link:definition>100070 - Disclosure - Organization and Basis of Presentation</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>100080 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurements" id="Role_DisclosureFairValueMeasurements">
        <link:definition>100090 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponents" id="Role_DisclosureConsolidatedBalanceSheetComponents">
        <link:definition>100100 - Disclosure - Consolidated Balance Sheet Components</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies" id="Role_DisclosureCommitmentsAndContingencies">
        <link:definition>100110 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoan" id="Role_DisclosureTermLoan">
        <link:definition>100120 - Disclosure - Term Loan</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensation" id="Role_DisclosureStockBasedCompensation">
        <link:definition>100130 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxes" id="Role_DisclosureIncomeTaxes">
        <link:definition>100140 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShare" id="Role_DisclosureNetLossPerShare">
        <link:definition>100150 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureSubsequentEvents" id="Role_DisclosureSubsequentEvents">
        <link:definition>100160 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>100170 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables" id="Role_DisclosureFairValueMeasurementsTables">
        <link:definition>100180 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsTables" id="Role_DisclosureConsolidatedBalanceSheetComponentsTables">
        <link:definition>100190 - Disclosure - Consolidated Balance Sheet Components (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" id="Role_DisclosureCommitmentsAndContingenciesTables">
        <link:definition>100200 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanTables" id="Role_DisclosureTermLoanTables">
        <link:definition>100210 - Disclosure - Term Loan (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables" id="Role_DisclosureStockBasedCompensationTables">
        <link:definition>100220 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables" id="Role_DisclosureIncomeTaxesTables">
        <link:definition>100230 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareTables" id="Role_DisclosureNetLossPerShareTables">
        <link:definition>100240 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails" id="Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails">
        <link:definition>100250 - Disclosure - Organization and Basis of Presentation - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>100260 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" id="Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails">
        <link:definition>100270 - Disclosure - Fair Value Measurements - Summary of Financial Assets Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails" id="Role_DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails">
        <link:definition>100280 - Disclosure - Fair Value Measurements - Schedule of Contractual Maturities of Cash Equivalents and Available-for-Sale Securities (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails" id="Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails">
        <link:definition>100290 - Disclosure - Consolidated Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails" id="Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails">
        <link:definition>100300 - Disclosure - Consolidated Balance Sheet Components - Schedule of Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" id="Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
        <link:definition>100310 - Disclosure - Commitments and Contingencies - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails" id="Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails">
        <link:definition>100320 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" id="Role_DisclosureTermLoanAdditionalInformationDetails">
        <link:definition>100330 - Disclosure - Term Loan - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails" id="Role_DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails">
        <link:definition>100340 - Disclosure - Term Loan - Schedule of Repayment of Principal Amount (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" id="Role_DisclosureStockBasedCompensationAdditionalInformationDetails">
        <link:definition>100350 - Disclosure - Stock-Based Compensation - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails" id="Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails">
        <link:definition>100360 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails" id="Role_DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails">
        <link:definition>100370 - Disclosure - Stock-Based Compensation - Summary of Estimated Fair Value of Stock Options Granted Using Black-Scholes Option-Pricing Model (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" id="Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails">
        <link:definition>100380 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails" id="Role_DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails">
        <link:definition>100390 - Disclosure - Income Taxes - Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails" id="Role_DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails">
        <link:definition>100400 - Disclosure - Income Taxes - Summary of Income Tax Benefit (Expense) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails" id="Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails">
        <link:definition>100410 - Disclosure - Income Taxes - Summary of Components of Deferred Tax Assets (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" id="Role_DisclosureIncomeTaxesAdditionalInformationDetails">
        <link:definition>100420 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails" id="Role_DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails">
        <link:definition>100430 - Disclosure - Income Taxes - Summary of Loss from Operations Before Taxes on Income (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails" id="Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails">
        <link:definition>100440 - Disclosure - Income Taxes - Summary of Reconciliation of Income Tax Benefit (Expense) Statutory Tax Rate to Effective Tax Rate (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails" id="Role_DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails">
        <link:definition>100450 - Disclosure - Net Loss Per Share - Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" name="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization" name="IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="etnb_ShortTermAvailableForSaleSecuritiesCurrent" name="ShortTermAvailableForSaleSecuritiesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="etnb_TermLoanCurrent" name="TermLoanCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="etnb_OtherNonCurrentLiability" name="OtherNonCurrentLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" name="IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing" name="IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="etnb_ATMFacilityMember" name="ATMFacilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="etnb_TemporaryEquityIssuanceCosts" name="TemporaryEquityIssuanceCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="etnb_ConvertiblePreferredSharesMember" name="ConvertiblePreferredSharesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" name="AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="etnb_DeferredTaxAssets" name="DeferredTaxAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="etnb_PaymentForPurchaseOfAvailableForSaleSecurities" name="PaymentForPurchaseOfAvailableForSaleSecurities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="etnb_ProceedsFromIssuancePublicOffering" name="ProceedsFromIssuancePublicOffering" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="etnb_OtherRisksAndUncertaintiesPolicyTextBlock" name="OtherRisksAndUncertaintiesPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock" name="AccruedResearchAndDevelopmentExpensesPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock" name="ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock" name="ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="etnb_UnderwrittenPublicOfferingMember" name="UnderwrittenPublicOfferingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember" name="SVBLeerinkLLCAndCantorFitzgeraldCoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="etnb_PaymentsOfStockIssuanceCostsOther" name="PaymentsOfStockIssuanceCostsOther" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="etnb_SellingCommissionPerSharesSoldPercentage" name="SellingCommissionPerSharesSoldPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="etnb_SummaryOfSignificantAccountingPoliciesLineItems" name="SummaryOfSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="etnb_SummaryOfSignificantAccountingPoliciesTable" name="SummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="etnb_AgencyDiscountSecuritiesMember" name="AgencyDiscountSecuritiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="etnb_PrepaidResearchAndDevelopmentCurrent" name="PrepaidResearchAndDevelopmentCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="etnb_AccruedResearchAndDevelopmentExpenseCurrent" name="AccruedResearchAndDevelopmentExpenseCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="etnb_OperatingLeaseMonthlyRentalPayments" name="OperatingLeaseMonthlyRentalPayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="etnb_SanFranciscoOfficeMember" name="SanFranciscoOfficeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="etnb_RestrictedCashAndOtherAssetsMember" name="RestrictedCashAndOtherAssetsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="etnb_TevaAgreementMember" name="TevaAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="etnb_TevasGlycoPEGylatedFGF21ProgramMember" name="TevasGlycoPEGylatedFGF21ProgramMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="etnb_TevasDevelopmentProgramMember" name="TevasDevelopmentProgramMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment" name="AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones" name="ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice" name="AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure" name="AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled" name="AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="etnb_MilestonePayment" name="MilestonePayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="etnb_LoanAndSecurityAgreementMember" name="LoanAndSecurityAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="etnb_TermALoanFacilityMember" name="TermALoanFacilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="etnb_TermBLoanFacilityMember" name="TermBLoanFacilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity" name="LineOfCreditFacilityIncreaseInBorrowingCapacity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="etnb_NetCashProceedsFromSaleOfEquitySecurities" name="NetCashProceedsFromSaleOfEquitySecurities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="etnb_PercentageOfFeeOnLoan" name="PercentageOfFeeOnLoan" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="etnb_FairValueOfWarrantsAssumptionsDividends" name="FairValueOfWarrantsAssumptionsDividends" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement" name="NumberOfSharesIssuableUnderShareBasedPaymentArrangement" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance" name="PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding" name="PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="etnb_TwoThousandAndNineteenEquityIncentivePlanMember" name="TwoThousandAndNineteenEquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="etnb_TwoThousandAndTwentyEquityIncentivePlanMember" name="TwoThousandAndTwentyEquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="etnb_ServiceBasedRSUsMember" name="ServiceBasedRSUsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="etnb_PerformanceRSUsMember" name="PerformanceRSUsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate" name="ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="etnb_IncomeTaxDisclosureLineItems" name="IncomeTaxDisclosureLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="etnb_IncomeTaxDisclosureTable" name="IncomeTaxDisclosureTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="etnb_EightyNineBioLtdMember" name="EightyNineBioLtdMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="etnb_EightyNineBioManagementIncorporationMember" name="EightyNineBioManagementIncorporationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="etnb_UABEightyNineBioLithuaniaMember" name="UABEightyNineBioLithuaniaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="etnb_AccumulatedTaxLossCarryForward" name="AccumulatedTaxLossCarryForward" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="etnb_TaxableIncomeUtilizationPercentage" name="TaxableIncomeUtilizationPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal" name="DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="etnb_UnvestedRestrictedStockUnitsMember" name="UnvestedRestrictedStockUnitsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>16
<FILENAME>etnb-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-03-24T17:57:06.7575097+00:00 -->
<!-- Version            : 5.0.1.728 -->
<!-- Package ID         : 577eac3b881348d89343ad261f9a5e63 -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef xlink:type="simple" xlink:href="etnb-20211231.xsd#TemplateLink" roleURI="http://www.89bio.com/20211231/role/TemplateLink" />
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="etnb-20211231.xsd#Role_StatementConsolidatedBalanceSheets" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ShortTermAvailableForSaleSecuritiesCurrent" xlink:type="locator" xlink:label="etnb_ShortTermAvailableForSaleSecuritiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TermLoanCurrent" xlink:type="locator" xlink:label="etnb_TermLoanCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_OtherNonCurrentLiability" xlink:type="locator" xlink:label="etnb_OtherNonCurrentLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:type="locator" xlink:label="us-gaap_LongTermDebtNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="10080.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="10090.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LongTermDebtNoncurrent" order="10100.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="etnb_OtherNonCurrentLiability" order="10110.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="10120.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="10130.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="etnb_TermLoanCurrent" order="10140.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="10150.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10160.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="10170.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10180.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_RestrictedCashCurrent" order="10190.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="etnb_ShortTermAvailableForSaleSecuritiesCurrent" order="10200.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="10210.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="etnb-20211231.xsd#Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLoss" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10060.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="10080.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="10090.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="10100.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="etnb-20211231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_DeferredTaxAssets" xlink:type="locator" xlink:label="etnb_DeferredTaxAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:type="locator" xlink:label="us-gaap_Depreciation" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" xlink:type="locator" xlink:label="etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_PaymentForPurchaseOfAvailableForSaleSecurities" xlink:type="locator" xlink:label="etnb_PaymentForPurchaseOfAvailableForSaleSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ProceedsFromIssuancePublicOffering" xlink:type="locator" xlink:label="etnb_ProceedsFromIssuancePublicOffering" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_RestrictedCashCurrent" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="etnb_ProceedsFromIssuancePublicOffering" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" order="10080.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="10090.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts" order="10100.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" order="10110.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="etnb_PaymentForPurchaseOfAvailableForSaleSecurities" order="10120.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="10130.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="10140.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="10150.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="10160.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" order="10170.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_Depreciation" order="10180.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="etnb_DeferredTaxAssets" order="10190.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="10200.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="10210.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="10220.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="10010.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="10030.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails">
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" xlink:type="locator" xlink:label="etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" order="10020.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:type="locator" xlink:label="us-gaap_OtherPrepaidExpenseCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes" xlink:type="locator" xlink:label="us-gaap_PrepaidTaxes" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_PrepaidResearchAndDevelopmentCurrent" xlink:type="locator" xlink:label="etnb_PrepaidResearchAndDevelopmentCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="etnb_PrepaidResearchAndDevelopmentCurrent" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidTaxes" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent" order="10030.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AccruedResearchAndDevelopmentExpenseCurrent" xlink:type="locator" xlink:label="etnb_AccruedResearchAndDevelopmentExpenseCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="etnb_AccruedResearchAndDevelopmentExpenseCurrent" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="10040.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="10020.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:type="locator" xlink:label="us-gaap_LongTermDebtCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:type="locator" xlink:label="us-gaap_LongTermDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:type="locator" xlink:label="us-gaap_LongTermDebtNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebt" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtCurrent" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="10040.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree" order="10070.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="10060.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="10020.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOther" order="10080.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization" xlink:type="locator" xlink:label="etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="10060.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>17
<FILENAME>etnb-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-03-24T17:57:06.7575097+00:00 -->
<!-- Version            : 5.0.1.728 -->
<!-- Package ID         : 577eac3b881348d89343ad261f9a5e63 -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef xlink:type="simple" xlink:href="etnb-20211231.xsd#TemplateLink" roleURI="http://www.89bio.com/20211231/role/TemplateLink" />
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" xlink:href="etnb-20211231.xsd#Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing" xlink:type="locator" xlink:label="etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" xlink:type="locator" xlink:label="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ATMFacilityMember" xlink:type="locator" xlink:label="etnb_ATMFacilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:type="locator" xlink:label="us-gaap_IPOMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_2" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_2" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_ATMFacilityMember" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="10320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="10460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10480.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="10600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="10620.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="10740.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="10760.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" order="10880.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="11020.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing" order="11440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="11580.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="11720.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" xlink:href="etnb-20211231.xsd#Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical">
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TemporaryEquityIssuanceCosts" xlink:type="locator" xlink:label="etnb_TemporaryEquityIssuanceCosts" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ATMFacilityMember" xlink:type="locator" xlink:label="etnb_ATMFacilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:type="locator" xlink:label="us-gaap_IPOMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ConvertiblePreferredSharesMember" xlink:type="locator" xlink:label="etnb_ConvertiblePreferredSharesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="etnb_ConvertiblePreferredSharesMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_ATMFacilityMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_TemporaryEquityIssuanceCosts" order="10240.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="etnb-20211231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows">
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" xlink:type="locator" xlink:label="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="locator" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaidNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ProceedsFromIssuancePublicOffering" xlink:type="locator" xlink:label="etnb_ProceedsFromIssuancePublicOffering" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_PaymentForPurchaseOfAvailableForSaleSecurities" xlink:type="locator" xlink:label="etnb_PaymentForPurchaseOfAvailableForSaleSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_DeferredTaxAssets" xlink:type="locator" xlink:label="etnb_DeferredTaxAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:type="locator" xlink:label="us-gaap_Depreciation" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" xlink:type="locator" xlink:label="etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10230.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="10420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="10460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="10540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="10580.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" order="10620.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" order="10660.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="etnb_DeferredTaxAssets" order="10700.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="10740.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="10820.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="10860.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="10900.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10940.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="10980.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" order="11060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="etnb_PaymentForPurchaseOfAvailableForSaleSecurities" order="11100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="11140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="11180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="11220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" order="11300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="etnb_ProceedsFromIssuancePublicOffering" order="11340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" order="11380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="11420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts" order="11460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="11500.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="11540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="11580.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" order="11660.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="11740.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_RestrictedCashCurrent" order="11780.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="11860.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="11940.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_IncomeTaxesPaidNet" order="11980.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" order="12020.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" order="12100.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_SellingCommissionPerSharesSoldPercentage" xlink:type="locator" xlink:label="etnb_SellingCommissionPerSharesSoldPercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_PaymentsOfStockIssuanceCostsOther" xlink:type="locator" xlink:label="etnb_PaymentsOfStockIssuanceCostsOther" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:type="locator" xlink:label="dei_EntityIncorporationDateOfIncorporation" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember" xlink:type="locator" xlink:label="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ATMFacilityMember" xlink:type="locator" xlink:label="etnb_ATMFacilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_UnderwrittenPublicOfferingMember" xlink:type="locator" xlink:label="etnb_UnderwrittenPublicOfferingMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="locator" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="etnb_UnderwrittenPublicOfferingMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10630.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_ATMFacilityMember" order="10650.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember" order="10670.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="srt_RangeAxis" order="10740.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_2" order="10750.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10770.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10790.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10810.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dei_EntityIncorporationDateOfIncorporation" order="10840.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10890.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="10910.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="10930.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="10950.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="etnb_PaymentsOfStockIssuanceCostsOther" order="10970.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="11320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="etnb_SellingCommissionPerSharesSoldPercentage" order="11380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="11560.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments" order="11650.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_SummaryOfSignificantAccountingPoliciesTable" xlink:type="locator" xlink:label="etnb_SummaryOfSignificantAccountingPoliciesTable" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="locator" xlink:label="etnb_SummaryOfSignificantAccountingPoliciesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="etnb_SummaryOfSignificantAccountingPoliciesTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_RangeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_2" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" order="10310.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AgencyDiscountSecuritiesMember" xlink:type="locator" xlink:label="etnb_AgencyDiscountSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryBillSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USTreasuryBillSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember" xlink:type="locator" xlink:label="us-gaap_ShortTermInvestmentsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsMember" xlink:type="locator" xlink:label="us-gaap_CashEquivalentsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_ForeignGovernmentDebtSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MunicipalBondsMember" xlink:type="locator" xlink:label="us-gaap_MunicipalBondsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AgencySecuritiesMember" xlink:type="locator" xlink:label="us-gaap_AgencySecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateDebtSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember" xlink:type="locator" xlink:label="us-gaap_CommercialPaperMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="10040.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_2" order="10080.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_InvestmentTypeAxis" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember_2" order="10320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="10360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CommercialPaperMember" order="10380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" order="10400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="10420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_AgencySecuritiesMember" order="10440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_MunicipalBondsMember" order="10460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_ForeignGovernmentDebtSecuritiesMember" order="10480.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CashEquivalentsMember" order="10500.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_ShortTermInvestmentsMember" order="10520.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USTreasuryBillSecuritiesMember" order="10960.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="etnb_AgencyDiscountSecuritiesMember" order="10980.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="11050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="11350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="11650.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="11950.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
    <link:loc xlink:href="etnb-20211231.xsd#etnb_MilestonePayment" xlink:type="locator" xlink:label="etnb_MilestonePayment" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled" xlink:type="locator" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure" xlink:type="locator" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice" xlink:type="locator" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones" xlink:type="locator" xlink:label="etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment" xlink:type="locator" xlink:label="etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecurityDeposit" xlink:type="locator" xlink:label="us-gaap_SecurityDeposit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:type="locator" xlink:label="us-gaap_LeaseAndRentalExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_OperatingLeaseMonthlyRentalPayments" xlink:type="locator" xlink:label="etnb_OperatingLeaseMonthlyRentalPayments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DescriptionOfLesseeLeasingArrangementsOperatingLeases" xlink:type="locator" xlink:label="us-gaap_DescriptionOfLesseeLeasingArrangementsOperatingLeases" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TevasDevelopmentProgramMember" xlink:type="locator" xlink:label="etnb_TevasDevelopmentProgramMember" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TevasGlycoPEGylatedFGF21ProgramMember" xlink:type="locator" xlink:label="etnb_TevasGlycoPEGylatedFGF21ProgramMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TevaAgreementMember" xlink:type="locator" xlink:label="etnb_TevaAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_RestrictedCashAndOtherAssetsMember" xlink:type="locator" xlink:label="etnb_RestrictedCashAndOtherAssetsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_SanFranciscoOfficeMember" xlink:type="locator" xlink:label="etnb_SanFranciscoOfficeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable" xlink:type="locator" xlink:label="us-gaap_LossContingenciesTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:type="locator" xlink:label="us-gaap_LossContingenciesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="srt_StatementGeographicalAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="etnb_SanFranciscoOfficeMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain_2" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="etnb_RestrictedCashAndOtherAssetsMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_TevaAgreementMember" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" order="10320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_2" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="etnb_TevasGlycoPEGylatedFGF21ProgramMember" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="etnb_TevasDevelopmentProgramMember" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10560.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_2" order="10570.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="10610.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_DescriptionOfLesseeLeasingArrangementsOperatingLeases" order="10640.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_OperatingLeaseMonthlyRentalPayments" order="10660.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" order="10680.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" order="10810.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LeaseAndRentalExpense" order="10880.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_SecurityDeposit" order="10920.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment" order="10990.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones" order="11010.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice" order="11100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure" order="11120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled" order="11140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_MilestonePayment" order="11190.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureTermLoanAdditionalInformationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTerm" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_FairValueOfWarrantsAssumptionsDividends" xlink:type="locator" xlink:label="etnb_FairValueOfWarrantsAssumptionsDividends" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMeasurementInput" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_PercentageOfFeeOnLoan" xlink:type="locator" xlink:label="etnb_PercentageOfFeeOnLoan" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_NetCashProceedsFromSaleOfEquitySecurities" xlink:type="locator" xlink:label="etnb_NetCashProceedsFromSaleOfEquitySecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit" xlink:type="locator" xlink:label="us-gaap_LineOfCredit" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity" xlink:type="locator" xlink:label="etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross" xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityDescription" xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityDescription" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputExpectedTermMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedDividendPaymentMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputExpectedDividendPaymentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:type="locator" xlink:label="us-gaap_ValuationTechniqueOptionPricingModelMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:type="locator" xlink:label="us-gaap_ValuationTechniqueDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:type="locator" xlink:label="us-gaap_ValuationTechniqueDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:type="locator" xlink:label="us-gaap_ValuationTechniqueAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrimeRateMember" xlink:type="locator" xlink:label="us-gaap_PrimeRateMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain" xlink:type="locator" xlink:label="us-gaap_VariableRateDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain" xlink:type="locator" xlink:label="us-gaap_VariableRateDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis" xlink:type="locator" xlink:label="us-gaap_VariableRateAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember" xlink:type="locator" xlink:label="us-gaap_OtherAssetsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TermBLoanFacilityMember" xlink:type="locator" xlink:label="etnb_TermBLoanFacilityMember" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TermALoanFacilityMember" xlink:type="locator" xlink:label="etnb_TermALoanFacilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_LoanAndSecurityAgreementMember" xlink:type="locator" xlink:label="etnb_LoanAndSecurityAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_LoanAndSecurityAgreementMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_2" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="etnb_TermALoanFacilityMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="etnb_TermBLoanFacilityMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="10440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="10470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherAssetsMember" order="10490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_RangeAxis" order="10720.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10750.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10770.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10790.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_VariableRateAxis" order="11100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain_2" order="11110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="11130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_PrimeRateMember" order="11150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_ValuationTechniqueAxis" order="11380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueDomain_2" order="11390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueDomain" order="11410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ValuationTechniqueDomain" xlink:to="us-gaap_ValuationTechniqueOptionPricingModelMember" order="11430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_MeasurementInputTypeAxis" order="11480.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain_2" order="11490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain" order="11510.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember" order="11530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedDividendPaymentMember" order="11550.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember" order="11570.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedTermMember" order="11590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="11740.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityDescription" order="11780.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="11830.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="11850.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate" order="11870.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DeferredFinanceCostsGross" order="11890.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="11930.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="11950.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="11970.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity" order="12040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCredit" order="12150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1" order="12170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="etnb_NetCashProceedsFromSaleOfEquitySecurities" order="12190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" order="12210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" order="12230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="etnb_PercentageOfFeeOnLoan" order="12250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMeasurementInput" order="12360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="etnb_FairValueOfWarrantsAssumptionsDividends" order="12380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTerm" order="12420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DeferredTaxAssetsGross" order="12510.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails">
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary" xlink:type="locator" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue" xlink:type="locator" xlink:label="etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate" xlink:type="locator" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriod" xlink:type="locator" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod" xlink:type="locator" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding" xlink:type="locator" xlink:label="etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance" xlink:type="locator" xlink:label="etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement" xlink:type="locator" xlink:label="etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ExecutiveOfficerMember" xlink:type="locator" xlink:label="srt_ExecutiveOfficerMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="locator" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_PerformanceRSUsMember" xlink:type="locator" xlink:label="etnb_PerformanceRSUsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ServiceBasedRSUsMember" xlink:type="locator" xlink:label="etnb_ServiceBasedRSUsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TwoThousandAndTwentyEquityIncentivePlanMember" xlink:type="locator" xlink:label="etnb_TwoThousandAndTwentyEquityIncentivePlanMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TwoThousandAndNineteenEquityIncentivePlanMember" xlink:type="locator" xlink:label="etnb_TwoThousandAndNineteenEquityIncentivePlanMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_2" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="etnb_TwoThousandAndNineteenEquityIncentivePlanMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" order="10510.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="etnb_TwoThousandAndTwentyEquityIncentivePlanMember" order="10770.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10840.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="10850.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10870.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="etnb_ServiceBasedRSUsMember" order="10890.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10970.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="etnb_PerformanceRSUsMember" order="11010.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" order="11080.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_2" order="11090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="11110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="us-gaap_ShareBasedPaymentArrangementEmployeeMember" order="11130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ExecutiveOfficerMember" order="11210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement" order="11300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance" order="11320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding" order="11340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="11360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="11410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" order="11430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" order="11450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod" order="11470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="11490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" order="11600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriod" order="11650.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate" order="11670.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="11720.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" order="11770.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="11830.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="11890.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="11950.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="12010.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue" order="12070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="12130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="12250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="12310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary" order="12550.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="10140.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" order="10300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="10380.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:type="locator" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:type="locator" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TwoThousandAndNineteenEquityIncentivePlanMember" xlink:type="locator" xlink:label="etnb_TwoThousandAndNineteenEquityIncentivePlanMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="etnb_TwoThousandAndNineteenEquityIncentivePlanMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="10300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="10360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="10380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="10400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="10440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="10490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="10530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="10550.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="10570.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="10590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="10630.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" order="10680.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="10880.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="11080.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" order="11210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="11250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="11290.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_UABEightyNineBioLithuaniaMember" xlink:type="locator" xlink:label="etnb_UABEightyNineBioLithuaniaMember" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_EightyNineBioManagementIncorporationMember" xlink:type="locator" xlink:label="etnb_EightyNineBioManagementIncorporationMember" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_EightyNineBioLtdMember" xlink:type="locator" xlink:label="etnb_EightyNineBioLtdMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IncomeTaxDisclosureTable" xlink:type="locator" xlink:label="etnb_IncomeTaxDisclosureTable" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IncomeTaxDisclosureLineItems" xlink:type="locator" xlink:label="etnb_IncomeTaxDisclosureLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_IncomeTaxDisclosureTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="etnb_EightyNineBioLtdMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="etnb_EightyNineBioManagementIncorporationMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="etnb_UABEightyNineBioLithuaniaMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="10160.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IL" xlink:type="locator" xlink:label="country_IL" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:type="locator" xlink:label="country_US" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IncomeTaxDisclosureTable" xlink:type="locator" xlink:label="etnb_IncomeTaxDisclosureTable" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IncomeTaxDisclosureLineItems" xlink:type="locator" xlink:label="etnb_IncomeTaxDisclosureLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_IncomeTaxDisclosureTable" order="10090.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="srt_StatementGeographicalAxis" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_IL" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" order="10380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsOther" order="10420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsGross" order="10460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="10500.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsNet" order="10540.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal" xlink:type="locator" xlink:label="etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TaxableIncomeUtilizationPercentage" xlink:type="locator" xlink:label="etnb_TaxableIncomeUtilizationPercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwardsLimitationsOnUse" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AccumulatedTaxLossCarryForward" xlink:type="locator" xlink:label="etnb_AccumulatedTaxLossCarryForward" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:type="locator" xlink:label="country_US" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IL" xlink:type="locator" xlink:label="country_IL" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IncomeTaxDisclosureTable" xlink:type="locator" xlink:label="etnb_IncomeTaxDisclosureTable" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IncomeTaxDisclosureLineItems" xlink:type="locator" xlink:label="etnb_IncomeTaxDisclosureLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_IncomeTaxDisclosureTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="srt_StatementGeographicalAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_IL" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_AccumulatedTaxLossCarryForward" order="10380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLimitationsOnUse" order="10460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_TaxableIncomeUtilizationPercentage" order="10500.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal" order="10570.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="10610.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" order="10680.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="10720.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IL" xlink:type="locator" xlink:label="country_IL" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_LT" xlink:type="locator" xlink:label="country_LT" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:type="locator" xlink:label="country_US" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IncomeTaxDisclosureTable" xlink:type="locator" xlink:label="etnb_IncomeTaxDisclosureTable" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IncomeTaxDisclosureLineItems" xlink:type="locator" xlink:label="etnb_IncomeTaxDisclosureLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_IncomeTaxDisclosureTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="srt_StatementGeographicalAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_LT" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_IL" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="10160.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" xlink:label="us-gaap_WarrantMember" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_UnvestedRestrictedStockUnitsMember" xlink:type="locator" xlink:label="etnb_UnvestedRestrictedStockUnitsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="etnb_UnvestedRestrictedStockUnitsMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="10160.00" priority="2" use="optional" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>18
<FILENAME>etnb-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-03-24T17:57:06.7575097+00:00 -->
<!-- Version            : 5.0.1.728 -->
<!-- Package ID         : 577eac3b881348d89343ad261f9a5e63 -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#axisDefault" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" xlink:type="locator" xlink:label="etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" />
    <link:label xml:lang="en-US" xlink:label="etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Available for sale securities debt maturities after one through two years fair value.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" xlink:to="etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_lbl" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization" xlink:type="locator" xlink:label="etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization" />
    <link:label xml:lang="en-US" xlink:label="etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Income tax reconciliation change in effective tax rate due to reorganization.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization" xlink:to="etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Voluntary Filers</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Voluntary Filers</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:type="locator" xlink:label="dei_EntityFilerCategory" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFilerCategory_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFilerCategory_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Well-known Seasoned Issuer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Well Known Seasoned Issuer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:type="locator" xlink:label="dei_EntityPublicFloat" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityPublicFloat_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Public Float</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityPublicFloat_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Public Float</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Common Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ICFR Auditor Attestation Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Icfr Auditor Attestation Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:type="locator" xlink:label="dei_EntityShellCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityShellCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityShellCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:type="locator" xlink:label="dei_EntitySmallBusiness" />
    <link:label xml:lang="en-US" xlink:label="dei_EntitySmallBusiness_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntitySmallBusiness_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line2</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:type="locator" xlink:label="dei_DocumentAnnualReport" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentAnnualReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Annual Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentAnnualReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Annual Report</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:type="locator" xlink:label="dei_DocumentTransitionReport" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentTransitionReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentTransitionReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="locator" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Documents Incorporated by Reference</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Documents Incorporated By Reference [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:type="locator" xlink:label="dei_AuditorFirmId" />
    <link:label xml:lang="en-US" xlink:label="dei_AuditorFirmId_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Firm ID</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AuditorFirmId_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Firm Id</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:type="locator" xlink:label="dei_AuditorName" />
    <link:label xml:lang="en-US" xlink:label="dei_AuditorName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AuditorName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:type="locator" xlink:label="dei_AuditorLocation" />
    <link:label xml:lang="en-US" xlink:label="dei_AuditorLocation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AuditorLocation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Location</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ShortTermAvailableForSaleSecuritiesCurrent" xlink:type="locator" xlink:label="etnb_ShortTermAvailableForSaleSecuritiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="etnb_ShortTermAvailableForSaleSecuritiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Short term available for sale securities current.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ShortTermAvailableForSaleSecuritiesCurrent" xlink:to="etnb_ShortTermAvailableForSaleSecuritiesCurrent_lbl" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TermLoanCurrent" xlink:type="locator" xlink:label="etnb_TermLoanCurrent" />
    <link:label xml:lang="en-US" xlink:label="etnb_TermLoanCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Term loan current.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_TermLoanCurrent" xlink:to="etnb_TermLoanCurrent_lbl" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_OtherNonCurrentLiability" xlink:type="locator" xlink:label="etnb_OtherNonCurrentLiability" />
    <link:label xml:lang="en-US" xlink:label="etnb_OtherNonCurrentLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Other non-current liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_OtherNonCurrentLiability" xlink:to="etnb_OtherNonCurrentLiability_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Financial Position [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets Current [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents At Carrying Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedCashCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashCurrent" xlink:to="us-gaap_RestrictedCashCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedCashCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash Current</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_ShortTermAvailableForSaleSecuritiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term available-for-sale securities</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_ShortTermAvailableForSaleSecuritiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Short Term Available For Sale Securities Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense And Other Assets Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Net</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets Noncurrent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Assets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Assets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities and stockholders&#8217; equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities And Stockholders Equity [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Current [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities Current</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_TermLoanCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term loan, current</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_TermLoanCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Term Loan Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:type="locator" xlink:label="us-gaap_LongTermDebtNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term loan, non-current, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_OtherNonCurrentLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other non-current liability</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_OtherNonCurrentLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Non Current Liability</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Liabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Liabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and contingencies (Note 5)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders&#8217; equity:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, $0.001 par value, 10,000,000 shares authorized as of December 31, 2021 and 2020, respectively, no shares issued and outstanding as of December 31, 2021 and 2020, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, $0.001 par value, 100,000,000 shares authorized as of December 31, 2021 and 2020, respectively; 20,317,204 and 19,931,660 shares issued and outstanding as of December 31, 2021 and 2020, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid In Capital Common Stock</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated other comprehensive loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income Loss Net Of Tax</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings Accumulated Deficit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders&#8217; equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities and stockholders&#8217; equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities And Stockholders Equity</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, par value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Par Or Stated Value Per Share</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Authorized</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Issued</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, par value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Par Or Stated Value Per Share</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Authorized</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Issued</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">General And Administrative Expense</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss from operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income Loss</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other expenses, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income Expense</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss before income tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Income tax benefit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense Benefit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Income Loss</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossTaxAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossTaxAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive (loss) income:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossTaxAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossTaxAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income Loss Tax [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized (loss) gain on available-for-sale securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign currency translation adjustments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other comprehensive loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income Loss Net Of Tax</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Comprehensive loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income Net Of Tax</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share, basic and diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Basic And Diluted</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average shares used to compute net loss per share, basic and diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number Of Share Outstanding Basic And Diluted</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" xlink:type="locator" xlink:label="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" />
    <link:label xml:lang="en-US" xlink:label="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock warrant in connection with term loan facility.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" xlink:to="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility_lbl" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing" xlink:type="locator" xlink:label="etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing" />
    <link:label xml:lang="en-US" xlink:label="etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock warrant in connection with debt financing.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing" xlink:to="etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Stockholders Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Components</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Equity Components [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-in Capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid In Capital [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Other Comprehensive Loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Retained Earnings</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary Sale Of Stock [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sale Of Stock Name Of Transaction [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:type="locator" xlink:label="us-gaap_IPOMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IPOMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Public Offerings</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IPOMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">I P O [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Type Of Arrangement [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Arrangements And Nonarrangement Transactions [Member]</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ATMFacilityMember" xlink:type="locator" xlink:label="etnb_ATMFacilityMember" />
    <link:label xml:lang="en-US" xlink:label="etnb_ATMFacilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">A T M Facility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ATMFacilityMember" xlink:to="etnb_ATMFacilityMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_ATMFacilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">A T M Facility [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance, shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value New Issues</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock, shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares New Issues</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of stock options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Stock Options Exercised</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of stock options, shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Stock Options Exercised</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon ESPP purchase</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Employee Stock Purchase Plan</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon ESPP purchase, Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Employee Stock Purchase Plans</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock warrant in connection with term loan facility</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock Warrant In Connection With Term Loan Facility</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance Of Common Stock Warrants In Connection With Debt Financing</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock Warrants In Connection With Debt Financing</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Other comprehensive loss</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance, shares</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TemporaryEquityIssuanceCosts" xlink:type="locator" xlink:label="etnb_TemporaryEquityIssuanceCosts" />
    <link:label xml:lang="en-US" xlink:label="etnb_TemporaryEquityIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity, issuance costs.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_TemporaryEquityIssuanceCosts" xlink:to="etnb_TemporaryEquityIssuanceCosts_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Class Of Stock [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Stock [Domain]</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ConvertiblePreferredSharesMember" xlink:type="locator" xlink:label="etnb_ConvertiblePreferredSharesMember" />
    <link:label xml:lang="en-US" xlink:label="etnb_ConvertiblePreferredSharesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible preferred shares.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ConvertiblePreferredSharesMember" xlink:to="etnb_ConvertiblePreferredSharesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_ConvertiblePreferredSharesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Shares</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_ConvertiblePreferredSharesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Shares [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_TemporaryEquityIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary equity, issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_TemporaryEquityIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Issuance Costs</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" xlink:type="locator" xlink:label="etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" />
    <link:label xml:lang="en-US" xlink:label="etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Amortization of debt issuance costs and accretion of final payment fee.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" xlink:to="etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee_lbl" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_DeferredTaxAssets" xlink:type="locator" xlink:label="etnb_DeferredTaxAssets" />
    <link:label xml:lang="en-US" xlink:label="etnb_DeferredTaxAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_DeferredTaxAssets" xlink:to="etnb_DeferredTaxAssets_lbl" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_PaymentForPurchaseOfAvailableForSaleSecurities" xlink:type="locator" xlink:label="etnb_PaymentForPurchaseOfAvailableForSaleSecurities" />
    <link:label xml:lang="en-US" xlink:label="etnb_PaymentForPurchaseOfAvailableForSaleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Payment for purchases of available for sale securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_PaymentForPurchaseOfAvailableForSaleSecurities" xlink:to="etnb_PaymentForPurchaseOfAvailableForSaleSecurities_lbl" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ProceedsFromIssuancePublicOffering" xlink:type="locator" xlink:label="etnb_ProceedsFromIssuancePublicOffering" />
    <link:label xml:lang="en-US" xlink:label="etnb_ProceedsFromIssuancePublicOffering_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from issuance public offering.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ProceedsFromIssuancePublicOffering" xlink:to="etnb_ProceedsFromIssuancePublicOffering_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Cash Flows [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ESPP Purchases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockMember" xlink:to="us-gaap_EmployeeStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProfitLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProfitLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Profit Loss</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Amortization of premium on available-for-sale securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accretion Amortization Of Discounts And Premiums Investments</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Amortization of debt issuance costs and accretion of final payment fee</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amortization Of Debt Issuance Costs And Accretion Of Final Payment Fee</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:type="locator" xlink:label="us-gaap_Depreciation" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Depreciation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Depreciation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_DeferredTaxAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Deferred tax assets</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_DeferredTaxAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in operating assets and liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Operating Capital [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Prepaid Deferred Expense And Other Assets</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accounts Payable</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accrued Liabilities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Operating Activities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from investing activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Investing Activities [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from sales and maturities of available-for-sale securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Sale And Maturity Of Available For Sale Securities</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_PaymentForPurchaseOfAvailableForSaleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of available-for-sale securities</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_PaymentForPurchaseOfAvailableForSaleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payment For Purchase Of Available For Sale Securities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of property and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire Property Plant And Equipment</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by (used in) investing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Investing Activities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from financing activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Financing Activities [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from term loan facility, net of issuance costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Other Long Term Debt</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_ProceedsFromIssuancePublicOffering_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock upon public offerings,net of issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_ProceedsFromIssuancePublicOffering_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Public Offering</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock upon stock option exercises</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock upon ESPP purchases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Common Stock</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Payment of debt issuance costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments Of Debt Issuance Costs</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Financing Activities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net change in cash and cash equivalents, and restricted cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash and cash equivalents, and restricted cash at beginning of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash and cash equivalents, and restricted cash at end of period</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Components of cash and cash equivalents, and restricted cash:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total cash and cash equivalents, and restricted cash</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosures of cash information:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest Paid Net</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaidNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Taxes Paid Net</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="locator" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosures of noncash information:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Noncash Investing And Financing Items [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Organization Consolidation And Presentation Of Financial Statements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Organization and Basis of Presentation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Significant Accounting Policies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_BalanceSheetRelatedDisclosuresAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="locator" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consolidated Balance Sheet Components</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:type="locator" xlink:label="us-gaap_LongTermDebtTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term Loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTextBlock" xlink:to="us-gaap_LongTermDebtTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Of Compensation Related Costs Share Based Payments [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Events</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Basis Of Accounting Policy Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Principles of Consolidation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign Currencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Foreign Currency Transactions And Translations Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Use Of Estimates</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement Policy Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentrations of Credit Risk</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Credit Risk</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_OtherRisksAndUncertaintiesPolicyTextBlock" xlink:type="locator" xlink:label="etnb_OtherRisksAndUncertaintiesPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="etnb_OtherRisksAndUncertaintiesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Other risks and uncertainties.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_OtherRisksAndUncertaintiesPolicyTextBlock" xlink:to="etnb_OtherRisksAndUncertaintiesPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_OtherRisksAndUncertaintiesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Risks and Uncertainties</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_OtherRisksAndUncertaintiesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Risks And Uncertainties Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segment Reporting</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting Policy Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents and Restricted Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents Restricted Cash And Cash Equivalents Policy</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investment Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of Long-Lived Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Impairment Or Disposal Of Long Lived Assets Policy [Text Block]</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock" xlink:type="locator" xlink:label="etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued research and development expenses.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock" xlink:to="etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued Research and Development Expenses</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Research And Development Expenses Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Leases Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense Policy</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Option And Incentive Plans Policy</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basic and Diluted Net Loss per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Comprehensive Loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income Policy Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recent Accounting Pronouncements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements Policy Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Financial Assets Measured at Fair Value on Recurring Basis</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="locator" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Contractual Maturities of Cash Equivalents and Available-for-Sale Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investments Classified By Contractual Maturity Date Table [Text Block]</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock" xlink:type="locator" xlink:label="etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of prepaid and other current assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock" xlink:to="etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Prepaid and Other Current Assets</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Prepaid And Other Current Assets Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Accrued Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Accrued Liabilities Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Future Minimum Rental Payments For Operating Leases Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Repayment of Principal Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Maturities Of Long Term Debt Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock-Based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Estimated Fair Value of Stock Options Granted Using Black-Scholes Option-Pricing Model</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock Option Activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock" xlink:type="locator" xlink:label="etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of effective income tax rate of company and subsidiaries.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock" xlink:to="etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Effective Income Tax Rate Of Company And Subsidiaries Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Income Tax Benefit (Expense)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Components Of Income Tax Expense Benefit Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Components of Deferred Tax Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Deferred Tax Assets And Liabilities Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Loss from Operations Before Taxes on Income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Income Before Income Tax Domestic And Foreign Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Reconciliation of Income Tax Benefit (Expense) Statutory Tax Rate to Effective Tax Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="locator" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsidiary Or Equity Method Investee Sale Of Stock By Subsidiary Or Equity Investee [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary Or Equity Method Investee Sale Of Stock By Subsidiary Or Equity Investee [Table]</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_UnderwrittenPublicOfferingMember" xlink:type="locator" xlink:label="etnb_UnderwrittenPublicOfferingMember" />
    <link:label xml:lang="en-US" xlink:label="etnb_UnderwrittenPublicOfferingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Underwritten Public Offering [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_UnderwrittenPublicOfferingMember" xlink:to="etnb_UnderwrittenPublicOfferingMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_UnderwrittenPublicOfferingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Underwritten public offering</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_UnderwrittenPublicOfferingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Underwritten Public Offering [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_ATMFacilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">ATM facility.</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember" xlink:type="locator" xlink:label="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember" />
    <link:label xml:lang="en-US" xlink:label="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Svb leerink llc and cantor fitzgerald &amp; co.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember" xlink:to="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">SVB Leerink LLC</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">S V B Leerink L L C And Cantor Fitzgerald Co [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Range [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Range [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:label xml:lang="en-US" xlink:label="srt_MaximumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_MaximumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:label xml:lang="en-US" xlink:label="srt_MinimumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_MinimumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsidiary Sale Of Stock [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary Sale Of Stock [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:type="locator" xlink:label="dei_EntityIncorporationDateOfIncorporation" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Date of incorporation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationDateOfIncorporation" xlink:to="dei_EntityIncorporationDateOfIncorporation_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation Date Of Incorporation</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_PaymentsOfStockIssuanceCostsOther" xlink:type="locator" xlink:label="etnb_PaymentsOfStockIssuanceCostsOther" />
    <link:label xml:lang="en-US" xlink:label="etnb_PaymentsOfStockIssuanceCostsOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Payments of stock issuance costs, other.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_PaymentsOfStockIssuanceCostsOther" xlink:to="etnb_PaymentsOfStockIssuanceCostsOther_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares issued and sold</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Proceeds from issuance of common stock, net of underwriters discount and commissions</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">IPO price per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Shares Issued Price Per Share</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment of underwriting discounts, commissions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments Of Stock Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_PaymentsOfStockIssuanceCostsOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other offering expenses</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_PaymentsOfStockIssuanceCostsOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments Of Stock Issuance Costs Other</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_SellingCommissionPerSharesSoldPercentage" xlink:type="locator" xlink:label="etnb_SellingCommissionPerSharesSoldPercentage" />
    <link:label xml:lang="en-US" xlink:label="etnb_SellingCommissionPerSharesSoldPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Selling commission per shares sold percentage.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_SellingCommissionPerSharesSoldPercentage" xlink:to="etnb_SellingCommissionPerSharesSoldPercentage_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_SellingCommissionPerSharesSoldPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Selling commission per shares sold percentage</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_SellingCommissionPerSharesSoldPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Selling Commission Per Shares Sold Percentage</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock, weighted average price per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents and short term available-for-sale securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents And Short Term Investments</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="locator" xlink:label="etnb_SummaryOfSignificantAccountingPoliciesLineItems" />
    <link:label xml:lang="en-US" xlink:label="etnb_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="etnb_SummaryOfSignificantAccountingPoliciesLineItems_lbl" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_SummaryOfSignificantAccountingPoliciesTable" xlink:type="locator" xlink:label="etnb_SummaryOfSignificantAccountingPoliciesTable" />
    <link:label xml:lang="en-US" xlink:label="etnb_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Information related to various accounting policies of the entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesTable" xlink:to="etnb_SummaryOfSignificantAccountingPoliciesTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment By Type [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Type [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold Improvements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Leasehold Improvements [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of operating segments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Operating Segments</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, estimated useful lives</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Useful Life</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold improvements amortization, description</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Estimated Useful Lives</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value By Measurement Frequency [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement Frequency [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recurring</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurements Recurring [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value By Fair Value Hierarchy Level [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurements Fair Value Hierarchy [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 1</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Inputs Level1 [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 2</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Inputs Level2 [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investment Type [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_InvestmentTypeCategorizationMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investment Type Categorization [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Money Market Funds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember" xlink:type="locator" xlink:label="us-gaap_CommercialPaperMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommercialPaperMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commercial Paper</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommercialPaperMember" xlink:to="us-gaap_CommercialPaperMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommercialPaperMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commercial Paper [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. government bonds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" xlink:to="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">U S Government Agencies Shortterm Debt Securities [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateDebtSecuritiesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Corporate Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateDebtSecuritiesMember" xlink:to="us-gaap_CorporateDebtSecuritiesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AgencySecuritiesMember" xlink:type="locator" xlink:label="us-gaap_AgencySecuritiesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AgencySecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Agency bonds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AgencySecuritiesMember" xlink:to="us-gaap_AgencySecuritiesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AgencySecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Agency Securities [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MunicipalBondsMember" xlink:type="locator" xlink:label="us-gaap_MunicipalBondsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MunicipalBondsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Municipal Bonds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MunicipalBondsMember" xlink:to="us-gaap_MunicipalBondsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MunicipalBondsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Municipal Bonds [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_ForeignGovernmentDebtSecuritiesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ForeignGovernmentDebtSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-US debt securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:to="us-gaap_ForeignGovernmentDebtSecuritiesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ForeignGovernmentDebtSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Foreign Government Debt Securities [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsMember" xlink:type="locator" xlink:label="us-gaap_CashEquivalentsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashEquivalentsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsMember" xlink:to="us-gaap_CashEquivalentsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashEquivalentsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Equivalents [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember" xlink:type="locator" xlink:label="us-gaap_ShortTermInvestmentsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShortTermInvestmentsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term available for sale securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestmentsMember" xlink:to="us-gaap_ShortTermInvestmentsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShortTermInvestmentsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Short Term Investments [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryBillSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USTreasuryBillSecuritiesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_USTreasuryBillSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. treasury bills</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasuryBillSecuritiesMember" xlink:to="us-gaap_USTreasuryBillSecuritiesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_USTreasuryBillSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">U S Treasury Bill Securities [Member]</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AgencyDiscountSecuritiesMember" xlink:type="locator" xlink:label="etnb_AgencyDiscountSecuritiesMember" />
    <link:label xml:lang="en-US" xlink:label="etnb_AgencyDiscountSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Agency discount securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_AgencyDiscountSecuritiesMember" xlink:to="etnb_AgencyDiscountSecuritiesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_AgencyDiscountSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Agency discount securities</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_AgencyDiscountSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Agency Discount Securities [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Short-term investments, Amortized Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Debt Securities Amortized Cost Basis</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term investments, Gross Unrealized Holding Gains</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Short-term investments, Gross Unrealized Holding Losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term investments, Aggregated Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Securities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Within one year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Maturities Within One Year Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">After one year through two years</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Maturities After One Through Two Years Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total cash equivalents and available-for-sale securities</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_PrepaidResearchAndDevelopmentCurrent" xlink:type="locator" xlink:label="etnb_PrepaidResearchAndDevelopmentCurrent" />
    <link:label xml:lang="en-US" xlink:label="etnb_PrepaidResearchAndDevelopmentCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Research and development expense prepaid current.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_PrepaidResearchAndDevelopmentCurrent" xlink:to="etnb_PrepaidResearchAndDevelopmentCurrent_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense And Other Assets Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_PrepaidResearchAndDevelopmentCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid research and development</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_PrepaidResearchAndDevelopmentCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Research And Development Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes" xlink:type="locator" xlink:label="us-gaap_PrepaidTaxes" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidTaxes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidTaxes" xlink:to="us-gaap_PrepaidTaxes_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidTaxes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Taxes</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:type="locator" xlink:label="us-gaap_OtherPrepaidExpenseCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPrepaidExpenseCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Prepaid Expense Current</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total prepaid and other current assets</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AccruedResearchAndDevelopmentExpenseCurrent" xlink:type="locator" xlink:label="etnb_AccruedResearchAndDevelopmentExpenseCurrent" />
    <link:label xml:lang="en-US" xlink:label="etnb_AccruedResearchAndDevelopmentExpenseCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued research and development expense current.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_AccruedResearchAndDevelopmentExpenseCurrent" xlink:to="etnb_AccruedResearchAndDevelopmentExpenseCurrent_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payables And Accruals [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_AccruedResearchAndDevelopmentExpenseCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued research and development expenses</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_AccruedResearchAndDevelopmentExpenseCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Research And Development Expense Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued employee and related expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Related Liabilities Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued professional and legal fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Professional Fees Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Accrued Liabilities Current</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total accrued expenses</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_OperatingLeaseMonthlyRentalPayments" xlink:type="locator" xlink:label="etnb_OperatingLeaseMonthlyRentalPayments" />
    <link:label xml:lang="en-US" xlink:label="etnb_OperatingLeaseMonthlyRentalPayments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating lease monthly rental payments.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_OperatingLeaseMonthlyRentalPayments" xlink:to="etnb_OperatingLeaseMonthlyRentalPayments_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable" xlink:type="locator" xlink:label="us-gaap_LossContingenciesTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LossContingenciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss Contingencies [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LossContingenciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingencies [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Geographical [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Segment Geographical [Domain]</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_SanFranciscoOfficeMember" xlink:type="locator" xlink:label="etnb_SanFranciscoOfficeMember" />
    <link:label xml:lang="en-US" xlink:label="etnb_SanFranciscoOfficeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">San Francisco office.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_SanFranciscoOfficeMember" xlink:to="etnb_SanFranciscoOfficeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_SanFranciscoOfficeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">San Francisco Office</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_SanFranciscoOfficeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">San Francisco Office [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Balance Sheet Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Balance Sheet Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_BalanceSheetLocationDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_RestrictedCashAndOtherAssetsMember" xlink:type="locator" xlink:label="etnb_RestrictedCashAndOtherAssetsMember" />
    <link:label xml:lang="en-US" xlink:label="etnb_RestrictedCashAndOtherAssetsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Restricted cash and other assets member.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_RestrictedCashAndOtherAssetsMember" xlink:to="etnb_RestrictedCashAndOtherAssetsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_RestrictedCashAndOtherAssetsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Cash And Other Assets Member</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_RestrictedCashAndOtherAssetsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash And Other Assets [Member]</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TevaAgreementMember" xlink:type="locator" xlink:label="etnb_TevaAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="etnb_TevaAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Teva agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_TevaAgreementMember" xlink:to="etnb_TevaAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_TevaAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Teva Agreements</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_TevaAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Teva Agreement [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Arrangement, Contract to Perform for Others, Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Arrangement Contract To Perform For Others By Type [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Arrangement, Contract to Perform for Others, Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Arrangement Contract To Perform For Others Type [Domain]</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TevasGlycoPEGylatedFGF21ProgramMember" xlink:type="locator" xlink:label="etnb_TevasGlycoPEGylatedFGF21ProgramMember" />
    <link:label xml:lang="en-US" xlink:label="etnb_TevasGlycoPEGylatedFGF21ProgramMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Tevas glycoPEGylated FGF21 program.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_TevasGlycoPEGylatedFGF21ProgramMember" xlink:to="etnb_TevasGlycoPEGylatedFGF21ProgramMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_TevasGlycoPEGylatedFGF21ProgramMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Teva&apos;s GlycoPEGylated FGF21 Program</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_TevasGlycoPEGylatedFGF21ProgramMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tevas Glyco P E Gylated F G F21 Program [Member]</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TevasDevelopmentProgramMember" xlink:type="locator" xlink:label="etnb_TevasDevelopmentProgramMember" />
    <link:label xml:lang="en-US" xlink:label="etnb_TevasDevelopmentProgramMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Tevas development program.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_TevasDevelopmentProgramMember" xlink:to="etnb_TevasDevelopmentProgramMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_TevasDevelopmentProgramMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Teva&apos;s Development Program</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_TevasDevelopmentProgramMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tevas Development Program [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:type="locator" xlink:label="us-gaap_LossContingenciesLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss Contingencies [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DescriptionOfLesseeLeasingArrangementsOperatingLeases" xlink:type="locator" xlink:label="us-gaap_DescriptionOfLesseeLeasingArrangementsOperatingLeases" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DescriptionOfLesseeLeasingArrangementsOperatingLeases_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee, operating lease, description</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DescriptionOfLesseeLeasingArrangementsOperatingLeases" xlink:to="us-gaap_DescriptionOfLesseeLeasingArrangementsOperatingLeases_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DescriptionOfLesseeLeasingArrangementsOperatingLeases_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Description Of Lessee Leasing Arrangements Operating Leases</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_OperatingLeaseMonthlyRentalPayments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease, payments</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_OperatingLeaseMonthlyRentalPayments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Monthly Rental Payments</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee, operating lease term of contract</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Term Of Contract</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee,operating lease, renewal term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Renewal Term</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due Next Twelve Months</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due Year Two</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total future minimum annual payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Future Minimum Payments Due</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:type="locator" xlink:label="us-gaap_LeaseAndRentalExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating leases, rent expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="us-gaap_LeaseAndRentalExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease And Rental Expense</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecurityDeposit" xlink:type="locator" xlink:label="us-gaap_SecurityDeposit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SecurityDeposit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security deposit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityDeposit" xlink:to="us-gaap_SecurityDeposit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SecurityDeposit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Deposit</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment" xlink:type="locator" xlink:label="etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment" />
    <link:label xml:lang="en-US" xlink:label="etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Asset transfer and license agreements initial nonrefundable upfront payment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment" xlink:to="etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment_lbl" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones" xlink:type="locator" xlink:label="etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones" />
    <link:label xml:lang="en-US" xlink:label="etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Obligation to payment upon maximum achievement of certain clinical and commercial milestones.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones" xlink:to="etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Nonrefundable upfront payment</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Asset Transfer And License Agreement Initial Nonrefundable Upfront Payment</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment upon achievement of certain clinical and commercial milestones</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Obligation To Payment Upon Maximum Achievement Of Certain Clinical And Commercial Milestones</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice" xlink:type="locator" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice" />
    <link:label xml:lang="en-US" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Asset transfer and license agreement termination period after written notice.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice" xlink:to="etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice_lbl" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure" xlink:type="locator" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure" />
    <link:label xml:lang="en-US" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Asset transfer and license agreement termination period notice of failure.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure" xlink:to="etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure_lbl" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled" xlink:type="locator" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled" />
    <link:label xml:lang="en-US" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Asset transfer and license agreement termination notice period if bankruptcy petition filed.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled" xlink:to="etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset transfer and license agreement, termination period after written notice</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Asset Transfer And License Agreement Termination Period After Written Notice</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset transfer and license agreement, termination period notice of breach</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Asset Transfer And License Agreement Termination Period Notice Of Failure</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset transfer and license agreement termination notice period if bankruptcy petition filed</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Asset Transfer And License Agreement Termination Notice Period If Bankruptcy Petition Filed</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_MilestonePayment" xlink:type="locator" xlink:label="etnb_MilestonePayment" />
    <link:label xml:lang="en-US" xlink:label="etnb_MilestonePayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Milestone payment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_MilestonePayment" xlink:to="etnb_MilestonePayment_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_MilestonePayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Milestone payments</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_MilestonePayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Milestone Payment</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Table]</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_LoanAndSecurityAgreementMember" xlink:type="locator" xlink:label="etnb_LoanAndSecurityAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="etnb_LoanAndSecurityAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Loan and security agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_LoanAndSecurityAgreementMember" xlink:to="etnb_LoanAndSecurityAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_LoanAndSecurityAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loan Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_LoanAndSecurityAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Loan And Security Agreement [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument, Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Name [Domain]</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TermALoanFacilityMember" xlink:type="locator" xlink:label="etnb_TermALoanFacilityMember" />
    <link:label xml:lang="en-US" xlink:label="etnb_TermALoanFacilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Term A loan facility.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_TermALoanFacilityMember" xlink:to="etnb_TermALoanFacilityMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_TermALoanFacilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term A Loan Facility</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_TermALoanFacilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Term A Loan Facility [Member]</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TermBLoanFacilityMember" xlink:type="locator" xlink:label="etnb_TermBLoanFacilityMember" />
    <link:label xml:lang="en-US" xlink:label="etnb_TermBLoanFacilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Term b loan facility.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_TermBLoanFacilityMember" xlink:to="etnb_TermBLoanFacilityMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_TermBLoanFacilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term B Loan Facility</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_TermBLoanFacilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Term B Loan Facility [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember" xlink:type="locator" xlink:label="us-gaap_OtherAssetsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAssetsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsMember" xlink:to="us-gaap_OtherAssetsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAssetsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis" xlink:type="locator" xlink:label="us-gaap_VariableRateAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VariableRateAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VariableRateAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Variable Rate [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain" xlink:type="locator" xlink:label="us-gaap_VariableRateDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VariableRateDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_VariableRateDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VariableRateDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Variable Rate [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrimeRateMember" xlink:type="locator" xlink:label="us-gaap_PrimeRateMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrimeRateMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prime Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrimeRateMember" xlink:to="us-gaap_PrimeRateMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrimeRateMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prime Rate [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:type="locator" xlink:label="us-gaap_ValuationTechniqueAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationTechniqueAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Valuation Approach and Technique</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationTechniqueAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Technique [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:type="locator" xlink:label="us-gaap_ValuationTechniqueDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationTechniqueDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Valuation Approach and Technique</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueDomain" xlink:to="us-gaap_ValuationTechniqueDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationTechniqueDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Technique [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:type="locator" xlink:label="us-gaap_ValuationTechniqueOptionPricingModelMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationTechniqueOptionPricingModelMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Valuation Technique, Option Pricing Model</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:to="us-gaap_ValuationTechniqueOptionPricingModelMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationTechniqueOptionPricingModelMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Technique Option Pricing Model [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Input Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Input Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Input, Risk Free Interest Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Risk Free Interest Rate [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedDividendPaymentMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputExpectedDividendPaymentMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputExpectedDividendPaymentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Input, Expected Dividend Payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedDividendPaymentMember" xlink:to="us-gaap_MeasurementInputExpectedDividendPaymentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputExpectedDividendPaymentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Expected Dividend Payment [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Input, Price Volatility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Price Volatility [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputExpectedTermMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Input, Expected Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Expected Term [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of credit facility, maximum borrowing capacity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Line Of Credit Facility Maximum Borrowing Capacity</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityDescription" xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityDescription" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LineOfCreditFacilityDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of Credit Facility, Description</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityDescription" xlink:to="us-gaap_LineOfCreditFacilityDescription_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LineOfCreditFacilityDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Line Of Credit Facility Description</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants to purchase common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant exercise price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant expiration date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Warrants And Rights Outstanding Maturity Date</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross" xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredFinanceCostsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Debt issuance costs, gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsGross" xlink:to="us-gaap_DeferredFinanceCostsGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredFinanceCostsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Finance Costs Gross</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk free interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected terms (years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity" xlink:type="locator" xlink:label="etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity" />
    <link:label xml:lang="en-US" xlink:label="etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Line of credit facility increase in borrowing capacity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity" xlink:to="etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of credit facility increase in borrowing capacity</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Line Of Credit Facility Increase In Borrowing Capacity</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_NetCashProceedsFromSaleOfEquitySecurities" xlink:type="locator" xlink:label="etnb_NetCashProceedsFromSaleOfEquitySecurities" />
    <link:label xml:lang="en-US" xlink:label="etnb_NetCashProceedsFromSaleOfEquitySecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Net cash proceeds from sale of equity securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_NetCashProceedsFromSaleOfEquitySecurities" xlink:to="etnb_NetCashProceedsFromSaleOfEquitySecurities_lbl" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_PercentageOfFeeOnLoan" xlink:type="locator" xlink:label="etnb_PercentageOfFeeOnLoan" />
    <link:label xml:lang="en-US" xlink:label="etnb_PercentageOfFeeOnLoan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of fee on loan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_PercentageOfFeeOnLoan" xlink:to="etnb_PercentageOfFeeOnLoan_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit" xlink:type="locator" xlink:label="us-gaap_LineOfCredit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LineOfCredit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term loan amount drawn</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LineOfCredit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LineOfCredit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Line Of Credit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Credit facility maturity date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityExpirationDate1" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Line Of Credit Facility Expiration Date1</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_NetCashProceedsFromSaleOfEquitySecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from sale of available-for-sale securities, equity</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_NetCashProceedsFromSaleOfEquitySecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Proceeds From Sale Of Equity Securities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Interest Rate During Period</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, basis spread on variable rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Basis Spread On Variable Rate1</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_PercentageOfFeeOnLoan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of fee on loan</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_PercentageOfFeeOnLoan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Fee On Loan</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_FairValueOfWarrantsAssumptionsDividends" xlink:type="locator" xlink:label="etnb_FairValueOfWarrantsAssumptionsDividends" />
    <link:label xml:lang="en-US" xlink:label="etnb_FairValueOfWarrantsAssumptionsDividends_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair value of warrant assumptions, dividends.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_FairValueOfWarrantsAssumptionsDividends" xlink:to="etnb_FairValueOfWarrantsAssumptionsDividends_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMeasurementInput" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentMeasurementInput_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair measurement input</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMeasurementInput" xlink:to="us-gaap_DebtInstrumentMeasurementInput_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentMeasurementInput_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Measurement Input</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_FairValueOfWarrantsAssumptionsDividends_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of warrant assumptions, dividends</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_FairValueOfWarrantsAssumptionsDividends_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Of Warrants Assumptions Dividends</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTerm" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair measurement input</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Term</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Gross</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt Maturities Repayments Of Principal In Rolling Year Two</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt Maturities Repayments Of Principal In Rolling Year Three</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total principal repayments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Carrying Amount</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: unamortized debt discount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Unamortized Discount</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:type="locator" xlink:label="us-gaap_LongTermDebt" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total term loan, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:type="locator" xlink:label="us-gaap_LongTermDebtCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: term loan, current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt Current</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Term loan, non-current, net</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement" xlink:type="locator" xlink:label="etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement" />
    <link:label xml:lang="en-US" xlink:label="etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of shares issuable under share-based payment arrangement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement" xlink:to="etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement_lbl" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance" xlink:type="locator" xlink:label="etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance" />
    <link:label xml:lang="en-US" xlink:label="etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Period for increase in number of shares of common stock reserved for issuance.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance" xlink:to="etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance_lbl" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding" xlink:type="locator" xlink:label="etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding" />
    <link:label xml:lang="en-US" xlink:label="etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of increase in number of shares of capital stock reserved for issuance.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding" xlink:to="etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TwoThousandAndNineteenEquityIncentivePlanMember" xlink:type="locator" xlink:label="etnb_TwoThousandAndNineteenEquityIncentivePlanMember" />
    <link:label xml:lang="en-US" xlink:label="etnb_TwoThousandAndNineteenEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">2019 equity incentive plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_TwoThousandAndNineteenEquityIncentivePlanMember" xlink:to="etnb_TwoThousandAndNineteenEquityIncentivePlanMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_TwoThousandAndNineteenEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2019 Plan</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_TwoThousandAndNineteenEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Nineteen Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TwoThousandAndTwentyEquityIncentivePlanMember" xlink:type="locator" xlink:label="etnb_TwoThousandAndTwentyEquityIncentivePlanMember" />
    <link:label xml:lang="en-US" xlink:label="etnb_TwoThousandAndTwentyEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand and twenty equity incentive plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_TwoThousandAndTwentyEquityIncentivePlanMember" xlink:to="etnb_TwoThousandAndTwentyEquityIncentivePlanMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_TwoThousandAndTwentyEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2020 Plan</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_TwoThousandAndTwentyEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Twenty Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ServiceBasedRSUsMember" xlink:type="locator" xlink:label="etnb_ServiceBasedRSUsMember" />
    <link:label xml:lang="en-US" xlink:label="etnb_ServiceBasedRSUsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Service-based RSUs member.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ServiceBasedRSUsMember" xlink:to="etnb_ServiceBasedRSUsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_ServiceBasedRSUsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Service-based RSUs</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_ServiceBasedRSUsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Service Based R S Us [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Stock Units (RSUs)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock Units R S U [Member]</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_PerformanceRSUsMember" xlink:type="locator" xlink:label="etnb_PerformanceRSUsMember" />
    <link:label xml:lang="en-US" xlink:label="etnb_PerformanceRSUsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Performance RSUs.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_PerformanceRSUsMember" xlink:to="etnb_PerformanceRSUsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_PerformanceRSUsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Performance RSUs</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_PerformanceRSUsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Performance R S Us [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Title Of Individual [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Title Of Individual With Relationship To Entity [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="locator" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:to="us-gaap_ShareBasedPaymentArrangementEmployeeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Payment Arrangement Employee [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ExecutiveOfficerMember" xlink:type="locator" xlink:label="srt_ExecutiveOfficerMember" />
    <link:label xml:lang="en-US" xlink:label="srt_ExecutiveOfficerMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Executive Officer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ExecutiveOfficerMember" xlink:to="srt_ExecutiveOfficerMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_ExecutiveOfficerMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Executive Officer [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of common shares issuable under the plan (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Shares Issuable Under Share Based Payment Arrangement</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Period for increase in number of shares of common stock reserved for issuance</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Period For Increase In Number Of Shares Of Common Stock Reserved For Issuance</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of increase in number of shares of capital stock issued and outstanding</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Increase In Number Of Shares Of Capital Stock Issued And Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock reserved and available for issuance as future option grants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Capital Shares Reserved For Future Issuance</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod" xlink:type="locator" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod" />
    <link:label xml:lang="en-US" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award remaining options vesting period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of option vesting</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Terms of award</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Terms Of Award</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Remaining option vesting period</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Remaining Options Vesting Period</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expiration period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percent of purchase shares of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriod" xlink:type="locator" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriod" />
    <link:label xml:lang="en-US" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment first offering period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriod" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriod_lbl" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate" xlink:type="locator" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate" />
    <link:label xml:lang="en-US" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment first offering period commencement date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">First offering period</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment First Offering Period</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commencement date of first six month offering period</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment First Offering Period Commencement Date</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares of common stock available for issuance under ESPP</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Research and Development</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and Administrative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">General And Administrative Expense [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total stock-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Allocated Share Based Compensation Expense</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility, minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility, maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate, minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate, maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected dividend</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Roll Forward</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding, Beginning Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Exercised</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Cancelled and forfeited</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding, Ending Balance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercisable as of December 31, 2021</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Rollforward</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Weighted Average Exercise Price Outstanding, Beginning Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price, Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price, Cancelled and forfeited</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Weighted Average Exercise Price Outstanding, Ending Balance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price, Exercisable as of December 31, 2021</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:type="locator" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" />
    <link:label xml:lang="en-US" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award options weighted average remaining contractual term.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Remaining Contractual Term (In years)</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted Average Remaining Contractual Term (In years), Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Remaining Contractual Term (In years), Exercisable as of December 31, 2021</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:type="locator" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" />
    <link:label xml:lang="en-US" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award options aggregate intrinsic value.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Aggregate Intrinsic Value Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Aggregate Intrinsic Value Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value, Exercisable as of December 31, 2021</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue" xlink:type="locator" xlink:label="etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Sharebased compensation arrangement by sharebased payment award options grant date fair value.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue" xlink:to="etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue_lbl" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary" xlink:type="locator" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary" />
    <link:label xml:lang="en-US" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Period of share based compensation arrangement by share based payment award anniversary.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated total grant date fair value of options vested</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average fair value options granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized stock option granted under plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized weighted average period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares granted</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total grant date fair value</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Share base compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Cancelled shares</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Anniversary period</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Anniversary</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IncomeTaxDisclosureLineItems" xlink:type="locator" xlink:label="etnb_IncomeTaxDisclosureLineItems" />
    <link:label xml:lang="en-US" xlink:label="etnb_IncomeTaxDisclosureLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Income Tax.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_IncomeTaxDisclosureLineItems_lbl" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IncomeTaxDisclosureTable" xlink:type="locator" xlink:label="etnb_IncomeTaxDisclosureTable" />
    <link:label xml:lang="en-US" xlink:label="etnb_IncomeTaxDisclosureTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Income Tax.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="etnb_IncomeTaxDisclosureTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_IncomeTaxDisclosureTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Disclosure [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_IncomeTaxDisclosureTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consolidated Entities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consolidated Entities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="srt_ConsolidatedEntitiesDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_EightyNineBioLtdMember" xlink:type="locator" xlink:label="etnb_EightyNineBioLtdMember" />
    <link:label xml:lang="en-US" xlink:label="etnb_EightyNineBioLtdMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">89Bio Ltd.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_EightyNineBioLtdMember" xlink:to="etnb_EightyNineBioLtdMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_EightyNineBioLtdMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">89Bio Ltd</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_EightyNineBioLtdMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Eighty Nine Bio Ltd [Member]</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_EightyNineBioManagementIncorporationMember" xlink:type="locator" xlink:label="etnb_EightyNineBioManagementIncorporationMember" />
    <link:label xml:lang="en-US" xlink:label="etnb_EightyNineBioManagementIncorporationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Eighty Nine Bio Management, Inc.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_EightyNineBioManagementIncorporationMember" xlink:to="etnb_EightyNineBioManagementIncorporationMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_EightyNineBioManagementIncorporationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">89bio Management, Inc.</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_EightyNineBioManagementIncorporationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Eighty Nine Bio Management Incorporation [Member]</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_UABEightyNineBioLithuaniaMember" xlink:type="locator" xlink:label="etnb_UABEightyNineBioLithuaniaMember" />
    <link:label xml:lang="en-US" xlink:label="etnb_UABEightyNineBioLithuaniaMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">UAB Eighty Nine Bio Lithuania.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_UABEightyNineBioLithuaniaMember" xlink:to="etnb_UABEightyNineBioLithuaniaMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_UABEightyNineBioLithuaniaMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">UAB 89bio Lithuania</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_UABEightyNineBioLithuaniaMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">U A B Eighty Nine Bio Lithuania [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_IncomeTaxDisclosureLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Disclosure [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_IncomeTaxDisclosureLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Effective income tax rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Continuing Operations</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Income Tax Expense Benefit Continuing Operations [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Federal Tax Expense Benefit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current State And Local Tax Expense Benefit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Foreign Tax Expense Benefit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Income Tax Expense Benefit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Expense Benefit Continuing Operations [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Federal Income Tax Expense Benefit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Expense Benefit</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Income tax benefit</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:type="locator" xlink:label="country_US" />
    <link:label xml:lang="en-US" xlink:label="country_US_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">United States</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl" />
    <link:label xml:lang="en-US" xlink:label="country_US_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">UNITED STATES</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IL" xlink:type="locator" xlink:label="country_IL" />
    <link:label xml:lang="en-US" xlink:label="country_IL_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Israel</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IL" xlink:to="country_IL_lbl" />
    <link:label xml:lang="en-US" xlink:label="country_IL_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">ISRAEL</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Operating Loss Carryforwards</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets In Process Research And Development</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Other</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax assets</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Valuation Allowance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Net</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax assets, valuation allowance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax assets, change in valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Allowance Deferred Tax Asset Change In Amount</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AccumulatedTaxLossCarryForward" xlink:type="locator" xlink:label="etnb_AccumulatedTaxLossCarryForward" />
    <link:label xml:lang="en-US" xlink:label="etnb_AccumulatedTaxLossCarryForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Accumulated tax loss carry forward.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_AccumulatedTaxLossCarryForward" xlink:to="etnb_AccumulatedTaxLossCarryForward_lbl" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TaxableIncomeUtilizationPercentage" xlink:type="locator" xlink:label="etnb_TaxableIncomeUtilizationPercentage" />
    <link:label xml:lang="en-US" xlink:label="etnb_TaxableIncomeUtilizationPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Taxable income utilization percentage.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_TaxableIncomeUtilizationPercentage" xlink:to="etnb_TaxableIncomeUtilizationPercentage_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_AccumulatedTaxLossCarryForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated tax loss carryforward</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_AccumulatedTaxLossCarryForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Tax Loss Carry Forward</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwardsLimitationsOnUse" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLossCarryforwardsLimitationsOnUse_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating loss carryforwards limitations on use</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:to="us-gaap_OperatingLossCarryforwardsLimitationsOnUse_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLossCarryforwardsLimitationsOnUse_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards Limitations On Use</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_TaxableIncomeUtilizationPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Taxable income utilization percentage</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_TaxableIncomeUtilizationPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Taxable Income Utilization Percentage</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal" xlink:type="locator" xlink:label="etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal" />
    <link:label xml:lang="en-US" xlink:label="etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets tax credit carryforwards research, federal.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal" xlink:to="etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal research and development credit carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Tax Credit Carryforwards Research Federal</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State research and development credit carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Tax Credit Carryforwards Research</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_LT" xlink:type="locator" xlink:label="country_LT" />
    <link:label xml:lang="en-US" xlink:label="country_LT_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">LITHUANIA</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_LT" xlink:to="country_LT_lbl" />
    <link:label xml:lang="en-US" xlink:label="country_LT_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">LITHUANIA</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss before income tax</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income tax benefit computed at statutory rates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign rate differential</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Foreign Income Tax Rate Differential</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in Israel effective tax rate due to the 2019 reorganization</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Change In Effective Tax Rate Due To Reorganization</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development credits, net of uncertain tax position</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Nondeductible Expense Research And Development</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Other Adjustments</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in unrecognized tax benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:to="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits Period Increase Decrease</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized Tax Benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities, Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Name [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options to Purchase Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Option [Member]</link:label>
    <link:loc xlink:href="etnb-20211231.xsd#etnb_UnvestedRestrictedStockUnitsMember" xlink:type="locator" xlink:label="etnb_UnvestedRestrictedStockUnitsMember" />
    <link:label xml:lang="en-US" xlink:label="etnb_UnvestedRestrictedStockUnitsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Unvested restricted stock units.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_UnvestedRestrictedStockUnitsMember" xlink:to="etnb_UnvestedRestrictedStockUnitsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="etnb_UnvestedRestrictedStockUnitsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unvested Restricted Stock Units</link:label>
    <link:label xml:lang="en-US" xlink:label="etnb_UnvestedRestrictedStockUnitsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unvested Restricted Stock Units [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" xlink:label="us-gaap_WarrantMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WarrantMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants to Purchase Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WarrantMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Warrant [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive common stock equivalents excluded from calculation of diluted net loss per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>19
<FILENAME>etnb-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-03-24T17:57:06.7585091+00:00 -->
<!-- Version            : 5.0.1.728 -->
<!-- Package ID         : 577eac3b881348d89343ad261f9a5e63 -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.89bio.com/20211231/role/TemplateLink" xlink:href="etnb-20211231.xsd#TemplateLink" xlink:type="simple" />
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="etnb-20211231.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:type="locator" xlink:label="dei_AuditorLocation" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:type="locator" xlink:label="dei_AuditorName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:type="locator" xlink:label="dei_AuditorFirmId" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="locator" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:type="locator" xlink:label="dei_DocumentTransitionReport" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:type="locator" xlink:label="dei_DocumentAnnualReport" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:type="locator" xlink:label="dei_EntitySmallBusiness" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:type="locator" xlink:label="dei_EntityShellCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:type="locator" xlink:label="dei_EntityPublicFloat" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:type="locator" xlink:label="dei_EntityFilerCategory" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityVoluntaryFilers" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFilerCategory" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityPublicFloat" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_IcfrAuditorAttestationFlag" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityShellCompany" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitySmallBusiness" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentAnnualReport" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentTransitionReport" order="10690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorFirmId" order="10750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorName" order="10770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorLocation" order="10790.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="etnb-20211231.xsd#Role_StatementConsolidatedBalanceSheets" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_OtherNonCurrentLiability" xlink:type="locator" xlink:label="etnb_OtherNonCurrentLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:type="locator" xlink:label="us-gaap_LongTermDebtNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TermLoanCurrent" xlink:type="locator" xlink:label="etnb_TermLoanCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ShortTermAvailableForSaleSecuritiesCurrent" xlink:type="locator" xlink:label="etnb_ShortTermAvailableForSaleSecuritiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_RestrictedCashCurrent" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="etnb_ShortTermAvailableForSaleSecuritiesCurrent" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="10540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="10620.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="10700.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="10780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="10860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="10900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="etnb_TermLoanCurrent" order="10940.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="10980.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LongTermDebtNoncurrent" order="11020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="etnb_OtherNonCurrentLiability" order="11060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="11100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="11140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="11180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="11260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="11300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="11340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="11380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="11420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="11460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="11500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:href="etnb-20211231.xsd#Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesIssued" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="etnb-20211231.xsd#Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossTaxAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossTaxAbstract" order="10510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" order="10630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="10750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="10790.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" xlink:href="etnb-20211231.xsd#Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing" xlink:type="locator" xlink:label="etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" xlink:type="locator" xlink:label="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ATMFacilityMember" xlink:type="locator" xlink:label="etnb_ATMFacilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:type="locator" xlink:label="us-gaap_IPOMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_ATMFacilityMember" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="10730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="10750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" order="10870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="11010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing" order="11430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="11570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="11710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_li0l2" order="11850.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_li0l2" order="11870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" xlink:href="etnb-20211231.xsd#Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical">
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TemporaryEquityIssuanceCosts" xlink:type="locator" xlink:label="etnb_TemporaryEquityIssuanceCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ATMFacilityMember" xlink:type="locator" xlink:label="etnb_ATMFacilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:type="locator" xlink:label="us-gaap_IPOMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ConvertiblePreferredSharesMember" xlink:type="locator" xlink:label="etnb_ConvertiblePreferredSharesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="etnb_ConvertiblePreferredSharesMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_ATMFacilityMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_TemporaryEquityIssuanceCosts" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="etnb-20211231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows">
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" xlink:type="locator" xlink:label="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="locator" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaidNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ProceedsFromIssuancePublicOffering" xlink:type="locator" xlink:label="etnb_ProceedsFromIssuancePublicOffering" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_PaymentForPurchaseOfAvailableForSaleSecurities" xlink:type="locator" xlink:label="etnb_PaymentForPurchaseOfAvailableForSaleSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_DeferredTaxAssets" xlink:type="locator" xlink:label="etnb_DeferredTaxAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:type="locator" xlink:label="us-gaap_Depreciation" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" xlink:type="locator" xlink:label="etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="etnb_DeferredTaxAssets" order="10690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="10730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="10810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="10850.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="10890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10930.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="10970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" order="11050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="etnb_PaymentForPurchaseOfAvailableForSaleSecurities" order="11090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="11130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="11170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="11210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" order="11290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="etnb_ProceedsFromIssuancePublicOffering" order="11330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" order="11370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="11410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts" order="11450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="11490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="11530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="11570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_li0l2" order="11610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" order="11650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="11730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_RestrictedCashCurrent" order="11770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="11810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="11850.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="11930.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_IncomeTaxesPaidNet" order="11970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" order="12010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" order="12090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentation" xlink:href="etnb-20211231.xsd#Role_DisclosureOrganizationAndBasisOfPresentation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentation">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies" xlink:href="etnb-20211231.xsd#Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurements" xlink:href="etnb-20211231.xsd#Role_DisclosureFairValueMeasurements" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurements">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponents" xlink:href="etnb-20211231.xsd#Role_DisclosureConsolidatedBalanceSheetComponents" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponents">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="locator" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies" xlink:href="etnb-20211231.xsd#Role_DisclosureCommitmentsAndContingencies" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoan" xlink:href="etnb-20211231.xsd#Role_DisclosureTermLoan" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoan">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:type="locator" xlink:label="us-gaap_LongTermDebtTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensation" xlink:href="etnb-20211231.xsd#Role_DisclosureStockBasedCompensation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensation">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxes" xlink:href="etnb-20211231.xsd#Role_DisclosureIncomeTaxes" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxes">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShare" xlink:href="etnb-20211231.xsd#Role_DisclosureNetLossPerShare" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShare">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureSubsequentEvents" xlink:href="etnb-20211231.xsd#Role_DisclosureSubsequentEvents" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureSubsequentEvents">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="etnb-20211231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock" xlink:type="locator" xlink:label="etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_OtherRisksAndUncertaintiesPolicyTextBlock" xlink:type="locator" xlink:label="etnb_OtherRisksAndUncertaintiesPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="etnb_OtherRisksAndUncertaintiesPolicyTextBlock" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables" xlink:href="etnb-20211231.xsd#Role_DisclosureFairValueMeasurementsTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="locator" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsTables" xlink:href="etnb-20211231.xsd#Role_DisclosureConsolidatedBalanceSheetComponentsTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock" xlink:type="locator" xlink:label="etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" xlink:href="etnb-20211231.xsd#Role_DisclosureCommitmentsAndContingenciesTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanTables" xlink:href="etnb-20211231.xsd#Role_DisclosureTermLoanTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables" xlink:href="etnb-20211231.xsd#Role_DisclosureStockBasedCompensationTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables" xlink:href="etnb-20211231.xsd#Role_DisclosureIncomeTaxesTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock" xlink:type="locator" xlink:label="etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareTables" xlink:href="etnb-20211231.xsd#Role_DisclosureNetLossPerShareTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_li0l2" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_SellingCommissionPerSharesSoldPercentage" xlink:type="locator" xlink:label="etnb_SellingCommissionPerSharesSoldPercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_PaymentsOfStockIssuanceCostsOther" xlink:type="locator" xlink:label="etnb_PaymentsOfStockIssuanceCostsOther" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:type="locator" xlink:label="dei_EntityIncorporationDateOfIncorporation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember" xlink:type="locator" xlink:label="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ATMFacilityMember" xlink:type="locator" xlink:label="etnb_ATMFacilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_UnderwrittenPublicOfferingMember" xlink:type="locator" xlink:label="etnb_UnderwrittenPublicOfferingMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="locator" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="etnb_UnderwrittenPublicOfferingMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10620.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_ATMFacilityMember" order="10640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="srt_RangeAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems" order="10820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dei_EntityIncorporationDateOfIncorporation" order="10830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="10900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="10920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="10940.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="etnb_PaymentsOfStockIssuanceCostsOther" order="10960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="11310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="etnb_SellingCommissionPerSharesSoldPercentage" order="11370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_li0l2" order="11430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="11550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments" order="11640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="locator" xlink:label="etnb_SummaryOfSignificantAccountingPoliciesLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_SummaryOfSignificantAccountingPoliciesTable" xlink:type="locator" xlink:label="etnb_SummaryOfSignificantAccountingPoliciesTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="etnb_SummaryOfSignificantAccountingPoliciesTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_RangeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesTable" xlink:to="etnb_SummaryOfSignificantAccountingPoliciesLineItems" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AgencyDiscountSecuritiesMember" xlink:type="locator" xlink:label="etnb_AgencyDiscountSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryBillSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USTreasuryBillSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember" xlink:type="locator" xlink:label="us-gaap_ShortTermInvestmentsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsMember" xlink:type="locator" xlink:label="us-gaap_CashEquivalentsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_ForeignGovernmentDebtSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MunicipalBondsMember" xlink:type="locator" xlink:label="us-gaap_MunicipalBondsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AgencySecuritiesMember" xlink:type="locator" xlink:label="us-gaap_AgencySecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateDebtSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember" xlink:type="locator" xlink:label="us-gaap_CommercialPaperMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10060.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_InvestmentTypeAxis" order="10060.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CommercialPaperMember" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_AgencySecuritiesMember" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_MunicipalBondsMember" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_ForeignGovernmentDebtSecuritiesMember" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CashEquivalentsMember" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_ShortTermInvestmentsMember" order="10510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USTreasuryBillSecuritiesMember" order="10950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="etnb_AgencyDiscountSecuritiesMember" order="10970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="11030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="11040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="11340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="11640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="11940.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" xlink:type="locator" xlink:label="etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:type="locator" xlink:label="us-gaap_OtherPrepaidExpenseCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes" xlink:type="locator" xlink:label="us-gaap_PrepaidTaxes" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_PrepaidResearchAndDevelopmentCurrent" xlink:type="locator" xlink:label="etnb_PrepaidResearchAndDevelopmentCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="etnb_PrepaidResearchAndDevelopmentCurrent" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_PrepaidTaxes" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_OtherPrepaidExpenseCurrent" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AccruedResearchAndDevelopmentExpenseCurrent" xlink:type="locator" xlink:label="etnb_AccruedResearchAndDevelopmentExpenseCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="etnb_AccruedResearchAndDevelopmentExpenseCurrent" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
    <link:loc xlink:href="etnb-20211231.xsd#etnb_MilestonePayment" xlink:type="locator" xlink:label="etnb_MilestonePayment" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled" xlink:type="locator" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure" xlink:type="locator" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice" xlink:type="locator" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones" xlink:type="locator" xlink:label="etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment" xlink:type="locator" xlink:label="etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecurityDeposit" xlink:type="locator" xlink:label="us-gaap_SecurityDeposit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:type="locator" xlink:label="us-gaap_LeaseAndRentalExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_OperatingLeaseMonthlyRentalPayments" xlink:type="locator" xlink:label="etnb_OperatingLeaseMonthlyRentalPayments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DescriptionOfLesseeLeasingArrangementsOperatingLeases" xlink:type="locator" xlink:label="us-gaap_DescriptionOfLesseeLeasingArrangementsOperatingLeases" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:type="locator" xlink:label="us-gaap_LossContingenciesLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TevasDevelopmentProgramMember" xlink:type="locator" xlink:label="etnb_TevasDevelopmentProgramMember" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TevasGlycoPEGylatedFGF21ProgramMember" xlink:type="locator" xlink:label="etnb_TevasGlycoPEGylatedFGF21ProgramMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TevaAgreementMember" xlink:type="locator" xlink:label="etnb_TevaAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_RestrictedCashAndOtherAssetsMember" xlink:type="locator" xlink:label="etnb_RestrictedCashAndOtherAssetsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_SanFranciscoOfficeMember" xlink:type="locator" xlink:label="etnb_SanFranciscoOfficeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable" xlink:type="locator" xlink:label="us-gaap_LossContingenciesTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LossContingenciesTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="srt_StatementGeographicalAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="etnb_SanFranciscoOfficeMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="etnb_RestrictedCashAndOtherAssetsMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_TevaAgreementMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="etnb_TevasGlycoPEGylatedFGF21ProgramMember" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="etnb_TevasDevelopmentProgramMember" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10030.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesLineItems" order="10620.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_DescriptionOfLesseeLeasingArrangementsOperatingLeases" order="10630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_OperatingLeaseMonthlyRentalPayments" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" order="10800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LeaseAndRentalExpense" order="10870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_SecurityDeposit" order="10910.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment" order="10980.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones" order="11000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice" order="11090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure" order="11110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled" order="11130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_MilestonePayment" order="11180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureTermLoanAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTerm" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_FairValueOfWarrantsAssumptionsDividends" xlink:type="locator" xlink:label="etnb_FairValueOfWarrantsAssumptionsDividends" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMeasurementInput" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_PercentageOfFeeOnLoan" xlink:type="locator" xlink:label="etnb_PercentageOfFeeOnLoan" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_NetCashProceedsFromSaleOfEquitySecurities" xlink:type="locator" xlink:label="etnb_NetCashProceedsFromSaleOfEquitySecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit" xlink:type="locator" xlink:label="us-gaap_LineOfCredit" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity" xlink:type="locator" xlink:label="etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross" xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityDescription" xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityDescription" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputExpectedTermMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedDividendPaymentMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputExpectedDividendPaymentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:type="locator" xlink:label="us-gaap_ValuationTechniqueOptionPricingModelMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:type="locator" xlink:label="us-gaap_ValuationTechniqueDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:type="locator" xlink:label="us-gaap_ValuationTechniqueAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrimeRateMember" xlink:type="locator" xlink:label="us-gaap_PrimeRateMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain" xlink:type="locator" xlink:label="us-gaap_VariableRateDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis" xlink:type="locator" xlink:label="us-gaap_VariableRateAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember" xlink:type="locator" xlink:label="us-gaap_OtherAssetsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TermBLoanFacilityMember" xlink:type="locator" xlink:label="etnb_TermBLoanFacilityMember" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TermALoanFacilityMember" xlink:type="locator" xlink:label="etnb_TermALoanFacilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_LoanAndSecurityAgreementMember" xlink:type="locator" xlink:label="etnb_LoanAndSecurityAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_LoanAndSecurityAgreementMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="etnb_TermALoanFacilityMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="etnb_TermBLoanFacilityMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherAssetsMember" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_RangeAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10740.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_VariableRateAxis" order="10030.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="11120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_PrimeRateMember" order="11140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_ValuationTechniqueAxis" order="10030.10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueDomain" order="11400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationTechniqueDomain" xlink:to="us-gaap_ValuationTechniqueOptionPricingModelMember" order="11420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_MeasurementInputTypeAxis" order="10030.12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain" order="11500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember" order="11520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedDividendPaymentMember" order="11540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember" order="11560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedTermMember" order="11580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="11720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="11730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityDescription" order="11770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="11820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="11840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate" order="11860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DeferredFinanceCostsGross" order="11880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="11920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="11940.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="11960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity" order="12030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCredit" order="12140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1" order="12160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="etnb_NetCashProceedsFromSaleOfEquitySecurities" order="12180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" order="12200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" order="12220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="etnb_PercentageOfFeeOnLoan" order="12240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMeasurementInput" order="12350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="etnb_FairValueOfWarrantsAssumptionsDividends" order="12370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTerm" order="12410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DeferredTaxAssetsGross" order="12500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:type="locator" xlink:label="us-gaap_LongTermDebtNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:type="locator" xlink:label="us-gaap_LongTermDebtCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:type="locator" xlink:label="us-gaap_LongTermDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebt" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtCurrent" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtNoncurrent" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails">
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary" xlink:type="locator" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue" xlink:type="locator" xlink:label="etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate" xlink:type="locator" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriod" xlink:type="locator" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod" xlink:type="locator" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding" xlink:type="locator" xlink:label="etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance" xlink:type="locator" xlink:label="etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement" xlink:type="locator" xlink:label="etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ExecutiveOfficerMember" xlink:type="locator" xlink:label="srt_ExecutiveOfficerMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="locator" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_PerformanceRSUsMember" xlink:type="locator" xlink:label="etnb_PerformanceRSUsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ServiceBasedRSUsMember" xlink:type="locator" xlink:label="etnb_ServiceBasedRSUsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TwoThousandAndTwentyEquityIncentivePlanMember" xlink:type="locator" xlink:label="etnb_TwoThousandAndTwentyEquityIncentivePlanMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TwoThousandAndNineteenEquityIncentivePlanMember" xlink:type="locator" xlink:label="etnb_TwoThousandAndNineteenEquityIncentivePlanMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="etnb_TwoThousandAndNineteenEquityIncentivePlanMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="etnb_TwoThousandAndTwentyEquityIncentivePlanMember" order="10760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="etnb_ServiceBasedRSUsMember" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="etnb_PerformanceRSUsMember" order="11000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" order="10030.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="11100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="us-gaap_ShareBasedPaymentArrangementEmployeeMember" order="11120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ExecutiveOfficerMember" order="11200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="11280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement" order="11290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance" order="11310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding" order="11330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="11350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="11400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" order="11420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" order="11440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod" order="11460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="11480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" order="11590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriod" order="11640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate" order="11660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="11710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" order="11760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="11820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="11880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="11940.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="12000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue" order="12060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="12120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="12240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="12300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary" order="12540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:type="locator" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:type="locator" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TwoThousandAndNineteenEquityIncentivePlanMember" xlink:type="locator" xlink:label="etnb_TwoThousandAndNineteenEquityIncentivePlanMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="etnb_TwoThousandAndNineteenEquityIncentivePlanMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_li0l2" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="10540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_li0l2" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="10620.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="10870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="11070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" order="11200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="11240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_li0l2" order="11260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="11280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IncomeTaxDisclosureLineItems" xlink:type="locator" xlink:label="etnb_IncomeTaxDisclosureLineItems" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_UABEightyNineBioLithuaniaMember" xlink:type="locator" xlink:label="etnb_UABEightyNineBioLithuaniaMember" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_EightyNineBioManagementIncorporationMember" xlink:type="locator" xlink:label="etnb_EightyNineBioManagementIncorporationMember" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_EightyNineBioLtdMember" xlink:type="locator" xlink:label="etnb_EightyNineBioLtdMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IncomeTaxDisclosureTable" xlink:type="locator" xlink:label="etnb_IncomeTaxDisclosureTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="etnb_IncomeTaxDisclosureTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="etnb_EightyNineBioLtdMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="etnb_EightyNineBioManagementIncorporationMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="etnb_UABEightyNineBioLithuaniaMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="etnb_IncomeTaxDisclosureLineItems" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IncomeTaxDisclosureLineItems" xlink:type="locator" xlink:label="etnb_IncomeTaxDisclosureLineItems" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IL" xlink:type="locator" xlink:label="country_IL" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:type="locator" xlink:label="country_US" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IncomeTaxDisclosureTable" xlink:type="locator" xlink:label="etnb_IncomeTaxDisclosureTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="etnb_IncomeTaxDisclosureTable" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="srt_StatementGeographicalAxis" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_IL" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="etnb_IncomeTaxDisclosureLineItems" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsOther" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsGross" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsNet" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal" xlink:type="locator" xlink:label="etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_TaxableIncomeUtilizationPercentage" xlink:type="locator" xlink:label="etnb_TaxableIncomeUtilizationPercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwardsLimitationsOnUse" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_AccumulatedTaxLossCarryForward" xlink:type="locator" xlink:label="etnb_AccumulatedTaxLossCarryForward" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IncomeTaxDisclosureLineItems" xlink:type="locator" xlink:label="etnb_IncomeTaxDisclosureLineItems" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:type="locator" xlink:label="country_US" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IL" xlink:type="locator" xlink:label="country_IL" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IncomeTaxDisclosureTable" xlink:type="locator" xlink:label="etnb_IncomeTaxDisclosureTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="etnb_IncomeTaxDisclosureTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="srt_StatementGeographicalAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_IL" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="etnb_IncomeTaxDisclosureLineItems" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_AccumulatedTaxLossCarryForward" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLimitationsOnUse" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_TaxableIncomeUtilizationPercentage" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IncomeTaxDisclosureLineItems" xlink:type="locator" xlink:label="etnb_IncomeTaxDisclosureLineItems" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IL" xlink:type="locator" xlink:label="country_IL" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_LT" xlink:type="locator" xlink:label="country_LT" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:type="locator" xlink:label="country_US" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IncomeTaxDisclosureTable" xlink:type="locator" xlink:label="etnb_IncomeTaxDisclosureTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="etnb_IncomeTaxDisclosureTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="srt_StatementGeographicalAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_LT" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_IL" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="etnb_IncomeTaxDisclosureLineItems" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization" xlink:type="locator" xlink:label="etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails" xlink:href="etnb-20211231.xsd#Role_DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" xlink:label="us-gaap_WarrantMember" />
    <link:loc xlink:href="etnb-20211231.xsd#etnb_UnvestedRestrictedStockUnitsMember" xlink:type="locator" xlink:label="etnb_UnvestedRestrictedStockUnitsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="etnb_UnvestedRestrictedStockUnitsMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870569049288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 01, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">89bio, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001785173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 165.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,351,384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ETNB<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">36-4946844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">142 Sansome Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address Address Line Two</a></td>
<td class="text">Second Floor<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Francisco<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">432-9270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Portions of the registrant&#8217;s definitive proxy statement relating to its 2022 Annual Meeting of Stockholders, to be held on or about June 1, 2022, are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such proxy statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">KPMG LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">San Francisco, California, USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870567962840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 52,432<span></span>
</td>
<td class="nump">$ 98,183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_ShortTermAvailableForSaleSecuritiesCurrent', window );">Short-term available-for-sale securities</a></td>
<td class="nump">98,288<span></span>
</td>
<td class="nump">106,446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid and other current assets</a></td>
<td class="nump">11,237<span></span>
</td>
<td class="nump">5,548<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">161,982<span></span>
</td>
<td class="nump">210,202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">290<span></span>
</td>
<td class="nump">706<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">162,422<span></span>
</td>
<td class="nump">211,074<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">6,843<span></span>
</td>
<td class="nump">2,065<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">10,194<span></span>
</td>
<td class="nump">6,048<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_TermLoanCurrent', window );">Term loan, current</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">19,537<span></span>
</td>
<td class="nump">8,113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Term loan, non-current, net</a></td>
<td class="nump">16,898<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_OtherNonCurrentLiability', window );">Other non-current liability</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">36,465<span></span>
</td>
<td class="nump">8,113<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 5)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value, 10,000,000 shares authorized as of December 31, 2021 and 2020, respectively, no shares issued and outstanding as of December 31, 2021 and 2020, respectively</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value, 100,000,000 shares authorized as of December 31, 2021 and 2020, respectively; 20,317,204 and 19,931,660 shares issued and outstanding as of December 31, 2021 and 2020, respectively</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">339,218<span></span>
</td>
<td class="nump">326,046<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(64)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(213,217)<span></span>
</td>
<td class="num">(123,095)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">125,957<span></span>
</td>
<td class="nump">202,961<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 162,422<span></span>
</td>
<td class="nump">$ 211,074<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_OtherNonCurrentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other non-current liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_OtherNonCurrentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_ShortTermAvailableForSaleSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Short term available for sale securities current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_ShortTermAvailableForSaleSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_TermLoanCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term loan current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_TermLoanCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870567170632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement Of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">20,317,204<span></span>
</td>
<td class="nump">19,931,660<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">20,317,204<span></span>
</td>
<td class="nump">19,931,660<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870567883000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 70,330<span></span>
</td>
<td class="nump">$ 36,199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">19,413<span></span>
</td>
<td class="nump">13,156<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">89,743<span></span>
</td>
<td class="nump">49,355<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(89,743)<span></span>
</td>
<td class="num">(49,355)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expenses, net</a></td>
<td class="num">(526)<span></span>
</td>
<td class="num">(203)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before income tax</a></td>
<td class="num">(90,269)<span></span>
</td>
<td class="num">(49,558)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="nump">147<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(90,122)<span></span>
</td>
<td class="num">(49,499)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Other comprehensive (loss) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized (loss) gain on available-for-sale securities</a></td>
<td class="num">(71)<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">17<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive loss</a></td>
<td class="num">(54)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (90,176)<span></span>
</td>
<td class="num">$ (49,509)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share, basic and diluted</a></td>
<td class="num">$ (4.48)<span></span>
</td>
<td class="num">$ (3.08)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted-average shares used to compute net loss per share, basic and diluted</a></td>
<td class="nump">20,098,340<span></span>
</td>
<td class="nump">16,087,785<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870565237368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>A T M Facility</div></th>
<th class="th"><div>Public Offerings</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>A T M Facility</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>Public Offerings</div>
</th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>A T M Facility</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Public Offerings</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th">
<div>Accumulated Other Comprehensive Loss </div>
<div>A T M Facility</div>
</th>
<th class="th">
<div>Accumulated Other Comprehensive Loss </div>
<div>Public Offerings</div>
</th>
<th class="th"><div>Retained Earnings</div></th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="nump">$ 89,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 163,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (73,596)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,788,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 157,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 157,674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,072,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock upon ESPP purchase</a></td>
<td class="nump">134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock upon ESPP purchase, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility', window );">Issuance of common stock warrant in connection with term loan facility</a></td>
<td class="nump">634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">3,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing', window );">Issuance Of Common Stock Warrants In Connection With Debt Financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(49,499)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(49,499)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">202,961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">326,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(123,095)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,931,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock upon ESPP purchase</a></td>
<td class="nump">144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock upon ESPP purchase, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility', window );">Issuance of common stock warrant in connection with term loan facility</a></td>
<td class="nump">574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">8,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(90,122)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(90,122)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(54)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">$ 125,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 339,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (64)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (213,217)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,317,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock warrant in connection with term loan facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock warrant in connection with debt financing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870570538776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (Parenthetical) - Convertible Preferred Shares - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=etnb_ConvertiblePreferredSharesMember', window );">A T M Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_TemporaryEquityIssuanceCosts', window );">Temporary equity, issuance costs</a></td>
<td class="nump">$ 165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=etnb_ConvertiblePreferredSharesMember', window );">Public Offerings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_TemporaryEquityIssuanceCosts', window );">Temporary equity, issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,208<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_TemporaryEquityIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity, issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_TemporaryEquityIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=etnb_ConvertiblePreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=etnb_ConvertiblePreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=etnb_ATMFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=etnb_ATMFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870569147928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (90,122)<span></span>
</td>
<td class="num">$ (49,499)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">8,678<span></span>
</td>
<td class="nump">3,807<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of premium on available-for-sale securities</a></td>
<td class="nump">865<span></span>
</td>
<td class="nump">268<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee', window );">Amortization of debt issuance costs and accretion of final payment fee</a></td>
<td class="nump">617<span></span>
</td>
<td class="nump">230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="num">(150)<span></span>
</td>
<td class="num">(69)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid and other current assets</a></td>
<td class="num">(5,672)<span></span>
</td>
<td class="num">(3,600)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">4,778<span></span>
</td>
<td class="nump">1,131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">4,146<span></span>
</td>
<td class="nump">1,428<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(76,781)<span></span>
</td>
<td class="num">(46,244)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Proceeds from sales and maturities of available-for-sale securities</a></td>
<td class="nump">148,422<span></span>
</td>
<td class="nump">12,189<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_PaymentForPurchaseOfAvailableForSaleSecurities', window );">Purchases of available-for-sale securities</a></td>
<td class="num">(141,200)<span></span>
</td>
<td class="num">(118,895)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(63)<span></span>
</td>
<td class="num">(126)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">7,159<span></span>
</td>
<td class="num">(106,832)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt', window );">Proceeds from term loan facility, net of issuance costs</a></td>
<td class="nump">19,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_ProceedsFromIssuancePublicOffering', window );">Proceeds from issuance of common stock upon public offerings,net of issuance costs</a></td>
<td class="nump">3,289<span></span>
</td>
<td class="nump">157,680<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from issuance of common stock upon stock option exercises</a></td>
<td class="nump">487<span></span>
</td>
<td class="nump">271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(161)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">23,871<span></span>
</td>
<td class="nump">157,924<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash and cash equivalents, and restricted cash</a></td>
<td class="num">(45,751)<span></span>
</td>
<td class="nump">4,848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, and restricted cash at beginning of period</a></td>
<td class="nump">98,208<span></span>
</td>
<td class="nump">93,360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, and restricted cash at end of period</a></td>
<td class="nump">52,457<span></span>
</td>
<td class="nump">98,208<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Components of cash and cash equivalents, and restricted cash:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">52,432<span></span>
</td>
<td class="nump">98,183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash and cash equivalents, and restricted cash</a></td>
<td class="nump">52,457<span></span>
</td>
<td class="nump">98,208<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosures of noncash information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility', window );">Issuance of common stock warrant in connection with term loan facility</a></td>
<td class="nump">574<span></span>
</td>
<td class="nump">634<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember', window );">ESPP Purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock upon ESPP purchases</a></td>
<td class="nump">$ 144<span></span>
</td>
<td class="nump">$ 134<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization of debt issuance costs and accretion of final payment fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock warrant in connection with term loan facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_PaymentForPurchaseOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment for purchases of available for sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_PaymentForPurchaseOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_ProceedsFromIssuancePublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_ProceedsFromIssuancePublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870566906744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization Consolidation And Presentation Of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization and Basis of Presentation</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1. Organization and Basis of Presentation </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Description of Business</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc. (&#8220;89bio&#8221; or the &#8220;Company&#8221;) is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The Company&#8217;s lead product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21, is currently being developed for the treatment of nonalcoholic steatohepatitis and for the treatment of severe hypertriglyceridemia. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc. was formed as a Delaware corporation in <span style="-sec-ix-hidden:F_000299">June 2019</span> to carry on the business of 89Bio Ltd., which was incorporated in Israel in January 2018. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Public Offerings</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In July 2020, the Company completed an underwritten public offering of 3,047,040 shares of its common stock at the public offering price of $27.50 per share. The Company raised a total of $78.2 million in net proceeds after deducting underwriting discounts and commissions of $5.0 million and offering costs of $0.6 million. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In September 2020, the Company completed an underwritten public offering of 3,025,000 shares of its common stock, at a public offering price of $28.00 per share. The Company raised a total of $79.5 million in net proceeds after deducting underwriting discounts and commissions of $4.6 million and offering costs of $0.6 million.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2021, the Company entered into a sales agreement (the &#8220;Sales Agreement&#8221;) with SVB Leerink LLC and Cantor Fitzgerald &amp; Co. (the &#8220;Sales Agents&#8221;) pursuant to which it may offer and sell up to $75.0 million of shares of the Company&#8217;s common stock, from time to time, in &#8220;at-the-market&#8221; offerings (the &#8220;ATM Facility&#8221;). The Sales Agents are entitled to compensation at a commission equal to 3.0% of the aggregate gross sales price per share sold under the Sales Agreement. <span style="color:#231F20;letter-spacing:0.1pt;">During the fourth quarter of 2021, the Company received proceeds of $3.3 million, net of commissions and offering expenses from sales of 186,546 shares of its common stock at a weighted-average price of $17.97 per share pursuant to the ATM Facility.</span> </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Liquidity </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. To date, the Company has not generated revenues from its activities and has incurred substantial operating losses. Management expects the Company to continue to generate substantial operating losses for the foreseeable future until it completes development of its products and seeks regulatory approvals to market such products. The Company had cash and cash equivalents and short-term available-for-sale securities of $150.7 million as of December 31, 2021. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company expects that its cash and cash equivalents and short-term available-for-sale securities as of December 31, 2021, together with proceeds available from the Company&#8217;s term loan (see Note 6) and its ATM Facility, will be sufficient to fund operating expenses and capital expenditure requirements for a period of at least one year from the date these audited consolidated financial statements are filed with the Securities and Exchange Commission (&#8220;SEC&#8221;).</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870567077800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2. Summary of Significant Accounting Policies</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Basis of Presentation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;).</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Principles of Consolidation</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Foreign Currencies</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain transactions during the years ended December 31, 2021 and 2020 were denominated in currencies other than the U.S. dollar. Gains and losses from foreign currency transactions were not material for all periods presented and are reflected in the consolidated statements of operations and comprehensive loss as a component of other expenses, net. The Company&#8217;s subsidiary in Lithuania uses the Euro as its functional currency for financial reporting. The re-measurement from Euros to U.S. dollars results in translation gain and loss adjustments, which are reflected as a component of comprehensive loss as foreign currency translation adjustments.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions made in the accompanying consolidated financial statements include but are not limited to accrued research and development expenses and the fair value of stock options. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Fair Value Measurements </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial assets and liabilities are recorded at fair value on a recurring basis in the consolidated balance sheets. The carrying values of Company&#8217;s financial assets and liabilities, including cash and cash equivalents, restricted cash, prepaid and other current assets, accounts payable, and accrued expenses approximate to their fair value due to the short-term nature of these instruments. The fair value of the Company&#8217;s term loan approximates its carrying value, or amortized cost, due to the prevailing market rates of interest rates it bears. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. Assets and liabilities recorded at fair value are categorized based upon the level of judgment associated with the inputs used to measure their fair value. Hierarchical levels are directly related to the amount of subjectivity with the inputs to the valuation of these assets or liabilities as follows: </p>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1<span style="font-weight:normal;">&#8212;Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date; </span></p>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2<span style="font-weight:normal;">&#8212;Inputs (other than quoted prices included in Level&#160;1) are either directly or indirectly observable inputs for similar assets or liabilities. These include quoted prices for identical or similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Level 3<span style="font-weight:normal;">&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentrations of Credit Risk</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial<span style="letter-spacing:0.05pt;"> </span>instruments<span style="letter-spacing:0.1pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>potentially<span style="letter-spacing:0.1pt;"> </span>subject<span style="letter-spacing:0.05pt;"> </span>the Company to a concentration<span style="letter-spacing:0.1pt;"> </span>of credit<span style="letter-spacing:0.05pt;"> </span>risk<span style="letter-spacing:0.05pt;"> </span>consist primarily<span style="letter-spacing:0.1pt;"> </span>of cash and cash equivalents and short-term available-for-sale securities.<span style="letter-spacing:0.1pt;"> </span>Bank<span style="letter-spacing:-0.05pt;"> </span>deposits<span style="letter-spacing:0.05pt;"> </span>are held by accredited<span style="letter-spacing:0.1pt;"> </span>financial<span style="letter-spacing:0.1pt;"> </span>institutions<span style="letter-spacing:0.1pt;"> </span>and these deposits<span style="letter-spacing:0.05pt;"> </span>may at times<span style="letter-spacing:0.05pt;"> </span>be in excess<span style="letter-spacing:0.05pt;"> </span>of insured<span style="letter-spacing:0.05pt;"> </span>limits. The Company limits<span style="letter-spacing:0.1pt;"> </span>its<span style="letter-spacing:0.05pt;"> </span>credit<span style="letter-spacing:0.05pt;"> </span>risk<span style="letter-spacing:0.05pt;"> </span>associated<span style="letter-spacing:0.1pt;"> </span>with cash and cash equivalents<span style="letter-spacing:0.1pt;"> </span>by placing<span style="letter-spacing:0.05pt;"> </span>them<span style="letter-spacing:0.05pt;"> </span>with financial<span style="letter-spacing:0.1pt;"> </span>institutions<span style="letter-spacing:0.1pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>it believes<span style="letter-spacing:0.05pt;"> </span>are of high quality.<span style="letter-spacing:0.05pt;"> </span>The Company has not experienced<span style="letter-spacing:0.05pt;"> </span>any losses<span style="letter-spacing:0.05pt;"> </span>on its<span style="letter-spacing:0.05pt;"> </span>deposits<span style="letter-spacing:0.05pt;"> </span>of cash or cash equivalents. The Company <span style="color:#000000;">limits amounts invested in available-for-sale securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. The Company is not exposed to any significant concentrations of credit risk from these financial instruments.</span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Other<span style="font-weight:normal;font-style:normal;"> </span>Risks and Uncertainties </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s future results of operations involve a number of other risks and uncertainties. Factors that could affect the Company&#8217;s future operating results and cause actual results to vary materially from expectations include, but are not limited to, the Company&#8217;s early stages of clinical drug development; the Company&#8217;s ability to advance product candidates into, and successfully complete, clinical trials on the timelines it projects; the Company&#8217;s ability to adequately demonstrate sufficient safety and efficacy of its product candidates; the Company&#8217;s ability to enroll patients in its ongoing and future clinical trials; the Company&#8217;s ability to successfully manufacture and supply its product candidates for clinical trials; the Company&#8217;s ability to obtain additional capital to finance its operations; uncertainties related to the projections of the size of patient populations suffering from the diseases the Company is targeting; the Company&#8217;s ability to obtain, maintain, and protect its intellectual property rights; developments relating to the Company&#8217;s competitors and its industry, including competing product candidates and therapies; general economic and market conditions; and other risks and uncertainties.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s product candidates will require approvals from the U.S. Food and Drug Administration and comparable foreign regulatory agencies prior to commercial sales in their respective jurisdictions. There can be no assurance that any product candidates will receive the necessary approvals. If the Company was denied approval, approval was delayed or the Company was unable to maintain approval for any product candidate, it could have a materially adverse impact on the Company.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The ongoing COVID-19 pandemic has disrupted and may continue to disrupt the Company&#8217;s business and delay its preclinical and clinical programs and timelines. <span style="color:#000000;">The Company does not yet know the full extent of potential delays to clinical trials, which could prevent or delay the Company from obtaining approval for&#160;pegozafermin.&#160;</span>The extent to which the COVID-19 pandemic may impact the Company&#8217;s future operating results and financial condition is uncertain.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Segment Reporting</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has one operating<span style="letter-spacing:0.05pt;"> </span>segment.<span style="letter-spacing:0.05pt;"> </span>The Company&#8217;s chief<span style="letter-spacing:0.05pt;"> </span>operating<span style="letter-spacing:0.05pt;"> </span>decision<span style="letter-spacing:0.05pt;"> </span>maker,<span style="letter-spacing:0.05pt;"> </span>its<span style="letter-spacing:0.05pt;"> </span>Chief Executive<span style="letter-spacing:0.05pt;"> </span>Officer,<span style="letter-spacing:0.05pt;"> </span>manages<span style="letter-spacing:0.05pt;"> </span>the Company&#8217;s operations<span style="letter-spacing:0.05pt;"> </span>on a consolidated<span style="letter-spacing:0.1pt;"> </span>basis<span style="letter-spacing:0.05pt;"> </span>for the purposes<span style="letter-spacing:0.05pt;"> </span>of allocating resources<span style="letter-spacing:0.05pt;"> </span>and evaluating<span style="letter-spacing:0.05pt;"> </span>financial<span style="letter-spacing:0.1pt;"> </span>performance.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Cash and Cash Equivalents</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be cash equivalents. Cash equivalents consist primarily of amounts invested in money market funds and commercial paper that are stated at fair value.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Restricted Cash</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash consists of a money market account that serves as collateral for the Company&#8217;s operating lease agreement for its facility in Israel.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Investments </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investments have been classified as available-for-sale and are carried at estimated fair value as determined based upon quoted market prices or pricing models for similar securities. Management determines the appropriate classification of its available-for-sale investments in debt securities at the time of purchase. Generally, investments with original maturities beyond three months at the date of purchase are classified as short-term because it is management&#8217;s intent to use the investments to fund current operations or to make them available for current operations. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrealized gains and losses are excluded from earnings and are reported as a component of comprehensive loss.&#160;The Company periodically evaluates whether declines in fair values of its available-for-sale securities below their book value are other-than-temporary. This evaluation consists of several qualitative and quantitative factors regarding the severity and duration of the unrealized loss as well as the Company&#8217;s ability and intent to hold the available-for-sale security until a forecasted recovery occurs. Additionally, the Company assesses whether it has plans to sell the security or it is more likely than not it will be required to sell any available-for-sale securities before recovery of its amortized cost basis. Realized gains and losses and declines in fair value judged to be other than temporary, if any, on available-for-sale securities are included in other expenses, net. The cost of investments sold is based on the specific-identification method.</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> The Company has not experienced material realized gains or </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">losses</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or other-than-temporary losses in the periods presented.</span><span style="font-size:12pt;color:#000000;">&#160;</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest on available-for-sale securities is included in other expenses, net and is not material for all periods presented.</span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Property<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>Equipment, Net</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property<span style="letter-spacing:0.05pt;"> </span>and equipment<span style="letter-spacing:0.05pt;"> </span>are stated<span style="letter-spacing:0.05pt;"> </span>at cost, less<span style="letter-spacing:0.05pt;"> </span>accumulated<span style="letter-spacing:0.1pt;"> </span>depreciation.<span style="letter-spacing:0.1pt;"> </span>Depreciation<span style="letter-spacing:0.1pt;"> </span>is calculated<span style="letter-spacing:0.1pt;"> </span>on a straight-line<span style="letter-spacing:0.15pt;"> </span>basis<span style="letter-spacing:0.05pt;"> </span>over the estimated<span style="letter-spacing:0.1pt;"> </span>useful<span style="letter-spacing:0.05pt;"> </span>lives<span style="letter-spacing:0.05pt;"> </span>of the related<span style="letter-spacing:0.05pt;"> </span>assets,<span style="letter-spacing:0.05pt;"> </span>generally<span style="letter-spacing:0.05pt;"> </span>ranging<span style="letter-spacing:0.05pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>three<span style="letter-spacing:0.05pt;"> </span>to seven years.<span style="letter-spacing:0.05pt;"> </span>Leasehold<span style="letter-spacing:0.05pt;"> </span>improvements<span style="letter-spacing:0.1pt;"> </span>are amortized<span style="letter-spacing:0.1pt;"> </span>on a straight-line<span style="letter-spacing:0.15pt;"> </span>basis<span style="letter-spacing:0.05pt;"> </span>over the shorter<span style="letter-spacing:0.05pt;"> </span>of the assets&#8217;<span style="letter-spacing:0.05pt;"> </span>estimated useful<span style="letter-spacing:0.05pt;"> </span>life<span style="letter-spacing:0.05pt;"> </span>or the remaining<span style="letter-spacing:0.1pt;"> </span>term<span style="letter-spacing:0.05pt;"> </span>of the lease.<span style="letter-spacing:0.05pt;"> </span><span style="color:#000000;">Upon retirement or sale of the assets, the cost and related accumulated depreciation and amortization are removed from the consolidated balance sheets and the resulting gains or losses are recorded in the consolidated statements of operations and comprehensive loss. </span>Maintenance<span style="letter-spacing:0.1pt;"> </span>and repair<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>are expensed as incurred.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Impairment<span style="letter-spacing:0.1pt;"> </span>of Long-Lived Assets</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company periodically<span style="letter-spacing:0.1pt;"> </span>evaluates<span style="letter-spacing:0.05pt;"> </span>its<span style="letter-spacing:0.05pt;"> </span>long-lived<span style="letter-spacing:0.05pt;"> </span>assets,<span style="letter-spacing:0.05pt;"> </span>including<span style="letter-spacing:0.05pt;"> </span>property<span style="letter-spacing:0.05pt;"> </span>and equipment,<span style="letter-spacing:0.05pt;"> </span>for impairment<span style="letter-spacing:0.1pt;"> </span>whenever events<span style="letter-spacing:0.05pt;"> </span>or changes in business<span style="letter-spacing:0.05pt;"> </span>circumstances<span style="letter-spacing:0.15pt;"> </span>indicate<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>the carrying<span style="letter-spacing:0.05pt;"> </span>amount<span style="letter-spacing:0.05pt;"> </span>of the assets or group of assets<span style="letter-spacing:0.05pt;"> </span>may not be fully<span style="letter-spacing:0.05pt;"> </span>recoverable.<span style="letter-spacing:0.1pt;"> </span>If indicators<span style="letter-spacing:0.1pt;"> </span>of impairment<span style="letter-spacing:0.1pt;"> </span>exist<span style="letter-spacing:0.05pt;"> </span>and the undiscounted<span style="letter-spacing:0.05pt;"> </span>future cash flows that<span style="letter-spacing:0.05pt;"> </span>the assets<span style="letter-spacing:0.05pt;"> </span>are expected<span style="letter-spacing:0.05pt;"> </span>to generate<span style="letter-spacing:0.05pt;"> </span>are less<span style="letter-spacing:0.05pt;"> </span>than the carrying<span style="letter-spacing:0.05pt;"> </span>value of the assets,<span style="letter-spacing:0.05pt;"> </span>the Company reduces<span style="letter-spacing:0.05pt;"> </span>the carrying<span style="letter-spacing:0.05pt;"> </span>amount<span style="letter-spacing:0.05pt;"> </span>of the assets<span style="letter-spacing:0.05pt;"> </span>through an impairment<span style="letter-spacing:0.1pt;"> </span>charge,<span style="letter-spacing:0.05pt;"> </span>to their<span style="letter-spacing:0.05pt;"> </span>estimated<span style="letter-spacing:0.1pt;"> </span>fair<span style="letter-spacing:0.05pt;"> </span>values<span style="letter-spacing:0.05pt;"> </span>based on a discounted<span style="letter-spacing:0.05pt;"> </span>cash flow approach<span style="letter-spacing:0.05pt;"> </span>or, when<span style="letter-spacing:-0.05pt;"> </span>available<span style="letter-spacing:0.1pt;"> </span>and appropriate,<span style="letter-spacing:0.1pt;"> </span>to comparable<span style="letter-spacing:0.1pt;"> </span>market<span style="letter-spacing:0.05pt;"> </span>values.<span style="letter-spacing:0.05pt;"> </span>There were no such indicators<span style="letter-spacing:0.1pt;"> </span>for the periods<span style="letter-spacing:0.05pt;"> </span>presented.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;color:#231F20;letter-spacing:0.05pt;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Accrued Research and Development Expenses</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company estimates preclinical<span style="letter-spacing:0.1pt;"> </span>and clinical<span style="letter-spacing:0.1pt;"> </span>study and research<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.05pt;"> </span>based on the services<span style="letter-spacing:0.05pt;"> </span>performed,<span style="letter-spacing:0.1pt;"> </span>pursuant<span style="letter-spacing:0.05pt;"> </span>to contracts<span style="letter-spacing:0.1pt;"> </span>with research<span style="letter-spacing:0.05pt;"> </span>institutions<span style="letter-spacing:0.1pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>conduct and manage<span style="letter-spacing:0.05pt;"> </span>preclinical<span style="letter-spacing:0.1pt;"> </span>and clinical<span style="letter-spacing:0.1pt;"> </span>studies<span style="letter-spacing:0.05pt;"> </span>and research<span style="letter-spacing:0.05pt;"> </span>services<span style="letter-spacing:0.05pt;"> </span>on its<span style="letter-spacing:0.05pt;"> </span>behalf. The Company records<span style="letter-spacing:0.05pt;"> </span>the costs<span style="letter-spacing:0.05pt;"> </span>of research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>activities<span style="letter-spacing:0.1pt;"> </span>based upon the estimated<span style="letter-spacing:0.1pt;"> </span>services<span style="letter-spacing:0.05pt;"> </span>provided<span style="letter-spacing:0.05pt;"> </span>but not yet invoiced<span style="letter-spacing:0.05pt;"> </span>and includes<span style="letter-spacing:0.05pt;"> </span>these<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>in accrued<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.15pt;"> </span>in the consolidated<span style="letter-spacing:0.1pt;"> </span>balance sheets.<span style="letter-spacing:0.05pt;"> </span>These costs<span style="letter-spacing:0.05pt;"> </span>are a component<span style="letter-spacing:0.05pt;"> </span>of the Company&#8217;s research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>expenses.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accrues for these costs based on factors such as estimates of the work completed in accordance with agreements established with its third-party service providers. The Company makes judgments and estimates in determining the accrued expenses balance. As actual costs become known, the Company adjusts its accrued expenses. The Company has not experienced any material differences between accrued costs and actual costs incurred. However, the status<span style="letter-spacing:0.05pt;"> </span>and timing<span style="letter-spacing:0.05pt;"> </span>of actual<span style="letter-spacing:0.05pt;"> </span>services<span style="letter-spacing:0.05pt;"> </span>performed<span style="letter-spacing:0.1pt;"> </span>may vary from<span style="letter-spacing:0.05pt;"> </span>the Company&#8217;s estimates,<span style="letter-spacing:0.1pt;"> </span>resulting<span style="letter-spacing:0.1pt;"> </span>in adjustments<span style="letter-spacing:0.1pt;"> </span>to expense in future<span style="letter-spacing:0.05pt;"> </span>periods.<span style="letter-spacing:0.05pt;"> </span>Changes in these<span style="letter-spacing:0.05pt;"> </span>estimates that<span style="letter-spacing:0.05pt;"> </span>result<span style="letter-spacing:0.05pt;"> </span>in material<span style="letter-spacing:0.1pt;"> </span>changes to the Company&#8217;s accrued expenses<span style="letter-spacing:0.05pt;"> </span>could materially<span style="letter-spacing:0.15pt;"> </span>affect<span style="letter-spacing:0.05pt;"> </span>the Company&#8217;s results<span style="letter-spacing:0.05pt;"> </span>of operations.<span style="letter-spacing:0.05pt;"> </span>Contingent<span style="letter-spacing:0.05pt;"> </span>milestone<span style="letter-spacing:0.1pt;"> </span>payments,<span style="letter-spacing:0.05pt;"> </span>if any, are expensed when<span style="letter-spacing:-0.05pt;"> </span>the milestone<span style="letter-spacing:0.1pt;"> </span>results<span style="letter-spacing:0.05pt;"> </span>are probable and estimable, which is generally<span style="letter-spacing:0.05pt;"> </span>upon achievement<span style="letter-spacing:0.1pt;"> </span>of the milestone.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Leases</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company leases<span style="letter-spacing:0.05pt;"> </span>its<span style="letter-spacing:0.05pt;"> </span>office<span style="letter-spacing:0.05pt;"> </span>facilities<span style="letter-spacing:0.1pt;"> </span>under non-cancelable<span style="letter-spacing:0.1pt;"> </span>operating<span style="letter-spacing:0.05pt;"> </span>lease<span style="letter-spacing:0.05pt;"> </span>agreements<span style="letter-spacing:0.1pt;"> </span>and recognizes related<span style="letter-spacing:0.05pt;"> </span>rent<span style="letter-spacing:0.05pt;"> </span>expense on a straight-line<span style="letter-spacing:0.15pt;"> </span>basis<span style="letter-spacing:0.05pt;"> </span>over the term<span style="letter-spacing:0.05pt;"> </span>of the lease.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Research and<span style="letter-spacing:-0.05pt;"> </span>Development<span style="letter-spacing:0.05pt;"> </span>Expenses<span style="font-weight:normal;"> </span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.05pt;"> </span>consist<span style="letter-spacing:0.05pt;"> </span>primarily<span style="letter-spacing:0.1pt;"> </span>of costs<span style="letter-spacing:0.05pt;"> </span>incurred<span style="letter-spacing:0.05pt;"> </span>for the development<span style="letter-spacing:0.05pt;"> </span>of the Company&#8217;s lead product<span style="letter-spacing:0.05pt;"> </span>candidate,<span style="letter-spacing:0.05pt;"> </span>pegozafermin. Research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.05pt;"> </span>consist<span style="letter-spacing:0.05pt;"> </span>primarily<span style="letter-spacing:0.1pt;"> </span>of external<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>related<span style="letter-spacing:0.05pt;"> </span>to<span style="letter-spacing:0.1pt;"> </span>preclinical<span style="letter-spacing:0.1pt;"> </span>and clinical development<span style="letter-spacing:0.05pt;"> </span>and related<span style="letter-spacing:0.05pt;"> </span>supplies, and personnel<span style="letter-spacing:0.05pt;"> </span>costs.<span style="letter-spacing:0.05pt;"> </span>Personnel<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>consist<span style="letter-spacing:0.05pt;"> </span>of salaries,<span style="letter-spacing:0.1pt;"> </span>employee<span style="letter-spacing:0.05pt;"> </span>benefits<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:1.05pt;"> </span>stock-based<span style="letter-spacing:0.1pt;"> </span>compensation<span style="letter-spacing:0.1pt;"> </span>for individuals<span style="letter-spacing:0.1pt;"> </span>involved<span style="letter-spacing:0.05pt;"> </span>in research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>efforts. Payments<span style="letter-spacing:0.05pt;"> </span>associated<span style="letter-spacing:0.1pt;"> </span>with agreements<span style="letter-spacing:0.1pt;"> </span>to acquire<span style="letter-spacing:0.05pt;"> </span>licenses<span style="letter-spacing:0.05pt;"> </span>to develop, use, manufacture<span style="letter-spacing:0.1pt;"> </span>and commercialize<span style="letter-spacing:0.15pt;"> </span>products and purchases of pegozafermin from contract manufacturing organizations<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>have not reached<span style="letter-spacing:0.05pt;"> </span>technological<span style="letter-spacing:0.1pt;"> </span>feasibility<span style="letter-spacing:0.15pt;"> </span>and do not have alternate<span style="letter-spacing:0.1pt;"> future </span>commercial<span style="letter-spacing:0.1pt;"> </span>use are expensed as incurred.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Stock-Based Compensation</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company provides equity awards in the form of stock options and restricted stock units. The Company measures<span style="letter-spacing:0.05pt;"> </span>its<span style="letter-spacing:0.05pt;"> </span>equity<span style="letter-spacing:0.05pt;"> </span>awards made to employees,<span style="letter-spacing:0.05pt;"> </span>directors,<span style="letter-spacing:0.1pt;"> </span>and<span style="color:#000000;"> </span>non-employee<span style="letter-spacing:0.05pt;"> </span>service<span style="letter-spacing:0.05pt;"> </span>providers<span style="letter-spacing:0.05pt;"> </span>based on estimated fair values and recognizes stock-based compensation over the requisite service period. The Company accounts<span style="letter-spacing:0.05pt;"> </span>for forfeitures<span style="letter-spacing:0.15pt;"> </span>as they occur.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company estimates<span style="letter-spacing:0.1pt;"> </span>the fair<span style="letter-spacing:0.05pt;"> </span>value of stock option<span style="letter-spacing:0.05pt;"> </span>awards on the date of grant<span style="letter-spacing:0.05pt;"> </span>using a<span style="color:#000000;"> </span>Black-Scholes<span style="letter-spacing:0.05pt;"> </span>option pricing<span style="letter-spacing:0.05pt;"> </span>model.<span style="letter-spacing:0.05pt;"> </span>The Company recognizes<span style="letter-spacing:0.05pt;"> </span>compensation<span style="letter-spacing:0.1pt;"> </span>for the value of stock options<span style="letter-spacing:0.05pt;"> </span>awards, which have graded vesting,<span style="letter-spacing:0.05pt;"> </span>using the straight-line<span style="letter-spacing:0.15pt;"> </span>method<span style="letter-spacing:0.05pt;"> </span>over the requisite<span style="letter-spacing:0.1pt;"> </span>service<span style="letter-spacing:0.05pt;"> </span>period<span style="letter-spacing:0.05pt;"> </span>of each award. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Black-Scholes option pricing model requires a number of assumptions, of which the most significant are expected volatility, expected option term (the time from the grant date until the options are exercised or expire), risk-free rate, and expected divided rate. These assumptions include:</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Expected volatility&#8212;Since the Company has limited trading history for its common stock, expected volatility is estimated based on weighting the Company&#8217;s volatility and the volatility of comparable publicly traded biotechnology companies during the equivalent period of the calculated expected term of the options granted. The comparable companies were chosen based on their similar size, stage in the life cycle or area of specialty. There is a degree of uncertainty in determining a comparable peer group as each of the peers are engaged in varied research and development activities, the timing and progress of which differ within the peer group. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Expected term&#8212;The expected term of options granted to employees and directors is determined using the &#8220;simplified&#8221; method. Under this approach, the expected term is presumed to be the midpoint between the weighted-average vesting term and the contractual term of the option. The simplified method makes the assumption that the employee will exercise share options evenly over the period when the share options are vested and ending on the date when the share options would expire. The expected option term for options granted to non-employees is estimated on a grant-by-grant basis.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Risk-free interest rate&#8212;The risk-free interest rate is based on the U.S. Treasury zero coupon bonds in effect on the grant date for periods with an equivalent expected term as the option.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Expected dividend&#8212;The Company has never paid dividends and has no foreseeable plans to pay dividends on its shares of common stock. Therefore, an expected dividend of zero is used.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of restricted stock units is based on the fair value of the Company&#8217;s common stock on the date of grant. The grant date fair value of restricted stock units with service vesting conditions is recognized over the requisite service period on a straight-line basis. For restricted stock units with performance vesting conditions, the Company evaluates the probability of achieving the performance condition at each reporting date and recognizes expense for such performance awards over the requisite service period using the accelerated attribution method.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Income Taxes</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income<span style="letter-spacing:0.05pt;"> </span>taxes<span style="letter-spacing:0.05pt;"> </span>are accounted<span style="letter-spacing:0.05pt;"> </span>for under the asset<span style="letter-spacing:0.05pt;"> </span>and liability<span style="letter-spacing:0.1pt;"> </span>method.<span style="letter-spacing:0.05pt;"> </span>Under this<span style="letter-spacing:0.05pt;"> </span>method,<span style="letter-spacing:0.05pt;"> </span>deferred<span style="letter-spacing:0.05pt;"> </span>tax assets<span style="letter-spacing:0.05pt;"> </span>and liabilities<span style="letter-spacing:0.15pt;"> </span>are recognized<span style="letter-spacing:0.05pt;"> </span>for the future<span style="letter-spacing:0.05pt;"> </span>tax consequences<span style="letter-spacing:0.05pt;"> </span>attributable<span style="letter-spacing:0.15pt;"> </span>to differences<span style="letter-spacing:0.1pt;"> </span>between the consolidated<span style="letter-spacing:0.1pt;"> </span>financial<span style="letter-spacing:0.1pt;"> </span>statements<span style="letter-spacing:0.1pt;"> </span>carrying<span style="letter-spacing:0.05pt;"> </span>amounts<span style="letter-spacing:0.05pt;"> </span>of existing<span style="letter-spacing:0.05pt;"> </span>assets<span style="letter-spacing:0.05pt;"> </span>and liabilities<span style="letter-spacing:0.15pt;"> </span>and their<span style="letter-spacing:0.05pt;"> </span>respective<span style="letter-spacing:0.1pt;"> </span>tax bases and operating<span style="letter-spacing:0.05pt;"> </span>loss and tax credit<span style="letter-spacing:0.05pt;"> </span>carryforwards.<span style="letter-spacing:0.1pt;"> </span>Deferred<span style="letter-spacing:0.05pt;"> </span>tax assets<span style="letter-spacing:0.05pt;"> </span>and liabilities<span style="letter-spacing:0.15pt;"> </span>are measured<span style="letter-spacing:0.05pt;"> </span>using enacted<span style="letter-spacing:0.05pt;"> </span>tax rates<span style="letter-spacing:0.05pt;"> </span>applied<span style="letter-spacing:0.05pt;"> </span>to </p>
<p style="margin-bottom:0pt;margin-top:6pt;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">taxable</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">income</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in the years</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in which those temporary</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">differences</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">are expected</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to be realized.</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The effect</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">on deferred</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tax assets</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and liabilities</span><span style="letter-spacing:0.15pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of a change in tax rates</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">is recognized</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">as income</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or loss in the period that</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">includes</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the enactment</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">date. A</span><span style="letter-spacing:-0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">valuation</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">allowance</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">is established</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">when</span><span style="letter-spacing:-0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">necessary</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to reduce</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">deferred</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tax assets</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to the amount</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">expected</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to be realized.</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and penalties</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">related</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to unrecognized</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tax benefits</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">are included</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">within the provision</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of income</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tax. </span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Basic and<span style="letter-spacing:-0.05pt;"> </span>Diluted Net Loss per Share</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic loss per share<span style="letter-spacing:0.05pt;"> </span>is computed<span style="letter-spacing:0.05pt;"> </span>by dividing<span style="letter-spacing:0.05pt;"> </span>the net loss by the weighted-average<span style="letter-spacing:0.05pt;"> </span>number<span style="letter-spacing:0.05pt;"> </span>of common stock<span style="letter-spacing:0.05pt;"> </span>outstanding<span style="letter-spacing:0.05pt;"> </span>during the period.<span style="letter-spacing:0.05pt;"> </span>Diluted<span style="letter-spacing:0.05pt;"> </span>loss per share<span style="letter-spacing:0.05pt;"> </span>is computed<span style="letter-spacing:0.05pt;"> </span>by dividing<span style="letter-spacing:0.05pt;"> </span>the net loss by the weighted-average<span style="letter-spacing:0.05pt;"> </span>number<span style="letter-spacing:0.05pt;"> </span>of common stock<span style="letter-spacing:0.05pt;"> </span>outstanding<span style="letter-spacing:0.05pt;"> </span>together<span style="letter-spacing:0.05pt;"> </span>with the number<span style="letter-spacing:0.05pt;"> </span>of additional<span style="letter-spacing:0.1pt;"> shares of </span>common stock<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>would have been outstanding<span style="letter-spacing:0.05pt;"> </span>if all<span style="letter-spacing:0.05pt;"> </span>potentially<span style="letter-spacing:0.1pt;"> </span>dilutive<span style="letter-spacing:0.05pt;"> </span>common stock<span style="letter-spacing:0.05pt;"> </span>had been issued.<span style="letter-spacing:0.05pt;"> </span>Since the Company is in a loss position<span style="letter-spacing:0.05pt;"> </span>for the periods<span style="letter-spacing:0.05pt;"> </span>presented,<span style="letter-spacing:0.05pt;"> </span>basic<span style="letter-spacing:0.05pt;"> </span>net loss per share<span style="letter-spacing:0.05pt;"> </span>is the same<span style="letter-spacing:0.05pt;"> </span>as diluted<span style="letter-spacing:0.05pt;"> </span>net loss per share<span style="letter-spacing:0.05pt;"> </span>since<span style="letter-spacing:0.05pt;"> </span>the effects of potentially<span style="letter-spacing:0.1pt;"> </span>dilutive<span style="letter-spacing:0.05pt;"> </span>securities<span style="letter-spacing:0.1pt;"> </span>are antidilutive.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Comprehensive<span style="letter-spacing:0.05pt;"> </span>Loss</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s comprehensive loss is comprised of net loss and changes in unrealized gains or losses on available-for-sale securities and foreign currency translation adjustments.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2016, the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-02&#8212;<span style="font-style:italic;">Leases </span>(&#8220;ASU 2016-02&#8221;), requiring the recognition of lease assets and liabilities on the balance sheet. The standard: (a) clarifies the definition of a lease; (b) requires a dual approach to lease classification similar to current lease classifications; and (c) causes lessees to recognize leases on the balance sheet as a lease liability with a corresponding right-of-use asset for leases with a lease-term of more than twelve months. As an emerging growth company, ASU 2016-02 is effective for the Company for the year ending December 31, 2022 and interim periods within the year ending December 31, 2023. The Company expects to adopt ASC 842 using the modified retrospective method with a cumulative effect adjustment, if any, to equity at the beginning of the period of adoption. The Company anticipates electing several practical expedients that permit the Company not to reassess (i) whether a contract is or contains a lease, (ii) the classification of existing leases, and (iii) whether previously capitalized initial direct costs would qualify for capitalization. The Company also anticipates electing not to separate non-lease components from the associated lease components and to not to recognize lease assets and liabilities for leases with a term of 12 months or less. Based on its existing facility leases as of December 31, 2021, the Company does not expect the adoption of this new standard to have a material impact on the Company&#8217;s consolidated financial statements.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In June 2016, the FASB issued ASU 2016-13,&#160;</span><span style="font-style:italic;Background-color:#FFFFFF;">Financial Instruments&#8212;Credit Losses (Topic 326)</span><span style="Background-color:#FFFFFF;">: </span><span style="font-style:italic;Background-color:#FFFFFF;">Measurement of Credit Losses on Financial Instruments </span><span style="color:#000000;">(&#8220;ASU 2016-13&#8221;)</span><span style="Background-color:#FFFFFF;">, which replaces the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measured at amortized cost to be presented at the net amount expected to be collected. As an emerging growth company, ASU 2016-13 is effective for the Company </span><span style="color:#000000;">for the year ending December 31, 2023 and interim periods within that fiscal year</span><span style="Background-color:#FFFFFF;"> and must be adopted using a modified retrospective approach, with certain exceptions. The Company is evaluating the impact of this standard on its consolidated financial statements and related disclosures.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870567098552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">3. Fair Value Measurements </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents the Company&#8217;s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of December 31, 2021 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Valuation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Hierarchy</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-top:solid 0.75pt #000000;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,477</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,477</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59,647</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59,637</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government bonds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,662</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(42</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,620</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,776</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,776</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency bonds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,747</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,741</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Municipal bonds</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,251</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,247</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-U.S. debt securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,506</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,505</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">126,066</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(65</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">126,003</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Classified as:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,715</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term available-for-sale securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,288</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">126,003</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the Company&#8217;s cash equivalents and available-for-sale securities by contractual maturity as of December 31, 2021 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.14%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Within one year</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">120,726</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">After one year through two years</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,277</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">126,003</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents the Company&#8217;s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of December 31, 2020 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Valuation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Hierarchy</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-top:solid 0.75pt #000000;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46,134</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46,134</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76,605</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76,603</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency bonds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,654</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,669</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,890</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,884</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government bonds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,093</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,093</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Municipal bonds</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,592</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,593</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. treasury bills</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,680</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,680</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency discount securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">200</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">200</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">181,848</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">181,856</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Classified as:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,410</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term available-for-sale securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">106,446</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">181,856</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the Company&#8217;s cash equivalents and available-for-sale securities by contractual maturity as of December 31, 2020 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.14%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Within one year</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">160,304</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">After one year through two years</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,552</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">181,856</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870568021656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Balance Sheet Components<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Consolidated Balance Sheet Components</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">4. Consolidated Balance Sheet Components </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Prepaid and Other Current Assets</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid and other current assets consist of the following as of the periods presented (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.4%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid research and development</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,895</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,534</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid taxes</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">836</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">481</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid other</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,506</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,533</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total prepaid and other current assets</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,237</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,548</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Accrued Expenses </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses consist of the following as of the periods presented (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.4%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued research and development expenses</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,195</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,884</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued employee and related expenses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,168</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,552</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued professional and legal fees</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">495</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">453</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">336</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">159</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accrued expenses</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,194</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,048</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870568954136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments And Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">5. Commitments and Contingencies </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Leases</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May 2018, the Company entered<span style="letter-spacing:0.05pt;"> </span>into an operating<span style="letter-spacing:0.05pt;"> </span>lease<span style="letter-spacing:0.05pt;"> </span>agreement<span style="letter-spacing:0.1pt;"> </span>for its<span style="letter-spacing:0.05pt;"> </span>facility<span style="letter-spacing:0.1pt;"> </span>in Israel.<span style="letter-spacing:0.05pt;"> </span>The Company amended the lease term to expire in April 2022, with an option to renew for an additional 12 months. Under the lease agreement,<span style="letter-spacing:0.1pt;"> </span>monthly<span style="letter-spacing:0.05pt;"> </span>lease<span style="letter-spacing:0.05pt;"> </span>payments<span style="letter-spacing:0.05pt;"> </span>are approximately<span style="letter-spacing:0.1pt;"> </span>$4,200. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2019, the Company entered into an operating lease for its headquarters in San Francisco, with a lease term that was due to expire in January 2022. In July 2021, the Company amended the lease agreement to extend the term of the lease to January 2023, with an option to renew the term for one year.&#160;Under the lease agreement, monthly lease payments are approximately $18,000. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Future minimum<span style="letter-spacing:0.1pt;"> </span>lease<span style="letter-spacing:0.05pt;"> </span>payments<span style="letter-spacing:0.05pt;"> </span>under the Company&#8217;s non-cancellable<span style="letter-spacing:0.1pt;"> </span>operating<span style="letter-spacing:0.05pt;"> </span>lease<span style="letter-spacing:0.05pt;"> </span>obligations<span style="letter-spacing:0.1pt;"> </span>as of December<span style="letter-spacing:0.05pt;"> </span>31, 2021, are as follows<span style="letter-spacing:0.05pt;"> </span>(in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:77.1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">212</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:77.1%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:77.1%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total future minimum annual payments</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">219</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Rent expense was $290,000 and $273,000 for the years ended December 31, 2021 and 2020, respectively. The Company has security deposit balances of $95,000, a portion of which is included in restricted cash and a portion in other assets in the consolidated balance sheets as of December 31, 2021 and 2020.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Asset Transfer and License Agreement with Teva Pharmaceutical Industries Ltd </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2018, the Company concurrently entered into two Asset Transfer and License Agreements (the &#8220;Teva Agreements&#8221;) with Teva Pharmaceutical Industries Ltd (&#8220;Teva&#8221;) under which it acquired certain patents and intellectual property relating to two programs: (1)&#160;Teva&#8217;s glycoPEGylated FGF21 program, including the compound TEV-47948 (pegozafermin), a glycoPEGylated long-acting FGF21 and (2)&#160;Teva&#8217;s development program of small molecule inhibitors of fatty acid synthase. Pursuant to the Teva Agreements, the Company paid Teva an initial nonrefundable upfront payment of $6.0&#160;million and the Company could be obligated to pay Teva up to $67.5&#160;million under each program, for a total of $135.0&#160;million, upon the achievement of certain clinical development and commercial milestones. In addition, the Company is obligated to pay Teva tiered royalties at percentages in the low-to-mid single-digits on worldwide net sales on all products containing the Teva compounds. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Teva Agreements can be terminated (i)&#160;by the Company without cause upon 120 days&#8217; written notice to Teva, (ii)&#160;by either party, if the other party materially breaches any of its obligations under the Teva Agreements and fails to cure such breach within 60 days after receiving notice thereof, or (iii)&#160;by either party, if a bankruptcy petition is filed against the other party and is not dismissed within 60 days. In addition, Teva can also terminate the agreement related to the Company&#8217;s glycoPEGylated FGF21 program in the event the Company, or any of its affiliates or sublicensees, challenges any of the Teva patents licensed to the Company, and the challenge is not withdrawn within 30 days of written notice from Teva. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the years ended December 31, 2021 and 2020, none of the development and commercial milestones were met and accordingly, there were no milestone payments related to the Teva Agreements. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870566915608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Term Loan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Term Loan</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">6. Term Loan</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Loan and Security Agreement</p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2020, the Company entered into a Loan and Security Agreement, (the &#8220;Loan Agreement&#8221;) with the lenders referred to therein (the &#8220;Lenders&#8221;), and Silicon Valley Bank (&#8220;SVB&#8221;), as collateral agent. The Loan Agreement provided for (i) a secured term A loan facility (the &#8220;Term A Loan Facility&#8221;) of up to $10.0 million and (ii) a secured term B loan facility (the &#8220;Term B Loan Facility&#8221;) of up to $5.0 million that became available upon the satisfaction of certain milestones, each of which was available to be drawn through May 31, 2021 pursuant to an amendment executed in April 2021. The term loan is secured by certain assets of the Borrowers (as defined in the Loan Agreement), including substantially all of the assets of the Company, excluding the Company&#8217;s intellectual property. The term loan contains customary representations, warranties, affirmative covenants and also certain restrictive covenants.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2020, in connection with the execution of the Loan Agreement, the Company issued SVB a warrant to purchase 25,000 shares of the Company&#8217;s common stock with a warrant exercise price of $22.06 per share that is immediately exercisable and expires on<span style="font-size:12pt;">&#160;</span>June 30, 2025, as amended. The fair value of the warrant at issuance date was determined by using the Black-Scholes option-pricing model with the following assumptions: risk-free interest rate of 0.75%, no dividends, expected volatility of 92.3% and expected term of 10.0 years. Upon issuance, the fair value allocated to the warrant of $0.6 million met the requirements for equity classification within additional paid-in capital in the consolidated balance sheets. Additionally, the Company incurred $0.2 million in closing costs, which together with the value of the warrants, were recorded as debt issuance costs classified within other assets in the consolidated balance sheets.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May 2021, the parties further amended the Loan Agreement (as amended, the &#8220;2021 Loan Agreement&#8221;). The 2021 Loan Agreement increased the Term A Loan Facility to up to $20.0 million thereby increasing the total term loan facility from $15.0 million to $25.0 million. The Term B Loan Facility of up to $5.0 million remains available to be drawn upon the achievement of certain additional milestones, and each loan facility is available to be drawn upon on or before September 30, 2022. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Concurrent with the closing and as a condition of the 2021 Loan Agreement, the Company drew $</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.5</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and in </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December 2021, drew the remaining $18.5 million </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">under</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the Term Loan A Facility. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 2021 Loan Agreement provides for interest</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">only payments </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">until</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> October 1, 2022, followed by consecutive monthly payments of principal and interest starting on October 1, 2022 and continuing through</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">September 1, 2024</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the maturity date of the term loan. The interest only period may be extended to April 1, 2023, if on or before September 20, 2022, the Company receives net cash proceeds of at least $</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75.0</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million from the sale of its equity securities. The term loan bears interest at the greater of (i) </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.25</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">% and (ii) the sum of (a) the Prime Rate as reported in The Wall Street Journal plus (b) </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.00</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">% (or </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for both amounts drawn </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.25% initially and as of </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 3</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, 2021). In addition, a final payment fee of </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5%</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the principal amount of the loan is due when the term loan becomes due or upon prepayment of the term loan. If the Company elects to prepay the loan, there is also a prepayment fee of between 1% and 3% of the principal amount of the term loan depending on the timing of prepayment.</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May 2021, in connection with the execution of the 2021 Loan Agreement, the Company issued SVB a warrant to purchase 33,923 shares of the Company&#8217;s common stock with a warrant exercise price of $19.12 per share that is immediately exercisable and expires on May 28, 2031. The Company determined the fair value of the warrant at the issuance date by using the Black-Scholes option-pricing model with the following assumptions: risk-free interest rate of 1.6%, no dividends, expected volatility of 98.6% and expected term of 10.0 years. Upon issuance, the fair value of the warrant of $0.6 million was recorded as a debt issuance cost and met the requirements for equity classification within additional paid-in capital in the consolidated balance sheets. In addition, closing costs incurred were not material. In connection with Term Loan B Facility, if funded, the Company will issue additional warrant to purchase 11,305 shares of the Company&#8217;s common stock with the exercise price at the Company&#8217;s stock price at the time of issuance.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 2021 Loan Agreement was accounted for as a modification to a credit facility. The related debt issuance costs incurred in May 2021, including the fair value of the warrant, together with the remaining unamortized debt issuance costs related to the Loan Agreement of $0.4 million were recorded as deferred assets and recognized on a straight-line basis as interest expense over the availability of the draw period. As of December 31, 2021, all amounts were drawn under the Term Loan A Facility such that all debt issuance costs were recorded as a debt discount. The carrying value of the debt discount, together with the final payment fee, are recognized using the effective interest method. Interest expense is recorded within other expenses, net in the consolidated statements of operations and comprehensive loss. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;<span style="font-size:10pt;">The expected repayments of principal amount due on the term loan, excluding the final payment fee, as of December 31, 2021 are as follows (in thousands):</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,500</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,500</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total principal repayments</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: unamortized debt discount</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(602</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total term loan, net</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,398</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: term loan, current</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,500</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term loan, non-current, net</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,898</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870566949656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">7. Stock-Based Compensation </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Equity Incentive Plans</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s board of directors approved the 2019 Equity Incentive Plan (the &#8220;2019 Plan&#8221;), which became effective in September 2019. The Company initially reserved 2,844,193 shares of common stock for issuance under the 2019 Plan. In addition, the number of shares of common stock reserved for issuance under the 2019 Plan will automatically increase on the first day of January for a period of up to ten years, commencing on January 1, 2020, in an amount equal to 4% of the total number of shares of the Company&#8217;s capital stock outstanding on the immediately preceding December 31, or a lesser number of shares determined by the Company&#8217;s board of directors. As of December 31, 2021, there were 1,428,304 shares of common stock available for issuance as future option grants under the 2019 Plan. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The board of directors determines the period over which options become exercisable and options generally vest over a <span style="-sec-ix-hidden:F_000467">four-year</span> period, with 25% of options vesting on the first anniversary of employment, and thereafter, the remaining options vesting quarterly, over the following 36-month period. The options will expire within ten years from the date of grant. The exercise price of awards granted will not be less than the estimated fair value of the shares on the date of grant.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Employee Stock Purchase Plan</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In October 2019, the Company adopted the 2019 Employee Stock Purchase Plan (&#8220;ESPP&#8221;), which became effective in November 2019. The Company initially reserved 225,188 shares of common stock for purchase under the ESPP. The number of shares of common stock reserved for issuance under the ESPP will automatically increase on the first day of January for a period of up to ten years, in an amount equal to 1% <span style="color:#000000;">of the total number of shares of the Company&#8217;s common stock outstanding on the immediately preceding December 31, or a lesser number of shares determined by the Company&#8217;s board of directors. Purchases will be accomplished through the participation of discrete offering periods and each offering is expected to be 6 months long. For each offering period, ESPP participants will purchase shares of common stock at a price per share equal to</span> 85% <span style="color:#000000;">of the lesser of the fair market value of the Company&#8217;s common stock on (1) the first trading day of the applicable offering period or (2) the last trading day of the applicable offering period</span>. The first six month offering period under the ESPP commenced on January 1, 2020.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, there were 544,410 shares of common stock available for issuance under the ESPP.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recorded stock-based compensation for the periods presented as follows (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,966</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,250</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,712</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,557</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stock-based compensation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,678</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,807</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of stock options granted for the periods presented was estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (years)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000485">5.5-6.1</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000486">4.0-6.1</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000489">86.9-91.9%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000490">86.4-97.6%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000493">0.7-1.3%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000494">0.2-1.5%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes stock option activity for the year ended December 31, 2021: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Term</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In&#160;thousands)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance outstanding as of December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,898,395</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.79</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000509">8.6</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,918</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">830,013</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22.22</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(188,286</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.59</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cancelled and forfeited</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(133,454</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19.55</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance outstanding as of December 31, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,406,668</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.46</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000510">8.1</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,970</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercisable as of December 31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">922,104</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.76</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000511">7.3</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,800</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-right:1.92%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The estimated grant date fair value of stock options that vested during the year ended December 31, 2021, was $7.0 million. The weighted-average<span style="letter-spacing:0.1pt;"> </span>grant<span style="letter-spacing:0.05pt;"> </span>date fair<span style="letter-spacing:0.05pt;"> </span>value of stock options<span style="letter-spacing:0.05pt;"> that were </span>granted<span style="letter-spacing:0.05pt;"> </span>during the years ended December 31, 2021 and 2020 was $16.18 and $21.88 per share, respectively.<span style="letter-spacing:0.05pt;"> </span>As<span style="letter-spacing:-0.05pt;"> </span>of December<span style="letter-spacing:0.05pt;"> </span>31, 2021, there<span style="letter-spacing:0.05pt;"> </span>was $17.9 million of unrecognized<span style="letter-spacing:0.05pt;"> </span>stock-based compensation<span style="letter-spacing:0.1pt;"> </span>cost related<span style="letter-spacing:0.05pt;"> </span>to stock options<span style="letter-spacing:0.05pt;"> </span>granted<span style="letter-spacing:0.05pt;"> </span>under the 2019 Plan, which is expected<span style="letter-spacing:0.05pt;"> </span>to be recognized<span style="letter-spacing:0.05pt;"> </span>over a weighted-average<span style="letter-spacing:0.1pt;"> </span>period<span style="letter-spacing:0.05pt;"> </span>of <span><span style="color:#000000;">2.3</span> years</span>. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Restricted Stock Units (&#8220;RSUs&#8221;) </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2021, the Company granted 56,545 service-based RSUs to its employees with a total grant date fair value of $1.3 million. The RSUs vest annually over a <span style="-sec-ix-hidden:F_000523">three-year</span> period. During the year ended December 31, 2021, the Company recognized $0.3 million in expense related to the service-based RSUs. As of December 31, 2021, 11,651 RSUs were cancelled and 44,894 remain outstanding.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2021, the Company granted 61,500 performance-based RSUs to certain executives, one-third of which vest on each <span style="-sec-ix-hidden:F_000529">one-year</span> anniversary of the grant date subject to achievement of a development milestone and continued service to the Company. The performance-based RSUs have a total grant date fair value of $1.4 million. During the year ended December 31, 2021, the Company recognized $0.8 million in expense, using the accelerated attribution method, related to the performance-based RSUs. As of December 31, 2021, all of the performance-based RSUs remain outstanding. Subsequently, one-third of the performance-based RSUs vested in February 2022, upon achievement of the development milestone and satisfaction of the continued service condition.</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870567076408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;color:#auto;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;">8. Income Taxes</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Tax Rates Applicable to the Income of the Company and its Subsidiaries</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is taxed according to U.S. federal and state tax laws and Israeli tax laws. The statutory tax rates applicable to the income of the Company and its subsidiaries for the periods presented are as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.52%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc.</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89Bio Ltd.</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89bio Management, Inc.</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UAB 89bio Lithuania</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The income<span style="letter-spacing:0.05pt;"> </span>tax benefit<span style="letter-spacing:0.05pt;"> </span>is comprised<span style="letter-spacing:0.05pt;"> </span>of (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax benefit</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Deferred<span style="letter-spacing:0.05pt;"> </span>Income Taxes</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred<span style="letter-spacing:0.05pt;"> </span>income<span style="letter-spacing:0.05pt;"> </span>taxes<span style="letter-spacing:0.05pt;"> </span>reflect<span style="letter-spacing:0.1pt;"> </span>the net tax effects<span style="letter-spacing:0.1pt;"> </span>of temporary<span style="letter-spacing:0.1pt;"> </span>differences<span style="letter-spacing:0.1pt;"> </span>between the carrying<span style="letter-spacing:0.05pt;"> </span>amounts of assets<span style="letter-spacing:0.05pt;"> </span>and liabilities<span style="letter-spacing:0.15pt;"> </span>for financial<span style="letter-spacing:0.1pt;"> </span>reporting<span style="letter-spacing:0.05pt;"> </span>purposes<span style="letter-spacing:0.05pt;"> </span>and the amounts<span style="letter-spacing:0.05pt;"> </span>used for income<span style="letter-spacing:0.05pt;"> </span>tax purposes. Significant<span style="letter-spacing:0.1pt;"> </span>components<span style="letter-spacing:0.05pt;"> </span>of the Company&#8217;s deferred<span style="letter-spacing:0.05pt;"> </span>tax assets<span style="letter-spacing:0.05pt;"> for the periods presented </span>are as follows<span style="letter-spacing:0.05pt;"> </span>(in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. net operating loss carryforwards</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,094</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,342</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expenses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,529</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,392</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Israel net operating loss carryforwards</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,262</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,978</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,969</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">610</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">220</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">635</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">191</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,265</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,005</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: valuation allowance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(42,046</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(21,936</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">219</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As<span style="letter-spacing:-0.05pt;"> </span>of December<span style="letter-spacing:0.05pt;"> </span>31, 2021 and 2020, the Company recorded<span style="letter-spacing:0.05pt;"> </span>a valuation<span style="letter-spacing:0.05pt;"> </span>allowance<span style="letter-spacing:0.05pt;"> </span>of $42.0 million and $21.9 million, respectively,<span style="letter-spacing:0.1pt;"> </span>in respect<span style="letter-spacing:0.05pt;"> </span>of deferred<span style="letter-spacing:0.05pt;"> </span>tax assets<span style="letter-spacing:0.05pt;"> </span>resulting<span style="letter-spacing:0.1pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>tax loss carryforwards<span style="letter-spacing:0.1pt;"> </span>and other<span style="letter-spacing:0.05pt;"> </span>temporary<span style="letter-spacing:0.1pt;"> </span>differences.<span style="letter-spacing:0.1pt;"> </span>Realization of deferred tax assets is dependent upon future earnings, if any, the time and amount of which are uncertain. The Company regularly assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes based upon the weight of available evidence that it is more likely than not that all or a portion of deferred tax assets will not be realized, a valuation allowance is established through an adjustment to income tax expense. The valuation allowance increased by $20.1 million in 2021, which primarily relates to significant taxable losses. The Company continues to record a partial valuation allowance against the deferred tax assets in Israel due to achievement of recent profitability and the expectation of future profitability in the jurisdiction. The valuation allowance increased by $11.9 million in 2020, which primarily relates to significant taxable losses. The change in valuation allowance during 2020 also includes a partial release of the valuation allowance against deferred tax assets in Israel due to achievement of recent profitability and the expectation of future profitability in the jurisdiction, which decreased the valuation allowance by $69,000 in 2020. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Available<span style="letter-spacing:0.05pt;"> </span>Carryforward<span style="letter-spacing:0.05pt;"> </span>Tax <span style="letter-spacing:-0.05pt;">Losses and Credits</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, the Company had an accumulated tax loss carryforward of approximately $138.5 million and $18.5 million for U.S. and Israeli tax purposes, respectively. As of December 31, 2020, the Company had an accumulated<span style="letter-spacing:0.1pt;"> </span>tax loss carryforward<span style="letter-spacing:0.1pt;"> </span>of approximately $54.1 million and $17.3 million for U.S. and Israeli tax purposes, respectively. Federal net operating losses generated after 2017 can be carried forward indefinitely but utilization will be limited to 80% of taxable income in the period that net operating losses are being utilized. Carryforward tax losses in Israel have no expiration date.<span style="letter-spacing:0.1pt;"> </span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;letter-spacing:0.1pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021 and 2020, the Company had federal research and development credit carryforwards of approximately $2.1 million and $0.6 million, respectively, which expire beginning in 2040. As of December 31, 2021 and December 31, 2020, the Company has state research and development credit carryforwards of approximately $1.1 million and $0.7 million, respectively, which will carry forward indefinitely. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Loss from Operations, Before Income Tax</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-weight:normal;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">The Company recorded a loss from operations, before income tax for the periods presented as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.77%;font-family:Times New Roman;font-size:10pt;font-weight:bold;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(91,141</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(58,760</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lithuania</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(73</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Israel</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">862</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,275</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss before income tax</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(90,269</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(49,558</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Reconciliation of Income Tax Benefit</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The reconciliation<span style="letter-spacing:0.15pt;"> </span>of income tax benefit based on the statutory<span style="letter-spacing:0.1pt;"> </span>tax rate<span style="letter-spacing:0.05pt;"> </span>to the effective<span style="letter-spacing:0.1pt;"> </span>tax rate<span style="letter-spacing:0.05pt;"> for the periods presented </span>is as follows<span style="letter-spacing:0.05pt;"> </span>(in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax benefit computed at statutory rates</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,757</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,285</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in valuation allowance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,111</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11,914</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign rate differential</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,671</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in Israel effective tax rate due to the 2019</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; reorganization</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">647</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development credits, net of</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; uncertain tax position</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,331</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">815</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">191</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">555</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax benefit</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Utilization of U.S. federal and state net operating losses and credit carryforwards may be subject to an annual limitation provided for in Section 382 of the Internal Revenue Code and similar state codes. Any annual limitation could result in a deferral of the utilization of the net operating loss and credit carryforwards.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Unrecognized Tax Benefits </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the years ended December 31, 2021 and 2020, the amount of gross unrecognized tax benefits increased by $0.5 million and $0.3 million, respectively. If the total amount of unrecognized tax benefits was recognized, it would not have an impact to the effective tax rate as it would be offset by the reversal of related deferred tax assets which are subject to a full valuation allowance.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes interest and penalties related to uncertain tax positions as part of the income tax provision. As of December 31, 2021 and 2020, such interest and penalties were not material.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is subject to taxation in the United States, California, and several foreign jurisdictions. To date, the Company has not been subject to any federal or state income tax audits. The Company is currently under examination by the Israeli taxing authorities for 2018 and 2019. As of December 31, 2021 all tax years remain open to examination. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870566901048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">9. Net Loss Per Share </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following outstanding potentially dilutive shares, including all outstanding stock options, have been excluded from the calculation of diluted net loss per share for the periods presented due to their anti-dilutive effect: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.52%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options to purchase common stock</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,406,668</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,898,395</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested restricted stock units</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">106,394</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants to purchase common stock</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58,923</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,571,985</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,898,395</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870566916168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870569197288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Basis of Presentation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;).</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Principles of Consolidation</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currencies</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Foreign Currencies</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain transactions during the years ended December 31, 2021 and 2020 were denominated in currencies other than the U.S. dollar. Gains and losses from foreign currency transactions were not material for all periods presented and are reflected in the consolidated statements of operations and comprehensive loss as a component of other expenses, net. The Company&#8217;s subsidiary in Lithuania uses the Euro as its functional currency for financial reporting. The re-measurement from Euros to U.S. dollars results in translation gain and loss adjustments, which are reflected as a component of comprehensive loss as foreign currency translation adjustments.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions made in the accompanying consolidated financial statements include but are not limited to accrued research and development expenses and the fair value of stock options. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Fair Value Measurements </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial assets and liabilities are recorded at fair value on a recurring basis in the consolidated balance sheets. The carrying values of Company&#8217;s financial assets and liabilities, including cash and cash equivalents, restricted cash, prepaid and other current assets, accounts payable, and accrued expenses approximate to their fair value due to the short-term nature of these instruments. The fair value of the Company&#8217;s term loan approximates its carrying value, or amortized cost, due to the prevailing market rates of interest rates it bears. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. Assets and liabilities recorded at fair value are categorized based upon the level of judgment associated with the inputs used to measure their fair value. Hierarchical levels are directly related to the amount of subjectivity with the inputs to the valuation of these assets or liabilities as follows: </p>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1<span style="font-weight:normal;">&#8212;Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date; </span></p>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2<span style="font-weight:normal;">&#8212;Inputs (other than quoted prices included in Level&#160;1) are either directly or indirectly observable inputs for similar assets or liabilities. These include quoted prices for identical or similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Level 3<span style="font-weight:normal;">&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentrations of Credit Risk</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial<span style="letter-spacing:0.05pt;"> </span>instruments<span style="letter-spacing:0.1pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>potentially<span style="letter-spacing:0.1pt;"> </span>subject<span style="letter-spacing:0.05pt;"> </span>the Company to a concentration<span style="letter-spacing:0.1pt;"> </span>of credit<span style="letter-spacing:0.05pt;"> </span>risk<span style="letter-spacing:0.05pt;"> </span>consist primarily<span style="letter-spacing:0.1pt;"> </span>of cash and cash equivalents and short-term available-for-sale securities.<span style="letter-spacing:0.1pt;"> </span>Bank<span style="letter-spacing:-0.05pt;"> </span>deposits<span style="letter-spacing:0.05pt;"> </span>are held by accredited<span style="letter-spacing:0.1pt;"> </span>financial<span style="letter-spacing:0.1pt;"> </span>institutions<span style="letter-spacing:0.1pt;"> </span>and these deposits<span style="letter-spacing:0.05pt;"> </span>may at times<span style="letter-spacing:0.05pt;"> </span>be in excess<span style="letter-spacing:0.05pt;"> </span>of insured<span style="letter-spacing:0.05pt;"> </span>limits. The Company limits<span style="letter-spacing:0.1pt;"> </span>its<span style="letter-spacing:0.05pt;"> </span>credit<span style="letter-spacing:0.05pt;"> </span>risk<span style="letter-spacing:0.05pt;"> </span>associated<span style="letter-spacing:0.1pt;"> </span>with cash and cash equivalents<span style="letter-spacing:0.1pt;"> </span>by placing<span style="letter-spacing:0.05pt;"> </span>them<span style="letter-spacing:0.05pt;"> </span>with financial<span style="letter-spacing:0.1pt;"> </span>institutions<span style="letter-spacing:0.1pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>it believes<span style="letter-spacing:0.05pt;"> </span>are of high quality.<span style="letter-spacing:0.05pt;"> </span>The Company has not experienced<span style="letter-spacing:0.05pt;"> </span>any losses<span style="letter-spacing:0.05pt;"> </span>on its<span style="letter-spacing:0.05pt;"> </span>deposits<span style="letter-spacing:0.05pt;"> </span>of cash or cash equivalents. The Company <span style="color:#000000;">limits amounts invested in available-for-sale securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. The Company is not exposed to any significant concentrations of credit risk from these financial instruments.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_OtherRisksAndUncertaintiesPolicyTextBlock', window );">Other Risks and Uncertainties</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Other<span style="font-weight:normal;font-style:normal;"> </span>Risks and Uncertainties </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s future results of operations involve a number of other risks and uncertainties. Factors that could affect the Company&#8217;s future operating results and cause actual results to vary materially from expectations include, but are not limited to, the Company&#8217;s early stages of clinical drug development; the Company&#8217;s ability to advance product candidates into, and successfully complete, clinical trials on the timelines it projects; the Company&#8217;s ability to adequately demonstrate sufficient safety and efficacy of its product candidates; the Company&#8217;s ability to enroll patients in its ongoing and future clinical trials; the Company&#8217;s ability to successfully manufacture and supply its product candidates for clinical trials; the Company&#8217;s ability to obtain additional capital to finance its operations; uncertainties related to the projections of the size of patient populations suffering from the diseases the Company is targeting; the Company&#8217;s ability to obtain, maintain, and protect its intellectual property rights; developments relating to the Company&#8217;s competitors and its industry, including competing product candidates and therapies; general economic and market conditions; and other risks and uncertainties.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s product candidates will require approvals from the U.S. Food and Drug Administration and comparable foreign regulatory agencies prior to commercial sales in their respective jurisdictions. There can be no assurance that any product candidates will receive the necessary approvals. If the Company was denied approval, approval was delayed or the Company was unable to maintain approval for any product candidate, it could have a materially adverse impact on the Company.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The ongoing COVID-19 pandemic has disrupted and may continue to disrupt the Company&#8217;s business and delay its preclinical and clinical programs and timelines. <span style="color:#000000;">The Company does not yet know the full extent of potential delays to clinical trials, which could prevent or delay the Company from obtaining approval for&#160;pegozafermin.&#160;</span>The extent to which the COVID-19 pandemic may impact the Company&#8217;s future operating results and financial condition is uncertain.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Segment Reporting</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has one operating<span style="letter-spacing:0.05pt;"> </span>segment.<span style="letter-spacing:0.05pt;"> </span>The Company&#8217;s chief<span style="letter-spacing:0.05pt;"> </span>operating<span style="letter-spacing:0.05pt;"> </span>decision<span style="letter-spacing:0.05pt;"> </span>maker,<span style="letter-spacing:0.05pt;"> </span>its<span style="letter-spacing:0.05pt;"> </span>Chief Executive<span style="letter-spacing:0.05pt;"> </span>Officer,<span style="letter-spacing:0.05pt;"> </span>manages<span style="letter-spacing:0.05pt;"> </span>the Company&#8217;s operations<span style="letter-spacing:0.05pt;"> </span>on a consolidated<span style="letter-spacing:0.1pt;"> </span>basis<span style="letter-spacing:0.05pt;"> </span>for the purposes<span style="letter-spacing:0.05pt;"> </span>of allocating resources<span style="letter-spacing:0.05pt;"> </span>and evaluating<span style="letter-spacing:0.05pt;"> </span>financial<span style="letter-spacing:0.1pt;"> </span>performance.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash and Cash Equivalents and Restricted Cash</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Cash and Cash Equivalents</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be cash equivalents. Cash equivalents consist primarily of amounts invested in money market funds and commercial paper that are stated at fair value.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Restricted Cash</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash consists of a money market account that serves as collateral for the Company&#8217;s operating lease agreement for its facility in Israel.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Investments </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investments have been classified as available-for-sale and are carried at estimated fair value as determined based upon quoted market prices or pricing models for similar securities. Management determines the appropriate classification of its available-for-sale investments in debt securities at the time of purchase. Generally, investments with original maturities beyond three months at the date of purchase are classified as short-term because it is management&#8217;s intent to use the investments to fund current operations or to make them available for current operations. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrealized gains and losses are excluded from earnings and are reported as a component of comprehensive loss.&#160;The Company periodically evaluates whether declines in fair values of its available-for-sale securities below their book value are other-than-temporary. This evaluation consists of several qualitative and quantitative factors regarding the severity and duration of the unrealized loss as well as the Company&#8217;s ability and intent to hold the available-for-sale security until a forecasted recovery occurs. Additionally, the Company assesses whether it has plans to sell the security or it is more likely than not it will be required to sell any available-for-sale securities before recovery of its amortized cost basis. Realized gains and losses and declines in fair value judged to be other than temporary, if any, on available-for-sale securities are included in other expenses, net. The cost of investments sold is based on the specific-identification method.</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> The Company has not experienced material realized gains or </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">losses</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or other-than-temporary losses in the periods presented.</span><span style="font-size:12pt;color:#000000;">&#160;</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest on available-for-sale securities is included in other expenses, net and is not material for all periods presented.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Property<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>Equipment, Net</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property<span style="letter-spacing:0.05pt;"> </span>and equipment<span style="letter-spacing:0.05pt;"> </span>are stated<span style="letter-spacing:0.05pt;"> </span>at cost, less<span style="letter-spacing:0.05pt;"> </span>accumulated<span style="letter-spacing:0.1pt;"> </span>depreciation.<span style="letter-spacing:0.1pt;"> </span>Depreciation<span style="letter-spacing:0.1pt;"> </span>is calculated<span style="letter-spacing:0.1pt;"> </span>on a straight-line<span style="letter-spacing:0.15pt;"> </span>basis<span style="letter-spacing:0.05pt;"> </span>over the estimated<span style="letter-spacing:0.1pt;"> </span>useful<span style="letter-spacing:0.05pt;"> </span>lives<span style="letter-spacing:0.05pt;"> </span>of the related<span style="letter-spacing:0.05pt;"> </span>assets,<span style="letter-spacing:0.05pt;"> </span>generally<span style="letter-spacing:0.05pt;"> </span>ranging<span style="letter-spacing:0.05pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>three<span style="letter-spacing:0.05pt;"> </span>to seven years.<span style="letter-spacing:0.05pt;"> </span>Leasehold<span style="letter-spacing:0.05pt;"> </span>improvements<span style="letter-spacing:0.1pt;"> </span>are amortized<span style="letter-spacing:0.1pt;"> </span>on a straight-line<span style="letter-spacing:0.15pt;"> </span>basis<span style="letter-spacing:0.05pt;"> </span>over the shorter<span style="letter-spacing:0.05pt;"> </span>of the assets&#8217;<span style="letter-spacing:0.05pt;"> </span>estimated useful<span style="letter-spacing:0.05pt;"> </span>life<span style="letter-spacing:0.05pt;"> </span>or the remaining<span style="letter-spacing:0.1pt;"> </span>term<span style="letter-spacing:0.05pt;"> </span>of the lease.<span style="letter-spacing:0.05pt;"> </span><span style="color:#000000;">Upon retirement or sale of the assets, the cost and related accumulated depreciation and amortization are removed from the consolidated balance sheets and the resulting gains or losses are recorded in the consolidated statements of operations and comprehensive loss. </span>Maintenance<span style="letter-spacing:0.1pt;"> </span>and repair<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>are expensed as incurred.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Impairment<span style="letter-spacing:0.1pt;"> </span>of Long-Lived Assets</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company periodically<span style="letter-spacing:0.1pt;"> </span>evaluates<span style="letter-spacing:0.05pt;"> </span>its<span style="letter-spacing:0.05pt;"> </span>long-lived<span style="letter-spacing:0.05pt;"> </span>assets,<span style="letter-spacing:0.05pt;"> </span>including<span style="letter-spacing:0.05pt;"> </span>property<span style="letter-spacing:0.05pt;"> </span>and equipment,<span style="letter-spacing:0.05pt;"> </span>for impairment<span style="letter-spacing:0.1pt;"> </span>whenever events<span style="letter-spacing:0.05pt;"> </span>or changes in business<span style="letter-spacing:0.05pt;"> </span>circumstances<span style="letter-spacing:0.15pt;"> </span>indicate<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>the carrying<span style="letter-spacing:0.05pt;"> </span>amount<span style="letter-spacing:0.05pt;"> </span>of the assets or group of assets<span style="letter-spacing:0.05pt;"> </span>may not be fully<span style="letter-spacing:0.05pt;"> </span>recoverable.<span style="letter-spacing:0.1pt;"> </span>If indicators<span style="letter-spacing:0.1pt;"> </span>of impairment<span style="letter-spacing:0.1pt;"> </span>exist<span style="letter-spacing:0.05pt;"> </span>and the undiscounted<span style="letter-spacing:0.05pt;"> </span>future cash flows that<span style="letter-spacing:0.05pt;"> </span>the assets<span style="letter-spacing:0.05pt;"> </span>are expected<span style="letter-spacing:0.05pt;"> </span>to generate<span style="letter-spacing:0.05pt;"> </span>are less<span style="letter-spacing:0.05pt;"> </span>than the carrying<span style="letter-spacing:0.05pt;"> </span>value of the assets,<span style="letter-spacing:0.05pt;"> </span>the Company reduces<span style="letter-spacing:0.05pt;"> </span>the carrying<span style="letter-spacing:0.05pt;"> </span>amount<span style="letter-spacing:0.05pt;"> </span>of the assets<span style="letter-spacing:0.05pt;"> </span>through an impairment<span style="letter-spacing:0.1pt;"> </span>charge,<span style="letter-spacing:0.05pt;"> </span>to their<span style="letter-spacing:0.05pt;"> </span>estimated<span style="letter-spacing:0.1pt;"> </span>fair<span style="letter-spacing:0.05pt;"> </span>values<span style="letter-spacing:0.05pt;"> </span>based on a discounted<span style="letter-spacing:0.05pt;"> </span>cash flow approach<span style="letter-spacing:0.05pt;"> </span>or, when<span style="letter-spacing:-0.05pt;"> </span>available<span style="letter-spacing:0.1pt;"> </span>and appropriate,<span style="letter-spacing:0.1pt;"> </span>to comparable<span style="letter-spacing:0.1pt;"> </span>market<span style="letter-spacing:0.05pt;"> </span>values.<span style="letter-spacing:0.05pt;"> </span>There were no such indicators<span style="letter-spacing:0.1pt;"> </span>for the periods<span style="letter-spacing:0.05pt;"> </span>presented.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock', window );">Accrued Research and Development Expenses</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;color:#231F20;letter-spacing:0.05pt;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Accrued Research and Development Expenses</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company estimates preclinical<span style="letter-spacing:0.1pt;"> </span>and clinical<span style="letter-spacing:0.1pt;"> </span>study and research<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.05pt;"> </span>based on the services<span style="letter-spacing:0.05pt;"> </span>performed,<span style="letter-spacing:0.1pt;"> </span>pursuant<span style="letter-spacing:0.05pt;"> </span>to contracts<span style="letter-spacing:0.1pt;"> </span>with research<span style="letter-spacing:0.05pt;"> </span>institutions<span style="letter-spacing:0.1pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>conduct and manage<span style="letter-spacing:0.05pt;"> </span>preclinical<span style="letter-spacing:0.1pt;"> </span>and clinical<span style="letter-spacing:0.1pt;"> </span>studies<span style="letter-spacing:0.05pt;"> </span>and research<span style="letter-spacing:0.05pt;"> </span>services<span style="letter-spacing:0.05pt;"> </span>on its<span style="letter-spacing:0.05pt;"> </span>behalf. The Company records<span style="letter-spacing:0.05pt;"> </span>the costs<span style="letter-spacing:0.05pt;"> </span>of research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>activities<span style="letter-spacing:0.1pt;"> </span>based upon the estimated<span style="letter-spacing:0.1pt;"> </span>services<span style="letter-spacing:0.05pt;"> </span>provided<span style="letter-spacing:0.05pt;"> </span>but not yet invoiced<span style="letter-spacing:0.05pt;"> </span>and includes<span style="letter-spacing:0.05pt;"> </span>these<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>in accrued<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.15pt;"> </span>in the consolidated<span style="letter-spacing:0.1pt;"> </span>balance sheets.<span style="letter-spacing:0.05pt;"> </span>These costs<span style="letter-spacing:0.05pt;"> </span>are a component<span style="letter-spacing:0.05pt;"> </span>of the Company&#8217;s research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>expenses.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accrues for these costs based on factors such as estimates of the work completed in accordance with agreements established with its third-party service providers. The Company makes judgments and estimates in determining the accrued expenses balance. As actual costs become known, the Company adjusts its accrued expenses. The Company has not experienced any material differences between accrued costs and actual costs incurred. However, the status<span style="letter-spacing:0.05pt;"> </span>and timing<span style="letter-spacing:0.05pt;"> </span>of actual<span style="letter-spacing:0.05pt;"> </span>services<span style="letter-spacing:0.05pt;"> </span>performed<span style="letter-spacing:0.1pt;"> </span>may vary from<span style="letter-spacing:0.05pt;"> </span>the Company&#8217;s estimates,<span style="letter-spacing:0.1pt;"> </span>resulting<span style="letter-spacing:0.1pt;"> </span>in adjustments<span style="letter-spacing:0.1pt;"> </span>to expense in future<span style="letter-spacing:0.05pt;"> </span>periods.<span style="letter-spacing:0.05pt;"> </span>Changes in these<span style="letter-spacing:0.05pt;"> </span>estimates that<span style="letter-spacing:0.05pt;"> </span>result<span style="letter-spacing:0.05pt;"> </span>in material<span style="letter-spacing:0.1pt;"> </span>changes to the Company&#8217;s accrued expenses<span style="letter-spacing:0.05pt;"> </span>could materially<span style="letter-spacing:0.15pt;"> </span>affect<span style="letter-spacing:0.05pt;"> </span>the Company&#8217;s results<span style="letter-spacing:0.05pt;"> </span>of operations.<span style="letter-spacing:0.05pt;"> </span>Contingent<span style="letter-spacing:0.05pt;"> </span>milestone<span style="letter-spacing:0.1pt;"> </span>payments,<span style="letter-spacing:0.05pt;"> </span>if any, are expensed when<span style="letter-spacing:-0.05pt;"> </span>the milestone<span style="letter-spacing:0.1pt;"> </span>results<span style="letter-spacing:0.05pt;"> </span>are probable and estimable, which is generally<span style="letter-spacing:0.05pt;"> </span>upon achievement<span style="letter-spacing:0.1pt;"> </span>of the milestone.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Leases</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company leases<span style="letter-spacing:0.05pt;"> </span>its<span style="letter-spacing:0.05pt;"> </span>office<span style="letter-spacing:0.05pt;"> </span>facilities<span style="letter-spacing:0.1pt;"> </span>under non-cancelable<span style="letter-spacing:0.1pt;"> </span>operating<span style="letter-spacing:0.05pt;"> </span>lease<span style="letter-spacing:0.05pt;"> </span>agreements<span style="letter-spacing:0.1pt;"> </span>and recognizes related<span style="letter-spacing:0.05pt;"> </span>rent<span style="letter-spacing:0.05pt;"> </span>expense on a straight-line<span style="letter-spacing:0.15pt;"> </span>basis<span style="letter-spacing:0.05pt;"> </span>over the term<span style="letter-spacing:0.05pt;"> </span>of the lease.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expenses</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Research and<span style="letter-spacing:-0.05pt;"> </span>Development<span style="letter-spacing:0.05pt;"> </span>Expenses<span style="font-weight:normal;"> </span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.05pt;"> </span>consist<span style="letter-spacing:0.05pt;"> </span>primarily<span style="letter-spacing:0.1pt;"> </span>of costs<span style="letter-spacing:0.05pt;"> </span>incurred<span style="letter-spacing:0.05pt;"> </span>for the development<span style="letter-spacing:0.05pt;"> </span>of the Company&#8217;s lead product<span style="letter-spacing:0.05pt;"> </span>candidate,<span style="letter-spacing:0.05pt;"> </span>pegozafermin. Research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.05pt;"> </span>consist<span style="letter-spacing:0.05pt;"> </span>primarily<span style="letter-spacing:0.1pt;"> </span>of external<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>related<span style="letter-spacing:0.05pt;"> </span>to<span style="letter-spacing:0.1pt;"> </span>preclinical<span style="letter-spacing:0.1pt;"> </span>and clinical development<span style="letter-spacing:0.05pt;"> </span>and related<span style="letter-spacing:0.05pt;"> </span>supplies, and personnel<span style="letter-spacing:0.05pt;"> </span>costs.<span style="letter-spacing:0.05pt;"> </span>Personnel<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>consist<span style="letter-spacing:0.05pt;"> </span>of salaries,<span style="letter-spacing:0.1pt;"> </span>employee<span style="letter-spacing:0.05pt;"> </span>benefits<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:1.05pt;"> </span>stock-based<span style="letter-spacing:0.1pt;"> </span>compensation<span style="letter-spacing:0.1pt;"> </span>for individuals<span style="letter-spacing:0.1pt;"> </span>involved<span style="letter-spacing:0.05pt;"> </span>in research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>efforts. Payments<span style="letter-spacing:0.05pt;"> </span>associated<span style="letter-spacing:0.1pt;"> </span>with agreements<span style="letter-spacing:0.1pt;"> </span>to acquire<span style="letter-spacing:0.05pt;"> </span>licenses<span style="letter-spacing:0.05pt;"> </span>to develop, use, manufacture<span style="letter-spacing:0.1pt;"> </span>and commercialize<span style="letter-spacing:0.15pt;"> </span>products and purchases of pegozafermin from contract manufacturing organizations<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>have not reached<span style="letter-spacing:0.05pt;"> </span>technological<span style="letter-spacing:0.1pt;"> </span>feasibility<span style="letter-spacing:0.15pt;"> </span>and do not have alternate<span style="letter-spacing:0.1pt;"> future </span>commercial<span style="letter-spacing:0.1pt;"> </span>use are expensed as incurred.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Stock-Based Compensation</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company provides equity awards in the form of stock options and restricted stock units. The Company measures<span style="letter-spacing:0.05pt;"> </span>its<span style="letter-spacing:0.05pt;"> </span>equity<span style="letter-spacing:0.05pt;"> </span>awards made to employees,<span style="letter-spacing:0.05pt;"> </span>directors,<span style="letter-spacing:0.1pt;"> </span>and<span style="color:#000000;"> </span>non-employee<span style="letter-spacing:0.05pt;"> </span>service<span style="letter-spacing:0.05pt;"> </span>providers<span style="letter-spacing:0.05pt;"> </span>based on estimated fair values and recognizes stock-based compensation over the requisite service period. The Company accounts<span style="letter-spacing:0.05pt;"> </span>for forfeitures<span style="letter-spacing:0.15pt;"> </span>as they occur.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company estimates<span style="letter-spacing:0.1pt;"> </span>the fair<span style="letter-spacing:0.05pt;"> </span>value of stock option<span style="letter-spacing:0.05pt;"> </span>awards on the date of grant<span style="letter-spacing:0.05pt;"> </span>using a<span style="color:#000000;"> </span>Black-Scholes<span style="letter-spacing:0.05pt;"> </span>option pricing<span style="letter-spacing:0.05pt;"> </span>model.<span style="letter-spacing:0.05pt;"> </span>The Company recognizes<span style="letter-spacing:0.05pt;"> </span>compensation<span style="letter-spacing:0.1pt;"> </span>for the value of stock options<span style="letter-spacing:0.05pt;"> </span>awards, which have graded vesting,<span style="letter-spacing:0.05pt;"> </span>using the straight-line<span style="letter-spacing:0.15pt;"> </span>method<span style="letter-spacing:0.05pt;"> </span>over the requisite<span style="letter-spacing:0.1pt;"> </span>service<span style="letter-spacing:0.05pt;"> </span>period<span style="letter-spacing:0.05pt;"> </span>of each award. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Black-Scholes option pricing model requires a number of assumptions, of which the most significant are expected volatility, expected option term (the time from the grant date until the options are exercised or expire), risk-free rate, and expected divided rate. These assumptions include:</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Expected volatility&#8212;Since the Company has limited trading history for its common stock, expected volatility is estimated based on weighting the Company&#8217;s volatility and the volatility of comparable publicly traded biotechnology companies during the equivalent period of the calculated expected term of the options granted. The comparable companies were chosen based on their similar size, stage in the life cycle or area of specialty. There is a degree of uncertainty in determining a comparable peer group as each of the peers are engaged in varied research and development activities, the timing and progress of which differ within the peer group. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Expected term&#8212;The expected term of options granted to employees and directors is determined using the &#8220;simplified&#8221; method. Under this approach, the expected term is presumed to be the midpoint between the weighted-average vesting term and the contractual term of the option. The simplified method makes the assumption that the employee will exercise share options evenly over the period when the share options are vested and ending on the date when the share options would expire. The expected option term for options granted to non-employees is estimated on a grant-by-grant basis.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Risk-free interest rate&#8212;The risk-free interest rate is based on the U.S. Treasury zero coupon bonds in effect on the grant date for periods with an equivalent expected term as the option.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Expected dividend&#8212;The Company has never paid dividends and has no foreseeable plans to pay dividends on its shares of common stock. Therefore, an expected dividend of zero is used.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of restricted stock units is based on the fair value of the Company&#8217;s common stock on the date of grant. The grant date fair value of restricted stock units with service vesting conditions is recognized over the requisite service period on a straight-line basis. For restricted stock units with performance vesting conditions, the Company evaluates the probability of achieving the performance condition at each reporting date and recognizes expense for such performance awards over the requisite service period using the accelerated attribution method.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Income Taxes</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income<span style="letter-spacing:0.05pt;"> </span>taxes<span style="letter-spacing:0.05pt;"> </span>are accounted<span style="letter-spacing:0.05pt;"> </span>for under the asset<span style="letter-spacing:0.05pt;"> </span>and liability<span style="letter-spacing:0.1pt;"> </span>method.<span style="letter-spacing:0.05pt;"> </span>Under this<span style="letter-spacing:0.05pt;"> </span>method,<span style="letter-spacing:0.05pt;"> </span>deferred<span style="letter-spacing:0.05pt;"> </span>tax assets<span style="letter-spacing:0.05pt;"> </span>and liabilities<span style="letter-spacing:0.15pt;"> </span>are recognized<span style="letter-spacing:0.05pt;"> </span>for the future<span style="letter-spacing:0.05pt;"> </span>tax consequences<span style="letter-spacing:0.05pt;"> </span>attributable<span style="letter-spacing:0.15pt;"> </span>to differences<span style="letter-spacing:0.1pt;"> </span>between the consolidated<span style="letter-spacing:0.1pt;"> </span>financial<span style="letter-spacing:0.1pt;"> </span>statements<span style="letter-spacing:0.1pt;"> </span>carrying<span style="letter-spacing:0.05pt;"> </span>amounts<span style="letter-spacing:0.05pt;"> </span>of existing<span style="letter-spacing:0.05pt;"> </span>assets<span style="letter-spacing:0.05pt;"> </span>and liabilities<span style="letter-spacing:0.15pt;"> </span>and their<span style="letter-spacing:0.05pt;"> </span>respective<span style="letter-spacing:0.1pt;"> </span>tax bases and operating<span style="letter-spacing:0.05pt;"> </span>loss and tax credit<span style="letter-spacing:0.05pt;"> </span>carryforwards.<span style="letter-spacing:0.1pt;"> </span>Deferred<span style="letter-spacing:0.05pt;"> </span>tax assets<span style="letter-spacing:0.05pt;"> </span>and liabilities<span style="letter-spacing:0.15pt;"> </span>are measured<span style="letter-spacing:0.05pt;"> </span>using enacted<span style="letter-spacing:0.05pt;"> </span>tax rates<span style="letter-spacing:0.05pt;"> </span>applied<span style="letter-spacing:0.05pt;"> </span>to </p>
<p style="margin-bottom:0pt;margin-top:6pt;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">taxable</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">income</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in the years</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in which those temporary</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">differences</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">are expected</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to be realized.</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The effect</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">on deferred</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tax assets</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and liabilities</span><span style="letter-spacing:0.15pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of a change in tax rates</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">is recognized</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">as income</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or loss in the period that</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">includes</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the enactment</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">date. A</span><span style="letter-spacing:-0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">valuation</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">allowance</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">is established</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">when</span><span style="letter-spacing:-0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">necessary</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to reduce</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">deferred</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tax assets</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to the amount</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">expected</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to be realized.</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and penalties</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">related</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to unrecognized</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tax benefits</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">are included</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">within the provision</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of income</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tax. </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and Diluted Net Loss per Share</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Basic and<span style="letter-spacing:-0.05pt;"> </span>Diluted Net Loss per Share</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic loss per share<span style="letter-spacing:0.05pt;"> </span>is computed<span style="letter-spacing:0.05pt;"> </span>by dividing<span style="letter-spacing:0.05pt;"> </span>the net loss by the weighted-average<span style="letter-spacing:0.05pt;"> </span>number<span style="letter-spacing:0.05pt;"> </span>of common stock<span style="letter-spacing:0.05pt;"> </span>outstanding<span style="letter-spacing:0.05pt;"> </span>during the period.<span style="letter-spacing:0.05pt;"> </span>Diluted<span style="letter-spacing:0.05pt;"> </span>loss per share<span style="letter-spacing:0.05pt;"> </span>is computed<span style="letter-spacing:0.05pt;"> </span>by dividing<span style="letter-spacing:0.05pt;"> </span>the net loss by the weighted-average<span style="letter-spacing:0.05pt;"> </span>number<span style="letter-spacing:0.05pt;"> </span>of common stock<span style="letter-spacing:0.05pt;"> </span>outstanding<span style="letter-spacing:0.05pt;"> </span>together<span style="letter-spacing:0.05pt;"> </span>with the number<span style="letter-spacing:0.05pt;"> </span>of additional<span style="letter-spacing:0.1pt;"> shares of </span>common stock<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>would have been outstanding<span style="letter-spacing:0.05pt;"> </span>if all<span style="letter-spacing:0.05pt;"> </span>potentially<span style="letter-spacing:0.1pt;"> </span>dilutive<span style="letter-spacing:0.05pt;"> </span>common stock<span style="letter-spacing:0.05pt;"> </span>had been issued.<span style="letter-spacing:0.05pt;"> </span>Since the Company is in a loss position<span style="letter-spacing:0.05pt;"> </span>for the periods<span style="letter-spacing:0.05pt;"> </span>presented,<span style="letter-spacing:0.05pt;"> </span>basic<span style="letter-spacing:0.05pt;"> </span>net loss per share<span style="letter-spacing:0.05pt;"> </span>is the same<span style="letter-spacing:0.05pt;"> </span>as diluted<span style="letter-spacing:0.05pt;"> </span>net loss per share<span style="letter-spacing:0.05pt;"> </span>since<span style="letter-spacing:0.05pt;"> </span>the effects of potentially<span style="letter-spacing:0.1pt;"> </span>dilutive<span style="letter-spacing:0.05pt;"> </span>securities<span style="letter-spacing:0.1pt;"> </span>are antidilutive.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Comprehensive<span style="letter-spacing:0.05pt;"> </span>Loss</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s comprehensive loss is comprised of net loss and changes in unrealized gains or losses on available-for-sale securities and foreign currency translation adjustments.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2016, the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-02&#8212;<span style="font-style:italic;">Leases </span>(&#8220;ASU 2016-02&#8221;), requiring the recognition of lease assets and liabilities on the balance sheet. The standard: (a) clarifies the definition of a lease; (b) requires a dual approach to lease classification similar to current lease classifications; and (c) causes lessees to recognize leases on the balance sheet as a lease liability with a corresponding right-of-use asset for leases with a lease-term of more than twelve months. As an emerging growth company, ASU 2016-02 is effective for the Company for the year ending December 31, 2022 and interim periods within the year ending December 31, 2023. The Company expects to adopt ASC 842 using the modified retrospective method with a cumulative effect adjustment, if any, to equity at the beginning of the period of adoption. The Company anticipates electing several practical expedients that permit the Company not to reassess (i) whether a contract is or contains a lease, (ii) the classification of existing leases, and (iii) whether previously capitalized initial direct costs would qualify for capitalization. The Company also anticipates electing not to separate non-lease components from the associated lease components and to not to recognize lease assets and liabilities for leases with a term of 12 months or less. Based on its existing facility leases as of December 31, 2021, the Company does not expect the adoption of this new standard to have a material impact on the Company&#8217;s consolidated financial statements.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In June 2016, the FASB issued ASU 2016-13,&#160;</span><span style="font-style:italic;Background-color:#FFFFFF;">Financial Instruments&#8212;Credit Losses (Topic 326)</span><span style="Background-color:#FFFFFF;">: </span><span style="font-style:italic;Background-color:#FFFFFF;">Measurement of Credit Losses on Financial Instruments </span><span style="color:#000000;">(&#8220;ASU 2016-13&#8221;)</span><span style="Background-color:#FFFFFF;">, which replaces the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measured at amortized cost to be presented at the net amount expected to be collected. As an emerging growth company, ASU 2016-13 is effective for the Company </span><span style="color:#000000;">for the year ending December 31, 2023 and interim periods within that fiscal year</span><span style="Background-color:#FFFFFF;"> and must be adopted using a modified retrospective approach, with certain exceptions. The Company is evaluating the impact of this standard on its consolidated financial statements and related disclosures.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued research and development expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_OtherRisksAndUncertaintiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other risks and uncertainties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_OtherRisksAndUncertaintiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870568303256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Summary of Financial Assets Measured at Fair Value on Recurring Basis</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents the Company&#8217;s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of December 31, 2021 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Valuation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Hierarchy</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-top:solid 0.75pt #000000;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,477</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,477</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59,647</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59,637</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government bonds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,662</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(42</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,620</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,776</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,776</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency bonds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,747</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,741</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Municipal bonds</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,251</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,247</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-U.S. debt securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,506</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,505</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">126,066</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(65</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">126,003</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Classified as:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,715</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term available-for-sale securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,288</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">126,003</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents the Company&#8217;s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of December 31, 2020 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Valuation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Hierarchy</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-top:solid 0.75pt #000000;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46,134</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46,134</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76,605</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76,603</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency bonds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,654</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,669</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,890</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,884</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government bonds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,093</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,093</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Municipal bonds</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,592</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,593</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. treasury bills</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,680</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,680</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency discount securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">200</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">200</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">181,848</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">181,856</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Classified as:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,410</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term available-for-sale securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">106,446</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">181,856</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of Contractual Maturities of Cash Equivalents and Available-for-Sale Securities</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the Company&#8217;s cash equivalents and available-for-sale securities by contractual maturity as of December 31, 2021 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.14%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Within one year</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">120,726</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">After one year through two years</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,277</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">126,003</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the Company&#8217;s cash equivalents and available-for-sale securities by contractual maturity as of December 31, 2020 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.14%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Within one year</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">160,304</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">After one year through two years</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,552</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">181,856</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870567011096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Balance Sheet Components (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock', window );">Schedule of Prepaid and Other Current Assets</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid and other current assets consist of the following as of the periods presented (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.4%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid research and development</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,895</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,534</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid taxes</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">836</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">481</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid other</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,506</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,533</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total prepaid and other current assets</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,237</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,548</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Accrued Expenses </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses consist of the following as of the periods presented (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.4%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued research and development expenses</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,195</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,884</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued employee and related expenses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,168</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,552</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued professional and legal fees</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">495</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">453</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">336</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">159</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accrued expenses</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,194</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,048</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of prepaid and other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870566934440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments And Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Future minimum<span style="letter-spacing:0.1pt;"> </span>lease<span style="letter-spacing:0.05pt;"> </span>payments<span style="letter-spacing:0.05pt;"> </span>under the Company&#8217;s non-cancellable<span style="letter-spacing:0.1pt;"> </span>operating<span style="letter-spacing:0.05pt;"> </span>lease<span style="letter-spacing:0.05pt;"> </span>obligations<span style="letter-spacing:0.1pt;"> </span>as of December<span style="letter-spacing:0.05pt;"> </span>31, 2021, are as follows<span style="letter-spacing:0.05pt;"> </span>(in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:77.1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">212</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:77.1%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:77.1%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total future minimum annual payments</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">219</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870566927112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Term Loan (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Repayment of Principal Amount</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;<span style="font-size:10pt;">The expected repayments of principal amount due on the term loan, excluding the final payment fee, as of December 31, 2021 are as follows (in thousands):</span></p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,500</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,500</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total principal repayments</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: unamortized debt discount</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(602</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total term loan, net</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,398</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: term loan, current</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,500</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term loan, non-current, net</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,898</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:12pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870571524136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of Stock-Based Compensation</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recorded stock-based compensation for the periods presented as follows (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,966</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,250</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,712</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,557</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stock-based compensation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,678</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,807</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of Estimated Fair Value of Stock Options Granted Using Black-Scholes Option-Pricing Model</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of stock options granted for the periods presented was estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions: </p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (years)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000485">5.5-6.1</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000486">4.0-6.1</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000489">86.9-91.9%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000490">86.4-97.6%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000493">0.7-1.3%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000494">0.2-1.5%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activity</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes stock option activity for the year ended December 31, 2021: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Term</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In&#160;thousands)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance outstanding as of December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,898,395</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.79</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000509">8.6</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,918</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">830,013</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22.22</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(188,286</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.59</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cancelled and forfeited</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(133,454</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19.55</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance outstanding as of December 31, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,406,668</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.46</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000510">8.1</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,970</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercisable as of December 31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">922,104</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.76</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000511">7.3</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,800</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-right:1.92%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870569226712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock', window );">Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is taxed according to U.S. federal and state tax laws and Israeli tax laws. The statutory tax rates applicable to the income of the Company and its subsidiaries for the periods presented are as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.52%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc.</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89Bio Ltd.</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89bio Management, Inc.</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UAB 89bio Lithuania</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Summary of Income Tax Benefit (Expense)</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The income<span style="letter-spacing:0.05pt;"> </span>tax benefit<span style="letter-spacing:0.05pt;"> </span>is comprised<span style="letter-spacing:0.05pt;"> </span>of (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax benefit</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Summary of Components of Deferred Tax Assets</a></td>
<td class="text">Significant<span style="letter-spacing:0.1pt;"> </span>components<span style="letter-spacing:0.05pt;"> </span>of the Company&#8217;s deferred<span style="letter-spacing:0.05pt;"> </span>tax assets<span style="letter-spacing:0.05pt;"> for the periods presented </span>are as follows<span style="letter-spacing:0.05pt;"> </span>(in thousands):
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. net operating loss carryforwards</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,094</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,342</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expenses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,529</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,392</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Israel net operating loss carryforwards</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,262</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,978</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,969</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">610</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">220</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">635</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">191</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,265</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,005</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: valuation allowance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(42,046</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(21,936</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">219</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Summary of Loss from Operations Before Taxes on Income</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-weight:normal;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">The Company recorded a loss from operations, before income tax for the periods presented as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.77%;font-family:Times New Roman;font-size:10pt;font-weight:bold;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(91,141</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(58,760</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lithuania</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(73</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Israel</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">862</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,275</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss before income tax</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(90,269</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(49,558</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Summary of Reconciliation of Income Tax Benefit (Expense) Statutory Tax Rate to Effective Tax Rate</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The reconciliation<span style="letter-spacing:0.15pt;"> </span>of income tax benefit based on the statutory<span style="letter-spacing:0.1pt;"> </span>tax rate<span style="letter-spacing:0.05pt;"> </span>to the effective<span style="letter-spacing:0.1pt;"> </span>tax rate<span style="letter-spacing:0.05pt;"> for the periods presented </span>is as follows<span style="letter-spacing:0.05pt;"> </span>(in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax benefit computed at statutory rates</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,757</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,285</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in valuation allowance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,111</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11,914</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign rate differential</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,671</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in Israel effective tax rate due to the 2019</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; reorganization</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">647</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development credits, net of</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; uncertain tax position</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,331</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">815</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">191</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">555</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax benefit</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of effective income tax rate of company and subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870670517944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following outstanding potentially dilutive shares, including all outstanding stock options, have been excluded from the calculation of diluted net loss per share for the periods presented due to their anti-dilutive effect: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.52%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options to purchase common stock</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,406,668</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,898,395</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested restricted stock units</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">106,394</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants to purchase common stock</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58,923</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,571,985</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,898,395</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870570271256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Basis of Presentation - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationDateOfIncorporation', window );">Date of incorporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun. 30,  2019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Cash and cash equivalents and short term available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,700<span></span>
</td>
<td class="nump">$ 150,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_ATMFacilityMember', window );">A T M Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,289<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_ATMFacilityMember', window );">A T M Facility | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember', window );">SVB Leerink LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued and sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net of underwriters discount and commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_SellingCommissionPerSharesSoldPercentage', window );">Selling commission per shares sold percentage</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock upon ESPP purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Issuance of common stock, weighted average price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | A T M Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued and sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186,546<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=etnb_UnderwrittenPublicOfferingMember', window );">Underwritten public offering | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued and sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,025,000<span></span>
</td>
<td class="nump">3,047,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net of underwriters discount and commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79,500<span></span>
</td>
<td class="nump">$ 78,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">IPO price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28.00<span></span>
</td>
<td class="nump">$ 27.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payment of underwriting discounts, commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_PaymentsOfStockIssuanceCostsOther', window );">Other offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock upon ESPP purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79,500<span></span>
</td>
<td class="nump">$ 78,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationDateOfIncorporation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when an entity was incorporated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationDateOfIncorporation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_PaymentsOfStockIssuanceCostsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments of stock issuance costs, other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_PaymentsOfStockIssuanceCostsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_SellingCommissionPerSharesSoldPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Selling commission per shares sold percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_SellingCommissionPerSharesSoldPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=etnb_ATMFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=etnb_ATMFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=etnb_UnderwrittenPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=etnb_UnderwrittenPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870569082680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>Segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Leasehold improvements amortization, description</a></td>
<td class="text">Leasehold improvements are amortized on a straight-line basis over the shorter of the assets&#8217; estimated useful life or the remaining term of the lease.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, estimated useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, estimated useful lives</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123364984&amp;loc=d3e1205-110223<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870564607128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Summary of Financial Assets Measured at Fair Value on Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments, Aggregated Fair Value</a></td>
<td class="nump">$ 126,003<span></span>
</td>
<td class="nump">$ 181,856<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Short-term investments, Amortized Cost</a></td>
<td class="nump">126,066<span></span>
</td>
<td class="nump">181,848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Short-term investments, Gross Unrealized Holding Gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Short-term investments, Gross Unrealized Holding Losses</a></td>
<td class="num">(65)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments, Aggregated Fair Value</a></td>
<td class="nump">126,003<span></span>
</td>
<td class="nump">181,856<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments, Aggregated Fair Value</a></td>
<td class="nump">27,715<span></span>
</td>
<td class="nump">75,410<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Short-term available for sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments, Aggregated Fair Value</a></td>
<td class="nump">98,288<span></span>
</td>
<td class="nump">106,446<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Short-term investments, Amortized Cost</a></td>
<td class="nump">21,477<span></span>
</td>
<td class="nump">46,134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments, Aggregated Fair Value</a></td>
<td class="nump">21,477<span></span>
</td>
<td class="nump">46,134<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Short-term investments, Amortized Cost</a></td>
<td class="nump">59,647<span></span>
</td>
<td class="nump">76,605<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Short-term investments, Gross Unrealized Holding Losses</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments, Aggregated Fair Value</a></td>
<td class="nump">59,637<span></span>
</td>
<td class="nump">76,603<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | U.S. government bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Short-term investments, Amortized Cost</a></td>
<td class="nump">21,662<span></span>
</td>
<td class="nump">7,093<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Short-term investments, Gross Unrealized Holding Losses</a></td>
<td class="num">(42)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments, Aggregated Fair Value</a></td>
<td class="nump">21,620<span></span>
</td>
<td class="nump">7,093<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Corporate Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Short-term investments, Amortized Cost</a></td>
<td class="nump">8,776<span></span>
</td>
<td class="nump">11,890<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Short-term investments, Gross Unrealized Holding Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Short-term investments, Gross Unrealized Holding Losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments, Aggregated Fair Value</a></td>
<td class="nump">8,776<span></span>
</td>
<td class="nump">11,884<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Agency bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Short-term investments, Amortized Cost</a></td>
<td class="nump">7,747<span></span>
</td>
<td class="nump">29,654<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Short-term investments, Gross Unrealized Holding Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Short-term investments, Gross Unrealized Holding Losses</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments, Aggregated Fair Value</a></td>
<td class="nump">7,741<span></span>
</td>
<td class="nump">29,669<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Municipal Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Short-term investments, Amortized Cost</a></td>
<td class="nump">4,251<span></span>
</td>
<td class="nump">5,592<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Short-term investments, Gross Unrealized Holding Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Short-term investments, Gross Unrealized Holding Losses</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments, Aggregated Fair Value</a></td>
<td class="nump">4,247<span></span>
</td>
<td class="nump">5,593<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Non-US debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Short-term investments, Amortized Cost</a></td>
<td class="nump">2,506<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Short-term investments, Gross Unrealized Holding Losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments, Aggregated Fair Value</a></td>
<td class="nump">$ 2,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | U.S. treasury bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Short-term investments, Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,680<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments, Aggregated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,680<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Agency discount securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Short-term investments, Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments, Aggregated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_AgencySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_AgencySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryBillSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryBillSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=etnb_AgencyDiscountSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=etnb_AgencyDiscountSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870568318024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Contractual Maturities of Cash Equivalents and Available-for-Sale Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Within one year</a></td>
<td class="nump">$ 120,726<span></span>
</td>
<td class="nump">$ 160,304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue', window );">After one year through two years</a></td>
<td class="nump">5,277<span></span>
</td>
<td class="nump">21,552<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total cash equivalents and available-for-sale securities</a></td>
<td class="nump">$ 126,003<span></span>
</td>
<td class="nump">$ 181,856<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Available for sale securities debt maturities after one through two years fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870569006312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid Expense And Other Assets Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_PrepaidResearchAndDevelopmentCurrent', window );">Prepaid research and development</a></td>
<td class="nump">$ 7,895<span></span>
</td>
<td class="nump">$ 2,534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid taxes</a></td>
<td class="nump">836<span></span>
</td>
<td class="nump">481<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Prepaid other</a></td>
<td class="nump">2,506<span></span>
</td>
<td class="nump">2,533<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total prepaid and other current assets</a></td>
<td class="nump">$ 11,237<span></span>
</td>
<td class="nump">$ 5,548<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_PrepaidResearchAndDevelopmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and development expense prepaid current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_PrepaidResearchAndDevelopmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870569158936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheet Components - Schedule of Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables And Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_AccruedResearchAndDevelopmentExpenseCurrent', window );">Accrued research and development expenses</a></td>
<td class="nump">$ 6,195<span></span>
</td>
<td class="nump">$ 2,884<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued employee and related expenses</a></td>
<td class="nump">3,168<span></span>
</td>
<td class="nump">2,552<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional and legal fees</a></td>
<td class="nump">495<span></span>
</td>
<td class="nump">453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued other</a></td>
<td class="nump">336<span></span>
</td>
<td class="nump">159<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued expenses</a></td>
<td class="nump">$ 10,194<span></span>
</td>
<td class="nump">$ 6,048<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_AccruedResearchAndDevelopmentExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued research and development expense current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_AccruedResearchAndDevelopmentExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870570449064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>Apr. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DescriptionOfLesseeLeasingArrangementsOperatingLeases', window );">Lessee, operating lease, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company amended the lease term to expire in April 2022, with an option to renew for an additional 12 months.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_OperatingLeaseMonthlyRentalPayments', window );">Operating lease, payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, operating lease term of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Operating leases, rent expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 290,000<span></span>
</td>
<td class="nump">$ 273,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_TevaAgreementMember', window );">Teva Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment', window );">Nonrefundable upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones', window );">Payment upon achievement of certain clinical and commercial milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice', window );">Asset transfer and license agreement, termination period after written notice</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">120 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure', window );">Asset transfer and license agreement, termination period notice of breach</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled', window );">Asset transfer and license agreement termination notice period if bankruptcy petition filed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_TevaAgreementMember', window );">Teva Agreements | Research and Development Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_MilestonePayment', window );">Milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_TevaAgreementMember', window );">Teva Agreements | Teva's GlycoPEGylated FGF21 Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones', window );">Payment upon achievement of certain clinical and commercial milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_TevaAgreementMember', window );">Teva Agreements | Teva's Development Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones', window );">Payment upon achievement of certain clinical and commercial milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=etnb_RestrictedCashAndOtherAssetsMember', window );">Restricted Cash And Other Assets Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95,000<span></span>
</td>
<td class="nump">95,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=etnb_SanFranciscoOfficeMember', window );">San Francisco Office</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DescriptionOfLesseeLeasingArrangementsOperatingLeases', window );">Lessee, operating lease, description</a></td>
<td class="text">with a lease term that was due to expire in January 2022. In July 2021, the Company amended the lease agreement to extend the term of the lease to January 2023, with an option to renew the term for one year.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_OperatingLeaseMonthlyRentalPayments', window );">Operating lease, payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lessee,operating lease, renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset transfer and license agreements initial nonrefundable upfront payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset transfer and license agreement termination notice period if bankruptcy petition filed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset transfer and license agreement termination period after written notice.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset transfer and license agreement termination period notice of failure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_MilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Milestone payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_MilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligation to payment upon maximum achievement of certain clinical and commercial milestones.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_OperatingLeaseMonthlyRentalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating lease monthly rental payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_OperatingLeaseMonthlyRentalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DescriptionOfLesseeLeasingArrangementsOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A general description of the nature of the existing leasing arrangements of a lessee for all operating leases including, but not limited to: (1) rental escalation clauses; (2) renewal or purchase options; (3) guarantees or indemnities, if any, (4)  restrictions imposed by lease arrangements; (5) unusual provisions or conditions; (6) contingent rentals, if any; and (7) lease expiration dates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123389372&amp;loc=d3e36991-112694<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DescriptionOfLesseeLeasingArrangementsOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8,17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=etnb_TevaAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=etnb_TevaAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=etnb_TevasGlycoPEGylatedFGF21ProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=etnb_TevasGlycoPEGylatedFGF21ProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=etnb_TevasDevelopmentProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=etnb_TevasDevelopmentProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=etnb_RestrictedCashAndOtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=etnb_RestrictedCashAndOtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=etnb_SanFranciscoOfficeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=etnb_SanFranciscoOfficeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870657243368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments And Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total future minimum annual payments</a></td>
<td class="nump">$ 219<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870564068392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Term Loan - Additional Information (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>May 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected terms (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_PercentageOfFeeOnLoan', window );">Percentage of fee on loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,265<span></span>
</td>
<td class="nump">$ 22,005<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected terms (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected terms (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_LoanAndSecurityAgreementMember', window );">Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityDescription', window );">Line of Credit Facility, Description</a></td>
<td class="text">In May 2021, the parties further amended the Loan Agreement (as amended, the &#8220;2021 Loan Agreement&#8221;). The 2021 Loan Agreement increased the Term A Loan Facility to up to $20.0 million thereby increasing the total term loan facility from $15.0 million to $25.0 million. The Term B Loan Facility of up to $5.0 million remains available to be drawn upon the achievement of certain additional milestones, and each loan facility is available to be drawn upon on or before September 30, 2022.<span></span>
</td>
<td class="text">In April 2020, the Company entered into a Loan and Security Agreement, (the &#8220;Loan Agreement&#8221;) with the lenders referred to therein (the &#8220;Lenders&#8221;), and Silicon Valley Bank (&#8220;SVB&#8221;), as collateral agent. The Loan Agreement provided for (i) a secured term A loan facility (the &#8220;Term A Loan Facility&#8221;) of up to $10.0 million and (ii) a secured term B loan facility (the &#8220;Term B Loan Facility&#8221;) of up to $5.0 million that became available upon the satisfaction of certain milestones, each of which was available to be drawn through May 31, 2021 pursuant to an amendment executed in April 2021. The term loan is secured by certain assets of the Borrowers (as defined in the Loan Agreement), including substantially all of the assets of the Company, excluding the Company&#8217;s intellectual property. The term loan contains customary representations, warranties, affirmative covenants and also certain restrictive covenants.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common stock | shares</a></td>
<td class="nump">33,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="nump">$ 19.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Warrant expiration date</a></td>
<td class="text">May 28,  2031<span></span>
</td>
<td class="text">Jun. 30,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs, gross</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity', window );">Line of credit facility increase in borrowing capacity</a></td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_NetCashProceedsFromSaleOfEquitySecurities', window );">Proceeds from sale of available-for-sale securities, equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax assets</a></td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_LoanAndSecurityAgreementMember', window );">Loan Agreement | Measurement Input, Expected Dividend Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_FairValueOfWarrantsAssumptionsDividends', window );">Fair value of warrant assumptions, dividends</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_LoanAndSecurityAgreementMember', window );">Loan Agreement | Valuation Technique, Option Pricing Model | Measurement Input, Risk Free Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Fair measurement input</a></td>
<td class="nump">0.016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_LoanAndSecurityAgreementMember', window );">Loan Agreement | Valuation Technique, Option Pricing Model | Measurement Input, Price Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Fair measurement input</a></td>
<td class="nump">0.986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_LoanAndSecurityAgreementMember', window );">Loan Agreement | Valuation Technique, Option Pricing Model | Measurement Input, Expected Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Fair measurement input</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_LoanAndSecurityAgreementMember', window );">Loan Agreement | Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_LoanAndSecurityAgreementMember', window );">Loan Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_LoanAndSecurityAgreementMember', window );">Loan Agreement | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt instrument, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_LoanAndSecurityAgreementMember', window );">Loan Agreement | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_LoanAndSecurityAgreementMember', window );">Loan Agreement | Term A Loan Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Term loan amount drawn</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Credit facility maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep.  01,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_LoanAndSecurityAgreementMember', window );">Loan Agreement | Term B Loan Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common stock | shares</a></td>
<td class="nump">11,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_FairValueOfWarrantsAssumptionsDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of warrant assumptions, dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_FairValueOfWarrantsAssumptionsDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of credit facility increase in borrowing capacity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_NetCashProceedsFromSaleOfEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net cash proceeds from sale of equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_NetCashProceedsFromSaleOfEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_PercentageOfFeeOnLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of fee on loan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_PercentageOfFeeOnLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the terms of a credit facility arrangement. Terms typically include interest rate, collateral required, guarantees required, repayment requirements, and restrictions on use of assets and activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the credit facility terminates, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=etnb_LoanAndSecurityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=etnb_LoanAndSecurityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_PrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=etnb_TermALoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=etnb_TermALoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=etnb_TermBLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=etnb_TermBLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870569059944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Term Loan - Schedule of Repayment of Principal Amount (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths', window );">2022</a></td>
<td class="nump">$ 2,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo', window );">2023</a></td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree', window );">2024</a></td>
<td class="nump">7,500<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total principal repayments</a></td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Less: unamortized debt discount</a></td>
<td class="num">(602)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total term loan, net</a></td>
<td class="nump">19,398<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: term loan, current</a></td>
<td class="num">(2,500)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Term loan, non-current, net</a></td>
<td class="nump">$ 16,898<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870564616552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share base compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,678,000<span></span>
</td>
<td class="nump">$ 3,807,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=etnb_ServiceBasedRSUsMember', window );">Service-based RSUs | Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares granted</a></td>
<td class="nump">56,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue', window );">Total grant date fair value</a></td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share base compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=etnb_PerformanceRSUsMember', window );">Performance RSUs | Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares granted</a></td>
<td class="nump">61,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue', window );">Total grant date fair value</a></td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share base compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary', window );">Anniversary period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember', window );">ESPP Purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement', window );">Number of common shares issuable under the plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding', window );">Percentage of increase in number of shares of capital stock issued and outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Percent of purchase shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriod', window );">First offering period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate', window );">Commencement date of first six month offering period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan.  01,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares of common stock available for issuance under ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">544,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=etnb_TwoThousandAndNineteenEquityIncentivePlanMember', window );">2019 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement', window );">Number of common shares issuable under the plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,844,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding', window );">Percentage of increase in number of shares of capital stock issued and outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved and available for issuance as future option grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,428,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Percentage of option vesting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward', window );">Terms of award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The board of directors determines the period over which options become exercisable and options generally vest over a four-year period, with 25% of options vesting on the first anniversary of employment, and thereafter, the remaining options vesting quarterly, over the following 36-month period. The options will expire within ten years from the date of grant.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod', window );">Remaining option vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized stock option granted under plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">830,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,406,668<span></span>
</td>
<td class="nump">1,898,395<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=etnb_TwoThousandAndTwentyEquityIncentivePlanMember', window );">2020 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Estimated total grant date fair value of options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.18<span></span>
</td>
<td class="nump">$ 21.88<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | ESPP Purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance', window );">Period for increase in number of shares of common stock reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | 2019 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance', window );">Period for increase in number of shares of common stock reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issuable under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of increase in number of shares of capital stock reserved for issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period for increase in number of shares of common stock reserved for issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of share based compensation arrangement by share based payment award anniversary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award remaining options vesting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment first offering period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment first offering period commencement date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sharebased compensation arrangement by sharebased payment award options grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of terms of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=etnb_ServiceBasedRSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=etnb_ServiceBasedRSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=etnb_PerformanceRSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=etnb_PerformanceRSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=etnb_TwoThousandAndNineteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=etnb_TwoThousandAndNineteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=etnb_TwoThousandAndTwentyEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=etnb_TwoThousandAndTwentyEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870569063528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Stock-Based Compensation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">$ 8,678<span></span>
</td>
<td class="nump">$ 3,807<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">2,966<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">$ 5,712<span></span>
</td>
<td class="nump">$ 2,557<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870568933816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Estimated Fair Value of Stock Options Granted Using Black-Scholes Option-Pricing Model (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected terms (years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86.90%<span></span>
</td>
<td class="nump">86.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91.90%<span></span>
</td>
<td class="nump">97.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected terms (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected terms (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870564578968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Stock Option Activity (Details) - 2019 Plan<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, Beginning Balance | shares</a></td>
<td class="nump">1,898,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted | shares</a></td>
<td class="nump">830,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised | shares</a></td>
<td class="num">(188,286)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled and forfeited | shares</a></td>
<td class="num">(133,454)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, Ending Balance | shares</a></td>
<td class="nump">2,406,668<span></span>
</td>
<td class="nump">1,898,395<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable as of December 31, 2021 | shares</a></td>
<td class="nump">922,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Outstanding, Beginning Balance | $ / shares</a></td>
<td class="nump">$ 12.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Issuance of common stock, weighted average price per share | $ / shares</a></td>
<td class="nump">22.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised | $ / shares</a></td>
<td class="nump">2.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Cancelled and forfeited | $ / shares</a></td>
<td class="nump">19.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Outstanding, Ending Balance | $ / shares</a></td>
<td class="nump">16.46<span></span>
</td>
<td class="nump">$ 12.79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable as of December 31, 2021 | $ / shares</a></td>
<td class="nump">$ 10.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract', window );"><strong>Weighted Average Remaining Contractual Term (In years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term (In years), Outstanding</a></td>
<td class="text">8 years 1 month 6 days<span></span>
</td>
<td class="text">8 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Term (In years), Exercisable as of December 31, 2021</a></td>
<td class="text">7 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value Outstanding | $</a></td>
<td class="nump">$ 25,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value Outstanding | $</a></td>
<td class="nump">9,970<span></span>
</td>
<td class="nump">$ 25,918<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable as of December 31, 2021 | $</a></td>
<td class="nump">$ 6,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options aggregate intrinsic value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options weighted average remaining contractual term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=etnb_TwoThousandAndNineteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=etnb_TwoThousandAndNineteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870569212344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=etnb_EightyNineBioLtdMember', window );">89Bio Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=etnb_EightyNineBioManagementIncorporationMember', window );">89bio Management, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=etnb_UABEightyNineBioLithuaniaMember', window );">UAB 89bio Lithuania</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_IncomeTaxDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_IncomeTaxDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=etnb_EightyNineBioLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=etnb_EightyNineBioLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=etnb_EightyNineBioManagementIncorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=etnb_EightyNineBioManagementIncorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=etnb_UABEightyNineBioLithuaniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=etnb_UABEightyNineBioLithuaniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870564244424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Income Tax Benefit (Expense) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="num">$ (2)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="nump">$ 147<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870560536376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Summary of Components of Deferred Tax Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Research and development expenses</a></td>
<td class="nump">$ 6,529<span></span>
</td>
<td class="nump">$ 5,392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">1,969<span></span>
</td>
<td class="nump">610<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">220<span></span>
</td>
<td class="nump">635<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">191<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">42,265<span></span>
</td>
<td class="nump">22,005<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(42,046)<span></span>
</td>
<td class="num">(21,936)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="nump">219<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">29,094<span></span>
</td>
<td class="nump">11,342<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 4,262<span></span>
</td>
<td class="nump">$ 3,978<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_IncomeTaxDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_IncomeTaxDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870564085416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred tax assets, valuation allowance</a></td>
<td class="nump">$ 42,046,000<span></span>
</td>
<td class="nump">$ 21,936,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Deferred tax assets, change in valuation allowance</a></td>
<td class="nump">20,100,000<span></span>
</td>
<td class="nump">$ 11,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLimitationsOnUse', window );">Operating loss carryforwards limitations on use</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Federal net operating losses generated after 2017 can be carried forward indefinitely but utilization will be limited to 80% of taxable income in the period that net operating losses are being utilized.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_TaxableIncomeUtilizationPercentage', window );">Taxable income utilization percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal', window );">Federal research and development credit carryforwards</a></td>
<td class="nump">2,100,000<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">State research and development credit carryforwards</a></td>
<td class="nump">1,100,000<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease', window );">Increase in unrecognized tax benefits</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized Tax Benefits</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Deferred tax assets, change in valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(69,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_AccumulatedTaxLossCarryForward', window );">Accumulated tax loss carryforward</a></td>
<td class="nump">18,500,000<span></span>
</td>
<td class="nump">17,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_AccumulatedTaxLossCarryForward', window );">Accumulated tax loss carryforward</a></td>
<td class="nump">$ 138,500,000<span></span>
</td>
<td class="nump">$ 54,100,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_AccumulatedTaxLossCarryForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated tax loss carry forward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_AccumulatedTaxLossCarryForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets tax credit carryforwards research, federal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_IncomeTaxDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_IncomeTaxDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_TaxableIncomeUtilizationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Taxable income utilization percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_TaxableIncomeUtilizationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLimitationsOnUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLimitationsOnUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870568932968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Loss from Operations Before Taxes on Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before income tax</a></td>
<td class="num">$ (90,269)<span></span>
</td>
<td class="num">$ (49,558)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before income tax</a></td>
<td class="num">(91,141)<span></span>
</td>
<td class="num">(58,760)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_LT', window );">LITHUANIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before income tax</a></td>
<td class="nump">10<span></span>
</td>
<td class="num">(73)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before income tax</a></td>
<td class="nump">$ 862<span></span>
</td>
<td class="nump">$ 9,275<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_IncomeTaxDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_IncomeTaxDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_LT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_LT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870569187672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Reconciliation of Income Tax Benefit (Expense) Statutory Tax Rate to Effective Tax Rate (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income tax benefit computed at statutory rates</a></td>
<td class="nump">$ 18,757<span></span>
</td>
<td class="nump">$ 8,285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(20,111)<span></span>
</td>
<td class="num">(11,914)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential</a></td>
<td class="num">(19)<span></span>
</td>
<td class="nump">1,671<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization', window );">Change in Israel effective tax rate due to the 2019 reorganization</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">647<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment', window );">Research and development credits, net of uncertain tax position</a></td>
<td class="nump">1,331<span></span>
</td>
<td class="nump">815<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">191<span></span>
</td>
<td class="nump">555<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="nump">$ 147<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation change in effective tax rate due to reorganization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible research and development expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139870567214984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive common stock equivalents excluded from calculation of diluted net loss per share</a></td>
<td class="nump">2,571,985<span></span>
</td>
<td class="nump">1,898,395<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options to Purchase Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive common stock equivalents excluded from calculation of diluted net loss per share</a></td>
<td class="nump">2,406,668<span></span>
</td>
<td class="nump">1,898,395<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=etnb_UnvestedRestrictedStockUnitsMember', window );">Unvested Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive common stock equivalents excluded from calculation of diluted net loss per share</a></td>
<td class="nump">106,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants to Purchase Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive common stock equivalents excluded from calculation of diluted net loss per share</a></td>
<td class="nump">58,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=etnb_UnvestedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=etnb_UnvestedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>etnb-10k_20211231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:etnb="http://www.89bio.com/20211231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="etnb-20211231.xsd" xlink:type="simple"/>
    <context id="C_0001785173_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_0001785173_20220301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
        </entity>
        <period>
            <instant>2022-03-01</instant>
        </period>
    </context>
    <context id="C_0001785173_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementClassOfStockAxis_etnbConvertiblePreferredSharesMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">etnb:ConvertiblePreferredSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementClassOfStockAxis_etnbConvertiblePreferredSharesMember_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">etnb:ConvertiblePreferredSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200701_20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">etnb:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">etnb:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200901_20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">etnb:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">etnb:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="C_0001785173_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210301_20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapTypeOfArrangementAxis_etnbSVBLeerinkLLCAndCantorFitzgeraldCoMember_20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:SVBLeerinkLLCAndCantorFitzgeraldCoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapTypeOfArrangementAxis_etnbSVBLeerinkLLCAndCantorFitzgeraldCoMember_20211001_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:SVBLeerinkLLCAndCantorFitzgeraldCoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_srtRangeAxis_srtMinimumMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_srtRangeAxis_srtMaximumMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesShorttermDebtSecuritiesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMunicipalBondsMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtSecuritiesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCashEquivalentsMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesShorttermDebtSecuritiesMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMunicipalBondsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBillSecuritiesMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_etnbAgencyDiscountSecuritiesMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">etnb:AgencyDiscountSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCashEquivalentsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_20180501_20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
        </entity>
        <period>
            <instant>2018-05-31</instant>
        </period>
    </context>
    <context id="C_0001785173_srtStatementGeographicalAxis_etnbSanFranciscoOfficeMember_20191201_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">etnb:SanFranciscoOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_srtStatementGeographicalAxis_etnbSanFranciscoOfficeMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">etnb:SanFranciscoOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_srtStatementGeographicalAxis_etnbSanFranciscoOfficeMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">etnb:SanFranciscoOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapBalanceSheetLocationAxis_etnbRestrictedCashAndOtherAssetsMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">etnb:RestrictedCashAndOtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapBalanceSheetLocationAxis_etnbRestrictedCashAndOtherAssetsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">etnb:RestrictedCashAndOtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20180401_20180430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TevaAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_etnbTevasGlycoPEGylatedFGF21ProgramMember_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20180401_20180430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">etnb:TevasGlycoPEGylatedFGF21ProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TevaAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_etnbTevasDevelopmentProgramMember_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20180401_20180430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">etnb:TevasDevelopmentProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TevaAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TevaAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TevaAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TevaAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermALoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TermALoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermBLoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TermBLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20200401_20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapBalanceSheetLocationAxis_us-gaapOtherAssetsMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="C_0001785173_20200401_20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermALoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TermALoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210501_20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermBLoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TermBLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermALoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TermALoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermALoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TermALoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_srtRangeAxis_srtMinimumMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_us-gaapVariableRateAxis_us-gaapPrimeRateMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputRiskFreeInterestRateMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_us-gaapValuationTechniqueAxis_us-gaapValuationTechniqueOptionPricingModelMember_20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputExpectedDividendPaymentMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210501_20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_us-gaapValuationTechniqueAxis_us-gaapValuationTechniqueOptionPricingModelMember_20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputExpectedTermMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_us-gaapValuationTechniqueAxis_us-gaapValuationTechniqueOptionPricingModelMember_20210501_20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_srtRangeAxis_srtMaximumMember_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20191001_20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_srtRangeAxis_srtMaximumMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20191001_20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_srtRangeAxis_srtMinimumMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_srtRangeAxis_srtMaximumMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndTwentyEquityIncentivePlanMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndTwentyEquityIncentivePlanMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_srtTitleOfIndividualAxis_us-gaapShareBasedPaymentArrangementEmployeeMember_us-gaapAwardTypeAxis_etnbServiceBasedRSUsMember_20210201_20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">etnb:ServiceBasedRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="C_0001785173_srtTitleOfIndividualAxis_us-gaapShareBasedPaymentArrangementEmployeeMember_us-gaapAwardTypeAxis_etnbServiceBasedRSUsMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">etnb:ServiceBasedRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_srtTitleOfIndividualAxis_srtExecutiveOfficerMember_us-gaapAwardTypeAxis_etnbPerformanceRSUsMember_20210201_20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">etnb:PerformanceRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="C_0001785173_srtTitleOfIndividualAxis_srtExecutiveOfficerMember_us-gaapAwardTypeAxis_etnbPerformanceRSUsMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">etnb:PerformanceRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_srtConsolidatedEntitiesAxis_etnbEightyNineBioLtdMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">etnb:EightyNineBioLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_srtConsolidatedEntitiesAxis_etnbEightyNineBioLtdMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">etnb:EightyNineBioLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_srtConsolidatedEntitiesAxis_etnbEightyNineBioManagementIncorporationMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">etnb:EightyNineBioManagementIncorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_srtConsolidatedEntitiesAxis_etnbEightyNineBioManagementIncorporationMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">etnb:EightyNineBioManagementIncorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_srtConsolidatedEntitiesAxis_etnbUABEightyNineBioLithuaniaMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">etnb:UABEightyNineBioLithuaniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_srtConsolidatedEntitiesAxis_etnbUABEightyNineBioLithuaniaMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">etnb:UABEightyNineBioLithuaniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_srtStatementGeographicalAxis_countryUS_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_srtStatementGeographicalAxis_countryUS_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_srtStatementGeographicalAxis_countryIL_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_srtStatementGeographicalAxis_countryIL_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001785173_srtStatementGeographicalAxis_countryIL_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_srtStatementGeographicalAxis_countryUS_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_srtStatementGeographicalAxis_countryUS_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_srtStatementGeographicalAxis_countryLT_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:LT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_srtStatementGeographicalAxis_countryLT_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:LT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_srtStatementGeographicalAxis_countryIL_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_etnbUnvestedRestrictedStockUnitsMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">etnb:UnvestedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001785173_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <unit id="U_iso4217USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="U_xbrlishares">
        <measure>shares</measure>
    </unit>
    <unit id="U_iso4217USD_xbrlishares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_xbrlipure">
        <measure>pure</measure>
    </unit>
    <unit id="U_etnbSegment">
        <measure>etnb:Segment</measure>
    </unit>
    <dei:AmendmentFlag contextRef="C_0001785173_20210101_20211231" id="F_000001">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="C_0001785173_20210101_20211231" id="F_000004">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="C_0001785173_20210101_20211231" id="F_000006">0001785173</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="C_0001785173_20210101_20211231" id="F_000010">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_0001785173_srtRangeAxis_srtMinimumMember_20210101_20211231"
      id="F_000317">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <dei:EntityIncorporationDateOfIncorporation contextRef="C_0001785173_20210101_20211231" id="F_000299">2019-06-30</dei:EntityIncorporationDateOfIncorporation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      id="F_000467">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_0001785173_srtTitleOfIndividualAxis_us-gaapShareBasedPaymentArrangementEmployeeMember_us-gaapAwardTypeAxis_etnbServiceBasedRSUsMember_20210201_20210228"
      id="F_000523">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <etnb:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary
      contextRef="C_0001785173_srtTitleOfIndividualAxis_srtExecutiveOfficerMember_us-gaapAwardTypeAxis_etnbPerformanceRSUsMember_20210201_20210228"
      id="F_000529">P1Y</etnb:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_0001785173_20211231"
      id="F_000066"
      unitRef="U_iso4217USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_0001785173_20201231"
      id="F_000067"
      unitRef="U_iso4217USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_0001785173_20211231"
      id="F_000068"
      unitRef="U_iso4217USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_0001785173_20201231"
      id="F_000069"
      unitRef="U_iso4217USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231"
      decimals="-3"
      id="F_000151"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231"
      decimals="-3"
      id="F_000152"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <etnb:IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231"
      decimals="-3"
      id="F_000153"
      unitRef="U_iso4217USD">0</etnb:IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001785173_srtRangeAxis_srtMinimumMember_20210101_20211231"
      id="F_000485">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001785173_srtRangeAxis_srtMinimumMember_20200101_20201231"
      id="F_000486">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_0001785173_20210101_20211231"
      decimals="INF"
      id="F_000489"
      unitRef="U_xbrlipure">0.869</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_0001785173_20200101_20201231"
      decimals="INF"
      id="F_000490"
      unitRef="U_xbrlipure">0.864</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_0001785173_20210101_20211231"
      decimals="INF"
      id="F_000493"
      unitRef="U_xbrlipure">0.007</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_0001785173_20200101_20201231"
      decimals="INF"
      id="F_000494"
      unitRef="U_xbrlipure">0.002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001785173_srtRangeAxis_srtMaximumMember_20210101_20211231"
      id="F_000487">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001785173_srtRangeAxis_srtMaximumMember_20200101_20201231"
      id="F_000488">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_0001785173_20210101_20211231"
      decimals="INF"
      id="F_000491"
      unitRef="U_xbrlipure">0.919</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_0001785173_20200101_20201231"
      decimals="INF"
      id="F_000492"
      unitRef="U_xbrlipure">0.976</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_0001785173_20210101_20211231"
      decimals="INF"
      id="F_000495"
      unitRef="U_xbrlipure">0.013</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_0001785173_20200101_20201231"
      decimals="INF"
      id="F_000496"
      unitRef="U_xbrlipure">0.015</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20200101_20201231"
      id="F_000509">P8Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      id="F_000510">P8Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      id="F_000511">P7Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <dei:DocumentType contextRef="C_0001785173_20210101_20211231" id="F_000000">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="C_0001785173_20210101_20211231" id="F_000030">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="C_0001785173_20210101_20211231" id="F_000002">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="C_0001785173_20210101_20211231" id="F_000003">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="C_0001785173_20210101_20211231" id="F_000031">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="C_0001785173_20210101_20211231" id="F_000020">001-39122</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="C_0001785173_20210101_20211231" id="F_000005">89bio, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="C_0001785173_20210101_20211231" id="F_000021">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="C_0001785173_20210101_20211231" id="F_000022">36-4946844</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_0001785173_20210101_20211231" id="F_000023">142 Sansome Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="C_0001785173_20210101_20211231" id="F_000024">Second Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="C_0001785173_20210101_20211231" id="F_000025">San Francisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="C_0001785173_20210101_20211231" id="F_000026">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="C_0001785173_20210101_20211231" id="F_000027">94104</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_0001785173_20210101_20211231" id="F_000028">415</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_0001785173_20210101_20211231" id="F_000029">432-9270</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="C_0001785173_20210101_20211231" id="F_000036">Common stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="C_0001785173_20210101_20211231" id="F_000037">ETNB</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="C_0001785173_20210101_20211231" id="F_000038">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="C_0001785173_20210101_20211231" id="F_000012">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="C_0001785173_20210101_20211231" id="F_000008">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="C_0001785173_20210101_20211231" id="F_000007">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="C_0001785173_20210101_20211231" id="F_000009">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="C_0001785173_20210101_20211231" id="F_000011">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="C_0001785173_20210101_20211231" id="F_000017">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="C_0001785173_20210101_20211231" id="F_000018">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="C_0001785173_20210101_20211231" id="F_000019">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="C_0001785173_20210101_20211231" id="F_000015">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany contextRef="C_0001785173_20210101_20211231" id="F_000016">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="C_0001785173_20210630"
      decimals="-5"
      id="F_000013"
      unitRef="U_iso4217USD">165500000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_0001785173_20220301"
      decimals="INF"
      id="F_000014"
      unitRef="U_xbrlishares">20351384</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000032">Portions of the registrant&#x2019;s definitive proxy statement relating to its 2022 Annual Meeting of Stockholders, to be held on or about June 1, 2022, are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such proxy statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId contextRef="C_0001785173_20210101_20211231" id="F_000033">185</dei:AuditorFirmId>
    <dei:AuditorName contextRef="C_0001785173_20210101_20211231" id="F_000034">KPMG LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="C_0001785173_20210101_20211231" id="F_000035">San Francisco, California, USA</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000039"
      unitRef="U_iso4217USD">52432000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000040"
      unitRef="U_iso4217USD">98183000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000041"
      unitRef="U_iso4217USD">25000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000042"
      unitRef="U_iso4217USD">25000</us-gaap:RestrictedCashCurrent>
    <etnb:ShortTermAvailableForSaleSecuritiesCurrent
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000043"
      unitRef="U_iso4217USD">98288000</etnb:ShortTermAvailableForSaleSecuritiesCurrent>
    <etnb:ShortTermAvailableForSaleSecuritiesCurrent
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000044"
      unitRef="U_iso4217USD">106446000</etnb:ShortTermAvailableForSaleSecuritiesCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000045"
      unitRef="U_iso4217USD">11237000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000046"
      unitRef="U_iso4217USD">5548000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000047"
      unitRef="U_iso4217USD">161982000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000048"
      unitRef="U_iso4217USD">210202000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000049"
      unitRef="U_iso4217USD">150000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000050"
      unitRef="U_iso4217USD">166000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000051"
      unitRef="U_iso4217USD">290000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000052"
      unitRef="U_iso4217USD">706000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000053"
      unitRef="U_iso4217USD">162422000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000054"
      unitRef="U_iso4217USD">211074000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000055"
      unitRef="U_iso4217USD">6843000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000056"
      unitRef="U_iso4217USD">2065000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000057"
      unitRef="U_iso4217USD">10194000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000058"
      unitRef="U_iso4217USD">6048000</us-gaap:AccruedLiabilitiesCurrent>
    <etnb:TermLoanCurrent
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000059"
      unitRef="U_iso4217USD">2500000</etnb:TermLoanCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000060"
      unitRef="U_iso4217USD">19537000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000061"
      unitRef="U_iso4217USD">8113000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000062"
      unitRef="U_iso4217USD">16898000</us-gaap:LongTermDebtNoncurrent>
    <etnb:OtherNonCurrentLiability
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000063"
      unitRef="U_iso4217USD">30000</etnb:OtherNonCurrentLiability>
    <us-gaap:Liabilities
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000064"
      unitRef="U_iso4217USD">36465000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000065"
      unitRef="U_iso4217USD">8113000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_0001785173_20211231"
      decimals="INF"
      id="F_000082"
      unitRef="U_iso4217USD_xbrlishares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_0001785173_20201231"
      decimals="INF"
      id="F_000083"
      unitRef="U_iso4217USD_xbrlishares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_0001785173_20211231"
      decimals="INF"
      id="F_000084"
      unitRef="U_xbrlishares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_0001785173_20201231"
      decimals="INF"
      id="F_000085"
      unitRef="U_xbrlishares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_0001785173_20211231"
      decimals="INF"
      id="F_000086"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_0001785173_20201231"
      decimals="INF"
      id="F_000087"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_0001785173_20211231"
      decimals="INF"
      id="F_000088"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_0001785173_20201231"
      decimals="INF"
      id="F_000089"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_0001785173_20211231"
      decimals="INF"
      id="F_000090"
      unitRef="U_iso4217USD_xbrlishares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_0001785173_20201231"
      decimals="INF"
      id="F_000091"
      unitRef="U_iso4217USD_xbrlishares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_0001785173_20211231"
      decimals="INF"
      id="F_000092"
      unitRef="U_xbrlishares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_0001785173_20201231"
      decimals="INF"
      id="F_000093"
      unitRef="U_xbrlishares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0001785173_20211231"
      decimals="INF"
      id="F_000094"
      unitRef="U_xbrlishares">20317204</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0001785173_20211231"
      decimals="INF"
      id="F_000096"
      unitRef="U_xbrlishares">20317204</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0001785173_20201231"
      decimals="INF"
      id="F_000095"
      unitRef="U_xbrlishares">19931660</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0001785173_20201231"
      decimals="INF"
      id="F_000097"
      unitRef="U_xbrlishares">19931660</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000070"
      unitRef="U_iso4217USD">20000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000071"
      unitRef="U_iso4217USD">20000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000072"
      unitRef="U_iso4217USD">339218000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000073"
      unitRef="U_iso4217USD">326046000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000074"
      unitRef="U_iso4217USD">-64000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000075"
      unitRef="U_iso4217USD">-10000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000076"
      unitRef="U_iso4217USD">-213217000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000077"
      unitRef="U_iso4217USD">-123095000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000078"
      unitRef="U_iso4217USD">125957000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000079"
      unitRef="U_iso4217USD">202961000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000080"
      unitRef="U_iso4217USD">162422000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000081"
      unitRef="U_iso4217USD">211074000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000098"
      unitRef="U_iso4217USD">70330000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000099"
      unitRef="U_iso4217USD">36199000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000100"
      unitRef="U_iso4217USD">19413000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000101"
      unitRef="U_iso4217USD">13156000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000102"
      unitRef="U_iso4217USD">89743000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000103"
      unitRef="U_iso4217USD">49355000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000104"
      unitRef="U_iso4217USD">-89743000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000105"
      unitRef="U_iso4217USD">-49355000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000106"
      unitRef="U_iso4217USD">-526000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000107"
      unitRef="U_iso4217USD">-203000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000108"
      unitRef="U_iso4217USD">-90269000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000109"
      unitRef="U_iso4217USD">-49558000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000110"
      unitRef="U_iso4217USD">-147000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000111"
      unitRef="U_iso4217USD">-59000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000112"
      unitRef="U_iso4217USD">-90122000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000113"
      unitRef="U_iso4217USD">-49499000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000114"
      unitRef="U_iso4217USD">-71000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000115"
      unitRef="U_iso4217USD">8000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000116"
      unitRef="U_iso4217USD">17000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000117"
      unitRef="U_iso4217USD">-18000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000118"
      unitRef="U_iso4217USD">-54000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000119"
      unitRef="U_iso4217USD">-10000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000120"
      unitRef="U_iso4217USD">-90176000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000121"
      unitRef="U_iso4217USD">-49509000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001785173_20210101_20211231"
      decimals="2"
      id="F_000122"
      unitRef="U_iso4217USD_xbrlishares">-4.48</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001785173_20200101_20201231"
      decimals="2"
      id="F_000123"
      unitRef="U_iso4217USD_xbrlishares">-3.08</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001785173_20210101_20211231"
      decimals="0"
      id="F_000124"
      unitRef="U_xbrlishares">20098340</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001785173_20200101_20201231"
      decimals="0"
      id="F_000125"
      unitRef="U_xbrlishares">16087785</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:SharesOutstanding
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231"
      decimals="INF"
      id="F_000126"
      unitRef="U_xbrlishares">13788982</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231"
      decimals="-3"
      id="F_000127"
      unitRef="U_iso4217USD">14000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231"
      decimals="-3"
      id="F_000128"
      unitRef="U_iso4217USD">163526000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20191231"
      decimals="-3"
      id="F_000129"
      unitRef="U_iso4217USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231"
      decimals="-3"
      id="F_000130"
      unitRef="U_iso4217USD">-73596000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001785173_20191231"
      decimals="-3"
      id="F_000131"
      unitRef="U_iso4217USD">89944000</us-gaap:StockholdersEquity>
    <etnb:TemporaryEquityIssuanceCosts
      contextRef="C_0001785173_us-gaapStatementClassOfStockAxis_etnbConvertiblePreferredSharesMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200101_20201231"
      decimals="-3"
      id="F_000194"
      unitRef="U_iso4217USD">1208000</etnb:TemporaryEquityIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200101_20201231"
      decimals="INF"
      id="F_000132"
      unitRef="U_xbrlishares">6072040</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200101_20201231"
      decimals="-3"
      id="F_000133"
      unitRef="U_iso4217USD">6000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200101_20201231"
      decimals="-3"
      id="F_000134"
      unitRef="U_iso4217USD">157674000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200101_20201231"
      decimals="-3"
      id="F_000135"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20200101_20201231"
      decimals="-3"
      id="F_000136"
      unitRef="U_iso4217USD">157680000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="INF"
      id="F_000137"
      unitRef="U_xbrlishares">63366</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000138"
      unitRef="U_iso4217USD">271000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231"
      decimals="-3"
      id="F_000139"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000140"
      unitRef="U_iso4217USD">271000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="INF"
      id="F_000141"
      unitRef="U_xbrlishares">7272</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000142"
      unitRef="U_iso4217USD">134000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231"
      decimals="-3"
      id="F_000143"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000144"
      unitRef="U_iso4217USD">134000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000145"
      unitRef="U_iso4217USD">634000</etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility>
    <etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231"
      decimals="-3"
      id="F_000146"
      unitRef="U_iso4217USD">0</etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility>
    <etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000147"
      unitRef="U_iso4217USD">634000</etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000148"
      unitRef="U_iso4217USD">3807000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231"
      decimals="-3"
      id="F_000149"
      unitRef="U_iso4217USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000150"
      unitRef="U_iso4217USD">3807000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231"
      decimals="-3"
      id="F_000154"
      unitRef="U_iso4217USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231"
      decimals="-3"
      id="F_000155"
      unitRef="U_iso4217USD">-49499000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000156"
      unitRef="U_iso4217USD">-49499000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231"
      decimals="-3"
      id="F_000157"
      unitRef="U_iso4217USD">-10000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000158"
      unitRef="U_iso4217USD">-10000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231"
      decimals="INF"
      id="F_000159"
      unitRef="U_xbrlishares">19931660</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231"
      decimals="-3"
      id="F_000160"
      unitRef="U_iso4217USD">20000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231"
      decimals="-3"
      id="F_000161"
      unitRef="U_iso4217USD">326046000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20201231"
      decimals="-3"
      id="F_000162"
      unitRef="U_iso4217USD">-10000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231"
      decimals="-3"
      id="F_000163"
      unitRef="U_iso4217USD">-123095000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000164"
      unitRef="U_iso4217USD">202961000</us-gaap:StockholdersEquity>
    <etnb:TemporaryEquityIssuanceCosts
      contextRef="C_0001785173_us-gaapStatementClassOfStockAxis_etnbConvertiblePreferredSharesMember_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210101_20211231"
      decimals="-3"
      id="F_000195"
      unitRef="U_iso4217USD">165000</etnb:TemporaryEquityIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210101_20211231"
      decimals="INF"
      id="F_000165"
      unitRef="U_xbrlishares">186546</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210101_20211231"
      decimals="-3"
      id="F_000166"
      unitRef="U_iso4217USD">3289000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210101_20211231"
      decimals="-3"
      id="F_000167"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210101_20211231"
      decimals="-3"
      id="F_000168"
      unitRef="U_iso4217USD">3289000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="INF"
      id="F_000169"
      unitRef="U_xbrlishares">188286</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231"
      decimals="-3"
      id="F_000170"
      unitRef="U_iso4217USD">487000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20210101_20211231"
      decimals="-3"
      id="F_000171"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000172"
      unitRef="U_iso4217USD">487000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="INF"
      id="F_000173"
      unitRef="U_xbrlishares">10712</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231"
      decimals="-3"
      id="F_000174"
      unitRef="U_iso4217USD">144000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20210101_20211231"
      decimals="-3"
      id="F_000175"
      unitRef="U_iso4217USD">0</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000176"
      unitRef="U_iso4217USD">144000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231"
      decimals="-3"
      id="F_000177"
      unitRef="U_iso4217USD">574000</etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility>
    <etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20210101_20211231"
      decimals="-3"
      id="F_000178"
      unitRef="U_iso4217USD">0</etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility>
    <etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000179"
      unitRef="U_iso4217USD">574000</etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231"
      decimals="-3"
      id="F_000180"
      unitRef="U_iso4217USD">8678000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20210101_20211231"
      decimals="-3"
      id="F_000181"
      unitRef="U_iso4217USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000182"
      unitRef="U_iso4217USD">8678000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20210101_20211231"
      decimals="-3"
      id="F_000183"
      unitRef="U_iso4217USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210101_20211231"
      decimals="-3"
      id="F_000184"
      unitRef="U_iso4217USD">-90122000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000185"
      unitRef="U_iso4217USD">-90122000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20210101_20211231"
      decimals="-3"
      id="F_000186"
      unitRef="U_iso4217USD">-54000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000187"
      unitRef="U_iso4217USD">-54000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20211231"
      decimals="INF"
      id="F_000188"
      unitRef="U_xbrlishares">20317204</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20211231"
      decimals="-3"
      id="F_000189"
      unitRef="U_iso4217USD">20000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20211231"
      decimals="-3"
      id="F_000190"
      unitRef="U_iso4217USD">339218000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20211231"
      decimals="-3"
      id="F_000191"
      unitRef="U_iso4217USD">-64000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20211231"
      decimals="-3"
      id="F_000192"
      unitRef="U_iso4217USD">-213217000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000193"
      unitRef="U_iso4217USD">125957000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000196"
      unitRef="U_iso4217USD">-90122000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000197"
      unitRef="U_iso4217USD">-49499000</us-gaap:ProfitLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000198"
      unitRef="U_iso4217USD">8678000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000199"
      unitRef="U_iso4217USD">3807000</us-gaap:ShareBasedCompensation>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000200"
      unitRef="U_iso4217USD">-865000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000201"
      unitRef="U_iso4217USD">-268000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <etnb:AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000202"
      unitRef="U_iso4217USD">-617000</etnb:AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee>
    <etnb:AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000203"
      unitRef="U_iso4217USD">-230000</etnb:AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee>
    <us-gaap:Depreciation
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000204"
      unitRef="U_iso4217USD">79000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000205"
      unitRef="U_iso4217USD">60000</us-gaap:Depreciation>
    <etnb:DeferredTaxAssets
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000206"
      unitRef="U_iso4217USD">150000</etnb:DeferredTaxAssets>
    <etnb:DeferredTaxAssets
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000207"
      unitRef="U_iso4217USD">69000</etnb:DeferredTaxAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000208"
      unitRef="U_iso4217USD">5672000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000209"
      unitRef="U_iso4217USD">3600000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000210"
      unitRef="U_iso4217USD">4778000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000211"
      unitRef="U_iso4217USD">1131000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000212"
      unitRef="U_iso4217USD">4146000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000213"
      unitRef="U_iso4217USD">1428000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000214"
      unitRef="U_iso4217USD">-76781000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000215"
      unitRef="U_iso4217USD">-46244000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000216"
      unitRef="U_iso4217USD">148422000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000217"
      unitRef="U_iso4217USD">12189000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <etnb:PaymentForPurchaseOfAvailableForSaleSecurities
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000218"
      unitRef="U_iso4217USD">141200000</etnb:PaymentForPurchaseOfAvailableForSaleSecurities>
    <etnb:PaymentForPurchaseOfAvailableForSaleSecurities
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000219"
      unitRef="U_iso4217USD">118895000</etnb:PaymentForPurchaseOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000220"
      unitRef="U_iso4217USD">63000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000221"
      unitRef="U_iso4217USD">126000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000222"
      unitRef="U_iso4217USD">7159000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000223"
      unitRef="U_iso4217USD">-106832000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000224"
      unitRef="U_iso4217USD">19951000</us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt>
    <etnb:ProceedsFromIssuancePublicOffering
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000225"
      unitRef="U_iso4217USD">3289000</etnb:ProceedsFromIssuancePublicOffering>
    <etnb:ProceedsFromIssuancePublicOffering
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000226"
      unitRef="U_iso4217USD">157680000</etnb:ProceedsFromIssuancePublicOffering>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000227"
      unitRef="U_iso4217USD">487000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000228"
      unitRef="U_iso4217USD">271000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20210101_20211231"
      decimals="-3"
      id="F_000229"
      unitRef="U_iso4217USD">144000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20200101_20201231"
      decimals="-3"
      id="F_000230"
      unitRef="U_iso4217USD">134000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000231"
      unitRef="U_iso4217USD">161000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000232"
      unitRef="U_iso4217USD">23871000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000233"
      unitRef="U_iso4217USD">157924000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000234"
      unitRef="U_iso4217USD">-45751000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000235"
      unitRef="U_iso4217USD">4848000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000236"
      unitRef="U_iso4217USD">98208000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_0001785173_20191231"
      decimals="-3"
      id="F_000237"
      unitRef="U_iso4217USD">93360000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000238"
      unitRef="U_iso4217USD">52457000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000239"
      unitRef="U_iso4217USD">98208000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000240"
      unitRef="U_iso4217USD">52432000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000241"
      unitRef="U_iso4217USD">98183000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000242"
      unitRef="U_iso4217USD">25000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000243"
      unitRef="U_iso4217USD">25000</us-gaap:RestrictedCashCurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000244"
      unitRef="U_iso4217USD">52457000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000245"
      unitRef="U_iso4217USD">98208000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000246"
      unitRef="U_iso4217USD">16000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000247"
      unitRef="U_iso4217USD">142000</us-gaap:IncomeTaxesPaidNet>
    <etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000248"
      unitRef="U_iso4217USD">574000</etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility>
    <etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000249"
      unitRef="U_iso4217USD">634000</etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000250">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;1. Organization and Basis of Presentation &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Description of Business&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;89bio, Inc. (&#x201c;89bio&#x201d; or the &#x201c;Company&#x201d;) is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The Company&#x2019;s lead product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21, is currently being developed for the treatment of nonalcoholic steatohepatitis and for the treatment of severe hypertriglyceridemia. &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;89bio, Inc. was formed as a Delaware corporation in &lt;span style="-sec-ix-hidden:F_000299"&gt;June 2019&lt;/span&gt; to carry on the business of 89Bio Ltd., which was incorporated in Israel in January 2018. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Public Offerings&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In July 2020, the Company completed an underwritten public offering of 3,047,040 shares of its common stock at the public offering price of $27.50 per share. The Company raised a total of $78.2 million in net proceeds after deducting underwriting discounts and commissions of $5.0 million and offering costs of $0.6 million. &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In September 2020, the Company completed an underwritten public offering of 3,025,000 shares of its common stock, at a public offering price of $28.00 per share. The Company raised a total of $79.5 million in net proceeds after deducting underwriting discounts and commissions of $4.6 million and offering costs of $0.6 million.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In March 2021, the Company entered into a sales agreement (the &#x201c;Sales Agreement&#x201d;) with SVB Leerink LLC and Cantor Fitzgerald &amp;amp; Co. (the &#x201c;Sales Agents&#x201d;) pursuant to which it may offer and sell up to $75.0 million of shares of the Company&#x2019;s common stock, from time to time, in &#x201c;at-the-market&#x201d; offerings (the &#x201c;ATM Facility&#x201d;). The Sales Agents are entitled to compensation at a commission equal to 3.0% of the aggregate gross sales price per share sold under the Sales Agreement. &lt;span style="color:#231F20;letter-spacing:0.1pt;"&gt;During the fourth quarter of 2021, the Company received proceeds of $3.3 million, net of commissions and offering expenses from sales of 186,546 shares of its common stock at a weighted-average price of $17.97 per share pursuant to the ATM Facility.&lt;/span&gt; &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Liquidity &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. To date, the Company has not generated revenues from its activities and has incurred substantial operating losses. Management expects the Company to continue to generate substantial operating losses for the foreseeable future until it completes development of its products and seeks regulatory approvals to market such products. The Company had cash and cash equivalents and short-term available-for-sale securities of $150.7 million as of December 31, 2021. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company expects that its cash and cash equivalents and short-term available-for-sale securities as of December 31, 2021, together with proceeds available from the Company&#x2019;s term loan (see Note 6) and its ATM Facility, will be sufficient to fund operating expenses and capital expenditure requirements for a period of at least one year from the date these audited consolidated financial statements are filed with the Securities and Exchange Commission (&#x201c;SEC&#x201d;).&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200701_20200731"
      decimals="INF"
      id="F_000300"
      unitRef="U_xbrlishares">3047040</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200731"
      decimals="2"
      id="F_000302"
      unitRef="U_iso4217USD_xbrlishares">27.50</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200701_20200731"
      decimals="-5"
      id="F_000301"
      unitRef="U_iso4217USD">78200000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200701_20200731"
      decimals="-5"
      id="F_000303"
      unitRef="U_iso4217USD">5000000.0</us-gaap:PaymentsOfStockIssuanceCosts>
    <etnb:PaymentsOfStockIssuanceCostsOther
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200701_20200731"
      decimals="-5"
      id="F_000304"
      unitRef="U_iso4217USD">600000</etnb:PaymentsOfStockIssuanceCostsOther>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200901_20200930"
      decimals="INF"
      id="F_000305"
      unitRef="U_xbrlishares">3025000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200930"
      decimals="2"
      id="F_000306"
      unitRef="U_iso4217USD_xbrlishares">28.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200901_20200930"
      decimals="-5"
      id="F_000307"
      unitRef="U_iso4217USD">79500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200901_20200930"
      decimals="-5"
      id="F_000308"
      unitRef="U_iso4217USD">4600000</us-gaap:PaymentsOfStockIssuanceCosts>
    <etnb:PaymentsOfStockIssuanceCostsOther
      contextRef="C_0001785173_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_etnbUnderwrittenPublicOfferingMember_20200901_20200930"
      decimals="-5"
      id="F_000309"
      unitRef="U_iso4217USD">600000</etnb:PaymentsOfStockIssuanceCostsOther>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001785173_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210301_20210331"
      decimals="-5"
      id="F_000310"
      unitRef="U_iso4217USD">75000000.0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <etnb:SellingCommissionPerSharesSoldPercentage
      contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbSVBLeerinkLLCAndCantorFitzgeraldCoMember_20210331"
      decimals="3"
      id="F_000311"
      unitRef="U_xbrlipure">0.030</etnb:SellingCommissionPerSharesSoldPercentage>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbSVBLeerinkLLCAndCantorFitzgeraldCoMember_20211001_20211231"
      decimals="-5"
      id="F_000312"
      unitRef="U_iso4217USD">3300000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbSVBLeerinkLLCAndCantorFitzgeraldCoMember_20211001_20211231"
      decimals="INF"
      id="F_000313"
      unitRef="U_xbrlishares">186546</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbSVBLeerinkLLCAndCantorFitzgeraldCoMember_20211001_20211231"
      decimals="2"
      id="F_000314"
      unitRef="U_iso4217USD_xbrlishares">17.97</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="C_0001785173_20211231"
      decimals="-5"
      id="F_000315"
      unitRef="U_iso4217USD">150700000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000251">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2. Summary of Significant Accounting Policies&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Basis of Presentation&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (&#x201c;U.S. GAAP&#x201d;).&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Principles of Consolidation&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Foreign Currencies&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Certain transactions during the years ended December 31, 2021 and 2020 were denominated in currencies other than the U.S. dollar. Gains and losses from foreign currency transactions were not material for all periods presented and are reflected in the consolidated statements of operations and comprehensive loss as a component of other expenses, net. The Company&#x2019;s subsidiary in Lithuania uses the Euro as its functional currency for financial reporting. The re-measurement from Euros to U.S. dollars results in translation gain and loss adjustments, which are reflected as a component of comprehensive loss as foreign currency translation adjustments.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Use of Estimates &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions made in the accompanying consolidated financial statements include but are not limited to accrued research and development expenses and the fair value of stock options. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Fair Value Measurements &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financial assets and liabilities are recorded at fair value on a recurring basis in the consolidated balance sheets. The carrying values of Company&#x2019;s financial assets and liabilities, including cash and cash equivalents, restricted cash, prepaid and other current assets, accounts payable, and accrued expenses approximate to their fair value due to the short-term nature of these instruments. The fair value of the Company&#x2019;s term loan approximates its carrying value, or amortized cost, due to the prevailing market rates of interest rates it bears. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. Assets and liabilities recorded at fair value are categorized based upon the level of judgment associated with the inputs used to measure their fair value. Hierarchical levels are directly related to the amount of subjectivity with the inputs to the valuation of these assets or liabilities as follows: &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;span style="font-weight:normal;"&gt;&#x2014;Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date; &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;span style="font-weight:normal;"&gt;&#x2014;Inputs (other than quoted prices included in Level&#160;1) are either directly or indirectly observable inputs for similar assets or liabilities. These include quoted prices for identical or similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3&lt;span style="font-weight:normal;"&gt;&#x2014;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Concentrations of Credit Risk&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financial&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;instruments&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;that&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;potentially&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;subject&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;the Company to a concentration&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;of credit&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;risk&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;consist primarily&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;of cash and cash equivalents and short-term available-for-sale securities.&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;Bank&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;deposits&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;are held by accredited&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;financial&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;institutions&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;and these deposits&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;may at times&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;be in excess&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of insured&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;limits. The Company limits&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;its&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;credit&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;risk&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;associated&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;with cash and cash equivalents&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;by placing&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;them&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;with financial&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;institutions&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;that&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;it believes&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;are of high quality.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;The Company has not experienced&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;any losses&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;on its&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;deposits&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of cash or cash equivalents. The Company &lt;span style="color:#000000;"&gt;limits amounts invested in available-for-sale securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. The Company is not exposed to any significant concentrations of credit risk from these financial instruments.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Other&lt;span style="font-weight:normal;font-style:normal;"&gt; &lt;/span&gt;Risks and Uncertainties &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s future results of operations involve a number of other risks and uncertainties. Factors that could affect the Company&#x2019;s future operating results and cause actual results to vary materially from expectations include, but are not limited to, the Company&#x2019;s early stages of clinical drug development; the Company&#x2019;s ability to advance product candidates into, and successfully complete, clinical trials on the timelines it projects; the Company&#x2019;s ability to adequately demonstrate sufficient safety and efficacy of its product candidates; the Company&#x2019;s ability to enroll patients in its ongoing and future clinical trials; the Company&#x2019;s ability to successfully manufacture and supply its product candidates for clinical trials; the Company&#x2019;s ability to obtain additional capital to finance its operations; uncertainties related to the projections of the size of patient populations suffering from the diseases the Company is targeting; the Company&#x2019;s ability to obtain, maintain, and protect its intellectual property rights; developments relating to the Company&#x2019;s competitors and its industry, including competing product candidates and therapies; general economic and market conditions; and other risks and uncertainties.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s product candidates will require approvals from the U.S. Food and Drug Administration and comparable foreign regulatory agencies prior to commercial sales in their respective jurisdictions. There can be no assurance that any product candidates will receive the necessary approvals. If the Company was denied approval, approval was delayed or the Company was unable to maintain approval for any product candidate, it could have a materially adverse impact on the Company.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The ongoing COVID-19 pandemic has disrupted and may continue to disrupt the Company&#x2019;s business and delay its preclinical and clinical programs and timelines. &lt;span style="color:#000000;"&gt;The Company does not yet know the full extent of potential delays to clinical trials, which could prevent or delay the Company from obtaining approval for&#160;pegozafermin.&#160;&lt;/span&gt;The extent to which the COVID-19 pandemic may impact the Company&#x2019;s future operating results and financial condition is uncertain.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Segment Reporting&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company has one operating&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;segment.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;The Company&#x2019;s chief&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;operating&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;decision&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;maker,&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;its&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;Chief Executive&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;Officer,&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;manages&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;the Company&#x2019;s operations&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;on a consolidated&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;basis&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;for the purposes&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of allocating resources&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and evaluating&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;financial&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;performance.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Cash and Cash Equivalents&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be cash equivalents. Cash equivalents consist primarily of amounts invested in money market funds and commercial paper that are stated at fair value.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Restricted Cash&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted cash consists of a money market account that serves as collateral for the Company&#x2019;s operating lease agreement for its facility in Israel.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Investments &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Investments have been classified as available-for-sale and are carried at estimated fair value as determined based upon quoted market prices or pricing models for similar securities. Management determines the appropriate classification of its available-for-sale investments in debt securities at the time of purchase. Generally, investments with original maturities beyond three months at the date of purchase are classified as short-term because it is management&#x2019;s intent to use the investments to fund current operations or to make them available for current operations. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized gains and losses are excluded from earnings and are reported as a component of comprehensive loss.&#160;The Company periodically evaluates whether declines in fair values of its available-for-sale securities below their book value are other-than-temporary. This evaluation consists of several qualitative and quantitative factors regarding the severity and duration of the unrealized loss as well as the Company&#x2019;s ability and intent to hold the available-for-sale security until a forecasted recovery occurs. Additionally, the Company assesses whether it has plans to sell the security or it is more likely than not it will be required to sell any available-for-sale securities before recovery of its amortized cost basis. Realized gains and losses and declines in fair value judged to be other than temporary, if any, on available-for-sale securities are included in other expenses, net. The cost of investments sold is based on the specific-identification method.&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; The Company has not experienced material realized gains or &lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;losses&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; or other-than-temporary losses in the periods presented.&lt;/span&gt;&lt;span style="font-size:12pt;color:#000000;"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Interest on available-for-sale securities is included in other expenses, net and is not material for all periods presented.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Property&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;Equipment, Net&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and equipment&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;are stated&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;at cost, less&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;accumulated&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;depreciation.&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;Depreciation&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;is calculated&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;on a straight-line&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;basis&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;over the estimated&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;useful&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;lives&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of the related&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;assets,&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;generally&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;ranging&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;from&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;three&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;to seven years.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;Leasehold&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;improvements&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;are amortized&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;on a straight-line&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;basis&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;over the shorter&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of the assets&#x2019;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;estimated useful&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;life&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;or the remaining&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;term&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of the lease.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#000000;"&gt;Upon retirement or sale of the assets, the cost and related accumulated depreciation and amortization are removed from the consolidated balance sheets and the resulting gains or losses are recorded in the consolidated statements of operations and comprehensive loss. &lt;/span&gt;Maintenance&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;and repair&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;costs&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;are expensed as incurred.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Impairment&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;of Long-Lived Assets&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company periodically&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;evaluates&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;its&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;long-lived&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;assets,&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;including&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;property&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and equipment,&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;for impairment&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;whenever events&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;or changes in business&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;circumstances&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;indicate&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;that&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;the carrying&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;amount&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of the assets or group of assets&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;may not be fully&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;recoverable.&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;If indicators&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;of impairment&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;exist&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and the undiscounted&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;future cash flows that&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;the assets&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;are expected&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;to generate&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;are less&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;than the carrying&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;value of the assets,&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;the Company reduces&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;the carrying&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;amount&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of the assets&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;through an impairment&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;charge,&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;to their&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;estimated&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;fair&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;values&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;based on a discounted&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;cash flow approach&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;or, when&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;available&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;and appropriate,&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;to comparable&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;market&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;values.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;There were no such indicators&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;for the periods&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;presented.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;color:#231F20;letter-spacing:0.05pt;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Accrued Research and Development Expenses&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company estimates preclinical&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;and clinical&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;study and research&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;expenses&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;based on the services&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;performed,&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;pursuant&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;to contracts&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;with research&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;institutions&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;that&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;conduct and manage&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;preclinical&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;and clinical&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;studies&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and research&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;services&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;on its&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;behalf. The Company records&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;the costs&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of research&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and development&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;activities&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;based upon the estimated&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;services&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;provided&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;but not yet invoiced&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and includes&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;these&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;costs&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;in accrued&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;expenses&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;in the consolidated&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;balance sheets.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;These costs&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;are a component&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of the Company&#x2019;s research&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and development&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;expenses.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company accrues for these costs based on factors such as estimates of the work completed in accordance with agreements established with its third-party service providers. The Company makes judgments and estimates in determining the accrued expenses balance. As actual costs become known, the Company adjusts its accrued expenses. The Company has not experienced any material differences between accrued costs and actual costs incurred. However, the status&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and timing&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of actual&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;services&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;performed&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;may vary from&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;the Company&#x2019;s estimates,&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;resulting&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;in adjustments&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;to expense in future&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;periods.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;Changes in these&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;estimates that&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;result&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;in material&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;changes to the Company&#x2019;s accrued expenses&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;could materially&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;affect&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;the Company&#x2019;s results&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of operations.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;Contingent&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;milestone&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;payments,&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;if any, are expensed when&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;the milestone&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;results&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;are probable and estimable, which is generally&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;upon achievement&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;of the milestone.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Leases&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company leases&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;its&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;office&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;facilities&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;under non-cancelable&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;operating&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;lease&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;agreements&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;and recognizes related&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;rent&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;expense on a straight-line&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;basis&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;over the term&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of the lease.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Research and&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;Development&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;Expenses&lt;span style="font-weight:normal;"&gt; &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and development&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;expenses&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;consist&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;primarily&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;of costs&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;incurred&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;for the development&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of the Company&#x2019;s lead product&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;candidate,&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;pegozafermin. Research&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and development&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;expenses&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;consist&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;primarily&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;of external&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;costs&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;related&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;to&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;preclinical&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;and clinical development&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and related&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;supplies, and personnel&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;costs.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;Personnel&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;costs&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;consist&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of salaries,&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;employee&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;benefits&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and&lt;span style="letter-spacing:1.05pt;"&gt; &lt;/span&gt;stock-based&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;compensation&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;for individuals&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;involved&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;in research&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and development&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;efforts. Payments&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;associated&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;with agreements&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;to acquire&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;licenses&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;to develop, use, manufacture&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;and commercialize&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;products and purchases of pegozafermin from contract manufacturing organizations&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;that&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;have not reached&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;technological&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;feasibility&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;and do not have alternate&lt;span style="letter-spacing:0.1pt;"&gt; future &lt;/span&gt;commercial&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;use are expensed as incurred.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Stock-Based Compensation&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company provides equity awards in the form of stock options and restricted stock units. The Company measures&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;its&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;equity&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;awards made to employees,&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;directors,&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;and&lt;span style="color:#000000;"&gt; &lt;/span&gt;non-employee&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;service&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;providers&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;based on estimated fair values and recognizes stock-based compensation over the requisite service period. The Company accounts&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;for forfeitures&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;as they occur.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company estimates&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;the fair&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;value of stock option&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;awards on the date of grant&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;using a&lt;span style="color:#000000;"&gt; &lt;/span&gt;Black-Scholes&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;option pricing&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;model.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;The Company recognizes&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;compensation&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;for the value of stock options&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;awards, which have graded vesting,&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;using the straight-line&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;method&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;over the requisite&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;service&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;period&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of each award. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Black-Scholes option pricing model requires a number of assumptions, of which the most significant are expected volatility, expected option term (the time from the grant date until the options are exercised or expire), risk-free rate, and expected divided rate. These assumptions include:&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:10pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;Expected volatility&#x2014;Since the Company has limited trading history for its common stock, expected volatility is estimated based on weighting the Company&#x2019;s volatility and the volatility of comparable publicly traded biotechnology companies during the equivalent period of the calculated expected term of the options granted. The comparable companies were chosen based on their similar size, stage in the life cycle or area of specialty. There is a degree of uncertainty in determining a comparable peer group as each of the peers are engaged in varied research and development activities, the timing and progress of which differ within the peer group. &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:10pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;Expected term&#x2014;The expected term of options granted to employees and directors is determined using the &#x201c;simplified&#x201d; method. Under this approach, the expected term is presumed to be the midpoint between the weighted-average vesting term and the contractual term of the option. The simplified method makes the assumption that the employee will exercise share options evenly over the period when the share options are vested and ending on the date when the share options would expire. The expected option term for options granted to non-employees is estimated on a grant-by-grant basis.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:10pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;Risk-free interest rate&#x2014;The risk-free interest rate is based on the U.S. Treasury zero coupon bonds in effect on the grant date for periods with an equivalent expected term as the option.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:10pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;Expected dividend&#x2014;The Company has never paid dividends and has no foreseeable plans to pay dividends on its shares of common stock. Therefore, an expected dividend of zero is used.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The fair value of restricted stock units is based on the fair value of the Company&#x2019;s common stock on the date of grant. The grant date fair value of restricted stock units with service vesting conditions is recognized over the requisite service period on a straight-line basis. For restricted stock units with performance vesting conditions, the Company evaluates the probability of achieving the performance condition at each reporting date and recognizes expense for such performance awards over the requisite service period using the accelerated attribution method.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Income Taxes&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Income&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;taxes&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;are accounted&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;for under the asset&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and liability&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;method.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;Under this&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;method,&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;deferred&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;tax assets&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and liabilities&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;are recognized&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;for the future&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;tax consequences&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;attributable&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;to differences&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;between the consolidated&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;financial&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;statements&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;carrying&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;amounts&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of existing&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;assets&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and liabilities&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;and their&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;respective&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;tax bases and operating&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;loss and tax credit&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;carryforwards.&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;Deferred&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;tax assets&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and liabilities&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;are measured&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;using enacted&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;tax rates&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;applied&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;to &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;taxable&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;income&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;in the years&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;in which those temporary&lt;/span&gt;&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;differences&lt;/span&gt;&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;are expected&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;to be realized.&lt;/span&gt;&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The effect&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;on deferred&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;tax assets&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;and liabilities&lt;/span&gt;&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;of a change in tax rates&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;is recognized&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;as income&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;or loss in the period that&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;includes&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the enactment&lt;/span&gt;&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;date. A&lt;/span&gt;&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;valuation&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;allowance&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;is established&lt;/span&gt;&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;when&lt;/span&gt;&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;necessary&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;to reduce&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;deferred&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;tax assets&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;to the amount&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;expected&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;to be realized.&lt;/span&gt;&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Interest&lt;/span&gt;&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;and penalties&lt;/span&gt;&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;related&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;to unrecognized&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;tax benefits&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;are included&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;within the provision&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;of income&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;tax. &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Basic and&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;Diluted Net Loss per Share&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic loss per share&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;is computed&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;by dividing&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;the net loss by the weighted-average&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;number&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of common stock&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;outstanding&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;during the period.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;Diluted&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;loss per share&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;is computed&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;by dividing&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;the net loss by the weighted-average&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;number&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of common stock&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;outstanding&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;together&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;with the number&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of additional&lt;span style="letter-spacing:0.1pt;"&gt; shares of &lt;/span&gt;common stock&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;that&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;would have been outstanding&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;if all&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;potentially&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;dilutive&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;common stock&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;had been issued.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;Since the Company is in a loss position&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;for the periods&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;presented,&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;basic&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;net loss per share&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;is the same&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;as diluted&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;net loss per share&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;since&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;the effects of potentially&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;dilutive&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;securities&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;are antidilutive.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Comprehensive&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;Loss&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s comprehensive loss is comprised of net loss and changes in unrealized gains or losses on available-for-sale securities and foreign currency translation adjustments.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Recent Accounting Pronouncements&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In February 2016, the Financial Accounting Standards Board (the &#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2016-02&#x2014;&lt;span style="font-style:italic;"&gt;Leases &lt;/span&gt;(&#x201c;ASU 2016-02&#x201d;), requiring the recognition of lease assets and liabilities on the balance sheet. The standard: (a) clarifies the definition of a lease; (b) requires a dual approach to lease classification similar to current lease classifications; and (c) causes lessees to recognize leases on the balance sheet as a lease liability with a corresponding right-of-use asset for leases with a lease-term of more than twelve months. As an emerging growth company, ASU 2016-02 is effective for the Company for the year ending December 31, 2022 and interim periods within the year ending December 31, 2023. The Company expects to adopt ASC 842 using the modified retrospective method with a cumulative effect adjustment, if any, to equity at the beginning of the period of adoption. The Company anticipates electing several practical expedients that permit the Company not to reassess (i) whether a contract is or contains a lease, (ii) the classification of existing leases, and (iii) whether previously capitalized initial direct costs would qualify for capitalization. The Company also anticipates electing not to separate non-lease components from the associated lease components and to not to recognize lease assets and liabilities for leases with a term of 12 months or less. Based on its existing facility leases as of December 31, 2021, the Company does not expect the adoption of this new standard to have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;In June 2016, the FASB issued ASU 2016-13,&#160;&lt;/span&gt;&lt;span style="font-style:italic;Background-color:#FFFFFF;"&gt;Financial Instruments&#x2014;Credit Losses (Topic 326)&lt;/span&gt;&lt;span style="Background-color:#FFFFFF;"&gt;: &lt;/span&gt;&lt;span style="font-style:italic;Background-color:#FFFFFF;"&gt;Measurement of Credit Losses on Financial Instruments &lt;/span&gt;&lt;span style="color:#000000;"&gt;(&#x201c;ASU 2016-13&#x201d;)&lt;/span&gt;&lt;span style="Background-color:#FFFFFF;"&gt;, which replaces the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measured at amortized cost to be presented at the net amount expected to be collected. As an emerging growth company, ASU 2016-13 is effective for the Company &lt;/span&gt;&lt;span style="color:#000000;"&gt;for the year ending December 31, 2023 and interim periods within that fiscal year&lt;/span&gt;&lt;span style="Background-color:#FFFFFF;"&gt; and must be adopted using a modified retrospective approach, with certain exceptions. The Company is evaluating the impact of this standard on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000260">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Basis of Presentation&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (&#x201c;U.S. GAAP&#x201d;).&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000261">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Principles of Consolidation&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000262">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Foreign Currencies&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Certain transactions during the years ended December 31, 2021 and 2020 were denominated in currencies other than the U.S. dollar. Gains and losses from foreign currency transactions were not material for all periods presented and are reflected in the consolidated statements of operations and comprehensive loss as a component of other expenses, net. The Company&#x2019;s subsidiary in Lithuania uses the Euro as its functional currency for financial reporting. The re-measurement from Euros to U.S. dollars results in translation gain and loss adjustments, which are reflected as a component of comprehensive loss as foreign currency translation adjustments.&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="C_0001785173_20210101_20211231" id="F_000263">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Use of Estimates &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions made in the accompanying consolidated financial statements include but are not limited to accrued research and development expenses and the fair value of stock options. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000264">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Fair Value Measurements &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financial assets and liabilities are recorded at fair value on a recurring basis in the consolidated balance sheets. The carrying values of Company&#x2019;s financial assets and liabilities, including cash and cash equivalents, restricted cash, prepaid and other current assets, accounts payable, and accrued expenses approximate to their fair value due to the short-term nature of these instruments. The fair value of the Company&#x2019;s term loan approximates its carrying value, or amortized cost, due to the prevailing market rates of interest rates it bears. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. Assets and liabilities recorded at fair value are categorized based upon the level of judgment associated with the inputs used to measure their fair value. Hierarchical levels are directly related to the amount of subjectivity with the inputs to the valuation of these assets or liabilities as follows: &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;span style="font-weight:normal;"&gt;&#x2014;Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date; &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;span style="font-weight:normal;"&gt;&#x2014;Inputs (other than quoted prices included in Level&#160;1) are either directly or indirectly observable inputs for similar assets or liabilities. These include quoted prices for identical or similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3&lt;span style="font-weight:normal;"&gt;&#x2014;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="C_0001785173_20210101_20211231" id="F_000265">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Concentrations of Credit Risk&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financial&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;instruments&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;that&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;potentially&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;subject&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;the Company to a concentration&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;of credit&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;risk&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;consist primarily&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;of cash and cash equivalents and short-term available-for-sale securities.&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;Bank&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;deposits&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;are held by accredited&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;financial&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;institutions&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;and these deposits&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;may at times&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;be in excess&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of insured&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;limits. The Company limits&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;its&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;credit&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;risk&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;associated&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;with cash and cash equivalents&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;by placing&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;them&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;with financial&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;institutions&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;that&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;it believes&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;are of high quality.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;The Company has not experienced&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;any losses&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;on its&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;deposits&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of cash or cash equivalents. The Company &lt;span style="color:#000000;"&gt;limits amounts invested in available-for-sale securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. The Company is not exposed to any significant concentrations of credit risk from these financial instruments.&lt;/span&gt;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <etnb:OtherRisksAndUncertaintiesPolicyTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000266">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Other&lt;span style="font-weight:normal;font-style:normal;"&gt; &lt;/span&gt;Risks and Uncertainties &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s future results of operations involve a number of other risks and uncertainties. Factors that could affect the Company&#x2019;s future operating results and cause actual results to vary materially from expectations include, but are not limited to, the Company&#x2019;s early stages of clinical drug development; the Company&#x2019;s ability to advance product candidates into, and successfully complete, clinical trials on the timelines it projects; the Company&#x2019;s ability to adequately demonstrate sufficient safety and efficacy of its product candidates; the Company&#x2019;s ability to enroll patients in its ongoing and future clinical trials; the Company&#x2019;s ability to successfully manufacture and supply its product candidates for clinical trials; the Company&#x2019;s ability to obtain additional capital to finance its operations; uncertainties related to the projections of the size of patient populations suffering from the diseases the Company is targeting; the Company&#x2019;s ability to obtain, maintain, and protect its intellectual property rights; developments relating to the Company&#x2019;s competitors and its industry, including competing product candidates and therapies; general economic and market conditions; and other risks and uncertainties.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s product candidates will require approvals from the U.S. Food and Drug Administration and comparable foreign regulatory agencies prior to commercial sales in their respective jurisdictions. There can be no assurance that any product candidates will receive the necessary approvals. If the Company was denied approval, approval was delayed or the Company was unable to maintain approval for any product candidate, it could have a materially adverse impact on the Company.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The ongoing COVID-19 pandemic has disrupted and may continue to disrupt the Company&#x2019;s business and delay its preclinical and clinical programs and timelines. &lt;span style="color:#000000;"&gt;The Company does not yet know the full extent of potential delays to clinical trials, which could prevent or delay the Company from obtaining approval for&#160;pegozafermin.&#160;&lt;/span&gt;The extent to which the COVID-19 pandemic may impact the Company&#x2019;s future operating results and financial condition is uncertain.&lt;/p&gt;</etnb:OtherRisksAndUncertaintiesPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000267">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Segment Reporting&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company has one operating&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;segment.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;The Company&#x2019;s chief&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;operating&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;decision&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;maker,&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;its&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;Chief Executive&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;Officer,&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;manages&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;the Company&#x2019;s operations&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;on a consolidated&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;basis&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;for the purposes&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of allocating resources&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and evaluating&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;financial&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;performance.&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="C_0001785173_20210101_20211231"
      decimals="INF"
      id="F_000316"
      unitRef="U_etnbSegment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="C_0001785173_20210101_20211231" id="F_000268">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Cash and Cash Equivalents&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be cash equivalents. Cash equivalents consist primarily of amounts invested in money market funds and commercial paper that are stated at fair value.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Restricted Cash&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted cash consists of a money market account that serves as collateral for the Company&#x2019;s operating lease agreement for its facility in Israel.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:InvestmentPolicyTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000272">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Investments &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Investments have been classified as available-for-sale and are carried at estimated fair value as determined based upon quoted market prices or pricing models for similar securities. Management determines the appropriate classification of its available-for-sale investments in debt securities at the time of purchase. Generally, investments with original maturities beyond three months at the date of purchase are classified as short-term because it is management&#x2019;s intent to use the investments to fund current operations or to make them available for current operations. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized gains and losses are excluded from earnings and are reported as a component of comprehensive loss.&#160;The Company periodically evaluates whether declines in fair values of its available-for-sale securities below their book value are other-than-temporary. This evaluation consists of several qualitative and quantitative factors regarding the severity and duration of the unrealized loss as well as the Company&#x2019;s ability and intent to hold the available-for-sale security until a forecasted recovery occurs. Additionally, the Company assesses whether it has plans to sell the security or it is more likely than not it will be required to sell any available-for-sale securities before recovery of its amortized cost basis. Realized gains and losses and declines in fair value judged to be other than temporary, if any, on available-for-sale securities are included in other expenses, net. The cost of investments sold is based on the specific-identification method.&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; The Company has not experienced material realized gains or &lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;losses&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; or other-than-temporary losses in the periods presented.&lt;/span&gt;&lt;span style="font-size:12pt;color:#000000;"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Interest on available-for-sale securities is included in other expenses, net and is not material for all periods presented.&lt;/span&gt;&lt;/p&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000273">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Property&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;Equipment, Net&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and equipment&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;are stated&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;at cost, less&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;accumulated&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;depreciation.&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;Depreciation&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;is calculated&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;on a straight-line&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;basis&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;over the estimated&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;useful&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;lives&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of the related&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;assets,&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;generally&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;ranging&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;from&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;three&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;to seven years.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;Leasehold&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;improvements&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;are amortized&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;on a straight-line&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;basis&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;over the shorter&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of the assets&#x2019;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;estimated useful&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;life&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;or the remaining&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;term&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of the lease.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#000000;"&gt;Upon retirement or sale of the assets, the cost and related accumulated depreciation and amortization are removed from the consolidated balance sheets and the resulting gains or losses are recorded in the consolidated statements of operations and comprehensive loss. &lt;/span&gt;Maintenance&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;and repair&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;costs&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;are expensed as incurred.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_0001785173_srtRangeAxis_srtMaximumMember_20210101_20211231"
      id="F_000318">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="C_0001785173_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20210101_20211231"
      id="F_000319">Leasehold improvements are amortized on a straight-line basis over the shorter of the assets&#x2019; estimated useful life or the remaining term of the lease.</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000274">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Impairment&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;of Long-Lived Assets&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company periodically&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;evaluates&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;its&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;long-lived&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;assets,&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;including&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;property&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and equipment,&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;for impairment&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;whenever events&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;or changes in business&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;circumstances&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;indicate&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;that&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;the carrying&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;amount&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of the assets or group of assets&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;may not be fully&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;recoverable.&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;If indicators&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;of impairment&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;exist&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and the undiscounted&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;future cash flows that&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;the assets&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;are expected&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;to generate&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;are less&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;than the carrying&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;value of the assets,&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;the Company reduces&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;the carrying&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;amount&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of the assets&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;through an impairment&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;charge,&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;to their&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;estimated&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;fair&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;values&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;based on a discounted&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;cash flow approach&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;or, when&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;available&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;and appropriate,&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;to comparable&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;market&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;values.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;There were no such indicators&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;for the periods&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;presented.&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <etnb:AccruedResearchAndDevelopmentExpensesPolicyTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000275">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;color:#231F20;letter-spacing:0.05pt;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Accrued Research and Development Expenses&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company estimates preclinical&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;and clinical&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;study and research&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;expenses&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;based on the services&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;performed,&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;pursuant&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;to contracts&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;with research&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;institutions&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;that&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;conduct and manage&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;preclinical&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;and clinical&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;studies&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and research&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;services&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;on its&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;behalf. The Company records&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;the costs&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of research&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and development&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;activities&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;based upon the estimated&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;services&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;provided&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;but not yet invoiced&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and includes&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;these&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;costs&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;in accrued&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;expenses&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;in the consolidated&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;balance sheets.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;These costs&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;are a component&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of the Company&#x2019;s research&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and development&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;expenses.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company accrues for these costs based on factors such as estimates of the work completed in accordance with agreements established with its third-party service providers. The Company makes judgments and estimates in determining the accrued expenses balance. As actual costs become known, the Company adjusts its accrued expenses. The Company has not experienced any material differences between accrued costs and actual costs incurred. However, the status&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and timing&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of actual&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;services&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;performed&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;may vary from&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;the Company&#x2019;s estimates,&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;resulting&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;in adjustments&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;to expense in future&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;periods.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;Changes in these&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;estimates that&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;result&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;in material&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;changes to the Company&#x2019;s accrued expenses&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;could materially&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;affect&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;the Company&#x2019;s results&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of operations.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;Contingent&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;milestone&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;payments,&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;if any, are expensed when&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;the milestone&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;results&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;are probable and estimable, which is generally&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;upon achievement&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;of the milestone.&lt;/p&gt;</etnb:AccruedResearchAndDevelopmentExpensesPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000276">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Leases&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company leases&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;its&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;office&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;facilities&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;under non-cancelable&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;operating&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;lease&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;agreements&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;and recognizes related&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;rent&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;expense on a straight-line&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;basis&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;over the term&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of the lease.&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="C_0001785173_20210101_20211231" id="F_000278">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Research and&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;Development&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;Expenses&lt;span style="font-weight:normal;"&gt; &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and development&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;expenses&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;consist&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;primarily&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;of costs&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;incurred&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;for the development&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of the Company&#x2019;s lead product&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;candidate,&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;pegozafermin. Research&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and development&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;expenses&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;consist&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;primarily&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;of external&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;costs&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;related&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;to&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;preclinical&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;and clinical development&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and related&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;supplies, and personnel&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;costs.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;Personnel&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;costs&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;consist&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of salaries,&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;employee&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;benefits&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and&lt;span style="letter-spacing:1.05pt;"&gt; &lt;/span&gt;stock-based&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;compensation&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;for individuals&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;involved&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;in research&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and development&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;efforts. Payments&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;associated&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;with agreements&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;to acquire&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;licenses&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;to develop, use, manufacture&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;and commercialize&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;products and purchases of pegozafermin from contract manufacturing organizations&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;that&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;have not reached&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;technological&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;feasibility&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;and do not have alternate&lt;span style="letter-spacing:0.1pt;"&gt; future &lt;/span&gt;commercial&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;use are expensed as incurred.&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="C_0001785173_20210101_20211231" id="F_000279">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Stock-Based Compensation&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company provides equity awards in the form of stock options and restricted stock units. The Company measures&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;its&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;equity&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;awards made to employees,&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;directors,&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;and&lt;span style="color:#000000;"&gt; &lt;/span&gt;non-employee&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;service&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;providers&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;based on estimated fair values and recognizes stock-based compensation over the requisite service period. The Company accounts&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;for forfeitures&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;as they occur.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company estimates&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;the fair&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;value of stock option&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;awards on the date of grant&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;using a&lt;span style="color:#000000;"&gt; &lt;/span&gt;Black-Scholes&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;option pricing&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;model.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;The Company recognizes&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;compensation&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;for the value of stock options&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;awards, which have graded vesting,&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;using the straight-line&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;method&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;over the requisite&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;service&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;period&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of each award. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Black-Scholes option pricing model requires a number of assumptions, of which the most significant are expected volatility, expected option term (the time from the grant date until the options are exercised or expire), risk-free rate, and expected divided rate. These assumptions include:&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:10pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;Expected volatility&#x2014;Since the Company has limited trading history for its common stock, expected volatility is estimated based on weighting the Company&#x2019;s volatility and the volatility of comparable publicly traded biotechnology companies during the equivalent period of the calculated expected term of the options granted. The comparable companies were chosen based on their similar size, stage in the life cycle or area of specialty. There is a degree of uncertainty in determining a comparable peer group as each of the peers are engaged in varied research and development activities, the timing and progress of which differ within the peer group. &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:10pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;Expected term&#x2014;The expected term of options granted to employees and directors is determined using the &#x201c;simplified&#x201d; method. Under this approach, the expected term is presumed to be the midpoint between the weighted-average vesting term and the contractual term of the option. The simplified method makes the assumption that the employee will exercise share options evenly over the period when the share options are vested and ending on the date when the share options would expire. The expected option term for options granted to non-employees is estimated on a grant-by-grant basis.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:10pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;Risk-free interest rate&#x2014;The risk-free interest rate is based on the U.S. Treasury zero coupon bonds in effect on the grant date for periods with an equivalent expected term as the option.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:10pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;Expected dividend&#x2014;The Company has never paid dividends and has no foreseeable plans to pay dividends on its shares of common stock. Therefore, an expected dividend of zero is used.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The fair value of restricted stock units is based on the fair value of the Company&#x2019;s common stock on the date of grant. The grant date fair value of restricted stock units with service vesting conditions is recognized over the requisite service period on a straight-line basis. For restricted stock units with performance vesting conditions, the Company evaluates the probability of achieving the performance condition at each reporting date and recognizes expense for such performance awards over the requisite service period using the accelerated attribution method.&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000280">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Income Taxes&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Income&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;taxes&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;are accounted&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;for under the asset&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and liability&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;method.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;Under this&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;method,&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;deferred&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;tax assets&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and liabilities&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;are recognized&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;for the future&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;tax consequences&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;attributable&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;to differences&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;between the consolidated&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;financial&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;statements&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;carrying&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;amounts&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of existing&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;assets&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and liabilities&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;and their&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;respective&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;tax bases and operating&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;loss and tax credit&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;carryforwards.&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;Deferred&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;tax assets&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and liabilities&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;are measured&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;using enacted&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;tax rates&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;applied&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;to &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;taxable&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;income&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;in the years&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;in which those temporary&lt;/span&gt;&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;differences&lt;/span&gt;&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;are expected&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;to be realized.&lt;/span&gt;&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The effect&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;on deferred&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;tax assets&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;and liabilities&lt;/span&gt;&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;of a change in tax rates&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;is recognized&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;as income&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;or loss in the period that&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;includes&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the enactment&lt;/span&gt;&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;date. A&lt;/span&gt;&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;valuation&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;allowance&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;is established&lt;/span&gt;&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;when&lt;/span&gt;&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;necessary&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;to reduce&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;deferred&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;tax assets&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;to the amount&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;expected&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;to be realized.&lt;/span&gt;&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Interest&lt;/span&gt;&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;and penalties&lt;/span&gt;&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;related&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;to unrecognized&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;tax benefits&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;are included&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;within the provision&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;of income&lt;/span&gt;&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;&lt;span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;tax. &lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000281">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Basic and&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;Diluted Net Loss per Share&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic loss per share&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;is computed&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;by dividing&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;the net loss by the weighted-average&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;number&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of common stock&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;outstanding&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;during the period.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;Diluted&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;loss per share&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;is computed&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;by dividing&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;the net loss by the weighted-average&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;number&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of common stock&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;outstanding&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;together&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;with the number&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of additional&lt;span style="letter-spacing:0.1pt;"&gt; shares of &lt;/span&gt;common stock&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;that&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;would have been outstanding&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;if all&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;potentially&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;dilutive&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;common stock&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;had been issued.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;Since the Company is in a loss position&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;for the periods&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;presented,&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;basic&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;net loss per share&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;is the same&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;as diluted&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;net loss per share&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;since&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;the effects of potentially&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;dilutive&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;securities&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;are antidilutive.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000282">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Comprehensive&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;Loss&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s comprehensive loss is comprised of net loss and changes in unrealized gains or losses on available-for-sale securities and foreign currency translation adjustments.&lt;/p&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000283">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Recent Accounting Pronouncements&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In February 2016, the Financial Accounting Standards Board (the &#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2016-02&#x2014;&lt;span style="font-style:italic;"&gt;Leases &lt;/span&gt;(&#x201c;ASU 2016-02&#x201d;), requiring the recognition of lease assets and liabilities on the balance sheet. The standard: (a) clarifies the definition of a lease; (b) requires a dual approach to lease classification similar to current lease classifications; and (c) causes lessees to recognize leases on the balance sheet as a lease liability with a corresponding right-of-use asset for leases with a lease-term of more than twelve months. As an emerging growth company, ASU 2016-02 is effective for the Company for the year ending December 31, 2022 and interim periods within the year ending December 31, 2023. The Company expects to adopt ASC 842 using the modified retrospective method with a cumulative effect adjustment, if any, to equity at the beginning of the period of adoption. The Company anticipates electing several practical expedients that permit the Company not to reassess (i) whether a contract is or contains a lease, (ii) the classification of existing leases, and (iii) whether previously capitalized initial direct costs would qualify for capitalization. The Company also anticipates electing not to separate non-lease components from the associated lease components and to not to recognize lease assets and liabilities for leases with a term of 12 months or less. Based on its existing facility leases as of December 31, 2021, the Company does not expect the adoption of this new standard to have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;In June 2016, the FASB issued ASU 2016-13,&#160;&lt;/span&gt;&lt;span style="font-style:italic;Background-color:#FFFFFF;"&gt;Financial Instruments&#x2014;Credit Losses (Topic 326)&lt;/span&gt;&lt;span style="Background-color:#FFFFFF;"&gt;: &lt;/span&gt;&lt;span style="font-style:italic;Background-color:#FFFFFF;"&gt;Measurement of Credit Losses on Financial Instruments &lt;/span&gt;&lt;span style="color:#000000;"&gt;(&#x201c;ASU 2016-13&#x201d;)&lt;/span&gt;&lt;span style="Background-color:#FFFFFF;"&gt;, which replaces the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measured at amortized cost to be presented at the net amount expected to be collected. As an emerging growth company, ASU 2016-13 is effective for the Company &lt;/span&gt;&lt;span style="color:#000000;"&gt;for the year ending December 31, 2023 and interim periods within that fiscal year&lt;/span&gt;&lt;span style="Background-color:#FFFFFF;"&gt; and must be adopted using a modified retrospective approach, with certain exceptions. The Company is evaluating the impact of this standard on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000252">
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;3. Fair Value Measurements &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table presents the Company&#x2019;s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of December 31, 2021 (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Valuation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Hierarchy&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gains&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-top:solid 0.75pt #000000;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,477&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,477&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial paper&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;59,647&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(10&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;59,637&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,662&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(42&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,620&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,776&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,776&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Agency bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,747&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,741&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Municipal bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,251&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,247&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Non-U.S. debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,506&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,505&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cash equivalents and available-for-sale securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;126,066&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(65&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;126,003&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Classified as:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash equivalents&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;27,715&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Short-term available-for-sale securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;98,288&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cash equivalents and available-for-sale securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;126,003&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes the Company&#x2019;s cash equivalents and available-for-sale securities by contractual maturity as of December 31, 2021 (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.14%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Within one year&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;120,726&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;After one year through two years&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,277&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cash equivalents and available-for-sale securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;126,003&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table presents the Company&#x2019;s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of December 31, 2020 (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Valuation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Hierarchy&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gains&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-top:solid 0.75pt #000000;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;46,134&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;46,134&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial paper&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;76,605&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;76,603&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Agency bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;29,654&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;29,669&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,890&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,884&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,093&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,093&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Municipal bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,592&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,593&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. treasury bills&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,680&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,680&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Agency discount securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;200&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;200&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cash equivalents and available-for-sale securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;181,848&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;181,856&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Classified as:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash equivalents&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;75,410&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Short-term available-for-sale securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;106,446&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cash equivalents and available-for-sale securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;181,856&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes the Company&#x2019;s cash equivalents and available-for-sale securities by contractual maturity as of December 31, 2020 (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.14%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Within one year&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;160,304&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;After one year through two years&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,552&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cash equivalents and available-for-sale securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;181,856&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000284">
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table presents the Company&#x2019;s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of December 31, 2021 (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Valuation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Hierarchy&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gains&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-top:solid 0.75pt #000000;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,477&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,477&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial paper&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;59,647&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(10&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;59,637&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,662&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(42&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,620&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,776&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,776&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Agency bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,747&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,741&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Municipal bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,251&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,247&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Non-U.S. debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,506&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,505&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cash equivalents and available-for-sale securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;126,066&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(65&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;126,003&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Classified as:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash equivalents&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;27,715&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Short-term available-for-sale securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;98,288&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cash equivalents and available-for-sale securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;126,003&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table presents the Company&#x2019;s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of December 31, 2020 (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Valuation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Hierarchy&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gains&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-top:solid 0.75pt #000000;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;46,134&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;46,134&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial paper&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;76,605&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;76,603&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Agency bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;29,654&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;29,669&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate debt securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,890&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,884&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,093&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,093&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Municipal bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,592&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,593&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. treasury bills&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,680&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,680&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Agency discount securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;200&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;200&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cash equivalents and available-for-sale securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;181,848&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;181,856&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Classified as:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash equivalents&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;75,410&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Short-term available-for-sale securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;106,446&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cash equivalents and available-for-sale securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;181,856&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20211231"
      decimals="-3"
      id="F_000320"
      unitRef="U_iso4217USD">21477000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20211231"
      decimals="-3"
      id="F_000338"
      unitRef="U_iso4217USD">21477000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20211231"
      decimals="-3"
      id="F_000321"
      unitRef="U_iso4217USD">59647000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20211231"
      decimals="-3"
      id="F_000331"
      unitRef="U_iso4217USD">10000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20211231"
      decimals="-3"
      id="F_000339"
      unitRef="U_iso4217USD">59637000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesShorttermDebtSecuritiesMember_20211231"
      decimals="-3"
      id="F_000322"
      unitRef="U_iso4217USD">21662000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesShorttermDebtSecuritiesMember_20211231"
      decimals="-3"
      id="F_000332"
      unitRef="U_iso4217USD">42000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesShorttermDebtSecuritiesMember_20211231"
      decimals="-3"
      id="F_000340"
      unitRef="U_iso4217USD">21620000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20211231"
      decimals="-3"
      id="F_000323"
      unitRef="U_iso4217USD">8776000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20211231"
      decimals="-3"
      id="F_000328"
      unitRef="U_iso4217USD">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20211231"
      decimals="-3"
      id="F_000333"
      unitRef="U_iso4217USD">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20211231"
      decimals="-3"
      id="F_000341"
      unitRef="U_iso4217USD">8776000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20211231"
      decimals="-3"
      id="F_000324"
      unitRef="U_iso4217USD">7747000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20211231"
      decimals="-3"
      id="F_000329"
      unitRef="U_iso4217USD">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20211231"
      decimals="-3"
      id="F_000334"
      unitRef="U_iso4217USD">7000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20211231"
      decimals="-3"
      id="F_000342"
      unitRef="U_iso4217USD">7741000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMunicipalBondsMember_20211231"
      decimals="-3"
      id="F_000325"
      unitRef="U_iso4217USD">4251000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMunicipalBondsMember_20211231"
      decimals="-3"
      id="F_000335"
      unitRef="U_iso4217USD">4000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMunicipalBondsMember_20211231"
      decimals="-3"
      id="F_000343"
      unitRef="U_iso4217USD">4247000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtSecuritiesMember_20211231"
      decimals="-3"
      id="F_000326"
      unitRef="U_iso4217USD">2506000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtSecuritiesMember_20211231"
      decimals="-3"
      id="F_000336"
      unitRef="U_iso4217USD">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapForeignGovernmentDebtSecuritiesMember_20211231"
      decimals="-3"
      id="F_000344"
      unitRef="U_iso4217USD">2505000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231"
      decimals="-3"
      id="F_000327"
      unitRef="U_iso4217USD">126066000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231"
      decimals="-3"
      id="F_000330"
      unitRef="U_iso4217USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231"
      decimals="-3"
      id="F_000337"
      unitRef="U_iso4217USD">65000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231"
      decimals="-3"
      id="F_000345"
      unitRef="U_iso4217USD">126003000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCashEquivalentsMember_20211231"
      decimals="-3"
      id="F_000346"
      unitRef="U_iso4217USD">27715000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20211231"
      decimals="-3"
      id="F_000347"
      unitRef="U_iso4217USD">98288000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231"
      decimals="-3"
      id="F_000348"
      unitRef="U_iso4217USD">126003000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000285">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes the Company&#x2019;s cash equivalents and available-for-sale securities by contractual maturity as of December 31, 2021 (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.14%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Within one year&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;120,726&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;After one year through two years&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,277&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cash equivalents and available-for-sale securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;126,003&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes the Company&#x2019;s cash equivalents and available-for-sale securities by contractual maturity as of December 31, 2020 (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.14%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Within one year&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;160,304&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;After one year through two years&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,552&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cash equivalents and available-for-sale securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;181,856&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000349"
      unitRef="U_iso4217USD">120726000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <etnb:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000350"
      unitRef="U_iso4217USD">5277000</etnb:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000351"
      unitRef="U_iso4217USD">126003000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20201231"
      decimals="-3"
      id="F_000352"
      unitRef="U_iso4217USD">46134000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20201231"
      decimals="-3"
      id="F_000368"
      unitRef="U_iso4217USD">46134000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231"
      decimals="-3"
      id="F_000353"
      unitRef="U_iso4217USD">76605000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231"
      decimals="-3"
      id="F_000364"
      unitRef="U_iso4217USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231"
      decimals="-3"
      id="F_000369"
      unitRef="U_iso4217USD">76603000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20201231"
      decimals="-3"
      id="F_000354"
      unitRef="U_iso4217USD">29654000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20201231"
      decimals="-3"
      id="F_000361"
      unitRef="U_iso4217USD">15000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20201231"
      decimals="-3"
      id="F_000370"
      unitRef="U_iso4217USD">29669000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20201231"
      decimals="-3"
      id="F_000355"
      unitRef="U_iso4217USD">11890000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20201231"
      decimals="-3"
      id="F_000365"
      unitRef="U_iso4217USD">6000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20201231"
      decimals="-3"
      id="F_000371"
      unitRef="U_iso4217USD">11884000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesShorttermDebtSecuritiesMember_20201231"
      decimals="-3"
      id="F_000356"
      unitRef="U_iso4217USD">7093000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesShorttermDebtSecuritiesMember_20201231"
      decimals="-3"
      id="F_000372"
      unitRef="U_iso4217USD">7093000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMunicipalBondsMember_20201231"
      decimals="-3"
      id="F_000357"
      unitRef="U_iso4217USD">5592000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMunicipalBondsMember_20201231"
      decimals="-3"
      id="F_000362"
      unitRef="U_iso4217USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMunicipalBondsMember_20201231"
      decimals="-3"
      id="F_000366"
      unitRef="U_iso4217USD">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMunicipalBondsMember_20201231"
      decimals="-3"
      id="F_000373"
      unitRef="U_iso4217USD">5593000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBillSecuritiesMember_20201231"
      decimals="-3"
      id="F_000358"
      unitRef="U_iso4217USD">4680000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBillSecuritiesMember_20201231"
      decimals="-3"
      id="F_000374"
      unitRef="U_iso4217USD">4680000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_etnbAgencyDiscountSecuritiesMember_20201231"
      decimals="-3"
      id="F_000359"
      unitRef="U_iso4217USD">200000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001785173_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_etnbAgencyDiscountSecuritiesMember_20201231"
      decimals="-3"
      id="F_000375"
      unitRef="U_iso4217USD">200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000360"
      unitRef="U_iso4217USD">181848000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000363"
      unitRef="U_iso4217USD">17000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000367"
      unitRef="U_iso4217USD">9000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000376"
      unitRef="U_iso4217USD">181856000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCashEquivalentsMember_20201231"
      decimals="-3"
      id="F_000377"
      unitRef="U_iso4217USD">75410000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20201231"
      decimals="-3"
      id="F_000378"
      unitRef="U_iso4217USD">106446000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000379"
      unitRef="U_iso4217USD">181856000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000380"
      unitRef="U_iso4217USD">160304000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <etnb:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000381"
      unitRef="U_iso4217USD">21552000</etnb:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000382"
      unitRef="U_iso4217USD">181856000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000253">
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;4. Consolidated Balance Sheet Components &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Prepaid and Other Current Assets&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid and other current assets consist of the following as of the periods presented (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.4%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid research and development&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,895&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,534&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid taxes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;836&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;481&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,506&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,533&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total prepaid and other current assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,237&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,548&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Accrued Expenses &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued expenses consist of the following as of the periods presented (in thousands): &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.4%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued research and development expenses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,195&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,884&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued employee and related expenses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,168&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,552&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued professional and legal fees&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;495&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;453&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;336&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;159&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total accrued expenses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,194&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,048&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <etnb:ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000286">
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid and other current assets consist of the following as of the periods presented (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.4%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid research and development&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,895&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,534&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid taxes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;836&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;481&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,506&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,533&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total prepaid and other current assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,237&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,548&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</etnb:ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock>
    <etnb:PrepaidResearchAndDevelopmentCurrent
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000383"
      unitRef="U_iso4217USD">7895000</etnb:PrepaidResearchAndDevelopmentCurrent>
    <etnb:PrepaidResearchAndDevelopmentCurrent
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000384"
      unitRef="U_iso4217USD">2534000</etnb:PrepaidResearchAndDevelopmentCurrent>
    <us-gaap:PrepaidTaxes
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000385"
      unitRef="U_iso4217USD">836000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000386"
      unitRef="U_iso4217USD">481000</us-gaap:PrepaidTaxes>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000387"
      unitRef="U_iso4217USD">2506000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000388"
      unitRef="U_iso4217USD">2533000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000389"
      unitRef="U_iso4217USD">11237000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000390"
      unitRef="U_iso4217USD">5548000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000287">
&lt;p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Accrued Expenses &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued expenses consist of the following as of the periods presented (in thousands): &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.4%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued research and development expenses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,195&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,884&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued employee and related expenses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,168&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,552&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued professional and legal fees&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;495&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;453&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;336&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;159&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total accrued expenses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,194&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,048&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <etnb:AccruedResearchAndDevelopmentExpenseCurrent
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000391"
      unitRef="U_iso4217USD">6195000</etnb:AccruedResearchAndDevelopmentExpenseCurrent>
    <etnb:AccruedResearchAndDevelopmentExpenseCurrent
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000392"
      unitRef="U_iso4217USD">2884000</etnb:AccruedResearchAndDevelopmentExpenseCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000393"
      unitRef="U_iso4217USD">3168000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000394"
      unitRef="U_iso4217USD">2552000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000395"
      unitRef="U_iso4217USD">495000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000396"
      unitRef="U_iso4217USD">453000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000397"
      unitRef="U_iso4217USD">336000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000398"
      unitRef="U_iso4217USD">159000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000399"
      unitRef="U_iso4217USD">10194000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000400"
      unitRef="U_iso4217USD">6048000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000254">
&lt;p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;5. Commitments and Contingencies &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Leases&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In May 2018, the Company entered&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;into an operating&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;lease&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;agreement&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;for its&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;facility&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;in Israel.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;The Company amended the lease term to expire in April 2022, with an option to renew for an additional 12 months. Under the lease agreement,&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;monthly&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;lease&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;payments&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;are approximately&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;$4,200. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In December 2019, the Company entered into an operating lease for its headquarters in San Francisco, with a lease term that was due to expire in January 2022. In July 2021, the Company amended the lease agreement to extend the term of the lease to January 2023, with an option to renew the term for one year.&#160;Under the lease agreement, monthly lease payments are approximately $18,000. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Future minimum&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;lease&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;payments&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;under the Company&#x2019;s non-cancellable&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;operating&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;lease&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;obligations&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;as of December&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;31, 2021, are as follows&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;(in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:77.1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;212&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:77.1%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2023&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:77.1%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total future minimum annual payments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;219&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Rent expense was $290,000 and $273,000 for the years ended December 31, 2021 and 2020, respectively. The Company has security deposit balances of $95,000, a portion of which is included in restricted cash and a portion in other assets in the consolidated balance sheets as of December 31, 2021 and 2020.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Asset Transfer and License Agreement with Teva Pharmaceutical Industries Ltd &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In April 2018, the Company concurrently entered into two Asset Transfer and License Agreements (the &#x201c;Teva Agreements&#x201d;) with Teva Pharmaceutical Industries Ltd (&#x201c;Teva&#x201d;) under which it acquired certain patents and intellectual property relating to two programs: (1)&#160;Teva&#x2019;s glycoPEGylated FGF21 program, including the compound TEV-47948 (pegozafermin), a glycoPEGylated long-acting FGF21 and (2)&#160;Teva&#x2019;s development program of small molecule inhibitors of fatty acid synthase. Pursuant to the Teva Agreements, the Company paid Teva an initial nonrefundable upfront payment of $6.0&#160;million and the Company could be obligated to pay Teva up to $67.5&#160;million under each program, for a total of $135.0&#160;million, upon the achievement of certain clinical development and commercial milestones. In addition, the Company is obligated to pay Teva tiered royalties at percentages in the low-to-mid single-digits on worldwide net sales on all products containing the Teva compounds. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Teva Agreements can be terminated (i)&#160;by the Company without cause upon 120 days&#x2019; written notice to Teva, (ii)&#160;by either party, if the other party materially breaches any of its obligations under the Teva Agreements and fails to cure such breach within 60 days after receiving notice thereof, or (iii)&#160;by either party, if a bankruptcy petition is filed against the other party and is not dismissed within 60 days. In addition, Teva can also terminate the agreement related to the Company&#x2019;s glycoPEGylated FGF21 program in the event the Company, or any of its affiliates or sublicensees, challenges any of the Teva patents licensed to the Company, and the challenge is not withdrawn within 30 days of written notice from Teva. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;During the years ended December 31, 2021 and 2020, none of the development and commercial milestones were met and accordingly, there were no milestone payments related to the Teva Agreements. &lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:DescriptionOfLesseeLeasingArrangementsOperatingLeases contextRef="C_0001785173_20180501_20180531" id="F_000401">The Company amended the lease term to expire in April 2022, with an option to renew for an additional 12 months.</us-gaap:DescriptionOfLesseeLeasingArrangementsOperatingLeases>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="C_0001785173_20180531" id="F_000403">P12M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <etnb:OperatingLeaseMonthlyRentalPayments
      contextRef="C_0001785173_20180501_20180531"
      decimals="0"
      id="F_000402"
      unitRef="U_iso4217USD">4200</etnb:OperatingLeaseMonthlyRentalPayments>
    <us-gaap:DescriptionOfLesseeLeasingArrangementsOperatingLeases
      contextRef="C_0001785173_srtStatementGeographicalAxis_etnbSanFranciscoOfficeMember_20191201_20191231"
      id="F_000404">with a lease term that was due to expire in January 2022. In July 2021, the Company amended the lease agreement to extend the term of the lease to January 2023, with an option to renew the term for one year.</us-gaap:DescriptionOfLesseeLeasingArrangementsOperatingLeases>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="C_0001785173_srtStatementGeographicalAxis_etnbSanFranciscoOfficeMember_20211231"
      id="F_000406">P1Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <etnb:OperatingLeaseMonthlyRentalPayments
      contextRef="C_0001785173_srtStatementGeographicalAxis_etnbSanFranciscoOfficeMember_20200101_20201231"
      decimals="0"
      id="F_000405"
      unitRef="U_iso4217USD">18000</etnb:OperatingLeaseMonthlyRentalPayments>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000288">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Future minimum&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;lease&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;payments&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;under the Company&#x2019;s non-cancellable&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;operating&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;lease&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;obligations&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;as of December&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;31, 2021, are as follows&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;(in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:77.1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;212&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:77.1%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2023&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:77.1%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total future minimum annual payments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;219&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000407"
      unitRef="U_iso4217USD">212000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000408"
      unitRef="U_iso4217USD">7000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000409"
      unitRef="U_iso4217USD">219000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <us-gaap:LeaseAndRentalExpense
      contextRef="C_0001785173_20210101_20211231"
      decimals="0"
      id="F_000410"
      unitRef="U_iso4217USD">290000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:LeaseAndRentalExpense
      contextRef="C_0001785173_20200101_20201231"
      decimals="0"
      id="F_000411"
      unitRef="U_iso4217USD">273000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:SecurityDeposit
      contextRef="C_0001785173_us-gaapBalanceSheetLocationAxis_etnbRestrictedCashAndOtherAssetsMember_20201231"
      decimals="0"
      id="F_000413"
      unitRef="U_iso4217USD">95000</us-gaap:SecurityDeposit>
    <us-gaap:SecurityDeposit
      contextRef="C_0001785173_us-gaapBalanceSheetLocationAxis_etnbRestrictedCashAndOtherAssetsMember_20211231"
      decimals="0"
      id="F_000412"
      unitRef="U_iso4217USD">95000</us-gaap:SecurityDeposit>
    <etnb:AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment
      contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20180401_20180430"
      decimals="-5"
      id="F_000414"
      unitRef="U_iso4217USD">6000000.0</etnb:AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment>
    <etnb:ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones
      contextRef="C_0001785173_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_etnbTevasGlycoPEGylatedFGF21ProgramMember_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20180401_20180430"
      decimals="INF"
      id="F_000415"
      unitRef="U_iso4217USD">67500000</etnb:ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones>
    <etnb:ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones
      contextRef="C_0001785173_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_etnbTevasDevelopmentProgramMember_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20180401_20180430"
      decimals="INF"
      id="F_000416"
      unitRef="U_iso4217USD">67500000</etnb:ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones>
    <etnb:ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones
      contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20180401_20180430"
      decimals="INF"
      id="F_000417"
      unitRef="U_iso4217USD">135000000.0</etnb:ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones>
    <etnb:AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice
      contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20210101_20211231"
      id="F_000418">P120D</etnb:AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice>
    <etnb:AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure
      contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20210101_20211231"
      id="F_000419">P60D</etnb:AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure>
    <etnb:AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled
      contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20210101_20211231"
      id="F_000420">P60D</etnb:AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled>
    <etnb:MilestonePayment
      contextRef="C_0001785173_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20200101_20201231"
      decimals="INF"
      id="F_000422"
      unitRef="U_iso4217USD">0</etnb:MilestonePayment>
    <etnb:MilestonePayment
      contextRef="C_0001785173_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_us-gaapTypeOfArrangementAxis_etnbTevaAgreementMember_20210101_20211231"
      decimals="INF"
      id="F_000421"
      unitRef="U_iso4217USD">0</etnb:MilestonePayment>
    <us-gaap:LongTermDebtTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000255">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;6. Term Loan&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Loan and Security Agreement&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In April 2020, the Company entered into a Loan and Security Agreement, (the &#x201c;Loan Agreement&#x201d;) with the lenders referred to therein (the &#x201c;Lenders&#x201d;), and Silicon Valley Bank (&#x201c;SVB&#x201d;), as collateral agent. The Loan Agreement provided for (i) a secured term A loan facility (the &#x201c;Term A Loan Facility&#x201d;) of up to $10.0 million and (ii) a secured term B loan facility (the &#x201c;Term B Loan Facility&#x201d;) of up to $5.0 million that became available upon the satisfaction of certain milestones, each of which was available to be drawn through May 31, 2021 pursuant to an amendment executed in April 2021. The term loan is secured by certain assets of the Borrowers (as defined in the Loan Agreement), including substantially all of the assets of the Company, excluding the Company&#x2019;s intellectual property. The term loan contains customary representations, warranties, affirmative covenants and also certain restrictive covenants.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In April 2020, in connection with the execution of the Loan Agreement, the Company issued SVB a warrant to purchase 25,000 shares of the Company&#x2019;s common stock with a warrant exercise price of $22.06 per share that is immediately exercisable and expires on&lt;span style="font-size:12pt;"&gt;&#160;&lt;/span&gt;June 30, 2025, as amended. The fair value of the warrant at issuance date was determined by using the Black-Scholes option-pricing model with the following assumptions: risk-free interest rate of 0.75%, no dividends, expected volatility of 92.3% and expected term of 10.0 years. Upon issuance, the fair value allocated to the warrant of $0.6 million met the requirements for equity classification within additional paid-in capital in the consolidated balance sheets. Additionally, the Company incurred $0.2 million in closing costs, which together with the value of the warrants, were recorded as debt issuance costs classified within other assets in the consolidated balance sheets.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In May 2021, the parties further amended the Loan Agreement (as amended, the &#x201c;2021 Loan Agreement&#x201d;). The 2021 Loan Agreement increased the Term A Loan Facility to up to $20.0 million thereby increasing the total term loan facility from $15.0 million to $25.0 million. The Term B Loan Facility of up to $5.0 million remains available to be drawn upon the achievement of certain additional milestones, and each loan facility is available to be drawn upon on or before September 30, 2022. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Concurrent with the closing and as a condition of the 2021 Loan Agreement, the Company drew $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.5&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; and in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 2021, drew the remaining $18.5 million &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;under&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; the Term Loan A Facility. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The 2021 Loan Agreement provides for interest&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;only payments &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;until&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; October 1, 2022, followed by consecutive monthly payments of principal and interest starting on October 1, 2022 and continuing through&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;September 1, 2024&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;,&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; the maturity date of the term loan. The interest only period may be extended to April 1, 2023, if on or before September 20, 2022, the Company receives net cash proceeds of at least $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;75.0&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million from the sale of its equity securities. The term loan bears interest at the greater of (i) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.25&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;% and (ii) the sum of (a) the Prime Rate as reported in The Wall Street Journal plus (b) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.00&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;% (or &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;for both amounts drawn &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.25% initially and as of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; 3&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, 2021). In addition, a final payment fee of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5%&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; of the principal amount of the loan is due when the term loan becomes due or upon prepayment of the term loan. If the Company elects to prepay the loan, there is also a prepayment fee of between 1% and 3% of the principal amount of the term loan depending on the timing of prepayment.&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In May 2021, in connection with the execution of the 2021 Loan Agreement, the Company issued SVB a warrant to purchase 33,923 shares of the Company&#x2019;s common stock with a warrant exercise price of $19.12 per share that is immediately exercisable and expires on May 28, 2031. The Company determined the fair value of the warrant at the issuance date by using the Black-Scholes option-pricing model with the following assumptions: risk-free interest rate of 1.6%, no dividends, expected volatility of 98.6% and expected term of 10.0 years. Upon issuance, the fair value of the warrant of $0.6 million was recorded as a debt issuance cost and met the requirements for equity classification within additional paid-in capital in the consolidated balance sheets. In addition, closing costs incurred were not material. In connection with Term Loan B Facility, if funded, the Company will issue additional warrant to purchase 11,305 shares of the Company&#x2019;s common stock with the exercise price at the Company&#x2019;s stock price at the time of issuance.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The 2021 Loan Agreement was accounted for as a modification to a credit facility. The related debt issuance costs incurred in May 2021, including the fair value of the warrant, together with the remaining unamortized debt issuance costs related to the Loan Agreement of $0.4 million were recorded as deferred assets and recognized on a straight-line basis as interest expense over the availability of the draw period. As of December 31, 2021, all amounts were drawn under the Term Loan A Facility such that all debt issuance costs were recorded as a debt discount. The carrying value of the debt discount, together with the final payment fee, are recognized using the effective interest method. Interest expense is recorded within other expenses, net in the consolidated statements of operations and comprehensive loss. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;span style="font-size:10pt;"&gt;The expected repayments of principal amount due on the term loan, excluding the final payment fee, as of December 31, 2021 are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,500&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2023&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2024&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,500&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total principal repayments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less: unamortized debt discount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(602&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total term loan, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,398&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less: term loan, current&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,500&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Term loan, non-current, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,898&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:12pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:LineOfCreditFacilityDescription
      contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20200401_20200430"
      id="F_000425">In April 2020, the Company entered into a Loan and Security Agreement, (the &#x201c;Loan Agreement&#x201d;) with the lenders referred to therein (the &#x201c;Lenders&#x201d;), and Silicon Valley Bank (&#x201c;SVB&#x201d;), as collateral agent. The Loan Agreement provided for (i) a secured term A loan facility (the &#x201c;Term A Loan Facility&#x201d;) of up to $10.0 million and (ii) a secured term B loan facility (the &#x201c;Term B Loan Facility&#x201d;) of up to $5.0 million that became available upon the satisfaction of certain milestones, each of which was available to be drawn through May 31, 2021 pursuant to an amendment executed in April 2021. The term loan is secured by certain assets of the Borrowers (as defined in the Loan Agreement), including substantially all of the assets of the Company, excluding the Company&#x2019;s intellectual property. The term loan contains customary representations, warranties, affirmative covenants and also certain restrictive covenants.</us-gaap:LineOfCreditFacilityDescription>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermALoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20200430"
      decimals="-5"
      id="F_000423"
      unitRef="U_iso4217USD">10000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermBLoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20200430"
      decimals="-5"
      id="F_000424"
      unitRef="U_iso4217USD">5000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermALoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20200430"
      decimals="INF"
      id="F_000426"
      unitRef="U_xbrlishares">25000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermALoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20200430"
      decimals="2"
      id="F_000427"
      unitRef="U_iso4217USD_xbrlishares">22.06</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20200430"
      id="F_000428">2025-06-30</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_0001785173_20200401_20200430"
      decimals="4"
      id="F_000431"
      unitRef="U_xbrlipure">0.0075</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_0001785173_20200401_20200430"
      decimals="3"
      id="F_000432"
      unitRef="U_xbrlipure">0.923</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="C_0001785173_20200401_20200430" id="F_000433">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20200430"
      decimals="-5"
      id="F_000429"
      unitRef="U_iso4217USD">600000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="C_0001785173_us-gaapBalanceSheetLocationAxis_us-gaapOtherAssetsMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20200430"
      decimals="-5"
      id="F_000430"
      unitRef="U_iso4217USD">200000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:LineOfCreditFacilityDescription
      contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210501_20210531"
      id="F_000438">In May 2021, the parties further amended the Loan Agreement (as amended, the &#x201c;2021 Loan Agreement&#x201d;). The 2021 Loan Agreement increased the Term A Loan Facility to up to $20.0 million thereby increasing the total term loan facility from $15.0 million to $25.0 million. The Term B Loan Facility of up to $5.0 million remains available to be drawn upon the achievement of certain additional milestones, and each loan facility is available to be drawn upon on or before September 30, 2022.</us-gaap:LineOfCreditFacilityDescription>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermALoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210531"
      decimals="-5"
      id="F_000434"
      unitRef="U_iso4217USD">20000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <etnb:LineOfCreditFacilityIncreaseInBorrowingCapacity
      contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210501_20210531"
      decimals="-5"
      id="F_000435"
      unitRef="U_iso4217USD">15000000.0</etnb:LineOfCreditFacilityIncreaseInBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_0001785173_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210531"
      decimals="-5"
      id="F_000436"
      unitRef="U_iso4217USD">25000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermBLoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210531"
      decimals="-5"
      id="F_000437"
      unitRef="U_iso4217USD">5000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermALoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20211231"
      decimals="-5"
      id="F_000439"
      unitRef="U_iso4217USD">1500000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityExpirationDate1
      contextRef="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermALoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210101_20211231"
      id="F_000440">2024-09-01</us-gaap:LineOfCreditFacilityExpirationDate1>
    <etnb:NetCashProceedsFromSaleOfEquitySecurities
      contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210101_20211231"
      decimals="-5"
      id="F_000441"
      unitRef="U_iso4217USD">75000000.0</etnb:NetCashProceedsFromSaleOfEquitySecurities>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="C_0001785173_srtRangeAxis_srtMinimumMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210101_20211231"
      decimals="4"
      id="F_000442"
      unitRef="U_xbrlipure">0.0425</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_us-gaapVariableRateAxis_us-gaapPrimeRateMember_20210101_20211231"
      decimals="4"
      id="F_000443"
      unitRef="U_xbrlipure">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <etnb:PercentageOfFeeOnLoan
      contextRef="C_0001785173_20210101_20211231"
      decimals="2"
      id="F_000444"
      unitRef="U_xbrlipure">0.05</etnb:PercentageOfFeeOnLoan>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210531"
      decimals="INF"
      id="F_000445"
      unitRef="U_xbrlishares">33923</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210531"
      decimals="2"
      id="F_000446"
      unitRef="U_iso4217USD_xbrlishares">19.12</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210531"
      id="F_000447">2031-05-28</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="C_0001785173_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputRiskFreeInterestRateMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_us-gaapValuationTechniqueAxis_us-gaapValuationTechniqueOptionPricingModelMember_20210531"
      decimals="3"
      id="F_000448"
      unitRef="U_xbrlipure">0.016</us-gaap:DebtInstrumentMeasurementInput>
    <etnb:FairValueOfWarrantsAssumptionsDividends
      contextRef="C_0001785173_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputExpectedDividendPaymentMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210501_20210531"
      decimals="-3"
      id="F_000449"
      unitRef="U_iso4217USD">0</etnb:FairValueOfWarrantsAssumptionsDividends>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="C_0001785173_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_us-gaapValuationTechniqueAxis_us-gaapValuationTechniqueOptionPricingModelMember_20210531"
      decimals="3"
      id="F_000450"
      unitRef="U_xbrlipure">0.986</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentTerm
      contextRef="C_0001785173_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputExpectedTermMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_us-gaapValuationTechniqueAxis_us-gaapValuationTechniqueOptionPricingModelMember_20210501_20210531"
      id="F_000451">P10Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210531"
      decimals="-5"
      id="F_000452"
      unitRef="U_iso4217USD">600000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_0001785173_us-gaapDebtInstrumentAxis_etnbTermBLoanFacilityMember_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210531"
      decimals="INF"
      id="F_000453"
      unitRef="U_xbrlishares">11305</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_0001785173_us-gaapTypeOfArrangementAxis_etnbLoanAndSecurityAgreementMember_20210531"
      decimals="-5"
      id="F_000454"
      unitRef="U_iso4217USD">400000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000289">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;span style="font-size:10pt;"&gt;The expected repayments of principal amount due on the term loan, excluding the final payment fee, as of December 31, 2021 are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,500&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2023&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2024&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,500&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total principal repayments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less: unamortized debt discount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(602&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total term loan, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,398&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less: term loan, current&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,500&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Term loan, non-current, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,898&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:12pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000455"
      unitRef="U_iso4217USD">2500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000456"
      unitRef="U_iso4217USD">10000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000457"
      unitRef="U_iso4217USD">7500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000458"
      unitRef="U_iso4217USD">20000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000459"
      unitRef="U_iso4217USD">602000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000460"
      unitRef="U_iso4217USD">19398000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000461"
      unitRef="U_iso4217USD">2500000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000462"
      unitRef="U_iso4217USD">16898000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000256">
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;7. Stock-Based Compensation &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Equity Incentive Plans&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s board of directors approved the 2019 Equity Incentive Plan (the &#x201c;2019 Plan&#x201d;), which became effective in September 2019. The Company initially reserved 2,844,193 shares of common stock for issuance under the 2019 Plan. In addition, the number of shares of common stock reserved for issuance under the 2019 Plan will automatically increase on the first day of January for a period of up to ten years, commencing on January 1, 2020, in an amount equal to 4% of the total number of shares of the Company&#x2019;s capital stock outstanding on the immediately preceding December 31, or a lesser number of shares determined by the Company&#x2019;s board of directors. As of December 31, 2021, there were 1,428,304 shares of common stock available for issuance as future option grants under the 2019 Plan. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The board of directors determines the period over which options become exercisable and options generally vest over a &lt;span style="-sec-ix-hidden:F_000467"&gt;four-year&lt;/span&gt; period, with 25% of options vesting on the first anniversary of employment, and thereafter, the remaining options vesting quarterly, over the following 36-month period. The options will expire within ten years from the date of grant. The exercise price of awards granted will not be less than the estimated fair value of the shares on the date of grant.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Employee Stock Purchase Plan&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In October 2019, the Company adopted the 2019 Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;), which became effective in November 2019. The Company initially reserved 225,188 shares of common stock for purchase under the ESPP. The number of shares of common stock reserved for issuance under the ESPP will automatically increase on the first day of January for a period of up to ten years, in an amount equal to 1% &lt;span style="color:#000000;"&gt;of the total number of shares of the Company&#x2019;s common stock outstanding on the immediately preceding December 31, or a lesser number of shares determined by the Company&#x2019;s board of directors. Purchases will be accomplished through the participation of discrete offering periods and each offering is expected to be 6 months long. For each offering period, ESPP participants will purchase shares of common stock at a price per share equal to&lt;/span&gt; 85% &lt;span style="color:#000000;"&gt;of the lesser of the fair market value of the Company&#x2019;s common stock on (1) the first trading day of the applicable offering period or (2) the last trading day of the applicable offering period&lt;/span&gt;. The first six month offering period under the ESPP commenced on January 1, 2020.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2021, there were 544,410 shares of common stock available for issuance under the ESPP.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company recorded stock-based compensation for the periods presented as follows (in thousands): &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,966&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,250&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;General and administrative&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,712&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,557&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total stock-based compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,678&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,807&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The fair value of stock options granted for the periods presented was estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions: &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected term (years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000485"&gt;5.5-6.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000486"&gt;4.0-6.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000489"&gt;86.9-91.9%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000490"&gt;86.4-97.6%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000493"&gt;0.7-1.3%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000494"&gt;0.2-1.5%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected dividend&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes stock option activity for the year ended December 31, 2021: &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Remaining&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number of&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contractual&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intrinsic&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Price&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Term&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(In years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(In&#160;thousands)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance outstanding as of December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,898,395&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12.79&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000509"&gt;8.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25,918&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;830,013&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22.22&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercised&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(188,286&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.59&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cancelled and forfeited&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(133,454&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19.55&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance outstanding as of December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,406,668&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16.46&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000510"&gt;8.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,970&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercisable as of December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;922,104&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10.76&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000511"&gt;7.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,800&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-right:1.92%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The estimated grant date fair value of stock options that vested during the year ended December 31, 2021, was $7.0 million. The weighted-average&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;grant&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;date fair&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;value of stock options&lt;span style="letter-spacing:0.05pt;"&gt; that were &lt;/span&gt;granted&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;during the years ended December 31, 2021 and 2020 was $16.18 and $21.88 per share, respectively.&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;As&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;of December&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;31, 2021, there&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;was $17.9 million of unrecognized&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;stock-based compensation&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;cost related&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;to stock options&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;granted&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;under the 2019 Plan, which is expected&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;to be recognized&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;over a weighted-average&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;period&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of &lt;span&gt;&lt;span style="color:#000000;"&gt;2.3&lt;/span&gt; years&lt;/span&gt;. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"&gt;Restricted Stock Units (&#x201c;RSUs&#x201d;) &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In February 2021, the Company granted 56,545 service-based RSUs to its employees with a total grant date fair value of $1.3 million. The RSUs vest annually over a &lt;span style="-sec-ix-hidden:F_000523"&gt;three-year&lt;/span&gt; period. During the year ended December 31, 2021, the Company recognized $0.3 million in expense related to the service-based RSUs. As of December 31, 2021, 11,651 RSUs were cancelled and 44,894 remain outstanding.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In February 2021, the Company granted 61,500 performance-based RSUs to certain executives, one-third of which vest on each &lt;span style="-sec-ix-hidden:F_000529"&gt;one-year&lt;/span&gt; anniversary of the grant date subject to achievement of a development milestone and continued service to the Company. The performance-based RSUs have a total grant date fair value of $1.4 million. During the year ended December 31, 2021, the Company recognized $0.8 million in expense, using the accelerated attribution method, related to the performance-based RSUs. As of December 31, 2021, all of the performance-based RSUs remain outstanding. Subsequently, one-third of the performance-based RSUs vested in February 2022, upon achievement of the development milestone and satisfaction of the continued service condition.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <etnb:NumberOfSharesIssuableUnderShareBasedPaymentArrangement
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      decimals="INF"
      id="F_000463"
      unitRef="U_xbrlishares">2844193</etnb:NumberOfSharesIssuableUnderShareBasedPaymentArrangement>
    <etnb:PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance
      contextRef="C_0001785173_srtRangeAxis_srtMaximumMember_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      id="F_000464">P10Y</etnb:PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance>
    <etnb:PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      decimals="2"
      id="F_000465"
      unitRef="U_xbrlipure">0.04</etnb:PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20211231"
      decimals="INF"
      id="F_000466"
      unitRef="U_xbrlishares">1428304</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      id="F_000469">The board of directors determines the period over which options become exercisable and options generally vest over a four-year period, with 25% of options vesting on the first anniversary of employment, and thereafter, the remaining options vesting quarterly, over the following 36-month period. The options will expire within ten years from the date of grant.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      decimals="2"
      id="F_000468"
      unitRef="U_xbrlipure">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <etnb:ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      id="F_000470">P36M</etnb:ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      id="F_000471">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <etnb:NumberOfSharesIssuableUnderShareBasedPaymentArrangement
      contextRef="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20191001_20191031"
      decimals="INF"
      id="F_000472"
      unitRef="U_xbrlishares">225188</etnb:NumberOfSharesIssuableUnderShareBasedPaymentArrangement>
    <etnb:PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance
      contextRef="C_0001785173_srtRangeAxis_srtMaximumMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20191001_20191031"
      id="F_000473">P10Y</etnb:PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance>
    <etnb:PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding
      contextRef="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20191001_20191031"
      decimals="2"
      id="F_000474"
      unitRef="U_xbrlipure">0.01</etnb:PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20191001_20191031"
      decimals="2"
      id="F_000475"
      unitRef="U_xbrlipure">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <etnb:ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriod
      contextRef="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20191001_20191031"
      id="F_000476">P6M</etnb:ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriod>
    <etnb:ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate
      contextRef="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20191001_20191031"
      id="F_000477">2020-01-01</etnb:ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_0001785173_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20211231"
      decimals="INF"
      id="F_000478"
      unitRef="U_xbrlishares">544410</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000290">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company recorded stock-based compensation for the periods presented as follows (in thousands): &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,966&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,250&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;General and administrative&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,712&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,557&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total stock-based compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,678&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,807&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001785173_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20210101_20211231"
      decimals="-3"
      id="F_000479"
      unitRef="U_iso4217USD">2966000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001785173_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20201231"
      decimals="-3"
      id="F_000480"
      unitRef="U_iso4217USD">1250000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001785173_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20210101_20211231"
      decimals="-3"
      id="F_000481"
      unitRef="U_iso4217USD">5712000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001785173_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20200101_20201231"
      decimals="-3"
      id="F_000482"
      unitRef="U_iso4217USD">2557000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000483"
      unitRef="U_iso4217USD">8678000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000484"
      unitRef="U_iso4217USD">3807000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000291">
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The fair value of stock options granted for the periods presented was estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions: &lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected term (years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000485"&gt;5.5-6.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000486"&gt;4.0-6.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000489"&gt;86.9-91.9%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000490"&gt;86.4-97.6%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000493"&gt;0.7-1.3%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000494"&gt;0.2-1.5%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected dividend&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000292">
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes stock option activity for the year ended December 31, 2021: &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Remaining&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number of&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contractual&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intrinsic&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Price&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Term&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(In years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(In&#160;thousands)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance outstanding as of December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,898,395&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12.79&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000509"&gt;8.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25,918&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;830,013&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22.22&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercised&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(188,286&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.59&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cancelled and forfeited&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(133,454&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19.55&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance outstanding as of December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,406,668&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16.46&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000510"&gt;8.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,970&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercisable as of December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;922,104&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10.76&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000511"&gt;7.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,800&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-right:1.92%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20201231"
      decimals="INF"
      id="F_000497"
      unitRef="U_xbrlishares">1898395</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20201231"
      decimals="2"
      id="F_000503"
      unitRef="U_iso4217USD_xbrlishares">12.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20201231"
      decimals="-3"
      id="F_000512"
      unitRef="U_iso4217USD">25918000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      decimals="INF"
      id="F_000498"
      unitRef="U_xbrlishares">830013</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      decimals="2"
      id="F_000504"
      unitRef="U_iso4217USD_xbrlishares">22.22</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      decimals="INF"
      id="F_000499"
      unitRef="U_xbrlishares">188286</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      decimals="2"
      id="F_000505"
      unitRef="U_iso4217USD_xbrlishares">2.59</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      decimals="INF"
      id="F_000500"
      unitRef="U_xbrlishares">133454</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      decimals="2"
      id="F_000506"
      unitRef="U_iso4217USD_xbrlishares">19.55</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20211231"
      decimals="INF"
      id="F_000501"
      unitRef="U_xbrlishares">2406668</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20211231"
      decimals="2"
      id="F_000507"
      unitRef="U_iso4217USD_xbrlishares">16.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20211231"
      decimals="-3"
      id="F_000513"
      unitRef="U_iso4217USD">9970000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20211231"
      decimals="INF"
      id="F_000502"
      unitRef="U_xbrlishares">922104</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20211231"
      decimals="2"
      id="F_000508"
      unitRef="U_iso4217USD_xbrlishares">10.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20211231"
      decimals="-3"
      id="F_000514"
      unitRef="U_iso4217USD">6800000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndTwentyEquityIncentivePlanMember_20210101_20211231"
      decimals="-5"
      id="F_000515"
      unitRef="U_iso4217USD_xbrlishares">7000000.0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndTwentyEquityIncentivePlanMember_20210101_20211231"
      decimals="2"
      id="F_000516"
      unitRef="U_iso4217USD_xbrlishares">16.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndTwentyEquityIncentivePlanMember_20200101_20201231"
      decimals="2"
      id="F_000517"
      unitRef="U_iso4217USD_xbrlishares">21.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20211231"
      decimals="-5"
      id="F_000518"
      unitRef="U_iso4217USD">17900000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231"
      id="F_000519">P2Y3M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_0001785173_srtTitleOfIndividualAxis_us-gaapShareBasedPaymentArrangementEmployeeMember_us-gaapAwardTypeAxis_etnbServiceBasedRSUsMember_20210201_20210228"
      decimals="INF"
      id="F_000520"
      unitRef="U_xbrlishares">56545</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <etnb:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue
      contextRef="C_0001785173_srtTitleOfIndividualAxis_us-gaapShareBasedPaymentArrangementEmployeeMember_us-gaapAwardTypeAxis_etnbServiceBasedRSUsMember_20210201_20210228"
      decimals="-5"
      id="F_000521"
      unitRef="U_iso4217USD">1300000</etnb:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001785173_srtTitleOfIndividualAxis_us-gaapShareBasedPaymentArrangementEmployeeMember_us-gaapAwardTypeAxis_etnbServiceBasedRSUsMember_20210101_20211231"
      decimals="INF"
      id="F_000522"
      unitRef="U_iso4217USD">300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_0001785173_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231"
      decimals="INF"
      id="F_000524"
      unitRef="U_xbrlishares">11651</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0001785173_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20211231"
      decimals="INF"
      id="F_000525"
      unitRef="U_xbrlishares">44894</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_0001785173_srtTitleOfIndividualAxis_srtExecutiveOfficerMember_us-gaapAwardTypeAxis_etnbPerformanceRSUsMember_20210201_20210228"
      decimals="INF"
      id="F_000526"
      unitRef="U_xbrlishares">61500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <etnb:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue
      contextRef="C_0001785173_srtTitleOfIndividualAxis_srtExecutiveOfficerMember_us-gaapAwardTypeAxis_etnbPerformanceRSUsMember_20210201_20210228"
      decimals="-5"
      id="F_000527"
      unitRef="U_iso4217USD">1400000</etnb:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001785173_srtTitleOfIndividualAxis_srtExecutiveOfficerMember_us-gaapAwardTypeAxis_etnbPerformanceRSUsMember_20210101_20211231"
      decimals="INF"
      id="F_000528"
      unitRef="U_iso4217USD">800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000257">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;color:#auto;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;"&gt;8. Income Taxes&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Tax Rates Applicable to the Income of the Company and its Subsidiaries&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company is taxed according to U.S. federal and state tax laws and Israeli tax laws. The statutory tax rates applicable to the income of the Company and its subsidiaries for the periods presented are as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.52%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;89bio, Inc.&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;89Bio Ltd.&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;89bio Management, Inc.&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;UAB 89bio Lithuania&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The income&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;tax benefit&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;is comprised&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Current:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Federal&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(11&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;State&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(10&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Federal&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Income tax benefit&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;147&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;59&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Deferred&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;Income Taxes&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;income&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;taxes&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;reflect&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;the net tax effects&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;of temporary&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;differences&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;between the carrying&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;amounts of assets&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and liabilities&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;for financial&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;reporting&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;purposes&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;and the amounts&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;used for income&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;tax purposes. Significant&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;components&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of the Company&#x2019;s deferred&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;tax assets&lt;span style="letter-spacing:0.05pt;"&gt; for the periods presented &lt;/span&gt;are as follows&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;(in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. net operating loss carryforwards&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;29,094&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,342&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development expenses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,529&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,392&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Israel net operating loss carryforwards&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,262&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,978&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock-based compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,969&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;610&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued expenses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;220&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;635&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;191&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;48&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42,265&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,005&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less: valuation allowance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(42,046&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(21,936&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;219&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As&lt;span style="letter-spacing:-0.05pt;"&gt; &lt;/span&gt;of December&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;31, 2021 and 2020, the Company recorded&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;a valuation&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;allowance&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of $42.0 million and $21.9 million, respectively,&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;in respect&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of deferred&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;tax assets&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;resulting&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;from&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;tax loss carryforwards&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;and other&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;temporary&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;differences.&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;Realization of deferred tax assets is dependent upon future earnings, if any, the time and amount of which are uncertain. The Company regularly assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes based upon the weight of available evidence that it is more likely than not that all or a portion of deferred tax assets will not be realized, a valuation allowance is established through an adjustment to income tax expense. The valuation allowance increased by $20.1 million in 2021, which primarily relates to significant taxable losses. The Company continues to record a partial valuation allowance against the deferred tax assets in Israel due to achievement of recent profitability and the expectation of future profitability in the jurisdiction. The valuation allowance increased by $11.9 million in 2020, which primarily relates to significant taxable losses. The change in valuation allowance during 2020 also includes a partial release of the valuation allowance against deferred tax assets in Israel due to achievement of recent profitability and the expectation of future profitability in the jurisdiction, which decreased the valuation allowance by $69,000 in 2020. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Available&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;Carryforward&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;Tax &lt;span style="letter-spacing:-0.05pt;"&gt;Losses and Credits&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2021, the Company had an accumulated tax loss carryforward of approximately $138.5 million and $18.5 million for U.S. and Israeli tax purposes, respectively. As of December 31, 2020, the Company had an accumulated&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;tax loss carryforward&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;of approximately $54.1 million and $17.3 million for U.S. and Israeli tax purposes, respectively. Federal net operating losses generated after 2017 can be carried forward indefinitely but utilization will be limited to 80% of taxable income in the period that net operating losses are being utilized. Carryforward tax losses in Israel have no expiration date.&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;letter-spacing:0.1pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2021 and 2020, the Company had federal research and development credit carryforwards of approximately $2.1 million and $0.6 million, respectively, which expire beginning in 2040. As of December 31, 2021 and December 31, 2020, the Company has state research and development credit carryforwards of approximately $1.1 million and $0.7 million, respectively, which will carry forward indefinitely. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Loss from Operations, Before Income Tax&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-weight:normal;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company recorded a loss from operations, before income tax for the periods presented as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.77%;font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;United States&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(91,141&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(58,760&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Lithuania&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(73&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Israel&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;862&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,275&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss before income tax&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(90,269&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(49,558&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Reconciliation of Income Tax Benefit&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The reconciliation&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;of income tax benefit based on the statutory&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;tax rate&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;to the effective&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;tax rate&lt;span style="letter-spacing:0.05pt;"&gt; for the periods presented &lt;/span&gt;is as follows&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;(in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Income tax benefit computed at statutory rates&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,757&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,285&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in valuation allowance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(20,111&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(11,914&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign rate differential&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(19&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,671&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in Israel effective tax rate due to the 2019&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; reorganization&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;647&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development credits, net of&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; uncertain tax position&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,331&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;815&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;191&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;555&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Income tax benefit&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;147&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;59&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Utilization of U.S. federal and state net operating losses and credit carryforwards may be subject to an annual limitation provided for in Section 382 of the Internal Revenue Code and similar state codes. Any annual limitation could result in a deferral of the utilization of the net operating loss and credit carryforwards.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Unrecognized Tax Benefits &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;During the years ended December 31, 2021 and 2020, the amount of gross unrecognized tax benefits increased by $0.5 million and $0.3 million, respectively. If the total amount of unrecognized tax benefits was recognized, it would not have an impact to the effective tax rate as it would be offset by the reversal of related deferred tax assets which are subject to a full valuation allowance.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company recognizes interest and penalties related to uncertain tax positions as part of the income tax provision. As of December 31, 2021 and 2020, such interest and penalties were not material.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company is subject to taxation in the United States, California, and several foreign jurisdictions. To date, the Company has not been subject to any federal or state income tax audits. The Company is currently under examination by the Israeli taxing authorities for 2018 and 2019. As of December 31, 2021 all tax years remain open to examination. &lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <etnb:ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000293">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company is taxed according to U.S. federal and state tax laws and Israeli tax laws. The statutory tax rates applicable to the income of the Company and its subsidiaries for the periods presented are as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.52%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;89bio, Inc.&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;89Bio Ltd.&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;89bio Management, Inc.&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;UAB 89bio Lithuania&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</etnb:ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_0001785173_20210101_20211231"
      decimals="2"
      id="F_000530"
      unitRef="U_xbrlipure">0.21</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_0001785173_20200101_20201231"
      decimals="2"
      id="F_000531"
      unitRef="U_xbrlipure">0.21</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_0001785173_srtConsolidatedEntitiesAxis_etnbEightyNineBioLtdMember_20210101_20211231"
      decimals="2"
      id="F_000532"
      unitRef="U_xbrlipure">0.23</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_0001785173_srtConsolidatedEntitiesAxis_etnbEightyNineBioLtdMember_20200101_20201231"
      decimals="2"
      id="F_000533"
      unitRef="U_xbrlipure">0.23</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_0001785173_srtConsolidatedEntitiesAxis_etnbEightyNineBioManagementIncorporationMember_20210101_20211231"
      decimals="2"
      id="F_000534"
      unitRef="U_xbrlipure">0.21</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_0001785173_srtConsolidatedEntitiesAxis_etnbEightyNineBioManagementIncorporationMember_20200101_20201231"
      decimals="2"
      id="F_000535"
      unitRef="U_xbrlipure">0.21</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_0001785173_srtConsolidatedEntitiesAxis_etnbUABEightyNineBioLithuaniaMember_20210101_20211231"
      decimals="2"
      id="F_000536"
      unitRef="U_xbrlipure">0.15</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_0001785173_srtConsolidatedEntitiesAxis_etnbUABEightyNineBioLithuaniaMember_20200101_20201231"
      decimals="2"
      id="F_000537"
      unitRef="U_xbrlipure">0.15</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000294">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The income&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;tax benefit&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;is comprised&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Current:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Federal&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(11&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;State&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(10&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Federal&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Income tax benefit&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;147&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;59&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000538"
      unitRef="U_iso4217USD">-11000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000539"
      unitRef="U_iso4217USD">-2000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000540"
      unitRef="U_iso4217USD">1000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000541"
      unitRef="U_iso4217USD">-1000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000542"
      unitRef="U_iso4217USD">-3000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000543"
      unitRef="U_iso4217USD">-10000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000544"
      unitRef="U_iso4217USD">150000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000545"
      unitRef="U_iso4217USD">69000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000546"
      unitRef="U_iso4217USD">150000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000547"
      unitRef="U_iso4217USD">69000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000548"
      unitRef="U_iso4217USD">-147000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000549"
      unitRef="U_iso4217USD">-59000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000295">Significant&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;components&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;of the Company&#x2019;s deferred&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;tax assets&lt;span style="letter-spacing:0.05pt;"&gt; for the periods presented &lt;/span&gt;are as follows&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;(in thousands):
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. net operating loss carryforwards&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;29,094&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,342&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development expenses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,529&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,392&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Israel net operating loss carryforwards&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,262&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,978&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock-based compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,969&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;610&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued expenses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;220&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;635&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;191&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;48&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42,265&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,005&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less: valuation allowance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(42,046&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(21,936&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;219&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_0001785173_srtStatementGeographicalAxis_countryUS_20211231"
      decimals="-3"
      id="F_000550"
      unitRef="U_iso4217USD">29094000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_0001785173_srtStatementGeographicalAxis_countryUS_20201231"
      decimals="-3"
      id="F_000551"
      unitRef="U_iso4217USD">11342000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000552"
      unitRef="U_iso4217USD">6529000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000553"
      unitRef="U_iso4217USD">5392000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_0001785173_srtStatementGeographicalAxis_countryIL_20211231"
      decimals="-3"
      id="F_000554"
      unitRef="U_iso4217USD">4262000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_0001785173_srtStatementGeographicalAxis_countryIL_20201231"
      decimals="-3"
      id="F_000555"
      unitRef="U_iso4217USD">3978000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000556"
      unitRef="U_iso4217USD">1969000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000557"
      unitRef="U_iso4217USD">610000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000558"
      unitRef="U_iso4217USD">220000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000559"
      unitRef="U_iso4217USD">635000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000560"
      unitRef="U_iso4217USD">191000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000561"
      unitRef="U_iso4217USD">48000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000562"
      unitRef="U_iso4217USD">42265000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000563"
      unitRef="U_iso4217USD">22005000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000564"
      unitRef="U_iso4217USD">42046000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000565"
      unitRef="U_iso4217USD">21936000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_0001785173_20211231"
      decimals="-3"
      id="F_000566"
      unitRef="U_iso4217USD">219000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_0001785173_20201231"
      decimals="-3"
      id="F_000567"
      unitRef="U_iso4217USD">69000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_0001785173_20211231"
      decimals="-5"
      id="F_000568"
      unitRef="U_iso4217USD">42000000.0</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_0001785173_20201231"
      decimals="-5"
      id="F_000569"
      unitRef="U_iso4217USD">21900000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_0001785173_20210101_20211231"
      decimals="-5"
      id="F_000570"
      unitRef="U_iso4217USD">20100000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_0001785173_20200101_20201231"
      decimals="-5"
      id="F_000571"
      unitRef="U_iso4217USD">11900000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_0001785173_srtStatementGeographicalAxis_countryIL_20200101_20201231"
      decimals="0"
      id="F_000572"
      unitRef="U_iso4217USD">-69000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <etnb:AccumulatedTaxLossCarryForward
      contextRef="C_0001785173_srtStatementGeographicalAxis_countryUS_20211231"
      decimals="-5"
      id="F_000573"
      unitRef="U_iso4217USD">138500000</etnb:AccumulatedTaxLossCarryForward>
    <etnb:AccumulatedTaxLossCarryForward
      contextRef="C_0001785173_srtStatementGeographicalAxis_countryIL_20211231"
      decimals="-5"
      id="F_000575"
      unitRef="U_iso4217USD">18500000</etnb:AccumulatedTaxLossCarryForward>
    <etnb:AccumulatedTaxLossCarryForward
      contextRef="C_0001785173_srtStatementGeographicalAxis_countryUS_20201231"
      decimals="-5"
      id="F_000574"
      unitRef="U_iso4217USD">54100000</etnb:AccumulatedTaxLossCarryForward>
    <etnb:AccumulatedTaxLossCarryForward
      contextRef="C_0001785173_srtStatementGeographicalAxis_countryIL_20201231"
      decimals="-5"
      id="F_000576"
      unitRef="U_iso4217USD">17300000</etnb:AccumulatedTaxLossCarryForward>
    <us-gaap:OperatingLossCarryforwardsLimitationsOnUse contextRef="C_0001785173_20200101_20201231" id="F_000577">Federal net operating losses generated after 2017 can be carried forward indefinitely but utilization will be limited to 80% of taxable income in the period that net operating losses are being utilized.</us-gaap:OperatingLossCarryforwardsLimitationsOnUse>
    <etnb:TaxableIncomeUtilizationPercentage
      contextRef="C_0001785173_20201231"
      decimals="2"
      id="F_000578"
      unitRef="U_xbrlipure">0.80</etnb:TaxableIncomeUtilizationPercentage>
    <etnb:DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal
      contextRef="C_0001785173_20211231"
      decimals="-5"
      id="F_000579"
      unitRef="U_iso4217USD">2100000</etnb:DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal>
    <etnb:DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal
      contextRef="C_0001785173_20201231"
      decimals="-5"
      id="F_000580"
      unitRef="U_iso4217USD">600000</etnb:DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_0001785173_20211231"
      decimals="-5"
      id="F_000581"
      unitRef="U_iso4217USD">1100000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_0001785173_20201231"
      decimals="-5"
      id="F_000582"
      unitRef="U_iso4217USD">700000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000296">
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-weight:normal;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company recorded a loss from operations, before income tax for the periods presented as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.77%;font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;United States&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(91,141&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(58,760&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Lithuania&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(73&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Israel&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;862&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,275&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss before income tax&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(90,269&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(49,558&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0001785173_srtStatementGeographicalAxis_countryUS_20210101_20211231"
      decimals="-3"
      id="F_000583"
      unitRef="U_iso4217USD">-91141000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0001785173_srtStatementGeographicalAxis_countryUS_20200101_20201231"
      decimals="-3"
      id="F_000584"
      unitRef="U_iso4217USD">-58760000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0001785173_srtStatementGeographicalAxis_countryLT_20210101_20211231"
      decimals="-3"
      id="F_000585"
      unitRef="U_iso4217USD">10000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0001785173_srtStatementGeographicalAxis_countryLT_20200101_20201231"
      decimals="-3"
      id="F_000586"
      unitRef="U_iso4217USD">-73000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0001785173_srtStatementGeographicalAxis_countryIL_20210101_20211231"
      decimals="-3"
      id="F_000587"
      unitRef="U_iso4217USD">862000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0001785173_srtStatementGeographicalAxis_countryIL_20200101_20201231"
      decimals="-3"
      id="F_000588"
      unitRef="U_iso4217USD">9275000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000589"
      unitRef="U_iso4217USD">-90269000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000590"
      unitRef="U_iso4217USD">-49558000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000297">
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The reconciliation&lt;span style="letter-spacing:0.15pt;"&gt; &lt;/span&gt;of income tax benefit based on the statutory&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;tax rate&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;to the effective&lt;span style="letter-spacing:0.1pt;"&gt; &lt;/span&gt;tax rate&lt;span style="letter-spacing:0.05pt;"&gt; for the periods presented &lt;/span&gt;is as follows&lt;span style="letter-spacing:0.05pt;"&gt; &lt;/span&gt;(in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Income tax benefit computed at statutory rates&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,757&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,285&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in valuation allowance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(20,111&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(11,914&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign rate differential&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(19&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,671&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in Israel effective tax rate due to the 2019&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; reorganization&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;647&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development credits, net of&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; uncertain tax position&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,331&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;815&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;191&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;555&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Income tax benefit&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;147&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;59&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000591"
      unitRef="U_iso4217USD">18757000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000592"
      unitRef="U_iso4217USD">8285000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000593"
      unitRef="U_iso4217USD">-20111000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000594"
      unitRef="U_iso4217USD">-11914000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000595"
      unitRef="U_iso4217USD">-19000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000596"
      unitRef="U_iso4217USD">1671000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <etnb:IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000597"
      unitRef="U_iso4217USD">-2000</etnb:IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization>
    <etnb:IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000598"
      unitRef="U_iso4217USD">647000</etnb:IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000599"
      unitRef="U_iso4217USD">1331000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000600"
      unitRef="U_iso4217USD">815000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000601"
      unitRef="U_iso4217USD">191000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000602"
      unitRef="U_iso4217USD">555000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0001785173_20210101_20211231"
      decimals="-3"
      id="F_000603"
      unitRef="U_iso4217USD">-147000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0001785173_20200101_20201231"
      decimals="-3"
      id="F_000604"
      unitRef="U_iso4217USD">-59000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease
      contextRef="C_0001785173_20210101_20211231"
      decimals="-5"
      id="F_000605"
      unitRef="U_iso4217USD">500000</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease
      contextRef="C_0001785173_20200101_20201231"
      decimals="-5"
      id="F_000606"
      unitRef="U_iso4217USD">300000</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0001785173_20211231"
      decimals="INF"
      id="F_000607"
      unitRef="U_iso4217USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:EarningsPerShareTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000258">
&lt;p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;9. Net Loss Per Share &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following outstanding potentially dilutive shares, including all outstanding stock options, have been excluded from the calculation of diluted net loss per share for the periods presented due to their anti-dilutive effect: &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.52%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock options to purchase common stock&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,406,668&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,898,395&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unvested restricted stock units&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;106,394&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Warrants to purchase common stock&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;58,923&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,571,985&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,898,395&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000298">
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following outstanding potentially dilutive shares, including all outstanding stock options, have been excluded from the calculation of diluted net loss per share for the periods presented due to their anti-dilutive effect: &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.52%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock options to purchase common stock&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,406,668&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,898,395&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unvested restricted stock units&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;106,394&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Warrants to purchase common stock&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;58,923&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,571,985&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,898,395&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001785173_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20210101_20211231"
      decimals="INF"
      id="F_000608"
      unitRef="U_xbrlishares">2406668</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001785173_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      decimals="INF"
      id="F_000609"
      unitRef="U_xbrlishares">1898395</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001785173_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_etnbUnvestedRestrictedStockUnitsMember_20210101_20211231"
      decimals="INF"
      id="F_000610"
      unitRef="U_xbrlishares">106394</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001785173_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20210101_20211231"
      decimals="INF"
      id="F_000611"
      unitRef="U_xbrlishares">58923</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001785173_20210101_20211231"
      decimals="INF"
      id="F_000612"
      unitRef="U_xbrlishares">2571985</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001785173_20200101_20201231"
      decimals="INF"
      id="F_000613"
      unitRef="U_xbrlishares">1898395</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SubsequentEventsTextBlock contextRef="C_0001785173_20210101_20211231" id="F_000259">&#160;</us-gaap:SubsequentEventsTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>67
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M*/N7'(IW)^<#$N9*B[0,!@8ISXK_]*5,Q%' U#D1X)4!WKL -S@1X)<!?M^
MH P(;&:*3[%Y6%!-;ZZD.!!IW@8T\\,FTT;#Y_/,]/M:2WC*(4[?+$280S=J
M0K.(?,PTUZ]DF17CR?3+D'Q9+\@/'WXD'PC/R#U/$KBMKL8:&C<0X[!LZ+9H
MR#O1D.N1>Y'I6$$K$8O> HR!=4W=JZC?>BCB@H4CXKMGQ',\MX70' ^_IW)$
MG"+<:PE?X.&_Y1FT[K2U_N9K_+HC?(OGG\";BV<FR7]F&Z4E3(;_(I!!#1E8
MR*"K;Y]>]ZRMQ_!PUQE^0EA,:A83%&8&%")+XRZANS8:>/R6)HHA/,YK'N?]
MLK%BD@LSV","4Z8U,1U(Y<#[_KOO.CK_HN9VT8_;'5<A3<A71B6Y@YNM$PW'
MZJ TK2E-_Q:E,FLG2>%H=U\12I<UI4L4I)2G1[;C9I( MP>:MO8?CC.]W'!Q
M!C(7CA!6KM-(J-.'UQRR)2%32]"W%_*)O;:*) [E.(Y[,9VX%S[&[$C<W5[,
M<BE-5SZRO9":9SNRUE2W]V,'XE>F,&9>P\SKP^P/D>29!L,!PRQALIT1CO0@
M,$*-_+I^'T++3#-9F!&C#K3*72LQ'+$C58V*N[@.5[UWK V8>'7 #8>N-_0Q
MB7 ;:7=Q;2Z39ON.S('/3LCV88_C/(AL2,,0W* $D*@ Q!@VHN_B6ETR_!.,
MY?!;)@X963.J1 :-+)7*W[=2LL4Q\1'7:+Z+"W5);95O$AY"<12T;90M2I2)
M13$V_OG&/9^,)E?CY[;F&WUW<4FNM$&D*?B\M1;AMS.RCJEDBOR>:Z7!$8)4
MM!FK$OG\B)+G^!/7GP8G6#42[^+:O)S?/9)9'G$M))EIS8"'-:*GS$,'7I=[
M\!J5]WJI_#J&H62RMJ=9ZU#O@.DDU(B[UTO<URD%0K>Y@L>J54 [<+3,44*-
MIGN]-/UCRN3.%)E? $'':*YPP"YFC;A[O<3]XPMY M^@N!U1A:-II86C=79A
M(^T>KL5/7">,B"UQO1\V/X(TA;D$HJV<.HI$,8U5,8WW4"*>:9(S\L$9@:4@
M>]!G9>8V1KN1?0^7:TAB9%W$:[H122O;CKKQ]'"+,6GDW<.EN,H8=&T8TVS'
M3EK"#J"'V7HQ^Q?&J=%UKY>NFQI&'O)TTUYC.D"@TX;^I?M^9?J64J/U7B^M
M!\<K)%A JZAGU@3"Z(/*+<"$25,+HO;<=2P5/F(D&^GW>MG[)_I"EA$8'K[E
M8:']2!9Q2/]\&%P&Y],@P%;H30GP>Y6 611!D51GU0_R&=XCOV>MN>N = ./
MK$&21,J@/R1C&F/:U :_5VVH"+XA^G00K41Q1)AI DPGV!2!.3._J19^KVI1
M)W-NKF P/H%):^6'PT$2R1V(>P@N&?-G_M&&3*^B41.LI\M*BF>>A>W=C6/.
M9QBUIF[XN-J_I[828),2\F^^/SF'.Q O ]=!)TE3''Q<VVT_SB2CIZG@ ($[
MP8@TM<'')?VSL/L6,9A]1$$Z0 +?&UYZ%P[&J*D,?L]MGEF6Y<"M6(^WLL*!
M.HR1WQ0&O^<NSY$O0ECA8%V^R&]*@8_K=D5+'94L6+%MS.;/EL%J^,3DPU%7
M9O-#9,H8+ATS(NN-I'_^8^JY%S\K<V+ ,VY7_WLI7EZ)67XPFR')$FKW3K0@
M')B9;>.J(^]!M\TC +8+J5@D$9,P,>'=#2.P9(@(9!:T@VY$KLEO.8S)<NOY
MC( M(_S==\KJ.^$)@*RHU&2Y7!;4N7H[@@RV.04A9LN6'&)F 2-3/EDT(NL\
MC/_O<PX<5@W ;0LV)8(K,.HF)U]&ZU'E0SFL!.VQ0.6MC,GDRA[YF ">@6]U
M2$1?X;VM!HMI$!A$E G>%CL6KV;' C[B$/,P+NC+@K?-*5/8-ES05.< +Z75
MJO&.0R:6B]8-[XYB/,64)VBJ;X#7RHK)*2_:$?YI=?\+^?QYA7%IRFR U\6*
MBU%#,_I;^?R-T@J%FB9\*V3&Z1GYLFXM:..C RFS&K0'>XJ$QF<69U/UW?KP
M<&:/S,;-Z\7)XSTUBTE%$K:%4&=T <5#%H=YQ846>WN\M1%:B]3^C!F%Z6=>
M@.=;(71U81JHCU1O_@=02P,$%     @ K(MX5*OSV?!C!0  *14  !@   !X
M;"]W;W)K<VAE971S+W-H965T,BYX;6RU6&UOVS80_BN$5PPM8,<D)<M2ZAAH
M4PS;AVU!TVZ?&8F.B4JB2U).LU^_(ZU(LD0I*=9]2*R7N^-S=^)S=]P\2/5%
M[SDWZ%N1E_IJMC?F<+E<ZG3/"Z8OY(&7\&8G5<$,W*K[I3XHSC*G5.1+BG&T
M+)@H9]N->W:CMAM9F5R4_$8A714%4X_O>2X?KF9D]O3@H[C?&_M@N=T<V#V_
MY>;SX4;!W;*QDHF"EUK($BF^NYJ](Y?7=&T5G,1?@C_HSC6RKMQ)^<7>_)9=
MS;!%Q'.>&FN"P<^17_,\MY8 Q]?:Z*Q9TRIVKY^L_^*<!V?NF.;7,O];9&9_
M-8MG*.,[5N7FHWSXE=<.K:R]5.;:_4</M2R>H;321A:U,B H1'GZ9=_J0'04
M2#BB0&L%^E*%H%8(G*,G9,ZM#\RP[4;)!Z2L-%BS%RXV3AN\$:5-XZU1\%:
MGME>RU++7&3,\ R]9SDK4XYNK3F-%NCS[0?T^M4;] J)$GW:RTJS,M.;I8&5
MK?XRK5=Y?UJ%CJSR@:<7*"!S1#$E'O7KEZOC<_4E^-LX31NGJ;,7C#E=*<5+
M@YC6X.?EA,6@L1@XB^&81:;W"&*#4GO!OU;BR')8PANKDZFU,V6WV7&[HF%
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MVA9V.EW8H?6HBBIW4WX]I\@"/KJ]/9 Y<JAEVDO<=%CJ%U&_&?$)D;$(M^T
MG6X'NI SOA.I\-96.JSP"TH"X+D^2H\@S%TX&>GK:-L-T&>Z 5<"]2C1>F%[
M6@*Z2E8#U$,YV!E)1$9 M[T#?<DLV*G;;M=]IQ/KP1F%=Y;PR'EGB67G',L>
M(O[.U+TH-<KY#A3QQ1I2J$[G<J<;(P_N:.M.&B,+=[GG#,!; 7B_DU#;ZQM[
M6M:<CF[_!5!+ P04    " "LBWA4/>P?S;X"  !'"0  &    'AL+W=O<FMS
M:&5E=',O<VAE970S+GAM;)V676_:,!2&_XH5[6*3.N(D?%80J:6JMHMIJ&C;
MQ;0+DQR(5<=FMH%NOWZV$S)""81R ;9SWO<\QSG!&>^$?%89@$8O.>-JXF5:
MKV]]7R49Y$1UQ!JXN;(4,B?:3.7*5VL))'6BG/DAQGT_)Y1[\=BMS60\%AO-
M*(>91&J3YT3^N0<F=A,O\/8+3W25:;O@Q^,U6<$<]+?U3)J97[FD- >NJ.!(
MPG+BW06WTP!;@8OX3F&G#L;(EK(0XME./J<3#ULB8)!H:T',SQ:FP)AU,AR_
M2U.ORFF%A^.]^Z,KWA2S( JF@OV@J<XFWM!#*2S)ANDGL?L$94$]ZY<(IMPW
MVA6QO8&'DHW2(B_%AB"GO/@E+^5&' B";H,@+ 5A6T%4"B)7:$'FRGH@FL1C
M*79(VFCC9@=N;YS:5$.YO8US+<U5:G0ZG@JN!*,IT9"B>\((3P#-K9U"[V=$
M M<9:)H0]@%]1.^0CU1F5M78UR:[]?"3,M-]D2ELR/0 20=%P0T*<1B<D$_;
MRW%=[IN:J\+#JO#0^44-?G-M2C;]J-'7)7JDW!1."4,SH:CKKY]W"Z6EZ;)?
M9Y)%5;+()>LV))N9W@0IS1:;&YH\WZ UD6A+V 9.[6/A-71>]C'<QKB#L=FS
M[>%V78JJ@78KT.YUH,7=1F2C,R'I7TA/ 1>>_0.4 !>?(^86@37L7H7=>Q,V
M56IS&KGWBN28]5Q$#;)?0?;?!&G^7)4F/*5\=8JT?Y'T7$2-=%"1#LZ23D6>
MFT>@3:\.6O7JI:@:Y;"B'%Y!V:I1AXW]=[RG;2)KU*.*>G0]=7.?CEYQA#@*
M!B'N'@&_#@Q&HRCH]QMX _S_A,#7$U]HVM*R!?>)R 9P_^"4LZ\87XA<4:X0
M@Z61XL[ /+&R.+6+B19K=_ MA#;'J!MFYDT'I TPUY="Z/W$GJ75NU/\#U!+
M P04    " "LBWA4R9L)?$H$  !U#@  &    'AL+W=O<FMS:&5E=',O<VAE
M970T+GAM;)V766_;.!" _PIA]*$%ZDB49!V!8Z!Q]BBPW09)LWUFI+&EK21Z
M2=I.]]?OD%)D6Z*$8%^LPS.C;X;D',LC%S]D#J#(2U76\F:6*[6[=AR9YE Q
M><5W4.,_&RXJIO!1;!VY$\ RHU25CN>ZH5.QHIZMEN;=O5@M^5Z510WW@LA]
M53'Q\Q9*?KR9T=GKBX=BFRO]PEDM=VP+CZ">=O<"GYS.2E944,N"UT3 YF;V
MB5ZO::P5C,1?!1SEV3W1KCQS_D,_?,YN9JXF@A)2I4TPO!Q@#66I+2''/ZW1
M6?=-K7A^_VK]5^,\.O/,)*QY^;W(5'XSBV<D@PW;E^J!'W^'UJ&%MI?R4II?
M<FQEW1E)]U+QJE5&@JJHFRM[:0-QID##$06O5?#Z"L&(@M\J^,;1ALRX=<<4
M6RT%/Q*AI=&:OC&Q,=KH35'K97Q4 O\M4$^MUKR6O"PRIB CCPHON$9*$KXA
M7W<@F(ZU)*S.R)I7N%%RO8('(']P*<F</#W>D??O/I!WI*C)MYSO)8K*I:,0
M37_ 25N,VP;#&\&@'OG":Y5+\DN=079IP$&?.L>\5\=NO4F+=Y!>$9]^))[K
M40O0^NWJ[@2.W\79-_;\$7MM,.LM@1<\@A+D]835H+,:&*O!B-4'D,!$FIL%
MRN" IW*GU\^V (VER%C2A_NPBES?1]\.YU$92ODA39).Z@)ST6$N)C%_@QJ]
M+PTERW 7%U+I:!S !MK8"L\0:!)0OP=JD?+I(K2#AAUH. GZC2O$Y(.ULF&&
M X XB8(^YE J2/S%PHX9=9C1)*8Y?!O!JU=4/*,VQ&CP\;F-T2(V 1EWD/$D
MY%>5@^@B^)'48-V6\?#C"R_L$5J$/->W\R4=7S+)]R?6R%('\AFP&@(FL)17
M0!1[L6$F0X+$]<*D!VH1"Y+%(K:C4O>4I=U)V,\='.+6L"FLL6R-7!R*(.HA
M6H06(^>;GE41^J9@6JFH+7;4\_I@%KD@"<:2#_5.<-YT[C4[,;VH7^\U[8=V
MT:=2,3UE>.I/QN"IQCZJ+/[%0MI:WV(;172O<F!%R9Y+F.-.FTM6 I&0[D6A
M"GMN:;]T$8J(]N,U%!K;9Z=Z0J<+"K9&V/C4V'D( 77ZDV">KF7)FI8K^QL;
M$M,?6*&#X>X;;+ZAS)R.49_*"YVN+VW:MBSSZ)X<EH_Y(NC#6H2H.P)[*C%T
MNL:LWP88#@JQ/C11/S/:Y##CN&.'YE1BZ'2-Z=(C5A@B<R;@H^Z7B[3I-8IR
MK_I]6DO>V$TNB*Z"N ]N$?.OW+&]<*HZ=+KL?#>-.V1S=L#2N(6&79*]Q'.I
MN-D?B*[+T?_T;UB,<&9*8C_H]U(621JZ<13%_=+JG#7P%8BMF6LDLNYKU;2\
MW=MN=OID)H;>^UL]4YG!X&2F&<B^,+$ML)4O88,FW:L(-[=H9ISF0?&=&1.>
MN<*AP]SF.!>"T +X_X9S]?J@/]!-FJO_ %!+ P04    " "LBWA4S4&C<P4&
M   K'@  &    'AL+W=O<FMS:&5E=',O<VAE970U+GAM;+59:W/:.A#]*QJF
M,[>=*<62WYV$F2:0)J5)F::]_:S8(GAJ6]06H?WW5S+&!CV,0VZ_!!O.69_=
MM736\=F&%C_+)2$,_,[2O#P?+!E;O1^-RFA),ER^HRN2\U\6M,@PXZ?%XZA<
M%03'%2E+1\BRO%&&DWPP/JN^FQ?C,[IF:9*3>0'*=9;AXL\%2>GF?  'NR^^
M)H]+)KX8C<]6^)'<$_9]-2_XV:B)$B<9R<N$YJ @B_/!!_C^#@6"4"'^3<BF
MW#L&(I4'2G^*DYOX?& )120E$1,A,/]X(I<D344DKN-7'7307%,0]X]WT:^J
MY'DR#[@DES3]D<1L>3X(!B F"[Q.V5>ZN29U0JZ(%]&TK/Z"38VU!B!:EXQF
M-9DKR))\^XE_UX78(T#;0$ U <D$UT"P:X(M$WP#P:D)3E]);DUP)0(R7<&K
M"9Y," T$OR;X?:\0U(1 (CC00 AK0B@33$E#:]<Y2Z+8)E&P:;;<;=<D"^[:
M#>5^NT9ANX9#I>.!B;)K.:QZ/MK>OM6]/\$,C\\*N@&%P/-XXJ!:0!6?W_))
M+M;Z/2OXKPGGL?$ES4N:)C%F) ;WC'_PA<Q*0!?\C$8_ES2-25'^ Z:_U@G[
M UY/R"*)$O8&#,'W^PEX_>H-> 62''Q;TG6)\[@\&S&N2T0?1;6&BZT&9-#P
MC3*<:FB7W;0/X!NX!5<X2E*N3,.?=//GZX<TB<"7Q8(42?ZH$S[MCG!)LXSO
M5U6A-.RK_NRCN7SL'ZM'7M='*AO'B=B)<0KF.(F'O+V7>)7HNW1S:JRC.7\Z
M-7*/"LR.Q(ZB=;9.JU7QA2U) 7B%N9DNA<L]$?"9EKJHGU\>]6A5;E]^C1[U
MN>N^RE?"^!S!+S'%1:Z&&/%=J-F*4+,5H2JF8XAY01Z37 3CYIWB/"( ,S A
MT3M@P[< 63#4;2W;F'X54PPV3^,@#!WG;/2TOXY5%)0@UQJ(9[O(.X3-5)AU
MB+A3$4/?=L,VT$%U[*8Z]O.J\Q:42UR0LD^5IMO8WGYRMA\$88#TJIQ&E=.I
MZJ8LUU6KN%]$VSVH-.R&$T<ML.M[@52^CRI,:L$G?2!?:NBM"K/TR;I-LNY)
MR>XZH=NV7:7PGN4CRS%(\1HIWDE2P'K%#\EO4D1)6?VZ_9JNQ$ZI]69/48A\
M**V-'IB9BC'DZ#<Y^G\CQXYN3'VU&[;M&59FT.@,7J!S>C^?@]6ZB);\B417
M_T"S-.6]J0=FIF(,]0^;O,+_*Z^WX-Y8\U#1Y2/?L.U JQU;K=/$;7!1X)R)
MD32B>5X_4FX2M@2,%!E(*<[!PFRO%_6%#V\2N2%]0#,-R- 2N#>NP\Z\JPEO
M*)YN8Y$W?^0OL<A0FPE4KF\'EB^GT@<UTZ!,N;1^#[L-O^GAEP78'V#!CVT/
M2W##1[JVB3]$$R?D@8&K).=$;H;:R0[UEMJ:+^QVWSO"^)VCG?DNH&JN0R=T
MPE NH8J31X?CH0[UMS8-NWUZ.PE&!Y.@,1]'%0$M.9ENT*',UF!AM\-.\]@\
M_R%+JU9U6 X-/<F>IC7./\#)2T&-92//<N094(-3*G2G!2';"EU#E5KOA]WF
M?U@EPQRHK=84JBX-P]"&GF?J7>O6\#2[UC[8^THS;!1("^:F%^JS!F7*I75T
M>)JE=\P65U!CTH'G.H;I K8V#%_BP\^:]:!JQDZ@&$(/T$P#,E0=M9Z.3O3T
MTP<^I%HP# (4&)J"6A]&W3[\PJ$/J78*Y8?6ZSZ@F09D:L3>@WA/8W[9Y(=4
M(X:6#PVS'VK-&'6;\=^;_9#JOZ[\7'G=!S33@$QM:4T<=9OX<V8_I/ISX/F!
MG$H?U$R#,N72.CWJ=OJN@0IIG#.T($*R+A6G_"_F:*A#_:T'HVX/?LY A533
M';K*#=,-.I39FC+J-N7N@0IJU:I^"I$;NI(#3#4X9:#28&P[1%"YPU3<T'/D
M7FI "-H(^H8JM7:/NNV^WT"EJ]84J:Z/+!N*?_%(JD9[+VG$:]1;7#PF>0E2
MLN!4ZYW/;]5B^V9R>\+HJGIO\T 9HUEUN"0X)H4 \-\7E++=B7@5U+P?'O\'
M4$L#!!0    ( *R+>%3M&?$9=P(  /P%   8    >&PO=V]R:W-H965T<R]S
M:&5E=#8N>&ULK51=3]LP%/TK5]&D@<3(1S] *(U$"VA[0*LH;,]N<M-8.':Q
MG1;^_:Z=-.L8K?:PE]C7ON?X'-_XIENEGTV%:.&U%M),@LK:]548FKS"FIES
MM49).Z72-;,4ZE5HUAI9X4&U"),H&H<UXS+(4K\VUUFJ&BNXQ+D&T]0UTV]3
M%&H[">)@M_# 5Y5U"V&6KMD*%VB?UG--4=BS%+Q&:;B2H+&<!-?QU6SL\GW"
M#XY;LS<'YV2IU+,+OA63('*"4&!N'0.C88,S%,(1D8R7CC/HCW3 _?F._<Y[
M)R]+9G"FQ$]>V&H27 908,D:81_4]BMV?D:.+U?"^"]LN]PH@+PQ5M4=F!34
M7+8C>^WN80\0CP\ D@Z0O <,#P &'6#@C;;*O*T;9EF6:K4%[;*)S4W\W7@T
MN>'257%A->URPMELIJ11@A?,8@$+2P.5R!I0)44J?ZZ4*%";SW#[TG#[!B=S
MIBFA0LMS)D[A"Q##!K7E2X$PIQJ@UHZJHCQ#VT^+&SCY= J?@$MXK%1CF"Q,
M&EH2[R2$>2=TV@I-#@B-$[A7=+"!6UE@\2=!2*Y[Z\G.^C0YRGB#^3D,XC-(
MHB3^0-#LW^'1$3F#OA(#SS<\P'<-CW /=RSG@B[Z".&P)QP>)7S$>JTT/4U
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MR0V3^*9O._[AX:+M^W;#+]<6);&G!_#]LD5AK&_H@/1+U-?_ E!+ P04
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M&FRT;EKCRP;*.N!^):49%S; ]%:N?@%02P,$%     @ K(MX5( L1GZQ!@
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M4IRRP%$&$4>/:*7S2ML)[6YN$,#QWT%KTH$D'7P%E0IMC<'X=MTK*$%9[FP
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M]A-4^8W%*2B#\J+Z.:TI*V.Y)4OHF[5P)8HK45WQ7#:%0=G8<.PR/SCXG%*
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M<[KVEPO!D1S:@.=SK=WFA@QL/Y-=_Q=02P,$%     @ K(MX5 RR]<[1 @
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M*]EF?F2;RWGQLVW:M2_>-I6NA@#.@7-"?!X1?S6?A/A&EV?%P\M9,;^87T[
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MVV%95?S>4C]-S?T7/LV;]YWD^70O^).FJ=C!U^W.-I;B_Z/MY6F0Q\H3T_M
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M)D4US[!>"BM0P!D"'_.?U./_ZPR^OI7OR&#H.CW7?SF#<$$) O*3"-7=>MA
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;(U4WV_3,!!^[U]QBG@
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MRE+?^\^2'EK4;@+E"Z7L/G +]$_W_!]02P,$%     @ K(MX5+:F<&65!
M@@H  !D   !X;"]W;W)K<VAE971S+W-H965T,C,N>&ULE59;;]LV%'[GKR"\
M94@ 699H2Y8RQX"=IET>L@9.VF(8]D!+QS81271)VD[VZW=(R4K2Q4;Z(EYT
MSL?O7,G13JH'O0(P]+$L*GW161FS/N_U=+:"DFM?KJ'"/PNI2FYPJ98]O5;
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ML >/*W[H\W]"QJX;8R#Z<_*V!0/YD?S\0QJQZ%<8#1DC9P0Q+,@P@B$C0(%
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M]VWURJT$R[5+S;(XB(%(&N1B(*+F\S-W-*RW\&@XZ ];"*RDR;5KTT(*G])
MH944<99)TY8>( X?TC"9PODJ-R!(5"H4,.6+E.M<V\ <X""YC4KE[FI0K]>Z
M_Y4$N78-6L)G+^/K6G244+G]PC%LFF???"NM:6-AVOWWCASG3]M>5]KF>J]
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MNHDBV)YZ#K&($AAX$FCH KOQTDQ@PQ>VUM!GCRD'>J<)"IU04)225<B[ F?
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MLQF7I8#^_DD(]?VB?.%L^X+AQ;]02P,$%     @ K(MX5$^RJBN5 @  /08
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M90/,?BXE[2?V">G^,29_ 5!+ P04    " "LBWA4J_:SXYD"  "M!@  &0
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M((R!_K[A7!TGIF5U?ZCT'U!+ P04    " "LBWA4S<*GU;@"  !)!P  &0
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M]>X< 4G*8JWYRDB/LR0GZ0I1+:<B):LR1$I7*;,?:5AP96P=X%-TTDB1]NR
M@@9H5]T6JZP"PN#UF9N5<09O;>"4]ZT!2I\]@I]"\,-W$L=TA48D?48GU8#'
M[Z/&S0)!400"C')P/6B-5):1W\K-G&<+IC8!.!6=L/>P4J$66#$C).IFA)H6
MMF5RO5Z33&XSH]4B3MCN/*.N>4:=\VQD_9Q(R)00]G CH^ID%2!,Q8R457HC
M6YLIJM,3?EO.&7Q8DGVI*><\*Y[FJ%DOH;S@HB#@7Y4[:4DEVM_T!58M=5J9
MS'/+T)@-#?M@[1W8_?5>TL),V:36,,HX,*W*)$56$9U!:FO873J#?  &B8M(
M$8@HID*":0Q2:(7@SQIP$[[:!N"'E_7(QF7E?O?LD]!%1ZSZ'06D&213#K:N
MMI<#&2LUAY2E/.$KR/X<:A4E@U4,P-U+PKFR2K/#;,9TW;V@,'9!4_A!Z-0A
ML<AJ?ZABA[-P\[:^[4@R>MBU"^(_2VN$BA_$,IP#?<,<"9SQ")80/J/_H[W5
MZJ@"'S8DL.==8*]= KM& [MV$5Q9I9*(APPL@@0**9AB2NA6<TK4BX8Y[D7?
MQ>WF8*.CL7.@.3GC99<D:B\]1QU(^IP^/_W7+[]@QW-;VPIV@-^*5/<5- (.
M;.T/H^*Q73-KW<.$VL>A"KY0?9XGGHE6)U=@S;)GZ#B;I=&XXZ9-0XT"QW8%
MOM9/8:F?S&E:Z0Y%"E/-%FH7AR2'&UJ+\E$U43-QW<#9:Z&1\]BSE[P\"RF-
M1"E0!(FUO36??H##YX.^*LK#5;, _5&TFSFI9FNZ\<QBIBD*L%V('U8&CRJ4
MII?\O9,;Y8Y?H]QA4]]#[. (T-_NTKP G5%7+1.F3FT@Q >RZA#ZV A]?!2A
MCXW0QW:U]9DPCA8D+G3X*\97CBZ2O#H&HFIA[8X_VXG[/K<;IL=VIM]Q.TBK
MHB2SKS2<I^Q'04_1']H^] !\J_;0?1;1N#U$NA_W6?7C[M;]N"\[I+AIJ^%_
M?'&, 'F&T3T[C>H )8U%,;6HME!40*K38F+1=]QA>SP\P[J>G77?.AX/^HC\
MOJ<7N6FD85P/'R40C9ZQG3!?$0BO+1 7Y_L"8<C0LY/A6P>BYBXEYVU.,HSI
M!4>)@B%$S][T?444_G'WV#,LZG6T2[8# \Z',J>#93S#B-[Y4=QJ:,RSR]A2
M6-43G*IGG*KBT<]X596_()SI.FO/DXQ)QP1N1UO<-X3HVPEQ]U#N[$/[ANI\
M]RA/A@Q-^3\E#$_5HU/=LSU,%5:S;'3T]\LMWY"<;R>Y7><>WDKV&\_'_*-X
MV="0;Q=N.^G<]2!NT@'H]['U29QO",RW\\Z.A__0C<^;%FF[.8,A(__L*-XU
M;.1W/9IZ114V]G<K;[PW40UA^78^V7%C6^?+]NC4\$UPE$=3@>&<H$->O0TE
M5+-L^7FGW@UVZUW7V<L<@2&VP$YL_Z@],PYVJUP+GP6&SP([G_U<>V9<H3;;
M,QCWG3T"+C#$%]@%W->Z_T:2K "[=+^RC8\JH(TP!7O]T7@1P,YCXZU^1$)D
MV3G?TR6:=. ]TKR/W*K'X]NV@R'(X)4$V=9KMLUDB#(X"E$&ABB#CD+VC7;V
M[N/[H&5C=]RUN09#M,%!#<Z?;+M6X!O=*]?;>?-@T'A/+*'\2;^@IQZ7P!XI
M7^NIK]8O =[H5]^VKH_<CV.WY?K$_7A;ON)GX,LW#N\)?U)]\)C.8"KUQDT/
M\?(EOO*+S'+]EMHTDS)+],<YB&+*U0WP^RS+Y/J+FJ!^E?+Z;U!+ P04
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M--C-W#3#'PY0U@#?SZ4TVX4]H/J%Z?T#4$L#!!0    ( *R+>%1@JI>*9 ,
M /<,   9    >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;,U7VV[;.!#]%4)
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M- 9Z/Q$"=Q/CH&G]IG\!4$L#!!0    ( *R+>%0AU/\@P@(  'X(   9
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M">#WC5+V^<4YJ&^/RW\!4$L#!!0    ( *R+>%1U*TJ&Z@(  & )   9
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M* MJ6KY$,.5^T;J,#3R4K)06>0DV"G+*BR?9E$;L 7!\ A"6@/ 0T#@!B$J
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M@Q0FT^1!))#\:L#'D+1Q"5_BL@RO6EQ#?$<&]"T)@Y#V %K]N7IP!<Z@3=/
MV1O\-DUDS76<2UTI(%_O=]HHO G?KK@8MBZ&SL7PN@N#+G9-=G&CK PDA!FB
MV_PJS&)OCFK[D;-OV\=A02?1*)KYA]/ G4M-PLFH%?H%^ZC%/KJ*?94QL0=;
M1 >65W7!LAQ;%!,Q]$&MS8U/0+P+ TII!VN/&*53.NQ'.V[1CJ^BQ?Z#W46X
M0)*$XQ51( QG>1_2<0^$:0?FN0P=1[0?9-2"C/XPI(]:,<@)M%?9EDB-O7*7
MW&2 =4ZGV-9QGC#!?[H,]+&)>N+>(7,N,AY&_5PF+9?)52X;T,!4G!'L+MCC
M#SB\2AQ%6. *$F[T6R)P8&*'J[!<%'8GX3B64O-+1";G(1\,NN5S+C2A%RI]
MVE*97J7R$8.M^@!-SP%-NWC.94:C"WAH\#I @O_9-WK[=W#>'(;=UM C-)IV
M\/DGLZX M7=/ (VMJA*F;N_M;OO,N'?#M;._M,\/-T-?S=1OEP],[;G0)(<4
M309W$;8!53\'ZH61I9NH.VEP/KO/#)]0H*P GJ=2FI>%== ^RA;_ 5!+ P04
M    " "LBWA4)KXP;#0#  !B"P  &0   'AL+W=O<FMS:&5E=',O<VAE970T
M-BYX;6S-5MM.XS 0_14K3[O2+KFU:8O:2E! BP1+1<7RL-H'DTP;"\<.MM/"
MW^_8"6FY9=$^]:7Q;<Z<F3.U9[R1ZE[G (8\%ESHB9<;4Q[ZODYS**@^D"4(
MW%E*55"#4[7R=:F 9LZHX'X4!(E?4":\Z=BMS=5T+"O#F8"Y(KHJ"JJ>CH'+
MS<0+O>>%:[;*C5WPI^.2KF !YJ:<*YSY+4K&"A":24$4+"?>47@X"V-KX$[\
M8K#1.V-B0[F3\MY.SK.)%UA&P"$U%H+B9PTSX-PB(8^'!M1K?5K#W?$S^ID+
M'H.YHQIFDM^RS.03;^B1#):TXN9:;GY $U#?XJ62:_=+-LW9P"-II8TL&F-D
M4#!1?^ECDX@=@S#YP"!J#*+7!KT/#.+&P&7.KYFYL$ZHH=.QDANB[&E$LP.7
M&V>-T3!A95P8A;L,[<ST)U;*A=2:S$&114X5D.]D@<6251R(7)*KRFA#1<;$
MBLRE 6$8Y?R)G#!>607( M)*,<- D]/'E%<99.1,R8+,*$\K3IU:".0,<*_U
M^.4$#&5<?T6/VGK68]]@2):8GS;TCVOZT0?TPXA<2F%R]"W0\4L 'W/1)B1Z
M3LAQU(EX ND!B<-O) JB\!U"L\^;!QUTXE:?V.'%'^ =8;ZS?Z=:%F5EZE1?
M+<DI50+UVA7U]P4"DW,#A?[30:O7TNHY6KW/T$IE4:!CK-7TGL!#Q=:48YUH
M L\DEY9D^K(>LJ8>!-8#M_50(EE7!^^504TG<73LU;2>1OU!.!KVQ_YZ5YVW
MY\+A:!B/MN=>Q-MOX^UWQKMPL5V5EKPF1I)YI=(<KP^;>AN\.]"1V*1UE.R3
MWH.6UF"_]!Z\U;L7)$DR?*7WVW.=>@_;>(>=\=Z(-6C+]AH_BJ5V6-? C6!&
M=V1TU'H8[9/08;!]$(+]DKKA\T+#((E'O?<E#'>>MK SDENJ%+5D_^/_&D9;
M+]%>";E].<)XSX2,WPC9'XZB^)6._DZW4H!:N29.(\-*F/J=;E?;1O'(M4>O
MUH]M ^FZH"U,W7U>4K5B>%%S6")D<## VUW5#5T],;)T/=&=--AAN6&.33 H
M>P#WEQ);G69B';1M]?0O4$L#!!0    ( *R+>%3NON^_* ,  ! 3   -
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M:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " "LBWA42PY%U>(#   3'P
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M.@C[.:M.RF-?=J:\K9OM.]WM^^AWOP%02P,$%     @ K(MX5/TLU:6N 0
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MR7$'DN,>) <?HP1!(2I'02I'82I'@2I'H2I'P2I'X2I' 2M'(:M (:M (:M
M(:M (:M (:M (:M (:M (:M (:M (:M$(:M$(:M$(:M$(:M$(:M$(:M$(:M$
M(:M$(:M$(6N"0M8$A:P)"ED3%+(F*&1-4,B:_"=9W[5>_?7_IG:-:U4V1W_6
M_=2;?P)02P$"% ,4    " "LBWA4!T%-8H$   "Q    $
M@ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( *R+>%1(6#9/[P
M "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4
M Q0    ( *R+>%297)PC$ 8  )PG   3              "  <T!  !X;"]T
M:&5M92]T:&5M93$N>&UL4$L! A0#%     @ K(MX5*A)@%]"!P  7AT  !@
M             ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4
M Q0    ( *R+>%2K\]GP8P4  "D5   8              " @88/  !X;"]W
M;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " "LBWA4/>P?S;X"  !'
M"0  &               @($?%0  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL
M4$L! A0#%     @ K(MX5,F;"7Q*!   =0X  !@              ("!$Q@
M 'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( *R+>%3-0:-S
M!08  "L>   8              " @9,<  !X;"]W;W)K<VAE971S+W-H965T
M-2YX;6Q02P$"% ,4    " "LBWA4[1GQ&7<"  #\!0  &
M@('.(@  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ K(MX
M5)=$:3SC!@  "1T  !@              ("!>R4  'AL+W=O<FMS:&5E=',O
M<VAE970W+GAM;%!+ 0(4 Q0    ( *R+>%03?^+C00<  ((1   8
M      " @90L  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4
M" "LBWA4_4@&%B,4  "5.@  &               @($+-   >&PO=V]R:W-H
M965T<R]S:&5E=#DN>&UL4$L! A0#%     @ K(MX5)P[N!:9!   6PX  !D
M             ("!9$@  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"
M% ,4    " "LBWA4./" D $#   W!P  &0              @($T30  >&PO
M=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( *R+>%2 +$9^L08
M *D/   9              " @6Q0  !X;"]W;W)K<VAE971S+W-H965T,3(N
M>&UL4$L! A0#%     @ K(MX5$-H,+Q+"0  G!@  !D              ("!
M5%<  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " "LBWA4
M6!/]]J<'  "Y$P  &0              @('68   >&PO=V]R:W-H965T<R]S
M:&5E=#$T+GAM;%!+ 0(4 Q0    ( *R+>%2E]3<N?P<  #(3   9
M      " @;1H  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%
M  @ K(MX5 RR]<[1 @  #@8  !D              ("!:G   'AL+W=O<FMS
M:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " "LBWA4C"<KY.\!  !;!
M&0              @(%R<P  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+
M 0(4 Q0    ( *R+>%3+Y[E"N!4  ,5%   9              " @9AU  !X
M;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ K(MX5+6RH'C<
M!   0P\  !D              ("!AXL  'AL+W=O<FMS:&5E=',O<VAE970Q
M.2YX;6Q02P$"% ,4    " "LBWA4C(*JSQD#  "-!P  &0
M@(&:D   >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( *R+
M>%1CTU$15 (   $%   9              " @>J3  !X;"]W;W)K<VAE971S
M+W-H965T,C$N>&UL4$L! A0#%     @ K(MX5&YPJQRS @  Q@4  !D
M         ("!=98  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4
M    " "LBWA4MJ9P994$  """@  &0              @(%?F0  >&PO=V]R
M:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( *R+>%1*BI%G904  ,4-
M   9              " @2N>  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL
M4$L! A0#%     @ K(MX5(CH\T?\ @  5 8  !D              ("!QZ,
M 'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " "LBWA4F9P(
M0A\%  #Z%   &0              @('ZI@  >&PO=V]R:W-H965T<R]S:&5E
M=#(V+GAM;%!+ 0(4 Q0    ( *R+>%2C:=!O#P,  )X)   9
M  " @5"L  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @
MK(MX5+D6;AUC!@  ;"@  !D              ("!EJ\  'AL+W=O<FMS:&5E
M=',O<VAE970R."YX;6Q02P$"% ,4    " "LBWA43[*J*Y4"   ]!@  &0
M            @($PM@  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4
M Q0    ( *R+>%2K]K/CF0(  *T&   9              " @?RX  !X;"]W
M;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ K(MX5,W"I]6X @
M20<  !D              ("!S+L  'AL+W=O<FMS:&5E=',O<VAE970S,2YX
M;6Q02P$"% ,4    " "LBWA4@%^G6YT%  #!%@  &0              @(&[
MO@  >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( *R+>%2>
M7XW35@(  "T%   9              " @8_$  !X;"]W;W)K<VAE971S+W-H
M965T,S,N>&UL4$L! A0#%     @ K(MX5+)Y5IEY"0  5BD  !D
M     ("!',<  'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *R+>%3X<KZAB00  ,01   9              "
M@3WB  !X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ K(MX
M5"[!>A;2 @  !@H  !D              ("!_>8  'AL+W=O<FMS:&5E=',O
M<VAE970T,"YX;6Q02P$"% ,4    " "LBWA4(=3_(,("  !^"   &0
M        @($&Z@  >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0
M   ( *R+>%1VQ@%J8@,  "\+   9              " @?_L  !X;"]W;W)K
M<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ K(MX5#?*J(,=!   20X
M !D              ("!F/   'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q0
M2P$"% ,4    " "LBWA4=2M*ANH"  !@"0  &0              @('L]
M>&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( *R+>%2B ]'%
M;P,  * )   9              " @0WX  !X;"]W;W)K<VAE971S+W-H965T
M-#4N>&UL4$L! A0#%     @ K(MX5":^,&PT P  8@L  !D
M ("!L_L  'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    " "L
MBWA4[K[OOR@#   0$P  #0              @ $>_P  >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( *R+>%27BKL<P    !,"   +              "  7$"
M 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( *R+>%1+#D75X@,  !,?   /
M          "  5H# 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "LBWA4
M_2S5I:X!  #!&P  &@              @ %I!P$ >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'-02P$"% ,4    " "LBWA4)OJ'I[4!  #<&P  $P
M        @ %/"0$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     -@ V +$.
(   U"P$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>145</ContextCount>
  <ElementCount>294</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>60</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100020 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100040 - Statement - Consolidated Statements of Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100050 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100060 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100070 - Disclosure - Organization and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentation</Role>
      <ShortName>Organization and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>100080 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>100090 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>100100 - Disclosure - Consolidated Balance Sheet Components</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponents</Role>
      <ShortName>Consolidated Balance Sheet Components</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>100110 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>100120 - Disclosure - Term Loan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoan</Role>
      <ShortName>Term Loan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>100130 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>100140 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>100150 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>100160 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureSubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>100170 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>100180 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurements</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>100190 - Disclosure - Consolidated Balance Sheet Components (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsTables</Role>
      <ShortName>Consolidated Balance Sheet Components (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponents</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>100200 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>100210 - Disclosure - Term Loan (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanTables</Role>
      <ShortName>Term Loan (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoan</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>100220 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensation</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>100230 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxes</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>100240 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShare</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>100250 - Disclosure - Organization and Basis of Presentation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails</Role>
      <ShortName>Organization and Basis of Presentation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>100260 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>100270 - Disclosure - Fair Value Measurements - Summary of Financial Assets Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Summary of Financial Assets Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>100280 - Disclosure - Fair Value Measurements - Schedule of Contractual Maturities of Cash Equivalents and Available-for-Sale Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Contractual Maturities of Cash Equivalents and Available-for-Sale Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>100290 - Disclosure - Consolidated Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails</Role>
      <ShortName>Consolidated Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>100300 - Disclosure - Consolidated Balance Sheet Components - Schedule of Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails</Role>
      <ShortName>Consolidated Balance Sheet Components - Schedule of Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>100310 - Disclosure - Commitments and Contingencies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>100320 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails</Role>
      <ShortName>Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>100330 - Disclosure - Term Loan - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails</Role>
      <ShortName>Term Loan - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>100340 - Disclosure - Term Loan - Schedule of Repayment of Principal Amount (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails</Role>
      <ShortName>Term Loan - Schedule of Repayment of Principal Amount (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>100350 - Disclosure - Stock-Based Compensation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails</Role>
      <ShortName>Stock-Based Compensation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>100360 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Stock-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>100370 - Disclosure - Stock-Based Compensation - Summary of Estimated Fair Value of Stock Options Granted Using Black-Scholes Option-Pricing Model (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Estimated Fair Value of Stock Options Granted Using Black-Scholes Option-Pricing Model (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>100380 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>100390 - Disclosure - Income Taxes - Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails</Role>
      <ShortName>Income Taxes - Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>100400 - Disclosure - Income Taxes - Summary of Income Tax Benefit (Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails</Role>
      <ShortName>Income Taxes - Summary of Income Tax Benefit (Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>100410 - Disclosure - Income Taxes - Summary of Components of Deferred Tax Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails</Role>
      <ShortName>Income Taxes - Summary of Components of Deferred Tax Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>100420 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>100430 - Disclosure - Income Taxes - Summary of Loss from Operations Before Taxes on Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails</Role>
      <ShortName>Income Taxes - Summary of Loss from Operations Before Taxes on Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>100440 - Disclosure - Income Taxes - Summary of Reconciliation of Income Tax Benefit (Expense) Statutory Tax Rate to Effective Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails</Role>
      <ShortName>Income Taxes - Summary of Reconciliation of Income Tax Benefit (Expense) Statutory Tax Rate to Effective Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="etnb-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>100450 - Disclosure - Net Loss Per Share - Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails</Role>
      <ShortName>Net Loss Per Share - Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="etnb-10k_20211231.htm">etnb-10k_20211231.htm</File>
    <File>etnb-20211231.xsd</File>
    <File>etnb-20211231_cal.xml</File>
    <File>etnb-20211231_def.xml</File>
    <File>etnb-20211231_lab.xml</File>
    <File>etnb-20211231_pre.xml</File>
    <File>etnb-ex231_7.htm</File>
    <File>etnb-ex311_9.htm</File>
    <File>etnb-ex312_6.htm</File>
    <File>etnb-ex321_10.htm</File>
    <File>etnb-ex43_8.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>gb2k1ptlkg5v000001.jpg</File>
    <File>gb2k1ptlkg5v000002.jpg</File>
    <File>gb2k1ptlkg5v000003.jpg</File>
    <File>gb2k1ptlkg5v000004.jpg</File>
    <File>gb2k1ptlkg5v000005.jpg</File>
    <File>gb2k1ptlkg5v000006.jpg</File>
    <File>gb2k1ptlkg5v000007.jpg</File>
    <File>gb2k1ptlkg5v000008.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="498">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="40">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>73
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "etnb-10k_20211231.htm": {
   "axisCustom": 0,
   "axisStandard": 22,
   "contextCount": 145,
   "dts": {
    "calculationLink": {
     "local": [
      "etnb-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "etnb-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "etnb-10k_20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "etnb-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "etnb-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "etnb-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 457,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 24,
    "http://www.89bio.com/20211231": 2,
    "http://xbrl.sec.gov/dei/2021q4": 5,
    "total": 31
   },
   "keyCustom": 42,
   "keyStandard": 252,
   "memberCustom": 21,
   "memberStandard": 39,
   "nsprefix": "etnb",
   "nsuri": "http://www.89bio.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100090 - Disclosure - Fair Value Measurements",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100100 - Disclosure - Consolidated Balance Sheet Components",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponents",
     "shortName": "Consolidated Balance Sheet Components",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100110 - Disclosure - Commitments and Contingencies",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100120 - Disclosure - Term Loan",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoan",
     "shortName": "Term Loan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100130 - Disclosure - Stock-Based Compensation",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100140 - Disclosure - Income Taxes",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100150 - Disclosure - Net Loss Per Share",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShare",
     "shortName": "Net Loss Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100160 - Disclosure - Subsequent Events",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureSubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100170 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100180 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010 - Statement - Consolidated Balance Sheets",
     "role": "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20211231",
      "decimals": "-3",
      "lang": null,
      "name": "etnb:ShortTermAvailableForSaleSecuritiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "etnb:ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100190 - Disclosure - Consolidated Balance Sheet Components (Tables)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsTables",
     "shortName": "Consolidated Balance Sheet Components (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "etnb:ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100200 - Disclosure - Commitments and Contingencies (Tables)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables",
     "shortName": "Commitments and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100210 - Disclosure - Term Loan (Tables)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanTables",
     "shortName": "Term Loan (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100220 - Disclosure - Stock-Based Compensation (Tables)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "etnb:ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100230 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "etnb:ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100240 - Disclosure - Net Loss Per Share (Tables)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareTables",
     "shortName": "Net Loss Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20211231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100250 - Disclosure - Organization and Basis of Presentation - Additional Information (Details)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
     "shortName": "Organization and Basis of Presentation - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210301_20210331",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_etnbSegment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100260 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_etnbSegment",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100270 - Disclosure - Fair Value Measurements - Summary of Financial Assets Measured at Fair Value on Recurring Basis (Details)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails",
     "shortName": "Fair Value Measurements - Summary of Financial Assets Measured at Fair Value on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100280 - Disclosure - Fair Value Measurements - Schedule of Contractual Maturities of Cash Equivalents and Available-for-Sale Securities (Details)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails",
     "shortName": "Fair Value Measurements - Schedule of Contractual Maturities of Cash Equivalents and Available-for-Sale Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "etnb:ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "etnb:PrepaidResearchAndDevelopmentCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100290 - Disclosure - Consolidated Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails",
     "shortName": "Consolidated Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "etnb:ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "etnb:PrepaidResearchAndDevelopmentCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "etnb:AccruedResearchAndDevelopmentExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100300 - Disclosure - Consolidated Balance Sheet Components - Schedule of Accrued Expenses (Details)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails",
     "shortName": "Consolidated Balance Sheet Components - Schedule of Accrued Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "etnb:AccruedResearchAndDevelopmentExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20180501_20180531",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DescriptionOfLesseeLeasingArrangementsOperatingLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100310 - Disclosure - Commitments and Contingencies - Additional Information (Details)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
     "shortName": "Commitments and Contingencies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20180501_20180531",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DescriptionOfLesseeLeasingArrangementsOperatingLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100320 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations (Details)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails",
     "shortName": "Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20200401_20200430",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100330 - Disclosure - Term Loan - Additional Information (Details)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails",
     "shortName": "Term Loan - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20200401_20200430",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100340 - Disclosure - Term Loan - Schedule of Repayment of Principal Amount (Details)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails",
     "shortName": "Term Loan - Schedule of Repayment of Principal Amount (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100350 - Disclosure - Stock-Based Compensation - Additional Information (Details)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
     "shortName": "Stock-Based Compensation - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_srtTitleOfIndividualAxis_us-gaapShareBasedPaymentArrangementEmployeeMember_us-gaapAwardTypeAxis_etnbServiceBasedRSUsMember_20210201_20210228",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100360 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation (Details)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails",
     "shortName": "Stock-Based Compensation - Summary of Stock-Based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20210101_20211231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20200401_20200430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100370 - Disclosure - Stock-Based Compensation - Summary of Estimated Fair Value of Stock Options Granted Using Black-Scholes Option-Pricing Model (Details)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails",
     "shortName": "Stock-Based Compensation - Summary of Estimated Fair Value of Stock Options Granted Using Black-Scholes Option-Pricing Model (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100380 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails",
     "shortName": "Stock-Based Compensation - Summary of Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss",
     "role": "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
     "shortName": "Consolidated Statements of Operations and Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "etnb:ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100390 - Disclosure - Income Taxes - Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries (Details)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails",
     "shortName": "Income Taxes - Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "etnb:ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100400 - Disclosure - Income Taxes - Summary of Income Tax Benefit (Expense) (Details)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails",
     "shortName": "Income Taxes - Summary of Income Tax Benefit (Expense) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100410 - Disclosure - Income Taxes - Summary of Components of Deferred Tax Assets (Details)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails",
     "shortName": "Income Taxes - Summary of Components of Deferred Tax Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100420 - Disclosure - Income Taxes - Additional Information (Details)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
     "shortName": "Income Taxes - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100430 - Disclosure - Income Taxes - Summary of Loss from Operations Before Taxes on Income (Details)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails",
     "shortName": "Income Taxes - Summary of Loss from Operations Before Taxes on Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_srtStatementGeographicalAxis_countryUS_20210101_20211231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100440 - Disclosure - Income Taxes - Summary of Reconciliation of Income Tax Benefit (Expense) Statutory Tax Rate to Effective Tax Rate (Details)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails",
     "shortName": "Income Taxes - Summary of Reconciliation of Income Tax Benefit (Expense) Statutory Tax Rate to Effective Tax Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100450 - Disclosure - Net Loss Per Share - Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss (Details)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails",
     "shortName": "Net Loss Per Share - Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040 - Statement - Consolidated Statements of Stockholders' Equity (Deficit)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit",
     "shortName": "Consolidated Statements of Stockholders' Equity (Deficit)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_us-gaapStatementClassOfStockAxis_etnbConvertiblePreferredSharesMember_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "etnb:TemporaryEquityIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)",
     "role": "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical",
     "shortName": "Consolidated Statements of Stockholders' Equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_us-gaapStatementClassOfStockAxis_etnbConvertiblePreferredSharesMember_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "etnb:TemporaryEquityIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100070 - Disclosure - Organization and Basis of Presentation",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentation",
     "shortName": "Organization and Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100080 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "etnb-10k_20211231.htm",
      "contextRef": "C_0001785173_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 60,
   "tag": {
    "country_IL": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ISRAEL",
        "terseLabel": "Israel"
       }
      }
     },
     "localname": "IL",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_LT": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LITHUANIA",
        "terseLabel": "LITHUANIA"
       }
      }
     },
     "localname": "LT",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r476",
      "r477",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm Id",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r476",
      "r477",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r476",
      "r477",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r476",
      "r477",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated By Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address Address Line2",
        "terseLabel": "Entity Address Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when an entity was incorporated",
        "label": "Entity Incorporation Date Of Incorporation",
        "terseLabel": "Date of incorporation"
       }
      }
     },
     "localname": "EntityIncorporationDateOfIncorporation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well Known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r476",
      "r477",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Icfr Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "etnb_ATMFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ATM facility.",
        "label": "A T M Facility [Member]",
        "terseLabel": "A T M Facility"
       }
      }
     },
     "localname": "ATMFacilityMember",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_AccruedResearchAndDevelopmentExpenseCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails": {
       "order": 10010.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued research and development expense current.",
        "label": "Accrued Research And Development Expense Current",
        "terseLabel": "Accrued research and development expenses"
       }
      }
     },
     "localname": "AccruedResearchAndDevelopmentExpenseCurrent",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued research and development expenses.",
        "label": "Accrued Research And Development Expenses Policy [Text Block]",
        "terseLabel": "Accrued Research and Development Expenses"
       }
      }
     },
     "localname": "AccruedResearchAndDevelopmentExpensesPolicyTextBlock",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "etnb_AccumulatedTaxLossCarryForward": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated tax loss carry forward.",
        "label": "Accumulated Tax Loss Carry Forward",
        "terseLabel": "Accumulated tax loss carryforward"
       }
      }
     },
     "localname": "AccumulatedTaxLossCarryForward",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_AgencyDiscountSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency discount securities.",
        "label": "Agency Discount Securities [Member]",
        "terseLabel": "Agency discount securities"
       }
      }
     },
     "localname": "AgencyDiscountSecuritiesMember",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10170.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of debt issuance costs and accretion of final payment fee.",
        "label": "Amortization Of Debt Issuance Costs And Accretion Of Final Payment Fee",
        "negatedLabel": "Amortization of debt issuance costs and accretion of final payment fee"
       }
      }
     },
     "localname": "AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset transfer and license agreements initial nonrefundable upfront payment.",
        "label": "Asset Transfer And License Agreement Initial Nonrefundable Upfront Payment",
        "terseLabel": "Nonrefundable upfront payment"
       }
      }
     },
     "localname": "AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset transfer and license agreement termination notice period if bankruptcy petition filed.",
        "label": "Asset Transfer And License Agreement Termination Notice Period If Bankruptcy Petition Filed",
        "terseLabel": "Asset transfer and license agreement termination notice period if bankruptcy petition filed"
       }
      }
     },
     "localname": "AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset transfer and license agreement termination period after written notice.",
        "label": "Asset Transfer And License Agreement Termination Period After Written Notice",
        "terseLabel": "Asset transfer and license agreement, termination period after written notice"
       }
      }
     },
     "localname": "AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset transfer and license agreement termination period notice of failure.",
        "label": "Asset Transfer And License Agreement Termination Period Notice Of Failure",
        "terseLabel": "Asset transfer and license agreement, termination period notice of breach"
       }
      }
     },
     "localname": "AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails": {
       "order": 10020.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available for sale securities debt maturities after one through two years fair value.",
        "label": "Available For Sale Securities Debt Maturities After One Through Two Years Fair Value",
        "terseLabel": "After one year through two years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_ConvertiblePreferredSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible preferred shares.",
        "label": "Convertible Preferred Shares [Member]",
        "terseLabel": "Convertible Preferred Shares"
       }
      }
     },
     "localname": "ConvertiblePreferredSharesMember",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_DeferredTaxAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10190.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets.",
        "label": "Deferred Tax Assets",
        "negatedLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssets",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets tax credit carryforwards research, federal.",
        "label": "Deferred Tax Assets Tax Credit Carryforwards Research Federal",
        "terseLabel": "Federal research and development credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_EightyNineBioLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "89Bio Ltd.",
        "label": "Eighty Nine Bio Ltd [Member]",
        "terseLabel": "89Bio Ltd"
       }
      }
     },
     "localname": "EightyNineBioLtdMember",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_EightyNineBioManagementIncorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eighty Nine Bio Management, Inc.",
        "label": "Eighty Nine Bio Management Incorporation [Member]",
        "terseLabel": "89bio Management, Inc."
       }
      }
     },
     "localname": "EightyNineBioManagementIncorporationMember",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_FairValueOfWarrantsAssumptionsDividends": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of warrant assumptions, dividends.",
        "label": "Fair Value Of Warrants Assumptions Dividends",
        "terseLabel": "Fair value of warrant assumptions, dividends"
       }
      }
     },
     "localname": "FairValueOfWarrantsAssumptionsDividends",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_IncomeTaxDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax.",
        "label": "Income Tax Disclosure [Line Items]",
        "terseLabel": "Income Tax Disclosure [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureLineItems",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "etnb_IncomeTaxDisclosureTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax.",
        "label": "Income Tax Disclosure [Table]",
        "terseLabel": "Income Tax Disclosure [Table]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTable",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails": {
       "order": 10040.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax reconciliation change in effective tax rate due to reorganization.",
        "label": "Income Tax Reconciliation Change In Effective Tax Rate Due To Reorganization",
        "terseLabel": "Change in Israel effective tax rate due to the 2019 reorganization"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock warrant in connection with term loan facility.",
        "label": "Issuance Of Common Stock Warrant In Connection With Term Loan Facility",
        "terseLabel": "Issuance of common stock warrant in connection with term loan facility"
       }
      }
     },
     "localname": "IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock warrant in connection with debt financing.",
        "label": "Issuance Of Common Stock Warrants In Connection With Debt Financing",
        "terseLabel": "Issuance Of Common Stock Warrants In Connection With Debt Financing"
       }
      }
     },
     "localname": "IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of credit facility increase in borrowing capacity.",
        "label": "Line Of Credit Facility Increase In Borrowing Capacity",
        "terseLabel": "Line of credit facility increase in borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityIncreaseInBorrowingCapacity",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_LoanAndSecurityAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan and security agreement.",
        "label": "Loan And Security Agreement [Member]",
        "terseLabel": "Loan Agreement"
       }
      }
     },
     "localname": "LoanAndSecurityAgreementMember",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_MilestonePayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone payment.",
        "label": "Milestone Payment",
        "terseLabel": "Milestone payments"
       }
      }
     },
     "localname": "MilestonePayment",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_NetCashProceedsFromSaleOfEquitySecurities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net cash proceeds from sale of equity securities.",
        "label": "Net Cash Proceeds From Sale Of Equity Securities",
        "terseLabel": "Proceeds from sale of available-for-sale securities, equity"
       }
      }
     },
     "localname": "NetCashProceedsFromSaleOfEquitySecurities",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issuable under share-based payment arrangement.",
        "label": "Number Of Shares Issuable Under Share Based Payment Arrangement",
        "verboseLabel": "Number of common shares issuable under the plan (in shares)"
       }
      }
     },
     "localname": "NumberOfSharesIssuableUnderShareBasedPaymentArrangement",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligation to payment upon maximum achievement of certain clinical and commercial milestones.",
        "label": "Obligation To Payment Upon Maximum Achievement Of Certain Clinical And Commercial Milestones",
        "terseLabel": "Payment upon achievement of certain clinical and commercial milestones"
       }
      }
     },
     "localname": "ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_OperatingLeaseMonthlyRentalPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease monthly rental payments.",
        "label": "Operating Lease Monthly Rental Payments",
        "terseLabel": "Operating lease, payments"
       }
      }
     },
     "localname": "OperatingLeaseMonthlyRentalPayments",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_OtherNonCurrentLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10110.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other non-current liability",
        "label": "Other Non Current Liability",
        "terseLabel": "Other non-current liability"
       }
      }
     },
     "localname": "OtherNonCurrentLiability",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_OtherRisksAndUncertaintiesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other risks and uncertainties.",
        "label": "Other Risks And Uncertainties Policy [Text Block]",
        "terseLabel": "Other Risks and Uncertainties"
       }
      }
     },
     "localname": "OtherRisksAndUncertaintiesPolicyTextBlock",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "etnb_PaymentForPurchaseOfAvailableForSaleSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10120.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment for purchases of available for sale securities.",
        "label": "Payment For Purchase Of Available For Sale Securities",
        "negatedLabel": "Purchases of available-for-sale securities"
       }
      }
     },
     "localname": "PaymentForPurchaseOfAvailableForSaleSecurities",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_PaymentsOfStockIssuanceCostsOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments of stock issuance costs, other.",
        "label": "Payments Of Stock Issuance Costs Other",
        "terseLabel": "Other offering expenses"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCostsOther",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_PercentageOfFeeOnLoan": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of fee on loan.",
        "label": "Percentage Of Fee On Loan",
        "terseLabel": "Percentage of fee on loan"
       }
      }
     },
     "localname": "PercentageOfFeeOnLoan",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of increase in number of shares of capital stock reserved for issuance.",
        "label": "Percentage Of Increase In Number Of Shares Of Capital Stock Issued And Outstanding",
        "terseLabel": "Percentage of increase in number of shares of capital stock issued and outstanding"
       }
      }
     },
     "localname": "PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "etnb_PerformanceRSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance RSUs.",
        "label": "Performance R S Us [Member]",
        "terseLabel": "Performance RSUs"
       }
      }
     },
     "localname": "PerformanceRSUsMember",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period for increase in number of shares of common stock reserved for issuance.",
        "label": "Period For Increase In Number Of Shares Of Common Stock Reserved For Issuance",
        "terseLabel": "Period for increase in number of shares of common stock reserved for issuance"
       }
      }
     },
     "localname": "PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "etnb_PrepaidResearchAndDevelopmentCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails": {
       "order": 10010.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and development expense prepaid current.",
        "label": "Prepaid Research And Development Current",
        "terseLabel": "Prepaid research and development"
       }
      }
     },
     "localname": "PrepaidResearchAndDevelopmentCurrent",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_ProceedsFromIssuancePublicOffering": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10070.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from issuance public offering.",
        "label": "Proceeds From Issuance Public Offering",
        "terseLabel": "Proceeds from issuance of common stock upon public offerings,net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuancePublicOffering",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_RestrictedCashAndOtherAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted cash and other assets member.",
        "label": "Restricted Cash And Other Assets [Member]",
        "terseLabel": "Restricted Cash And Other Assets Member"
       }
      }
     },
     "localname": "RestrictedCashAndOtherAssetsMember",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Svb leerink llc and cantor fitzgerald &amp; co.",
        "label": "S V B Leerink L L C And Cantor Fitzgerald Co [Member]",
        "terseLabel": "SVB Leerink LLC"
       }
      }
     },
     "localname": "SVBLeerinkLLCAndCantorFitzgeraldCoMember",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_SanFranciscoOfficeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "San Francisco office.",
        "label": "San Francisco Office [Member]",
        "terseLabel": "San Francisco Office"
       }
      }
     },
     "localname": "SanFranciscoOfficeMember",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of effective income tax rate of company and subsidiaries.",
        "label": "Schedule Of Effective Income Tax Rate Of Company And Subsidiaries Table [Text Block]",
        "terseLabel": "Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of prepaid and other current assets.",
        "label": "Schedule Of Prepaid And Other Current Assets Table [Text Block]",
        "terseLabel": "Schedule of Prepaid and Other Current Assets"
       }
      }
     },
     "localname": "ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "etnb_SellingCommissionPerSharesSoldPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Selling commission per shares sold percentage.",
        "label": "Selling Commission Per Shares Sold Percentage",
        "terseLabel": "Selling commission per shares sold percentage"
       }
      }
     },
     "localname": "SellingCommissionPerSharesSoldPercentage",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "etnb_ServiceBasedRSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service-based RSUs member.",
        "label": "Service Based R S Us [Member]",
        "terseLabel": "Service-based RSUs"
       }
      }
     },
     "localname": "ServiceBasedRSUsMember",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of share based compensation arrangement by share based payment award anniversary.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Anniversary",
        "terseLabel": "Anniversary period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award options aggregate intrinsic value.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award options weighted average remaining contractual term.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]",
        "terseLabel": "Weighted Average Remaining Contractual Term (In years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award remaining options vesting period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Remaining Options Vesting Period",
        "terseLabel": "Remaining option vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment first offering period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment First Offering Period",
        "terseLabel": "First offering period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriod",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment first offering period commencement date.",
        "label": "Share Based Compensation Arrangement By Share Based Payment First Offering Period Commencement Date",
        "terseLabel": "Commencement date of first six month offering period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sharebased compensation arrangement by sharebased payment award options grant date fair value.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Grant Date Fair Value",
        "terseLabel": "Total grant date fair value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_ShortTermAvailableForSaleSecuritiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10200.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short term available for sale securities current.",
        "label": "Short Term Available For Sale Securities Current",
        "terseLabel": "Short-term available-for-sale securities"
       }
      }
     },
     "localname": "ShortTermAvailableForSaleSecuritiesCurrent",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_SummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Summary Of Significant Accounting Policies [Line Items]",
        "terseLabel": "Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "etnb_SummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information related to various accounting policies of the entity.",
        "label": "Summary Of Significant Accounting Policies [Table]",
        "terseLabel": "Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "etnb_TaxableIncomeUtilizationPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Taxable income utilization percentage.",
        "label": "Taxable Income Utilization Percentage",
        "terseLabel": "Taxable income utilization percentage"
       }
      }
     },
     "localname": "TaxableIncomeUtilizationPercentage",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "etnb_TemporaryEquityIssuanceCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity, issuance costs.",
        "label": "Temporary Equity Issuance Costs",
        "terseLabel": "Temporary equity, issuance costs"
       }
      }
     },
     "localname": "TemporaryEquityIssuanceCosts",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_TermALoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term A loan facility.",
        "label": "Term A Loan Facility [Member]",
        "terseLabel": "Term A Loan Facility"
       }
      }
     },
     "localname": "TermALoanFacilityMember",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_TermBLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term b loan facility.",
        "label": "Term B Loan Facility [Member]",
        "terseLabel": "Term B Loan Facility"
       }
      }
     },
     "localname": "TermBLoanFacilityMember",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_TermLoanCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10140.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term loan current.",
        "label": "Term Loan Current",
        "terseLabel": "Term loan, current"
       }
      }
     },
     "localname": "TermLoanCurrent",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_TevaAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Teva agreement.",
        "label": "Teva Agreement [Member]",
        "terseLabel": "Teva Agreements"
       }
      }
     },
     "localname": "TevaAgreementMember",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_TevasDevelopmentProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tevas development program.",
        "label": "Tevas Development Program [Member]",
        "terseLabel": "Teva's Development Program"
       }
      }
     },
     "localname": "TevasDevelopmentProgramMember",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_TevasGlycoPEGylatedFGF21ProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tevas glycoPEGylated FGF21 program.",
        "label": "Tevas Glyco P E Gylated F G F21 Program [Member]",
        "terseLabel": "Teva's GlycoPEGylated FGF21 Program"
       }
      }
     },
     "localname": "TevasGlycoPEGylatedFGF21ProgramMember",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_TwoThousandAndNineteenEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 equity incentive plan.",
        "label": "Two Thousand And Nineteen Equity Incentive Plan [Member]",
        "terseLabel": "2019 Plan"
       }
      }
     },
     "localname": "TwoThousandAndNineteenEquityIncentivePlanMember",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_TwoThousandAndTwentyEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand and twenty equity incentive plan.",
        "label": "Two Thousand And Twenty Equity Incentive Plan [Member]",
        "terseLabel": "2020 Plan"
       }
      }
     },
     "localname": "TwoThousandAndTwentyEquityIncentivePlanMember",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_UABEightyNineBioLithuaniaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "UAB Eighty Nine Bio Lithuania.",
        "label": "U A B Eighty Nine Bio Lithuania [Member]",
        "terseLabel": "UAB 89bio Lithuania"
       }
      }
     },
     "localname": "UABEightyNineBioLithuaniaMember",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_UnderwrittenPublicOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Underwritten Public Offering [Member]",
        "label": "Underwritten Public Offering [Member]",
        "terseLabel": "Underwritten public offering"
       }
      }
     },
     "localname": "UnderwrittenPublicOfferingMember",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_UnvestedRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unvested restricted stock units.",
        "label": "Unvested Restricted Stock Units [Member]",
        "terseLabel": "Unvested Restricted Stock Units"
       }
      }
     },
     "localname": "UnvestedRestrictedStockUnitsMember",
     "nsuri": "http://www.89bio.com/20211231",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r99",
      "r194",
      "r198",
      "r203",
      "r331",
      "r332",
      "r337",
      "r338",
      "r380",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r99",
      "r194",
      "r198",
      "r203",
      "r331",
      "r332",
      "r337",
      "r338",
      "r380",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ExecutiveOfficerMember": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Officer [Member]",
        "terseLabel": "Executive Officer"
       }
      }
     },
     "localname": "ExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r208",
      "r232",
      "r252",
      "r253",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r430",
      "r432",
      "r469",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r208",
      "r232",
      "r252",
      "r253",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r430",
      "r432",
      "r469",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r208",
      "r232",
      "r243",
      "r252",
      "r253",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r430",
      "r432",
      "r469",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [Axis]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r208",
      "r232",
      "r243",
      "r252",
      "r253",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r430",
      "r432",
      "r469",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [Member]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r152",
      "r153",
      "r241",
      "r242",
      "r431",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Geographical [Domain]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r152",
      "r153",
      "r241",
      "r242",
      "r431",
      "r455",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Geographical [Axis]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r154",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title Of Individual [Axis]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title Of Individual With Relationship To Entity [Domain]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r33",
      "r383"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10120.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10160.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion Amortization Of Discounts And Premiums Investments",
        "negatedLabel": "Amortization of premium on available-for-sale securities"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10130.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities Current",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r9",
      "r10",
      "r37"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails": {
       "order": 10030.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees Current",
        "terseLabel": "Accrued professional and legal fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r23",
      "r51",
      "r52",
      "r53",
      "r419",
      "r437",
      "r438"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10070.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income Loss Net Of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r50",
      "r53",
      "r61",
      "r62",
      "r63",
      "r101",
      "r102",
      "r103",
      "r336",
      "r433",
      "r434",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10060.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid In Capital Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r101",
      "r102",
      "r103",
      "r285",
      "r286",
      "r287",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid In Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r254",
      "r257",
      "r291",
      "r292"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AgencySecuritiesMember": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities issued by government sponsored entities.",
        "label": "Agency Securities [Member]",
        "terseLabel": "Agency bonds"
       }
      }
     },
     "localname": "AgencySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r257",
      "r281",
      "r290"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Allocated Share Based Compensation Expense",
        "terseLabel": "Total stock-based compensation",
        "verboseLabel": "Share base compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount",
        "terseLabel": "Antidilutive common stock equivalents excluded from calculation of diluted net loss per share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Arrangements And Nonarrangement Transactions [Member]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r95",
      "r138",
      "r146",
      "r150",
      "r166",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r331",
      "r337",
      "r356",
      "r381",
      "r383",
      "r400",
      "r417"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r6",
      "r8",
      "r45",
      "r95",
      "r166",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r331",
      "r337",
      "r356",
      "r381",
      "r383"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10150.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails": {
       "order": 10010.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax",
        "terseLabel": "Short-term investments, Gross Unrealized Holding Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r161"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails": {
       "order": 10020.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax",
        "negatedLabel": "Short-term investments, Gross Unrealized Holding Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r158",
      "r168"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available For Sale Debt Securities Amortized Cost Basis",
        "totalLabel": "Short-term investments, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r162",
      "r163",
      "r412"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails": {
       "order": 10010.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Available For Sale Securities Debt Maturities Within One Year Fair Value",
        "terseLabel": "Within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r156",
      "r159",
      "r168",
      "r404"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails": {
       "order": 10030.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available For Sale Securities Debt Securities",
        "terseLabel": "Short-term investments, Aggregated Fair Value",
        "totalLabel": "Total cash equivalents and available-for-sale securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r258",
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r342",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis Of Accounting Policy Policy [Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r29",
      "r87"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10180.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10010.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash And Cash Equivalents At Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r12",
      "r88",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash And Cash Equivalents Restricted Cash And Cash Equivalents Policy",
        "terseLabel": "Cash and Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "auth_ref": [
      "r29"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.",
        "label": "Cash Cash Equivalents And Short Term Investments",
        "terseLabel": "Cash and cash equivalents and short term available-for-sale securities"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r81",
      "r87",
      "r90"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents, and restricted cash at end of period",
        "periodStartLabel": "Cash and cash equivalents, and restricted cash at beginning of period",
        "totalLabel": "Total cash and cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Components of cash and cash equivalents, and restricted cash:"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r81",
      "r357"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect",
        "totalLabel": "Net change in cash and cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsMember": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash Equivalents [Member]",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r93",
      "r95",
      "r113",
      "r114",
      "r115",
      "r117",
      "r119",
      "r125",
      "r126",
      "r127",
      "r166",
      "r194",
      "r198",
      "r199",
      "r200",
      "r203",
      "r204",
      "r230",
      "r231",
      "r233",
      "r234",
      "r356",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class Of Stock [Domain]",
        "terseLabel": "Class of Stock"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1",
        "terseLabel": "Warrant exercise price"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights",
        "terseLabel": "Warrants to purchase common stock"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r41",
      "r182",
      "r405",
      "r423"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10020.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments And Contingencies",
        "terseLabel": "Commitments and contingencies (Note 5)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments And Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r179",
      "r180",
      "r181",
      "r189",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments And Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock Capital Shares Reserved For Future Issuance",
        "terseLabel": "Common stock reserved and available for issuance as future option grants"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r101",
      "r102",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock Par Or Stated Value Per Share",
        "terseLabel": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock Shares Issued",
        "terseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r20",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock Shares Outstanding",
        "terseLabel": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r20",
      "r383"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10050.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock Value",
        "terseLabel": "Common stock, $0.001 par value, 100,000,000 shares authorized as of December 31, 2021 and 2020, respectively; 20,317,204 and 19,931,660 shares issued and outstanding as of December 31, 2021 and 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r56",
      "r58",
      "r59",
      "r68",
      "r409",
      "r426"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income Net Of Tax",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income Policy Policy [Text Block]",
        "terseLabel": "Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r130",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk Credit Risk",
        "terseLabel": "Concentrations of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r92",
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation Policy [Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r244",
      "r251",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate Debt"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r96",
      "r314",
      "r321"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails": {
       "order": 10040.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense Benefit",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r96",
      "r314"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails": {
       "order": 10060.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense Benefit",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r96",
      "r314",
      "r321",
      "r323"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails": {
       "order": 10010.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense Benefit",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense Benefit Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r96",
      "r314",
      "r321"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails": {
       "order": 10050.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State And Local Tax Expense Benefit",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r15",
      "r16",
      "r17",
      "r94",
      "r99",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r225",
      "r226",
      "r227",
      "r228",
      "r369",
      "r401",
      "r402",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument Basis Spread On Variable Rate1",
        "terseLabel": "Debt instrument, basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r17",
      "r223",
      "r402",
      "r416"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails": {
       "order": 10030.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Debt Instrument Carrying Amount",
        "totalLabel": "Total principal repayments"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r39",
      "r218",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument Interest Rate During Period",
        "terseLabel": "Debt instrument, interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMeasurementInput": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt.",
        "label": "Debt Instrument Measurement Input",
        "terseLabel": "Fair measurement input"
       }
      }
     },
     "localname": "DebtInstrumentMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r40",
      "r94",
      "r99",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r225",
      "r226",
      "r227",
      "r228",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument Name [Domain]",
        "terseLabel": "Debt Instrument, Name"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r40",
      "r94",
      "r99",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r225",
      "r226",
      "r227",
      "r228",
      "r236",
      "r237",
      "r238",
      "r239",
      "r366",
      "r367",
      "r369",
      "r370",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Debt Instrument [Table]",
        "terseLabel": "Debt Instrument [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument Term",
        "terseLabel": "Fair measurement input"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r212",
      "r366",
      "r370"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails": {
       "order": 10040.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument Unamortized Discount",
        "negatedLabel": "Less: unamortized debt discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r96",
      "r315",
      "r321"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails": {
       "order": 10030.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense Benefit",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r368"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Deferred Finance Costs Gross",
        "verboseLabel": "Debt issuance costs, gross"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r85",
      "r96",
      "r315",
      "r321",
      "r322",
      "r323"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails": {
       "order": 10020.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense Benefit",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense Benefit Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r306"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": {
       "order": 10010.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets Gross",
        "terseLabel": "Deferred tax assets",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "auth_ref": [
      "r312",
      "r313"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": {
       "order": 10040.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.",
        "label": "Deferred Tax Assets In Process Research And Development",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r308"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets Net",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r312",
      "r313"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": {
       "order": 10030.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r312",
      "r313"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": {
       "order": 10080.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "auth_ref": [
      "r311",
      "r312",
      "r313"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
        "label": "Deferred Tax Assets Tax Credit Carryforwards Research",
        "terseLabel": "State research and development credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r312",
      "r313"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": {
       "order": 10060.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r312",
      "r313"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": {
       "order": 10070.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r307"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": {
       "order": 10020.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets Valuation Allowance",
        "negatedLabel": "Less: valuation allowance",
        "terseLabel": "Deferred tax assets, valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r85",
      "r173"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10180.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DescriptionOfLesseeLeasingArrangementsOperatingLeases": {
     "auth_ref": [
      "r371",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A general description of the nature of the existing leasing arrangements of a lessee for all operating leases including, but not limited to: (1) rental escalation clauses; (2) renewal or purchase options; (3) guarantees or indemnities, if any, (4)  restrictions imposed by lease arrangements; (5) unusual provisions or conditions; (6) contingent rentals, if any; and (7) lease expiration dates.",
        "label": "Description Of Lessee Leasing Arrangements Operating Leases",
        "terseLabel": "Lessee, operating lease, description"
       }
      }
     },
     "localname": "DescriptionOfLesseeLeasingArrangementsOperatingLeases",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Disclosure Of Compensation Related Costs Share Based Payments [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share Basic And Diluted",
        "terseLabel": "Net loss per share, basic and diluted"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r120",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share Policy [Text Block]",
        "terseLabel": "Basic and Diluted Net Loss per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r120",
      "r121",
      "r122",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Continuing Operations",
        "terseLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails": {
       "order": 10020.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee Related Liabilities Current",
        "terseLabel": "Accrued employee and related expenses"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]",
        "terseLabel": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1",
        "terseLabel": "Unrecognized weighted average period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r282"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options",
        "terseLabel": "Unrecognized stock option granted under plan"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "ESPP Purchases"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Stock Options to Purchase Common Stock"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r61",
      "r62",
      "r63",
      "r101",
      "r102",
      "r103",
      "r105",
      "r110",
      "r112",
      "r124",
      "r167",
      "r235",
      "r240",
      "r285",
      "r286",
      "r287",
      "r317",
      "r318",
      "r345",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r364",
      "r433",
      "r434",
      "r435",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r347",
      "r348",
      "r349",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r214",
      "r225",
      "r226",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r348",
      "r386",
      "r387",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value By Fair Value Hierarchy Level [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r347",
      "r348",
      "r351",
      "r352",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Fair Value By Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r214",
      "r244",
      "r245",
      "r250",
      "r251",
      "r348",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value Inputs Level1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r214",
      "r225",
      "r226",
      "r244",
      "r245",
      "r250",
      "r251",
      "r348",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value Inputs Level2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Fair Value Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement Policy Policy [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r214",
      "r225",
      "r226",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r386",
      "r387",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Measurements Fair Value Hierarchy [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r353",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value Measurements Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions And Translations Policy [Text Block]",
        "terseLabel": "Foreign Currencies"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignGovernmentDebtSecuritiesMember": {
     "auth_ref": [
      "r244",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security issued by government not domiciled in United States of America (US).",
        "label": "Foreign Government Debt Securities [Member]",
        "terseLabel": "Non-US debt securities"
       }
      }
     },
     "localname": "ForeignGovernmentDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10100.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General And Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General And Administrative Expense [Member]",
        "terseLabel": "General and Administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "I P O [Member]",
        "terseLabel": "Public Offerings"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r171",
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment Or Disposal Of Long Lived Assets Policy [Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r65",
      "r138",
      "r145",
      "r148",
      "r149",
      "r151",
      "r398",
      "r406",
      "r410",
      "r428"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10050.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest",
        "terseLabel": "Net loss before income tax",
        "totalLabel": "Net loss before income tax"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r176",
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r97",
      "r302",
      "r304",
      "r310",
      "r319",
      "r324",
      "r326",
      "r327",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r98",
      "r111",
      "r112",
      "r137",
      "r300",
      "r320",
      "r325",
      "r429"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10060.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense Benefit",
        "negatedLabel": "Income tax benefit",
        "negatedTotalLabel": "Income tax benefit"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r60",
      "r298",
      "r299",
      "r304",
      "r305",
      "r309",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax Policy [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r301"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails": {
       "order": 10020.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r301"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails": {
       "order": 10030.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Income Tax Reconciliation Foreign Income Tax Rate Differential",
        "terseLabel": "Foreign rate differential"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r301"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails": {
       "order": 10010.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate",
        "terseLabel": "Income tax benefit computed at statutory rates"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment": {
     "auth_ref": [
      "r301"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails": {
       "order": 10050.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible research and development expense.",
        "label": "Income Tax Reconciliation Nondeductible Expense Research And Development",
        "terseLabel": "Research and development credits, net of uncertain tax position"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r301"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails": {
       "order": 10060.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Income Tax Reconciliation Other Adjustments",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r89"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid Net",
        "terseLabel": "Cash paid for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10210.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase Decrease In Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10220.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase Decrease In Accrued Liabilities",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase Decrease In Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10200.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase Decrease In Prepaid Deferred Expense And Other Assets",
        "negatedLabel": "Prepaid and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r79",
      "r82",
      "r89"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid Net",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r165",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment Policy [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investment Type Categorization [Member]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified By Contractual Maturity Date Table [Text Block]",
        "terseLabel": "Schedule of Contractual Maturities of Cash Equivalents and Available-for-Sale Securities"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseAndRentalExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "Lease And Rental Expense",
        "terseLabel": "Operating leases, rent expense"
       }
      }
     },
     "localname": "LeaseAndRentalExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee Leases Policy [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r378"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails": {
       "order": 10010.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability Payments Due Next Twelve Months",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r378"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails": {
       "order": 10020.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability Payments Due Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee Operating Lease Renewal Term",
        "terseLabel": "Lessee,operating lease, renewal term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee Operating Lease Term Of Contract",
        "terseLabel": "Lessee, operating lease term of contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r36",
      "r95",
      "r147",
      "r166",
      "r194",
      "r195",
      "r196",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r332",
      "r337",
      "r338",
      "r356",
      "r381",
      "r382"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10010.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r26",
      "r95",
      "r166",
      "r356",
      "r383",
      "r403",
      "r421"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities And Stockholders Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities And Stockholders Equity [Abstract]",
        "terseLabel": "Liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r38",
      "r95",
      "r166",
      "r194",
      "r195",
      "r196",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r332",
      "r337",
      "r338",
      "r356",
      "r381",
      "r382",
      "r383"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10090.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r17",
      "r402",
      "r416"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Line Of Credit",
        "terseLabel": "Term loan amount drawn"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityDescription": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the terms of a credit facility arrangement. Terms typically include interest rate, collateral required, guarantees required, repayment requirements, and restrictions on use of assets and activities of the entity.",
        "label": "Line Of Credit Facility Description",
        "terseLabel": "Line of Credit Facility, Description"
       }
      }
     },
     "localname": "LineOfCreditFacilityDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityExpirationDate1": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the credit facility terminates, in YYYY-MM-DD format.",
        "label": "Line Of Credit Facility Expiration Date1",
        "terseLabel": "Credit facility maturity date"
       }
      }
     },
     "localname": "LineOfCreditFacilityExpirationDate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r34"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line Of Credit Facility Maximum Borrowing Capacity",
        "terseLabel": "Line of credit facility, maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r17",
      "r213",
      "r224",
      "r225",
      "r226",
      "r402",
      "r418"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails": {
       "order": 10010.0,
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long Term Debt",
        "totalLabel": "Total term loan, net"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails": {
       "order": 10020.0,
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long Term Debt Current",
        "negatedLabel": "Less: term loan, current"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails": {
       "order": 10050.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails": {
       "order": 10070.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long Term Debt Maturities Repayments Of Principal In Rolling Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails": {
       "order": 10060.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long Term Debt Maturities Repayments Of Principal In Rolling Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10100.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long Term Debt Noncurrent",
        "terseLabel": "Term loan, non-current, net",
        "totalLabel": "Term loan, non-current, net"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long Term Debt [Text Block]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputExpectedDividendPaymentMember": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using expected dividend to be paid to holder of equity or financial instrument.",
        "label": "Measurement Input Expected Dividend Payment [Member]",
        "terseLabel": "Measurement Input, Expected Dividend Payment"
       }
      }
     },
     "localname": "MeasurementInputExpectedDividendPaymentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.",
        "label": "Measurement Input Expected Term [Member]",
        "terseLabel": "Measurement Input, Expected Term"
       }
      }
     },
     "localname": "MeasurementInputExpectedTermMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.",
        "label": "Measurement Input Price Volatility [Member]",
        "terseLabel": "Measurement Input, Price Volatility"
       }
      }
     },
     "localname": "MeasurementInputPriceVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.",
        "label": "Measurement Input Risk Free Interest Rate [Member]",
        "terseLabel": "Measurement Input, Risk Free Interest Rate"
       }
      }
     },
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money Market Funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MunicipalBondsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments.",
        "label": "Municipal Bonds [Member]",
        "terseLabel": "Municipal Bonds"
       }
      }
     },
     "localname": "MunicipalBondsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10050.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided By Used In Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10040.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided By Used In Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r81",
      "r83",
      "r86"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10030.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided By Used In Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r54",
      "r57",
      "r63",
      "r66",
      "r86",
      "r95",
      "r104",
      "r106",
      "r107",
      "r108",
      "r109",
      "r111",
      "r112",
      "r116",
      "r138",
      "r145",
      "r148",
      "r149",
      "r151",
      "r166",
      "r194",
      "r195",
      "r196",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r346",
      "r356",
      "r407",
      "r424"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10010.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income Loss",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements Policy Policy [Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing And Financing Items [Abstract]",
        "terseLabel": "Supplemental disclosures of noncash information:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number Of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r138",
      "r145",
      "r148",
      "r149",
      "r151"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10070.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income Loss",
        "terseLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": {
     "auth_ref": [
      "r373",
      "r374"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.",
        "label": "Operating Leases Future Minimum Payments Due",
        "totalLabel": "Total future minimum annual payments"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLimitationsOnUse": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.",
        "label": "Operating Loss Carryforwards Limitations On Use",
        "terseLabel": "Operating loss carryforwards limitations on use"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLimitationsOnUse",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization Consolidation And Presentation Of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r2",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Organization and Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r9",
      "r10",
      "r11",
      "r37"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails": {
       "order": 10040.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities Current",
        "terseLabel": "Accrued other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r342",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10170.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r48",
      "r49",
      "r51"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10030.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax",
        "terseLabel": "Unrealized (loss) gain on available-for-sale securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10040.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r55",
      "r58",
      "r61",
      "r62",
      "r64",
      "r67",
      "r235",
      "r358",
      "r363",
      "r364",
      "r408",
      "r425"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10020.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income Loss Net Of Tax",
        "totalLabel": "Total other comprehensive loss",
        "verboseLabel": "Other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income Loss Tax [Abstract]",
        "terseLabel": "Other comprehensive (loss) income:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10080.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income Expense",
        "terseLabel": "Other expenses, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPrepaidExpenseCurrent": {
     "auth_ref": [
      "r4",
      "r7",
      "r170"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails": {
       "order": 10030.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Other Prepaid Expense Current",
        "terseLabel": "Prepaid other"
       }
      }
     },
     "localname": "OtherPrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables And Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10100.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments Of Debt Issuance Costs",
        "negatedLabel": "Payment of debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r78"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments Of Stock Issuance Costs",
        "terseLabel": "Payment of underwriting discounts, commissions"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10130.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments To Acquire Property Plant And Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r258",
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r19",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock Par Or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r19",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock Shares Issued",
        "terseLabel": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r19",
      "r383"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10040.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock Value",
        "terseLabel": "Preferred stock, $0.001 par value, 10,000,000 shares authorized as of December 31, 2021 and 2020, respectively, no shares issued and outstanding as of December 31, 2021 and 2020, respectively"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r6",
      "r27",
      "r28"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10210.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense And Other Assets Current",
        "terseLabel": "Prepaid and other current assets",
        "totalLabel": "Total prepaid and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense And Other Assets Current [Abstract]"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r5",
      "r7",
      "r169",
      "r170"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails": {
       "order": 10020.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrimeRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.",
        "label": "Prime Rate [Member]",
        "terseLabel": "Prime Rate"
       }
      }
     },
     "localname": "PrimeRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10090.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds From Issuance Of Common Stock",
        "terseLabel": "Proceeds from issuance of common stock upon ESPP purchases",
        "verboseLabel": "Proceeds from issuance of common stock, net of underwriters discount and commissions"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10060.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of long-term debt classified as other.",
        "label": "Proceeds From Issuance Of Other Long Term Debt",
        "terseLabel": "Proceeds from term loan facility, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfOtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r75",
      "r284"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10080.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options",
        "terseLabel": "Proceeds from issuance of common stock upon stock option exercises"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r72",
      "r73",
      "r157"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10110.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds From Sale And Maturity Of Available For Sale Securities",
        "terseLabel": "Proceeds from sales and maturities of available-for-sale securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r1",
      "r54",
      "r57",
      "r63",
      "r80",
      "r95",
      "r104",
      "r111",
      "r112",
      "r138",
      "r145",
      "r148",
      "r149",
      "r151",
      "r166",
      "r194",
      "r195",
      "r196",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r330",
      "r334",
      "r335",
      "r339",
      "r340",
      "r346",
      "r356",
      "r410"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10140.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Profit Loss",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r31",
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Property Plant And Equipment By Type [Axis]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).",
        "label": "Property Plant And Equipment Estimated Useful Lives",
        "terseLabel": "Leasehold improvements amortization, description"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r13",
      "r14",
      "r175",
      "r383",
      "r413",
      "r422"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10160.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property Plant And Equipment Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r30",
      "r175",
      "r457",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property Plant And Equipment Policy [Text Block]",
        "terseLabel": "Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r13",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Property Plant And Equipment Type [Domain]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property Plant And Equipment Useful Life",
        "terseLabel": "Property and equipment, estimated useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis": {
     "auth_ref": [
      "r295",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by form of arrangement related to research and development.",
        "label": "Research And Development Arrangement Contract To Perform For Others By Type [Axis]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain": {
     "auth_ref": [
      "r295",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others.",
        "label": "Research And Development Arrangement Contract To Perform For Others Type [Domain]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r294",
      "r396",
      "r471"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10090.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research And Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research And Development Expense [Member]",
        "terseLabel": "Research and Development Expenses",
        "verboseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research And Development Expense Policy",
        "terseLabel": "Research and Development Expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r3",
      "r12",
      "r90"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10190.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10020.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash Current",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units R S U [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r22",
      "r240",
      "r288",
      "r383",
      "r420",
      "r436",
      "r438"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10080.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings Accumulated Deficit",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r101",
      "r102",
      "r103",
      "r105",
      "r110",
      "r112",
      "r167",
      "r285",
      "r286",
      "r287",
      "r317",
      "r318",
      "r345",
      "r433",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale Of Stock Name Of Transaction [Domain]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule Of Accrued Liabilities Table [Text Block]",
        "terseLabel": "Schedule of Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]",
        "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]",
        "terseLabel": "Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule Of Components Of Income Tax Expense Benefit Table [Text Block]",
        "terseLabel": "Summary of Income Tax Benefit (Expense)"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule Of Deferred Tax Assets And Liabilities Table [Text Block]",
        "terseLabel": "Summary of Components of Deferred Tax Assets"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block]",
        "terseLabel": "Summary of Reconciliation of Income Tax Benefit (Expense) Statutory Tax Rate to Effective Tax Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r257",
      "r280",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]",
        "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r257",
      "r280",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]",
        "terseLabel": "Summary of Stock-Based Compensation"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r347",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table [Text Block]",
        "terseLabel": "Summary of Financial Assets Measured at Fair Value on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.",
        "label": "Schedule Of Future Minimum Rental Payments For Operating Leases Table [Text Block]",
        "terseLabel": "Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule Of Income Before Income Tax Domestic And Foreign Table [Text Block]",
        "terseLabel": "Summary of Loss from Operations Before Taxes on Income"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule Of Maturities Of Long Term Debt Table [Text Block]",
        "terseLabel": "Schedule of Repayment of Principal Amount"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r258",
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r264",
      "r270",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]",
        "terseLabel": "Summary of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]",
        "terseLabel": "Summary of Estimated Fair Value of Stock Options Granted Using Black-Scholes Option-Pricing Model"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecurityDeposit": {
     "auth_ref": [
      "r44"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.",
        "label": "Security Deposit",
        "terseLabel": "Security deposit"
       }
      }
     },
     "localname": "SecurityDeposit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting Policy Policy [Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10150.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share Based Compensation",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate",
        "terseLabel": "Expected dividend"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum",
        "terseLabel": "Expected volatility, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum",
        "terseLabel": "Expected volatility, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate",
        "terseLabel": "Risk free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum",
        "terseLabel": "Risk-free interest rate, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum",
        "terseLabel": "Risk-free interest rate, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]",
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant",
        "terseLabel": "Number of shares of common stock available for issuance under ESPP"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number",
        "terseLabel": "Exercisable as of December 31, 2021"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Exercisable as of December 31, 2021"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period",
        "negatedLabel": "Cancelled and forfeited",
        "verboseLabel": "Cancelled shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross",
        "terseLabel": "Granted",
        "verboseLabel": "Shares granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average fair value options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r283"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value",
        "periodEndLabel": "Aggregate Intrinsic Value Outstanding",
        "periodStartLabel": "Aggregate Intrinsic Value Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r266",
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number",
        "periodEndLabel": "Outstanding, Ending Balance",
        "periodStartLabel": "Outstanding, Beginning Balance",
        "terseLabel": "Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Roll Forward",
        "terseLabel": "Number of Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price",
        "periodEndLabel": "Weighted Average Exercise Price Outstanding, Ending Balance",
        "periodStartLabel": "Weighted Average Exercise Price Outstanding, Beginning Balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Rollforward",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward": {
     "auth_ref": [
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of terms of award under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Terms Of Award",
        "terseLabel": "Terms of award"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r256",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Cancelled and forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price",
        "terseLabel": "Issuance of common stock, weighted average price per share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r258",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share Based Compensation Option And Incentive Plans Policy",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedPaymentArrangementEmployeeMember": {
     "auth_ref": [
      "r255",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.",
        "label": "Share Based Payment Arrangement Employee [Member]",
        "terseLabel": "Employee"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementEmployeeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage",
        "terseLabel": "Percentage of option vesting"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period",
        "terseLabel": "Expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r275",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1",
        "terseLabel": "Expected terms (years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r283"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1",
        "terseLabel": "Aggregate Intrinsic Value, Exercisable as of December 31, 2021"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1",
        "terseLabel": "Weighted Average Remaining Contractual Term (In years), Exercisable as of December 31, 2021"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2",
        "verboseLabel": "Weighted Average Remaining Contractual Term (In years), Outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of options vested.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value",
        "terseLabel": "Estimated total grant date fair value of options vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent",
        "terseLabel": "Percent of purchase shares of common stock"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued Price Per Share",
        "terseLabel": "IPO price per share"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares Outstanding",
        "periodEndLabel": "Ending balance, shares",
        "periodStartLabel": "Beginning balance, shares"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r451",
      "r452",
      "r453",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short Term Investments [Member]",
        "terseLabel": "Short-term available for sale securities"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r91",
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r18",
      "r19",
      "r20",
      "r93",
      "r95",
      "r113",
      "r114",
      "r115",
      "r117",
      "r119",
      "r125",
      "r126",
      "r127",
      "r166",
      "r194",
      "r198",
      "r199",
      "r200",
      "r203",
      "r204",
      "r230",
      "r231",
      "r233",
      "r234",
      "r235",
      "r356",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Statement Class Of Stock [Axis]",
        "terseLabel": "Class of Stock"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r43",
      "r61",
      "r62",
      "r63",
      "r101",
      "r102",
      "r103",
      "r105",
      "r110",
      "r112",
      "r124",
      "r167",
      "r235",
      "r240",
      "r285",
      "r286",
      "r287",
      "r317",
      "r318",
      "r345",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r364",
      "r433",
      "r434",
      "r435",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Statement Equity Components [Axis]",
        "terseLabel": "Equity Components"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Stockholders Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r101",
      "r102",
      "r103",
      "r124",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r19",
      "r20",
      "r235",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period Shares Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock upon ESPP purchase, Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r19",
      "r20",
      "r235",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period Shares New Issues",
        "terseLabel": "Issuance of common stock, shares",
        "verboseLabel": "Shares issued and sold"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r19",
      "r20",
      "r235",
      "r240",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Stock Issued During Period Shares Stock Options Exercised",
        "negatedLabel": "Exercised",
        "terseLabel": "Issuance of common stock upon exercise of stock options, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r19",
      "r20",
      "r235",
      "r240"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period Value Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock upon ESPP purchase"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r19",
      "r20",
      "r235",
      "r240"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period Value New Issues",
        "terseLabel": "Issuance of common stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r43",
      "r235",
      "r240"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period Value Stock Options Exercised",
        "terseLabel": "Issuance of common stock upon exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r20",
      "r24",
      "r25",
      "r95",
      "r155",
      "r166",
      "r356",
      "r383"
     ],
     "calculation": {
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10030.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders Equity",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders Equity [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r384",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary Or Equity Method Investee Sale Of Stock By Subsidiary Or Equity Investee [Table]",
        "terseLabel": "Subsidiary Or Equity Method Investee Sale Of Stock By Subsidiary Or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Subsidiary Sale Of Stock [Axis]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary Sale Of Stock [Line Items]",
        "terseLabel": "Subsidiary Sale Of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Consolidated Balance Sheet Components"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosures of cash information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Type Of Arrangement [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit",
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae) which have maturities of one year or less. Excludes US Treasury securities and debt issued by Government-sponsored Enterprises (GSEs), for example, but not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae).",
        "label": "U S Government Agencies Shortterm Debt Securities [Member]",
        "terseLabel": "U.S. government bonds"
       }
      }
     },
     "localname": "USGovernmentAgenciesShorttermDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasuryBillSecuritiesMember": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about negotiable debt securities issued by the United States Department of the Treasury which generally have maturities of one year or less, are interest bearing, and are backed by the full faith and credit of the United States government.",
        "label": "U S Treasury Bill Securities [Member]",
        "terseLabel": "U.S. treasury bills"
       }
      }
     },
     "localname": "USTreasuryBillSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r297",
      "r303"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.",
        "label": "Unrecognized Tax Benefits Period Increase Decrease",
        "terseLabel": "Increase in unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r128",
      "r129",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use Of Estimates",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r308"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance Deferred Tax Asset Change In Amount",
        "terseLabel": "Deferred tax assets, change in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationTechniqueAxis": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation approach and technique.",
        "label": "Valuation Technique [Axis]",
        "terseLabel": "Valuation Approach and Technique"
       }
      }
     },
     "localname": "ValuationTechniqueAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueDomain": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique.",
        "label": "Valuation Technique [Domain]",
        "terseLabel": "Valuation Approach and Technique"
       }
      }
     },
     "localname": "ValuationTechniqueDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationTechniqueOptionPricingModelMember": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation technique calculating price of option.",
        "label": "Valuation Technique Option Pricing Model [Member]",
        "terseLabel": "Valuation Technique, Option Pricing Model"
       }
      }
     },
     "localname": "ValuationTechniqueOptionPricingModelMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrants to Purchase Common Stock"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingMaturityDate": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.",
        "label": "Warrants And Rights Outstanding Maturity Date",
        "terseLabel": "Warrant expiration date"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number Of Share Outstanding Basic And Diluted",
        "terseLabel": "Weighted-average shares used to compute net loss per share, basic and diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123364984&loc=d3e1205-110223"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4549-113899"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123389372&loc=d3e36991-112694"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 1)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8,17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r472": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r473": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r474": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r475": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r476": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r477": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r478": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r479": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r480": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r481": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r482": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r483": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3151-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>74
<FILENAME>0001564590-22-011706-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-22-011706-xbrl.zip
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M%TV%MYZ4MKH6*.&<.@MS-;ICPQH(Z[L!B_UN. P'+>_2"0W3> ";N/K=\Q\
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MQM%S==M9"\E=(GXRX#4<Y"\($1?.]IKR:6XT7.9Z2G,:9KPL5N0VR%CI[J5
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M]DIV5A!V]K%D9R_-SCY^^WIU>]ZYOOSC_.Q;YZYU<?'M]/H+I3 MP=N^>H$
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M->.O9JB6]35C4_?WX?I>!-BJ>REV0[)DFDAGS2Q[\6E:?ZINUZI^ YX$LL0
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M&#/N9\;S&#U0]B1JH<H<QB/R,D]9:$K?D+89FQ56 K::\1E4(=AC16X+I03
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MZ%+0;B;3*05M*6A+0;M^07NN$H_9#I/L%S-O C.,@IAD&)IT&"SM"[\/1#<
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MRU,9 >QHE;G#HM=S+(<-;EB=3S:A- DUI^[/3+9>*"]PFD$L4!\P(W[[]+1
M3*&[4"=SF1SJ*1_JE^10S_A05U49L;:9NR8-KDJ2_[0BMDG4EU%ZH$-*'N39
MYYC^SJG3/ SA7F3G)FC=851]@S<1_5@T.3 4R6==&TPZ'&)HH:+-IE!)CWW7
M[Z+O".N *:50Q588_8<XV1<S/&K&F0A'6+R+#:+N>2X237V575[@$; %$ J4
M7(F#+_P(232B\(<C(CGC! $6(LUV'35L!>O6^A.]PZ5F:YCWIN.2/HA\1$N>
MSFR8BX9YW)B6O9Y#ZSV5JY^.J4_3,Y';R1D4\A0,/XXP;L4K5863H*%W8] U
M/>ZN0A!D*%B(,>$XC,1PYAC&I2I,UX__J<-10W]_]OB\3# *4X:6GHY'>4J5
MV9E6"4)G@G-3'C<:,$2X+9<VYXF99*BGM>F?<^=36O;3\^9G6U5FQGJQ13V2
M'3>!9UZ$-7Y?5 ]B,:+I?4F&%]8-XFZ(1P&#^D[=42\NS_0A(_;DQ"1)@!5T
M/2N.DXPFUUMOTI"\4(X:X>>FR5@!"V^G&T=RJS/>4S-:2.&<&5;1-0 GDLVK
MU"!R7(0G'G26'"8\I:=Z8LTXHXFW9ZM ,\>F"K:TOH.;3O4S*LDG?>J/%I0G
ME=_DN7A"^??43! E/^6T!F3=>BX!E5+3,!DU<S%E[.GT>C6$A4Y.C\IG.$ J
MC=.&:%K?WO1I"5IL5Y'-N\(7V2Q#7VL$Y+3IMYYUR-KUF0;I>E9%+1:UAH*9
M\OVDGVW!%IT?J5WC@NZ4\JLWXL!N#C@Z*U5ZDEI;UI^!,Q9L'S,<&.O$S]FS
MA_(<]45#C$2D%6Q="+B"+4EV%2G:LC(]O;/]>C)M3=1LL*FF*8C 5-BOJ%^-
M\BW81HN)I-.=C=(9SZP <H5H,E.3IP;&%N:CL&J<SC$CMI&HI!GSI;!YI04[
MDX727->D%11L/7I-SA8XGJ5#V;@&&^S>@7=69<W=)CN8Y7A'.?F:QZ*20^KB
M\JQ"LP$')L8T@.-C R=])"[0L!P1JLV29YJV!)>?]UQS*'N14+T;SFCU,7).
M3@TYF58%\>^=T.$.9L#A?$]YN ?FA$L5.[UBLW.: .MQA_&D U4FWS\928\Q
MD\Q0W8HV(AUXS.?3T]J4^;RB9GSK.]<LBW5Q>"^[D&7U:3_P'V3R(L!]F*]/
M4A\OE8I2,\X<$V&NW'0T6%FV) @<.9T:/2YZ_6$R(-@.3!K02+@CW^;!GD"$
M6*8M5-,U3"U1."0140ZXE.U02)'XX6 3%WA0\^ 7U<Q$^L%'_B@9C8P+8B3G
M9TAI1;Z7B>?4?\'5RL=E/81$"C(PR0J.DZ)_FJGC=P6-+9*N3>N1'FL95V*4
MLW<X0YYYJ)R?$[- /.J8YRD AMA*#WLAHPSNP\6 >4!G8#EX=M+7*?L.N6*,
MU\ RZ($X=(.'<0+H[L8C+%>Q';,K(M4$(OL(.993M;H*)\M/D^/OQ0$I+/ 6
MXI_RT&*/XQ9CPXM!O2!NP:&9-,$'9X'$PY%22TR.Y@R 7*CU'F8V^>@$ANL#
M-20]Q('=Y-;OF:IO9(@&:83J:5<  CMD6YE1ALL90]\6 ;;/PS'G8^P4_;SM
M.M=FLAL6@AO5.HHFC ;C4+KCT\*J4/=*YW4>F9C#34BK&AFJ*3E:3 *>BFW%
M5/?_%+6G$;"2S"[WE>@8*Y8T,2.=[QL!EHCLU?(1M8F"Y&16_0]4D]&-:UI6
MK$:\TO0*,U(4P^]B.F5^J1B '!P.$/0##KB:W^%17?^>4; KQCYU0A-!?TS!
MOQ![$BM\YP=CSKR)C3E=C@/ LH %]7 N>C>.DEE$-'%\*+!_-DD[VA"F#,C[
M.:1(MR,G@_N16#$(U>4SU[S'E*:/P0X..#);2(\1OE)Z =_C"2"K:B+/T1C!
M;J*B(JD'WDF1.$QTM\P@H"Q[<KIC:S</*3@SXX0#:[@='O*N"^I4,&OG;#HN
MU070C+CTBD>9^?Y!IG<U347 UW+S-ET+4$M@B&"N34ZUNA(B6F, L-J!6"F<
M34NU0<3UQ31<,AO)C#&IR- 1CD,9<CTBWGPTT76;NMES=HBMCW]QD]X0K,8P
M 88R2N&*'W+L9\^TA&RU3MR87F+[(E35E)'Q+^J_P"W#$L2O&3>9-=#S>YA#
MRA%9(B6V1/6X=Q*68(]YMF)2%E5(YI[((&JM+2>%F!4,<Q&;P$_,O2FHC>%^
MO##"'MQ83V*2>(!C3ZF7CPG55W\XI+[S@0";+6")1$,)5=0D''LVD+'858V%
M-4F5THDB$S7<9E9T<'MM'33@-]O6^?/G@H&?">DT!QBBI2IF@BN28J8IJPGT
M1.&"RL2ZB)QZY)KAT,SM%OS/?QPVWS?K=6/8?VM?)ID&U#,,YX/R&'G1<SQN
MJ9OW#%@UK.>H?O#^0#VHECQE<G83IBDD<EAAN-2\DV2'?(P/:<0G3=Y .\U"
M4@%5"1^&\5'\V;+\V*,](W!Y7IZ<*6#B;5/WH/H<@@Y&LI)ZF5:Q:_!8=A:.
M(T<F.^$4A:'HF]4]E&J8+F0Y=G(DZJ>+5G(RF6&IS.&\[\BN0;E]0%/&-.:X
M.ZGQ8I(-,0&/Q$.FLG4>T_T3F]D%SB?]^7P&88;3:)BZV)&L5%U=([FV\Z0B
M9UDA&>_C6 ?7T;/5<@U8=@WDD\C<$Y+T(X&ID=&ULGGT1)F<M2I4GYB?(5N[
MYV7@D=X*,@EUM#>J4??\;L&*RG_YYS\.CM^GWOALVX&T4[C6=9OO /%_V'C?
MV-^5&ZUHTWQIJ1,FH#[Q]_! 7D.6V.79I50Y5>9::HC/- KM.)&M<$A:7I"5
M,4^GY76^>9K1JZ1O"M4Z(EGI51ZH2(7N*X+%D>\B-<G9A47+)&;S %C'O679
M;E6I/E::-HC7)9P^!^<JJ4W.6^84X\BW31X/C!88<&:/DEN!QF@T,@(V>8#&
M;1/08;=GYI!:.9+H]:@+A@YUE1*9'^1>C0MLS2:M/B2H#Z_WTIX>TBH-R7F
M/@ X9X"$' /#U@;@7A7C*U35BX.-M <J?54-1ZBDTD>.3Y!#8APL!0!QBUB:
M3%V@DC!JIL*MZW%%:-_)/MC*(M4:KI"X#(5J\_U(VW!)OBI%=JC2[$"\>5%:
M_#M;PZE(KB9OD&EX0R<RM01B3(+"Y0[1T(7KAS+!D7+^7%>SM+ CM?AAH@E2
M2>=)T%,S8C@[F3PK<9/)X]N5VG14IC9M5VI3UO=P %(12*71E"-(]*1R,".
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MRMOQN\EG4$+2]$/DG7OJ3C!.:4L3O^_+WQ->O+OI6O9G#9<561+E#JGY&:G
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M+#2SQHEB_H8N\K#M%):@PRM]U8@Q,G#,3#71D92' _2DQCL>/-9X=[@+1/N
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MVYURMNPUC]^=[;WGIS3A(7*A!(W0!](QZK5W!Z/(4&XB=8$$X-QKT%<U_XJ
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ML6]9ON^SV?_O.4W["O4J#)*(HSRY=4A&K2NJXHF?_*LRKD\:S '?BO.$.9F
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M9A.S.J)GTS@]#Z)C^ 800C+/0;O"28'Z>GXZN?WYE90#+DO/D[<"-RW(&7>
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MTHX]#A7"1R82&%+=29K%DMJ9;FO":]=0O=N11)I=C?^D "N-\\TT',_.E(.
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M=\Z6.=F&W IO4_%A:\IV*ZK%;F:9KGZQEY_Z]W_;/_Y1CF9J>\LX!\TG^ER
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MID9,5]6%SI-A6N<^/AA>A_-\(IV,Y:/.LGJQ)H47&WQZ*4FBP=P+"L*9INU
M#D5QFY0VLIW'$VN^N.%U+$V*D.I)[^^Z$DH')F-#OR?O?0Q4GP%L\L^:,Z4Z
M>R19ZIDA<(5;V6G..:E;.K(\P_SYM10E,*4%!]YEUR2"EV,PG35+V^46BR3.
M&V,VTC&VT0!AT#"! ,3=M.!,+ 3KE21@K\I$HE)6KKN/./M6<3O5F&->,X-9
M)%'0;8*=G?/;L; ..@U@'C$/8*AK;4#!1?.8=LPY5)P/,U\HEA"!9\[K\V_B
M@="* ;;#/T_X8R=\,"5UZ5=BNL>L<8;L%1+QYS@=2G5\0:Y&N?:PM5_J25*B
M:I$%;IBI,8DHV5AR%#4J*W@UB#N25E4"22=_"GF*85SAHSH6YB3'#UOIS#'\
MF_VA)M.7D["B ;K&' IXQ<YD-'_/N0[V0JWAW+S1HCII4VO^P^0JAEP,&.$/
MQ\P5!<H\^)JIV<+A1B$(>@X71P#@.,;G1^?;1[5DNGE^46.0%55=)B:G8&]&
M4]J8,F<VM<VU.>I&%S:TMQJ^_B<B.J!Y<K;T7AMZ9@ONNTO=6Z_4E'C=5I]1
MO"WZM"G867%J\,J+VKX(J2V=" _%MB?0;9OFCKCG]K5<D%5Z=^A"2-D@ ^>M
MM>D4(L@!E33,[Q/LSSXWBV8=CRDF*YJ,<3"K+,Q("PA[?67I*3.RHW(,T%2S
M(A^,1PR=M=Y2]:(=($+F6UIQ=S4#ZAOJ3.CY]R9 (@N5,9$7.+Q]QC U7K6M
M3 O!6;NL-(421LX+)@XB+LZ2YI,;SS.%VVUL:EJ7:(C]<#?#M(?B.(YA0'YT
M3,:3R6EYFQN(0S/LYCA4_0ES-/\6'!?.88:Z?QFYSZI6+=,=+0\V;NB=SHFS
MM8W]+ 1G2!R5UCDMO>^M+*A<5:J(1#+]XURI0IB;U-(6+=TJ[ L$SL[#<S'&
M7&_,B'AY=BUU4C@M P#+4*SW7 B'!5<L-*-M18=KGA#8WR0$_KC9?94,M3!+
M IGL7BO.E"NC;A098@R0!8'8479-C[I+!0LG^;S3$T_(0E'0H'^.3*940TD2
MNA\E @, J1]  OA? 0EXUD)>D)Q/\9+1%""<N0K!I4=6-<%=AV[I;Y&,ECQF
M@[%#8P)SZ20FX=_H<E&F"8UO"<^.*Z&M0+ /U9=@DTJSP3Z%)0>A9Z:\+2T9
MOQP.LI17 1T(0S8YS.XN-KTE_))]5YG.//S\-G9HAAC9RL4FMM../;C2WC,U
MKQUS<797+'%C>V@@RUS,-I^E.48Q>FVXYJ1%#FABV3.07]M*AGK* 5T#!4>&
M8.E^Y5!'+$@H1DC16W-"5:/'N5)&"BT5)Z>#3=RN\DPH53H C,)6(;"[!UKI
MK%M/T/6DA]I%]MT">N4,KS>%ATH/VB,YR! M$I(PKAF##6UW=':8<^(><ZUF
MNH,^<0,C$R =) PFL*D[>DEV_#C]HWNQP6[*&IK3$TU2<K,[FIH_Y"0#'BG)
MQL9M\^B)2MG;HUKXUEW-A<=ZR\@'KZ0COHG33/C"%]#:COJTGJ6&V:P!-5?@
M!FBXT_@J+]!3BDF(*WNL[K)_S1N+B+ 2X3-FL\Y(6GJ/;R#TVHO3MJ,+A:T.
MKQ%S,P0:2[9$\-2.'T?G+,P]'MB1LVI=[[;I6OOLQ$)-$>?R_#BPAF9 MD*.
M1%TV4-#NTJI)[&MSWK(XU:RKA3:-^'>0UQ\Z M!.@Q8@OVM?R2<>ZE&<"JU6
M45G"+<Z8I-SLJ1;M*RT/3#]M6GNSWURU.(L(^KB\4I9IPS[F9)N72^XPN,C4
M%R4>51F4F8FZ"7;17(/I:M 5(AIWOWUK'@#VE:&NE_G,#2IU2X_M;=I:<*!M
ML<P? J^86E:(8*&LB@X6>$(3B.UB2(O<KSEM;]?V1LT91=N'L'H6NVR,R2;R
M'NCN+S$RPT0HO(1M/K)H:76-*\_[)N.V%/XWUKIN2RS*+O]V7"8X4L.8"P>"
M'T-,.]/8JS;#:+5XQY/3E=G8AJYWE$STI/F:8(WC2E[IR@=P#DW6.XJT-&;#
M-52M92(=K1&V2$GC3#B&H@&8QQ5!8J2N(3#SN8.40DKCRT*Q;#YT+EH#E%3-
M*P#^U5K%/@0%CEH@TA[!D7'ZY:5M[IPYP1ZV1@D][2^9DB.=N:IB250Q[MLE
MJB3)1\IY3F^>96VVN MNM8P/OH.:S22F&'>F#A* Z@;(;^)%2Q8MR:J$N^^8
M-4I#P+&!7'!T3/A"()%TQNG#A6GV2,A8B8ZX 9;!M!JK)4#25A#?'&Z^\1L&
M:K!<X!?\ZIS!61XF2YJJ M4DM%IS5T,1E 2,BV'ML;(*'9;,BVOL%?BRLI*"
MR)G$OX-4T]NLP@*)?ZZ]A;30T*&%]($GR>L,EYGS.0H0@>3SYC:<3J<M91XJ
MFD#N'18$".582RS2!"&U$*;E\1PH1KC"M[B"=%4[FR%Y60JF%G\?MH2&1N)L
M6"M8LDP&]@P:'%91SZR:LG MDV)QL*WBUNP0'^.EP?7*$L&VP-B=/V@CH*_H
M0:0X,!@'Y%)+S;P&>.SKB?N-&;L=".RJ<#3W?9)MT;;T4C5I&;/BO"XE&@,R
M9FIS="X+545)KE7B:>[N&P2H@YASQ^2=DM'BO.9,LPCX&IH1*A8L_F16SRQ0
M*3 N?UBRCB*F79=B0S_K=V>;B104>I*;Q%6*%;2G,3RM);,[W'Q!(V T6%>J
M=WP<E"9D:PEGLV>)6X<6,$HDXG)XO>XBY9+U"SDJ6 NIF))R_TQ#]J&':U:M
M4;#=(@A8(9 QRRB_J+_3.T(]0ZCK7J6JM4\+,IC)/ %\F>Y^24*.IK@6?AKE
MJ&@3-D(T .X"]:Q8O;#\@>0IX3F8V,K,<>5X0"2I;[#$ [?<8V5*@E+.Z"F)
M*F9V9JQ@[U#DGK6S<3FI?KE<14GXBA?U%%Z@O*$)CD"TH(@2YVQF,EM23.;X
MB#/D =/Q&#5+:%<8F:9H,H;@QA9E:D=&QHIT<E-F:JV0\R;*JWMK9QVB;8!V
M[\CH:[4A1RSKG(N,PH1YN$N6;XF &^*ZN)4PEBO$]Y);1O$SO@E3S+@M]*VP
MF(!;TADXT:EV:VO;(APXT4A4Z$(M.K$^SM</]SRQY-3!)CGUQ\WN;S C# 'G
MG=*+DU"AI>:QBZH8,TA5/%>C@+Z'Y@@WO<,X*F[S6W1^A4[E1E+->)4-'6GZ
MPB7I35QAD8I9G$/X:<I>G\T9.QE@^M#$3^G@#6BE)?\<9)7EM+>@41N,HK'E
M"@AN;S'?DM%2.U4\+)&4(7&'N#R59=H)XD,.;130-V#R93C&1:WU>4)4;&*Y
M'-.3R#M=50-R-6-U:;Q*=C,[41&V^DC\K(]A9C!/E2F72I_<\;TJRC+W-MO(
M/-9,Q6(621>;N8UL0^YL;MNXFQC//;$B6N 4@#YYF]$N50]#&%!'CDO.\[7-
M4Q='NNY651#*ML% XY0&A>T.6,?IH:HR-H]9^,8)ZRR=V788K3+L^!ZQ"10$
M-;(2M;'A4=@;::Z4/JUZ-8:-%0^9G'O-E^M2 V&6TL%$W!>B7CYWBQ^%633\
ME"Q9NRP74N##)=QP;ECZ2II!:1OHV)O^8J9CA1^<LW$XY2[BW(BQ3HWABY1#
MV@S$&8?6WWZ>"]7NCP\8^\W!\8!M!:?6&W[')WYBJ=IP,-4C]\O6$-52<@2A
MA]#  $J++$^&A_7S_4H;CW89&]GY#*=8U"'-)*R-+!A.?$V@TGG]=3@KQ%/I
M[[A^(=S*=L1='#FW/G(=96V25.ZTX/YZ#69FHH7(G+4J*""K=$&*H--$S)0D
MHB3+]"K-M8FT^OZ<50)@CI6CB?$.@5?A)KUM_LAV=&YYQN4M+\MZ,@U0LE)2
M)H&,V+A,+\E7IE7)9QWC*B%/G,5"$,-E'&YG) :D++0QM6R+8@@:/0XLNM(Z
M%77&ZG$$8U+6Q?$4N7&P#X:.H=3%7:2&)+DJ.-['D5<,"PI?W=8[^0<@[G+$
MB/^9+*ZFO"&3AM TJ?$D[E/J='?'?V]VF9:_NTO031%D&<PMXGOMU=])AEJG
M*XDWOP2PN;G!.$@YB^<:PG)DD&*H@$T4B8LL!N,[&;NSQ-M=C5(S/J%*I-6V
MFSO.BS>V[Y(Q(<H#E(WKM\O;TW1 ]PWO*DD^<H2KH2%:ZK>L<<D)..G7P"_#
MVV&-<V@.=A)]L"NR]GDT/Q'-J"<2K%>%L-H70X0A%H/%35:9I9F=LZJ,$XYD
MF*R8-!J6JG\@;IGDZ+8H/VJ261M/^=U$ KL!Y0<W:5F8:+TK\("ER";$/^$+
MFITG>11\Q*4\XGX.PUI%C/W7X;">FAJY"Y>$USIF]E]QW8>D(O.42:-S1%OC
M7,& 'Q)M;F&R GP^BT_ID!P<\U3\BH<E(2?G1CB'\I+30,Y3Y#H0+7G!E5Q=
M =(LOTT1*Q$I^95.:RZL@XZPR<3&>\IXE!9"U^_-A@"<4LV)DJV+!33N':1-
MIU'^TE;/ZGQ75G 69ZA1-V_=(LFHH3;$C\8SO8)9*D%8M"_=;>)\B$PJ2-BZ
M,06/X19!W'"4.AI+R*P@X\-%,MO1;S ]LS2Y<6$" :1@OX(\+%OHI>)AF\)G
MVLJEPM]7"FWG1+5L,;[.&@4"WO$>PE8Q/\DV4A/7V UIT44.]Q.]U1"ME*#$
M89#2OKLFY7X#;"XBDEX:U15+-KU<K?_TU_\W\9;I%-5E6)7$6K_1LJ&R[(O-
MVNF<QB!,>RQ]^$%W8BV/[A-O_'%(^[_\X=_B>E9\7L NZ(Y%]?+(:AYKMJVW
MGD!<B4[CLLQVJKTFN2+6VJKJ0WJE6F4\Y7(*2Z_/WWM[AT3Y=6X#TK2U<0HX
MWM4XGDGT,0D?-=9>90Z@["$>FETN_1H<"0Q!2@5M7G4#[?#_HRF8DE;\)QU:
MX*>U1ZJ$#T#)*,>C)00% >+:M7C@KEF!OI,:'.)X6<:.(L29ALU((MPD.7>M
M8R.ZJ+15'>E!0^A'K^6CZX:-3@:!/RC$B>82OX)GPG1;1DI-E["_=HQ33]N,
MG3B[6G/_HCI/N8#0,L39CD*<061 M69EF/<GKSEE)NUQO%NR5W\7$2VW(K0$
M[WY+\T9/W/ N)ND$"*'LC@IU^+8/J2_[Y2).0EU,D/(I677%)>W#DDX3 LQA
M>VQ&]+.?JS43H6BT<]\)L=&6(:_(LGA0J"F]2%>184 =5]ZEZH*?OQV]1;K6
M0JJQO##\9?O\<G+QDV$KS]*/239WT7JW!.YE8/$K7U,C<&G]"ASGQ#4]#5J^
M<OY9SAHLOZ([26C(@ ;9F79E5S(V25VI<_O4DE"'FR34'^C&H%K>B6?F8S'!
MIM;=*1M.Q;8O-+7F&X>8GE)I;H'T&C2)W?^:I>+HE"]Y/*?BA^A-6E8%C*%X
M]N+M17?G^/" VUV<G)[29<R;52BMUFF:%>/D4U'BPN.#PSV^\,W_^R&*KPJX
MUAT9QUM2$C$Y6$/3RO0L'VY+D[?3+*EB?=KYF^[.?K_?V]W96_9$7')PM+M_
MW#L&3N'GGW[VK^"'G8]IO4KO$;^2\$QOXN;8Y.HS[FR03&<-XLI@D.0\D1A(
MA; 3T<^X.[N>EP49!=>TEJ #1KQWBG[RP=W?QZ,RO6**JZ4W_\?/_:.=XP?>
M^!\I"[E+%F9\U^">)]E(]Y2\]=LWO>,(?5P*Y:;\Y>U[M!.:+A_6^Y^[NP?[
M^^;W'WK#%S^_>VE'@7S6H!C-3::P''Z,_OW?=H]H18MM_SZOQV7]*;6#P;WZ
M/=K"E99RS9)4J6]./B9EL?257B99S-U4^2YO8^9/R+N[;OUUK^DWP8W\J2GC
MR?"ZR'"7:I[3$9NQ 9+_7E\Q]0DIDVN6]_%0J=OB$I1;(_.1>0PH/!OK&KV;
MC?0Y%PDY=1E]/F*&T+?OSKN])8OY2W%3T'](W50?HY,7%W*#\V0"!Q,W>''R
M[K)[M-/#C1@.PW=[0;<?XD;AW4[0$0$LVG*;R[3\9P)/3L8A/S\[?W'7@%YG
M:?0NS92?_%1:K<CM\,&[&)8!$&%\+*/S\Q,Z51EMIA>C))O%+Z[BR21NGK,;
MCMK&<IM??CG=Z1WO=7?VCH_-%J-M$6Q1;U9T"_QZT=T_VEER_4L2(C07C15Q
MHW[YYN>71WM'1R=N2]^QH]^299K#JEO[K-F#E<S%3Y=O.59Q*T42\3#4-=*6
MUZH2>S/) L%^=7B$!3*6-.?4Z$"+2?\15[0!XVCK'!KM]?G)<Y'S[\C3^B=]
M3)_PWZ]^XF\<S]UB78Y6[K:I1:<1'Z8*?\V2?\;DA>0O3GX^?7W2/3G_]?3L
M[*S[[L,G45#T]X( .L-V4MEW0][)L)[$ [D<?1E.?GE[?OEN5Z[]D/![+&Y;
M7_*1((AUQL+3%IZPGXO;&)I*O)4S]582_TZ8R9,/O_)[[,J0IL5IEUZI^1(G
M95G<7D-IMPYLW<_$>Z_LW'<LA3DTP/I<,:%MZ=+Y'?'V)49Y38N;A]XBAUG9
M'<MQB$:%A5\,$ E !#E"U=ET*F!$W7Q!'VKO+(6Q!>ZGQ$UY?"1*@&.8./Z]
M*FEYNP"3GQ7DI]EH*&H+:#\5-CMM7M[UH;?OQ3=+M1/!3-AS:<H7NOQR()MG
MJ=G1"M1G8)D(?>7 60/5HRW6;$&V\$WD[C.G[KV9N7.A?6\TZ"V,V&)N:$8D
M9^Y@0'YP.,@I<BD(BRBY?5Z(HZAW$P+WJ81)V.U=7+:%(9H%8,H]M..XREV4
MA//^C#&O&"\2^.!^PKY97-^<C<_ AQ;>5<OQ$!43=]SL=(Y@V'L![21)?LME
M97!;"+LQ!58M2T[;BYL_TP'72(;4Y#7XZ8Q'?Q<RRX6Q#)GDTC#78F3)AD)\
MJ!6'VI+&;@RX<;PD.5-,%*67+.W(WS8L-M,/;LDD U^# ?0PT:_2%M ]-6"N
M$D-#<!IQDSGWX6@FMM$X\O9]!CHJAR>SZV:3!7[BR@D@1PGA"9RQ^6&=&U2=
M/-9[;]@&5S'"9M[ --A&'^0&N&9JT]U]OGAA^0*RV1.>0C_<:ON):^#>M'J_
M1'>\VWN1)#;A@XN[B&?<S ?'O^I*,);#LDXM85F9F,W$55MCD#LX'HJ.%G2T
M!7^%]RU'BM(*,4Y$!B*69+TM5>."$<Y("C1'JSM"D1Q86-QOFZ%*V !6"1FV
M68%JHN% P4A)*4W&!V-X!;INTCWAB:1%WB^<D(L:I?[KG2/YC24W#B%87(K2
MDH"& D%Q4G[@5,^=JL.'9B% L8,&059? J94!5*^5F:98"!>YM8DWPH$Z:7+
ML";B.'UH3?R2*5BT3,G0[P7P;'Q?:"&W954V[]EX_E+V%^G1Y%I^!D0R*('B
M/(AWQ!JT:N%STD<D=CXC%UTA^V))[%<!,X5C_(:;^MR?G+MF42 ^-DD/[S@
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M@?87BOE??W)T+:=B^\D?+2/8\O^XD @ZBXN#%WT2*@=[.\_#45E6;-2:\JA
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M0<*S\I<"8JY]"?X6DTE#^[U_; Z L6OZO1> M>SM"1B])48%$GNCF#T]-BO
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M(+F;FV9./&(I4:5)Y7I@.ZO.'S&W\C? 4[%KSB9> )8F[V6B7 "O)PE>X,K
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MXRD\8J'NRF.C)'Q'QX&[%)$60'EJ+NL")G@J$IC;Y[%[%+/WW\"I&X6A$'#
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MW4;5-/7^7"'&^,#B)5T4Z-H+!VFOUQMHXJKQ00UQK>$5&0-ITF40U)3IL7X
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MH"PKK2Q9(\8]Z 3BA1,2WE@G9[KV$P!-]FU;XROP$N\,R5#13$E*]^^#3S^
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M*"Y8V>?B1EN%@<G#SD_"G>I.I]2!<=H;3J<\GUH9P9^75T:P%"-_+N@%TP'
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M)'5U1NE*<9(Y<GM#, ?1<[Z;5'1?FMBR&/ -J9N)FEUAKK9S5TA$YW$>+$4
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MM&5P1O&8T)HUV6GIZ>^]I409& >\?4$5M+>AW!>#L#$M+1,,6\IG;U,F0U;
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MOOGA?][\\YL?K#R%O8*$)J&H!/A0:[@K>B_"B$-RT/<56%WV;?]I7V*'1S7
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M1#8)",G"J&;T&YDZUK]3* H19EARU*K(A2:JQ<&/$539A^(.-IB_-G4OD^R
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MM.MTPT7<!Y'H?IM+D"['9P"1:& +8_*Z?C>$L/2]0,QU'9:1E(8B!>4\7!#
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M-5'3D<(>.$A81.: 099M9?Z*_5S2V@[TY!$^49B(1,4NE=V8K+<7$<D!)9-
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M6W.<Z.ZG1X^ ]10\7P4&[#@[U<]+6HO5M?ET:2N;J+)7YEWR+=UFJZ[J"/_
M"^#2+;G:] B%8$CE%(T-FBM%$="@3BFJQ-,7P!MV>JUM\@J# B7F:[NLZZ/+
M[S%E_==.;PCZ*Y3KL(8C0<*FI4TM3&],:.'2OQ?I YU5^JIU'(.O6ZI$E_M[
M=.S3 K)1.:;(.?]J\^(&1\.?GASFTTR$? 4RC5X)YK!6R<.)RYV3G?WD&*6L
M@@P9BY$GT1I)Z$F9H0PK)\"8RIFRK_M#5??"O0D!8UO:Y_&W*+AJ=WMTJ+D
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M:IXHYT"J-3<P@8XZGV%/E"Y !0B8^(!:V-3X''G?:HVI:B]NALKJJ_$)@L'
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MYZ6Q5XS3&5$1CO<RH[Y6O:<(HL)8,-ZC<V(T>9.DO@/!LD%<V1BX;3A ^G+
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MW+[F!F-J#)*)@%/.F<XR!4K@>O%&DEE+@O2?TG?9O)KMS/JA0G,9L3?:GR!
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M!SWL>R2&EC? O:F\K:7[>F]I-N\9]Z)ZM9J&;*N4!22C5EX(1-EZTG-4RL%
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M+B12ZBJ48E=*;5+)B[QH1=8X@DN:Y9[4>=M^C)4GFW?$!>&]Y>MX$/N$R)5
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MUS C,ULBB60K9Y>S$M:F<XYY>9RFD09OZ]P*/-T_%@<E6/:0:R>9ZENN[V&
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M!KWZY7P--7LE*I:N !3]0=IRU =2/^RVB([QE)M>=PB"RWJP7 ^C?^S%IEG
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MZQY4GR L8<64L5XC*;^EFCO/,D32C404 ,&AZPN>0[3YTJ'TF1#SC7V\&WX
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M((MMJ$\1D)YGA85^7(W.45_.V>@<C<[1Z!PUUCFVDFT=18'M;GXD*'4[LV+
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M5OM%(,!<X"<D23!S37$T8 ]P=.#71)#9SG G+:P3Q,_--E$*(C, >B): =O
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M%DB>0>@\PNS,I4L&)2X:_KITU>I*@JP\J>'NL]P]G51=TFQ5E[YWF-W.65&
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M^0)36D.+"_X$+P-A!DB,IL0$@BU<=  0CPC.,)A8GO),QBC8T7RR,+--Q_E
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MRFG_*R7.6E2BA:J5Q,'Z%#/M!QROT3E[OD-J3E?RZL)GWBW41_[?J3/_[Y.
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M/K+[H7[PW_\U8N+\GE?\AR_Z19*Q/%*#[D2T=G2E4];D07.F-,2K?=FB'F1
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M*E *X0CAJ/2T03A"4B <58%2"$>'RDD.5G.2FRI0(47YE88WTWORK%_=:YP
M3>S^*V[U'^*TCI4]"-'55_P(T66A%$(T>HREIPUZC$@*A*,J4 KAZ% >X[!@
MCQ%]N^HJAP)*6O>M+MY2TFIYBXE#C<[YP6$U>:X3S['V(U!>:GPD#G%-:I#
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MQ3E1RKR,8<[#T:FUFY^C2R4-$B\M9"A#&I#A, "#QUX.B$%#8"N5.KOYE2H
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MT4EHV$&P(*X)"U2",#"(:\'N%2'A\"98I0*[5EY C(TII?J%R="LP>AD?<F
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M20=2ZIJ&P K8TI *NS(.974-"K6Z7C&B<MM.XU&CTRK.>,+,4'65"&*O/K1
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MJ'T)D;)^ULH%D]MP=CBTAH/>P&SVB$F:/6I:S8EIT69G.B##<=NB_6G[; L
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MFQ4\ "=_WB'R!O;#AMN+8X0)]1XK#ZDXSU.QG,W',2/,"I)Z-*<--5F$7)6
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M501IRF<N>;+"P/:3!V0MHK\G\T[,4I: (!(LS YF<B&L('XT:<VV/9.4N(5
MIK^2Y]J ]GP&!DS9_\5S.$'82-X6]*P3&ZK6HC2KSZ_$^^JABC.(_F*'S!]E
M]N.Y\7EY>S;D=AF9A$$H+@BU+1PV?W%E-:'+(BWVI;R^$NX;3AINCE,"[H:S
M*U1AQB1^,=ZP=])G.Q27?6O80D7##"PGY1NPKPE_@;LLGP)F"-FF/2<<'<,5
MT+.$;EW/\!N8G7>$L\\],"#XB_,T=" LYK*MVP&H@F/[]\)ZF$E>\ACSALET
MF.W.%R&@BC@,:;%G&.?<^!^;>2(,!CGF\&L+2;28"6-"X[]/Q=  24>!]QP(
M%Y-_4U$K\)+Y8OEN 8C2KI)9/G$8C" K]LB4N0W>K^"=NIY+CA 3>DZ7--87
M3JQVJCIQC6*-EX[>3 +J/_'DKCQ(7HS 3F?A"KRG5L/XS\(+>26B;8I2$%ZR
M025+BO2K#<_.B;KAP 6K)ETY8-;__J_^^+V19]!5&0C1V9D0U^+TWR0""ZNG
MSJU,[NSSBXN8=/NMJ BV^>=B(>(+N9>_9:@,% N8C<K\YO7TXOJ:JW!AW*9O
M)DWPUZZUAF- ->U[R>A:PI.1AK?X'L%5\"7;.6MS6C$G9QTA#2(XJ[LS9WUW
ML^2/CRQ8S*5?-7EAYQN&[#WLI-VX-HE$"E<X)]''$CZ5U+Q9:%_/5PF"[&[-
M9ZN0H,;-#84/_<T.?E[ZU+)#^*E^]GOJ,(2]R4_#@.,HP(A/E[>?,)D;F_0I
MYL_4V[?Z/&D7R7[""MW^N7;J8\#L2M\S9^J,%Q4Z+RK?(\T:I:]:J7(DHN8S
M8@&5;X?@#6<6I>_W@;%4/@!.DQUP:Y>QFZUV0G"/A92^G:M\ZT?B;GW&9N8A
M+6:&!_9K7+;R(5"GC]3A"AC<,,IKTE1N=+J;5+0S0F&'"ZXQ5#XG8U0!)$=R
M/"VTI($E"'I#Z8,3'IVCSR:,G5/Y(/?WP.1\Y4Q7/L8#>"OA-O$WI5-6/)YC
MB.+2>U-Y$NYO;91"E2LQ/I\[_"55E3=3^@"_XZ/*AC)B\,B#8S.#3EUG,+Y^
M9, *362BYT/E ND2<U&BOXS_JDD*EPR>Z%232]=0E8Y<&B<"#V:&KG)M6KK7
M=?3)>=-G4AW$R0>;5[D+9VQ[L37C=B'4ABAL;D"&%UY\@1B?Q1QL_P4:$1?S
MAKRJR-^\S$48WH8>,K_!-=\\%'[;\NK\50X=<1;ZP7NBOBN:%)./9\=4]F2,
M!OZ:-.3-C!D9W3E3,7$!=4 3T<MD@&^;8?_[2M54E0H,.UA@6)&G*DN!X4[U
M@5L+#,>T->J-QLU)F_2:O8%E-L?MSJ YZ(\)I>U);S0RMQ48#E+-X7R>!KB:
M4%OU'7K/H  ']%/M,VO\:%Z+U&1Y=HE>_%@Y$*0.M@)=D9F4V$*V]8A\<+IF
MB2&CYSPQ1#3<!2_8BLN3_/B %LD#@ER.R%SSF)7(+B>J'39\^[+_*+H/8>TN
M((^03E@S-?$$%4]1P9;S(B!2=&W%]\VCIXT-M0&-M?="":2 ^$!I@<)RQK1A
M^8N'9.6 B'*NNT2490*4MYYXAC(SY#G@4TQ$_B]8F.!831?P&%%W8V/YS2$\
M81 -^@7OS8&N3X/GKSP(7P0[W@Q,I @I^Q:+SCRP'D1#9MP)%I IE=%&"G\D
MYLM*8V7B"7;Z3NKZ'M31,9)$M31PM:@:@D^)%M1?>=R=KIXZ.28Z"RA\6/A4
M'NM\SOZ\_N:Y+9?G*[T)+W"$93I1(9WLCX,V.HY65#QB+$#BNBD)6<VS23I&
MIA_/[#(% #_+HS/FWGPARV8YR<2 A65GG9PTGBH>9F9GR)01!:%2>#HPD]E]
M\I_@)-G=A2"[-B<@8R HU@-Q9"_ %.\7@V^:D@^:D!'YG+P\R-LTS67.;B\N
M<Q%?(2SS5!Y>O(^WXV1H*<,B8D:[N G9J6-0!GK>C $HO$=&U=F?!/&"9:9B
MNSXKK*]5'XV_YAAY:ZBL9TNT2L<LQCV<SYXG*AP^@3Z\L&9,A +IML35K<07
M':NR2#/9@?T@:WCGO@V]WEYB^+Z<#R(J/6P?E/V<BLS5OYG/%4#U4ER&Q=/F
MD)^'= D40/E<\D22A+'^YN?C10.BGYZ"]B#)QO!SXSI=?P^3TQD5;4C<RS<U
MXI_DJPYY@>4"?N:#"Y>? Z\'% *U_"@O,5YWHPW1Y Z8R<OU21+E&*!0:/ZW
MV9>8880)\CNKP*<1,ES>_//Z4[,]9OK/A>4 )@^5,"WG+^91'3;$,Y,S!N2K
M:Q5-/!]?%  RDDEDH#$*<.Z-?F%D>?#)3"J7"'/7CQZ* Q5)E]_RJ'#Z7YC*
M^>EZOT2BCD$5LU)"6=P<9RW$+7'#9@65EI,D@"/F?((#KW 1#Y%D.2ZI0H5S
M<$VPFG!QDHLESB.O)XY)R=N*AYCQ2V?( (<NN4_9EEO&+F(=#!@5*UO%,L/,
MI,T[RFMDOD45.1J6&*;\GC6YO9RNMX*4R4,RXE.J4I)R-;:Z9>8&'QDDSB(U
M=",S$O<K]WINIC<13\M/*;8#;!X)!5L_8"S4+\^W NJ>?6 /F)V^$8N44@0V
M$/>:.T*]M-0>;3I5"_[FNF$XIN#5/&HFL_63^@W%\+]:*/L2GM^X>J;F DP2
MI<_>@#.E>H.BH4#M)M=IY*4CHIHB(*ER6Z4T$]3L*GU=-/EGOO A1JZ<9F#6
MD6?&B.,M?%,UK0-.KZQ@5&397'DN1A6N ACV*<)>9I(Q3 3B\\Y2@X&^Q?7)
MZU\7L%CPM)+!Z ?$.-MEC1E>1DE6_D/BM#:1:$.T.#Z'+8?443@D[0K\DT#+
MZTLL"BX\LVXA,>J\R'%FB;1: +)M/O+Z9IX>]GR;/1XS!F52SHZ&OOJ4&C/V
MM8^B?@VL]M@)C:XA1PEYX %F4XN7JX4JF1(8WF&U)J'(OI>^1)$"&(NTG#\N
MO=0YF8LB45F-%XHM:\FJ[J5 I_)NK_-+9QN_=,LJ5$M-Q F3]W!4GE\[>?F6
M[A:)&%)T^J6Y3G:)"!:#XE%1,6]"HVW(HUK3=*QA%>IAGAX$ Q/#L7F!+Y0>
MRT%@RP5P6WAU+?P,,_W^RZESQ7E:Z\1@V!$)M#XQIR89CINCG@DC/KK#YJ@[
M93\-Q@.KV[%&G<FXK**2F.!71 ?8QF7JQV;_Y',MAU"8#@D">VK+QN]L+4?4
M;0_=1[;0LE%/HI7JHH$P7,CC&ND>&EGF'K7OB&IW: ]B/_'N),^"'IAD17ZB
M8C$YXS*^O@BQ\^ *NPJ@4/08YG)Y:+CV<9)@R 30HI,P-1LPC#,\/#@DH>[<
M^$<T=ZJ1NL1&%)W0%X_'Q!-(*B\>-0#'.,J/-T6'1$'GA(KTFQU"G&;9XAQK
M'$@'B)@1O$VT!"UO,)HL&/7!)9**(OC+VZ2AN"PYY]#SUWQ #)>L56U+%VM;
M*O)4I:EMV:4T95MM2W?:G[:M0;_9,X<,D-M]TAP/>^,F'0T[HU9K3$<M<K;M
M3@Z%\>MS'=K XY:LP@GOZKLKIE7#3NG5L3J\[^U9=L6)V@OBNWROQG)$3C0U
M8H>A+C(=D70KQ0R):+]U/&WAUZ.8DVOQS(U(&"Y-@6 +_"8K0ZDC,C+L<Q//
M^YGHQN6IX"8T 39A=+?G$_\%4HX, .FRPS5IO_.5UDR,136PV!DN>NQ@SK7\
M0S3, =9?^%8T,8-_-.KPLA;+L23PXF)Y_M'<FU^\SSG8FL?G>?08EQ]AEP:W
M6#8>R(L<KDUXQI:Y)V)4N G%K,Q1-MF;8,Q87/( =DAJ1AEP1) @#3,7(/@^
M=X@;Q-W9XG'E%W)WA-L4[!L-Q_X)52F\\1)29NRE:$ZQS$<GF[Q?7J4M/$;B
M 21#I-K5Q5B!<^/;9@[GB<)U/,:;L<4M36AJ&E7$+\Q.F\*=-O@P@^T#H?VX
MSY,'(#8.?N)WS1LJE@867Y3"3E%8O#(;'.V%;XJ.SM@NG3'B>%9<*JRERC%6
M$S@KQ?'+$5TKJHDQE-8/)HOT=;Y%.,-URB\2"#F"(S,3;2U'K1@BJYGR5/)9
MS^.XC@95O"K"=O":!,MN@AV'S&6J^7>,S&2W),OZK%L'1I:[%L2SY\4&:HX3
M9RD\"1Z=C&J*2*TG,3[O!KOIL$IY]KSGQX/R_$B4>ZY$H%WM8Z$<3>.H-BX2
M9O3,%HYJWM.B4%!DRS&J"A_\E/B@4K<<3.9Q3/4[Y>E=*-P#EFB"D?/*IU<Z
M0I43O&"+<?R( W@JM[L(Z'2AUGGNV*J=?=+LEK6YJGV=,.%)Z3/Q-'FUEE/B
M/B@GJ)E_IEA'X%.U$H?EFL,,,'7;V=V[FX#I.Z?S%WNZ;1/8]NV5:Q!KM=:&
M.5IQK0UX8*X83+L:750KFMG\^..='S^:LVE%Y_"TRPJ[C9?[^ +;TI(K<[]
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MZIR4Z SF> %&^ G-[OOUS>G+\Y U%/*O8KSW=&GB\+51O-Z'ZUR(0(F KO%
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M\1++FS-%<7=IC'J=Q("-F6>)F9T^#7TOZK&-)GA&)[N8P2AO>$%./EO"1,,
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MK UZW<40YDZQOL6P,2QP2Q(JMVHK-PPC:D('% <=R(!8GP?K7YV*C45!Q1@
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ME 8,7".<!@Y,.6>!$U/.^6+'E$,#!J8<&C@PY9P%3DPYYXL=4PX-&)AR:.#
ME',6.#'EG"]V3#G%E,(H\>'Q4K&+0A+X^ R-TIKS\3$)&,HL^H6FJ9:<@4G
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MRQP'[?2.4$Z?XY\<_SP[U:'2M[*\"1PWSG@L757C?Z)/Y'Z=N$]:4O"25O^
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MA[+='XR:6G74;+:JK5:S5]7;>K,JVT,I^X.^-C*Z&8W>_OJTX]A[[9\X=.V
M<;5KC=9O=)R(QV<)G&I9SBMPEE 65WC3,4P 7@EB!'^^<<83W9[]]W_UP*5X
M[^V1AR0&,^5 ( ]/002!P?$O,Z%[PAF)3])0I"^:6D4@\8LWI@VO=J8>/-I[
M^^X@00T6?$]9@+<B^Z"_H)8FX.]_7-7!(Y*6A0P-ZS;_.>1^]7-BK._TJ>^\
M#]D?P+?TB2??1?]X+P(/H5\/2]L54M6GVZGU>P56P:"ZXSU- 9(>%R!9!P2,
M#F8.2#2N"*34-^HUK;5;3OT)DNE2;L8ZM[ZWBUN_+VS7J^UXX7G>I]A'T4"
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MA':HI$1A)6 B8P&0RU\3TY4"9GP]<4T+I*G1J(A7TW\.I$%Y.? YH&*0:P0
M?HVL[@?7I];/.77[/YAF<DZ/,(S[$1H5]$NV3A -<\SGJ7K2>#><NF/XUO/5
M!ZVQS(1"_<6KI7[_ Y;#C2W'7!PK6>1$/=W:(EH'J\I$GREIR*9? *H^F;C.
M+W '?;EMD,EY_2V[FYLL0)4$^<]@F;[#)'3K6SB;3,(<<WOKF[S>#ZU*HUY/
M^;JU;+VWM 9!4S_O4 .+TE]I[T7*AH?"'9I-\2SUX7^FN@N?]E#C'^"SL$9
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MALT]5B1S,0RR\\G.6MQ2I1!6XO8Y?.TW5\4ZE\'2S@*M!@#2J-73G4KQ4"7
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M<CG(,:T0P*!TM$(Z"+;6?)7&5KVYL\5,ZJ[WEIZNL+TJ'@.V5VRO*&$&]BJ
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MP2."YP7_QI8E\/\\WS2N[2%LY&".]B-ZV(\P[(^68_R5[1A% K03='O<J<S
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M]ECV\EC6M%]*>2RA'4P<-'R*F<-<]O Q7R2_DCNL^45OTIGR+LS6EDSPJ<+
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M>]C;R;3A*V")OD\M^*76U*M:^XU\JSZMM8?A3T&;&IP-[#F4^0*CY+\-&ML
M78T%'HTVZN^WO[BB/JF]%X>_OR+&$C!+OLF!3[GQB<(*ZYBSJIKO^,^ZKQI7
M#24V%@W:-$E;#5C]S;2#G0YBXX*;9KK!9P8R6M2@:=SBD6'7(5=.'!<S9=53
M?, ()X1-@::#,;8>6ST'; >$/:5@FS*L!,/V//RG-QV#'J@.9CBMX/'X!Q2L
M\)T^R/Z\30'V13-'9K"<^->'SS?JP+K['EZAEA<?A-/S:G%%72<A0=L%&;S1
MF?JQIHR5M5^BM*ZZ84S'TZ ;E^K^Z(S'L/LVHO9<L0Y/\X6*J_"B[P2^9Y6*
M!I-?JY9>!:5<G\#ZP*>P-Q3VC,+^%PHZ['4!F'FJ2)PKGW17O6R^/ MEJHD_
MY^.*MR +Q!D6:YVR@>'"#F"@HN(9WOHJ+6L!D5(7U203Y<K0YST]P>FPL-69
M[CFVZC.A>S *;.6FM,EX-N6+&31H-%WAJ'98L!S!VQ<K*&R)T@Q2#$^#5;"P
M>Q4NY?].AT_J X!Q:+C"Q\%$/#]JUQ>T4L/5>38G^.:)XWDFCF?-=&OBHVKJ
MZ*#H@ #(.3=5\K"R^-JPK8A:^!TMK6K%MFC%IZ_IU84I]N'RKUSYE!J]2F7)
MXMH4J1(N;$)QX+.H. N]V=\<51+V:#=S!*9HV00%CU&#"_O8+6:V@^XNT^U"
M5W.ATZ3:5O;6VWQZRQ;AU\5V*?,VOJ%+)YP76,?%-N2[D@5<@AQ\.SIQ6RPZ
M'$WDX[H8I6IJ!%H8]EL4QF+94,C,:.F,^-(M!,Z=+]TJ?RS8'H=.T>AM\"/(
M;_C[P#V*?K_&1Q..H=H-8O>B>5?=_TS!*<7&@XF^NL%S%@8)=1,['T8M)-&*
M*S.&1@";/GL+2S4#[^ OU S?27^^DFTM0&MP[=>%KP[=#YY >19L/7<LKH/&
MUH&N($.EM.I^C5:54:GN$^8]D#1O O96T3]VZ)(>AJM-< W"L CVML1>J^KG
M(=CBH!?G(?HGYJJW?@=TM_,;D-4B2ETX88L'Q[>%.*$U.\APQWA$\MOFB2PH
M+W#0+5,?F);ISW!LJV8>,+W$3FHPE_DT%A_UYBT; VQ_A6LZF;K@\X6Q,@/=
M$C4 M3)/X"2Z@9$Q##E1CL(B4!9.T J^FVH+N\7$K.'GU4UQSTZY=HQAJ&[/
MZ/TE>TG;*+ZA$.ZN7E-O[N&[IJ('@8VG84X 9=CS%O9BX)GZ4NTR'E#;'<58
M]^Z3#ON=8"L0-4U^!-$<ONJSX%N>%S8 7K:J5?S%DQNT"'7UL7QUW+^6]PG!
M1 -=6EJ#%2[_[I/&;N-;'7^,>ZZ4Q3,_Y.B<WR''&7@6"1TO;!37H*5>$ J:
M>S0C^->3Z6$W\J'X-@5N-N(G%[>F.UXGZ67P:*YQ[RO J.#$G@1\ZA4L7QCL
MJD2;>6PR'M_01SP<,*BYPHV\A8$(K5[]_\30D4&7\C!PA^_38T"Y\^]DLV)@
M7*=!<&Y5P Q1F4@%#3H&D0!, @&(,?((!* FT+%37=$=UP,>MZRPKWIBUBH2
M@,SN3, ?"\STP0P$OH0W!>SP!0\RR,5IU5MO!F\C2GG0W8$.#Z_>_[+D3(5#
MX"^->KTA< [6 B1A.> !NAL13?J3^/S_F8XG  9@@*OP$2D19_* OYI.O,4+
MM480'5EZ&?S;KJ*S8P4Q.Q72<8^\6SKIZ=G'G_???]Y]O;W__N?UX]W]U^C@
M[",(CHKKWRVB1!O/"_G,\X2HW>"1]\V7^X<?WS___/[YC^OOG^Z^_A%A=Y,X
M;/@^WSN X8)1VZ 5KND-32/LE8)>UC?W_V_O6I<35Y+T$^P[5'CB;'3/V!B)
MB\'>TQ&^=C/'MP%W]YS]XRBDPFA;2*PN]F&??BNK)! 8C(0Q*D'^Z08,4BDK
M,[_,KRJS&&R-X;,-+*+X0^$7N /)@!N02[V>]H+'>D<%BO46BKH8^TWN3]L/
MCZU6:^\+O"+\U9L^)+WJY.I#M#+W(>W+\X>[=N?Q\M^7Y]\?6C\N'Z]:YY?\
M@_.[]OU=Y$^T,O@3C[L%%];7+L<4QUVTYB:0\]SU..X# _05 @*(!MYVMFE]
M2.'B3EBAG[OX*N(Y'E%&4@5ZB@>.L=Q, K0V#URZL!#8XZ_%&I0[O4[C1&22
M^]=HPN$("@<^Y]FM'@>L-XR)* PR>V@<U>=J!I/U"0*C:/. ^/Z]N%@GOEBT
M6^ SCY#[EM&'$(S]!: 0+1Y#")2@RF"A*5J1TO0R,;G+B:,[!M27#!I['(_X
MF$:,SE+@"3)D0JI-*+H^H^*3:, KZF'T3"GBMN766U"M_,EE28$3,5W)W)$7
M#Z@?A\?/IN!_NG%XS -[,S0"(4[&9]:(E[VC!>5H,="<S(6;G $6->GW,]"D
M^V_SHY,_)M*;F&%UO3@5L>&[_.V0#P5"&_X_R ^^[%M\<KCR]4(G"F_(*?_9
M<!0KJY ",%//E'\1Z-<H;7MA7=_BZF2[<BF4"R+6HY2B?WEYR?B+4J/9M=P2
MSVPR_G _,IW(7.890]:A9/S^C*FE_!7Y*5<.G.E%]9DI@'T7E/LH4Q+7@2MF
M^X5R1>*ZU_/<P?YD+E-I],QJ_M3>F&3Z"E=-;#R(?B.'P6\D/'JM5*[!&\$/
M- [^B-UB#QYA/!3A('LN+&W'_*P)$Q2IX?CQ)D^V1>FFIB5"C?.[F_O+VTXR
M[=2T4L*O _'!''\K<L^408'VCJ!@'IB_!M4(4/W81<P7]WC+(#>8-4%O\957
M?^3!SO=VZ^'/Q[N?MSQ,_M:Z?^3A\L-IZ_;Q[/+V\BI68[U$HJ*Q$;E[<;B
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M9O['5A#S-9XC?VN=M1XZCU>MVU/N_[G[[SSP2 CJ6Q\[Y]]BKU^#;+EO=:V
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M37#UHSA0F-D!^>:.1_'-Y#$Q6:F-3?8"U#%HP*"AD*X,MQXJ'"[42UKZ:*&
M04$1#49Y[)^[CU [TNHUV$?8K-6;0!?4,^\C%-WM2<]S!^2"V:[%WQ+1GH\\
MN*$!>?[U_?3I;[K<1E!>FK?7U['%3\]SBY\J'@WAMUC>9%?A5TG"7M=*&G8#
M*K U%1";YW01T#.WZ;VV>+[,TVT_[/J6:5'1"G<)Z(*R%ZS27P&_A2!;0+>
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M,.B['A>:^;:^['U9Y# WYSC4Z/V7$\M?;6XSQ:]HHSAMYV3.1P=6_ON>OJ>
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M#<1;,6CN+GS*L^:W)TL8TV@R5;(1@^7!"]!G^(]/V]@$F?C*Y"V_Q(".(@?
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M#YER9,H+,!E*V HRY<B4;QM3/A46[)/[/M+D^=-82@@=:7+4]5T1.M+D>4\
MTN0J3 -2ASL M"AVU/6= -K\9:XLT")-OH F_^JQ)]<;D:]>Z'29]X3LGP*S
MHP3[ATPY,N4%F PE; 69<F3*MXTIGXT,<$NY$ER6$D)'KAQU?5>$CEQYWA.
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MT5:E!+NN.1+"ZP<#F[_X?U!+ P04    " "LBWA4=3&BY= 2  !%NP  $0
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MSP:6J?F3)[?W!AC'F$&P\MO_ E!+ P04    " "LBWA4(+V-%F</   1W0
M%0   &5T;F(M,C R,3$R,S%?8V%L+GAM;.U=2W/C-A*^;]7^!ZYR26I7EFS/
MC!\5)R6_4J[RC%VV)YL]I2 2LI!0@$*0MI5?OPV0%/4@10*D0,')'&9&$MGH
M_@ TNAN-QO<_ODU\YP4'G#!ZUMG?ZW<<3%WF$?I\UHEX%W&7D,Z//_SS']__
MJ]MU+J]OOC@#-R0O^))PUV<\"O"WCY^_<WXY?[AU;@G]?8@X=BZ9&TTP#9VN
M,P[#Z6FO]_KZNN>-".7,CT)HC.^Y;-)SNMV4]$6 D?C!N40A=N2?4^>@?W#0
M[1]V#SX\[1^=?CPZ[7_:._IX]+%_<O3O?O^TWU\@\',LA;/PY]3YN-??V]\[
M.CA>>/ >N;^C9^S<7"X^>'2$D7LX/#[>/_QP[!V?''XX1-[!I_W1"?J(/QTN
M<LJFLX \CT/G6_<[R2+(2RGV?3QSK@E%U"7(=QY32?_CW%!WSQGXOO,@7N/.
M ^8X>,'>7D+5!]Q._10\Z!+*Y<>SS@)Z;\/ WV/!<^^@WS_LI4]WDL??UIY_
M/91/[Y^<G/3DK_-'.<E[$,CN]W[Y?/OHCO$$=:&K0I!$-,#)*9=?WC)7]E$%
MOIS")\2G;OI85WS5W3_H'N[OO7&O V@X3HQ'P'S\@$>.Y/TTG$WQ68>3R=07
M+,GOQ@$>G75P2(= YF!__R F\LT3AJ=@%-U*H06=KP\W2SP?GPP)DR,P?;$G
M'NLMO]G+X:8BM1"],<HFLYCL8P@TQ7RX8&("$ \^>N?(%_@^CC$.>9E(#T#F
MU^IDEM%:E,-%OAOYLA>%D$O/X[<04P][*17!>^."2EY2;GSF+@DNVN+0F!PQ
M(\2'<MB 'GI&:"H;[6$_Y.DW$J-N?S\9/=\D7_]Z'^ I(M[5VQ13C@?4NPO'
M.!AP#@Q<1$$ #"XCY8N!S8+T2Q\-L2_U7W5RO8V"K?>H^.;7QS$+PB<<3 8O
MB$"K/KYFP2/R\2-VHX"$!*OPJTQR,\\-=08HNS @+@R$"\3'&O 7$##"O&@1
M.ES\<_5'1%X 1QKR07B!@F &B^3/R(^PBC 5"1H1;F$8?V'45>^9 @)&F+\/
MV!0'X>P>E$L(B HTIT+U?,&*DWL3'2.B:"LF)174*+/J7&IJ2*');AFBJFIP
M[3TSX+AN$&'OEJ A\575=P4BIH1@$2BE>S03RX>>!+D4M$: 5#*@7A(J*2RS
MRD.AF( 1.&\9?1:C\1(/0STU6T3!#/NUQG)K@_@!AXA0[%VA@,*RRF%(1A-A
M^&+O$H^(2Q1-D')JIN9FVK <UA=L,@WP&.Q2<,G!S603?,LXA[7K;O2$WA0G
MK1II,P)['A'."O+OP02_H1=H2D+D W,31A]#YOZN)&,%:F;LRJQ%=1-R[5U#
M!A<>89C"GA[7N:\;85PV.&:^AP,NK+MJ2\>FMXT-$1).I'L #@.C(6@>3%U0
MI:JCI9",Z15$<^DPSRA 56_8E--:%FDA+C,(W*6&4."FC<!_UX(RR]&UY(D>
MCR832:U+0CQ)WQ\%;*+"8\(&*^@5%L##9YW]?G^_O]?O=YQI0%@ ;YYU#CI.
MQ(%1-HWU;<=YQ2+X*8/,?5NEWSB9,C0._AIHY#V5@7!H'PC5Q,Y=R3*Y/[Q7
MN=?MCDSHC^]5Z"H68P;#IW<+@ZISD&%R]%XQJ>(49C <VP=#GN&6;PK,??M,
MWI/W)V]!&&8N,TC]7F0N"9QE(MMM^*U&M)8U7FX,,Q/=;BMOL^A% >A,>@O-
MN\W2YV\;9 );:->M[-6PU5]RI+30D"N6<O/>7B:TA69;L= %F[*9M!8:9/D[
MI(N^2;5M]0P$"\VQ4A *$B4RH2VTR0J%5DYVF<-P8*&95MKWE7*4,@@TS;;O
M>ZL(W,+GK:;)S;_D=Z,[T.:RU3CZMN"""N=3/X=.O8V=2K!38-]$&/TG3($'
M']H?>!-""2@E)#*&D[&I$D4O)64J@PW#9!4+S"5^P3Z3-H2&."6$S"1]Q0.$
M/B?-*NW)Y+QL+E,-K!F6MA^'G#2ZH(R2V3[((F=:O;#XNA'&XP:?T%N"USG,
MSY%:*D4A"8,"",2N87V--W B0#)3F^=XQ (\YQ+SJS=0.K!R$HJ"V0TH6FE6
MPYN@D'W9"2$.P/)2!V%+;)B;D0518+#!P'9(?&AW]A0@RI$K[27JR4^)]>3]
M%O$P\<>4\U6VQ4'K\!7;LML#3*W-UB%J6GS#HD%S>II_Y453>2BKD.G OY%,
M^PY6%2E984=8G0BA*+KJ_I^%87(EU5,1&C4-:W4:Q3;@J[.B6YV;D;]6,$.V
MI-49'A6AR_%%M#(ZNKLBMPDGAY6XHU;G?Y@&L"0F874227&\B54.C%F=55()
M@-) 9^TDDY9#]V)'ZMIGKPU%Z=?([6Q /N/44'PKP(CC2QS_>T/7DSD4 U45
MZ)D*W:VSLIBB4UNN96(M"95LY%TF.<:Y&WKU)*W6@M99S90F+(G5.2UZTT@'
M7&+P-EPBU8,*K,OO:8$UF+ @)']*$G<CD55XPWDD2F5<,"X/&(BYAN.?15T9
M'\:FT"K7N-)8;Z 18X>F)0,KO!(>STC@$8;LA$03?D-?<.S=J9U UVS!S/&T
M,0KP.<Q,N5T+4U%Y+!91,%6' 5PFU4#FXEMFV(Q'-7]B _>/B 2X,#=,20P%
MJEHZ(IV,++B/P#Z&/KX;%4>2*FL%5;*F1I*+L2=]+L$ P/<9A8*'65VA:S=A
M=(SFZ&F=09E+QGA/INV#):QW9KL"L1:%DKJ7?P4G(@!+"V 'ITT<H,M5R4(K
MP KC^I$HL">9OY-.F_8@W@(C>GHJAZ?[:.@3]VX$AATT4ETW52#58H=+(WGQ
M*$C]KLLA:6H;4GBGP-0+ 2?X?/85ALD-34H8TF=9Z%%9QZI0;5/,V-)K6LQ<
MJFV*.0\_-2IF+E5C%=E6TKR7\YY!Z2U_L?#D/>@/YJV[Q(DBO'H#6X@^XP<4
MXBM0-J[2Y#;-V=_5^_[2U?MJ#3=CXWH7(O#-(%7CM(F562%-@U9V.L7&1)&6
M%B.FMSY;G52RLU#G6GQ6IYSL+-2Y/H3M*2JJ+AC3<">MKE"BAU'E6(+5F2K;
M&#^-19*LSEO9!K(%58,L3&JIB<ZF"+56ILO.Y-YI!)L*AHW2_H35!5GT,-/:
MR-*JWO)>!I?"9J56G9==QVE3*'1Y$L[WIJTN_U(/AJ*L JMKQ=2#1#>/1*O2
MC.6SJ8'L(ZV2-9;#EI]?9G7=FAKC)R<K4*N:S3L9%+JYG%JE;]XM9FN9OK7+
MXKPS=-;RNS. -&/TVSU\D%U%>8U((#=?/H,P\%FNOX\"Q6 6+S#R;L9X7B3/
M>(-P_MH=?1#.@@@,@>5#^*4H\>I7.[-@C(NVCCIL7T CV<:%WJ$P3_32"JO3
M-)-0O<+.,A,+98I_"L#)^4IAYOOD3YCS\"D^V*9Z=4PS#>XT.#\A0HV"L]+@
M+H 36_/"(>2AG+@-XI!#N_W%51L/UGC_:R43[(P-UR:0*UK&ZH2#;>!8O%K5
M3AAHU^YSQ]B+?+GO0L, N6&$_"2<#N+%1S,7\W>HMPF:YBS!+?*UJ[;A-D36
M.G.W<>QG' U&(0[N*'X:!RQZ'C^]LO]A%/"Y<-7/WS768"L&0!&[_R7AF%#@
M5W"IA$I3+>T '&:=A5U8;DKEK[S,E'>PU=F3.L UK"]JVSFF%N_%R@GGR!>[
M X]CC$.Q[<3H\O*1Q#O3 &>211H'&O26Z"VUWOY"W+1@QFH^+I<RUSARL(F*
MJ:M21=NR,)#:\;#%]S0/XDD2^05U5"]1KT;,)*2;Z]LK([V97/O+B(K43*G3
MK%Y=%6')GUY6QP$T$=BD&:UQ]E46MF0W*RV]M7T387.#=ED%!;(8,P0VW$.F
M: QLH&2LQ VT+S++,.=R#EUC+7'**!D1YPK&+YMAF,PRWEJO@RH0TRNO%".U
ML;2@JD&D1-/DR*K7!96G1RNN=*F$3*=WK#: *F&B,,&LMH64P"C3GU:?D51"
MHFQAK'V$T9P].)F0.-56WGDEJO4^8^J",)DM<QV%\.AG0LDDFMR*5*<T'5X>
M=!*WW I;R)>QMWGRE'SP;NB3Y[CLKZ[]V!:#NV!O&I?=Q+)["\H#K[ ROQ\Y
M9?XRDC'MIU>FLA@KDS9B9U3EZ@L,GJ=7[+_@S]#78Z7PEWX;9F_MDHSQI4&[
MP)V2<U*59/MKBZKTK(E^M=I(,X#87 =8L]F37K"=*?\'/(T%$ML0!%:&*?('
M$Y&AK;?:UFBA_>52AWDCZG^AG$"V"3GGC2\P=T,?XBL/Y. $+I0T8LV&S*R%
MNCPJ&@)UFMD]((1V3[C4-A ::<]07?%A>$-Y&$2"LZ\4I:EYZ6%!%;DK$&M!
MJ+3:5:R-].59I6-\Z&I$S')?-\ZX+L<ML"INPZD'\R*%]HV[$ME8$?!66[1Z
M0K^/*&/NO&-5=9K5844UT7.7)ZU@XLZ<7JBT[A6,?GT[Q>K"9EN%;-78M;J\
MF3&D8@^I=KDS4Y&"A<OUYD=+Y]\E-S4FFWIZ@0+]!MJ/$VCP;J0F<;S4)Y>U
MYERL6=WT*R5EILARS(6\T&U O5M@V6]"K#*")H6[QIZX>["1WBHD9<@_C<M@
M)&P47N^JXJE6HVA4O ;E:E>@9-0T($\9)5.7^=65HZ( [5V*6RP=J]X;5CO!
M"CB4SC*K/>*JZB@'D#)U:K6[7%&KK<^7XM73[G+BNGB4&4E6.\CZHZ30(J[M
M!K?IVF4)Z*)0X$K9M^8</)5F=M/-JR2!27-TWKC,*-2Q0E<I&+6FYXW#?U;J
MZ(E,XN %IW4J(^3S>M=I-]?FKD"T6!L66$YT$<\O'BO*DC0,ET;[[4 G:C4R
M%W.>GYY>"Y92VNV(G.4O,<YE8'/$@E<4>/7FS":R[0@J3MS'(]#WV:M(5:TE
M8!ZY=@23E91JR9)0:(?]+[C>O)+OMV\J;I0KQ[M:!=]J=UM;^+Q9I.5O[] V
MY,;IN0F,33K3:F>[!B:EJZ;57G<-8!JQLBS?DVT0O(H6O=7W4-513;'/5_NR
MJ#:#%P_89=2%KI3M%F[%BH!6!/;'#'X1%^ ]L?@*//*"DV^:"W1LBZ7=#(HT
M+JW1_:(5[N7!3.^W:'Y_B,;^41E)LQMBR]Q\86(H1 #[T,<+2K*>5]Q 8UIU
M!@K:O9#77-[0M0$6P:A[P( GHLG-*%6D;*RI-CL^"5UGOPHFB;B)$> G0K'7
M[N[R)MH$(.VIAB,(3;36)BP%FR"#=$=LKK:7NK4!A'0;_CN=P.0V>L.=9W4X
MI#YL2EK!Z@2%^EB5KR96!T\J -28W6%U,*7^2%(Q0ZW.:Z@/U;JSLKW$AN0'
M\=<0<?S#_P%02P,$%     @ K(MX5(Q[8D.M*@  EO8" !4   !E=&YB+3(P
M,C$Q,C,Q7V1E9BYX;6SM75MSVSJ2?M^J_0_>S,M.[3J^Y)Z:S)1\R[I*MER^
MG,P^I6@2DKBA" U(.M;Y]0N $D%)O  @"("4SL.)+8N-[H] H]'HR]_^\3H+
M#EX BGP8?GMS\O;XS0$(7>CYX>3;FR0Z="+7]]_\X^___F]_^X_#PX.+J^O;
M@X$;^R_@PH_< $8) O_Y<//7@W^>W0\/AG[XZ]F)P,$%=),9"..#PX-I',^_
M'AW]_OW[K3?VPP@&28P'B]ZZ<'9T<'BX(GV.@$/^<'#AQ." _O?UX/3X]/3P
M^-WAZ?O'DT]?/WSZ>OSQ[:</GSX<?_GT7\?'7X^/<P3^2*4XR/WW]>##V^.W
M)V\_G7[.??'.<7\Y$W!P?9'_XJ=/P''?/7_^?/+N_6?O\Y=W[]\YWNG'D_$7
MYP/X^"[/*9POD#^9Q@?_Z?Z5LHCE#4,0!&!Q<.6'3NCZ3G#PL)+TOP^N0_?M
MP2 (#N[)8]'!/8@ >@'>VR75 ./V-5B!AU])&-%?O[W)H??ZC(*W$$V.3H^/
MWQVMOOUF^77R5R_.'LA_^<-1^L?LJUND?[^CWSWY\N7+$?UK]M7(+_HB)GIR
M],^;X8,[!3/G$+_5& M->(G\KQ']< A=^CHY1#@H_0;Y[7#UM4/RT>')Z>&[
MD[>OD?<& W=PD$+G(!?! -R#\0%E_VN\F(-O;R)_-@\(5_2S*0+C4FY6&)%!
M/A#R?W&"X,W!DO#3_?4VLGX8'WG^[&CYG2/ZP%'+7.$!04BF^:$'QDX2Q&(\
M%CRND6,X<_Q0FN'ETZWS2\<YG('9,T""S*X_VC:G4TP"N<DS.,Q0$N.WD$">
M:UZ601P^8[Y.3TY.T\7YET> OX45^9 JDTV.B&R?OSS[D&X"JP>/*%/K3Q9Q
MPTDM=EYA"&>+E.Q#C&F2+>D<DCW(]_"O7O9A-!H_Q-#]-86!A[>1RW\E?KRX
M &/?]>,Z4>\Q^9_-R:^CFY<;+U4_](DR)9BL?1V\QB#T@+<B0D35A@ME<<5D
M -VM61RM)M_8B9[I#,06Q<1QYI29(Q#$T>H3"NGA\<E2N?]E^?'/43P%Z!S.
MY@A,R0Q] 7@OA3,PA%%T"^+1^-%Y74<P(!L/1*L/ ^<9!-24$:!WI$,T/!P;
M6T2&C0>KF=V>K^23G]=1E) M>S3&8,Q@2-_R#P<A![_TZ_"<V#,NF7(__'AZ
M 9[CI5T33G@X;3R$EA<P\/XOB6(ZS1_AP//H$G.".\?W,'O.W(^=X&'J($"L
M#X],&CQCJ%%S#_!"B/P8/& SSG?!'4 ^].Z!"R?I0OW#"1(@\D[;YT7Y--E\
MA8\ S8;0":\<UP^PFE R4>H'T3)5*$N$3^!=) A/T11E^D:B2ZRRX0( ^J6[
M!+E3_([N B<46M720Y@$@,ZM4N84B%\W@/FW3_\XFM.3WN4KMJ?\B.W'C5]\
M"77C[[PMJ:N(FW_7M^ W_9.ZA9VC:/R=JI1NDZ >X2BDHR0F[@B/TU:I>%C?
M&UFSKX7AWWA::J<?/-ZL]M2;Y?F5<_LN>%*/^48,A$EZ3!F$WBVVE]@GC_BG
MR*%F0\0OCS3I'1/XYZDFD1\Q[Z-QCKO!JR^DGDH(:&'^^FXD_B9R#^E1/TX
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M?<#)GG;](,Q7)[:D\@6Y_$M::DCG!L7-DAT E[JXRY-8M2&MG+=N0+YBVC[
M!3GK!MR5A5S,82W"EAU \UONMNAJ;I;Z!/ ]#((Q1&G!3>NP7N.N$[#G-OQ5
M/0(CUL9J\$Z 5E@;0Q]LA</K 8[5"+](6*%!RFV4#]1?K0HQ7"2H=V*^%-9'
MTC=?"H?O!' %U5*,Z/Q.::<<WV0_NC*Z6ZYQ(.73$.Y;RNF3$*:KY>67M*?B
M>&F;3VIE5[0TP_IS^VC8?33L/AIV'PUK1S1LL8[J2%!LI6+F:71N<8ALS1[9
MO-&YQ<&TE@;:U!A\^W"Q%@XA^[BP5@[$#-:=#2.5\+](Q,_U#;4VO'D9K._W
MBE.9;YF!NE><^JY!&.I[ZZKEB[X,Z@_[JN<:+JX9W/MJZ'IB,ACB]I]2+45<
M..R(8;[7WRT'U650?]PU_6TF2I3AO=.'%]VAS1GLG_>P:PSES_I<'>\:['IR
M5#)\3W>Z@H&:@\YF>A0#=Z=M;34Z8RN#CZ'+;>-IRH)-*SX_.J\@RB5T.G$2
M0[3 'Y,LWF@PGP>^2R1[A.D#M#WSW D7@]![2)XCW_,=Y(-(+D6V72:,Y\^V
M))Z6'A'C,2 YO4P&PBS9^_PPH1WE0=K_7*S]@P!5J9BFI\'9)=FV%^1V\LR'
M0S^>)D[H.X(Q3+5TI+A;(WGCA$ZJ7P@8: Y3R049%2'9G.=A[#7A+_=X:\4#
M\62*8.![I-CU)9Y7,5DXW#%?=10ZR?;/VJQ'Q8R+U&XL?UYJNF:*A6EA[MBR
M&@*J^-DV1B1X&AH*U.(7"M8"VO-8*K[Y".N6@8WQ46#L)$&\+BZ7,JB0ENDJ
M)K'I(TEMF<3F G<C0HQSBX(UNWX7 L*:B%IC@'6A%*.@^+6&,I/97M>[T*8F
M<Y9A('"'0!ET Y#3)PS)E==H? '& "'@X6\,H@C$"@_Z(L-8>93G$D#'87UK
M\%O 54*D^GDM>1%;0Q//6=9IZ[<3BJ5^<Y$S(YAP=F(9!3/LC^*I6)9@&04S
M[!.]OOQLV66-]/!#+]A<"[V!ZZ+$"2+Z+_"&OO-,JJ'B7:^1P-)CV@+1FC\\
M],Y B)5M'!6[X4GW.\5P28QO!KKK\ Y!%T11<6/(1K#4TC:D#U+S)IP,L5(Z
M=Q!:+ ,3FZV9*K("@D; ?3N!+T<N3,(8+5(YE[]0$:EPRP]^7@]Y>,Y_NS56
MGAY$6"'?;LVS]Y"Z5KX#.$'.?.J[3B#FD:P@T![3JQ:F^5%%_)$5!/8.R9UQ
M2'*X)WKND*Q8!^PT:[H*?ZU_KEX=P%I=Q<0U[8ZL]MK4ZVNXOG,PP>QV/ H)
M1G9G)IB];D8IGY.0N=2%9AEJ4*@UD;O0R4(-%$H.45U(A&T++LXC>A?2,Q6I
MF-1MP[+-^JY--M.6W_==9Q3Y2%ERBKUYLFJDI[YN)BZWQM-_03/P/#_EX3K$
MV_R,OK/&]S$\5&VZ?JGD5X<K["E$P(63T/^3SJ+5ABKB]BHEH<675S)ZFK.&
MD48 FP47(/U7@5AEA(VYN<_Q[WZ\9BZO+,>F'NQ*TE(.&\%1K@#69$[ (T<C
M\G(E!YW7-$R>K.8GTG+N3[I\\0PAY8.<";];C(>4E@E6?@0;^C,_3D, 1N&3
MV%(2H2KU*K!1F\R2@(1X8"BS402*6G*1T?(*M@V8S5E]/B7)'-?A8$;<!"(O
M0ISV_M[<JDL/BZZ"]O<O^_N7_?W+/B!<U?V+11'A.NY?+(^/EK^FL#P:NL'%
MDKTW9AI<9Z<]<YV)F\(,"M.:2A$47&>>WMX-B!Q*>^<^Y_8Z],YUWLA/U(7*
M8LKN$BN]?ZPHDKW9/U)("+I]NU <2B4..8D_<=^=&DS_(<K]"J/ $IC. )[-
MZ;=&8?J(NC0@F>%LNH^2$T2'CS =<<56469:RF!.F,O7&#EXNOHA%HE.]%L8
MDB,VEC](JP<!!,0"_5MEHYN.0#%6AH\BK)!O=]-3NW>/[MVC>_?HWCVZ=X_N
MO'MTS8O8)_<HV9V[4@:B0=Q]SVH]M&K"VEL<XA;$1&9\D*?1XJPI7*Z>Z!W$
MIZK8QQO?XL(/$E(0XP&X":)QTI>O;I#@(Q=%S0E<XC3%W([&]*O 6PX@=Y@T
MQ)WQLZ=NN74<50>86:^:43B;)_&2T4L'D5+,&0;B83V*!M02Z_/#(;5H8_[*
MBR4/RE74#%^PE@+>/?X_\EW\$VU8]80G>B1:5).#E!9 +_':A0L <JVWQ,&M
M(*)%B.(9+-?BN)Y6[T22+8JI6[6=+8H)B#:&;I4-S7VF&\K2H-FTFI&[,.^$
MO"[JQS32?5HY9(4]J-7,H9X[@UI>]%"38K31%U54O%7G9E6+_?HFW9%JL)8B
MV W_H+ !"+GL\"YX$&5$YSY-=<'3V.3=;QQPN^!_U&%K*')N*'1,+C\G_R-M
M=/[^_U!+ P04    " "LBWA4>1/6# !O   9K 8 %0   &5T;F(M,C R,3$R
M,S%?;&%B+GAM;.V]>W/C.)(O^O^-.-\!M_?&1D\<NUX],SW5NS,GY%>O8UV6
MPW9UG[T5-SIH"9)Y&B+4).6RYM-?//D2'P (D*!J=V.Z;%G,3.8O,_%*9/[[
M_WK=(/ "XR3$T=^_>__FW7< 1@N\#*/UW[_;):=!L@C#[T"2!M$R0#B"?_]N
M#Y/O_M<__L?_]>__]^DIN+BZO@6S11J^P(LP62"<[&+X_<.G/X'_?79_ V["
MZ/>G(('@ B]V&QBEX!0\I^GVI[=OOW[]^F:Y"J,$HUU*N"=O%GCS%IR>2M+G
M,0SH'\!%D$+ _N\G\.'=AP^G[WXX_?#GQ_<__O27'W]Z]]<W/_[EQ[^\^_CC
M_WSW[J=W[PH$?N&O!0K_]Q/XRYMW;]Z_^?'#WPI?O L6OP=K"*XOBE_\\4<8
M+'YX^MO?WO_PY[\M__;QAS__$"P__/7]ZF/P%_C7'XJ2XNT^#M?/*?A^\2<F
M(GG?*(((P3VX"J,@6H0! @_R34_ =;1X V8(@7OZ6 +N80+C%[A\(Z@BHK>?
MD%0>P2A*V*]__ZZ@O=>G&+W!\?KMAW?O?G@KO_V=^/KKP?>__L"^_?[CQX]O
MV5^SKR9AW1<)V?=O__>GFX?%,]P$IP0J8@4+RB )?TK8AS=XP3!2D LT?H/^
M=BJ_=DH_.GW_X?2']V]>D^5W1!L <'W$&,%[N +TW\_WUXT\/[ZEWW@;P34Q
MG.5-\ 01D9F1>([AJOXY%,>EQZ@<'ZD<[_]*Y?B7.FKI?DO\(0DW6T2T\K:W
MJ+<PM2MME:!M@>]@'.+E9619R?5DW0C_D :Q9:TW$;;] H\DOD&[HA^2M"XT
M3@-D6>@#DA:%-K"-]%#.OH:P"I(GQH8,R>L@V')6B!)]&[R&R05<!3N4'HJ9
MD(>9C <4R##U_BU$:4(_H>224_K1Z;OW(O3^2PWA9LF9+'2X%]^D%%M&!2X_
M'X,*E.%K"J,E%&$_HXT7S2^6P,6;-7YYNX0A>Z<__DQ_/.4_LO<@O_YV&:5A
MNC\G,Y X0->$Q>M_PGV9-Z)C&8[EA^R%_OY=R\-ORT+2[],!E?Q$)T\P.OW\
MH$KL-_14L8X8)G@7L]%669]I[KW_X&R X ,8(T X_?O;7*!#^6?QHB1%$"^D
M .3'#AG$-]XN,)DE;--35+3Y58PWK=H4;'&GEMZVV@9,HR<&_OL/PHSI)[_-
M7H*0R(/@%8X? @0?X&(7AVD(B84_I9^"5/PV6Q$ESB/X^!SCW?KY\2O^+QC$
MR540QK\$: =53,8R0WTSLRJ '=-<BOD_FRU^]X],.+#",4B(>"#)Y -+(B#8
M9!*"@(H(R.(#I%Q(D'[%8$_%!"LB)WBA@KX9U[3=F!EV@J:1"Y$U"][ Q^#U
M'E(UA"AD8)X_$SN$U]'E:@79.I!^@PS+%SOXB.\A46$0A?_DN*LZCPU6AF[3
MG[43A^%B@31X!7%),+!@DH$P E#*QK]&5\W+'?D%DT>* OK@*!:-"5M&KMTY
M#.8>Y_@%QK.GA QEBU1USE%YR&RN42)BQRXYH/]@E,$72?O_&W]:4:]EW*@(
MZS#++:Y'\HJJ*)>?,0.Y2,/^/#+;N*/DQT>Y5LFX21&^*!1IZ;*_*<X(ER7E
M=(6"M:HM5AXRTUV)B'UKS,@#2G]\<ZQ7-&[4A3=*17KZM!<=L[T]NJNO&R8K
M#_=S[Q(QAX&3\P&$$3O)&-]HVZ' G5KR3NW5\*JL<7MF?14FBP#1M=85^231
M->R#Q_OIN$+.H7%S3H"R HR7/^;=! E6T)6'ZJ\:N8;F;9LY]Z\>AEXB8$/7
M!8+NC5V$%R_-O0Z:6H,_T)B7,#08O1H"MDX-[N$ZI"O'*+T--LISEOIG^YP9
ME&DY.S+(V0#*9WP+;T4!=VG(-XTC<V6/>[I4%ESC8,G:Z=TNC@G7>[C%<1I&
MZX<T2-5'H'8:O<[R:FFZ.]+C[$#&#W"&OCAJ!TQ8576^0H)ZHF'+'7[!:!>E
M0;R_"A&Q$CT_.'BXC[8KQ)Q9?L8'<$:^6'P3$KA32=YI'1DJW)917T<$]X#G
MDP9I(+Q+S[:;:/11=CU-9Y9>8$>W, (99GRQ^ Z8L*KJ?(4$]43#PJ$A9Y%O
M)6ANF38_;WB4V$#/O@O($;6XP>'/YFDG+EA%7SYB@/JHWU;\9^/,.6&UQK%F
M?E[ET3ZAI43*69!G7(!D,[YIMR& .]3CF;:1D:)M&?&O$*'_C/#7Z $&"8[@
M\CI)=C#6,^=&(GU4W4#4F8E3?J>_4X9 <@2<I2_FWH455E:?M[B@ TC ?^I!
M8LLQ[G9/*%Q<(1QH3NE+#_91=(&0,Z/G/ !CXHN9UVD>MRK&*RTC P5;VW;$
MFPV.'E*\^/WA.2#2SW<INP\91LJY-2J4>NUWM5!VMQ')F +&]01POJ# V!?;
M5P(0ZZG3;[!0(TY:,/7WH.O%*I[MEB'QBEF:PH2G,^MDI;51, .AF:)]3[D^
MO[H'@ADH</,D?4T!'JRF-#^A$'Y V1B@8&L >7@F4R[BA-L@TES2EI_L$W.*
ME)P-"(P)$%S&M^X6[>-VW?BE:62B9&O&NPD0.MLE8003S3.FRJ.]E%HDY<Y^
M*1<@V7ACP+4(X [U>*9M9*1H6T9\N8'QFDQU?H[QU_39*!0WD.BCYEJ2SHQ;
M<@.<G6]ANATBK*@W3^% _9"PY@:OCW$0)2&=^_ 4.DT?J'F^E\8/Z+FS_E>0
M\Q+Y@]Z8?C,L6$5=/D* >FB_O[F+V]'[]Q^>'L,4*1^:'CYGIMLJ'?MFS<@"
MO +O/WS_]"<@&8YOTHVJQVVJ\4G-PG0+Q &C[M)@B7?0K9B'_>8)(U5KK3QD
MIL,2$0=VRLD#3G]\\ZQ7-&[4A3=*17KZM!=#+U]YA0&=W/?Z9_LY>9&6?3N5
M7(!DXTGN>RL*N$M#OFD<F2G;9G+)[6[SI'L47WRN;Z(#I^,TIP1P'N,;;Z/6
M#[))BEKQ2<-(7[GV,F$7.-[BF.U4TYQR>(YW41KOS_%2\Q)2!ZE^29@MI!VF
MQQ:XGK",>S(9CH'@#2AS7\Q?#4>LJ53/,4/-< FTU*"RY4R/P>OU$I(?5R$O
M6&LR##02Z0-& U%GKD/X@3)#SX:++JBPLO:\A07U1<266\R62R)_(OZY"2/X
M7L\E:@GTT7L-06>N()B<R!]HM7((YI$W0T<;/%A):UY"@>I0*('P?@S3_]#7
M]#_8UO<'UZ9?MOS'K]A?R_^@:OD?7%B^)22Z+?_#8)9_3GZ<QX_XJU)9SM;'
M+>@Z)^<^W%->=+5 N7EF\#6@U)E[55L> E!OZDSU\R[56[9TMN"8QW<Q?@FC
MA>;:N8F&!957:+HW_&R=+%EZ9OU-0-6Y0*WR? 6EWADX'',5."Q[Q!U.T@#]
MO^%6?R^IGH(%Q9<HNO<%S@X0?E[M%K4"5.<'-6KS$XQZ'U"&P<*-:OIZ,0QT
M;+[\C.&MW0(-![>EF38)>4_,N%;+N$D3OF@4Z2FSOS'2QEGH[AE'F@=2A\^9
MJ;!*Q[YA,@Z L?!FA[%1Z[A-*SYI&.DKUU[UQUD4[0+$*QVI&FS]L_V*#19I
M.2SWR-F(RD[C&V\K"KA+0[YI')DIVV*9_BPAT<R@#Y_O66V^0L]E*?\\%],W
MXVY$I5KCOU9;/B)0-70-Y=LS]B0_@H7+L_T]7,$8$D >X6MZ1OC\KFO]"@3[
M@=')P)U_)*#(&SS1*IV"NS^.HHXH-E+L)-!#K<"=%8 #7RAKP'BW-*NQT'J#
M7S.]"N/-M?+UBLI#AETBBD0<M-X0]V<I?7!],;XGU&L:-RK#&ZVB.H4ZO0\A
M6.FD\)8>Z:4Z-PF[4GM^I.G6*1@W:,$392(=/5HS0=DP7-,,\\=Z:4^2<6>.
MDH,W)GF@<-RB$8^4BW3UJM;$\N&9S+@?8;QI;JBI47-6FZ1A4TIU%DZ:3S+V
M@)C[!@2MC5L77 @?&DP: (T-M6W43972O\%!I&MM!\\9FE2%CA.[H3P (DQ\
M,HPFQ>,VQ1A!/$^?87R+):6;,'@*49@J%1[H(& (>A-!)^@S9B#"T:E 'R#)
MSP,SZ 0'*^E,HXOH*DB>F)R[Y'0=!%LV67H+49K(3Y@-G;Y[?RJL2'S\&TL4
MH)J=KZ["*(@688#N,-]$TNDKJT=/W\9TZ-N]4"89@OD*9"R!Y.E-GUHC0+&)
M8@>QRUF2P#0QL<#JD^:V5J;D8&+/Z/MA-@WZQNW:\$NWJ*A6)<=T:;LBJ)N;
M\ &!OMJN$'177C]@['[RR;*;T#@P\%HE>:GYLKE+W8]G]N=!\CR+EO2?RS]V
MX0M9U43$Q=/S(([W8;3^)4 [I3U"38+FX"@Q<. FA!\(HB58T!]@SMD/A]'#
M$1NI<Q*8H0)<A"5@/Q28@ED*)%O ^ [M<O>0^'JX2"'3A\9ZOX. .3RU!.V[
M4,Z&.9$?CM..!E92DI>:1P=*9ZZ@U#C*QSW(4G46RONTO %YNL+Q:64#<GIO
MB0HO"-A^6<88$,Z L@8Y[WZ=I\QCV%T,MT&XO'S=PBB!),ZR79'2O$DGHBF1
M,_<R!?+V;50P97,&S+:^%J69MA_A3P=(;*#1"8"&RG@)AFSRP+<LRY/U41>F
MQ@M2:\LA2XZ"TP )1WFD/WOI')UN8-7@W9GVN 9\%^,MC-/]'5%!2KR*3L:W
M=-/R%FH.$FUT^@2:9KHNA@7.C8T+4+(Z 1$<.>M6"RZLHSZ?H4$55!@G%OLS
M7N"V#1HW/E,8ZVX)9/K!OX& .12U!.V[!Q]Q?1H$VJ' 2AKR4NVHJ'$Q1.0\
MQIGFZ,]O^H^XKF8T/AEQ1;L'4Q@[<Q<'DY:AS5 >YY.U-1D$6(NL9XR6)$+1
M\2#=FYP,J=,T!T"5AX-[G3EG-J=)"KS_]5_^]N']C__&YCEC9WD8(XQ-M3P5
M--$AD'0"5&0+.-\1#ZH*TO4XI&VC8@6NP8YK4<[3DS-;!83J7<GRZ:UK-&K<
M9?QSW-EB00NH)G?!GNX5FVP7-5#H,2FHI>@@)4?P 5O.R ]WZ$ $J^G)3^VC
MBN(%C]&V2!>+> >7AXZO:?]-1'J!4$_4B1=05@#R_6M?%AZ=T&!E;7D+ RHC
M4#,R]#^(=)*?7^K,(I/S3T#G%L"H0J."O)3X6%&G7[BQ&V><!9C&<YK"_-./
M2*,68NS'%L=!12N8.#)T'*VIMUW I]1L-[J)0@^MUU)T&A4+-U<\.J[I  >K
MJ<Q/(*0+$!8\%X8R4=JC5AV@W%Z .CS8,+C]-/YKE X*")=LN7O3_0;.AU[#
M,==2Q'<UROH\NG8,JQ;'4U<#Z>!)]GBS"5-6D89F0>,H#:,UC!::YMM*ID=R
M=C-9!]N7.3.>35]D![Z_Q2D$?_F3'S:O AO6T*/'$*%#=%CR?)'3T%YCY_#-
MS7';D =L#XT':IYL_.N=H;D[-1OHG,RO<[&[F)8TBR$_)=2^KE7[>*^DW2HY
M)YG5G D_:SX!_\^[-^_>O0?;( 8OE.4)>/_NY-T[]C^0/ <Q/9K>I<\X#O])
MG@H2VBC[ BX@+90+?GA_ JARV7A$?GAW L@#6[A(PQ>(]G3A)XF$24(W^%A*
M]RY-4O(#O4:D1] /IVVS&ZP J(<V@JKFP1B,<\F+CJ2TF:*)3QX^VV_F4*3E
M9D9'UH0MKFC/%_^-?';RP_L?3SZ\^S/[RON/)Q_),W_]Z[LC=-%&&\)=^/IF
M+ZAD*B.ZY6RY9,4Q G07A,OKZ#S8AF2]77AKK2-#!6H]#JTZJ3LX1,QX GH9
MYC2,P(*S]<,E-/##^IKT'RMT !/E!ZXC(#B"HH^-< Z_V^P0+;;+-@N)+-L8
M/L,H(5&5EN+=P!N<)+<PG:\>@U?-TWD]TKT.BW58.3G)EP+(FX-%$0 BW#UQ
M1T/ <4]M3PQ<=(@KWTPO<0></:#\Z9T36KN*B#!\>8(T"".XO SBB,R<DH+4
M%W 5+D+-6@7=U/I<G^^B[M8[EYR)'\ZH 1S65Z'_( DOD^R Y >*B%UT(3;4
M7F:_/4R[VV2N3K%\OPK0@DKKAJ7]C4K7&Y2^7:,Q/+5MH.7NHL4 Y[M'<6FF
MXTRX1;>^8W=X>MQT.6;<G?^[()['K![HDNVLW,'X@>Z(F1\&-%.TM??;Q&&
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M&DZ7.K7NX=TZ1PFS-D>QN,)QCT^+RXRXMN%I1%EK.)-+4XTDS-%H(&D5")%
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M9LP=B6ZMX8BU!7\-M9(A.PA9T'X=8?LV+^)FSL8SFV_%J<X%FM7F-28'#G(
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M7.^NUS*N5887&A4FRZB"+Y3N<):H/H@=/-)#=\YBE]?V>#B>U"K$$[V6K7+
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M %):^3\H=;9,Z%E:XEEG2P,;P.8H3 =O5(#ZH&LI*R/'8&8-'@K,>Z_)>*$
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M9!DD!?;!L]Q9(G:+\\3C=7%V<]L6?BVTMO+DE<4\@P]-4AXVAQ82%>IX")E
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M5-F95G[SH'!:) LEJ>^4*M,SW,M2I.]D=XN=J+VP$S5B05]%IGV0LS\!2RF
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MH8X%_O9=D8#SP0_?LVH/V(7>CP%[>>)'!.(5,]E8F,L$<J'HU# 3BZ:P4<&
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MHN*E7ED@F]8[2*YI'<8G!#]'2Q@?EJK)2R0H)ZX9TS>]\&O&S\WU7U[K&Z]
MPJ3A92YIBN>.RL,_/>5%)L3:"02Y3#[DNO4U#VP#%M.;PB%>7N$XOY1?%F*^
M.F=5^1]H4?Y[F,#X!;+OBUJDRB9N@9/Y#>1^G%W=5B92@16.2T48HJHWT*(-
MA;X((!;R\2>%A#XX@3U3PG:!ZWV%OH5]L W) ,3X4Z9P.8N6A=K).MYAA9V%
M2_KF[ >XU=_I*ES$"?B*3>NJ*Q_0%\9!4JL?%L]PN:,W+CN+ B9-50$?Z1BI
MLS"RR+1''3!;0M@_69*BL?8K"K4/D_;BAU^8F)XTG+1O<-@9ID=C7&@<NW(3
MLNZ(^F^##9R]AEJ);N7GS+$MTG%P3XU0!Y2\'^Y:JVS<I@R?%(LJ.@5?*.W1
M+/8";X)0JT=D]<G^RN64OAF[K:B\QG*+"O%+O8?6RZFKVV_#TNKQ*WY\QKN$
MS#;)Q/,VC& *8<3+7I!9*XGPX0ND;"L=U+O64-IT#1=+FGR<K(H^O'O_45;&
M"R5/L$5^%#LS11CWT?"4T"PG<A$H*8/^E]9&>1<1)PAO()FS3E*2O2QHDPG
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MME4F3^RZ148'UT$)L],5X09"P0[$A-\QSV!5[-)5=.W$]ENQ0=>1E;X H&\
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M*GLB;2BA/?6J <DI- [<1[N!$S<5D+"1P\'[;#=X;1_L:ELW?[A/[859Z.Z
M:B\ZO)S]L=7;LOJBB"IOLARC42<W.;HEWHW\D7UO+;S5WB'4P+F5(OC1[@VJ
MZE!$Y8Y0#MW[$;H*Z,2=VQQ1RZW$EJ3ESMM&7CI^M [.XK<?5/#TE"+QR<Z-
M5?8\API?"#D:=MXGZM#(/^:F:'RVVXSMQ&URPU_T.<YV6QJ",1)(+KR#HS=
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MC)IB\J;)0I11,%3&+TXX DVW4PTA0V*7[V:&*F& 21UR#UPUG: "<6.%&&D
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M'P1H5PC/ :1MJ(-K7[XI9RO#FRF;ZK&9@5GQ%&@<FA](^:]$*2I5K%4.LDN
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M)*=G[Y]UMEN3&ZJWC=<$IS'D9E$F&] D'),_3>>[ER%6P6)?6NAJ-2,SM!'
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M5D]RS3)V/E1RQWWWGT% S@VQ2D(,7?*GAQ"Y/[_[, S$.1(F90302R+@T 8
M-OR4Z3!Y<"N(='AP;IT5$ \:$Z=U"++@;%-,0#0:S0@;1H#D:K/A7(0CY]H:
MV8P\V%6 "F[!<AJ=7PAJIX?:6S_;0_1:/G'(D%2R/4+0I(:I7;.L7K4]Y%#:
M6D%"%I;M08DJL G;V+8'+S;9<SM7)MM#&@]&?=T,)W2R-<^(OM78J\/1;4QE
M\B_T_YZ< /S[_P=02P,$%     @ K(MX5*I;U;6' @  !@@  !    !E=&YB
M+65X,C,Q7S<N:'1MS55=3]LP%'U'VG^X5-K$)!(W22DE9)6VEB^M=!5T0GM"
M3N(TUAP[<@RA^_6[^0"5,AC;^K G)_<>7Y]SSXT3;(^_C.;?9D=P.C^?P.SK
MI\G9"#H6(5?>B)#Q?-PD>G;7@;FFLN"&*TD%(4?3#G128W*?D+(L[=*SE5Z0
M^05)329Z1"A5,#LV<6?X9BNH8O7*:%RMAAO!\($9&5KLSO6<ZWT;09@B][F
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M323>D[1=R$8BP.Y&-TU6A.BVGZ[,V( 5SWAJ>R#TU]]S["$0( G9O!"1R8?
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M#,'"(<M[/F@/AE"!AE)9$D YE$M"Y90DTNJ$0:G4L@@"%R0&)1$<0?,%&=
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M>S^V_?\FB(:X>W,<#:=2(J8@Q$B"M@7<&?[/5!@^P3M""D1)#L?>]DN&D&K
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M)$.+I0X_'84_QJW#-^9FZO1I&_QXIQJZ;W,W:2:GJA^ -/J^3QKI@8R7<F5
M$XZ*&< !IMEI6>2?Z/A[H$3[")^[/=Z;56VRDJ,A-KVGR[V&S]WO=:\SX6ZV
M,A M)H*"V1(07E717F<<[)$3D9K4G.)#"5R2-,M"Q*!Z%N*[W:];9&.?ZZ.Z
M4/-ZGSTH31+VO0;QVSS0OZKH7J]1G)E<JEB<R[Q(\ 3.SGKB]>!\@)K3O5[Y
M%P'=\UPO4*4](QD1!2(C_@\A?-ZKY4I2Y<E\!N@8ZHQ\VG(*(M24G>>@S)(N
M3QHH2E<.@_XQLM8QV$U,)F6R3J&2W41D<I2SF9>]RMSMLC_B#XCYI5%$OE0>
M:K)IHX$H30@)08 %P9(,9*K6C#N$<R:(:#_.R@!D')3I9:Q8E"62@N.0 L_F
M(NY0"V0=BX2=.VNB<YB@FX<?@-+ @0H8)N 9%SP#V<#=E0<N[IU7$OZCU4?/
MRQPM5Y4:29Q*3Y!9N6M&%LXV[=2REHGU8*7+1,B0U ^DB<X?5SV:N!O(?&HE
M:K-VD[$UF)KU'@+577EKW&#*5NG#WW7N>EDGF(]]/1\C0BM!L>&J:9+RT4'\
MILCJA3Q=)]9IATIXE,LE@:>!X#H!M.)X&XX[JJUOJ-E&-M"'4'JM(]O\TUB1
M)I<K?/S@M2Z?@NWSART^;N(C7?E83\DV_+'L:]\Z26\E;XY:Y<UV69.\J(K<
MQ:T_PZ R\9AT91VN>?-W:ZRY15#&63Z.[<H-INNQT$_GL/N?C<,^; ?Q,=#F
M_EB^5^D"0')*9T*WJ".NH;<6 $$ J^(,7\OEXT#_SCBK)&J)$JFXGO1<C%ZH
M)LG+R+@^S0>4\'UFWDN.8?)(Y6Q29(<0&CJM[3,!/I_+*0G@%.%C.,(P8J&\
M3("O@=1.442*]&02V$WM="L3'<-N<QE3F Y='=A.EH)43+B=J&E*K)5-X!U.
M=D!Y=H !X<F0GBI&6@!\OQK!1J!6\V ,T#PK'&9&>B$H@OVGG5A-"K2K%41I
M@C2'I?^TL[L#XD,<FTR&L+OJ>R:CR'UW=Y6[X#V-96;4@?MP*-8L=T6._T04
MTX8SPR7><8-PT^\'SW[\&B-D"]7'J?&.+7.9[72$W^/:K_<1/8.O'R$(R+)(
M;W^A8X6157T+I(/;49P*\7PCX]&PB&X"SO[@A^_^>N!<0SW^N;;A?_XA2*[9
M)6^Q3)HM4J$-+N?I-BDI;>.OVE*+E>)CID?_Z0][>\\./16V_>X\3(QI *[C
M:%NO03OHFXQQY_F9'^ +--P R$C360MZ.'!>[([3O(EEKL_+=M4[C;8BO]<?
MB+:Z#AS68^OY%NMH)]]8:P,CG)/2&W S+JLS[I*%6W6%$JP]*B\% *.3ZIBI
MSE@Q17*UZ8(L+&*.@;2ZX%BR2$_@+,J8Q&#+2DDB#DC!;DH+L/*YDIQ*(N%C
M/E5YKR$3]&PH,/8CY22O(VL'ZY@-_^3X#RX8_@+GWO+O>T*-MOQ[R[^W_/L>
M\>^36!IC\Q21JG]N/MVEOU8!QF@1$N':*IJ\Q::ED4**1JA<*>[!G*IJR,P<
M35[3*9EJJ&E_I63.WM>!>(LYH!CS3/V;TU3I )@B@7ZD@N.*)><6SI5R2]B,
MPZ:)46"P$9EV=<BN=%)2C*>U?G,2 3,V:YRV@5N:5/+U%5.Z:9U;<(/RWHC3
M])ALAV"PY9Q?#!W8<LXMY]QRSGO$.4]=)AW'_LQ3@&B3H> /3'07,@0E62MS
ME^S5FH!=&B#9>KNY&^A<4F1QF<O8)6AVYQCB3M;-\9@\WYCK!IV[<JYT)M/@
MX3DW$P]DTV\FN/8*AB[UDYH,Q,M&G@BYB. LR%$#O)Z2(25ZBJQ&+T$O!5"Z
MU$C5XM>J'%'/GAV9,MO$/:2ML4Y4?\;'-=H#KH5E<0!:L44>PJN]HR$,0'B(
MIV[*H'TPL=:9L6WG^3[V#YY7SC=<L+7B2\J*;LHA8DE9+6LIC2%N!3,9$R?*
M="2!LG#4?HH8.U/;#!IGXMVRF<X,96\BZZ<9FME.39D.EEBR2-6=]Q.@[[#@
MLZ1"&E7:IXS2K+K(K8G&GG4"\ZG0F8Y&">4BU3W'B/5R-*%))A9[6W&9_AWM
M6#)>V*E-$KU1_,*E(QC=V+"Y,B: U'>=!$LL=('!%$DZAUNG;BFW75-]YRZC
ME3^W!PQP2#[_<D*?M]+R?>#]6VEY*RUOI>5/EI8_YKRO/]3;R=*W:7/!D3\<
M"4PE%J(%>9Z2M*CRNM>*D##'E'7$314\\"<(XG4.O;_2D.2.4$5EKC83]_RU
MUX$.+DVVW@W58L+<<(P=-,T")522I)9\0%;D *15%=Z8^Z"4QH66%7I.\1^4
M!(=SDK>%(S6EOS2;KF?LA@;B10D"DC)>@$F@*-BI=):T6OCT[&A-V=4J*!04
MQ3(FR)M&5=58$!XJ1SD0+B'J$EXPI1VT1;+#Q71XIER<:F,96,B PE/<M'86
M;'C##M#"E[I#\L5/VK_?U6P4R]E:XKX82KF5+;:RQ5:VN$>6N#=I%;R,9@7+
ML7SR^F=YM:P]S#/1^ Q=VNHRP.0PRC!ATT6C-)K/3AI<,[5AQ#4/L<5IB+_[
MW9#A8;49KFN6K+R(EG4H@2@0:U6ZL(N*A6K#7)C&BE4R)?L)6<_F+G6#0D[\
M:&R:KVV[N$PV3#DK"X\$X*O*9VU*3U22I\6HVE(&J8KAP>_L!.M@T;>Y35M6
M_.40EBTKWK+B+2N^7ZRXP0)L42OR0B W;+*P/XTOM_BOFJXK*@U>>Q$L.YY3
MI1ESC06_Z5APFJ^T"5FM>]Y0&RF5 Q?05'?1[8$Y3#.7M6BM!TY4: [K*=V4
M8('^+V+!MBXY21,;G;9:Z!>+R%O6MV5]6]9WCUC?L5-HC,LD[WR' P6&$!OZ
MW SP&/6]2K-R+T=HX8AM^;3(N3+DBQM>]6L<WJ!]*2J13%G):T6NA0UZ;,W1
MV.2W+57>N^I^UYNDDFBW&<K5B>70SXV!;<U7?F<(M:GJ>-=E1GREU<^K3"UL
M7"!KZ&H+;.C#O<;5J 8T/9L1[$2F9B1$:8KUXT$=/[8V]^3^A:I\REE6U8"+
M=*HX&X=>X */8ANR.Q#77G$KW+7!RQ:GN-6M3O/'"MZ/BRQYH$G7&TXD3#GG
MW"L&KTIFY-!#\,;ZO8KU+$WI#MF(;TJ;DG5)7VR([QA*N7KO#1%$&.^346ZT
M+9O-51QS.565#Z]89;82-FY)5H6KK?]-)XLTQJJ96(*EL!9$C"X'JH.;\$H)
M>RG;6%%4167([JY%&2<J]W0X&,Q/VO;'<,Y**HU"L8$UO-:AV;$AW$/8="&6
MAFN)<_+7Q-94^R5=J@5EB*V/S%6=V^+CW7S:E4.VX5US^9XPHI%_7CD&&;$D
MUBEGMH"&TP\E9M'1["NN?8S;M7";Q"6"FT_#'GQ;&617-KVN1<W17RZMWAU9
M7J+3,A)=:>G;NL>?J^YQIY1ZIZ5N+MEISWO=V]UW]+VJ=/%*)53_X,23'Q]-
M]8O?N,B-5U$%8=-\]]BG0I#B5*?\6V]S%)C$OF),VF)L\4K,5!QMONR,WOF!
M:*N2*5,8C+9U)8D#%QL!]#^PX1NV1C&'?P!5M4WQO77X'@*7=%M'6V!CBGGQ
M,X0RE>LT\MZ-9X,XE!-8M6D(H 'H-7.B9Z)]IAZ0=ROS*-&V;@H#=C(5;1)?
MUQ/F.E!8!CX!8#[XXE0GL]32\9]3H,Z/ Q&[#*M6WS.UBG0"W(U8[@F)2'FE
MD5T65A>N\">P7/HJC.&N+>C-1>6\RI3S[K63=9R8PZ_;"96*R*+*Y;.K<;'F
M%2CS.'55H Y^.A!/1M^ZHHTK@55H%IP'X-[^Y(]:11FE7(,M4#,93P[%DSUO
M#.DBK@S"A#R/&),,2B8L=J)!(M#XYLFH1&UC:=5J>FL2BWL]:SCVWC,!S#U.
M5TIQ@2O1$J($:]B_?@T@RFL0(C 0'?0@'L6?ED;MG!@.G\+=L[7*8S<1U&O?
M:-54T [QT9.G=[D+NI! KJ8H-24,>GIU"%*^!%8O)Q.I0=B+TK#(@=)MI%JR
MSYK>#YIE,3LQ<$FFNAJD"<!U#;'@$A]R[JGP(4G;U<Q>V?S3*YNE69?;?^J7
MV^^YO5;II)KQPKW($K!#170(*-86AF7>&I-^AYE,Q*^SZ4[KJ<(57/&+"HO=
MZ)'FM^*X:2PNOTM( 2"4KB/WNI"9DC867$%JQ:]:A3,MFH=-.3H5BE>7L.LE
M!8VRC2Y6$3J@38#]'8!_=,S1[V7DHD.M0+Y)BNR^[&EZ-A@J K>^J>J.8-%_
M##V8SK!&70!ZH&+5HZF6!( P$UW84A?U>U]<)E3D4IQ!L:C41?NR5:>A54M%
MLYHCD75EN0T2::-='8WLK4M.78G$OJ*$J%J2"-1 0D3SAJW$8N&&3O)E)Y[L
M?UF))P^W=.#UOIR_9DUC:@6DZ7CJC-"N1&E^I\62[YMD"'P%&(2T+[\5%5P0
M(N,<[; G0/"!\/?$Z]<G^(*SA>*@<U16JM85%%V1SKJ,<.-U3P_]KK_F0A>/
MX^Z\72\@38&'I)7"(RQ:]4::2'X0K^(T %[^*QO2:IG K.9P5DY]/AV_>3&P
MVO*#XD1/'2<Z&@9IM$*&-)P5\Q@^_!=02P,$%     @ K(MX5'P-X11!P0,
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M-@*=;]ZK9S,RQEE9J9[9;HJBA,5XK?"A115";U0>->P:"CR>QF66GQ43]'Q
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MK6Q)S^IU)VK[U6('>FR_@6];C",GX,S;7@&FK_7EAP3+*$K(.7O^XR+G"J-
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M@XL]?Y9Y^^=63VZR@1$^=_&]<+TKWL8$/">TF$'VT#3PYX9,6L\E\(EI)6=
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MZL4OPM?W=S]^Y?/AXS^XR0,=1]>]1;_+X @M@0Y> U@]B$.2\\-21,"UR2O
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M#6%D'8:WHHBSZ&X2=.ML%Q:\J>;B_@KCZ-^1&J(Y7@^N;73W%):%1;VG2"X
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M&*K1S!I,$RW:!'83;O!/#A,3)0+U"44ZC@Q$J[S<KM@Y_HZ E^9#XV7$4(.
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M++D3#IDM-9<QE$-3 S'*>!W;4"H=U\!BJ?O @L*&SW!^T@9$AA"UY(4R?N8
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MS-+N963<S3VD*>4-G="X$7DZ^@]^.FWG(@6Y$5?D6*W,$W<4^M#)3H6Q$6*
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M0\Z]<\=OO!W'(N2)D!DD \)XA]WDQG'A-3%5!V= NET*^<6N4C= ^&^?N]#
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M!_\.%91#>:= D[I:%A:AN: P:(LFATEZ3KPF?R+_,,P N<4'':'NJ4$\#$F
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MUWL-^!9$3_ ^UBM4XT0(/2P9".9#9LQ)NHB\=7JX45]FC9!.]"C2RD?'IP1
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MG:G+WH!^VZ9:I$:48O_PDI)6<%S$;2&?^JE/Z;XU0!79+]R]P$@*:1OYXF!
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MO:-UX8 G)$H--";%=-8<);G89G&WDHP!>9$4JT-$N:LE1XV:_3DRZ\A.]$X
M^WM#(-Y)RT:*TT 984'K>)81T:KS--$4MQ;*&.O( DS5Z*&QE_SO=:B^.X"[
M4TGGHJ,G5@U2,VA\[.9)/=)14",7QLF9>SU;+C@3Q'E^G2K]MV33P^G,S/@5
MQ*851#CL#OW-W3<P$1KA3U@[WE&\#8X_^*1;#ROL;Q.4'JYE]+Q^V!!(/71^
M!E='9EV<&PQ$I58X^%:9W[E<>O]FK53A)?A(/L/QG531:MZHS$DXR <(/-8
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MH?\'+Z+O%J4^\24AC;L'.JTX-4W>!7D"KI)$/DL'1TQL1ZV_&N_C&@(8_KZ
MT8I9"M9_4P/R/7C/!VKG&VJR&EXM6CMX-1<._+*[I:[NWD-.SI*37 95 PYB
M^BP'Q$@3Y\R #C@"LI84B MD&.KJMHE-X'=09P2]$_+X#R QU872JR<G-@_G
MYTG' X\)5A!20G6("7*6-^>">3.\[\D_=PI7-2)-J(SLMI%JKZI=MTO-QX]>
MJ##^B[K/S##!,HY_F7U[.$Q<%P\>B:GG2RW;?ZOL=<RR[$J[OXUE9G:YHL=Z
MOKY?V*W.J#:[%00A"",N%ZTEW00SL&D@C#+5A%X]@2UR^-6R$2@CX9<%&H+D
M /+@W0>G&6UA:XWCBY#@3PNLV4N#"6NS[.*',.Q*Q[^>#JX@3N _B-X1I(R7
MHCS*,Q$?F26JC^2O!O!J$U+2];F-KM67VF(H7BT9K(#=P1M_2-W1NE#R8SQZ
M\X O6SIN%0:NBR_U^C"-$O*$2;2"QQ.BD,X/.(X'O.6S_$>C$\53G&(AG?JQ
M,0Q!-KJ[>1!M0K(8;+%E$47>0*[5(U?;#I1N$%339;JAOP&C@:X/7T&LGRAR
M&>$H7TA#8^=E0%5Z[3NB7[<C-?W%]-O2*[$Q6\^;G?,>\T_;7U/,]#I_.[H=
M&^2@B;X\QB[],/#BR=ZN,N/2X$7)'L41KW/4J.-7/8.CHXJ<\'>MO]P.1;Y=
MMOK>-D 1?\2.9L&!LF;<9E4?#_6$I%'%4F-2*(7_%3XB@*-EJQ,J>VQS#;NX
MZX=)$1*7U9*9J*2W:H6,><?349G9YMB],!]># !"WUL^.$_^3.ZC--#:D,(:
MR1!*7X4@'1M0[2+JQD8& K--S/2RN@I1=+&*ZNA6'=6T@LB O:LFN1; 1/6V
M0T$QA2/&JKRJ]]-HU' #1G>J/Q2BA/6SG3YG]=2].U(M_8T=?=S'[*@[T!QX
M.BY/^E P&NOM497?N>FRH>[[J$#&&>_ +<J9,,''&[$W*V,#FBK>[V'E4V)%
M8W&2R%D]@*&6]%O1-A!>:IM-<I!B,X,#^7AKC*2L2)(2$J96<LX.TKXM(6&A
M8\3Z3M7&P8)?\OEMPCMZ?>NJKY$X' .=;D8/P:RWE]&%,E$+Z!>B.LK+&MM;
M?<PIW-:6B%K210@C9N7%01X2U1]JUQ0$&K;C-I$\ !;5.5(<:BB=EW,ZQC5<
M^YWQ4BP2RK*W(FPB1H2 Z1\S2B[8]T8W]"&)12^#>3E5^1I&F?X?/;0"'M=8
M=I6D;;M3ZA0WW?BQJ?F&UTRHAY]AQH,/CT<8/FUNK[P\[2J!*4'QFU>AS8?D
M =EPH/)/GOB%&HTI<Z=!$XF@+07+YVWF;B"= 559#'[4!-I4]P44D@P>_^1R
MT (Z*\%F.D9F41K9*;B@H=I%$PPB9F(OH/%[K#/!O"2VPB.V IKOX!H [G6*
MTZ>SVJ7[[[H4FN=.OGG_^E! 2UA13N"90)_0P[7%XX;NK=M.')WTSSLWT=LY
MT1N/CY^+O%Q0C[VL_X%LK?P'O1I:W4TV@D)DO#SZ>E@?=.JBOZMH$VF30L!=
M;5P34)2#D9B-U)*.2OH@=]*.)S.'R3\+>!S8-3+QGTG>:%**0%[+QL=5OON^
M]-9[E40U2&E(Y&-&+<2X#J304*H<J<.+4=0;P?["^V33 0M!@C(D +3(C*=I
M$#WX2>8E>FVKIU56("TS'KEI2A#,EO\EZ3W\+8!Z!G3_L7ZR=G!,\3@52 0Y
M\C[H$GA(M;$)<W4.R:=LOD+69<S]I#@(!ZC-0,2Y0>=#&AV%P%(;81U)%UC*
MWE?D^12\6B'!S3'=%9+&%Q;4N;$N[XB$V(2'KZJG'4\63+A&B.Y>LC]T-.!&
M]4;_:O^8AS\_K S>:[/EJM"SUTL9'Q9ICD%MVA)=TS9T7_S"S+SXX9A?]8,D
M=Q&E O/V:S9,4!92Q!RU69N[!GZ3+,W. )\EK#G#?Z!!Z8DR2YK;,!PG(:0+
M$]/WT=):D%(**L:Z9H)(D6ED+?X=(/,$*I6EM'?QV]T>#MOLN_ \).2H#8%)
M.:DZ#*= M@H'HO&,U*.;D%6V&0H5]T3;6O\ZW!)4TQ9N_J(F:-)1D$7+()D]
M3#5GR[!&89-AVP4)6B9M8;J#;);!##@56#>99%/N;*W_VTB;].EBQ''VQH89
M'_=3#Z7?/SQ\?T&F?V-^3P.SV6>[?YV=E=_=X+/ACM=BO:(5==&6Z,NS=PM\
M1!?[0A_P2GH]5-KGE/=X$DM G_N'PDGUUM!T]9 ,M"+Y")Q]K@&#Q\"^5-,Q
M;TY)6QW1]N4R*L_YDH27J<[8X!DLZ(I'Z9%-+-(:WOTZO) J2RXIZF?R_"@7
M^B!+S&R=@A@R?0.WM@7+G*)L)F$J7DEM]> =$+7"0\+*;$)2>9(=/&"NL>GG
M.I[ V4*:MS-ZKJ%G3#'_$\3I_),8(.HD:]>!]<0('&A>^N 5F\3:S_>3#P,)
M4P,#WWYKRALO<F&]2F3P>FJ\'W/]Z]XY#LKCZ[8P7&+UK4/9:M X7*S@#"CO
M+;'U/XFVHO>3[*"U0%\7;BMW/\3S!E!\ F(*R808G<8\X45.'?M;>7U#0_W3
MIYP?/4B)P4-?GL1C-D$1/WJ0/*4LG>G@P S8H3*F2?ZC!PF3;<R#MUU3;(QN
MFGA1>0Y:+2\#M>D/9QRKBA@0_1< R4].T>LT,# <% 9!!:Z-(+)+2Z-CI.GP
M"\*FI*HB@I2F#<5U_'9N_)C!"XG2Q"^$Z3CF?%C#*/?3<J,I\Q(RJ]VZR[:^
MH($P(FAEUR74G2.YM+;&Q-]G9]]Y(OQ2*/_&IHFR522*^!]<8]^<)Q"HVLA4
MZ)'?8#155GT2["V>P0I"4JP^PJ'MSGK 8#!61VVN$A2_$/M>3MAJ23&ZD&TP
MF%&@Y$BLK;#]%U5MH':1LJRP?07AH7HS7$D_5;2@(=^JYLT252^*HX!$7M!Q
MU2& FM>BL3LQB<XG9 LI&7;(;3%DW7MVDP^@/R0]MII0<U>Q.T<,+9;^ATCP
M?]XPPFLD.3 KT\B6_7;>2'TBZA3H(>V&];'_LXC=&M$*HAGS/XO89845GDV]
MUCW"E^V7W]E/K&XZ.\7H,?,HUOMX.V9Z^M3MK]=2?/>1=T)>9W\;;AV]$.7F
M7^DBG0X^_2EG[.$#># 4.3V0#>M#:JVCL8G<Q=ODG""=1T 6;2L( ]6A/O&\
M,3&9'P<MM36JUK AK)2)4D2Z<J!4*1(!/5[J>H97F>$V3 K0YFJ8":T"+A=(
M"%EAEL#<W4*JS E%Y5H,HO=ZR)=F'=2BV$&=+(31%D(%_#.]"ZT'=O\N=!K'
M2CB=/D[\)(V\1>SZUTWQ&\#5_!MAQF!D;GQI7%L_WO$61 A0_Q^^]9)2@L(1
MHQ]5O)V6#2,ITOR-]ZZB\]9FU:2Q-A[&"KVT=I<^^<#=PTB(W%UPM?O\@>=>
M=U/RG-TLAP7O<PMBF0/)GK6O.!=%K@L'L[_/RZN5#V$=Q0YX+2B:TP'5MN@&
M3]Q'Y0$Y*X@K4Z9KZOKM4?JAZHH/DF&T(116U5,/&F8Z6U?XR%,".T8< D57
M!%=(K8=-7L6JAF_\&?2>? .2J33I"D-(0^SQLB\_J;$ S%]48=X37U,VP#OZ
M&Y!4CF@K"2.Q74T4=(F0]I1,\M%^NC2%EPH[B7OFMQ)-5Q#NP-",+%F9V'EH
MO#[*>%TY*EVUPR'U8$5JIW27T5O^<(W1</Q.B<;NZ4?)'EJ.C\D*;K8CYV+H
M25_3W/LQ(PS?TXRYX/MW@JL^_K>2Y8%)2+C>'T/N.8V[)5JC9GX)[5V?E)('
M6XHQVXA8:7=;4$NHS'8S= -E2AP0O11@-CK;5FA%AG @BA1I"CWK[HJN)8:3
M A^,0=$M9Z;$<W[M/"W2::GFC#6A*W$%@80//8+/E"Q5Y?HB]5/OA&>7G\E]
M6$)S?';;M[?+"[Q;)K\J"!S7SC#/,+?QW]O^.*?A?NCL7$)"$\^;F3#;G@WU
MR(7*%O0J<AM*:X&723&>3U#Z?NL0_AN,^D-E0MPH.#&L,H.^3%OEZ$@U>5J3
M:MV5J7[#VBSQ^$&5-;ZS;(>@Q;5\,NFB;G3QON!T4:[S:;%(BTC[ZJK:Z:?\
MFR+YE1+Y8WK*CWU7T_W4DC103H7-30E\%G1.!-1A&F$:Y(:1G%-7,D[]*P_>
M(0+4WJUC4*4G@LZCQC!C/!"K_K%9]68%D?V S?_X-WS>I1:E&<QT8K^IB.)L
M'[ID?J<XR=ZD>:KI$#.O/?SCJQ =W_L+).:$I\O9@>:\D<?RIB$5S0H<4VD2
M%*?A).5MRB4L5:2+B:1DZI*.@+5LQ7%B8)MC%0>5#NM(!V]*8KTEO,Z\&TN>
ML4[=7",PX*]5?340P;55D5!+7\<P.6?=XE G/#\Q]E[)5.PDC]'K.7,\<8C(
M!%X%WFGZM\S4%,4!/]]BSQW^S%<Y0PE/H)P3J2$-_:3 ?\;G,TXUL[5V(K=
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M0-4.OJ1O/0?V$VU0[89P7OU^[0'%A%2]=K5;\?Z?4:5J7=+F>@5&1M>JNNC
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MKEY90C8*)N+.]\/'B^?Z^%H6?+)&[ 6D$5;:EX%#?AQ [X*6NL)V0ZDUD)=
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M'/&B93LBVY#0+B2?GH?>6S?"QFPB[8 (BE/P*="T1-*<;,+3B3%&_HZV@:^
M8741_PBGB_-I5>]G I/(!=<(E6/3CHU%$?8+?WHD/AH-:2@Z0-ZH!IT=E,A>
MK&HC1G$-]H*F%&$A,SS3!B0U#%4/E8"&'6B+$6<'TQRI*'?Y4_/#*<P&>)>,
MM>YQR#@>A:QM<9#,9ZIO*J9LB!)&\E,,NB4T*AHU,S)"1]I>X9I"#'F1?#V
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MFW'L6U5K?:WZF1_&__=B!*)>EF)P  &C/*QZ,QBSQTP[F9U[NC4DJ]A[?^=
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M8D<0=7>1J=5=!#7)L2]JINP)[?3UT$Q;9?:R;[=@AJ,%Q<DVL4LA=+NO[4-
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MRS,B.2@2>NO"'$$Z7B5[P]F"+X<8WJ#C6'D2]1#]\9314NL*#BA;5FVZ")$
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MUZD,O__5&6'<?%GJJIK>E"^^^R^^] Q\&9'N,[US1-0XE[9]".&FWTBT[4U
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M%U63>ITX@EG-2IN'@R%98*EC/7/986MGXF2OYQFPY8'Y"7LYG#7P;XYYRH+
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MK,2%R&@+O(1]K?12L(+<?(N4F'"I5WW-8"O1R9>J-+W>"D\8NT"9[^B+RCT
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MR0$6OZXPN@4%<3ET"I#K&K->?4F9OT.W7-DSS2OKHM[8,[8!>T>F[J&3,MK
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MD$E3!EVO51,6H=OM2MVO5_-:S=&^%EL^-;JH)D2,>=A,:>Y@4-I3)@Q4Z]K
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M2WFC7IV<GH]#2$E_5-9N-X=.I(./E=VK]I#K+S0/@$^E\\4U!GT(9&H!B3/
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MQ++8BAEBQ;;7JFB78'5PCZB8_GI7 ^Y]TR4'@\=$ Z4Q])LQN3J>?V;>H]>
M3!R9,#NEKBJS;(0<'-_TK>^U/QS9[F47J4&8FYW%L Z+<D*B-"1F:MR !%Z]
M1;_\^\U--(W!K&%XST!',>3$OCAMZ^E5V"<S!Z0S5?]U)5('5UM%R0<P-X'D
M8!(OWP)>V!C+US*/0!M0$UDQ=ESVID(9(MK6=D'3T?]XKVF/&SY(S,-\K<T1
M2WEPN;M!V/S6R8;;A99#@Q)RH$\73X._KS,$DS]-X8)6 ^AHK]QC@#)%CSS?
M7G%J.OI9$R]E3'3J$"#3OD?[.S.WVIF3V[EM!GW@Y;A=_QPY[ZG$-_U*-5K+
M6<;!D _R^>E^1VV;,!#&[PWVCJ!;;J#.?^@F0[@XR4?#^;R!O!"!KPG][LYF
M^[0RNKV,M*6K-;PR9_GS[?@](FZW:;I$MNV4RN*>(BRQS9FB(N=ZV<9.P&L@
MTF,@^?U;K-87Y7L>A>KF]V9-[H5,I>G:+"$#E7B<:F4KY%6/;GOT9Y>TPL?N
M(:MP#HZ&>,LCWY1_C?WL55?@'8(#DC(,05-PS&7 BV;'K&"8"=0E.\?UW0 L
MJ*^<&C?(U&GSVC%T.".LQ$$]@S=1X)C5&#AV+><\]>G;42]EI3A&UA3_?0Y=
M:R%4J[?S)F/XT(\F#%I>!K] !'UBZ7S 0QZFS_!-+8\=HR1TG3^X>Q9UW'"Y
M0X_"$5SO*+W9PR+1G6S06!!LL+4S,8RT'BE^[,-WR>>_[K_^_8P64<D&P:[(
MUEW:G3SP+-_? *UJ^U:\@A/+;C'?O>& B!QE]1 .KR(-9I3$QF3:T'RVMD 9
M6:"W+E[;H\P6\+,:>.PM33U>[UU@HU<,NP4/$*@;BTS$O6H[8'(UW5=R -XR
M=(DZDU!WJBT0&Y>FW99U;'$P\L#DX9.K,B;?N K(LX@+&T7E(O$X=!#E//:$
M\\=UF3V\H !UD+*;V2:;=G[VJG8U7ZD^5K:D_**&JDS9+"YM:);1S0:UU>,U
MT7UU+(M*", $4];@29A-#L])74YF06!OIB@ E9/\,+LW82R]?!98'#)/9(,N
MQ+-!GP.8O-LL#@W,"^!M9H,V"$NL=-8BBTC=SXH\[8/Q8D"VYD>H*RCD_T 7
M_F'H!/2"H]XZFH'=(Q0FKT).0!;,HA9IA#8VR#0,+=ZU%,00[:)K ,O3AQFJ
M.PSIJF T)9W#3/YF];)!^BE3D!\02@-KE%4UA8+4>H>X^@1_(R4OFA.X"=/Q
ML%H#ABJ6H5*TAL0"UR D4W1/3/4$A])8,Q2@MUTV.==V9(INKSP>!&E096#)
MM^X\=%+YYI9<)&)3CW8+M?,%7!^7_54R?JM9BDM'L +3CE*R_"J'B&U753:Z
MG)><03.H*^1Q%7U@^\##_C;CGJ6&CD"6EV-KW 5L-$3UO_X0&=*[R3KZ,%^,
MFW5T']W)EO_B/". .OEAW]A3[5MEQMBU@WRJG&OU6&LQG]%Z$"S)(P%C1J"G
M<S%GT'!(C!D0^DF0E]07':(P2V#(0^)#>E,'$+"6O= KVK6T+^(_@/B.H+M\
M*C!NCYV+ <'*"IUY?@7N3SSMAC'T?&K6[]TLJ,JTK[]_],GJ%]>B?EAB@XZQ
M08]"H4((#N$WHY:G/[U>B;SIA8UF\0UN.YXB)6A&/+T>'#\>NQ5FW'E*JBL:
MQ[V )4?QN%H-%%%FT,;@(RA>I K 3=EIPQQEG41 ;E,@S[3E'J6'Z$?F?W)-
M<+;NPQ,:7A8T#=4DWKCF$V#B9O&Q<4C5N"MEC;5&)AN\8-*48A9)ETX;7340
M^=CM?(FQ 920QO.Y-_USG 9I\</OOO#M:NN::.LKG31O2+W4WVXY:U<R7&/H
M/7QI7><,OLNJ*8-FQ$S6/8+JF#KFK2O,$**,V=R2'>LC$X0\Y0Z.)""#RNUO
M+JBB^;U.MG'_Q'FK=A-Q/?YU RJ(-1^)@15O/-%_DVE\2X"2)CM881[@^<U2
MUF33U,_'_%68/?KI"LX.;'GD1K:$:?:]<P=2704>I"R\,+LE</!_]=MA__/-
M>F9]]7>MRQSF/P07MR$&5X&IK@82677%WIC2UI)9T8S/(!E/'SI%-DB\A<\K
M A[=$^U9T S(;2:WO[A6-R;^^F&P8''.QV.-8IDN$I&?G$O)93U.1KX#EQM,
M Z17C]XC>FBF29V6'OI5F<P;@\@X1[I36PEOMWTG)-NSZ+Y,?C18>J\Z)3\J
M_Z F4'XSU3X*S&-4$5SPTP.70[A?-@M)(-2IKX32=;O]O*C1M!> P72S7>^8
M%H;' 6B[,Z3M?$K"&PDH7\^PI-J>)'1+*"98@G^YB,:Q> F>;! @-[+:1K=S
M\E1S.@]4E" O Z'!\]>%6MF@\#J[C&>,2S2^[L:5!EJ>6YA,G#9L[GP++:;)
MI'))TPUS,K/-F!B1?)+1(9EB^/OO5PI4,B4D)223J:5 J2V?$7E=ZU)<]X@"
M7)!-2=S&5:EZ'Y2J-LLS5Q][:@R;5;RP9^?L/E02/;TFDG[EY-,$97E:T_O!
M=\-Q=WLN(8<*C:"3":4SE.W@QT4W^+P-Z%O49,89#B<^,$II'^C(1^R0H>U2
MR8]&&6*4_ ZU)U]MTVQN<4+6BM.1C)UK&7Z29F6RZBD#5;?0YP;1T[.0'XI?
M?K5X4]9I1</GCR0H^:^#D)?B1E]'W7$.@">*.,X!>QI>UX5E?@4)2P#N;_'I
MF*@F]0.IN<Z6.R5QS^&]=%G^D9_I\[,?DPME8K<+9DV>S)U4#SBF:V%GEK0G
M$]]%+G*;5]NR\K)G@WPA5+Z=%1DVZ":&QN%;K:>FU]D@2!R$++7^ \J*A:QZ
ML4$1,BU3++0 0\W1R7[48,[ALX13G(;B/+TX7+Z+\FFI_;A7$IXJ];6]\ U=
MQ9;T3210?#XM63?^8]* R'(^"<UK#5R8X8>[:;C,Y;-!!1.$FXR5L+I#0-',
MCF@O5#;)T$ Q85=V#F"\S04KA9L2$S4S<NY8VHP-%$84VMT;=QH9O:AOL/-,
MB7&FFWZHM?$=8$NW:2=,ON+H_T/?4=[4A:,]&:SCG(3U'-WIRY%I!%K-BZ1^
MQ'X2=S)]F27T7@]0W\).=X_9VC0E2B9-..D_<MU^)(EI)P:J%VVP02);YT@0
M;JGU<B1FQ]='CAJ1Q= UV%(TBYOQ5"');\85NY;9:N@I?'XOC!(S+H?'L+Y7
MF,L]5%DPLM]H9931.^" IA#M+S%=/M3(:A\%V#\],K^)1,&HM'=L4/O=J?=@
M)A]X_# G*?$^9X.8)P08XA$Z !-=H92QOH?>7H8"D=H2G$3*\1RPA[!N[B'F
M7R=8YMB8L$$J)18<;BJ9( & )WD9MWCH^]B@_G/,]VC*WX 2YW"?P7]V$M:R
M\Z^6%S:8;!"4U0SYCQT8[!'R8..CT9OF'$IES.A;/\PZ'\7\FPU:>,'Z 0&N
M(84XAW_G_V<GL=/TGATF9&\K&,4&%;%!3LG_3=-OT/!'X%YC3OQ1VH0T@8$X
M4=I^-NBM'IU#X$C[*##.\5_)_^E90OBZTM06&[3</TMG89@A$#(_)9FQR]'+
MI,=LT"YXB?6,V?P/6E6)P4_XRJ*@R1?@/WA9L;RKX9P)>K@%S8HY"OE/SK%X
MFPAH#C'!&OP74-B@&(M6R.8\F V*K&:#?J'+]@[3:,Z,00*% X@RO87SA3S"
M?<B>)*26EW4"?) -VCM[X3\[*0?H_AO"XC#"(ALTDL\Z!^6DYKYL-$NPCPUZ
MR<(N@/\ _0?H/T#_ ?H/T'^ _@/T'Z#_ /T'Z#] _P'Z_[] 8[L@P$4VB,&/
M_@W)\Q= -0D2!R&=9;Y'\:!;L93U6'_>]VQ0FQI2"(AEUK-!7(*%[Y8@7G0H
M0\W@&:%:MXN)^;4+=AO4[9\/SO47=^IB/?T/5[Q,[ :X)3Y?WO+3?H=@2&M&
M>':FH<LML#TB@[/Z;VDVF0+%/9G9LZ)?LKPRJ;A4.]K3X[IDE%#O!3=;0;7T
MPU?:]'$77%!%$>T;!B?U$2$]/V8ND"]MS!>:/VE:-.QD]/NFF,,"F1F_O<^/
MY>AF*A>>FPW:^K1 5UKAR'2#4[\'F7SJ]]4N/AMI=?HWK/XUD;9I**(R&Y0W
M#.%<UP::%< &66]!]-B@V%1J!BON"PQ(IDRQ09J\C:B>?PGS]M_(14S]QO^^
M?]A_V^DR2>D_3"*==VYLD%XYFG7J%P?CY=\C0KV2>X73DJWQ[RHJHFS0_'6F
M'&> %-B@Z:*I]V#&*7N6$(9A@GX,3@13&B D6W1O/4,(\&.#CHPPY#" #60;
MX:3%&F6-<N;8.BL/QOD_"MM@TM:W(,/8_^NI_?TN38/&F=%.>#FUZ6/1.E\O
M"U=ZR:/DP'$TITG"\,7OM-S62'E5I0GG8K-\<3L5C[:?1>)>?D:;/M#-\ITD
M(".VVL$J*&?FHJO?'?C[O6&Y)82#>LU>K4@27_+:D]1B9U)W=-M $;WA[MRO
M>8S*[$7(?]?JWG0-02M1\[V.=^VR0;*;A/]F!4:__/=+D#.L_P_7X/%ZL5O\
MZ/:+)/#N9C(;U,J!; ,RQ-Q/#[W$\H0!%]&OF:N+,(H?EG%JRBPX?9/$!JU:
MY\D;E:=X$H[CA;]F'(P]>$X$W!GVZ-8#D+)HQ+,CSE43=?O66 ?8H/!(]'3&
MY)64TZKP^$D5 *[3VC);E,3B X!.&<P7\*/,G18[2,(6W2JRX&'NW-*:F"9$
MVE9WS&7CURO&LGNY+&#<6G/J;KK']>9"J+"I";+,N;1H/F!H;,PN'S.3OA31
M[-'-&<1]V=#M4$".#D/UP'"/GX"?87!"K= X(;]V(MH% >W2Y&&#XA3R;<8>
M:49'L$;!L;A.F[1"]VTQZ>%;L78W\O:I;GFC7_ D;J^]#O8H7JP+LD/E.?OR
MS"9N)[;79J0'!0[(U^Y89=S5]AO_>5U6\GT?=T'5[=*%+U^.,-_\+G<VW82N
M,U@I"WZW,*E(366#<%VM/7X'A)P. [UEL*5<B>JJF+^[2="X.TI(YWQ'>3FQ
MBFR[3:"M+5"P^\-XV]%?MPG@;(1.?#[74+?R!5?Y+)L[CP7%<14T#_+]67V_
M, $C!"(HLWZ!!$1E9R9)QQ>A=X,--[N&6L8,E=;J"1),H6)L+_2''.MH%?TB
MNN4:[A]Y71%$+O0P$E9#S*6WP_8C@Q3>Y<R4'5F]*Z9WE[+<)>>1JT%9K?9Y
ML2PN^O%C_8?J4-LFPP)$X-R:G"Q3#OO9]\<Q']O8DO N4IGS996<(GW<&<D,
M0[G%JT8CD;<U;GC9=%= WQ1:Y;C+IA:)O$@?B&_8"LM<RLD<+> WN_54Y'_]
M@X'_B7;N[%^&H'TI4-"^P920?<:P;UB&()%U%%S,T.A7(KBN/P_Y-:RK375Z
M=0PCS+ M=#RMR)":9KH,FGA-FVB2^:3K1AC.15"!N<:GR:*+^%/U==6Q;IAV
MK.[+U2>L6TED[8$HZV?)Z[)UFC5V/KFBO(>:*\]7X#M4!HP6!TLNF"<3KF*X
MR 8QP8<C&5+_4.$GAF;;G/G=[U.>9+O&]OII+J$M>BYY6C<C;^9=-$5^2 +S
MF.(52VDJLJJ;,(9 -(O;I-P!ALBB>3#C&1:^!6,VT. W#". GN=P9'U][>T5
MNR4G(<"LN+5CY;'"KTV% *48P40!YNS7IP;3NQ6/SX6WV]5M5.AF2 UN.OSL
M5NCH;?\ ]?754JGNTZY\D.Y1^ *7TB.?T">9]'5MQ396,G.[;T6)=GB1Q8]V
M1K^'0"G8I:97$4^$#QT]K<TCZB$$.WFU8Z1]R-"IPF,[B" I4$*,GXUPR8)T
M3>I2\V.0M_J\W()9.C6]5V=WO;F^:: L(E/?S$2VW/4N+D@-JPG>=+EL$5?B
M5##; Q=GM<.@#'\S9@P> RQ@G5FM;-!]%(9D0!.B[^=$\Z,T2#6ZD0U*P2HM
ML\0P)S[FPZ=T,1YLD-\>&Q1MD(QV42IB:<J)VMB'*9Y5VZTS_\LYVKU3,SC%
M]>5IC<5-C8/6IQ_!W(>\SP^L3"[=.S#_X#+U]:/[1C*FA_:YZ;RT2:CEWU49
M>UQGT>T'69=.J[O<<GHFTO*,;'%K\9F#H*/K+0\\JVEI$O1B7,6#^MG"H9T/
MDR;PVHQ YJM6Y/,SMO&LD6]%YMHZSRI.ATII$-.]XI*K7[7=*+!+O80+&XDO
M.U2HZ$Y:Z#:UE+V[\7J+'M]]9^3XP.V)&)+!P[M'[MV%'GUS?#[%XU ,\R]7
MR J'*X6LZ(*G$MYH2"2( _/OGD#V9BH>CP/V08SJSZLC)5>W(*]7M[!>2R>?
M&Z?=DBQ/Z5<02"%@MT/1GLZ(:MZ(/ /NB'OO?WCRDXRBP+Q'!O+TL_GO.1OE
MJ)Z^<=+0[G*<H;_V-??C^H$O ?1VZ772G Z'Z 00]H:V5'1/N@CM7 O8UF;=
M# TLZYY>(S0<+MK]1=T;AA]-3W<BJ#1R<E6;_[*#JSI\4C?1GC7!!BD1JW4Y
M&2LB@'X(3.&#Y-S1UISF3>MC'-;H^ZBZ54SQ"MCXJ/N1Q>E#MT86N)J #,]V
M>]95>;488;.+=B $3J%[>7PCMI@SB\-3/<.3&+076#GYN ;K+]U2 U:O*:=E
M#^9A3K?/K(GA+=%-GNCIJRP<:;J?#=*.WF7(HLK  )P>U#>R!KOLB\0QEQ>'
MV:">Q=D=S"5.[E-AA3/8H$_%_ZZ503 EBG=W#H-A@^R2 ;W#C$THAS]6& SE
M%?6P0=Z;K/*F2C9H>->#ONB_S )#H$V[:-;)HBWP/.N@ 4,"N@#I8QS%O^&T
M> G=I\)I?6\0W7H:,I^)0C,]=2MX=&%T.&;[X:P?$YZ.P6>8$DB;6_2^#$Y>
M%T%?9Z&G[Z'_JU=E2[S_KG_&N7!6<-$\I^O\I>_$63:HEN.NE9,UY(\K?USY
MX\H?5_ZX\L>5/Z[\<>6/*W]<^?^J*]%M/I#HC0-LD#2VF#?\&AN4;H3"L$H]
M*/ "(\@QCK(!6R;_RY,]9L\<NF*#N/-A<82AB\($;[!!# DLLQ-,V<\T+,YJ
M2_D+1=-1VZ-]PA:+MK3[OG?#\_,6WD2*_"2?#0/8H&-$&YM=?\;,%'&VR#B>
M^22S;AUF6K<(5H(2&G1==,6<Q['0-$)GOBX8A;( >&=?9NYY,,1:F-]TH.($
MS**E)"7\&&L!O#A%I"QI6I9?"3O%2J,'L1J4MCL]IYK"U-'3'&4S4JKKZ<W3
M11$/=860[M;&&5 X9QN[-C]AWQ11\B^P09;?$+^VYK_[ L/R++$?-L%A]5<A
M@VC%M/(GAEO0HMEA.HN@I3>C7Q%2.[K.$JK96B!\I9XJ.#F(PC!#H"L8^.\;
MQTX->V<7[H:*&PR_T53C$C5@Z=C)-[!!#_V9D&^3#<)L4"6-#<J8J/5F@V2V
MV:#CP5 :M.Y?=W7I,N._[W..E+)!KFS0!X@=I(H-&@570%;6U[!+DT[HC"<.
M\+IUC"F6CAEA:%[%<'OF2E,@,5NPTPCE=I&1"(8UJ5E_W/KW+AM(C1*GA;&U
MV-+1VU*X0?\*:VCN)*V5-OF_L?>F84VD6[MP;%M1$2(R#Y)6!&2, XA@(*TV
MT( 0 9F%B(A,(H(@ 4.B,H31=,ND($1$)ADBRJ (B20!6E#F05 )251FJ6((
M!23AI/=Y]][O^WWG]_ES]H_*53\JM9YGK7NM==]7U5./)5SJ0QW8I;J[<I?H
M"W&"C 4\'Q"# H"%N8X-M^ <,[?Y[7TU!1.(E#"IPLPB?,#AQXN1WCYCHP9U
M0CC7SZHFE%>7],D*).?T3?<&K:_%GQW:A*7#YXA\ZUG7J]5(HT]=]M8.KU\]
M']0WO-A22WOQ*F]XL7-Q^'SAV(_^F>WW;H7D!_%L'A<JVOAF[_W]B_<IQ)$V
ME$0.Z/H3[H+_B?ZVTT=Q^G$GRI(9+D$>99=GSF7E\3_&V)RNNCJ0Z.)0C<;H
M@H8-;BF)@>?Y=5ZIU*1'%,W 6RF5HXOG;47=3^S;?I3LM-V["7-[I@<ZBW:(
M)>6V7S+Y[R%K$P8]=>QQ/O]/Z.234;(,^\+1*K8L7D:M-R@OC/5[UC9MS_K7
M>3U6X.#OI?NK+DPW?<7(^6C:G[075E)Y:DN:'0 _**WSF*Y/EV)\Q3L][X'*
MG9JZ+E/O2GJL6DQ4LKY=7KN<E76E1%ZHF7D%4ELU8'Q_&.7B)9E*,O)YM/R=
M8F!K?"G_6Z5M\+D*U?HHW&O+]K-/4O7>F1]^DGH(]G_IV,I!0CJY'6$IZ)?8
MN9,@FX=@2-F=[;/0@&Y@  <R)^.62[]!U!3^9#AO(:50$HJ)XY[<I^&X9)0V
M3V2.N:4NK%!W6U-'0RQ4L'O=IYV@7&:A5J_?(!Y=09 @MIK3)QHI*G,T PC+
MH<R_ 9%O1;J0'<_>[T+\>6B)9R_)I$@;BZM%[FJ>YA_ GT,U-&7(C<F&:T'7
MFD1_K#LTQG Q.Z;<?%2(^]BXC3:L?.3?RW-5[+>'C2(A VM!\1G^/7%J4>\B
MUOL0.T/6I/OH_D8@6B#;U8YN4+]S]> @08DPHC+"0*=)&O<G:T%A/$3B)NRE
M@"B]\B2O(TU_^5,4T//W/FV?(<<ZBB0.[0Y:IQD2#H_.F T)&TDH6"E['<$T
MW,?9S;X3+LY!!4GIVIA&^4'.^^T1'$2U_\=T5\?XRES;;->!N^O+GWVE@H:J
M?62HRHXWOHG\0;\4Z),F*&DH+L='H-SX=S@+BMP59;E@NYF'I8H["_P.??^S
MVE*K##D'Z707U]N>/[RB3<H*6;Q!+)HG'A%G(!HZ1)Y/W% 4#8I^&A!M$7BF
M,<>W#-!@D!TWIQYH](2(P !+) -2DZL(&G@7TOEZT+"V"G>:F)*39Y(:B96<
MHJF-&."500F&2<.8=UVNC_(@_B17]6%]N_#@)NSNKX01ZH:+Z*]QY5KP"FV]
MIQU[AWX)<@./VSN[Q=FQ:+_4]<_EBN076-6>]E[MZH9@3BWR7K/FMA9ZLB"<
MV]A_$,QM(^_&GZ=8]T_TUWW\5;!]$Q:?2?\ZU6RZ";MRXREQA@G-8H]Q%G;U
MEW"E_9EXFUQ?,*+KA>!'P=7C6GF5EB-,QQ8U>V/C*G]%%2BXP9YQO4+5^]@L
MRHZW:ZC9N!,J3EQ".4B;%OHS5P(O/<_V5IF%I[)*L)*NY\?OIV<]AYX9U#US
MKK -&BW>L!6G#LCC\^Y!:>!6!GJG"(&;Y5+(*V%S\"T"(R Z14#DA4;/J116
M"M,XB.U3N>,'0*UJX<,GH\%FW<7"_.*@D4;*Q?[(#:'#TKL-\\3LH<$_Q7U-
M[>]OMP..R'AT8X= ?Q,&G?>!0U0.!G+9VJK-TN;>S)CXH#T_V?&/I2'^4K(B
M&80Z]/FS*@8Z$X6<1\]O*=U!&RH3IK-C<K%^D+-($K-A)?K(EA)(\)#QQ)WH
M*WW<A=%*;L=<'^AG"XV &R(9BK+@5PN9 8%-,2Z?,6Y>NZ%]U]C<L&<"@,(G
ME$.;@S9ADA+<2,_)!/P%O.NE?J,-'$T1-Q2%;D5"VMKSUALAA \4X)6X5Y.)
M 3V0CWCX>41&R__>?%4A@ =O8T.61(Z:N/GSQ*-=TU0_T(OFJ(L^B[Z(,X<D
M&A%6"\F;L+UTC0T3QR6Z'P>[F]X((4[VE&"WJ74[=]&?%YSE29 8O67"8OWC
MOL(*Y>//AW2=$H853CP<R)J<$SZ*>3H@.)F.<A<77-2O'-&^>PB$?L49HTV8
MNXL^636EC:M+]&?*YQ O.QS!*#ID!V>-'\5Y1LF?N(4),G0OI;?LTEO:A(EV
M=H"K_!+A$Y$DKJN=6-_82H><$#)&86F>/0D"- <+N;!E+62)03B%GE8T?*4%
MS<)^1,BMM-SR&:0-<0V(;698/I\2+4U"\]'\RPJ5%4%F3P=$-T5LL4,\J7L$
M\M ',;T8VM# F_42#@H\@4;6%Y.W!).1YI"2S[C5UG'-X:@XQ&\-_2)5_'Y@
M@4%.;@I+$UB"*E@$[B%*DKNC?MK(VYFI;@)<>SFABMB"HSN!\@VO.6326^!*
MW,/)5S3UKBE?$/=9HK[P:(N:C[K'395$:6Q(:N4#TRJCZ[W?[<:6-OJ#]SCE
M.Q(??T=%,5]CX!=?Y1YE7;KNOKOCH_56$O4NJ^-8VZ4C)I&'(R.&[+G?TBCZ
ME!?GA7^5.3TMMC>E3MFFBAP7Z!.E%, =/4H81ZH0^M$OCT)I''):/1F.#VD9
M0?D"V#8?I0&+?0)=B,PU/VG;1]OEB?\-BHGQY6 25;XE]-%)>!/.)FQLJRV8
MV]&S*Z3P0/\WJ* ,5[]@9*^[L!K/5Q(VB?80OM!WT3DG(&*X^AT>=7?'TX]X
M;\BR?.8Z%BKCD)/KW0W'WP4\#%U>!27NXFW'KE2'3\"3%9K\D_*Y709(EQ>O
MGXO91[K F(?=CG.[NGKGQF?2EMUCE5TO]9]$#<M_?ZWEG_CANE&M_0U]\]A7
M09WG=8TO%[A;/7K*V_&AVS'M.V=ASZM;R4NZ#PWD\_QCAE GVZJ*T9U@C(5%
M@XP%MHHS?:E(::0DSK/$R45#7J<S+\%?D]\F+P )0W3 ?2%5S)HZYF=!NPDM
M^L1"0E[C6RK)0KEY2+\P5)6K26)19:$G&_Q+V!3:ST "S:1/3+_D<43FGU '
MSZ*$0_WY S?%8F^("C&I^4B5.;_R,H$95=,&%C0*%+1%NXB5N$XV/P>@SS&K
MH48^=D@=_C,4PK$F$:2@R?-0##?_ X8GYZ/26[V,( ^K*[> TM4;O\[FU0W3
M89%IPI-.KZ%P(N_D)^(+4?>(^K&<?08M5TT2\=[)K9PE16LD\V+X0Q])XU9N
M[<,<54EK><SA8I25XL[3+I=?@XO%$DZX$*2?\IFQ;O5^M7$+O7;U70P>:.I)
M?7CIY6Z%,/([\-59:9>TMI'6H:Z0 087?)#LE,:/B0P9S-#%5<?5%3LZ)@BS
M';"SI:D"7W%':-Z$M9ZAF8E:S^%_)MXEJ$*.7&6:#A,,K_\&43@]2KC;GET3
MYZ%KD4>>4!,$Q G71J\D,*G4^+>64,N:W\QP=;>V2K6^$?"%Q?2)6F*#V_Q6
M'C&5MD5\YZMX'3")"C 91R [.Q)/X@X!!G7QM-MO>:W5SY\6Y[OL#<[TWXP5
M_E9=$B('<3X$,$2RP"2+DAC+3OG1?+(T1*05BF&J'Z:IJT#A75FXT#;E86S.
M=RCXA*ZI@_]N?]N80A/$F9UW&1W;,CSB7#*J7:B^3J6:KSCE)68?DQE/IYVS
M@@;#Y[J;G3GZ:<<^'#WK?34./ZM;<:?$6>>MN)-?0RNB"%LW;#/?GBM6 .6F
M?4T#4JN^F"D%.128#6F8U0W2G\7JK25!JILP"8F00F70) TENW$=__,KH+3H
M<1</DGX)>)T"#7):BG"-C+S09X'LG2@W@-BQ/EY2^1&7Y@,>S^12=WV&QI>X
MVS.>0GYM>=1X(ZP*SII!VU,/]K0AI'#D-CID !?(27#_YL\6VH0NQ+:HL)VB
M]XB=!"TBP[H<QW: E+F4E C*%H$Y,-28C/*>((Y9<\4>9'@ /:UFVLEU!@X]
M'>-FI-8T8*&=*"TX0GSB/L66_U[[X@W8D;I1S$&JZ$==5=>6N/O6J7B7K$?I
MR2.,WDZ]*GM1M9JA:?<YUA"UR]#3R,_L^3?"L-P/ZJ1=.V%K#O;,OH0.OY<J
M0Y,^<)VNQ>8KVF9,H7/NK'.[_\RC8%\=WS7>!Y_F(JLRDQ_:KOV-*SW8#'&A
M=5U(_KM]8A)[\5M Q)Q.  AW[+WVPT)[BJA415 5: %A[08>];=>X;>6XPV;
MZ, X=8*B!KUQ&#"8JZ.F]!U_P]F01$I]&O?V#!HWH(D&AU#RH19$P=Z7HEU%
M-80OL?1[%@IX5P =+Y !P]Z.R]2!'^X53=A1%=!)HOU01)C\3"PZF:HO,*D.
M&AOT$0,Q07H?EG,O$Z72V(:0#_8Q&VQV?!:2I_6P:#K6L*C,_5:T0-Z-_PZJ
MV("+>GRDH%J 9 D1:Z!,%EJYV1Q87._A6F5PS</.D,\,-<-!65:NB4(.30F,
MCD=RAS+/ 3D/U11E@Z,50@*,!4Y!BSW&+1_*#!V9HY/P\!_8/_T6U=X<^5!Q
M*?O0U[6.%]1LOV%M*>>/W25VW8F>>\L<W8J=Q\]5[VBODK>-TC%\OY#RBB@6
M;.\ADB$7-:#_+IBSSR/@X8%J4O?1R<2V?GYOF4,ORY%E56)"HF(^9]O*:^NZ
M[#.KFT5?%=XV)HZYL= OD SX'L)(L1=V3 +;"!:^YAUJMA$7^UTX#&M/X#J=
MA54,1DL;U%,E<<=L>NO"I&9NTG<;XI7#;CW^'-B$38E,X<:AVQL4QH\UCG"Q
MM97MZ !$<NQ"&WMT<L*DC2CG-7V\4 NB 'Z<:!9:QC-0820G5K[F#0^S=8IP
M<&A^V<O<^MQ0O:2WUKXS3J_(#@VTH:B3?^D/*]5$28YF_[@LD!XB3C19G( L
M-^P)(W0ID0D.P1FO &8GZE<[X#OQ"GT$!!3=/H9D(9*),N(($ZT!-^:"-*ZQ
M?:PQ'>_-0< #&PEP<5#+6!:FX!' /_63%LEX,JFNQ=I#Q?IVLSTSGG-A$Y:Z
MY/.+AX4;"?=HNVX]WL'K3I:.$U/HA]!'7?^XRPE?D[CK)?_ZA1FYY\#DH\']
M.L@SJNTHT]8U].[F)1-6E:%_0A&)<>5U0K!+=>IZ@]?NL[4Q&8'M(.O2(>;8
M8&9:P55[3, .VZ<\1:&^(_8OGS*QO!2KDKNU@85*O1;'<?G\8*#T#I"'W'XJ
M7#O=D'X%3LZ#O\7*,T&$$V **)*].M87[E&W&.AY3='A&))(>Q3R8UW'6PWN
M'UQ>4)C=B],[![!_A ED3XIVR3\FL!$[Z[V^6)]1WPNQ@1K$[B"*"@I9.KW^
M#&>ZT&PG_0)ESL/ 9G(79[8TZ_%,@([DTGA&4\[+<NC-VZ:DW/) E?GVUT^1
MB<VW>!E+;.E7N:3%QD?<Z8DC'E%FH+A#*/OX);WWN\WJMCU<G+'>_&W.7Z=S
MS_<+RSRG$MV(1P&NC_P_,&G: '7O]]D#K>??7W]8<,&H]H'^\;"<2XOOKKB[
M6W9' 0B/A+AFOQW=97I?*W4C9X8239V+7<\)M9_0Y= 35 3@V"-VT',K^H9Q
M$'$[RAC(9"FPE2+)]SQ)J5@ND83WHV("3)AV/7>'UW^"X@0ZX-:WX&A')$6F
MOGUX>[%"S8A!R%-ARC(G#(?<A#FA ^#)L:MB4/+^ <I/_P!EP7^!<FQ*#$I/
M^8;_ 4K'H15)^_\-2GLQ*.OM_@'*>M71OA_^0#C*_"'GJ'YC\JSSTQ?O/\FF
M,B[.6%7YN[H\C\C2J^CS$9ZH.'WA1<[]AGR*=0(77Z;*\J!*]E9X?%\[KK@S
MH\,I>V=[^B&_HIV]V68+GRNT5?[\GAZ5,<</>-F'34<#;F)11^I ?C2<Y./2
M)GI(%G*X.Q;ZIT "9J^XA'<#JVDKPW5AL'= ;21F3H,C)IN_>!J\!1MJA>7&
MVX;L6^/MCV=<_*5)D4X4* H?/QFA7Q+#?Q-6[]9^,D.#>2X$^U+B#CH0F9I+
M4.[#GSI^Y[%EN4"GGZ:!XTXR1>I)1'GHF;>&K4V]362!BAYE+^[.W./&6IN5
MC-]2#)$R3(\&5:UW+Z=[TP%EOH9B8E=<MJ6;C"=-NOGY4$4S"NET-.H)S]ZC
M*2^BVH4GU19S'&G>@[M9$,,\PGEO(:F8MQ'L5))41.KPY:46.9UX.);%+?]@
M6]ET?N7[Z,OI=;TUJT'T1#41<&1_\N.B6=0$['/%UDIQ$IMX%C[<A.UPRZA;
M(/''-<45I8-Y_1-[UO-F)>C6(4*#\&3TE;!MP5C97P#%#(/(?+@JSM[H<6,T
M&RZ0H>*8'2J&^3QSS (=TEH0R&'XKX1/T8%T-5$/O;YL;A-6C)<;KJ;MT&Y?
MV.9IPB2G8;?C Z032Z$%6T!S.8]]U\(P1$542YTB: VB3C6>!O?=Q7E^.D,'
MW)*-7E<W.Q]_^1W"L-\+3+CZQ5M3V_V"+_=2;S//*)([=2;==[T>EI!R= ZO
M3.GBN RFASK-GW;..Y?_[45:[H=O%CK7VZ,>^!YVW^4Q!ZS=T\7IOS&K^..[
MT0M]@FY^>8FUU$.'U#(=GSQ;YXP3)DYYW]_<)\^OR#EB?R+<^Y\[$6!3Q<BA
M?UKE1<^IUA"ZS,10"6PVJ HL-*-!;Q3)S1K<+VK8H''-.H"%ED+7#IL[=(<8
MW/JM:: CQ3@EM,:HVG:'_ZM"A2']E9,AE^O1]JT"[?SP#IF+)[ :[@%YW\,[
M4 ?#HPK5$[[=[JJ-R;9UJG[GZ%S@><(L:^IUFW-4B;U+A6U^MCN^424\R?$M
MWOA!N$_<2DG6MQMOK97U]VU+83G?\WUX<;')Q<]RL'3F=#8^5#<[Z^",KDR%
M[OF9P7,EZ+$9O44)OH6X*O83WK'KU@;P1[A"-Y'R*K?@8RH"LB0<F&FPX=C[
M\*T^_B(68L[JE"?LDV].[5;P.5 /U%!OQ5QOR//)KY +RE]9\?!VR4IRW9(M
M_G$ZJOS[7[_$_V']<X2>A2;'4'-BCN'A)OOUU5R^JGJ "J[3T&B68=A=(RLK
M@3(\GO@E&Z\9/.C5YS!=[*/(DU;B76A0;MPUB=N]L,701?>5V>>APTOWFXK3
MF?9GY.]20WT0BE89E^NOUS^H<[3$3R_?L90[)]$CSC5D1P:"'PA)@$B>5:V:
MHOW$ MS^>&()1CNG:2'-6%FC7Z#S9.\^S<5Z \(B0W+48/5#2)EJUU!&SE ;
M$48P&T$Y@MKM/H>@.SQO)YX/&)9>_P7#*CPP]..OH(654)\?7EWO_I*X[/C0
MW__N^"]_>+ZM_?2I0TW&*DV()+9&6.A_F5%$[$0'5!^]J>!X*AST:_NC6-"H
MN+>K H=M?6[SLFQ4([YMQ/E3Y^_$^NE&5;DVV<:E47%VB8_",W\_/@A97VJ]
M)HVS4/;X%JPW^W#>YGR9CJ6I<]?SE7WZQL:1GUV"4VLT1\=*S+),LSFR O?U
M*(@M?,U](U9P6]-R^4C2JUCW"Y:Z4>@;*=P+G4D(U8?<@YFV$:V^SR86RZV"
MNN#)S._JW;8G4I,!RAR6;RU<1+>3_WG2\DDD\_(?[_1LPF[W_8]A\3%S%41M
MSO2W::$Y,5E1R7F '6?1+YJDK!"]<!@^<D-#M(;@6?_SQ&?^?_P;@>WO?EC,
M]OEY2S_"4);=_3#AB,S;[H[K7[>NGB\<Y&6=?U2LQ%C,=+3]XI7JC1KAL7V:
MZ<F3#_V>>]R47^*&?ZPZ+IT04Y=]U=[3**AL]$:G29PLW3KL#SQ&,M@LLSW^
M>(/EX^0MV3%;A,O-X3GAM9@S*OL1N&$C,QF_530HGLB,(.Z83RV"M$3^8Z^-
M]M_/:0I"1W'7C]U0N0-19FZI+5LDT>Z;HFL3+CX>])7+?1,B,*.;'O^TM(*F
M1Z@Q"JUS_->LMMN>N"JM+J=#3QR\;^L28J_C,<ARR;8=PHY5F)X<G?[>1$SJ
M"A7V]G1])&@K:SRZ-9GW0Q^E\VKK-^G1"4)!>/JMD?(@=:6?D3\Z?KYI\7IU
M<E$8TG<5=?0GY(_V\-ZM'5@BDS[<_,AUE^/-EXT0042)MN];@5#\NI4HY+/A
MA6KJR +*@<T(N8TJ^4OMXM:I..+Z4#EM[U:1!YR%^'K,9PU.DO-;/5,JO=VB
MX'?EK8+5RC-,D+QV!8WXMEK9E;,W+)!6@!I9H:^I-]]XEN<31QNJ6XWL6U^>
M_8Y?I\EAU[Y+< 1+=YS(DG<Z<NAEBQ]N;<+XNS9A/>C)35B;H_!N\5.B.+U2
MR]<?L4>)-[S?H-&M.2^;FCR?NK)#!.HAQ)%!X @G$KW8A?XUBPZD404@^OX(
MC>B[5? SN6(3QLU \G\2WTY+T ,-"FVQG>N1FS#XRBK?->1D1=F"(J8N=S%F
M/4YD?8?(,*0OL41VUH(#LV(L8K[6+] _2HK/\I?08H#]\R9]*\I$O>D! 7KD
M'=]5(=H9,VY("2+>Z!E86$1)BF2BQ-C37O1$<Q2Q:URB)C5.]!:[]I4M[F0J
MZ.>*HAB3[\1V<GG7&M:!PA'1,"^>OVS*(X"1&W8;A00*\<\)[']-X>\L:!*;
ME%TSN+7P;^/"V_2E=_1C(J,XJW].93$N.[%@<& UK6P,^WEI>4- %E^=X$V<
M3!'DD"'+$1&.\BZ$3?R7\;EMXB':KU' XIFC(K>!,HA(S9RKTO]12FGV_D=F
ME;&_XA3_Z82Z?[K%9^-?MHD7D8+%L/>;L R$8^XBK0#-%.(I_KX!449"[C0_
M=Q4E%!=UC;?T__)!\;^\LLK^M_&-+<3)3$* (' ]G9Z]/"U"S'[=T)/\KYC0
M7T].KZZI;_NW$Q#_"NTF[-_F_QV?07\!M0PCKD98[5%WCR_V:%Q37(FP!XVA
M_P4@_\L+@?_R2\OJO\S_.SX6Q<AO<69$TOJ:12>C>R9HHVU@'OGC/^#X#SC^
M X[_@.,_X/@/./X#CO^ X_]I<$C7(M[I_?>X[C&S8H)H[J'_[E#$IRCTY'\+
MRN02)W%>29!%U!#)R^)<,(*7B+,!2[]LPLS6X1L[,>=[_L7T<9LP](*SNRGU
MA2AH+69-M-ON9&79PH'A@E!!85C7@@7.0M8)/01_BQ#5.U,8OV[7V@^5KZ\+
M0Z8U'N^?55I?71?^J-]=N._T#IF 0<I(^O>:$S:;,+V-ZI)<P?'9,+T_EIKR
M;LUZQ5&!-6HN]>%BXD+";>=DDO+!BS<G[S5OPAR&6#,6RGKTU5\7P]_V4+\5
MBFA#?)?)I%/.#SJ^AD\+):C*;VO@KL#;-7KDXQL?-Y8[(-$CM^*DUDY[0V]$
M]D8,D1GR>:G6XYM[!T2YT1B&9@(6OS;UVM8*/ZI_W(J89-,LZA^L:V^HD?FW
MB+KKR'- [S;ZS=<]F ?1ZCSJMX4+GVF(KZ*Y&^U6&.H(96"LI2GFPM/BP,9-
MV+4W<90.[,SD';>42LM/8P2#39CN-#(?&^V%H_S_-3!3'*I-V(;DVC]682<0
MA8D"^OI*4Z=F6=-Z7*ZP!T+TCR!62JD"H2 .W3(K- Y3%[5MPBX3V1IB;/[S
M+.0CD8/8A/D2D:(6!$#>A#VGYV["?!*S[#!1RQO(#0J +JD0U0UMPBAT<MEJ
M"[&TNE_42503!&UH"^*@</#3V\4/PI*)@IL[5T*U3-,5QG6 DLEUQ52\3GF$
M8]7*_-Z0KOT'4_;7-M^R=_JHN9)8U4<L[F#VJ$-8+N6V8!^HW6J6&BR2 =E)
M=6$*N!N.Y*WSGE9O?+<77UYL5\YHZ61>K_TR]A=^UNYIWEB4QY,HQ/>V?T]\
M=D,L(N_"!5>;0/K<:VY8O$I+UX5@^A;!Q>'U<_?M?Q1NAQ+6<Y/K3KB_/EK;
M &J6983R?JZ[[JY%"97^B_/[R-K(],Y670\%>-HAQP9M':KU5G)>QNO%N<N#
MAQR*&ZA2]PK,(G/R_)Y]H;E3^NE6;!EMBP/MUV\>I1]'G&"Z=GRKC:!K^=]Y
M^NR2SH#;)NS!(YK\L\'8V=MEE[.>]GRV/?2$3H;/__&/]ZUHI__>2OU:SRB)
M;]ZOV0*-@,BS ZA?AZ\LV$+1CQ\(3H&JWJY)7"]'7XZ7:>*'['JPOE#2/H1U
M++!0+21K ]7T_NB>,C!L(E>@T,@MF_?;B!3LAHR!D=98-&/A3N$!L%Y44,6L
M; OE8I/5C_5S>P6_]AK6/CM+&?51J<]SK_O@:F["O$D<BXU;J1SMX;8$..2X
MEPA5DP2'>#4Z[Y8L#G0M>@Z>(.ITA8^6:IN^CWGNKE)W6"GXU;,ZX%B%A-OA
MZA-.V68A$K;UAX;"[QVHWM%HO%8F"[UY>T&[P/^"R8/)R' UR_SO#PG.B>^.
M=E^XZ6LM\X [Q3DTV,%X-*3?E*#M*:^+"@TV]K>Q=8\U_IJ%6&9:RKE-:D_[
M6LJ=V_*O0WXM>A.V+5#8L(+Y2.?[-=&@&UP##2OA8PO]X(H)<GP[OXM9>.!-
MKY-68PNX"6,Q.5+1%P9*!I<7?L)Y?[B76R4%;Q]7[;/0Q;WAV%/O->^OP6&\
M!R,WJ-8ZG>#K<?\[G1$S/I]4'UP*XCQ?7NA2='I:_<$TN,CA49A3U?@?9<KV
MTPHQ#[O#[OQUM(IPX^$P7VEWHY2;8DK%M2#=R&*"9WA?=[5-Q$"Q?8A3%6?'
M[,$X9_$@^!^$.43_-[?:(1#L>$O8,E15%ZK("FAU#G;"Q7/%A9F$/\/506F7
MX.+/0(X<N[AH;D!RG<[*[*T-TY4,"49L3H&O ID:K)+XH2:?(PQ>9'ZGB-M3
MZR7B1#[-''3(G!"J\O/ZC5J</45]&X9%O!X275&DB+,8#(IUX;^,7)]D(5(H
M\&;-";24QNCTJHR[#1>Y-RCHV0S9OV@Z-*9Z)O8:)5K %]_2G#Z1ZW-"G#'W
MIO,6YI$;UH(;4'4I3@6C\&&BN";XR.RX 30$%@FT)\J739MMG@H\H&J%EB=E
MI&9$)7D'9#O2=B,(K9CKW0P$L#!)(S=]=@PUZX14(6>LTX@37]BCR//U0V5
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MO?->I[-FJVI"AU/Z:TUGB93BE#+E:IY.WR/N4WKVF[5M\E]%!M J<.RMA0G
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M64V>X7NM]9$/"\VF7 P<U\$<@Z<U:U #QW4!2FI=*))%4 +1)&.[?3>8XQH
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MFD!G*LI0Q<5/(=OZ=.9]_)^-0,?&#3P""&-A( ,3<=+<Y@Z(]F"WX3'"$G0
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MM^XM*K8SN3>+F?%)P[:]Y%K3)6X'M[C@ 3LI(FL3LMOC6(-MZ\:Q4>!>.)
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M:)#;VXP8Y8!2N-8) 9V0IL"/8"X"F6U$'MH@RY8Z&R<+&VO2+*;,@Y^.;4X
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MOO0*2R%Q0+>P>V?%R( [FIL$%T?)I['!LQ-(ZE(;.7D2$M=R$KB!<FP;PYZ
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MVI?+.)7D8Z.]?/E#2;=9:AH@N'^4Y0+LER=BP7Z,'\:B=>]JI693FDP#BEV
M!WTS ?$V/T^?O4W" M=(JP'1 3@IV;2UP,KS0\+MXFS9MR,5VIK[Z?0&-F_^
MOB(:1F^N3ZQ$"<'C]QC?U"IH')#TM+LEMMAJ:]JJ>F(Y*K W([' CWEK;F)\
MRFDBAK06N'Z,5+(:E63C'\K2G)L%%$_FT#_,01\;RP"'6S5[YYNE!&RF[$:;
MKJJ*M]5;1M+X>UW7LRU3,HNQOJN9X@\RM\J)DPI_X!$CZH:4RLDRT]"]S/W3
MJ/UVK C<!XHC&#(>5(56H1*16(GNDI6Q$.=+1M_KC8T85IG"I):< *^BJ?('
MHQ<IHJ3D],+")O4N 5+3Q5=G 0^%15F%D;8>G3Z_6WJAN)(ES<_WUXY)-7'S
MFWUN2+H?K5JP4#N^O<3Z8W=GY9E!KNH^B5(Q2'8AR6W+"GG/"-ET4.0_E7F^
M*XA?^6ZW53YTL8,ZGUSP^!7AMV0W62G[E_1W9E*_GH@4>]K?M6PNA%%$%:T+
MS.']9NNI^WJ ST=B';&=S(_6H;.,9>@>1'CL3ZUD,?X*\SU^16WL$2#8><2!
M=\?PPRKI4:#/C>$@SWK=8Y.?]3,^=RH'2$<'^&*\_I.?PN QW]BZB5</RHR5
M_'J/WVG@@)Y 5-,EMS RJ,N8%<1O;N%5S[#_\@Y84SHZ-&%:KFTDADAB-ND_
M&V:2SB_9%!D[/\FLR_T^7:C_[;--:F#WFV\_L1=#VC<-9 (ZMF,*"M90!?#"
M-3\YOK!F0F "KK;H^.3%)RKSQSLN="HIGO_O^]H]^+_\D#'R_U\N[7_N OS/
M78#_P=?_M_#EBG\<5<?<H@CW^)S_VB,2\6"9W\VEZ>FGS(NJT^(.%5HG_JQ6
M[25UO ^WUA(V:]39SCO'C 1,2WR9O5 <RS9 V37'HB>484C[1)A<%-49LRY<
MZ$]4#>=-]S8+<+]:;N/Q\>;PS?N9@E>_@?]5M^(ZR.E)A:3 P!/&IL3$+1]E
MD^ 7-(9V;$YOT8Q[<\:S_<)1K0#%[>AF5_=1FZ-- RQIZL'9D:KP6UR!G@>O
MRZ00A;?ZCUU I7--@V!(,'B1+>+8>6=BE"=VBS6O6)1-C_.1.2VS)?JT;>'%
M%YBZ1.ZC-^##.2:"#JK4FFS]G@^+CY#3D$MJ1O0M189YPZ&0!PC*^TXDS4A&
MS3W]UA:+J/+%YR_:7?*JZ/U<;9DK<+!'F*_/Q0XOC:7+N<^KLNP^/T] ]_[B
M]O"QJO6@C;NW_(+FW[X/\-U0B'^2>2\RI#<@]'R\MY>?UI:+Y>$9Z>-'T\0[
M5_J$<WSL[^#IC_==.QX80X;=KZ0+I'>6T=X%5MZN'SZ6'"KPD_AZ?.K;\AXI
MI3;?8S6[L=LHKOIH.>/:&R"@0ZP^,RKH;6/,#GG 6*>^92@HK%_*[YK*D.^R
M<6;5,B/KFS;TA/_SR][O]O5'MGM5@UG:I9>\*BCE_@_V>CLSJ?GSELHF0QT<
M4,+Y%W=1'J,_^ZT:1T@U@3M&=VB6R!MQD=Y.=8F7^$S>+)_5)ZG:C'Y:=K%O
MKO'O?N->B8^DB8UI3UE$8]<C,\C/]?J93Q>=R5_Q"OF92Z2+'H8A1R,!Y]SY
MBR]*!OHOUM6XD0\Y&C%XP!Z)!4@P$M8=XARCY/1%D]+#TYXUJA$9BAQ?[]JS
MC6UYDA7DO%WUI5KBRRL],J^&OSJ#7[GMUCU&69I#1?9\2%I-"G_9E2I2@4<*
M(MNSFE046UG:)?AL 77!*Y4]6-?B"^33S[4*^M43I.@"LT]9RO,;I^H:I*Q(
M@?.J/NU1<;B7/W8-L"PY Y:L!&/L:3@1[-]]NJ7 DUJL!FW2IUD$"GLP/!Z6
MN_T8NS&I,[OHT[5+/LV6 /H[("=9G@SXO!SN*>M<V8RORVLDG811N71BPW?_
MYHA6UTAXGJ9-XT!XF4[#* Q>VNL5<%#Q"NFW5R?X%'K&Z\#>%;6$,&@IHUV8
M;_';>7'W;D'*(I,#6GOKV_CG9%JVQJ6"&=>)CL*9/FW77A,'Z$UMGZ9F]I=A
M;?Y5 7'3A"Y&%9LOF=XV9#/"4M__ PBX=BIGFT0W:R>_=7HSVO1(-_@(0+8U
M0.*&-[)'U)J$*X#4#MFSYW2XLDHU?X+G&04;'0-&0QA@"@*$PC3$9\T*A_!(
M,-PC&971%O&U36/Z%92TT"^R2 L5*@NFZ6;J=W/IKYZ++Y2R.J3"J'I+>N6=
MZ>;C23K"O!>P1D#5/!@'"Y[_&9YZ+\.L[5<$W\T+MG,LO&#Z]TBKWPBA+[Z_
M* ^_:Q5H4PD6 )=;?ZD>__) 6CFT1 ]QV$2YS#P#(IC8<05KP_[LPLUVLNSC
M/SQTU()A9@4(^..F>Y8?E'43MI4#%(.@$Z\&PBS5<]H-C-AX6HEJG;)S6-Z9
MG<ZO9]YG+YDW"K)F]T-9KL-LX1\N9I3^XRNS$\:ZC%(/MY7=#(V/VOB3@*Q$
MI<J=#S797$GM2%\DT8P\_GQ+GR'+YH0+5@^@???LV:DT(ZC%<"!&X^ IV5>:
M.+$[3\"7(&=)Y+^:(OE0XEW,,?'G)H6N$RN.%V9.,\*_.+JP8ZG[KG@>U%]3
MB$B:98BVXU<8;RGK4L.@BA0'Y/K-PX2Q2V,7,GIH8TEL>7_YGY-=SL,>D!/+
MCA4P'PK[Y)"F'[7WPH1%^6I]E/ORT+R[8WM&XY57>ZI=B3L(P54I](VN4@W'
MG2=;"4,]WI>#1A:T329+M'4OY_I]#G=%^E>,*(8'CCPGO<)H/Z*7"> 80JC,
M2W;4:6U]'ZT?=D62GGEH2Y>W;0OHYTW>"%X7T8 +UZR@ B9@OH;P;"-EIA<9
MZ&+PS$<\#G,WI!';71/=E2SPHL KU>@N;NT3M3KI04^9;P,>C&&D&(CXR2[K
M1 ^BW1#LC.AZ12&[D%K& 0F- Y6=PQ;YB3G8<2/'/SZAVT/[K8=%X46;/TPC
MB6LA=/G9.2YK[\=$.-202<!#AGR7V2C+_>A.9PF$Z9Y<,ER)5J#VKQE=Z;H6
M"+XQ4-<;%,$0K>C+DR\E* QKY_#GN5H/UGWCDP:_)EW,02H9LCT(BRV[3S8=
M8ULOA_\LN_6]^F3V_7L%EL6=:?H0%7NS(T7.Q5?0FTR-O*O6A7* >"++_6$?
M4"!\@@B.*\CPUIIQQ%7@\B\G58]<L,^M=BJQ2@HVL&GO*X3)K9B#^<WS4)>3
MKUNBX#DD!/@^D/@A#()_R0&!]!??2VZ?=-U5'7LSBX["[G#Y?K?"5#B,>&$^
MA(VDNCWY@5/P72*RHLC7V^84[\L/+J\VA;N@^S^&..<Y];9\$^: !$@<D*IV
M#$+!@ >^,AY]*Y4MR $QI3?_^<^ZZ)??P8!9!O&;Z,0.'S*3/<5&9F:U'A0Z
M]G- OW% X%]PRL+B_[[=U.P_VTWA 3,.:#RXYY^')1(7BG9-95VP8=;_<>H+
MK)_]UC*33%GXSCV9^[$-SJ9@D =1!UD<T"-9@##?!B=%Q+/.;AGXS0H:BP0P
MB=[GE2PK !^' >T#G>^/,#[U@YX,F:LOA>LWK\PI5O4@5>&-RML\;-[ L+O8
M(/+#"@G#("3M=%KI:P'&-$N)T7;AUJ5?7B],=8[Q2SSZ?J>%IP.6"4ZBSZ8H
M6BJL 5YZG9>TP]=KUD2V^*1W[-_^[;?M9[ST@PU> G+!"1X0A\=I[AXJG^C"
M_@X'?7XI^1DTJ'=IF+J]K?NM]>6#>&M34;8-9 WEN/F8 SIZB1M"&68&*<#R
MK&!)T&=;-P39GV:DWZ7:U [!@LM- JJ K:ZH/P7DRAN[GK!"O)BS1Y:SP[YZ
M+&\VS1Q[/QJ>QV-W; 1]NT%1M1'K.++$ 0FWB+"T@0&J@-E'N!@,3"4^-3XY
M8K9WYR$M3W[,H7HK_7R*]*IUJ+1%T4K&(\=H 5?$\S';H<6ST=(?(D=N0UZA
M?#IRM5M9IA9:M!2!CXR40_<O4!GI_E<J?PO)8S?$4H;3-J>]_\R;@:BWC3S)
M/;,60)7KMT'F  5M,HC.7&U71:J5]A<]Y8N9=??;YY9MTU7:A!Y9\"2V#R5I
M7A>5'\DXI])ADVMO3I@%)^'DN"+R!9-,$XCN<.DKHD&%5PVJGC9=*I^97G%I
M::B8_>:?75]2[/%E5S>B,2X_6F4W(B)"5Z@;MBO<<[ZFY]RGM2_MQ :R5YXE
M!HR:YX[+]:-T?+L.5@+KNR& _O-= YW+/\\*6 8 J13H:I>*]HNJJ!X+9%E0
M9T]XH&ZQQUW?OV=W#I)<D]&*TZ-G]8IN'[P]J,7.S0!W#,@IV%MD$?Z(L[2=
MEN/H2R/7XI^ZEL3B'[*P41,FYPY2/E/,&<./](81$<4H:KQ%%.L]MR/#6;]S
MR1G.YHO9UP=X:$L/89;T_8X]9$K5T;YX6K+2JD4C"OM6&\AOJ=$5+#=(R8K\
MWBU/+'6Z%EJT(D8-NEOITQ#VC#PH2L/_%K(+8HCIQM6ZH%XLH VSYVO5Q,K?
M B=BT"?%E3L,?AE[/:ZX0HIR#E*"K.TPWAM=-1>S.)HU]#R" ](@TT08'!"N
MY0Q]E"=!(^&=WYTFB]0YC3Z55PS]."2NZ]86^KROC_,=G61_B:@)@A!V7>NB
M_HA^IV/PZ?3A1#QT#<<RBF;S/>. KA;_,Z,QCLA\R@$MZN#_R^ETV&M:CG0P
MZ\\4$ =4(->&!;"T*NC>BU]8E]D#,%?O^M @!Q K*%>)1S]I(J^X+@![L[_J
M_\M9C0/_]8S JF7Y!#CM_#V> TDU;N;Y9Z9L)':XJV=O=(EE C_% ?W8"\&R
MSTW++7! -K/0KE$.J+?AOQD"UX (GOL+_J/['I$- <IZV&^,D:,-<)HD@..
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M/?U)JFBMDO=PY:%S"O5FQ54S'- XSS][/2/7C/;/KQ#$Q[:10GX9Y-JN-J3
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M,MS[FFE(R2G PI%17S+W@R0 M6SXBC[T"ML&Y<&3UJ7Z@H^A%"CB4O49C='
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M0DF.HG9Q0H]5OD32B["RKDI_^P#TE<1Z&B*= I*F\)V"#>-<,@2)*UW?+ M
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M*->"9JF0K!$X*8+DIF](-''SOOW7H)5Z_WMOJQZVC 4%?LCY_B%!QHWO:=*
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MW$JGC[)W220?HT*ZDBW[RO%RO;<I^%\&S"MV)PRX@**572Y@HV(%2;= <J*
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MY:_?FM!$RA3V_)8Z?.%$D4QF@ICCS=;=A^D-R@ZY&UUS%[$\M4GLP$*W&4;
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MM"#_RXCLFKT?659OWJ6H'1IP!OY/KV?XW[;1[7G!R$XV5F$&P:6;*3%?:+%
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M@>:0GF=<P%1%-Z_,"Q_@V0=< *&$^9@+@"/F$>PH4 -PE_;]+VV7N_)#EWC
MONIIB$@<&*;N1-"&Z;<1:^]B>0HMA7>3@0P_Y!LN@/2_\@291LQY&OT_[+T)
M4%-IVS:8=J,5(6Z @! 5E4U,*R"*0%II0$"(K)$@1$6%$#$J(!%"TK+OO(J
M@I!FC9$E(IMLB1"65D2$L @((4%%-LE1"4>R_<?WFYFW__][_ZJ9FIGZ_IGJ
M*NXJZG#JG/NYGNNY[NLF)^>!DI*P43OEL(1(.<P9XTSC?Y$QYZA7_OE<:H[N
M1Q3X&"I 4$^;^#U=9M",_DLF?[DH6MQ-I_Y'3@@ SIYY.<.56.$&I<0%FO ?
M4''Y3=(EAZE ?$1]ZT,=A ##),IA5Q&+Z>)%.8QI]Z^Y^4;%RV&W0A:EO"\2
M2;1LU_\^OA5VA;3Z7V-Z])?T -0"1PJ942C_I4^R=R@>8IGWSY?$H18/Y/W
M&$?[![4=(CC=D(Z&RB%FB5U';;.&ZN_6KPB)!^(O"?KJ_IO9ZY/2I1^X[&5J
M]]<O<#">!TW=C R!G)75_U\$'%4CAS4WALD6OU,HQZ%63"Q[6)F'XGR0XH9D
MT$I<#Y>:H%]1 ?>_)$>B_16:OP!&6\YVEL/&(4?<^R=*@*!R,[ETD,PN6^&-
M_66ZTO^5'W/K7Z'Y"V!<V9<9GIC]X?MW!8GUXLJ-QI!_UGNJM]C_7]/E\J_T
M/ 34OT#S?\#U-YG^)M/?9/J;3'^3Z6\R_4VFO\GT-YG^)M/_.3+M GZ6P_+O
M+X_3YGSU_PV7WE3;LD9G!O\'G'Y\"P&)ZGJ1S_TGS*9R&"IO%P"3R:C(V;9F
MW+]#B2YE2#^/XY;)S;2IKS@ 3H50ZOM.I0F:C$?0"7#_U;P/<I@&?MA^=NH;
M] O0^V^'%9OCO7!S%AK6A_=R&,*0!L QDN\_()(I\-^*D L\4=>,S(1Z50ZK
M@]I3IM;_A$(#,@A_IICEBUZD&LMV01>D_4!'#GLN.:;=(6V2O96B.M/_XVJF
M4^Q_2Q\:[W]K*J6+'ZGMEKBO_UQE("+>[RV[GCJ&H(/#_7+84__Y$2!"] KL
MX?.B> HA<:PA4XQW[R92U*Q^5[R%(C]@7YPEIF/"@!6[1]7<]F&U[9T_E&X]
MGC4>"1AU5\.6%O@3D$%BF!S6>@@%<0/44TC<3Q=:W0Z>Q$6K+G?"MTEN C?S
M;B&B0\"%#R.1?OPSBJ-G2>)V82QIV/J-OVI=F-,J4KJ7<*&B/2Q>/"Y-IEZ
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M]CJU:T 6*GO^#3(OF^DR!E/RZH?BH_Y.\.\$_T[P[P3_3O#O!/\CP2-'W]^
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M;=9B2 X,A6@9=[ V@Q4_WF\3(-L9U=7AB8T=CK.PNQ0VR58%E]O,1JT:KA>
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M*21MY7O4Q0O&M,Q7/O;WME,0=0"RLQ=.RA^V':Z83';OKY!@^+R-I"1%S;&
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M?#"0Y7!0E*C'WSU5KO(QXV90=?;H$"/F54OL?E-]UXX+C[K?W=LVXQ;UD7'
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MDC]5,FH*DT@/D'$NSP++$ )THDI@#O%)%2C C'8L87!T@F+4L]\MJ0;9(*F
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MEAXJ,B54*G!Z<&$[L8$WO>G.F(7%6\?0[7-V44<E3B7>2MJCDO*Q1=^2N'-
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M!)'EH*C1-K5VGC)27B\'8)%/YQV_LL$/2_/I?5&B<[WU$#=^QE^K:3O&M35
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M5]ZM<OK"SFG@Q7]Y\SVM+EDM2[Y,6<XZDF??&Q5H?:)HR=KJ?._TNJ.+5W7
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M_=_Q__=@&&_E\45Y)(/_&>?,=R:FA2&.T5D<:9O? 4QZ:*0!_\R.1"=4X9!
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M^L!(FY)GH))+-6WQ?R'CTVJ&T&-MYP0FHYLFUA!(L)%,4W1\R:)1>?(35?S
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MYA-DJC>"DXFZ%L_!2!,"L ,]TX:C@B#>&5-%D+(S-,N<E-V* .0I7%U',S#
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M@31\[M\R]J39V+]I:OK.+=[Y]GM(JNE_+8^2">_E@9Z]7&F%?3%[E-*$'V>
MC9P=:!=%A_ 3XA1?LEOW!9C>B1;'J=8NLD/+DP6>W,O$&R^!K:3;F,VW9*E
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MKN-DPM^#?DH)I<C.H@YNWD=>X5OOW+\8A9">*95MLWH\[A>JFD6/)#R9*4$
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MW%4[XFV]FO(,BM<LYL\L+M"#F@:^#I$D:7,_QB<Q57YFK&I\OEV\1F9?27%
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M*OA\N!'-HN?[G0VQE(> 6%OW9(@L$1*3#XZ_67//IZ@LUQJ$A[OM3Y9.G^F
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MDR[U'DKGNM(L(M\9'CHJ%5[A^KC8"UZ$95(YR_M%)S8KHF'4CAU#2TV$?;:
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MEHT6;']+CX;Q;R!\L10,ZB,?F2N0S01MA?ULQ,Z/T#2_)U4_:EF1B/;ED>0
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M>9?IR%U46OU^NJX!X^\-W@WFP?_%_:TE#^87<^GG>2UV>5-@<=:UR[;!_>W
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MD,!;HRA%=KJNHN;PQY(VY5=$I^ZRM/L6(..?L.DD,,-YU)OE)UY8*\@FZQR
M=G9HAD 2_>L"')A&Z!0.F7?=2@SP_O&#N=I]@X" +_H9AXFNG+$13)R45QZI
M8E>C@0HMO0)$]49X/=\7BQ@]J'K;.M'?GJ O9O%V0O0P "**<QY[8.Y*Y&:'
M2,H=W."")_62]V/C@I0T'@?-J#O7]H^VKDR4G$=Y-$>Y-QY^MR\FBP^%SRNC
MQ#"V<=G5AF,B55#;=_R$ )>_=$.D+[P&6K5@<"Z:%\ 1'ZH Q:K2YH;2<$J"
MI+D/SQJ#,#T.-$@CBQ==%>3D6=1HLF8"4P2+#T2]6&@7JM4E. V77]-" :*:
MII7?,0/](F-P OCR>R_ ]IYSXN1,8-&-F)#^;C5,U+Y8OY;6C,G8TC?$(6BN
M:)Z;;U5\+#HATNQ[T.UUG.1>_;Y83"7LZ-H<C@&X^ EP3Q>4)K88!)'^%%)2
M^!O061_"B[ZH]7WX(P>O*+P8>II( M]$=?=$J@WMBQ%H<L& \_"IKNFDMT8Q
MEIH'M,>BFU P^)W>/0HME'L1VL^ H)G0:IFN0(B'H+,&:.? I.E:H.D 9^-&
M8S3.8**#D8/\^9D@CNW8\QZ(K6Q@9-)D>!1Y5ES+',9P@EU.E$U"RZ]J6;H4
M#,<C8':$:Z_@?]UCP(AY>:VN=C\SO0*2,YZ';I\-B>]H6\OU2B'4L(R-!LKL
M5-98$+].M+ANDD#C'BSNZ"XH[9SN;M+O)3 MSM:[]>;\U 7+R469&38O!'$Q
MDAOT^^=5ZH74>R-DFF6];L<*[V')>\=*A?4#.K]$1ZZF$ ^\6LA&"J=:$EC,
MI1[B0\1 '9YA*3<GB;$!5ZE2HF!-^)55R(N'_D/TK?01&#1D'?X7#<&$!::X
M3FV;HYY@S92['@7Z_)(RA7NA9DCE'K#]#+>(R)-1]P1$C8;E3:N;=='=Z0O%
MY->S8#Z[8B;'^"FU$/I[WJ+'Z+;M.-7J;-R60=@X*V L]F&YX_36AI57!ZVM
M:V=3$A/R*V"713-;&I&>I1.YC*/+:JAL!"K88$-4?ZHH]Y_(Z3FON^&GZYK>
M!JVF;,8$1\9)+:R:=:5\O9R=-MB<GWNR].O:;I<X5R2/P&<*K&&%' _>(S#-
MFB4,@T)TS__[,=-W$D.0*ZRQQ7@6^C2&(;96''SJ?_GCS1] $W45-G2OZ$PK
M&,0XPGT\&7*'KMO(44G=]K2[;]L^^+[4C379J#8BO=RBH_^A%.HZT^-9A8K_
M=F%G%DRKQ7S<21-44YM>I,2E 7F#;N @=[?GC$GZ)0Q%".$.W=AN5MFZ"/<;
MJYDQ1-@M%5ISJA4>=TT--Y,B_:H9H3Q,4J"U[ZAQJ<LK_&L6]YV6V5X=XO2=
M2#G'@Z/]T3>:J(3]STSU3TAM@+/35D\MRUUZ:[@;>"-FJU@<G!<I0(ZM+,H+
MY9K0-HUK:AG",P*I9<MK;U92<,>!CV\7NS8&"FA.2_BC6!6@G,F 8D3SO"-=
ML'RA.WD%>7@:Z\E=E(Y$B0MMEC:5EDW=5^=,OJ,(B)06K'4WX$Q=>C>9E![N
M-"6\L+28^S,^/*K[>BG&%/4'/KN++@4ZDL$ZMJ5L30VF?6#!>&;N,XN]($8'
MS J3#MI%V[4'L"5PWX9N/\P/FNFP2 Z$<5#':+!';^<BNZ,C87(+Z?+]:58#
M,]N+'X/,EZY"87OZ3^5I1I?=^@"(I"L/J3,<2J"XP%^=?ZW?WZF3]?G1](/C
M6>R0<^9O8B&:KLSDU>F^J6JUATH(Z5[B*LV"?:](!;#.C70\7RO0<*F:?'D-
M2S>)'%'*9ETYU['\T7S&V:@TRN.\^=6+6(1'G;/B&M,DQ!#K\&&WC $YV(]Q
ML^+]J!^2-V7 W:7KQ0*= "#NEHF3#GM!:E+X@U8O'YT'DZ3N6NVA6)9A1=W(
MLN3-')2<<8SM"-L[U?/M&TM(H8%),>$:9N82R(])X;JV1N.,]Y[7,O "*V:U
MNL#%<##^V1!V0G?HFD;J$"8Z]XFTW^ 7$>Q5W?H\._3U@'-+B.1P(:S%M<KB
M4EW=I19-?2^83$[--X)X0F=,'X86>)5>+:5^ZQ4P<KCRO6H]A!QZOT'NBU^9
M+@&A7HI,K7[Y,*S^L-O#DR1;<I0G2J%^DA$+FW.WZ053&B/P\L<!K$@1L&-M
MYOC%%2+55QA'ME#*?JMS934Q+9A-=FIQ >T45R:-[43VG0LHSA,I@?X79[(J
MF:,VM2R@01VO-% +$C>(F; G,ME9N[ 5=#N4$^BL:;-I@E;"#+"]#]2!DHR6
MG5O&&0C"^V-2^-0"+>7)]_YIY+")Y]7P:?VK,<FP8Q&=%2YLJW2QMR#CN7(J
M--<$_R-GAZ/T#HC+\ V7N9*('4'QJN$"J/G(-8<W9O=",//&1:%91;_D-#7Q
MKCV0];3-DE:&'LXOB1Q4E;"6<^NU<<--RU&\'O2TBU#]85OQ*HCVT_\^=?^A
M[(/Q%ZPAC!#OQO2Z477FFNO E83V1F\Y?[E?+'3EW>K5XM\5GZPR=\+)C@"D
MG4=[);CCJW1C )^-/!XX#\_!6BU=%Z!9,*GB7"W8P23[^V<*Z/<AN4@H&(K]
M[\]0(1'GOOG-9&_#Y4 B*TAC!JD9U3U2B$4!F[P -7SA!LV;'_@6[[O7M2\6
MV3.B& $#,K'.Q<RO6J= W%><I !U4QN$ KO,A,6!O=(C;=&M6)M1A $_#H9Q
M_ZUG(HZ6S$^_X#1-/Q<]=Z1^QY^LSLS'+AP"5O8XM0Q4\5CX2=92,S"-YKGD
MW8@CW&MZFE<*BHNS2T+N[DI[-(W(E8YS/)Y/#DR\:)-O-LE][D#VO>*QZMQY
M I/;O;9ZBH\,\99S-./$%Q_FFS=DGKU$5. 95=P9V'4XGQD9$N5:=-H\,DRQ
M1'L]X7RF$E1%UZ/. 3D$%C^'W*3#P!^6;('L_,8HO_<B<O,@KQB*R7"M>&_[
MC-?<"[<?^[39\5;-<7 0+ATQNM*M=;=A)0@V_BZ"O+X%4DS2WJ9QH/_];P*5
MD8$\@Y4&>UIQ\\K51N-"\>:WH,.^&,^;6:SI!Y99;%'6W;GX;$"H."$,3$O!
M)<L=N?O(]RUU+C)(;=K?1>"2MS2VO6?'M#S=TQ"16K]!69-1^IX"Q5@Q-?Q9
M&MI,^2*KX_\^U4;]>T&8+_'W)'/4HSE^0\-9_?"M%L'3RWAJWW"VX1.V<4U^
ML_>=CK8 T<R<$&<S,+MC\^#CLZT@=:-73_/U7WVFO:2'2TX%K'R@GIEF7SG;
M<A%K=OJ$R1GW)+KN,8*)B5WYW;]K\_2VW7DN!?B8S6R\'%)7B 3QW$V"EB*1
MDUI*Y$1KAOL6&82P*HPBN@__-VLBIQ/>\L:1YQ1B5_09LE%E9S-^N+KL:W<-
MT3M[W:?*=,*-U@[NBS'1D@?<7 N#;*F[2( *?@)H%D*/Y/1HI&%9^1INR(],
MS:R@DVZ0HVSU#B U(O53U[F>*:KZVC@\V9]RJM5/*N[$L%X:!A_RB,+$##Q'
M%.<_793CR<B:"?0R,,5*=[A/I)UPXCS](W;.=/^LEN;^0E_/%^=?/[.M]W%M
M]"-.BR@6W&67U_WQ'_ /WR%/?[" R8YS4Q]8,2U$GG;GR!6N)/8-+[WSI8C
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M1&V-]M<5KO!+_EK]88QR6<FB3UD$))2#B&Z\ GRO&](#B)L=(9_@KWQN4TV
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MQEFJ;POP3\)@Y11ERI6<+)@R-@B+FU' !K[4SS07HKU$TH7.\7$<VVVY!T1
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M]%_L<9$CLCD&%)65@Y)M(*>]._4 244PMS9L*?9Z!@K=&S+8U.7XTVN@48Y
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M=2,GEP:<9 [SEOXMK9SCA+G"4"2"]1C_.0M) DY#QU2Z%256P,/KFTKV%(H
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M "C^7DDS0^T%QC)9)Z3*$W($$("&C-CEP-)TNX[,!"H7=FNWED.%IQ,$HPU
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M@ +8?8MU%)_>E'YC"_*6Q!W<,<]MX7#]U?"JQ+$GT#2?K0O2LB^:+=2A_=G
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M["%?[R>)QIVFK8::2O84G?M'FG= JPSE,X0OP$/&(YP9N"_K+:456 ? \Q_
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M&YWB0<C$ZHJD>:JO-'7YNW:%NJ:T[M3%O0/O I4&^ /AFZN-N>'/D%-C=_'
MY6S)0V3KV%((7A&&RQA9WZ+40?8:_^,\NL%>6F _,R9'/(IN;9(\H[5R\3_^
MC5>D?2J2H.6(@:$5PM"BT0I"CGB30FU#+X6AG])DU=T;AKK!2DE!)#RFT]]B
MY8AJ:V2Y@/ +*[.@#=7#U_4[A@PN_HI9)2TXN K)L3*E3Q' I;?C0F<YHHVF
M+0EY#BX.IE?89)I1T= -1V"<9RLQU$G#+**W.-PG=[CE^^2X0ZF"E3CD;XW
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M!+-*19A4/61Z4Q)XU8Y/-05#DA>=O5N]4*J =HZ(.4!,&@/.R!'QG$;%V;\
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M,PTXYLN-$^>I+Y.J$Y/P)'=]9>OHK<=BHJQ]$DT<+Q?4)2PW?T-*#';""*\
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M8LV;840_CLF@K<BXNH_$T))%^UZ1[9A4W^%&!'#U7WC9_BZ-HR]>@-J9=!^
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MB;W5XBBKPR7?I;S$3L?ND$V_:R84]1L3,)(,#4B>BV-O'/RJL14*FIG>1<
M3DDQ,JX>%D9)!.6G7E 4.]YN)*;GHX/W<%]A24BS1]"YD55U:[>V[\2A9WX?
M?;OUOQ.ZN4A(NVLQ>08[L84TD<UB2JHZ0$M1O&EU_"Q)'9F*W&M$[]\KM&\
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M&\6R9*RK:M$DOD5#"UO%I@O$ KB[!'U"V#YL%!LUC7S3QLXBFAUYG(M(,6"
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M^8&\7(ZZ'Z#T_:-$C;LK9AI;YTP5(*KGEIW9.P=8Y'9*G&H[SO0IX)L"; Y
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M C GCLDU*U8-?4VD_LBFLP2Y484>_D(8D((1PMJ5$;V1%4%CG]>X\6RM)X5
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MST3+[B]!!;FDNMTIC$NY^:*NML4Z6<74W!D1;J!A73R]0S'L09PW1/!D6 7
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M3-:IUPM4 ,[]6P8-C\MV-!9)U.2$D&5F,Z)C?,+F&,_GE@B0Q.[\@FE&_\:
MB]X^POZ"N8Z4I?&.X@S9QD-IS<$40\*@$-;LPT+OX\<%++-N72,N,:KYQ8RZ
M";.^C^X;"*L^>Y3N6[5?%F<&JT<[HW''B@-9UZ39!H6Q+<ZQ$,-KE-5S4A^,
M*W,(RV.JF0_$VAI93+",@@AAT;.B]ZK==MK<8YVGP%U%,\/VJJB_&>XYN704
M,Q*/U18]57;V(N^8<HWNQ5+G0D*+8XF#40X[S[W*WH:)2J(!MCJCI&E:"_P
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MU_U3",L.^2TF9A[*Y6=LQ+_V<W06].%\RW$NQ$&1ICWSB8D"[V)^N1#F+W,
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M_9!OJQBH'G0A2$T$80"HNHB25:?0N\1Q)M"I/OY+@*?B19U:3U."<&4F!7\
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M=!JL9OY!"6HCQW!"TLN<%3A#FY>>*3=TNHLH&!S@D!K D>!/(\S 1+YDUL\
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MI95EM65E-6_>1BQ\7-CD1]1F>";0J=-4NGZJ1 :"[A43HO:@^Y+G ^I)98]
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M%CL(P&8!]7&Z)O8<N>!O.OP2\XOBU:XK]A84L69XV@ >SP$(XACS/=^;$$M
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M)I0,UE,:='ZK[;=O(-VRQU5W$$8.'9VJ3LR/R82#/8J6[?31>:N0.)/++*O
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M<.NAJ2>.A0?M;PTJ34[(JJF/=#ZWFEUJ(.BQOQ0]94(DD$4VOZ'.,9NBVD)
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M-UM1.RD6VT_(8EN2<?@>%+ =FE/V_?]3'-X. (ARF^_< *BJKIFB1^[R;38
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M?3CA3(6WI@<W *T*NV.D4!?XEDR,&ZB.JU+*7(PUV\/I^Q5G:M/F%F84EHG
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MU:*GO$<+S A)R-8!1;N)G'FO)2+-QHCH9S=I^[%OTQSO.#HT>#V=5.#\9/\
M?<3L-"ILO9PTGD^2,CE9P7==F=C!)[72]P[AK@8L 1\*3:AFYU >1'[IVA4;
MIMA!^(KW">[\JOVOJ*!Q2-SJGH?+4]SC0AF"D,8E/%C02Y'9O+/,5Z3.:F9%
MSHZ?/A#57ODW2W%JGQ3PX:UF,@.A8SM:<X]_T!TUE;WT05=3IE?.^&I_J)>B
M7>RH_0 N1]V^EE"U6<7*(C7F;X_'4BA'7SXYC"COZ;S97/^D%/+4*;'^I%U6
MN/.,XT.HTZ-5_%Z+19OW"^]YQF=Q9IA+$A$O/M47&N+]C-+27GP.S'R6DVGN
M&_XSM@_"/YTG2!/=(VQQ4U@%OW2;=HF)W(IKV0!\^LT?R#M2MP$8&/NQNG4#
M()^RCHJ;C'NR 0C?_%)[%V\ "FJXM^)/8U^;N?\'NZ/O>LZRJ8WY^CTSTSDC
M_5?1!;.K]G'-!K!(U_(BKX_N,-"MPAN<6>-RN<OVS?A4]7+U.?62U_6XQMH,
M0_94LN&KITKF-[X]8 %ED=T=FK+\QO9F5:Y-JW:>"#_%>PC1$1^\9^1A?VUQ
M>*BC0X P95)-[%/,G!FDV[::6YP8RC@($QXD$SU88+&]_/O&?,2BB >\H1 ;
MIU>'L%$B(R[@HP^*E"SU6)M:VB4;BRPUX9\':>3;@.\I[:U*AM67,-=SK,F9
M&DT%WR:*JE8*-1E@/ &>@^":4=+W!SNF5!=W:8;F->Z=;XC"6GY<RQ3N8V\"
M#(#!4T2F;0"L0^,36(C,^\O T>H-P#5^7$! U/B8#<LO-I0=V"'L%5G76E6?
M$Y6A4#K!N(;[D[UH,3JC&PYG[6IZ.)PD!5YI0@:X0M,F2&+\[+;<(X,66";D
M$#SWV%#&L0"JTV91A,Z'G:)'-X?^N&)75UM_J >/&G[8J$1K'!QWL06[#^'7
M+1;=J0A;2]#0XN>O6+PMB#?E,!ATBU8Z.<;PMM'K^:/QL-,?66X!9>4O #^<
M$:64.^6^+Y2VN?+M-4.;V*09<^^X==)^Y_KC.2:7*A:H&JFD1FK48M#3M8MK
MSC,*>"%^@G1P)F\'V+V6(]F1_1IL'\QL"FFA*\#E8-$@H2C$D:J-,%[7\;21
M4[=.'1!.TGK!C> DL_X;'Y;6[=M2<\Y/9*V3\HEQ/#]^4%#)[)NYK'1LBD 1
M6CJGOU!]N0P6EKN;6UB;CY:M_$':K<I>[:AC87QU^8_Y7WJ$VBB0#%"@V,I*
M:0N:E[KX0S^)>6%SG?<;SK0WND[>E<DK'J%:KHD<'34_G*16,'J7<FO&]4;/
M;(P>-P/#7#=NH6$34+:E?!_+5+70E(,P&5YYU,L9Q];C'RZKY!1XCED5#W=)
M2!N<;>-1N+K!GO8R_TA])VMT],S3]&-=_=:)>6^EBG5'*7>AWC:_X*UNKQC!
M?4I[)?./4@)Q+M\^U?\\8/TAOL%AC)"?%KE$F,,F$@W+8VB0JK[6".*>"G\N
MG]%*;98<TAL[$M6EL43@YCU:4M\ [$<R6L(SJ5E'9J6"?T<TV8 Y^/DLBQ2%
MQP.C+2L=T0:M\J>,XH5A NOUS!AM82]==*#Y'+_<F1.860:EG^W']1U ZJQ9
MP#$VKE2*J;UW=6,==U=F3O%,6*T-<_)6U1LRT0J-]HL(+S7VGV@MZH1P4@[R
M.]N%>XE-S1RW!!/[\3FVG;%ZM-U*2Y80P^QNLAZUJ<^=L\<-!H;"N]6P&(T%
MK85/]P=F/M=>CD"^UB2XB:A $E ^K V [-C(K+P>U^\)T0==U!H15,1 8B%#
M1,N(8M"LV_4Q!@BZ8M0^-D_1#W>3X@UT0V%<\#D\7OXZV']GI&,+2\W 3B]_
M.=SL5E9,?Q%55RK#VL$UP"9L+'TDR?.6?!FO^I5V1<G=HD(8BI*0.)8SFI@%
MU5URO1OFNM[)7PGAADPLMO3%HB4V #Z,QVX#T)5SLV[AD79)%>W,38P^/ (7
M+0)KA%?/N8%\F].Q2$6' ;RI@2>GMYD65E[(^ B7"1@ S<EXTKPZ?R>)FRD(
M&3+ EKS'9LK\FHF^P\BHWU?-<J!!E3,@4MN8V<)4VVI,52FTP20K(-%,8A"/
MU-)<^#1(&=@ V%&TE^KP-N<BBK\9S(1+YBRVQXCSXR86X^R10@"7D("2T!.U
M-H4XQ[4TGQI:$O&".-;B"&]BOX)P POL ,3S_"H<KGJ/<RS;MA"#J5&+I4M<
M)?IP(:R49/:G&BZV#2V'K'Z[",3MSF9I2\%I'>FBS&]7*%E>ZX+5Z*?F[Y(T
MV"^33[A;/#Y6H_O&!8I7X'E<M,^FV67JP2$!+D0JD19E?+#2+,GYDY @DWR\
M\H7ZA>M-F&BYE9GN6]D!GNMW-E'!5\X$)<)O1D2]P[&5D.]7UIRNU]7=[Q41
M-18>8JNS"35>8^A\4#L\8+)/N;USX<05J.\Z#1]A_WL?7U6[76P7*HJ3\H0(
MQR#M7?C1XT#Q$3[)GBMUK]3K;00K0F <J0?9>U3W&&:R?B P4,_82W[SLD$.
MQ"XLK8D@!D/9P#;Y$\YX4K.@J9I+2M(-$D/&M1@!$X@.A4C[]C!"AMEI3D<V
M=K;63)ZKG%%XDW8KWP\[74L(AC:T8X392EG1[.;\@&#1H<04J)%5(/O8X!O^
M$#?[,D?0+-$?HXUR'##1[[O9[]_@UP:4'I[AG1W64#^85P@>A1_62LE__^81
MZ<,2MFIZ]67J)UB8 ?IVX]><:RJ*N<12EX<^CP>"4]$BMJ8!VA$J Z-6IDY5
MNMRZP&NZ<(>2S[$U#\>I'2^\>QU6P%:-! Y&;F3UAS4/X4"SP@=TX&*L_+D!
MO48Y<(O"3H56[V/<%ZN(@M7RF15;5D!$C'JVFJX_(KLIR&&SXJFP++)DSFGJ
MK%T2D_(WRHCWC5]ETEIIP*"@$9O-LAA75,79Q&6_W[-S%%B2A7WW0K%B<BJ=
M;3%RU?A!7<72V6:5S>,))N<P, -7D#SF1NE;%KP_6BEK"<X#!\A,6!*:P(W?
M3@IT_2=B]>)/#YQ^;:]U.O_ZTTZ9T\[)NM<E#TOL<KDNZ0P _-BTXRU$-N8L
MZNP;+U7F8AOC.-+8PDI[0?S2!Y1-V;"_.J+<RRJBU+LR3O+=@/DR^Q/9ZR-$
M!(CO0NA258*,/.3PJTD@N)B3J..Y4HL7I23_PBX]-6O;QA P_07-%>WGI26B
M8(VEG'Q2J&J-=W&(TJ^?>/_J* 9D/U:\DP85>,V3_'3[#I+F%==VH2Y_$$1C
MIC\(;/GW<XW2K <T*C-!-1N AXR.2#G"0Z*QSPV)8O-L]YH/H5X&YE2!EUQ-
MIVCCQ<I1Z.KFDEKLS4";?<\M5*_FNB6B?"; GX=,X)LKEA22ZARO0DAPX:8\
MP?=)PIZ"FOZ@WNS5M(20!H-\JF*C2FFT+E6PS96T+GSL41<?;_UMS05QX^S
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M1I?=,Q>CX+&2RNIH!GQ$B1 >]%T1V]ZH#_W+R,W*:?07R!JT[9\S-/_7,9S
M("%]_9K\XI#PUG<+@/[WX9[?XR^V4\C<Y*C%,S\<&]B:0AF#3?EV*&;?!F!$
MBJ,@3!US^[QS:\XQI'Q">$7A/IIG3MRS 2@@N'0GTC,K-@!*X3_SL,*CZ)E;
MOA(.GG'7_\,\I.4U$+^SG;Y_/9WD9VKYMEF-J_ 0+\(X)# F:VL+="IAD:*?
MZ=FJ;_..,\SR0A"%7B![TP3ZL/M84T$E1V\HO?!M8G>02/&GVO(*&(T]!P--
MEI;,&26T2XBBR^@?9PTP.XW_.(L?^EAC=_-QU\GX\VN*]#7 QY%!"A$ZH7!D
M*U&5>)G5=V2.MB=.J3:[E2:/KYS-*DIYV>-;]'&:=W>:YKL\R -Y9F29?YY,
MO\T[^],'*,%-_YP$/M<].ZORMK["\,4.N_.9.JFIH(()27A3I Y6^LEJV^#K
MPJ,EI^L(H;1GA5&:1MBZ=>--TO?; +SKX4*$OWL?W0"08S'7A9T99ON;UBO,
M-+NQ(-H8DF#3R*44CKLUU]Q'5MPR.YUWC2LIS$0$[\C6/I2DZ+2VJV;DX\5H
M8-RRF,254KU[@RALG]@!/K7#6R1K=N(M79-K\'!!^W6R[(A !PMK.$#]1]MG
M5ORLE];"T,*II)'<"Y_]G,,T7AZQO06&@WIR,?(D:#DLK&'>K=@Q 51+:GC@
MFN)P_GF/(/*9(X;E_?QYD8'-V1?OK\7:?LJ*_\W##ODDI&3-OT7=$M'5U4PS
M T<"GX9R@XL/Z$8<S]G7:\<&6:/6PH(G&T@N'];O]^,@H^<WKUG/A&1N3%4I
M$CT^F<+*\7%.W0 (CXCMIR'U)UKT&[HM7R$C-15M2;80!Q(U=.Y1<N^4XX!2
M'2Z^%XJR*872\F<R:"D]&P".@Y>?(V>*O6_<_M#TAU'/V56QUB 1N)%+T_PB
MW,^LL) _T4&EG!W[V F-X?$&QBX>L3=RIQ//Z;RKS52^HLU-)G#=6"F/7U7A
MN6)MV,<RR[49JRB*U"HU46!9UAH044@<&(99R0D+[Q2[$U)9%C+=L4._M%T"
M=Q[Z27$2Y<+JDT2^7S5U:A<J<_?$XR\$G*I*<."JU)3,97(]S'7)[7YRD\4A
MB#L953TAP;IA<R>>*.=")7>\_UP9>S#X!<QVP&;$*%#B-2L+]K$79&CG%FA;
MS@C0+^,/6S][9>L:1#M3AB@H((.^%&#]RY4E<C"5[+PJ(-ZO17.KKQGRU[XF
M G.):C.X0+YBZW:)FU29O"(>2"1_JJOBNL4N0T1'9L*;CP]5ZIZ\J8VR/%@Q
M5^E?&^F\ 0 P!$I<[+S'!.D>1,I,:8XN^^,&H*-_#.8M_B%_:#DZZ HG\%[X
M*\N))#^VC"]^O?/QLL*\V&'Z92@S3VS:8'\F#^3[AKM+T'SFJHGIU\S8YI/\
M#<#O3\?>CJ./\SO?UJZLS)7._J6Y*75XICRJE#9C0,E831H8OACDG^;=:5R@
M7_OX870JX_TGE U+X1 ?ZQ00T@X2UK-R@N=OXT;T^H[,KB:3,+;%,XO&[B-]
MY3"J0=9#'B4)$<KC]-R=D<AT.W]"S*3BLX;*J<.A7OY$XRG;TVL+.K879C$2
MH\VI :8.DE6_0?M&R\17W]\)O[O.T#.\6.J_,);?7;T2&DU=4&#;,M&TD,Z5
MYCW\1VOJ@HO$(>(Q#-+-/M9+L45>IS\T060H-]H21"8&%,,:8K&^K^8B PE%
ML##])WKI,R_,?6\$_TBG>9G40G*!"JC#:_Y\.%-QCB$O0&# _,O7N:Z9S&\F
MTF6"2[5#B_B$J03'(=VYYTL; #%OF)%48=&H?B+M/LUK=F ,/-9YHU3KF3*9
M/F?_+:Y%02KF-.H"/L&.(]T&E.$#K>[/.339BK?2E2FZ30#ZG'AW1)EW]TO:
M6&=^7U1TE,D*P2!DN"M8>?ZKU_.8?HU4@@&K[[$WD/NN!B*+G.N(.2\E:CR<
M(H7,]^2J#F<Q";8\G0H&/?O&R?$*66E_9\"ILD>6^UQ?O,P;\CRIK(7VC>SM
M,?;"R% S/'MM;%<EN3A81[[]L6.##U)J>)174F2WZO1/N2_Z@QTRRMZO .'H
M_QD@@PQ/\ YM YG+GT &V07-&O3^#F1EL 8>H7 ,&1.U]'4)H^_R 8,SM0=?
M1]A$ZSBD?HDV@LRWN4^=%5ZRG4#+6#&/F2ETL18E@+\6-Q":\]Z*86=[F,>P
MM_$V7G=[OT!$LVORK1!0C/L(7(HJ]LNM!\XX_."IT$9"_"^D<I0?O[.<[R60
M+$>!^:_*^'8.T7)]<<O Q_*:I('%>80Q/$&]2=89WS@T:>O6FO=+?:I(T('9
M4W.MO,.8AN&96H8O_HOS&V3LW!D$M.3F&6NGQ-<+SPH1?G[AM\@@;;.A_UH;
M2U"@U;P-4^ XK#NQGM$U/HR.\P@A"JT*_&OHR<,WF,SQ,6-S'!6-_XYC@4(5
M:,86CF5LXYCT7W$L:NU.3 MZ$\<$H8/-9U!JWW%L#7U0I<HO!.L/DJ,^Q(N*
M7R2;G/UJ!/LZ\P3]TA-*,X\M/LZ3!C57!RT@P"%%G?#=+P*!LK[;:DHATH_W
M*__S>,!N!1$DD+78%B2Z6>Y9)UB20^44.V38N6GYT(SIFP3<A]NGFJ1H.\.X
M/QP7S;?T43I7IF17]E@ZJ-2EV AQ-OWD,8MG4"L71URJ0R!(#67O^K]7Q_"^
MLM:,_>2L%2A.L 'P1$/K0_M&+(7[OC&Q(QUKD('%&&5DN0UY"5)%NXJX8#)F
MTZ'8J7 $H>Z^<#"I!!B+D9GPX$S>P]C[!MW11HCNGIVR5M:N8 G$MJ-40VE"
M$DML2QTS4^7N;F(EP29/*S923>PQL-Q3U*!'%?O@.V9E*/CPZ#*8N&70 8=]
MBX%3SY]*Z"8E4G6V)UG/M=S(E7GQK+#/L>#CK$U^VG1FD.EHD.\O=57#A4]>
M&-[HLMZDL>MC)32M+Y%S ]1JJ\ %^I\#M=]O/P=8]U8 :T7I=AP':LO'QSS_
M^=\)%Y2";>$L<_O1<JN6(<^N>7>OKIW[YVVZOL]!+OYK]H54=W_,E>=?OO<W
M>0HL,4'L$F--W.2'#4")ZP-(RI&_.>)YH8_EL '8%;1^YLGTSQN N,<; $F%
M]?=W!AW,0^3^:JS<,T=EPR<4I)'J/-?U%\L*N_G%;3%'!K51ESF+UX@D3F]]
MZ;1!9N3MO-VH$-1J= \E'0$UX6E'W? )XZ4V_DYU=<W<K:-)U,I+I556E<,)
MF%)X5E%^Q:RVQ'4]87E42 D==VCQ; O5[6Z/8;RB4NSI[OF4J/D=(7Y.(&YQ
M(LHJ?YHNSQ5+,+'!^LL?3Z4%B?E'4AK+8%EF#_0RLD/R1[KSH9E4IQ'H71!4
M.C/+I6;X[8Z+16.>PVV.E(B;@;#Z-\/H&WN.77COV6MM!4M+=*E<GNXE>JO.
MB3O&/[OY\C5KC QS3)_'S39/+"T*]^5M !0-VM%K/R WRR$[&?SE-7EW_ID5
MWAL^0:L)#D>PQK06.T&9][Q7>_>QJG[COX[6:7-;]1IJ.WB;>$DWR7Y>JL\O
M>->24&'0Q.%( 66/PQ>2B8G.EI:C!2]/V8,DM-'%ZYKC+P3Y<7J;RJ9UO"^+
M9\:KEX8V-KK5Q1O<0DZDYS@,5_]JI?<\  /7C\1%KA=A2FES5=XYUIHPFG!6
M%&1ZY;V? 7?6P9KP)/+6K=_&-%I"U,X?,TB%G;GA:\A2[LUGY^_%R%%55=;\
MOP5,"\W)[1TOSO9_NANJ:FB,AZI]98]T9LVNNUWF[;'H1]\>W0#0G-;L.V0Z
M"K?ZEEG >$22HPV7]1<\>\G_"YZ-/OPKGEG]B6?I,<-",_M'C%KMM_8*GB<"
M#%ICQ#GFD\0K;@3QR\PGQ*@)L+;$F,?(#"VF-+H$YAISO&%("]=S?J!K:G#Y
M:$ H?Q('?QJQ9ZH9SP5O,AKSWXR6J?SPWXP67MBEFR&3:HDNM8MS)T1\NE%1
M%^!Z[8HR,7CGCV8^[68:7+=$+-69BWZ"NLC"V,FZ5]P81%E5S!I]%K@ZV&AP
M/3K#2S^.>2I7A'A^M)5K>'?*RB_+_*<O]7XVNY25SR2GVB66U TD) WF=__Q
MB=VCGWTW("@P&^HDMT<>!*O(PLB\=RDH6#RF=G?$P+\H-=X>WC0*]-@ W%X<
M">_<&@SL-HZ-!^[#B^YIH_U"WXWCK/<\S%K(\PN\/3ZXK'W(W^P49YE;"Y>[
MV0FNY2H+(A,'YH*5<:# !UHIOJBLW-(0/XY%^3CDD+ =>%QX<"[7F*L0AX]J
MC.H[B)QKHZ%C-1&-]0+M\>R\(][(J+:SIT"T6:/.^&4+#B\'"\OZF8P"%FF5
MEV5PTM/QG;P09*83UU:$%=?&V#US^1('W896X-M<L1A22K'@D!(%5LSU,VK+
M447-@Y5,,B[)KK=7=JV;FO$%SG]E0VG(98W;*=?E?!K7PS@Y41%>]EZ495FV
M#YBBY?C5C8( -R9==AG2HM#I_8%XN4L+5I6+E:X#%-J07WV6AWD3\5#L%V:2
MZ\R-JL,I5:4@K?N)$]U'U[XX):9GP\<<[C;49%!H73? TH^>K3<9B;MGG@F9
M?$8*E]YWR<T*&/'^W.?PQ/ @M]*UG#4G/H27PUV?NF]V,N8]XU"07M!NN+?$
MFU@OA>^P)MMO0DO&%_%'[880<M[=ERA+8T'7!N<#I.#JY OQ[UM8.YMP#1&W
MT29F0*0BKY]#;3%$+*;$&%,P H429+$-1Y K,A1S$@Q;H;6OM9?.9B$&5]%Q
M6#TY$4=R0+:%T?^&U1YLLEKS:8$!;I/5Q-KLMUEMROD[JPTM;;+:[,H1.BR\
M>EJ?$#S]E<[PMC=EMW_DG?>TBC"AWK+'67\Q,& QMECM/0V;1$1, (^)B)G.
M6R:8.%7RT^9M[[07K2GP>M9G:H\<__'-;:][UP&/RU22CV ,+P++ZBY9>PK?
M+^=DA36"]+ :]2\RLI?*^#0]'X?BQ,39BYTC_Q=W[QW55-JU#V=&'0LB*DU!
MR*@4Z180:<DH(B5"I",M8T$("!$A$&I&D=X&$% 0HA1#"Y$24%J&/HKT$@E"
M2!B0*HE .$)(OACF>1_?,NM[__C6^G[K]\=9BQ5.3LZYS[[WOO9]7WM?FU[7
MXI&EHV9?X!8>KXNZ;-U"<"0>J#(Z4C4T:/.'"8ST-=8N?.1-5@'XD+XBBB$]
M2\^EP(;UC1EJAL;]^(P!KW$MM#"U<2E!J?!E_@W?DK<GD".9-;7VUWIRD9O'
MPEO HA"14,\(!JK].D=#F/BP>MP3*JP115K(L=5R"70:* ^%&FQ\W;![JCQK
M1Y7%$XIT"YN>%KT-@N1HL&^J^GV%_NX'T#I2,9=0T0,8<KO(I-)GM64\TW!A
MHPISR6O,P&K,N:HAL_7*XNR BZ.7W7G'=E+KZ-'GPZI+Z#TY/DN,IYI:J$3P
MD37L?NA#$BH>*Z:%V-O%GBUO,"CF_,+RYF9B;Q53G:^/S]85$B:(9SV;CFVJ
MO?_=">-E*>D*?I7H/=)I7K.I1DR%[8KUJ<,[9D6=*"B\\$Y]_FR69V^&?48-
M=E\EC60H$UDC,YQO.]1JG8!\=];NOJ7IN-^5=_-SF[U=^9N,3G89TR6:(Q9A
M#13^:RM3XWNXIOV_A&MA_Y_!-2F!\B+Q*K-WZ0=6UQ_4_1 ))K:=%C,AS1S/
M39=(?CFK:YR@-6:@>&50K:\=A7S^P2A8K7K/$N/'"])7DCI,;MF8Y-@>5._=
M9?>X>+C%YI&;U)E">?OL#-/K;SP*63[#95EV7[IO>0SC_UX\8U?XOT%)K)H-
M3 ,!,XT?G>"]:YWL[,RK6X^QD[A<J:UG*-*6^CK#/JZZ$6JT*5,0;1W1/=1P
M4]^7I6A%2IJ<I48 GOWE6K@#'E)#;+OU']>O]?F4^^=9;?1H_#'Z;57*WI*X
M(%@[._\?:V<W'^HU^K5MC!0SU ( QS\R_G'M[/[*MSX7Y64*1^G%;\V<UY3-
M>PKJ=""Q 2OC-6P[6+1TG$-6RG2TO/*U1 %:6T^CN&8TIL(" U:VZ?W;#5W+
M!.MBZ8*>&\M.H5-?+]-#0BDS"6^_ZY]1*A"Y%*RI%:*^)'\2E?S6,.)]-IFS
MKXJ/H)>!D<>"JV0+R&C53AI&7_?$#7*A93S0P@R-!S)6,]WD@Z^W?:'WO\W2
M<AYHEFY)Q7:NX;9"^9%Y=KH8>A?\55<D"<&^MD;;.J:RAM@+_0O[!/LAE\A]
M.0FG+^.QG.SP@_PO3X W7G3W9A?EQ7$?0;M W_6+_8^CY(N@0$&Y?;LEAF,O
M"C?;4>M:NJ(B*$\H(0I:0SA^WR_CSU6D/S][_2K^SPTIQ"-H?Y'EOK6VB.?$
MH?ZQM85Q!0P/D/\L_;X!A^?W_3(D:!>XE@9F+M!6KE'@]]?W%;2O*$&M)],Y
MD;?_7W](Q%4ZE >Z;+_]KX)OBYDE8UM3 /:XK8 ,Z&# A7TQSA?<3;X :1=M
M]^BP%6#P86/!;Z<L6LUQ-;X8E++Y.# M;2N7O/@F5)X'&MIL7>.FYQ[A@5*\
M6FGL'0/8U8<3Y&[X_^JT;(X/_X,,0Q[HUPO$+0,3'NA24S3BBP4K<ROI;._6
MQ1(?2R-Q(&CK=_&O^9M.W%$PTZS>8 _&D%T-X#8U0J\/<HZS+ID?6*#GUO+!
MFDCXH.ZG!^'*'N=E5?H_?T;W1KH>9O) ;;3# -B9.5[MJL+L*6:XH%IU]5UE
M&H=\0E6*YFMT,V/45KL-*WF@A\G<-N[/6TU-H#G$#ZNH)-WD/[IU(') 8 =7
M=8@0>C)D*D>[4U<D6A,N=M%M$G4(N$/IQ(E,#FD^8@64TK&R3DV%Q?,! >$_
M,]4C@R22T!<TEYQ,.7(LX\7=/-!.O:W(!D0>!LKNW<)S?PYU )X&3J9_*X/B
M'NTLP<R8[[[$>AR,>A!Z$3M52ML3_BY<N X@,^^$>;8ZUC8!0?3D.)P$R4##
MAAD8AU8J<^K,BHZFM =KE_[6.CE?J$RJJ&KS@S@K[-@_;S^=K%82<AUB%$)R
M.WJ!NC2?TAQ/B(WPQ<.%I>R</R2XN.VS#VPPR'+N>8M.M6 [G5N)9S\!1OFW
MF N,$H!S5[8RH;]BJ=$M7"B0S8*L7V/MA,@"8WFARJPKA0RH&$TM.I)[A',6
MN$,-7"IDTJSZ]1$,#3$7-7R$_H[)Y2CM"<DA?8-)LC"PZ_.J,,*J3PUK@9V<
MH(VVL@>!,RQ[1C@?TM*3.Y8?(:I(R[]Q4 6UD4W'1S')=/M($BHYTY'O319>
M<YS<F'H=CADI#!FX0Q. +71%GD=(JC6(%\VF.GALX!XR6*V>4F$S,;A\7!69
M(^;$W9,SB95R!>S9@:S:Q2WFR3:PJ!&9(Y?5D[BI!^2SO9GX&.OF+/N8M1PY
MSB] 9CF'_V8G]?S[">H-QI)1\,0&2P]"R4+J;#CX[$*X7.W@&O@#7!B3V9JK
MR?P4S;DUN82]S')_%'H]#^DJSZR-"]4J^;#0=(RE$:TUMD?+7*1-%DS1?/.Y
MNMO]\HA_5ZF+L=FP_T)IMO"5EAFA>M.9VBP=Z;[..^AB.OZWC22%=-V*REPW
M^T.N9&7DQ&-/9?\YQQ'G%$^:ROT;]S3QKD?(!,OB"WI?)HO["\V6O+7A66A)
M1+ I60U5:R1FWRW;WP+ N8:Y4!ZH(HOO-:]*&07:_O>/;'YHQX"Y^FL\T*;,
MM\TL_,*[):\X)I03M, #L74!/D2'4]*I?3\@'B.8-EA OB>-GP K#$#VZX;>
M>@UH38D\I"8G91J/J'-EJ1PX<X1()\9*3(A#3@UJB0@E2W @P[]21&V8(A&?
MJ]6"!SM,\1\<C!D&4"MF3ZU?V9PN,0IK[[7BQ]UGQ+^L(N#'-[%YIN1#DG=(
MBQ2QK3>6+(96<Z30B:U.PE<^M8Q(]:33A8C[>:"69A8X1C^8*\M2>$K/.=<R
M(JO2-U5=Y:+HP-H=JW^QW"/+YVE>^:-<51;BD>XKJ./&,+C8+PSYMD2_1'O&
M%\D)9SB7._>XSB>.(56>W R+?E6\EAVR,ZVXN]M+(0L(6UAQ?*=;>[N\MX5V
M"-M<I4(7$5EH4F6Y<\3 ]/5(C@H]#&S-DHP-A3$T1DT\<L',Y>A5F-*:FKL+
M!9T#8Q-J^-D!V&204(X6AEL/J7LOEJD2/M75Y9XZD6K$Q4(]X ]XH ,0V="[
M-8#6IFXH*I--S!(YVLUD+[?K2BX"^L)\5W4,>+?QJ378.%(3\5MI?J@O4,O0
MB(>.<96&M7KWM(<I1C7(H\J\',^GH)G=X8J86QU2T)BI+6.F+:43#"@OMX'W
M<RYM-9!1R;^1=T'O=,&E.HDPYF8[HAK<@HVBYN;DS6U\:O<XD,UT8GN9W_]K
M%G*6.8B8!XMHDN.QU:[9>,XOV"C(>>:G>+4&V\U?/+(N]J$1LV-LLT'R9!*T
MPB)%G/P',1E1\3EG:N_JC3P@GO$I%NN!C9A0!.H98R'Q&ON<%E(\FRX,Z=N@
M_'-$VK(R(S3!HO,3(*8S1 RXL3N.,$/QA^Z8I=@?%EU;EDGJXH$F?(\\ZQ3+
MW*R1>G3K4:&:)B'.QJ;D+3I2+!59#'<)1]^X][H^9)_F/7_-K2W/)(?80A3=
M$AWT:Y;98&F@EY9,/P/,-$0!BK0ER<V#0,C4>@S6 RH":#13>"!I:[KCK*M0
M?ZBM&R/Y*"8 'A5<VZ$G;(.AH@Y<GP DA,+N=+7GRE)"3W$E6+WQT]D60^J3
MK/VR1T;NOAS K9<TX.G)G<D/:-+86BC]*N<.8,WRXQ["+=( 4RC=@7.9&9U,
MIH.Y5&X?MY/[D0=Z9.\P3*[$DLB5:/@BK78+MT0;K8L>#:55? P*)R!.)K79
MM]\LO7GFS#6"97O/O@-9<0DGC\CO#DA]=,NKACI<,T[KHWL,O+B4(R62]5C4
M,BTU.S#MO@_LRL?LQK*,MW)EXE_Y\W.7* ^4>N,Y#_3!;(H'@OGOV]KWWWI>
MV#E@I[Z)%/W.Z6-!/_/G^<(0#[2:$:[:;R2^:MSUO4K1]F%?FORHK@&\^S;0
M73)O%^P:'<28U3]*]U;V<K%PL6[;B!MS<?6LK>F5>?ZJ>D!S5DW]IODEIS<G
MZH;NHF7.M!=^/(\LNHH_<G]%S\_TDMZ"TMUJ;FI]\(G\O?#L=$2J^OU1QS/C
M\Q1_0KVW7+9[JND8BYLN)$ BUM_][7(0L.]=N?UT8(WC]'5D6[[)2K"WNJT)
M99DV-KWQRSL!9-R6^_(3U* 2(SFB4R)@S]:+3./(M66)!061ZIIL^I+RNEU]
M7+_[PPG8V).R%T^H'UJUNAO\:,Y!=AE+^J[^_<O.>'FQ:85\\5+O40V[U<L=
M9],L$YP+QA_?S/9FFWJ.M@K$X\N^"DI8EZ$'R>Z().A^_V*MY6.<LRR[B!>7
M:WK]"&]O:E2'' KTDTDOF==]F2F_E)0MW_[Q%;59?*N]NO(C?.>IA)4V8MHD
M+H*:W :.PA[E'I_-&D[]R!$;\ >+ FFMVG:U=NO:X0>&:/9<"DLMH\+WKSEA
M%-W+Y?"F#<7;J"UM%'E/:Y@V>KN^__GP"KKX_LJFR6N_4WY&*T:FU:D^VC"[
M\O'4NL9$.]EZ7!7;VE;'^:O<&SE&FG<AQ&[5XJU+O<=3NJA@H&X+AM1"4'3[
M7C"DZ-9O1;=/G@YLU^-"!"C3X_OGO@)'9<[M^,?*WP$<(G/^8N:_%>P)I@+0
MKRZX$DP@5"^H(GGJ]]VWAKZ]PTI!%SJ[W[=?^C;@5ED58GORX6$X"[&58:[-
M UV+C^-L;3=L?8ZHLN=DK\?Q0(N52/+&(V=[R#E A=MDS0,-I% BN*KDA6'X
MGZN>I_)>6_3]=U"_AI4(E1_FB#.GZ,MMPEBK*E(VXS:UNS>J05T-#5VRI'=+
M+U9 8[2DGWH??U6=M,'X,F)^ME\AA[A:WZ5F,1#TF.8TMZ+4H:Y4K]/D4'I^
MK"I,(P]FM^KB6GCE<&IV7-VCH()54Y7"X=(:JJD:PBA?/]6"EKQ:!,9/;0G#
M%5&=&S8B@RQN5-UQ)A$W\Z<@/QK]A\J<HK>+9&*5J+HK+@*K_'Y[T.\+6 [Y
M&*%)> <\K@*&GA2):M)@23RI>"KJ$F'\II(YW&6,#G3S];[%"#._VV!0A!@=
M_^#<7(0<T<UIYSYC' KS]E$G7!U4:MFW\OC7^G=F*LO>!\3F;0+P>[L)CH_<
M%#)#Y'HE!#]V?5"0%FYVRO[(JFUM=)AUU6.^)-/57%Y(GG%8V'"9>*K5_2+#
M1.)+[]*9*YDU<$U1(YFE_&XON12SE/?O$W;#)HD1==O&WO2WL8L.5(/%,-\9
M^YC#?S9VB?_!V&=LD1W[?+Q2+93,0_H;<C(JZJJ"$6[#Z5):[MKFEUP'E&IW
M?W[7;Q]LUL.FI'MN*& N"]1-G@H2I^KI.4#[2]E;@16/U'PE=S]I_*8<%RJP
MP!X!6\-#8+)E<]^R6.NS(1H+BVU=F?A)VKO*&4$Q5.JW0?];^,1$0 M1L/E/
MI4_(KG]71=D(ZJ2VFV[_<TF5[WAP^.]R/8(N[8@"Z"[R7Q_UA7D@M]T,.#<-
M R%K_U,957FH>S.<V\0#?=:-OB/"(/! KMAU+='BO#B5F,7OFVYO'T1[EGN+
M"Z(9P0<<G%\H:RIZUYL4S,L^ EXM#(HU=UCV6']3ER@08?DF8T!:R&2Y7$/M
M]J#:8225'U(:*H>6%)^:KS7ASCZ[R<BNRIZ.J_*NUQ[8D".AC(;G;6XH*;TN
M+3+.@E].K7-QK/<N2!U>=3SW)XU(WS*_M 4%SWJZ+P!8ZVMD>.>&U-RW5/ZP
MV_?Z>\^^5^8[)^@<N;WI<T>@ND?0$627/^RGB!JC4&)IO?IO]Q\TE(9I#IJ-
MG8P[U7?NK5S2NYB8PIP8VYV_GSJ4*6!!5TT+QNTEL$D/;$-%N9L@8B#[6. (
MI[9#+A\]2ADRZ@M7O<U4=GAJ<-_5GHHR517>BFF,_M'+,,1#_63RTB'4"!/>
M/&[,$&F%)M .KII[OO4)WSL7+!FG;TK/+G4J#<DF[_:\[P6E<N4K1]3U<XX3
M.&I>>33/K*6BUZDA:NH_U=5OJF8&:THU^9#D=T$PKW5.K;2O7%GZ0KCE3^JO
MS9OOK_:P>SPN;V&6%Y_V*%.N+'TBM<J'6D *$]67_4<V=XE>&&W#[,PYP<.-
M^ OVO/*WG[?PVT97R6D!*?S-=USR8D&BWB70U:G^IH."TN@^+&A;ZO>=F*+5
M=R1SPV^K$C>_"2?^?<K;[7H]O.!*[[<%!3I1?+]N>FG[3OY'[OC72,&-D>'A
M8![H;4/H3A[HE7$;?,LQ7*W<V;W5F$O&?I;J#-@=:KP5P;?BCF/U_(SEZ)"8
MI1'H/Q^N1$;OHSKRPZ9CH0;  ^*\74!5Z-7LZV^8E,CV<OQ6B;Y.?EB&(NNG
M?#^U@O,2*31G5\>W+QWE!DG<S""W8BK\;/9"&,3M0GN[MKMVE_B=L0!4X:JI
MYT1\Z5!1BY6UK_VU9,W<6'G_.E+ F*E\Z6RU>PI4L'JR4^ ]] 0+(-=@@TS4
MM(N*VRSYQ-5M'R((<I[;L?'-MR!7_*0+2^:!S.YL![7WVT,NB&KV91@]MB^P
MS)(T2T,PL2W)TIY9/\>IE+JX>DM\,AE$A\"R]4(V0V@')A8,+6I96@ELRIDC
MQ% #!;R7',/+Z,GXF/-%,8L"I=&>>P^#%75.T0:6G._AK?(]<W2&O.Q>[#4M
M'"_"W_KC+X%@4H_ 9=711#'N;>$B(^H-!HS&W0[,D?I?K[G.;K"S@PKF YK\
M+7MWP-W"]DL>*F":'F/J73F,D4OR>,KPOS6FT3Q^97-2@L!:N3I21M3$"G$N
MD_A 6F;ODD^9!D='O<(M[RU]";VLT1!O #<;(9F'F#)7#R/)'CM<AM3\/]RN
M:XAVJ!W8;?<L[%FA?)=.QYG4>O,N^K"+W&:]<:]E1_KU-QVG?6RFE'HTC(]T
M?.SIZ2:A\^J_?&0^%0SK4X$-(K<]\5N!<>9]DX/ZZ8[_-Y[<]0&!#T[X]]^V
MVUI2;[ZCY.$%2X^"Q<3J:!Y(G@>JB?D_4([J_R\D$BOHUULR^&UREVH(%@?M
MMC?Z"9EYG)@0J/'7HU6"(7HJ<"35@H"G\,U%^+]W_49TO+NM_?4-T6QS(:V0
MCN>)##5[B[Y5F;,\T/41M%/18O6X"JPZ=_,:N3[G8;LW$GDW%:X_H"UTS.-]
MT(4_%*(6LX/E2U&74\=K]IX?,*T93S5;JJV$E;KK?4-'?X/3O@;T)%B*HSUR
MD[F>''JF#( Y9<(C;*.O4E0+*^JSK]9ES5#'KD7I_+)2-O.FHK$&%A/?YJ/Z
M^?GXS-C[V'Z1B*S$]3_4G*9FGA*NNWIP)8%8=^9ZAZXH==R!!MQW<1TTRFRE
M+DP@@B2"<],(GEG<=/JLW& H4ZO[$L4\"E;Z)SH^[(0!Z<*FCD[Y]9[3"9F-
MDDH&XE/^:<C2FO35N_V6I4H6RL_>%#?W^'IE6"9X!W:I&*CGI/I0J9V/!+&K
M[,TV\Z!8X LKI[^M;%.N!FR25Q_?=M\&"W.",4[X&T?T;*<V\0*D_,\4B)%7
M8Y\V3ES==M[;U3_%WXE_X,O"[*=%)2NY3>__/N=?&A]( 2%5$$_X&,2H<A61
MHA#Z]V]O10-\3WR\49O;U@O"SHL_ITRU_>._#IP#'F.;G?@S(B_X")3.@+8;
M\T#WGVF)63IW_O(=2_7O(YC<KL%WXBTV3'-<+%I%FZ48WW#2?4J/=L").N_K
M@D%8#/OXW!Q0)7EE+\!,$/99>C#<D@QDU]DY[8!!IW=W:D.D%T;]XA[?'"_4
M^U)J$&1+*\P,"1C/>*%SQ<^,A>_J^9S^!J<:&.C=%/>9$J+0>]P SD]Q=0D"
M[%>6BY_'YM@)P.RV#]__YKNTQ-/\WSV(E)X8;(L%?[?Y\%*P172=&;A(9TTQ
MU-,4&B=YH$C9\\.:%U'"W>7$\_%^!<BZQL+NQY+L]2:9QI&.'!3#Z^A2>=X7
M@0]'\GVXUC<?WOQ??7B1=;$ER>+9O%;IM4<% Y^'K"LF4[]'AQ0 UPHYR0RO
M"*(OB\_J=D:1QGXXTMB_MG1^Q71H*70V R,5HC+[Z^M$Q8<FGQY03Z<UR_E=
M[A7-E_T0>FP(Q?UAG@;V[_9YMV+,)+=Y0:.;SO;ECLRW\$"M]^?9CJJYLA37
M+YM_5@VM$KQL**LXD6:%[$\/RCTEZNZ>=7$U+'.:$Z$.)LL5RN5;74N0*Q]\
MG.7+]^*+BV.PPL]]4V9E'Z>.:"O[/OXDF9]PR\?=_0ZUKM_EJP]&_[^-7=GH
M]BP8^-;K_*P@U_FZ_<E3@9L=% C+7$_[YG->;B./?^JI[BGHNZZ!RN+T/_WW
M%A+ISK^WGVP(7$L.X_NKW/W;B >^VUV*YUO!\4.._[QAI*P'![A5/! Q&[MU
MC*2XQ#=_Q8NL+NX[6;[EY$>&E](5.<DK(INBPSS0T,>]'(-5_BVDH5K ;"<^
M%K+1>;."%K-$]$5__?5?2":<P?F9!WHHSNV3U61NE=>S8 SCA^&'X$4?'%U'
M@3MJVE8L6NQ=5WI@EQO#Q%N= WTQ%Q@P:WT?&;P>L_N)JU*"R-'=,R)C,.[>
M1%85^T(?H2$,6SI+$X5(.'O:40UZ$SAGW(H<7#%^UYIV^:^QL-$^W"&J6@;^
M'L$-[\FN>TDHJ'D^DN6VMA2%+T%*.$8_!.K9S5NOPC4QR[ 1-#P)+$G"'77U
MU/5.CO(G_P1$.S'G#4NZY$D9F>YT^#Z,S&J.[J!MPQLGDWQNQ\#4T)KY+YU:
M;9E9CPB:N,%/'''1=N-F'-.\5W(6)[JFIK[>.7&ZGRN*.=UQ68()1#..N<HQ
MR\G$WD*G![Y'O%2P!S#);6R6T9N;$:8GE*9N'.L"%-QP0'RKOF'+A]"Q"UU^
M1FU'IBV:C#-_/3U_P5%(-*+0*D=Y600F]3$_MNC5<(G=8W$S<1FXUQY3\"QY
M'^"W>IN%:(5+GH,(3^8JTX\"WJU?VB8O\$"QK^//I5^EG YR#4QH99P)"M/O
M/)IR1;-D&H.<>;W__$\Y@9'O3_>WE,D$KU(YFEO)?-M]C#W( WGA(FIXH*.:
MR7$3!Y@6*5B&&NKBX&H._,H(*?&*45_!0^H,>P9F7%U;LX*2Q=!K$\MC'XKE
MS%QYTBPYA&-.8N,0J_<F0#Q0BUX;@O.*V):\A^,.M#+YZ52:(5.R'1OKNJ??
MK2'3,M.8F9S48$EO5'>YA'G^,&1.<TO:IK(ZY.T+4DV4T\M'O7)VS"N?K4[Q
M9^U5&M.X"QLS OZ1J\P=IE6#VY-CI"B1:W+#BZ%JOBR1SJ;CE%5AD3_ (B?>
M#.FCISPF1[3B-_4<?+3J8=TGO-[2:QLKDYL=4\QK'*.?^O5W I^A]+OG]?2C
MC_PZY[96!2V=#G+3S];(\6@]9%=X%7*4<>:(5+GUBPB\7:%CNJ)ZX!6[P&=6
M*Y D?>CJ/5:@YK>-M 5 ,8<!9.YJ*3W#Z%%M8W4>ZOMCJ,WM]54%\)GNDQG3
MH]S#FD5WCDZH"$>VT.\-*86Y7J"J^TX76N)Z\$OFFWJ89+8M,,;H?>BJ1-'$
M'I[/E8R_7.\2> GVI__2E<XV*?FHQAO*8S0C\6%"6P#UH=.$$S0KQ:7U;+,?
M&C7M#%L9#D_B:&5?YD^K*&RSR>HF.:ZTW EC/<7/^0[27)%4MS5"%,F-#A;&
MP.WJF8&1/049M;X_O^*_ALAJ$>%Y^XR^PN'V9]I6HR[77;N$%\$E$'W^M3RP
MS;K8.^08:F8\UF,YOE;V&. [I=<-A0%&S'I'5GCAK0 IBMG "]858MF"E$$E
M4&]/JJ64=QEI92,WP%%WU<MP;;K#G#H"H>;I:CK 318:?%OIH_ B^Q80?^CW
M&^?TX6P?1%2Q%!!723"KD1(KONE1&(NW%H[QF\Z'[9L;1(O-O5$^PZG5V+AP
MJ\&1/ZK2@&7RY&<99J<:2U*'?K70U_[PS&O/)\?JA> [XOZ805<\*2N5^I3.
M>/7UI<M^W=*D]AE6&R,_,N>88Z$J&C%SI72[B][<YA24<RB0[3[0X%3(L1Z$
MG)U'[,7>(4"-ADC+L>P-<HSF^)5/9K51:@;^$DQP FE,I5Y/3=%!]",L!,VH
M8H24>E77))NZV&H]4:T.EM7F#]7-<+YA5KLOTAC)L> *Q7@4E"[/;']9Z>\2
M3FD/_YFE'DL$LEL=_:5R/D6$>KT "G@@Y*PDE?1XY.7>Q>=]Y=4O1_QQ!V6T
M[?M=U<Y=ZX!HW@NS?>B9B]YWH>3W0H2XM<;#5C<27C<E415M&YL^'Z*,O5ZS
MZY;]JU1D74JQ&8X8L[$?H$0&C4/+F.=/@A_W$1+^<+L0+D?4'XR[YQ!\Q#/]
MS#-H9*XM/%-DK<SLW5#5U[^LN'WX4^\.M0RW,"K [R]_KS5A/^_.$;5G[QJ
MWB6+ 5-MM,/ZQL48Z\G>EB?^Q?J6D*2^T057A>$U!Y)0O8N(Q3!QR:=Z7-%B
M<-&_/A'6MI'?B@[Q0D*>NKEYB661V1TI&Q>9VNQO!@4)_Y UT3B)^(W:V[XG
MU'*R] ?"O.\8$-^1)5%*Q 2HO.9?WA#IS=IM/$0HKRX<0@OK2@_>PL\%CDAJ
M9]UT&1WM#)-R#K[^*?:ZNG'"^WM672N+W=-"(EN$N'=G-S#/))Q4;6R*K#MN
MEC!>K19;%'ZU'4NN3IA="?%$'P=G,3=G&SM#@U*8/4'PF 8HW825_5YR][3S
MK3:'LE(((UC'9EP_7$7^W>FG%FYQ'3>8G)(R:H+GEMU+L%2QOJRB2$PII_U[
MH0]B)0_D@XC&5>%:B,F.GWXCWT&( EUM7"%F3VZ61EP!J[L\WZMLEGRX.LS+
MJ9_C0A\RMV_)%6D(<5&=V\"<K<E!"]',0]70*MEN<2I8$_[PV')D^KF:W(_8
MW:N(PPY.GKE'F8\V*&T$SY89^R2]#.:5%-]BP'>_V2^-L:%W0K7DEQX5C+DB
MWP8)#_DY:;Z"+3(NI(D81JGX7F8^>7<A..CVRI%?*QXW$1(""J8O13H8CI6<
M:X.G'LJ9O[2OP-/TBT)OXCO.F?<5$\J3H4KYSVZ_YK0>:K_@(TW(O8TA+NFG
M'AN>:Y5Y<D-EY+H_J_KL!M2!8!6?)-7H^<3SB:.O[4?K]=[16NZ>M$T8!\5L
MRIS"QNCR0-&0'0#*I2+"LK^:!Q+]X"G[,VMI./WCF8^CKN, I,5%5_CPQ,S1
M'\[7+?.G6/CH R?"OF/%D&R6.W?/#M9ZR\2QAI$F,8X+$]P>=K.#&H)G9N#S
M:1S=81+BQ-X<57TH-J0$D_S+ZV'U0I.?:Y+;I&JC_'LGWLKW$.^^*LKN@T[6
M84F(=C5MQJ=([)WEGS#U+DS< TW<CTC(.58B/IJD,BZ%E0"2VQQSB>+I&6_\
M;K-7/*5DHPOF B3MI&Y=I8;6O<2C@T*\?0/Q2*L/G!P>:*??%IZKQ-'=*H=(
M<V01$EY9R2VXN"\+$'&*OFB1IS9E0P%71(Q&JUFW<H_W:8Y^;FK/]Y+(ZDC'
MCTZX4O\0GGC@5S0*%ZL,BW*"OIN[XZIX$[A?*SW0\Z7NB$D?,6N0OKRXJ#K'
M [G?<+.SO:7J7*QOAA*Y8DL7(;RK9@S)>&HAJI+9,N%'-M1O3\A--@BWW],6
MO[42>T<'NY<1:L3/,,\Y7HAN>UJH+W<O'?G7*NM>US&[&XGXS!'B5AIL]Z4"
M&8]?64^,UDIP6;)[ "T&7(+CSXS^0^.@">08IKZ-_XXT12+KTC ]K59\:WX$
M:].EQ!#TS[* "(NDX35I^\$UZ13QH<,7)1_/AP]JE?WH]*2I>*N)/)F3:[ 5
MH0!X*<9R?)]S+O6'*[0R;@^2PG:8#&NF#ZS!]YGF:7&SBYUHIOYQ/@2M36G"
M^=OUM("?A_J<GK]"RF^Z<X6:F5P:';>$8G9-24;D"N]P!"+XX<AL!"U$4'.E
MV$!T 31C[^H"5AQV[S=%ZMBEM!:IL((*[H8V<R[C$JS#:W4'=Q\+A><.8)E7
MDR/)U0$Q*8:R\44<6>"/O?'O<V5V,WQB<L7(_=JJCQS?2M1/844,)F\=-UU%
M5;Z:""2B-E:R*1T ZFE_2?%?#9;*3WW<'^"C\,HPK4B/27G/M7M?VBT?^:8_
M?L6*4A]&TA6FCUZTR4&<E]W%3'))W9)[;2_^*$,Q,50U223F]2V#MCNV<S<+
M6]"OP&.K0\PC5SMR;1.(^MF[E(,>S4^K.SA?\3;3++$FZAL<4Z2++![BF]4G
M('(SN)NEC-J/&?L%".)CB*@4C(^,L1/K0$KI/(U:UQD'M@N1T3"M>;6IU4"^
M6=FW7+X6^]>0E3=TR5'UYCNZ%AQ"F491 R=%XJ!NO4D\T*'P'9A.RT&M1"R=
M77P#>9Z8+U0P2'*!.O:MDD4]'-,;[%^U^OF@5F6\KM;E#ABE+68>[KZ;J>W;
MEFF-M0$S3=#,SD5^@K"3V1]^&EB:KJP"*"R*Q>MS;_<9H;U$$K@G 2@[F/GD
M=EAJ4YI7R:@I([9 12X^GS8OE2#K1GSLM9+//2 $&*M';)J%R@*E^+&(W>WD
MJ#3@II-7R)V04IH8YSSELGVF?+XJY;"S!T2+&96S4TCR"6ZT5>34TY-19UUU
MW_LVG;SS5/WDP5PCI1F'_379+ZZ(S=VZ'Z=9<K/$6'(_E%16N!^B3C"AM.G>
M2SKQ+(_1F*C#]DU^H&^0&G;LM7WBO2-[#9/F!NAEF[%GA&02B#'MMS\B$MKH
ME>^UG/-JH/.O=:R)3]P<',5/7P_U%7?/9"B-1)HVW#F1W-$DQO>^KJ&76)*+
M2H3PCU0R?V;\!,!:V*['6-!XO@-9D+(@;[TIG9TXQA*G1*G9F</?QO6T6K,L
MBO$?D_>/&7L5.="H$Q[:9STS6/-56/=PAVWFV987MMD%K8<:C>#N3=DT"'^G
MZ[UH:,LZ#2#XMFY3DS*LCD:(A/[,G,$QP.)>$&>UZ;<JF"^=S?:2#WZH,27=
M_//@UQ_)J9D"<::FM-;WRUH,??+Y[I7]QJ16^QY6=66<;*LP;'X4K6YJ%6VP
MYU(AS*RLB':XT"7D0)!-5M%3%@1Z#R&$"<IE$O?>X[JL.??N:'X*48SW);N^
M]T50]0WCV*_:AMD.5-(K(&2PU5#R;J4-4V-AHB-GW]G6"^G;?+AB07):\[U>
ME/W'QF\<.,8VE>[<=[I03H(U&AL!(T])MET=Q^"!3E+)=Z!?=:"C"]RNS!;$
M%KP!BIB[3D_^*M%@P /]:J#( YFH+7"&>*#_Q6E?R1W+7X_>AK)WQ/% @T/)
MJRJS:!Y(;ODH]L.4*C\'E7HYS4\XHW&CNZ=H'$DA=@'P=%.-VZ:M&]VB!G-B
MUB9RSX7"F>1F(7A,KA3E9E^H,9-F,L+1FX+* -EMCON7\SPI(J4+KL> P))0
M@XK& 8T&)09B+WP*S>*C9?WK!0"N1?>2R[>ESYV?^&;S$T<D<Y+\$*+*I08;
MQS?<FNJ-F1".=JD!A"4*IZ"/N.* Z7-,'JU5EQ*IB9-PG#O/_0D@*780]\_5
M!+)=-2L:* T&D^3]- #OQ!3%2+=E93[T)\9F?1K!,>^YMXC(AEIM/;!N<]U3
M86XU.&G?@=C#\0 >X%N1Y?-2@Z%ZKYC1;=#HNL^$/ >/8(57\O"]KIPK Z'(
M*:$MS[ =K5PIP(O>*PW4VE!^3?XEJ?/:,O1&+Z#2N1C!\F,'\OUW!XV*I]-^
M:]+#0.G$UFZ5J?S0X&%],/.$>2 #P7:9B&:@1 '/!0?L?LXYUOD<QO)!C/MU
M%KH)Q^RT),/WSD).,+N)<?PG<('953(_0K:DGI3H:+IGUOW^F)6>GU1J^-0N
M+E$789> W]6[S]PLO\Y3/=AU*?]M\3YQ/R5CB1?RQPRT(_%V/8^?X:&H4QVN
MBR4*Q:5>\C+>MPD]'%/^\(*PS1<XWB^05.,(SE$6;#)Q+:/>NW0<@Z/7MO-
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M'^[7K4M?L#$T,<YQS26-J-"+S!V==5&D_ MV54,HS<3 YF#7;(-WXA^[D7@
MAR E[+8YXYEY?#CVTE-E(/T2!N<EZX@^9JMQIQ%8*:):]7=\I-Y?<"OUGALH
MNI'CB<&Z0SP?/\Z!>U#D&K/3IV2LR2KW9P:6QTU5P <]N& 6.(ZD\.^@:OV?
M@NJG2E+]$ W6=Q<MM#KHK4Z2T1U9N!:"KJJM^W_8>_-H-O=V#=C>N[.JTJ)H
MV:VIQ-"JJ:;L5E$414V)8;>J1(JJ*2ID[U)3#-O<QI 6D9J+Q!A)B6&KJB&&
MBAJ2M-2<*)$2?*F^Y[P]Y[SO^?[]UEG?6K*61?)[,OR>Z[ZN)_=U7T/W58J?
MR;?@S1Z)1Q[F^M]G3/MW,C9(WR[[KE"J8@#N-+48XD58<V>HA-KK*LZ-@\D4
MLFXQ-FCR,*L<(;A^FZ9G:4<>::KY $M@M!.%'[M>QB>9DN_YGIP?M(QX6!<Z
M !E5+.H-]%A#[JG4-.E&GDK57=_&XJK(.U#GB@6Z#Z7LO$FEL"+8O+)*EV"W
MT1BT$/S)(RM&-!/D$XA)3/>S0"44+E+MH%:A;Y=JP]VVOV4.Q,,E&>[[+>\1
M+S%-$[@RFC-SB\K<@.DE#_*L;<(8_00!Y)^@T6P\M#CP\7JEZ5BEBG38XP>M
MSP3#&-+4;,:WQYN%,50<&0HI0645);_6]1/ Y1QWLJYE2QSA_(B4U$!5N<:9
MRVG453K_DK%RS(L2ZJ%T9R()#$L <V:GK:F"K:#BN"G<R1V#;,=AC:]=L1ZL
MKO8!UAD&Y;Z?*77*\@*LIX/]2+<[&%:P:"J7U/LU^<,'N78'AQBI/MK!)4@X
M$X4XT@P_L)VK.8[FOW.("_9E4ET%Z1';!/6F\0\?.,R%)@*R<CNNRS^TK#*Q
M.U!=LPW"'M"EFEJ^"9JSOW6>[J,I![-2$G+T807;<U$3AIZ1S S%X3)C^L53
MYF9MYIIG%6QM/R$W,L4\)]6;'3Z%$"=Y;'__\09?B]=3-9%X^E;@P4X!1UKN
MJ)3N%XTE;:OA0-64Z9YF).(XM<AA,S,5SS*>BMOEJ];X]-A Z]T,0L0D]<J#
M(\"?=OGV[2!W3DR8,OH6O[[LVU_\)RMJ>A)G.,G"]$X^HT<<F9FR[ \6T!VA
MOUGN[\..<ZH<1Z)'CU9C9I#%4?XADTY1H>P6#H*&B',_HL^_Y<$Y]J7SSBA=
M%4=50.JKT5>.NW RN0;A,[#'(\ZX"$<P,<+\S(D;+,%8_)EC4V8X:#.P=E[7
MN#,> T.8X)IP]5]X)VS@/'++&:XO 3>3*YS+OVP9D-LN<489IN **T*^33W=
M.))^/3I.U!G>>%?^XB&44R,]FQU\+3>CI/$R0*?)WL/&.DV[V:5RPF]Y,@G7
M=/=CK;EM3<#+YX6 DG"0;?$T5C[-LELA0J0\;4R;&?'V(5FVVO+DJ]X33S_%
M>$^*%Z1*0CN4;96Z3U:_ L@^5&K247IS2LA9_5LE&RV'WTT^%*D"MXL9T2FH
M0]+5DN[4)^R[/IU\B&M1HFS3EOJGQ+74)TX#?,:__?S'<\?TO5+EUJ'UZ939
M\G1.?>[O?>>@60^3B8M%^"F3$>*_\^DY8"]-;)+>]OQK']YW/[5W8LF_MO%A
MEWCE<ZHDZML*;WZ8K ^RVUMB[)O':9[1M+;]JXSN-U=:U3!KE^^<8"MPZ]SD
M+[QR"2[E/D^O9VP#UN&(OZ.8UCM_U__Q[7O,^<: G,%U],?D12F>?"<+;BN_
M+4@ _#7_WPW4VG"5YRZPV@[#4\R\O-Z6O)4$KNESCEO;S(KTO=B;+-$R2*&3
MQO-NT?4MST69'F>/,#.APH.>FFM32_@2$#JY/O+H(&Y. RT(!S"]_MR1@H5T
M2M9% +;D^ZY$M;_JQ<ZQ)C^ G0V:.7EKDL\L*Y*VWW@[O)J096?IWN]Z"_0Z
M?P?-F&I=0YV?,>;$TB"/S9'GXGW7H9#I#,#C?7]9GPZ\.NV7X#1X3>ESN<8N
MGX\I"4$5HX\-&?'_R>!?3WEH$KMXZ*_BK-_B[<WS+OH>N2QU-[[.S!GCY?%V
M2DM="'$G&BO-,O<19+H"96H,EP\\! ^U=^:2R$?\H#RE'N%']" (;%V .W.0
M-/\#, 8YBRB=TT;4(K#N'O<)G*^O*Z&!@?N@HSMG6 >J&27+.&^-/$%+L2;?
MX<[,;709M"D&>UOR>M;Q29GWJMA$H"="^#/B:' ?,E*<D\1$TE.B]!6P/-H/
M(]ERH Q-UFDIZ5?UE,ZJ4I]Z,?3M.DK1 "Y/A3:TXB_P4?O!W"75"M4\J;PS
M'6\-L^D17@ZO>&@-AQ\=7 SF;[8$NG+R6%<%[@U2O6)4;">[Z%[M"UL68):X
M73!D/_>FNTH1IJ)WJ2)O_-JH:$B-$9@M.*2FP$EAV;6=L!KD>+5+\U1:\KH
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M+6$IDI^CQHYEX5>0OV_GI[3O)PSZ$O34DB1?DX1_Y_CF^)J["RD\B2D+"&8
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M=Q?B28O#0*C@25BI)'CES^JZC/JFH!!'"6)](-W@(%F"6$CG!"W)6"5 >Q;
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M$53@"K!VK1?:F:\_M(8D+6GA)8S[AS26H#<(R9(J5V=F)E3A.9]]_6@-]0G
M,34Z,&I'E&O+\HJ#!Y8:(@OF$?NXX30PX-.KH>"SVG%X?R'8SQL6@SM]&-"4
MF\E&79-AB;IKCQ\JZ.?NM-55JO.2,&,&N_<=;MG>. J\$\A?4$D,+3NE%^HR
M^M!N8)4ZZFI'61$;*56JKBP\]NC!)_/!3Y K9/O>\+$UJ'L#F5132U!D-UN
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ME3[]\Q)R&8]2XC3!BAI5@AR''K*6S7R>&O=$)<.2F9)(U('[CLJ JXYQA3F
M\@7J6]%G32.W&X8QV3<IQLDY^^PF72Q+/^_PLY*2$L!M7UPG3927/!HRJ4K<
MG;W3W*VW& X?(AAL 3G8Z6.QTPLJ6FJG86]&VXD7.7],RFW=*ZF$@%PDKJ&
M3WYG#G*LNK;.=4[9O@)WJTEV--5&^88(#Y'IX!Q7,47:5V]] QZ=Q(I<)CTR
M,S=[5S1>5V&:;=QL)M?T^?^%4"+'>82R^!^$TAG;3&A8Y6XU/WO:;?!V\D:
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M4?V/"%I2E*_*)=RSO'HI*M9G$V0KLO*"6II8^F(U-CHA&]557@BN&&$I[!1
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M/5USMS$K=]L//7M.$YMW(3YLCKB_^_R1%A\PW87P(5$C(/ P8TGV;C7F+R-
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MZ\U(7S:8"ORQRK4KH(S1<?XI.9S<$SMRX2UV8Z_.92/?R\[C"^V3\88KA%6
M=1]'1 "$#!]S8K3)L^Y,6P1:GMC]FDG.&\+^>#+)ORD#,?ZO"&-@N50%L<,P
M4^)2[]PK5Q #4E3* A%&UU_&&5+45-\35NS=T]?[5!8@=M1&F EL:]L/?:S;
MT:MW$T'2*S[K@1J18+YQ_WG/OT25M62.**%X0'*#22;I\9'9RY8X9\#+4OC;
M@'>UB(08F.AG)<$P=;7M2?$F[L[:^?:M\974F39;+OKG/7()82Q%W9HE_3B
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M[RBW1BIL."G^4U:U[Z2\TL/(-5G&J)M<)CC/%P5ORL-3ARZVRDY\W23?)E:
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M1) CQP4\_0RT%WVHCP3=X4EE\5)E[;HX)T>"CKYQ66XU^YR3*R])TSBT\&Q
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M73XJE&6K::IR?%X!5%<U&SF.E^0271$96'ZRVBZ(_=Q$@!LY9 G7R6GB&$V
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M]')K#)_1K!&E-XVFE32\]+/Q?:C 5SQE]I@56.!#BGRK6?@+X+';"-K"S^#
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MT9=0/%&_@N7U#^T4Z9T"\F:Z+4F*"\--KYO&PEK"MOUV;9IN%FT=G">P!/=
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M4*,]^MJNKK>DJKXTZ8N3(N+74_->.HY.?TYQ)I%I0X#RSRZV-$U_K697FV7
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M&Q\B^'<^!"/YG_B0,</_9S[$Z__R(>RS?G_G0P)%EL:_\2%U^WQ(XS<^I,#
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M5WK6D'$ C!6^PHTT>B!WON'C:=1WWR%ZY5@G^!B>%(PT:+.KQ)*O'];@SQ-
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M()>NW*#T]S_Z"R\T GY7<:G#:_R(4$:71J%=UD&U\UZZZZL($1\#^H05&\[
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M]&B^K'Q>+M$RK_J.9OK<2,6'\M91A&YTO?YW9;Y-V*VHF-V4 1V#(\)6$=*
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M<S4"1NJA,FGER=5:9Q+DEVT-UR!S7Z'3N\Z/\VUX$.&0LD)U6&(M<!XBP_<
ML"%RYR,V,_ '9KS#(=*ZQ[IL3T;<,2D0RVS5%AP_Q\TA+*FKC%5XUS>LS"Z,
M8N9FI-,GK#0 #QX4/92PI#O>]I 9I<@,2,X:Z[[NFY+%V74>LQO9]D9W4"Q[
MXCU4[)ON35F9-\>[_;[DEE3,DZ/N)@KWB93O;AE!,?H4>GSV(*<?RW[%K6:'
M42RA5/+'A/Q4(V(*YB#?BTF6 M#Z@!U?B:6_&TZT2N9 5N/SS2#)<QS8O7YB
MK7_'2*R$]"%2PG4S(P@M?B6(%\[W%R1UZ]-1X8!IT-R0'S4A_X$Q^9?(3CM<
M2WV(-WN"P/B,<!F.RTC5JX\%'T#"/.U7MQ!2WZ:S*KB%XPU3*P\U'3-\CK?G
MX$XP%JA6AX(!J&0^ZP5_XT3_>0]&41 K>6&H]'#P@M;-FY/2%KIW&"?'BB/&
M"%+V#O)'(SQ7WG<4W*!E(/4,^N9];H=1?L[NJ3BU97#=L3_1HO!,Z+TD+1N[
M2TX6T>J'WK:4:;4LN7/_2G9PG4^67HP7BI^;6]8'- ?X,M8]F!=561B,%9%%
M5P9N,?KFZ^$WVK:3WVW3,U'VG-'^^.W,--V6(<*L#>,-7Q>#B,ZQG>CL:WBH
M\7+D:_X@5W_*[[4GGNVZ!AQ1I-#O%>95Q IN71HE&;.KUG= T)?-IIWR Z]Q
MZ<K'IL4>6I4A;B'@=YZC3#_$RA=$ZUZ5\5N^92?>:630OG&8%X_I<=X!A>.
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M=Y;(=4A>=-:MMDU6U!^' &>;61H='*\5,L_PF^\#WX](:&_W,:"5"9/V.Z]
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M#+ =9(HE$4JYLZQ5Y="!#/7Y49?[Q^X+63RM,]2V%VDF.R Y3+OB*H-#Y/*
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M:]&5VP'-U<-:\ ^L5"W [!0 0Z$K7(\M,G>+X%H>A *7+*1-ZAF)QUYXI*B
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M506P#+\NN-<'DE,,RR] F^F[M,B4":GV ?HIY_U24UX^5S. $Z4"!$](Z(2
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MK/=CI1:0'>TK?S?;+1/]UKX[O->4-,S[RCN/>;M_4YIW> ?4K"FL0R1M9>V
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M@S+ON,*/9E@F*QF->BB]XC7ZA7ZJR;NY"5-BHA9PT9(IP+X0(@R[X1;!?1N
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M&J9,Z \/48^.;0=SF[J[*[\==OA@^H"*DQ#_X*N<]U9CV%7<)S"(]ER]_9&
M/%9>XVO ^3N;))'?)?0R/6WN73^A*?.VW/U\#-G-QWHG2&$(N=9WTN1N85Q
ME-<0T7/;R[QBV2C?S'24]NJ'U]HACUS/ L^Z)7@C%P9._X5>BKF@K:PTH=Y/
MLT?X/W&[:(9%P5Z)QI8G]Q7:MCK[:?Z KAAOE5 ^[H%T^VD9"%F/W?_A,_+'
MME-HZ9W'@# ]H6=A8FUW8<8M2!')/^FMZ%&&#K'*T;NL[#[ZL::YI;:M)N<
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MM5N$ M+P3A_B#Q%S2+X@?)"+(C4UMB68-M')>T8DIWN?'.*J.#S/\^5Q[R>
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M".E'K$<E^/6L+'  HO,B &\*,8[$SR:7B1VLL^-!@[^X?#9;()Y:GOQ"+/H
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MZ5<-.1<;VBHGX/,E.-H-O1#CYB%_$HJ4</<#TJFU;M-;+"6/PKSQ6U_=,]_
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M&2'(_+,>=V0E+*1]4 *=L]\^>Y+>_W8/Y;UW (JK&UR/)E6/5+1-!\=;CB/
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M1<5UNGU2A\C:FQ27.(+I>XK\T$X=#2@+4K"J=!*.:Y,J*A_!7^7;;QY)':/
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M[X'ZI<5=]RF'"^0SO],-H0;,CZC#!;L8E#?Q*?0(N_(7^$;[-NLSBJ69'JX
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M\^PRC^^L0[=IJ56<74T,#*> C\"=H(-?24;"S!W+P>_SDL4I#9_Z&RHSTUD
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M@1Z=^R?_].^%#&S:#T!1\2_L%['_]1\]?X>*9\3!#D[Q;R+5[.]R><,*$RQ
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MW.*V>I(*.!E:+9;Q\K6/ED(FA>-<->U80@,4XW-A6+BF9@CW\A[,DZ<[+LV
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MGN=>I!J]&?EU'[V7:VR7[;HT4<F=)?00^K31P)%PEWQQL)R6/E6VE/5H>0)
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MH1>WG CIV)\"\_T];E7'TBX=N1KQ0)7QE17J4F^LC7G1):C0* 2*5@D&)9\
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MWG,M,9EX^D?;<?H5R7EB"7\>2?'V?_G7GX2B]2U$$43*_7O/IZ/DF#&;/Z]
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MK@2Z!^WG&Y(!<R]4''_HS1XCW%)1;S'2E8K=T:1E9%J,KN-TA#_X3I!]GJ4
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M _\ 2:GC&\F60^&1$55.3J7B6Y,&RJ31,0Z397;32(;6,ZQ8_/9:QO7'3F.
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MWN(XV$I-\92WC239QIY7#O5]P7?>?"NP%F8C(DP6DX4580YT1\!]GP%CO%Y
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M.:?)*O*R F?FWBX@(>B9XHX-JFKBJ%8L+F(,!$*-]=1KP(,^H9NI?_G^V55
M5C1T.HF_OT.8"W/>(CA0Q0[QY^N/J_>0-=#V1U#K# ?$TD>'P.<;KP"?[_(9
M-9D!Y@D?H=Q\=(-&,C[=@5ZPF0=]L$6@;RZ>"K)UE5QJ\,T6[NN6[3SV1J(K
MA&)= 0L;/6* '( [35[C%"!/LOCI5?#482@IZLOZ28^YL(_0:YL)[T'#M+XD
M9;4 2FT -+4W$W3MERE<Z)M_YTW_2U;H%E"C"$4-QJE&B/YG='@[4"V=DYV:
M,T@Q_PSP\4 .X%N/E,]J*R"'GI:^ LU;YC8@G!S[9IB%:%=Q>\,<Q;X3:MR.
M'D6.2R;ATL2941VS?J"<N,[M;P5.0AH1B,;9O@: F1O#19BR%] +@R%486@"
MQ*?0V;(XU$>^ 2?_VM0>" OPH;Y4ZFSL?:)!5?9L6I*G]]Q]:S 29/NX_RE5
M^R4@7T'"FW@Q9-R4E BAE'F^X1BZK):_UQD)8#'#W+B3U7?.<FK!7\GK$?)%
MD@5G3NM;R2'6@>=;6KR*DK&LD!=?QO;O_A0V/UK#M,A/O*44I->Z5&:, S!>
M/IYK>N9!O^?@WO*S+Y(3-SY/)5AEF!C9&N[)J%VRK;MD^Z?);^F,?OPBXJP1
M2[-![?W9[Q]=?$]]R2[=V?8IJ^7I"$O#+L5-/5;&Y%F]478O[Q4N<6@A58LV
M^C.PQUH1QM5JKP@#Y.#$$M  >T8<ZK^.B5PQ&P?CU&01+QCX%XU5+5Y>%Q:@
M.P+*X7GI>N#1=2!FWX- ! ,<(<*<&XS^_ATK, ;0,$!H*]46O+;1EBS^0E8P
MYVM<ES4:*34!"$TH05(^(*6+384)'QL$FK+=<B+,"IB"%8R,X)X,A<;@>"63
MWO-R=J"D5(B2=G)^!_%]2J_TEL\H)<$('FD2%$H.FCY,:&6),+>VHC5N<<@I
M;*$:;D97<  ,)SQ0590MY!K<]*_018) '06*=>II+LR^4 +@ZX\20$56SL!S
M9Q_/JQ%+_='JV]_@P>M@="9B:^8D5_)<%9\(2QM- -:1!=99!#X2VZU$G7]H
MK 1-/7V*1;8PQU.O@[:$\L%KK-.<SR),RFZUZ61.T5-Z<8H'/(P7VV85#MA7
M,;Y#ZC90]D=KE#N$AKC$@D:A[+](F>T0NBR KY:*8YTE-PI$F-:NA9+ * AC
MOG0?XTKS(H#Q"UC ZPR/1P3M,-*Z7!15#W,:'&O15,A.+Z[)O+(B;\8HR@\X
M:<!1P.FQ-8X25HR7++5#]IGH,E?^]E1\!:Y; UB9&08+AL64=?%NX=U?J@6:
M^&YMR6.J8#@G1;A-L,>=EN=F2)M?)[9^6..\.O**1E(QR8,' T!L3)RC?FP2
MFZAUK62.P'.^&L<Y G5MF@)A6)$7,X0^G0R#!,/N &(6@V'RD%9!Z#[X]  W
M@*&-^NG&S_]"/ ]ZWJ,>A+,T$P)Z&N 7GS%<P/X44/8UD(F:V9#@D2Y!HF3;
MA:W&?)<WLGEV//P+-IQ92"&G:B,N0!L(P8>LVB"\#0^GH\TXQ%ZP!_3YH5/F
M(QM8Z7:G<ONA^75@' ]03I"C>C74GLMM WZC(RDW3G+-N.3F*/N9;JCO%OQR
MD3\2QS_&%6&L*0Q9]&H1& 6WI,C5F;2*N&Z VM*R@"0)AC0V!&TMT;OV2DT?
M^,Z^!W3"-&<8./TY+F <WY*U:E$W'9((,\*D]D%;,L7;/&P7+@>?X4!]-W'Y
M72#>X"=V-P@M<=+P7%TK(*.+EPAC@75HW00@2N+*F>A5VP;<$VV*S$AD73%A
M2CVGB3;YT&RXEGUW@"ZWO9DY=2"]!651/RSZ:^^>E4*7_<#?I(('Y;B!C]4.
MI0H&/<2"1$BNJG!!%0@30 .')I7#Z%7Y:/IM9V40^ L'/SNB)OZ!CG/UX4$;
M2WZUIRON& &JY09.D(L:824 $R%A];S-4!^3T-DH!IA/PDP<IP !)JEW?@ >
MXSH_<<@[R"U4Y+0 $+PA[5. &$&<2?3656^!;ANP/[6C)X@U?9EKJ <J$ LM
M_?0!$<:RH3]%'$I;W239<YUE0!8"?'*1^X@\Y.,AEAL'@.6CHBWBQ["+'/!0
M9G<@=?X1*@]-W<MEQM%51!B@PE^"L'_&.9)9[V<V/,!V<!?:JRTH>SM(29(F
M;D;H M0^^ 9TCC?&/<C[HQ_-Q(?B! /N@&WBQL](V.8?_V:;R<0YUIA%D)NN
M9#X5*+\J;20)*X<;5OQWN5*2*[H(7;M N8"LM8"H\/_! 6UP*B7&P-7=Z_R.
M01_$A&V'!STV=?NVI+8K04F".O%$[0(-)M"815*"Q%]$F/&'XK,TVBSZ:H29
M_[0&T$0W "YZ&*UCKBX:X*J\ZZ?&\.9O#=.5&DFE:A7.BUX5\!5#2;BGB*=%
M?$T)<OE9'2_+3ZC>[3ABW#)@09RJ7:SPPNA:TP9"G#/V[(%T[3K/<U=M0QA?
MDP=_S(D];6>KH(J-88TB?FD- 5)XK8JICSC_JA4-*=+Z\P9(4@QK4ZU:6NC'
M7GUY*@=U.;ZO+LOT(<.U<]4V!MLI._"@J6_6@[,V6SSK#&-(&T68G9+32Q[_
MB3.PJW69>'<=Q++E](,P9Z*/;KK#5X>:?A*"GN#D(+[ N1[#A\' 2N'0T%M3
ML&"_. I1 :,'JL1*\!L(WD; X+()N#G[&6_ H+7D%[*1":TT@8$J#Y#6QZ "
M$)+M%VH 8K5L#>RZ#ZARZ46\D/\"LAOX$0.6"UY(._@9#6F#Y]RHK&$;<D3J
M'K6 6Q_$L6E 5GO>#]HM*QEG1PFM76*@(=?\#,:4U,1R"8I!J-\T0$G%<<".
M3:1XH9+"85"X1RVZP[.<"4!2'*@!#FPT&TYA?W<7XH%7,P9D41M(H\T9SO9&
M?&?'TR0OATFB?+'X93?!@4D>'C3D[]@"N*&S_UO@^8>\8@&B<9X%R0F<[>FR
M6]J94T:@H)JX ?>_I%;#V2 J+S84Q@.FK*G=C05QOB&,*1CQ$!_7HR>,!Y1%
M<0) ;Z@;@X#Z)3ZBWT45C3W/3>5Y>R-F>1TH&V [O6E^%_+ZWFNC*&A>N7%<
M'$0SCK71J<U9"^L*-+Q@=37/_-(0&SLAWR"T@&6,J=._C(IKT!3>Q4NQU284
M00W>##SJ9QM"OTM>K]/17D 5Z$C@)5\,+XFILEN9*,5/$J$?M2V<,24\#TP5
M(<ZLF=\)%WJC\LR5(LQ<8XL2NNP87U7O*E>1%SO44LE<"<\UVNV3P K!H1['
M:;*7 ..T/J7)K?)^-V(4)T9&?S/Q;-='&\EL5Y;D2KR9ETS.86:7S+S 5/@$
M)ZLHV#L/1#-6AP&^'&!+'):3#\8M5J"!KH>F4G-=IZ,Y31.1]0>A#T]I_B(,
MWBCV?I!BB5WT<TZR&JIR<0XWQX-4_YPX#Y:L=8X5P7VWJ/E\"<!,5ZOL0<X"
M_[X&!,!/S,[I[^1MY&88.44"\#MD ,!+CE4@PMQ_Q 3HU3:>)!!\-\2Q3Y4
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ME5T*?>8<Z,-Y_2%?!0HRY(93U>5OR30B:']5^=BTO4;_Z?KQR)H@J^9C$J]
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MK\$=^@MWY&7K;\*7>5FU.H=..5P5XINVUW9Z=9TAO],*3>_T[BJQ2W0U2"]
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MK?9ZH).N;YFK]7--VT>7'D7A* 4!+KUGSGX,+!R11^ P %&N\OU+I3*0UB%
MQ%4PE! 'ECU#>(R>4=5J \R-:V4 <UR&.HP198<0^A2HAX@#R!JV2:VBQ-IP
MZ&_S.IMJ*;\!,X9V@[1P[-II#+HAT$%TY19I5S6H),KCF#VE>2S0+[&!@_AA
MIHB'V#=)#X!<%Z?<:=9+2B +).1'K^7*([ +=#*N;(*]!DDO\TJ0#FB9E?"
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M[AYGRC<\(LKC,*=[B&JT_T@_&!!/^YVTA-N-A7]__#V%Q;\AA]PI)LK4-6G
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M;_B)">MIE3YU.%_GP@_6IA^^W; M"G6R;/MXA'(:K2J[G<Q]'C+YHD;/^^%
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M0I76HNV3T/&CE8 N']6/L]RPQ?>+]@P+D,_G&[;/O,A]ELXICZ%+R@A\#]=
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M284J>(%]GBJG<&X\KA@2&-9R:&@E2>W2CJDVV&*YRH8)87PK>WFQ?<,.)P-
M%S=X"GQ<#>G[)"'X$:X&N/J^PQ&H8Q+.*9M0%W<(,,F*9!NHS"M[E8N>CP=F
M^3^>ZGF"784'2:8/Q;""?4 +E4O;#58L_#R8ABR" 7_3=M%FN>UDT+3JW_2K
M_V$X(JGO-7=.N9#2)@Y35%^6*Y< CL,AI4XE8D@Z@6)7KH5,<; S2?R*+(QT
M,HCG+9G9W',J" MR4NW($T,2R'?T?$^.&[C=!;]N',2_%4->2BWZ<:"[!&?
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M#(OFUZ[=.VH/<V4*<O/$B%2S7J 3MX^,39@/QWP.&_BJ-CC8MO=\XQ97B"3
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MHR)PPP2PB4N!7T= [5R!K[]1[)(>[$$H[^-':C=6MEB!>KX%Z@P=\C?1I/A
M0[E#U5'*[K5[SU;E-$WD^M A^OD@--6@ZX.IBTF[SKK-E;.46VOW]T 8[[HC
M3GU$:LXB3PYL(O=QE_3R#BS(M9%_;M3].T_L]@K&Z3&1JR<8/_60 -P@.3XP
MO0LAMD^]$&Z#GP/Z2P9D_[O"WP:*\1')EC@D&76/T6[\?5")0=#M^O&/]QB=
MZ8\J(+.Z-GA.#M3'N,DG1V!\>U7W\_(2_L'TGO6=?JYAD.-)99_?^S/!C(=
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M(@5IBTM+]SR+P\A\VPT>APU[*-^?.6[PF[PFPY3+F5#9RV*[J*)9\M:LE0!
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MEB&7(V[/YC8Q?QV7?1HF)4D;I8?RF@_0PX*+D5SR* Q!SSAZV[AU'?Y>BMZ
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M+.A*%WR'*^N9\<;M13L]^/C-96=_(@5=#E>]LS@7"SI3V9DS)<*/4+)QLVW
MZ;7/IN_6/04&/ >*0E\2[@I1SLP$?@8!LWR#[UP<3CGA!9W"?@91"2[_WL.M
MY=T?_G9W%#8P EO$U"(+W! Q3@A% N4O(P:[Q(BW%[K/G6+\:*H,R6;.LS%<
MUYT#0]'S"UD$-,1121O?TS.?CJ#MS*ST1ZH2MV?Y+%3VN:0?^""JAX^DF331
M_ 1%R<EH@^J=2W.P+@O@S.YF.'&7-3U3'%$H99<P3SL-.-JZPV[I=U?9EX&"
ME^KS>PF=H>1F$L%()M^<WFPKV]UNEKMW3+/H/C67,:O'Y^'="[&>#>93=(YQ
M^L8]6$?J2>3-F2.&A9W[E&^7+MAUB5M/=F;EPV;#20MLCPITKZ'T]*S'#9!M
M,+$.VH/^\329ZMMW.UL%,<D.\@LYQFG3'"&>KGNT)7>*N^*>[8)[0A\KZ(/@
M K&;&?#\YX.WE#/PTHS_!;R/!\H'W"_FH*8&)$#L#(M8-9JH?@6?!9WV><SK
M,RMN[8(6E7R9<B%1HBQ#,.#S8%!^!MU+<O9W<OBV?N@/&\$_3=5)T+G#>="-
M*(7<=T.@O8)]!(W;:H=^WN.6F<(/?,_\"<SRS^ [9BKY,%^(DI'N@>*.L3O8
M83V6ZV*<<NDX[W!S"#!KOOM+UB3?[55]HWGP==>XNQ-!Y'H5'"$H137\)1@1
M/K*>%B&!8;ME[KD)4M@\-J@")+ 7;3N)!/PA*W$M_@BT2MV(N1T%,1?CCG,(
M,G,$U9L)0<#!43KKC/J3/<$ "'**E3W(*8Y2QY11ST'7C@6H'0%7?FWH+ WO
M&!)0ALA6Z&:#$^ID*-LB@?=^$PZG2JX"NZ\J)TZ=<^^A.UJ"P9_F.AC\=4&%
M+#ZM:+Z8A+*4-ULZ-[<#W42^N!(IZ'1-GEO3Q213O/S]1_2O Z._CC\8&Y)>
M&$+?L(JFHR,V\1_WFL3['(:LG,4OG%,7A-B8'*+B-M@-U]'")>SOLE!Y^F1X
MZN0"A-+UTMEC:)OG$G"%!!@ ?(L@NWL31Y=4PR^ZYV0K[,VV,&7VZ<QL>SW8
M.U;DPT62DH3K7ZOZU*'/ZHY?\$LO27N<O>;/EB)PK0&>83?>P%N]Z%^2]A22
M\R^+)LM>WJ;F.XY8FDBRYWK\2(7?>U@;OTX@8__ZOJ+Z\B5^@[#QL?GAQ3)U
M-6K:&V\)V6!8]G[AY$_#T\SRAN06=+0JNC5NK;V_!(A1VQJ^B7VTW5VJ05^L
M-L-JZ^MM\3W+CI[\>)7$0%N1+Y[#K8ST%AH0]IM!N=X"&4VFA:,.9N:.F)2A
M8WA;:)S//5%:L28QZBVVXIDB679-+OFQ3C6?Y6&*$:E,RVLO.>N[&DMH;'*^
MD5'N<"^,4V\$>'S6/G!>>92[=<?UZ3"/%?<(HQ1?#3O5O6SQ"PY]?8V!!>\L
MJ=)O9ON"+ :DD@/!L$4K+2J'V M)=C]GHOK==G'VC"2HPL&%GW.@0.#Y).K(
M"_K'C9T?_A$?4S%?'@7;5$T^C.G7/J%;08 T5!5S\0Q#$%;0.W:\FB]&RQMQ
M&RX(0]T],,.8J:8,A+^\ 3K/P!DW'PY=YIXVA/JSKL3MD+).2BP<@GVU&N15
M63=)$+_)2".&8(N]6?'G6:6YQ$'NKK@R2.!9Q1VY020?;M__F<6 #:/\PL%"
MENYY6NE(#/=E57%EP9^2Z *7J$[NX>10#SD$*=4([#09##3:FUX(/?C>!!(P
M'9#%/^A"E%(63TQ*SQW&Z(+[+7QY<.[$_IP#JVB?]^]'B.O:4'^(^%DJ2>X)
M[4$\X'2=V%786>D[.H;M+M>IRAU>:=N']4GT9*NNK((62P>3U+D,.II>8[=^
M2%H /3H&"R11[N4Y7<H*? C? <VR,3CJZHTKYQ*<(<CBQ)D"CW:L3G&9 LXG
M6![. \(=@1S=]:N[PN*@.T6(Y)RY4,>%#%IB/K%U=QFVN\2*>&U>8S[27(GI
M'(-GO=G0"4KOXE/^['Y,%VFBD]VY8BH+I^$ PMG5C 3&11Y]/PL<VTM_^)1C
MB1PEK!6,=/I@_(TL+9T3 D?FF#CULH#MF:6LT>7V@7NF$3*?!HF+"GQW-O:(
M8@!#>^'<(7'%=]Z-^)=K3 ?=(* +^7\..'@)(!0"G?\"!3F=;1W<C16$1 4O
M F2IB\G93METD!/E)81Q03@,\P@,M""FJYU_@*JE5T',]>96W$6PI9P']-S$
MS_G+\6/'C/31HNME[ ."0X0^"![VWHME4<IY$JG1A6!V50B%34EWQ>""'2I?
M=E[,D>O0<U51^ 4*J8-N-=W2%RLM>J"P<U8FBL>= _29#_Z4P'K<$5RP+*^[
MO >$AZ^,P\\0%2MRCLBG3H'*S8<=G7J!\",.UX@!2\*@= DPF@S"=M@?0SW"
MY68DNO+!2F1I9^[OLY/RWV$>()XJW3_QTX@]=05].BYRGW%CS 4ASB*'J)P#
M?:;-N42U@56TH5WDRE'$60*5<#NWGL$?.<)G!E$!(D_TX4QZ[H$5F/V(&TZ=
M>1&>H6U^"+0*O R2XUIA.060<L[+99S%-<[=]4,2.^C1#NA$][BG"M8T]D]\
M2V-/G<&2_C/YQO#>5K:;3K)[U$OK'5"\0K3A7'%PGB7J:)\OEMS9$1BM.S;P
M_< 007+Z^,J71_)_=(ER/FYG99V#?)K@NU^\[!<O^[?G9>>2Q!\5(FD!TRY4
MVD0*BISUE1=*__&+QV'C-3 LNO9IN/_9T_*&43_/L2QR_K1K<N+<V< 6J+$Z
MG=AY%W6'C=CL0U"[6G2?SW#VL@(,LMT0QHOX<_;Z&>+:YTC,.S\$%SS+JU,/
M_@82.P]*OZ"ZKP6OU3TDX&8]-@+QJGB&UY\O?C(ATPU]9*H(H@JR23"1N"RT
MH5_D2=M@)OI-YB^9:.",]H \[);I#QXF7F%'/*F"8*Y0W\F'>D!^ V=\8D9\
M#N!G/OD[A]'F@\Y('"W:S,#>L(;/.YTA:VC[W&G/A2BN;G<^RG,>J-LBN%PI
M0-VTQ\K^/4DA_@<>((]RX:#+YL+10'KH2YL=H9<SDX&IL># ^8XW?U[1^>)?
MX,(YV&#'I'3G\C=8N6CO[EF(?7)4=1;IH!>/N.8NG Y8,1[<7G;D;VB W ,A
MTROT<YP$LA7.,L>MU893UR+$Z]"YON4?_J9]YF^%H.,0%G-")E]V2# A <=#
MSMRS<Y&.I#_\Z.,YNK)\K@!/2RB.:5 5(U+R^T7/?]'S7_3\%SW_1<__=>AY
MT#LL2<5:G$D[;G>>,I@^=U#O3J->45F$GJK/2JOC6.6BT2"&#AYF US#5 OW
MB.G6C%J)A88VK\S7@'D3&G4ZI^2MA$"',2T/ [7)*$/2=27H%%W86GL?"[6T
MRV&VS(=4OO$<R<]Y"VB6I)0VG$$]2=<-2GH4M'I?T48M,0NE)/;)](;)UY9@
M,OO46M9+70%&G?C(9@?$KKY_X/94/-QD7/YJXGX5[>0K+F[]4==SSUG9V?U\
MT=([\RO)_$HR_X9)!F>WI/=6C$1Y8:Y;'2I[E Z[7D+)8U+4B?F9\9)U@JH]
M"=F^@+B[25]713J,1=H"M-Y\K-6WJ2*\;S%(=C1@<(\&[0EYG'F\*0_GX9ZS
M=FCY($VKYQA!CO,6.M?W.W[^I-Y@2J*_7=W$&R2DMVL[E!_T_4K=XZY59M9G
M!2W'T[CNRXI:-7SOOUP"A.KLJ -$;?"WLV+V'_7LLL1:YA:6;FWG=7CH6CK/
MT 2$,@V/-#UCB1F_4P30OWM/7+7(WN.'Y8!-*5-17KAM6L2>O@2BFN0RMLT]
M)Y:XX6[CA8YU6CWLZVA;& K:O%Y6QI7=Y2T1:%\EA'(./Z/,H]G$Y? UH499
M1_5[]"45[."BCY6K7BW$#%#"2Z;B$WH\Y<GDJ$AJ*!E_OX" "%UA$5@2=4#+
MX%GF3\J/%'0Z>1?#HS8_2-%BP/?L!AX^7[;(YN6(K"'M V<9N5K=8;;HIT,J
MD%Q:04VZ^>:H'33#\0KR<_G;NT*,)>#7B?&O:/'O%BU^4=)?E/3_>DKZZ\3X
MUXGQKQ/C7R?&OTZ,?YT8_Z+GO^CY+WK^;T+/,R!D2P/.16^S,YX9;%L:;>W=
MF2RI]9&C?=-)WNW[,%%SS2_]SI+4W=;#+9]EZ)2V8SKBC>XA.PG(KR1.F+*)
M89U@]+@#YH+I]-$]T(H1K@L=QUCP9L1,>'QIX(&J#B-H%E7$(W#2.@4D@+52
MI[N#A02:O.$':<(%T'E=1Y=_,>G>5^>8F J^.]=*!5VU"@]OEY,JN].GGN?/
MGHK3O)=<%+-2]5)/5I1Q,.Y4D%'T<3TS5\0OGO8OQM,2:1F#G5%"U%5>T?84
MX-,/^PX1/G[[7DWVZO$:@Y_+ I$:KAFCQUJ>H?[SL&TI&BV!]:O?L%N/G2T9
M7[_GK)>L$V7U9A:/MG)YUF%?I'CE<P# *[EP\,H H,$0]*[',QWR:--@HG=T
M:SDFUY9YFTK)W-5TC7X;[?4JP^OGF@ZH&%$^W>]:WR=Z\OI]=5/8+'$-X.!\
M6"7R3T49OHGK!]@(PF@5IO55UJ^'SZ_8.U%L>QI&K4'&3YE0$43[IQ*P+="
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M#T:/DOP+\K2D[:[Z6<[R3#]<> [82'YKO/%!+DUM1).[MDCA2OV:J"5ME@.
M0>M'^69)72/P[?==?+R&^/SNS'S1_7N3'O7V[GZ$)$(O0@*D$A0VHF/BI@9W
M5"*5"[U?+5)>+6[OM'9[L!!@8]W$M8,K,_C%QW:"Z-TM-U7&(3(,--?[:(^7
M"V,-KT?HXW[ F2<5'ZRA#-6I6<2@W&Z@C3%K^_&U9/_-F2*^V$TPW=1B'JV!
M\<-STE3J#2?*P.K7M+3TM.^!V1 =W>GGPWNA=M,,]X^97]19?8DC/12JFV#M
M\Z[:N[$[E.R^XVUA15TH[2TR@'J?)K,UP#ZF>%P28R/+L'8<,VR@Y@$3U6/M
M<H)RR; O>LM$;! [U9R%$6+KKT^:][C+7>U33;\L;>5/CQ]]EWB>P\19KD<H
MC[X0\J9.4+IWAZAOE1D^!?GTL-3(ZJMP6[ $/. !&QT&E031Q-7%\/YA^Y 7
MR07M2=9)VIC-'=2F3T6C:X2>3&XVF'E*90NI9YNLWPB"Z1LEMUH^#3MB98C(
MW4K+DG5:-E')L:,?4QL[_:34DY@3-=&6YIMBV4K7HK:?CL%A2Z%$X/9BA#CU
M<H)1NKF\6:G':D6%WZ/'TIY.RCCK^QK/;E3ZKG8X=_9/E_:S&G89!IADJ+]L
M6?%/$DTV"2H+6P]P7U$[RDQ07RYM;DF2<T"?>_M<_0I+JT^9*"H9S5LRZNTW
MZW6"HWB?-//+*KJ3W.JM;DUYC]R=YGDQ0$5QVO-M7:U0X$X!OGM]S/XG.YP[
M0^4UQSG$CH,B.NQ%)H*:9'2T_7M!5L)?_ TM;$:2?="D*/A;T(&^8=^1^X-S
MS+8R9A ,?^%UGF52F3PGKWT]QLV<E^6&EIWVA1RR4ID0;-/]HZ=>N(4)K)\$
M/ Z+;"GN8><_+ZX74;Q?[QRBJ20_J$9_]AUNOS[8^#_^P<:?VA\\9-*G,"IG
MF [21_$?_$M\7:R[ +-\98RC>5Z>9ST2W;[ABV1ZKSP&=]R!XH340('TIJG!
M.R%O"Z&4*A.ENZ2V%#:N KW;)N&\,>Q%?98QUXR,4335WMPNKS]N%V?CF[3+
M7&88\VGT7!SUE7I5?XM74.[#;=H[:T/4UWRJK;#2#U36'YH'6ZZC!+M\Y7=Z
MAV$OS &@YI!F!?A<R_FN;SK\-'YX8J\PS4)1;?55&Y%]>WLQ,]G',-3@>U4-
M-[X4F<1[KH$T2_%O-Q]SRR"+>G]X\?H%M5?DIQBVM7[ND_"/C#>33FU%W-%/
MKIP@ 3;0_!^7__2O8OS+P9NQKQR2K6W..W!UT-)'\QT51?O]]VKOG<QV-9@2
M\-]%7QYUCAJ,8F;'9"A*-FR 3UW9)#E%A6\)P4Z4(1MO'7T1;R8.;T 1C!6>
M/LN(WLRA5]!Y&]@3>7 :_"TA%\350 )8)UCTT#3\Y7#@BH0W?)$*A.C,V<'&
MH$G"L6*1T0%8UO]/]U&5FHS%,RL5S^.NV\T.O:;Y]?(V<<EH,N6U1?.*^+S4
MC\JI&)?#X ,V2T;YJ3*R+&/.L+\<(MW\M_W0_7_Z+15_O;K[[[K2^Z/X<M;^
MM4YI_[K+A]OJW3M+OZD.AT;G^Y6YR0G$T0R@[:0R[V*SB/,$UV^-+W,+JG_^
MP(?10[V;):VM]GFS6WM\L4C#(Z[GK5[=$V,LA+[(1PSBBCB=Q4B/Q!H)R00Q
MF[S:]X>/_'MPBM$@&VGF]W45!_NY:ISVV%.&*>*M9YU6X"*?7D1&+F_UUZ,*
MC[7R;+B[T[832$R;MYV 2+KRKGM$M.OS5_*2"'WW9C^F^BE/:4F)W&6GK 0M
MMVE<W?N589A9JRPOZXJOUAKI?7_-]!T(:7="]>MJ9HJF56P0DF;F8 XJ;B[E
M$<67-\W1^F9'\LF*ZX5$<-F,7@WUI%^@J!95QOY5TY[%G*(]%^U1&3NF$LP]
M"A[+Y..,T4G[)B&#,AF:8S[3YV))TFAAUJSA9&]JLF_,5."JF8[F&_D]NLE!
M'?HA1Z;&&I6,;V?VE2V9X;4KC[QO&S%?>SYZKUY6F!\2_4+UQK5@*^([6:SV
MM7C;5NYSP5@S#*,;LM\#/]YL(-)RE)4J5XHLKABY*MA6B1\FR>27_.*;X%<1
M/2]*A2<DQ@__P21'<VM"=+3CC#):.JO>5/,3&"VTQ/6/2R:CAR!LH@%,*8G?
MSZ(\V;]I3OVC]K)"S%54S%EW&#IV IN\H;IGO _'/Z!KZ57MY5(X33B=:$
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MN99>/\GQ-<H3(PZC^S75N4BHK7VNJ%!RN/;CMB?H#^N0_VK[EZS;_UM:$TV
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M-@6[=%'_L'[D*=AF_(!I ^.TAA+5 IV&4- U]DL#&'%R<3@QF7<4K4+8A5Q
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MQ269R/=1];&);UEA9O> &#BPU2<WX66)X?62GV1(<Y26&-B"X7)1EX!@I*N
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M;WE[ ^[7G+[=DW=,<4PM JK;Y5MEA6NN\7]QX>9[O)S_CN5&X>6^"V:G;V6
M.3<\=.9I+X?_7)\H294S+'% .S@NK* @N=JL0EE^!PW^+9(I%?3VFY$I012'
MS#_O _8]H_3]1J]K-QI7FSO8LIWK&_'(T(/NCQ*U. ZGR+K8O+C9-R.I3>B5
M9L'^S(C@9OG:/L@C'_=#J8?">K0P1-BW:,.P(]-1J.)/>>YG#)_Z#8U6MIQ:
M+:RZ;:Y@1X-%!&<?@%-^M*_3!MS.?+T6A:IL0.*]<IEG]!&!\K+LLH17 R
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M6>6@+&BHBQGEE#A6IZ[YL<@0^T*[$F!#-:EE;A(C2Z4-R:[(>";DVT*5U7,
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M5XO[^;C^>=-7ELHW?J1_\Y[UP 8FF!L\X&A"/K/5L [QB#:)XJ_\@VH&7^1
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MSABDBDX%*-E)"[H,->J?;3QAO),D";\-2@-L).?^?J1Q0!9QT&> 8U'C+A&
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M0HK0VE">X"EE"T";^RQE:$] [D=+M/?Y@:3\[V51PM'RNC4]='C+3UW%5M6
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M[:ENPGI[6PN^29)>A'#Y7:-T;%[O-^!S242L^19N_]PNEET\0NY@!VF"#GE
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MVD3@X][Z]$P1QF:E1 $KCP=XDI!3=3X-0[:1TGYGLS[0Y6_8?9P$8+$KU*B
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M/5!DOK'*SY,3._;1,S\\(=C!KKWT^JVR$=NO-SX,5VSW]ZOS\7OXV>3)OKS
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M[9;]$M+J/NETBWU-M!F:$4;7I5Q9\]74W/<I ]H)G+ZE.(2,GR2($VA%TQQ
M7*!8#[^SM1UB=]V<T ,MEB_A?Z5J02GKJJ2F![3,]_>/AA2VD[2HND6MW0R\
M:52RJK5RNA0+O0#1PF0B4V5^4+:06[H9RJU*OD4+U/0QUO[OB5T8OQ[@\9&2
ML^Z^B3$3)9\&KI G>"'G!*W8Z("KQSUK;CS;>^Z_TT=JO#08=\&-+\'S&3M.
MK3F@4;Q<L$7.:MX7^H?,I_S&]+UBU1<[]GB\?.?H4@E:V&0PGZC8.1OQ&^C0
M?!<B"9/U\\%%B4]Y+936P=\R;&M'6 <E'1S<#@?;?ZY[,/M]6)G'NCOML#Z,
M---4,5_)/A'G\N[?G8)TV@0&\"-=$@-$%]*D*A?DM),,<,1$L-X;NE5-"2!F
M?$>G)=:DXL42_U%A+G$])PO327,!CMVLC_  ";_'&B9\XAU[ZN7RI]B#8]]Z
M?09SC:U#F!2Q5J'30L(P:H0HL3YA7KW\T_J^NAB!CIV+&2&-I$T]>F*R-\"&
M:>/U&F?+Z9'1TXS4<O";2G2.,$C-(+:[Q/TY39/E/X 1DK277M39_T/8NH*:
MK,+48^=-%>940P2=$F!=987*$6E_HQ8/R5?ELV()'&'*$[ 1<[M&M<$]4:$3
MC=>""&64YK!!.X(NM.#^NG(@D:4;7<3-3K UHJ\)IG2ATTM-ZND_4QV!@@_B
M"Z2;IX+^[?GU0-Z.!ULS*"=2>88(,+=:'0<2:P8*=[=$JK_2D#1B;;Q[;MT_
M+P6?PGBTCF_%VH28@9NF S6&")"Y56YE6G475&SK=3L?_>JEQZ>[D\]^S%2]
M8<G?0Z8*&FPQPL?"ZOF=(]_=,_";R&(-7+2DSY222B5(V6N@J?T#5!=IL%VL
M]W9[K3AA4=$,?AVB2JGAG)D(/= RJX$[)] 9BV[*^,R6UCEWT$S[\4*N+%ZU
MQ@)!OC5*%N%$WUB^/ MPG]<#2[N?XW> C?/-H$UGB!JCKL4<5.LV*J;$>RJ+
M!"<0XUUW6BR92F\)FM ?7++U2<G%:(51RA6&N/#XNY0'V+4EIUJ,I6WE=&]Z
M?=R\1+&9-IJ4_*! X4)- %BL%M>[E36)]RF[@WA]:A1E G,]Q3\Q3E<$NX ?
M\R5TXY@(]8?-H""C(9=M&MWTJS@MO\.H@6:B>NNTU/JQ)$XRVO[7-DY 4#(@
M;,K3G7UU0^9)^UIN%O+ >D-<P7C!S."3?Y>L BO\QMK\*ZQ?,:WS*PS;7NTX
M5K9O0GW1U7)'C2NY?C;'Y@-+9""?4%X7G-J?HM:]P!*OXYO-RIVPF;"GZN>G
M(_1&E?4[*+)SPNHI$'%9FFHN,<C8-,JWG.4;MH 6F=P3CED))'72)]$9,PR(
MKZJ.&(O&&X!:\EM?/K*0<-Y'2NPDN>A5]ITQVI 1U6 "49%T]!MB+=46$DOF
MC32427Z\@3.<$=B="]L-XEPD=1LT:OXY-8+SDKKX>0)3C(2.II&6_=7312[,
M>653IH:A;SY7<^O6A WYB64':JLL?KWH>'1_>W_("[%KS6.31WLIQ#&?UHW'
M^E/V_3^U8]6QP)L06Q;9SEX#ZX+H>>,:BNR/)LA4PLIH:NSJ]9(&9E:PNTI-
MGD)^=R$?67=@Z3X GEB7%O$4/)V-3;>]-_JUBFH36]O+#;)#E[7=;QVNC:=J
MW*.WD063A46]<FY%FR*$$N@SE$#_&1)(-ST"':_0ME/P"V&O<1IFQ8@A7/AU
MO[0/]>DQ=3\HSJ\6]=Z!;0%K*%<:EUO&.E+8'J$]:CY@?_IQ#H7J&F7=<#^@
MQON5W;!G F>O4WZCA?W>SLY78?T?F-\J_JTMZ?>M\=21QU?YZ.T[A??PV<7>
MHENQ[\L3]O9C)S_8A%COCKUWZ_LM5]I?D)]* XM0V;\@*RM!K!6]@N+1TQ-"
M6[WM]YT8;DF58+/%&BW&'.&]*%%>:^HY*2:+L*$%+2'\3 D93E#NF(Y]@$AZ
MEZT3*R@_LNFZ]M"2N&.#=HJ^ 8PV)5>H6@^HFJ5B_=DFQPS81I)J[ <:9+=X
M2VU]>OY R)!!)=P-)E:1G3XWU\[$CT>+W)CWHD=&G3(Y53,&#O^GM:V^8=-_
MO\J_/* @D.Q;Y?/W_6\-S+)M5?C(NX,1E]<.50M%?E4^%2ZID,^>S")!LFVW
M3].G,_VD0J-16+]0I9Y_AYP\<CE5<60Z7QQE]*JFC$2\"^^"QJ3A&U+>&1]Y
M.GAVJI_J)>G+%'$9.(]R[W/D[46!62W.U3-\S&B"O'&XP85X=&#!%FLIF%R
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M?O+/1[QS-\[Y'2LS[.>&,/<NXH.;Z&I[R%[-5O:<8WFA*F.AW'0%5=ZCO"$
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MKIZJ5_?PO3J[;;"(87^L@K*_IC&Z.<(J9MQ35.?[D5;H2B..KZ#:_D8\3F$
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M^S2Z;!0_[GWQWO0HVN(V_N *:C4_*GEK.3BK6KM*FJLT.-0*.J;S#53_3)@
MC5F?&WJ,F70AS0Q<SB9$MX9VA^AGU/:LBG'R8<E<_"1BH=*],SF6^:\^;5,K
M@$T[RZ.<_0CP,^6$!XA$"6.-$>27E0_IIXEI)#0A$LOH!8T[509*#G4?J-9A
M= @,O(+;;"=6"Z+J0?,2K]9H+GQ12M*8+O0RR*(>E]0Y*@C$EN;A$IYK<UY;
M@\+%[7/?%!?Z30SK=,OO*K/A_8KCT+(\'\C,F/P);!J57P"X5W!6:E=;'!&
MU6F@KRZ47:B28C?,#%"L$9;"ZPU^U8H@74W&YTO^Z<[^C',_5T6)ZXRKI:3\
M,5 .3'"D)!WMD!S)[4:MM4/O0BC3^UXS7:T?59;G-50?O#5TI*5*,1AP]LC(
M/&FXPJ>F;]>;[$&VQ6'K#]630Q9'>S3^+7,^OQCL,[-#[COP@OT; L*OU:.H
M%Q%YK+KNS8XEJM/&K,ZLK:+7OZA1_9,)E.MM1UUWWMD6?O"D?J!H;:HKDHHN
M>M0*2FA"&\+$B3_0A?&00+'GP@H*JW!6&3+D1\;??U:AGZ36_SO^);6\KY-V
M"3F'_PIJLL0H$M8]..F0+Q&CR6:F0&!W7WKR2(6,?IGO#*YF'C]7X5TU8V0Q
M<DU*S, [@EK\M%IH7+B"6DNS?&X73?5+G$QR_.YX%38%>J2V*ZA,OGD([,22
MC.80;A/'%E3J@T@;\I6YM"WP03!PKG?2F*46\UW)+P.F.O#FK_'6M-ZBY2M\
M2TI@.]^JE8W\0(@**PV\>G8[M^[6".)TH=@'E)[G(H,.P6I*4M>$93^3<>4L
M-5JVH#GQE5OS\:)^^)4\9_7TC@_#LTTW0%YKNO6!NL/>KKX;ZENN=]SOK-AZ
M@^SF:7TNOTUQ9ATYM[-'*ZOC2-?KC+T]6D31J]L2$\?F;96W_2CD1LN-/-\=
MNV^4;\-.L*"]/\5B5.HNBD.V7[I&>F6$L;V[7^XQ_(]JC%2_,-9F\KZ89?/G
MM. L^9LN0IKGJ6N5'$*40$0,A!(5F^'0PDE29S/VLFH?^* "U*7\T"J:QXLE
MKW)EXO0BI#YU5=NAR'NS-*N;X2D=$]: 6S.&<7IP]/>APG;?F9",]T9YC+MM
MB<IU]#;''XLLDLQHAM'L)_@*100<".IGQ"IB5/\V+2-]K0MY2=R[8@]V\*T*
M2= R(NE]ZD"NU+WK$^P/+ 8!24CGH1G+376M B$V9P2_&ZJ_QXR4HKN+2_Z$
M2GLZ+Q15UGV;E_9!F\2P+DON"8TB:23,54A-U62EK9/>_E2_2=95_JJ1%D/@
M1"<BK_2O291JQ.%38*10G#/AJ/IW\ PNSC(;/B?9VV(K$1O!$< HXF^G51;]
M-,LG!150CVK]?&C-]DY)U:DW;Q]G.OZJ^<>NP8[CCS9^I_[WL+>CIIT%/:IB
M8^C,EP\?ST8/<7QO6Y]_9:.9N'9X%^5P8IC#UF.G&'+[^\=/?\@JLQG]FYQ?
M\$39$/8L==ROP.EZAE1\!W9'$O +O<V3OXM2C36EABDK\+_ ?F"#&>8A<-ML
M%\0"63(Q$_9'9R34N0>-V FT7*4(?QL/+5%@0N6,:M/HDI>6X8ZNDLC[LT6=
M2ZT-24XE<_5#R%&OJUZ*M0E_L:'-W7,8A0,U8!BG74=9?,YN7.Z()04/\4UC
MDC\^DFADX;=&"1H7.F,UHXL0V[=G4GDZ)0OG(DNU'@\.Y:*#MQB]=RK@W6YB
M7G40E4R50U,22]BD"BRCFD^*#2%6-WY]_Q:PCW$*$2&KH6;%3JH1WLAK^1DP
M/)6-"^=25X'NF?Q-LQ.K@9%"[HS9)M @_>MXW,8P4F5A;-4G_&K0\6H#74-D
M*4)@TX_TQD_^$EI"@..-,HT>R5H;S09>TQLBGZ^@C.$U0WAGB*72/WUM!:5G
M5C-)'R/(T$)T%DF;+G&&^FHA\P"P4+[<P=6-CE]!1<W,8IB)8H2YYN<#W3+*
M1TX^.MKE??J;4]>)+Z*A3]O)4VTOM87'CTV[;ANJV7'(,7BLS35D=\:AEZ^.
M?C0SPV+_+<6H,SE.@H"PIP56 0\DEK71'*N0HO[&E"HWD6L%T @;?=C"!.-4
M:UV,G1O.099RDUUEIZT,4P/E/3N.>H@J_OGUR>6GEWS^MODVJ'RX@DI1>-/;
M7*\3)RQAAX7Y;V;=WT9[XD1^4I4?^>09YV(;)B?^Y'GR]QDD<VMI;1A>X5PH
MB)&/C0JBZ1D8H"Z!G<O75][X*F84TH$2JCW(@K<X"K2XB#6_!9/1UR;1&Z'J
M*0]59ZX4G6[\[^BFP;^&Z#SY]&X2+[-RN\!L!44F09O12)MT$!HLYV])XQA(
ME.V(V68Z2-)<:0/TC;A5TC@M:ACD41Y$QIM ,M"@4Z"+<^1X<> #(.<*SKUB
M5J3'N1H+VTJ+4_T.U@_&PO[ELX0W3MPLG*WRFI1)TEQMB=8,U-LW6KY1NO-;
MD?#9L2O,)-R)OX^%7JBQ:@][?>3C#>G;N[?/]CZZ0?;2N.:F6^UY[)PAM;IK
M9W["C9WQ5S\<M:!L([XK+KAQ<B#?FWWN!Y%@ON!_/,POF#NB?"SXNJCX;;1?
M )#[X%OB><3V17Z3Q2E/<<>,^-=^O%^,[.E(LZ:]F_@5LI)Q+PU.)S,Z$9T@
MG96^'(<,.O@[>$!EMJR/0=^ LRHGFR$><)]%7\:2L0TW=[34!?(""MT@FFH[
MR!&R,^5.6YMETW"DU#DI%GUD@&XM^(L]9JS2:%68S9B90+% 9)L1MAV;'N&B
MO(/3D[%S]Y#K:2_8^CCG2&5C(K#PO'0?B,B3!'>(4P8? 1T9":3,":T!8A;.
M&!B7.J;APNL^T4S91,",6T;I\7LRXN;_X:"!\%G"IMSV0>[-6G(=HR[P>JM/
M,I0#,M=2'Q<$O[*WVA95U6AEZ;OC]K4$_S"'^*NW'RY->9EJXJQ&..MB$D1!
M,6?].8E&?^>6'^U],J5[]YO)Z5M*9N"WNTA@W/!Z9+JFX*QXG",IS$WT7N4W
M@A5$8Z_B":4DK8B(B3=C4+S\/R-G"5'<GZ='?4G31?9O\;\-TDSAXT =.\?V
MU^*Q,4J15LC@H6'[^<T:6BF^*RBO:C@,B3L'.?PF.S2T3;]>PK[*_P7*09P6
M/8JTBF*D>/[W6TJF%JF#H$7;"NTY;+83=+R"TY.F[AX_&LIB%.4QD3(S:+R)
MM#1NT[U9488@ _:2:6$[Z6C^UK!0ZMY\B=R$P!(>MY%&G0C-,S#-O&EVOK[!
M,D%B]85C8: 6D!^=\J VTL;-MBZ>:G'&V\A_ITBZDU<>HO''E+']-DM;+,TS
MFY ]>'2&=H76B3%-1(O(\H/*(A6>/,I?W0(R.@E7Q&B</VB$SFQD7IPL49/R
M1C/G-D'UD^\TO>N@/(4/\6?8LQ$,3,,V:)T('TY<06G%)&LM,%H.7MSQK#+F
MEU0"J6/J.?H-4AH\A0$B^Q_1_E5A0+6,A-Q><N?W\*].!EWTL442Y"$;LQBB
M[BMGYP20-/"6%.F4D$$"\0Q@$:%"@ G-=F+6?47GB@B7RY\ -^_Q]:XL=T3H
M<N_23W(A"RRL*Y"ZSS<"N?(^90-_$\1XGEPHQ%S]0DGK-"H0S_\45TU- M72
M6@AD:5RV"@/0A9'0Q4KJ$>CB/=6K""S$EBGC) PF;0U1AL[X?JJPG;2>&@,(
MTJF;$.DT6ZK'[C!Y<[4Z3Y\9<KWWX<:\/PHV'N?,UXQ27]J(_*X<O?.6A&N=
M[K+=6SGPC&>2>M@U:/\IJ&F=S]*I +-7S(UB\?NJK>].&2NRW7;?+YCCD;^5
M*[/>7R>($!72^*&Y6R!_^6/!IRZ%82$U3N$*FZ"-8\W/[Y3<^!#T]W[NIV[5
MNO^<QA@@8J'XTH95%'/Y1\V??MMIQ)D[_7SGYU6HYV:39G<"A83'4[ V4;66
M#$S)L'/N4H$AK9?PYKM:.P9)J1.4 6Y80:D,+.=64/?I[2X2= ;=B&8$-78W
M"<82N#F-HTV-<C0#)M3,8/Y\/<]S\3NFL!RS(]NZR5-"HP5_(R=O$0!$M(@E
M?P,:S,7+Q&/<=B.#CI^  ^/R'(";A[,B(/):@M:Y1S<LARRJ*4D=35X0HO&$
M$_I#=EJ;26E%_&O2O:SL2=""7R$EK?4HAU)"!T@=39Q,6J'VU7;\[J"*'&&+
MHVWB4D%$<5ED6D<G]DS%W-P4_M@SWHVZ9ESR1NH!R;,C"3;6GQL='R545O/Z
MTD?'GB[.J]4]R9VCLA' SE!6-Y#>Y*K4M15G:(-%HU=X[*PCL(ORD<630=C@
M#NE-U"AM"TABJ3:JNL6:.(-3]V>;KA#779;T05XXTIT7B#O8<+"2PC@&+*3'
M+C$C70%.[E(J7MC^O9$!FR,Y*D!:^:P@CFXRTQ0WUU"*'ES"_DQ!'W@&3C'X
M&ZB[H4 )HI)'#'1FG>[I3VP=@KT47C."]0^^TG4I7>2J.;LX-7;V@K*FC+)U
M!744&,V,S!?27$:GE"AE!F&R &-H'P=M-9@G*[15PT47GOUX@4H6.6]NT,%5
MGPW1;P1D4M-W3$YZB[EB-Y3VO-3RV1- D(WSNAL3898OC6S7*#'OC-CP; 3>
M)66>$ 88]586U$)NLJ#7N./D;V4*9^3B70B3STB/&"S:;V1Q?>2ELU3#*C+Y
M/D6CPVCB,DB2QX"6E_%;H!0A?LNS?&&I[1. T=%GT!N;%.GLFE1'Q8U23TUB
MM:B' 2X#%\J==C0*O/*@)506IQ7VY<_2\+VGES9_R3Z]^Q6XR-DN(LW5/S_6
MN<^WRFV9Z>$#9;L=.RM*^. X]V%U;/;W]Q$D]>UMQ_7#,ZZ._$1O<-=;JW\C
M)O5^EY5?KM]C;Q^K^$I6FSA/ !30VQ,5/BNH=H2HKC<BN,F0(^B9@83YMX5O
M.\3 0VHDLI&C^IT$'EY!O4 ^Z6R5*P8J%WPZMH+*5I.GTMXCP^X2?[GV8XY[
M[!J,7D$-+RA" E_A'9"$;J:W!2RQ(6)DB_+V>_#T,VG-/JI_JC0;44B8R]_Y
M/!EZ(_404,F6L8W"($X@2.K4(@0/X5*.(P9;E\)J7T&MYRE#9H\U@-B\KT1M
M2HT[F'05MZ=VVFP74OMA@DD> ? 6C!/E/.43W#XP7DZ%=B$7O$HRSYCC 5Q)
MISB+(/D+W@9P"F0$+3A8609[UT6)Q_ .X&CFT@M\YUW*;'NC0+0KFEL11H])
M+1KXGM)LZC;1-Y)'0"W6VD?)=O+;3CZJF'>I<SI63HC5K]KVBO3L>D[+WXNT
M@1L;T@ND8U,]ZCG!9S<7"Z6F'J?/W[\CL2XXI:9.B+;<J *?K* N!MC<3#0I
MXLW%J+H&7F!A(X[BP(OMK"T,.6(\KS1_>'?K[3Q4H3A5_>&_-YW]#W!Q*-3D
M6C@4^9N%:E&U]K)"IR4MA>DGPUT6?_QS7K$%3@GXNWN+LTW3S5>'3O\BR:-7
MQKU9E&]0WFWY\<*9.719\3/5#9"G <WR;(@)>*G6J@&/!Q'+G].0&B<T,T7"
M%B5 XM_ 7!:&!W;0K" R@55+?WBV@9!MI@NN?N3(\.MP>I+/>?<VQ*O\Q8.Q
ML$_3T+CB)R3+SH(SK#<$^3UHG^(OVK!@]3TH4+%/U6NF"X&@HXS1L0M<)0G,
M*W[.7S- .$5G)E\HKVM,QQM!4UUX9W#7$\%0;2RA'F<@86G/ZK2^[(GE],::
M+'8N&IX*H<]\CLU(W+14-/RX\^"Z]ZVMIZOQ<:<\!-%'*PL=MYR4?5X,^;2\
M"RCN/?^R/[W$VFMG8LQ]0:3/;N8Z4K3=LS_OE>^(.,V-)(^Q_[.">KS,I/H#
MQO)G4(H4_<8!8T#U'^*;P7]"^96J?X )R" (7&#A=U$WOMY.VQ1=:MP,!@H5
MA%^A$QWG8P3:@M.AWB?\H6LG*B!"FYDE4%E<0V$?ZY=!%Z5:^J\6A&(:G* L
M%4S68@"_%93H6LM%F6",V*72@C*J(>-VO.8 MB4:X';2ZU=0SP69!"VJE90<
M:^\K0QI,NS:OHGKZNV..:ANE7)HIN"-\@##D^(-HD2#O/10GP>I0Z&W?B6E(
M(;/G3@$8:6.70+38+E87_$4R@-V!N*S8I;[<9$X;-[=T>Q-HF4&- X02-<97
M[,;03V:6T*A,?%GDF!4+KY*FDB4?Y$R@N:O4"NBL9$^RUL-$Z#)YLG5C<'2$
MP\#7*46@?* 5*3(N8I/Y-K#1:]HNU1C=B+H_7M;JH)#&"8EZD+/\.L1%]&JR
MO HH[BPUQ&\'6%DM>V3-K6;+OOG"0+/-4.I]2KF0M@_0&A7&F4*1W0%%6JUB
MYI^-4 ;"ZZF9#DM[-$^9"+0+#]I5N?8S0U[2P^4Q5VU>#"4,55F_O2;G#]P^
M%1/CD%[59KGXE.RN<>"!==YNRIH >7W&#F+U,Z>!RM;"A@_5G]YUF;WRV1U7
MNF3URN?(]TC5N@V0JP1S*<($&8$'K Y4?'Y40TF99,TM*3Q@"R"B1GKKJZ)/
M5PR=D'3=4FR@[/$9LA_OM?3JMZLI.;MXN/_KMZ6:DCUN W;?%CX4>=GN;A^3
M->1^7("V$N?(*ZA?M905?"W8&RR<BU,<[5'@8!PPU6T:VA:Q ^A@&_,=8$N2
M+M6M 3H!<#H*5?:,/R!_"9/^QXCY4X"1@].3I$EM0SZ.DXI(:WO*>T\W^>26
MOWU'>P"C^W%TY.@_OB'@2DPHA8"TS$$@168P]T(1%AUB1#T.L#,;Z#I1)'T>
M^V?8&'@WWY=#307N&N(,(^^]I7 EG'E#J99:T&NJ#L*DFM,.!#W8N1SV?[UI
M@*IU?@7U\[Q*![)!4& <.<&XJIVMJ]H4(WC\ZO*]4#$E?S^PG X3D72*-_!_
M(9/6T2RB]0/D-*O!+:QVDBFWA5 ]\18R"!N!727O=$@@78A>![%_;VT&E8*T
M*>(:ROC1(5R@],]S?U]TT,&69?4\#'K[F)>L]^ET3-&]R4=[2T]YQOJ8#=RN
M5A#>.;&6[<VW==V>'G;9'F#FM:N.6>5NF-TNNW^TQK/RUQZ1I7701==7ZEV>
MNS/PM. O-<.YS57J!_;2-Q FQPGCB]W)A Y&$R146,6H;*$<OOUPXKND#I(V
MWR[L'<3JPN_+]QNB[I?2=6<W4%</);KX!8&KFZLG9B,VCRR8#]E[AQYM:1G"
M1GS^\C$8HZ!R/QR46,Z]0P*O@%H5@?!ZL&]>!R1T$S3Y)K +V-@FW@C_?H-*
M PPN\XTHXY)1(8')UP:)5_D&CNW<L?CPH:\+NI0IJ=J5I3A#D84XEX\)H9SH
M+%J=;YFF^@UV';3KH:M'&V"&4ZFJ^ C>F9,N3RRU<@MPMD:TT=6",6F!Y\*;
MSK%XSY+/[PMM,CRC8RHV?O\6:YT #,@3R*_].OS9]1TK*"/O]L*%DP_>^KLG
MOESZF%XBBF8+,?\O*XK3]].!WPG?7-7F$(X^P9X_OH*JRU?\/OIQ%-9GJ]0?
M*<BT$4'CCLM@FCP5LIX@0.=.*+91+:#8>"D)"A*K4ZT?0>-"$J)VHQ"&)1=M
M',#%RL1:T&61\  H3E]X=:_(*VK9/%#_20BS=SZS*O:$0ANIJ$O03V"*/!RI
MJQ18%\* X^U:DX2<"&W0?5Z++L5H.+1*Z#HE^!_?"]+0W87%0 'T><%J,FTS
M\.'-<,LF:8E:<- <+^56;> 1(QI'[V8-.?5X[-CMT?) [#_'/>NL\\LSZHQ>
M9QSR.79/ENYI;Z[_P<>[/<#/@Q\8>ZOO4H7O1G@BGK.WO2)L#V>?VU'F'U6>
MGS=$6]T3^9Z+M2RO)_0UR@-??R7JP?'*=*JAM,[@$.B8!I]3!-,Z2M> G R<
M:V70+,T83$)\+[@L";@L%:A3B@\.338-VHNU*,7[!8+7\/ZRF0N-(:?KR\41
MT\E,7B_S7<<&>A(!(.G5TR$+Q_G-V)L.::H-@K$SEW>^3*V@D\67ZOXZIUQJ
MU9\WQ*G_G/_<'IZD_2, _L! 5A@&(0KSIJ]#L)Z_)HJMU6*%.*<,91$?2U%T
M\"V@9T!^\,-^V!EPEF)_W'/-]\X12J:8N'-26S_2Z';8.%X2IQ$ZG6SQ\=8Y
M:0G)7?5NN(4@B:^!V!ZJ$7HT=FP%)9F:]T,H@CNW  9T+N T0'*;B)O.(Q>'
MHM>)9R-,FIN89W$$&7L-6C\*OPV0ER"*BL'?\F0 EP@L=CBQ&+Q$0)!'=98L
M; @=\TJJ"+T\=EL&@-(B"G0LTQ+-Z)R<73QRV[HKX5, ,]A-Y^IMTWE;G4:[
MDJ4S4R\?\@0/3Z7?MCC BY*6]01LX&Q[^<"L8-NKH^1;-C41O2*GB']4=O3)
MM^QY#'0Q*?="G.H?1+=OA*:FYL4?_J?RVI7*:ZH7'_]GV=GZU$;$-74WSKO4
MS' A)XS"7:4?">L(_EDDU!,D6DJ>H &_@LJ7L^;I;Q84A MX$D%%P-6MH+[T
MS#M?Y!9A"9,, 7 L;NR$E"MD9PM0<; Z&-HE0,/GI!AM*A[B "G2U=G(J,V,
M6<) \CTH*0)D9>!WB2D./6Y/H1J)%OG80S 2$9OK()8,>V7\=\1P"#$F4'YG
MZ;KA,G;7^/<5%+S!6;56K#A+Z^\#U>1/<P\!9[G<J CC0:H7V"AU9.'UH'R/
MUSA#B7?D@?X[ /$2WXBZ =1_+!=5E+)^K#..6#6SU0-?D<K0A-VEQ223F8CM
MT.5)I/4IJJD.,_-YSI*F0V*HRTUR6E7&#1M_CF>)!]%XGW^[UYKI'O3+:E?7
M?9X&K(:_F4X[;L3-!]KQ>8';*V[4KMZ\-^N%7X%'F_O:<A._SA37T%MM/1'A
M&,O=4TP/PM]?^BZ?%WD@<9Y'!-PA_3<_;2< 1]B7SI$F$YOQVY%^/NM9\8S@
M^.9#O:G!I;V$BUQDMV?GD7] NX*'0\4O"0\=N[,U0XM[%O\7;W\6U43VO8_#
ML1T0$"(S@A(5E4F( X-@3#Z*BD!#%! 0A+3:R)#&M"(2(2:M#&%.*R+=($1$
M1$"(RJ08$B$DM"(BLX"0J15DD*I60DDJX5]\KW^7[WHODL5:":?.V6>?_3Q/
MJO;>&K-HY6;KO/-7YK2\TD2S#[(E0]_-E;\AW\?-VR-*6T?&^F"EV 5<:9''
M^A_M5VMV2;JTA?A][\^"5ID7ZCDC BE?U)U)MQVBA<K#0MO41HT##><;P:%<
MRO=I5ZZK]&7HWP^ [C]H3O>_[*;&M=T1%S& (RQH!VNV0;F=/H[L@8@SHBWA
MP)LQZ^88OV*S&-HUW.76!1@I-I,KWD1ERUUFQ+(NM+M:!!!9.$_9*N65ZQ*L
M,6D)%?VZ? <K5I6G".TZ-*Y0^C1R_XLY^VA ^C;@6KGUV=VX(YDB+K:>V9"#
M._S[ &>F[_-EJ7^A5@76+M^EIJ\IWLW(9B+8X[7KB=*\WC8EW3/)Q2W@J6--
M]X7@-^3\*MJ0U\7<)A^U"V*+L_]>6:X 0A?;AF[%;H1_"A:A1BH4-JJ__K7<
M_!,]X?SK;=F2C2B-KT&SW8[=R+;4T?2*/]VL8 R3U)HV=F_?==EYB4T8Y]*B
MS0YYUV>WU[ENS]+W?,VY19 \6$(!GGS(&MTQ!UE39J^!W5*K5UC(&V],.X$X
MKP[Q%<\:D6X50-!!]=A3H&GF!6 I'7Q)4%AE\"PGQ[?VX05R[!IJ@<=_\SF6
MQ,)II8ORT+O].;;_M2U.SW<K,E6IR,ED9;.!@XPT_I,Y)FY_:32IGIVRA(I8
M0GTX=W" IB?#&DX.*C0Z"'5'7P :';P#P&I.5GU13F2;/WGQ)G1*AM&D^@?&
MGB>LC+&P?MGS[P#MS'VJK^R;T'D3]6.@1?"X[MV+AA'K',Q7/=V3$^RU[ZJ[
MTJXX*,;GQ.UK^;X1_OF<R/VP;D]J6: C-<,KYUCS_(/)"E_/05_7M/H\$M?G
M'49G8 +S.0A>;EU]\201-G3IN!! (7WHE"U6_W)!2VR.S/6_-^:/UIW01OWN
M54FX?&ZA3JV+2)?;ONI>C,)-_9J].,RN^T2_BNR4X1)*<I?0R)RYJ8R@ULDJ
M9C6!,SP,M#) ]3?=$B8\ ]'P3F**VNX4[4PM+0#2D1VP.NH6=(.6(/.YY-S2
M0]LD(W_JW]9GXOE'M$]L H-R]>K#T7$U0O-;@Y=0Y]F9F(:)F=6@6&+56A1F
M<APJD(6R4\)M =%-3@P8Y9P(\S7IKC1'J+42BND+:L[X/KJ)T3Z"_6/>?F7;
ML^D",V+::/MB[DV3#)J[M'C%/';]E[OQU>]I8?/E(7D"1LRGD^%;?!U8=17,
MSC*_B@;BS;:B%+FK38B#OD^%\9UZFY.GM.Y_Z0I<+'&S>"WRJG"<DMVU_&=H
MS^W;]V4U5QX4!L8LH?XI@/6"%)&0I3*4/E*R _)6'H2LU,8:@EF"(@PJ!8V[
M!8C+W:*^;"LA9G/W@^<4-& PYS$C!K(*!\:;K#Y\)VZDWN]4XL,\OU>S9HGU
M8\'="1$5Q.B/__<KSB^<Y"74DXX.[(T"\4\1 ]]9:>+ZR&3UMIA OG:#C9-]
MXJB4G<[3] 381\#5(J8\)R&T'_:L@1)D1GSA)I-@ID"]P\<[".!G?*>8AHU2
M^0$ /Y.V5R)FAK%G$#!;A5SFQA#]-4%OCFY/[V:O84A)\,%^G$$-[,8%-9#-
M&W81TA.2:4=J(6)[\SN6*E].V43-.\R:+11?A[%)JE+CPL(:OH(T7$.Y5]_2
M_\O+/G YSA/4VGK**!H%) B)(UAWX,K?H-U)P*C\+L9 [0B?AA)B)741DM>.
MLRYM?*WOFTPDJS"&#<25T4-^9-YF\%KCWU)6:B'E.J$Q5(;)=NI\ %V7V[!%
MI(,; W[_P7/9Q2DY8QMQ<JNJY*<2A^#*T2E'ZTL=VD;6?F037VI)C.ZE6U=N
M-<144K\F5Q<<;^U[ ^IU['CQ=*] E'+AJ9/MF&R;W,;J8%5@=:=%AO)/RE<T
MM#UA]I.,/QRG7CND/$)+@!Z-[X*^2+N'B8H_DB7\5C3S3_$7MPNERSF'$$>
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M[-:&8+H(T?<W5^G]L_F_M?]:'*&G,UH="9+;A*:%F1_+?5)5>707. SZ:=P
M(@&C[7QC"DR170>)DH=<1SN" ?TM?R-N1>F[$6P:?1L9O[4_=2$;%R;M,N_L
MJ<_Q(I_O3RN]NHF7%_V(-(*%#1?4F@>5='4/IHD_>P:LELR](D(_XS? WH,\
MDS#(JIT/U/.TJ0QEC%C KR.V4IB+;]D?QFV@G/O49!\E)HN[7:9C=;ZF//A
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M8&;;UWL'\SWYD@^$'V8,"DF)HO^#X-!%597=IR44B_\D"#;)4]Q?[F>] DX
M+K2 W@+2BIV7BXE23AHW$O&$*[G?@@?+^4""0+LF9 D5WHN+17A<.SIS$2/H
M8@C#;;)D)J+8\(6P@K9$HO":@T#V$R26A2[WWYIBP^NS%!M4581SQ/7T(9?E
M%FDBB$(&78ZJBNVY.@1X!T+.<;\TSW9<YS"B-&E!:UFO$/7S\\BY:#VHK^UK
M]V-AQ1&:4X39Z8+NB,J:@LHB693WMO*TD\^:,M(.^-:LJ_E/6I:H3_M^3WS@
MR!M)5=")XW$QK ZO(,FK$U5UKD$*A&7\ N2NKV8%U8Y4 V^\CWD$?NFC%,D?
M<394,S:*G[K =PFP0:2ZVT6M^6T)5;,!N,3O_\Q/Q1K\7]0J%=<EB,9T*<,O
M7R42A P-VE8HM10^JF+3K4;A ,CCZN-)!49';3WE-O1*#)TR(PJ/T0U'Q?!9
MX!U+TKV"^E*FTY@#+/A!/A=E.B'[L;IDL_G;B;R;#Q!L8P _IR(G^29?T)VY
M0 #\M+NVXW[!;QL-AFU[-)AJ]$'9,9H1&8E$Z(]3XY8\D/**;3H5OFH0M[>6
MRCK^LI?F*LT)>J4V1@1J:@-#"U%I0[0C<K0VU/=JA'+C!?5^P.Y]P^>#?PLW
M;MGH_[#,*S_\-Q_"I4N7JCT]%G[WVITU<>M1%?%FW^F:X@UFU>Y:@-.3^2\!
MI6YU\9':QPOI;84Y;CG*;Y?\;IWPU;U[M7]LAG\$=U)*6D>=%E@@LC$'=KD'
M=;26['X?S]*"7K;A;7N^+Z'60^>$X::@+OOB [)Z(VAQO7IT/#KD<W)M=%!!
MXOFG95-7"D+H%15CIT^%CW;'XIZZ_$B'=X&1&0B_IHQ$OJ);@^+T>"7'0-U.
M:%A3]) 6V:_^B6R24TUM[%9<@%ZIM56EL!/PW\(IMO3[XM<L<'];B0&4(?FK
MGFA(2-D)1TB)1A\ABG"PV??OFIC&BXQ'$8R-!,"? 5D29R/!E0H9U W&*4Y"
M3F4(G[82_0M4",F(1*\&_*4.>9+NC)':;)XQ(I?^=F3KT3S?-[",(:8P? =
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M=XL-ZX-W]-)PA5:S&A6CU.J3S74#]C1+V?A;ON;.*RXZ*4'AX_5;7.VE7O!
M%9DA[?5_-% 4X^SYTBK-3F^C@T7C5J^I?%=/^Q?EY$.:TX\_RU=_[H'_4G>7
M; "'8,-J!02Y2DFLID2-=/B,\@S]_25JI_QA5BU4)SO*DG;.,=TB:E^ %7)&
M&V/5M**0GZ'>1J7\KP?_$X06+I>I6_W%6&T=RM*,#J$(YK0\Y!C=Z! _:IZ7
M2G<)E9R\A(J<GDME-''9)GZC8<\!QBP)Z!30]S(#AYS$VN+H_V@_0^X/HD@:
M>$OJ_C8\IF]K/8AG2ODZ-%PO#P7=5\B%@<TI9MV9ZAW4FS!!YCU*WB_6I7JT
M+Z$D?Y$ ;Q5%K87#NY$\03L29"5E)1=@=+[7[!?YPYO[<4E2D@54)+HS[MA/
M\Y0>L#R=)RI9U7L/Q AJS \!X4VRV*WO%D[WQU[F9%J@6_IG+Y-CB<>*0A8X
MD'4!K+<W5)5".(]9K^YKQ-2G)8-!!P%"-L]\,MP%^/P4&#H.13+("#_(*''N
MX9E&FW6GSFL3-L">#>":%V1PI<A"L^$E\)F#3ODNEY+G]*$;!*/B(,%B9"K-
M?^$V>"I.II67>T[#MG[0>V/#&;M'A]8_*B7J;/RYJ"R&^J'2U6MC;J'"P=.Z
MG_7Z3=I>I>6M8!O'A]]<SX4E^L;=EE7X-3TA<5M^/M";F5?@.';X;OF;)50I
M G];"CHZ";D$P*?[>K/!QTD-(:$N[,$2ZEE35CU;)RK<IN=RUT]BR4!N_AG@
MSIMH+G'[Q\2%="?&\&@ M!>1K:9DWH;^>8PV48[6GQYTNYRX^AT;T>W(3J[@
MU_%32#+?ETI[V)(93-(-H\5"&4I7VKJG(*[9%=3AIU)X>Z&^5H*./>YD@O3[
M(.[ #GZTM!+V+1Q[EZK++^UZ+/QEY->0=[<6W$\TJID$R1AQI(X(A2E]H 7%
M2?!"-4?'2E$&J!KY0-5@;)S09-RD5[T+-GW/#961#*+-@FX\=CS@+RC$\T$/
M"5RH:)$QTD<:ZZ36)%]5,7>#I.@U[D35E%K[2<\2JG@)-3PM(@.=)%4^;Z?#
MW^AT+&\=?$QU5^T2'6[\?)#)W *F50 DH5H'*B=+-\1+'U#38O71>FQ-Y[SX
MFE J(_QY3^R%AP/RGGC*DR+MW'45VIFOI-1JC93/P7</G#;".;VX5I:<=@:'
MNS_QU:U/X'NW+(%"=@@Z?S<HG*#G;D+:W"[[;3+P9$5&RX\+5;](,YK#%Q]6
MB1ZR3>KJ?(/\&.\1FL)1:S( ;841%*ITIIV%]#@0W^<)B,V^C!DNZ[!8!\:/
M4!\2-T)\M1&_?2ZC.:$#"WF&^+C"3G*=P$YI+?\^[7] ;L9]*T'+Q0:"9@Q]
M!3#4QH:.T(@1H'DKX]?N=%(]NAT-62[ 1GV*BT!N3567A')CD3(C!X>\G"WV
M#L NCZD)4D([,=-M(9WP&W*8-X6&@[5%4F]L<@)I#?XGZJBHQ!**E+;L]2KJ
M<%E"Z>'WA<0,X@F#=!O!O==S?""$!=EJ($I &0_O4!71U\/:[W$1CT*@.!$>
MHRJ'R3*Q28B'-)J[&O$M*%!L@#<+IND6"5*=#LHHIM'.)'WX8#6D%)9@ALJA
MA/O>#ZG^OH!))MZ6DP%[7@664)4(:!^%/0>74+\P("OQK!B!0!L><.4I:'!P
MB&='?T=:A=L.- 7[N$MS;\J*T"C8NP&Z5HL(R@(AN<52.%BRH^<!R)KUD!%6
MCX=,JM>^>-(+DP$3H84^NSUNVNQ.I<8-KV?"#GMI1WJYVX_[[ZRY3NO\+[:?
M](J_:W-V>\B I1;K0]OCZOJ\.Y@1)X>#?8O\H6^4,_MZ$:IYWN>L[7O/WN0&
MAZL] 7G)GS+]6'6^O@_((XOBY6+H0]7J5@5I$Z>&(+E'-P ]TNGKIM4_#?R&
MVROS0;>/.SX%.JYS8RE7*Z:=F_G9-#N@SK<)*I:18Q,\^S@X%VE79%N)@QDE
MU2GLB 0D"$AF7]2VC>!"*V6&I=:\JMQ%%Y T'!G9?+/EIT&RFB>$!)3Z?7/!
M#:NAR\HYLZAPNUZZ:5-:+/>$G*-%<VGHE0&\9%#CU>($D^8$5HV,!@-,T?Y9
MDBSM[P><U"&1SG)A9O[ $HJ-'>E0(*'D!IX^A*G#BOBY). >[@Q@IU /XBPI
M%1"YE;>Z8>"WS2!&E!-T_!F(_ \K8H#K$E<!KP0G!*/BC' "&,$4BC.74 :P
MC80]0I1I"-@ZU$;E42"6DQU+U_WP.DFM4X]')$%:/]3K* 3_ANB,B*Y?H;%Z
M,72,( WG9'L(66F6TACH;8@+O%4,_-V8*38E"K"SG_";U>W$+!*0L>=+AZCU
M2;=-?WO$0)T#K4/KSI[;MI]>)!=8YEVN/$JUWG^IS:&^O,NHTV_7X_Y?[A5Q
MGQTOS2Z[\:GUK+F@/Q]W7L<A:;M;[;X"XSF[@^[Y]9+B_6]\7F-NBM?C76$B
MLGZ6>@B_&JQ @,9D"F\*8F=)H%AJTD986=NRC:17SQ]>KB]A3K>?5&M!D1(=
M[9][Y="9<S*V)FSZ#(3MG6KS-033_ RW!G8&C2S3;B%T6.P'/3(N,*@$"8</
M'!,/GT-X>MIC1A3G>A!]-\#,4*^8$FMR;<#5L,?C<&B,'V7O(FMJ)Z;Q5P6%
M@931>1T73\"$=9E@"%7[@-_-N@6Q)H+QE<^?/@>'4FIY)L^FQ]<.J4V64*Z+
MV#3<-:6)NM="%^A %J U3.:;$,XLH48\I CJ=6O4+*3#YJ50GY!?QVIGKZ6Y
M]Y#<08T,FAXFXS*;R3?Y+D; P@K08-6J+8@[:H ^D=H<_%PDS2$2^V<>7UA"
ME6$@NR'8J%,1J*IEG$DB#,LEL4W9W" 9FU58T48TIJK%[85.<S?*5>SO2ZA4
M1!R;T2Z8:61US>96W(?F.@J[,W%V%= :>TMI[4L9<<7H\"@D%^;!OKLGZ9KO
M>5:)'QK^JMW2&:@Q^KC80W-&Q7+IQY>_4W$:FKZ.+E:QGG[FMK"?+E;,A?)U
M-T@0?+LH#E.01GP?6K%'ML]S8KX<]%<$J62,4PHN7.2E'GE_#!;\7\.[$/!S
M,J"AUM91$CZ,";!MC P,X$48M90_?/$@/)QZXWP/SP:V@Y(>T%QZ&^:THY/#
M66V)/ATY7"/PZ,0Q**^*K3U&+1 &+J'6J=<'\]-W7N:L<G\H_D8"CG)^>(EG
M[)90YY@=#-4Y9#(M'6K-'TH[F@_Q0Y-:2Z",(M]Q$Z?Q#"M@?:6B%UH)S,[;
MZXXY<K(2%[)PZ 09QX*:)7#C%L[SJ@HCV\PYR86$E+DY@[9$5AK-7T; 3"?N
MR)--$_5IUF 3LT#P_WJ8Y^KS#L]/=WT!F-?Z^<-RX=(XFXAJ W*"\+%[2,/Y
MFJAAAS<6/6>?7SW)KP_>&>GB]+54V?T+VV?7N/"(?=FOJD];)V#C#K5?ZG)V
MR(=0"5_]S..5K>J>JI[_*0"!5*6ZRT2MB5Y"5?LK]G+^84$.'C=H)Z4(")C,
MNL3):FPN%^^7E60!WC(/P6AJ?SUYF'L$ 'EKJ&BI8<EVY8ZB2M+XY"3? *]/
M\P7JKUALJ>^9CWX /&A^;/;;B&[Y_9A%#H_>3P).B/\()RPGH=,[^0!Q3B.$
MRO&'.)% EB(4"@/O?#M53]+^0EA;@Q@[+$GJ\")!QIC=L&7P,FMC!YA,@HY4
M8)B%)&:#H[H3NBJS)PD)^@V$%52Q(!"CQ0WB66JGMY^C>NL=O3UUO/R/-V$Q
M/4'E1\Y$2VT#%77ALRZFE9=$/EZ/RZS]_!_=/2:06;\O:W>LZL^V[1?*#A0[
M+Z&N^H]X;S!-VD?9_Z)-$3YU-\+NR,=/#,D-DBZ\"60H^B$Y4"3;\>?X9H@!
MNJLU/RF]X/W@NQO-=VK*G)LD<^:T8%4!["2+W1)_;8W2>^CRP_[Z,%_%VY@0
MAXJ*F,$=E(;HH<&"F^X7,<+EVD;B% ::$<D8%2N>0'9 PO*3_4QX+Q1=0W.H
M!Y#8T-#0O9YQ-A3*4D1#]N#*4RQEI-#L3A-GBO0;F)!%.U@]-S ?NM"D?J]<
M77WP8<BI4Z'T&TCD>CY! $YP-NC]0WA*$#U;.X=$N2'%<<X=OJ01;S&$A&%;
MTFSNXKO4FLDK);M?0A@949,T;79$71PAXVOS9UX 0:T4&5O[X[C[*OP6X%_\
M;B AF[;%H:'<,_YA129WBXRMV_!^ "94AX0$ZI9'MI\..E3L52@I]<O9[EPV
MSW[T[^^IQXY.V3;973QI]/#^R.<3+])VK%<+7\<\/SJMM^]=A>TE!5Z\)R\K
MO_;+BU/_P0Z!5UI8DQX*.U41XU?6L+E:LPB(5&L5WZ-WC:!S^-%\%*-UCR-E
MA!$T-,\VHSX/API$B\R9\@J:-Y2N-LUK+Z [ JRVL"393D39A,A%%AJ 4<M$
M&FPO$^M#".06M26.-TF+@WX<@BZ"B.S39\00-&D1*IX3.Y-@#MO(*!M.4_D*
MU@!M>T+9".P#I2G"C?I#/7J^6T^\!'C7[T-(5!2&4))Q6Y*D8MTIND8=8J)_
MYK&ZL-US(%5T73)Z;?]BFRJ;$34W;**H7\XDIF&0]T!J@N(O8"YE"17-V(1L
MS-[+G.&X@-YXPBJHYX(CUBR:_:R6#73*#"!?C'&T>A70(<PA2Y7%<<)GT/[6
M<>=8[_9P0Z B W>D(DP@C46'@19Y\$WU&X(!C %<%/F0$TB4#[U"D(B.AH+D
M'/UHAMER-^9-4<WQN35V'R&2B*%%BY<2C2 3F6Z.\TU".SI9O7EH#G<R OC6
M$>BV:B^-""4\@")#00306M2[ #'^V-3C-7%N_>! ')ZV57C0JWQGU_O\?<U>
M!E4M7-+6NP_*YIZWW>@E!;E]B_"4_3?9<\?85&.G5^EV4^)/54IO/%6PX( ;
M.0COYFWU7SCI/DRXP#&AM_'V@6*!3X)B-10*9B%!/3FOK<2F%X]%E,GGBMC*
MZ%Y$&Y_LP>(Q4)GT^W^T_T'5LO/\@7H54=3LT9YTC2$R;E[ES+. R-AD[OYS
MC[KE-1ZAZBJ&9 R3K<9!Y<I5U*Q6O%,+T[^/<+Y[1%M$6$$WB]$/@Y*/#_*E
MP:W M-0%.7&Z48EC7UMJIO7^PNE<!9."H21)F)T B++8 '#:$' G %=NWANU
M8I9S^=\(%O1Q D#AI^#L*JE,@7@E?04M8&#FUS[]H5<E*U5,QYS]PI WXJE!
MM_C^D=@)!(E3EY\PT3-,M"\>$_$K<\Z)0@)ZO[B%?7=S#&E\N>/O^U.$:@Q
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MGX4B!53X(F\7^HH*^PE4.\TIM85(?)X&=HM.EATG> S;\%2FWCN!&OT\C<[
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M-E5K\/#[45+QMD(K2U*\)M&$R89,1:OR0'X(L3%+%IB/'\57@H92Q+XR7D!
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M&D[@"._3#RNI<Z_%=E#(DL GTEI':PY3&[0E,U3AO2@-;OCHABKF3,<X =F
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MR?.%*$KZNX-U"A\SV<]73)?IO5O>I9B9D(Q8=4SNDQV[/QT&!F;9%,7I$US
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MZ>!^;F,H1.7GS+)9*S].70_U3>1)E\"!$KB1(J7K(390<%*S?BA'#]'@TD*
M53^_&!]]%F!B66'C'>ML],;4K=S7-<%R;&]?&35G1VY,V!M[M]+"T?WV)5WJ
M5IWI'3TM?1D.+\]]SMY^PFF;LZ>SZPW7FZ[IO]PMV]+KT!6+16EMF-GW<4P&
MK&)] &J),UD/T,%CK%[::K8@F6P0JL)53S<O2T-7<I+(>'\MFL$'))JZ^JAA
M2\!*L*;A^H!;FY&AI_])IT/[-Y:4][F^X%KI-2(S"R_? ZVTA07V+@/U8S/6
MH F6Q-KS="1);=V7]2G+2;OOA5ZPXQ.36%N:!M52R8N0'7 /EU'4;E O(&C
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M..FURJLLS*-__4[YDSO4);:;^957>X6A)&N$!Y '/H%F3#6Z!B6E,P-=@3C
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ME"LPV@IMR8-T?)Y#$35&:T#C>L%'?(O!:3)>N/T/.!/R<Q]DFE<PNCIXPH_
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M=66I< X$T)WW_0@%61V,OCHL;U3A!EEP JU]#-'V0EVS%&N!=^$R.OH$Z&Q
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MFE9A;V]6,]G7]$P6FQ&N"-\P]2(ERWXXP-L4WK?OY;#MD;NCL24%UG)_WEL
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MW_Z@! !3KS\,.SCE.%2UC-U66=@GG"<&*D<J'I<?WNQJL(?MAPNIC)1NO17
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MD#OYB!S ;H)C@:!7G8G2^?6?>1=G1-H4"^FLFU<#U6(FG)!71_G'8"MC':?
M(7G!:'H!083P+<% /'H\8<O#MZ]P6J!MV7'O<LSF"(/P@O"3->[C38'"4S7&
M7JD-G?:F?GO3B_=?#[<[^R9\)OW.SFIZM=:6VJ.7,MV][VS98>)MG[BS,ODO
MIEWBQ8^?F<[@5X2W:*+_\Y[]_5:\+CE%SE*V4C16*XY'Q!(.OR[MI>Z BD"9
M/!VD\^I0AN2X(Q=QO\,:H!%W4FLH.4J*UX\A:#T$@TNH.R$]H\'Z<4+J^_B3
MP-A-R7N\8GU%[J?>J'A9;6]#BC:WI-K/<;JWS"5IA!5X>V^Z3WB1K6_[Y8_.
M#?6WWU"<]NPQM[$)#TR\PSKDEUB:'S5@X_7LGJ:[U=F8!LSE%;5_8B:L59H^
MJSLIE0C(Q^"$J;(1M,F*VMGX]XG2;WQ!MBDB>QIA?RDIFVK!'G9=%^_*UH=0
M=\GW^[M%S8O"TR[,:VQ4#%JWRZ+A?9C.9;EJEG=3-.."J-O6^#K1YCC.&)J[
MD,76@O8" HFH>R&K8S\Y43+.I?T >4J:?G=U%98_:FC+%#?]0*;A 4YFTKDQ
MRK$'<4)5HY"061T:9H$_/9KL]@O<+7^&/]GU[';JGX=K;607W^13'KSL9"C<
M-,\\X&[^D.ER:C$_RJ"BY514];,W1P\?66^F[:-56^L=TA0<5/LRX-*M&>_Y
MMN6W+Q,<"A/;^8+/S2JM602D:5"WXK+J-5J;Z@9K@PN_N[K53=,T+B KR6>0
M:D]NXE_%_MY!NNX:7PL)))=KQ/;[NU=WX411EWOFQ_F"7#ES,Z9U16USQ-MG
MMTL!(4IW:A"/RL%<>(0UIG6C:;&1.-4&-P62K;IQU)WP!6 M^R R[^/'H&X@
M.F08R8S:?<2-79OO08?YS.85M9X$G(1S4XK1@? AP*X,&2,/IT5)?D NZMHA
M>9^(!Q"5VZ.3*$UHRY2A]8FS!),16L6,'6W^?'1S?\U7A J?'<ND['SO.&,3
M>*M:<^3F6+7C1X,7]O;>-X1W3JCNT8/V)B?L!$?*S'\Z)<S(K]1L-V[8<>#N
MLX\-'YV[/M)D)$D?O.F82NLLD,C?#W5*C.8/ 3@),<^A)5Z@&TEF2OIZ&0R5
M!J@CH+=JSV,".:^CQ[KV BD^(_<'FUKM]=U',(Y/'<)[/RF.#_W]Z=KGX?F=
M>?/,MYVJ#9W("F- *8JC% -P18TO@':+)M@F9(QT5Z84GX-%0B5S&/PL(\&[
MV.K#X;&N0<!7E8&@!Z\Y15TW@I/\$KO^<S<:N#E34F7*XN'F$8H4CMV4J^@M
MWPC\S4Q16@V&_]+<=6Y?67CRO4SJ1''Y15Y@$!%CSVQI+AK*CTI][QX6<<S6
MA&"&<DFLMIU]VU^R-[EJ>G+^+4\2VS;A&_;^_>'F[PB$I#^B=6_EQ-(FVN5M
MK]FNE!U@^W.!+MG91UF&-:?L8.(AAI2&GK;<1=,G>TJ)?1B3N)0_0J%H"2-O
ML?F>;S7%Y_76AYUI"4X;6K4C?S$K<!B:%+Y<.*GT0 []*[6?LXD3A7Y3*<',
M24!\,'"A4\9<,\LT=;(GGH)H#V:OME__.T&UG9("E8*XHY$'D($B6"!4R'%L
MTA(L+XJOLQK+.'=[^2_3S-8['9GY!X1%HLF6D%W6%MD]@]R3]=)I<<W+HG7&
M#UHWV,9^=0(/!V0RFQ(K"@T+M%IG P,"^2_\&CX(.RY19Z93;)QGJV\\#)%B
MYIXA]%*Q6IZ4=BZVWO(;=_*PLJK!T1?E^]KU\%WJ<$G?===4\<"N5Q.\2223
M/"3!:R2D'\C:S]FNEC9#KB<K@QY!E1*!1<RR7XV$HPW1N\.CK\/NK--Q[:+V
M4\&;FL++;%MB1^_8A'R0C\BLC4?E%#BW@K@E2F#G/NF<$C<=$1; .C1<<] C
ML'I@[N/N^^*/_7^)15S1GN3PZ?@9;N[N^H(?V*O;O/]%_0NW"7>^Z4V3=/4^
M?V<P<)DN8UC.K*AI-+44!/8)"]NKH "AZ#G:G&I&\1I?7TV3B'2AII#<6!@G
M5@9,>/M$:H$.R3DMBHBG20J;1B<[?.=4P\,WN?\Z[;XQR,[V2=Q(W="ETX-!
MNU\Y;17./*UH[&C8.!M0<#4H9L27VWIHJ,1/<*/JM%7TX-M.+%UJ!&\>5FVH
M Y$?\P^H0RDT$S@$*.6#<%0S9$.29$)G&B%>>*H1=!'7\SV9U\@P@/2[?>+:
M?4!U#U/_X8E3^TL3\/-YOVQK=>9848>)P!%<[AC3$O91^*JXZ!95-:"0XOG$
M?-H6J@.Y<5R:DD-Q%R?$=Q-V01(I*8]Z "IKA!V@3B">VSPK+]GSC7IHB+)!
M@B3>959ZY<@](/-;7BMZ$R4*5'\1*TD53;_,G:LND>V67C1^X&<.W9_<KL?:
M,%AWI?9VT:$:J]CJW:VQGK_."2E+/QK'W;(Y\]'DTLG8P;A+^=,O?RQRLCK8
M\OUIM%7#,+LN"E*,X<2_TX"3N$*</@4G)0JCY4\@HO1??H4JPS&V]:SE(6@<
M%$E)=-B^*@RJBP#:"B1*?:G&]:Y-[&V#$K"M=2L-]1[V 0K+*MY"K!["[N%J
M]N@?+?:T95ME-D[,%#4WS:T1D_3)Q\3G& W$>,+A\?6=H+ZTF.'0DA8OI3.8
M^">C.,GFP2YWJ8[146#R3W0FU7(ZO/7O/#%-*\;%,$<R;T%:K1 YP"*2O_:N
MJ&URC91RVAX\Z/U$_HMWXV!NSG#5@G?^-M.D6#8AHG>3UZ'P:>_30[FW*HV,
M7_#)IPW1&UY-==>,!-<$!-R:\3UD<^FI5WO_7Q7O@FY>S"^YY)5)PZ!;O\%F
M#&2XC2!1'W,S)PJ5@]6$#E="?RS:!QY1EG2=D?@&^D$1$J*>",I&9>M!UE+K
MS O)#8&2;[RGKKB+UMFN1D#YN 27VR+0(3\6KJAQ"28@.H-M,(O5!\:YS!G+
MW#NZ47G]M2[_"N\J]++]Y\5 5H#->QNN5^.TGVOKUFH'KYX7CQ^%GL#NTRK?
MSG3Q V.?O-);,-E5\C6\-[BETNH>?)$\KM+T1[#7'^3PFC92]H*X>7\@HH^P
M!DK4+<;P<%D$)TBI\(BCZ7:9I4J:=.(L]8 6JC$@OP>$1 Q2+'0+)&7XDT!C
M<<K=F!\B]7GAM^]538^Q\$_+>VG")LC:&M9#231@?5F/R[>>4F*VRAGB@'T]
MEFM'L*9QU#VCVQG=Y6L&NRQHLFM213].@_+CT)).U%PX,WO':Y5%&,2* )OR
M5%OCUBN>_S@):>'I)?A<^(QD('KIU1-<;OE:)"]4 SPICH>!3G1= 3ZK#)U_
MAXEB/!2*TX*/(>*7@:#V#S1NI&3>D[>B!OQ).0A&OUE"01ZN5R2,>=0\1Y-,
MGS,2O6%O>S3<BGGT3EGZ(NU16.-^,S_CJZ/;\#I&1G,Q 9FV(0&D\I/I?I<O
MS-@_81GL[O&9O"+Y A\PO=!PT#NH)%XX>J?VE'_<@/N+5@N'4B^O^]*)O$>J
M1'2[];R!% /M)LXW@#[2]N[C3ARS/K!3ZIRA0JE>E&\9ZSK[H#JK4_(A35V\
MHO9\ J>-Z]%&T0&*W6OV07)#)<1)%#,WQ4X:#%/49>A\JAV#_VT\_ &(RFTE
M+N(A(X"!= KA!=V8#,X:V*H&HD< 3=VX3!J*NAF*#@,3)IDTZ3,B;]4+V*J*
M[.PQ N/3JJ:O6A:E2LV4SAYMG6.-BP-&GL-_)]M<./=X:%$173B$[L>_):DT
MSRJL5?\665+UJ*^9&[$[58-">AY51R"]TG7X+M3>0]->Z+*H8^4B@HTG2?[8
ME+VHU$;Z0$_.*XVPU^\MR6+=[ZF:%>ZE$QX.7;A 6,"W/QW&X*)GSW^U.&:1
M5_7P3K]Z.G>0>V;+*.N%GXUW@EN43:]C[*MOB4D[ @)N%G?>#LFLR[H7'%I(
M;/BE3K"9^,>D3=MW&];HD9?U%6.Y3E?T3C=P^'AH#PG64T@%\):C"_(X$-\M
MRB;JPM92W#4[L!A1/&X@1J47N?^G<1@'%E -9XQ,/])S8$P%N6-Y. SHK0$R
MC@]+@(]]US\\'F]9M4L)KX.8QYX #8T,*><O=!83^$D V85T)QB=!$3=@@D<
MPDQ)NC/"D<D=HTFH+&9+R+R]V-<H$-3I+;L?:V0JOU=-CI!X%$5=:<!7374<
M*#Y0D[BV>&A:Z/?GKU];6S/K_6E$QX![Y5$/H?"#!^M=I\Y\5]Z*DTC\>UY5
M>]](*2;$C>[YSYU&EZ<$P]:K_\IQ&:P+*?(=KML=Z?%C>G"DO9]SQ(&FI_ L
MK ,E(G&[9K68$L5%V80[CYJ@R?M?<V)PF3@4[MQ[VDG \SEF,R4.',\YC]U*
MN3#LM'M!92J,H/P"B201;IX22XXT[6=/((1;;@IX7)..0,U21GZ':\FG@E0I
M*FM%#944F?*]'3G!857_8_BRLI/V*Y-^0-[Q&=Z&Q!1\1+(@M.Y=IF<YB39.
M"8OI%#>%XT %U/[\ZJU!J,SAT[CKH7HXK1VR%J.,8MAFPTZ8+9%D8N]R0T\>
M1!T;0Q2HI;EJDB.N9#YBYM%(Q+=2D?SR:^PAZ^<B'21IZ[D:('(H)^0&Q6&(
M:H/AHS:0]7R/\85&OZM>/("87"/VEGA2;AM:A[VC3SJ@'IX7) ) BMU%4C*"
MN5MF_]G^.ZU[/TY\@Z"&]" 9HDLY_$.JG33N M0 [C^!".",>M=8&B Z KB0
MU25M=%?AP+?K75:;1^%X:>DA.$7:7YI&D@8)H4F,+M2!5H=WM&%UAUOQ=!8!
MU/"4%QA_^)[I=!"11.?>" F312Z)F2X'O3>\\ GM+:I-E.[N2/HD#*IYY>VM
ME_Y"/./:M\8A+"T0PWN55.L=%UB^*W'(X4NR><U!_P;3&PQ;[Y/Y32\KEV?=
MMX0(RA_^5PF2_\^V-5\9\T$*&]A(^5BE&\]9RSY$)BE(/)<[+^IB7";+Q]JH
M>Z$KLL-VAQ7V^E(CWOO+GU[!Y-1>%W/3\LIXTF5YBC"XN2+NZN?KKA&5$*/;
MT@ITSFIEO%S(1 ,^J(D%\>?NU(5KA(W(S#TG*WP!C^J[+R0+CUESX]$U!"CB
M!&W]-'9MQG$H4,HP@%-!3SXN@V ^Z*BCCV=TJ]#061E3)PRR#O!A;(*"%IOT
M13.F[T5_*PW&?2QR*KW\K]>\O!-M>TL2@:+S;8-VWK@UU;%8Z[+O1OZ5,FL-
M:^/VE"WC;B?L39N3K4QZ+Z6S#@76A>?=T>_(Q)\]F'J<=;D2^VOC?'SS=VME
M.4Y\6P0$8B K5&]"E PW=T^R\#9%_GK0J6$'EZB9C-'VO1]+7,_>%H_;<*\3
M67)\M-%IB(K+=OG8T#2W='E9E)6,RNI((FQ4WE5A(#P_,0ZMB[6F^$%[9=.4
MS9(R=8GSO#6\94&UX:E$!-F@>(Q,MDX'R*%3MR"DFL'W63 (@SW8$)X%^X);
M5%KC74:K)9EXDJQBQTE[9-B04$"1!03F<TL'<-_$;$@)H3D-X'&!F7(TN^/Q
MX%*D]N)0[N"G4&9#GX6&WVU[FT-CK'57FTONQ 75^%$6[\QX7,K_;L/5$]W\
M\^FA4!=<R&W#TU]Y;4]C7^*_7?3;EV_SRK5U2]3N&H^OMRKD-X)]OC;+?9!)
M2Z3L4=Y943O#V:SBL0\4'X':);B<$EKO@)&L.+<%K_$.-A^A[HM943-MHGA5
MSL1+:=!/<$0MN<*"Y@UYU2!Z:5U[G@3\:W(7?B-DQJ-[C%#<XN_'E'CD@"A8
MGZ72C*VD<G$MA44*#_)-V7B6"AO78<05F$#[CPPNH=[.G@!\O]%=:3)MIOI;
M7Y#$L[3NA.[)%$TH<OKX\PY4(=;\A6XQZT@-$1%II&S'*ZY>NH7)%G:GE6#%
MP]#ZH[QQKBUC!BJY53MV?X3HYKWO\_6G)8EYGUONW]M=6^CXWAT7K1MIH>70
MH 7G"24U(]4>(;%'RT)M$W-S*067W#U<!R^4->&+9K;XNR>6_E=AI_^-1C6:
M7"V_[(H'F/(BT+F/^08M[P6=Y]PD&$/>_9EP1(5JPKLS^D0Z&GD-<Y3X2D(+
MU7#5LY.D%B?224@2F(B(D+H$GT]%DYL\(4_IA#(E'+I8.V7J#&^=-(12%??<
MDT[VC/-L_ZC>_27(/\@FJ-K[F<F7 Q(;_R:M6W>FV]X?>I(X_*EX9^6 G2PX
MT_9=8]79@?7?K3>,5 >XCGWRK_,^^:#2SH%<<^E5_Y^'=WP_H418B3A=U,:9
M-P+WH0K'5]3:K;D,H;7T?G6B.$$[E"[K>UY'HV,M7G>9B6.2"T(\,[P&%WN5
M=]E;(!;W-MLJ8@U-@9MEKEE$UKP3S93B Q(+E^PO*_B65L!"X?**6BX1\&9.
M1*BTGJ9). 7(\<<+'9EO%J0I/-*&>/0ZU_U XO/PC31#+%I$3CT).CR2S?O(
MHM-I$K22U=I)RB38@)/%4H$&O!W*J Z'Z"$@)L<)];:?-^G*Y!]@FX]UZ8LY
M/]!.W@H)'P!S3SYXEM[D5WIOH^?HU-/Z/97^/AOFWEFBWU"7OC2=F;?IMG6L
M/8:RO15-EU,M:KH5Q+,!<?53BKBN&TU&?F_H6%+"?(+W!D[\BP-%7MR@2JT_
MX-0A)$"8D WN.JQ_']*6C,,&I<>@*TC$;H3"!5SLND%X[XK:V@_*/UL6=,AH
MC\&D?[60-DZ76P(-A<_.5H3&4$T?M3UN&4K2/ISJZS#&?2GR:\_2/C[DI%RC
MK,=%SVO(ZY0E;&?5*_:VFT<>MT%/ 1E_<M-0UQ$I7N,-],T/P.5C'+_O HSX
M=;0-,\["4RYMSP!>GZ'*$J)+SJQOOA<7C+4&7OU1$[.LRJP+>QLG)QX9/,TP
MB)@8XGN^#:@[,EQD<Y(G <#\&GRYGCS))K#JHTG\P.X#0_F_OHO:TF%@;)M8
MI:R2!):6!=4%MY3<N?+KTYE7B5Y-CZMN)+3<3.#T$:%=&%CO,(\#^!'-$!FZ
MU->#T:7$@QB^8"/9F4LU'V>*[S.!;WR.;DN:7008DDVAW8\E[*19DK\&= Y2
M;6:^3:Y!"&W%VP/7HA-K*1C@%:N>QCV2'%^%S?CRK4< .==)Z'S!A!T?W?*^
MN!>E.XW6Z2(J/,D1LF_YM&CB%GACL33KFG0V0F0&^4@]^Q;H[)U@2+X*\ZZG
M#DJ57P.+Z'QMY867"]V/R2'<CA ^!G)O$:V;P1H#[+*J]RMJ[DE!]9?M7:/D
MK[YGNMQZ1)VS#S:(_-30'Y<P:V#KK9=YR.^6>>PK_XM+X>9/0A5.YRV.!_,<
M8G'1 4SG/4T#5V9M#MG> >^4WAJI_G]6@?OO]M_MO]O_O:'[:+#>K/P)PB]:
M5TNR)3&%^!- W_QX!<4%%#Q'9:ZHJ7>%2&9I^M17S#6M1!WX!!C=V^ LVSN4
MA-\4W^',BX]?O?FUJZR>LK.='@SN*I+@LHMSSDA3\V;1&T[[WG6OGBT?4*!I
MW7ZJ?:NNEQQQ,0T(5.#REZVO7T@F98@>]F4[)6A(:5D-5L!D':CO#E4K#E'B
M'I=U71'_*WR!UT$L/)_,R3)MRDE^1NL.P5H"EQ^MJ&T8L;1XC<AD!U&WM3\8
M_:D8WH0^H6QM?4([/V\F-P2-YI02E#$B>=:OJ/TZL%]*R\/%[':-3KPH(2\L
MKJ@)P\<E^&RV3@2$/PKZ95Z4)N@M$]$SA%UT*2F+XBZY<L&^2^N?4^'/,L@W
M\4^4=&BUREM]L6H#$_GL6[TQ.B#%Y1JRL1 =K)1O ]N84KPNA'=/0$M2>/9V
M$L^YCV!,["0*")I\L!,D%OQMWQ4&ZO=)OTG].E$942 Q\RY@]8S#9:R9Z<!D
M.W3AY0<9=8$#RKQ0IW"F'O?@P9\?!%9,_3PML^,V[,$_K/2^4Z^J,_4OK0GR
M+HL>,'XO^/R;2GCE:FVY]5O!SDO\?H/@Y*#S[B?<3+A);@W>-WU5JL!;AVR^
M>.^-?>J.089+G$O8!8C2.>(;N!\H9V6833'E>@#]^EWE?8JOM,F 7!KT\#7%
M6<+4F<*UT/MT0DZ#&ME. \'2X1.#+;YF)UHZ1I(3(@(ZVAX.U]LW8C .V]JS
MO(P6C;J)K7USU:!=CXOG-;:Y:IC6+&+ "5(-MJ]&]Z06- C(>@@V8Z(30PNM
MS[P<&:@IPD[.:*OU\&+D_H#1A=NOAJ)BJZ>_":]+#_OXY$2I8KLLI)@W$]T<
M@"2:JY&A)S 2W1I0Y 7T]3(*2QC/\9E7D42RG7((:Z>L:*3:4L==<)GSR40T
M[#;B^-W52%*'4#.F/H82)"7IW6^MBE&9MX\L)*$UH0GI3P1U@/KT^U=$W^\$
M!/2N"(6VZH5H2]<A9$)[ 8VY*P"=/Z;2'6(;4"X!3?/:8E&^$=.,;0S[0-I2
MC&&,I2Z461$C]"N0,<UG+?< @NM)Z.P_*)&0N'P'*"]VSNPZ4A49)W<1]."-
M'9Y^>-T?E<-RN5'D'<@<M_8.O&VZY?,2V:^Z)J"&<+#^1 2CN2:XP-ITW^U:
MR@U\1]LAR7<]_QK-8QMK=_>VL#2"O3'E%^]/^5,*]U>;MNZPG?SB;7<[0#77
ME0;J(UR&R]2*([A"E;(F#<H! %MPH(A4!PGZ)G<-4BPDOK:RR#''%37=J=_B
M"-M! WE95>A /901/+3H9FM7]V^F_YB3/>Y$2U@3R5Y\\S9T!E2(\;W3R1!6
M&XZ#?,#+-*V^*A]I-M68X@FD,*J!=X2M"4&.)LD0;%,_(ZCL:V!G-C3^<SF[
M/=*K)2'H_%]]^,Y-*VKF*VIHIX)HE9:&(A@)<RVJ)76,8^J*BY)@\ID/C>:2
MP3RI;KO4'LUEZ]+YHLV(QB_%ZY%Y,GIF4EET=SM'NY6F0[XI[QK#:L(_0FA)
M!$D;NHG/Z+9T&',]5$.Q OX)_M1T%V(LZW4BX8>GOEA1T\+%1QJIM R %&10
M^&7Z4B87K0,Q3P.<.0F /PGY2$C758? 1-@4H@.W/U+VBP46L533UQ03&<84
M.MSK/^4?'HLS9&^";9Z"68Q[Y.$>KZJ9DL_\52=43F&;&>IHP>Z7#2%Y=?1[
MN5Y'M3?>WM9[\NZG3[6)?2BK\.0K;B4U5G3_EK.G9S/#1VU'6VP46D$SDM)/
MQ:V7*FZ4_?3TRJ&TNJ01\UO?M\^()C.=OZ7P:<)4>1QT6'J<8@8FRK,@,Z"Y
MYYNI%2.G ;8#T5+![Q24U MVKA'-+ >72C63</KQRP260\Z#N*OK.UFA,R_B
MQHQ2EG<U19,N6O667C%W6^ )<HBZ; ?(\P1T#6#V(4''%-O'I1'&/4 .3V 0
M0W ""AL2)?,D?V",0[I/OLE+62XOH&'I4C=T\&LG<@/I[$W?L<5GGM[/0DGU
M%W[.@U8=U4[#KF.<6&V\L$Y:WJG0@!)56H=!HG1@K#T>K P>75&+$UQ;46MN
MA@\_@;[+5]0L(9Y4@\Y&=4OF-7K*UT$Y8&IO,=9^+ DE-.+I31WC#4$1_@!C
M3GD1$(4"[3UO70,5J_4[,,I<7!SM#?NKO&.0ZDK>T8?359G#_QC#;IJE:5#V
M2E?4\G$Z;)O.R9@A2L2P:V1#7 Y0Z=\&I,/NI5P]>"OPC=&5&BU&T3.D.ZG&
MP/.6U_6+3*WI$HVLY>8]CV^O"\Z_^&,9Y8"]Q'8X^>'-Y"L&H:,-?F4;W<-'
MHKQ;+3U]]/T,S&VY@?+D,P$Y@HQ>P9;I%X-W8L?NS4MP9[-STV^R;$_>F1ED
M^575!M0,"#PN78_6,%:$>COA7S AIPR9!I>8+M*FQ3+T*%%0)3 K<:8GTWZ@
M\BW-AI!LFE-^ !C_?3$2SP\QC9Z/KH^8<J'62,OPWH^>C;&&''VC3]%]VLHC
MII/F=P2RCYL*N3.AG,?H++0)&P5?&%PB;8*-H09@0KI 7[2X2M2:+?G,0YE#
MQ#XA-D]*=BQ#$YB\DC:6Q#<P^/%PZU02;M.4Z5\=;A^ F<W3+I\8#YX]:1ZI
MOU\*Y:RH99Q!DB#Z=V9+]0(#NQV^"&#_!*U4:V 3:$.\F+F6W,CS&E-9Q+DP
M>GUP>1V76Z4H4W)(X+"#!,RJE!1@)$ SX%%:?WI $FDXVT/="MJ+Z$YXXUBV
M.FB4KL3)HX9WK6YVOT"#]B!K!W>64\B)!]J?T]Y8R\= )L\^A+O\&&+RL,8@
MG><CNJYR@8AWR4W'06*.RFJ*N5FUC=H7_KFP*QIPD/&)^KM Y^RSH&XQN(?<
M?.+U$MX,^LQE->]]/M3SR:1IM%8PNZ59,_7XV/4S'OZ]GT[]YLQRLO%*W>CG
MD'[C%BF@N+5&D[5N0Z(8W,^3_(:=W'3*]LRG>[N] ^I,3G*#>AS(3QZT!M\V
M?>R][]O.Z:]>DUZTTZI]RB;.KP(Z8<\X91VH(;^G+.O:(&O2QI])D)+60?VR
M:!YQ([F95^S26'"?S/!I'Z<<:H!*^D*'K$>ZW!IBEI>NAV>6=167'&BX'W=[
MUJI 6?]%0:>[>DD6C*'4(V#*]>1YLQZ"/AA<L&H+:FD-?*J):B2G\JF6XWM^
M'EF,3#TRUO+B[Y;W41YCCA-U"<=\1AT5I7D61WNEVIU>G])C/I ^Z?_G@=+:
M)64>VT[537 &0_C,]91MT+P4G:MR!D4\IE[L_NG+CR&6_"+ RG#L 0YD ,7'
MQY)$^L19VD;XRH.I\12<10+EBG@*:P#[I*G+C'B]SL[+*>E8<_+CTR+H ,?3
M4@.ZMIH=H<A[E*@V:%",4H=DXB)F%H4DB1C)D##X_<\.$Y15E#7.\^KB)NU8
MK!6(O][R)_8 M%\BXLU[R\( >7-#8ZL$KP/I>V-W@Y8%$A+J=/='Z8]/SGJT
MGK<*'PX]?>K'T;1GNP/EM?7Q"MO%6];8GR9-*XM,B^]$!3#9[VQW/"ZX^JIZ
M=PC+#QW*ZW+'G3WD.WPK+:_(],Y@;E%E)%7.?/+1S\N]][<_E(&(NOML<<]]
MRTD-#1"O,DR![=#9(J!J14VBOJ*6.;"BIHG.0WY!1HX[O%I&4F7 @/<L0)Y+
M*.@?'$D4C6N% 'T(O)4&%-%^7?5)1OY# )]" PPD.]&B:/R^N5'H"#C<+0(B
M:!FX9MR\E\(7/J)DLS4@&@$ZPJ*<@ 8J820F@6//"3; 'J:&ZXYJ=U"='TXH
M JW[:.L6FTRFJ#N =OHO(#M#C-*$Z%R<WD[P!W+@\T>02(:1,_)A?REQ ^U8
M,JRD=?OBQ*4<X"1:R!+W]9:9'5>V[80&)$[@IVJ0)*'/93AW"^B<]4EI5\>/
M@81[4O0/E-VCU!]CL;O;\WK'56M?_ST?(8&@%RPO,4H?#@?H/&0%2K\]#R\O
MC0)W/%>U!07<:- ,J;G&<A^OF*DGF 27Q5T(+K--MCY:M=LA*-8OZ&&M0QSU
M[>ZGQ^AHTQM5[W?_<M8_L+ZFRRW%PW'F8*/72'[<<!$A^-F;VN3%S\J1*BGS
M&9+KMR/T\NZDG;(.]PO&DA*M9"TQUY$CPI0EKLE23J;(@+T_+IQ-%Z^H:9/;
M>2MJ**H^[ PU/8#/@Z.5H5!J-T?[[TJ@G;\6O4DR'-T&['1A9K4*S&."R]<"
MC9PH0-%-2UI1X_U&[6&^D6.W(6J#K2SF/'1RBPA_[?@^466$S!QC+NU8)#!9
M*DF(YH?;%[(0?1#]IG$I0=T3%*0G1\;[M9?[#-CY@O3,IJ9[Z>-\TQ/MM+_Z
MYF(5@?!6:-7][P0"7,]@/>BBPA7:+[;.P>JH^G MJQ:09J?A?3?YW]@_0)5G
M%3_!.LJ[U@ ^OWJ4NI,\@0@!PT;VMEA3/+=_80VY8KC/TAY,+F!<AZV #Q":
M+XR^_G<]5I^R"SE%NCZMVV5%[1Q3V"?'*^O8V^$S@*JR#A+U7OV<CSOKIL[?
MC,FZ\!'RDI0=$Q=S.5LB*0%0"(N,(,;6P21&X6#<BMHFR<V?H"*I[_Z>%.RF
M-L SLYYBPB)?'CX%%: 8C)HSTX$]8[VN'N@WT>BW AV_'VM<O"_VC21]#$CT
MZM=ZV,4>3'7/_NWQ!WEMJ]-2[C#YX!EE03010V81*LL.#@R%:BK<-8^T/-+K
M.70IM;S'ZS N>JY:&43FR"N4?ZK0,:H?0!2#%L.\1M5\C;6-V4^NDV0]15)T
M'E4-&&. :)[A6(?.4E\VO*YF%KOU\6,P*V-=<6X7YLJ!1Y+I)0NL'5$OQAGU
MVZ-XT]1W2>'H/DQZ^2XHA 8.\VC&6$.(+BXLKH(Z"2.JO5.T3:[6=12[X18<
M_=O55TS9 -)YJ4%6TT6)G9MUM[/*'-0ISFLU*R <QNF\GW(9:&MVNB6,_'($
M)JR^#2IJ=IY;4(1!Q7+@(;2B!L1W$S>?>0AA%/NFA;\*&QJ66E6W.);W(.59
M4#]L<&&Q3HF5_01VC1&UNG3B);2<\!VQG,U=ZKI%O['7@2%TCT?U:9U?4B76
MO:CL$CJLSY+?@)*O@-X37)Q. BVFZ<T.F0=+'#J_Y&8ZT:?:C^3L*'G_($Q;
M]W$ALVMOLD9.17N&/ 6R (^I$-J;7VX]1#6;VJ02M"U_3O];##UVM4/HJ^G2
MGI);=2,\GKY_O\:?]>UFSMZ;\JOG'HU:A6PLB]A]Y..;W 2I;2!]3TU(34"^
M1>@03^%16VGZY9YE.(1J.G//M&# X?Q. ]NFFV'XV5L?RHQ?I>37'"T*>W*(
M5O$/91?MS/"_E<VXL]M16QG"'1(4[CLYI(OB"A4!L]*%ZTF";/0&.$W<E*/Z
M88PU.I]$,H-=P>!,&5%S9AQK.;:$UHF7+T?GN#K3:J;&OR*0-HC$5DCNF#S,
M\3W)9R2I;C1KN?>3)B>+)E27[X-F%6&K]UG32:H!3C-SS@:<%1OUTM92U,>H
M6M1AIBE[IZI_G-D\SFO*)AH[H;)$Z^K[^M#FE!C@[S^OU&&O27R/29IZ40:^
M"!$)?TO^'-P)5M]GB&FZY$HI,:]E07.&^*Z/)\CBZ+(WDQ'F2P.8SRVUH#-B
M>\,TPJP'X,D3:$T1M(#"FXE2"Y(_Z,"Y>)],XETV/5=P!OM4ZA85/+YT)>%\
MQ<V L25?SZ!GL4U-C='% WUGILZH&DP#'LR<NCLCM1DILO%!68=7NR1531^X
M]=XEKC.@Y5E9'*;(.N5M9EWPX_I/]UYHU9;9WI(%[&TP\-,K.UY;XU-<0AUP
M+/G$\B=,5PL'W0VXR?_7K18U9&WZX<[W"]YXRET1BBSB&9:KC6-WKZC%DGV>
MX];#:-"(3S\R2 D#S?K*=SP<_/E+RZQ/J3VMCPC\3O:'0T Z$4J5^,Q;\PEV
M2!]I!F\CR,7=E^/39$1=E5$<S0P!XB>6]LC 7R;WJ;2.21:$@1X -7,7HM"E
M/ IR_DP=((5+W0D0YRHEBB;]R#B<(6S6 (=#813AG*7)PZ'/8#N/L99<N-"3
M0MS,.3>!0\$^0VQ[^#A4*K7?+RE&R&0%<8(D#QWD)!#?IDB;Y@2-Y+YP*"T!
M-!7P]K\A"XX\?#C:"..D^!^@"1YQ,[PM+;5B9I>QTX(N@M,A$@M#M"&9JN-Y
M9&1I0=NG?FK9.9=B73?Y!BKU4L53;50O<< IW)L=J@WK%'BJ0.4 \10:H=0!
MEQ0>(V^9E7VWN!>]20H5D"2"?)?,WD>@OOPRA)?1-L.&@""S-4(@5.^CVH'T
M:UU;5/N QDK0]FLOVNP^@"PU(_*^):S1!%E;U.]V??KG:?>?(V//[2_<9]QA
M6^W]QHNGO=')]7"1[8W<Q.7/+<MU6=9EK^,N7_0LSI>7C[54+U5['#S>Y0HL
M'=J!W\0*&R\+FH_U\#TV,U2]E">Y%44L&4]1(HHFG4+K/LE&4\?0CT39B# H
MQ(M%;Y^R-U%\&.*47HX>>:)'A0:*N\>@+"&>YXMW!]'I<(B4LVG;$&PE6X3:
MQ8=UM(^ !8L(Z%-2ZN/0NO:M:'.'X@KRYUY:^*3J'>X1H32J*NXJ8YZF<)A>
M)F4[E@ZD'AG!4'&P=>NCL44W'+]\!Y"L:JV*%$C?S"_9[^KKF42!I$R2DYG-
MKN8VT#JSR_/>P+ZXJ[M8\0EP F3M,;XH@ ZP$!4WXD33C>^P+)+B)_KEJ:/P
MMIH98?"],_<AWC\>00B#6KL(-'S+=K6A74E8UYZ=9(<RAD@]U(V=HXM_DO;8
MPR$2C#Z9&I^]E(8Z];AEF2Z/6AT/ZL"D'?*Y437$:1EKDLP?41TB"R2"^<U@
M+3K[GNO>E"9([YO\&%0,'CX).*=C37SJR<2@=L SPS4-P[W<#@TFWH] 6\*>
MP]AMY GW$=>+\15OX /#;,O//@Y<OXOYL^/>;<F%+Q_^77;0U];1]G6F^:F/
M-GUEET+R;IV!(VJ.GBSX>W+_IAJN=Y%#S$?RZ;2S-J^,:H)OEGF?]-;I>>E_
MP<$KU?'.N3OUC)E^*7[^B,*18@INH6Z".(J?*!NA0.F+%CO,%G<D+2"QHBXF
M;?:1E'DK0H86%S9[5I"9?%-"U;*!JEJB3/5[/#KV9OI;B'!74^PZ?K%IPH??
M%L,Y?:ATH09WX+#L?B=(DUS. 7Q"AUQW2'5VR R;9 A/F>9H._FJ2]>]*C@K
M=B/Y09E7ZHY)[.9W](Z7;P>4K.O)=@F$"(S>Z=D.1U/'\<<SE[UP(#*P:V7*
M$DZT( <'># AN^)>DBG%'/!H!7TDSMFTF!3HBBRKF=T,:EQG06C%;HJ]LL)U
M7;)D0HD[V5+*&]<!(WK+MX]U75A6CXV2EC.NENM"=]@8(+FA,0/UR3FORP=D
M245S&Q0X6!OXQB\X&D.Q5B2HWJQN?%H'FP"J JF)DP]G$^4GR$>Q!?8&.-F+
MI(UD3ZZ=!&])IO,X)K083MY5OZ(:J)]O)#+=,<J)=0?:N4H[/E6C"^RB:B8]
M[C!X[^S=&FT0\F-UI'?9P9<!_4! [\M3Q):+^7:]!C;<H#M!Z$L-Q.17/UH7
MU.'+_,H<)]$;<JI&/HS$2L&DW_X("K%V9/F%E@3>BK4Y)*S:=F7W(=J]0.HD
M\:'0[K#J+>=Q;D7Z7P,(9=L6%.1_^UR43$U-3<_KH/I-XG%R2 _!&!S_+Q="
M1H9KU-TIE>VJ"Z%=W;1JV_]T(;3 BD)>NWI*!FC'5UT(!S1._\>%$!WZ'Q="
M_/]T(2P7DC^09"QIR%R*E#E!4VG1%?N@4GF:\G?5+E4_[G%[1A+I=\)62"!!
M,VC-ZQASB)P.'%9IJ5ZS=T"98(4O88+7<:%5S%E]J]9(90XQN]%:2?@UWD)F
MMNLE><CE2:M!QU6+$#.0E4]Q5N:10[B3Q@ &N7I$NT.)1X"4#%<+Y.H- ,9U
MBEWEM,H2Z$.(AV0>*SK^VO609$#]>'O+4(N;QK&A!GO' ;3GL+U]DG(_OK7]
M\>/V=*&FC&">IF4<-S)]\LX,$>7=0$CQ([QL\(N73%2]2ZL^V+NOK#2X1N?4
M=XENO55X:\VKZM!>F^ B%S^MV""69G?'BU/^Q79WJKU2ZT25 :_\/]Z<K,BU
MNS[]'^,BI.$,..(&7+MH'J_8 T7T8=<IBU>K*^6R=X_4(U\$V2(SRAE%)%/K
MQ0.**;3F'AGG#19G+^4LSA80>4(6CV-$\7^-1<-[H0)I*.P,FO'+#08=<7IQ
MN+4)=P%.[W?V]A> 6(A C)EJC(CFG,>_I4D7^$2A75^?U#K?=:_"!\I[;JK[
MD&(G;M(L16N\@4T@,VF_V]9IU=K5'?EU-PTY,O1F4:FBTZ[ ]U6E/ Q#>#G$
M%8[/HB!;(ER)5FGM1RYTFX) F\51CC;]A8,.)*I.,&4"93DN#[=4QCD7MQ2?
M:O/KK>B-;K9!VTJ'*FT'?<?J3,Z^>7E37K3SW5.K@T>];QW:W7=CWTGYG25K
M'CK6O,=]M.;@J>?2F=1#CC7=0ST?!UDO-*N>WHH_Y5?UM!9[^>DM>\WOKXH4
M%-4[8GL[O&56AIF+5UC#OP&<.1:0(K\Z2HMQ.QP!WJ\!?+K9./!S]GF5.L24
M")ZOJ%F<CK^*SUO"9YNB<I.)4,R?2PPHZ!$Y/@S:$;VBIN79<Y65C=TJG+7$
M ;T%$KLRS-MHE9:;XCP%Z69Z Q[!EJ?*VBX\()+36\:PVRA'@5XFR/(%6ED\
MC/'TR6[%W@G5"%HG.0US FC,JR ?"P&4XSP!JK\*&G\>4FY0S,=:0$4R99PO
M1A:=YVH!S!X?[HH&&/P)O#%"@<[@Q'66#J#&W/HD_-N)?T H2>> >B^SC7&-
MXB-[MC\<JJF(5>T=5FFOAL.B((^H3DKFK!=(17J4 R-=9^^K7I2;#+GBQ:0M
M\'EHFUA@0$ XONPL,VLK(+B&79/J#.OC^@Q%@!\'VBW(HT5Q)O9+K'F1SO)_
M0O-G).\-^^2CCT!/?L-1F9140+6+)&?(PAXQI=;SZQY (7CPVW75C\@!(S+$
M'SEY*A0%!Z!R*&D*'Q@#K*A=8^\DI\B,"@8X^5BSY8,SCL%&)EI)P-])/WY/
MNJVW9?=P[]F; =S GA&^5%QT@M12^J#:;U_]=-?YX.WE6J&>OI?.L/REN_T"
M&EZ$Z!?D-MFV6M-[>FH%.MZ%EOC;&==/;Z]]$E#@=>;7*8$>J.6YR,+-ERDL
M)^((SH.-M+B%MXVB4"CZ8GTXY?A0-#0-L.U])$OC=,K%2LH^<%U[P=ROH/=[
M<H#L*'13BD'!V+%MXQ4/;YX >SLKR7Y+/X^W'K;;L*R-$^;)HT>HYE"&3)>)
MP*,V&_*4N%WE<=FV4'4T2'INA-.E.$G3@C_SQL*CZ:Y'9&37?ZA,!EOG/;[V
M3&YI>3BX9.$W<;+K*8BCWVUOOQ$9[^O#E"&,3:!P@-'*.HZX3=3V.5-U8&H?
MN8F+UD+H[0*TNZ\O J/YPNIQC"4&],S@7/#!:TU96H(?N]I2C%P6?@^0]0V1
M2\. S&>3?YZ1OH_@82T'77]&HIJG8!J1[7I.OJ6^1/_@ZKRBIK&5'"V/X "6
M!3)\NI QOP'4Y_.XEGN&6MR'D_I1^M0>U4YE\WFLY;0++3.)J1U[0*0%6X"^
MBV[:/!'J\_"%1;=C$M;U%K0Z>1)C'#O?X%5_:;0?.%6=?_V1<?&>]6:8WI!6
MT\MW]K9\69JS<0[QZF5'T:F3/D4!1>YS5BXVXT+CKA/*O%,/ODCW'GQGCYGT
M V_KW=^;&IYWX]UC5D;-57_*.[C@E/^#4<R\IX0TKP-HR(H^YR (GLXTIZ+@
MGSG >5.#\;PYJB%\ B#RM05:$>1[2_^"G2Y*?4@;9J]V"<TMMR-2)]/1)OFG
M5D9(FD98I%NC;C%EZ\>NLPHB]053MRNL$=*6HN:/*0Z3]?L(AN7<"?ZD-EC<
M*\AB&X/1=(?D2+,3H&4QJ1%*C "="A]5X6O(J>&#2[.:K=J'KV <$R).C-J/
M^9@IPCZJ@MG:H=.<9B/87$0#B.)=-ZLHCE"D#&\"?96PLKLL*F,O.PO/3ZJ#
M*VISZO=5;PA6P/T\!\[Z)IIX?CU1B.):&H+E1=7D70N\VY;F0S"N&M+@C2T3
M>9TTR)WX52'?^'J)I$]9BPQ D74.+1I30&O'\#&%(NT+[/_!WIM'-9&U_:+I
MMAT ,2*3@)!61 34J( (0JJ5!AH4(K."D%9$)C&M@D0)J19$9,SK@+1,41&9
MB0J!5B$1PM!(8V06: E)5&:I",225(I;]/NM=<YYC^>N^ZUUO[.^<^_W1R4K
M6;OV\-3S_'Z_IW;5WAK(MXJ')#VT@V&HN#_'2@*KG\'FDL3/*8P]X> ZTM:Q
M2_AFLLJD4,V2E498P2 >"[=A79TBF0>&R09#KM$OBE15FC?Q#]T>#]8(]N'9
MA5<F6K]WR;U?W)U=E/-S(;/(H[JTQ^L^U/.SR"?7R-AZ^,'FD@,7[GQ0/UP0
MZIGNW*H_;9UWM(&\+.6(<XMRIK77C3)KTW_DQ!]F?GQ7Z''X _J1L8'1PZHB
MMA UVD>H5\!JR@L6UK6$'WC2DR@>/BM=FGA*1SSQB=453DZ=\^1U[7\_:I3D
MV5OPVN*M?Y/-BBRPO/YN=_F\_GFG)[\_S1CU?)("7F WS,#?"Z>VBUD#3-FY
M?I(9G0;;B\"52"S<+HD$F_/QO<A^T6\_P[,CU %Y<_X*>/OQ(OHV:3/*ON]'
M8XO^TIU))ZU_B[CVDE0JB_M00GV?Q3[>AE"N 5R$3T&((O:PKM3,]&R%G\7)
M41?-\ -Y3M3A ^JW#+W]AJ=_S/PIP+AMZZSC[F>!F<;N786FC]^5F7J->K"0
MA=R10E.R[XP'=4#@.]/BT]7@H.$3G+B4O&Y&!P:=IMEB_)6:0?R4D9CY*W<E
M_+@"CI_\26J5SK!K$#_/ 5;123UU*I)8:UMWJ%'(S]>5/KQ^5GJ>CP(Y(EF%
MJ)AA2-O7S%(M[(RT/92_!>I[UA%4^):AP_B+L($W4@E"AP2)O*K15BQSJG%J
MX UJ40UH#Y =4F'C]AA9''0[?<1.7=S'@U);#'9U35G,K(/5?X#/2F:N"?$6
M_LP5L/B+K>^:6L@0T][,JXCR&40[]@'\O E+N$;GVL4L35K0B^'U4D)Z7:38
M;F7#\&KH0D(97-0\O$/JQBZ"8_D&6E!K4K4\W9\B)5R;5_B)NUU>S^GC7:J?
M]\S'43R?<[KGWI+ZQ#*96"_TY'4P?1''7,2M1XW!!A"(%%XEX( 0MC)ME"]\
M#+S JZ7'M C75G*8:V&M3Y(7@2:]V^8H6HS7#/-.^OZ"250#8C6!:G 0GVL*
M 5/[(7XS84VT(-5]$7<&<93Z-NVCJM#V-8'ZML;0LH%VH^7*3YI?W[-]EF9V
M4,WZ=>%TJ7>)XUG^\;$3Q^+J(EX]22A4MMQT/].EU[- N>+BF[%7;KF_S)NV
MZG@<SC#856;IZJAI:#,?WD4><+EE8C5=Y*->?7&C6Z_Q<F LW$=1AO5^8%0&
M*.XMXD*(@Y>!XS#7!%D%\9IG"+0U0+QPZ<WQ:_.I@K3A57"$A*DR=AUFMTKA
M/1$:<. 36I%C@*<SA-[B6E'6I1_T[+*(Z9R3&R%^6,#?1'L)D#OKS<H6RG*N
M&LT?539D,[H)^JAY:VG$'H)2G9I<%^WP<[I6353R#]?*UX*:IX>3'[A*EXE7
M%(G!5,):R\T0M8&U>AS$&S^&D^-$0(K[$5I^]S%H<Z"^5'N> #T7L>.YJ^GF
M< P4*ZI,&]X 1T.L%UPU.&($C]]35!X1>8]F]B*?T(V%18 .A[5V0K>&5U:3
M=2_,1\O)L]\R@'R$MS..[=E#) ;G?R"_RY%Y>_[;:]\=-):,4[];R&A?Q#TQ
M:KV,!$&B&-7=$@^HE2]0I]U%6_V\FPX3$EC:%L%PCO1$M]AWFE75$HB7/H9R
MN5I]0 @^^?X,_Y(@*2BLO:RG,*')N\FSH:\PGA^[=W9DY[E,.L/DU?I0E_(Q
MM[I;X2XU.XYU9SYZX]SENO^ 84M7XB$'TZB0Y")/3<J=WT\\WN7U2[5U2&!X
M=GEQ\S/WQ%4/;M#2'*RY8=96BFUC/ .ZD=R<KJU@U>V3TQA+SV%<1NW"*2L1
M.T(308/&%X?\BNK ,6)J$PL'.S5J\3;0@Z&%_N;#=$M7<F--/K%OI'='81>=
M()IT57&36B7UR?FHKJM+ZR'R3YU V,P NXFG1A#ADX!0RF7N]W"55JT86-T&
M\7Z$JT:V^XHW,PPA^J7JX1V0'#;E4UA-)16PW_9E 5E-ESS#XA=Q/S(=>EF>
M\;U10WS\IQ*,Q8_\%9<EUD;4^R;;XB53PM4\:@ZSZJW3J)_@78=<O^W=7_S,
MV9^SSK05_&75\N=3G0XK5"4'4Z9CBM\6<2>);XIDSO7P/E%J^\%%W KZX7[T
M.[C H_]GZ&%9&?V7+M28ODLJ;)I92^N7W*[F:E3WT2,DV\V;L':W]S=<>,:X
M)Q+B:-I\U%8JO%)G/!)@W'@#/O@CE'G\R5_;QD<VVKK2O)M%N[Q[\BQ]\HRN
ME*3&RVY$:_I55O]2\^SS/6.3ME<3FYJ"RCSS3</3C0^J!E[9_/2]3H=ONA)P
MZM:QH"D%>_#"C?<I[ZL?\(K'@=/L@14$'6-^"1C.&WA&O+:;-DW2:ATY2K*F
M[R3K $T#MEC,K[(%U]SDJXHO5]1FO),6(1Y*(LW'I.^I&F#3Y:C9,O"^;XC4
M218/JT"D47X-19=A1=\([[\HABV?LY0&Z>YPYH@ =PS.'^*3"QS$^YAK&L0=
M$<Y9?@D_W&P*)##]LUP/_C97U!]UDANJY_5$'8,MH!;C\S:Y'>R$KEK:O>8N
MW"\"KI#60,)F0AJ# .-#I%8M-J[UB!\[?1H,I6*YO]BX%4C92>.,]NS8)#T6
M(U2C&]T/A _3\NU.(I80XLM5@L_0C4<Z_'U>4^E%HOXF@0']'!9'=Q@OP6I,
M7XN :X1:3KU@*EB^E7X:GH?\1?T-J8)T[L8X8S$FVV-$\]R*>VU0;""6P)(P
M=SW0A0$/,=T//ZT26X1895 2;%8422/<>JH[_-K%PR5BP;(QRX/;[OGM8KL]
MW.1E%)^_W>-LP6K[6^;*UK&%KR9B5\G?I$0_S:U_5WA V7N#D9%M<+A'F>.#
MK2V<;=[;;!\6>GAY5"2R4])ZO(&(+=PROQQGLT!-RC:-'I"C;RX;4:1:5H3L
MASZFRP/1]L'::[:>8E5\(V/]ZVH!AOS*Q'F6&ES4M%#Q,%'$5@VU"6:G&M5C
MS"W6/X.V.KV>BR2II#OY]%(C+>0J$:G/KQT'BR.^[, ,XK2T*S<]6@P,R64Y
MB@J&!:/=@VZGR*VFZ"%GGBGRN?IH)[CB+@R*V:M@80M83>;/, DXSB(N4;AR
M7O'MI--K8T4>JC.V9UBS"BX3M95OLS43QYTB*"/&&'7-6+"3G4=XDXYU4Y&F
M&KNBQXY/V/24N.Q*/S72ZSC>>/[]+V>V'SB7N:4O(VKTY>B:H^UL58_"8W8V
MG)]+>DH$.WY\<",^M\#-)]N3<\3!AVD11 SQV-"9]O1^RM;[3UT;4[;>_9:7
MB>7&+$2S2O89/B@^V*$RPGP!I@B?A#0"WS*Z!I,:5@&AS.1%W)IJ?<=9V;5^
MIWBN2<#83IH>?Q&G@:C%B<R Q,'"UH:ER:/=CZ3&OX; URMI"7R;D :\QB1C
M*^P4(1EB)Y%VH&637QXO;5H OA/P3L[( ;(2.&G"Z.=,GU1./]2MXEACD+')
MLM04Y*;F'M?6>6KIR@NQ;CMJ[&-IN/RBHVF1T4\7OQ15']G@[1)=ZA[U2^\$
M^V1/L$GWP_??C9ZA-3L'E)Y9=SNY/2M[MR( /BCW.(9%@U(R))#UP3/G*^&N
M&3[A44P"$$Y.RV)H=]E:1H@I6L?&>%4?<J0A8GU!4I3F[U!20@7G[07_R!,!
MQC_YLU7@<#UY6>S&L_?#(C[X,W:CC< &8(3-@CR!Q$5<-7[ZFQ'!$&$$B[V/
MMIKB5,I5[C>PZUV&(%^UWW99)=WG-1=/,V]^)F-MJ9>DKQ3CFPA)K-6<"*$6
MO .FU1Z6 JV@UI:G8LJUDHB1:2(?5<5$C)C<2QYHEWSF\P8B4*5OY#O1URQ-
M#OX135OD-*4BWPN7^5[5M^<_N\ 6JSP'+P]_5P,MW9G=BF[KI^\2*>Q;66MM
MG:,?T/1$GY/F"6O#S,3@!EH2']U04Y<RZUTK^*20FX$-)-YI+(\SO@*&"P>U
M93_WTI7D:Y'OX$G)C#9M=ZLL]C7]HOP'9#?L*\E3)S^'7J6"D"(R"O@N?%@7
MYD!X?OY*F"5]?I#5='Y@DH+_2+*%(UJ$*Q$"I#?RF1\0,#>34'6C%!QX7>9'
MH]N.7FMH/B']/?S(&]^'Q:[BG;?&O=/R;&I+G-1L7>^1;ZL5^&LFREY'IS5W
MB#-MSE9XF^XM<;EJP#ED(=IQR25C4_3WXKRMGWKNEP1ZWBJ5NT29R76V,OJP
MJ-,&1RJ&[10<5(?1905RS.D64"1[J@*:' &;\F(D:9]KA&M.6Q*2@+7(1NF.
MR)@FBHZ%J\<4;-5PZ7/B&8827-:"[I96)I3"%-'< B7UIFLWLFPD#GA1-9&_
M51&^B+N*@0;P>(INOXA3C9,3P9_#+]5P[H8]&T6(6/02WBQ<?2ZJMVH<%%RK
M]M<GH^L$CP,F!E<P):SO)I[UY5%ML[)]<B1X%0K%?CG[FL6=,XNX.\*!\S(.
MO$\R QOREI9\/=S-6[J/@[8MXO2Y:HP62BV^"=A -^D6),_I4UKW#!O!WE(R
M'_U>NJ- 1$P+M))F37^7#\#6)>/YZV$[:79[Z[/:Y"DN@0E[V6C=%-LM<Y"N
M3&*H(]9-_QNFJ4LK\2KDR=_3#IU=_Y/'J_P5ZUV.9;YWR0N53#JNJ7YX?]@@
M7\?OK.Q117N;5H&'Y<B]:^RM(R7NF::?RK($:ML<W"ZYYSZ:6>;</M"RQK?,
M]M#3@AW.GHRYF[?T319QWH%$13'O%)@T"/Q:9R\1#AJ/4.(M\"G9JX=-X>.5
M-)Y8^*NM90'B!#5S*A/BSHJ!;\(O":YM*Z\[?K<A6,Q6&78MIUV*<R*G]#=E
MJ_+_VN;7DO]97RM)VCY2E,S5%")1D+ %G\C="!L6CI-V]'. M$N$)KS2A%!Y
M;AHO4@Q7%<&S?CPX\7C97S07@3/DNHA+LK4/%D\[2GPS!/R82VNJ(LL[@O=D
MT?\!:O.@,S%3'?)]:!_#2%&WC00@NI!OTY'3)!7TSV<7[NPIBXB+! N)K<4,
MX"C]Q[ZH6(7I(H[\>Z<MU3*KD;W,#Z:(?:X-4INH.'[A,>)ENK>HLSR"< ;)
MAYVE">(MF)C_;ESQ@*L?2/>H@9A\?\J@F6P5W%D":^V+(SO68/E\&FI&7Z]X
M,@<2&B[&BJBK _:+0RM&,&9923^\B+L"2HR3YUA7%[X#JJ:Y3T>>_T[:QE2&
MP9;G_\ZIZO;_FJK^/VBJFG$:'3!8AIFDD&X/WQMQU9;M@8?D%L@R6(F*P8Y,
MWCJ\1TI)BF9CR>SNB1DQ@1 &:)1;"%3A+$SR$:\,SEP^35<JA9<U<U>]OI<E
M^IQ>MU]JQM?-2"A'W"#FY?E]R1BJ.9>-@H/^(E[K3#*J_+H:&.B782G7U6/2
M#)9$SR["7]J/F B6(TL;LR8T'@XUV-Q=B6"R=55K!K5:07217WA> L<V4: ;
M?H<6\FH10\* VH^GY\M&F04J))>VV>.B:*/I75Z!F](L>.8/BL76.;7;P/,>
MKWS#B!># \Y[W'A?9A?T\77)5&F;B0-'-[^+N;WK<W;9"LF?]S]V(O.T;MG8
MTNK.C$8 \A+\RGH2,[U,OI]V4/8[["FMF9&!T/N*<M9JD@&B\Y2LBG;SM+5'
M*M.E:]M&6,MV/!8QDP$5U! F-W?[PPYU1Z4J+P)MX;"<@/V(N82J%^8G;!!4
M@B,%BSC("Y_*6L,+8R?R(+>9-PD'(%XR&#:3ZIN_'II)Y6Z:D#&E*W^"#:.E
M'NU'JZ&.6F0C0^5FT[/A= D51POU9W2!ZY:>-"6I]")ZT-"((TLTHQM.P).,
MX9!6O_29RTMK^88)5M!NHDHZ6%:K ?5/.\@C$!*4-#TCHB:3]I '@8/P9[&)
M9?H^<<7'"JC]@*Y3DZK]"W#U9OB>-B;75B.'8;52N%WTB@/Q&@GJ=782P15=
MRA5;/<C,'LLWST+:38-N[#AHSR)NF@ Q#\/S6)IE0LL1 8E<(\0>MJRDW92P
M^3FIPE2*$N)43@L2:U^N%BB##>9U:A)0RTF41^$/<M//!Y709E\8Z/<QM/V%
MX543NJ2T85L;]+$(U WS.Y:/[Z__(H+:U:\U[Q5)'&\[);:X%Q>7B,[N399L
M#9Y__$MCMYN)W"^S@+S20Z.$KWDU[7'46&>)C]JG I_:1XDJ_9G.'SB/9IG5
M[NP#\?RZX&VV91V3-,<=M&LORQ49&UL273@FW4 L70<R1%4"1G@$],]\$TPQ
MG,$/]$N !,?GHK*9P2%13!JZ+C3PFZXHP9JWKJ)8O#Y,'>E/)1G0OV<V\]2C
M[?8Y]*+?3PCQ]*-B,\' )S4)905B\50*7ID'5]&J6H;7=H*.T8NX0;[,#RK*
MJ'.">,U -?L%7I5^$(K+OU<,UXJ&>5*FJ"]=PE8)6W#B?^%N"Z]%#:';!>)]
MD>"/5=TD+7^!E'CX6<^<_,@V+J'!*JTRD+BF9>'&(@Y3&)R09NI@$:JDO;2O
M ;R>JZ6H1$GH(+B*81+*-7C&DAV59C%MC\KW,[IVP\N.2)F)=!T)<TUM@YRU
M;HQDT(]^C]CWET>K+.+>S(I9B05P7!DMM770. U5G1BT&TVLTY%^.R,A=A V
M@"&\)) 3@FQX+GT^LK+Y-TX)N@&62XB-_BPM/SC&.VZ97T^U<.F9E]U<'82L
MN[SVVG;13:_7Y;:^T2-EH#+MIA<TM4!.W8Z85$P6-!ILAHJ2A<Y2TO56VPW&
M'IS3KD=BU[^_5:5KN9-V*2KSTKD6_K<EB@#'=!M+.W9-X9[[]PM7]9ZY']G^
M<'WR@;6%+KF99/9!%8_U*=VEXZ^.A(HUZI]G'NUY6.*2Z57Y[NF$I\MN)YF#
MB+HT]R$5)-7%B87+&9W M\AQ$3G1!H\8433HKB)J*@.'22&N'BUHRF9XZ2E"
M I-38=RD?8F:4$V8$JK2F(?1-U+55WE%BJ0?^CZBG>_"?+M^$"81.,93[=+4
MYMVPGH@PK0T9BUGI=U\3D:-  KJ!'@"#$E"#+XHT<^^<B_-L>@*#?-+&GOG0
M.54K'^F:RX7"26*HQ:2=T['.J<H=04][INZSX"4M5HF^)'R[M*A9\"(NF)T8
MN!XR2 ^#RF3_@*_+OYW@;H=#BL+\C*_0]48F,1RI-A),/9>J\WG*Y5R#<9)J
M#WWY0UK!"P#_KI\ZKZ+J 6JT2@0;:*--/J2-5:E>W=5O#8= JE )=I+MQ1J;
M933>0-O1M5!60V@=10R\\?7HF^.MI$4X,/D19Y<\AJ(.GJ2FJ8@P& [W\6->
M0;2UTTG?[+=*8'LVV!@GN3XL*9EDV'5CJ?F6VE):Y;1/^Z/.1&IP8%VI9_O8
M!W?/PE7=,F\?_6?KP@NR:N(KC*<-"2$[CFR^F5M_YZ!VH.?=(I<;B<=BVUG;
MWKV?_I(;Y&'28.1<ZS;.I0W'?G(0+#S'=&R<? O=1GKJ^0CQ&L#!3TTO+4/H
M%ZM"5:<16RAZ)%TXJ#E_P]/>J$CSIDL!W.>B#FI3GTW+=5*A:#K"J;]\4\^V
MZ7=UG9Q(<Z_:H]NHTR%99%'KM+-\-W)">HB[ G:2.R!*<)$DU *+ "WRTM(K
M!&T& 18V[X3]77JBX@A>4BSH(,&U:#L_NV6NO77V=\-B%MH'56T$[OT6L6:I
MOWV,WK>U"%7C_=R!]Y%:O2##)AZT+-DYN%]^#CD 3T,UDR+R"^)@D(@WU2\&
M!HG.<(S\(#N!M)="*Y*<*I(:BC.2[B)>$+=>JGYT:<4Z\7Q+00E\AB^Q_,"*
M?$A+:LU?^[K.8YM%&_C@/W@6H<"\_=$7>LARGW+IVI;>AD_.G<>@NP]+3_3N
M=?,VZ<K\*=92.=W[RN@J9^>6LH<_GXU^?"[MJ4GI[L;6M>\)H6^M>Z(4MPT\
M;P6Y11LIO:3W_'5O:V>)4>BS,V"=A;L#K>B^AKL#[K^.__N#@;%JPU9@Y 8%
MFM(/D7RLP-+*;Q9Q*GQ4FWEE$8?E@2H*%JI)1LS(L,,B3N3 2C.>'J8BVUB$
M15PDV.B)%0A"[>KJC>7J\F4HR1*<IL"WT=\P[%/BB1@,@5"?M'QIY\!&8ZSD
MTF+EPBM"Z!8&-R FTAHML3_U&OR$"8NXVD7<8Z"ZFCK-FL*.:<(4>SK.3&X_
M)3R)=CV>Y?9J/W8/P&L&B-^GG^>:'KESXFW@D8AKF;Z!WM;6<?D<_ZQ-29M@
MKXM1N[U,'*_\\A+X/7V]2*+2[K+K88GCAO[1+B6G.^TY99GS@-;2"E/?A4!
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MJK<-T&*+B-HTJF]2*W<S3*U ]L#L$:$Z#6C*!W2SDNEDJ2[^.]H.OHN,F$"
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M@3G5?Y_Q)X@'P\#U]J+M#+G$*9E#T$6,(>JOF^$#ZSY[P -HO/<'G@9I-4*
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M^K*<NW[6*VR_I<F?]U/,KOVW-R&L@#/X-Q)9OJ+"MS5_&42>7MK6@"@["Y=
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M'<-^$2P_)]44+N* , RH,*%L/C9H-DJ$3Y,'"&A&CNS<(HXOA+#Q95\"OM*
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M0WK'91@)SD?I@+?PF]M._+5;+K%GAWG8II.>H7^<V?$VR;TL<\KSKH^R];'
M%X&&6&6[E;I[>>U_*V!1/#KPBO/Y=)H4U]J$,153<B_YP3CG,QY39C$+G*75
M7UPZT;65&( ]XS0.A7B)CC?76V\OWGA[VS"P"0BP"ID?.T5P')(9R_X!?CPQ
MW:[BZ21G<#:AJN3L@]&E7WSD?NG[QYX7LEO'**+Y-I;)+,,?T:\G!(J)HG@6
M5KI:&T$EWARA7HHKO%8SR_,?D6"NQQPVB\7)$@NR0/NKAG)??<7BZ>/IM!'R
MMR9[#Q:";&CY.4>*"V_]"W.J3K;=\!="ISJB9B_Z7I+..2?%):[L_[\/I/+)
MR)9&<@)=)JHR>", YB-.D/KHHE73H6M^FWM&;;R$9K].\T(J=K9_'.U1?/*N
MJ>T7T\DO[U!5)I;#RQO)7^H$!-3':P%3)3(M4ESZ(.B/OHC$:DIQ3CYCF]>R
MP_CP.G LD,]<*_Q*TOGSJ_:O!JM\:7D7]AD]/P/1$BNX&C+&<)Z=3G'0HZ,I
M/Q>[70K:F>+^Z(@49X)$"GUWO;3Q%IYL,!*,Z;_\,KO=+RY.?56V_TB5@DQ<
MS*-7B@Z'\+'<,Z5'"S4\\B:$+GGN><7Z3XK>?6'!;F3,69^/8Q@QG  LA=@C
M1H18*6[!%/@4W$9&ZMF>]S@N4IP;;3>:J(,E#W?-,2GN5?Q'#J2\LD?QO:^8
M](8,>\A+C_]+;3$7#:+)GV_RF<B.LU3D3\+_Z%;0.+(?'MY&1E2X@LY9#A@E
M,&C#C\R+@0Z2,3C8<9<=3 #K25:!U-"GSJ'':D\ -0O4Q"L7LH.3KP;X?9FM
M"!'LL\S<WOUZX=L_ZAFLLY53ACZ^!/Q[Q"I5G$7=89,Y[(;IXWZ-Y%:(N?'T
MQ<<5+EJ*<8+SRW$$_,%GWN:&1PMSSI3V%MJE[K7+-_8H[=A1XJ*<LF7M@W;#
M(N:B%/=;J5O'1<LU9Z"(4D$UK4J%_][%1"TQ)EBPTRIIB:14&;0X<\RMU+LN
M*#W+L2[(T;UTKV-X1L;Y_R9.+?V=Y\V0"C&)<<>&B*I@^?H1_R=O_?_S2$-D
MO>;)U6#Q[B4OSRNDDL@0(K(]=%0&>3(W6Y*CL<<!.B&\EKZU?D3Y9G6<I]L!
M]"!668^L'!%U%RNT)KY;,+Y=!]RS3"9_/ 992I*7>]#<JF 8SY[%W^OVR0Y3
M(J06LS[!IA#?Y.)R:Y-0[M!NVEEOC:Z*A_-:+D_OE35ZY!^C9(]>M:8/?TSE
M)*!_:(@N<ZW2<$S%R;UL?$6(CCZM/?V<U:OB,V,ZE^7O0":K?)3*&XWKSCH,
M3H@80R4&1!OV)S)8Q%"7XMY42W%9;&Q>7T:9_SFT?"MM@1-27*F-QLH1C^L
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MH%+E79J_D))$YJ^%KRG&Y19VW8>OMKF>"&A\.JVR[!]CT%_)&>\_\FEPG4D
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M]8U=[)G&%,USV6KIY6FM9XP$%Q=)-78I)5F.L0'N)=[E)WSEFU<9+Q3[Q@
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MM3Z!FBGMJ=;+>&S< /S9"?,%!'N0U:)H+AB^ _4UD^.VC=1;E$.,N,JG+"W
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MS& 1[BIA&:;G75NEN&Y'_3<>KK: +[[YKQL1Y";9B,XS67X!NHB^;O.3I1?
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MKB?P[_M8B]HFO$6[J#K\R0IB"+8&#G\3&\.%WS.4"W=P98F\D6@\G$/;) C
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MXLM,[E'7E=,N_%5>%Z^ RJO>,\K'!D9W:2G*)1/&W2*WY:B+-[0.O%+[#Q^
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M!+&B:0/&@$?P%>8F, G=R'ICK80M5;CNAU?N-RV*,=>0X,HM3_%UC0D+H/)
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MK:=SN/DL3A;Y1M>:ML*H'2-*-/H'@(QXQ),;W"&?RYXH0I4H0I$X@MT=#QB
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MS5TW;$/?/N@J5+IXH:C R"(T5YKYN++FD#<E]Z!#)C',==TQFO\EB=>##R_
MV0RF4J9%L8E96W5F0>N7?1"*#Z5:S"9"U?EB,>\Z^W%? S..4>V'<J-@/6W.
M+JHJ_ 8:;.1O_!%.6[+E4S3<[1A-TRLH54(Y)I6F2MG+&=[=B3>&\X<'9AN&
M"5!E)B.!M!;Y+G3@:*_41T1/8.FQOB1(N!!1JL67L&!%$;L_H1$'$AE86ON
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MU!A&:?]YOTW7_6*_ZZ*18?CA'9KX)^X'!OWNAYA<$HY'V^5L>W&BPC)R>"K
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M]^%,F\8\OV8>5"M62;@A51%&0L34&CIF;''J657![A?02A'Y&M6<5I?97OQ
MSV9&%U'V05]%088RY'/,&X35B!K""]3M!H*G!Q2\X,(B?^E..+T )HH(UR,9
ML9X3=KRXN3P_%'YW6O.5@_%6<+.(/& 1D&8DK(U'E(/MMM4*]<*.U=3 :<S
MXU0W^#A(W <![-N=%YA*3PJ3TVRV^YC:/GSOJZS@6FB7<9+JN/I53IZUB7>9
MN_AV=?=IXKHO!J0W?Q85.A4:V:F>USSCM4K+*+G)NWA/CW>PCZ=GZ$79D*W,
MU^.SIT?NW8@O<@QLWI>,_X[V.QH7/ #8D"_5F&AR^S;G,P,,<NG&FU&RA2,W
MJ0>"!'J7%R3ZL#E(%_:,_,H6;GP!2JY=@)1?TPSA%"CZ!SA;&,U>S[W'3(AD
MWL!C>S^"/[,,[AYF@<!X[53/D@*%U,  #V(UD;;U.0LWVFN6OD/:\[7ABD*I
M5PWL=J^?*"(F,JKPF2'07E'QS6I@37.E%FB4NLSH25CI$9"7*CU:##-\>^<>
M(384OF</L_Z29(A,A(P^D::24,=^+BM$,_SU/;3F'".ZO4*9U$M6P?Z9J47A
M.W=+S05#@"BAA:07C*LJGC*#<$WKU:18$)= W5A(H3M"\??!RA:QY&27O2-9
M*Q510.UB0D!."V=IPPB04*=53[/NE]U'(^/CX76R^X#@=CX65A0PDO&V4/'4
MTM(^ZE[89&DOU:.CFAYK%]E2(,9J4(K]P+[K0+">YQ\<#W"JCZ/;AI.D@1\9
M:?7F(-L)=JKC-NF&>XD)G%&J@X"^ HYO]4E_O?JD1_E]3N9C*.-[V/3VXM!!
M_I.&GILV [UER;GECUJ.:<4%]M9=K_"X<>]%WL9F^S.NH5>:S*HG?BII.)+Z
M(._P83W%QCQ[>S^;O?&F/KDE7B]3)QHOAUZX]84I(B<0:A*DFMJ(HC)XEB]<
M2]AD?Y[PX_2 'XIW)IDB9GR^6G?]<2C,%T+B(/IKDA)M&U47GB<+=?6<],[W
MXOJCW&'&J24;BO9KFCZ8W=2*6CW5$LI.I)XN@F.%7(Z*1HL./J^/UH.K87/)
M_0"BE V1$26_(NH6V0.6 AS-]5W+6,O:A'3FJ[Z";8JH^Y,(/P.KI&M[JNDI
M^EK/X4PA?1TL%M ;Y9B-\,X120*4(#4M(R</G+\+81N!*H SG>B'@C-[1VA!
MR&\FKY%C#K/!P]/]8C1G70\$&O;4O J2)'59D>-9V[O2Q=I3 4M^H?H;>JC'
M_Q_VWCR@B6W+%XXC @(R3T)44&9Q !E-CGH  0$!&00A1Q$1$","$B6D5$!F
M<A2$(PA1 9$Q*I,R10B!HZC(+*"$)"JS5%1"29+**^[K=U]_W9[;_=WN^U[W
M]YT_"A1"5>VUUU[K]UM[[;6XNZ3T'1TE4Y_,GS6L.4C\:6A,%]29_8H04!8U
MSOHHJSL^U[.<U>S"@"4&3X&.T*<9+\QV+HYM=AFSBM2'+ TOI@;I'0"Z\6G2
MA)FV(7@U),5M9'D)Y,7H>UK4H#"0ZL;U2J\1H<0$Q#Y:D*\N,;J"T'FLZ8T@
MG&\J.,"]D,/%>D+U]Z';DPWXN5ML1+"(P=!H0K.HPUW>T/&BB02&6[82J3=!
MA77G[I5[TPV_IA.Z=V8$76OMOWK#-5W_VYB6NL^>V^<4R@XG;MMV7\W%H49G
M[D&'8M#<A*)/B7Y\\\V#X]EBBBEI(V%?;<^JA(0]CPVIU.O.C0\M7JP7R-+'
M:;,TOOR4O^X0#:&-(P#/@XL5*#AR.MOS[9[!EGY>O 10.8-D 4DCA'IL1T_D
M+>PIXPV$$D\HDZUAUT%3;W+D=O2Y<G4Z'><EWKZ=IFV +68N15^)BK5C-Q"U
MH2A.I<N2-?7+)Z[2=7 .>]+):EP1@>E*[^'A53PV1&'EH:6#QZ2&Y@2.Q8+5
M_0@6!^)I8K\(;PGLQ[.>/AIL<N<&,8#:"WG;\A%#GD62Y )I F6VS#JBUQMV
M)FOP+M>(:,5U%-J&DLWHCE*I.7L=%O0';UZJ)56O<V^/J/#?DEEJ[GY6-CW*
MR>O^G2P%_:TNN3?B)ZK\_+S:^L(3S/=ON'/GP0OW$I5NJ?W41^=SW:,>.!26
M''WQ)<(KORSB#K5-9B-A%2S)Q:83CV.O8,Q(+Y7\Q?(8F$TYK767"C)9)?UA
MUGK;*B_ &G7]:B[Q7N=-9]7V5:?,%34\C; \Z,\^M<U6R+SW]-R3DH2(D&M*
M-$N'MV6R585!,:V.+'RY;Z5T2K]BE,+T4/&+T6:UQ_??SW%](RM+NI\*GL)M
MEW!S-@CC;0V!-WG#;TE:8% *;%XR6TE:&GPTKFLX)S#;GJK-E%:G/QQE!-R!
MSKX[MN_^Q?#W-WOO!>S86GSK\<12&O49<ZT(]:*-J03,=D<RA=I0,*[%8_2V
MRXA'ZY$/\19?WFU\JM=YXS9>%>.]+UBE*OE,QID&ZRSNAJ;BKO1VN]SSYV]7
M;JTH6LBB>"X>1U#=KY=^E$.WEE1QL'=A2W%6.@:\9M\[T)]Z<9U!Q*:=HP^M
M*SY+[ _76ED6DIB@2FD;4P^ZJ'WAC<F%B]N:4]UOOIT:9!3X.: >ALCMU&Z>
MU7_D]VAWQ\J#:W #5RS]BQ2/)O?-HXY<V9Z?7/\KJJY75H,NW_;L@W:G[".)
MC@<$UZ/61JR:R!MF?JOLO.PK3O1MM?6S?+O+L>0G'RF,S:;$QPFY!K9KUST_
MV/H_]UN-:^J'E\ZV1 NDEG3O%1W_HY3 8]'M+BI 6Q,$<*AH$:K-B(/>B'R3
M&I^7A^CP!FKB);1 &P%5QQ%&_SHYMA)H,QK'20G+NF Y&14H;A8WC%'IP8P&
M"\LKW[]]&UO&G-,,N6#B85.L^]2N0-_^A5GXIY1+G;="U2NWUWHUR#<ZZ;P8
M";;R?SUBM5>COM[]2XH+I%^?L_$&0*\'QLNICU1Y=GS-S]=YI6&/$/2R[^FH
MBL?O71MVX^X4R$.=K$K\..X:[31:+7A)A'I&$PMABM?@TTB&O2U[1[R)N[@N
MK4PI'(09[6CX3.'>Z_0<V-H+:\X@1"?RZ=G*%BV?$)_^7"!^04/+^]K7(S$Q
MXMN[*X:^+#=L'H<2^"?AWI':Q=GC()IG)BP1' #C6$&IUO*<[HT"]QZ,&A'7
M#&([:9K[QKO0JM#N-I)ZO[5XT0Q&$7DJ+3&7G!J9[MN>0]*NYFI\8];(7/WV
MW80F17#CCY/RJP0_?7OX).1HAKY":8>YY8[X,K:^0_D#CH-4A,/M4^QICQR3
MX-YB=,KYU,P$4XO.C.:0WRSE2UV[Y%U?["A>UW>XZ4-^H8[Z _J<<U&+"N-+
MJ7V'')3(4< I8,>;EG=6Y4/!T] 4 B)E$G@MXJ!1?5H5P-H,A86!=%YL;& 4
M.D6$4J8X<'^%KMPEQ'#F.YLO&2L,$U5[BZ"H>U!CQY@"B'TFQ++GZ7CI8&2B
M,=M#QR3@$:(1"[^>H$[7W BZ7"5:W(&PK04R;R+)D@2[-HQ2KPDB5RB@;4P%
MA"GXHDG,1O!37-'H2+#/MKA[P9[9N:>N%P5G9S>0\DI&1H>/^M+#UH=3OY(1
MC/(%2@7QR_6-2/B5D!@LSD FP(=+;F>JM=RL$$1 G'*8<7BJ0!]ZQ&[>)?GD
M&\1YB$M1*P6CZ=BUZ2Z>?; 2T>C1H*G3[E8?_Y+RZ4L%5+8(E:QI#)&YZ$YL
MO::,\#XY%<'^W1M(?3/\O7#?F&J86!M.B>B)#<*K$/6<)'F%0S)MZ2X=:K^
MW8FP_'.V:B&-BV^O9LG4"[;U:G,U'A/HA[AV<?-J\X?\3E>6OWQ_:6#2[JVE
MPF9G\V-K-5[??J?;%]QR<;_S]EJ?VD"?IF]NI:Y%[T[\]E _2V\@Y'&E3[$+
M/K6R2]?68ZNB0N'KS".GVS1?IV0_ND_=[K7=0_ 4:"6UF(W!?92ZH5D.?[7
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M"I DA.5_N#[Z4\_PAUR>D;-70(FOTL4HW96M#PZVWUA\6,:XT-ZM(KY)$1<
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M%^H&[6:D%A[; :7<#-R?+S%@P'B]JU#"_:9W0UA9RA&.LLEXG[N3OY')W(E
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M/5]/D&'P #"%:,C-$1A0D\=T^"Z)"^L EB84@2 X>5H"$[P*??5A"O-8,JI
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M1;XO(+?>QP]&)O4NJ1\+_8)!,,O7K;@J+&B#'B[A94 >_! &FYJ"1F'V$,W
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M=0,XW=\N?R9+W=2ZZY<T[#:KGM)GW  $ A]6*JC<0N!:9AUM>W?]:_VDM;\
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MBA+6-Q,;?93[QZ5IGVNN)DQ"N,C#],V1F?MY[N$:(][/.TQ\RX)#B)6^*][
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M*E0\0GY6ZZ*4[VJA^C[H%4V+)YN6_>6P Z'H8U(\\+P[Y)I?>N1'Z\/.?/M
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M/(C>.QM\ZE!Q0^3-@L*;SS!^@=UJ'W_<<R[_;Q!^>%Y_^/H3[L/%C'MA15S
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M3<6GI<I=^LWU/,UTK[LE+HL3+;Y,M"Z=_7 +UN2[.LPSH.GB+D$_?G:]^]3
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M-R:67A.<)G2?)O:S\LX*79X9LU]9QLH@F;'YNA8@O !W%@SE9XV@Y-C30BV
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M^2YD/AHVSP\"OS-B#F'^DG(#=N7& /0>JYE%!AH>::O6P]J+#96D/ER(YO
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M7\)H]KIT%![339'^$'E/K')OD4,B4G?P2.E3-&40F4%5CKTL5EZ>0X#!^>'
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M6Z;6T?_2;C2F"WD2T.-A3:'JG'2H(*TPH]8&PO3,K 1M1S:_^FD60539<::
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MGPHS.XX5QJ4JN>1HDS.ZL ?W"V^,!-JL3Z]S&N"<YP0O:'>=B1/%[]B 9PM
M]I8;B$K2[3_8;@J("N(@1!)7O31$#I?$-68/J FA-6OP0[U;[J&\^P%%RS(K
M[#5S%K/%:+,Y!PALQVQ]D@*CI4GYX*"O]=E_(A1L71X/QP<[0GBW\C%'2/*3
M5:/<HTP5V6[LQ_QKF9G!YN/'A"PVJG=^?X,O5F?^FW\^&VBX7B7]I5_B?D_7
M8+R;S\HH\WWFH_!'66H;06.QJ1GVR1.36&B1I_!DAZ]GW^\)[)PG 4[@XIY
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ME @FH%\@J+\NU18%L7/A][Y V^Q4,]44C J>,KB@\;"[/"1YJ%9GZN#4[TQ
MCV8V&>5R%/''DXFYF;.]3^)6XN!4#'^3](BVM0?1I2Y19BJ0?JS,K-J0=!'
M)9SX#I?-%3F3KV&^G2>^F=H,U>:A' 15T\-6:(71VK RX)^DF@M?75$XWS+3
M_L?NV>7F*4L?QE[&9Y4B*V8;.O#4%N[M\IY^@G-156,!7;,B'-]X6'BQUC[D
MS*+^R,-TA8-92WYM.?6W/VJ@NH<;DDR_WU8U5J&A/)YF(F*925>O^N!H<S-B
M]8.;[J^[XH."GD$9(J>7<74Q%3_;7EW"^_'_5[6V(0I(^'C:G3,P'Q=FXBQG
M&BD0[-EY_>/H_HP:4F3T/292@"+)"U?XC2R"8S%_;O^2JUVUQJN? 1L=JL'K
M6@_;3#M-\:D:&:54?1^#]61G/L:/?[&SZ/(<_F\0IWH>?Z\^8 QO7*FG299O
MU3F@5=AE[)V7>-LTJ,W(^U;D!Z?9RZY'JVMXGC@J]S%7O-^1[[P:GM@ 75AW
M84!4\-E J,ZT^#@?D;.@-[4Q:B#"8'O&4:=1EH)M6)&>_C,181LFE0&H94AK
M'PF^BG)K@**&0JTFO]E_6_/K0\BC4N^+':&;F!R))EDBYP@:G(.P26 +B_IP
M,3^5F1?[L[PF"C1&%#E\%QMG4)1B&(9/@5V#14F@^1#/O)$O\NN&BF(PUVP.
MYX?B8B2&68LG,LU#+K_;J%M[7ZL.SBA%0!=GC/^.\MM9TF0<D'G1-^S6AQNO
MED\DW+I;=G;4$D*=BM$/R)"+V.BP;1<>)VXF98-/* ,4.(2U;+L513BN95^J
MEI-DMVHN9_:/5=6'RO2^<[G!<P'FN$KOX3 '+Q_>5R-^.K"^HO0<0=A:I/7C
MYI'2? -2^/"UM$21!0$.90!+N/^"6!8E9ZZA!;PA][(=;4B(@M;B@!$OR.>N
MV/+I:X8^WLD-X.295@C42O@A;N? 9R&Q#"0X_?R!_WP,^E> PYI/W"_V^3DW
M(Y$]SH<78#K]V/!24J=M/P5!2(9R >$@3D%L(D#,MMLUC!,M_/TAD: ]EV>'
M"DF_#QUTA6A6^+/X$R(V8G\*2?%3N9;D6E,T PZBK[4N2]1 F5Q49CR/^I&\
M&0O^V[I11[*  7K%1L!*,$06+I'B2//>@EO<7U"H&1#?OSB(4._&S@6N#&[#
M]OZ1:>LT8].$<@-"20BHE#MP9@&>Z5D/X=IJ<"RB:A*A%K&ULY^F8/F$\VW&
M[A^[N!W5%^QPID.\(ZMDS*N'3T/4![I ^WB;?8M[<58C22F OZG>87JCZ;F'
ME<9007\9ZF*2M8[ZQP4+J*GBPP_<K[PG&85)59GF5H)]%2O!)UD_?*UL6YRS
M0:57^I7A1RY&Z-"L7F"M:R[JZMCHZ!I>Z#Q]JC[PX<CB'H]+DMO,"[12S&,:
MFUO([$J[AHDC93$0$+:18#Y&E!D%OGL"0W_2$^L^U9I.BU-EV&MN0P]CF,K?
M2+K0(O\[6X136')P9I$<D&3;,#J\)>YJ>Y%0;K[FPF?NF=<2+JX IW!;8$J5
MF1E:D$TL.@L9PPNL".:X_9^B!*8XA?;4>8K<//XG]M>B;1CDXMWGIZ??U0NL
MZAG'6T1[K3R>T3J3MO; 2;\7<EZEB/Y#<-NZ1] 6<I3%9[=J4$DBF]@%%:@B
MF9>IWK^ (BF]?  Q60 $?Z%G1AFJC@$-_F0@.%O7T=V"K<3^/=8BW2@/R3B0
MT%B2VKWS0?2_W<_>D #W;5C>-JP[D2+&@$PLR"Q"*XLS@0JR6).?N5.@EOLL
M>)STB+X#5%@4(+/:4Y&RV <QZKZ2 \#A;@%<=UEO%XC,$GOR2G!G0)FBP6Z!
M&T7C.#]Q;XR6\T?E_@_V9+5(/$J:K[)YS8B05Q;=B[=X*XL!:,^J,.-_2ESW
M?^(GO7GE<[%>\&FJ3L<#5S :Y7IK:::?95&W9[!Q&8\*C?N31V#JLCQ?X;^K
M/<2C?'>*2.K.O_V3W+K[,-TD^4*+X#)]-T*^:F*D!1/AIOOG2#A.Z52-Z47
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MM ;:!I[G-M3SH_[M#M6 7]^\ ?8,TN8PF_D@98CS"[[3#QI]$$BPF$K9ANE
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M2.';L&RIJC!^$UN/$=3;X] FT% ] 3493T]NC*NNK5(HR@36!;BBR-Y'Y/^
MB+R$NBEU+R"RXM=D;$9RM&D4LZ2U-CW^<SSI> N8+)$KVX8='@%PDG](+.;/
M^Q+4M$0IPOY*NL!9-L*>H5".,1\4+D\,A)DT?)IIU%$POE<\&1SD>BFG*\Z_
M#JN>?''H(, IL2+4J?OMJ(KXH6>BDC5X-L:7-9---@M,<'5QM;W2&_?WST[)
MWILB+_'QK2Y,.)R,Z/(;T$7TS<%+Z#@A90[!"BROX.EB@L;%9KO(_;@Y-\%B
M'U?!+3Q"@%2$&GT+/W]GH7>,K7<_-;<9J4Q(G:]Q_=@O;XNMGCG3*5I@WL)
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MY%6&=Y/E\YCY,X]_W.;WB-4RV%2--?2!)80LY@*ND*1$/"0V!;E]HR:#1#B
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M]C.D6+.XDULWQ#X @]7'A0>=I9R3:DX3U+*9/OE98AI E?^$4VP?RMMH8>Z
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M-MG10.5 ?6.S7,6JX'ROM@\_<LUY:XCR BCQ:^\JD<;5I=B#1!X))C# %S3
M%BZKI#C+^/+BWB#;O+BPAOB*7 ]_[\%-X,;18 Y<^95*D&Q%CPG&!.'-WW&-
MLI'E?U918Q=DL==!C3Z7%M/>:2YM_EHW@7GPXO0R]]<;5 >3\1H[_&6C_O3!
M]ARQH3\#$X /7S X5/7SP=7\0D*G9.\];B9N2#&E [\9+EI%2T_*^+E[!N+E
MLA#A<DSVOG%/V<(>,P'./CONP _&F-OR]35$^F-IJ<R (B\,:?%B?)I<SR]+
MP^9EFYE&X\F,P"89%[)I FA?O^HLOFF27\H=0)!+>XX#=L/>XOP%J8E,1[&K
M7X/LQD>/7D-)MJ-'EW%_$D3,7([P1:G^^S7$*<X8;OEOL+(C-)ZG3_KJL.H)
M<Y;/LT%4!H46#G@OKB/7 .^*5[U#X.G01FAC"8#7[10CD=UBXE@Y3]\Y]>TX
M/K4)O?E7AQ!<UE(V6FEN^"=;A:@'$B6HQ*-P9BW9O+-40YK%2HR'S+NQ9O!S
M(%P8*\@*/G>?DT7"J,7'U<#X([#U$W)L!W8'%,7[;,XCJCOB]&!Q3U086,3U
MB>@X"@=?^=!(RBA5::-E[ Z]ZDPWC.*1=TR-[?;:^5_HX0LXA:7Q>Y(&I13N
MJ4NP<.[46;'=<<D%_4*E?7O2U;5B(R+I%=DU04>[WC6=':Q$FCA!N)LN8?6:
MEB)UTS3,<+UWT=2/IWRKMW.B[QCCW4],U#RT;W2>W.52+(H5Q9Y\GA!9*"PG
MZM'+#U7$M%XCGTWR7]G\B*-*1:TA.J^PU\<.$(,H(?!!R!+XW/?O'5%R4D<P
M_SI=8L-<#[]14]D+#E>6PWYK"-YXX"W C?,;O,IW;J-GE8&/2ZW?6U'5UA!G
MR('#8A[:P!&M 3,]P;2+UVPE*+=@FKID-T24P_SI/8X/%?CCZ54DXR9 D.=/
MSO]SZ#P6#?-]P:B>*3B\+A:]@67PA')PB*T]CW)N4Y,5_L1N:39VS#X,YN<D
MD.@_]1^/K$15(A4QAZN(N[K6$-7'9TY=>M-Z7WN&P"P"YD_%AN]:0X3P_-]$
MB^SN5I2^T8W2GSV=O6OY[MS1 IN$X")<,8&/4[8X^4PO16RH?=@LPE>[ZAA7
M^/W<L6>-49F%ZD[Q62[GV$V4FW>Z]U]V?W(5;W/S@5G)B=NQ*\J/6*CE4])R
M+)HZ3/M-HK#Z!\66SAL.VPQ]K6]\/C/I\,& .VD#\C,DIJ+SL1VR/2 IL[&[
ME3/ ::%HBQEJY/RN:T_*@+X(7ICZ,-,QNHFQ'J[IIFH,.N(UYABYD]IRJEF%
M?_O.I6U.H!E1^XVW@Q<J_H+17<86H*$.%I<=*G<[3(E'N>3(8 (LB1#7$3M*
MD>_E<A_2D5BJ F(9(O>8UY@$T:RU;,?L^&01.+=Z 'S7?HGC]K^+>.TX'TS"
M";H9[\RN7CNRH4[X0G7X;*\BT:ZBF,!-ND;.&JSV+UNX1'E3;ZXC7CJLC;&J
MR*VC^S^>2_;:+ <JQ8N5RU$K7(;PVVC4\7-7'';6'274I//#O\$GIS,+5 /U
M<\]AG@R'IQP/MJFNRR_=]A"S >/CW4W;>YD@_)G-$3:UR5&/J1L$1XC-%[PA
M7*=_R(P]_(H7IM,"];V@$(E*8=%LNQ;PR7.A@([68*F #0>AG7 EWUBKJ.N*
M/TSG3ZY_OUZ';37XE>+Q=*Y4DZ8ZQXF0#0E /V(:HX&V,+:*I7XLU0=;,F2V
M<,1R)43B,E0DFBT-(?WTX94*)B\_K=0.!AZ3BWJLQ4;ZMCIDRT,X58R"R/+O
MQ@FF0@QV)U[G$YS8-2Z@-ZHD24EAX,@%'+?4H3>^-E].;E:S4Q3OX'3TUC3,
ME9#,SC,%<=JSX66&-N?3>X;?1/4&-^TXM1UZGHX:WW>\ZFC.W3RK2IYL8[]]
MZ>_O7GQ:=GJ&L4RORQ'I#O=^/Z<3?A<X&[Y37$%$W1$_TSTWZ3B=5A9<;\17
ML*VK]L]#3?C:6/Z(R9*@X(@UQ(;GD%?/@;H?^'3!LU];=&I(#@PL(3-Q8 '9
MC-\-Q6[%6 !(G6@J&NS/EVC@4C%*(J86N:@+:](PM'!Z9 FI Z.!!MB?A[IV
M)?>)I]@'&?0!0WPJG5AUED_Y/ZAZE%/2#"O:!5HFE\M8S]9G-T")OD-TB9D_
MY<\!JSJ9/B41&NGHVQRM/UD,A"KX08F9V*TQLBT?^>DL%-"O/ EG^T.)68W]
M]%*=)NA"NUDQMJ'O 8C6 267^"7_#%ULBL_J118)"TTV9+Z=&V&8/R\C[.PZ
M%3MU_%!K@=\#\"YT[S &NCNW[XEV8.K=TD_N(J\-<0'G$@Q3,)7WK%J4EA;.
MF)[\;K4[U%OUKGO=@:E[;XW1UDPKR_OIKH5H5&#S;]4/#<^[:D</IE)7'W$V
M2GYU47D^+#.3[!N4J(!)R[;0S[Q%!O<9>82+U2)F-(\0]<S!R,(282].+W;2
M#HX"%SO0FHU,M0DR3H3,/@4&3)4!^1GHS1)K# &K.?0$VL]X"K.1:M&E:XC5
M7YT\@K &E'#X*56)$@8GU/[:9%2C":<W)U,":\-^ATQ;,C"6--'YW3X*GHT@
M*G.IW<,#W-\D9&2M+.;:4(* \YJ=]QEI-HW>?1Y<_0NIF L<#58LT$^_M/*2
MF8:AW?[2RIJP ^;N@E>371,:M.EO[1]0':S+_=0?U15'WE.E6MKWSG0IO6D_
M<69+&L:5^'7+8_)_I)Q)_3/_/='<T1'GHWR/Q=6T,@X-KB<^"+=G]6HKE_;.
MC5VXFM,[<_IEVM4AZ6?]XU9=K/E!7RWM@V9%\];:< .3UAGF1%LG&RY<0[P8
MX3'&""'O;2:6'X'3"]/)(K2:Y"38GYM0ASL 5XFD#ESB;U3+/L ;KS)[_X\/
MF*N/X'D Q6/HP&%$HTX1*9V]#FIN'CE"SNZ95+G3J;\XM]A#RESQZD2GK"&T
MV0YPBA>$RKB,3"6JL1(@7,A[S-;82B*YX<1'C *0[-]]K3 ?2+*."'C?6-*O
M$7,E^/!PL&E]5=W,2D)/A7LCH:V><>[;9^[WJY6J42]WNUGU-ABR+\<5#Q,+
MS[STV1GP;+3I7N1_;Z^^8 7JU*LW;\L-)O=%>!>6WWX0Z1N7>^"0Y?RW"Q9_
M.ZQ<[3M18Y>^C8$\\U^>QT/7NW$NSD5G7A),^$ -W\!+#1NL4:54>]@$8QKC
M%W"64(.?=#?+DKR37J<)RW<36YRSJ2YD2YGV:9QJ$^>FL1YL)_()TZ7^[IQ7
MY)<M-OK9/:^B:S^Y"8P>2"^R[7+W%!>GB>?B8@Y\/?\DVW.5E$'Y\]?#?Q)W
M8K8KH8LVQA1.9ZPAHDOZ\$$0CGZY/8D[N9/N.2#;%C.)!K\69?F)A1=*_B)'
MB,S:(0(WQ7. O6UR;G*[?E1:;4^!4(\2(6R5)('BL!=0>PLS%9S.>3XV&<<=
M/5$R/D7!^5UNX,!'WE1]^2_RN.^Q]E('UYJ\=)]#\35Z'\M1^>W7GE4=RF^L
M\HW+OY$)>=W8]6#/'2C,!)MK591A],*5:=-7D=_'<!0-*VS/^RUHTK3>RWGA
MQ6QP=EIBC)/%8-'_%_MVE!!;&!+M=S^7=TK_8GF#2!]IR07LKCE7]$*OD#%N
MS"4TP%7FJ39+O0)]>$+,2+&FK(L%8+8NW'.L-9V6HO&ILYY?]?EULFV6SFO'
M308'4/J-_5RV(WVSG!U>_!UGB2U4T+C_H:-Z=$\RR89[<EY<+=ZE^U04IF)7
M9K5;GS6#5\CD604<\BM+6Q[-]DOTYOV[@<EU8>^JX&F9<L>HKNE!]\34JGL]
MS:'W3MFU'F87JNSJC4P)>J*HO51[98OV#A%X+.9(99AN%E1)GZKF1#UE=AS
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MP/'FW&1PRM9,'G'V__6>TZ@"$:HO $F=G(T4;Q+0/W:[5^R9+3D,_LQ=*JZ
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M=$7"]2>:\U"KGN)O$KZ*G,4NG-SUK MO1XY)B,CL&NH:KMI7TFUZ0ZYHJJ"
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M=6.,;:&IFK\D6/8'20"0[+9\^$YGV_)#;#$@0,YCG:"'^=F2\_%QYY,>PV@
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MM;C#AR]:0#Q)4QXN/)0&G)Z2XR%SX!LQ:VP9T)0&!XLQ.I1]?;:$$6Q+@(J
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M%9B]JC2E#B^B5+C;D 38IMS53S7TGQQ3K87*[U'[C7'  J]U5J6=39X245<
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MRL(]Q'VOT^JI=T"B.%80*5FX334F%QT#L(+WL:2^?"%&@W)1@86&CD.A5:Z
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M8Q&EB/6K1%B'MHB2R>1!BZA:K+Q\$86X</C\S'^[-N2X]A*SS4];#M80=;)
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M67U3\LOW2Q]\<7!.YZ6']\361R<1U^U]I&306K2H*R&LU$\TKD>) -V'LBI
MS+1(S$"-47;UQ,_\E6S&9P+7X80>/):,$8Y9@KZW@M?K<\T';+&KR($^P'A:
M?*F7=W[+<PIU#WB05P61 L&,(N"[L&Q5';!'J?H3+&IA AY8R)S>AFA5JU@H
MD%!?!.O(9$1^[/ +<0V;/W-P5GX-8*1:*S5@'V[^?EZ3O96,I DUR:^!00W
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M5@OZR512&I*C/8"AF0J%)^4LD/L^EY7%V269S40$,B_B%75S]/.\:D D5%H
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MSG*W*'NH:C2C=F2U7"@8*4_WLS$::!J=YNJ1OW6*]D)[[K<_@/3Z^)?U,V7
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M_:H'?.Q%<2J0GO?ZD21WC_(W3./W:.:]!,^8>$;Y-/C8G*A^$&#COO/O'XD
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MPTW):.>V>J9/'09[NY;WX$)_&64M_*GA!'S*?/KXW16HH-MZ'9%N:;(*V[?
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MY4HQHA<P97S<*-L&[RJKQWL<*P+0 @\J,XVMCEOC$AS^ACS^PFW7H"V@M&:
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M\:2X9RW/J'[>*6@%5C;Y=[EY'C.[F!?E[=5^H=/Z4=USYS9C9^O=8;KC-%+
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M+PW;6PEA.NX"U!8HY7T,WA7<TIO,U@.86:O!,,&&TA\KY+W0!/??LZWI!/B
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MJ*U2;^!!$?C^GW$*+(FHA"L.&D"^ES4H^& ML1F1A^(_Q&S>42,@8Y*"X*I
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MZP#?@::%E89-3O2#U E1\2^%G+&8ME^>*@BF-$MU)G)9OF T<]=XS^&8ZW+
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MGBO"YDAZ,?!Z5[SB4UU>U]EA2MQBGG.#-J$JY.V;S.WV>C<K<@6>[N/R:=_
M&=F'C.J9P'LU1(^10S6/QKD!9E2:KX5P3&777[G[=(PJ]$DEX5Q.&=[@ZG6B
MLY2SQ4M4?_*8L_K.HW\>->\JPX2?YGK&"VL&MEHJ/"-R64,=SQH;>+"LD98*
M?#  &EEJ%K]Y"6UIG3>BQ$W2GP%/CF*YZ4_@C(J?/IDPU^%RW2>)AB6N]"_R
MGQF02P,LU!1/A'%AG[-0,<U=/=I=0Z6=^ILA.*6,&E-G["#('L:;=C*4-'49
MJKNR8UZ+=@!TDKJF [+OX%,R^V6-S;%EEB!?N;*?C:QFIRHDYM1<.2'7!IV
M[C;+\7KA&/F'>[O+MHX0:^8C/IKC6[& FFX8FPYN"=[WSLA><'*WHZEMXION
MR-GG34]/[PU\,I,T%#[QD:SI]VK_@SOE+_Y^=^>ZE:]79VC]2)4'SF?'1&P@
M)_L.]WYP;-/5\,_S]I7G& 6,!,:$J](1-GH8#:QFQ"1HXUCH'KC+)CV!:*&R
MH:;(?BF!&GL8!K_3?,&'V;*#(I"0M9V\)HR<H. TCB!:^%O)?;@9RSTCB(Y\
M,\]P F[MX>FT]=?QG0#I'7Z#S7PV*%;FM:GO)V'">Y;_N&C.1Z&S?>IDHSJ-
M2(9R>_CF'1ZU$CA7RNJ:7]<;.EI'C(S3Z4FKBR7M>?,WU%('F<O)B)6DB9/6
MC/_N-+)^"-$\ \Z*6MON,?CC'EWDM A+N%3.SF_3%) SW? ]"5NFWT1CJ>?I
M ZJVH"U!M+ YQKB%9#[HD,0WA+_U>C&[([8.UC5)UE$!\DUQ\'#]?#G&N#/G
MK;)_>M/TUWRJ6YU\Z-+MKOZ'PV[U=V9?-Y6&V#V^5/K)+^:$L'+7/W:\UP_W
M=GFZ&WF5AM[9B-9_R+JUO7:PD$3MS]^O.GC$LV<X=N?,<.>_I:3H,PN]KXX]
MF!94(5PJ6QF[<C27RD8WY"L6)E@*+F(P]8S=3,D@F<Y:.L%75=94#]0DZAF0
M8>::UJ$)]LH_UE6A+P%CVBOW'OK>89J'/-]>.,[*I^_"?(!V E16U40#F^D.
M>#/X+)!9)-%&S>&0+HQ',;KJRJR@A72Z'1(&,H4X)AYLI1O#4S+F7-4#6B2,
MC='*S)?B8;\($Y"2QH_+3Y 1,("24>!,;;8>S1?C.</R?^L1/?4-65R)#\:*
MW_)EUM#NUM!S+_UPGU?S]JA_8TC+^"M%H+82?P;. >D4L%HLTM&43642,9\U
M6NK&;6'$13,V,&1[2:NP<;DL!<5$G:;21 W^UZC@P33[;,<PT,R7)U]^I$X[
MKL+[7.@II5G$Z@OZ.:&5ISL%2;R&_ZOZZ1)\SRT^L#LP+W978/KV<O+8:Y?+
M+K$<REB@G[>6V\FLX9,YC0\K<JZD#VNW_5X\9.="/9%W#_AE,7'J9B63HSD7
MN0OH)H][HUJ]&%AY#:Z44V$W1?60QT8I8$HFT19TE2VJ'V9#;*G)_"J&Z@>R
M+ %/#7$'1[,0 [!>*&3H\H@29!^TK)%/LK:(>\9;.T@WA'.[Z;H00V1/SAY?
MQY0N6% UNR<)()/5Q*KD2]^3-R/G( IB\ T5RRL7\@@=#E)"_J0UML0 SG#Z
MRF%.#&4-X@I*9,!;Q%Z*TR5S3KVCMLNF;M)M(K!UC6(FF"V=>@+^7+RN'"PZ
M_+0?&SMU#&1EHO\=84BS*:"W^LJ7T[RGZKMSN_$BL[O-U1&GX 1YJYBR/EII
M$#<Z>BWC R<SB;"!1NY/(J_[U)(8T:O)[#@HLP#<WQ!M'QX]5T&E'.__FN]*
M;FA6X__7.7M40%@_S<:A!O":+LI&XMK[?37OHR?7PU=EX=I=$7H#%VGN=3,D
MZ]'/SGTZ\$7A\?Y:FU&B1VWL.,IUJ+OC'QLZ6?5HIK7.97'QY3^U]'V;B_?<
MKU'L+;AE=S(C1WS,KL.VS9^S>#*4M].?X_?"I>9 D%]R]$#2=(!ZKKK6T3*P
MVJNFDBGDN+]MVQ_\WJYPRW1@\M2U0/][A^Y5]7MM\N.$5A>>VGD;/<B7ONU,
M.:(N(1VB#ZV</Q);)!Z%4U7NL^@&V 84KM B%X<P\M!.""<BCQF<4E<VX<;-
MNT@6T+&,R]6PE8AD"U]/EGO['//1_ %R0:OD!.UINB-4E#Z?+-&B&O2TC=RX
M 1;(/81\%AN\XIJ/P>]"^B0 >N0PSO=EA/:)%C!M"4\ N<ZXC32W-[P-M*U8
M5"=.4YX4B?"Y>V!6][?,&U%<Y$ _?3^5_1]PGI]/W#,^RG3ITXG]16+H;.$=
M  =3>G+53BN]-V^>IG=)FOJZP\,4"3WL7\U2<D@V<-K1-TD$79CM#8UVXU>S
M]4+A\UJU33[N(C= N+"%&O:?49K/N0>='"9?MG>XJ:;/^!T<Y@YR,P@N[2P=
MV%TP'L'ZTC>_TDM>/+!=S>3M1)\S0#)!@V8#KZJG71KJP,GZLMEZ+I0LO"Y-
M3Y[J+HMB$J]6TSR@==ER=E8;Q@#M$#+<&RGW2Y7CTW7 +^*(;8,TITBP1M['
M2E*%7\/C8GZC'82B?F@XN=N']O/36;^[EX-O=[]HWF^W?T.RT\9]@)%;8H;G
M4/>5UTP'^X%R:Y\F67 E]W9E=H5OALRW]@H<6&CD%9!\V3]3GV>6;JUU9._]
M?V,Y^ZJ#_>\E*2\7_(U,8K;1@-U%_*8E3)-@@J\K $FNF_W%C"^B;*%*I"UI
MX.@)^+='R.%AH@$#L@F!$U5'J(HN^I[A9,G:Z2*SUTPP40:KBTGZM'7#30X)
MAQL&$9L_J<L:PF\L8:JFYQ/0;.R:!-$+0/W-,1WZ!F-OQ=B/Q4H@H4V=NO($
MF=X;PFY(F8L"\<J+(RZ#<K(AC!.ZU7,4[R,L3L^V$24&="NX480WI.\*A3V"
M"@0\K<YVF%&)'($XV4U\ILU)L*=(OIFF>4XVP="KF^PTKF DRU$7[-H'5GI,
M\K931WOX>L1(E1OC E4LQ^?1@A08(9A= >N#,<L:$Y:.4 O_$5PA^M:JI!=!
MI%YO#+Z:%M\'HZHYL_#\NW^<FU*7D)\T->:84_^EMS*[4Z_*PVG 2$/27N>*
M(_E$CX;*(YNK Q_7D?682WN^VON5>WGY>Y6N-=HL+G3@<4.9PT%&7HWE1^K,
M;E6>&E 6VKW.]VH>S#!;2JX)J F.45?7??%\SQ\,7=8@L6 KCY72_Y^PV2M/
M'_URBHS]\1@.OE *##7%@9I*]-VV-1FK2JS_0^DPWWR)O)0(XJ6N M98D8R2
MR=-"=$$.L@W82-MV61[&W01'J1)%93O0U^QNU'Z4F""W!5IHX;5QZ-9VM!_R
MR':I(\<K:Z[<9<>KC'(F8D:4=__+V&.YLKOX'/H.W\CIP<&[;024-/Q:B0C_
M!)BO4#G01_$ZZ#K"KQ3E3W""]!RT),(ST5UPMLJ9&MZQK18)&>S 8.X99<TB
M+H=B"OQ<NBK)PNDXN)#E$A\GB  @W WD("@WI^C1]H\ZU/@Z5_HFIF]Q.EYA
M?NUVWH&J,U,Y@F&_CS%>?M1OR5&&"V;.LT'T#P><0]+5G78YW\>>/'W1]!^.
MM6E0X%Z].[7U]]&'TT<G0IMC>B;5HR\EH \##ES #.:-?8,^,2;T A<@TV0@
M^TKT<T4"?"1,U+M>781N=IV[NB.W/LK?6*A\D"OV41UL_K\)3.:. ,9LI@UJ
M,#0,P7^H0CRA'#)LPYW+E.AOU &_QO)!;!;%^7^!62S4\.L55.@'_Q^C>]^Z
MQH^L\7P@NO\ ? /+QU?O_7CA.;@-] 2&4A#]"71]B/1WG@XM'@_ZL\=*_"BY
MU\1B=3RZA05'XPT?YTH3:=MA(.:!Q6[:=_!+VM[R*?D16N!_<UESRQHF)4^6
MEMQ5^WQ6RS!VSX])@'<6S1U21< ,64HZCX1\U]\1)"/?+-.$F$*,W&P&IW)X
MVVCVX-(-VEI%.W[---T:+$N[CUA#*3>:)E+-4EUE_)M):L?^^4J*SMM/>T*I
MT=.ZIR7BY%H(CKU2M2%!+]3IZKLI_P<Q579/[ZX^Z>;'=#A5_=^\>>(QZQ?W
MJL5W_83=PKLG3PA#+@E?/X@>O+/GWR#K]0?XB5JAF=NO%!?N=TL._&E:D/^@
MRBOH[$SS0?$_$\H!=>=%*VPU*FC?JV\S(A/&#BHCX6Y5 C4>Q5,/!J@K,/88
M/)/*D.GP<^CFM$",7O*9+>,2)? KS:\<4];+&JN)\>>@$C^(?P-UI/;T!H&C
M(G(67PMQ MM%@&%SU5=O_M\A/;P=<*Z"FP^T<O*3XA.EG#SB(;F*=8MG#ZOE
ML^$>$:.(D9RK32U!-S!4.ZEI/I#K7#9W>C \-&Y2']*<M[H*,D[!876P_//"
M\6%&E'TIXT18%1)GDVD-?"I580[5=0B(9$VLZ2XSA23S>J"W)[32#DTVR]>*
MGMS5 @&W$+UZUTS'YFVU1_^,"RT22@QA_ZEN,]_?JGD5C^"SO:)_XG2IQ[Z(
M2(YLP?.*YPK J*6Q"]'&;!.(/F,T,K([*/*%=$GC1_;#&12 XQ7<-)X+LQL3
MJ%PH1(C:P.$0(0A\W:S@KHXCZ<%<!=^<ZKLD++/J!!G,BH[!#_T;+T_?#8B^
MRX[J;[;P%RR=WA>?)@CX<_K$HYG!JL+@*LWUE79_T%VULZHGMXU6N96-&]9<
MQ[WS/WDQ^H1?E>^BX? SN?UKSJ$?[:[<.K/>T]>G9__+3?;:FT+M[EAI^B:7
MV_+C#@0US1RP#?T#FIKSQ B ?%F#>0CMIH #>/ 5'^R3@,QN]5-,;V-QL'X!
ML>?"L0YL?4!6P6_DRSB,-_P6OBR&(3RRK'&>\?.R1C> #?- =N#!.H9\ /LP
M1+J Z-LHKZ@K@6C)+4DK)PW=BKZ1:--7T8=#,S/J8&]E37]'O,H-?2EIXM5
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M'_6]$%3K4UO8S%98AZ>+SRJ@'096]^5JP7N>>"JF!K+Z^W+-^'^N_?\>QQ\
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M^B?]_\B0":IK]8B3\_43R9IMRCASU4H\K3J !)9(7X0O:R0P[C,$/Y-<WM&
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M9,>!33H0I]FD!KIPZ /Z_8&,U?0Q?"M\ K>19QXA!JU4S\!4WMH1.&6KI1W
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M+M'U0(ION?OSNAGWW3<;1Z9+1MVYGYOD#78!UZ7.MY>U;F*R21N6M>+)A3B
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M$4J;1K!9C.RM((\[+QCV\O4ZRD?GV]_:_+,DML1IDC1Y< 8*\9 # S8Q5$5
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M)++NA$<FF-7<2DL^<R;YT)^@2!JQLFR6]%-DBNHU&@]S^J14EX"Y]:&++U[
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M'X&YZ?",\=)7;)N$;B!YG'R-YU2Z6_, 'ZED62)KGL%KYD9>-4._D*S2WUH
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M9G0P48#-ERWHM)!$T:5D0U@2F_4C;*7"#!0HKY=5P?R?"'8@^H#G5#0VHKX
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M61_[E9UCD<WDNH#[Z;ENV6D1(T&9G[8,T9[^O];&K+4%'V%7CEF6<LOIJ&7
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MP=6!OOZ%]L&9![[-OT@/WG=^Y%#P/G.=___S_ZG/DH6!_P-02P,$%     @
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M)(JCEU/.0.%--<W"OO40Q1?(-, ,V)\5DM9-J7^Z 67T-,TS.)MZ(D43O8?
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M=6O@0='\\@B^#F<S10GT:!NCQ%ZJAFV!:WB=%F+)-&XSU /@CP5$/('UMLV
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MS_:+K'GGY0Y3\LU/1W'H\,;<(LQ:ZKXQR/@8B"C?)%%>_ ^:51/BM<+S-=A
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MOUOVI6RQ=7&V9E:"WZI "<HPCS"P>J'DQ[<AS;M#!*DW.4F(F5MQMG!Z\A>
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M&M:BN9ZN^;%LN;*3%J*@]\G5C/@]8=S'2(SMW;D;X8E$)3%Z5H&R+W0ET&E
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MT<R@CQ>?Y-O!W]I/U#Q5!0ND@8CU.%FX%ZX*!>U^=WCF#!A]U.FJ9$RZHI%
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M(M'0@9]]3\GI")ZK$]04;P='V$2:I%>;<;"31.@C!DD(!I$%O+067PE]XU2
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M$ [QAT8;4XC4TJ,TF=UZCNH1+,]_^['XC* FDH!?'((<2^)C?%TYK?U3QL2
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MP>[;(RMWE%9E>+X0M%)@*QZB4S C'X/Z6:_)WS)CQ5PVU020Z/8Q;:0<=<;
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MM79,F0)()D1KB50P&C6X@9S$!E8E'6Z$W-"-1T$[Y+OUW8J(UN)O08[<?(H
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MA,2GZ-H53OMMEH1\O(Z]8;MI>M10<H7JCW<HG1S5]CU/C;9_XHMU?I1 *'C
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M*/YCX9T$Z$?"% !:2@E2 KQ)\%4#>87T*3!9V$<*S'UZN8N/DWE'IS9QX[1
MTU'_I>;53.RE-7OCZS4)9^7#&5X7*#ZCD^;I3_VW,'(U76KU"^LGB+GWJX[M
MX5H2K ?4NH^8F 2?^L8X*,^TU?6C_Y&[7'Z#LYOL;=E.8MANA+:#TV.#R5L&
MJB]7!^.T>> \SQ;;O;.)&%P\$C0XG!5G_J2&LN8U]3'/.B%-9"A1C<';D8N"
M]?4D6ZT_IA5/[U9@=K/T"6-#<ZF[@[H-9^8ETT)+/F[EE'57\D1]#]UVDFX
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M* %RDVQQY(#$F)#(CIX:(QI9HLS3WP-1A%C-(/5@V]T#.^']%=.CZP?AI5$
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MF2V$]1P<Y'DBDHBAJK8.7RIY !M!_F(5'%^G<)C(7Q_9I7'R7'8=GZD]1+9
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M+PK)76JN4^ZEV=UMSSW(/65N&;?=4N_ED3WOWLNS7U=]BFRN=,S#G&&Q.:Q
M>5_???J4BQT-15Q'.+QOD50FE$N4CT#&$J;X[?#TL&<2&J>UGW:M>$,=Z=BV
MWSETZ.O-_)$]?T1<M9DI;8@?O312\^+1EOF8IG,'/0QU+GC=0@-P1,5HRDFS
MK#)RU/[MCKM2[N6@,7GF;5:^,S?=]EH^=QM>">6;_B!2)_$1DEH%R=PJU5FF
M;!\VE;ZW%]&G8MM)&VW7DJ@.K5=8:36WUWZ@ZR=_/%E8GSWGUD@-F??Q>:$9
M=]$<R9<VT-3?="QT>7OQO'C[2K^\L1*-*U&?[SGRI+9HI:/I"[/^C[GO7-F.
M51E%YK9>G28Z89><MQ5F>#F;%[&.Y=EI>"[/^R<(I?\MX__$:R.)8'B+\">6
M_N(Y^ANLI:<E*\!4[@9D#>P,N6"31P[;;B*M/B+1;O$6Q*GS37Y/<SMD_;K;
MYX3._U.W)_7?Z_8D)X=EI+AZ[ZONG>EM *C9KL=,?,UZ?7N[6<^49CI0U\ ,
M$ *X0WO$R,H028IT/?2531^4<I3E1=64!(%2#2EN&->.97!UJN>TITE:M)/Z
M92(6ID4D4(;8(FRK,DN#*)Y;3>50XA9(_+EE4(>0&Q/)U:(&=#045;"CBL^9
M<4R!%AON>=4AKG3Q1?,I^,@K^IHIKF[39=D&.$KBU4&Y05C:I"Q1;N?@)=1!
M&D72*%3B,QFH@-#*H!1 O<2>)LO%]JNKOPA6TORJ(:N"*40?[&":RP-%MYE"
M8F*V?K'$6'0!:31BDV2^[04E3BK'](>;*M<_J.^[%_PRHJS[7D!I1,GS]=G2
MY(M!;L2<!W:X_6?F8^*F7_H]3R]@!*U-+3FXM\#5Y(.\L.^#ZWSVD0<UG9<M
M@)VVN^3WFP+02>)!<E0'64J#("7Q!@7&ORL&JU,-) NJN<D< A3\M ZKW$0I
MAPR]0?Z" L.;]0-41V!G</8C^SYL*-E6D$\-%K[(8D;N=Q!%=G6<_$C_@68%
M=O'0Z-\A^@E;C%(.=^X-@>Z7J^IC'3,^LAT6Y2@S&,Z03O8W+;9Q2&"I_RY)
MB!USUA8&QMIJ#%,#V[$Z32Z71;HCSL%\Z4(GC._'G?_R#*_TNV5:Q/XU1"UH
M\&G#;!9?L)*ZE)>[2T[*KQ]/BRU)&.<=.-YJ3W\>5[PCV6/;.('L[8P+E@UJ
M&UULWUN\HJ?;S[Z;=^1@G?EEZR=)#L,>+BY!:BX,@WW%YZ*3'?<TW0NT=//Z
M!=@DJ!Y$51()VMHUNUV!^?Z+_'>:!]C)!]8#I]E#O6.S?,%Z0X@"+LA\*H'A
M+B)I'37\A+P0'_([S4&B!AT!.]L!3<XVFH,\>\YV?;#^5NB987*("-(5=GU'
MM9TU$UPGK?PR(%\L/;B>IB<1M*H.!8I7HH'ZJVAN*,H1RI1YP43H)M@YUG7C
MZ_YH+PDQSG;]6ZJE$(BE[2\(\D+VUO5R?IC:#5U18%JN#,9]$:R%?WK51!"Q
M=<E^^E62.>GY!NWDB/U>;O*"_)SS[46T/7G[1BF9[@\GMKTO\&ZF<HCQ[I&[
M-:VF?.N-M^9_NY>)W[C=,]+?V,ZW-3W5-3;3VCVGB&MHL/XBS\FF=C39X)>@
M[.7QY;^MJ<DGZ]37KE,.*"777KE>MV[F\T_+/VZ@Y>&RL'?&9P7C]V=F3P5W
M^UT)":I@1>:]IIM/-AS++ !:(H8'#_>:R7?THXPI.\W&AUSK*;68W8N\.LS<
M>RAXH\N=DUO2= XV#KEHI&O^*+_%[N!^>RF0BPD*#'T=U]^X47^$:O$5.,ZC
MNUKM8GW61/TS$C!"1< II1/_Z!= _TWCN[](GK^IF>!A,@CYHZ+EI]]0_MY&
MD)L>^%]ZY324@=B]!9"G#<7(KUT."0K,.]]7A!GE(@5F<K4&]>]<U"0%(*/R
ME3) .C<5\K]*+F 3L+7$F2A9(&V;O+*&"1EUP>HICI";F))$-X?<R*!8S'K*
M2K+TVCU*<^?4U8.,^(CRJ!_[8"\Q01ER'7X^TLK9" %EP=:F&1+M,:ONK9"V
M_X,34UAU<V)2[DZP2%"%\%A5I%F[8-E/\.%%HA,BT**>Y4FO0S5@5BMK);P?
MW"+T8U=,8Y4Y*C0;7TOA1&)-\YK+36YE$,>9T"8 [U*/':E170WC)0F/P<&C
M$@-47*U_32WK&,2N*R\"HZ8]-(<E7]^JGNXWEADP(C/-9T?UCCB:^3K!*]NV
M?G/_IKWE+J/AXD,# X_^9J+(>K0K1V;@46:=C/WSZR4N;N]%E_=]2 !-1:8!
MM'ASQ^YY^5G+<[ECK 5F*RZ5]#BJ@X45!.ECH0+);IINL 0G/5??UV0EI"Q[
MAH*]EG=[R5B(C8]D?V[6ME]#F?&PKLP.(O$OT#1C^0/ TB:5:)%,D)"[7:XM
M3^2>IB1Q06<%YO52$:%5@8G7R4V3Q$HS^\QPB:SU9N7JQS^5(]J^,- $^>=#
M0 MW#=XT4N704YV[L%E='UYU3+Y$?%)"2H)Q9=3;'REKH=KW"HSP):OB)#6@
M15 6X>'Y9_!@2MKA[OF)8T67[5D[)7L+[_T\_=S$ZJ25[Z&;1YZ]]&(U9>[4
MV^'J&EORL?U"89&E47>:_;W,K;TU;P("3<^FNWC>8(Q%7>>._>IU91!6GY#F
M@]I\W+KI#NDK>9/9G#(< 7T6-4>?  4)>*M"I#MW@^26 (M?!GZ<<X0N%U%E
M0BD#5&#09]OP=;_7,:A8A 8^[&!DE]X(-:7#FQL?:;+7CI+@MP%4,I&IT_D"
MT&6:.;Q72H2NRTA3W&7TC3 J^6/"J;HBI47EJBV<XWUP(PUR=IZ;!/,),0M1
M;77]Y5_+KWSL=8(RA&6S6._F1>&"707%M*,QVYY!D>V&]]5+.A)A%'!?]6O@
M.]>)?0F!N) =S#LM?EDU13,[[-.RT_8]CW_P:>A!K^,NERJR_%C:I/G+YO28
MJML9[QZ4'>CK^9Q>VEP0=<PMY/G\*J/\)VL*)-/(JBP%QH"!K#RCP)"7+O:S
M*LAGO_:&452.0=?7,W2YQIP$AG]$-($/'\JD6HT2PL>34=!NTD+&EG2&[*4E
M'$'XPE^2;%2Q].$_^I7@_^A7BTIB 3Q!020L!8:[DO0H$YI78*Q&%)@F%#OG
M6KUF#*+$\RWH&ENN^^GFLSC!_Q\__M^,'W\=6"8)Y7[?=A) )YSL,+:5+=?3
MI+<.B@=A31SBI JOZT1ZE, R!<;!CO2H1H *Q(N=W)9D!:;OSL9;A-$PKCA/
M@;F_";W3"WK_*AN>_ZC$/(*^ C-A \RG*C!RR%$>]U>BQ<5R5)&GNP2W;AS=
M!K%ERF7??D07]9AUZS]!CLC_!_),_M/(P=7GCI4 GTX 8[=)TE\)\:0%ZQWR
M^ J8*+OMBZSV0@K_>)>'?$Y38/14Y;LQ^<G&UZ;_T3F3_VWC;U[S^YJ'VZY3
M8'[U&)2GCIJC.-'I5]R]P'Z6CJ!PET"ZMP+_-RF %4Y_DRBH/]>/^*O&$(3,
M=S')1H7_4;+:=W\31^C[%9B7E] ?4(DL S-E*WTA.0A(OTN "R_Z6[8!KWU)
MS]'U[?7=P#\Z7^+_$[7;E/Z3( )]56"6.2DPZ3Q4O%<I,-77X1T*3'>WUXQ)
ME AX4S4'GN9^W>9@H#I_CP)] "83_Z6HP#\H)U'U+[%$,H>$URDPU"X%1A#'
M?NTXUS$7BQI[M>7XEHR5'&.D=0HY_F],^M'_3G[P__'!W;58WY8%NB@P*D#+
M?KH:6;O6>H,$Z*"D>(Z:]-*5J%XN/5\O-VDU,.-#OIA+5-/H/P1)U<DWVX2X
M92]$W-5.X<+]EKZ]M$!QYZPW[R XTV#Z*_ZD>&X)C*ZH[U&>$\.AG94WVII"
MC6.&':KQ@M41@.8Y8 T^0'*%)\*VEM \A( JJJ (0H$ZO T\DQ4S9ZL'-9Z$
MDAZ\"=X[98L?,.]DZQR2Z+_LG/%L.,O0CG&-:!@,C<Z[+=[Q\P0S#2OU#BEQ
M#X^C:^6_\=^^_=EV6Y\V\XB> =,W5>W"O*0;ZSP(@%EV3&KN9/6]]+ 4LN^V
M@=M743'S>[+QMU\7"\LI;?2&=: 12=G8"/+';603!;7C>LYV>!ME+79XV_Z-
MT#783#*1B%>3-T6$@TYNUH>"":])PX%'K'.+Y;^%IC&EF>A2E]8W#1,@*]'V
M ^>XIZGCF+'?4-5TYH+JJ75<S!]*WV_T.K4/L"Q9<6R]G='+W?=( [M*)>FN
MQUXV!$V.OMC64)![DN.[TG$=W]LE(S6KDEV8/]/?;VQCV_$US ZP(M0ZP-JZ
M(LM6  6GJM";H)(T.(6/U5-@@ME#C#'+V1^$(Q0-7RA61(BC8<,D K?>'\#B
M5K8*=8MP1E\+2I&,M#<4-D2EPCMO3F8!J]Y5]Z-S/*VCQ1(WID6= CWC9[&@
M(PLR=N!31D@B+S32GN4.+QWSINV"/H.#3T<-)76)M /":,):*JDU*IQ*%'FP
M8O >8UUJ\ Z(<?FJ1%N(2Z-M14S!8^D1SD1^[OX,O_XO78E>V6+8_$E/!&'5
M]$;VSO:.U9+0='?WRX*Y[3)B8->,G%WE)LWM8KV=&*\C,=SR BZ\K.*5,H<M
MGS<_^Q3^Z?.GZ&-^Q^BDZ*QL:>]5U3=3QJ"A%%UO,34TIV[N>4(<4$F U:<Z
MA4KMN!3OCM2ON 3!^DC51-M5T$TQL!2R[,AJN)]R)J#@!!I95]'"\J>Z.T#&
MT4K4F*AME*<!96J=$W2YD/Q^=,*U2H*]AFRC1AV42Q\&^P?[3PJG/))C^"W]
MQ<L5F,LS??7NXRKB#5.3=9(VBVJS8K^<D_WQ%N,S9_.L3GX*'_ZX^W;/K0@W
M)V%HUW&4G_SV^C\3D*(OA&\;\6&H"NA"LL<K>I[\Y>Q%Z>UI&%V2/9N/7@)$
M+"1K4W[R#L=%HK";=F21<W$7.9<;RKD""WC )],/6.EB:]0O":OP?_\RNU*!
MH=#CY%Q9U%>+!_]^>N-O,8X-[2#!M[&009:\4%7HA=Q(YOH'_Z=; 7-\-'">
M$8RU 5-';SABY_8))"C?[%W[/P#W_OG/;&"9P.<<KJP=0& #>JO77_8 !,S%
MP@<_KZ<\=]BF3O.2Q_?#O_]S:\@3G*T20T:3GG VNFW4=+":M HBMC:8EHB(
MZA"+GUUT@R&<6T.-/E3)<ANHF8WV[INHZ8VXJNW0&Q(:J>+FWF<:,A,AT[W\
M\>-$PNB&K;ZED!>RRA_T$1-G564J]%<$)2#PQ4$G;#*R!U1@&%M>A9R6G.F(
MP;;IV":)NU91,SH(JEE\%[S%!:#U3W -4P0PBITER]YGC<VM9:JSUD""D]UX
M;.ET=LWM6P4ZF>36<'>A]:]QI4["N#-;BRS'-=ZPTK==#(L;7U__?/>M@F5-
MV<X/V%;[M4O@'GCM[<^(,@4E92$,L4-2DU(YF?N8T-*\M'5T,Q=DIE435:;2
M[M.V0%% 9#C8)51-FZL6,) =X)K'%30R5%<!,=OI.(@L#@EV29\6MA=)!EM'
MET$9(ET"PUK_=ZH" UDJ(<0Y$6ZQLR.ZYN2^V,=IEQVN<<?N",!3W'@=YPD&
MH@[92#,A9^'L(?>L4UQPHI4[PA!V\2AK1J<SAEY/#NKT#UP?8PY''^PQ'#"-
MD...5M;W&U0%3Z?LMVX=#F8DO'R[Y9L 6>DP!@PO[<#649[RY2P#R1M+NIJ$
MB1)-/3B(L@1V9 HKLZ07P(EV(!X+UH0T_=Q+Y;4JB[N6/)_/U:&HT<R8R+K+
M\,F-ER:UXR+9E=8M"\L<(X)^WNM]@A:ZZL1A_UVW+DB*?'+\A7;]&;=_*#KC
MI6YUY#[[A4'@MOZN7^.F'+2OE?BH))U($AGWEV_O&8\\X^*:G*;Q]IM1F\'S
MF?R<GOXBA*%O(,$Q\-J+5>P[VJV1)"%A!43\J9_F)&)I0%D>E:^:K(3L-><\
MU:>RT;!]H"(H8W@RVR*I@'R[SOM&6>F4I>> 3F1\]7Q4.(^R.AT'>N5-Y:(2
M(*9#@6GQQ!/*@OPV#-1P$VSW07<*IW2*8V&G,+%<]Q@4*=M(V\6-^>P*3B2:
MPKHB52P1K./K&X(JMX;M"R*%)(T/B%(_@:S )!];,.4*+25?:XN"Y>N!ELN$
M\TMEUL@?;K2-8'\W0^0U>V:Q) W/9W/(ZNY)UHKJ$1,;1)M>]:*$ZL"G:W.M
M[R>)<*JP<<BZ>0^0F[RY#BH.%[.631&!,5W!E@DN9+E%^DLOW@!<*C*<]65#
M/_/$A-317?T<+&PK,?C"6=/O@:C 5@VUCP9":<9AQ=YOJ-S6 -1SUH?  4(%
M!GO.&V$'JB:^APZAB\6'P;.0>I]-8T^/+O?F/JYJ.AML8GP:=[V%Y' 9T'H(
M\ +/UC1O[_CIZU<)>_HWV.([F]XBI#_9UT0W>I_3P-3D9-#-Z (A%S(A/.7J
MT3L%H OA.Z#E$&P./NY +*'#'$-Y-G".D(C@FIMJ:R'R?9HKI"3F,CBK4H05
MY6(]59XW7[#"C*E%#7Q*6AXAUSX%Q1=-%?#]=DD&$WU:U*%29W4WD)% 5X?L
M9+ZTT_)[38=D;D"+/4T[SYNV=X ;FL0E$U<C+[0;:ED$?HC^8)OM;GDA70]V
MAWI% M6@AH0[0NY*B-7*Q7Q9^96PY#6U@V\17#RMP.A&LI>1!PBK.)NH 2WH
MO$10$KAOYF=WRWZ"K>09G&7P(7F>[<XC%>SK](WDVY8-.74)9F14?JE-+=RH
M*Y_,U0:YC(C]>PSKZD*\^*/&@V9$U1.CP3H):<*<'1-N3 \)*1%O(RPS\?'M
M56#N<J%M$S/3$EUD5;#,E]J%K J3G>B0'.P5"JYQMI&MYV?JA,X.)Q-45P=9
M9\7A ]C3N:H@)8%VJ-!!J.>IP B!F6= \8?;@R&H"9="%!YK/;*#-+7 7&Q8
M0XUUA#Z/*3":<]<Z2L8,W38P&/V/?J/^/.Z337O]H#2Y9N/J[?#&3^G,VE)V
MYP&;=E.7[$[M^&#-%?[3Q)'3QDYJ.HZ[QW__IFG]I*1+-)Y*F1F;?>%1>._6
M*5\F9(CELX:4D95)0N9:VL_R9@X^B*,OK^,&;;E<1I4)!<EX%1$[18'1X:RB
MNIH<Q.I.7@EL6P;Y"KDH_]=L6BH&;BP0TYHV2,K:;P/KOV*_G_8SN3'=HK-_
MXEHY? 8L:[?FY,E_A)1$V&NVQE2WHY*)UKF-$$%$O%Y38KXO@K(!4N(/XU+Q
MV\N<\J<&AY<_UKJ#+@^_*6L[./M88]'4%=/[M^O2:Q+*BTGDP8/&G4Z) 0H,
M'K>2&OV4NY9.6.QO$$D<*3L*18*#8M.[,EOD+5;+3'5YA^389V%'@MD<9&3'
M8G[1<SL$6EX+K<8EV:LF>5?;6@QPMIZ  H1%7<FV!F1]BYK'3[+?\]H/$9DN
MV!X!K!NH4DBJQ+9;UAZ^'<P<%K?WDG[K/[3_-60H(SQE[L9H9<WL&MID<OO3
M[1]R\G[LW/>T^%BM=>0447VE4/,7X0IAT49G_2L76C]-Y1W<[G;JI5<RT:%Y
M_ GWRFTMLSR=/6G V;[":4/[XIWCON:A056A5[Q?C/BQ7F5JN)!V15__3Z+L
M/U>JZ5\'?3_0XJK O'N$6F0G=W83L(K[)<)#IDSZC_?0Z8;R3E,%9KFQ N/Z
MR\7C* UO5V!N,)#?KKG8:3Z-C/\G.(CZWS+^9K^O(ONO;2;=/LB]WCT#-@(\
MW,OO]?]F!V/0X*_;'*I14PK,+D8+%NSX=,!.P_4_WI"-5F#NH38;W:O S N-
MI>NX?]E KX#I$$&&^;?$A+LB[HPI>_R?>/O5^ 5]!WP:"@ )/#6H2]25^H6R
MA.KMZ]IKQ_09W)IMO*V?DM>0V\,WV_42H8%#OD?6#U4_5+V]'@,OMJG=*&<0
M/HS3%XLZAZ*+Z/G4ET?U%F$WBF;!DYYG4O/^%,X^>K+1<W,6/N0%ENQX2_A"
MMZQ]WLO+NV#\,WW?6%.LMIS%"@.4WZ&Z/W"5P/7%9[C8I$VFD^4^)??9D%+@
M,]07EAY_[-C)H4]U9Z]6VM&(_]%G$H1BUJ,)^48V#X!5^@C??'T)4X-J"LRK
M6!L%AN>)?KEUF=WTF2#:#J$0YZ![G2!9;*>*4-'?RDYS?I#?1?_5/5)EU@Q3
MLO0X5"3;3]M(4&V**H5L/,!E2+T"HZPNJDMNZXBK:0[F^6WN^U)01!5TV!IT
M%UA:=\3A;:CF*ZK?]9L@3P>D@X^&_:;6^CK_E^[3^] F4>+!(NO+IL"JR%L>
M)PZ9_!FPJM14XK'YP8,7=L^>?#8,-+'<[&<(^5H=O"A1OG;&.BIBW'2G<- H
M_*3M$7S+D\_&AL_[OW /<F>Q"LSW CD:3H*!Q$M83>XY8JRR9&G'0F"L&9-1
MZ[<)NY:^@^HL NFQ%=0"?K9]ZG!4##Y,6+XYLFJ@B2P*[FO.;?6U/U2*5_<[
M$D()5.$.H#.P4DB*SUT".O"P2\@A^=0MPJXXO/D88?F'K@=!V8V3^II@0MH9
M="95R6FETU$-MVM*:A)N%@\-6^2535DN%$TFOIG2KO.ZV(EG&0.\#H)_UX(5
M*0$EYKH/@$\-3(@Z,6.%VL,8%*"1.5(5\7+9R4@./):S_5T]/.G*K2K>V;@[
MTYHV(MMG;;JK^>NXXWR?B\2F]?5+CRTB;8Q]X6S7/DG@FI*7 W5FMPG9GCV#
MH<,GQE'%3H ,O5H%D)%G)MC[(U0G<1,+KN-MP X7B7U-,35<J)1"P^93H_G9
M"DS2SB]7K4?XMKNZ\<&@K&/A+)L-'7+NK0FQ;/&N::YE1?\^.6HN>9'<&1XB
M<GJ0,4V)%2AQ-M P4"#*&F*YR^$-!=!2(?O:%^X,4QGR^ND&4#5TP*2_/>^!
MW]M1/^?(TN KTL:RT2D4D)+QQ I!D-]6"2DITMF'SS'HC_2-]NB+U&7? _[J
M& XP/ERZ48$IR%RL)76]@:' &#^X?:AM7=&J=<_V#MK?*S)R0SH[/MF[U9G=
MNAI?GYL]5]X0@\[-N*N'5R+M^U)G^SVLA;>\-STND!LPK%W54#42\$XP7(>L
M").MH_<#:N;$Y,%#(A;*/:G%/H.PDT3)'5(6$5:>RP;XQ'74F/T;3T&Q?-OU
M4,H8(8FCT1.9V=B+JRF;/?0TVS"V N\CHFA 96U^MH 6E.&I4UXW16@%XA9[
M+B^G68',5F)<KEI/DS(X_;3AZ!5</+R[8&MK3^LK)Y/^/^>U+<-/35G75I8%
M:5MF=Z!:X^%HD,Y\DOGL(=?!KW(GUX$:8YF,F<W]KTQ*Z=0O]TYZYUB;7Z1O
M*G', DNZ3/\,7'$N?3SU076Y5H%NB/:9,WF[)'M;&\)S'.F;(&!5IJU51\J^
M2WMRANF?3\:_'7&>OQ0Z(SN=#+$0?2O9&J#[.6RIP#Q]>TB!R>S[6Z]%H[#G
M$R82MT& Z%0*X((75]\+)!KP;O2VTIZRH"Q4&: L"C\XBJ+5!9**K1'M_V+O
M7<.:R-9UT73;B((0%1$$(:V(* AI%00Q)JTT("!$0$!!R%0:N:0QK8!$B:E6
M+N&>J8A,18B(& $Q*K<6,!$"9"JMR+T!(3=OW)HJE5B22F47\YSUX\S5:Y]G
M[[.?M?;9S_P1'I+ J%%?C>_]WG>,;WR# G?(S?&6R%8HN$A)U8TKD(;%HM_V
MW+H2IE_YJ>MIG1J^>>9F>E?H>-ASAD.DZ:4=N(O/D^M?!U4$IWM?I@=6>M1O
M?E82&G34-FES?^K)Z[9[8[V-<@L"<B]=#HV]U5W;%OG=U0P3@_PGQ^[#KU9O
M2]_B9[0FK89JE-YQM'K/P?),\;%-SQ+I+VO\_$MLZ_BV2>NL-WEUW,:(Q?'$
M_[\4B/CJO[-V\Q^QHW"8]WE+,V(JT'A=?.JF>6>.NA+FC_V?M0[WG[7_^=_-
M[BWZYW6<?\>)FB'U0C'Y109?]KUN8V""YGZ3Z/+7_^E9378?/[?3P" \;#.;
M1MXU):T%<H!8@0X<IBA*3]H=Z ZYPEQOJ)0#*L77.CDWGBLLZ-Y#;)=)]IIZ
M>-VMR=#=C^M?7*PZ)$5^:'S4AT3%GY3I_UH&]:^$DT@T5-]9'469YJK-X2IQ
MF^7Z<T9*FJ3L'%@@__%:<.W&(@77<'AR< O9"J'V5/2TQ,JDYN]KF;JM?:]&
M8;JD='G!H:)6BDE+('CEW>%>?F_2YO.HJ1870QS6XMI%7Y,,P%T'(=]V>K+Z
M>_2Y*W5F17G,@ST5II_P.DQI!V\%0@$U1@=[6&X*?8LXHC%LU2HDP%S&ST]O
M3+HZ->:5@?F-\BD#AOAL[A#@?OG'.NA31=B*T$0K9Y>CD3HFMK45AF=K/Q=H
MQIQB&BZUC#TJ"&:3CU[MU@]PO-.7YVF\-.34B7YE@+>CXNZ0:'=X:8_7\.T9
M]-KX;I@CPZ='& V04B WB24>9LCB#>I>#[9$*Z5&,4(\6)H_+ZR,*INPJV+F
MM#LWG>;R&RIK)L^>X/+MQUYO_'RP?TN=^JC]V*OE3[\,V2"K<]"EA2;Y$G&1
MYLZGDP(MKBV.]$W25E"IM&/J)(D%!$,@AM(1!9]BFTADY^\L.B5=*>W4!^6.
M>+AJM,.M38N#7&IF85O=::*"!V\BM@(9-!V2,[1(+-*?J2/DFS':N4;P: 2(
MEBO4)59N/6QCUA%P[!J<T*HRXW+*(7+M.46W"?-8VQ2UGQ0E:]Y%6?8*SCF2
M$_:XORZ/(K9<A\:(9/=HH'?W<)\*!T>!/ EM*=F9M6>HA:KL)L2AQLUP%)1P
M&#YSEUEPY*5]"V7C@V0EH..<QMH*?C[0\)*E<R<L-E0W-WV(TQ(2?Q* B*T>
MX<EMM7OBCRJF3]TU#,M+O*/8>BCS6/6+G_G>>=9/#8.8SRJ\/+P^#C=[#/J,
MGWS51\CNE!=ZU]WQOV)Y.7+SBPJ/"KMFK[V;JT^-V36/39=*5-?)UBQ7BB&G
M\ROEK XAC=-* Q]R.M8I:I8@V,?YZ5K<TN\A$/I5I,6E_0AO@J-16R+L+:K#
MG%)T7Z1@J#!'Q51M-BR2\Q#C0'3I')2BF/G\1/H5VE>J)X+SZ#6^\F9S7[H/
MQ$LEV2FD*X@YB=V+#L40#,G6S"$QV1*F0YZAD$U64HEK=ZMKB)AKPKRMEEQ)
MU@T#CYBITG5>5. _S,J[EZ,]?1A,MXB6LUQ(YHL%X(5NU>]]R,X=98INP]^9
MIPEZZ M\)=-<<9W]'1S-<F#9$_/?/M(\<K@!/I[-#"5D.:N*QC= 6AQ'ISZO
M*#7X\Q-:$6\-:XW:Y7?VWVD/DK-)*RJ9(0?@&6@Q<=0,/R+U>@A?K616MYLY
M\=.$CC'S^&D-(9>])H)9?:A7N*JCFF7WZZ##)^)TMSZ3@AK-V#I#QC"T"C3P
M=OAMQQ[O6U6]U9F5W7.(Q]>7[[1M2XO>FUN=$HH\KU]CW?5T=<5J=&/^V>$6
MN5E"NNDI34"^PZTX;^^ O- 'MRI[8P_7)SM$)PY>KQPC3.R!\!+A*CA(AE^+
M'(#&*S;FR( ,% \Y<UE1=]UNQ\V_&J&FDP@WQV%.>^CUT!WGCU;1FUJNF'F4
MG$F\=CSG=IQKO?H'^\11_>:G1QL+GE&.<T<:9829\[+X2 5U>DK9"*?*'B_J
M&!K_9F NBV2C!'2=^-F?9HS$Z/K'O?E%2JD!3#M4_+2G)?#&^+DF*;78MVA&
M&IWQP:<Z[._V&&Z+%FI<SJQ8F&%+4D<PG=&E%]4V7=!>B;Q1+,TZ^R)5'0#?
M$WMD2,5FI36RV34Q9H0<!+NTX>2,W#Y4BY-SII_>F1CI']07P$JQT Q^"H7Y
M]_[4LDX^EAS>PU[$[.N@]7I.]ZE)K)V:R^3%R&X-CVW44<,_3UX;6S08&B[)
M2LJ:FUT^.9)17Q/'MH&<,Y,>>Q^\,#9'6PE7APVV[#D7?>M0#&K>^T?23D>1
M?HRE)3A66E@V@7I8Z5+UT\I<>WE#)^V#^'M<[O2TC8Y5AD*G5(6E=3>NGXGE
M;Y[LI^Z]LC$),H[TWLJ,<^:[WOLC:*M)2/KN@#>W[O$W5IQQ,AW>V)V "?07
MN_XL/0POH<(.1.0J^ZH6%R5X(IT_"E4 ZX(T"]LL3@*ONSYUJ^W9BS&^A,^S
M^Z(GF.K6H;S.IJEV2+2X"9<$)'B>J<4]_<S37'R%Z5#^]N78A>;$\),_BU9H
M-T663_MPE*"/>>2/,*9**U$1[4[AEV2,]IS2X@J6P#0L4MNT2S74N7G-#P(9
MNF.!%&53IL]=6YCQB$0Y"-:5 FLY45-\#Z_%#1A^@S7\)6'NK_\<P?\YQ^V?
MEUBKP@0@QK;V96W%XE$V,'_DPK\EJ'5 -DA.DQ:G.9]$U:PKY1I@%+'Y!O"[
M"4;0>DTW_7>_M15*-(_GC3#$F9'VC_S;*NV_STC\L\PVP9^OLXJ,T#=%0*HQ
M9JQM.S<!+4I @E'W_?_?<Q3Q)/@!%"GO?M+-B;"'ZZ&$CGG/\V0+)L$GGK90
M N+-Q2W3]OO!X9&P5IVZ$)/Y>P^J)T."0YTY+91;H;2I\0U#<P;.W[]T'/,)
M[;^[Y03%410)P/;$Z71U+"O@/FPGTY@K/=ND64*K*X=(NG)>CE /1&C@?>L^
MEKU"BS-C%CI:T.71>9AN3_' H#M0'+&LW\GB,))2S=RQ2_6X=YKE@*[KMVZI
M>XA@O/W" (LU )Q@C%2K .S=S^AO30T<Y3#)!MH<"=6/YQ-)GG(U?L3N8%$H
MN+;!<N/CEQAN<]I++7L7\A9PKV!E$%RKH'Y#9V_LJ;-W[M3BEM=U9UJ:WH<H
MK2GO';6X7(KLNL@@D9I* ,.I7R.6X(#J026<(/>42$<Q"<R9(RY_?C1!,&EF
M<YYM@/:4FO0*ZKOR[/QZ/G7E'?M#['/AG%_\+J_>:>O'EY)K^^[&C^R*$18;
M%!Q]<R6D71$=["*J"NI\6;'4W6/5MS7>28%IQ:H/ 2>]JOM"7;H"VP57!_-=
M"\V^NXWIJT/\].H KT;;VMKKL?4;BA[F7DJF2L^.'4+K*?1N>)-D^JIZ>?WM
M FA4L4$5L7L06:,@FL.>\N0T9'<-W"AA;^E+7+%E=</+/14CSAR6E4U.4J8#
M:9?L<9@B.A/1EU.73P6;3>\8M_*AZC/O?7:#PS FBZRU5G_-.@!U%*62_/&=
MW%^"72^?OG@(V0./R8DZO[-<T>%^IQF3O0]ZDLX!<DD[D!42L2)O*(1WI)\5
MI8RW$P/+D*WR,?TC ZQP9=[7NU)<9H5<S1V1K)!0BSE#L?H G*#B:,KJ 1.8
M+Q;B85^Y(,.5V"K 3X:0]<$_,#YYCT4;K,]C2"R_>RE8#PU6,'9+VAG+QN$P
M+]#C 3CY[OM!EL%)2F92]]KW9#N>V)7R ?,)G11XD7HKNTN+:_#,$N+9OU76
MQ*!&X- O)-T42+_UFJI:47-6+/_<;L%P/Q>G%,_CLTB,9?.JYK))'GZ6I*/L
MJA[M7L4<L:,MAR7M9C^0O[W/V6^)!RLOO_GB%]F5GB Y=^J@=7#2L<J[NS>[
M5W2MZBMN=#SQ^M&/GW(+8K8OBSB:^CAI+7&@\%!?GO.+J8,!(<W)_KX?GCUS
M[8A3VFU7;]4TB&2W:0\%T\:&O-NL'Z&-CP7(_J%$TY8@.>^":-FG%,9*Q'<(
MV89:/P1_$W[+3 H/%)<N _/S'8X/$AUKW!0VN8AYO'()R5R9@__JJ4*PG!D2
MW/,MY1@-WEPT7:T^*[X3RUN,> EB"$:.]HMIQLQBF:#]N>6HF&:4B%_&SV*P
MMIMDKK2P.P@14DGAY<5_2TQYCE&(9"5E31B3C%_#M!1++C%#VBUM>Q.]M+B+
MTM'B'^!*L%'U7I.*C8L+J<Q4+Z@A'>LM /K.T!0,#BO\&XKI7,TBF33-@61S
MDXTQ#;A]Q.^\PHZ7VR1LAH!6:=UL=M(7JWZRPRNF^GLH_G'>E<<U;N?BY?&$
M&DV:B$Y-U>(>8*,B 7M^RS7W2<8R"KQ/^,U[U!1^(Y_%\+B-;= S(S1FTB-H
MN83ZZ/-SA&&I_'AJO,*>^$,#?$[GLQC QXUOQ4##E6A 55*6(>OA0&A7>X0E
M'"MX"@X%@[TA*HLU?[$**&JLSBHU,\T,3LT1^]V";--^?L"MI9:,3ZC#/M)/
MA'_ST?MBAPMU.+#<[$.Y[:F H+(E/:I[+17=)X)JCUQI#)L$#DH;.,BJ1ADP
M[:GL3@/T6?&RA46MU>P-2 S'O[BM% ?KWX3-.\==&C[4UYB(2\UR@L'3S1"^
M%=WXD6W%3 WJ=Z1PK-Q[DVY!P0_D1)/8X.[59>4U]4/OTP&,G8">E-^UN !-
M#=F6A>'ZA;OLP7G#+.4YAD*WPR"R0XNK?5S8G2UHH=[X':.B0B*T,5TA,N,M
MH1=%V/8G/C:7#3;*GYO+BZ:EY4Q^YWSA._'?64:5M!'8HP,Q!VD2?ZQQ8^7;
M5=_!A_O$_@75$;FAG4$!?M>K&XKY7G;J.@IG<\3':U>R-IQU\:ZO[@R:=-];
MZ$7#^W945OFXNW*_5"%QFT.WOAEHP$*-@/1?-\7_KXSH_[<74-J-K"I07>\5
MN@*M^]E;F4HET#8UFT58QM9C[8<(TV_H8/(^N)P.=JHCX'AP4:?E=K ,5+-H
MH*1M)JR]R:- *<V4= (KYGHTJ97PE+@INMT^1:[%I9/7O:^-&5\-Y6>]H8 !
MU-'BA2W?V4AX#]E!RK)^ -LGE;'6]6&<5UY,S6PD&,7/!NZ'*/DM?J7?%D04
M8RV(K]J;O:6:"TOG][X/.3;F6/'8[-8,^Z=I0-AMB6*A^"&A@[9Z<IP,EZEM
MT>=:W$I2DD#SRY30$9I](LT@?P>=J-<4W3X<TQ2M:LQ$W.3G/ _U [5U\<Y^
MO3^1A\\X#SMVZ=OI PZ#@TO*$4NL<X4+Y??CU>X(K8<4HC9Y3WGH.?T9?-LM
M0XOE]B&M4&Q38]N^)$)F,&H#O:T %%F.A'3*$J<9O7<S9U<_DH?;UX]B?+CA
M;?BJP\]CMGQZOO.M^DCCSBZ+_1OH!TI7'SJR]L[>NNI&]PB[D=!K>8^FO,*?
M\S?._#96**2;7U%>IC\K.304!&VMMHV[%&3!>W2FD1WJXVY\,^1AOR994PPP
M>%\CAS5IK)WJ9!:]KPX_W/>D:"2:ZP2LCFU$'1]!;Z_*PRBZ+#\H1$Q?$D_R
M-$EML:IB5A^&PJ6<3Q_+F,E>X#'Z"!^S!!_>+IY/SG2ZFOAY@%+(72N8L<!
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M<JPH[YVAOU2T/0L0Y":D\AW..N=<CF*\<KL;%IJ^RC_BZ*O_F10"]C+L7EC
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M':7K(4G&ISP3^11]!:QL+P\%/QZ*LUP+HM45OC7,@S2\<8R(O%"Y%8BEY/#
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MAQA' >G$;QLHBT6396&4.4Y8%?)T8 :;Y:78:MXQ !W15_WY\[B'5TKI[=9
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MPT T$&@*QKSG'DA<Z.>#&E/0U0#L/8\;%&+2_%8/NJX"-6*H!(A59Q4VV@3
MJ'?3T7G<"A&Z=:$G2], VHWV:Z:0[90JH,6%MG#F!K;,1 PL57T84+HIJ$D(
M7D9,%:U6(B'L]<@)B!#')B/4#(Q4_@(S%HI(>DZ_H%EU8>]Y/P9';R%!,BI^
MD'FE+1 L>_U[8?BNJTJ!71V^.NS'=^]C!OV[&UT?\0,,5(-GUOJ(N_BWF;%I
M#2MR->O]'O,[MET>]ZQ-#WT--:2]@HJ3C]P.?6WV6F2;%_ ('*\TW/;[;-@1
M545E\&Z/UUOM31S75]_$S$Y4.1 O.D6_/8][^G%AJM?#,GDG1D,,V):?1AQ!
MGC*PV!FBHD:631)\:*9(>\=Y9)'L[P;-@R@Z%B#"?D,<H;UE;2I*"W5E:!UY
M4WA1Q+(/0-4IB"BS0=:DJ&(UQ0O-&BG+ZQTA \RI0'_&<+7<.:4^0AYJ2UR*
MV#R%,EOQB\>SGF7G'Q-6*+C&XPX9Q>HS$W,MF*HV*-31,0VG=[$,%(N"%7@"
MX@B."$+SAYB-+*="-!6CB$M.0Y2$*-[;:2G_5OTE^50B_0GVOU2N+VJDR:C?
M7]Q1P,QLM+\R0/X!?HW:]M;K0EH_OYDD[2GKD$_I#K$L,3W8B8=_^8C7.A8V
MLC-.OHPKN[9L5E[TI)B9:::@/\:,Y YVP?!*@8[+LIIK:A+0N--6"30;1>_$
M6-G87Q.2RFA._1E9&>5HG ^46IZ.Q>5 4*^:T-)@Y9HN1HT'[#H3S?3@S#ST
MI9E%'\FJ8!S5A3!89=A^GC,0W&H[E>][.4SV^*4BTF;\^>F2XIZB3]VNWMF%
MVWIRC'\LU';R.I^?]N0BZY[/]H,$O;'61U:^D>*CM)&ZR]^"+3S92B>EX9;6
M0B=/E^F'C6XNF\ZB;^BK*&$:ANKA0J8O=N<;LU6WX13PXCRN6?*T33Q%0/L
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M.5(013'JD#/>,(:#5%1XL?HD;+X?CE0[P:NIB30=4'+[$0O(_Y0DGUH/[XE
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MK23T"[5!?OQEJY24JC</G@._D9=@TV6PT*N.4M'6YH^281/9V:H29OKA/L1
M@-B"G6GU)TOAGD:>5E7GDI!H8_?R"NE$X.D.N<V:L.$$/LG,+M!+89\DW":!
M*6T!M"0Y/8% _J[F367O,XW-?QNX9/&;,5I!Q,:\I5% 7PS*EMNK+)'-DN'<
M;5V8"EI(#)1M_H*]F"PD%BBCL=EJ6F@%K)5#4%FJJH<H5?6#:*,J=>(>4;EY
MW%7'A.734'HKG#V/&[ZZ@W;>9VI:<SXY#6DW<+$J@3PMTU[^>J?X=OO&Q\+N
MD1Z#>+K?G&C@FJ"%\EY-G*QO[&UHR&Y_DG:%Z?":%TY/DZP72>-%CRW;&"E7
M@'517%V6&P@D,82;88%<T*QT;)S'K;9SS-%14!-)$?(Z^EKF'7&;MF*":AI.
M(W0QHFR4[<QS0NT)0/M\I=*Q):!#F V$6O#B1\&I\:+_+J ?O=C6S#;KG;EV
MZ>>>J/<F1P;J=PZ'P>D'GO1M+Y\!\+N>A#"^Q@_8#EK>F7:)\'UA\MZ6+C[/
M*%M4\VSZY+?QK:0K1C,AFG"]^P;W#FVKE$O[UEENM;(T.;7S2\IYB3#? G&-
MF-CNX9=\_T)W\Z^1AM<*BEOCRGXII$9H!VW8<I#W4V;E[2^33:MOGG@IC7Q\
M!P.!\KR_Z16"R0[01G48CB0V,88F9!__!!4O4LHGR)8U/=L%50V7//M)S@+W
M]5D9=7+*&ICO/8#QD53_LK)*C?'K>5QSP$AQ5"$<?!"<C;<MWEYO)WNOX]+S
MS68H6K5=DRDZI5G<S#;1_"G4#^'I?)TBC(3Z"3?G#GAA!+3J/4/]7:N[HW@.
M$X_)K- R3#U/AY#-JFMZZ6+4Q.$YB'*NE3/3O;HKV_>Z-8]\7]<KS'_P.*I$
M%)(3D.I[Y][QU]3A5];/7Q5*1)O>AKY2[AKNJWCB551C[:$SQ#>^DGPBJ2 K
M(7<\=%/ON2R7R^1(31EPUN8[=(A2,<45!>.3 @92D#W2SL14V5:[",8+/YK9
M4^A*#N4F$BD3)!K;M:9&R46Z3+$8[-#4R +M=I@< 3\6Z*:_*WOZEF;7H'PV
MT (,\:6,5M&-:J#"K]F&4WMF]$5=@WUCK UBQ=6EAP/XRVZZ!-E(C6Q*GVEU
MX(T%'%/"]/,$T129DMHD)*KU?L^CCPU']E1^^NJO+'ISMJ;GXZSKEM2 )T>.
M%N\NB3(-8#V-_+OD&Z$RQ7UWY^R%V8S2>_Z?]%:EIU](N723;U7P[:^:AK9K
MBBDWY_RZFF])ZA^!1C)P6@);\)MX2?35;"UD"YP)[9=K): $N E;+-3J9I-8
M;J\T@;S$(^N?#Y Q*&VJ PD)E3KXI? .23/9HB[.M<NV4QN36=77(X3FX6:F
M<"SIW-P\+M'6U(96_6T671ZL)K'\X4N@N8*H)*A=F,=/8)ZNM%0'LL(@"E?X
M_0ELTF@[X4L*M6:Q.+:\*I0OX@I7AZ/K0(\;X#2M3[@U7&*,  5OF<Y-&;7L
M"BDCT0PO0M^D4P--Q",$3<.#:N:K;G[BK;_'W0RV[2CS?^7Y4.;\9U/.6WC/
M_=/]M3U%]^X>[C>['^QZ)/E62.L#OH?VP14^,3'\TT*KK9OF<:)=G]\W)6\I
MWW_A?[;]_V?;__^M;7^:,S2E"+Y)"<;'$0W(#HASS1U)HTBG?L,C9K5O=55=
MUZ.9B(BO$U<<Z/$DVQ'+_OH]>31F6VN > PU &G<AQ.UW@%3*78Y)DYN@Y:]
M&R,G[B%+@,9?YW$,ZFU)E9_2$G*6?A20R&M@>_4NY"2< [:_X.E^3765SSKW
MU?N! RUL"_A2"7(,*I0,?9T=0(+DEMTSYOG#[>%F/%#25%LPL@H</Q&6Q4FK
M/Z.8\MK2'IQUJL_08L5EA3*\7;DMS,5N:?_%""?ZH?<OE<&-?P0%W<A3KH_A
MV[]TW;MG^/R7:^9KRI6E0XRHJZH+\%'('-6QQ'BT!41LQB?1\/T"LB&3U]8.
M$50WGU>EF?#T$!)L6?#V70!32_JL5(%?2063QQ5'(6H\LC6/M0RL3D(<,H@&
M58Y,N\[;P>+:3F0#>Z_H"6:+-Y]CPBP3 (\!R2\)"1_@T2@IUP3M" @62VZB
M/W5%B9+1-=#>O^"]8' +B*RO@H.69-K'SL:QOV>V-QMC1CT@YNKN/S]BW<=B
MR(,BS@^/)@EVE)-_UV12I+7T%92@SKA<,]@<=$:U9Y:ER"(,"WKM OV.:![>
MF6[)=83.*!L>&4O2D)BR1K7=D&YT2^VGIY5IX^..CM8V+MV3EWDZ\/%#& #&
MU5-D$KTQ\D*K\XN/H?-QZD-H)Q'TIE^O#6Z6+&=JJ9[#0>I=[#<47>$69J<'
MN+DB2,I(FZ/<L V7:#%UU,NZB:L^Q5HF7J8FD)? )Q42V*F>89]B"QA/?$$.
MI3?%2E(64O\,/J&KU"L8!BN'[_ZP-D2VLW-1XHL/=\-\"BTLE[H,G[_G\OQU
MP<9T%_ZK_.4U+GLHN7?RM@L+'@Y$33SR6>_A4+#!<P?I<VR+]ZV8?.U=/54U
M@JU;BN[,<--$SW@(0:':-H^+CU%0AR\=[ZW$+Y\PVYXP<!A8Q7+0I",GI51C
M"7SMT4SIU'=P73-Q<:5CW92.37+E'P)/TSVLHU+\NHDY4W[R%+*T9/\E66"0
M;Q?YE:8:0\$I0XS@,BBGZ4,\U9#FSWI#&7$)<J "]&L%=.$>&9TK<>XA14%X
MEZXH#4,L?C&R#A;SVS29I2T+9<@70X6<)NN?Y$MHR\'<J@+D9!_KDGSO)>E(
M(3&19/>(?0IHQ"2"M(R&*;2;OR-[8'V0V 14?.7A/YO#G&#Y^^"?GT!FQ9!?
M*WD+W!)]34%-$*UD:8,U7^EZ3,]1>L\,?3G<9%)7MP=S]Q22%V30\BQW)3B2
MSA]DZA'U6;[H;50/(^/8U7\!&C>3UU.46H]".C'5R&$OALX6GY3J!GL] ?NF
M4MB.+.\!5A04YZ2Y_S6"VI1)7*.<V1M\: !QBI%:N[71C*HA6K+0#.0EHC_0
M0F.#;UYN.+67V-&B/F&QO5I_I1%!ZWZ[H>_]"X-A1XZ6<NX&4V?O!FTMOE1S
M4/N5>]5FQ::WU6>)0_)M02'M!G2#C))5]TO]BC?+ GZ\-6#A<G 'J=BE\HY+
MX64L6.^45"[E*^/4%K"ZE5<UH"Q4P"Q3=0SBW4-RDL[CEC')/6U$75M>LG&T
M6&2 : V@2^%LE0#2G9VLVS2R##3C2D7+-M%7HDO'YBA)J DL:::OO?S>6?[O
M"DD(Y3N2EXR1,H]S199KBLFK@,85ER4$A (-O(@@*BC*J4=NTI?"'^D=\C_8
MALS%*@!V47"UQLQV@@.3,T6L8%$W:L%/)3&*7A)OL+]G[0<2L%L1Q;/->X7?
MAY(-TN6BM!G*]>$UZ1I,X2VYKKE?'ZZ^S'XSCUO02(^(5;E<*4__79C9KMH>
MLB%\GLJI_<S)'T%\P;W<&U_=K>2BN WU&1*Q S>.K 5?$O>+M-FFX]&9%$.[
M=FYBEE[#(SBN>1C? MQ4C9A#-DVB]:1K"^76%L31%#-=T=96*KI--T*L98(D
MT6KRCP&TH1!]?BK+!52HKL-$R%P\LGAA2V$0-8='#W4A+E(@SJ&Z68=Q$^,R
M#(4C$;^_B&4Z4'E-Q_U-%1&/7S1VO*;-P&'HG,)XYL(@,3PQ+U[S[Q\,'R/)
M:8'[FKX<8]F3/E@8C7I6W.T^RMEZY_;#@[F[=GB/];=L\2RESSXM=*W2E/]8
MDE[]3/!R3;;KSJ*[T:&\GE'$H Y=X8ZQDQ664A$A+'<IV):"+(*T9.?,%J?(
M!==)7@RCO*!\.G-JO["AI\IF*:PX?#0??MM8'3O+83%D'43/A@J0F_J!O(IW
M#***N<O&AC'?SP[0& H^*%#=.[ +9-DHT0%"\4GLS6"NH(A%@;DVC0Q=A P5
M/?CM^#%XVAL.(%N/H>3,GZOO>/=.58KTQFD6W;9UO%76R3![BIX> *+9Q;3P
M7$.(QGLPCSLR\V6HW"S-@)@HEKV]7/QJA?V=[)1[6UPOO\OXG./BFCU^_]S,
MX=D+AB7RG7?#?5V\[Y]^_T!></?#V@[+I_?7!+\=J>UN=%KCEWOE?_\*(H*<
MS9K'P.GLT,+JYYIB2K#;U928TPG,S?!;L'MK7I;EUNV>S>AFO[1C[_TWI?;Y
MF[H^7J(?N)ME9D-X_?CY"0^+G@^C<PTKJFKVE.=W3BIVT,+)QX=55X9RSY[)
M^7OHQP?3K+?;7V5LZ#@Y<H;;)/6)=DL?WF9CZ)M9=5E32&9[G/=@7CJ>93^W
M(_F;"#4Q5V'*/K]8DSV/ V'DAWG<QP=<^!QW"(^F\54,S!,48-L\+BMY#&WK
MF,=]\OD3D.EA7.!>C*#^RSQN8*%\\8.Z! KF,_> :7J6NO.F2%HRCWMLH]R@
M/CD!5!";14/'%;[Q(%W>-CGS$*'U*&=R_%K,*'!4,9\C_/$331^3RXPFWFJR
M\1A[ W204S[6!9L1=3ME\&6W<(H!?+6U=K*:O>W-P"_N!BU YTH>Z$:'K4>5
M^@^95V6=;3ZPF'*3W_<9<3*J47NPAXUM6H $LQ60$5<F6=56.!%=NXP#I2LX
M*>>B EU'5.JF (]2J8@3,*,IA0L:BX69LK>IESR?H,V8O']*.4V9<^ -B>9Q
M>*Z8B(9MF<<E_$OS&_;#QX&S\SB$3%D)?'LH.+X<YFBYKBD^#2>IR8P@SW(O
M6M3#Z9<=:H?<#DIR1/GYTS5U_F9L\R2F@8&GCV4KB6+&IH>N8+G<:\WQ\%E;
M'G(MHO3+PS+KJ/.UO.QNH'$;$@GR4.U B*Y:I<DE;P^YP_H5+I8SZ_?+.V\[
M?&CCLM<P+[6F/$*\09^!V^?L<BS%<YTM#7[B6(]B-9GI,2#]_$36L*@<^4DQ
M>.[SWY#9/?XP_+9EA^AWNAX&JS<DH)?-+6--6[)0'^TE+A6N@1],':H%-9(D
M\CKD@B:O?K'@_2?"0.WYPI@'@1-F!O#^@C![!Z?^_/PQ^UGC<[.K_=VO%H[-
M>O[2,_2V'NBM1G8Y3W(PQNREML=F#8(Q8=+A1 2'B$^)&E/JI 2+GFTR[CS.
M;LW)T>;!J,#M%>O\)GP"PSX_\Z?E%^_94L9PV1%(V&[=3GQZK\4O$5Y6\4!B
M!+[;&V_G<:>P.>;$GE,Y?64I#3/]?G7=2M[OP&/1Y$*I^U -CQ(JX4CTR7O1
MM\;TEJD;1P+@=F>X#)P]!L] $OG[CZ('X[G:T'?P,3A\'RP /X4X^-84((<Y
M+[)ZT>][[ 0KPT'F)0]H6?JR)]&%X0ZBA/I]TP--#-A22WE-O9#M<6"F\ZT!
MNL(--&_BZ9#U0MP*:)\PJ=B6C&YB HJ,W^6I5DY=4=8$F:C)5)MD %DVQ^[@
M2;E+)PZ)UI!MJ'*K"'PC<0TIJB2\?Q>P=(:(1WZ%K^<NT7S[1TO*_T<'S!,G
MFKK.Y*?+0_L$^TZ^=_4_N_E^<<_Y+RK754=OC6_.<[C_E&=]]T3TE>>\&]Y;
MO5A!XAZ^J^#9D>+F&._>T3/MG1W)YX^F5.8OZ8W)&8XE+O3.# "D//9&+ A>
M1Y:#C'BR\3AO)6(#Q<D$S<>)1DROYH4$RG!)Q7O8R[=G86.U<U&+XIJ.RT"]
MES3')I! 7@]5S:KH',29CZEE.%AFJA70O;T[W(8 4Z$VE2YV92_VB$0?"&5<
MIQAA.N8/.\$MH98FF44$[<64)9?%96AG[!3&P&2\&[D;>UG[08YLQ^^6C=;4
MYCDGWLUZW1*+EBDNZPRT]CVR'S)+?^3/#/JEMRK[_:EY7"M/%RC$_Q,J4?ZK
MRVX+V9_X& Z.Y]]3Q%!BBU_[G]_H$U(R=K DW][MG2KY58!]>>HNA_JC+^Z5
M;IN6?S;YJ)'8!C7[!_"]ALAA[&X=PM3%75E]UH++US8XL3!+UOU=C=G>FUX4
M@S^8Q5X[CYL^ZOR/#A C&?PFTJRHL$$V8-/Y16 WFR.:$"T#W@2*B3#P2O1_
ML/?F44VDW;YPNFU%18C** AIM0$5(:V""$+22@,-"&D9%82T32-#&J,B$B6D
M6IDG\[:(M$QI&41DB I(BR$!PM!**S(K")D:D4FJ%$))*I6O>,]9W_KN^WKN
M76>=]:W[WG/[C_P!5<GSU-[[^>W??FH_>W_@/HV?Z-7V3V:$R3G*/":-&\'7
M!>FS>'!O.]]L,&S?,#G%?B]$:[:3-]UY5>7E.;ATZN<RQN6Y;_F%)]*/9?H]
M>/?[UG37M3/.VUY-7^4;:B5=33;'4S5L78J^Y#J7;7*SJ"LM\=I]RL8CR#S(
M.G[3]/C+!_[YO87,\CU=[]VTI^(,<N[/G"08NA7ZZC_M+3QL[78WR].UE7DU
M\GAM9G6$Z9/MQ7<=_O/MI?_A\X^5]@;Z_K' 3SSA#G*#*&/#H1^:$_XII>1/
MWC\EGMQ\JZ2^7@]O0_71Y5*Q3A\/\X'WA0)%!X B)JQ6?YD(F:"C$$>%$ZRA
MWLT1L45J*MQW^O0G+J9:3']ET@#RZ[]%],'NT$2@"I=($PO:\1M4N%;Z+63/
M\DO5%M+GR]6I?HCD8V%FXK,AR:+<-W$(6Z3Y[1C)W@G ;@O$M1<((\,VR;PT
M04-,AKH1\4GV;""^VO\J<F'YJP8P$7)L \#\2<$Z@80 4E*M!? Q VZR0+*W
M'HY7YIS ^ MB"C'(3SCHQB;WUB(7N3Q+PMU*GQW]OK73_5VIPD\X]-/Q%S/:
M%RY\N,<(?_<NSI,V>'E<#OBWOW\?]7CAL+_U!Q8W 'T63-[@(S].+AJ0%W6^
M_/-#(84VRZ^>>?BE[_@LZ9ZR+#M.TSTZCC[+K'P9R%&XK^A:N$--(+\S!P9V
M8;3PF JG5XL2PQ _[.F>", "X.E;=$0 8<Q*O0M=>Q#JFB5 64 M%3D,2+";
MPR/(T(XZA=D3X/=J%<ZG%M4)0X*[X28.A E2B 69K1CCMGFT#*>=G0B1".]0
MZR36 1W6Z%, P@ N*4QYLU2%:[O5-\/9H<)M;5!Z=<.^'"B.+)4#[=CJ7E>I
MPJWI1,;F9A^I< 0"R!.(2PF;^5B0H#^T7)NOK1/5X<B3LU6XC?F4^\QR)%VT
MX$Z6^ 'M,RI<QDL53D> [.$B9H3W<8('<P@3:,6HRN6_,<\J7) 0Z@RF1"T"
M[ <,&U 0MRC28^SB5PA5-*'"_5: ]JEP:Y7<^B61TED!U*AP?_0IO-&][/=T
MF#H_\4*%>]5P=ZD!W<2O6*#,T)<P/ _#[ I;_29H!=!)YOPETW^7*4=O$7-Y
M;\W(RR=\!;195H,*=X0OFA:\MT+[5;A,,:JGM)63%RUF2-@#)]/OQ'LK#-%2
M,C;2"_)[5^ .%>J>^"]/XK^-.MJ5**!(ZYXE@]QA!16;4S^]86D.>4JN)\OV
MDY-4.,]XMK(K#E\)2/*G.#YH!P:=>#D@QR.]U*E<)/K#OX1-_$NH P( #BJ-
M5E 0<SE_:!I8,)Q%L>??2YFEP,_P$J"/@WGSLV/"*1%\<JE\@'Q/,.6HY"@3
M5#BKW*4R%6XS^J]B%/_[]<'\G\-FPE^@^7\>:*(Y0 O96V'0+2U/Y+'A0^CC
M&+%H$]!:#!T7@#^CSQLIR"Y]'@433>N$LH89?X,E4GS#>B[X :-)C]H$FOQ>
M$5C!VU#*)#TG=87*5;@= FO@3TRE=S"5K?V[?C$E8?.7Y "2_2I<_JBR 9#)
M4+U<1#M!ECM,EF&$ZZ0 _@4;H!9]W@M(O2/DE-SY2G3-$N?%(*!C;_(GT*HG
M=^>N@KM0';WT<6Q@MCRI%Y!\URZ-IZ)ZY-EHV4P7-O*PHSQ)88:8C)G ,?+K
MF,(]Q%G;)/)+\D!BPP>/]\R@N=.H+>+/.":2-4&_7'C_GJH5IPP;CJ/2#BCI
MP\J+P#"!*L6PEJF/A<J;'0SCS%UL;CZFG^CZD;WGY@(0UI7S;D1A/J7">2_E
M:%)GZ!4J7&4=,,!9B&ZA]$1N+Q;HD1L_7MS9_)T07;L&BVE/PEHJW&?*H7E.
M"FD72&^CI%'U>+[@2""<)*&O@3V[W7MY%A%K@Z8NFETN@>:NU"L4]!D-LP[^
M]A[KT>U4F"BD;ER8TSC*B/,?C!&L<<XE:=^'//N_7(!\0USP;C&13^2).J-7
M']&+74^-N,;NK0PH7&V74VYPVH]7.E,S>O7M2)Q)Q1+'"?A2L)HL?DU(OKB8
M-6O%90/W%]/XZYGVC]('Q^BII$_@(M(^ZAN#G+%'Q2_X)5+RIUU@IR3YSMC:
MGG/JU7%M>6B%>-:QH\B6\.)ZHTT2:L"H/3+X[5$5SIF@S]_-W*/DH)L8G3*S
M#HK^)/9C-+'1%].D'9#G_5,&8T]&:SZ_=Z^V]MZ]R^_]AJR5T7Z\N\^91$G\
M*J$W1,RP=Z^8)!F @]F5M*6:PO*@J/3FD"^]D^P]C<^5^\,T5X6'5]WFS26F
M!5?/>-0--PYL>MXN@79?>^.;]8U0=K$SUUWQQ,W"W.SD0"'GY$5?'>1WY$<5
M+B&'OPFF=.8E)X"&\M A="]#S\.]T@F^)*.G.XK;AM]6AU9/[S-]+V2M3Y"P
MVS7<**NF\JQKTKCA%[O3B4P3Z23PP'*^*4ZRF&(YG[7$?A/60H3-1<W$=,[=
M[G;V"*=M; V<"[YO)7QJ[UC.M(<YXNX9);$C8'RB/7!N';)SX'.0*U0?U3O2
MD-)^<=5#*2?36!MT2;*/D,41DZ[?#WX<+2481U U>>810.4Q6N"./T[/3_97
M)U:N]BV(Z!.89U>0+VNN]3QS[<&1:]YT]TV]G>)IS]/EJ8GCGGL*9F-T5H_D
M'7^Z_;?*J;X(0I6/_WM#4(1J1L%X+C,(PB?QS=#N,0LX%F0)??*Z#L/Y$FZJ
M76P[?O/DQ=")M/EI"[4V@19_W>08'IP=2IQ/!'V6N)G,H% Q<3/V?>?<V%+V
M.L8VH6!CN2#!AS)*'#&45\)QBDUH-]\!GH96?-NSXHV!9TF$&+]ZVN#/I96=
M[<2T]Y,&A7.7^?KAL0_LS-(6OHDAZX@F>YTNW(E ]:%/&>["\UC0>"6FR0%3
M?=1Y>=_.EZQ]26X^D9(IY[+8+F<[]V'W&R[7+2U='[O>?F+#"W1SU:/H)5>N
MS=DQF'C3-;BT9FCK^&NOW#T>3IV^YL>J\TF_%O.7SSQ?9 T5[5 ^)(<=( QO
MH\*[\2T>V]I8>Z'SE\3Q6_%I>;'MJQ%_"5<MV%'21&D7#5\GZ8/Q@TE;&0H*
MU) 0"H[5W@R,/.,N7AR\ZIYE?KQWG/Y;95'UCN<5=M8;L]S.GB[P*;'>Y#1\
MY'7"M4"*R\F9OL"2R)AM?NLK5KTRT]G>L,D9NMIX_JJ7?T!EV:]'G'1NG/A(
MQ?J_&M;^7]2P]I_;!@C$%<"[HX#X.E7^-W(2=<ENIS*)^_'.$P(M=#P72-#!
MA+7'=CO DP&=CBK<X8\T$KAG[R[A:C+ZA$6?@[&93'(QH[:5M*O'FJK!*&\=
M,^FMBA%I,G*%>;.)2\$/)2K<^O"+I7H!)VN+:7:A X.%=R8#LJJ?)I><B'8H
M>Z45^/2+J 8GO14=Z$;6,T[M1#-A5H6#CQ ^96D@VIC_K3Z7"%&0G91DXS4P
M)M4U.QF XG"X.1?SX48WWXA&U(LU:$<-#DV1(PSH\@?E\BWXD;>\46XZ=14)
MSSS[_$=[<X@K<1%2,TGZO?6W[5UO,:*EN9>81$CM8!_/B58^=='C@>!$"=S@
M-C"O<(@4N0W69^W1\!L;._#FG#+0^_Z5F >"QBM4M^+*(N8KI/>U*&\NWT/W
MT>24I>^I8-^NX2>B\QTV*?:VDCDU..X@R$X\9V38.J8-/L@J@Z.%QOK@Z]S0
M8D:<L,BX9]=W?59!:@=[SOUN<6YTFW.OU4A@%-F]=UY!BS,B=8RINW^S]?)V
M63!1VM!"2: :VSN$2@A7R&M(FYBAX*T;U8%PMB?8V4[_A.$O-4O!B-R&@*.1
M 4&W!*'%L,!MT&HD*'+H\&!,O)W(]_+P@3<_6@>Y/;,='%N:LHW?E^[F0?IA
M.+:I+U80-W?Z?GU5=7UU^:OO&31A\&:0FF)/%L^I,8"O04XBTZPX(M@ ;$CB
M69<=?8-='4JQ,E]MU807HH3G\[]9G'MJ^'5/75=@T &WWKKI0)J&7>LP-O,M
M#<G[ATZE[UCW'W500I;/$L+8$EX#8]@92CN"L9\#OMSQZX(*+DQD(W_C7!+)
M_>H)2L?Z /0834%H$7W8LD>%4ZC_(5C84X$:*VV \2V,?+3M[QU =NDO)R>E
M(5<_FIP42@6=*1]V$S\#7LQ"VU0XKXP[2C_N$\['FE2"[,W8K$+;5#BY/3;4
MSILJG&,P#GC\-S!_>6=6'9@J66Y(P:Q8 O^'XN(?>AG=J M>%WC1A84ED[U3
M@IY3@F?9'<O92K5H1]!R%XE<7^4&,1YBE*--?XJ6_,*!&YRZ:&5W*U&Q1L91
M6K>&63MI^\]?0H,^NO$8 [3L!?Y4 "?G%$9<\H+>T+3B.E=2CJ[! ,UL1&&#
M/=P%%>XV7T!]50^8PW,JG(DE)M;O]P-3+(S^4LEAN4@>'Y-A[:54%6XP.@5;
MQ5QA]USS7SNQ?^W$_E\6 /^U$_O?=%/AOX\Z_MJ)_6LG]E]0'W_MQ/[W \V_
M=F+__]^)Y1/A^N4-6&4.G\1ZGF<S:P9U2ZISV^<,X!#)6 (XU%JD#REN/0(;
M#O74Q3M*K]R,NWV<N?_J:L16YA#8Y@%Y+3DXHKI.#5E6\;JRUB+U(7M\">S2
MMG2RK(9&#O>7 (A.+;IV\E=6IX%S):@GMBPO9>3*[PY9_;:J_,+XB^D O9F%
M$EH TV882$6.A9S.M6.50T3_7GI4#)"BPN&M]UM:6%B-/+61$MH,-]EOBY'@
MUR+>,\T][=+=&VY>CO:]4[Y*LN-0_^C#5Q-&(1Y$=N/BCR-'F/"=WRY:A?IO
M+)YLJ3#97A%,DWR;,1:%.#0TNM8C,J E"-FKL'\%M'QE[P&6R'?#WK?":9)I
M_*>(!41-(&F&!X0.)?$"H0_![A:4;V!_,3MEZ4K]B8B*EP%3P9IPB)2X"@:$
M1;H#^3*S)&9T6+S$G*,]&KG<QI1\6""N:YQ@DT\28#,VHI4B7S\P3)Z-8!G#
M[H?A&U+ZIW!W8"UXDGM&88KLA,/$[MVKR"EOK2R,ISN-UT!F6:RMD\$.ST_Q
MOLDCRHTKP<[6X:HQ[?S HHYIH3$&)Y^=5OXB^(Z3U,,@RN\JJP61Q)>Z^-1!
M,S>(T,R^A%ELIRCAM!"\]O*7&H0,F4E)"='2\:_AZLC'4;=A?//BH)BY^:HY
M46M:_ABZ:K'-$][[5@2>/9\5+Q/@6$*R$4_']&>I(.%O71#[(#7UHEHJ<N!.
MN-X2IWU67:*7M9P =*+^5H6%*'5>L(GA+LF]LJ#<VT8BU/<C#CK)E]G G0#7
M:@;+P7]:66][\H8I=6Z@Y*>S"6T#F5>Y:5EZ]+ =='V?<F/W??GG/8]DAA(+
MY=%'UW5M>GOHEL4AMZ1]G/N_3IE7F-25K>'3RD(K71_D9O];50GQ;3+H.0>;
MI31[V$C:!4+!%6 ]:S?C2><AJ*&3DH&N@$/$U7;='22+02O1[.A>B;)JC Q+
MRN&?Y^D_8;9U$G8]95''T8#-J9!_"I,..;8V:KM(3U96TT04UIA=V,RXPA4;
MRH#G L6B:\9O11#4^!MA=VEN FL?$@(3P0.24S^+\ZM9B\Y]NYCJD'HSV1A1
M!^_/N?=:.3A*@O.EQ,^0DU!NFG47V0 .%@D)GR&&LO@]V.IOIHGGTNS\T]ZL
M!UJVQ:AP\-9GCZ0O[3<H'!AQLO(4UF=/Q4\/O0]@M^;ESE+*T<&E2GC6_A.'
MM_42#WH[P6"^::^TH5V4PC?%_(]P5MU[<!?3.E;A$#&<-XWJ@Q,MY.6C?*3-
M4V3QBV[\E!Q"1X+-\X5+3_F7JAXK]C-B/2"?):=YDO%@#&>=66<\Y3@HO\%U
M/=5XJJR:<;*S'37J7Y@U[GT;I]PH;!\S;.J/JHY"',NZ+G2E)JUVT<GW2K8L
M,B/^\49Q5'IGA^.F_8-9@S\?O\JV[DV/+#QP]FU!;,G.WIQU_%+P?4E&<_^?
MUXTU]P@[?$8\%YF/AX>1LX.! =0$X]UP!5WQ%?H'YZ[_3!FXV,JWY$C),\_)
M48$"P\C@+9R6 #5A$\T=ED"G.F6G<J469NU#Z)XOWQAO@,\L9Z0;O*V PCH
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MS) ]MMAOF\V.4DO&5BI_B^G6 5I<2'O0Y@!1RP&.VC"R#R:4,V- H%WIWM'
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MM@]$=%\?*M3?[\6CUE4HWH;J=3%:%AO1]\QC&"# J^$?&!,=_(W@"8B;<0[
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MT[:N/EYNI$'?\9V5/[\_6UI5Q$D!P&!\HF#3%I [4ZN@,_5[MT$LKF(U<F2
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M8UUX<OS=T'"[B[MI]FO4ARQ^11[.$(==8NG!#?+#D']6::\@')\AJ.->85X
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M)O!4"Y)6GEVP.LHH;7U97>K:B\99)Z=,*+.^[/&.7P878T@0?6 880AV@#E
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MH^0!5;S-^>CY6'$ /&Q_-&E5)IF$#8L[P6?*N8SB/K\)]^]C:\PN)DY^EEW
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M&.G$'.HW&6L3RJ#8_L<1]=Y[MN U\"&:I> U<(!]+M/^>HZSGPFT"8,?-?$
M/\_DH +J1M=)8UP$W66@?LS^I5(!2QU$C07\_!)V##%LU\06B_N_7LRA2H'-
M[<D3$%I:J!7\BL+!IMVQ#":=BG3D=Q=_[,=._,%7AX$/6\"=V!^FI5()4U-J
M#0)>Z8ZLF4/.PZN07ZY3!7#S/:1[QX _>1X9 K<*RLX1X9Z]+<=$W4Y,C3E0
MHIZ+2RCK4'OXE49*/7PW64NKOG!BG9/Q@(+XX:./X"]"G9G]\X3 G*GG\]S
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MR$Y<Z5J7K.YO!4PA]2)592V=J,LC:50%_QZP+^]/B"'K%IAJ:7-#3\U"2$<
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M^^_>UISTB>][F?)Z0M$YJ]75_(YK-P]5'<OR3AMU;N[K)66LK)!N3J>MQA/
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MW:J)/PY^E6AI_SCYU5/I^.V_C17@_(L.Y?(,34U J.3P?J !+:RLJ/=E1Z#
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M]PJ_T-)>J;FN0$_-P^!>^"@K,P^\3)APX*L/!DV?T=)PIBEQJ:58I%FDI8V
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M9/SK(GC$<E4H_<%AZLJP=\D*<:3[+K.ZU,!#2MTP&D@YM0XROHJ-R5 NA2<
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M+D<Z2.[O]RGU^Y3Z?4K_T>+H]RE]23ZEST(]OQQC27_#PPQ:$+>M^$8)YRS
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M%5I /=J%)5770HQL^_3[]MT*E,_#C.CX12HVDT-<IXB<R(@0=(<GJD4V<)!
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M08L%"K]/ FJ3X;Z:X8)7#LI30>=IQ7!;*C91!:VQ6LBK-T)YEF-5T+E9@&$
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M0YV@07##%X]CG:;V])Y">AZ*BN6OP0C*;\#V[2N \A7ZD(+- $^4RP)4T!/
MK)/2Q?:(5@]Q%\F:CC;HH2D=1"E"N C'>$J])B/U9PO1MKALI"7%#$Y'W-/P
M&*9:)CNN(*U.63;-0,[TYQK*<?V9;OV9;O_Q;K[^3+?^R,;G*8W^R$9_9..S
ME,:_/;+Q6:CGEV,L^S/=^C/=^C/=^C/=^C/=^C/=_BN\GOV9;OTACL]9(/TA
MCB\MQ/$9*.D7$Q?NSW3KSW3[[\UT(SV1VEJZ?#CSN5 V @/?'T\?;JQPY#6F
MD2,'J: ?^6U@UWXG#$,5FR39Z"K)>7+MX!7D)' R;\2ZY-[-5U20H4BL002(
MJ,3^1X?)PWNNA9"OX.R^XBH0KSV0' H$:]A#<)$/P.2U?,#.TW,)9!]5LJI#
M;L-K4ZH@'T"!G'QSHW!G/ET^XU"'TE#"5=PN$GP05K:K( ,NV $5[G1%J62]
M8AD03.<),N^3R*&WU1@P]TWE1%@-,)XEA:YWHAYSAR(_&[62^5ZZ:B;%V_">
M<*HO0"8A.;277^M]DDE4/O/C=".*;XL*FLO*HDKXG6!@Q[YOP'T<*4+U5%#3
M$J07;!8"LR5.W<&9&*R$<IB.B^=&B]&V.;R&O]QW^U,C/0%[,SAU+\&30\JS
MD!"]Z> )H3VV"_RWNA+P,G42T\^E#+ V0Z_P<CK:DH;RU-E,H5GD1G ,1+:X
MCNV$TQYXC?#70@ZTCAMG08\TJ'JHE_%5(_^[N$)!46B.#>=\E;?K QU:BB*3
MQHT^X'#K^\>\PIZCY;)#4BPDX;X(E_$>R*P$!B]:CM'W]WCM*CC)HWGTL-MG
M1U<<<HZN1CP;7)^_54%56_3HR8[XA,_!#_D9> $Y"HV_[\)#HI'^B$=_Q*,_
MXO$?+8W^B,>7%?'XMVOG%V,L_P7-#>5)?T:SL7BZQ*&$S$_!$D6TZ>0H]+Z+
MGUD^77(SPXF&ST >S %_J#F8I@4@HN2Q"O+D4G?3T\@WU >T2E@T1TK+X3U(
MPXV\OO:@4AY0[E<&H,^]HL4=QUA2@3@]^Z4*FMP1EB/@1F'1PE:KXBKE5F$K
ML[RUF'RE -N!C*OE?\!7B=Y75VY;_'2DW;&1SCO](RE)2JOMO(O"2KJ3@EMR
M\Q"@+P$.A$L<"?9%4LPP9NCZ%=K88Z+LXUM5")?>;@)P]$3 \,E"]SPZL3:U
M16HA$U0YDVO-Z@!,O2@(0157/$O%/F10 ]HYYQE2,4Y'!:W9 #>>#X'K;XAI
M2KU&%:2XFPNPMDO"J4_N;?7=7!%_PBNA8]/9.#<MAZH<EZF/M SD.;TXR,//
MJJ] ?C^\6@6M\^3>]J. V:5DTY7F;R>"3\$'$%=>K]#&)R&O/Z%'.$<%9?FA
M]1U6@!]7IF'6*FBS;_XPW(%73>FS%R-1("K'STXR \-5(0H7:Q+)/(]V(@RP
M>^_'H.0UD3K'YP$\I,^@Q1M 9'E=EX%%^3@1::"TN._6BJAD.UT^GUA %M)/
MH-TY=;;D\B1%5Y:#?!J'" ?:I%@+)JZ=&0-W!C2IH)V^(U50\XM<=6^8'\BY
M?4XB1=!G7T4F4-2L26A]MA605$6!%'SA!H*)KC?&X'"T_JZ8K:3N1A67MJB@
M6!4T *TO4/>TW-T:J()ZK$^HXV;;B9T?<YF/(T:/GE)(&\HDY"TXU&\\]GQP
MZV(K/E<%O9FVY@@BYI*<*7\-]\QCK%9G#Z'J["' 45:YQ^4@G7/>4V6#WJB@
M[N!AEG__9QY8&"_F*0)5^O8LNGDMY%S?11SZ#!9)6\EA8%/,9)%# =GQ&(@!
M2QYWC5>QK2,7V*Y=PMH\I&5-A"VUPUPH?07X]ZA?"SNH92BO^\P:'#XU"$/%
M%Z5("%KOC/UB5'.CFO(%V!U4G"9AM:E?EI_@ \!7NG+K7_Q<U5V_6%:M_V]9
MBTU'#/SUE/%'_^ECACP=U[$^7B9O!O0_X3+YQE@P07WF*NN>_FT1A.APHFP!
MV(9S B*,4,+Z&"5I$Y<XPU2[Z0]4:O1[0OOP0<[YWWST=9S^H$=_T*,_Z/$%
MB..S"'I\'CKZA42*"]NX*35G4NJ\<F@CD>S1=P ,'>(>>E@8 DN227T_S@L4
M XA;T[0JA]2-EC5(65&(R W)6H9X"-LI;=23\->62A[F6#-1JB%+D 6P9)N[
MI?_\82USJ.SXME*:)N*P8-&0\JF /BW(>^*5!T0 !&%IUTC'QX&71+7O4$$C
M[)6'L)PB6'(/K;V*/NB0L624+.I)O8!R?);7""Q0N4%IE:,T/GIH]QBP<GR[
M:(:^_O:WRJ[7T8TR[I9R;JMODZ+4P;.GFG";3"2TFU>_%?V$Y*_.Z7[*S8G9
MM9#@W,,"(F *U;T':2LM:(/OR0/8LI43 8?<SJU\K*%([*$/@'T!Z"29\)M/
MTC$D[GWG%=U ^TA":D,TD/I3A2JHC38?F*GG"=BQ;L#B+P2)O91:DC3RYMT=
M*\8ZM1ATKNHKX )@7M8$N#XW8S3@4VFY;,)V3E+/-M0(J0WC=G[O.D0%W:L6
MVY#Q.IL4R?1L2V\ -3D ;55TJ<>ZQ2)&^ T -, ZVTMIA@.9WPI3=W#O3&C-
M^DTAAD\;+:J@%4]4D(7#!'5/<[% .<%'2%BX.'7;'(?SQ%Q%[WFD>6LLN9OY
M6M +#T';#"*0[O*AETO'KJ>_T9 ?[JM/5$#I[_19#.9B^EXXUZL-K(I;:A-Y
M34$@ATIQ7AV*7WAL0YP6 =.-U1$,(H;>N1=0[Y>#IZN@K2^IZOMS%!C];2)0
M7\E%Y(6D/G.1WEC. -,Y<19A+51!I5:6Y':%._+<W.^$"J+[ :DZ'Y@,7]$%
MHSR@2&[V%5PQ5@*E/6F#/%^*N N58,T4Z9DSRJ4PO5H#'[.$7-^JM%)![YS
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MV+*(J7^W/#5@H&,OMX(CFX'-4GZ%ZR GA%_Q0P]8FOJ+V]WY%HVI=0$'A,[
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MI<=4T,B'@'[\?!C).8G4<JG=7V-/P1\X ]9;;T'< NOPHHX,]NO 9P'9%2#
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M0[V4N-/QMD]I'FM=7Z8:^>SPR)Y/+^S%K:_4T10PL,;2";-1N?QUGR@,51!
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M_(*3CJ0ZWUT,Y_ @W-I*2\H[SF9;ZHB\)G"_PE>_X@=;3<-F8W'6]\HII_
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MR:*X/)RG[@#>%CR*;JYD5OV]HC0%M_TBEFYP!HEI=OV8+J4^B&-4DNF\$#-
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MV5UK"+M3K!TO1S475-S;;'OGV^:&M]F5Y_LWUXI3K#HQFBL,C;,+:P0>,<.
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M>%Q$W$AFSC%NX]E<6"].]@Y*!.FR'[Z,-6P43ZRC+AGG1G?I"S8K#U%^A%Z
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M%3:[:[J[&7#$3P^16WC],CE#N[MBGL8W3BB>.5:+36LL.*B[KT_+(?[RKX]
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M$Y^+:\GA2K5((%JV$:)]&;(8Q__,U:9L&>%LHY@JF%1CRM>* H[I)#>+:K*
M%$4Y@>5Q?\%H<'917 83\$:+&!62<B?TBB<VK0"]UO!&E$/04];\//Y6\(J
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MARR8=/FU*KG4 CV#./PNCS44V=L!#_G,N- N>=XRE^TX_5/TM!>MRY48FK]
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M2IWD\@5V+ZO @+C1%U8,B+V*>(6JK5](9M@[.AS)&%-K7@(C>$33. P=IE^
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M@NSI;UB_3QQ<<XD5>ELZ(UQ)V8TT*HCMZM5@KALBLGQN@!+QF+^87\PS$[@
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MDFBH\S,<=0F-4@2''P![$.$M717;*4G86MK.7SROSPC'SG %N9BRO([3X;]
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MF\#R[4NEVK;443<G,Q*J4Z)I%QDH^=Z4S9?_]5ZQ+:_R-U0]..A)J=WLN_=
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M<+ @J@XT--?'WTV,>+;VVHD*8GSPD:3!LJ;_U#D=B:[>Y>0D&=M3=WF\+#C
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MBC%IM0&!ALBL(*1M6ADBIE60J#'5,@]B6@%Y!24*(C)&!*2%D @)I)569(R
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M8"V-/"HL_BEEDVO^>-NQ2B_F(W]?&C,N&*+7G3KCISAE7'S]3^J-<,(+]0-
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MI8"E9Z_9KCJEK@>B65^IS$!-G92(HEO!SZ#N[UI =!H'5TV[T,4OYW,QA*]
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M]^:7XO'WW@Q8VOQ:T=0U_0?-Z8'L3@7IQIF"1[]OVN_ P@U,O3Q[R]*%\NN
M7T.XMQLAL/9/9A=YL6Z.!V,G39LO5#218#O@BL9:,]#\YS5)!F>?<C6%]6A,
M&,:[7)A3 H^TG0LM3SW%<:N>6-P*BL)JQ0[RT W6"<P,A@V\!Q0_+7S768]A
MXEW *1F7ERCCP8>+;=1#ZHI&\7"B@@V[*%WI0=BFQ+99V+)[F@F)%13837X[
M+!18^P+=J0Y ;/&+$R]K< &E5\W=$FLJ>EI/D; -:$9N5\8C-L QD,M3@B-T
M=!!8/<<R4^$AC\N-7=$JJT]#( D!C VD5+J1]G1%!?)&'&)]@0 WC)-BVUX[
M/5M 1>,RBG7@O?=5VZ!35<?NCBL8*R%J!IXB8Z*.TG? 7?*@1I'*ZCQ$^@8D
MS9S0V$+=65L9&\BA;U2$PNZ(/OSJ]PLHT(\YA)5'709B<4-[%'U@]S0:[%,4
MPQ@0IP@"R]N(F<1'Z/;2<KB/7T@H+V5F%6-><;2ELTO>T-<TBSB1(+OM EN(
M-9ABZ3OCEM)7#)RJ/JG!4$QYV1QM,-VMOL_9Q6XK'G**-$DML^XRL4TX_U=E
M7866+Z$S):;OT%VM+;RAR1]D8YB=;!NWS1-*6L^#$4&@SS&YZZG=J;OW^P*<
MJFX7V_H8EYF[:;$[_$+>^31-( _M*1XFRVJ9RA.:5V*0)%[#&&@2-T7QT6F
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M.*1XHW/%7];\CZM+Y/Y%G,!W=C7FWWD+O1PJ[^?3K/?[5\U*/\5\...?8Q/
M<LR;#>KW3VGZ(ZM^DN!,:]'HO8N3$@T90Z%-6<3CW4/>4I=_,ZE8)KQ"C!PI
M>JLM S*C0)?V\)#.B%T<<):)/WZ?;@D7%N,@ZA6Z7MD0+=%OD&M"/P\'E%),
M]\>XWF"6JBR@G%%.,^ -X31ZVR$']&LD^>M"34\7^XY%7>7%\D;* P8(6)CT
M+>33R$XCK(H!C!@F*G<$)<]F#=9-_$4/]*%,$USAN^RV$H22(0RB.:B&E9H
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MH5:?EF'-U;2&'V9Y&Q<:[TC^MGUNQZ$)/JJIL&$A"'PD^1-$IG&FG@I>?:\
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M_D#(='L4&C'2W8HN7#WU#7J\3X1.81\E<42&J8L*N[G\'^1C /,VXI<A%L*
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M_]*9RIQL_E8;L$>2H9ICD:('_:JG!V- Z4O^&1H#6[L5:H-DSR1QR-(?D\8
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MD9?/D3S.!/)^D;^B(&2N+Q5]@\]IM+9=58I>,SVH-JE<(\NY>W I4.J1K;"
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M!Z,E1>99:#U^U-$%V3=)5A "H9C.)ZR*+3U;)#$W/@R3P&GYU:&DKIU]ZN_
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MS_H#3]U%7N& 5A]WQ;W E\,F:^4YH)*CEMRGJL$<T-D=> 2SA-T<8<X2R^>
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MF7,:C==YK0V3]@P4>(4H[A.)*W6:#&=RE=:%JSJR'987-](R[GN=6A]<#/'
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M]UK>!C7=B&-VW>;@[!6#EI#'UV_/YA@B+)["M^Z'\";TCY5MUN<L;[2?[_Y
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M9^(-TYO0N\.71RR74JG?>YEHGI5.-[7QI+:\Y M&>LEN-59?4M:FH\['2 A
M6,6_O255J/T2'!?<3B1]_O+PH(\_YQB96N,<%>&X-K3=:4FUU* LC,=3GD3
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M:;(_XGF-(FFM;^]O$SH@@@A>1YI&5L6:M](4TA0+9%_KHN(3F] 22TJ/PK"
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M#-L/X3I!J]-[JK);+L1118_U1J_W!9F8TNKUKF*J!RF *=K/YI>DSO=1WD)
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M/F_>5].X.I+DEE!A@[73.';07?HE-47]3NS(*$WDC3$V%](%2*65V'AC/])
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MCXHE-.KCJ WP6+& ."7_*J9HV/NU"1N%@&+#P(F*XO7]**6Q1L=9;:7-O=D
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MVJ,R\Z#N83M4A7D7]'EY^G6L%&K5DX0Z _:E'[(Y[])&*3ABBV( V+T4*0%
M*[W:7 HCI/*EZE5BS5Y2N9*E9AA(A[ME/K?"0\CXS,F1F;6MJ GZPH(W(T!C
MCY"+ZI YXO  )4+K?S1W#<81Q,%W0FC429=Z&CN^:,WE<GMS?9LO+X]QM8_+
M%?J%JB?*8K.PD<WD_B0=9];WE]57G!_].(TOJ'%:!\751LT<<30*$F*BA!'R
MO=1C- 1"%_%E11L@'J5G^?R=X:8KL5L-DKPVM('\?%_3(:603QZ#;+[-4+OA
M@-W!BSXZU>\JO7,ROA7@O".YL0J-P#%LG+[$JHY20\BO4+:2V-=U$+96H_I9
MU-L@'B"4&"740M?[*'JZ9R,G$XVU]U'Q*]55</ )U\>$E*R*)1?[X=3?O0\[
MQD>QJL65Q(M?U7Z=)"X!"BR+)8@LCB3:Y#:8,]%?5^WT_*3@N9&D5=?KMHRQ
MNCZNF',/*OKC8WPT;B+ X EY>-L#>F]'V<J<)O6:K/+29%<>9Z>6O]C7N@&3
M@EC3O 7EOD#+?&]+DINO*RO9:?;&"LF*9/&]<R Y'*'H?PUDF;HAS+R4V.40
M2H+/&#"V@.@/ >RO],GD)TQW[.\W7P4PT_.R]!52OW\OTJ*\EY^5<Z TW%-Q
M1:*B]*%>%#][&+,=B)$\#MTZ)NP85Q:<JN O40TKW:#IZBU2Z,)IL#]2.)@Z
M&WEKDJ2*ZM2D@/AX[O%<,?[:\/WFL6R9?-1X:\1'..EJG7'857[!=]^M_X/7
MQ&VT-2=H?/,EM>TMK>NLQ#7Z&3A/A'!>DON.'V^,^-K(H[]]?W,I]MS\^C;5
M>_K/!#GSO,J@]Z?-#T&<B+!LVD+<')RL2GY8_CULPI 8IF^M9X.SU"AAH=-_
MO LQ7!:8/Q][26K$3K3G$I$JOU.F;X'5:SX7)=X5=<T=:4E!G0I\'9A]H,V^
MBPFR"<Z=R 3QPF3+V#6>VM7>1@6.UFYTD>E#N:6USD"R:^FVD5J2SX2YM2SK
M+^:]T3WXE"/# C O8W?!3ZACXO$J='&$1S=)2ON8EFJ7G'V6%VQHY%_U84NI
M?*GG51$I>R$?^R?:G/;%/D@)_7NJ(KD@WD_@^:28\ANH)=V23!!K/X;C4P0
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MX=6CNX/U_+Q+DF_#"'14#/(F52F\W]S:[6,6O'WDF&3V/MV[\R%WD-]YX^G
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MOOQ6R/V2LM6;'*8NJQ2U^)X@ ?550<]X$N%Q41* ZS^K8O#$ABT1;/?+7:B
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M99*T %Q';Z;1C0T^T7Z5T&U@7*L.Z7_,L[L_.T@E4Q0JL@]T4)VZ)3.H3NL
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MW5&GY'N(ES->GKIX_\_O0?:$_X:&*+!I% ,'9!S*(O9)(+XHD#?^(OW"1VH
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M_?L>NGG.R^XL9[DMF^QW>CUQ-CW+.<MCT"?;N':.=./S3U]1W2N30]/X964
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MR+;GD ,[\)K?!)"OCW\50):UC(+XC9&5CGOJ3CFNNB+L.NR(]U].J[Z[5*"
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M\-+I&:#Y##!IRU.\I/J[I Z.W$Q-EBI]%_._'#LH2Q*BL^C].ZC4+(&Y/AI
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M!HB8#NO_F$?003#4VA^Y MF![<#)=N?"MJ?. ,V]3<P+,%I)BN+XWGP"G4E
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M:@;<TE)1<OSNG:MT565!PK%/1C))Q\(U7_875;%<JSP_[SCH<V2@7&LNU*/
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MHW5[+8'",OM!2R]ETXR[=NIYW/4?8C>V&:$GDQ!-J7_=9-)JK%YLU=UXM'Z
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MX_.E9J\ES'(U?>]%7=.3[3P?:9G@<EBORLD6I1JQEK%<9G@8<X[T/CGR (2
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M9WY(=4".N6S\\KZ4/MV[!N.LS'0*_(OE;300IB#?!KE-*GA<%Y.%+*9DWC\
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M-@7*JT!K9+TY^U??C_PYE"HKZV=*8!(>XZ/-K^G]]N$DHAH\GJ IN*JA&97
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M,5VM^Y+9IVD+ +;(D!UX1]=]%&_'>E[B%N3OE=(! X]7BC$'(.T#T$+#'V*
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M/&0G'_#+/CZ &1*LO;PF NG[?%Q5T,&_;.[WO3Z=%;H5C?/>DI6RYP-^UZ
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M4EVFS:U;,T4.0;J$U\ J,3,'E. KA$U);A1'F"V'!%Z/3.S@ V0X,"\ DP_
M=@C-S9W%LHQ:M#;C!N9AC,+H'L74Q9U;<82G6(=A>K3'0$BNY-<DO'HW$P(I
MTI"V+GZYF>!8YMI4>_/%5?M/-A]]C=7N6$7GP'>H\*XA3:G@.(P9'[#O*T23
MUM)WW$GBW1%X8@.Q12*@4'B R@,5JG*=/-'E*PO4VT.^7!.E5VSUC<53+0I
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M%0!T&^3HX#E7&:%],;?TN,X3<VN6 _-YG]]_='.;='H4K&M6]Z[PR)$WUTP
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MNO=[N'F;9%Q7'[KZ"9E0_L4EY['[DCKE/>DRL)"0 C*=,-2XV*6@]/;K-NJ
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ML/Z"9;(Z^@E&D(V92Q7#?)& AACF0HW!\3,EQI])>HU58P20WS+<(5L T<P
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MBDHNJ'Q7?X]:90>?J_!].IV3U_PFB.D4X/'V]!?[E:S[X4Y1'WA9Z>/D_0C
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M*AH/Y+UD*8FD0>X45S7=/S#'&4?+I6  X4@,6HVGUC86W,NA+[+#:=LI'D=
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MQD7#WOEVMX^^ZL+(YQRL+!&_T\5;X=A-ZG& 'IL+M#%CT:ZADSF<+%JKXMB
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M*$BP&U#+/I%%%2-P=Z:[IUOM[G^7;'FG\I='9OMH)PC 5!)X@"W<B96B<=Z
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MFU<OM'7<)N+,WA]H,W,Y;&?M(9<L2(OJ=D$N7!2HDEW/OC:@;:/"'+\*'V5
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M)*O-WRZDKXS6XX 1/@FX1(Z?5Y7GR625@Y]A\DS;%0C/;%@3GNF2'AG(_I9
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M'S0D5EE=6C2*!7.,]LTN G>B#_-4@);N"8>'1"7-K6&<NC&&,_FB%^HZH2L
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MI!/O&%%P4#P<1TZBHBG04'?G_F'Q5ISG6Z%9)&=I!]3;8ZUIOD0T(6V"*/;
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M3;ZY)X&U.)/YEU"_JIK26@O$5UBME(6;8!_? .I7_0T5/* "J?825,3:D-T
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M;XELN/ 4-E,"*_C;H=[?<2=%7O24]OD5*@PNM,=(/Q'V>J\^E< V0<)=4 >
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M;W&Q%,B D\J,N!W;N1F\-103(8=UZL:K UYYW!(;SAI]*06$2$SU';61%V-
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M+]F?B%)Q/"QR=1C)V^E.&K0QJYF[EO^-.+6ATAF)7!<.0JSRHJ"V2;@J-)5
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M]"KBUMC6@.MRQ+D!CCXOS4QH4P4C&M%S. 2R-DDT'JD!7.Q$HVLF'%_YO!3
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M])AJ']:<M;:@O)M-(L15&PR9B; 1FRK>?958?QR-ET"4O56-'Q; 1CHY2V#
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MS*+&@>0\N0&S$-9$AZ\4>'.\Y_)8&J)];#M;["X3&L?.,X.A*VFG [/Y<3>
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M$B?475>E(,.8JWES2[(.+(#[]Y8FG \KK.@5WN3VA:WAWRK;_>I<8!@BZA]
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M%#Q\=_5'_!4K&IO'>+VZX^B4KM0H6G\M#2:'?;$-5FFP#^<0!N%M)UV^8 C
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M9#KFWH-/>H1>T#L*!M%4M*QQ?9<)[N]HZNOODJ[! HBQ$AS6&2[C:N[SW3]
M@QMK-?G2*7<J3?6?]C0R)[&S>XP>OYY.N\X-VO(Z7<<ZAY^"7.TDO5F8@T\
M1#?C]MB^9J[ WM5 !E\0AZ98:FQ%?%^,@2YH34Z;SA7<[V;:OB$@FP<(WN,%
M92]>69&Z!>]XXI_(M).L 9$M@\^C50.T?6TW%IL_/=\-/2&#@& C?%PZ"6ZH
MD]VVDYK@G)$>; [-F>^*K;:)F;Z\0-37<E!,*''C.CV'A+?(JMBYDLB;< S@
MRW=JJMFCX:R-3L@C*81.Q#.IVA*UJO&U95?B+W824YC#K@G/-<OT>1H8V2P2
M1K"S&3149%E+""L7)!C)<I8CMU)>*Q P0B]CRSLDXZW;""P]DSD#G'Z?/>:
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MT)&!GGPO_,YK7/RBC_-\K= %[X"1OT&86Y!EC*T$WD_H#$SP3S#?69V31*.
M8M/SPOMFP9J?(T0*63YU:MMO?&?PM6H]&I!A)QTP.V#KD<)&UD3L0R1622C=
M.&[8L!'*N82JLQAL?7VJ<6E>@HDU[D!Y"4Q8 W*0AKEE6*X1LCH6;(T5][<2
MCGW-:,;-=ST&=U%E"^B43NC"-GR'[6>NY9S,D!<8B8@*'R ?KR/+3?IZ[DN1
M5J5<*S.\UXXW)NV)MI,2["0NA+PO!O,T!-D&<\7]:ROPQ[(9TKE<)R-+(9Z)
M'47-37;2M#W8LAK4"=#DCHIH"H#USG/D7E29L6*M7#N<-^8)?T8O?WY;=;F=
MY B@_@A9#@=;DE#R*HP_LP:-S8&(< B6B7$FI+\N&NJR$"#E"='W^7%'*=C,
M0&+6#;:[3!K< #'G$ [<%=*+156.3>1T4:6X?]CJP7/70)_5!S<P%R.:X_Q5
M"=&N!-(PGZ#.!V(T>$^U[7)R(EU%9:(]304Q4;82?YH;]A'BJ!#.W-5'64,[
M3BX86A+0(/70#$IC<&<BOJ6'X%J:.T%,.,"7\)=RO1DL#AB D-,67BN3_DKG
M^ANQX$+G"-Y.."-"G"EUP=N+5K=*DI&F7Q-76(H07;JC %\5Q9VC6%.8Y\7*
M"/<ZRC(]C[5&OH_N*4\]=(-/>.&&)[K7Z3*"9]_%'^E&-##I>QKP5^';MENG
MV$G/?[*3^O;B3SXF7QF"TX/T LPC 9],<+WQ,T:7EOCOG3<A?3X1DNRD/!%R
M)6F)F^IH30-K.A:*B+*'H$Q\#:I2F+.>1H!1Y<ZI-N=%E&4-LG.@28SQ5D84
MX8C+,LN>2ATEW7- <2DWV#B^/>L6>N%]<$'/%AP-^FJT$%=&(L3A@#G"!EDV
MA&R3 5\9YEZN9-+!+>M:P(>SV=,8?I>Q-:<M1^H[I Y<EP/,N;P-YU*?!YK8
M"O-XWIXGDH!#>A&9JU)"8Z1S7]*0+&PSHA+XI\)T)75!*V\%8FV""Z63;=]!
MB31M)>XRFH9XB4>Q$8K_>:*CA6Z[-*33QEJ&VE>:9Q PC\I<P%>/"!3JB2]I
MU=32<B TT#.3B7&.+)696-,3WD1$:GG!]Y ETK-,44 F/AV<;HK(_ZHL8]IV
MJY-1!@)$N$L<VI,I"=;#,^&&3Y/H,[A^34<GW#*PIG,#E>R:V(%>(\T)B!N[
MWVF]F22<RN4HSD\0(P??;-&L=#Z\65+7,E1 "ZVJ;1U:M^:5\:&E.S7N1<YQ
M,8#E=7C]*OR$3)_#1L+W6A/@AGG^G*Y02T5'^/MH2C^!89T.-\BJ98H$N@.A
M52 E[+2>G5XERJU5*=DN +I?$[VPS=Q4BD0JJ624G)^D<^&RY4U]QB3^VA9L
M#&+:C)3PI[7^!GTM2M>681[>N,N/M@I9W+I%)LL%E-R?9AT/O#]$\ID0"#40
MOK10*9J(C3?D%7 41;-M(LSI,++V(U0@/P 3R#^O>R$J3!^B3P>51MG)4'GM
M_K,!F?Y11Q];&SJB?< \9 >L43\KQR>*T#Y\XF@V)4$,TE\]L'[ VP4VHTXJ
M6E5L?PCZ_3K?]>!=7DPY8,N97N #ZW+^DX&]Y=&@3D7U0JCEL!@4AX&R&YW/
MN5^0QS64<5-9R-7"ZTJC>.H>[O?F38CHL)TT83LA[1H1$B+4!MZW1,]]LE22
M:-!UI311%Z&T$TNJTY@<]P/\&6CA??&Q\ZP,;/.-EZX_KRJ_^I*YJ$WB9(JB
MRX\^&BA9\^6]:]P 9=B:?8_:U8)D[HT&.+PK:M4;-I+&*[8L)T9/F$D#%]9_
M92?5./;?,^@ZZRP7B07")U4?,0U ]V%/S,D(91_FKFB )^..7)V2.J4#7P$Z
MABV?@.OHYI6T,6 X!"43V,<DRXJ>;;O BT-]E=INL?[1EC>J<YXC00JA*\\/
M%;T9+6GM.(OH;K4L'GXVC?VLFZ5EX9,/$Q:/3YXOHQ">X\ R?3:^.I+W80U[
M].S=C)H&-Z.#@0U83 C[FPOO*&/?I8)8ZVR>GQ"L7WDZS599J[;ZVB+[ )G0
M]5]D/13:T%OK?CO)7+;-*:SJ59WHCNR'(,PUW/+6=DI&V$FFK(K6I 9+"P=@
MZS["RJ9Q7_ V6U?S=E2"1Y3C_-DB#]X:E),^N%\S%^4,I**L]T,-/JF*"/;)
M)'4-EQ+A&XZTIVOO?,O]I/T&7%S[)QS7_E?[W]8<D5)"(1FC)^3J2]C(-G-7
MGU[4)'OVQO+%J*8@S8W0;?@XTXLK4,B0&JD#<+!"3=J )N%)_N*V*G8_)Q=R
M9[@9G6257+B).;,-JKJ15'[Q'<X [7:7KCDU#DY,L'4\W>!PT$[2?,V^C*>Q
MD;]I,._#UD_P)[*:+RNLX7##>\QQ+VG3,&_K!NY1LCOO"V3_672.'FX\@KFB
MIHU?+_%5,GVKGS!2TI#"H-HG3'KOPDO<ONWM_;P@U*DI>A9HU$W'MIN^'?1.
M2VW<_DI& %[,M<8R$]7UCU;NR;-=@#]E:4T-W6,TO*BKV%H@+L'B0-S*6D@A
M'/NH!.. R^@*HV<%(E>FOWK8T\A_UY/I 0IHZ?S9NW;3LR7.W\=;NF>U#J[C
M*''WK^711)B-NG8IZ*WF9\*,Z9"^AF )T  '+3>9L6D7&M;H!BY:?4#A^I;"
M;<C9@5*1(C%8Q:1HANILY ;I>-!L]0=.2GP2D)DX>2('2>!-^/,XFB>?]-)U
M%]DIGM*]Y*X4"3\NB4%K]'AF \8#B<0*$02T01F ^P GU&S9@_3T)U@9O%6H
M8Q;CT/>=6!A89N)TIAH\+Z*^'R'J)C^.,V]#&LLTODPATZ88J?7E!VI_JT/Z
MMCW!IQ+\* :QD^0!7L+CR1QO[MI&\O6: C'4LCS7\35>]=;VTUNR9:)-R'.T
MCN&KH$IS?QIB[+.&RF4.DC&QAF:=ZUNO^AQ47# 4W&7VX&T%64E$')&^6X\8
M0 'JQT8Y)X69L]&EY27<3> $2)"_";K4&Y$H@:*W;Q@+$=BDBXY/)'#>>(*Q
MIQ.K'\0@O._X!<2'V2"..1];@-*QQ>+<[@#@:*A&* +5,0Q*^S[01,^!;N/E
MR%)Y!#@J\R;(TX.S\\%LO3#]?(A&27=>E5',C9'7+A6@H095HSJ/NN9E%0P6
M<3 ?C75/;_<BL %)P"<)#>).>5/+RU7X'('QMSKK<@+_Z'<."U8.4)14;Z],
M628CQ)J$?5H+'&_V:8W1\P6'#)%VD@M7IAAF4MH8FV^"A(VW[R&#^$+$/'QQ
M@\-'H!"?]*"8K]62^T,13Q4^>:%13>:V6AY=D-?^)D9ENQ%E37K%RN:H4 5S
M);I*9F YA5#DL#.79; F2,<C$\H,T#CN55-#Q$Y5IIG!,@Q\:OX0I>0GO1W
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M*>)NGA^"7S1Z)PC'<><T15-V8S&&>D^SXESM\YJ\*@+SXS>>C-D KV/.)US
M-Y"^Z+PCYKZT"Y]4?16$6LZCPJ8$H9;3R+[]8=$ZI$<N&JO%9E8"E9$U\Z5N
M2G6DT\48I9WD(?$S69Y(G%&'C^L066YU,RMK>%OT'@"'MS-<*?F2=<SC-Q)$
M3ZH)#V8(P-SK<)>YHT^WB"DMP9<=$%4.-QV1+L7V@.8CEWQS>&P]O;-5SA^/
MWBQ'+FQMV]LJ9LQ+1#?V-<FF2;U[J50-=KB4?4=FD$W>]2I"G?L.(O%D+D3G
M"PUF%V[=?:^RO+MDX%N(S20&-FZ(Z.<4WBKUM'W-G\8-LEP$L6B"ZJACOK]H
M++U)EX6/;^$%& <"[X^,U^7[ZR8_B[>3G/E^V(X+P9K6AC50+H.= .6NM#G(
M ];$9B9'K>86\%AIA@H'-@G/6B#^40@6E6&>0DL$T<\'HF/%EG,(7:7V(KC[
MAP_0571"CQN%B%AN=H/WRQK%(%R&?$5\M=U.FJ13TK)D>RDRY'85O3^T%$Y,
M*^X_7],EJY3D035X';$H_, :S+/0LIL%%O7#2-#?[PSBKF_[L8CP@R?"#</8
M@L9BRQ>G+1??0R%L"0VPQA#?3UC5<HA8UE9\([(8^F4*7-,W9/R]?W5 S0.[
M"5ZYB# BV7$[R1V*HQV#G?&5V";BOY-X:\$')ET^1&;0T""5#"GD9ID;F6[$
M)?I]ZFS"@1C5[L0,6,9Z)C%)J@\N;^'([D@"]Z5<Z97%M55<O?,^F7<E%S\,
MZ84ZY!#4* )^90/!UO?YCY@NMO/X;)XG)Q,?KV$NP5:B93F\0P8UA:Y@95&I
M(.<RF(#WJ9C4EL&"Z=ABU"2:R6.V?X[-N=0GHC"@=Z7HV?QNYIW1N6^H0W]P
M'(S]-Y^MYSO8RJ%]YER1.R\.66L0#!!<U0@UB8G(B7PERA8Y8HZHP-"3AR\
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M[F>,*4THLQS7) E/A-&JA,1\XYC+P/4C2+%*YL*?'T==#)*- T[A;7>P@TB
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M!DZZEEH!I?=+0O?IKV/T (7.'10;/\.GH_M/Z^L=&HZRB%69.37H$O>TDKH
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M-]%3[CH*:K>"N+44HN:5_EW\35]S[P=4=9X! G_59)B80_1-36O(C#JPP]Q
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M;F(M,C R,3$R,S$N>'-D4$L! A0#%     @ K(MX5""]C19G#P  $=T  !4
M             ( !LN4" &5T;F(M,C R,3$R,S%?8V%L+GAM;%!+ 0(4 Q0
M   ( *R+>%2,>V)#K2H  );V @ 5              "  4SU @!E=&YB+3(P
M,C$Q,C,Q7V1E9BYX;6Q02P$"% ,4    " "LBWA4>1/6# !O   9K 8 %0
M            @ $L( , 971N8BTR,#(Q,3(S,5]L86(N>&UL4$L! A0#%
M  @ K(MX5+ 5?)?100   /P$ !4              ( !7X\# &5T;F(M,C R
M,3$R,S%?<')E+GAM;%!+ 0(4 Q0    ( *R+>%2J6]6UAP(   8(   0
M          "  6/1 P!E=&YB+65X,C,Q7S<N:'1M4$L! A0#%     @ K(MX
M5"G)JEQ-"0  S%(  !               ( !&-0# &5T;F(M97@S,3%?.2YH
M=&U02P$"% ,4    " "LBWA4DN:;5W@)   L5   $               @ &3
MW0, 971N8BUE>#,Q,E\V+FAT;5!+ 0(4 Q0    ( *R+>%1!>,UMS08  ,PU
M   1              "  3GG P!E=&YB+65X,S(Q7S$P+FAT;5!+ 0(4 Q0
M   ( *R+>%2=-O(&@!4  #V$   /              "  37N P!E=&YB+65X
M-#-?."YH=&U02P$"% ,4    " "LBWA4? WA%$'! P"O5@0 %@
M    @ 'B P0 9V(R:S%P=&QK9S5V,# P,# Q+FIP9U!+ 0(4 Q0    ( *R+
M>%1):.D+GU\$ .A>!0 6              "  5?%!P!G8C)K,7!T;&MG-78P
M,# P,#(N:G!G4$L! A0#%     @ K(MX5//>L5+B1   L8,  !8
M     ( !*B4, &=B,FLQ<'1L:V<U=C P,# P,RYJ<&=02P$"% ,4    " "L
MBWA4MK=N'783   ]%@  %@              @ % :@P 9V(R:S%P=&QK9S5V
M,# P,# T+FIP9U!+ 0(4 Q0    ( *R+>%0FU'WW9<0% ,6X!@ 6
M      "  >I]# !G8C)K,7!T;&MG-78P,# P,#4N:G!G4$L! A0#%     @
MK(MX5 ":4HZ)U@( PL,$ !8              ( !@T(2 &=B,FLQ<'1L:V<U
M=C P,# P-BYJ<&=02P$"% ,4    " "LBWA4A<NX8(=L   M=0  %@
M        @ % &14 9V(R:S%P=&QK9S5V,# P,# W+FIP9U!+ 0(4 Q0    (
M *R+>%0@9$=BK@$# $\,!  6              "  ?N%%0!G8C)K,7!T;&MG
B-78P,# P,#@N:G!G4$L%!@     3 !, Y 0  -V'&     $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
